Citrus Sinensis ID: 043702
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 711 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LFH9 | 715 | L-type lectin-domain cont | yes | no | 0.947 | 0.942 | 0.717 | 0.0 | |
| Q9LYX1 | 711 | L-type lectin-domain cont | no | no | 0.933 | 0.933 | 0.668 | 0.0 | |
| Q9FHG4 | 681 | Probable L-type lectin-do | no | no | 0.893 | 0.932 | 0.496 | 1e-176 | |
| Q9FHX3 | 691 | L-type lectin-domain cont | no | no | 0.853 | 0.878 | 0.398 | 1e-114 | |
| Q9M2S4 | 684 | L-type lectin-domain cont | no | no | 0.801 | 0.833 | 0.407 | 1e-112 | |
| Q9LXA5 | 651 | L-type lectin-domain cont | no | no | 0.803 | 0.877 | 0.383 | 1e-106 | |
| O81291 | 669 | L-type lectin-domain cont | no | no | 0.805 | 0.856 | 0.385 | 1e-104 | |
| O80939 | 675 | L-type lectin-domain cont | no | no | 0.832 | 0.877 | 0.376 | 1e-104 | |
| O81292 | 674 | L-type lectin-domain cont | no | no | 0.797 | 0.841 | 0.379 | 1e-103 | |
| Q9M345 | 677 | L-type lectin-domain cont | no | no | 0.783 | 0.822 | 0.384 | 1e-102 |
| >sp|Q9LFH9|LRK81_ARATH L-type lectin-domain containing receptor kinase VIII.1 OS=Arabidopsis thaliana GN=LECRK81 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 971 bits (2510), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 497/693 (71%), Positives = 579/693 (83%), Gaps = 19/693 (2%)
Query: 8 ILTSLNLSLVFCLFVINNAVITISTATEFDFGTLTLASLKLLGDAHMNNGSVRLTRDVTV 67
+ S +S++ C F N A T T+FDF TL +++LKLLGDA ++NG V LTRD++V
Sbjct: 3 LFLSFFISILLCFF--NGA-----TTTQFDFSTLAISNLKLLGDARLSNGIVGLTRDLSV 55
Query: 68 PYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLNPSSIGAGLAFVITPDGEQVGS 127
P GAGK LYS P+RFR PGTH P SFS+FFSFSITN+NPSSIG GLAFVI+PD +G
Sbjct: 56 PNSGAGKVLYSNPIRFRQPGTHFPTSFSSFFSFSITNVNPSSIGGGLAFVISPDANSIGI 115
Query: 128 AGGSLGLLDEKGAGLGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDL 187
AGGSLGL G+G FVAVEFDTLMDV+F DIN NHVG D+N +VS+ +L T+N+DL
Sbjct: 116 AGGSLGLTGPNGSGSKFVAVEFDTLMDVDFKDINSNHVGFDVNGVVSSVSGDLGTVNIDL 175
Query: 188 KSGDLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGS 247
KSG+ +NSWIEYDGLTR FN+SVSYSNLKPKVPILSF LDLD+YVNDFM+VGFSGSTQGS
Sbjct: 176 KSGNTINSWIEYDGLTRVFNVSVSYSNLKPKVPILSFPLDLDRYVNDFMFVGFSGSTQGS 235
Query: 248 TEIHSIEWWSFSSSFESNSGTGSGSAPPPPTASLMNPTANSVKSPPP-------SLAPSG 300
TEIHSIEWWSFSSS S GSGS PPP A+LMNP ANSVKSPPP S P
Sbjct: 236 TEIHSIEWWSFSSS--FGSSLGSGSGSPPPRANLMNPKANSVKSPPPLASQPSSSAIPIS 293
Query: 301 SSTTQKSSKSSSCHNQLCKQGAGAVAGVVTASAFF-AIFAGVLIWFFSKRYKHVKKSESF 359
S+T K+S SSSCH++ CK+ G +AGVVTA AFF A+FAG L W +SK++K V++S+SF
Sbjct: 294 SNTQLKTSSSSSCHSRFCKENPGTIAGVVTAGAFFLALFAGALFWVYSKKFKRVERSDSF 353
Query: 360 TSDIIRMPKEFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQG 419
S+II+ PKEFSY+EL++ TK FN +RIIGHGAFG VY+GILP+ GDI+AVKRCSH+SQ
Sbjct: 354 ASEIIKAPKEFSYKELKAGTKNFNESRIIGHGAFGVVYRGILPETGDIVAVKRCSHSSQD 413
Query: 420 -KDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPH 478
K+EFLSELSIIG+LRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFE+R LPW H
Sbjct: 414 KKNEFLSELSIIGSLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFESRFTLPWDH 473
Query: 479 RSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDA 538
R KILLGVASALAYLH+ECENQVIHRDVK+SNIMLDE FNA+LGDFGLARQ+EHDKSP+A
Sbjct: 474 RKKILLGVASALAYLHRECENQVIHRDVKSSNIMLDESFNAKLGDFGLARQIEHDKSPEA 533
Query: 539 TVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEI-TGVGKVGVASNL 597
TVAAGTMGYLAPEYLLTGRA+EKTDVFSYGAVVLEV SGRRPIEK++ VGV NL
Sbjct: 534 TVAAGTMGYLAPEYLLTGRASEKTDVFSYGAVVLEVVSGRRPIEKDLNVQRHNVGVNPNL 593
Query: 598 VEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657
VEWVW L++EG++ AAD+RLEG+FDE EM RVL+VGLACSHPDP RPTMR VVQML+G
Sbjct: 594 VEWVWGLYKEGKVSAAADSRLEGKFDEGEMWRVLVVGLACSHPDPAFRPTMRSVVQMLIG 653
Query: 658 EAEVPIVPRAKPSMTFSTSHLLLSLQDSVSDCN 690
EA+VP+VP+++P+M+FSTSHLLLSLQD++SDCN
Sbjct: 654 EADVPVVPKSRPTMSFSTSHLLLSLQDTLSDCN 686
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LYX1|LRK82_ARATH L-type lectin-domain containing receptor kinase VIII.2 OS=Arabidopsis thaliana GN=LECRK82 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 872 bits (2253), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 457/684 (66%), Positives = 548/684 (80%), Gaps = 20/684 (2%)
Query: 33 ATEFDFGTLTLASLKLLGDAHMNNGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTHTPA 92
AT FD GTLTL+SLKLLGDAH+NNG+++LTR+++VP AGKALY KPV+FR P T +PA
Sbjct: 34 ATRFDLGTLTLSSLKLLGDAHLNNGTIKLTRELSVPTSTAGKALYGKPVKFRHPETKSPA 93
Query: 93 SFSTFFSFSITNLNPSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAGLGFVAVEFDTL 152
SF+T+FSFS+TNLNPSSIG GLAFVI+PD + +GS GG LGL +E G+G GFVAVEFDTL
Sbjct: 94 SFTTYFSFSVTNLNPSSIGGGLAFVISPDEDYLGSTGGFLGLTEETGSGSGFVAVEFDTL 153
Query: 153 MDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLTRAFNISVSY 212
MDV+F D+NGNHVGLDLN++VS V +L +++DLKSG+ VNSWI YDG R + VSY
Sbjct: 154 MDVQFKDVNGNHVGLDLNAVVSAAVADLGNVDIDLKSGNAVNSWITYDGSGRVLTVYVSY 213
Query: 213 SNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGSTEIHSIEWWSFSSSFESNSGTGSGS 272
SNLKPK PILS LDLD+YV+D M+VGFSGSTQGSTEIHS++WWSFSSSFE +S +
Sbjct: 214 SNLKPKSPILSVPLDLDRYVSDSMFVGFSGSTQGSTEIHSVDWWSFSSSFEESSES---- 269
Query: 273 APPPPTASLMNPTANSVKSPPPSLAPSGSSTTQKSSKSSSCHNQLCKQGAGAVAGVVTAS 332
M + + + + SSSC N+LCK+ AVAGVVTA
Sbjct: 270 ------PPPMPNSPPPSSPSSSITPSLSTVRRKTADPSSSCRNKLCKKSPAAVAGVVTAG 323
Query: 333 AFF-AIFAGVLIWFFSKRYKHVKKSESFTSDIIRMPKEFSYRELRSATKCFNANRIIGHG 391
AFF A+FAGV+IW +SK+ K+ +KSES S+I++ P+EF+Y+EL+ AT CF+++R+IG+G
Sbjct: 324 AFFLALFAGVIIWVYSKKIKYTRKSESLASEIMKSPREFTYKELKLATDCFSSSRVIGNG 383
Query: 392 AFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEI 451
AFGTVYKGIL +G+IIA+KRCSH SQG EFLSELS+IGTLRHRNL+RLQG+C EKGEI
Sbjct: 384 AFGTVYKGILQDSGEIIAIKRCSHISQGNTEFLSELSLIGTLRHRNLLRLQGYCREKGEI 443
Query: 452 LLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNI 511
LL+YDLMPNGSLDKAL+E+ + LPWPHR KILLGVASALAYLHQECENQ+IHRDVKTSNI
Sbjct: 444 LLIYDLMPNGSLDKALYESPTTLPWPHRRKILLGVASALAYLHQECENQIIHRDVKTSNI 503
Query: 512 MLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVV 571
MLD FN +LGDFGLARQ EHDKSPDAT AAGTMGYLAPEYLLTGRATEKTDVFSYGAVV
Sbjct: 504 MLDANFNPKLGDFGLARQTEHDKSPDATAAAGTMGYLAPEYLLTGRATEKTDVFSYGAVV 563
Query: 572 LEVASGRRPIEKEITGVG-KVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRV 630
LEV +GRRPI + G + G+ S+LV+WVW L+REG+LLTA D RL +F+ EM RV
Sbjct: 564 LEVCTGRRPITRPEPEPGLRPGLRSSLVDWVWGLYREGKLLTAVDERLS-EFNPEEMSRV 622
Query: 631 LLVGLACSHPDPLARPTMRGVVQMLVGEAEVPIVPRAKP--SMTFSTSHLLLSLQDSVSD 688
++VGLACS PDP+ RPTMR VVQ+LVGEA+VP VP AKP SM+FSTS LLL+LQDSVSD
Sbjct: 623 MMVGLACSQPDPVTRPTMRSVVQILVGEADVPEVPIAKPSSSMSFSTSELLLTLQDSVSD 682
Query: 689 CNGMI----TLSSSSSEND-FIHG 707
CN ++ T S SSSE+D FI G
Sbjct: 683 CNEVLAPISTTSCSSSEHDIFIVG 706
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FHG4|LRKS7_ARATH Probable L-type lectin-domain containing receptor kinase S.7 OS=Arabidopsis thaliana GN=LECRKS7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 617 bits (1592), Expect = e-176, Method: Compositional matrix adjust.
Identities = 338/681 (49%), Positives = 443/681 (65%), Gaps = 46/681 (6%)
Query: 23 INNAVITISTATEFDFGTLTLASLKLLGDAHMNNGSVRLTRDVTVPYDGAGKALYSKPVR 82
++ + S F F + T+ +L LGD+H+ NG V LTR++ VP +G +Y+ P+R
Sbjct: 20 MSKPIFVSSDNMNFTFKSFTIRNLTFLGDSHLRNGVVGLTRELGVPDTSSGTVIYNNPIR 79
Query: 83 FRLPGTHTPASFSTFFSFSITNLNP--SSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGA 140
F P ++T ASFST FSF++ NLNP +S G GLAF ++ D + +GS GG LGL++
Sbjct: 80 FYDPDSNTTASFSTHFSFTVQNLNPDPTSAGDGLAFFLSHDNDTLGSPGGYLGLVNSSQP 139
Query: 141 GLG-FVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEV-DNLDTINVDLKSGDLVNSWIE 198
FVA+EFDT +D F+D NGNH+GLD++S+ S D L + +DLKSG + SWI+
Sbjct: 140 MKNRFVAIEFDTKLDPHFNDPNGNHIGLDVDSLNSISTSDPLLSSQIDLKSGKSITSWID 199
Query: 199 YDGLTRAFNISVSYSN-----LKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGSTEIHSI 253
Y R N+ +SY++ KP+ P+LS +DL ++N MYVGFSGST+GSTEIH I
Sbjct: 200 YKNDLRLLNVFLSYTDPVTTTKKPEKPLLSVNIDLSPFLNGEMYVGFSGSTEGSTEIHLI 259
Query: 254 EWWSFSSSFESNSGTGSGSAPPPPTAS-LMNPTANSVKSPPPSLAPSGSSTTQKSSKSSS 312
E WSF +S G P ++ L N + +SV + P + PS K
Sbjct: 260 ENWSFKTS---------GFLPVRSKSNHLHNVSDSSVVNDDPVVIPS--------KKRRH 302
Query: 313 CHNQLCKQGAGAVAGVVTASAFFAIFAGVLIWFFSKRYKHVKKSESFTSDIIRMPKEFSY 372
HN G G V+ A F V +F K++K VK + +++I +EFSY
Sbjct: 303 RHN--LAIGLGISCPVLICLALF-----VFGYFTLKKWKSVKAEKELKTELITGLREFSY 355
Query: 373 RELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS-QGKDEFLSELSIIG 431
+EL +ATK F+++R+IG GAFG VY+ + +G I AVKR HNS +GK EFL+ELSII
Sbjct: 356 KELYTATKGFHSSRVIGRGAFGNVYRAMFVSSGTISAVKRSRHNSTEGKTEFLAELSIIA 415
Query: 432 TLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARS----PLPWPHRSKILLGVA 487
LRH+NLV+LQGWC+EKGE+LLVY+ MPNGSLDK L++ L W HR I +G+A
Sbjct: 416 CLRHKNLVQLQGWCNEKGELLLVYEFMPNGSLDKILYQESQTGAVALDWSHRLNIAIGLA 475
Query: 488 SALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGY 547
SAL+YLH ECE QV+HRD+KTSNIMLD FNARLGDFGLAR EHDKSP +T+ AGTMGY
Sbjct: 476 SALSYLHHECEQQVVHRDIKTSNIMLDINFNARLGDFGLARLTEHDKSPVSTLTAGTMGY 535
Query: 548 LAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHRE 607
LAPEYL G ATEKTD FSYG V+LEVA GRRPI+KE V NLV+WVW LH E
Sbjct: 536 LAPEYLQYGTATEKTDAFSYGVVILEVACGRRPIDKEPESQKTV----NLVDWVWRLHSE 591
Query: 608 GRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEAEVPIVPRA 667
GR+L A D RL+G+FDE M+++LLVGL C+HPD RP+MR V+Q+L E E VP+
Sbjct: 592 GRVLEAVDERLKGEFDEEMMKKLLLVGLKCAHPDSNERPSMRRVLQILNNEIEPSPVPKM 651
Query: 668 KPSMTFSTSHLLLSLQDSVSD 688
KP+++FS LSL D VS+
Sbjct: 652 KPTLSFSCG---LSLDDIVSE 669
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FHX3|LRKS6_ARATH L-type lectin-domain containing receptor kinase S.6 OS=Arabidopsis thaliana GN=LECRKS6 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 413 bits (1062), Expect = e-114, Method: Compositional matrix adjust.
Identities = 266/667 (39%), Positives = 362/667 (54%), Gaps = 60/667 (8%)
Query: 36 FDFGTLT------LASLKLLGDAHMNNGSVRLTRD------VTVP-----YDGAGKALYS 78
DF TL+ L +L L GDA + ++ LT+ VT P G G+ALY
Sbjct: 19 LDFPTLSHRFSPPLQNLTLYGDAFFRDRTISLTQQQPCFPSVTTPPSKPSSSGIGRALYV 78
Query: 79 KPVRFRLPGTHTPASFSTFFSFSITNLNPSSIGAGLAFVITPDGEQVGSAGGSLGLLDEK 138
P++F P T+T ASFS FSFSI G G AF+IT + + + G LGL +
Sbjct: 79 YPIKFLEPSTNTTASFSCRFSFSIIASPSCPFGDGFAFLITSNADSFVFSNGFLGLPNPD 138
Query: 139 GAGLGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIE 198
+ F+AVEFDT D DIN NHVG+D++S+ S + + DLKSG + +WIE
Sbjct: 139 DS---FIAVEFDTRFDPVHGDINDNHVGIDVSSIFSVSSVDAISKGFDLKSGKKMMAWIE 195
Query: 199 YDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQG-STEIHSIEWWS 257
Y + + + V YS +KP P+LS +DL V ++M+VGFS S G + +H +E W
Sbjct: 196 YSDVLKLIRVWVGYSRVKPTSPVLSTQIDLSGKVKEYMHVGFSASNAGIGSALHIVERWK 255
Query: 258 FSSSFESNSGTGSGSAPPPPTASLMNPTANSVKSPPPSLAPSGSSTTQKSSKSSSCHNQL 317
F + F S+S L+ + V P + G + L
Sbjct: 256 FRT-FGSHSDAIQEEEEEKDEECLV--CSGEVSENPKEIHRKGFNFRVTVVGLKIPVWSL 312
Query: 318 CKQGAGAVAGVVTASAFFAIFAGVLIWFFSKRYKHVKKSESFTSDIIRMPKEFSYRELRS 377
A V ++ A F++ G K + + S ++RMP S E++S
Sbjct: 313 LPGLAAIV--ILVAFIVFSLICG---------KKRISEEADSNSGLVRMPGRLSLAEIKS 361
Query: 378 ATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRC--SHNSQ-GKDEFLSELSII-GTL 433
AT FN N I+G GA TVY+G +P G + AVKR H Q ++ F +E + + G L
Sbjct: 362 ATSGFNENAIVGQGASATVYRGSIPSIGSV-AVKRFDREHWPQCNRNPFTTEFTTMTGYL 420
Query: 434 RHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLP--------WPHRSKILLG 485
RH+NLV+ QGWC E E LV++ +PNGSL + L + S P W R I+LG
Sbjct: 421 RHKNLVQFQGWCSEGTETALVFEYLPNGSLSEFLHKKPSSDPSEEIIVLSWKQRVNIILG 480
Query: 486 VASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHD---KSPDATVAA 542
VASAL YLH+ECE Q+IHRDVKT NIMLD FNA+LGDFGLA EH AT+ A
Sbjct: 481 VASALTYLHEECERQIIHRDVKTCNIMLDAEFNAKLGDFGLAEIYEHSALLAGRAATLPA 540
Query: 543 GTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVW 602
GTMGYLAPEY+ TG +EKTDV+S+G VVLEV +GRRP VG G LV+ +W
Sbjct: 541 GTMGYLAPEYVYTGVPSEKTDVYSFGVVVLEVCTGRRP-------VGDDGAV--LVDLMW 591
Query: 603 SLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEAEVP 662
S G++L AD L +FD EM RVL+VG+ C+HPD RP ++ V+++ GEA +P
Sbjct: 592 SHWETGKVLDGADIMLREEFDAEEMERVLMVGMVCAHPDSEKRPRVKDAVRIIRGEAPLP 651
Query: 663 IVPRAKP 669
++P +P
Sbjct: 652 VLPARRP 658
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M2S4|LRKS4_ARATH L-type lectin-domain containing receptor kinase S.4 OS=Arabidopsis thaliana GN=LECRKS4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 404 bits (1039), Expect = e-112, Method: Compositional matrix adjust.
Identities = 257/630 (40%), Positives = 343/630 (54%), Gaps = 60/630 (9%)
Query: 57 GSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLNPSSIGAGLAF 116
G++RLT T G A YS P+RF+ G + SFST F+ ++ + G GLAF
Sbjct: 50 GAIRLT---TETQRVIGHAFYSLPIRFKPIGVNRALSFSTSFAIAMVPEFVTLGGHGLAF 106
Query: 117 VITPDGEQVGSAGGS-LGLLDEKGAGLG--FVAVEFDTLMDVEFSDINGNHVGLDLNSMV 173
ITP + GS LGLL+ F AVEFDT+ D+EF DIN NHVG+D+NSM
Sbjct: 107 AITPTPDLRGSLPSQYLGLLNSSRVNFSSHFFAVEFDTVRDLEFEDINDNHVGIDINSME 166
Query: 174 STE-------VDNLDTINVDLKSGDLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTL 226
S+ + N + L G ++ +WI+YD + ++ +S + KPK+ +LS+ +
Sbjct: 167 SSISTPAGYFLANSTKKELFLDGGRVIQAWIDYDSNKKRLDVKLSPFSEKPKLSLLSYDV 226
Query: 227 DLDQYVNDFMYVGFSGSTQGSTEIHSIEWWSFSSSFESNSGTGSGSAPPPPTASLMNPTA 286
DL + D MYVGFS ST H I W+F+ S E+ S SL
Sbjct: 227 DLSSVLGDEMYVGFSASTGLLASSHYILGWNFNMSGEAFS------------LSL----- 269
Query: 287 NSVKSPPPSLAPSGSSTTQKSSKSSSCHNQLCKQGAGAVAGVVTASAFFAIFAGVLIWFF 346
PSL SS ++ K S + + + V+ A++ F +
Sbjct: 270 -------PSLPRIPSSIKKRKKKRQSLILGVSLLCSLLIFAVLVAASLFVV--------- 313
Query: 347 SKRYKHVKKSESFTSDIIRMPKEFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGD 406
++ K + E + D P FSYREL+ AT F ++G G FG VYKG LP + +
Sbjct: 314 -RKVKDEDRVEEWELDF--GPHRFSYRELKKATNGFGDKELLGSGGFGKVYKGKLPGSDE 370
Query: 407 IIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDK 465
+AVKR SH S QG EF+SE+S IG LRHRNLV+L GWC + ++LLVYD MPNGSLD
Sbjct: 371 FVAVKRISHESRQGVREFMSEVSSIGHLRHRNLVQLLGWCRRRDDLLLVYDFMPNGSLDM 430
Query: 466 ALFEARSP--LPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGD 523
LF+ L W R KI+ GVAS L YLH+ E VIHRD+K +N++LD N R+GD
Sbjct: 431 YLFDENPEVILTWKQRFKIIKGVASGLLYLHEGWEQTVIHRDIKAANVLLDSEMNGRVGD 490
Query: 524 FGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEK 583
FGLA+ EH P AT GT GYLAPE +G+ T TDV+++GAV+LEVA GRRPIE
Sbjct: 491 FGLAKLYEHGSDPGATRVVGTFGYLAPELTKSGKLTTSTDVYAFGAVLLEVACGRRPIET 550
Query: 584 EITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPL 643
V +V+WVWS + G + D RL G+FDE E+ V+ +GL CS+ P
Sbjct: 551 SALPEELV-----MVDWVWSRWQSGDIRDVVDRRLNGEFDEEEVVMVIKLGLLCSNNSPE 605
Query: 644 ARPTMRGVVQMLVGEAEVPIVPRAKPSMTF 673
RPTMR VV L E + P P P+ F
Sbjct: 606 VRPTMRQVVMYL--EKQFP-SPEVVPAPDF 632
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LXA5|LRK91_ARATH L-type lectin-domain containing receptor kinase IX.1 OS=Arabidopsis thaliana GN=LECRK91 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 388 bits (996), Expect = e-106, Method: Compositional matrix adjust.
Identities = 251/655 (38%), Positives = 360/655 (54%), Gaps = 84/655 (12%)
Query: 43 LASLKLLGDAHMNNGSVRLTR-DVTVPYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFS 101
++ + GDA N G+V LT D T AG A Y K V PGT P+ FST FSF
Sbjct: 31 VSEIAYQGDARAN-GAVELTNIDYTCR---AGWATYGKQVPLWNPGTSKPSDFSTRFSFR 86
Query: 102 I--TNLNPSSIGAGLAFVITPDGEQV--GSAGGSLGLLD---EKGAGLGFVAVEFDTLMD 154
I N+ + G G AF + P Q+ SAGG LGL + + + V VEFDT +
Sbjct: 87 IDTRNVGYGNYGHGFAFFLAPARIQLPPNSAGGFLGLFNGTNNQSSAFPLVYVEFDTFTN 146
Query: 155 VEFSDIN-GNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLTRAFNISVSYS 213
E+ ++ +HVG++ NS+VS+ N + N + D+ I YD R N+SVS++
Sbjct: 147 PEWDPLDVKSHVGINNNSLVSS---NYTSWNATSHNQDIGRVLIFYDSARR--NLSVSWT 201
Query: 214 NLKPKVPI----LSFTLDLDQYVNDFMYVGFSGSTQGSTEIHSIEWWSFSSSFESNSGTG 269
P+ LS+ +DL + + + +GFS ++ G TE + + W FSSS E
Sbjct: 202 YDLTSDPLENSSLSYIIDLSKVLPSEVTIGFSATSGGVTEGNRLLSWEFSSSLE------ 255
Query: 270 SGSAPPPPTASLMNPTANSVKSPPPSLAPSGSSTTQKSSKSSSCHNQLCKQGAGAVAGV- 328
L S K G + G+
Sbjct: 256 --------------------------LIDIKKSQNDKK---------------GMIIGIS 274
Query: 329 VTASAFFAIFAGVLIWFFSKRYKHVKKSE------SFTSDIIRM--PKEFSYRELRSATK 380
V+ F LI F KR + KK+E S D+ R P++F+Y++L SA
Sbjct: 275 VSGFVLLTFFITSLIVFL-KRKQQKKKAEETENLTSINEDLERGAGPRKFTYKDLASAAN 333
Query: 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLV 439
F +R +G G FG VY+G L ++A+K+ + S QGK EF++E+ II +LRHRNLV
Sbjct: 334 NFADDRKLGEGGFGAVYRGYLNSLDMMVAIKKFAGGSKQGKREFVTEVKIISSLRHRNLV 393
Query: 440 RLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECEN 499
+L GWCHEK E L++Y+ MPNGSLD LF + L W R KI LG+ASAL YLH+E E
Sbjct: 394 QLIGWCHEKDEFLMIYEFMPNGSLDAHLFGKKPHLAWHVRCKITLGLASALLYLHEEWEQ 453
Query: 500 QVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRAT 559
V+HRD+K SN+MLD FNA+LGDFGLAR ++H+ P T AGT GY+APEY+ TGRA+
Sbjct: 454 CVVHRDIKASNVMLDSNFNAKLGDFGLARLMDHELGPQTTGLAGTFGYMAPEYISTGRAS 513
Query: 560 EKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLE 619
+++DV+S+G V LE+ +GR+ +++ G+V +NLVE +W L+ +G ++TA D +L
Sbjct: 514 KESDVYSFGVVTLEIVTGRKSVDRR---QGRVEPVTNLVEKMWDLYGKGEVITAIDEKLR 570
Query: 620 -GQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEAEVPIVPRAKPSMTF 673
G FDE + +++VGL C+HPD RP+++ +Q+L EA VP +P P T+
Sbjct: 571 IGGFDEKQAECLMIVGLWCAHPDVNTRPSIKQAIQVLNLEAPVPHLPTKMPVATY 625
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81291|LRK44_ARATH L-type lectin-domain containing receptor kinase IV.4 OS=Arabidopsis thaliana GN=LECRK44 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 381 bits (978), Expect = e-104, Method: Compositional matrix adjust.
Identities = 244/633 (38%), Positives = 348/633 (54%), Gaps = 60/633 (9%)
Query: 46 LKLLGDAHMN-NGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITN 104
+ +LG A + NG ++LT G A Y+KP+RF+ T +SFST F F+I +
Sbjct: 40 ISILGIATITPNGLLKLTNTTM---QSTGHAFYTKPIRFKDSPNGTVSSFSTTFVFAIHS 96
Query: 105 LNPSSIGAGLAFVITPDGE-QVGSAGGSLGLLDEKGAGL---GFVAVEFDTLMDVEFSDI 160
P I G+AFVI P+ GS LGL + G AVE DT+M++EF+D
Sbjct: 97 QIP--IAHGMAFVIAPNPRLPFGSPLQYLGLFNVTNNGNVRNHVFAVELDTIMNIEFNDT 154
Query: 161 NGNHVGLDLNSMVSTEV-------DNLDTINVDLKSGDLVNSWIEYDGLTRAFNISVS-Y 212
N NHVG+D+NS+ S + +N N+ L S + W+++DG T +++++ +
Sbjct: 155 NNNHVGIDINSLNSVKSSPAGYWDENDQFHNLTLISSKRMQVWVDFDGPTHLIDVTMAPF 214
Query: 213 SNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQG-STEIHSIEWWSFSSSFESNSGTGSG 271
+KP+ P++S DL + M+VGFS +T +EI + W SF N G
Sbjct: 215 GEVKPRKPLVSIVRDLSSVLLQDMFVGFSSATGNIVSEIFVLGW-----SFGVN-----G 264
Query: 272 SAPPPPTASLMNPTANSVKSPPPSLAPSGSSTTQKSSKSSSCHNQLCKQGAGAVAGVVTA 331
A P + L + P L P+ ++ + V +
Sbjct: 265 EAQPLALSKL-------PRLPVWDLKPT----------------RVYRFYKNWVPLISLL 301
Query: 332 SAFFAIFAGVLIWFFSKRYKHVKKSESFTSDIIRMPKEFSYRELRSATKCFNANRIIGHG 391
F + ++ + +R K ++ E + ++ + +++L ATK F I+G G
Sbjct: 302 LIPFLLIIFLVRFIMKRRRKFAEEVEDWETEFGK--NRLRFKDLYYATKGFKDKNILGSG 359
Query: 392 AFGTVYKGILPQNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGE 450
FG+VYKGI+P+ IAVKR S+ S QG EF++E+ IG + HRNLV L G+C + E
Sbjct: 360 GFGSVYKGIMPKTKKEIAVKRVSNESRQGLKEFVAEIVSIGQMSHRNLVPLVGYCRRRDE 419
Query: 451 ILLVYDLMPNGSLDKALFEA-RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTS 509
+LLVYD MPNGSLDK L+ + L W R K++ GVASAL YLH+E E VIHRDVK S
Sbjct: 420 LLLVYDYMPNGSLDKYLYNSPEVTLDWKQRFKVINGVASALFYLHEEWEQVVIHRDVKAS 479
Query: 510 NIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGA 569
N++LD N RLGDFGLA+ +H P T GT GYLAP+++ TGRAT TDVF++G
Sbjct: 480 NVLLDAELNGRLGDFGLAQLCDHGSDPQTTRVVGTWGYLAPDHIRTGRATTTTDVFAFGV 539
Query: 570 VVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRR 629
++LEVA GRRPIE + G LV+WV+ E +L A D L ++D+ E+
Sbjct: 540 LLLEVACGRRPIEIN----NQSGERVVLVDWVFRFWMEANILDAKDPNLGSEYDQKEVEM 595
Query: 630 VLLVGLACSHPDPLARPTMRGVVQMLVGEAEVP 662
VL +GL CSH DPLARPTMR V+Q L G+A +P
Sbjct: 596 VLKLGLLCSHSDPLARPTMRQVLQYLRGDAMLP 628
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O80939|LRK41_ARATH L-type lectin-domain containing receptor kinase IV.1 OS=Arabidopsis thaliana GN=LECRK41 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 379 bits (972), Expect = e-104, Method: Compositional matrix adjust.
Identities = 248/659 (37%), Positives = 347/659 (52%), Gaps = 67/659 (10%)
Query: 56 NGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLNPSSIGAGLA 115
NG ++LT + TV G A Y+KP+RF+ T +SFST F F+I + G G+A
Sbjct: 50 NGLLKLT-NTTV--QKTGHAFYTKPIRFKDSPNGTVSSFSTSFVFAIHSQIAILSGHGIA 106
Query: 116 FVITPDGE-QVGSAGGSLGLLDEKGAGL---GFVAVEFDTLMDVEFSDINGNHVGLDLNS 171
FV+ P+ G+ +GL + G AVE DT++ EF+D N NHVG+D+NS
Sbjct: 107 FVVAPNASLPYGNPSQYIGLFNLANNGNETNHVFAVELDTILSTEFNDTNDNHVGIDINS 166
Query: 172 MVSTEV-------DNLDTINVDLKSGDLVNSWIEYDGLTRAFNISVS-YSNLKPKVPILS 223
+ S + + N+ L S + W++YDG T +++++ ++ KP P+++
Sbjct: 167 LKSVQSSPAGYWDEKGQFKNLTLISRKPMQVWVDYDGRTNKIDVTMAPFNEDKPTRPLVT 226
Query: 224 FTLDLDQYVNDFMYVGFSGSTQGSTEIHSIEWWSFSSSFESNSGTGSGSAPPPPTASLMN 283
DL + MYVGFS +T H I WSF G PP S +
Sbjct: 227 AVRDLSSVLLQDMYVGFSSATGSVLSEHYILGWSF----------GLNEKAPPLALSRLP 276
Query: 284 PTANSVKSPPPSLAPSGSSTTQKSSKSSSCHNQLCKQGAGAVAGVVTASAFFAIFAGVLI 343
P P S + K G ++ F IF+ + +
Sbjct: 277 KL--------PRFEPKRIS-------------EFYKIGMPLIS-------LFLIFSFIFL 308
Query: 344 WFFSKRYKHVKKSESFTSDIIRMPKEFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQ 403
+ R + E + F +++L ATK F ++G G FG+VYKG++P
Sbjct: 309 VCYIVRRRRKFAEELEEWEKEFGKNRFRFKDLYYATKGFKEKGLLGTGGFGSVYKGVMPG 368
Query: 404 NGDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGS 462
IAVKR SH S QG EF++E+ IG + HRNLV L G+C +GE+LLVYD MPNGS
Sbjct: 369 TKLEIAVKRVSHESRQGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMPNGS 428
Query: 463 LDKALFEA-RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARL 521
LDK L+ L W R K++LGVAS L YLH+E E VIHRDVK SN++LD N RL
Sbjct: 429 LDKYLYNTPEVTLNWKQRIKVILGVASGLFYLHEEWEQVVIHRDVKASNVLLDGELNGRL 488
Query: 522 GDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPI 581
GDFGLAR +H P T GT+GYLAPE+ TGRAT TDVF++GA +LEVA GRRPI
Sbjct: 489 GDFGLARLYDHGSDPQTTHVVGTLGYLAPEHTRTGRATMATDVFAFGAFLLEVACGRRPI 548
Query: 582 EKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPD 641
E + + LV+WV+ L +G +L A D + + DE E+ VL +GL CSH D
Sbjct: 549 EFQ----QETDETFLLVDWVFGLWNKGDILAAKDPNMGSECDEKEVEMVLKLGLLCSHSD 604
Query: 642 PLARPTMRGVVQMLVGEAEVPIVPRAKPSMTFSTSHLLLSLQDSVSDCNGMITLSSSSS 700
P ARP+MR V+ L G+A++P + + S S ++ + D S+ + +S SSS
Sbjct: 605 PRARPSMRQVLHYLRGDAKLPEL----SPLDLSGSGMMFGVHDGFSE----LGMSYSSS 655
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81292|LRK43_ARATH L-type lectin-domain containing receptor kinase IV.3 OS=Arabidopsis thaliana GN=LECRK43 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 375 bits (964), Expect = e-103, Method: Compositional matrix adjust.
Identities = 237/624 (37%), Positives = 338/624 (54%), Gaps = 57/624 (9%)
Query: 55 NNGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLNPSSIGAGL 114
+NG ++LT + G A Y++P+RF+ T +SFST F I + P+ G G+
Sbjct: 51 SNGILKLTDKTVI---STGHAFYTEPIRFKDSPNDTVSSFSTTFVIGIYSGIPTISGHGM 107
Query: 115 AFVITPDGEQVGSAGGS--LGLLDEKGAGLG---FVAVEFDTLMDVEFSDINGNHVGLDL 169
AF I P+ + SA S LGL G +AVEFDT+M+ EF D N NHVG+++
Sbjct: 108 AFFIAPN-PVLSSAMASQYLGLFSSTNNGNDTNHILAVEFDTIMNPEFDDTNDNHVGINI 166
Query: 170 NSMVSTE---VDNLDTIN----VDLKSGDLVNSWIEYDGLTRAFNISVS-YSNLKPKVPI 221
NS+ S + V D IN + L S + W++YD T +++++ + +KP+ +
Sbjct: 167 NSLTSVKSSLVGYWDEINQFNNLTLISRKRMQVWVDYDDRTNQIDVTMAPFGEVKPRKAL 226
Query: 222 LSFTLDLDQYVNDFMYVGFSGSTQGSTEIHSIEWWSFSSSFESNSGTGSGSAPPPPTASL 281
+S DL MY+GFS +T H + WSF G PP T S
Sbjct: 227 VSVVRDLSSVFLQDMYLGFSAATGYVLSEHFVFGWSFMVK---------GKTAPPLTLSK 277
Query: 282 MNPTANSVKSPPPSLAPSGSSTTQKSSKSSSCHNQLCKQGAGAVAGVVTASAFFAIFAGV 341
+ P G ++ Q+ K N++ + ++ F +
Sbjct: 278 V-----------PKFPRVGPTSLQRFYK-----NRM------PLFSLLLIPVLFVVSLIF 315
Query: 342 LIWFF-SKRYKHVKKSESFTSDIIRMPKEFSYRELRSATKCFNANRIIGHGAFGTVYKGI 400
L+ F +R K ++ E + ++ + +++L ATK F ++G G FG VY+G+
Sbjct: 316 LVRFIVRRRRKFAEEFEDWETEFGK--NRLRFKDLYYATKGFKDKDLLGSGGFGRVYRGV 373
Query: 401 LPQNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMP 459
+P IAVKR S+ S QG EF++E+ IG + HRNLV L G+C + E+LLVYD MP
Sbjct: 374 MPTTKKEIAVKRVSNESRQGLKEFVAEIVSIGRMSHRNLVPLLGYCRRRDELLLVYDYMP 433
Query: 460 NGSLDKALFEA-RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFN 518
NGSLDK L++ L W R +++GVAS L YLH+E E VIHRD+K SN++LD +N
Sbjct: 434 NGSLDKYLYDCPEVTLDWKQRFNVIIGVASGLFYLHEEWEQVVIHRDIKASNVLLDAEYN 493
Query: 519 ARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGR 578
RLGDFGLAR +H P T GT GYLAP+++ TGRAT TDVF++G ++LEVA GR
Sbjct: 494 GRLGDFGLARLCDHGSDPQTTRVVGTWGYLAPDHVRTGRATTATDVFAFGVLLLEVACGR 553
Query: 579 RPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACS 638
RPIE EI V LV+ V+ EG +L A D L +D+ E+ VL +GL CS
Sbjct: 554 RPIEIEIESDESV----LLVDSVFGFWIEGNILDATDPNLGSVYDQREVETVLKLGLLCS 609
Query: 639 HPDPLARPTMRGVVQMLVGEAEVP 662
H DP RPTMR V+Q L G+A +P
Sbjct: 610 HSDPQVRPTMRQVLQYLRGDATLP 633
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M345|LRK42_ARATH L-type lectin-domain containing receptor kinase IV.2 OS=Arabidopsis thaliana GN=LECRK42 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 374 bits (959), Expect = e-102, Method: Compositional matrix adjust.
Identities = 241/627 (38%), Positives = 334/627 (53%), Gaps = 70/627 (11%)
Query: 56 NGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLNPSSIGAGLA 115
NG ++LT G A ++ +RF+ +SFST F F+I + P+ G G+A
Sbjct: 50 NGLLKLT---NTSVQKTGHAFCTERIRFKDSQNGNVSSFSTTFVFAIHSQIPTLSGHGIA 106
Query: 116 FVITPD-GEQVGSAGGSLGLLDEKGAGLG---FVAVEFDTLMDVEFSDINGNHVGLDLNS 171
FV+ P G +GL + G AVEFDT+ EF D N NHVG+DLN
Sbjct: 107 FVVAPTLGLPFALPSQYIGLFNISNNGNDTNHIFAVEFDTIQSSEFGDPNDNHVGIDLNG 166
Query: 172 MVSTEV------DNLDTI-NVDLKSGDLVNSWIEYDGLTRAFNISVS-YSNLKPKVPILS 223
+ S D+ D N+ L S + WI+YD + +++V+ + + KP+ P++S
Sbjct: 167 LRSANYSTAGYRDDHDKFQNLSLISRKRIQVWIDYDNRSHRIDVTVAPFDSDKPRKPLVS 226
Query: 224 FTLDLDQYVNDFMYVGFSGSTQGSTEIHSIEWWSFSSSFESNSGTGSGSAPPPPTASLMN 283
+ DL + + MYVGFS +T H + WSF + E+
Sbjct: 227 YVRDLSSILLEDMYVGFSSATGSVLSEHFLVGWSFRLNGEA------------------- 267
Query: 284 PTANSVKSPP-PSLAPSGSSTTQKSSKSSSCHNQLCKQGAGAVAGVVTASAFFAIFAGVL 342
P + K P P P S + K G ++ + S F F
Sbjct: 268 PMLSLSKLPKLPRFEPRRIS-------------EFYKIGMPLISLSLIFSIIFLAF---- 310
Query: 343 IWFFSKRYKHVKKSESFTSDIIRMPKEFSYRELRSATKCFNANRIIGHGAFGTVYKGILP 402
+ ++ K+ ++ + + ++ + F ++EL ATK F ++G G FG VY+GILP
Sbjct: 311 -YIVRRKKKYEEELDDWETEFGK--NRFRFKELYHATKGFKEKDLLGSGGFGRVYRGILP 367
Query: 403 QNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNG 461
+AVKR SH+S QG EF++E+ IG + HRNLV L G+C +GE+LLVYD MPNG
Sbjct: 368 TTKLEVAVKRVSHDSKQGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMPNG 427
Query: 462 SLDKALFE-ARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNAR 520
SLDK L+ + L W RS I+ GVAS L YLH+E E VIHRDVK SN++LD FN R
Sbjct: 428 SLDKYLYNNPETTLDWKQRSTIIKGVASGLFYLHEEWEQVVIHRDVKASNVLLDADFNGR 487
Query: 521 LGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRP 580
LGDFGLAR +H P T GT+GYLAPE+ TGRAT TDV+++GA +LEV SGRRP
Sbjct: 488 LGDFGLARLYDHGSDPQTTHVVGTLGYLAPEHSRTGRATTTTDVYAFGAFLLEVVSGRRP 547
Query: 581 IEKEITGVGKVGVASN----LVEWVWSLHREGRLLTAADARL-EGQFDEAEMRRVLLVGL 635
IE AS+ LVEWV+SL G ++ A D +L +D E+ VL +GL
Sbjct: 548 IE--------FHSASDDTFLLVEWVFSLWLRGNIMEAKDPKLGSSGYDLEEVEMVLKLGL 599
Query: 636 ACSHPDPLARPTMRGVVQMLVGEAEVP 662
CSH DP ARP+MR V+Q L G+ +P
Sbjct: 600 LCSHSDPRARPSMRQVLQYLRGDMALP 626
|
Required during pollen development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 711 | ||||||
| 357491803 | 700 | Lectin receptor kinase-like protein [Med | 0.942 | 0.957 | 0.783 | 0.0 | |
| 356551991 | 697 | PREDICTED: L-type lectin-domain containi | 0.956 | 0.975 | 0.752 | 0.0 | |
| 449440081 | 727 | PREDICTED: L-type lectin-domain containi | 0.990 | 0.968 | 0.760 | 0.0 | |
| 449516219 | 727 | PREDICTED: LOW QUALITY PROTEIN: L-type l | 0.990 | 0.968 | 0.758 | 0.0 | |
| 225439920 | 709 | PREDICTED: L-type lectin-domain containi | 0.943 | 0.946 | 0.818 | 0.0 | |
| 195536980 | 717 | lectin receptor kinase-like protein [Nic | 0.964 | 0.956 | 0.768 | 0.0 | |
| 224140175 | 601 | predicted protein [Populus trichocarpa] | 0.828 | 0.980 | 0.788 | 0.0 | |
| 15231802 | 715 | concanavalin A-like lectin kinase-like p | 0.947 | 0.942 | 0.717 | 0.0 | |
| 62318912 | 715 | receptor lectin kinase -like protein [Ar | 0.947 | 0.942 | 0.715 | 0.0 | |
| 297820064 | 713 | lectin protein kinase family protein [Ar | 0.949 | 0.946 | 0.715 | 0.0 |
| >gi|357491803|ref|XP_003616189.1| Lectin receptor kinase-like protein [Medicago truncatula] gi|355517524|gb|AES99147.1| Lectin receptor kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1087 bits (2810), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 535/683 (78%), Positives = 595/683 (87%), Gaps = 13/683 (1%)
Query: 30 ISTATEFDFGTLTLASLKLLGDAHMNNGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTH 89
I +TEFDFGTLTL SLKLLGDAH+NNG+V LTRD+TVP+ GAG+ALYS+P+RFR PGT
Sbjct: 25 IIASTEFDFGTLTLTSLKLLGDAHLNNGTVTLTRDLTVPFSGAGQALYSRPIRFRQPGTT 84
Query: 90 TPASFSTFFSFSITNLNPSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAGLGFVAVEF 149
TPASF+TFFSFS+TNLNPSSIG GLAF+I+PD E +G AGG LGL AG GFVAVEF
Sbjct: 85 TPASFTTFFSFSVTNLNPSSIGGGLAFIISPDDESLGDAGGYLGL-----AGNGFVAVEF 139
Query: 150 DTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLTRAFNIS 209
DTLMDVEF DINGNHVG+DLNS+VS++V +LD+I VDLKSGD VN+WIE+DG FN+
Sbjct: 140 DTLMDVEFKDINGNHVGVDLNSVVSSKVGDLDSIGVDLKSGDSVNAWIEFDGSNNGFNVW 199
Query: 210 VSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGSTEIHSIEWWSFSSSFESNSGTG 269
VSYSNLKPK PIL+ LD+ Y+NDFMYVGFSGSTQGSTEIH IEWWSFSSSF TG
Sbjct: 200 VSYSNLKPKDPILTMNLDMGLYLNDFMYVGFSGSTQGSTEIHRIEWWSFSSSFM----TG 255
Query: 270 SGSAPPPPTASLMNPTANSVKSPPPSLAPS-GSSTTQKSSKSSSCHNQLCKQGAGAVAGV 328
SG PPP S+MN TANS +SPPPS+AP+ SS ++ SCHN LCKQG GAVAGV
Sbjct: 256 SGGLSPPPAVSMMNTTANSARSPPPSMAPTMNSSNEERKESKKSCHNGLCKQGLGAVAGV 315
Query: 329 VTASAF-FAIFAGVLIWFFSKRYKHVKKSESFTSDIIRMPKEFSYRELRSATKCFNANRI 387
VTA AF A+FAG +IW +SK+ K V + +S S+II+MPK+FSY+EL+SATKCFNANRI
Sbjct: 316 VTAGAFVLALFAGSMIWLYSKKVKRVSRFDSLGSEIIKMPKQFSYKELKSATKCFNANRI 375
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHE 447
IGHGAFGTVYKGIL +NGDIIAVKRCSH+SQGK+EFLSELSIIG+LRHRNLVRLQGWCHE
Sbjct: 376 IGHGAFGTVYKGILTENGDIIAVKRCSHSSQGKNEFLSELSIIGSLRHRNLVRLQGWCHE 435
Query: 448 KGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVK 507
KGEILLVYDLMPNGSLDKALFEAR+PLPWPHR KILLGVASALAYLHQECENQVIHRD+K
Sbjct: 436 KGEILLVYDLMPNGSLDKALFEARTPLPWPHRRKILLGVASALAYLHQECENQVIHRDIK 495
Query: 508 TSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSY 567
TSNIMLDEGFNARLGDFGLARQ EHDKSPDATVAAGTMGYLAPEYLLTG+AT+KTDVFSY
Sbjct: 496 TSNIMLDEGFNARLGDFGLARQTEHDKSPDATVAAGTMGYLAPEYLLTGKATDKTDVFSY 555
Query: 568 GAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEM 627
GAVVLEVASGRRPIEK+ GVGKVGV+SNLVEWVWSLHREGRLL A D RLEG+FDEA M
Sbjct: 556 GAVVLEVASGRRPIEKDAAGVGKVGVSSNLVEWVWSLHREGRLLAAVDPRLEGEFDEAGM 615
Query: 628 RRVLLVGLACSHPDPLARPTMRGVVQMLVGEAEVPIVPRAKPSMTFST--SHLLLSLQDS 685
RVLLVGLACSHPDPLARPTMR VVQML GEAEVPIVPR KPS ST SHLL+SLQDS
Sbjct: 616 TRVLLVGLACSHPDPLARPTMRSVVQMLGGEAEVPIVPRTKPSTGLSTSHSHLLMSLQDS 675
Query: 686 VSDCNGMITLSSSSSENDFIHGD 708
VSDC+G++T+S+S+SEN F GD
Sbjct: 676 VSDCDGILTISTSTSENSFNGGD 698
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356551991|ref|XP_003544355.1| PREDICTED: L-type lectin-domain containing receptor kinase VIII.1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1065 bits (2755), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 524/696 (75%), Positives = 590/696 (84%), Gaps = 16/696 (2%)
Query: 17 VFCLFVINNAVITISTATEFDFGTLTLASLKLLGDAHMNNGSVRLTRDVTVPYDGAGKAL 76
+FC F ++ ATEFDFGTLTL SLKLLGDAH+NN +V LTRD+ VP AG+AL
Sbjct: 12 IFCFFSF------VTAATEFDFGTLTLGSLKLLGDAHLNNATVSLTRDLAVPTSSAGRAL 65
Query: 77 YSKPVRFRLPGTHTPASFSTFFSFSITNLNPSSIGAGLAFVITPDGEQVGSAGGSLGLLD 136
YS+PVRFR PG PASF+TFFSFS+TNLNPSSIG GLAFV++PD + +G AGG LGL
Sbjct: 66 YSRPVRFRQPGNRFPASFTTFFSFSVTNLNPSSIGGGLAFVLSPDDDTIGDAGGFLGLSA 125
Query: 137 EKGAGLGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSW 196
G GF+AVEFDTLMDVEF DINGNHVG+DLNS+VS+EV +L + VDLKSGDL+N+W
Sbjct: 126 AADGG-GFIAVEFDTLMDVEFKDINGNHVGVDLNSVVSSEVGDLANVGVDLKSGDLINAW 184
Query: 197 IEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGSTEIHSIEWW 256
IE+DG ++ ++ VSYSNLKPK P+L+ LD+D+Y+NDFMYVGFS STQGSTEIH IEWW
Sbjct: 185 IEFDGSSKGLSVWVSYSNLKPKDPVLTMNLDVDKYLNDFMYVGFSASTQGSTEIHRIEWW 244
Query: 257 SFSSSFESNSGTGSGSAPPPPTASLMNPTANSVK-SPPPSLAPSGSSTTQKSSKSSSCHN 315
SF SSF + + SLMNPT NSVK +PPPSLAPS S ++S SSCHN
Sbjct: 245 SFGSSFAAAAAVAPPPP----AVSLMNPTENSVKFAPPPSLAPS-HSEEKESKSKSSCHN 299
Query: 316 QLCKQGAGAVAGVVTASAF-FAIFAGVLIWFFSKRYKHVKKSESFTSDIIRMPKEFSYRE 374
LCKQ GAVAGVVTA AF A+FAG LIWF+SK++K VKK +S S+IIRMPK+FSY+E
Sbjct: 300 GLCKQNMGAVAGVVTAGAFVLALFAGALIWFYSKKFKRVKKFDSLGSEIIRMPKQFSYKE 359
Query: 375 LRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLR 434
L SATKCFNANRIIGHGAFGTVYKG+LP+NGDI+AVKRCSH SQGK+EFLSELSIIG+LR
Sbjct: 360 LNSATKCFNANRIIGHGAFGTVYKGVLPENGDIVAVKRCSHCSQGKNEFLSELSIIGSLR 419
Query: 435 HRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLH 494
HRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEAR+PLPW HR KILLGVASALAYLH
Sbjct: 420 HRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARTPLPWAHRGKILLGVASALAYLH 479
Query: 495 QECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLL 554
QECENQVIHRD+KTSNIMLDEGFNARLGDFGLARQ EHDKSPDATVAAGTMGYLAPEYLL
Sbjct: 480 QECENQVIHRDIKTSNIMLDEGFNARLGDFGLARQTEHDKSPDATVAAGTMGYLAPEYLL 539
Query: 555 TGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614
TG+ATEKTDVFSYGAVVLEVASGRRPIEK+ G GK G++ NLVEWVWSLHRE RLL AA
Sbjct: 540 TGKATEKTDVFSYGAVVLEVASGRRPIEKDANGGGKGGISCNLVEWVWSLHREARLLMAA 599
Query: 615 DARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEAEVPIVPRAKPSMTFS 674
D RLEG+FDE EMR++LLVGLACSHPDPL RPTMRGVVQ+LVGEAEVP+VPR KPS FS
Sbjct: 600 DPRLEGEFDEGEMRKMLLVGLACSHPDPLTRPTMRGVVQILVGEAEVPLVPRTKPSTGFS 659
Query: 675 T--SHLLLSLQDSVSDCNGMITLSSSSSENDFIHGD 708
T SHLLLSLQDSVSDC+G+IT+S+S+SEN F GD
Sbjct: 660 TSHSHLLLSLQDSVSDCDGIITISTSTSENSFNLGD 695
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449440081|ref|XP_004137813.1| PREDICTED: L-type lectin-domain containing receptor kinase VIII.1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1053 bits (2724), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 548/721 (76%), Positives = 623/721 (86%), Gaps = 17/721 (2%)
Query: 1 MLLFSCKILTSLNLSLVFCLFVINNAVI-----TISTATEFDFGTLTLASLKLLGDAHMN 55
M+L I +S+ +L+ LF I+N VI T++ A EFDFGT+ L+SLKLLGDAH+N
Sbjct: 1 MMLNFSSIFSSITFTLL--LFSISNTVIVDFTATVAAAAEFDFGTVELSSLKLLGDAHLN 58
Query: 56 NGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLNPSSIGAGLA 115
NGSVRLTRD+ VP G+G+ LY+KP+RFR PG ASFSTFFSFSITNLNPSSIG GLA
Sbjct: 59 NGSVRLTRDLAVPNSGSGRVLYAKPIRFRQPGIDYLASFSTFFSFSITNLNPSSIGGGLA 118
Query: 116 FVITPDGEQVGSAGGSLGLLDEKGAGLGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVST 175
FVI+PD E +G AGG LGL DE+G LGFVAVEFDTLMDVEF DINGNHVGLDLN MVS
Sbjct: 119 FVISPDAETLGGAGGLLGLADERG--LGFVAVEFDTLMDVEFKDINGNHVGLDLNEMVSL 176
Query: 176 EVDNLDTINVDLKSGDLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDF 235
EV++L I VDLKSGD VN+WI+YDG R F + VSYSNLKP P++SF LDLD Y+NDF
Sbjct: 177 EVEDLQGIGVDLKSGDTVNAWIKYDGSARIFEVFVSYSNLKPTEPLMSFNLDLDPYLNDF 236
Query: 236 MYVGFSGSTQGSTEIHSIEWWSFSSSFESNSGTGSGSAPPPPTASLMNPTANSVKSPPPS 295
MYVGFSGSTQGSTE+HS++WWSF+SS +S + GS PPPPT +LMNPTAN V+SPPPS
Sbjct: 237 MYVGFSGSTQGSTEVHSVDWWSFASS--FDSDSTPGSVPPPPTTTLMNPTANVVRSPPPS 294
Query: 296 LAPSGSS-TTQKSSKSSSCHNQLCKQGAGAVAGVVTASAF-FAIFAGVLIWFFSKRYKHV 353
PSGS TQK+ KS+SCHN LCKQGAGAV GVVTA AF A+FAG LIW +SK+ K V
Sbjct: 295 QPPSGSDSVTQKNFKSTSCHNGLCKQGAGAVVGVVTAGAFVLALFAGALIWVYSKKIKRV 354
Query: 354 KKSESFTSDIIRMPKEFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRC 413
KKS+S S+II+MPKEF+Y+EL+ ATKCFN+NRIIGHGAFGTVYKGILP+ GDI+AVKRC
Sbjct: 355 KKSDSLASEIIKMPKEFTYKELKIATKCFNSNRIIGHGAFGTVYKGILPETGDIVAVKRC 414
Query: 414 SHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSP 473
SH++QGK+EFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEAR+P
Sbjct: 415 SHSTQGKNEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARTP 474
Query: 474 LPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHD 533
LPWPHR KILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHD
Sbjct: 475 LPWPHRRKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHD 534
Query: 534 KSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGV---GK 590
KSPDATVAAGTMGYLAPEYLLTGRATEKTDVFS+GAVVLEVASGRRPIEK+ T V GK
Sbjct: 535 KSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSFGAVVLEVASGRRPIEKDSTAVGGGGK 594
Query: 591 VGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRG 650
G SNLV+WVWSLHREGRLLTAAD RL G+F+E+EMR+VLLVGLACSHPDP+ RPTMRG
Sbjct: 595 FGANSNLVDWVWSLHREGRLLTAADGRLGGEFEESEMRKVLLVGLACSHPDPMTRPTMRG 654
Query: 651 VVQMLVGEAEVPIVPRAKPSMTFSTSHLLLSLQDSVSDCNGMITLSSSSSENDFIHGDHL 710
VVQML+G++E+PIVPR+KPS +FST+HLLL+LQDSVSD NGMI +S+SSSE+ F +G+ L
Sbjct: 655 VVQMLIGDSEIPIVPRSKPSTSFSTAHLLLTLQDSVSDLNGMIAISTSSSEHSF-NGEDL 713
Query: 711 V 711
+
Sbjct: 714 I 714
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449516219|ref|XP_004165145.1| PREDICTED: LOW QUALITY PROTEIN: L-type lectin-domain containing receptor kinase VIII.1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1051 bits (2718), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 547/721 (75%), Positives = 622/721 (86%), Gaps = 17/721 (2%)
Query: 1 MLLFSCKILTSLNLSLVFCLFVINNAVI-----TISTATEFDFGTLTLASLKLLGDAHMN 55
M+L I +S+ +L+ LF I+N VI T++ A EFDFGT+ L+SLKLLGDAH+N
Sbjct: 1 MMLNFSSIFSSITFTLL--LFSISNTVIVDFTATVAAAAEFDFGTVELSSLKLLGDAHLN 58
Query: 56 NGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLNPSSIGAGLA 115
NGSVRLTRD+ VP G+G+ LY+KP+RFR PG ASFSTFFSFSITNLNPSSIG GLA
Sbjct: 59 NGSVRLTRDLAVPNSGSGRVLYAKPIRFRQPGIDYLASFSTFFSFSITNLNPSSIGGGLA 118
Query: 116 FVITPDGEQVGSAGGSLGLLDEKGAGLGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVST 175
FVI+PD E +G AGG LGL DE+G LGFVAVEFDTLMDVEF DINGNHVGLDLN MVS
Sbjct: 119 FVISPDAETLGGAGGLLGLADERG--LGFVAVEFDTLMDVEFKDINGNHVGLDLNEMVSL 176
Query: 176 EVDNLDTINVDLKSGDLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDF 235
EV++L I VDLKSGD VN+WI+YDG R F + VSYSNLKP P++SF LDLD Y+NDF
Sbjct: 177 EVEDLQGIGVDLKSGDTVNAWIKYDGSARIFEVFVSYSNLKPTEPLMSFNLDLDPYLNDF 236
Query: 236 MYVGFSGSTQGSTEIHSIEWWSFSSSFESNSGTGSGSAPPPPTASLMNPTANSVKSPPPS 295
MYVGFSGSTQGSTE+HS++WWSF+SS +S + GS PPPPT +LMNPTAN V+SPPPS
Sbjct: 237 MYVGFSGSTQGSTEVHSVDWWSFASS--FDSDSTPGSVPPPPTTTLMNPTANVVRSPPPS 294
Query: 296 LAPSGSS-TTQKSSKSSSCHNQLCKQGAGAVAGVVTASAF-FAIFAGVLIWFFSKRYKHV 353
PSGS TQK+ KS+SCHN LCKQGAGAV GVVTA AF A+FAG LIW +SK+ K V
Sbjct: 295 QPPSGSDSVTQKNFKSTSCHNGLCKQGAGAVVGVVTAGAFVLALFAGALIWVYSKKIKRV 354
Query: 354 KKSESFTSDIIRMPKEFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRC 413
KKS+S S+II+MPKEF+Y+EL+ ATKCFN+NRIIGHGAFGTVYKGILP+ GDI+AVKRC
Sbjct: 355 KKSDSLASEIIKMPKEFTYKELKIATKCFNSNRIIGHGAFGTVYKGILPETGDIVAVKRC 414
Query: 414 SHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSP 473
SH++QGK+EFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEAR+P
Sbjct: 415 SHSTQGKNEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARTP 474
Query: 474 LPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHD 533
LPWPHR KILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHD
Sbjct: 475 LPWPHRRKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHD 534
Query: 534 KSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGV---GK 590
KSPDATVAAGTMGYLAPEYLLTGRAT KTDVFS+GAVVLEVASGRRPIEK+ T V GK
Sbjct: 535 KSPDATVAAGTMGYLAPEYLLTGRATXKTDVFSFGAVVLEVASGRRPIEKDSTAVGGGGK 594
Query: 591 VGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRG 650
G SNLV+WVWSLHREGRLLTAAD RL G+F+E+EMR+VLLVGLACSHPDP+ RPTMRG
Sbjct: 595 FGANSNLVDWVWSLHREGRLLTAADGRLGGEFEESEMRKVLLVGLACSHPDPMTRPTMRG 654
Query: 651 VVQMLVGEAEVPIVPRAKPSMTFSTSHLLLSLQDSVSDCNGMITLSSSSSENDFIHGDHL 710
VVQML+G++E+PIVPR+KPS +FST+HLLL+LQDSVSD NGMI +S+SSSE+ F +G+ L
Sbjct: 655 VVQMLIGDSEIPIVPRSKPSTSFSTAHLLLTLQDSVSDLNGMIAISTSSSEHSF-NGEDL 713
Query: 711 V 711
+
Sbjct: 714 I 714
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225439920|ref|XP_002275244.1| PREDICTED: L-type lectin-domain containing receptor kinase VIII.1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1049 bits (2713), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 551/673 (81%), Positives = 610/673 (90%), Gaps = 2/673 (0%)
Query: 33 ATEFDFGTLTLASLKLLGDAHMNNGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTHTPA 92
+TEFDFGTLTL+SL+LLGDAH++NGSVRLTRD+ VP GAG+ LYSKPVRFR P +H A
Sbjct: 31 STEFDFGTLTLSSLRLLGDAHLSNGSVRLTRDLAVPNSGAGRVLYSKPVRFRQPDSHVTA 90
Query: 93 SFSTFFSFSITNLNPSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAGLGFVAVEFDTL 152
SFSTFFSFS+ NLNPSSIG GL F+I+PD E VG AGG LGL+D KG GFVAVEFDTL
Sbjct: 91 SFSTFFSFSVINLNPSSIGGGLTFLISPDDEAVGEAGGFLGLIDMKGLSSGFVAVEFDTL 150
Query: 153 MDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLTRAFNISVSY 212
MDVEF DINGNHVGLDLNSMVS++V +L I +DLKSGDLVN W+EYDG T+ FNISVSY
Sbjct: 151 MDVEFKDINGNHVGLDLNSMVSSQVGDLGAIGIDLKSGDLVNVWVEYDGSTQLFNISVSY 210
Query: 213 SNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGSTEIHSIEWWSFSSSFESNSGTGSGS 272
SNLKPK P+LSF LDLDQYVNDFM+VGFSGSTQGSTEIH+IEWWSFSSSF+ S TGS S
Sbjct: 211 SNLKPKEPLLSFDLDLDQYVNDFMFVGFSGSTQGSTEIHNIEWWSFSSSFDVVSATGS-S 269
Query: 273 APPPPTASLMNPTANSV-KSPPPSLAPSGSSTTQKSSKSSSCHNQLCKQGAGAVAGVVTA 331
+PPPPTASLMNPTANSV PPPS+APS S + ++K SSCHNQLCKQG GAVAGVVTA
Sbjct: 270 SPPPPTASLMNPTANSVIPPPPPSMAPSASDSVSHTAKPSSCHNQLCKQGPGAVAGVVTA 329
Query: 332 SAFFAIFAGVLIWFFSKRYKHVKKSESFTSDIIRMPKEFSYRELRSATKCFNANRIIGHG 391
AF +FAGVLIW FSK++KHVKKSES SD+I+MPKEF+Y+EL+SATKCFN+ RIIGHG
Sbjct: 330 GAFLVLFAGVLIWVFSKKFKHVKKSESLASDVIKMPKEFTYKELKSATKCFNSTRIIGHG 389
Query: 392 AFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEI 451
AFGTVYKGI+P GDIIAVKRCSH++QGK+EFLSELSIIG+LRHRNLVRLQGWCHEKGEI
Sbjct: 390 AFGTVYKGIIPDTGDIIAVKRCSHSTQGKNEFLSELSIIGSLRHRNLVRLQGWCHEKGEI 449
Query: 452 LLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNI 511
LLVYDLM NGSLDKALFEAR+PLPW HR KIL+GVASALAYLH+ECENQVIHRD+KTSNI
Sbjct: 450 LLVYDLMLNGSLDKALFEARTPLPWSHRRKILMGVASALAYLHEECENQVIHRDIKTSNI 509
Query: 512 MLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVV 571
MLDEGFNARLGDFGLARQ+EHDKSPDATVAAGTMGYLAPEYLLTGRAT+KTDVFSYGAVV
Sbjct: 510 MLDEGFNARLGDFGLARQIEHDKSPDATVAAGTMGYLAPEYLLTGRATDKTDVFSYGAVV 569
Query: 572 LEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVL 631
LEVASGRRPIEK+ +GVGK V+SNLVEWVWSLHREGRLLTAADARL G+F+E EMRRVL
Sbjct: 570 LEVASGRRPIEKDTSGVGKNLVSSNLVEWVWSLHREGRLLTAADARLGGEFEEGEMRRVL 629
Query: 632 LVGLACSHPDPLARPTMRGVVQMLVGEAEVPIVPRAKPSMTFSTSHLLLSLQDSVSDCNG 691
+VGL+CSHPDP ARPTMRGVVQMLVGEAEVPIVPRAKPSM+FSTSHLLLSLQDSVSD NG
Sbjct: 630 MVGLSCSHPDPNARPTMRGVVQMLVGEAEVPIVPRAKPSMSFSTSHLLLSLQDSVSDFNG 689
Query: 692 MITLSSSSSENDF 704
MIT+S+SSS++ F
Sbjct: 690 MITISTSSSDHSF 702
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|195536980|dbj|BAG68210.1| lectin receptor kinase-like protein [Nicotiana benthamiana] | Back alignment and taxonomy information |
|---|
Score = 1049 bits (2712), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 533/694 (76%), Positives = 592/694 (85%), Gaps = 8/694 (1%)
Query: 16 LVFCLFVINNAVITISTATEFDFGTLTLASLKLLGDAHM-NNGSVRLTRDVTVPYDGAGK 74
L+FC N ++ I TEFDFGTLTL++LKLLGDAH+ +N SV+LTRD+ VP GAGK
Sbjct: 16 LLFCSCSSNKSIFAI---TEFDFGTLTLSNLKLLGDAHLGDNNSVQLTRDLAVPNSGAGK 72
Query: 75 ALYSKPVRFRLPGTHTPASFSTFFSFSITNLNPSSIGAGLAFVITPDGEQVGSAGGSLGL 134
ALYSKPVRFR PG PASFSTFFSFS+TNLNPSSIG GLAFV+TP+ E VG AGG +G+
Sbjct: 73 ALYSKPVRFRQPGLDFPASFSTFFSFSVTNLNPSSIGGGLAFVLTPNDESVGDAGGYMGI 132
Query: 135 LDEKGAGLGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVN 194
LD KG G + VEFDTLMDVEF DINGNHVGLDLNSMVST+V +LD+I VDLKSGD+VN
Sbjct: 133 LDSKGTQSGTILVEFDTLMDVEFKDINGNHVGLDLNSMVSTQVGDLDSIGVDLKSGDIVN 192
Query: 195 SWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGSTEIHSIE 254
SWIEY G T N+ VSYSNLKPK P LS L++ +YVNDFM+VGFSGSTQGSTEIHSIE
Sbjct: 193 SWIEYSGSTGQLNVFVSYSNLKPKEPFLSVVLNIAEYVNDFMFVGFSGSTQGSTEIHSIE 252
Query: 255 WWSFSSSFESNSGTGSGSAPPPPTASLMNPTANSVKSPPPSLAPS---GSSTTQKSSKSS 311
WWSFSSSF+++ + + +APPPPTASLMNPTA+SV S PPS+APS S++ + S
Sbjct: 253 WWSFSSSFDASPKSAAAAAPPPPTASLMNPTADSVMSRPPSMAPSESNSSASIMQDKSSG 312
Query: 312 SCHNQLCKQGAGAVAGVVTASAFFAIFAG-VLIWFFSKRYKHVKKSESFTSDIIRMPKEF 370
CH+ CKQG GAV GVVTASAFF FA VLIW ++K++K VK SE SD+I+MPKEF
Sbjct: 313 KCHSNFCKQGPGAVVGVVTASAFFLAFATLVLIWLYTKKFKKVKNSEFLASDVIKMPKEF 372
Query: 371 SYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSII 430
SY+EL+ ATK F++ RIIGHGAFGTVYKGIL NG I+AVKRCSHN QGK EFLSELSII
Sbjct: 373 SYKELKLATKAFDSTRIIGHGAFGTVYKGILSDNGGIVAVKRCSHNGQGKAEFLSELSII 432
Query: 431 GTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASAL 490
GTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFE+R LPW HR KILLGVASAL
Sbjct: 433 GTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFESRMILPWLHRRKILLGVASAL 492
Query: 491 AYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAP 550
AYLHQECENQVIHRD+K+SNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAP
Sbjct: 493 AYLHQECENQVIHRDIKSSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAP 552
Query: 551 EYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRL 610
EYLLTGRATEKTDVFSYGAVVLEVASGRRPIE+E T V KVGV SNLVEWVW LHREG L
Sbjct: 553 EYLLTGRATEKTDVFSYGAVVLEVASGRRPIERETTRVEKVGVNSNLVEWVWGLHREGNL 612
Query: 611 LTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEAEVPIVPRAKPS 670
L AAD+RL G+FDE EMRRVL+VGLACS PDP+ RPTMR VVQMLVGEAEVPIVPR KPS
Sbjct: 613 LMAADSRLYGEFDEGEMRRVLMVGLACSQPDPMVRPTMRSVVQMLVGEAEVPIVPRTKPS 672
Query: 671 MTFSTSHLLLSLQDSVSDCNGMITLSSSSSENDF 704
M+FSTSHLL++LQDSVSD NGMITLS+SSSEN F
Sbjct: 673 MSFSTSHLLMTLQDSVSDLNGMITLSTSSSENSF 706
|
Source: Nicotiana benthamiana Species: Nicotiana benthamiana Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224140175|ref|XP_002323460.1| predicted protein [Populus trichocarpa] gi|222868090|gb|EEF05221.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 977 bits (2525), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 497/630 (78%), Positives = 541/630 (85%), Gaps = 41/630 (6%)
Query: 29 TISTATEFDFGTLTLASLKLLGDAHMNNGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGT 88
T +T+T+FDFGTLTL+SLKLLGDAH+NNG+VRLTRD+ VP GAGK LYSKP+RFR P T
Sbjct: 10 TKATSTDFDFGTLTLSSLKLLGDAHLNNGNVRLTRDLDVPNSGAGKVLYSKPIRFRQPST 69
Query: 89 HTPASFSTFFSFSITNLNPSSIGAGLAFVITPDGEQVGSAGGSLGLL---DEKGAGLGFV 145
H SFSTFFSFS+ NLNPSSIG GLAFV++PD + +G+AGG LGLL D A FV
Sbjct: 70 HAITSFSTFFSFSVANLNPSSIGGGLAFVLSPDSDALGAAGGFLGLLNVNDVPKAASSFV 129
Query: 146 AVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLTRA 205
AVEFDTLMDVEF DINGNHVGLDLNSMVST++ +L IN+DLKSGDLVN+WI+YDG ++
Sbjct: 130 AVEFDTLMDVEFKDINGNHVGLDLNSMVSTQIGDLGAINIDLKSGDLVNAWIDYDGTNQS 189
Query: 206 FNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGSTEIHSIEWWSFSSSFESN 265
FNISVSYSNLKPK PILSF+LDLDQYVNDFMYVGFSGSTQGSTE+HSIEWWSFSSSF
Sbjct: 190 FNISVSYSNLKPKEPILSFSLDLDQYVNDFMYVGFSGSTQGSTEVHSIEWWSFSSSF--- 246
Query: 266 SGTGSGSAPPPPTASLMNPTANSVKSPPPSLAPSGSSTTQKSSKSSSCHNQLCKQGAGAV 325
++ +KS SCHNQLCKQGAGAV
Sbjct: 247 -----------------------------------QLSSGSDAKSDSCHNQLCKQGAGAV 271
Query: 326 AGVVTASAFFAIFAGVLIWFFSKRYKHVKKSESFTSDIIRMPKEFSYRELRSATKCFNAN 385
AGVVTASAFF IFAGVLIW FSKR K VK+SESF S++I+MPKEFSYREL+SATKCFNAN
Sbjct: 272 AGVVTASAFFVIFAGVLIWVFSKRSKRVKESESFASEVIKMPKEFSYRELKSATKCFNAN 331
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWC 445
RIIGHGAFG VYKGILP+ GDI+AVKRCSHNSQGK+EFLSELSIIGTLRHRNLVRLQGWC
Sbjct: 332 RIIGHGAFGIVYKGILPETGDIVAVKRCSHNSQGKNEFLSELSIIGTLRHRNLVRLQGWC 391
Query: 446 HEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRD 505
HEKGEILLVYDLMPNGSLDKALFEAR+PLPWPHR K+LLGVASALAYLHQECENQVIHRD
Sbjct: 392 HEKGEILLVYDLMPNGSLDKALFEARTPLPWPHRRKVLLGVASALAYLHQECENQVIHRD 451
Query: 506 VKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVF 565
+KTSNIMLDEGFNARLGDFGLARQ+EHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVF
Sbjct: 452 IKTSNIMLDEGFNARLGDFGLARQIEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVF 511
Query: 566 SYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEA 625
SYGAVVLEVASGRRPIEKE +GVGKV + NLVEWVW+LHREGRLL AAD RLEGQFDE+
Sbjct: 512 SYGAVVLEVASGRRPIEKETSGVGKVTLNGNLVEWVWNLHREGRLLAAADDRLEGQFDES 571
Query: 626 EMRRVLLVGLACSHPDPLARPTMRGVVQML 655
EMRRVLLVGLACSHPDP+ARPTMRGVVQML
Sbjct: 572 EMRRVLLVGLACSHPDPMARPTMRGVVQML 601
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15231802|ref|NP_190906.1| concanavalin A-like lectin kinase-like protein [Arabidopsis thaliana] gi|75334943|sp|Q9LFH9.1|LRK81_ARATH RecName: Full=L-type lectin-domain containing receptor kinase VIII.1; Short=LecRK-VIII.1; Flags: Precursor gi|6729489|emb|CAB67645.1| receptor lectin kinase-like protein [Arabidopsis thaliana] gi|66792710|gb|AAY56457.1| At3g53380 [Arabidopsis thaliana] gi|332645557|gb|AEE79078.1| concanavalin A-like lectin kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 971 bits (2510), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 497/693 (71%), Positives = 579/693 (83%), Gaps = 19/693 (2%)
Query: 8 ILTSLNLSLVFCLFVINNAVITISTATEFDFGTLTLASLKLLGDAHMNNGSVRLTRDVTV 67
+ S +S++ C F N A T T+FDF TL +++LKLLGDA ++NG V LTRD++V
Sbjct: 3 LFLSFFISILLCFF--NGA-----TTTQFDFSTLAISNLKLLGDARLSNGIVGLTRDLSV 55
Query: 68 PYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLNPSSIGAGLAFVITPDGEQVGS 127
P GAGK LYS P+RFR PGTH P SFS+FFSFSITN+NPSSIG GLAFVI+PD +G
Sbjct: 56 PNSGAGKVLYSNPIRFRQPGTHFPTSFSSFFSFSITNVNPSSIGGGLAFVISPDANSIGI 115
Query: 128 AGGSLGLLDEKGAGLGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDL 187
AGGSLGL G+G FVAVEFDTLMDV+F DIN NHVG D+N +VS+ +L T+N+DL
Sbjct: 116 AGGSLGLTGPNGSGSKFVAVEFDTLMDVDFKDINSNHVGFDVNGVVSSVSGDLGTVNIDL 175
Query: 188 KSGDLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGS 247
KSG+ +NSWIEYDGLTR FN+SVSYSNLKPKVPILSF LDLD+YVNDFM+VGFSGSTQGS
Sbjct: 176 KSGNTINSWIEYDGLTRVFNVSVSYSNLKPKVPILSFPLDLDRYVNDFMFVGFSGSTQGS 235
Query: 248 TEIHSIEWWSFSSSFESNSGTGSGSAPPPPTASLMNPTANSVKSPPP-------SLAPSG 300
TEIHSIEWWSFSSS S GSGS PPP A+LMNP ANSVKSPPP S P
Sbjct: 236 TEIHSIEWWSFSSS--FGSSLGSGSGSPPPRANLMNPKANSVKSPPPLASQPSSSAIPIS 293
Query: 301 SSTTQKSSKSSSCHNQLCKQGAGAVAGVVTASAFF-AIFAGVLIWFFSKRYKHVKKSESF 359
S+T K+S SSSCH++ CK+ G +AGVVTA AFF A+FAG L W +SK++K V++S+SF
Sbjct: 294 SNTQLKTSSSSSCHSRFCKENPGTIAGVVTAGAFFLALFAGALFWVYSKKFKRVERSDSF 353
Query: 360 TSDIIRMPKEFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQG 419
S+II+ PKEFSY+EL++ TK FN +RIIGHGAFG VY+GILP+ GDI+AVKRCSH+SQ
Sbjct: 354 ASEIIKAPKEFSYKELKAGTKNFNESRIIGHGAFGVVYRGILPETGDIVAVKRCSHSSQD 413
Query: 420 -KDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPH 478
K+EFLSELSIIG+LRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFE+R LPW H
Sbjct: 414 KKNEFLSELSIIGSLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFESRFTLPWDH 473
Query: 479 RSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDA 538
R KILLGVASALAYLH+ECENQVIHRDVK+SNIMLDE FNA+LGDFGLARQ+EHDKSP+A
Sbjct: 474 RKKILLGVASALAYLHRECENQVIHRDVKSSNIMLDESFNAKLGDFGLARQIEHDKSPEA 533
Query: 539 TVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEI-TGVGKVGVASNL 597
TVAAGTMGYLAPEYLLTGRA+EKTDVFSYGAVVLEV SGRRPIEK++ VGV NL
Sbjct: 534 TVAAGTMGYLAPEYLLTGRASEKTDVFSYGAVVLEVVSGRRPIEKDLNVQRHNVGVNPNL 593
Query: 598 VEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657
VEWVW L++EG++ AAD+RLEG+FDE EM RVL+VGLACSHPDP RPTMR VVQML+G
Sbjct: 594 VEWVWGLYKEGKVSAAADSRLEGKFDEGEMWRVLVVGLACSHPDPAFRPTMRSVVQMLIG 653
Query: 658 EAEVPIVPRAKPSMTFSTSHLLLSLQDSVSDCN 690
EA+VP+VP+++P+M+FSTSHLLLSLQD++SDCN
Sbjct: 654 EADVPVVPKSRPTMSFSTSHLLLSLQDTLSDCN 686
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|62318912|dbj|BAD93993.1| receptor lectin kinase -like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 969 bits (2506), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 496/693 (71%), Positives = 579/693 (83%), Gaps = 19/693 (2%)
Query: 8 ILTSLNLSLVFCLFVINNAVITISTATEFDFGTLTLASLKLLGDAHMNNGSVRLTRDVTV 67
+ S +S++ C F N A T T+FDF TL +++LKLLGDA ++NG V LTRD++V
Sbjct: 3 LFLSFFISILLCFF--NGA-----TTTQFDFSTLAISNLKLLGDARLSNGIVGLTRDLSV 55
Query: 68 PYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLNPSSIGAGLAFVITPDGEQVGS 127
P GAGK LYS P+RFR PGTH P SFS+FFSFSITN+NPSSIG GLAFVI+PD +G
Sbjct: 56 PNSGAGKVLYSNPIRFRQPGTHFPTSFSSFFSFSITNVNPSSIGGGLAFVISPDANSIGI 115
Query: 128 AGGSLGLLDEKGAGLGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDL 187
AGGSLGL G+G FVAVEFDTLMDV+F DIN NHVG D+N +VS+ +L T+N+DL
Sbjct: 116 AGGSLGLTGPNGSGSKFVAVEFDTLMDVDFKDINSNHVGFDVNGVVSSVSGDLGTVNIDL 175
Query: 188 KSGDLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGS 247
KSG+ +NSWIEYDGLTR FN+SVSYSNLKPKVPILSF LDLD+YVNDFM+VGFSGSTQGS
Sbjct: 176 KSGNTINSWIEYDGLTRVFNVSVSYSNLKPKVPILSFPLDLDRYVNDFMFVGFSGSTQGS 235
Query: 248 TEIHSIEWWSFSSSFESNSGTGSGSAPPPPTASLMNPTANSVKSPPP-------SLAPSG 300
TEIHSIEWWSFSSS S GSGS PPP A+LMNP ANSVKSPPP S P
Sbjct: 236 TEIHSIEWWSFSSS--FGSSLGSGSGSPPPRANLMNPKANSVKSPPPLASQPSSSAIPIS 293
Query: 301 SSTTQKSSKSSSCHNQLCKQGAGAVAGVVTASAFF-AIFAGVLIWFFSKRYKHVKKSESF 359
S+T K+S SSSCH++ CK+ G +AGVVTA AFF A+FAG L W +SK++K V++S+SF
Sbjct: 294 SNTQLKTSSSSSCHSRFCKENPGTIAGVVTAGAFFLALFAGALFWVYSKKFKRVERSDSF 353
Query: 360 TSDIIRMPKEFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQG 419
S+II+ PKEFSY+EL++ TK FN +RIIGHGAFG VY+GILP+ GDI+AVKRCSH+SQ
Sbjct: 354 ASEIIKAPKEFSYKELKAGTKNFNESRIIGHGAFGVVYRGILPETGDIVAVKRCSHSSQD 413
Query: 420 -KDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPH 478
K+EFLSELSIIG+LRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFE+R LPW H
Sbjct: 414 KKNEFLSELSIIGSLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFESRFTLPWDH 473
Query: 479 RSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDA 538
R KILLGVASALAYLH+ECENQVIHRDVK+SNIMLDE FNA+LGDFGLARQ+EHDKSP+A
Sbjct: 474 RKKILLGVASALAYLHRECENQVIHRDVKSSNIMLDESFNAKLGDFGLARQIEHDKSPEA 533
Query: 539 TVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEI-TGVGKVGVASNL 597
TVAAGTMGYLAPEYLLTGRA+EKTDVFSYGAVVLEV SGRRPIEK++ VGV NL
Sbjct: 534 TVAAGTMGYLAPEYLLTGRASEKTDVFSYGAVVLEVVSGRRPIEKDLNVQRHNVGVNPNL 593
Query: 598 VEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657
VEWVW L++EG++ AAD+RLEG+FDE EM RVL+VGLACSHPDP RPTMR VVQML+G
Sbjct: 594 VEWVWGLYKEGKVSAAADSRLEGKFDEGEMWRVLVVGLACSHPDPAFRPTMRSVVQMLIG 653
Query: 658 EAEVPIVPRAKPSMTFSTSHLLLSLQDSVSDCN 690
+A+VP+VP+++P+M+FSTSHLLLSLQD++SDCN
Sbjct: 654 KADVPVVPKSRPTMSFSTSHLLLSLQDTLSDCN 686
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297820064|ref|XP_002877915.1| lectin protein kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297323753|gb|EFH54174.1| lectin protein kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 951 bits (2459), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 494/690 (71%), Positives = 575/690 (83%), Gaps = 15/690 (2%)
Query: 16 LVFCLFVINNAVITISTATEFDFGTLTLASLKLLGDAHMNNGSVRLTRDVTVPYDGAGKA 75
+F L N +T T+FDF TL +++LKL+GDA ++NG V LTRD++VP GAGK
Sbjct: 6 FIFILLCFFNG----ATTTQFDFSTLAISNLKLIGDARLSNGIVGLTRDLSVPNSGAGKV 61
Query: 76 LYSKPVRFRLPGTHTPASFSTFFSFSITNLNPSSIGAGLAFVITPDGEQVGSAGGSLGLL 135
LYS P+RFR PGTH P SFSTFFSFSITN+NPSSIG GLAFVI PD +G AGGSLGL
Sbjct: 62 LYSNPIRFRQPGTHFPTSFSTFFSFSITNVNPSSIGGGLAFVIAPDANSIGVAGGSLGLA 121
Query: 136 DEKGAGLGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNS 195
G+G FVAVEFDTLMDV+F DIN NHVG D+N ++S+ +L T+N+DLKSG+ +NS
Sbjct: 122 GPNGSGSKFVAVEFDTLMDVDFKDINSNHVGFDVNGVLSSVSGDLGTVNIDLKSGNTINS 181
Query: 196 WIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGSTEIHSIEW 255
WIEYDGLTR FN+SVSYSNLKPK PILSF LDLDQYVNDFM+VGFSGSTQGSTEIHSIEW
Sbjct: 182 WIEYDGLTRVFNVSVSYSNLKPKAPILSFPLDLDQYVNDFMFVGFSGSTQGSTEIHSIEW 241
Query: 256 WSFSSSFESNSGTGSGSAPPPPTASLMNPTANSVKSPPP------SLAPSGSSTTQKSSK 309
WSFSSSF S G+GS S PP A+LMNP ANSVKSPPP S A SS TQ +
Sbjct: 242 WSFSSSFGSGPGSGSVSP--PPRANLMNPKANSVKSPPPLASQPSSSAIPISSNTQSKTS 299
Query: 310 SSSCHNQLCKQGAGAVAGVVTASAFF-AIFAGVLIWFFSKRYKHVKKSESFTSDIIRMPK 368
SSSCH++ CK+ G +AGVVTA AFF A+FAG L W +SK++K V++S+SF S+II+ PK
Sbjct: 300 SSSCHSRFCKENPGTIAGVVTAGAFFLALFAGALFWVYSKKFKRVERSDSFASEIIKAPK 359
Query: 369 EFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQG-KDEFLSEL 427
EFSY+EL++ TK FN +RIIGHGAFG VY+GILP+ GDI+AVKRCSH+SQ K+EFLSEL
Sbjct: 360 EFSYKELKAGTKNFNESRIIGHGAFGVVYRGILPETGDIVAVKRCSHSSQDKKNEFLSEL 419
Query: 428 SIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVA 487
SIIG+LRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFE+R LPW HR KILLGVA
Sbjct: 420 SIIGSLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFESRFTLPWDHRKKILLGVA 479
Query: 488 SALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGY 547
SALAYLH+ECENQVIHRDVK+SNIMLDE FNA+LGDFGLARQ+EHDKSP+ATVAAGTMGY
Sbjct: 480 SALAYLHRECENQVIHRDVKSSNIMLDENFNAKLGDFGLARQIEHDKSPEATVAAGTMGY 539
Query: 548 LAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEI-TGVGKVGVASNLVEWVWSLHR 606
LAPEYLLTGRA+EKTDVFSYGAVVLEV SGRRPIEK++ VG NLVEWVW L+R
Sbjct: 540 LAPEYLLTGRASEKTDVFSYGAVVLEVVSGRRPIEKDLNVQRQNVGANPNLVEWVWGLYR 599
Query: 607 EGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEAEVPIVPR 666
EG++ AAD+RLEG+FDE EM RVL+VGLACSHPDP ARPTMR VVQML+GEA+VP+VP+
Sbjct: 600 EGKVSAAADSRLEGKFDEGEMWRVLVVGLACSHPDPAARPTMRSVVQMLIGEADVPVVPK 659
Query: 667 AKPSMTFSTSHLLLSLQDSVSDCNGMITLS 696
++P+M+FSTSHLLLSLQD++SDC+ + L+
Sbjct: 660 SRPTMSFSTSHLLLSLQDTLSDCSNTVALN 689
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 711 | ||||||
| TAIR|locus:2083986 | 715 | AT3G53380 [Arabidopsis thalian | 0.963 | 0.958 | 0.646 | 1.9e-241 | |
| TAIR|locus:2143528 | 711 | AT5G03140 [Arabidopsis thalian | 0.554 | 0.554 | 0.700 | 3.8e-227 | |
| TAIR|locus:2162212 | 681 | AT5G55830 [Arabidopsis thalian | 0.483 | 0.505 | 0.589 | 3.9e-153 | |
| TAIR|locus:2165740 | 691 | AT5G42120 [Arabidopsis thalian | 0.434 | 0.447 | 0.482 | 4.5e-105 | |
| TAIR|locus:2099941 | 684 | AT3G55550 [Arabidopsis thalian | 0.461 | 0.479 | 0.476 | 2.5e-104 | |
| TAIR|locus:2142499 | 651 | AT5G10530 [Arabidopsis thalian | 0.499 | 0.545 | 0.454 | 3.2e-100 | |
| TAIR|locus:2133239 | 669 | AT4G02420 [Arabidopsis thalian | 0.486 | 0.517 | 0.461 | 2.9e-99 | |
| TAIR|locus:2170224 | 652 | AT5G06740 [Arabidopsis thalian | 0.427 | 0.466 | 0.476 | 3.7e-99 | |
| TAIR|locus:2040681 | 675 | RLK "receptor lectin kinase" [ | 0.497 | 0.524 | 0.456 | 6e-99 | |
| TAIR|locus:2084375 | 677 | AT3G53810 [Arabidopsis thalian | 0.450 | 0.472 | 0.498 | 2.9e-97 |
| TAIR|locus:2083986 AT3G53380 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2327 (824.2 bits), Expect = 1.9e-241, P = 1.9e-241
Identities = 456/705 (64%), Positives = 536/705 (76%)
Query: 8 ILTSLNLSLVFCLFVINNAVITISTATEFDFGTLTLASLKLLGDAHMNNGSVRLTRDVTV 67
+ S +S++ C F N A T T+FDF TL +++LKLLGDA ++NG V LTRD++V
Sbjct: 3 LFLSFFISILLCFF--NGA-----TTTQFDFSTLAISNLKLLGDARLSNGIVGLTRDLSV 55
Query: 68 PYDGAGKALYSKPVRFRLPGTHTPAXXXXXXXXXITNLNPSSIGAGLAFVITPDGEQVGS 127
P GAGK LYS P+RFR PGTH P ITN+NPSSIG GLAFVI+PD +G
Sbjct: 56 PNSGAGKVLYSNPIRFRQPGTHFPTSFSSFFSFSITNVNPSSIGGGLAFVISPDANSIGI 115
Query: 128 AGGSLGLLDEKGAGLGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDL 187
AGGSLGL G+G FVAVEFDTLMDV+F DIN NHVG D+N +VS+ +L T+N+DL
Sbjct: 116 AGGSLGLTGPNGSGSKFVAVEFDTLMDVDFKDINSNHVGFDVNGVVSSVSGDLGTVNIDL 175
Query: 188 KSGDLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGS 247
KSG+ +NSWIEYDGLTR FN+SVSYSNLKPKVPILSF LDLD+YVNDFM+VGFSGSTQGS
Sbjct: 176 KSGNTINSWIEYDGLTRVFNVSVSYSNLKPKVPILSFPLDLDRYVNDFMFVGFSGSTQGS 235
Query: 248 TEIHXXXXXXXXXXXXXXXXXXXXXXXXXXXXXLMNPTANSVKXX-------XXXXXXXX 300
TEIH LMNP ANSVK
Sbjct: 236 TEIHSIEWWSFSSSFGSSLGSGSGSPPPRAN--LMNPKANSVKSPPPLASQPSSSAIPIS 293
Query: 301 XXXXXXXXXXXXCHNQLCKQXXXXXXXXXTASAFF-AIFAGVLIWFFSKRYKHVKKSESF 359
CH++ CK+ TA AFF A+FAG L W +SK++K V++S+SF
Sbjct: 294 SNTQLKTSSSSSCHSRFCKENPGTIAGVVTAGAFFLALFAGALFWVYSKKFKRVERSDSF 353
Query: 360 TSDIIRMPKEFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQG 419
S+II+ PKEFSY+EL++ TK FN +RIIGHGAFG VY+GILP+ GDI+AVKRCSH+SQ
Sbjct: 354 ASEIIKAPKEFSYKELKAGTKNFNESRIIGHGAFGVVYRGILPETGDIVAVKRCSHSSQD 413
Query: 420 K-DEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPH 478
K +EFLSELSIIG+LRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFE+R LPW H
Sbjct: 414 KKNEFLSELSIIGSLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFESRFTLPWDH 473
Query: 479 RSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDA 538
R KILLGVASALAYLH+ECENQVIHRDVK+SNIMLDE FNA+LGDFGLARQ+EHDKSP+A
Sbjct: 474 RKKILLGVASALAYLHRECENQVIHRDVKSSNIMLDESFNAKLGDFGLARQIEHDKSPEA 533
Query: 539 TVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVG-KVGVASNL 597
TVAAGTMGYLAPEYLLTGRA+EKTDVFSYGAVVLEV SGRRPIEK++ VGV NL
Sbjct: 534 TVAAGTMGYLAPEYLLTGRASEKTDVFSYGAVVLEVVSGRRPIEKDLNVQRHNVGVNPNL 593
Query: 598 VEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657
VEWVW L++EG++ AAD+RLEG+FDE EM RVL+VGLACSHPDP RPTMR VVQML+G
Sbjct: 594 VEWVWGLYKEGKVSAAADSRLEGKFDEGEMWRVLVVGLACSHPDPAFRPTMRSVVQMLIG 653
Query: 658 EAEVPIVPRAKPSMTFSTSHLLLSLQDSVSDCNGMITLSSSSSEN 702
EA+VP+VP+++P+M+FSTSHLLLSLQD++SDCN + L+SS S +
Sbjct: 654 EADVPVVPKSRPTMSFSTSHLLLSLQDTLSDCN-TVALNSSRSSS 697
|
|
| TAIR|locus:2143528 AT5G03140 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1447 (514.4 bits), Expect = 3.8e-227, Sum P(2) = 3.8e-227
Identities = 283/404 (70%), Positives = 335/404 (82%)
Query: 313 CHNQLCKQXXXXXXXXXTASAFF-AIFAGVLIWFFSKRYKHVKKSESFTSDIIRMPKEFS 371
C N+LCK+ TA AFF A+FAGV+IW +SK+ K+ +KSES S+I++ P+EF+
Sbjct: 304 CRNKLCKKSPAAVAGVVTAGAFFLALFAGVIIWVYSKKIKYTRKSESLASEIMKSPREFT 363
Query: 372 YRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIG 431
Y+EL+ AT CF+++R+IG+GAFGTVYKGIL +G+IIA+KRCSH SQG EFLSELS+IG
Sbjct: 364 YKELKLATDCFSSSRVIGNGAFGTVYKGILQDSGEIIAIKRCSHISQGNTEFLSELSLIG 423
Query: 432 TLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALA 491
TLRHRNL+RLQG+C EKGEILL+YDLMPNGSLDKAL+E+ + LPWPHR KILLGVASALA
Sbjct: 424 TLRHRNLLRLQGYCREKGEILLIYDLMPNGSLDKALYESPTTLPWPHRRKILLGVASALA 483
Query: 492 YLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPE 551
YLHQECENQ+IHRDVKTSNIMLD FN +LGDFGLARQ EHDKSPDAT AAGTMGYLAPE
Sbjct: 484 YLHQECENQIIHRDVKTSNIMLDANFNPKLGDFGLARQTEHDKSPDATAAAGTMGYLAPE 543
Query: 552 YLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVG-KVGVASNLVEWVWSLHREGRL 610
YLLTGRATEKTDVFSYGAVVLEV +GRRPI + G + G+ S+LV+WVW L+REG+L
Sbjct: 544 YLLTGRATEKTDVFSYGAVVLEVCTGRRPITRPEPEPGLRPGLRSSLVDWVWGLYREGKL 603
Query: 611 LTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEAEVPIVPRAKPS 670
LTA D RL +F+ EM RV++VGLACS PDP+ RPTMR VVQ+LVGEA+VP VP AKPS
Sbjct: 604 LTAVDERLS-EFNPEEMSRVMMVGLACSQPDPVTRPTMRSVVQILVGEADVPEVPIAKPS 662
Query: 671 --MTFSTSHLLLSLQDSVSDCNGMI----TLSSSSSEND-FIHG 707
M+FSTS LLL+LQDSVSDCN ++ T S SSSE+D FI G
Sbjct: 663 SSMSFSTSELLLTLQDSVSDCNEVLAPISTTSCSSSEHDIFIVG 706
|
|
| TAIR|locus:2162212 AT5G55830 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1039 (370.8 bits), Expect = 3.9e-153, Sum P(2) = 3.9e-153
Identities = 211/358 (58%), Positives = 265/358 (74%)
Query: 336 AIFAGVLIWFFSKRYKHVKKSESFTSDIIRMPKEFSYRELRSATKCFNANRIIGHGAFGT 395
A+F V +F K++K VK + +++I +EFSY+EL +ATK F+++R+IG GAFG
Sbjct: 321 ALF--VFGYFTLKKWKSVKAEKELKTELITGLREFSYKELYTATKGFHSSRVIGRGAFGN 378
Query: 396 VYKGILPQNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLV 454
VY+ + +G I AVKR HNS +GK EFL+ELSII LRH+NLV+LQGWC+EKGE+LLV
Sbjct: 379 VYRAMFVSSGTISAVKRSRHNSTEGKTEFLAELSIIACLRHKNLVQLQGWCNEKGELLLV 438
Query: 455 YDLMPNGSLDKALF-EARS---PLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSN 510
Y+ MPNGSLDK L+ E+++ L W HR I +G+ASAL+YLH ECE QV+HRD+KTSN
Sbjct: 439 YEFMPNGSLDKILYQESQTGAVALDWSHRLNIAIGLASALSYLHHECEQQVVHRDIKTSN 498
Query: 511 IMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAV 570
IMLD FNARLGDFGLAR EHDKSP +T+ AGTMGYLAPEYL G ATEKTD FSYG V
Sbjct: 499 IMLDINFNARLGDFGLARLTEHDKSPVSTLTAGTMGYLAPEYLQYGTATEKTDAFSYGVV 558
Query: 571 VLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRV 630
+LEVA GRRPI+KE V NLV+WVW LH EGR+L A D RL+G+FDE M+++
Sbjct: 559 ILEVACGRRPIDKEPESQKTV----NLVDWVWRLHSEGRVLEAVDERLKGEFDEEMMKKL 614
Query: 631 LLVGLACSHPDPLARPTMRGVVQMLVGEAEVPIVPRAKPSMTFSTSHLLLSLQDSVSD 688
LLVGL C+HPD RP+MR V+Q+L E E VP+ KP+++FS LSL D VS+
Sbjct: 615 LLVGLKCAHPDSNERPSMRRVLQILNNEIEPSPVPKMKPTLSFSCG---LSLDDIVSE 669
|
|
| TAIR|locus:2165740 AT5G42120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 737 (264.5 bits), Expect = 4.5e-105, Sum P(2) = 4.5e-105
Identities = 161/334 (48%), Positives = 210/334 (62%)
Query: 351 KHVKKSESFTSDIIRMPKEFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAV 410
K + + S ++RMP S E++SAT FN N I+G GA TVY+G +P G + AV
Sbjct: 335 KRISEEADSNSGLVRMPGRLSLAEIKSATSGFNENAIVGQGASATVYRGSIPSIGSV-AV 393
Query: 411 KRCS--HNSQ-GKDEFLSELSII-GTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKA 466
KR H Q ++ F +E + + G LRH+NLV+ QGWC E E LV++ +PNGSL +
Sbjct: 394 KRFDREHWPQCNRNPFTTEFTTMTGYLRHKNLVQFQGWCSEGTETALVFEYLPNGSLSEF 453
Query: 467 LFEARS--P------LPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFN 518
L + S P L W R I+LGVASAL YLH+ECE Q+IHRDVKT NIMLD FN
Sbjct: 454 LHKKPSSDPSEEIIVLSWKQRVNIILGVASALTYLHEECERQIIHRDVKTCNIMLDAEFN 513
Query: 519 ARLGDFGLARQVEHDK---SPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVA 575
A+LGDFGLA EH AT+ AGTMGYLAPEY+ TG +EKTDV+S+G VVLEV
Sbjct: 514 AKLGDFGLAEIYEHSALLAGRAATLPAGTMGYLAPEYVYTGVPSEKTDVYSFGVVVLEVC 573
Query: 576 SGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGL 635
+GRRP VG G LV+ +WS G++L AD L +FD EM RVL+VG+
Sbjct: 574 TGRRP-------VGDDGAV--LVDLMWSHWETGKVLDGADIMLREEFDAEEMERVLMVGM 624
Query: 636 ACSHPDPLARPTMRGVVQMLVGEAEVPIVPRAKP 669
C+HPD RP ++ V+++ GEA +P++P +P
Sbjct: 625 VCAHPDSEKRPRVKDAVRIIRGEAPLPVLPARRP 658
|
|
| TAIR|locus:2099941 AT3G55550 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 758 (271.9 bits), Expect = 2.5e-104, Sum P(2) = 2.5e-104
Identities = 163/342 (47%), Positives = 207/342 (60%)
Query: 335 FAIFAGVLIWFFSKRYKHVKKSESFTSDIIRMPKEFSYRELRSATKCFNANRIIGHGAFG 394
FA+ + F ++ K + E + D P FSYREL+ AT F ++G G FG
Sbjct: 302 FAVLVAASL-FVVRKVKDEDRVEEWELDF--GPHRFSYRELKKATNGFGDKELLGSGGFG 358
Query: 395 TVYKGILPQNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILL 453
VYKG LP + + +AVKR SH S QG EF+SE+S IG LRHRNLV+L GWC + ++LL
Sbjct: 359 KVYKGKLPGSDEFVAVKRISHESRQGVREFMSEVSSIGHLRHRNLVQLLGWCRRRDDLLL 418
Query: 454 VYDLMPNGSLDKALFEARSP--LPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNI 511
VYD MPNGSLD LF+ L W R KI+ GVAS L YLH+ E VIHRD+K +N+
Sbjct: 419 VYDFMPNGSLDMYLFDENPEVILTWKQRFKIIKGVASGLLYLHEGWEQTVIHRDIKAANV 478
Query: 512 MLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVV 571
+LD N R+GDFGLA+ EH P AT GT GYLAPE +G+ T TDV+++GAV+
Sbjct: 479 LLDSEMNGRVGDFGLAKLYEHGSDPGATRVVGTFGYLAPELTKSGKLTTSTDVYAFGAVL 538
Query: 572 LEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVL 631
LEVA GRRPIE V +V+WVWS + G + D RL G+FDE E+ V+
Sbjct: 539 LEVACGRRPIETSALPEELV-----MVDWVWSRWQSGDIRDVVDRRLNGEFDEEEVVMVI 593
Query: 632 LVGLACSHPDPLARPTMRGVVQMLVGEAEVPIVPRAKPSMTF 673
+GL CS+ P RPTMR VV L E + P P P+ F
Sbjct: 594 KLGLLCSNNSPEVRPTMRQVVMYL--EKQFPS-PEVVPAPDF 632
|
|
| TAIR|locus:2142499 AT5G10530 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 811 (290.5 bits), Expect = 3.2e-100, Sum P(2) = 3.2e-100
Identities = 168/370 (45%), Positives = 243/370 (65%)
Query: 338 FAGVLIWFFSKRY--KHVKKSESFTS---DIIRM--PKEFSYRELRSATKCFNANRIIGH 390
F LI F ++ K +++E+ TS D+ R P++F+Y++L SA F +R +G
Sbjct: 284 FITSLIVFLKRKQQKKKAEETENLTSINEDLERGAGPRKFTYKDLASAANNFADDRKLGE 343
Query: 391 GAFGTVYKGILPQNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKG 449
G FG VY+G L ++A+K+ + S QGK EF++E+ II +LRHRNLV+L GWCHEK
Sbjct: 344 GGFGAVYRGYLNSLDMMVAIKKFAGGSKQGKREFVTEVKIISSLRHRNLVQLIGWCHEKD 403
Query: 450 EILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTS 509
E L++Y+ MPNGSLD LF + L W R KI LG+ASAL YLH+E E V+HRD+K S
Sbjct: 404 EFLMIYEFMPNGSLDAHLFGKKPHLAWHVRCKITLGLASALLYLHEEWEQCVVHRDIKAS 463
Query: 510 NIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGA 569
N+MLD FNA+LGDFGLAR ++H+ P T AGT GY+APEY+ TGRA++++DV+S+G
Sbjct: 464 NVMLDSNFNAKLGDFGLARLMDHELGPQTTGLAGTFGYMAPEYISTGRASKESDVYSFGV 523
Query: 570 VVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLE-GQFDEAEMR 628
V LE+ +GR+ +++ G+V +NLVE +W L+ +G ++TA D +L G FDE +
Sbjct: 524 VTLEIVTGRKSVDRR---QGRVEPVTNLVEKMWDLYGKGEVITAIDEKLRIGGFDEKQAE 580
Query: 629 RVLLVGLACSHPDPLARPTMRGVVQMLVGEAEVPIVPRAKPSMTFSTSHLLLSLQDSVSD 688
+++VGL C+HPD RP+++ +Q+L EA VP +P P T+ H+ S SVS
Sbjct: 581 CLMIVGLWCAHPDVNTRPSIKQAIQVLNLEAPVPHLPTKMPVATY---HVSSSNTTSVSS 637
Query: 689 CNGMITLSSS 698
+T SS+
Sbjct: 638 GGATVTFSSA 647
|
|
| TAIR|locus:2133239 AT4G02420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 753 (270.1 bits), Expect = 2.9e-99, Sum P(2) = 2.9e-99
Identities = 166/360 (46%), Positives = 224/360 (62%)
Query: 342 LIWFFSKRY-KHVKKSESFTSDIIRMPKEFSYRELRSATKCFNANRIIGHGAFGTVYKGI 400
L+ F KR K ++ E + ++ + +++L ATK F I+G G FG+VYKGI
Sbjct: 311 LVRFIMKRRRKFAEEVEDWETEFGK--NRLRFKDLYYATKGFKDKNILGSGGFGSVYKGI 368
Query: 401 LPQNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMP 459
+P+ IAVKR S+ S QG EF++E+ IG + HRNLV L G+C + E+LLVYD MP
Sbjct: 369 MPKTKKEIAVKRVSNESRQGLKEFVAEIVSIGQMSHRNLVPLVGYCRRRDELLLVYDYMP 428
Query: 460 NGSLDKALFEARS-PLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFN 518
NGSLDK L+ + L W R K++ GVASAL YLH+E E VIHRDVK SN++LD N
Sbjct: 429 NGSLDKYLYNSPEVTLDWKQRFKVINGVASALFYLHEEWEQVVIHRDVKASNVLLDAELN 488
Query: 519 ARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGR 578
RLGDFGLA+ +H P T GT GYLAP+++ TGRAT TDVF++G ++LEVA GR
Sbjct: 489 GRLGDFGLAQLCDHGSDPQTTRVVGTWGYLAPDHIRTGRATTTTDVFAFGVLLLEVACGR 548
Query: 579 RPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACS 638
RPIE + G LV+WV+ E +L A D L ++D+ E+ VL +GL CS
Sbjct: 549 RPIEIN----NQSGERVVLVDWVFRFWMEANILDAKDPNLGSEYDQKEVEMVLKLGLLCS 604
Query: 639 HPDPLARPTMRGVVQMLVGEAEVPIVPRAKPSMTFSTSHLLLSLQDSVSDCNGMITLSSS 698
H DPLARPTMR V+Q L G+A ++P P + S ++L + ++ +GM T SS
Sbjct: 605 HSDPLARPTMRQVLQYLRGDA---MLPDLSP-LDLRGSGIMLGTHNGSNE-SGMFTSGSS 659
|
|
| TAIR|locus:2170224 AT5G06740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 755 (270.8 bits), Expect = 3.7e-99, Sum P(2) = 3.7e-99
Identities = 149/313 (47%), Positives = 207/313 (66%)
Query: 367 PKEFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS-QGKDEFLS 425
P++F REL+ AT F A +G G FG V+KG G IAVKR S S QGK EF++
Sbjct: 315 PQKFKLRELKRATGNFGAENKLGQGGFGMVFKG--KWQGRDIAVKRVSEKSHQGKQEFIA 372
Query: 426 ELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALF---EARSPLPWPHRSKI 482
E++ IG L HRNLV+L GWC+E+ E LLVY+ MPNGSLDK LF ++RS L W R I
Sbjct: 373 EITTIGNLNHRNLVKLLGWCYERKEYLLVYEYMPNGSLDKYLFLEDKSRSNLTWETRKNI 432
Query: 483 LLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVA- 541
+ G++ AL YLH CE +++HRD+K SN+MLD FNA+LGDFGLAR ++ + +
Sbjct: 433 ITGLSQALEYLHNGCEKRILHRDIKASNVMLDSDFNAKLGDFGLARMIQQSEMTHHSTKE 492
Query: 542 -AGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEW 600
AGT GY+APE L GRAT +TDV+++G ++LEV SG++P + + +++V W
Sbjct: 493 IAGTPGYMAPETFLNGRATVETDVYAFGVLMLEVVSGKKP-SYVLVKDNQNNYNNSIVNW 551
Query: 601 VWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEAE 660
+W L+R G + AAD + FD+ EM+ VLL+GLAC HP+P RP+M+ V+++L GE
Sbjct: 552 LWELYRNGTITDAADPGMGNLFDKEEMKSVLLLGLACCHPNPNQRPSMKTVLKVLTGETS 611
Query: 661 VPIVPRAKPSMTF 673
P VP +P+ +
Sbjct: 612 PPDVPTERPAFVW 624
|
|
| TAIR|locus:2040681 RLK "receptor lectin kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 763 (273.6 bits), Expect = 6.0e-99, Sum P(2) = 6.0e-99
Identities = 169/370 (45%), Positives = 228/370 (61%)
Query: 333 AFFAIFAGVLI--WFFSKRYKHVKKSESFTSDIIRMPKEFSYRELRSATKCFNANRIIGH 390
+ F IF+ + + + +R K ++ E + + + F +++L ATK F ++G
Sbjct: 298 SLFLIFSFIFLVCYIVRRRRKFAEELEEWEKEFGK--NRFRFKDLYYATKGFKEKGLLGT 355
Query: 391 GAFGTVYKGILPQNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKG 449
G FG+VYKG++P IAVKR SH S QG EF++E+ IG + HRNLV L G+C +G
Sbjct: 356 GGFGSVYKGVMPGTKLEIAVKRVSHESRQGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRG 415
Query: 450 EILLVYDLMPNGSLDKALFEARS-PLPWPHRSKILLGVASALAYLHQECENQVIHRDVKT 508
E+LLVYD MPNGSLDK L+ L W R K++LGVAS L YLH+E E VIHRDVK
Sbjct: 416 ELLLVYDYMPNGSLDKYLYNTPEVTLNWKQRIKVILGVASGLFYLHEEWEQVVIHRDVKA 475
Query: 509 SNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYG 568
SN++LD N RLGDFGLAR +H P T GT+GYLAPE+ TGRAT TDVF++G
Sbjct: 476 SNVLLDGELNGRLGDFGLARLYDHGSDPQTTHVVGTLGYLAPEHTRTGRATMATDVFAFG 535
Query: 569 AVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMR 628
A +LEVA GRRPIE + + LV+WV+ L +G +L A D + + DE E+
Sbjct: 536 AFLLEVACGRRPIEFQ----QETDETFLLVDWVFGLWNKGDILAAKDPNMGSECDEKEVE 591
Query: 629 RVLLVGLACSHPDPLARPTMRGVVQMLVGEAEVPIVPRAKPSMTFSTSHLLLSLQDSVSD 688
VL +GL CSH DP ARP+MR V+ L G+A++P P + S S ++ + D S+
Sbjct: 592 MVLKLGLLCSHSDPRARPSMRQVLHYLRGDAKLP---ELSP-LDLSGSGMMFGVHDGFSE 647
Query: 689 CNGMITLSSS 698
GM + SSS
Sbjct: 648 L-GM-SYSSS 655
|
|
| TAIR|locus:2084375 AT3G53810 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 745 (267.3 bits), Expect = 2.9e-97, Sum P(2) = 2.9e-97
Identities = 165/331 (49%), Positives = 207/331 (62%)
Query: 337 IFAGVLIWFFSKRYKHVKKSESFTSDI-IRMPKE-FSYRELRSATKCFNANRIIGHGAFG 394
IF+ + + F+ R K KK E D K F ++EL ATK F ++G G FG
Sbjct: 302 IFSIIFLAFYIVRRK--KKYEEELDDWETEFGKNRFRFKELYHATKGFKEKDLLGSGGFG 359
Query: 395 TVYKGILPQNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILL 453
VY+GILP +AVKR SH+S QG EF++E+ IG + HRNLV L G+C +GE+LL
Sbjct: 360 RVYRGILPTTKLEVAVKRVSHDSKQGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLL 419
Query: 454 VYDLMPNGSLDKALFE-ARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIM 512
VYD MPNGSLDK L+ + L W RS I+ GVAS L YLH+E E VIHRDVK SN++
Sbjct: 420 VYDYMPNGSLDKYLYNNPETTLDWKQRSTIIKGVASGLFYLHEEWEQVVIHRDVKASNVL 479
Query: 513 LDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVL 572
LD FN RLGDFGLAR +H P T GT+GYLAPE+ TGRAT TDV+++GA +L
Sbjct: 480 LDADFNGRLGDFGLARLYDHGSDPQTTHVVGTLGYLAPEHSRTGRATTTTDVYAFGAFLL 539
Query: 573 EVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQ-FDEAEMRRVL 631
EV SGRRPIE LVEWV+SL G ++ A D +L +D E+ VL
Sbjct: 540 EVVSGRRPIEFHSASDDTF----LLVEWVFSLWLRGNIMEAKDPKLGSSGYDLEEVEMVL 595
Query: 632 LVGLACSHPDPLARPTMRGVVQMLVGEAEVP 662
+GL CSH DP ARP+MR V+Q L G+ +P
Sbjct: 596 KLGLLCSHSDPRARPSMRQVLQYLRGDMALP 626
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9LFH9 | LRK81_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7171 | 0.9479 | 0.9426 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 711 | |||
| cd06899 | 236 | cd06899, lectin_legume_LecRK_Arcelin_ConA, legume | 6e-82 | |
| pfam00139 | 231 | pfam00139, Lectin_legB, Legume lectin domain | 4e-70 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-52 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-51 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-50 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-50 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-50 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-48 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-46 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-39 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-38 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-32 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-30 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-30 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-30 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-29 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-28 | |
| cd01951 | 223 | cd01951, lectin_L-type, legume lectins | 3e-28 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-28 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-28 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 9e-28 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-27 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-27 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-27 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-27 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-27 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-27 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-27 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-27 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-26 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-26 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-26 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-26 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-25 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-25 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-25 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-25 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-24 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-24 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-24 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-24 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-24 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-24 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-24 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 8e-24 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-23 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-23 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-23 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-23 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 9e-23 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-22 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-22 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-22 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-22 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-22 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-22 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 9e-22 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 9e-22 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-21 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-21 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-21 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-21 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-21 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-21 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-21 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-21 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-21 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-20 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-20 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-20 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-20 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-20 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-20 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-20 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-20 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-19 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-19 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-19 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-19 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-19 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-19 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-19 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-19 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-19 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-18 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-18 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-18 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-18 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-18 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-18 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-18 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-18 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-18 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 8e-18 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 8e-18 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-17 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-17 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-17 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-17 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-17 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-17 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-17 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-17 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-17 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-17 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-17 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-17 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-17 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-17 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 9e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-16 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-16 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-16 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-16 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 9e-16 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-15 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-15 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-15 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-15 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-15 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-15 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-15 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-15 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-15 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 8e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-14 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-14 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-14 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-14 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-14 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-14 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 8e-14 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 9e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-13 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-13 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-13 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-12 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-12 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-12 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-12 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-12 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 9e-12 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-11 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-10 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-10 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 6e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 9e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-09 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-09 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 8e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 9e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-08 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 9e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 9e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 9e-08 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-07 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-06 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 7e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 8e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.003 |
| >gnl|CDD|173887 cd06899, lectin_legume_LecRK_Arcelin_ConA, legume lectins, lectin-like receptor kinases, arcelin, concanavalinA, and alpha-amylase inhibitor | Back alignment and domain information |
|---|
Score = 259 bits (664), Expect = 6e-82
Identities = 105/237 (44%), Positives = 143/237 (60%), Gaps = 9/237 (3%)
Query: 34 TEFDFG--TLTLASLKLLGDAH-MNNGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTHT 90
F+F + ++L L GDA +NG+++LT D T P G+ALYSKPVR T
Sbjct: 1 LSFNFNGFSSDQSNLTLQGDATISSNGALQLTND-TSPASSVGRALYSKPVRLWDSTTGK 59
Query: 91 PASFSTFFSFSITNLNPSSIGAGLAFVITPDGEQVG-SAGGSLGLLDEKGAGLG---FVA 146
ASFST FSFSIT NPS G GLAF + P S+GG LGL + G VA
Sbjct: 60 VASFSTSFSFSITPPNPSLGGDGLAFFLAPTDSLPPASSGGYLGLFNSSNNGNSSNHIVA 119
Query: 147 VEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLTRAF 206
VEFDT + EF D + NHVG+D+NS+VS + D LKSG + +WI+YD ++
Sbjct: 120 VEFDTFQNPEFGDPDDNHVGIDVNSLVSVKAGYWDDDGGKLKSGKPMQAWIDYDSSSKRL 179
Query: 207 NISVSYSNL-KPKVPILSFTLDLDQYVNDFMYVGFSGSTQGSTEIHSIEWWSFSSSF 262
+++++YS + KPK P+LS+ +DL + + + +YVGFS ST TE+H I WSFSS+
Sbjct: 180 SVTLAYSGVAKPKKPLLSYPVDLSKVLPEEVYVGFSASTGLLTELHYILSWSFSSNG 236
|
This alignment model includes the legume lectins (also known as agglutinins), the arcelin (also known as phytohemagglutinin-L) family of lectin-like defense proteins, the LecRK family of lectin-like receptor kinases, concanavalinA (ConA), and an alpha-amylase inhibitor. Arcelin is a major seed glycoprotein discovered in kidney beans (Phaseolus vulgaris) that has insecticidal properties and protects the seeds from predation by larvae of various bruchids. Arcelin is devoid of monosaccharide binding properties and lacks a key metal-binding loop that is present in other members of this family. Phytohaemagglutinin (PHA) is a lectin found in plants, especially beans, that affects cell metabolism by inducing mitosis and by altering the permeability of the cell membrane to various proteins. PHA agglutinates most mammalian red blood cell types by binding glycans on the cell surface. Medically, PHA is used as a mitogen to trigger cell division in T-lymphocytes and to activate latent HIV-1 from human peripheral lymphocytes. Plant L-type lectins are primarily found in the seeds of leguminous plants where they constitute about 10% of the total soluble protein of the seed extracts. They are synthesized during seed development several weeks after flowering and transported to the vacuole where they become condensed into specialized vesicles called protein bodies. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. Length = 236 |
| >gnl|CDD|215744 pfam00139, Lectin_legB, Legume lectin domain | Back alignment and domain information |
|---|
Score = 227 bits (582), Expect = 4e-70
Identities = 100/235 (42%), Positives = 147/235 (62%), Gaps = 11/235 (4%)
Query: 32 TATEFDFGTLTLAS-LKLLGDAHMN-NGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTH 89
+ F++ + S L L GDA + NG ++LT V + AG+ALYSKP+R T
Sbjct: 1 STVSFNYNGFSNVSNLTLQGDATVLPNGLLQLT---NVTNNSAGRALYSKPIRLWDSSTG 57
Query: 90 TPASFSTFFSFSITNLNPSSIGA-GLAFVITPDGEQVGS-AGGSLGLLDEKGAGL---GF 144
ASFST F F+I N+ S+ G GLAF + P G Q G+ +GG LGL + G
Sbjct: 58 KVASFSTSFVFAIKNIPKSTNGGDGLAFFLAPSGTQPGASSGGYLGLFNSSNNGNSSNHI 117
Query: 145 VAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLTR 204
VAVEFDT ++ EF+DI+ NHVG+D+NS++S ++ + +DL SG + WI+YDG ++
Sbjct: 118 VAVEFDTFLNPEFNDIDDNHVGIDVNSIISVASESASFVPLDLNSGKPIQVWIDYDGSSK 177
Query: 205 AFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGSTEIHSIEWWSFS 259
+++++Y N KPK P+LS ++DL + +++YVGFS ST G+TE H + WSFS
Sbjct: 178 RLSVTLAYPN-KPKRPLLSASVDLSTVLPEWVYVGFSASTGGATESHYVLSWSFS 231
|
Length = 231 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 9e-52
Identities = 79/279 (28%), Positives = 127/279 (45%), Gaps = 33/279 (11%)
Query: 385 NRIIGHGAFGTVYKGILPQNGDI----IAVKRC--SHNSQGKDEFLSELSIIGTLRHRNL 438
+ +G GAFG VYKG L G +AVK + Q +EFL E I+ L H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 439 VRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECE 498
V+L G C E+ + +V + M G L L + R L L +A + YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE---S 120
Query: 499 NQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRA 558
IHRD+ N ++ E ++ DFGL+R + D + ++APE L G+
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKF 180
Query: 559 TEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADAR 617
T K+DV+S+G ++ E+ + G +P ++ ++E++ + G R
Sbjct: 181 TSKSDVWSFGVLLWEIFTLGEQP-YPGMS-------NEEVLEYL----KNGY-------R 221
Query: 618 LEGQFD-EAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655
L + E+ ++ L C DP RPT +V++L
Sbjct: 222 LPQPPNCPPELYDLM---LQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 177 bits (450), Expect = 3e-51
Identities = 70/190 (36%), Positives = 101/190 (53%), Gaps = 8/190 (4%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKR--CSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWC 445
+G G FGTVY + G +A+K +S +E L E+ I+ L H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 446 HEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRD 505
++ + LV + GSL L E L +ILL + L YLH N +IHRD
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRD 117
Query: 506 VKTSNIMLDEG-FNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLL-TGRATEKTD 563
+K NI+LD +L DFGL++ + DKS T+ GT Y+APE LL G +EK+D
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI-VGTPAYMAPEVLLGKGYYSEKSD 176
Query: 564 VFSYGAVVLE 573
++S G ++ E
Sbjct: 177 IWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 177 bits (450), Expect = 1e-50
Identities = 74/199 (37%), Positives = 101/199 (50%), Gaps = 9/199 (4%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVK---RCSHNSQGKDEFLSELSIIGTLRHRNLVRLQ 442
R +G G+FGTVYK G I+AVK + S S+ E+ I+ L H N+VRL
Sbjct: 5 RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64
Query: 443 GWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVI 502
+K + LV + G L L PL KI L + L YLH N +I
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYLSRGG-PLSEDEAKKIALQILRGLEYLH---SNGII 120
Query: 503 HRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGR-ATEK 561
HRD+K NI+LDE ++ DFGLA+++ S T GT Y+APE LL G K
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLK-SSSSLTTFVGTPWYMAPEVLLGGNGYGPK 179
Query: 562 TDVFSYGAVVLEVASGRRP 580
DV+S G ++ E+ +G+ P
Sbjct: 180 VDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 4e-50
Identities = 81/283 (28%), Positives = 134/283 (47%), Gaps = 40/283 (14%)
Query: 385 NRIIGHGAFGTVYKGIL---PQNGDI-IAVK--RCSHNSQGKDEFLSELSIIGTLRHRNL 438
+ +G GAFG VYKG L ++ +AVK + + Q +EFL E I+ L H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 439 VRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSP-LPWPHRSKILLGVASALAYLHQEC 497
V+L G C E+ +++V + MP G L L + R L L +A + YL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE--- 120
Query: 498 ENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMG---YLAPEYLL 554
IHRD+ N ++ E ++ DFGL+R + D D G ++APE L
Sbjct: 121 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD---DYYKVKGGKLPIRWMAPESLK 177
Query: 555 TGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTA 613
G+ T K+DV+S+G ++ E+ + G P ++ + ++E++ ++G
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEEP-YPGMS-------NAEVLEYL----KKGY---- 221
Query: 614 ADARLEGQFD-EAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655
RL + E+ +++ L C DP RPT +V++L
Sbjct: 222 ---RLPKPPNCPPELYKLM---LQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 174 bits (445), Expect = 5e-50
Identities = 79/281 (28%), Positives = 130/281 (46%), Gaps = 36/281 (12%)
Query: 385 NRIIGHGAFGTVYKGIL---PQNGDI-IAVK--RCSHNSQGKDEFLSELSIIGTLRHRNL 438
+ +G GAFG VYKG L + + +AVK + + + ++EFL E SI+ L H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNI 63
Query: 439 VRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECE 498
VRL G C + + +V + MP G L L + L ++ L +A + YL
Sbjct: 64 VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE---S 120
Query: 499 NQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMG---YLAPEYLLT 555
+HRD+ N ++ E ++ DFGL+R + D G ++APE L
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYED--DYYRKRGGGKLPIKWMAPESLKD 178
Query: 556 GRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614
G+ T K+DV+S+G ++ E+ + G +P ++ ++E + +G L
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEQPY-PGMS-------NEEVLELL----EDGYRL--- 223
Query: 615 DARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655
R E E+ ++ L C DP RPT +V+ L
Sbjct: 224 -PRPEN--CPDELYELM---LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 3e-48
Identities = 77/288 (26%), Positives = 124/288 (43%), Gaps = 45/288 (15%)
Query: 386 RIIGHGAFGTVYKGILPQNGD---IIAVKRC--SHNSQGKDEFLSELSIIGTLRHRNLVR 440
+ +G GAFG VYKG L +AVK + + + +FL E ++ L H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 441 LQGWCHEKGEILLVYDLMPNGSLDKAL--------FEARSPLPWPHRSKILLGVASALAY 492
L G C E+ + LV + M G L L +S L + +A + Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 493 LHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTM---GYLA 549
L + +HRD+ N ++ E ++ DFGL+R + G ++A
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSR--DVYDDDYYRKKTGGKLPIRWMA 175
Query: 550 PEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREG 608
PE L G T K+DV+S+G ++ E+ + G P G+ ++E++ R+G
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYP----GL----SNEEVLEYL----RKG 223
Query: 609 -RLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655
RL E+ ++ L+C DP RPT +V+ L
Sbjct: 224 YRLPKPEYCP-------DELYELM---LSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 4e-46
Identities = 66/197 (33%), Positives = 101/197 (51%), Gaps = 8/197 (4%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDE--FLSELSIIGTLRHRNLVRLQG 443
+G G+FG VY + G ++A+K KD L E+ I+ L+H N+VRL
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 444 WCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIH 503
++ ++ LV + G L L + R L L + SAL YLH ++H
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLL-KKRGRLSEDEARFYLRQILSALEYLHS---KGIVH 120
Query: 504 RDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTD 563
RD+K NI+LDE + +L DFGLARQ++ + T GT Y+APE LL + D
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLDPGEK--LTTFVGTPEYMAPEVLLGKGYGKAVD 178
Query: 564 VFSYGAVVLEVASGRRP 580
++S G ++ E+ +G+ P
Sbjct: 179 IWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 143 bits (364), Expect = 7e-39
Identities = 62/197 (31%), Positives = 98/197 (49%), Gaps = 6/197 (3%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEF-LSELSIIGTLRHRNLVRLQGWCH 446
IG G FG VYK + G +A+K S+ K E ++E+ I+ +H N+V+ G
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 447 EKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDV 506
+K E+ +V + GSL L L + + + L YLH N +IHRD+
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDI 124
Query: 507 KTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFS 566
K +NI+L +L DFGL+ Q+ K+ + V GT ++APE + K D++S
Sbjct: 125 KAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV--GTPYWMAPEVINGKPYDYKADIWS 182
Query: 567 YGAVVLEVASGRRPIEK 583
G +E+A G+ P +
Sbjct: 183 LGITAIELAEGKPPYSE 199
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 1e-38
Identities = 64/201 (31%), Positives = 109/201 (54%), Gaps = 10/201 (4%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVK--RCSHNSQGKDEFL-SELSIIGTLRHRNLVRLQ 442
++G G+FG+VY + G+++AVK S +S+ + E L E+ I+ +L+H N+VR
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 443 GWCH--EKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQ 500
G EK + + + + GSL L + LP P K + LAYLH N
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL-KKFGKLPEPVIRKYTRQILEGLAYLH---SNG 121
Query: 501 VIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVA-AGTMGYLAPEYLLTGRAT 559
++HRD+K +NI++D +L DFG A+++ ++ + T + GT ++APE +
Sbjct: 122 IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYG 181
Query: 560 EKTDVFSYGAVVLEVASGRRP 580
D++S G V+E+A+G+ P
Sbjct: 182 RAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 5e-32
Identities = 67/199 (33%), Positives = 104/199 (52%), Gaps = 7/199 (3%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVK--RCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWC 445
+G G G V K + G I+AVK R N + + L EL I+ +V G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 446 HEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRD 505
+ G+I + + M GSLDK L E + +P KI + V L YLH+ ++++IHRD
Sbjct: 69 YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE--KHKIIHRD 126
Query: 506 VKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVF 565
VK SNI+++ +L DFG++ Q+ + A GT Y+APE + + K+D++
Sbjct: 127 VKPSNILVNSRGQIKLCDFGVSGQLVNSL---AKTFVGTSSYMAPERIQGNDYSVKSDIW 183
Query: 566 SYGAVVLEVASGRRPIEKE 584
S G ++E+A+GR P E
Sbjct: 184 SLGLSLIELATGRFPYPPE 202
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 62/197 (31%), Positives = 107/197 (54%), Gaps = 8/197 (4%)
Query: 387 IIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKD---EFLSELSIIGTLRHRNLVRLQG 443
+IG GAFG VYKG+ + GD +A+K+ S ++ + E+ ++ L+H N+V+ G
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 444 WCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIH 503
+ ++ + NGSL + + + P P + + V LAYLH++ VIH
Sbjct: 67 SIETSDSLYIILEYAENGSLRQ-IIKKFGPFPESLVAVYVYQVLQGLAYLHEQ---GVIH 122
Query: 504 RDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTD 563
RD+K +NI+ + +L DFG+A ++ DA+V GT ++APE + A+ +D
Sbjct: 123 RDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV-VGTPYWMAPEVIEMSGASTASD 181
Query: 564 VFSYGAVVLEVASGRRP 580
++S G V+E+ +G P
Sbjct: 182 IWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 28/214 (13%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCS---HNSQGKDEFLSELSIIGTLRHRNLVRLQ 442
+ IG G+FG VY +G + +K + + +++ L+E+ I+ L H N+++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK-- 63
Query: 443 GWCHE----KGEILLVYDLMPNGSLDKALFEARS---PLP----WPHRSKILLGVASALA 491
+E KG++ +V + G L + + + + P P + + AL
Sbjct: 64 --YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQIL----DWFVQLCLALK 117
Query: 492 YLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPE 551
YLH +++HRD+K NI L +LGDFG+++ + A GT YL+PE
Sbjct: 118 YLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST-VDLAKTVVGTPYYLSPE 173
Query: 552 YLLTGRA-TEKTDVFSYGAVVLEVASGRRPIEKE 584
L + K+D++S G V+ E+ + + P E E
Sbjct: 174 -LCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 66/210 (31%), Positives = 103/210 (49%), Gaps = 17/210 (8%)
Query: 387 IIGHGAFGTVYKGILPQNGDIIAVKRCSH---NSQGKDEFLSELSIIGTLRHRNLVRLQG 443
IG G+FGTV K +G I+ K + + K + +SE++I+ L+H N+VR
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 444 WCHEKGE----ILLVY----DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLH- 494
++ I++ Y DL L + + R + +IL + AL H
Sbjct: 67 RIIDRSNQTLYIVMEYCEGGDL---AQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 495 -QECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYL 553
+ N V+HRD+K +NI LD N +LGDFGLA+ + HD S A GT Y++PE L
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF-AKTYVGTPYYMSPEQL 182
Query: 554 LTGRATEKTDVFSYGAVVLEVASGRRPIEK 583
EK+D++S G ++ E+ + P
Sbjct: 183 NHMSYDEKSDIWSLGCLIYELCALSPPFTA 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 65/207 (31%), Positives = 100/207 (48%), Gaps = 21/207 (10%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEF----LSELSIIGTLRHRNLVRL 441
IG G +G VYK + G+++A+K+ K+ F + E+ ++ LRH N+VRL
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIR-MENEKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 442 QGWCHEK--GEILLVYDLMP---NGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQE 496
+ K G I +V++ M G LD + + + L YLH
Sbjct: 64 KEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK----FTESQIKCYMKQLLEGLQYLHS- 118
Query: 497 CENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTG 556
N ++HRD+K SNI+++ +L DFGLAR S D T T+ Y PE LL G
Sbjct: 119 --NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPE-LLLG 175
Query: 557 --RATEKTDVFSYGAVVLEVASGRRPI 581
R + D++S G ++ E+ G +PI
Sbjct: 176 ATRYGPEVDMWSVGCILAELFLG-KPI 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 69/213 (32%), Positives = 108/213 (50%), Gaps = 20/213 (9%)
Query: 380 KCFNANRIIGHGAFGTVYKGILPQNGD---IIAVKRCSHNSQGKD--EFLSELSIIGTLR 434
++IG G FG V +G L G +A+K S K +FL+E SI+G
Sbjct: 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD 63
Query: 435 HRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLH 494
H N++RL+G + ++++ + M NGSLDK L E +L G+AS + YL
Sbjct: 64 HPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS 123
Query: 495 QECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMG------YL 548
+ +HRD+ NI+++ ++ DFGL+R++E +AT T G +
Sbjct: 124 EMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE---DSEATYT--TKGGKIPIRWT 175
Query: 549 APEYLLTGRATEKTDVFSYGAVVLEVAS-GRRP 580
APE + + T +DV+S+G V+ EV S G RP
Sbjct: 176 APEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 65/199 (32%), Positives = 97/199 (48%), Gaps = 19/199 (9%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHE 447
IG G FG V G G +AVK +S FL+E S++ TLRH NLV+L G +
Sbjct: 14 IGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 448 KGEILLVYDLMPNGSL-DKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDV 506
+ +V + M GSL D R+ + + L V + YL E +HRD+
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDL 128
Query: 507 KTSNIMLDEGFNARLGDFGLAR--QVEHD--KSPDATVAAGTMGYLAPEYLLTGRATEKT 562
N+++ E A++ DFGLA+ D K P + + APE L + + K+
Sbjct: 129 AARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLP--------VKWTAPEALREKKFSTKS 180
Query: 563 DVFSYGAVVLEVAS-GRRP 580
DV+S+G ++ E+ S GR P
Sbjct: 181 DVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 117 bits (292), Expect = 3e-28
Identities = 72/219 (32%), Positives = 111/219 (50%), Gaps = 22/219 (10%)
Query: 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVK--RCSHNSQGKDE--FLSELSIIGTLRH-R 436
+ R +G G+FG VY + ++A+K S+ K+ FL E+ I+ +L H
Sbjct: 2 YRILRKLGEGSFGEVYLARDRK---LVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 437 NLVRLQGWCHEKGEILLVYDLMPNGSLDKAL--FEARSPLPWPHRSKILLGVASALAYLH 494
N+V+L + ++G + LV + + GSL+ L + PL IL + SAL YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 495 QECENQVIHRDVKTSNIMLDE-GFNARLGDFGLARQVEHDKSP-----DATVAAGTMGYL 548
+IHRD+K NI+LD G +L DFGLA+ + S + + GT GY+
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 549 APEYLL---TGRATEKTDVFSYGAVVLEVASGRRPIEKE 584
APE LL A+ +D++S G + E+ +G P E E
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGE 214
|
Length = 384 |
| >gnl|CDD|173886 cd01951, lectin_L-type, legume lectins | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 3e-28
Identities = 63/211 (29%), Positives = 92/211 (43%), Gaps = 19/211 (9%)
Query: 55 NNGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLNPSSIGAGL 114
++G +RLT D + AG A Y P+ F+T F F + + G+
Sbjct: 27 DSGVLRLTPDTG---NQAGSAWYKTPIDLS-------KDFTTTFKFYLGTKGTNG-ADGI 75
Query: 115 AFVITPDGEQVGSAGGSLGLLDEKGAGLGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVS 174
AFV+ D GG G L G G VAVEFDT + + +D NGNH+ +D+N +
Sbjct: 76 AFVLQNDPAGALGGGGGGGGLGYGGIG-NSVAVEFDTYKNDDNNDPNGNHISIDVNGNGN 134
Query: 175 TEVDNLDTINVDLKSGDLVNS----WIEYDGLTRAFNISVSYSNL-KPKVPILSFTLDLD 229
+ L +G + + I YD T ++V N ++ +DL
Sbjct: 135 NTALATSLGSASLPNGTGLGNEHTVRITYDPTTN--TLTVYLDNGSTLTSLDITIPVDLI 192
Query: 230 QYVNDFMYVGFSGSTQGSTEIHSIEWWSFSS 260
Q Y GF+ ST G T +H I WSF+S
Sbjct: 193 QLGPTKAYFGFTASTGGLTNLHDILNWSFTS 223
|
The L-type (legume-type) lectins are a highly diverse family of carbohydrate binding proteins that generally display no enzymatic activity toward the sugars they bind. This family includes arcelin, concanavalinA, the lectin-like receptor kinases, the ERGIC-53/VIP36/EMP46 type1 transmembrane proteins, and an alpha-amylase inhibitor. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. Length = 223 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 65/208 (31%), Positives = 107/208 (51%), Gaps = 16/208 (7%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRC---SHNSQGKDEFLSELSIIGTLRHRNLVRLQGW 444
IG G+FG V+K + + + A+K+ N + ++E + E ++ L ++R
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 445 CHEKGEILLVYDLMPNGSLDKALFEAR-SPLP----WPHRSKILLGVASALAYLHQECEN 499
+KG++ +V + NG L K L R PLP W +ILLG LA+LH
Sbjct: 68 FLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----LAHLHS---K 120
Query: 500 QVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRAT 559
+++HRD+K+ N+ LD N ++GD G+A+ + D + A GT YL+PE
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAK-LLSDNTNFANTIVGTPYYLSPELCEDKPYN 179
Query: 560 EKTDVFSYGAVVLEVASGRRPIEKEITG 587
EK+DV++ G V+ E +G+ P + G
Sbjct: 180 EKSDVWALGVVLYECCTGKHPFDANNQG 207
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 6e-28
Identities = 56/197 (28%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 387 IIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEF----LSELSIIGTLRHRNLVRLQ 442
+G G +G VYK + G+I+A+K+ ++ L E+S++ L+H N+V+L
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKK-IRLDNEEEGIPSTALREISLLKELKHPNIVKLL 64
Query: 443 GWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVI 502
H + ++ LV++ L K L + PL I+ + LAY H ++++
Sbjct: 65 DVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS---HRIL 120
Query: 503 HRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRA-TEK 561
HRD+K NI+++ +L DFGLAR T+ Y APE LL + +
Sbjct: 121 HRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEILLGSKHYSTA 179
Query: 562 TDVFSYGAVVLEVASGR 578
D++S G + E+ +G+
Sbjct: 180 VDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 9e-28
Identities = 65/208 (31%), Positives = 110/208 (52%), Gaps = 11/208 (5%)
Query: 381 CFNANRIIGHGAFGTVYKGILPQNGD---IIAVK--RCSHNSQGKDEFLSELSIIGTLRH 435
++IG G FG V++GIL G +A+K + + + + +FLSE SI+G H
Sbjct: 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSH 65
Query: 436 RNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQ 495
N++RL+G + +++ + M NG+LDK L + +L G+A+ + YL
Sbjct: 66 HNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL-- 123
Query: 496 ECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMG--YLAPEYL 553
+ +HRD+ NI+++ ++ DFGL+R +E D T + G + + APE +
Sbjct: 124 -SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAI 182
Query: 554 LTGRATEKTDVFSYGAVVLEVAS-GRRP 580
+ T +DV+S+G V+ EV S G RP
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 58/199 (29%), Positives = 97/199 (48%), Gaps = 5/199 (2%)
Query: 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRL 441
F+ +G G++G+VYK I + G ++A+K E + E+SI+ +V+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-DLQEIIKEISILKQCDSPYIVKY 63
Query: 442 QGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQV 501
G + ++ +V + GS+ + L + IL L YLH N+
Sbjct: 64 YGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS---NKK 120
Query: 502 IHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEK 561
IHRD+K NI+L+E A+L DFG++ Q+ + TV GT ++APE + K
Sbjct: 121 IHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTV-IGTPFWMAPEVIQEIGYNNK 179
Query: 562 TDVFSYGAVVLEVASGRRP 580
D++S G +E+A G+ P
Sbjct: 180 ADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 62/194 (31%), Positives = 98/194 (50%), Gaps = 6/194 (3%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHE 447
IG GA G VYK G +A+K+ Q K+ ++E+ I+ +H N+V +
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYD-SYL 85
Query: 448 KGEIL-LVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDV 506
G+ L +V + M GSL + + + P + + V L YLH VIHRD+
Sbjct: 86 VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDI 142
Query: 507 KTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFS 566
K+ NI+L + + +L DFG A Q+ +KS +V GT ++APE + K D++S
Sbjct: 143 KSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV-VGTPYWMAPEVIKRKDYGPKVDIWS 201
Query: 567 YGAVVLEVASGRRP 580
G + +E+A G P
Sbjct: 202 LGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 67/206 (32%), Positives = 110/206 (53%), Gaps = 21/206 (10%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKD------EFLSELSIIGTLRHRNLV 439
++G G+FG+VY+G+ +GD AVK S G+ + E++++ L+H N+V
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 440 RLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWP----HRSKILLGVASALAYLHQ 495
+ G E+ + + +L+P GSL K L + P P + +ILLG L YLH
Sbjct: 66 QYLGTEREEDNLYIFLELVPGGSLAK-LLKKYGSFPEPVIRLYTRQILLG----LEYLH- 119
Query: 496 ECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLL- 554
+ +HRD+K +NI++D +L DFG+A+QV + A G+ ++APE +
Sbjct: 120 --DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVV--EFSFAKSFKGSPYWMAPEVIAQ 175
Query: 555 TGRATEKTDVFSYGAVVLEVASGRRP 580
G D++S G VLE+A+G+ P
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRC--SHNSQGKDEFLSELSIIGTLRHRNLV 439
+++G G+ G VYK G I A+K+ + + + + L EL + + +V
Sbjct: 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVV 62
Query: 440 RLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHR------SKILLGVASALAYL 493
+ G +++GEI +V + M GSL L + P +IL G L YL
Sbjct: 63 KCYGAFYKEGEISIVLEYMDGGSLADLL---KKVGKIPEPVLAYIARQILKG----LDYL 115
Query: 494 HQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYL 553
H + +IHRD+K SN++++ ++ DFG+++ +E+ T GT+ Y++PE +
Sbjct: 116 HTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT-FVGTVTYMSPERI 172
Query: 554 LTGRATEKTDVFSYGAVVLEVASGRRP 580
+ D++S G +LE A G+ P
Sbjct: 173 QGESYSYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 70/202 (34%), Positives = 98/202 (48%), Gaps = 14/202 (6%)
Query: 385 NRIIGHGAFGTVYKGILPQNGDI-IAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQG 443
R +G G FG V+ G NG +AVK + + FL E I+ LRH LV+L
Sbjct: 11 ERKLGAGQFGEVWMGTW--NGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYA 68
Query: 444 WCHEKGEILLVYDLMPNGSLDKALFEARSP----LPWPHRSKILLGVASALAYLHQECEN 499
C E+ I +V + M GSL L +S L P + +A +AYL
Sbjct: 69 VCSEEEPIYIVTEYMSKGSLLDFL---KSGEGKKLRLPQLVDMAAQIAEGMAYLESR--- 122
Query: 500 QVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRAT 559
IHRD+ NI++ E ++ DFGLAR +E D+ A + + APE GR T
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFT 182
Query: 560 EKTDVFSYGAVVLE-VASGRRP 580
K+DV+S+G ++ E V GR P
Sbjct: 183 IKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 59/195 (30%), Positives = 96/195 (49%), Gaps = 9/195 (4%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCS--HNSQG-KDEFLSELSIIGTLRHRNLVRLQGW 444
IG G +G VYK G+I+A+K+ S+G L E+ ++ L H N+++L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 445 CHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHR 504
KG++ LV++ M + L K + + + LP L + LA+ H + ++HR
Sbjct: 67 FRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS---HGILHR 122
Query: 505 DVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRA-TEKTD 563
D+K N++++ +L DFGLAR P T T Y APE LL + + D
Sbjct: 123 DLKPENLLINTEGVLKLADFGLARSFGSPVRP-YTHYVVTRWYRAPELLLGDKGYSTPVD 181
Query: 564 VFSYGAVVLEVASGR 578
++S G + E+ S R
Sbjct: 182 IWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 67/210 (31%), Positives = 109/210 (51%), Gaps = 13/210 (6%)
Query: 381 CFNANRIIGHGAFGTVYKGILPQNG---DIIAVK--RCSHNSQGKDEFLSELSIIGTLRH 435
C +IG G FG V +G L G +A+K + + + + +FLSE SI+G H
Sbjct: 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 64
Query: 436 RNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQ 495
N++ L+G + ++++ + M NG+LD L + +L G+A+ + YL
Sbjct: 65 PNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL-- 122
Query: 496 ECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS-PDATVAAG---TMGYLAPE 551
E +HRD+ NI+++ ++ DFGL+R +E D S P T + G + + APE
Sbjct: 123 -SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPE 181
Query: 552 YLLTGRATEKTDVFSYGAVVLEVAS-GRRP 580
+ + T +DV+SYG V+ EV S G RP
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 6e-27
Identities = 68/198 (34%), Positives = 103/198 (52%), Gaps = 13/198 (6%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHN--SQGKDEFLSELSIIGTLRHRNLVRLQG 443
IG G FG VYKG+L N ++ AVK C K +FL E I+ H N+V+L G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEV-AVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 444 WCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIH 503
C +K I +V +L+P GSL L + ++ L ++ L A+ + YL + IH
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIH 116
Query: 504 RDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGT----MGYLAPEYLLTGRAT 559
RD+ N ++ E ++ DFG++R+ E TV+ G + + APE L GR T
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRE-EEGGI--YTVSDGLKQIPIKWTAPEALNYGRYT 173
Query: 560 EKTDVFSYGAVVLEVASG 577
++DV+SYG ++ E S
Sbjct: 174 SESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 72/208 (34%), Positives = 108/208 (51%), Gaps = 19/208 (9%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDE--FLSELSIIGTLRHRN---LVRLQ 442
IG GAFGTV K + +G I+AVKR K++ L +L ++ +R + +V+
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVV--MRSSDCPYIVKFY 69
Query: 443 GWCHEKGEILLVYDLMPNGSLDK----ALFEARSPLPWPHRSKILLGVASALAYLHQECE 498
G +G+ + +LM + SLDK +S +P KI + AL YL +E
Sbjct: 70 GALFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL- 127
Query: 499 NQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRA 558
++IHRDVK SNI+LD N +L DFG++ Q+ S T AG Y+APE +
Sbjct: 128 -KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD--SIAKTRDAGCRPYMAPERIDPSAR 184
Query: 559 TE---KTDVFSYGAVVLEVASGRRPIEK 583
++DV+S G + EVA+G+ P K
Sbjct: 185 DGYDVRSDVWSLGITLYEVATGKFPYPK 212
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 75/277 (27%), Positives = 133/277 (48%), Gaps = 43/277 (15%)
Query: 386 RIIGHGAFGTVYKGILPQNGD------IIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLV 439
+++G GAFGTVYKG+ G+ I V R + + E L E ++ ++ H ++V
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72
Query: 440 RLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLG----VASALAYLHQ 495
RL G C ++ L+ LMP G L + + + S+ LL +A ++YL
Sbjct: 73 RLLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNI----GSQYLLNWCVQIAKGMSYLE- 126
Query: 496 ECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTM--GYLAPEYL 553
E +++HRD+ N+++ + ++ DFGLA+ ++ D+ + G + ++A E +
Sbjct: 127 --EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK-EYHAEGGKVPIKWMALESI 183
Query: 554 LTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLT 612
L T K+DV+SYG V E+ + G +P E G+ V + +L+E + RL
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAKPYE----GIPAVEI-PDLLE------KGERLPQ 232
Query: 613 AADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMR 649
++ V +V + C D +RPT +
Sbjct: 233 PPICTID----------VYMVLVKCWMIDAESRPTFK 259
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 62/211 (29%), Positives = 103/211 (48%), Gaps = 31/211 (14%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCS-HNSQGK--DEFLSELSIIGTLRHRNLVRLQGW 444
IG G FG VY + G+++AVK ++ K E E+ ++ L+H NLV+ G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 445 CHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKIL---------LGVASALAYLHQ 495
+ ++ + + G+L++ L +IL L + LAYLH
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELL----------EHGRILDEHVIRVYTLQLLEGLAYLH- 116
Query: 496 ECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMG---YLAPEY 552
+ ++HRD+K +NI LD +LGDFG A +++++ + G Y+APE
Sbjct: 117 --SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174
Query: 553 LLTGRATEK---TDVFSYGAVVLEVASGRRP 580
+ G+ D++S G VVLE+A+G+RP
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 9e-26
Identities = 66/238 (27%), Positives = 106/238 (44%), Gaps = 20/238 (8%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHE 447
IG G FG V+ G +A+K + +++F+ E ++ L H LV+L G C E
Sbjct: 12 IGSGQFGLVWLGYW-LEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 448 KGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVK 507
+ I LV++ M +G L L R + L V +AYL VIHRD+
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLA 127
Query: 508 TSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSY 567
N ++ E ++ DFG+ R V D+ +T + + +PE + + K+DV+S+
Sbjct: 128 ARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSF 187
Query: 568 GAVVLEVAS-GRRPIEKEITG-----------VGKVGVASN----LVEWVWSLHREGR 609
G ++ EV S G+ P E + K +AS L++ W E R
Sbjct: 188 GVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCWKERPEDR 245
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 13/200 (6%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHE 447
+G G FG V+ G + +A+K + +D+F+ E ++ L H NLV+L G C +
Sbjct: 12 LGSGQFGVVHLGKW-RGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 448 KGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLG----VASALAYLHQECENQVIH 503
+ I +V + M NG L L E + L ++ LL V A+ YL N IH
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKL----GTEWLLDMCSDVCEAMEYLE---SNGFIH 123
Query: 504 RDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTD 563
RD+ N ++ E ++ DFGLAR V D+ + + + PE R + K+D
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSD 183
Query: 564 VFSYGAVVLEVAS-GRRPIE 582
V+S+G ++ EV S G+ P E
Sbjct: 184 VWSFGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 68/208 (32%), Positives = 108/208 (51%), Gaps = 11/208 (5%)
Query: 381 CFNANRIIGHGAFGTVYKGIL--PQNGDI-IAVK--RCSHNSQGKDEFLSELSIIGTLRH 435
C ++IG G FG V G L P +I +A+K + + + + +FLSE SI+G H
Sbjct: 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDH 64
Query: 436 RNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQ 495
N++ L+G + +++V + M NGSLD L + +L G+AS + YL
Sbjct: 65 PNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL-- 122
Query: 496 ECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMG--YLAPEYL 553
+ +HRD+ NI+++ ++ DFGL+R +E D T G + + APE +
Sbjct: 123 -SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 181
Query: 554 LTGRATEKTDVFSYGAVVLEVAS-GRRP 580
+ T +DV+SYG V+ EV S G RP
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 70/197 (35%), Positives = 103/197 (52%), Gaps = 6/197 (3%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWC 445
R +G G FG V++G L N +AVK + +FL+E I+ LRH L++L C
Sbjct: 12 RKLGAGQFGEVWEG-LWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 446 HEKGEILLVYDLMPNGSLDKAL-FEARSPLPWPHRSKILLGVASALAYLHQECENQVIHR 504
+ I +V +LM GSL + L A L P + VAS +AYL E +N IHR
Sbjct: 71 TLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL--EAQN-YIHR 127
Query: 505 DVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDV 564
D+ N+++ E ++ DFGLAR ++ D A + + APE L R + K+DV
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDV 187
Query: 565 FSYGAVVLE-VASGRRP 580
+S+G ++ E V GR P
Sbjct: 188 WSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 65/212 (30%), Positives = 92/212 (43%), Gaps = 22/212 (10%)
Query: 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVK---RCSHNSQGK-DEFLSELSIIGTLRHRN 437
F R+IG GAFG V + A+K + +G L+E I+ L H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 438 LVRLQGWCHEKGEILLVYDLMPNGSL-----DKALFEARSPLPWPHRSKILLG-VASALA 491
LV L ++ + LV DL+ G L K F + K + + AL
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSE-------EQVKFWICEIVLALE 114
Query: 492 YLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPE 551
YLH +IHRD+K NI+LDE + + DF +A +V D +T +GT GY+APE
Sbjct: 115 YLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST--SGTPGYMAPE 169
Query: 552 YLLTGRATEKTDVFSYGAVVLEVASGRRPIEK 583
L + D +S G E G+RP
Sbjct: 170 VLCRQGYSVAVDWWSLGVTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 64/217 (29%), Positives = 94/217 (43%), Gaps = 23/217 (10%)
Query: 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVK--RCSHNSQGKDEFLSELSIIGTLRHRN 437
+ +G GA G+V K L G I A+K N + + L EL I + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 438 LVRLQGWCHEK--GEILLVYDLMPNGSLDKALFEARS--------PLPWPHRSKILLGVA 487
+V+ G ++ I + + GSLD + + L KI V
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVL-----GKIAESVL 115
Query: 488 SALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGY 547
L+YLH ++IHRD+K SNI+L +L DFG++ E S T GT Y
Sbjct: 116 KGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSG--ELVNSLAGTF-TGTSFY 169
Query: 548 LAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKE 584
+APE + + +DV+S G +LEVA R P E
Sbjct: 170 MAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 73/215 (33%), Positives = 108/215 (50%), Gaps = 26/215 (12%)
Query: 388 IGHGAFGTVYKGI-LPQNGDII--AVK--RCSHNSQGKDEFLSELSIIGTLRHRNLVRLQ 442
+GHG FG+V KG+ L ++G + AVK + H + GK EFL E S++ L H +VRL
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 443 GWCHEKGE-ILLVYDLMPNGSLDKAL-----FEARSPLPWPHRSKILLGVASALAYLHQE 496
G C KGE ++LV +L P G L K L H+ VA +AYL
Sbjct: 63 GVC--KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ------VAMGMAYLE-- 112
Query: 497 CENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGT--MGYLAPEYLL 554
+HRD+ N++L A++ DFG++R + AG + + APE +
Sbjct: 113 -SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECIN 171
Query: 555 TGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGV 588
G+ + K+DV+SYG + E S G +P E+ G
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAFSYGAKPY-GEMKGA 205
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 386 RIIGHGAFGTVYKGILPQNGD----IIAVK--RCSHNSQGKDEFLSELSIIGTLRHRNLV 439
+ +G G FG V GD +AVK S Q + +F E+ I+ TL H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 440 RLQGWCHEKGE--ILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQEC 497
+ +G C + G + L+ + +P+GSL L R + + + YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG--- 126
Query: 498 ENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHD------KSPDATVAAGTMGYLAPE 551
+ IHRD+ NI+++ ++ DFGLA+ + D K P + + APE
Sbjct: 127 SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF----WYAPE 182
Query: 552 YLLTGRATEKTDVFSYGAVVLEVASGRRP 580
L T + + +DV+S+G + E+ + P
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFTYGDP 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 67/225 (29%), Positives = 102/225 (45%), Gaps = 27/225 (12%)
Query: 375 LRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLR 434
L T F +IG G +G VYK + G ++A+K ++E E +I LR
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNI---LR 57
Query: 435 ----HRNLVRLQG-------WCHEKGEILLVYDLMPNGS---LDKALFEARSPLPWPHRS 480
H N+ G ++ ++ LV +L GS L K L + L +
Sbjct: 58 KYSNHPNIATFYGAFIKKNPPGNDD-QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA 116
Query: 481 KILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATV 540
IL LAYLH EN+VIHRD+K NI+L + +L DFG++ Q++ T
Sbjct: 117 YILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF 173
Query: 541 AAGTMGYLAPEYLLTGRATEKT-----DVFSYGAVVLEVASGRRP 580
GT ++APE + + + DV+S G +E+A G+ P
Sbjct: 174 -IGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 65/207 (31%), Positives = 105/207 (50%), Gaps = 17/207 (8%)
Query: 387 IIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKD-------EFLSELSIIGTLRHRNLV 439
++G GA+GTVY G+ Q G +IAVK+ ++ + E+ ++ +L+H N+V
Sbjct: 7 VLGKGAYGTVYCGLTNQ-GQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 440 RLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECEN 499
+ G C + I + + +P GS+ L PLP P K + +AYLH C
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSIL-NRFGPLPEPVFCKYTKQILDGVAYLHNNC-- 122
Query: 500 QVIHRDVKTSNIMLDEGFNARLGDFGLARQV-----EHDKSPDATVAAGTMGYLAPEYLL 554
V+HRD+K +N+ML +L DFG AR++ S GT ++APE +
Sbjct: 123 -VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181
Query: 555 TGRATEKTDVFSYGAVVLEVASGRRPI 581
K+D++S G V E+A+G+ P+
Sbjct: 182 ESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 20/208 (9%)
Query: 386 RIIGHGAFGTVYKG----ILPQNGDI-IAVKRCSHNSQGKD--EFLSELSIIGTLRHRNL 438
R +G G+FG VY+G ++ + +A+K + N+ ++ EFL+E S++ ++
Sbjct: 12 RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHV 71
Query: 439 VRLQGWCHEKGEILLVYDLMPNGSLDKALFEARS------PLPWPHRSKIL---LGVASA 489
VRL G L+V +LM G L L R L P K + +A
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 490 LAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV-EHDKSPDATVAAGTMGYL 548
+AYL + +HRD+ N M+ E ++GDFG+ R + E D + ++
Sbjct: 132 MAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 549 APEYLLTGRATEKTDVFSYGAVVLEVAS 576
APE L G T K+DV+S+G V+ E+A+
Sbjct: 189 APESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 16/208 (7%)
Query: 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGK-DEFLSELSIIGTLRHRNLVR 440
F R +G G FG V++G L +N +A+K + K +F E+ + LRH++L+
Sbjct: 8 FTLERKLGSGYFGEVWEG-LWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLIS 66
Query: 441 LQGWCHEKGEILLVYDLMPNGSLDKALFEARSP----LPWPHRSKILLGVASALAYLHQE 496
L C + ++ +LM GSL L RSP LP + VA +AYL
Sbjct: 67 LFAVCSVGEPVYIITELMEKGSLLAFL---RSPEGQVLPVASLIDMACQVAEGMAYLE-- 121
Query: 497 CENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHD-KSPDATVAAGTMGYLAPEYLLT 555
E IHRD+ NI++ E ++ DFGLAR ++ D + APE
Sbjct: 122 -EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIP--YKWTAPEAASH 178
Query: 556 GRATEKTDVFSYGAVVLEVAS-GRRPIE 582
G + K+DV+S+G ++ E+ + G+ P
Sbjct: 179 GTFSTKSDVWSFGILLYEMFTYGQVPYP 206
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 64/204 (31%), Positives = 106/204 (51%), Gaps = 14/204 (6%)
Query: 385 NRIIGHGAFGTVYKGI--LPQNGDI-IAVKRCSHNSQG--KDEFLSELSIIGTLRHRNLV 439
R IG G FG VY+G+ P+N I +AVK C + + +++FL E I+ H ++V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 440 RLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKIL--LGVASALAYLHQEC 497
+L G E + +V +L P G L L + L S IL +++ALAYL +
Sbjct: 71 KLIGVITEN-PVWIVMELAPLGELRSYLQVNKYSLD--LASLILYSYQLSTALAYLESK- 126
Query: 498 ENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGR 557
+ +HRD+ N+++ +LGDFGL+R +E + A+ + ++APE + R
Sbjct: 127 --RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRR 184
Query: 558 ATEKTDVFSYGAVVLEVAS-GRRP 580
T +DV+ +G + E+ G +P
Sbjct: 185 FTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 8e-24
Identities = 53/190 (27%), Positives = 98/190 (51%), Gaps = 4/190 (2%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHE 447
+G G +G VY+G+ + +AVK ++ +EFL E +++ ++H NLV+L G C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73
Query: 448 KGEILLVYDLMPNGSLDKALFEA-RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDV 506
+ ++ + M G+L L E R + + ++SA+ YL + IHRD+
Sbjct: 74 EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDL 130
Query: 507 KTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFS 566
N ++ E ++ DFGL+R + D A + + APE L + + K+DV++
Sbjct: 131 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 190
Query: 567 YGAVVLEVAS 576
+G ++ E+A+
Sbjct: 191 FGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 64/205 (31%), Positives = 107/205 (52%), Gaps = 15/205 (7%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKR--CSHNSQGKDEFLSELSI-IGTLRHRNLVRLQGW 444
+G GA+G V K G I+AVKR + NSQ + L +L I + ++ V G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 445 CHEKGEILLVYDLMPNGSLDK---ALFEARSPLPWPHRSKILLGVASALAYLHQECENQV 501
+G++ + ++M + SLDK +++ +P KI + + AL YLH + V
Sbjct: 69 LFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SV 125
Query: 502 IHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATE- 560
IHRDVK SN++++ +L DFG++ + + T+ AG Y+APE + +
Sbjct: 126 IHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA--KTIDAGCKPYMAPERINPELNQKG 183
Query: 561 ---KTDVFSYGAVVLEVASGRRPIE 582
K+DV+S G ++E+A+GR P +
Sbjct: 184 YDVKSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 2e-23
Identities = 63/192 (32%), Positives = 103/192 (53%), Gaps = 6/192 (3%)
Query: 387 IIGHGAFGTVYKGILPQNGDIIAVKRCSHN--SQGKDEFLSELSIIGTLRHRNLVRLQGW 444
++G G FG V+KG L ++ +AVK C + + K +FLSE I+ H N+V+L G
Sbjct: 2 LLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 445 CHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHR 504
C ++ I +V +L+P G L + + L K L A+ +AYL E +N IHR
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYL--ESKN-CIHR 117
Query: 505 DVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDV 564
D+ N ++ E ++ DFG++RQ + + + + + APE L GR + ++DV
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDV 177
Query: 565 FSYGAVVLEVAS 576
+SYG ++ E S
Sbjct: 178 WSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 3e-23
Identities = 61/223 (27%), Positives = 110/223 (49%), Gaps = 37/223 (16%)
Query: 386 RIIGHGAFGTVYKG---ILPQNGD--IIAVK--RCSHNSQGKDEFLSELSIIGTLRHRNL 438
R +G GAFG V+ G L D ++AVK + + ++ + +F E ++ +H N+
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70
Query: 439 VRLQGWCHEKGEILLVYDLMPNGSLDKALFEARS----------------PLPWPHRSKI 482
V+ G C E ++V++ M +G L+K L RS L +I
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFL---RSHGPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 483 LLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD-ATVA 541
+ +AS + YL + +HRD+ T N ++ ++GDFG++R V + D V
Sbjct: 128 AVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDV---YTTDYYRVG 181
Query: 542 AGTM---GYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRP 580
TM ++ PE ++ + T ++DV+S+G V+ E+ + G++P
Sbjct: 182 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 70/211 (33%), Positives = 104/211 (49%), Gaps = 23/211 (10%)
Query: 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDE----FLSELSIIGTLRH 435
K F R IGHG+FG VY + +++A+K+ S++ + +E + E+ + LRH
Sbjct: 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH 74
Query: 436 RNLVRLQGWCHEKGE---ILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAY 492
N + +G C+ + +++ Y L GS L + PL + I G LAY
Sbjct: 75 PNTIEYKG-CYLREHTAWLVMEYCL---GSASDILEVHKKPLQEVEIAAICHGALQGLAY 130
Query: 493 LHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEY 552
LH IHRD+K NI+L E +L DFG A V SP A GT ++APE
Sbjct: 131 LHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLV----SP-ANSFVGTPYWMAPEV 182
Query: 553 LLT---GRATEKTDVFSYGAVVLEVASGRRP 580
+L G+ K DV+S G +E+A R+P
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAE-RKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 9e-23
Identities = 57/217 (26%), Positives = 106/217 (48%), Gaps = 27/217 (12%)
Query: 388 IGHGAFGTVYKGIL--PQNGD---IIAVK--RCSHNSQGKDEFLSELSIIGTLRHRNLVR 440
+G GAFG VYKG L P +A+K + + + + EF E ++ L+H N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 441 LQGWCHEKGEILLVYDLMPNGSLDKALF---------------EARSPLPWPHRSKILLG 485
L G C ++ ++++ + +G L + L +S L I +
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 486 VASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV-EHDKSPDATVAAGT 544
+A+ + YL + +HRD+ N ++ EG ++ DFGL+R + D + +
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 545 MGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRP 580
+ ++ PE +L G+ T ++D++S+G V+ E+ S G +P
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 61/205 (29%), Positives = 109/205 (53%), Gaps = 14/205 (6%)
Query: 387 IIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKD--EFLSELSIIGTLRH---RNLVRL 441
+IG GA+G VY+G G ++A+K + ++ D + E++++ LR N+ +
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 442 QGWCHEKG-EILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQ 500
G + KG + ++ + GS+ + L +A P+ + S I+ V AL Y+H+
Sbjct: 68 YG-SYLKGPRLWIIMEYAEGGSV-RTLMKA-GPIAEKYISVIIREVLVALKYIHK---VG 121
Query: 501 VIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATE 560
VIHRD+K +NI++ N +L DFG+A + + S +T GT ++APE + G+ +
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTF-VGTPYWMAPEVITEGKYYD 180
Query: 561 -KTDVFSYGAVVLEVASGRRPIEKE 584
K D++S G + E+A+G P
Sbjct: 181 TKADIWSLGITIYEMATGNPPYSDV 205
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 72/221 (32%), Positives = 100/221 (45%), Gaps = 21/221 (9%)
Query: 378 ATKCFNANRIIGHGAFGTVYKG-ILPQNGDI----IAVKRCSHNSQGKDE--FLSELSII 430
R +GHGAFG VY+G ++GD +AVK + +DE FL E I+
Sbjct: 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63
Query: 431 GTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEAR------SPLPWPHRSKILL 484
H+N+VRL G E+ ++ +LM G L L E R S L
Sbjct: 64 SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 485 GVASALAYLHQECENQVIHRDVKTSNIMLD---EGFNARLGDFGLARQV-EHDKSPDATV 540
VA YL EN IHRD+ N +L G A++ DFG+AR +
Sbjct: 124 DVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGR 180
Query: 541 AAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRP 580
A + ++ PE L G T KTDV+S+G ++ E+ S G P
Sbjct: 181 AMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 2e-22
Identities = 74/266 (27%), Positives = 120/266 (45%), Gaps = 26/266 (9%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHE 447
+G G FG V G D+ A+K S +DEF+ E ++ L H LV+L G C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 448 KGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVK 507
+ I +V + M NG L L E ++ V +AYL + Q IHRD+
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLA 127
Query: 508 TSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSY 567
N ++D+ ++ DFGL+R V D+ + + + + PE LL + + K+DV+++
Sbjct: 128 ARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAF 187
Query: 568 GAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAE 626
G ++ EV S G+ P E+ S VE V R R A++
Sbjct: 188 GVLMWEVYSLGKMPYERFNN--------SETVEKVSQGLRLYRPHLASE----------- 228
Query: 627 MRRVLLVGLACSHPDPLARPTMRGVV 652
+V + +C H RPT + ++
Sbjct: 229 --KVYAIMYSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 58/198 (29%), Positives = 95/198 (47%), Gaps = 14/198 (7%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKD---EFLSELSIIGTLRHRNLVRLQGW 444
+G GA+G V K G+I+A+K+ + +D L E+ ++ LRH N+V L+
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68
Query: 445 CHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHR 504
KG + LV++ + L+ L + LP + + A+AY H + +IHR
Sbjct: 69 FRRKGRLYLVFEYVERTLLEL-LEASPGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHR 124
Query: 505 DVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLT----GRATE 560
D+K NI++ E +L DFG AR + + T T Y APE L+ G+
Sbjct: 125 DIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKP-- 182
Query: 561 KTDVFSYGAVVLEVASGR 578
DV++ G ++ E+ G
Sbjct: 183 -VDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (241), Expect = 3e-22
Identities = 58/200 (29%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVK--RCSHNSQGKDE--FLSELSIIGTLRHRNLVRLQG 443
+G G+FG V G + A+K + + K+ L+E +I+ + H +V+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58
Query: 444 WC--HEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLG-VASALAYLHQECENQ 500
+ ++ LV + P G L L R++ + AL YLH
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHL-SKEGRFS-EERARFYAAEIVLALEYLH---SLG 113
Query: 501 VIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATE 560
+I+RD+K NI+LD + +L DFGLA+++ + S T GT YLAPE LL +
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTF-CGTPEYLAPEVLLGKGYGK 172
Query: 561 KTDVFSYGAVVLEVASGRRP 580
D +S G ++ E+ +G+ P
Sbjct: 173 AVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 4e-22
Identities = 87/286 (30%), Positives = 136/286 (47%), Gaps = 44/286 (15%)
Query: 388 IGHGAFGTVYKGILPQNG-DIIAVKRCS-HNSQ-GKD---------EFLSELSIIG-TLR 434
+G GAFG VYK NG +++A+K + HN GKD + +SE++II LR
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 435 HRNLVRLQGWCHEKGEILLVYDLM---PNGSLDKALFEARSPLPWPHRSKILLGVASALA 491
H N+VR E + +V DL+ P G +L E + I + + AL
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 492 YLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDA--TVAAGTMGYLA 549
YLH+E +++HRD+ +NIML E + DFGLA+Q K P++ T GT+ Y
Sbjct: 128 YLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQ----KQPESKLTSVVGTILYSC 181
Query: 550 PEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGR 609
PE + EK DV+++G ++ ++ + + P + +A+ +VE V+
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST----NMLSLATKIVEAVY------- 230
Query: 610 LLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655
+ EG + E V V +C PD ARP + V M+
Sbjct: 231 -----EPLPEGMYSE----DVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 8e-22
Identities = 62/215 (28%), Positives = 107/215 (49%), Gaps = 33/215 (15%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKR---CSHNSQGKDE----FLSELSIIGTLRHRNL 438
+ +G GAF + Y+ + G ++AVK+ + S ++E E+ ++ L H ++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 439 VRLQGWCHEKGEILLVYDLMPNGSLDKAL-----FEARSPLPWPHRSKILLGVASALAYL 493
+R+ G E L + M GS+ L F+ + + ++L G L+YL
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTE--QLLRG----LSYL 119
Query: 494 HQECENQVIHRDVKTSNIMLDE-GFNARLGDFGLARQVEHDKSPDATVAA-------GTM 545
H ENQ+IHRDVK +N+++D G R+ DFG A ++ + T A GT+
Sbjct: 120 H---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARL----AAKGTGAGEFQGQLLGTI 172
Query: 546 GYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRP 580
++APE L + DV+S G V++E+A+ + P
Sbjct: 173 AFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 9e-22
Identities = 51/195 (26%), Positives = 91/195 (46%), Gaps = 8/195 (4%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKR-CSHNSQGK--DEFLSELSIIGTLRHRNLVRLQGW 444
IG GA G V+K + G+ +A+K+ +G ++ L E+ + +H +V+L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 445 CHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHR 504
+LV + MP L + L + PLP + + +AY+H N ++HR
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHR 123
Query: 505 DVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRA-TEKTD 563
D+K +N+++ ++ DFGLAR ++ + T Y APE L R D
Sbjct: 124 DLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVD 183
Query: 564 VFSYGAVVLEVASGR 578
+++ G + E+ +G
Sbjct: 184 LWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 9e-22
Identities = 67/202 (33%), Positives = 104/202 (51%), Gaps = 16/202 (7%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVK--RCSHNSQGKDEFLSELSIIGTLRHR--NLVRLQG 443
IG G G VYK + G ++AVK R + N + L +L ++ H +V+ G
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVV-LKSHDCPYIVKCYG 81
Query: 444 WCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIH 503
+ ++ + +LM LDK L + P+P K+ + + AL YL ++ + VIH
Sbjct: 82 YFITDSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK--HGVIH 138
Query: 504 RDVKTSNIMLDEGFNARLGDFGLA-RQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEK- 561
RDVK SNI+LD N +L DFG++ R V+ S T +AG Y+APE + K
Sbjct: 139 RDVKPSNILLDASGNVKLCDFGISGRLVD---SKAKTRSAGCAAYMAPERIDPPDPNPKY 195
Query: 562 ---TDVFSYGAVVLEVASGRRP 580
DV+S G ++E+A+G+ P
Sbjct: 196 DIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 1e-21
Identities = 67/196 (34%), Positives = 105/196 (53%), Gaps = 9/196 (4%)
Query: 388 IGHGAFGTVYKGILPQNGDI-IAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCH 446
+G+G FG V+ G NG+ +AVK + + FL E I+ LRH LV+L
Sbjct: 14 LGNGQFGEVWMGTW--NGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 447 EKGEILLVYDLMPNGSLDKALFEARS-PLPWPHRSKILLGVASALAYLHQECENQVIHRD 505
E+ I +V + M GSL L + L P+ + VA+ +AY+ + IHRD
Sbjct: 72 EE-PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRD 127
Query: 506 VKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVF 565
++++NI++ +G ++ DFGLAR +E ++ A + + APE L GR T K+DV+
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 566 SYGAVVLE-VASGRRP 580
S+G ++ E V GR P
Sbjct: 188 SFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 96.4 bits (241), Expect = 1e-21
Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 31/218 (14%)
Query: 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEF-----LSELSIIGTLRHR 436
+ + IG GA+G V + + G +A+K+ S+ D L E+ ++ LRH
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD--DLIDAKRILREIKLLRHLRHE 59
Query: 437 NLVRL-------QGWCHEKGEILLVYDLMPNGSLD-KALFEARSPLPWPHRSKILLGVAS 488
N++ L + ++ +V +LM D + ++ PL H L +
Sbjct: 60 NIIGLLDILRPPSP--EDFNDVYIVTELME---TDLHKVIKSPQPLTDDHIQYFLYQILR 114
Query: 489 ALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDAT----VAAGT 544
L YLH VIHRD+K SNI+++ + ++ DFGLAR V+ D+ V T
Sbjct: 115 GLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV--T 169
Query: 545 MGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPI 581
Y APE LL+ R T+ D++S G + E+ R+P+
Sbjct: 170 RWYRAPELLLSSSRYTKAIDIWSVGCIFAELL-TRKPL 206
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 1e-21
Identities = 64/196 (32%), Positives = 101/196 (51%), Gaps = 9/196 (4%)
Query: 388 IGHGAFGTVYKGILPQNGDI-IAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCH 446
+G G FG V+ G NG +A+K + + FL E ++ LRH LV+L
Sbjct: 14 LGQGCFGEVWMGTW--NGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 447 EKGEILLVYDLMPNGSLDKALF-EARSPLPWPHRSKILLGVASALAYLHQECENQVIHRD 505
E+ I +V + M GSL L E L P + +AS +AY+ + +HRD
Sbjct: 72 EE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRD 127
Query: 506 VKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVF 565
++ +NI++ E ++ DFGLAR +E ++ A + + APE L GR T K+DV+
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 566 SYGAVVLEVAS-GRRP 580
S+G ++ E+ + GR P
Sbjct: 188 SFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 1e-21
Identities = 69/201 (34%), Positives = 103/201 (51%), Gaps = 17/201 (8%)
Query: 387 IIGHGAFGTVYKGILPQNGDIIAVK--RCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGW 444
IIG G FG V +G G +AVK +C +Q FL E +++ L H+NLVRL G
Sbjct: 13 IIGEGEFGAVLQG--EYTGQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGV 67
Query: 445 CHEKGEILLVYDLMPNGSLDKAL-FEARSPLPWPHRSKILLGVASALAYLHQECENQVIH 503
G + +V +LM G+L L R+ + + L VA + YL + +++H
Sbjct: 68 ILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVH 123
Query: 504 RDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTD 563
RD+ NI++ E A++ DFGLAR D + + + APE L + + K+D
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARV--GSMGVDNSKLP--VKWTAPEALKHKKFSSKSD 179
Query: 564 VFSYGAVVLEVAS-GRRPIEK 583
V+SYG ++ EV S GR P K
Sbjct: 180 VWSYGVLLWEVFSYGRAPYPK 200
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-21
Identities = 60/211 (28%), Positives = 107/211 (50%), Gaps = 24/211 (11%)
Query: 387 IIGHGAFGTVYKGILPQNGDIIAVKRCS--------HNSQGKD---EFLSELSIIGTLRH 435
+IG G +G VY + G+++AVK+ H+S+ KD SE+ + L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 436 RNLVRLQGWCHEKGEILLVY-DLMPNGSLDKALFEARSPLPW--PHRSKILLGVASALAY 492
N+V+ G E L ++ + +P GS+ L R+ + V LAY
Sbjct: 68 LNIVQYLG-FETTEEYLSIFLEYVPGGSIGSCL---RTYGRFEEQLVRFFTEQVLEGLAY 123
Query: 493 LHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVA-AGTMGYLAPE 551
LH + ++HRD+K N+++D ++ DFG++++ + D ++ G++ ++APE
Sbjct: 124 LHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 552 YLLTGRA--TEKTDVFSYGAVVLEVASGRRP 580
+ + + K D++S G VVLE+ +GRRP
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 2e-21
Identities = 69/198 (34%), Positives = 99/198 (50%), Gaps = 13/198 (6%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQG-W 444
+ IG G FG V G G+ +AVK C N FL+E S++ LRH NLV+L G
Sbjct: 12 QTIGKGEFGDVMLG--DYRGNKVAVK-CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 445 CHEKGEILLVYDLMPNGSL-DKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIH 503
EKG + +V + M GSL D RS L K L V A+ YL N +H
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVH 125
Query: 504 RDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTD 563
RD+ N+++ E A++ DFGL ++ S + + APE L + + K+D
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALREKKFSTKSD 181
Query: 564 VFSYGAVVLEVAS-GRRP 580
V+S+G ++ E+ S GR P
Sbjct: 182 VWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 52/219 (23%), Positives = 96/219 (43%), Gaps = 28/219 (12%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSH---NSQGK-DEFLSELSIIGTL-RHRNLVR 440
+IIG G+F TV + A+K + K E ++ L H +++
Sbjct: 7 KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIK 66
Query: 441 LQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQ 500
L ++ + V + PNG L + + + S L + AL YLH
Sbjct: 67 LYYTFQDEENLYFVLEYAPNGELLQYIRKYGS-LDEKCTRFYAAEILLALEYLHS---KG 122
Query: 501 VIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAA------------------ 542
+IHRD+K NI+LD+ + ++ DFG A+ ++ + SP++
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASF 182
Query: 543 -GTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRP 580
GT Y++PE L A + +D+++ G ++ ++ +G+ P
Sbjct: 183 VGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 3e-21
Identities = 83/342 (24%), Positives = 151/342 (44%), Gaps = 36/342 (10%)
Query: 325 VAGVVTASAFFAIFAGVLIWFFSKRYKHVKKSES---------FTSDIIRMPKEFSYREL 375
+ + A A+ A ++ + +K+ E+ F S ++ K + ++
Sbjct: 632 ITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDS---KVSKSITINDI 688
Query: 376 RSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRH 435
S+ K +I G G YKG +NG VK + + ++++ G L+H
Sbjct: 689 LSSLK---EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADM---GKLQH 742
Query: 436 RNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQ 495
N+V+L G C + L+++ + +L + L L W R KI +G+A AL +LH
Sbjct: 743 PNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL----RNLSWERRRKIAIGIAKALRFLHC 798
Query: 496 ECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLT 555
C V+ ++ I++D L L + D + A Y+APE T
Sbjct: 799 RCSPAVVVGNLSPEKIIIDGKDEPHL-RLSLPGLLCTDTKCFISSA-----YVAPETRET 852
Query: 556 GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615
TEK+D++ +G +++E+ +G+ P + E GV ++VEW + + L D
Sbjct: 853 KDITEKSDIYGFGLILIELLTGKSPADAEF------GVHGSIVEWARYCYSDCHLDMWID 906
Query: 616 ARLEGQ--FDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655
+ G ++ E+ V+ + L C+ DP ARP V++ L
Sbjct: 907 PSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 30/208 (14%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLS---ELSIIGTLRHRNLVRLQGW 444
IG G +G VYK G+++A+K + D+F E+S++ RH N+V G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIK--LEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 445 CHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKI----LLGVASALAYLHQECENQ 500
+ ++ +V + GSL R PL + + L G LAYLH+
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKG----LAYLHE---TG 121
Query: 501 VIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAA-----GTMGYLAPEYL-- 553
IHRD+K +NI+L E + +L DFG++ Q+ AT+A GT ++APE
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADFGVSAQL------TATIAKRKSFIGTPYWMAPEVAAV 175
Query: 554 -LTGRATEKTDVFSYGAVVLEVASGRRP 580
G K D+++ G +E+A + P
Sbjct: 176 ERKGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 4e-21
Identities = 55/199 (27%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLS--EL-SIIGTLRHRNLVRLQGW 444
+G G FG+VY + G+++A+K+ +E ++ E+ S+ H N+V+L+
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEV 66
Query: 445 CHEKGEILLVYDLMPNGSLDKALFEAR--SPLPWPHRSKILLGVASALAYLHQECENQVI 502
E E+ V++ M G+L + L + R P I+ + LA++H+ +
Sbjct: 67 FRENDELYFVFEYM-EGNLYQ-LMKDRKGKPFSESVIRSIIYQILQGLAHIHK---HGFF 121
Query: 503 HRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATE-- 560
HRD+K N+++ ++ DFGLAR++ P T T Y APE LL R+T
Sbjct: 122 HRDLKPENLLVSGPEVVKIADFGLAREIR--SRPPYTDYVSTRWYRAPEILL--RSTSYS 177
Query: 561 -KTDVFSYGAVVLEVASGR 578
D+++ G ++ E+ + R
Sbjct: 178 SPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 4e-21
Identities = 67/285 (23%), Positives = 129/285 (45%), Gaps = 49/285 (17%)
Query: 386 RIIGHGAFG--TVYKGILPQNGDIIAVK-----RCSHNSQGKDEFLSELSIIGTLRHRNL 438
R++G GAFG T+Y+ ++ ++ K R S + + + L+E+ I+ L+H N+
Sbjct: 6 RVLGKGAFGEATLYRR--TEDDSLVVWKEVNLTRLS--EKERRDALNEIVILSLLQHPNI 61
Query: 439 VRLQGWCHEKGEILLVYDLMPNGSL-------DKALFEARSPLPWPHRSKILLGVASALA 491
+ + +L+ + G+L LFE L W L + SA++
Sbjct: 62 IAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVL-W-----YLFQIVSAVS 115
Query: 492 YLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPE 551
Y+H+ ++HRD+KT NI L + +LGDFG+++ + + S TV GT Y++PE
Sbjct: 116 YIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV-VGTPYYMSPE 171
Query: 552 YLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLL 611
+ K+D+++ G V+ E+ + +R + A+N + V ++
Sbjct: 172 LCQGVKYNFKSDIWALGCVLYELLTLKRTFD-----------ATNPLNLVVK------IV 214
Query: 612 TAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLV 656
+ + +E+ ++ + DP RPT V+ +
Sbjct: 215 QGNYTPVVSVY-SSELISLV---HSLLQQDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 4e-21
Identities = 61/208 (29%), Positives = 92/208 (44%), Gaps = 19/208 (9%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKR-----CSHNSQGKDEFLSELSIIGTLRHRNLVRLQ 442
IG GA VY I N + +A+KR C + DE E+ + H N+V+
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSV---DELRKEVQAMSQCNHPNVVKYY 65
Query: 443 GWCHEKGEILLVYDLMPNGS-LD--KALFEARSPLPWPHRSKILLGVASALAYLHQECEN 499
E+ LV + GS LD K+ + R L + +L V L YLH N
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIMKSSY-PRGGLDEAIIATVLKEVLKGLEYLHS---N 121
Query: 500 QVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHD---KSPDATVAAGTMGYLAPEYLLTG 556
IHRD+K NI+L E + ++ DFG++ + GT ++APE +
Sbjct: 122 GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV 181
Query: 557 RA-TEKTDVFSYGAVVLEVASGRRPIEK 583
K D++S+G +E+A+G P K
Sbjct: 182 HGYDFKADIWSFGITAIELATGAAPYSK 209
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 6e-21
Identities = 67/209 (32%), Positives = 113/209 (54%), Gaps = 20/209 (9%)
Query: 386 RIIGHGAFGTVYKGILPQNGDII----AVKRCSHNSQGKD--EFLSELSIIGTLRHRNLV 439
+++G GAFGTVYKGI G+ + A+K + + K EF+ E I+ ++ H +LV
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 440 RLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLG----VASALAYLHQ 495
RL G C I LV LMP+G L + E + + S++LL +A + YL
Sbjct: 73 RLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIG----SQLLLNWCVQIAKGMMYLE- 126
Query: 496 ECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHD-KSPDATVAAGTMGYLAPEYLL 554
E +++HRD+ N+++ + ++ DFGLAR +E D K +A + ++A E +
Sbjct: 127 --ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 555 TGRATEKTDVFSYGAVVLEVAS-GRRPIE 582
+ T ++DV+SYG + E+ + G +P +
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 7e-21
Identities = 69/212 (32%), Positives = 110/212 (51%), Gaps = 22/212 (10%)
Query: 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDE----FLSELSIIGTLRH 435
K F+ R IGHG+FG VY +N +++A+K+ S++ + +E + E+ + LRH
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 436 RNLVRLQGWCHEKGE---ILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAY 492
N ++ +G C+ + +++ Y L GS L + PL + + G LAY
Sbjct: 75 PNTIQYRG-CYLREHTAWLVMEYCL---GSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 130
Query: 493 LHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEY 552
LH + +IHRDVK NI+L E +LGDFG A + +P A GT ++APE
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM----AP-ANXFVGTPYWMAPEV 182
Query: 553 LLT---GRATEKTDVFSYGAVVLEVASGRRPI 581
+L G+ K DV+S G +E+A + P+
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 7e-21
Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 29/210 (13%)
Query: 388 IGHGAFGTVYKGILPQ-NGDII--AVK-RCSHNSQG-KDEFLSELSIIGTLRHRNLVRLQ 442
+G G+FG V +G G +I AVK S D+FL E +I+ +L H NL+RL
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 443 GWCHEKGEILLVYDLMPNGSL-DKALFEARSPLPWPHRSKILLGVASALAYLHQECENQV 501
G +++V +L P GSL D+ +A + +A+ + YL + +
Sbjct: 63 GVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RF 118
Query: 502 IHRDVKTSNIMLDEGFNARLGDFGLARQV----------EHDKSPDATVAAGTMGYLAPE 551
IHRD+ NI+L ++GDFGL R + EH K P A + APE
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFA--------WCAPE 170
Query: 552 YLLTGRATEKTDVFSYGAVVLEVAS-GRRP 580
L T + +DV+ +G + E+ + G P
Sbjct: 171 SLRTRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 55/199 (27%), Positives = 96/199 (48%), Gaps = 10/199 (5%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGK-DEFLSELSIIGTLRHRNLVRLQGWCH 446
+G GAFG VYK + G A K S+ + ++F+ E+ I+ +H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 447 EKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDV 506
+ ++ ++ + G+LD + E L P + + AL +LH ++VIHRD+
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDL 129
Query: 507 KTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATE-----K 561
K NI+L + +L DFG++ + + T GT ++APE + + K
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTF-IGTPYWMAPEVVACETFKDNPYDYK 188
Query: 562 TDVFSYGAVVLEVASGRRP 580
D++S G ++E+A P
Sbjct: 189 ADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 2e-20
Identities = 57/195 (29%), Positives = 98/195 (50%), Gaps = 7/195 (3%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHE 447
+G G FG V+ G +A+K S + FL+E +++ L+H LVRL
Sbjct: 14 LGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVV-T 71
Query: 448 KGEILLVYDLMPNGSL-DKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDV 506
+ I ++ + M NGSL D L + +A +A++ ++ IHRD+
Sbjct: 72 QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDL 128
Query: 507 KTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFS 566
+ +NI++ E ++ DFGLAR +E ++ A + + APE + G T K+DV+S
Sbjct: 129 RAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 188
Query: 567 YGAVVLEVAS-GRRP 580
+G ++ E+ + GR P
Sbjct: 189 FGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 2e-20
Identities = 65/196 (33%), Positives = 98/196 (50%), Gaps = 9/196 (4%)
Query: 388 IGHGAFGTVYKGILPQNGDI-IAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCH 446
+G G FG V+ G NG +A+K + + FL E I+ LRH LV L
Sbjct: 14 LGQGCFGEVWMGTW--NGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 447 EKGEILLVYDLMPNGSLDKALFEARSP-LPWPHRSKILLGVASALAYLHQECENQVIHRD 505
E+ I +V + M GSL L E L P + +A +AY+ + IHRD
Sbjct: 72 EE-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRD 127
Query: 506 VKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVF 565
++ +NI++ + ++ DFGLAR +E ++ A + + APE L GR T K+DV+
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 566 SYGAVVLE-VASGRRP 580
S+G ++ E V GR P
Sbjct: 188 SFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 3e-20
Identities = 70/277 (25%), Positives = 122/277 (44%), Gaps = 38/277 (13%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWC 445
+ +G G FG V+ G + A+K + + +++F+ E ++ L H LV+L G C
Sbjct: 10 KELGSGQFGVVHLGKWRAQIKV-AIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 446 HEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLG----VASALAYLHQECENQV 501
++ + +V + M NG L L + + L +LL V + YL + N
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLRQRQGKL----SKDMLLSMCQDVCEGMEYLER---NSF 121
Query: 502 IHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEK 561
IHRD+ N ++ ++ DFG+ R V D+ ++ A + + PE + + K
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 562 TDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNL--VEWVWSLHREGRLLTAADARL 618
+DV+S+G ++ EV + G+ P EK+ SN VE + R R A+
Sbjct: 182 SDVWSFGVLMWEVFTEGKMPFEKK----------SNYEVVEMISRGFRLYRPKLAS---- 227
Query: 619 EGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655
V V +C H P RPT +++ +
Sbjct: 228 ---------MTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 3e-20
Identities = 83/280 (29%), Positives = 136/280 (48%), Gaps = 40/280 (14%)
Query: 386 RIIGHGAFGTVYKG-ILPQNGDII--AVKRCSH--NSQGKDEFLSELSIIGTLRHRNLVR 440
R+IG G FG VY G ++ +G I AVK + + + ++FL E I+ H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 441 LQGWC-HEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLG----VASALAYLHQ 495
L G C +G L+V M +G L + RS P K L+G VA + YL
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFI---RSETHNP-TVKDLIGFGLQVAKGMEYLAS 116
Query: 496 ECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV---EHDKSPDATVAAGTMGYLAPEY 552
+ + +HRD+ N MLDE F ++ DFGLAR + E+ + T A + ++A E
Sbjct: 117 K---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALES 173
Query: 553 LLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLT 612
L T + T K+DV+S+G ++ E+ + P ++ + ++ ++ +GR L
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD-------SFDITVYLL----QGRRL- 221
Query: 613 AADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVV 652
L+ ++ + V+ L+C HP P RPT +V
Sbjct: 222 -----LQPEYCPDPLYEVM---LSCWHPKPEMRPTFSELV 253
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 4e-20
Identities = 66/204 (32%), Positives = 101/204 (49%), Gaps = 22/204 (10%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDE----FLSELSIIGTLRHRNLVRLQG 443
IGHG+FG VY +++AVK+ S++ + +E + E+ + L+H N + +G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 444 WCHEKGE---ILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQ 500
C+ K +++ Y L GS L + PL + I G LAYLH
Sbjct: 89 -CYLKEHTAWLVMEYCL---GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--- 141
Query: 501 VIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLT---GR 557
+IHRD+K NI+L E +L DFG A + SP A GT ++APE +L G+
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASKS----SP-ANSFVGTPYWMAPEVILAMDEGQ 196
Query: 558 ATEKTDVFSYGAVVLEVASGRRPI 581
K DV+S G +E+A + P+
Sbjct: 197 YDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 5e-20
Identities = 57/197 (28%), Positives = 100/197 (50%), Gaps = 6/197 (3%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWC 445
+ +G G FG V+ G N +AVK + FL E +++ TL+H LVRL
Sbjct: 12 KKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 446 HEKGEILLVYDLMPNGSL-DKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHR 504
++ I ++ + M GSL D + + P +A +AY+ ++ IHR
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHR 127
Query: 505 DVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDV 564
D++ +N+++ E ++ DFGLAR +E ++ A + + APE + G T K+DV
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 187
Query: 565 FSYGAVVLEVAS-GRRP 580
+S+G ++ E+ + G+ P
Sbjct: 188 WSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 6e-20
Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 27/217 (12%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRC--SHNSQGKDEFLSELSIIGTLRHRNLVRLQG 443
IG GA GTVYK I G + A+K +H + + E+ I+ + H N+V+
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 444 WCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIH 503
GEI ++ + M GSL+ L + + + S +AYLH+ ++H
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGTHIADEQFL-----ADVARQILSGIAYLHRR---HIVH 191
Query: 504 RDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLT-------- 555
RD+K SN++++ N ++ DFG++R + P + GT+ Y++PE + T
Sbjct: 192 RDIKPSNLLINSAKNVKIADFGVSRILAQTMDP-CNSSVGTIAYMSPERINTDLNHGAYD 250
Query: 556 GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVG 592
G A D++S G +LE GR P GVG+ G
Sbjct: 251 GYA---GDIWSLGVSILEFYLGRFPF-----GVGRQG 279
|
Length = 353 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 6e-20
Identities = 57/201 (28%), Positives = 100/201 (49%), Gaps = 12/201 (5%)
Query: 387 IIGHGAFGTVYKGILPQNGDIIAVKRCS-HNSQGKDEFLSELSIIGTLRHRNLVRLQGWC 445
++G G +G VY IA+K +S+ E+++ L+HRN+V+ G
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 446 HEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLG--VASALAYLHQECENQVIH 503
E G + + +P GSL L PL ++ I + L YLH +NQ++H
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVH 131
Query: 504 RDVKTSNIMLD--EGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTG-RATE 560
RD+K N++++ G ++ DFG ++++ +P GT+ Y+APE + G R
Sbjct: 132 RDIKGDNVLVNTYSGV-VKISDFGTSKRLA-GINPCTETFTGTLQYMAPEVIDKGPRGYG 189
Query: 561 K-TDVFSYGAVVLEVASGRRP 580
D++S G ++E+A+G+ P
Sbjct: 190 APADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 7e-20
Identities = 62/198 (31%), Positives = 94/198 (47%), Gaps = 18/198 (9%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHN--SQGKDEFLSELSIIGTLRHRNLVRLQGWC 445
IG G FG V+ G L + +AVK C K +FL E I+ H N+VRL G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 446 HEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRD 505
+K I +V +L+ G L L +++ A+ + YL + IHRD
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRD 119
Query: 506 VKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMG-------YLAPEYLLTGRA 558
+ N ++ E ++ DFG++R+ E D V A T G + APE L GR
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSRE-EEDG-----VYASTGGMKQIPVKWTAPEALNYGRY 173
Query: 559 TEKTDVFSYGAVVLEVAS 576
+ ++DV+S+G ++ E S
Sbjct: 174 SSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 7e-20
Identities = 63/233 (27%), Positives = 106/233 (45%), Gaps = 49/233 (21%)
Query: 386 RIIGHGAFGTVYK----GILPQNGD-IIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNL 438
R IG GAFG V++ G+LP ++AVK + + +F E +++ H N+
Sbjct: 11 RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNI 70
Query: 439 VRLQGWCHEKGEILLVYDLMPNGSLDKAL---------------------FEARSPLPWP 477
V+L G C + L+++ M G L++ L PL
Sbjct: 71 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130
Query: 478 HRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV------- 530
+ I VA+ +AYL E + +HRD+ T N ++ E ++ DFGL+R +
Sbjct: 131 EQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 187
Query: 531 --EHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRP 580
E+D P + ++ PE + R T ++DV++YG V+ E+ S G +P
Sbjct: 188 ASENDAIP--------IRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 387 IIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEF----LSELSIIGTLRHRNLVRLQ 442
IG G FG V+K + I+A+K+ ++ K+ F L E+ I+ L+H N+V L
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLI 77
Query: 443 GWCHE--------KGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLH 494
C KG LV++ + L L K++ + + L Y+H
Sbjct: 78 EICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH 136
Query: 495 QECENQVIHRDVKTSNIMLDEGFNARLGDFGLAR---QVEHDKSPDATVAAGTMGYLAPE 551
+ N+++HRD+K +NI++ + +L DFGLAR ++ K T T+ Y PE
Sbjct: 137 R---NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPE 193
Query: 552 YLLTGRA-TEKTDVFSYGAVVLEVASGRRPI 581
LL R D++ G ++ E+ + R PI
Sbjct: 194 LLLGERDYGPPIDMWGAGCIMAEMWT-RSPI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 1e-19
Identities = 80/298 (26%), Positives = 133/298 (44%), Gaps = 57/298 (19%)
Query: 386 RIIGHGAFGTVYKGIL----PQN---GDIIAVK--RCSHNSQGKDEFLSELSIIGTLRHR 436
R++G G FG V L P N G+++AVK + Q + E++I+ TL H
Sbjct: 10 RVLGEGHFGKV---SLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHE 66
Query: 437 NLVRLQGWCHEKGE--ILLVYDLMPNGSLDKALFEARSPLPWPHRSKILL---GVASALA 491
N+V+ +G C E+G + L+ + +P GSL L + + L +++LL + +A
Sbjct: 67 NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNL-----AQLLLFAQQICEGMA 121
Query: 492 YLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV----------EHDKSPDATVA 541
YLH + IHRD+ N++LD ++GDFGLA+ V E SP
Sbjct: 122 YLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP----- 173
Query: 542 AGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVA----SGRRPIEKEITGVGKVGVASNL 597
+ + A E L + + +DV+S+G + E+ S + P +K +G +
Sbjct: 174 ---VFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTV 230
Query: 598 VEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655
V + L R RL + E V ++ C + RPT R ++ +L
Sbjct: 231 VRLIELLERGMRLPCPKNCPQE----------VYILMKNCWETEAKFRPTFRSLIPIL 278
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 3e-19
Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 10/208 (4%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTLRHRNLVRLQG 443
+G G FG V + G + A K+ +G+ L+E I+ + R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 444 WCHEKGEILLVYDLMPNGSLDKALFEARSP-LPWPHRSKILLGVASALAYLHQECENQVI 502
K ++ LV LM G L ++ P P + L +LHQ +++
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIV 117
Query: 503 HRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKT 562
+RD+K N++LD+ N R+ D GLA +++ K AGT GY+APE L
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR--AGTPGYMAPEVLQGEVYDFSV 175
Query: 563 DVFSYGAVVLEVASGRRPIEKEITGVGK 590
D F+ G + E+ +GR P + V K
Sbjct: 176 DWFALGCTLYEMIAGRSPFRQRKEKVEK 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 4e-19
Identities = 61/218 (27%), Positives = 109/218 (50%), Gaps = 31/218 (14%)
Query: 388 IGHGAFGTVY----KGILP-QNGDIIAVKRCSH-NSQGKDEFLSELSIIGTLRHRNLVRL 441
+G GAFG V+ +LP Q+ ++AVK + + +F E ++ L+H+++VR
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 442 QGWCHEKGEILLVYDLMPNGSLDKAL--------------FEARSPLPWPHRSKILLGVA 487
G C E +L+V++ M +G L++ L A L I +A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 488 SALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAG-TM- 545
S + YL +HRD+ T N ++ +G ++GDFG++R + S D G TM
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI---YSTDYYRVGGRTML 186
Query: 546 --GYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRP 580
++ PE +L + T ++D++S+G V+ E+ + G++P
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 4e-19
Identities = 54/210 (25%), Positives = 104/210 (49%), Gaps = 11/210 (5%)
Query: 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCS----HNSQGKDEFLSELSIIGTLRHRN 437
F + IG G F VYK I +G ++A+K+ +++ + + L E+ ++ L H N
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63
Query: 438 LVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARS---PLPWPHRSKILLGVASALAYLH 494
+++ E E+ +V +L G L + + + +P K + + SAL ++H
Sbjct: 64 VIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH 123
Query: 495 QECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLL 554
+ +++HRD+K +N+ + +LGD GL R K+ A GT Y++PE +
Sbjct: 124 SK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERIH 179
Query: 555 TGRATEKTDVFSYGAVVLEVASGRRPIEKE 584
K+D++S G ++ E+A+ + P +
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 5e-19
Identities = 73/219 (33%), Positives = 107/219 (48%), Gaps = 30/219 (13%)
Query: 386 RIIGHGAFGTVYKGIL-----PQNGDI-IAVK--RCSHNSQGKDEFLSELSIIGTLRHRN 437
+G GAFG VY+G P +G I +AVK R Q K EFL E ++ H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 438 LVRLQGWCHEKGEILLVYDLMPNGSLDKALFEAR-SPLPWPHRS-----KILLGVASALA 491
+V+L G C ++ +LM G L L +AR P + I L VA
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 492 YLHQECENQVIHRDVKTSNIMLDE-GFNAR----LGDFGLARQVEHDKSPDATVAAG--- 543
YL Q IHRD+ N ++ E G++A +GDFGLAR + D G
Sbjct: 121 YLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI---YKSDYYRKEGEGL 174
Query: 544 -TMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRP 580
+ ++APE LL G+ T ++DV+S+G ++ E+ + G++P
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 5e-19
Identities = 55/203 (27%), Positives = 97/203 (47%), Gaps = 12/203 (5%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKR---CSHNSQGKDEFLS---ELSIIGTLRHRNLV 439
+++G GAFG VY G +AVK+ + + K E + E+ ++ L+H +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 440 RLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECEN 499
+ G + + + + MP GS+ K +A L K + + YLH N
Sbjct: 68 QYYGCLRDDETLSIFMEYMPGGSV-KDQLKAYGALTETVTRKYTRQILEGVEYLH---SN 123
Query: 500 QVIHRDVKTSNIMLDEGFNARLGDFGLARQVE--HDKSPDATVAAGTMGYLAPEYLLTGR 557
++HRD+K +NI+ D N +LGDFG +++++ GT +++PE +
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG 183
Query: 558 ATEKTDVFSYGAVVLEVASGRRP 580
K DV+S G V+E+ + + P
Sbjct: 184 YGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 5e-19
Identities = 57/200 (28%), Positives = 104/200 (52%), Gaps = 12/200 (6%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRC-SHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCH 446
+G GAFG VYK + G + A K + + + ++++ E+ I+ T H +V+L G +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 447 EKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDV 506
G++ ++ + P G++D + E L P I + AL YLH ++IHRD+
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDL 136
Query: 507 KTSNIMLDEGFNARLGDFGL-ARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATE----- 560
K N++L + +L DFG+ A+ V+ + D+ + GT ++APE ++ +
Sbjct: 137 KAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI--GTPYWMAPEVVMCETMKDTPYDY 194
Query: 561 KTDVFSYGAVVLEVASGRRP 580
K D++S G ++E+A P
Sbjct: 195 KADIWSLGITLIEMAQIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 6e-19
Identities = 76/294 (25%), Positives = 133/294 (45%), Gaps = 49/294 (16%)
Query: 387 IIGHGAFGTV----YKGILPQNGDI-IAVKRCSHNSQGKD--EFLSELSIIGTL-RHRNL 438
+G GAFG V G+ N +AVK ++ KD + +SE+ ++ + +H+N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 439 VRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSP-------LPWPHRSKILL------- 484
+ L G C ++G + +V + +G+L L R P P P +
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 485 -GVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEH-DKSPDATVAA 542
VA + +L + + IHRD+ N+++ E ++ DFGLAR + H D T
Sbjct: 139 YQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195
Query: 543 GTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVW 602
+ ++APE L T ++DV+S+G ++ E+ + + G G+ VE ++
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT--------LGGSPYPGIP---VEELF 244
Query: 603 SLHREGRLLTAADARLEG-QFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655
L +EG R+E Q E+ ++ C H P RPT + +V+ L
Sbjct: 245 KLLKEGY-------RMEKPQNCTQELYHLM---RDCWHEVPSQRPTFKQLVEDL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 6e-19
Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 20/208 (9%)
Query: 386 RIIGHGAFGTVYKGIL-------PQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNL 438
R +G G+FG VY+GI P+ I + + + + EFL+E S++ ++
Sbjct: 12 RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71
Query: 439 VRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPL-------PWPHRSKILLG--VASA 489
VRL G + L++ +LM G L L R + P + I + +A
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 490 LAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV-EHDKSPDATVAAGTMGYL 548
+AYL+ N+ +HRD+ N M+ E F ++GDFG+ R + E D + ++
Sbjct: 132 MAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 549 APEYLLTGRATEKTDVFSYGAVVLEVAS 576
+PE L G T +DV+S+G V+ E+A+
Sbjct: 189 SPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 8e-19
Identities = 57/161 (35%), Positives = 79/161 (49%), Gaps = 12/161 (7%)
Query: 425 SELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALF---EARSPLPWPHRSK 481
E+ I+ T+ HR ++ L K + +V MP D LF + PLP
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCD--LFTYVDRSGPLPLEQAIT 189
Query: 482 ILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV-EHDKSPDATV 540
I + ALAYLH +IHRDVKT NI LDE NA LGDFG A ++ H +P
Sbjct: 190 IQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG 246
Query: 541 AAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPI 581
+GT+ +PE L KTD++S G V+ E++ +
Sbjct: 247 WSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 9e-19
Identities = 61/197 (30%), Positives = 94/197 (47%), Gaps = 12/197 (6%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCS--HNSQGKDEFLSELSIIGTLRHRNLVRLQGWC 445
IG G+FG VYK I + ++A+K ++ E+ + R + + G
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYG-S 67
Query: 446 HEKGEIL-LVYDLMPNGS-LDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIH 503
KG L ++ + GS LD L + L + + IL V L YLH+E IH
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLD--LLKP-GKLDETYIAFILREVLLGLEYLHEE---GKIH 121
Query: 504 RDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTD 563
RD+K +NI+L E + +L DFG++ Q+ S T GT ++APE + EK D
Sbjct: 122 RDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF-VGTPFWMAPEVIKQSGYDEKAD 180
Query: 564 VFSYGAVVLEVASGRRP 580
++S G +E+A G P
Sbjct: 181 IWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 58/209 (27%), Positives = 109/209 (52%), Gaps = 19/209 (9%)
Query: 387 IIGHGAFGTVYKGILPQNGDIIAVKRC---SHNSQGKDEFLS-------ELSIIGTLRHR 436
+IG G+FG+VY G+ +G+++AVK+ S ++ KD S E++++ L+H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 437 NLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQE 496
N+V+ G + + + + +P GS+ AL + + L YLH
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSV-AALLNNYGAFEETLVRNFVRQILKGLNYLHNR 125
Query: 497 CENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAA-----GTMGYLAPE 551
+IHRD+K +NI++D ++ DFG+++++E + T A G++ ++APE
Sbjct: 126 ---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182
Query: 552 YLLTGRATEKTDVFSYGAVVLEVASGRRP 580
+ T K D++S G +V+E+ +G+ P
Sbjct: 183 VVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 21/212 (9%)
Query: 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---QGKDEFLSELSIIGTLRHRNL 438
+ + IG G+FG +Y + + +K + K+ E+ ++ ++H N+
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61
Query: 439 VRLQGWCHEKGEILLVYDLMPNGSLDK-------ALFEARSPLPWPHRSKILLGVASALA 491
V E G + +V + G L K LF L W + ++ L
Sbjct: 62 VTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQISLGLK 115
Query: 492 YLHQECENQVIHRDVKTSNIMLDE-GFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAP 550
++H + +++HRD+K+ NI L + G A+LGDFG+ARQ+ +D A GT YL+P
Sbjct: 116 HIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGTPYYLSP 171
Query: 551 EYLLTGRATEKTDVFSYGAVVLEVASGRRPIE 582
E KTD++S G V+ E+ + + P E
Sbjct: 172 EICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 87.1 bits (215), Expect = 2e-18
Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 22/212 (10%)
Query: 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDE----FLSELSIIGTLRH 435
K F R IGHG+FG VY + +++A+K+ S++ + +E + E+ + ++H
Sbjct: 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH 84
Query: 436 RNLVRLQGWCHEKGE---ILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAY 492
N + +G C+ + +++ Y L GS L + PL + I G LAY
Sbjct: 85 PNSIEYKG-CYLREHTAWLVMEYCL---GSASDLLEVHKKPLQEVEIAAITHGALQGLAY 140
Query: 493 LHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEY 552
LH + +IHRD+K NI+L E +L DFG A SP A GT ++APE
Sbjct: 141 LHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIA----SP-ANSFVGTPYWMAPEV 192
Query: 553 LLT---GRATEKTDVFSYGAVVLEVASGRRPI 581
+L G+ K DV+S G +E+A + P+
Sbjct: 193 ILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 58/214 (27%), Positives = 109/214 (50%), Gaps = 22/214 (10%)
Query: 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRC---SHNSQGKDEFLSELSIIGTLRHRNL 438
F + +G G++G+VYK + A+K S + + +++ ++E+ I+ ++ H N+
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61
Query: 439 VRLQGWCHEK---GEIL-LVYDLMPNGSLDKALFEA---RSPLPWPHRSKILLGVASALA 491
+ E G L +V + P G L KA+ + R +P +I + + L
Sbjct: 62 ISY----KEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117
Query: 492 YLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPE 551
LH E +++HRD+K++NI+L ++GD G+++ + K A GT Y+APE
Sbjct: 118 ALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQIGTPHYMAPE 171
Query: 552 YLLTGRA-TEKTDVFSYGAVVLEVASGRRPIEKE 584
+ GR + K+D++S G ++ E+A+ P E
Sbjct: 172 -VWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR 204
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 59/198 (29%), Positives = 101/198 (51%), Gaps = 18/198 (9%)
Query: 385 NRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEF----LSELSIIGTLRHRNLVR 440
NRI G +G VY+ + G+I+A+K+ + K+ F L E++I+ L+H N+V
Sbjct: 11 NRI-EEGTYGVVYRARDKKTGEIVALKKLKMEKE-KEGFPITSLREINILLKLQHPNIVT 68
Query: 441 LQ----GWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQE 496
++ G +K I +V + + + L + + P ++L + S +A+LH
Sbjct: 69 VKEVVVGSNLDK--IYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD- 124
Query: 497 CENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLL-T 555
N ++HRD+KTSN++L+ ++ DFGLAR+ P T T+ Y APE LL
Sbjct: 125 --NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP-YTQLVVTLWYRAPELLLGA 181
Query: 556 GRATEKTDVFSYGAVVLE 573
+ D++S G + E
Sbjct: 182 KEYSTAIDMWSVGCIFAE 199
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 58/196 (29%), Positives = 93/196 (47%), Gaps = 13/196 (6%)
Query: 387 IIGHGAFGTVYKGILPQNGDIIAVKRCSHN--SQGKDEFLSELSIIGTLRHRNLVRLQGW 444
I+GHG GTVYK I+AVK + + + + +SEL I+ ++ G
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 445 CHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHR 504
+ I + + M GSLD +P +I + V L YL +++HR
Sbjct: 68 FFVENRISICTEFMDGGSLD-----VYRKIPEHVLGRIAVAVVKGLTYLWSL---KILHR 119
Query: 505 DVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDV 564
DVK SN++++ +L DFG++ Q+ + A GT Y+APE + + +DV
Sbjct: 120 DVKPSNMLVNTRGQVKLCDFGVSTQLVNSI---AKTYVGTNAYMAPERISGEQYGIHSDV 176
Query: 565 FSYGAVVLEVASGRRP 580
+S G +E+A GR P
Sbjct: 177 WSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-18
Identities = 57/204 (27%), Positives = 102/204 (50%), Gaps = 9/204 (4%)
Query: 387 IIGHGAFGTVYKGILPQNGDIIAVKR---CSHNSQGKDEFLSELSIIGTLRHRNLVRLQG 443
++G GA+G V K + +I+A+K+ N + K+ L EL ++ TL+ N+V L+
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 444 WCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIH 503
+G++ LV++ + L+ P RS I + A+ + H+ N ++H
Sbjct: 68 AFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIY-QLIKAIHWCHK---NDIVH 123
Query: 504 RDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTD 563
RD+K N+++ +L DFG AR + + + T T Y +PE LL + D
Sbjct: 124 RDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVD 183
Query: 564 VFSYGAVVLEVASGRR--PIEKEI 585
++S G ++ E++ G+ P E EI
Sbjct: 184 MWSVGCILGELSDGQPLFPGESEI 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-18
Identities = 59/198 (29%), Positives = 101/198 (51%), Gaps = 7/198 (3%)
Query: 385 NRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGW 444
+ +G G FG V+ ++ + AVK S + FL+E +++ TL+H LV+L
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 69
Query: 445 CHEKGEILLVYDLMPNGSL-DKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIH 503
K I ++ + M GSL D + S P P +A +A++ Q IH
Sbjct: 70 V-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIH 125
Query: 504 RDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTD 563
RD++ +NI++ ++ DFGLAR +E ++ A + + APE + G T K+D
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 185
Query: 564 VFSYGAVVLEVAS-GRRP 580
V+S+G +++E+ + GR P
Sbjct: 186 VWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-18
Identities = 57/200 (28%), Positives = 102/200 (51%), Gaps = 12/200 (6%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGK-DEFLSELSIIGTLRHRNLVRLQGWCH 446
+G GAFG VYK + G + A K S+ + ++++ E+ I+ + H N+V+L +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 447 EKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDV 506
+ + ++ + G++D + E PL P + AL YLH EN++IHRD+
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDL 129
Query: 507 KTSNIMLDEGFNARLGDFGL-ARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATE----- 560
K NI+ + +L DFG+ A+ + D+ + GT ++APE ++ + +
Sbjct: 130 KAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI--GTPYWMAPEVVMCETSKDRPYDY 187
Query: 561 KTDVFSYGAVVLEVASGRRP 580
K DV+S G ++E+A P
Sbjct: 188 KADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 4e-18
Identities = 61/205 (29%), Positives = 106/205 (51%), Gaps = 12/205 (5%)
Query: 386 RIIGHGAFGTVYKGILPQNGDII----AVKRCSHNSQGK--DEFLSELSIIGTLRHRNLV 439
+++G GAFGTVYKGI +G+ + A+K N+ K E L E ++ + +
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 440 RLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECEN 499
RL G C + LV LMP G L + E + + + +A ++YL E
Sbjct: 73 RLLGICL-TSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EV 128
Query: 500 QVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP-DATVAAGTMGYLAPEYLLTGRA 558
+++HRD+ N+++ + ++ DFGLAR ++ D++ A + ++A E +L R
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRF 188
Query: 559 TEKTDVFSYGAVVLEVAS-GRRPIE 582
T ++DV+SYG V E+ + G +P +
Sbjct: 189 THQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 5e-18
Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 22/214 (10%)
Query: 386 RIIGHGAFGTVYKGILPQNGDI---IAVKRCS---HNSQGKDEFLSELSIIGTLRHRNLV 439
+I+G G FG+V +G L Q+ +AVK H +EFLSE + + H N++
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 440 RLQGWCHEKGEI------LLVYDLMPNGSLDKALFEARSP-----LPWPHRSKILLGVAS 488
+L G C E + +++ M +G L L +R LP K ++ +A
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 489 ALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV-EHDKSPDATVAAGTMGY 547
+ YL IHRD+ N ML E + DFGL++++ D +A + +
Sbjct: 125 GMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 181
Query: 548 LAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRP 580
+A E L T K+DV+++G + E+A+ G+ P
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 5e-18
Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 53/220 (24%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVK--RCSHNSQG-KDEFLSELSIIGTLRHRNLVRLQGW 444
IG G +G VYK G+I+A+K R +G + E+S++ L H N+VRL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 445 CHEKGEILLVY-----------DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYL 493
H + ++ LV+ D P LD L + L + +AY
Sbjct: 67 VHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIK-----------SYLYQLLQGIAYC 115
Query: 494 HQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAG---------- 543
H ++V+HRD+K N+++D +L DFGLAR A G
Sbjct: 116 HS---HRVLHRDLKPQNLLIDREGALKLADFGLAR------------AFGVPVRTYTHEV 160
Query: 544 -TMGYLAPEYLLTGRA-TEKTDVFSYGAVVLEVASGRRPI 581
T+ Y APE LL R + D++S G + E+ + RRP+
Sbjct: 161 VTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN-RRPL 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 7e-18
Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 7/198 (3%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFL-SELSIIGTLRHRNLVRLQGWCH 446
IG GA GTVY I G +A+K+ + Q K E + +E+ ++ +H N+V
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 447 EKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDV 506
E+ +V + + GSL + E + + + + AL +LH NQVIHRD+
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDI 141
Query: 507 KTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFS 566
K+ NI+L + +L DFG Q+ ++S +T+ GT ++APE + K D++S
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRKAYGPKVDIWS 200
Query: 567 YGAVVLEVASGRRPIEKE 584
G + +E+ G P E
Sbjct: 201 LGIMAIEMVEGEPPYLNE 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 7e-18
Identities = 65/207 (31%), Positives = 99/207 (47%), Gaps = 20/207 (9%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKD------EFLSELSIIGTLRHRNLV 439
+++G G FGTV+KGI GD I + Q + E + +G+L H +V
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 440 RLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLG----VASALAYLHQ 495
RL G C + LV L P GSL + + R L P R LL +A + YL +
Sbjct: 73 RLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLD-PQR---LLNWCVQIAKGMYYLEE 127
Query: 496 ECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV-EHDKSPDATVAAGTMGYLAPEYLL 554
++HR++ NI+L ++ DFG+A + DK + + ++A E +L
Sbjct: 128 HR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL 184
Query: 555 TGRATEKTDVFSYGAVVLEVAS-GRRP 580
GR T ++DV+SYG V E+ S G P
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMMSYGAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 8e-18
Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 25/215 (11%)
Query: 386 RIIGHGAFGTVYKGILPQNGDI--IAVKR-----CSHNSQGKDEFLSELSIIGTLRHRNL 438
+ +G G FG+V +G L Q+ I +AVK C+ + ++FLSE + H N+
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEM--EDFLSEAVCMKEFDHPNV 62
Query: 439 VRLQGWCHEKGE------ILLVYDLMPNGSLDKALFEAR---SPLPWPHRS--KILLGVA 487
+RL G C + E +++ M +G L L +R P P + K + +A
Sbjct: 63 MRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIA 122
Query: 488 SALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEH-DKSPDATVAAGTMG 546
S + YL + IHRD+ N ML+E N + DFGL++++ + D +A +
Sbjct: 123 SGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK 179
Query: 547 YLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRP 580
++A E L T K+DV+S+G + E+A+ G+ P
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 8e-18
Identities = 67/218 (30%), Positives = 97/218 (44%), Gaps = 31/218 (14%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCS-HNSQGKDEF----LSELSIIGTLRHRNLVRLQ 442
+G G FG VYK + G ++A+K+ HN KD F L E+ I+ L+H N+V L
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNE--KDGFPITALREIKILKKLKHPNVVPLI 73
Query: 443 GWCHEKGEILL-----VYDLMPNGSLDKA--LFEARSPLPWPHRSKILLGVASALAYLHQ 495
E+ + VY + P D + L L +L + + YLH
Sbjct: 74 DMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLH- 132
Query: 496 ECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAG-----------T 544
EN ++HRD+K +NI++D ++ DFGLAR P+ G T
Sbjct: 133 --ENHILHRDIKAANILIDNQGILKIADFGLAR-PYDGPPPNPKGGGGGGTRKYTNLVVT 189
Query: 545 MGYLAPEYLLTGRA-TEKTDVFSYGAVVLEVASGRRPI 581
Y PE LL R T D++ G V E+ + RRPI
Sbjct: 190 RWYRPPELLLGERRYTTAVDIWGIGCVFAEMFT-RRPI 226
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-17
Identities = 60/219 (27%), Positives = 113/219 (51%), Gaps = 16/219 (7%)
Query: 382 FNANRIIGHGAFGTVYKGI-LPQNGDI---IAVK--RCSHNSQGKDEFLSELSIIGTLRH 435
F +++G GAFGTVYKG+ +P+ + +A+K R + + + E L E ++ ++ +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 436 RNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQ 495
++ RL G C + L+ LMP G L + E + + + + +A + YL
Sbjct: 69 PHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 126
Query: 496 ECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHD-KSPDATVAAGTMGYLAPEYLL 554
E +++HRD+ N+++ + ++ DFGLA+ + D K A + ++A E +L
Sbjct: 127 --ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL 184
Query: 555 TGRATEKTDVFSYGAVVLEVAS-GRRPIE----KEITGV 588
T ++DV+SYG V E+ + G +P + EI+ +
Sbjct: 185 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 223
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 62/211 (29%), Positives = 103/211 (48%), Gaps = 26/211 (12%)
Query: 386 RIIGHGAFGTVYKGILPQNGDII--------AVKRCSHNSQGKD--EFLSELSIIGTLRH 435
R +G G+FG VY+G DII AVK + ++ ++ EFL+E S++
Sbjct: 12 RELGQGSFGMVYEGNAR---DIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 68
Query: 436 RNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPL------PWPHRSKIL---LGV 486
++VRL G + L+V +LM +G L L R P P +++ +
Sbjct: 69 HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128
Query: 487 ASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV-EHDKSPDATVAAGTM 545
A +AYL+ + + +HRD+ N M+ F ++GDFG+ R + E D +
Sbjct: 129 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 546 GYLAPEYLLTGRATEKTDVFSYGAVVLEVAS 576
++APE L G T +D++S+G V+ E+ S
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-17
Identities = 53/162 (32%), Positives = 92/162 (56%), Gaps = 6/162 (3%)
Query: 420 KDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHR 479
+++ + EL ++ +V G + GEI + + M GSLD+ L EA+ +P
Sbjct: 47 RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR-IPEEIL 105
Query: 480 SKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDAT 539
K+ + V LAYL ++ +Q++HRDVK SNI+++ +L DFG++ Q+ D ++
Sbjct: 106 GKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSF 162
Query: 540 VAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPI 581
V GT Y++PE L + ++D++S G ++E+A GR PI
Sbjct: 163 V--GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 27/213 (12%)
Query: 387 IIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEF----LSELSIIGTLRHRNLVRLQ 442
IG G +G VYK G+++A+K+ +++ K+ F + E+ I+ L HRN+V L+
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLK 72
Query: 443 ----------GWCHEKGEILLVYDLMPN---GSLDKALFEARSPLPWPHRSKILLGVASA 489
+ +KG LV++ M + G L+ L H + +
Sbjct: 73 EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSED----HIKSFMKQLLEG 128
Query: 490 LAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLA 549
L Y H++ +HRD+K SNI+L+ +L DFGLAR ++S T T+ Y
Sbjct: 129 LNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRP 185
Query: 550 PEYLL-TGRATEKTDVFSYGAVVLEVASGRRPI 581
PE LL R DV+S G ++ E+ + ++PI
Sbjct: 186 PELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 58/198 (29%), Positives = 104/198 (52%), Gaps = 14/198 (7%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ--GKDEFLSELSIIGTLRHRNLVRLQGWC 445
+G G + TVYKG G+I+A+K +++ + E+S++ L+H N+VRL
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 446 HEKGEILLVYDLMPNGSLDKAL--FEARSPLPWPHRSKILLGVASALAYLHQECENQVIH 503
H + +++LV++ M + L K + R L + +A+ H EN+V+H
Sbjct: 68 HTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLH 123
Query: 504 RDVKTSNIMLDEGFNARLGDFGLARQ--VEHDKSPDATVAAGTMGYLAPEYLLTGRA-TE 560
RD+K N+++++ +L DFGLAR + + + V T+ Y AP+ LL R +
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV---TLWYRAPDVLLGSRTYST 180
Query: 561 KTDVFSYGAVVLEVASGR 578
D++S G ++ E+ +GR
Sbjct: 181 SIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 66/214 (30%), Positives = 99/214 (46%), Gaps = 28/214 (13%)
Query: 374 ELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEF----LSELSI 429
RS T+ NRI G G +G VY+ +G+I+A+K+ + +D L E+++
Sbjct: 2 RCRSVTEFEKLNRI-GEGTYGIVYRARDTTSGEIVALKKVRMD-NERDGIPISSLREITL 59
Query: 430 IGTLRHRNLVRL----QGWCHEKGEILLVY-----DLMPNGSLDKALFEARSPLPWPHRS 480
+ LRH N+V L G I LV DL SL L +P
Sbjct: 60 LLNLRHPNIVELKEVVVG--KHLDSIFLVMEYCEQDL---ASL---LDNMPTPFSESQVK 111
Query: 481 KILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATV 540
++L + L YLH+ +IHRD+K SN++L + ++ DFGLAR P T
Sbjct: 112 CLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP-MTP 167
Query: 541 AAGTMGYLAPEYLLTGRA-TEKTDVFSYGAVVLE 573
T+ Y APE LL T D+++ G ++ E
Sbjct: 168 KVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAE 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 24/207 (11%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQG---- 443
I GAFG+VY GD A+K K + +++ + R ++ +QG
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLK-----KSDMIAKNQVTNVKAERAIMMIQGESPY 58
Query: 444 -----WCHEKGEIL-LVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQEC 497
+ + + L LV + + G +L + LP + + V + LHQ
Sbjct: 59 VAKLYYSFQSKDYLYLVMEYLNGGDC-ASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQ-- 115
Query: 498 ENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGR 557
+IHRD+K N+++D+ + +L DFGL+R +K GT YLAPE +L
Sbjct: 116 -RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK-----FVGTPDYLAPETILGVG 169
Query: 558 ATEKTDVFSYGAVVLEVASGRRPIEKE 584
+ +D +S G V+ E G P E
Sbjct: 170 DDKMSDWWSLGCVIFEFLFGYPPFHAE 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 3e-17
Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 35/215 (16%)
Query: 387 IIGHGAFGTVYKGILPQNGDII--AVKRCSHNSQGKD--EFLSELSIIGTL-RHRNLVRL 441
+IG G FG V K + ++G + A+KR + D +F EL ++ L H N++ L
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 442 QGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWP-----HRSKILLG----------V 486
G C +G + L + P+G+L L ++R P + + L V
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 487 ASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMG 546
A + YL Q+ Q IHRD+ NI++ E + A++ DFGL+R E TMG
Sbjct: 134 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKTMG 183
Query: 547 -----YLAPEYLLTGRATEKTDVFSYGAVVLEVAS 576
++A E L T +DV+SYG ++ E+ S
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 4e-17
Identities = 65/213 (30%), Positives = 98/213 (46%), Gaps = 21/213 (9%)
Query: 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---QGKDEFLSELSIIGTLRHRNL 438
+ IG GA+G V I ++G +A+K+ H L EL I+ +H N+
Sbjct: 7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNI 66
Query: 439 VRLQGWCHEKGE----ILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLH 494
+ ++ G + +V DLM + L + + PL H L + L Y+H
Sbjct: 67 IAIRDILRPPGADFKDVYVVMDLMES-DLHH-IIHSDQPLTEEHIRYFLYQLLRGLKYIH 124
Query: 495 QECENQVIHRDVKTSNIMLDEGFNARLGDFGLAR-----QVEHDKSPDATVAAGTMGYLA 549
VIHRD+K SN++++E R+GDFG+AR EH VA T Y A
Sbjct: 125 SAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA--TRWYRA 179
Query: 550 PEYLLT-GRATEKTDVFSYGAVVLEVASGRRPI 581
PE LL+ T D++S G + E+ GRR +
Sbjct: 180 PELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 72/277 (25%), Positives = 128/277 (46%), Gaps = 29/277 (10%)
Query: 388 IGHGAFGTV----YKGILPQNGDIIAVKRCSHNSQGK-DEFLSELSIIGTLRHRNLVRLQ 442
+G G FG+V Y + G+++AVK+ H++ +F E+ I+ +L+H N+V+ +
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 443 GWCHEKG--EILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLG--VASALAYLHQECE 498
G C+ G + LV + +P GSL L + R L HR +L + + YL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLD--HRKLLLYASQICKGMEYLG---S 126
Query: 499 NQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGT--MGYLAPEYLLTG 556
+ +HRD+ T NI+++ ++GDFGL + + DK G + + APE L
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTES 186
Query: 557 RATEKTDVFSYGAVVLEVAS----GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLT 612
+ + +DV+S+G V+ E+ + P + + +G +V + L + L
Sbjct: 187 KFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLP 246
Query: 613 AADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMR 649
A AE+ ++ C + DP RP+
Sbjct: 247 APPGC------PAEIYAIM---KECWNNDPSQRPSFS 274
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 4e-17
Identities = 56/203 (27%), Positives = 103/203 (50%), Gaps = 11/203 (5%)
Query: 388 IGHGAFGTVYKGILPQNGDII--AVKRCSHNSQG--KDEFLSELSIIGTLRHRNLVRLQG 443
+G G FG V KG+ I A+K + ++ +DE + E I+ L + +VR+ G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 444 WCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIH 503
C E ++LV ++ G L+K L + + + +++ V+ + YL +H
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVH 118
Query: 504 RDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGT--MGYLAPEYLLTGRATEK 561
RD+ N++L A++ DFGL++ + D S +AG + + APE + + + +
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSR 178
Query: 562 TDVFSYGAVVLEVAS-GRRPIEK 583
+DV+SYG + E S G++P +K
Sbjct: 179 SDVWSYGITMWEAFSYGQKPYKK 201
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 4e-17
Identities = 76/295 (25%), Positives = 129/295 (43%), Gaps = 51/295 (17%)
Query: 388 IGHGAFGTVYK----GILPQNGD---IIAVKRCSHNSQGKD--EFLSELSIIGTL-RHRN 437
+G G FG V + GI D +AVK N+ KD + +SE+ ++ + +H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 438 LVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLP---------------WPHRSKI 482
++ L G C ++G + ++ + G+L + L R P P +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 483 LLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEH-DKSPDATVA 541
VA + YL + IHRD+ N+++ E ++ DFGLAR V D +
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 542 AGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWV 601
+ ++APE L T ++DV+S+G ++ E+ + + G G+ VE +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT--------LGGSPYPGIP---VEEL 245
Query: 602 WSLHREG-RLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655
+ L REG R+ ++ E MR C H P RPT + +V+ L
Sbjct: 246 FKLLREGHRMDKPSNCTHELYM---LMRE-------CWHAVPTQRPTFKQLVEAL 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 6e-17
Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 29/209 (13%)
Query: 386 RIIGHGAFGTVYKGI---LPQNGDIIAV-----KRCSHNSQGKDEFLSELSIIGTL-RHR 436
+ +G GAFG V + L ++ ++ V K +H+S+ ++ +SEL I+ L H
Sbjct: 41 KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSE-REALMSELKIMSHLGNHE 99
Query: 437 NLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLG----VASALAY 492
N+V L G C G IL++ + G L L R + LL VA +A+
Sbjct: 100 NIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFL---TLEDLLSFSYQVAKGMAF 156
Query: 493 L-HQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGT----MGY 547
L + C IHRD+ N++L G ++ DFGLAR + +D + V G + +
Sbjct: 157 LASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSN---YVVKGNARLPVKW 209
Query: 548 LAPEYLLTGRATEKTDVFSYGAVVLEVAS 576
+APE + T ++DV+SYG ++ E+ S
Sbjct: 210 MAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 6e-17
Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 10/207 (4%)
Query: 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS----QGKDEFLSELSIIGTLRHRN 437
F R++G G FG V + G + A K+ +G+ L+E I+ + R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 438 LVRLQGWCHEKGEILLVYDLMPNGSLDKALFE-ARSPLPWPHRSKILLGVASALAYLHQE 496
+V L K + LV LM G L ++ + + L LHQE
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 497 CENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTG 556
++++RD+K NI+LD+ + R+ D GLA V ++ V GT+GY+APE +
Sbjct: 122 ---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVVKNE 176
Query: 557 RATEKTDVFSYGAVVLEVASGRRPIEK 583
R T D ++ G ++ E+ +G+ P ++
Sbjct: 177 RYTFSPDWWALGCLLYEMIAGQSPFQQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 6e-17
Identities = 61/196 (31%), Positives = 103/196 (52%), Gaps = 8/196 (4%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVK--RCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWC 445
+G G G V K + +G I+A K +++ + EL ++ +V G
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAF 68
Query: 446 HEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRD 505
+ GEI + + M GSLD+ L +A +P KI + V L YL ++ ++++HRD
Sbjct: 69 YSDGEISICMEHMDGGSLDQVLKKAGR-IPENILGKISIAVLRGLTYLREK--HKIMHRD 125
Query: 506 VKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVF 565
VK SNI+++ +L DFG++ Q+ D ++ V GT Y++PE L T ++D++
Sbjct: 126 VKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFV--GTRSYMSPERLQGTHYTVQSDIW 182
Query: 566 SYGAVVLEVASGRRPI 581
S G ++E+A GR PI
Sbjct: 183 SLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 7e-17
Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 18/208 (8%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTL-RHRNLVRLQGWCH 446
IG G +G VYK ++G + AVK S +E +E +I+ +L H N+V+ G +
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89
Query: 447 EK-----GEILLVYDLMPNGS---LDKALFEARSPLPWPHRSKILLGVASALAYLHQECE 498
+ G++ LV +L GS L K L L S IL G L +LH
Sbjct: 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN--- 146
Query: 499 NQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRA 558
N++IHRDVK +NI+L +L DFG++ Q+ + T + GT ++APE + +
Sbjct: 147 NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT-SVGTPFWMAPEVIACEQQ 205
Query: 559 TE-----KTDVFSYGAVVLEVASGRRPI 581
+ + DV+S G +E+ G P+
Sbjct: 206 YDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 7e-17
Identities = 58/198 (29%), Positives = 100/198 (50%), Gaps = 7/198 (3%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFL-SELSIIGTLRHRNLVRLQGWCH 446
IG GA GTV+ I G +A+K+ + Q K E + +E+ ++ L++ N+V
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 447 EKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDV 506
E+ +V + + GSL + E + + + + AL +LH NQVIHRD+
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHA---NQVIHRDI 141
Query: 507 KTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFS 566
K+ N++L + +L DFG Q+ ++S +T+ GT ++APE + K D++S
Sbjct: 142 KSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRKAYGPKVDIWS 200
Query: 567 YGAVVLEVASGRRPIEKE 584
G + +E+ G P E
Sbjct: 201 LGIMAIEMVEGEPPYLNE 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 7e-17
Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 25/201 (12%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLR----HRNLVRLQG 443
IG G F V K + G A+K + + ++ ++ L I LR H N++RL
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VNNLREIQALRRLSPHPNILRLIE 65
Query: 444 WCHEK--GEILLVYDLMPNGSLDKALFEA----RSPLPWPHRSK-ILLGVASALAYLHQE 496
++ G + LV++LM D L+E + PLP R K + + +L ++H+
Sbjct: 66 VLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLP-EKRVKSYMYQLLKSLDHMHR- 118
Query: 497 CENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLT- 555
N + HRD+K NI++ + +L DFG R + + K P T T Y APE LLT
Sbjct: 119 --NGIFHRDIKPENILIKDD-ILKLADFGSCRGI-YSKPP-YTEYISTRWYRAPECLLTD 173
Query: 556 GRATEKTDVFSYGAVVLEVAS 576
G K D+++ G V E+ S
Sbjct: 174 GYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 8e-17
Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 33/210 (15%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDE-----FLSELSIIGTLRHRNLVRLQ 442
IG G +GTV+K + +I+A+KR + DE L E+ ++ L+H+N+VRL
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLY 65
Query: 443 GWCHEKGEILLVY-----DLMPNGSLDKALFEARSPLPWPHRSK-ILLGVASALAYLHQE 496
H ++ LV+ DL K F++ + P K + + LA+ H
Sbjct: 66 DVLHSDKKLTLVFEYCDQDL-------KKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH 118
Query: 497 CENQVIHRDVKTSNIMLDEGFNARLGDFGLARQ----VEHDKSPDATVAAGTMGYLAPEY 552
V+HRD+K N+++++ +L DFGLAR V + A V T+ Y P+
Sbjct: 119 ---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV---RCYSAEVV--TLWYRPPDV 170
Query: 553 LLTGRA-TEKTDVFSYGAVVLEVASGRRPI 581
L + + D++S G + E+A+ RP+
Sbjct: 171 LFGAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 9e-17
Identities = 64/208 (30%), Positives = 97/208 (46%), Gaps = 23/208 (11%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVK--RCSHNSQGKDEFLSELSIIGTLR------HRNLV 439
IG GA+GTVYK P +G +A+K R N G LS + + L+ H N+V
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLP--LSTVREVALLKRLEAFDHPNIV 65
Query: 440 RLQGWC-----HEKGEILLVYDLMPNGSLDKALFEARSP-LPWPHRSKILLGVASALAYL 493
RL C + ++ LV++ + + L L + P LP ++ L +L
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 494 HQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYL 553
H C ++HRD+K NI++ G +L DFGLAR + V T+ Y APE L
Sbjct: 125 HANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV--TLWYRAPEVL 179
Query: 554 LTGRATEKTDVFSYGAVVLEVASGRRPI 581
L D++S G + E+ R+P+
Sbjct: 180 LQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 22/209 (10%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKR------CSHNSQGKDEFLSELSIIGTLRHRNLV 439
+++G GAFG VY G +AVK+ S+ + E+ ++ LRH +V
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 440 RLQGWC---HEKGEILLVYDLMPNGSLD---KALFEARSPLPWPHRSKILLGVASALAYL 493
+ G C E+ ++ + + MP GS+ KA + + +IL GV+ YL
Sbjct: 68 QYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVS----YL 122
Query: 494 HQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAA--GTMGYLAPE 551
H N ++HRD+K +NI+ D N +LGDFG +++++ + + GT +++PE
Sbjct: 123 HS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPE 179
Query: 552 YLLTGRATEKTDVFSYGAVVLEVASGRRP 580
+ K DV+S V+E+ + + P
Sbjct: 180 VISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 1e-16
Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 26/208 (12%)
Query: 388 IGHGAFGTVYKGILPQNGD------IIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRL 441
IG G+FG K IL ++ + I + + + ++E E++++ ++H N+V+
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 442 QGWCHEKGEILLVYDLMPNGSLDK-------ALFEARSPLPWPHRSKILLGVASALAYLH 494
Q E G + +V D G L K LF L W + + AL ++H
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW------FVQICLALKHVH 118
Query: 495 QECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLL 554
+ +++HRD+K+ NI L + +LGDFG+AR V + A GT YL+PE
Sbjct: 119 ---DRKILHRDIKSQNIFLTKDGTIKLGDFGIAR-VLNSTVELARTCIGTPYYLSPEICE 174
Query: 555 TGRATEKTDVFSYGAVVLEVASGRRPIE 582
K+D+++ G V+ E+ + + E
Sbjct: 175 NRPYNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 57/196 (29%), Positives = 96/196 (48%), Gaps = 10/196 (5%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEF---LSELSIIGTLRHRNLVRLQGW 444
IG G+FG VYKGI + +++A+K + +DE E++++ + R G
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDL-EEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70
Query: 445 CHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHR 504
+ ++ ++ + + GS L PL + + IL + L YLH E + IHR
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDYLHSE---RKIHR 125
Query: 505 DVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDV 564
D+K +N++L E + +L DFG+A Q+ D GT ++APE + K D+
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLT-DTQIKRNTFVGTPFWMAPEVIKQSAYDFKADI 184
Query: 565 FSYGAVVLEVASGRRP 580
+S G +E+A G P
Sbjct: 185 WSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 71/281 (25%), Positives = 131/281 (46%), Gaps = 31/281 (11%)
Query: 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCS----HNSQGKDEFLSELSIIGTLRHRN 437
F + IG G F VY+ +G +A+K+ +++ + + + E+ ++ L H N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 438 LVRLQGWCHEKGEILLVYDLMPNGSLDKAL--FEARSPLPWPHRS--KILLGVASALAYL 493
+++ E E+ +V +L G L + + F+ + L P ++ K + + SAL ++
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL-IPEKTVWKYFVQLCSALEHM 122
Query: 494 HQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYL 553
H +V+HRD+K +N+ + +LGD GL R K+ A GT Y++PE +
Sbjct: 123 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERI 178
Query: 554 LTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTA 613
K+D++S G ++ E+A+ + P G NL +SL + ++
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPF---------YGDKMNL----YSLCK--KIEQC 223
Query: 614 ADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654
L E+R+ LV + C +PDP RP + V +
Sbjct: 224 DYPPLPSDHYSEELRQ--LVNM-CINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 50/219 (22%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDE-----FLSELSIIGTLRHRNLVRLQ 442
IG G +G VYKG + G I+A+K+ S+ +E + E+S++ L+H N+V LQ
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESE--EEGVPSTAIREISLLKELQHPNIVCLQ 65
Query: 443 GWCHEKGEILLVYDLM------------PNGSLDKALFEARSPLPWPHRSKILLGVASAL 490
++ + L+++ + +D L ++ + +IL G+
Sbjct: 66 DVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKS-------YLYQILQGIL--- 115
Query: 491 AYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV-------EHDKSPDATVAAG 543
+ H +V+HRD+K N+++D +L DFGLAR H+
Sbjct: 116 -FCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHE--------VV 163
Query: 544 TMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPI 581
T+ Y APE LL R + D++S G + E+A+ ++P+
Sbjct: 164 TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 29/218 (13%)
Query: 386 RIIGHGAFGTVY----KGILPQNGDI-IAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLV 439
R +G GAFG V+ + P+ I +AVK S + +F E ++ L+H ++V
Sbjct: 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIV 70
Query: 440 RLQGWCHEKGEILLVYDLMPNGSLDKAL----------FEARSP--LPWPHRSKILLGVA 487
+ G C E +++V++ M +G L+K L E P L I +A
Sbjct: 71 KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 488 SALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAG---- 543
+ + YL + +HRD+ T N ++ E ++GDFG++R V S D G
Sbjct: 131 AGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDV---YSTDYYRVGGHTML 184
Query: 544 TMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRP 580
+ ++ PE ++ + T ++DV+S G V+ E+ + G++P
Sbjct: 185 PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 59/198 (29%), Positives = 99/198 (50%), Gaps = 7/198 (3%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFL-SELSIIGTLRHRNLVRLQGWCH 446
IG GA GTVY I G +A+K+ + Q K E + +E+ ++ ++ N+V
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 447 EKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDV 506
E+ +V + + GSL + E + + + + AL +LH NQVIHRD+
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHS---NQVIHRDI 141
Query: 507 KTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFS 566
K+ NI+L + +L DFG Q+ ++S +T+ GT ++APE + K D++S
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRKAYGPKVDIWS 200
Query: 567 YGAVVLEVASGRRPIEKE 584
G + +E+ G P E
Sbjct: 201 LGIMAIEMVEGEPPYLNE 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-16
Identities = 62/211 (29%), Positives = 111/211 (52%), Gaps = 24/211 (11%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLS---ELSIIGTLRHRNLVRLQ 442
R++G GAFG V+ + ++ +K+ KDE L+ E ++ L H N++
Sbjct: 6 RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65
Query: 443 GWCHEKGEILLVYDLMPNGSLDK-------ALFEARSPLPWPHRSKILLGVASALAYLHQ 495
E +++V + P G+L + +L + + L + +ILL AL ++H
Sbjct: 66 ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHF--FVQILL----ALHHVHT 119
Query: 496 ECENQVIHRDVKTSNIMLDEGFNA-RLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLL 554
+ ++HRD+KT NI+LD+ ++GDFG+++ + KS TV GT Y++PE L
Sbjct: 120 K---LILHRDLKTQNILLDKHKMVVKIGDFGISKILS-SKSKAYTVV-GTPCYISPE-LC 173
Query: 555 TGRA-TEKTDVFSYGAVVLEVASGRRPIEKE 584
G+ +K+D+++ G V+ E+AS +R E
Sbjct: 174 EGKPYNQKSDIWALGCVLYELASLKRAFEAA 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 58/221 (26%), Positives = 108/221 (48%), Gaps = 32/221 (14%)
Query: 386 RIIGHGAFGTVY----KGILPQNGD-IIAVKRCSH-NSQGKDEFLSELSIIGTLRHRNLV 439
R +G GAFG V+ + P ++AVK + +F E ++ L+H ++V
Sbjct: 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 70
Query: 440 RLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPW------PHRSKILLG-------- 485
+ G C + +++V++ M +G L+K L A P P ++K LG
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFL-RAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 486 --VASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAG 543
+AS + YL + +HRD+ T N ++ ++GDFG++R V + V
Sbjct: 130 SQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVY--STDYYRVGGH 184
Query: 544 TM---GYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRP 580
TM ++ PE ++ + T ++DV+S+G ++ E+ + G++P
Sbjct: 185 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 3e-16
Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 22/217 (10%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVK--RCSHNSQGKDEF----LSELSIIGTLRHRNLVRL 441
+G G + VYK + G I+A+K + + KD L E+ ++ L+H N++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 442 QGWCHEKGEILLVYDLMPNGSLDKALFEARS-PLPWPHRSKILLGVASALAYLHQECENQ 500
K I LV++ M L + + + +S L +L L YLH N
Sbjct: 68 LDVFGHKSNINLVFEFME-TDL-EKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SNW 122
Query: 501 VIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDA--TVAAGTMGYLAPEYLLTGRA 558
++HRD+K +N+++ +L DFGLAR SP+ T T Y APE L R
Sbjct: 123 ILHRDLKPNNLLIASDGVLKLADFGLARSF---GSPNRKMTHQVVTRWYRAPELLFGARH 179
Query: 559 -TEKTDVFSYGAVVLEVASGRRPI---EKEITGVGKV 591
D++S G + E+ R P + +I +GK+
Sbjct: 180 YGVGVDMWSVGCIFAELLL-RVPFLPGDSDIDQLGKI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 6e-16
Identities = 67/217 (30%), Positives = 106/217 (48%), Gaps = 23/217 (10%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVK--RCSHNSQG-KDEFLSELSIIGTLRHRNLVRLQGW 444
IG G +G VYK + IA+K R +G + E+S++ ++H N+VRLQ
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 445 CHEKGEILLVY---DLMPNGSLDKALFEARSPLPWPHRSKILL-GVASALAYLHQECENQ 500
H + + LV+ DL +D + A++ P K L + +AY H ++
Sbjct: 70 VHSEKRLYLVFEYLDLDLKKHMDSSPDFAKN----PRLIKTYLYQILRGIAYCHS---HR 122
Query: 501 VIHRDVKTSNIMLDEGFNA-RLGDFGLARQVEHDKSPDATVA--AGTMGYLAPEYLLTGR 557
V+HRD+K N+++D NA +L DFGLAR P T T+ Y APE LL R
Sbjct: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAF---GIPVRTFTHEVVTLWYRAPEILLGSR 179
Query: 558 A-TEKTDVFSYGAVVLEVASGRR--PIEKEITGVGKV 591
+ D++S G + E+ + + P + EI + K+
Sbjct: 180 HYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKI 216
|
Length = 294 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 9e-16
Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 19/200 (9%)
Query: 387 IIGHGAFGTVYKGILPQNGDIIAVKR---CSHNSQGKDEFLSELSIIGTLRHRNLVRLQG 443
++G G++G V K + G I+A+K+ + K + E+ ++ LRH NLV L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 444 WCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIH 503
K + LV++ + + LD L + + L K L + + + H + +IH
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDD-LEKYPNGLDESRVRKYLFQILRGIEFCHS---HNIIH 123
Query: 504 RDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP--DATVAAGTMGYLAPEYLLT----GR 557
RD+K NI++ + +L DFG AR + +P T T Y APE L+ GR
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFARTL---AAPGEVYTDYVATRWYRAPELLVGDTKYGR 180
Query: 558 ATEKTDVFSYGAVVLEVASG 577
A D+++ G +V E+ +G
Sbjct: 181 A---VDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCS-HNSQGK---DEFLSELSIIGTLRHRNLVRL-Q 442
I GA+G V+ GDI A+K + K D+ L+E I+ + +V+L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 443 GWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVI 502
+ +K + LV + +P G L +L E L + + AL YLH N +I
Sbjct: 61 SFQGKK-NLYLVMEYLPGGDL-ASLLENVGSLDEDVARIYIAEIVLALEYLHS---NGII 115
Query: 503 HRDVKTSNIMLDEGFNARLGDFGLA------RQVEHDKSPDATV-AAGTMGYLAPEYLLT 555
HRD+K NI++D + +L DFGL+ RQ+ + GT Y+APE ++
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE-VIL 174
Query: 556 GRATEKT-DVFSYGAVVLEVASGRRP 580
G+ KT D +S G ++ E G P
Sbjct: 175 GQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 18/208 (8%)
Query: 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS----QGKDEFLSELSIIGTLRHRN 437
F R++G G FG V + G + A KR +G+ L+E I+ + +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 438 LVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHR-----SKILLGVASALAY 492
+V L K + LV +M G L ++ +P R ++IL G L
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCG----LED 117
Query: 493 LHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEY 552
LH+E ++RD+K NI+LD+ + R+ D GLA ++ +S V GT+GY+APE
Sbjct: 118 LHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV--GTVGYMAPEV 172
Query: 553 LLTGRATEKTDVFSYGAVVLEVASGRRP 580
L R T D + G ++ E+ G+ P
Sbjct: 173 LNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 61/207 (29%), Positives = 103/207 (49%), Gaps = 16/207 (7%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVK--RCSHNSQG-KDEFLSELSIIGTLRHRNLVRLQGW 444
IG G +G VYK G+++A+K R ++G + E+S++ L H N+V+L
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 445 CHEKGEILLVYDLMPNGSLDKAL-FEARSPLPWPHRSKILLGVASALAYLHQECENQVIH 503
H + ++ LV++ + + L K + S +P P L + LA+ H ++V+H
Sbjct: 68 IHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLH 123
Query: 504 RDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVA--AGTMGYLAPEYLLTGR-ATE 560
RD+K N++++ +L DFGLAR P T T+ Y APE LL + +
Sbjct: 124 RDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYTHEVVTLWYRAPEILLGCKYYST 180
Query: 561 KTDVFSYGAVVLEVASGRR--PIEKEI 585
D++S G + E+ + R P + EI
Sbjct: 181 AVDIWSLGCIFAEMVTRRALFPGDSEI 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-15
Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 21/207 (10%)
Query: 386 RIIGHGAFGTVYKGIL--PQNGDI-IAVK--RCSHNSQGKDEFLSELSIIGTLRHRNLVR 440
RI+G G FG + +G L P ++ +A+ R + + + FL+E +G H N+VR
Sbjct: 11 RILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVR 70
Query: 441 LQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQ 500
L+G +++V + M NG+LD L + L +L G+AS + YL E
Sbjct: 71 LEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYL---SEMG 127
Query: 501 VIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMG------YLAPEYLL 554
+H+ + ++++ ++ F R+++ DKS TM + APE +
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGF---RRLQEDKS---EAIYTTMSGKSPVLWAAPEAIQ 181
Query: 555 TGRATEKTDVFSYGAVVLEVAS-GRRP 580
+ +DV+S+G V+ EV S G RP
Sbjct: 182 YHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 55/194 (28%), Positives = 92/194 (47%), Gaps = 7/194 (3%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFL-SELSIIGTLRHRNLVRLQGWCH 446
IG G+ G V G +AVK+ Q + E L +E+ I+ +H N+V +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 447 EKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDV 506
E+ +V + + G+L + R + + + L V AL++LH + VIHRD+
Sbjct: 87 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLAVLKALSFLHAQ---GVIHRDI 141
Query: 507 KTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFS 566
K+ +I+L +L DFG QV + P GT ++APE + + D++S
Sbjct: 142 KSDSILLTSDGRVKLSDFGFCAQVSKE-VPRRKSLVGTPYWMAPEVISRLPYGTEVDIWS 200
Query: 567 YGAVVLEVASGRRP 580
G +V+E+ G P
Sbjct: 201 LGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 56/198 (28%), Positives = 95/198 (47%), Gaps = 7/198 (3%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFL-SELSIIGTLRHRNLVRLQGWCH 446
IG G+ G V + +G ++AVK+ Q + E L +E+ I+ +H N+V +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 447 EKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDV 506
E+ +V + + G+L + R + + + L V AL+ LH + VIHRD+
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLKALSVLHAQ---GVIHRDI 142
Query: 507 KTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFS 566
K+ +I+L +L DFG QV + P GT ++APE + + D++S
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKE-VPRRKSLVGTPYWMAPELISRLPYGPEVDIWS 201
Query: 567 YGAVVLEVASGRRPIEKE 584
G +V+E+ G P E
Sbjct: 202 LGIMVIEMVDGEPPYFNE 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-15
Identities = 57/197 (28%), Positives = 100/197 (50%), Gaps = 14/197 (7%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVK--RCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWC 445
+G G + TV+KG +++A+K R H + E+S++ L+H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 446 HEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILL-GVASALAYLHQECENQVIHR 504
H + LV++ + + L + + + + + H KI L + LAY H+ +V+HR
Sbjct: 74 HTDKSLTLVFEYL-DKDLKQYMDDCGNIMSM-HNVKIFLYQILRGLAYCHRR---KVLHR 128
Query: 505 DVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVA--AGTMGYLAPEYLL-TGRATEK 561
D+K N++++E +L DFGLAR P T + T+ Y P+ LL + + +
Sbjct: 129 DLKPQNLLINERGELKLADFGLARA---KSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQ 185
Query: 562 TDVFSYGAVVLEVASGR 578
D++ G + E+ASGR
Sbjct: 186 IDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 387 IIGHGAFGTVYKGILPQNGDIIAVK--RCSHNSQGKDEFLSELSIIGTLR------HRNL 438
IG GA+GTVYK G +A+K R + +G LS L I L+ H N+
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIP--LSTLREIALLKQLESFEHPNI 63
Query: 439 VRLQGWCH--EKGEILLVYDLMPNGSLDKALFEARSP---LPWPHRSKILLG-VASALAY 492
VRL CH L + + + D A + ++ P LP P K L+ + + +
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLP-PETIKDLMRQLLRGVDF 122
Query: 493 LHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEY 552
LH ++++HRD+K NI++ ++ DFGLAR + + + V T+ Y APE
Sbjct: 123 LHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV--TLWYRAPEV 177
Query: 553 LLTGRATEKTDVFSYGAVVLEVASGRRPI 581
LL D++S G + E+ RRP+
Sbjct: 178 LLQSSYATPVDMWSVGCIFAELFR-RRPL 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 54/205 (26%), Positives = 98/205 (47%), Gaps = 14/205 (6%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHN------SQGKDEFLSELSIIGTLRHRNLV 439
+++G GAFG VY G +A K+ + S+ E+ ++ L+H +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 440 RLQGWCHEKGE--ILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQEC 497
+ G ++ E + + + MP GS+ L +A L K + ++YLH
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGSVKDQL-KAYGALTESVTRKYTRQILEGMSYLHS-- 124
Query: 498 ENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATV--AAGTMGYLAPEYLLT 555
N ++HRD+K +NI+ D N +LGDFG +++++ + GT +++PE +
Sbjct: 125 -NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG 183
Query: 556 GRATEKTDVFSYGAVVLEVASGRRP 580
K DV+S G V+E+ + + P
Sbjct: 184 EGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 2e-15
Identities = 57/198 (28%), Positives = 99/198 (50%), Gaps = 7/198 (3%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFL-SELSIIGTLRHRNLVRLQGWCH 446
IG GA GTVY + G +A+++ + Q K E + +E+ ++ ++ N+V
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 447 EKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDV 506
E+ +V + + GSL + E + + + + AL +LH NQVIHRD+
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDI 142
Query: 507 KTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFS 566
K+ NI+L + +L DFG Q+ ++S +T+ GT ++APE + K D++S
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRKAYGPKVDIWS 201
Query: 567 YGAVVLEVASGRRPIEKE 584
G + +E+ G P E
Sbjct: 202 LGIMAIEMIEGEPPYLNE 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 58/197 (29%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEF---LSELSIIGTLRHRNLVRLQGW 444
IG G+FG V+KGI + ++A+K + +DE E++++ + + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDL-EEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 445 CHEKGEILLVYDLMPNGS-LDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIH 503
+ ++ ++ + + GS LD L E PL + IL + L YLH E + IH
Sbjct: 71 YLKDTKLWIIMEYLGGGSALD--LLEP-GPLDETQIATILREILKGLDYLHSE---KKIH 124
Query: 504 RDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTD 563
RD+K +N++L E +L DFG+A Q+ D GT ++APE + K D
Sbjct: 125 RDIKAANVLLSEHGEVKLADFGVAGQLT-DTQIKRNTFVGTPFWMAPEVIKQSAYDSKAD 183
Query: 564 VFSYGAVVLEVASGRRP 580
++S G +E+A G P
Sbjct: 184 IWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 37/211 (17%)
Query: 386 RIIGHGAFGTV----YKGILPQNGDIIAVKRCSHNSQGK--DEFLSELSIIGTLRHRNLV 439
R +G G FG V Y G+ +AVK S G + E+ I+ L H N+V
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69
Query: 440 RLQGWCHEKGE--ILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQEC 497
+ +G C E G I L+ + +P+GSL + LP R+K + + L Y Q C
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSL-------KEYLP---RNKNKINLKQQLKYAVQIC 119
Query: 498 EN-------QVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP-------DATVAAG 543
+ Q +HRD+ N++++ ++GDFGL + +E DK D+ V
Sbjct: 120 KGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVF-- 177
Query: 544 TMGYLAPEYLLTGRATEKTDVFSYGAVVLEV 574
+ APE L+ + +DV+S+G + E+
Sbjct: 178 ---WYAPECLIQSKFYIASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 4e-15
Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 36/238 (15%)
Query: 385 NRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEF---------------LSELSI 429
+G G +G V K G I+A+K+ D L EL I
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 430 IGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASA 489
+ ++H N++ L E I LV D+M L K + + + L ILL + +
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRKIRLTESQVKCILLQILNG 131
Query: 490 LAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDA----------- 538
L LH+ +HRD+ +NI ++ ++ DFGLAR+ + D
Sbjct: 132 LNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188
Query: 539 --TVAAGTMGYLAPEYLL-TGRATEKTDVFSYGAVVLEVASGRR--PIEKEITGVGKV 591
T T+ Y APE L+ + D++S G + E+ +G+ P E EI +G++
Sbjct: 189 EMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRI 246
|
Length = 335 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 56/196 (28%), Positives = 96/196 (48%), Gaps = 9/196 (4%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLS---ELSIIGTLRHRNLVRL- 441
R++G G++G V +G +K+ + + + E + E ++ L+H N+V
Sbjct: 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65
Query: 442 QGWCHEKGEILLVYDLMPNGSLDKALFEARSPL-PWPHRSKILLGVASALAYLHQECENQ 500
+ W E G + +V G L L E + L P + + +A AL YLH E
Sbjct: 66 ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKH 122
Query: 501 VIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATE 560
++HRD+KT N+ L ++GD G+AR +E ++ A+ GT Y++PE
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLE-NQCDMASTLIGTPYYMSPELFSNKPYNY 181
Query: 561 KTDVFSYGAVVLEVAS 576
K+DV++ G V E+A+
Sbjct: 182 KSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 55/194 (28%), Positives = 92/194 (47%), Gaps = 7/194 (3%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFL-SELSIIGTLRHRNLVRLQGWCH 446
IG G+ G V +G +AVK Q + E L +E+ I+ +H+N+V +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 447 EKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDV 506
E+ ++ + + G+L + + R L + + V AL YLH + VIHRD+
Sbjct: 89 VGEELWVLMEFLQGGALTDIVSQTR--LNEEQIATVCESVLQALCYLHSQ---GVIHRDI 143
Query: 507 KTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFS 566
K+ +I+L +L DFG Q+ D P GT ++APE + + D++S
Sbjct: 144 KSDSILLTLDGRVKLSDFGFCAQISKD-VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWS 202
Query: 567 YGAVVLEVASGRRP 580
G +V+E+ G P
Sbjct: 203 LGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-15
Identities = 60/210 (28%), Positives = 103/210 (49%), Gaps = 21/210 (10%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVK--RCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWC 445
+G G +G+VYK + G +A+K R + ++ + EL I+ +V G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 446 HEKGEILLVYDLMPNGSLDK--ALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIH 503
+G + + + M GSLDK A A +P +I V L +L +E + +IH
Sbjct: 69 FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIH 126
Query: 504 RDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMG---YLAPEYLLTGRATE 560
RDVK +N++++ +L DFG++ + A++A +G Y+APE + +G +
Sbjct: 127 RDVKPTNVLVNGNGQVKLCDFGVSGNLV------ASLAKTNIGCQSYMAPERIKSGGPNQ 180
Query: 561 ------KTDVFSYGAVVLEVASGRRPIEKE 584
++DV+S G +LE+A GR P E
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALGRYPYPPE 210
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-15
Identities = 62/227 (27%), Positives = 100/227 (44%), Gaps = 7/227 (3%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFL-SELSIIGTLRHRNLVRLQGWCH 446
IG G+ G V G +AVK+ Q + E L +E+ I+ H N+V +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 447 EKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDV 506
E+ +V + + G+L + R + + + L V AL+YLH + VIHRD+
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLSVLRALSYLHNQ---GVIHRDI 144
Query: 507 KTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFS 566
K+ +I+L +L DFG QV + P GT ++APE + + D++S
Sbjct: 145 KSDSILLTSDGRIKLSDFGFCAQVSKE-VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWS 203
Query: 567 YGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTA 613
G +V+E+ G P E + NL V H+ +L
Sbjct: 204 LGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRG 250
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 5e-15
Identities = 57/197 (28%), Positives = 104/197 (52%), Gaps = 10/197 (5%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSH---NSQGKDEFLSELSIIGTLRHRNLVRLQGW 444
+G G G V+K + + +I ++ H +++ + EL ++ +V G
Sbjct: 13 LGAGNGGVVFK-VSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71
Query: 445 CHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHR 504
+ GEI + + M GSLD+ L +A +P K+ + V L YL ++ ++++HR
Sbjct: 72 FYSDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREK--HKIMHR 128
Query: 505 DVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDV 564
DVK SNI+++ +L DFG++ Q+ D ++ V GT Y++PE L + ++D+
Sbjct: 129 DVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFV--GTRSYMSPERLQGTHYSVQSDI 185
Query: 565 FSYGAVVLEVASGRRPI 581
+S G ++E+A GR PI
Sbjct: 186 WSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 5e-15
Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 19/204 (9%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNS----QGKDEFLSELSIIGTLRHRNLVRLQG 443
+G G FG V + G + A K+ + +G + + E I+ + R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 444 WCHEKGEILLVYDLMPNGSLDKALF---EARSPLPWP----HRSKILLGVASALAYLHQE 496
K ++ LV +M G L ++ E P P + ++I+ G L +LHQ
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISG----LEHLHQ- 115
Query: 497 CENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTG 556
++I+RD+K N++LD N R+ D GLA +++ D AGT G++APE L
Sbjct: 116 --RRIIYRDLKPENVLLDNDGNVRISDLGLAVELK-DGQSKTKGYAGTPGFMAPELLQGE 172
Query: 557 RATEKTDVFSYGAVVLEVASGRRP 580
D F+ G + E+ + R P
Sbjct: 173 EYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 6e-15
Identities = 67/216 (31%), Positives = 103/216 (47%), Gaps = 45/216 (20%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCS---HNSQGKDE--------FLSELSIIGTLRHR 436
+G GA+G V+K I + +++A+K+ N+ D FL EL H
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNAT--DAQRTFREIMFLQELG-----DHP 67
Query: 437 NLVRLQGWCHEKGE----ILLVYDLMP---NGSLDKALFEARSPLPWPHRSKILLGVASA 489
N+V+L K E I LV++ M + + + E H+ I+ + A
Sbjct: 68 NIVKLLN-VI-KAENDKDIYLVFEYMETDLHAVIRANILEDV------HKRYIMYQLLKA 119
Query: 490 LAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV----EHDKSPDAT--VAAG 543
L Y+H VIHRD+K SNI+L+ +L DFGLAR + E+ ++P T VA
Sbjct: 120 LKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA-- 174
Query: 544 TMGYLAPEYLLTGRA-TEKTDVFSYGAVVLEVASGR 578
T Y APE LL T+ D++S G ++ E+ G+
Sbjct: 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 6e-15
Identities = 57/196 (29%), Positives = 98/196 (50%), Gaps = 10/196 (5%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSH---NSQGKDEFLSELSIIGTLRHRNLVRLQGW 444
+G G G+V K + + K+ H S + + L EL I+ R +V G
Sbjct: 13 LGAGNGGSVSK-VKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGA 71
Query: 445 CHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHR 504
+ I + + M GSLD+ + P+P KI + V L YL+ ++++HR
Sbjct: 72 FLNENNICMCMEFMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNV--HRIMHR 128
Query: 505 DVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDV 564
D+K SNI+++ +L DFG++ ++ + A GT Y++PE + G+ T K+DV
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVSGELINSI---ADTFVGTSTYMSPERIQGGKYTVKSDV 185
Query: 565 FSYGAVVLEVASGRRP 580
+S G ++E+A G+ P
Sbjct: 186 WSLGISIIELALGKFP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 7e-15
Identities = 53/207 (25%), Positives = 103/207 (49%), Gaps = 13/207 (6%)
Query: 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCS----HNSQGKDEFLSELSIIGTLRHRN 437
F + IG G F VY+ + +A+K+ +++ + + + E+ ++ L H N
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 438 LVRLQGWCHEKGEILLVYDLMPNGSLDKAL--FEARSPLPWPHRS--KILLGVASALAYL 493
+++ E E+ +V +L G L + + F+ + L P R+ K + + SA+ ++
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRL-IPERTVWKYFVQLCSAVEHM 122
Query: 494 HQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYL 553
H +V+HRD+K +N+ + +LGD GL R K+ A GT Y++PE +
Sbjct: 123 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERI 178
Query: 554 LTGRATEKTDVFSYGAVVLEVASGRRP 580
K+D++S G ++ E+A+ + P
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 7e-15
Identities = 60/201 (29%), Positives = 104/201 (51%), Gaps = 22/201 (10%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEF--LSELSIIGTLRHRNLVRLQGWC 445
+G G++ TVYKGI NG ++A+K S ++ F + E S++ L+H N+V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 446 HEKGEILLVYDLMPNGSLDKALFEARSPLPW-PHRSKILL-GVASALAYLHQECENQVIH 503
H K + V++ M D A + + P P+ ++ + + LAY+H + ++H
Sbjct: 73 HTKETLTFVFEYM---HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILH 126
Query: 504 RDVKTSNIMLDEGFNARLGDFGLARQVEHDKS-PDATVAAG--TMGYLAPEYLLTGRATE 560
RD+K N+++ +L DFGLAR KS P T ++ T+ Y P+ LL AT+
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLARA----KSIPSQTYSSEVVTLWYRPPDVLLG--ATD 180
Query: 561 KT---DVFSYGAVVLEVASGR 578
+ D++ G + +E+ G+
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 8e-15
Identities = 61/205 (29%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCS---HNSQGKDEFLSELSIIGTLRHRNLVRL- 441
R IG+GAFG V+ P++G +A+K+ N EL ++ +H N++
Sbjct: 6 RPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSAL 65
Query: 442 ------QGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQ 495
E EI +V +LM L K + + PL H L + L YLH
Sbjct: 66 DILQPPHIDPFE--EIYVVTELM-QSDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLHS 121
Query: 496 ECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLT 555
++HRD+K N++++ ++ DFGLAR E D+S T T Y APE +L
Sbjct: 122 A---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPE-ILM 177
Query: 556 G--RATEKTDVFSYGAVVLEVASGR 578
G T D++S G + E+ R
Sbjct: 178 GSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 77/297 (25%), Positives = 133/297 (44%), Gaps = 55/297 (18%)
Query: 388 IGHGAFGTVYK----GI---LPQNGDIIAVKRCSHNSQGKD--EFLSELSIIGTL-RHRN 437
+G G FG V GI P+ +AVK ++ KD + +SE+ ++ + +H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 438 LVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKI--------------- 482
++ L G C + G + ++ + G+L + L AR P + I
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYSYDIARVPDEQMTFKDLVS 141
Query: 483 -LLGVASALAYL-HQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEH-DKSPDAT 539
VA + YL Q+C IHRD+ N+++ E ++ DFGLAR V + D T
Sbjct: 142 CTYQVARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTT 197
Query: 540 VAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVE 599
+ ++APE L T ++DV+S+G ++ E+ + + G G+ VE
Sbjct: 198 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--------LGGSPYPGIP---VE 246
Query: 600 WVWSLHREG-RLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655
++ L +EG R+ A+ E + ++ C H P RPT + +V+ L
Sbjct: 247 ELFKLLKEGHRMDKPANCTNE----------LYMMMRDCWHAIPSHRPTFKQLVEDL 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 57/201 (28%), Positives = 107/201 (53%), Gaps = 13/201 (6%)
Query: 388 IGHGAFGTVYKGILP--QNGDIIAVK---RCSHNSQGKDEFLSELSIIGTLRHRNLVRLQ 442
+G G FGTV KG+ ++ +AVK +++ KDE L E +++ L + +VR+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 443 GWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVI 502
G C E +LV +L G L+K L + + + + ++++ V+ + YL E +
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKH-VTEKNITELVHQVSMGMKYLE---ETNFV 117
Query: 503 HRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGT--MGYLAPEYLLTGRATE 560
HRD+ N++L A++ DFGL++ + D++ G + + APE + + +
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSS 177
Query: 561 KTDVFSYGAVVLEVAS-GRRP 580
K+DV+S+G ++ E S G++P
Sbjct: 178 KSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 29/212 (13%)
Query: 387 IIGHGAFGTVYKGILPQNGDII--AVKRCSHNSQGKD--EFLSELSIIGTL-RHRNLVRL 441
+IG G FG V + ++ ++G + A+K + D +F EL ++ L H N++ L
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 442 QGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPH-----------RSKILLGVASAL 490
G C +G + + + P G+L L ++R P S+ LL AS +
Sbjct: 69 LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128
Query: 491 AY-LHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMG--- 546
A + E Q IHRD+ N+++ E +++ DFGL+R E TMG
Sbjct: 129 ATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEE-------VYVKKTMGRLP 181
Query: 547 --YLAPEYLLTGRATEKTDVFSYGAVVLEVAS 576
++A E L T K+DV+S+G ++ E+ S
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 65/202 (32%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS-QGKDE---FLSELSI-IGTLRHRNLVR 440
++IG G+FG V +G AVK + K E ++E ++ + ++H LV
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 441 LQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLG-VASALAYLHQECEN 499
L ++ V D + G L L RS P P R++ +ASAL YLH
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERS-FPEP-RARFYAAEIASALGYLH---SL 115
Query: 500 QVIHRDVKTSNIMLDEGFNARLGDFGLARQ-VEHDKSPDATVAAGTMGYLAPEYLLTGRA 558
+I+RD+K NI+LD + L DFGL ++ +EH K+ + GT YLAPE L
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPEVLRKQPY 173
Query: 559 TEKTDVFSYGAVVLEVASGRRP 580
D + GAV+ E+ G P
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 66/212 (31%), Positives = 103/212 (48%), Gaps = 23/212 (10%)
Query: 387 IIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSE---LSIIGTLRHRNLV 439
IIG G FG VY G + A+K QG+ L+E LS++ T +V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 440 RLQGWCHEKGEILLVYDLMPNGSLDKALFE----ARSPLPWPHRSKILLGVASALAYLHQ 495
+ H ++ + DLM G L L + + + + + ++I+LG L ++H
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIILG----LEHMHN 115
Query: 496 ECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLT 555
V++RD+K +NI+LDE + R+ D GLA K P A+V GT GY+APE L
Sbjct: 116 RF---VVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPHASV--GTHGYMAPEVLQK 169
Query: 556 GRATEKT-DVFSYGAVVLEVASGRRPIEKEIT 586
G A + + D FS G ++ ++ G P + T
Sbjct: 170 GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 55/197 (27%), Positives = 100/197 (50%), Gaps = 14/197 (7%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVK--RCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWC 445
+G G + TVYKG +++A+K R H + E+S++ L+H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 446 HEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRD 505
H + + LV++ + + L + L + + + + L + L Y H+ +V+HRD
Sbjct: 74 HTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRD 129
Query: 506 VKTSNIMLDEGFNARLGDFGLARQVEHDKS-PDATVA--AGTMGYLAPEYLL-TGRATEK 561
+K N++++E +L DFGLAR KS P T + T+ Y P+ LL + + +
Sbjct: 130 LKPQNLLINERGELKLADFGLARA----KSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQ 185
Query: 562 TDVFSYGAVVLEVASGR 578
D++ G + E+++GR
Sbjct: 186 IDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 56/197 (28%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEF---LSELSIIGTLRHRNLVRLQGW 444
IG G+FG V+KGI + ++A+K + +DE E++++ + + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDL-EEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 445 CHEKGEILLVYDLMPNGS-LDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIH 503
+ ++ ++ + + GS LD L A P + +L + L YLH E + IH
Sbjct: 71 YLKGTKLWIIMEYLGGGSALD--LLRA-GPFDEFQIATMLKEILKGLDYLHSE---KKIH 124
Query: 504 RDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTD 563
RD+K +N++L E + +L DFG+A Q+ D GT ++APE + K D
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLT-DTQIKRNTFVGTPFWMAPEVIQQSAYDSKAD 183
Query: 564 VFSYGAVVLEVASGRRP 580
++S G +E+A G P
Sbjct: 184 IWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 58/234 (24%), Positives = 110/234 (47%), Gaps = 38/234 (16%)
Query: 369 EFSYRELRSATKCFNANRIIGHGAFGTVY----KGIL-------PQNGD---IIAVK--R 412
EF ++LR K +G G FG V+ +G+ P+ ++AVK R
Sbjct: 1 EFPRQQLRLKEK-------LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLR 53
Query: 413 CSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKAL----- 467
+++FL E+ I+ L++ N++RL G C + ++ + M NG L++ L
Sbjct: 54 ADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREI 113
Query: 468 ---FEARSPLPWPHRSKIL---LGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARL 521
F + +P + +L + +AS + YL +HRD+ T N ++ + ++
Sbjct: 114 ESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKI 170
Query: 522 GDFGLARQV-EHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEV 574
DFG++R + D A + ++A E +L G+ T +DV+++G + E+
Sbjct: 171 ADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEM 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 2e-14
Identities = 58/220 (26%), Positives = 104/220 (47%), Gaps = 17/220 (7%)
Query: 375 LRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTL- 433
LR F ++G+G +G VYKG + G + A+K ++E E++++
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS 60
Query: 434 RHRNLVRLQGWCHEKG------EILLVYDLMPNGSLDKALFEAR-SPLPWPHRSKILLGV 486
HRN+ G +K ++ LV + GS+ + + + L + I +
Sbjct: 61 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI 120
Query: 487 ASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMG 546
L++LHQ ++VIHRD+K N++L E +L DFG++ Q++ T GT
Sbjct: 121 LRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPY 176
Query: 547 YLAPEYLLTGRATE-----KTDVFSYGAVVLEVASGRRPI 581
++APE + + K+D++S G +E+A G P+
Sbjct: 177 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 18/208 (8%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLR-HRNLVRLQGWCH 446
IG G +G V+K + +NG AVK +E +E +I+ L H N+V+ G +
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85
Query: 447 EKG-----EILLVYDLMPNGS---LDKALFEARSPLPWPHRSKILLGVASALAYLHQECE 498
+K ++ LV +L GS L K + + P + IL L +LH
Sbjct: 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---V 142
Query: 499 NQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYL----- 553
N+ IHRDVK +NI+L +L DFG++ Q+ + T + GT ++APE +
Sbjct: 143 NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT-SVGTPFWMAPEVIACEQQ 201
Query: 554 LTGRATEKTDVFSYGAVVLEVASGRRPI 581
L + DV+S G +E+ G P+
Sbjct: 202 LDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 53/205 (25%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHN------SQGKDEFLSELSIIGTLRHRNLV 439
+++G GAFG VY G +AVK+ + S+ + E+ ++ L H +V
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 440 RLQGWCHEKGE--ILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQEC 497
+ G + E + + + MP GS+ L ++ L K + ++YLH
Sbjct: 68 QYYGCLRDPMERTLSIFMEHMPGGSIKDQL-KSYGALTENVTRKYTRQILEGVSYLHS-- 124
Query: 498 ENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHD--KSPDATVAAGTMGYLAPEYLLT 555
N ++HRD+K +NI+ D N +LGDFG +++++ GT +++PE +
Sbjct: 125 -NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183
Query: 556 GRATEKTDVFSYGAVVLEVASGRRP 580
K D++S G V+E+ + + P
Sbjct: 184 EGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 20/218 (9%)
Query: 388 IGHGAFGTVYKGI-LPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLR------HRNLVR 440
IG GA+G V+K L G +A+KR + + LS + + LR H N+VR
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 441 LQGWC-----HEKGEILLVYDLMPNGSLDKALFEARSP-LPWPHRSKILLGVASALAYLH 494
L C + ++ LV++ + + L L + P +P ++ + L +LH
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 495 QECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLL 554
++V+HRD+K NI++ +L DFGLAR + T T+ Y APE LL
Sbjct: 128 S---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVVVTLWYRAPEVLL 182
Query: 555 TGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVG 592
D++S G + E+ R+P+ + + V ++G
Sbjct: 183 QSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQLG 219
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 56/198 (28%), Positives = 100/198 (50%), Gaps = 16/198 (8%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVK--RCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWC 445
+G G + TV+KG +++A+K R H + E+S++ L+H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 446 HEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILL-GVASALAYLHQECENQVIHR 504
H + + LV++ + + K + L H KI + + L+Y H + +++HR
Sbjct: 73 HTERCLTLVFEYLDSDL--KQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHR 127
Query: 505 DVKTSNIMLDEGFNARLGDFGLARQVEHDKS-PDATVA--AGTMGYLAPEYLL-TGRATE 560
D+K N++++E +L DFGLAR KS P T + T+ Y P+ LL + +
Sbjct: 128 DLKPQNLLINEKGELKLADFGLARA----KSVPTKTYSNEVVTLWYRPPDVLLGSTEYST 183
Query: 561 KTDVFSYGAVVLEVASGR 578
D++ G ++ E+A+GR
Sbjct: 184 PIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 73/295 (24%), Positives = 131/295 (44%), Gaps = 56/295 (18%)
Query: 385 NRIIGHGAFGTVYKG----ILPQNG-DIIAVKRCSHNSQGKD--EFLSELSIIGTLRHRN 437
+ +G G FG V K + + G +AVK N+ + + LSE +++ + H +
Sbjct: 5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPH 64
Query: 438 LVRLQGWCHEKGEILLVYDLMPNGSLDKALFEAR---------------SPLPWPHRSKI 482
+++L G C + G +LL+ + GSL L E+R S L P +
Sbjct: 65 VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 483 LLG--------VASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV-EHD 533
+G ++ + YL E +++HRD+ N+++ EG ++ DFGL+R V E D
Sbjct: 125 TMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED 181
Query: 534 KSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVG 592
+ + ++A E L T ++DV+S+G ++ E+ + G P G
Sbjct: 182 SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP---------G 232
Query: 593 VASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPT 647
+A E +++L + G + + E EM ++ L C +P RPT
Sbjct: 233 IAP---ERLFNLLKTGYRMERPENCSE------EMYNLM---LTCWKQEPDKRPT 275
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 5e-14
Identities = 47/175 (26%), Positives = 80/175 (45%), Gaps = 16/175 (9%)
Query: 423 FLSELSIIGTLRHRNLVRL--QGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRS 480
F E ++ L H N+V L G G + V++ +P +L + + A LP
Sbjct: 25 FRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYVPGRTL-REVLAADGALPAGETG 82
Query: 481 KILLGVASALAYLHQECENQVIHRDVKTSNIML---DEGFNARLGDFGLARQVEHDKSPD 537
+++L V ALA H ++HRD+K NIM+ +A++ DFG+ + + D
Sbjct: 83 RLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDAD 139
Query: 538 ATVAA------GTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEIT 586
GT Y APE L T +D++++G + LE +G+R ++
Sbjct: 140 VATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGASV 194
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 5e-14
Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 27/211 (12%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCS---HNSQGKDEF----LSELSIIGTLRHRNL 438
IG GA+G V G +A+K+ S H + F L E+ I+ +H N+
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQT-----FCQRTLREIKILRRFKHENI 65
Query: 439 VRLQ-----GWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYL 493
+ + ++ +V +LM L K + L H L + L Y+
Sbjct: 66 IGILDIIRPPSFESFNDVYIVQELMET-DLYKLI--KTQHLSNDHIQYFLYQILRGLKYI 122
Query: 494 HQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV--EHDKSPDATVAAGTMGYLAPE 551
H V+HRD+K SN++L+ + ++ DFGLAR EHD + T T Y APE
Sbjct: 123 HSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPE 179
Query: 552 YLLTGRA-TEKTDVFSYGAVVLEVASGRRPI 581
+L + T+ D++S G ++ E+ S RP+
Sbjct: 180 IMLNSKGYTKAIDIWSVGCILAEMLSN-RPL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 7e-14
Identities = 59/197 (29%), Positives = 95/197 (48%), Gaps = 15/197 (7%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKR---CSHNSQGKDEFLSELSIIGTLRHRNLVRLQGW 444
IG G++G V+K + G I+A+K+ + K L E+ ++ L+H NLV L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 445 CHEKGEILLVYDLMPNGSLDKALFEARSP--LPWPHRSKILLGVASALAYLHQECENQVI 502
K ++ LV++ + L++ ++P +P KI+ A+ + H+ + I
Sbjct: 69 FRRKRKLHLVFEYCDHTVLNEL---EKNPRGVPEHLIKKIIWQTLQAVNFCHK---HNCI 122
Query: 503 HRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKT 562
HRDVK NI++ + +L DFG AR + D T T Y APE LL G
Sbjct: 123 HRDVKPENILITKQGQIKLCDFGFARILT-GPGDDYTDYVATRWYRAPE-LLVGDTQYGP 180
Query: 563 --DVFSYGAVVLEVASG 577
DV++ G V E+ +G
Sbjct: 181 PVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 7e-14
Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 10/207 (4%)
Query: 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS----QGKDEFLSELSIIGTLRHRN 437
F R++G G FG V + G + A K+ +G+ L+E I+ + R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 438 LVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLG-VASALAYLHQE 496
+V L K + LV +M G L ++ +P R+ + L L +E
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121
Query: 497 CENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTG 556
++++RD+K NI+LD+ + R+ D GLA Q+ ++ V GT+GY+APE +
Sbjct: 122 ---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV--GTVGYMAPEVINNE 176
Query: 557 RATEKTDVFSYGAVVLEVASGRRPIEK 583
+ T D + G ++ E+ G+ P K
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQSPFRK 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 8e-14
Identities = 66/212 (31%), Positives = 104/212 (49%), Gaps = 23/212 (10%)
Query: 387 IIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSE---LSIIGTLRHRNLV 439
IIG G FG VY G + A+K QG+ L+E LS++ T +V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 440 RLQGWCHEKGEILLVYDLMPNGSLDKALFE----ARSPLPWPHRSKILLGVASALAYLHQ 495
+ H ++ + DLM G L L + + + + + + ++I+LG L ++H
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRF-YAAEIILG----LEHMHN 115
Query: 496 ECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLT 555
V++RD+K +NI+LDE + R+ D GLA K P A+V GT GY+APE L
Sbjct: 116 RF---VVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPHASV--GTHGYMAPEVLQK 169
Query: 556 GRATEKT-DVFSYGAVVLEVASGRRPIEKEIT 586
G A + + D FS G ++ ++ G P + T
Sbjct: 170 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 9e-14
Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 22/201 (10%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEF--LSELSIIGTLRHRNLVRLQGWC 445
+G G++ TVYKG G ++A+K + F + E S++ L+H N+V L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII 72
Query: 446 HEKGEILLVYDLMPNGSLDKALFEARSPLPW---PHRSKILL-GVASALAYLHQECENQV 501
H K + LV++ + D L + H ++ L + LAY HQ +V
Sbjct: 73 HTKKTLTLVFEYL-----DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RV 124
Query: 502 IHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS-PDATVAAG--TMGYLAPEYLLTGRA 558
+HRD+K N+++ E +L DFGLAR KS P T + T+ Y P+ LL
Sbjct: 125 LHRDLKPQNLLISERGELKLADFGLARA----KSVPSKTYSNEVVTLWYRPPDVLLGSTE 180
Query: 559 -TEKTDVFSYGAVVLEVASGR 578
+ D++ G + E+A+GR
Sbjct: 181 YSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 24/214 (11%)
Query: 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS----QGKDEFLSELSIIGTLRHRN 437
F R++G G FG V + G + A K+ +G+ L+E I+ + R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 438 LVRLQGWCHEKGEILLVYDLMPNGSLDKALF--------EARSPLPWPHRSKILLGVASA 489
+V L K + LV LM G L ++ E R+ + ++I G
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVF---YAAEITCG---- 114
Query: 490 LAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLA 549
L LH+E ++++RD+K NI+LD+ + R+ D GLA ++ ++ V GT+GY+A
Sbjct: 115 LEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV--GTVGYMA 169
Query: 550 PEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEK 583
PE + R T D + G ++ E+ G+ P +
Sbjct: 170 PEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 59/210 (28%), Positives = 90/210 (42%), Gaps = 20/210 (9%)
Query: 388 IGHGAFGTVYKG----ILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQG 443
IG+G FG V G + + ++ R S + FL E+ L H N+++ G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 444 WCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILL----GVASALAYLHQECEN 499
C E LLV + P G L L R + + +L VAS L +LHQ
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---A 119
Query: 500 QVIHRDVKTSNIMLDEGFNARLGDFGLA-RQVEHDKSPDATVAAGTMGYLAPEY------ 552
IH D+ N L + ++GD+GLA Q D A + +LAPE
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 553 -LLTGRATEKTDVFSYGAVVLEVAS-GRRP 580
LL T+K++++S G + E+ + +P
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWELFTAADQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 1e-13
Identities = 63/212 (29%), Positives = 101/212 (47%), Gaps = 29/212 (13%)
Query: 387 IIGHGAFGTVYKGILPQNGDII--AVKRCSHNSQGKD--EFLSELSIIGTL-RHRNLVRL 441
+IG G FG V K + ++G + A+KR + D +F EL ++ L H N++ L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 442 QGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPH-----------RSKILLGVASAL 490
G C +G + L + P+G+L L ++R P S+ LL A+ +
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 491 AY-LHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMG--- 546
A + + Q IHRD+ NI++ E + A++ DFGL+R E TMG
Sbjct: 122 ARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKTMGRLP 174
Query: 547 --YLAPEYLLTGRATEKTDVFSYGAVVLEVAS 576
++A E L T +DV+SYG ++ E+ S
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 52/213 (24%), Positives = 93/213 (43%), Gaps = 19/213 (8%)
Query: 387 IIGHGAFGTVY----KGILPQNGD-IIAVKRCSH--NSQGKDEFLSELSIIGTLRHRNLV 439
+G G FG V+ KGI + G+ ++ VK + + EF EL + L H+N+V
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 440 RLQGWCHEKGEILLVYDLMPNGSLDKALFEARS--------PLPWPHRSKILLGVASALA 491
RL G C E ++ + G L + L +S PL + + +A +
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 492 YLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPE 551
+L + +HRD+ N ++ ++ L++ V + + A + +LAPE
Sbjct: 132 HLSN---ARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188
Query: 552 YLLTGRATEKTDVFSYGAVVLEV-ASGRRPIEK 583
+ + K+DV+S+G ++ EV G P
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG 221
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 75/295 (25%), Positives = 131/295 (44%), Gaps = 51/295 (17%)
Query: 388 IGHGAFGTVYKGIL-------PQNGDIIAVKRCSHNSQGKD--EFLSELSIIGTL-RHRN 437
+G G FG V P +AVK ++ KD + +SE+ ++ + +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 438 LVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSP----------LPWPHRS-KILLG- 485
++ L G C + G + ++ + G+L + L R P +P S K L+
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 486 ---VASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEH-DKSPDATVA 541
VA + YL + IHRD+ N+++ E ++ DFGLAR + H D T
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 542 AGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWV 601
+ ++APE L T ++DV+S+G ++ E+ + + G GV VE +
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--------LGGSPYPGVP---VEEL 251
Query: 602 WSLHREG-RLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655
+ L +EG R+ ++ E + ++ C H P RPT + +V+ L
Sbjct: 252 FKLLKEGHRMDKPSNCTNE----------LYMMMRDCWHAVPSQRPTFKQLVEDL 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 59/197 (29%), Positives = 93/197 (47%), Gaps = 17/197 (8%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRC----SHNSQGKDEFLSELSIIGTLRHRNLVRLQG 443
+G GAFG V G +A+K+ S K + EL ++ LRH N++ L
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY-RELKLLKHLRHENIISLSD 76
Query: 444 -WCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVI 502
+ +I V +L+ G+ L +R PL L + L Y+H V+
Sbjct: 77 IFISPLEDIYFVTELL--GTDLHRLLTSR-PLEKQFIQYFLYQILRGLKYVHSA---GVV 130
Query: 503 HRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLT-GRATEK 561
HRD+K SNI+++E + ++ DFGLAR + P T T Y APE +LT + +
Sbjct: 131 HRDLKPSNILINENCDLKICDFGLARI----QDPQMTGYVSTRYYRAPEIMLTWQKYDVE 186
Query: 562 TDVFSYGAVVLEVASGR 578
D++S G + E+ G+
Sbjct: 187 VDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 10/208 (4%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTLRHRNLVRLQG 443
+G G FG V + G + A K+ G+ L E I+ + +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 444 WCHEKGEILLVYDLMPNGSLDKALFE-ARSPLPWPHRSKILLGVASALAYLHQECENQVI 502
K + LV LM G L ++ L + + +LH ++
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIV 117
Query: 503 HRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKT 562
+RD+K N++LD+ N RL D GLA +++ K+ T AGT GY+APE L +
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEPYSYPV 175
Query: 563 DVFSYGAVVLEVASGRRPIEKEITGVGK 590
D F+ G + E+ +GR P + V K
Sbjct: 176 DWFAMGCSIYEMVAGRTPFKDHKEKVAK 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 79/295 (26%), Positives = 134/295 (45%), Gaps = 55/295 (18%)
Query: 388 IGHGAFGTVYK----GI---LPQNGDIIAVKRCSHNSQGKD--EFLSELSIIGTL-RHRN 437
+G G FG V GI P +AVK ++ KD + +SE+ ++ + +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 438 LVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSP----------LPWPHRS-KILLG- 485
++ L G C + G + ++ + G+L + L R P LP + K L+
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 486 ---VASALAYL-HQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEH-DKSPDATV 540
VA + YL Q+C IHRD+ N+++ E ++ DFGLAR V + D T
Sbjct: 140 AYQVARGMEYLASQKC----IHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195
Query: 541 AAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVE 599
+ ++APE L T ++DV+S+G ++ E+ + G P G+ VE
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP---------GIP---VE 243
Query: 600 WVWSLHREG-RLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653
++ L +EG R+ A+ E + ++ C H P RPT + +V+
Sbjct: 244 ELFKLLKEGHRMDKPANCTHE----------LYMIMRECWHAVPSQRPTFKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 57/218 (26%), Positives = 101/218 (46%), Gaps = 22/218 (10%)
Query: 382 FNANRIIGHGAFGTVYKGILPQNGDI---IAVKRCSHN---SQGKDEFLSELSIIGTLRH 435
F R++G G FG+V + L +AVK + S +EFL E + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 436 RNLVRLQGWC---HEKGEI---LLVYDLMPNGSLDKALFEAR---SPLPWPHRS--KILL 484
N+++L G KG + +++ M +G L L +R P P ++ + ++
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 485 GVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV-EHDKSPDATVAAG 543
+AS + YL + IHRD+ N ML+E + DFGL++++ D +
Sbjct: 121 DIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 544 TMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRP 580
+ +LA E L T +DV+++G + E+ + G+ P
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 57/213 (26%), Positives = 88/213 (41%), Gaps = 13/213 (6%)
Query: 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDE----FLSELSIIGTLRH 435
K F+ ++G G FG V GDI A+K + E F E I+
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 436 RNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQ 495
+ +LQ +K + LV + P G L L L + A+ +HQ
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120
Query: 496 ECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLT 555
+HRD+K N+++D + +L DFG A ++ +K ++ + GT Y+APE L T
Sbjct: 121 M---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTT 177
Query: 556 GRATEKT------DVFSYGAVVLEVASGRRPIE 582
K D +S G + E+ GR P
Sbjct: 178 MNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH 210
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 7e-13
Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 44/219 (20%)
Query: 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCS-----HNSQGKDEFLSELSIIGTLRHR 436
F + +G G+FG V +G A+K S Q + L+E I+ ++RH
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIRHP 61
Query: 437 NLVRLQGWCHEKGEILLVYDLMPNG------------SLDKALFEARSPLPWPHRSKILL 484
LV L G + + LV + +P G A F A ++++L
Sbjct: 62 FLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYA---------AQVVL 112
Query: 485 GVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGT 544
AL YLH +++RD+K N++LD ++ DFG A++V+ GT
Sbjct: 113 ----ALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK----GRTYTLCGT 161
Query: 545 MGYLAPEYLLT---GRATEKTDVFSYGAVVLEVASGRRP 580
YLAPE +L+ G+A D ++ G ++ E+ +G P
Sbjct: 162 PEYLAPEIILSKGYGKA---VDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 7e-13
Identities = 58/220 (26%), Positives = 102/220 (46%), Gaps = 17/220 (7%)
Query: 375 LRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTL- 433
LR F ++G+G +G VYKG + G + A+K ++E E++++
Sbjct: 11 LRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYS 70
Query: 434 RHRNLVRLQGWCHEKG------EILLVYDLMPNGSLDKALFEAR-SPLPWPHRSKILLGV 486
HRN+ G +K ++ LV + GS+ + + + L + I +
Sbjct: 71 HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREI 130
Query: 487 ASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMG 546
LA+LH ++VIHRD+K N++L E +L DFG++ Q++ T GT
Sbjct: 131 LRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPY 186
Query: 547 YLAPEYLLTGRATEKT-----DVFSYGAVVLEVASGRRPI 581
++APE + + T D++S G +E+A G P+
Sbjct: 187 WMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 17/209 (8%)
Query: 382 FNANRIIGHGAFGTVYKGILPQ--NGDI------IAVKRCSHNSQGKDEFLSELSIIGTL 433
+N R++G G+FG + +L Q N D I + + S + + E ++ +
Sbjct: 2 YNVLRVVGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRK---EAVLLAKM 55
Query: 434 RHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYL 493
+H N+V + G + +V + G L + + R L +P + + V L
Sbjct: 56 KHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKL-FPEDTILQWFVQMCLGVQ 114
Query: 494 HQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYL 553
H E +V+HRD+K+ NI L + +LGDFG AR + + A GT Y+ PE
Sbjct: 115 HIH-EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY-ACTYVGTPYYVPPEIW 172
Query: 554 LTGRATEKTDVFSYGAVVLEVASGRRPIE 582
K+D++S G ++ E+ + + P +
Sbjct: 173 ENMPYNNKSDIWSLGCILYELCTLKHPFQ 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 50/191 (26%), Positives = 91/191 (47%), Gaps = 24/191 (12%)
Query: 407 IIAVK--RCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLD 464
++AVK R N +++FL E+ I+ L+ N++RL G C ++ + ++ + M NG L+
Sbjct: 48 LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107
Query: 465 KAL---------------FEARSPLPWPHRSKIL---LGVASALAYLHQECENQVIHRDV 506
+ L LP S +L L +AS + YL +HRD+
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDL 164
Query: 507 KTSNIMLDEGFNARLGDFGLARQV-EHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVF 565
T N ++ E ++ DFG++R + D A + ++A E +L G+ T +DV+
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVW 224
Query: 566 SYGAVVLEVAS 576
++G + E+
Sbjct: 225 AFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-12
Identities = 63/234 (26%), Positives = 100/234 (42%), Gaps = 42/234 (17%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRC----SHNSQGKDEFLSELSIIGTLRHRNLVRL 441
R+IG G G VY P +A+K+ S N K FL E I L H +V +
Sbjct: 8 RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 442 QGWCHEKGEILLVYDLMP--NG----SLDKALFEARSPLPWPHRSK--------ILLGVA 487
C + VY MP G SL K++++ S L K I +
Sbjct: 68 YSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKES-LSKELAEKTSVGAFLSIFHKIC 123
Query: 488 SALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLA--RQVEHDKSPDATVA---- 541
+ + Y+H + V+HRD+K NI+L + D+G A +++E + D V
Sbjct: 124 ATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 542 -----------AGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKE 584
GT Y+APE LL A+E TD+++ G ++ ++ + P ++
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK 234
|
Length = 932 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 56/233 (24%), Positives = 101/233 (43%), Gaps = 33/233 (14%)
Query: 378 ATKCFNANRIIGHGAFGTVY-----------KGILPQNGD-----IIAVK--RCSHNSQG 419
+ N +G G FG V+ + +N + ++AVK R +
Sbjct: 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNA 62
Query: 420 KDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSL----------DKALFE 469
+++FL E+ I+ L N+ RL G C + ++ + M NG L L
Sbjct: 63 REDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLAC 122
Query: 470 ARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQ 529
L + + +AS + YL E N V HRD+ T N ++ + + ++ DFG++R
Sbjct: 123 NSKSLSFSTLLYMATQIASGMRYL--ESLNFV-HRDLATRNCLVGKNYTIKIADFGMSRN 179
Query: 530 V-EHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRP 580
+ D A + ++A E +L G+ T K+DV+++G + E+ + R
Sbjct: 180 LYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQ 232
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 56/221 (25%), Positives = 105/221 (47%), Gaps = 35/221 (15%)
Query: 388 IGHGAFGTVYKGIL--PQNGD---IIAVKRCSHNSQG--KDEFLSELSIIGTLRHRNLVR 440
+G FG VYKG L G+ +A+K ++G ++EF E + L+H N+V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 441 LQGWCHEKGEILLVYDLMPNGSLDKALFEARSP----------------LPWPHRSKILL 484
L G ++ + +++ + L + L RSP L I+
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLV-MRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 485 GVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGT 544
+A+ + +L + V+H+D+ T N+++ + N ++ D GL R+V + D G
Sbjct: 132 QIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNVKISDLGLFREV---YAADYYKLMGN 185
Query: 545 ----MGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRP 580
+ +++PE ++ G+ + +D++SYG V+ EV S G +P
Sbjct: 186 SLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 65/216 (30%), Positives = 97/216 (44%), Gaps = 31/216 (14%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRN---------- 437
IG G FG VY+ I A+K S K E +++ + T+ RN
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLS-----KKEIVAKKEVAHTIGERNILVRTLLDES 55
Query: 438 --LVRLQGWCHEKGEILLVYDLMPNGSLDKAL-FEARSPLPWPHRSKILLG-VASALAYL 493
+V L+ ++ LV D M G L L E R R+K + + AL +L
Sbjct: 56 PFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFS---EDRAKFYIAELVLALEHL 112
Query: 494 HQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAA--GTMGYLAPE 551
H + +++RD+K NI+LD + L DFGL++ + + + T GT YLAPE
Sbjct: 113 H---KYDIVYRDLKPENILLDATGHIALCDFGLSKA---NLTDNKTTNTFCGTTEYLAPE 166
Query: 552 YLLTGRA-TEKTDVFSYGAVVLEVASGRRPIEKEIT 586
LL + T+ D +S G +V E+ G P E T
Sbjct: 167 VLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT 202
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 55/218 (25%), Positives = 105/218 (48%), Gaps = 29/218 (13%)
Query: 388 IGHGAFGTVYKG--ILP--QNGDIIAVKRCS--HNSQGKDEFLSELSIIGTLRHRNLVRL 441
+G AFG +YKG LP + ++A+K +N Q EF E S++ L H N+V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 442 QGWCHEKGEILLVYDLMPNGSLDKALFEARSP-----------------LPWPHRSKILL 484
G ++ + ++++ + G L + L RSP L I +
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLI-MRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 485 GVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV-EHDKSPDATVAAG 543
+A+ + YL + +H+D+ NI++ E + ++ D GL+R++ D +
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 544 TMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRP 580
+ ++ PE ++ G+ + +D++S+G V+ E+ S G +P
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 60/200 (30%), Positives = 91/200 (45%), Gaps = 10/200 (5%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVK----RCSHNSQGKDEFLSELSII-GTLRHRNLVR 440
++IG G+FG V +G AVK + N + + ++E +++ ++H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 441 LQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQ 500
L ++ V D + G L L RS P P +ASAL YLH
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERS-FPEPRARFYAAEIASALGYLHSI---N 116
Query: 501 VIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATE 560
+++RD+K NI+LD + L DFGL ++ +S T GT YLAPE +
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175
Query: 561 KTDVFSYGAVVLEVASGRRP 580
D + GAV+ E+ G P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 46/224 (20%)
Query: 388 IGHGAFGTVYKGIL--PQNGDIIAVKR---CSHNSQGKDEFLS-----ELSIIGTLRHRN 437
IG G +G VYK ++G A+K+ G +S E++++ L+H N
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTG----ISQSACREIALLRELKHEN 63
Query: 438 LVRLQGWC--HEKGEILLVYDLMPNGSLDKALFE--------ARSPLPWPHRSKILLGVA 487
+V L H + L++D + L++ R +P +L +
Sbjct: 64 VVSLVEVFLEHADKSVYLLFDYA-----EHDLWQIIKFHRQAKRVSIPPSMVKSLLWQIL 118
Query: 488 SALAYLHQECENQVIHRDVKTSNIML----DEGFNARLGDFGLARQVEHDKSPDATVAAG 543
+ + YLH N V+HRD+K +NI++ E ++GD GLAR +P +A
Sbjct: 119 NGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN---APLKPLADL 172
Query: 544 -----TMGYLAPEYLLTGRA-TEKTDVFSYGAVVLEVASGRRPI 581
T+ Y APE LL R T+ D+++ G + E+ + PI
Sbjct: 173 DPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-LEPI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-12
Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 20/199 (10%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEF--LSELSIIGTLRHRNLVRLQGWC 445
+G G++ TVYKG NG ++A+K + F + E S++ L+H N+V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 446 HEKGEILLVYDLMPNGSLDKALFEARSPLPW-PHRSKILL-GVASALAYLHQECENQVIH 503
H K + LV++ + D + + P P K+ L + L+Y+HQ ++H
Sbjct: 73 HTKETLTLVFEYV---HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILH 126
Query: 504 RDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVA--AGTMGYLAPEYLLTGRATEK 561
RD+K N+++ + +L DFGLAR P T + T+ Y P+ LL +TE
Sbjct: 127 RDLKPQNLLISDTGELKLADFGLARA---KSVPSHTYSNEVVTLWYRPPDVLLG--STEY 181
Query: 562 T---DVFSYGAVVLEVASG 577
+ D++ G + +E+ G
Sbjct: 182 STCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 22/206 (10%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSH---NSQGKDEFLSELSIIGTLRHRNLVRLQGW 444
IG GA+G V + + +A+K+ ++ N L E+ ++ L H N++ ++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 445 ----CHEKGE-ILLVYDLMPNGSLDKALFEA-RS--PLPWPHRSKILLGVASALAYLHQE 496
E + +VY+LM D L + RS L H L + L Y+H
Sbjct: 73 MPPPHREAFNDVYIVYELM-----DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSA 127
Query: 497 CENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLT- 555
V+HRD+K SN++L+ + ++ DFGLAR +K T T Y APE LL
Sbjct: 128 ---NVLHRDLKPSNLLLNANCDLKICDFGLAR-TTSEKGDFMTEYVVTRWYRAPELLLNC 183
Query: 556 GRATEKTDVFSYGAVVLEVASGRRPI 581
T DV+S G + E+ GR+P+
Sbjct: 184 SEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 4e-12
Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 22/203 (10%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCS--HNSQGKDE--FLSELSIIGTLRHRNLVRLQG 443
+G G FG V + A+K H + + SE I+ H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 444 WCHEKGEILLVYDLMPNGSL-----DKALFEARSPLPWPHRSKILLG-VASALAYLHQEC 497
+K I ++ + G L D+ LF+ + ++ + V A YLH
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYT-------ARFYIACVVLAFEYLH--- 110
Query: 498 ENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGR 557
+I+RD+K N++LD +L DFG A++++ T GT Y+APE +L
Sbjct: 111 NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLK-SGQKTWTF-CGTPEYVAPEIILNKG 168
Query: 558 ATEKTDVFSYGAVVLEVASGRRP 580
D +S G ++ E+ +GR P
Sbjct: 169 YDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 9e-12
Identities = 58/205 (28%), Positives = 106/205 (51%), Gaps = 15/205 (7%)
Query: 386 RIIGHGAFGTVY---KGILPQNGDIIAVK---RCSHNSQGKDEFLSELSIIGTLRHRNLV 439
+++G G+FG V+ K P G + A+K + + + + E I+ + H +V
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 440 RLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLG-VASALAYLHQECE 498
+L +G++ L+ D + G L L ++ + K L +A AL +LH
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYLAELALALDHLHSL-- 117
Query: 499 NQVIHRDVKTSNIMLDEGFNARLGDFGLARQ-VEHDKSPDATVAAGTMGYLAPEYLLTGR 557
+I+RD+K NI+LDE + +L DFGL+++ ++H+K A GT+ Y+APE +
Sbjct: 118 -GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVEYMAPEVVNRRG 174
Query: 558 ATEKTDVFSYGAVVLEVASGRRPIE 582
T+ D +S+G ++ E+ +G P +
Sbjct: 175 HTQSADWWSFGVLMFEMLTGSLPFQ 199
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 54/210 (25%), Positives = 86/210 (40%), Gaps = 23/210 (10%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFL---SELSIIGTLRHRNLVRLQ 442
+ + K ++AVK+ + +S K++ E+ L+H N++
Sbjct: 8 KCFEDLMIVHLAKHK--PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYV 65
Query: 443 GWCHEKGEILLVYDLMPNGS---LDKALFEARSPLPWPHRSKILLGVASALAYLHQECEN 499
E+ +V LM GS L K F LP + IL V +AL Y+H
Sbjct: 66 TSFIVDSELYVVSPLMAYGSCEDLLKTHF--PEGLPELAIAFILKDVLNALDYIHS---K 120
Query: 500 QVIHRDVKTSNIMLDEGFNARLGDFGLARQ-VEHDKSPDATV-----AAGTMGYLAPEYL 553
IHR VK S+I+L L + ++H K + + +L+PE L
Sbjct: 121 GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVL 180
Query: 554 ---LTGRATEKTDVFSYGAVVLEVASGRRP 580
L G EK+D++S G E+A+G P
Sbjct: 181 QQNLQGY-NEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 56/214 (26%), Positives = 99/214 (46%), Gaps = 38/214 (17%)
Query: 388 IGHGAFGTVYKGILPQNGDI--------IAVKRCSHNSQGKD--EFLSELSIIGTLRHRN 437
+G G F +YKG+L D+ ++V S +D F S++ L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 438 LVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQEC 497
LV+L G C I+ V + + G LD L ++ + + + +ASAL YL
Sbjct: 63 LVKLYGVCVRDENIM-VEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE--- 118
Query: 498 ENQVIHRDVKTSNIML-----DEGFN--ARLGDFG-----LARQVEHDKSPDATVAAGTM 545
+ +++H +V NI++ +EG+ +L D G L+R+ ++ P
Sbjct: 119 DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP--------- 169
Query: 546 GYLAPEYLLTGRA--TEKTDVFSYGAVVLEVASG 577
++APE + G+A T D +S+G +LE+ S
Sbjct: 170 -WIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 3e-11
Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 22/204 (10%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ----GKDEFLSELSIIGTLRHRNLVRL 441
+G GA+G V + G +A+K+ S Q K + EL ++ + H N++ L
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY-RELRLLKHMDHENVIGL 79
Query: 442 QGWCH------EKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQ 495
+ ++ LV LM L+ + L H ++ + L Y+H
Sbjct: 80 LDVFTPASSLEDFQDVYLVTHLM-GADLNNIV--KCQKLSDDHIQFLVYQILRGLKYIHS 136
Query: 496 ECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLT 555
+IHRD+K SNI ++E ++ DFGLAR + + T T Y APE +L
Sbjct: 137 A---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLN 189
Query: 556 -GRATEKTDVFSYGAVVLEVASGR 578
+ D++S G ++ E+ +G+
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 63/203 (31%), Positives = 93/203 (45%), Gaps = 16/203 (7%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS----QGKDEFLSELSII-GTLRHRNLVR 440
++IG G+FG V +G AVK + + ++ ++E +++ L+H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 441 LQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQ 500
L ++ V D + G L L R L P VASA+ YLH
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLE-PRARFYAAEVASAIGYLHSL---N 116
Query: 501 VIHRDVKTSNIMLDEGFNARLGDFGLARQ-VEHDKSPDATVAA--GTMGYLAPEYLLTGR 557
+I+RD+K NI+LD + L DFGL ++ VE P+ T + GT YLAPE L
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGVE----PEETTSTFCGTPEYLAPEVLRKEP 172
Query: 558 ATEKTDVFSYGAVVLEVASGRRP 580
D + GAV+ E+ G P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-11
Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 26/217 (11%)
Query: 376 RSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRH 435
RS K + IIG+G+FG VY+ I + +A+K+ + Q K+ EL I+ L H
Sbjct: 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR---ELLIMKNLNH 118
Query: 436 RNLVRLQGW----CHEKGE--ILL--VYDLMPNGSLDKALFEARSPLPWPHRSKILLGVA 487
N++ L+ + C +K E I L V + +P AR+ P L+ +
Sbjct: 119 INIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALP---LFLVKLY 175
Query: 488 S-----ALAYLHQECENQVIHRDVKTSNIMLDEGFNA-RLGDFGLARQVEHDKSPDATVA 541
S ALAY+H + + HRD+K N+++D + +L DFG A+ + + + +
Sbjct: 176 SYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC 232
Query: 542 AGTMGYLAPEYLL-TGRATEKTDVFSYGAVVLEVASG 577
+ Y APE +L T D++S G ++ E+ G
Sbjct: 233 --SRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 4e-11
Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 44/221 (19%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRL---- 441
R++G G+FG V L ++G + AVK KD L + + T+ + ++ L
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLK-----KDVILQDDDVECTMTEKRILSLARNH 55
Query: 442 ----QGWC--HEKGEILLVYDLMPNGSL------------DKALFEARSPLPWPHRSKIL 483
Q +C + V + + G L +A F A
Sbjct: 56 PFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE----------- 104
Query: 484 LGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAG 543
+ SAL +LH + +I+RD+K N++LD + +L DFG+ ++ + +T G
Sbjct: 105 --ITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTF-CG 158
Query: 544 TMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKE 584
T Y+APE L D ++ G ++ E+ G P E E
Sbjct: 159 TPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-11
Identities = 44/181 (24%), Positives = 86/181 (47%), Gaps = 16/181 (8%)
Query: 407 IIAVK--RCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLD 464
++AVK R N +++FL E+ I+ L+ N++RL C + ++ + M NG L+
Sbjct: 48 LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 465 KAL--FEARSPLPWPHRSKILLG--------VASALAYLHQECENQVIHRDVKTSNIMLD 514
+ L E + I +AS + YL +HRD+ T N ++
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVG 164
Query: 515 EGFNARLGDFGLARQV-EHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLE 573
+ + ++ DFG++R + D A + +++ E +L G+ T +DV+++G + E
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWE 224
Query: 574 V 574
+
Sbjct: 225 I 225
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 6e-11
Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 31/211 (14%)
Query: 387 IIGHGAFGTVYKGILPQNGDIIAVKRCS----HNSQGKDEFLSELSIIGTLRHRNLVRLQ 442
+IG G++G V I G+ +A+K+ + H S L E+ ++ LRH ++V ++
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDAT-RILREIKLLRLLRHPDIVEIK 65
Query: 443 GWCH--------EKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLH 494
H E +I +V++LM S + +A L H L + AL Y+H
Sbjct: 66 ---HIMLPPSRREFKDIYVVFELM--ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH 120
Query: 495 QECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDA---TVAAGTMGYLAPE 551
V HRD+K NI+ + ++ DFGLAR V + +P A T T Y APE
Sbjct: 121 T---ANVFHRDLKPKNILANADCKLKICDFGLAR-VAFNDTPTAIFWTDYVATRWYRAPE 176
Query: 552 YLLTG----RATEKTDVFSYGAVVLEVASGR 578
L G + T D++S G + EV +G+
Sbjct: 177 --LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 25/206 (12%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFL--SELSIIGTLRHRNLVRLQG-- 443
+G G +G VYK G++ AVK G D L E+ ++ +H N+V G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKL-EPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75
Query: 444 WCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIH 503
EK I + Y GSL + ++ PL + + LAYLH + + +H
Sbjct: 76 LSREKLWICMEY--CGGGSL-QDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK---MH 129
Query: 504 RDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAA-----GTMGYLAPEYLL---T 555
RD+K +NI+L + + +L DFG+A ++ AT+A GT ++APE
Sbjct: 130 RDIKGANILLTDNGDVKLADFGVAAKIT------ATIAKRKSFIGTPYWMAPEVAAVEKN 183
Query: 556 GRATEKTDVFSYGAVVLEVASGRRPI 581
G + D+++ G +E+A + P+
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 56/212 (26%), Positives = 90/212 (42%), Gaps = 12/212 (5%)
Query: 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDE----FLSELSIIGTLRHRN 437
F ++IG GAFG V L + A+K + K F E ++ ++
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 438 LVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQEC 497
+ L ++ + LV D G L L + LP L + A+ +HQ
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL- 121
Query: 498 ENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLT-- 555
+HRD+K NI++D + RL DFG ++ D + ++VA GT Y++PE L
Sbjct: 122 --HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME 179
Query: 556 ---GRATEKTDVFSYGAVVLEVASGRRPIEKE 584
G+ + D +S G + E+ G P E
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 19/209 (9%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCS-HNSQGKDEFLSELSIIGTLRHRNLVR---- 440
R +G G+ G V+ + +AVK+ + Q L E+ II L H N+V+
Sbjct: 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70
Query: 441 -------LQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYL 493
L E+ VY + D A + PL H + + L Y+
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYI 130
Query: 494 HQECENQVIHRDVKTSNIMLD-EGFNARLGDFGLARQVEHDKSPDATVAAG--TMGYLAP 550
H V+HRD+K +N+ ++ E ++GDFGLAR V+ S ++ G T Y +P
Sbjct: 131 HSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSP 187
Query: 551 EYLLTGRA-TEKTDVFSYGAVVLEVASGR 578
LL+ T+ D+++ G + E+ +G+
Sbjct: 188 RLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 59/245 (24%), Positives = 104/245 (42%), Gaps = 28/245 (11%)
Query: 352 HVKKSESFTSDIIRM-PKEFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAV 410
++K+++ + + R +LR + F+ ++IG GAFG V + + A+
Sbjct: 14 ALRKNKNIDNFLSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAM 73
Query: 411 KRCSHNSQGKDE---------FLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNG 461
K S K E F E I+ +V+L + + +V + MP G
Sbjct: 74 KLLS-----KFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGG 128
Query: 462 SLDKALFEARSPLPWP--HRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNA 519
L + P W + ++++L AL +H IHRDVK N++LD+ +
Sbjct: 129 DLVNLMSNYDIPEKWARFYTAEVVL----ALDAIHSM---GFIHRDVKPDNMLLDKSGHL 181
Query: 520 RLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRAT----EKTDVFSYGAVVLEVA 575
+L DFG +++ + A GT Y++PE L + + D +S G + E+
Sbjct: 182 KLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
Query: 576 SGRRP 580
G P
Sbjct: 242 VGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 2e-10
Identities = 46/171 (26%), Positives = 81/171 (47%), Gaps = 10/171 (5%)
Query: 411 KRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLV-----YDLMPNGSLDK 465
KR S+ + +E+ +G L H N+++++ + ++ +DL + D+
Sbjct: 198 KRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLY-SFMYDE 256
Query: 466 ALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFG 525
A PL R I+ + A+ Y+H + ++IHRD+K NI L+ LGDFG
Sbjct: 257 AFDWKDRPLLKQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFG 312
Query: 526 LARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS 576
A E ++ GT+ +PE L E TD++S G ++L++ S
Sbjct: 313 TAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 49/207 (23%), Positives = 97/207 (46%), Gaps = 32/207 (15%)
Query: 388 IGHGAFGTVYKGILPQNG-----------DIIAVKRCSHNSQGKDEFLSELSIIGTLRHR 436
+G G FG V+ + ++I +K+ H +E ++ + H
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQH-------VHNEKRVLKEVSHP 61
Query: 437 NLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEAR---SPLPWPHRSKILLGVASALAYL 493
++RL H++ + ++ + +P G L L + + + S+I+ AL YL
Sbjct: 62 FIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIV----CALEYL 117
Query: 494 HQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYL 553
H + ++++RD+K NI+LD+ + +L DFG A+++ D++ GT YLAPE +
Sbjct: 118 HSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKL-RDRT---WTLCGTPEYLAPEVI 170
Query: 554 LTGRATEKTDVFSYGAVVLEVASGRRP 580
+ + D ++ G ++ E+ G P
Sbjct: 171 QSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 61/201 (30%), Positives = 92/201 (45%), Gaps = 12/201 (5%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS--QGKDE--FLSELSII-GTLRHRNLVR 440
++IG G+FG V AVK + + K+E +SE +++ ++H LV
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 441 LQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQ 500
L ++ V D + G L L R L P +ASAL YLH
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLE-PRARFYAAEIASALGYLHSL---N 116
Query: 501 VIHRDVKTSNIMLDEGFNARLGDFGLARQ-VEHDKSPDATVAAGTMGYLAPEYLLTGRAT 559
+++RD+K NI+LD + L DFGL ++ +EH+ + + GT YLAPE L
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT--TSTFCGTPEYLAPEVLHKQPYD 174
Query: 560 EKTDVFSYGAVVLEVASGRRP 580
D + GAV+ E+ G P
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 58/200 (29%), Positives = 91/200 (45%), Gaps = 11/200 (5%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ-GKDEF---LSELSIIGTLRHRNLVRL 441
+++G G FG V +G A+K KDE L+E ++ RH L L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 442 QGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLG-VASALAYLHQECENQ 500
+ K + V + + G L L +R + R++ + SAL YLH +
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHL--SRERVFSEDRTRFYGAEIVSALDYLHS---GK 115
Query: 501 VIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATE 560
+++RD+K N+MLD+ + ++ DFGL ++ D + T GT YLAPE L
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF-CGTPEYLAPEVLEDNDYGR 174
Query: 561 KTDVFSYGAVVLEVASGRRP 580
D + G V+ E+ GR P
Sbjct: 175 AVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 54/201 (26%), Positives = 90/201 (44%), Gaps = 20/201 (9%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQG---KDEFLSELSIIGTLRHRNLVRL--- 441
+G GA+G+V + +AVK+ S Q EL ++ ++H N++ L
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 442 ---QGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECE 498
E+ LV +LM + + S H ++ + L Y+H
Sbjct: 83 FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSD---EHVQFLIYQLLRGLKYIHSA-- 137
Query: 499 NQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRA 558
+IHRD+K SN+ ++E R+ DFGLARQ + + T T Y APE +L
Sbjct: 138 -GIIHRDLKPSNVAVNEDCELRILDFGLARQADD----EMTGYVATRWYRAPEIMLNWMH 192
Query: 559 TEKT-DVFSYGAVVLEVASGR 578
+T D++S G ++ E+ G+
Sbjct: 193 YNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 20/201 (9%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQG---KDEFLSELSIIGTLRHRNLVRL--- 441
+G GA+G+V + G +AVK+ S Q EL ++ ++H N++ L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 442 ---QGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECE 498
E ++ LV LM G+ + + + L H ++ + L Y+H
Sbjct: 85 FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-- 139
Query: 499 NQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRA 558
+IHRD+K SN+ ++E ++ DFGLAR + + T T Y APE +L
Sbjct: 140 -DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH 194
Query: 559 TEKT-DVFSYGAVVLEVASGR 578
+T D++S G ++ E+ +GR
Sbjct: 195 YNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 52/175 (29%), Positives = 82/175 (46%), Gaps = 31/175 (17%)
Query: 486 VASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGT- 544
VA + +L + IHRD+ NI+L E ++ DFGLAR + D PD V G+
Sbjct: 183 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD--PD-YVRKGSA 236
Query: 545 ---MGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEW 600
+ ++APE + T ++DV+S+G ++ E+ S G P GV N E
Sbjct: 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP---------GVQIN--EE 285
Query: 601 VWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655
++G + A + E+ R++ LAC DP RPT +V++L
Sbjct: 286 FCQRLKDGTRMRAPE------NATPEIYRIM---LACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 59/218 (27%), Positives = 90/218 (41%), Gaps = 24/218 (11%)
Query: 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRL 441
F ++IG GAFG V + I A+K + K E L RN V +
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILN-----KWEMLKRAETACFREERN-VLV 56
Query: 442 QGWCH----------EKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALA 491
G C ++ + LV D G L L + LP + + A+
Sbjct: 57 NGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIH 116
Query: 492 YLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPE 551
+HQ +HRD+K N++LD + RL DFG ++ D + ++VA GT Y++PE
Sbjct: 117 SIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE 173
Query: 552 YLLT-----GRATEKTDVFSYGAVVLEVASGRRPIEKE 584
L G+ + D +S G + E+ G P E
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 211
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-10
Identities = 48/162 (29%), Positives = 80/162 (49%), Gaps = 7/162 (4%)
Query: 425 SELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEA-RSPLPWPHRSKIL 483
SEL + H +V+ ++LL+ + G L+K + + + LP+ L
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173
Query: 484 L--GVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD-ATV 540
L + AL +H ++HRD+K++NI L +LGDFG ++Q S D A+
Sbjct: 174 LFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230
Query: 541 AAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIE 582
GT YLAPE R ++K D++S G ++ E+ + RP +
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFK 272
|
Length = 478 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 5e-10
Identities = 56/212 (26%), Positives = 98/212 (46%), Gaps = 34/212 (16%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGW- 444
+++G G+FG V L G+ AVK + KD L + + T+ + ++ L W
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVK-----ALKKDVVLIDDDVECTMVEKRVLAL-AWE 54
Query: 445 --------C--HEKGEILLVYDLMPNGSL-----DKALFEA-RSPLPWPHRSKILLGVAS 488
C K + V + + G L DK F+ R+ + ++I+ G
Sbjct: 55 NPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATF---YAAEIVCG--- 108
Query: 489 ALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYL 548
L +LH +I+RD+K N+MLD + ++ DFG+ ++ + A+ GT Y+
Sbjct: 109 -LQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-RASTFCGTPDYI 163
Query: 549 APEYLLTGRATEKTDVFSYGAVVLEVASGRRP 580
APE L + T D +S+G ++ E+ G+ P
Sbjct: 164 APEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 52/215 (24%), Positives = 98/215 (45%), Gaps = 19/215 (8%)
Query: 376 RSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCS-HNSQGKDEFLSELSIIGTLR 434
R+ + F + IG G +G VYK G++ A+K + E+ ++ +
Sbjct: 5 RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCK 64
Query: 435 HRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLH 494
H N+V G + ++ + + GSL + ++ PL + + L YLH
Sbjct: 65 HSNIVAYFGSYLRRDKLWICMEFCGGGSL-QDIYHVTGPLSESQIAYVSRETLQGLYYLH 123
Query: 495 QECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAA-----GTMGYLA 549
+ + +HRD+K +NI+L + + +L DFG++ Q+ AT+A GT ++A
Sbjct: 124 SKGK---MHRDIKGANILLTDNGHVKLADFGVSAQIT------ATIAKRKSFIGTPYWMA 174
Query: 550 PEYLLTGRA---TEKTDVFSYGAVVLEVASGRRPI 581
PE R + D+++ G +E+A + P+
Sbjct: 175 PEVAAVERKGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 6e-10
Identities = 42/153 (27%), Positives = 70/153 (45%), Gaps = 10/153 (6%)
Query: 424 LSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSK-- 481
L E ++ + H +++R++ +V +P+ S D + + P P
Sbjct: 105 LIEAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALI 161
Query: 482 ILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVA 541
I + L YLH + ++IHRDVKT NI +++ +GD G A+ P
Sbjct: 162 IEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--PAFLGL 216
Query: 542 AGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEV 574
AGT+ APE L + K D++S G V+ E+
Sbjct: 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 56/206 (27%), Positives = 89/206 (43%), Gaps = 18/206 (8%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRH--------RN 437
R+IG G++ V L +N I A+K DE ++ + T +H
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDE---DIDWVQTEKHVFEQASSNPF 57
Query: 438 LVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQEC 497
LV L + LV + + G L + R LP H + AL +LH
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRK-LPEEHARFYAAEICIALNFLH--- 113
Query: 498 ENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVA-AGTMGYLAPEYLLTG 556
E +I+RD+K N++LD + +L D+G+ + E D T GT Y+APE L
Sbjct: 114 ERGIIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRGE 171
Query: 557 RATEKTDVFSYGAVVLEVASGRRPIE 582
D ++ G ++ E+ +GR P +
Sbjct: 172 EYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 6e-10
Identities = 57/225 (25%), Positives = 98/225 (43%), Gaps = 50/225 (22%)
Query: 388 IGHGAFGTV----YKGILPQNGDIIAVKRCSHNSQGKD----EFLSELSIIGTLR-HRNL 438
+G GA+G V + +A+K+ + N K L EL ++ R H+N+
Sbjct: 8 LGQGAYGIVCSARNAETSEEET--VAIKKIT-NVFSKKILAKRALRELKLLRHFRGHKNI 64
Query: 439 VRL------------QGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGV 486
L + + +E+ L+ DL + + PL H + +
Sbjct: 65 TCLYDMDIVFPGNFNELYLYEE---LMEADL-------HQIIRSGQPLTDAHFQSFIYQI 114
Query: 487 ASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMG 546
L Y+H V+HRD+K N++++ ++ DFGLAR S + AG M
Sbjct: 115 LCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGF----SENPGENAGFMT 167
Query: 547 -------YLAPEYLLTGRA-TEKTDVFSYGAVVLEVASGRRPIEK 583
Y APE +L+ ++ T+ DV+S G ++ E+ GR+P+ K
Sbjct: 168 EYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFK 211
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 6e-10
Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 31/209 (14%)
Query: 388 IGHGAFGTVYKGILPQNGDI----IAVK--RCSHNSQGKDEFLSELSIIGTLRHRNLVRL 441
IG+G FG V G + N + VK R S + Q + +FL E +L+H NL++
Sbjct: 3 IGNGWFGKVILGEV--NSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 442 QGWCHEKGEILLVYDLMPNGSLDKALFEAR---SPLPWPHR-SKILLGVASALAYLHQEC 497
G C E LLV + P G L L R P P ++ +A L +LH+
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK-- 118
Query: 498 ENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK-SPDATVAAGT----MGYLAPEY 552
N IH D+ N +L ++GD+GL+ H+K D V + ++APE
Sbjct: 119 -NNFIHSDLALRNCLLTADLTVKIGDYGLS----HNKYKEDYYVTPDQLWVPLRWIAPEL 173
Query: 553 -------LLTGRATEKTDVFSYGAVVLEV 574
LL T++++V+S G + E+
Sbjct: 174 VDEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 36/95 (37%), Positives = 51/95 (53%), Gaps = 3/95 (3%)
Query: 486 VASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTM 545
+ SAL YLH E V++RD+K N+MLD+ + ++ DFGL ++ D + T GT
Sbjct: 104 IVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF-CGTP 160
Query: 546 GYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRP 580
YLAPE L D + G V+ E+ GR P
Sbjct: 161 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 8e-10
Identities = 76/304 (25%), Positives = 127/304 (41%), Gaps = 55/304 (18%)
Query: 374 ELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCS---HNSQGKDEFLSELSII 430
+ K + +R++G GA GTV +G+ AVK + K+ +E+ +
Sbjct: 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCL 85
Query: 431 GTLRHRNLVRLQGWCHE----KGE--------ILLVYDLMPNGSLDKAL-FEARSPLPWP 477
++V+ CHE K I LV D G L + + A++ +
Sbjct: 86 LNCDFFSIVK----CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFR 141
Query: 478 HRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD 537
LL + LA +H +IHRD+K++NI+L +LGDFG ++ S D
Sbjct: 142 EHEAGLLFIQVLLA-VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDD 200
Query: 538 -ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASN 596
GT Y+APE ++K D+FS G ++ E+ + +RP + E N
Sbjct: 201 VGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE-----------N 249
Query: 597 LVEWVWSLHREGRLLTAADARLEGQFD------EAEMRRVLLVGLACSHPDPLARPTMRG 650
+ E +H+ L G++D EM+ + + L S DP RP+
Sbjct: 250 MEE---VMHKT----------LAGRYDPLPPSISPEMQEI-VTALLSS--DPKRRPSSSK 293
Query: 651 VVQM 654
++ M
Sbjct: 294 LLNM 297
|
Length = 496 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 9e-10
Identities = 62/243 (25%), Positives = 104/243 (42%), Gaps = 26/243 (10%)
Query: 346 FSKRYKHVKKSESFTSDIIRMPKEFSYRELRSATKCFNANRIIGHGAFGTVYKGILP--Q 403
F K + KK +S ++ + + Y + FN R +G G+FG V IL +
Sbjct: 3 FLKNLQLHKKKDSDSTKEPKRKNKMKYED-------FNFIRTLGTGSFGRV---ILATYK 52
Query: 404 NGDI--IAVKR---CSHNSQGK-DEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457
N D +A+KR Q + D SE I+ + H V L G ++ + LV +
Sbjct: 53 NEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEF 112
Query: 458 MPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGF 517
+ G L R +P+ L + + + N +++RD+K N++LD+
Sbjct: 113 VIGGEFFTFL---RRNKRFPNDVGCFYAAQIVLIFEYLQSLN-IVYRDLKPENLLLDKDG 168
Query: 518 NARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASG 577
++ DFG A+ V+ GT Y+APE LL + D ++ G + E+ G
Sbjct: 169 FIKMTDFGFAKVVD----TRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
Query: 578 RRP 580
P
Sbjct: 225 CPP 227
|
Length = 340 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 57/202 (28%), Positives = 87/202 (43%), Gaps = 20/202 (9%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCS---HNSQGKDEFLSELSIIGTLRHRNLVRL- 441
+ IG GA G V G +AVK+ S N EL ++ + H+N++ L
Sbjct: 27 KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 86
Query: 442 -----QGWCHEKGEILLVYDLMPNGSLDKALFEA-RSPLPWPHRSKILLGVASALAYLHQ 495
Q E ++ LV +LM D L + L S +L + + +LH
Sbjct: 87 NVFTPQKSLEEFQDVYLVMELM-----DANLCQVIHMELDHERMSYLLYQMLCGIKHLHS 141
Query: 496 ECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLT 555
+IHRD+K SNI++ ++ DFGLAR + V T Y APE +L
Sbjct: 142 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV--TRYYRAPEVILG 196
Query: 556 GRATEKTDVFSYGAVVLEVASG 577
E D++S G ++ E+ G
Sbjct: 197 MGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 1e-09
Identities = 50/176 (28%), Positives = 85/176 (48%), Gaps = 33/176 (18%)
Query: 486 VASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGT- 544
VA +++L IHRD+ NI+L G ++ DFGLAR + +D + V G
Sbjct: 223 VAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN---YVVKGNA 276
Query: 545 ---MGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEW 600
+ ++APE + T ++DV+SYG ++ E+ S G P + V S
Sbjct: 277 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYP-------GMPVDSKF--- 326
Query: 601 VWSLHREG-RLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655
+ + +EG R+L+ + +EM ++ +C DPL RPT + +VQ++
Sbjct: 327 -YKMIKEGYRMLSP-------ECAPSEMYDIM---KSCWDADPLKRPTFKQIVQLI 371
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 57/218 (26%), Positives = 93/218 (42%), Gaps = 17/218 (7%)
Query: 373 RELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDE----FLSELS 428
R+LR + + ++IG GAFG V + A+K S K F E
Sbjct: 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 429 IIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWP--HRSKILLGV 486
I+ +V+L + + +V + MP G L + P W + ++++L
Sbjct: 96 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVL-- 153
Query: 487 ASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMG 546
AL +H IHRDVK N++LD+ + +L DFG ++ + A GT
Sbjct: 154 --ALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 208
Query: 547 YLAPEYLLT----GRATEKTDVFSYGAVVLEVASGRRP 580
Y++PE L + G + D +S G + E+ G P
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 52/216 (24%), Positives = 93/216 (43%), Gaps = 43/216 (19%)
Query: 388 IGHGAFGTVYKGILPQNGD---------IIAVKRCSHNSQGKDEFLSELSIIGTLRHRNL 438
+G G F ++KGI + GD ++ V SH + + F S++ L H++L
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNY-SESFFEAASMMSQLSHKHL 61
Query: 439 VRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLP--WPHRSKILLGVASALAY-LHQ 495
V G C E ++V + + GSLD L + ++ + W L VA LA+ LH
Sbjct: 62 VLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK------LEVAKQLAWALHF 115
Query: 496 ECENQVIHRDVKTSNIML-DEGFNA-------RLGDFG-----LARQVEHDKSPDATVAA 542
+ + H +V N++L E +L D G L +++ ++ P
Sbjct: 116 LEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIP------ 169
Query: 543 GTMGYLAPEYLLTGRA-TEKTDVFSYGAVVLEVASG 577
++ PE + + + D +S+G + E+ SG
Sbjct: 170 ----WVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 17/218 (7%)
Query: 373 RELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDE----FLSELS 428
R+L+ + ++ ++IG GAFG V + + A+K S K F E
Sbjct: 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 429 IIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWP--HRSKILLGV 486
I+ +V+L + + +V + MP G L + P W + ++++L
Sbjct: 96 IMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVL-- 153
Query: 487 ASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMG 546
AL +H +IHRDVK N++LD+ + +L DFG +++ A GT
Sbjct: 154 --ALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPD 208
Query: 547 YLAPEYLLT----GRATEKTDVFSYGAVVLEVASGRRP 580
Y++PE L + G + D +S G + E+ G P
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 37/219 (16%)
Query: 386 RIIGHGAFGTVY---KGILPQNGDIIAVK-----RCSHNSQGKDEFLSELSIIGTLRHRN 437
+++G G +G V+ K G I A+K N + +E +I+ ++H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 438 LVRLQGWCHEKGEILLVYDLMPNGSL------------DKALFEARSPLPWPHRSKILLG 485
+V L G++ L+ + + G L D A F + S+I L
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACF---------YLSEISL- 111
Query: 486 VASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTM 545
AL +LHQ+ +I+RD+K NI+LD + +L DFGL ++ H+ + T GT+
Sbjct: 112 ---ALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF-CGTI 164
Query: 546 GYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKE 584
Y+APE L+ + D +S GA++ ++ +G P E
Sbjct: 165 EYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE 203
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 52/212 (24%), Positives = 96/212 (45%), Gaps = 34/212 (16%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWC 445
+++G G+FG V+ L A+K + KD L + + T+ + ++ L W
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIK-----ALKKDVVLMDDDVECTMVEKRVLSL-AWE 54
Query: 446 H-----------EKGEILLVYDLMPNGSLDKALFEARS------PLPWPHRSKILLGVAS 488
H K + V + + G L +F +S P + ++I+ G
Sbjct: 55 HPFLTHLYCTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICG--- 108
Query: 489 ALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYL 548
L +LH + +++RD+K NI+LD + ++ DFG+ ++ + T GT Y+
Sbjct: 109 -LQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTF-CGTPDYI 163
Query: 549 APEYLLTGRATEKTDVFSYGAVVLEVASGRRP 580
APE LL + D +S+G ++ E+ G+ P
Sbjct: 164 APEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 60/215 (27%), Positives = 93/215 (43%), Gaps = 18/215 (8%)
Query: 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDE----FLSELSIIGTLRHRN 437
F ++IG GAFG V + G + A+K + K F E ++ R
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW 62
Query: 438 LVRLQGWCHEKGEILLVYDLMPNGSLDKAL--FEARSPLPWPHRSKILLG-VASALAYLH 494
+ L ++ + LV D G L L FE R P ++ L + A+ +H
Sbjct: 63 ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLP---EDMARFYLAEMVLAIDSVH 119
Query: 495 QECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLL 554
Q +HRD+K N++LD+ + RL DFG ++ D + + VA GT Y++PE L
Sbjct: 120 QL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQ 176
Query: 555 -----TGRATEKTDVFSYGAVVLEVASGRRPIEKE 584
GR + D +S G + E+ G P E
Sbjct: 177 AMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 35/95 (36%), Positives = 50/95 (52%), Gaps = 4/95 (4%)
Query: 486 VASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTM 545
+ SAL YLH V++RD+K N+MLD+ + ++ DFGL ++ D + T GT
Sbjct: 104 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF-CGTP 159
Query: 546 GYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRP 580
YLAPE L D + G V+ E+ GR P
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 56/196 (28%), Positives = 89/196 (45%), Gaps = 18/196 (9%)
Query: 388 IGHGAFGTV---YKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRL--- 441
IG GA G V Y +L +N I + R N EL ++ + H+N++ L
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 442 ---QGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECE 498
Q E ++ LV +LM + +L + + + L S +L + + +LH
Sbjct: 85 FTPQKSLEEFQDVYLVMELM-DANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSA-- 138
Query: 499 NQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRA 558
+IHRD+K SNI++ ++ DFGLAR S T T Y APE +L
Sbjct: 139 -GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGY 195
Query: 559 TEKTDVFSYGAVVLEV 574
E D++S G ++ E+
Sbjct: 196 KENVDIWSVGCIMGEM 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 55/206 (26%), Positives = 90/206 (43%), Gaps = 18/206 (8%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRH--------RN 437
R+IG G++ V L + I A+K DE ++ + T +H
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDE---DIDWVQTEKHVFEQASNHPF 57
Query: 438 LVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQEC 497
LV L + + V + + G L + R LP H ++ AL YLH
Sbjct: 58 LVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEISLALNYLH--- 113
Query: 498 ENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVA-AGTMGYLAPEYLLTG 556
E +I+RD+K N++LD + +L D+G+ + E + D T GT Y+APE L
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGE 171
Query: 557 RATEKTDVFSYGAVVLEVASGRRPIE 582
D ++ G ++ E+ +GR P +
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 26/205 (12%)
Query: 391 GAFGTVYKGIL----PQNGDIIAVKRCS-HNSQGK-DEFLSELSIIGTLRHRNLVRLQGW 444
G FG ++ GIL P + + VK H S+ + L E ++ L H+N++ +
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76
Query: 445 CHEKGEILLV-YDLMPNGSLDKALFEAR-SPLPWPH----RSKILLG--VASALAYLHQE 496
C E GE V Y M G+L L + R P + + + +A ++YLH+
Sbjct: 77 CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR 136
Query: 497 CENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGT-----MGYLAPE 551
VIH+D+ N ++DE ++ D L+R D P G + ++A E
Sbjct: 137 ---GVIHKDIAARNCVIDEELQVKITDNALSR----DLFPMDYHCLGDNENRPVKWMALE 189
Query: 552 YLLTGRATEKTDVFSYGAVVLEVAS 576
L+ + +DV+S+G ++ E+ +
Sbjct: 190 SLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 47/176 (26%), Positives = 83/176 (47%), Gaps = 33/176 (18%)
Query: 486 VASALAYL-HQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGT 544
VA + +L + C IHRDV N++L +G A++ DFGLAR + +D + V G
Sbjct: 221 VAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN---YVVKGN 273
Query: 545 ----MGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVE 599
+ ++APE + T ++DV+SYG ++ E+ S G+ P G+ N
Sbjct: 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYP---------GILVN--S 322
Query: 600 WVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655
+ + + G ++ D F E+ ++ C + +P RPT + Q++
Sbjct: 323 KFYKMVKRGYQMSRPD------FAPPEIYSIM---KMCWNLEPTERPTFSQISQLI 369
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 57/219 (26%), Positives = 90/219 (41%), Gaps = 25/219 (11%)
Query: 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS-QGKDEFLSELS------IIGTLR 434
F ++G G FG V + G++ A+K +DE S + + R
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 435 HRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLG-VASALAYL 493
H LV L + + V + G L + P R+ V L YL
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP---RAVFYAACVVLGLQYL 117
Query: 494 HQECENQVIHRDVKTSNIMLD-EGFNARLGDFGLARQVEHDKSPDATVAA--GTMGYLAP 550
H EN++++RD+K N++LD EGF ++ DFGL ++ + GT +LAP
Sbjct: 118 H---ENKIVYRDLKLDNLLLDTEGF-VKIADFGLCKE---GMGFGDRTSTFCGTPEFLAP 170
Query: 551 EYLLTGRATEKTDVFSYGAVVLEVASGRRPI----EKEI 585
E L T D + G ++ E+ G P E+E+
Sbjct: 171 EVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV 209
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 24/208 (11%)
Query: 387 IIGHGAFGTVYKGILPQNGDIIAVK--RCSHNSQG-KDEFLSELSIIGTLRHRN-LVRLQ 442
IG G +G VYK G ++A+K R + +G L E+S++ L +VRL
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 443 GWCHE-----KGEILLVYDLMPNGSLDKALFEAR----SPLPWPHRSKILLGVASALAYL 493
H K + LV++ + + L K + PLP + + +A+
Sbjct: 68 DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHC 126
Query: 494 HQECENQVIHRDVKTSNIMLDEGFNA-RLGDFGLAR--QVEHDKSPDATVAAGTMGYLAP 550
H+ + V+HRD+K N+++D+ ++ D GL R + V T+ Y AP
Sbjct: 127 HK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV---TLWYRAP 180
Query: 551 EYLLTGRA-TEKTDVFSYGAVVLEVASG 577
E LL + D++S G + E++
Sbjct: 181 EVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (143), Expect = 5e-09
Identities = 61/230 (26%), Positives = 104/230 (45%), Gaps = 39/230 (16%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSH---NSQGKDEFLSELSIIGTLRHRNLVR---- 440
IG+G FG V+ + + K S+ + K + + E++++ L+H+N+VR
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80
Query: 441 LQGWCHEKGEILLVY----DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQE 496
++K IL+ + DL N +F ++ LL ALAY H
Sbjct: 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLL---HALAYCHNL 137
Query: 497 CE----NQVIHRDVKTSNIMLDEGFN-----------------ARLGDFGLARQVEHDKS 535
+ +V+HRD+K NI L G A++GDFGL++ + +
Sbjct: 138 KDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM 197
Query: 536 PDATVAAGTMGYLAPEYLL--TGRATEKTDVFSYGAVVLEVASGRRPIEK 583
+ V GT Y +PE LL T +K+D+++ G ++ E+ SG+ P K
Sbjct: 198 AHSCV--GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245
|
Length = 1021 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 5e-09
Identities = 53/207 (25%), Positives = 97/207 (46%), Gaps = 16/207 (7%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDE----FLSELSIIGTLR-HRNLVR 440
+++G G+FG V L ++ A+K + +D+ ++E I+ H L
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 441 LQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPH-RSKILLG-VASALAYLHQECE 498
L K + V + + G L +F+ + + RS+ V AL +LH+
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTLALMFLHR--- 114
Query: 499 NQVIHRDVKTSNIMLDEGFNARLGDFGLARQ-VEHDKSPDATVAAGTMGYLAPEYLLTGR 557
+ VI+RD+K NI+LD + +L DFG+ ++ + + + T GT Y+APE L
Sbjct: 115 HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYIAPEILQELE 172
Query: 558 ATEKTDVFSYGAVVLEVASGRRPIEKE 584
D ++ G ++ E+ +G+ P E +
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQPPFEAD 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 51/212 (24%), Positives = 89/212 (41%), Gaps = 26/212 (12%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTL----------RH 435
+++G G+FG V L ++ AVK KD L + + T+ +H
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVK-----VLKKDVILQDDDVECTMTEKRVLALAGKH 55
Query: 436 RNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQ 495
L +L K + V + + G L + + P + L +LH
Sbjct: 56 PFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGR-FDEPRARFYAAEIVLGLQFLH- 113
Query: 496 ECENQVIHRDVKTSNIMLD-EGFNARLGDFGLARQVEHDKSPDATVAA--GTMGYLAPEY 552
E +I+RD+K N++LD EG ++ DFG+ ++ T + GT Y+APE
Sbjct: 114 --ERGIIYRDLKLDNVLLDSEGH-IKIADFGMCKE---GILGGVTTSTFCGTPDYIAPEI 167
Query: 553 LLTGRATEKTDVFSYGAVVLEVASGRRPIEKE 584
L D ++ G ++ E+ +G+ P E +
Sbjct: 168 LSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 8e-09
Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 34/216 (15%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGW- 444
+++G G+FG V L + A+K + KD L + + T+ R ++ L W
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIK-----ALKKDVVLEDDDVECTMVERRVLAL-AWE 54
Query: 445 ----CH------EKGEILLVYDLMPNGSL-----DKALF-EARSPLPWPHRSKILLGVAS 488
H K + V + + G L F EAR+ + ++I+ G
Sbjct: 55 HPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARF---YAAEIICG--- 108
Query: 489 ALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYL 548
L +LH+ +I+RD+K N++LD+ + ++ DFG+ ++ + A+ GT Y+
Sbjct: 109 -LQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKE-NMNGEGKASTFCGTPDYI 163
Query: 549 APEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKE 584
APE L + E D +S+G ++ E+ G+ P E
Sbjct: 164 APEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 9e-09
Identities = 36/97 (37%), Positives = 51/97 (52%), Gaps = 8/97 (8%)
Query: 486 VASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAA--G 543
+ SAL YLH V++RD+K N+MLD+ + ++ DFGL ++ S AT+ G
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKE---GISDGATMKTFCG 157
Query: 544 TMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRP 580
T YLAPE L D + G V+ E+ GR P
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 54/199 (27%), Positives = 91/199 (45%), Gaps = 16/199 (8%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNS-QGKDE---FLSELSIIGTLRHRNLVRLQG 443
+G G +G V+ G+I+A+KR + +E L+E I+ T + LV+L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 444 WCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIH 503
+ + L + +P G + L L H + + A+ LH+ IH
Sbjct: 69 AFQDDEYLYLAMEYVPGGDF-RTLLNNLGVLSEDHARFYMAEMFEAVDALHEL---GYIH 124
Query: 504 RDVKTSNIMLDEGFNARLGDFGLARQ-VEHDKSPDATVAAGTMGYLAPEYLLTGRATEKT 562
RD+K N ++D + +L DFGL++ V + S G+ Y+APE +L G+ + T
Sbjct: 125 RDLKPENFLIDASGHIKLTDFGLSKGIVTYANS-----VVGSPDYMAPE-VLRGKGYDFT 178
Query: 563 -DVFSYGAVVLEVASGRRP 580
D +S G ++ E G P
Sbjct: 179 VDYWSLGCMLYEFLCGFPP 197
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 23/202 (11%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGK---DEFLSELSIIGTLRHRNLVRL--- 441
+G GA+G+V I + G+ +A+K+ S Q + EL+++ ++H N++ L
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 442 ---QGWCHEKGEILLVYDLMPNGSLDKALFEARS-PLPWPHRSKILLGVASALAYLHQEC 497
E + LV MP D L + PL ++ + L Y+H
Sbjct: 83 FTSAVSGDEFQDFYLV---MPYMQTD--LQKIMGHPLSEDKVQYLVYQMLCGLKYIHSA- 136
Query: 498 ENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGR 557
+IHRD+K N+ ++E ++ DFGLAR + + T T Y APE +L
Sbjct: 137 --GIIHRDLKPGNLAVNEDCELKILDFGLARHAD----AEMTGYVVTRWYRAPEVILNWM 190
Query: 558 ATEKT-DVFSYGAVVLEVASGR 578
+T D++S G ++ E+ +G+
Sbjct: 191 HYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 56/200 (28%), Positives = 89/200 (44%), Gaps = 18/200 (9%)
Query: 388 IGHGAFGTV---YKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRL--- 441
IG GA G V Y IL +N I + R N EL ++ + H+N++ L
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 442 ---QGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECE 498
Q E ++ +V +LM + +L + + + L S +L + + +LH
Sbjct: 92 FTPQKSLEEFQDVYIVMELM-DANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSA-- 145
Query: 499 NQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRA 558
+IHRD+K SNI++ ++ DFGLAR V T Y APE +L
Sbjct: 146 -GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVILGMGY 202
Query: 559 TEKTDVFSYGAVVLEVASGR 578
E D++S G ++ E+ G
Sbjct: 203 KENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 53/214 (24%), Positives = 94/214 (43%), Gaps = 24/214 (11%)
Query: 372 YRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGK---DEFLSELS 428
YR+L+ +G GA+GTV + + G +A+K+ Q + EL
Sbjct: 17 YRDLKQ----------VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELR 66
Query: 429 IIGTLRHRNLVRLQGWCHEKGEILLVYD---LMPNGSLDKALFEARSPLPWPHRSKILLG 485
++ ++H N++ L + +D +MP D L ++
Sbjct: 67 LLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQ 126
Query: 486 VASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTM 545
+ L Y+H +IHRD+K N+ ++E ++ DFGLARQ + + T T
Sbjct: 127 MLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTD----SEMTGYVVTR 179
Query: 546 GYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGR 578
Y APE +L T+ D++S G ++ E+ +G+
Sbjct: 180 WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 36/105 (34%), Positives = 52/105 (49%), Gaps = 4/105 (3%)
Query: 472 SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVE 531
PL + + + SA+ Y+H E +IHRD+KT N++++ + LGDFG A
Sbjct: 255 RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFAR 311
Query: 532 HDKS-PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVA 575
S P AGT+ APE L T D++S G V+ E A
Sbjct: 312 GSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAA 356
|
Length = 461 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 43/155 (27%), Positives = 70/155 (45%), Gaps = 7/155 (4%)
Query: 425 SELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALF-EARSPLPWPHRSKIL 483
+E I+ + H ++++L+G L+ +P D + A+ + I
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDILAIE 188
Query: 484 LGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAG 543
V A+ YLH EN++IHRD+K NI ++ + LGDFG A + AG
Sbjct: 189 RSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAG 245
Query: 544 TMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGR 578
T+ APE L D++S G V+ E+A+
Sbjct: 246 TIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 5e-08
Identities = 54/203 (26%), Positives = 91/203 (44%), Gaps = 12/203 (5%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVK----RCSHNSQGKDEFLSELSIIGTL-RHRNLVR 440
R+IG G++ V L + I A+K ++ + D +E + T H LV
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 441 LQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQ 500
L + + V + + G L + R LP H ++ AL +LH E
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRK-LPEEHARFYSAEISLALNFLH---ERG 116
Query: 501 VIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVA-AGTMGYLAPEYLLTGRAT 559
+I+RD+K N++LD + +L D+G+ + E + D T GT Y+APE L
Sbjct: 117 IIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPEILRGEDYG 174
Query: 560 EKTDVFSYGAVVLEVASGRRPIE 582
D ++ G ++ E+ +GR P +
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 59/207 (28%), Positives = 92/207 (44%), Gaps = 28/207 (13%)
Query: 386 RIIGHGAFGTV---YKGILPQNGDIIAVKRCSHNSQ----GKDEFLSELSIIGTLRHRNL 438
+ IG GA G V Y + QN +A+K+ S Q K + EL ++ + H+N+
Sbjct: 22 KPIGSGAQGIVCAAYDTVTGQN---VAIKKLSRPFQNVTHAKRAY-RELVLMKLVNHKNI 77
Query: 439 VRL------QGWCHEKGEILLVYDLMPNGSLDKALFEA-RSPLPWPHRSKILLGVASALA 491
+ L Q E ++ LV +LM D L + + L S +L + +
Sbjct: 78 IGLLNVFTPQKSLEEFQDVYLVMELM-----DANLCQVIQMDLDHERMSYLLYQMLCGIK 132
Query: 492 YLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPE 551
+LH +IHRD+K SNI++ ++ DFGLAR V T Y APE
Sbjct: 133 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPE 187
Query: 552 YLLTGRATEKTDVFSYGAVVLEVASGR 578
+L E D++S G ++ E+ G
Sbjct: 188 VILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 7e-08
Identities = 51/174 (29%), Positives = 79/174 (45%), Gaps = 29/174 (16%)
Query: 486 VASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATV---AA 542
VA + +L + IHRD+ NI+L E ++ DFGLAR + D PD A
Sbjct: 188 VAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD--PDYVRKGDAR 242
Query: 543 GTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWV 601
+ ++APE + T ++DV+S+G ++ E+ S G P GV + E
Sbjct: 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP----YPGV-------KIDEEF 291
Query: 602 WSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655
+EG + A D + EM + + L C H +P RPT +V+ L
Sbjct: 292 CRRLKEGTRMRAPD------YTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 9e-08
Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 29/215 (13%)
Query: 388 IGHGAFGTVYKGILPQNGDI--IAVKRCSHNSQGKDEFLS---ELSIIGTLRHRNLVRLQ 442
+G G +G VYK D A+K+ +G +S E++++ L+H N++ LQ
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQI----EGTGISMSACREIALLRELKHPNVIALQ 64
Query: 443 G--WCHEKGEILLVYDLMPNG-----SLDKALFEARSPLPWPHR--SKILLGVASALAYL 493
H ++ L++D + +A + P+ P +L + + YL
Sbjct: 65 KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124
Query: 494 HQECENQVIHRDVKTSNIML----DEGFNARLGDFGLARQVEHDKSP--DATVAAGTMGY 547
H N V+HRD+K +NI++ E ++ D G AR P D T Y
Sbjct: 125 HA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 548 LAPEYLLTGRA-TEKTDVFSYGAVVLEVASGRRPI 581
APE LL R T+ D+++ G + E+ + PI
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPI 215
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 9e-08
Identities = 29/100 (29%), Positives = 54/100 (54%), Gaps = 6/100 (6%)
Query: 486 VASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVA-AGT 544
+A L +LH + +I+RD+K N+MLD + ++ DFG+ + E+ T GT
Sbjct: 110 IAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGT 164
Query: 545 MGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKE 584
Y+APE + + D +++G ++ E+ +G+ P + E
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 204
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 9e-08
Identities = 58/203 (28%), Positives = 90/203 (44%), Gaps = 13/203 (6%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVK--RCSH--NSQGKDEFLSELSIIGTLRHRNLVRLQG 443
IG G+FG V + I A+K R +H + L+E +++ + +V L+
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 444 WCHEKGEILLVYDLMPNGSLDKAL-FEARSPLPWPHRSKILLG-VASALAYLHQECENQV 501
++ LV + G L L E R L R++ + AL LH + V
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDL---SRARFYTAELLCALENLH---KFNV 114
Query: 502 IHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEK 561
I+RD+K NI+LD + L DFGL + + GT YLAPE LL T+
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCGTPEYLAPELLLGHGYTKA 173
Query: 562 TDVFSYGAVVLEVASGRRPIEKE 584
D ++ G ++ E+ +G P E
Sbjct: 174 VDWWTLGVLLYEMLTGLPPFYDE 196
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 32/106 (30%), Positives = 55/106 (51%), Gaps = 6/106 (5%)
Query: 478 HRSKILLG-VASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP 536
++ + + AL +LHQ +I+RD+K NI+LD + L DFGL+++ ++
Sbjct: 105 SEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE 161
Query: 537 DATVAAGTMGYLAPEYLLTGRA--TEKTDVFSYGAVVLEVASGRRP 580
A GT+ Y+APE + G + D +S G + E+ +G P
Sbjct: 162 RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 33/106 (31%), Positives = 56/106 (52%), Gaps = 6/106 (5%)
Query: 478 HRSKILLG-VASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP 536
+I G + AL +LH+ +I+RD+K NI+LD + L DFGL+++ D+
Sbjct: 105 QEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE 161
Query: 537 DATVAAGTMGYLAPEYLLTGRA--TEKTDVFSYGAVVLEVASGRRP 580
A GT+ Y+AP+ + G + D +S G ++ E+ +G P
Sbjct: 162 RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 29/215 (13%)
Query: 388 IGHGAFGTVYKGILPQNGDI--IAVKRCSHNSQGKDEFLS---ELSIIGTLRHRNLVRLQ 442
+G G +G VYK D A+K+ +G +S E++++ L+H N++ LQ
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQI----EGTGISMSACREIALLRELKHPNVISLQ 64
Query: 443 G--WCHEKGEILLVYDLMPNG-----SLDKALFEARSPLPWPHR--SKILLGVASALAYL 493
H ++ L++D + +A + P+ P +L + + YL
Sbjct: 65 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124
Query: 494 HQECENQVIHRDVKTSNIML----DEGFNARLGDFGLARQVEHDKSP--DATVAAGTMGY 547
H N V+HRD+K +NI++ E ++ D G AR P D T Y
Sbjct: 125 HA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 548 LAPEYLLTGRA-TEKTDVFSYGAVVLEVASGRRPI 581
APE LL R T+ D+++ G + E+ + PI
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 54/232 (23%), Positives = 85/232 (36%), Gaps = 38/232 (16%)
Query: 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCS----HNSQGKDEFLSELSIIGTLRHRN 437
F ++IG GAFG V+ G + A+K +E I+
Sbjct: 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPW 62
Query: 438 LVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLG-VASALAYLHQE 496
+V+L ++ + LV + MP G L L + P ++ + + AL +H+
Sbjct: 63 IVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIR-KDVFP-EETARFYIAELVLALDSVHKL 120
Query: 497 CENQVIHRDVKTSNIMLDEGFNARLGDFGLA------------------------RQVEH 532
IHRD+K NI++D + +L DFGL V
Sbjct: 121 ---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177
Query: 533 DKSPDATV----AAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRP 580
V GT Y+APE L + D +S G ++ E+ G P
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 29/99 (29%), Positives = 53/99 (53%), Gaps = 4/99 (4%)
Query: 486 VASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTM 545
++ L +LH +I+RD+K N+MLD + ++ DFG+ ++ D T GT
Sbjct: 110 ISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTF-CGTP 165
Query: 546 GYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKE 584
Y+APE + + D ++YG ++ E+ +G+ P + E
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 47/159 (29%), Positives = 75/159 (47%), Gaps = 28/159 (17%)
Query: 502 IHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGT----MGYLAPEYLLTGR 557
IHRD+ NI+L E ++ DFGLAR + K PD V G + ++APE +
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIY--KDPD-YVRKGDARLPLKWMAPESIFDKV 251
Query: 558 ATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADA 616
T ++DV+S+G ++ E+ S G P GV + E +EG + A
Sbjct: 252 YTTQSDVWSFGVLLWEIFSLGASP----YPGV-------QIDEEFCRRLKEGTRMRAP-- 298
Query: 617 RLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655
++ E+ ++ L C H +P RPT +V++L
Sbjct: 299 ----EYATPEIYSIM---LDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 52/204 (25%), Positives = 89/204 (43%), Gaps = 26/204 (12%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGK----DEFLSELSIIGTLRHRNLVRLQG 443
+G G+FG V G+ A+K K E SI+ L H +V +
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 444 WCHEKGEILLVYDLMPNGSLDKALFEARSPLPWP------HRSKILLGVASALAYLHQEC 497
++ + + + + G L L R +P + ++++L A YLH
Sbjct: 86 SFQDENRVYFLLEFVVGGELFTHL---RKAGRFPNDVAKFYHAELVL----AFEYLH--- 135
Query: 498 ENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVA-AGTMGYLAPEYLLTG 556
+I+RD+K N++LD + ++ DFG A++V PD T GT YLAPE + +
Sbjct: 136 SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV-----PDRTFTLCGTPEYLAPEVIQSK 190
Query: 557 RATEKTDVFSYGAVVLEVASGRRP 580
+ D ++ G ++ E +G P
Sbjct: 191 GHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 32/108 (29%), Positives = 56/108 (51%), Gaps = 4/108 (3%)
Query: 477 PHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP 536
PH +A L +LH + +I+RD+K N+MLD + ++ DFG+ ++ D
Sbjct: 101 PHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT 157
Query: 537 DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKE 584
T GT Y+APE + + D +++G ++ E+ +G+ P E E
Sbjct: 158 TKTF-CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (123), Expect = 6e-07
Identities = 36/152 (23%), Positives = 67/152 (44%), Gaps = 12/152 (7%)
Query: 435 HRNLVRLQGWCHEKGEILLVYDLMPNGSL-DKALFEARSPLPWPHRSKILLGVASALAYL 493
+ N ++L +L+ D + +G L D L + L KI+ + AL L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD--LLKKEGKLSEAEVKKIIRQLVEALNDL 125
Query: 494 HQECENQVIHRDVKTSNIMLDEG-FNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEY 552
H+ + +IH D+K N++ D L D+GL + + S GT+ Y +PE
Sbjct: 126 HK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCK-IIGTPS----CYDGTLDYFSPEK 177
Query: 553 LLTGRATEKTDVFSYGAVVLEVASGRRPIEKE 584
+ D ++ G + E+ +G+ P +++
Sbjct: 178 IKGHNYDVSFDWWAVGVLTYELLTGKHPFKED 209
|
Length = 267 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 30/95 (31%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 486 VASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGT- 544
VA + +L +HRD+ N++L +G ++ DFGLAR + HD + V+ G+
Sbjct: 246 VARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSN---YVSKGST 299
Query: 545 ---MGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS 576
+ ++APE + T +DV+SYG ++ E+ S
Sbjct: 300 FLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 34/95 (35%), Positives = 54/95 (56%), Gaps = 11/95 (11%)
Query: 481 KILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD-AT 539
++LLGV Y+HQ +++HRD+K NI L ++GDFG++R + S D AT
Sbjct: 114 QLLLGVH----YMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLM--GSCDLAT 163
Query: 540 VAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEV 574
GT Y++PE L K+D++S G ++ E+
Sbjct: 164 TFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 52/214 (24%), Positives = 99/214 (46%), Gaps = 16/214 (7%)
Query: 382 FNANRIIGHGAFGTVY---KGILPQNGDIIAVK---RCSHNSQGK--DEFLSELSIIGTL 433
F +++G GA+G V+ K G + A+K + + + K + +E +++ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 434 RHRN-LVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLG-VASALA 491
R LV L + ++ L+ D + G + L++ R + G + AL
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ-RDNFS-EDEVRFYSGEIILALE 119
Query: 492 YLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPE 551
+LH+ +++RD+K NI+LD + L DFGL+++ ++ GT+ Y+APE
Sbjct: 120 HLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPE 176
Query: 552 YLLTGRATEK-TDVFSYGAVVLEVASGRRPIEKE 584
+ K D +S G ++ E+ +G P E
Sbjct: 177 IIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 49/208 (23%), Positives = 99/208 (47%), Gaps = 30/208 (14%)
Query: 388 IGHGAFGTVYKGILPQNGDI--IAVK--RCSHNSQGKDEFLSELSIIGTLRHRNLVRLQG 443
IG+G FG V + + + + VK + + +S+ ++EFL + L+H N+++ G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 444 WCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHR-SKILL------GVASALAYLHQE 496
C E LLV++ G L L + + W R S++LL +A+ + ++H+
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQ----WHRRNSQLLLLQRMACEIAAGVTHMHK- 117
Query: 497 CENQVIHRDVKTSNIMLDEGFNARLGDFGLA---RQVEHDKSPDATVAAGTMGYLAPEY- 552
+ +H D+ N L ++GD+G+ + ++ ++ D + +LAPE
Sbjct: 118 --HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVP--LRWLAPELV 173
Query: 553 ------LLTGRATEKTDVFSYGAVVLEV 574
L+T T+ ++V++ G + E+
Sbjct: 174 GEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-06
Identities = 26/93 (27%), Positives = 51/93 (54%), Gaps = 10/93 (10%)
Query: 486 VASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGT- 544
VA+ + +L +HRD+ N+++ EG ++ DFGLAR + D + ++ G+
Sbjct: 248 VANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSN---YISKGST 301
Query: 545 ---MGYLAPEYLLTGRATEKTDVFSYGAVVLEV 574
+ ++APE + T +DV+S+G ++ E+
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEI 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 59/234 (25%), Positives = 97/234 (41%), Gaps = 54/234 (23%)
Query: 388 IGHGAFGTVYKGILPQNGD--------------IIAVKRCSHNSQGKD---EFLSELSII 430
+G G +Y GIL D I+ V SH +D F S++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH----RDISLAFFETASMM 58
Query: 431 GTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASAL 490
+ H+++V L G C E ++V + + G LD + L P + K+ +ASAL
Sbjct: 59 RQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASAL 118
Query: 491 AYLHQECENQVIHRDVKTSNIML-DEGFNARLGDF-----------GLARQVEHDKSPDA 538
+YL + ++H +V T NI+L EG + G F L+RQ ++ P
Sbjct: 119 SYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERIP-- 173
Query: 539 TVAAGTMGYLAPEYLLTGRA-TEKTDVFSYGAVVLEVA-SGRRP------IEKE 584
++APE + + + D +S+G + E+ +G P EKE
Sbjct: 174 --------WIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE 219
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 58/246 (23%), Positives = 90/246 (36%), Gaps = 52/246 (21%)
Query: 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRN-LVR 440
F + ++IG GAFG V G I A+K K + L + + R+ LV
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILR-----KADMLEKEQVAHIRAERDILVE 57
Query: 441 LQG-WC-------HEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAY 492
G W +K + L+ + +P G + L + L + A+
Sbjct: 58 ADGAWVVKMFYSFQDKRNLYLIMEFLPGGDM-MTLLMKKDTLSEEATQFYIAETVLAIDA 116
Query: 493 LHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLA------------RQVEHDKSPD--- 537
+HQ IHRD+K N++LD + +L DFGL R + H+ D
Sbjct: 117 IHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSF 173
Query: 538 -------------------ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGR 578
A GT Y+APE + + D +S G ++ E+ G
Sbjct: 174 QNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233
Query: 579 RPIEKE 584
P E
Sbjct: 234 PPFCSE 239
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 37/123 (30%), Positives = 58/123 (47%), Gaps = 11/123 (8%)
Query: 489 ALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYL 548
AL LH+E ++ RD+ +NI+LD+ + +L F +VE +A Y
Sbjct: 97 ALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAV----ENMYC 149
Query: 549 APEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREG 608
APE TE D +S GA++ E+ +G+ +E +G+ N+ EWV E
Sbjct: 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINT-HTTLNIPEWV---SEEA 205
Query: 609 RLL 611
R L
Sbjct: 206 RSL 208
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 53/248 (21%), Positives = 91/248 (36%), Gaps = 56/248 (22%)
Query: 382 FNANRIIGHGAFGTV-----------YKGILPQNGDIIAVKRCSHNSQGKDEFLSELSII 430
F + ++IG GAFG V Y + + D++ ++ H +D + S+
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 431 GTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASAL 490
+V++ +K + L+ + +P G + L + L + A+
Sbjct: 63 -------VVKMFYSFQDKLNLYLIMEFLPGGDM-MTLLMKKDTLTEEETQFYIAETVLAI 114
Query: 491 AYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLA------------RQVEHDKSPDA 538
+HQ IHRD+K N++LD + +L DFGL R + H D
Sbjct: 115 DSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDF 171
Query: 539 TV----------------------AAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS 576
T GT Y+APE + + D +S G ++ E+
Sbjct: 172 TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231
Query: 577 GRRPIEKE 584
G P E
Sbjct: 232 GYPPFCSE 239
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 7e-05
Identities = 46/184 (25%), Positives = 80/184 (43%), Gaps = 37/184 (20%)
Query: 423 FLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKI 482
F S++ + H +L + G C E ++V + + +G LD L + + +P + +
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITV 122
Query: 483 LLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP-----D 537
+ASAL+YL + ++H +V NI+L ARLG + SP D
Sbjct: 123 AQQLASALSYLE---DKNLVHGNVCAKNILL-----ARLG-------LAEGTSPFIKLSD 167
Query: 538 ATVAAGTMG---------YLAPEYLLTGRA-TEKTDVFSYGAVVLEVA-------SGRRP 580
V+ + ++APE + G + + D +S+G +LE+ R P
Sbjct: 168 PGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227
Query: 581 IEKE 584
EKE
Sbjct: 228 SEKE 231
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 34/110 (30%), Positives = 53/110 (48%), Gaps = 13/110 (11%)
Query: 482 ILLGVASALAYLHQECENQVIHRDVKTSNIML-DEGFNARLGDFGLARQVEHDKSPDAT- 539
IL G L YLHQ N IHR++K S+I++ +G + G L V + +
Sbjct: 106 ILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162
Query: 540 ----VAAGTMGYLAPEYL---LTGRATEKTDVFSYGAVVLEVASGRRPIE 582
+ + +L+PE L L G K+D++S G E+A+GR P +
Sbjct: 163 DFPQFSTSVLPWLSPELLRQDLYGYNV-KSDIYSVGITACELATGRVPFQ 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 3e-04
Identities = 66/265 (24%), Positives = 101/265 (38%), Gaps = 55/265 (20%)
Query: 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDE----FLSELSIIGTLRHRN 437
F +++G G G V+ L G + A+K K L+E I+ TL H
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPF 62
Query: 438 LVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSP---LPWPHRSKILLGVASALAYLH 494
L L + + LV D P G L + L R P L V AL YLH
Sbjct: 63 LPTLYASFQTETYLCLVMDYCPGGELFRLL--QRQPGKCLSEEVARFYAAEVLLALEYLH 120
Query: 495 QECENQVIHRDVKTSNIMLDEGFNARLGDFGL--------------ARQVEHDKSPDA-- 538
+++RD+K NI+L E + L DF L R+ S ++
Sbjct: 121 L---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177
Query: 539 --TVAA----------GTMGYLAPEYLLTGRA-TEKTDVFSYGAVVLEVASGRRP----- 580
T + GT Y+APE +++G D ++ G ++ E+ G P
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236
Query: 581 --------IEKEITGVGKVGVASNL 597
++KE+T G V+S+
Sbjct: 237 RDETFSNILKKEVTFPGSPPVSSSA 261
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 40/145 (27%), Positives = 63/145 (43%), Gaps = 8/145 (5%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSH----NSQGKDEFLSELSIIGTLRHRNLVRLQG 443
I GAFG VY G N + AVK N + +E + + +V L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 444 WCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIH 503
+ LV + + G + K+L K + VA AL YLH+ + +IH
Sbjct: 72 SLQSANNVYLVMEYLIGGDV-KSLLHIYGYFDEEMAVKYISEVALALDYLHR---HGIIH 127
Query: 504 RDVKTSNIMLDEGFNARLGDFGLAR 528
RD+K N+++ + +L DFGL++
Sbjct: 128 RDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 41/172 (23%), Positives = 59/172 (34%), Gaps = 59/172 (34%)
Query: 502 IHRDVKTSNIMLDEGFNARLGDFGLARQVE--HDK--------------SPDATVAA--- 542
IHRD+K NI++D + +L DFGL HD P +
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 543 -----------------------GTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRR 579
GT Y+APE LL T+ D +S G ++ E+ G+
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242
Query: 580 PIEKEITGVGKVGVASNLVEWVWSLH--------REG-----RLLTAADARL 618
P + ++ W +LH RE RL A+ RL
Sbjct: 243 PFLADTPA----ETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRL 290
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 63/278 (22%), Positives = 98/278 (35%), Gaps = 66/278 (23%)
Query: 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFL--------SELSIIGTL 433
F + +G GAFG V + A+K + KD L +E I+
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTL----RKKDVLLRNQVAHVKAERDILAEA 58
Query: 434 RHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYL 493
+ +VRL +K + V D +P G + +L P + + A+ +
Sbjct: 59 DNEWVVRLYYSFQDKDNLYFVMDYIPGGDM-MSLLIRMGIFPEDLARFYIAELTCAVESV 117
Query: 494 HQECENQVIHRDVKTSNIMLDEGFNARLGDFGLA------------------RQVEHDKS 535
H+ IHRD+K NI++D + +L DFGL RQ D S
Sbjct: 118 HKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFS 174
Query: 536 PD----------------------------ATVAAGTMGYLAPEYLLTGRATEKTDVFSY 567
+ A GT Y+APE LL T+ D +S
Sbjct: 175 NEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234
Query: 568 GAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLH 605
G ++ E+ G+ P + ++ W SLH
Sbjct: 235 GVILYEMLVGQPP----FLAQTPLETQMKVINWQTSLH 268
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 8e-04
Identities = 29/116 (25%), Positives = 43/116 (37%), Gaps = 37/116 (31%)
Query: 502 IHRDVKTSNIMLDEGFNARLGDFGL------------ARQVEHDKSPD------------ 537
IHRD+K N++LD + +L DFGL R + H +
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 538 -------------ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRP 580
A GT Y+APE L ++ D +S G ++ E+ G P
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 34/104 (32%), Positives = 50/104 (48%), Gaps = 8/104 (7%)
Query: 386 RIIGHGAFGTVYKGI---LPQNGDI--IAVK--RCSHNSQGKDEFLSELSIIGTL-RHRN 437
RI+G GAFG V +G L ++ + +AVK + + S K +SEL I+ L H N
Sbjct: 43 RILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLN 102
Query: 438 LVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSK 481
+V L G C + G I ++ + G L L + R H K
Sbjct: 103 IVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEK 146
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 711 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06899 | 236 | lectin_legume_LecRK_Arcelin_ConA legume lectins, l | 100.0 | |
| PF00139 | 236 | Lectin_legB: Legume lectin domain; InterPro: IPR00 | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd01951 | 223 | lectin_L-type legume lectins. The L-type (legume-t | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.98 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| cd07308 | 218 | lectin_leg-like legume-like lectins: ERGIC-53, ERG | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.88 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.81 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.78 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.78 | |
| cd06901 | 248 | lectin_VIP36_VIPL VIP36 and VIPL type 1 transmembr | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.76 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.74 | |
| cd06902 | 225 | lectin_ERGIC-53_ERGL ERGIC-53 and ERGL type 1 tran | 99.72 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.71 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.71 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.69 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.69 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.69 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.66 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| cd06903 | 215 | lectin_EMP46_EMP47 EMP46 and EMP47 type 1 transmem | 99.57 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.56 | |
| PF03388 | 229 | Lectin_leg-like: Legume-like lectin family; InterP | 99.54 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.53 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.37 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.36 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.34 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.3 | |
| KOG3839 | 351 | consensus Lectin VIP36, involved in the transport | 99.25 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.21 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.12 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.11 | |
| KOG3838 | 497 | consensus Mannose lectin ERGIC-53, involved in gly | 99.1 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.1 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.09 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.04 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.99 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.95 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.92 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.84 | |
| cd06900 | 255 | lectin_VcfQ VcfQ bacterial pilus biogenesis protei | 98.75 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.69 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.48 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.47 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.43 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.43 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.35 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.24 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.23 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.21 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.12 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.12 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.98 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.96 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.9 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.85 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.85 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.75 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.69 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.68 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.65 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.57 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.55 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.49 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.43 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.42 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.34 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.29 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.1 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.05 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.7 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.59 | |
| PLN02236 | 344 | choline kinase | 96.5 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.12 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.07 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.01 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.9 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.83 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.78 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.69 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.69 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.62 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-57 Score=488.33 Aligned_cols=288 Identities=50% Similarity=0.854 Sum_probs=257.0
Q ss_pred CCCccCHHHHHHHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCC-hhhhHHHHHHHHhcCCCCeeeeeee
Q 043702 366 MPKEFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQG-KDEFLSELSIIGTLRHRNLVRLQGW 444 (711)
Q Consensus 366 ~~~~~~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~Ei~~l~~l~H~niv~l~g~ 444 (711)
..+.|+++|++.||++|...++||+|+||.||+|.+.+ +..||||++...... .++|.+|++++.+++|||+|+|+||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence 46789999999999999999999999999999999964 589999988875554 6779999999999999999999999
Q ss_pred eeecC-eEEEEEEcCCCCCHHHHHhhCCC-CCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEe
Q 043702 445 CHEKG-EILLVYDLMPNGSLDKALFEARS-PLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLG 522 (711)
Q Consensus 445 ~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~ 522 (711)
|.+.+ +.+||||||++|+|.++|+.... .|+|.+|++|+.++|+||+|||+.|.++|||||||++|||||+++++||+
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 99998 59999999999999999998776 89999999999999999999999998999999999999999999999999
Q ss_pred ecCCceecCC-CCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHH
Q 043702 523 DFGLARQVEH-DKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWV 601 (711)
Q Consensus 523 DFGla~~~~~-~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~ 601 (711)
|||+|+.... ........ .||.+|+|||++..+..+.|+|||||||+|+||++|++|.+.... .....+++|+
T Consensus 220 DFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~-----~~~~~l~~w~ 293 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRP-----RGELSLVEWA 293 (361)
T ss_pred CccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCC-----cccccHHHHH
Confidence 9999976654 22211111 799999999999999999999999999999999999998875431 1234599999
Q ss_pred HHhhhcCchhHhhhhhcc-CCCcH-HHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC
Q 043702 602 WSLHREGRLLTAADARLE-GQFDE-AEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEAE 660 (711)
Q Consensus 602 ~~~~~~~~~~~~~d~~l~-~~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 660 (711)
+....++++.+++|+.+. +.+.. +++.++..++++|++.+|.+||+|.||+++|+....
T Consensus 294 ~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 294 KPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 999999999999999987 66665 789999999999999999999999999999965433
|
|
| >cd06899 lectin_legume_LecRK_Arcelin_ConA legume lectins, lectin-like receptor kinases, arcelin, concanavalinA, and alpha-amylase inhibitor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-53 Score=431.33 Aligned_cols=227 Identities=46% Similarity=0.731 Sum_probs=206.0
Q ss_pred eeeecCCCCC--CCeEEeCceEee-CCcEEeCCCCCCCCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecCCCCCC
Q 043702 34 TEFDFGTLTL--ASLKLLGDAHMN-NGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLNPSSI 110 (711)
Q Consensus 34 ~~f~~~~f~~--~~~~~~g~a~~~-~g~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~ 110 (711)
++|+|++|.. .+++|+|+|.+. ++.|+||++.. ..+++|||+|++||+||++.+++++||+|+|+|.|.+.+...+
T Consensus 1 ~~f~f~~f~~~~~~l~l~G~A~~~~~~~i~LT~~~~-~~~~~G~v~y~~pi~l~~~~~~~~~sFst~F~F~i~~~~~~~~ 79 (236)
T cd06899 1 LSFNFNGFSSDQSNLTLQGDATISSNGALQLTNDTS-PASSVGRALYSKPVRLWDSTTGKVASFSTSFSFSITPPNPSLG 79 (236)
T ss_pred CceecCCCCCCCCCEEEecceEcCCCCeEEecCCCC-CCcceEEEEeCCCEEeecCCCCCceeEEEEEEEEEEcCCCCCC
Confidence 4789999975 799999999998 89999999872 1278999999999999999999999999999999998766788
Q ss_pred CCceEEEEcCCCCCC-CCCCCcccccccCCCC---cceEEEEeecccCCCCCCCCCCeeeEecCCCcccccccCCccccc
Q 043702 111 GAGLAFVITPDGEQV-GSAGGSLGLLDEKGAG---LGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVD 186 (711)
Q Consensus 111 g~GlaF~l~~~~~~~-~~~g~~lgl~~~~~~~---~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~S~~~~~~~~~~~~ 186 (711)
||||||+|+|....+ +..|++|||++..+++ +++|||||||++|.+++||++||||||+|++.|..+..+.....+
T Consensus 80 gdGlAF~i~~~~~~~~~~~G~~lG~~~~~~~~~~~~~~vAVEFDT~~n~~~~D~~~nHigIdvn~~~S~~~~~~~~~~~~ 159 (236)
T cd06899 80 GDGLAFFLAPTDSLPPASSGGYLGLFNSSNNGNSSNHIVAVEFDTFQNPEFGDPDDNHVGIDVNSLVSVKAGYWDDDGGK 159 (236)
T ss_pred CCeEEEEEecCCCCCCCCCcceeeeecCCCCCCcccceEEEEeecccCcccCCCCCCeEEEEcCCcccceeecccccccc
Confidence 999999999987654 5889999999887653 789999999999999999999999999999998877777665667
Q ss_pred cCCCCeEEEEEEEcccccEEEEEEEecC-CCCCcceeeEecCcccccccceeEEEeeeccCceeeEEEEeeccccc
Q 043702 187 LKSGDLVNSWIEYDGLTRAFNISVSYSN-LKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGSTEIHSIEWWSFSSS 261 (711)
Q Consensus 187 ~~~g~~~~~~I~Y~~~~~~l~V~~~~~~-~~~~~~~ls~~vdL~~~l~~~~~vGFsastg~~~~~~~i~sW~f~s~ 261 (711)
+.+|+.++|||+||+.+++|+|+|++.+ .+|..|+++..+||+++|+++|||||||+||...|.|+|++|+|+++
T Consensus 160 l~~g~~~~v~I~Y~~~~~~L~V~l~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFSasTG~~~~~h~i~sWsF~s~ 235 (236)
T cd06899 160 LKSGKPMQAWIDYDSSSKRLSVTLAYSGVAKPKKPLLSYPVDLSKVLPEEVYVGFSASTGLLTELHYILSWSFSSN 235 (236)
T ss_pred ccCCCeEEEEEEEcCCCCEEEEEEEeCCCCCCcCCEEEEeccHHHhCCCceEEEEEeEcCCCcceEEEEEEEEEcC
Confidence 8999999999999999999999999865 47888999999999999999999999999999999999999999885
|
This alignment model includes the legume lectins (also known as agglutinins), the arcelin (also known as phytohemagglutinin-L) family of lectin-like defense proteins, the LecRK family of lectin-like receptor kinases, concanavalinA (ConA), and an alpha-amylase inhibitor. Arcelin is a major seed glycoprotein discovered in kidney beans (Phaseolus vulgaris) that has insecticidal properties and protects the seeds from predation by larvae of various bruchids. Arcelin is devoid of monosaccharide binding properties and lacks a key metal-binding loop that is present in other members of this family. Phytohaemagglutinin (PHA) is a lectin found in plants, especially beans, that affects cell metabolism by inducing mitosis and by altering the permeability of the cell membrane to various proteins. PHA agglutinates most mammalian red blood cell types by bindin |
| >PF00139 Lectin_legB: Legume lectin domain; InterPro: IPR001220 Legume lectins are one of the largest lectin families with more than 70 lectins reported | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-51 Score=415.18 Aligned_cols=225 Identities=42% Similarity=0.678 Sum_probs=198.9
Q ss_pred ceeeecCCC-CCCCeEEeCceEe-eCCcEEeCCCCCCCCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecC--CCC
Q 043702 33 ATEFDFGTL-TLASLKLLGDAHM-NNGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNL--NPS 108 (711)
Q Consensus 33 ~~~f~~~~f-~~~~~~~~g~a~~-~~g~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~--~~~ 108 (711)
+++|+|++| +..+++++|+|.+ .+|.|+||++.. .+++|||+|++||+|||..++++++|+|+|+|+|... ...
T Consensus 1 ~~~F~~~~F~~~~~~~l~G~A~~~~~~~l~LT~~~~--~~~~G~~~y~~pi~l~d~~~~~~~sF~t~F~f~i~~~~~~~~ 78 (236)
T PF00139_consen 1 SVSFSFPSFSNSSNLTLNGDASISSNGSLQLTPDST--NNQAGRAWYNNPIQLWDSTTGNVASFSTSFSFSITNGPGSSN 78 (236)
T ss_dssp EEEEEESSBTTGTTEEEEETEEEETTSEEESSTBET--SSEEEEEEESSEEESBETTTTEBEEEEEEEEEEEEESSSSSS
T ss_pred CceEEcCCCCCCCceEEEeeEEeccCCeEEcCCCCC--CCcEEEEEECCcEEEeCCCCcceeeeeeEEEEEEeccCCCCc
Confidence 368999999 6789999999999 689999998643 3789999999999999999999999999999999643 457
Q ss_pred CCCCceEEEEcCCCCCC-CCCCCcccccccCCCC---cceEEEEeecccCCCCCCCCCCeeeEecCCCcccccccCC---
Q 043702 109 SIGAGLAFVITPDGEQV-GSAGGSLGLLDEKGAG---LGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLD--- 181 (711)
Q Consensus 109 ~~g~GlaF~l~~~~~~~-~~~g~~lgl~~~~~~~---~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~S~~~~~~~--- 181 (711)
.+||||||+|+|....+ ++.|++||+++..+++ +++||||||||+|++++||+++|||||+|++.|..+.+..
T Consensus 79 ~~~dGlAFvi~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~vAVEFDT~~N~~~~d~~~nHIgI~~n~~~s~~~~~~~~~~ 158 (236)
T PF00139_consen 79 NGGDGLAFVIQPDPNLPGGSSGGYLGLFNSSTDGNGINNSVAVEFDTYKNPEYNDPDDNHIGIDVNSVVSNKTASAGYYS 158 (236)
T ss_dssp S-BEEEEEEEEETTSSTTTSSGGGTTTSSSSSTTGGGGCEEEEEEETSTCGGGTTTSSSEEEEEESSSSESEEEE----E
T ss_pred cCCCceEEEEecCcccccCCCCCccCccccccCCCccCcEEEEEEeeeecccccccCCCEEEEECCCCcccccccccccc
Confidence 78999999999988544 5689999999876654 7899999999999999999999999999999998775554
Q ss_pred ccccccCCCCeEEEEEEEcccccEEEEEEEecCCCCCcceeeEecCcccccccceeEEEeeeccCceeeEEEEeeccc
Q 043702 182 TINVDLKSGDLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGSTEIHSIEWWSFS 259 (711)
Q Consensus 182 ~~~~~~~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastg~~~~~~~i~sW~f~ 259 (711)
....++.+|+.++|||+||+.+++|+|+++....+|..++++..|||+.+|+++||||||||||...|.|.|++|+|+
T Consensus 159 ~~~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~~l~~~vdL~~~l~~~v~vGFsasTG~~~~~h~I~sW~F~ 236 (236)
T PF00139_consen 159 SPSFSLSDGKWHTVWIDYDASTKRLSVYLDDNSSKPSSPVLSVNVDLSAVLPEQVYVGFSASTGGSYQTHDILSWSFS 236 (236)
T ss_dssp EEEHHHGTTSEEEEEEEEETTTTEEEEEEEETTTTSEEEEEEEE--HHHHSCSEEEEEEEEEESSSSEEEEEEEEEEE
T ss_pred cccccccCCcEEEEEEEEcCCccEEEEEEecccCCCcceeEEEEEchHHhcCCCcEEEEEeecCCCcceEEEEEEEeC
Confidence 346789999999999999999999999999987788899999999999999999999999999999999999999995
|
Leguminous plant lectins resemble each other in their physicochemical properties although they differ in their carbohydrate specificities. They consist of two or four subunits with relative molecular mass of 30 kDa and each subunit has one carbohydrate-binding site. The interaction with sugars requires tightly bound calcium and manganese ions. The structural similarities of these lectins are reported by the primary structural analyses and X-ray crystallographic studies. X-ray studies have shown that the folding of the polypeptide chains in the region of the carbohydrate-binding sites is also similar, despite differences in the primary sequences. The carbohydrate-binding sites of these lectins consist of two conserved amino acids on beta pleated sheets. One of these loops contains transition metals, calcium and manganese, which keep the amino acid residues of the sugar-binding site at the required positions. Amino acid sequences of this loop play an important role in the carbohydrate-binding specificities of these lectins. These lectins bind either glucose/mannose or galactose. The exact function of legume lectins is not known but they may be involved in the attachment of nitrogen-fixing bacteria to legumes and in the protection against pathogens. Some legume lectins are proteolytically processed to produce two chains, beta (which corresponds to the N-terminal) and alpha (C-terminal) (IPR000985 from INTERPRO). The lectin concanavalin A (conA) from jack bean is exceptional in that the two chains are transposed and ligated (by formation of a new peptide bond). The N terminus of mature conA thus corresponds to that of the alpha chain and the C terminus to the beta chain.; GO: 0005488 binding; PDB: 1VLN_B 2GDF_C 2JE9_C 2JEC_C 1DGL_B 2P37_B 2CWM_A 2P34_D 2OW4_A 3IPV_B .... |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-47 Score=405.10 Aligned_cols=248 Identities=34% Similarity=0.525 Sum_probs=208.6
Q ss_pred cceeecCCceEEEEEEeCCCCeE-EEEEEcccCCCC---hhhhHHHHHHHHhcCCCCeeeeeeeeeecC-eEEEEEEcCC
Q 043702 385 NRIIGHGAFGTVYKGILPQNGDI-IAVKRCSHNSQG---KDEFLSELSIIGTLRHRNLVRLQGWCHEKG-EILLVYDLMP 459 (711)
Q Consensus 385 ~~~LG~G~fg~Vy~~~~~~~~~~-vavK~~~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~lV~Ey~~ 459 (711)
.+.||+|+||+||+|.+. |+. ||||++...... .++|.+|+.+|.+++|||||+++|+|.+.. .+++|||||+
T Consensus 46 ~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 445999999999999994 555 999999864322 558999999999999999999999999887 7999999999
Q ss_pred CCCHHHHHhh-CCCCCChHHHHHHHHHHHHHHHHHHhccCCC-eeeccCCCCceEEcCCC-cEEEeecCCceecCCCCCC
Q 043702 460 NGSLDKALFE-ARSPLPWPHRSKILLGVASALAYLHQECENQ-VIHRDVKTSNIMLDEGF-NARLGDFGLARQVEHDKSP 536 (711)
Q Consensus 460 ~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~-ivHrDlkp~NILld~~~-~vkL~DFGla~~~~~~~~~ 536 (711)
+|+|.++|+. ....+++..+++|+.|||+||.|||+. + ||||||||+||||+.++ .+||+|||+++...... .
T Consensus 124 ~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~ 199 (362)
T KOG0192|consen 124 GGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-T 199 (362)
T ss_pred CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc-c
Confidence 9999999988 477899999999999999999999998 6 99999999999999997 99999999999765432 2
Q ss_pred CcccccCCCcccChhhhc--cCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhh
Q 043702 537 DATVAAGTMGYLAPEYLL--TGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614 (711)
Q Consensus 537 ~~~~~~gt~~y~APE~~~--~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 614 (711)
..+...||+.|||||++. ...|+.|+||||||++||||+||+.||..... .+-+. ..+
T Consensus 200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-----------~~~~~---------~v~ 259 (362)
T KOG0192|consen 200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-----------VQVAS---------AVV 259 (362)
T ss_pred cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-----------HHHHH---------HHH
Confidence 334467999999999999 66999999999999999999999999976432 11111 111
Q ss_pred hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 615 DARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 615 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
....+...+......+..++.+||+.||.+||++.+++..|+..
T Consensus 260 ~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~ 303 (362)
T KOG0192|consen 260 VGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI 303 (362)
T ss_pred hcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence 22223334444667788889999999999999999999999754
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-46 Score=381.26 Aligned_cols=257 Identities=28% Similarity=0.418 Sum_probs=212.4
Q ss_pred ccCHHHHHHHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEccc--CCCChhhhHHHHHHHHhcCCCCeeeeeeeee
Q 043702 369 EFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSH--NSQGKDEFLSELSIIGTLRHRNLVRLQGWCH 446 (711)
Q Consensus 369 ~~~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~ 446 (711)
.++..||+. .+.||+|..|+|||++++.+++.+|+|.+.. +....+++.+|++++++.+||+||+++|.|.
T Consensus 75 ~i~~~dle~-------~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~ 147 (364)
T KOG0581|consen 75 GISLSDLER-------LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFY 147 (364)
T ss_pred ccCHHHhhh-------hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEE
Confidence 355556544 5779999999999999999999999999954 3444678999999999999999999999999
Q ss_pred ecC-eEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecC
Q 043702 447 EKG-EILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFG 525 (711)
Q Consensus 447 ~~~-~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFG 525 (711)
..+ ...++||||.+|+|+.++... +++++...-+|+.+|++||.|||+. ++||||||||+|||++..|.+||||||
T Consensus 148 ~~~~~isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFG 224 (364)
T KOG0581|consen 148 SNGEEISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFG 224 (364)
T ss_pred eCCceEEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEecccc
Confidence 998 599999999999999998643 6799999999999999999999973 499999999999999999999999999
Q ss_pred CceecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhh
Q 043702 526 LARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLH 605 (711)
Q Consensus 526 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~ 605 (711)
.++.+... .....+||..|||||.+.+..|+.++||||||+.++|+++|+.||....+. .....+.+
T Consensus 225 VS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~------~~~~~~Ll---- 291 (364)
T KOG0581|consen 225 VSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP------YLDIFELL---- 291 (364)
T ss_pred ccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC------CCCHHHHH----
Confidence 99887654 345578999999999999999999999999999999999999999764111 01111111
Q ss_pred hcCchhHhhhhhccCCCcH-HHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 606 REGRLLTAADARLEGQFDE-AEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 606 ~~~~~~~~~d~~l~~~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
..+++.. ....+. ....++..++..||++||.+||+++|++++
T Consensus 292 -----~~Iv~~p-pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 292 -----CAIVDEP-PPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred -----HHHhcCC-CCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1112211 112222 355678889999999999999999999974
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=399.25 Aligned_cols=251 Identities=31% Similarity=0.467 Sum_probs=214.7
Q ss_pred cccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCCCCC
Q 043702 383 NANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGS 462 (711)
Q Consensus 383 ~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 462 (711)
...+.||+|.||+||.|.+. ....||+|.+.......++|.+|+++|++|+|+|||+++|+|..++.++||||||++|+
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs 287 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS 287 (468)
T ss_pred HHHHHhcCCccceEEEEEEc-CCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence 34577999999999999994 34589999999887778899999999999999999999999999989999999999999
Q ss_pred HHHHHhh-CCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCcccc
Q 043702 463 LDKALFE-ARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVA 541 (711)
Q Consensus 463 L~~~l~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 541 (711)
|.++|+. .+..+...+.+.++.|||+||+||+++ ++|||||.++||||+++..|||+||||||...++........
T Consensus 288 Ll~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~ 364 (468)
T KOG0197|consen 288 LLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGG 364 (468)
T ss_pred HHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeecCCC
Confidence 9999986 566799999999999999999999998 999999999999999999999999999996555443333333
Q ss_pred cCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccC
Q 043702 542 AGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEG 620 (711)
Q Consensus 542 ~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 620 (711)
.-+..|.|||.+..++++.|||||||||+||||+| |+.||..... . ++.+.++...+-
T Consensus 365 kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn-----------~----------ev~~~le~GyRl 423 (468)
T KOG0197|consen 365 KFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN-----------E----------EVLELLERGYRL 423 (468)
T ss_pred CCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH-----------H----------HHHHHHhccCcC
Confidence 45678999999999999999999999999999999 8888866432 1 222333333333
Q ss_pred CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 621 QFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
..++.++..+.+|+..||+.+|++|||++.+...|...
T Consensus 424 p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 424 PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence 44556777888999999999999999999999888754
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=396.69 Aligned_cols=247 Identities=29% Similarity=0.502 Sum_probs=212.6
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEccc----CCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSH----NSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
+.|...+.||+|||+.+|+++...+|+.||+|++.+ .....+.+.+||++.+.|+|||||+++++|++.++.|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 568889999999999999999988999999999987 4455678999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
|+|++++|.+++. .+..+++.+++.+++||+.||.|||+. +|+|||||..|+||+++.++||+|||||..+..+..
T Consensus 98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCccc
Confidence 9999999999886 678899999999999999999999998 999999999999999999999999999998876543
Q ss_pred CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhh
Q 043702 536 PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 615 (711)
. ....||||.|+|||++.....+..+||||+||++|-|+.|++||+... +.+- ...++..+.
T Consensus 174 r-k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-----------vket-y~~Ik~~~Y----- 235 (592)
T KOG0575|consen 174 R-KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-----------VKET-YNKIKLNEY----- 235 (592)
T ss_pred c-cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-----------HHHH-HHHHHhcCc-----
Confidence 3 345799999999999999999999999999999999999999997632 1111 111111110
Q ss_pred hhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 616 ARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 616 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
.++.....+..+|+..+|++||.+|||+++|+.
T Consensus 236 -----~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 236 -----SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred -----ccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 112233445668888999999999999999996
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=371.17 Aligned_cols=200 Identities=31% Similarity=0.533 Sum_probs=180.8
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC---CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
..+|...+.||+|.||+||+|+++..+..||||.+.... ...+.+..|+++|+.++|||||+|++++..++.++|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 356888888999999999999999999999999987643 23456789999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCC------CcEEEeecCCcee
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEG------FNARLGDFGLARQ 529 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~------~~vkL~DFGla~~ 529 (711)
|||.+|+|..||+. ++.+++...+.++.|||.||++||+. +||||||||+||||+.. -.+||+|||+||.
T Consensus 89 EyC~gGDLs~yi~~-~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR-RGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 99999999999975 45799999999999999999999998 99999999999999764 4589999999999
Q ss_pred cCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccc
Q 043702 530 VEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKE 584 (711)
Q Consensus 530 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~ 584 (711)
+.... .....||++.|||||+++.++|+.|+|+||.|++|||+++|+.||+..
T Consensus 165 L~~~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 165 LQPGS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred CCchh--HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 87433 345679999999999999999999999999999999999999999754
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=372.07 Aligned_cols=253 Identities=25% Similarity=0.354 Sum_probs=207.9
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC--------ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCe
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ--------GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGE 450 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 450 (711)
.+.|...+.||+|+||.|-+|..+.+|+.||||+++.... ......+|+++|++|+|||||++++++...+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 3567888999999999999999999999999999986321 22345799999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCC---CcEEEeecCCc
Q 043702 451 ILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEG---FNARLGDFGLA 527 (711)
Q Consensus 451 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~---~~vkL~DFGla 527 (711)
.|+|||||+||+|.+.+.. .+.+.+..-.-+++|++.|+.|||+. ||+||||||+|||+..+ ..+||+|||+|
T Consensus 251 ~YmVlE~v~GGeLfd~vv~-nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVA-NKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred eEEEEEEecCccHHHHHHh-ccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccchh
Confidence 9999999999999999864 34577778889999999999999998 99999999999999655 77999999999
Q ss_pred eecCCCCCCCcccccCCCcccChhhhccCC---CCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHh
Q 043702 528 RQVEHDKSPDATVAAGTMGYLAPEYLLTGR---ATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSL 604 (711)
Q Consensus 528 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~---~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~ 604 (711)
+..... ..+...|||+.|.|||++.++. +..+.|+||+||+||-+++|.+||.....+ ..+. +.
T Consensus 327 K~~g~~--sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~-------~sl~----eQ 393 (475)
T KOG0615|consen 327 KVSGEG--SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD-------PSLK----EQ 393 (475)
T ss_pred hccccc--eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC-------ccHH----HH
Confidence 987643 3456689999999999998764 345889999999999999999999765332 1111 12
Q ss_pred hhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 605 HREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 605 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
+..|+... ......+..++.++++.+||..||++|||+.|+++.
T Consensus 394 I~~G~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 394 ILKGRYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred HhcCcccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 22222211 122334556788899999999999999999999974
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=359.39 Aligned_cols=256 Identities=26% Similarity=0.401 Sum_probs=209.7
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEccc---CCCChhhhHHHHHHHHhcCCCCeeeeeee-eeecCe-EEEEE
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSH---NSQGKDEFLSELSIIGTLRHRNLVRLQGW-CHEKGE-ILLVY 455 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~-~~~~~~-~~lV~ 455 (711)
.|.+.++||+|.||+|||+....+|..+|.|.+.- +.+..+++..|+.+|++|+|||||+.+++ +.++++ ++|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 46778899999999999999999999999999875 33456789999999999999999999994 445555 89999
Q ss_pred EcCCCCCHHHHHh---hCCCCCChHHHHHHHHHHHHHHHHHHhccCC-CeeeccCCCCceEEcCCCcEEEeecCCceecC
Q 043702 456 DLMPNGSLDKALF---EARSPLPWPHRSKILLGVASALAYLHQECEN-QVIHRDVKTSNIMLDEGFNARLGDFGLARQVE 531 (711)
Q Consensus 456 Ey~~~gsL~~~l~---~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~-~ivHrDlkp~NILld~~~~vkL~DFGla~~~~ 531 (711)
|||..|+|..++. +.++.+++..+++++.|++.||.++|+.+.+ -|+||||||.||+|+.+|.|||+||||++.+.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 9999999999986 3456799999999999999999999996432 49999999999999999999999999999987
Q ss_pred CCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchh
Q 043702 532 HDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLL 611 (711)
Q Consensus 532 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 611 (711)
.... .....+|||.||+||.+....|+.|+||||+||++|||+.-+.||... ++.+... .+..++..
T Consensus 180 s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----------n~~~L~~-KI~qgd~~ 246 (375)
T KOG0591|consen 180 SKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----------NLLSLCK-KIEQGDYP 246 (375)
T ss_pred chhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----------cHHHHHH-HHHcCCCC
Confidence 6543 344578999999999999999999999999999999999999999753 2222221 12222221
Q ss_pred HhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 612 TAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 612 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
... ++--...+..|+..|+..||+.||+.-.+++.+..
T Consensus 247 ~~p--------~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 247 PLP--------DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred CCc--------HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 111 13335677888999999999999997666666654
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=390.96 Aligned_cols=258 Identities=29% Similarity=0.483 Sum_probs=223.0
Q ss_pred CCcccceeecCCceEEEEEEeCCCC---eEEEEEEcccC--CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNG---DIIAVKRCSHN--SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~---~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
...+.++||.|.||+||+|+++..| ..||||.++.. +..+.+|+.|..||.+++||||++|.|+....+..++|.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 4567789999999999999997665 46999999873 455679999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
|||+||+|+.+|+++.+++++.+..-++++||.||+||-+. ++|||||.++|||++.+..+|++||||+|.++++..
T Consensus 710 EyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~ 786 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 786 (996)
T ss_pred hhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence 99999999999999999999999999999999999999998 999999999999999999999999999998876653
Q ss_pred CCcccccC--CCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhH
Q 043702 536 PDATVAAG--TMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLT 612 (711)
Q Consensus 536 ~~~~~~~g--t~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 612 (711)
...+...| +.+|.|||.+...+++.++||||||+++||.++ |.+||.++.. .++..
T Consensus 787 ~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN---------------------QdVIk 845 (996)
T KOG0196|consen 787 AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---------------------QDVIK 845 (996)
T ss_pred ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch---------------------HHHHH
Confidence 33333333 458999999999999999999999999999988 9999976532 13334
Q ss_pred hhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCC
Q 043702 613 AADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEAEVP 662 (711)
Q Consensus 613 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~~p 662 (711)
.++...+-.-+.+++..|.+|+++||++|-.+||.+.||+..|.+....|
T Consensus 846 aIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 846 AIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred HHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 44444444456677888999999999999999999999999997654433
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=392.46 Aligned_cols=255 Identities=27% Similarity=0.467 Sum_probs=214.0
Q ss_pred cCCcccceeecCCceEEEEEEeCC-----CCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQ-----NGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEIL 452 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 452 (711)
.+....+.||+|.||+||+|+..+ ....||||.++... +..++|.+|++++..|+|||||+|+|.|.+++.++
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 455667889999999999998743 23579999998743 35679999999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhhC-------------CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcE
Q 043702 453 LVYDLMPNGSLDKALFEA-------------RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNA 519 (711)
Q Consensus 453 lV~Ey~~~gsL~~~l~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~v 519 (711)
+|+|||..|||.++|... ..+|+..+.+.|+.|||.||+||-+. .+|||||..+|+||.++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEE
Confidence 999999999999999632 12388899999999999999999987 99999999999999999999
Q ss_pred EEeecCCceecCCCCCCCcc-cccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccch
Q 043702 520 RLGDFGLARQVEHDKSPDAT-VAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNL 597 (711)
Q Consensus 520 kL~DFGla~~~~~~~~~~~~-~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l 597 (711)
||+||||+|.+-..+.+... .-.-..+||+||.+..+++|.+||||||||+|||+++ |+.||.....
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn----------- 711 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN----------- 711 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch-----------
Confidence 99999999976544433322 2234679999999999999999999999999999999 9999876432
Q ss_pred HHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 598 VEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 598 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
+.+-+.++.|++. ..++.++.++..|++.||+.+|.+||+++||-..|+.-
T Consensus 712 -~EVIe~i~~g~lL---------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~ 762 (774)
T KOG1026|consen 712 -QEVIECIRAGQLL---------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW 762 (774)
T ss_pred -HHHHHHHHcCCcc---------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence 1233344555543 34566778899999999999999999999999998764
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=345.10 Aligned_cols=262 Identities=23% Similarity=0.310 Sum_probs=205.5
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCC---hhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQG---KDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
+.|+...++|+|+||.|||++++++|+.||||++..++++ .+-.++|+++|++|+|+|+|.|+++|..+..++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 4577788999999999999999999999999999875543 3457899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCC
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP 536 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~ 536 (711)
||+..-|.+ |......++.+...+++.|+++|+.|+|+. ++|||||||+||||+.++.+||||||+||.+.. ...
T Consensus 82 ~~dhTvL~e-Le~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd 156 (396)
T KOG0593|consen 82 YCDHTVLHE-LERYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGD 156 (396)
T ss_pred ecchHHHHH-HHhccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-Ccc
Confidence 998855544 555566799999999999999999999998 999999999999999999999999999998874 223
Q ss_pred CcccccCCCcccChhhhcc-CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHH----------HHhh
Q 043702 537 DATVAAGTMGYLAPEYLLT-GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWV----------WSLH 605 (711)
Q Consensus 537 ~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~----------~~~~ 605 (711)
..+..+.|.+|+|||.+.+ .+|....||||.||++.||++|.+-|....+- ..+.... ..+.
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDi-------DQLy~I~ktLG~L~prhq~iF 229 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDI-------DQLYLIRKTLGNLIPRHQSIF 229 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchH-------HHHHHHHHHHcccCHHHHHHh
Confidence 4456778999999999988 57999999999999999999999988654221 1111100 0000
Q ss_pred hcCch-hHhhhhhcc-----CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 606 REGRL-LTAADARLE-----GQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 606 ~~~~~-~~~~d~~l~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
..... ....-|... ..--+....-+++++..|++.||.+|++-+|++.
T Consensus 230 ~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 230 SSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11100 000001110 0001122346789999999999999999999875
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=352.96 Aligned_cols=242 Identities=26% Similarity=0.332 Sum_probs=202.5
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLV 454 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 454 (711)
.++|+..++||+|+||+||.++.+++++.+|+|++++. ..+.+..++|..+|.+++||.||++.-.+++.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 45789999999999999999999999999999998863 34566788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCC
Q 043702 455 YDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~ 534 (711)
+||+.||.|..+|.+ .+.+++....-++..|+.||.|||+. +||||||||+|||||++|.++|+||||++......
T Consensus 104 ld~~~GGeLf~hL~~-eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQR-EGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred EeccCCccHHHHHHh-cCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence 999999999999964 56788998999999999999999998 99999999999999999999999999998654433
Q ss_pred CCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhh
Q 043702 535 SPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614 (711)
Q Consensus 535 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 614 (711)
. .+...|||+.|||||++.+..|+..+|.||+|+++|||++|.+||.... ...+.....+.. +
T Consensus 180 ~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~-----------~~~~~~~I~~~k-~---- 242 (357)
T KOG0598|consen 180 D-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED-----------VKKMYDKILKGK-L---- 242 (357)
T ss_pred C-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc-----------HHHHHHHHhcCc-C----
Confidence 2 3444799999999999999999999999999999999999999997642 223322222221 0
Q ss_pred hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCC
Q 043702 615 DARLEGQFDEAEMRRVLLVGLACSHPDPLARP 646 (711)
Q Consensus 615 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 646 (711)
...+.-...+..+++...+..||++|.
T Consensus 243 -----~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 243 -----PLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -----CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 011111233455677788889999996
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=360.77 Aligned_cols=266 Identities=26% Similarity=0.356 Sum_probs=209.5
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC---ChhhhHHHHHHHHhcCCCCeeeeeeeeeec--CeEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ---GKDEFLSELSIIGTLRHRNLVRLQGWCHEK--GEILLV 454 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV 454 (711)
+.|+..++||+|.||.||+|++..+|+.||+|++..... -..-..+||.+|++|+||||++|.+...+. +.+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 356677889999999999999999999999999876432 234467999999999999999999999876 689999
Q ss_pred EEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCC
Q 043702 455 YDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~ 534 (711)
+|||++ ||.-++....-.++..++..++.|+++||+|+|+. +|+|||||.+|||||.+|.+||+|||||+++....
T Consensus 197 FeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred Eecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 999988 99999987778899999999999999999999998 99999999999999999999999999999988877
Q ss_pred CCCcccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCcccccccccc---ccccchHHHHHHhhhcCch
Q 043702 535 SPDATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKV---GVASNLVEWVWSLHREGRL 610 (711)
Q Consensus 535 ~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~---~~~~~l~~~~~~~~~~~~~ 610 (711)
....+..+-|++|+|||++.+. .|+.+.|+||.||||.||+.|++.|....+-.... .......+-.|.. .++
T Consensus 273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~---~kL 349 (560)
T KOG0600|consen 273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPV---SKL 349 (560)
T ss_pred CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccc---ccC
Confidence 7777888899999999999875 69999999999999999999999987643210000 0000000001211 111
Q ss_pred h--Hhh------hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 611 L--TAA------DARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 611 ~--~~~------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
. ... ...+... -.......++|+..+|..||.+|.|+.++++
T Consensus 350 P~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 350 PHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 1 000 1111110 0111245667888899999999999999986
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=357.56 Aligned_cols=266 Identities=24% Similarity=0.331 Sum_probs=211.3
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhh--HHHHHHHHhcC-CCCeeeeeeeeeecC-eEEEE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEF--LSELSIIGTLR-HRNLVRLQGWCHEKG-EILLV 454 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~--~~Ei~~l~~l~-H~niv~l~g~~~~~~-~~~lV 454 (711)
.++|...++||.|.||.||+|+....|+.||||+++..-...+++ ++|+..|++|+ ||||++|.+.+.+.+ .+++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 457888899999999999999999999999999998755555554 57999999999 999999999999887 99999
Q ss_pred EEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCC
Q 043702 455 YDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~ 534 (711)
||||+. +|++++.+++..+++..++.|+.||++||+|+|.+ |+.|||+||+|||+..+..+||+|||+||.+....
T Consensus 89 fE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp 164 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRSKP 164 (538)
T ss_pred HHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccccCC
Confidence 999955 99999998888899999999999999999999998 99999999999999999999999999999876443
Q ss_pred CCCcccccCCCcccChhhhc-cCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHH----HHhhhc-C
Q 043702 535 SPDATVAAGTMGYLAPEYLL-TGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWV----WSLHRE-G 608 (711)
Q Consensus 535 ~~~~~~~~gt~~y~APE~~~-~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~----~~~~~~-~ 608 (711)
..+..+.|.+|+|||++. .+.|+.+.|||++|||++|+.+-++-|.+..+- +....+-+.+ ++-+.+ .
T Consensus 165 --PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~----Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 165 --PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEI----DQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred --CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHH----HHHHHHHHHhCCCccccchhHH
Confidence 445667999999999875 567899999999999999999999988654221 0000000000 000001 1
Q ss_pred chhHhhhhh--------ccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 043702 609 RLLTAADAR--------LEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655 (711)
Q Consensus 609 ~~~~~~d~~--------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L 655 (711)
++...+.-+ +....+ ....++++++.+|+..||.+|||+.|++++-
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 111111111 111112 2567788999999999999999999999854
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=401.47 Aligned_cols=261 Identities=29% Similarity=0.505 Sum_probs=219.4
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcC
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
.+.|...++||+|+||.||+|+...++..||+|++..... ...+|++.+++++||||++++|+|.+.+..++||||+
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 3457788899999999999999988899999999865332 2235688999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCc
Q 043702 459 PNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDA 538 (711)
Q Consensus 459 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 538 (711)
++|+|.++++ .++|.++.+|+.|+|+||+|||+.+.++|+||||||+||+++.++.+++. ||........
T Consensus 766 ~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~----- 835 (968)
T PLN00113 766 EGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD----- 835 (968)
T ss_pred CCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----
Confidence 9999999995 38999999999999999999998777899999999999999999988876 6665443221
Q ss_pred ccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhc
Q 043702 539 TVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARL 618 (711)
Q Consensus 539 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 618 (711)
....|++.|||||++.+..++.++|||||||++|||++|+.||+... +....+.+|++...........+|+.+
T Consensus 836 ~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (968)
T PLN00113 836 TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF------GVHGSIVEWARYCYSDCHLDMWIDPSI 909 (968)
T ss_pred CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc------CCCCcHHHHHHHhcCccchhheeCccc
Confidence 12358899999999999999999999999999999999999995432 223567788876666666666667666
Q ss_pred cC--CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 619 EG--QFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 619 ~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
.. ..+.+++.++.+++.+||+.||++||+|+||++.|+..
T Consensus 910 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 951 (968)
T PLN00113 910 RGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951 (968)
T ss_pred cCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence 43 34567778899999999999999999999999999865
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=350.83 Aligned_cols=256 Identities=27% Similarity=0.463 Sum_probs=205.8
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC-CChhhhHHHHHHHHhcCCCCeeeeeeeeeecC--eEEEEEEc
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKG--EILLVYDL 457 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV~Ey 457 (711)
++...+.||+|.||+||++....+|+..|||.+.... ...+.+.+|+.+|++++|||||+.+|...... .+++.|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 4666788999999999999998889999999876532 22566899999999999999999999855444 69999999
Q ss_pred CCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcC-CCcEEEeecCCceecCC--CC
Q 043702 458 MPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDE-GFNARLGDFGLARQVEH--DK 534 (711)
Q Consensus 458 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~-~~~vkL~DFGla~~~~~--~~ 534 (711)
+++|+|.+++...+..|++..+.++.+||++||+|||++ +|+||||||+||||+. ++.+||+|||+++.... ..
T Consensus 98 ~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~ 174 (313)
T KOG0198|consen 98 APGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK 174 (313)
T ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence 999999999987666899999999999999999999987 9999999999999999 79999999999987763 22
Q ss_pred CCCcccccCCCcccChhhhccCC-CCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHh
Q 043702 535 SPDATVAAGTMGYLAPEYLLTGR-ATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTA 613 (711)
Q Consensus 535 ~~~~~~~~gt~~y~APE~~~~~~-~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 613 (711)
........||+.|||||++..+. ...++||||+||+++||+||+.||... ....+++......+.
T Consensus 175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~----------~~~~~~~~~ig~~~~---- 240 (313)
T KOG0198|consen 175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF----------FEEAEALLLIGREDS---- 240 (313)
T ss_pred ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh----------cchHHHHHHHhccCC----
Confidence 22334467999999999999643 345999999999999999999998652 111222222222211
Q ss_pred hhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 614 ADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 614 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
...++.....+..+++..|+..||++|||++++++...-.
T Consensus 241 -----~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~ 280 (313)
T KOG0198|consen 241 -----LPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLK 280 (313)
T ss_pred -----CCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence 1123333445667788899999999999999999866443
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=324.82 Aligned_cols=275 Identities=21% Similarity=0.295 Sum_probs=214.1
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCC---hhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQG---KDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
.+|...++||+|.||.||+|++..+|+.||||++...+.. .....+||+.|+.++|+||+.|++++-..+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 3577788999999999999999999999999999874322 4578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCC
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP 536 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~ 536 (711)
||+. +|+..++++...++..++..++.++++||+|||+. .|+||||||.|+|+++++.+||+|||+|+.+......
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 9966 99999998888899999999999999999999998 9999999999999999999999999999988765543
Q ss_pred CcccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccccccc--------------cccccccchHHHH
Q 043702 537 DATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKEITGV--------------GKVGVASNLVEWV 601 (711)
Q Consensus 537 ~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~~~~~--------------~~~~~~~~l~~~~ 601 (711)
... .+-|.+|+|||.+.+. .|+...||||.||++.||+-|.+-|.+..+-. ..+.....+.+++
T Consensus 158 ~~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~ 236 (318)
T KOG0659|consen 158 QTH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV 236 (318)
T ss_pred ccc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence 332 3689999999999875 58999999999999999999987775432200 0000011111111
Q ss_pred HHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC-CCCCCCCCCC
Q 043702 602 WSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG-EAEVPIVPRA 667 (711)
Q Consensus 602 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~-~~~~p~~p~~ 667 (711)
. +.....+.+.. .=..+....++|+..++..||.+|++++|++++=-- ..+.|..|..
T Consensus 237 ~-------~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~~~ 295 (318)
T KOG0659|consen 237 K-------IQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPPSK 295 (318)
T ss_pred H-------HhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCChhh
Confidence 0 11011111111 112344566899999999999999999999975321 2444444433
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=357.85 Aligned_cols=265 Identities=24% Similarity=0.363 Sum_probs=209.9
Q ss_pred CHHHHHHHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC---CCChhhhHHHHHHHHhcCCCCeeeeeeeeee
Q 043702 371 SYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN---SQGKDEFLSELSIIGTLRHRNLVRLQGWCHE 447 (711)
Q Consensus 371 ~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 447 (711)
+.++.....+.+...+.||+|.||+||+|++-+ .||||++... .+..+.|++|+..+++-+|.||+-+.|||..
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred cccccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 334444555566778899999999999999943 4899998763 2346789999999999999999999999998
Q ss_pred cCeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCc
Q 043702 448 KGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLA 527 (711)
Q Consensus 448 ~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla 527 (711)
... .+|..+|++-+|+.+|+..+.++...+.++|++|||+||.|||.+ +|||||||..||+|.++++|||+||||+
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred Cce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccce
Confidence 876 999999999999999998888999999999999999999999998 9999999999999999999999999999
Q ss_pred eecCCCCC-CCcccccCCCcccChhhhccC---CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHH
Q 043702 528 RQVEHDKS-PDATVAAGTMGYLAPEYLLTG---RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWS 603 (711)
Q Consensus 528 ~~~~~~~~-~~~~~~~gt~~y~APE~~~~~---~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~ 603 (711)
..-..-.. .......|...|||||+++.+ +|+..+||||||+++|||++|..||.....+. .+|.
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq-----------Iifm 604 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ-----------IIFM 604 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh-----------eEEE
Confidence 64332211 122234578899999999754 68999999999999999999999997332210 0111
Q ss_pred hhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC
Q 043702 604 LHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEA 659 (711)
Q Consensus 604 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~ 659 (711)
...|.+ ..|.. .....+.+++.+|+..||..++++||.+.+|+..|+...
T Consensus 605 -VGrG~l--~pd~s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~ 654 (678)
T KOG0193|consen 605 -VGRGYL--MPDLS---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL 654 (678)
T ss_pred -eccccc--Cccch---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence 111111 11111 112344566777888999999999999999999887653
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=357.34 Aligned_cols=250 Identities=25% Similarity=0.363 Sum_probs=208.9
Q ss_pred HHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC----C--CChhhhHHHHHHHHhcC-CCCeeeeeeeeeecC
Q 043702 377 SATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----S--QGKDEFLSELSIIGTLR-HRNLVRLQGWCHEKG 449 (711)
Q Consensus 377 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~--~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~ 449 (711)
...++|...+.||+|.||+|++|.+..+++.||+|++... . ...+.+.+|+.++++++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3456899999999999999999999989999999976653 1 22446678999999999 999999999999999
Q ss_pred eEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCC-CcEEEeecCCce
Q 043702 450 EILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEG-FNARLGDFGLAR 528 (711)
Q Consensus 450 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~-~~vkL~DFGla~ 528 (711)
..++||||+.+|+|.+++.+ .+++.+.+..++++|++.|++|||+. +|+||||||+|||+|.+ +++||+|||++.
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 99999999999999999987 78899999999999999999999998 99999999999999999 999999999999
Q ss_pred ecCCCCCCCcccccCCCcccChhhhccCC-C-CccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhh
Q 043702 529 QVEHDKSPDATVAAGTMGYLAPEYLLTGR-A-TEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHR 606 (711)
Q Consensus 529 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~-s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~ 606 (711)
... .........+||+.|+|||++.+.. | ..++||||+||+||.|++|+.||++... ....+. ..
T Consensus 170 ~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~-----------~~l~~k-i~ 236 (370)
T KOG0583|consen 170 ISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV-----------PNLYRK-IR 236 (370)
T ss_pred ccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH-----------HHHHHH-Hh
Confidence 874 2223345578999999999999877 7 4889999999999999999999986321 111111 11
Q ss_pred cCchhHhhhhhccCCCcHHH-HHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 607 EGRLLTAADARLEGQFDEAE-MRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 607 ~~~~~~~~d~~l~~~~~~~~-~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
.+.. .++... ..++..|+.+|+..||.+|+++.++++
T Consensus 237 ~~~~----------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 237 KGEF----------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred cCCc----------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 1111 111111 466778899999999999999999995
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=359.06 Aligned_cols=257 Identities=28% Similarity=0.464 Sum_probs=201.9
Q ss_pred hcCCcccceeecCCceEEEEEEeC-----CCCeEEEEEEcccCC--CChhhhHHHHHHHHhc-CCCCeeeeeeeeeec-C
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILP-----QNGDIIAVKRCSHNS--QGKDEFLSELSIIGTL-RHRNLVRLQGWCHEK-G 449 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~-~ 449 (711)
.++|...++||+|+||.||+|.+. ..+..||+|++.... ...+.+.+|+.++..+ +||||++++++|... +
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 457888999999999999999752 235679999987532 2345788999999999 799999999998764 4
Q ss_pred eEEEEEEcCCCCCHHHHHhhCC----------------------------------------------------------
Q 043702 450 EILLVYDLMPNGSLDKALFEAR---------------------------------------------------------- 471 (711)
Q Consensus 450 ~~~lV~Ey~~~gsL~~~l~~~~---------------------------------------------------------- 471 (711)
.+++||||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 6899999999999999986432
Q ss_pred ---CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCC-CcccccCCCcc
Q 043702 472 ---SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP-DATVAAGTMGY 547 (711)
Q Consensus 472 ---~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y 547 (711)
..+++..+.+++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++........ ......++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 2478889999999999999999997 9999999999999999999999999999865433221 12223467889
Q ss_pred cChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccCCCcHHH
Q 043702 548 LAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAE 626 (711)
Q Consensus 548 ~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 626 (711)
+|||++.+..++.++|||||||+||||++ |+.||...... . . .......+... . .....
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~-------~---~-~~~~~~~~~~~-----~----~~~~~ 302 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN-------E---E-FCQRLKDGTRM-----R----APENA 302 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc-------H---H-HHHHHhcCCCC-----C----CCCCC
Confidence 99999999999999999999999999997 99998653210 0 1 11111111111 0 11122
Q ss_pred HHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 627 MRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 627 ~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
...+.+++.+||+.||.+||++.|+++.|+..
T Consensus 303 ~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 303 TPEIYRIMLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 34677899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=357.15 Aligned_cols=250 Identities=24% Similarity=0.367 Sum_probs=212.4
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChh-hhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcC
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKD-EFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~-~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
..|....+||+|..|.||.++...+++.||||++....+..+ -+.+|+.+|+..+|+|||++++-+..++++++|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 467778899999999999999999999999999988766655 4679999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCc
Q 043702 459 PNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDA 538 (711)
Q Consensus 459 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 538 (711)
++|+|.+.+.. ..+++.++..|++++++||+|||.. +|+|||||.+||||+.++.+||+|||+|..+..... ..
T Consensus 353 ~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR 426 (550)
T KOG0578|consen 353 EGGSLTDVVTK--TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KR 426 (550)
T ss_pred CCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC-cc
Confidence 99999998843 4599999999999999999999998 999999999999999999999999999998876554 34
Q ss_pred ccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhc
Q 043702 539 TVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARL 618 (711)
Q Consensus 539 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 618 (711)
...+||+.|||||++....|..|.||||||++++||+-|.+||-.+.+ ..-++.....|.. .+
T Consensus 427 ~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P-----------lrAlyLIa~ng~P------~l 489 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP-----------LRALYLIATNGTP------KL 489 (550)
T ss_pred ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh-----------HHHHHHHhhcCCC------Cc
Confidence 456899999999999999999999999999999999999999975432 1111222222221 11
Q ss_pred cCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 619 EGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
...+.....+.+++.+||+.|+++||+++|+|+.
T Consensus 490 --k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 490 --KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred --CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 1223344567788899999999999999999983
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=353.47 Aligned_cols=251 Identities=22% Similarity=0.327 Sum_probs=209.1
Q ss_pred HhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEccc----CCCChhhhHHHHHHHHhc-CCCCeeeeeeeeeecCeEE
Q 043702 378 ATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSH----NSQGKDEFLSELSIIGTL-RHRNLVRLQGWCHEKGEIL 452 (711)
Q Consensus 378 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~----~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 452 (711)
..++|...+.||+|.|++|++|+...+++.+|||++.+ .+...+.+..|-++|.+| .||.|++|+--|+++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 34568888999999999999999999999999999876 234456678899999999 6999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCC
Q 043702 453 LVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEH 532 (711)
Q Consensus 453 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~ 532 (711)
+|+||+++|+|.++|.+ .+.|++...+.++.+|+.||+|||+. |||||||||+|||||+|+++||+|||.|+.+..
T Consensus 151 FvLe~A~nGdll~~i~K-~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKK-YGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEEEecCCCcHHHHHHH-hCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 99999999999999965 46799999999999999999999998 999999999999999999999999999998753
Q ss_pred CCCC----------C--cccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHH
Q 043702 533 DKSP----------D--ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEW 600 (711)
Q Consensus 533 ~~~~----------~--~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~ 600 (711)
.... . ....+||..|.+||++..+..+..+|+|+|||+||+|+.|.+||....+ |
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne-------------y 293 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE-------------Y 293 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH-------------H
Confidence 2211 1 1447899999999999999999999999999999999999999976421 1
Q ss_pred HHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 601 VWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 601 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
. -+..+++ +.-.+++...+.+.+|+.+.|..||.+|++.+||-+.
T Consensus 294 l-------iFqkI~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 294 L-------IFQKIQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred H-------HHHHHHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 1 0011111 1112333334566778888889999999999999864
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=386.88 Aligned_cols=255 Identities=30% Similarity=0.452 Sum_probs=210.8
Q ss_pred cCCcccceeecCCceEEEEEEeCCCC-----eEEEEEEcccC--CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNG-----DIIAVKRCSHN--SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEIL 452 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~-----~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 452 (711)
++.+..+.||+|.||.||+|...+.. ..||+|.+... .++..+|.+|..+|+.++|||||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 45667788999999999999985432 24899998873 566789999999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhhC------CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCC
Q 043702 453 LVYDLMPNGSLDKALFEA------RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGL 526 (711)
Q Consensus 453 lV~Ey~~~gsL~~~l~~~------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGl 526 (711)
+++|||++|+|..+|++. ...|+....+.++.|||+|+.||+++ ++|||||.++|+||++...|||+||||
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccch
Confidence 999999999999999987 56699999999999999999999998 999999999999999999999999999
Q ss_pred ceecCCCCCCCcccc-cCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHh
Q 043702 527 ARQVEHDKSPDATVA-AGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSL 604 (711)
Q Consensus 527 a~~~~~~~~~~~~~~-~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~ 604 (711)
||.+.....+..... .-..+|||||.++.+.++.|+|||||||+|||++| |..||..... .+-...+
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n-----------~~v~~~~ 917 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN-----------FEVLLDV 917 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch-----------HHHHHHH
Confidence 996544332222211 23468999999999999999999999999999999 8889865422 1111112
Q ss_pred hhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 605 HREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 605 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
.+.|++ ..+..+.+.+.+|+..||+.+|++||++..+++.+...
T Consensus 918 ~~ggRL----------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i 961 (1025)
T KOG1095|consen 918 LEGGRL----------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI 961 (1025)
T ss_pred HhCCcc----------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence 233322 22344567788999999999999999999999977654
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=341.38 Aligned_cols=260 Identities=27% Similarity=0.361 Sum_probs=207.1
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
.+.|+..+.||.|..++||+|+....++.||||++..++ .+.+.+.+|+..|+.++||||++.+..|..+..+++||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 357888999999999999999998899999999987643 345789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhC-CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 457 LMPNGSLDKALFEA-RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 457 y~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
||.+|++.+++... ...+++..+..|++++++||.|||+. |.||||||+.||||+++|.|||+|||.+..+-+...
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 99999999999753 34599999999999999999999998 999999999999999999999999998876644332
Q ss_pred CCc---ccccCCCcccChhhhcc--CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCch
Q 043702 536 PDA---TVAAGTMGYLAPEYLLT--GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRL 610 (711)
Q Consensus 536 ~~~---~~~~gt~~y~APE~~~~--~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 610 (711)
... ...+||+.|||||++.. ..|+.|+||||||++..||++|..||....+- ..+ +..+ .+..
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm-------kvL---l~tL--qn~p 249 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM-------KVL---LLTL--QNDP 249 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH-------HHH---HHHh--cCCC
Confidence 211 44689999999999654 35899999999999999999999999765431 000 0111 1111
Q ss_pred hHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 611 LTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 611 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
....-..+..+.+......+.+++..||+.||.+|||++++++
T Consensus 250 p~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 250 PTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 1000000111111122346778889999999999999999986
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=343.15 Aligned_cols=254 Identities=22% Similarity=0.365 Sum_probs=205.2
Q ss_pred cCCcccceeecCCceEEEEEEeC---CCCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILP---QNGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLV 454 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~---~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 454 (711)
++|+..+.||+|+||.||+|.+. ..+..||+|++.... ...+.+.+|+.++++++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46888999999999999999874 345789999987643 2345788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCC
Q 043702 455 YDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~ 534 (711)
|||+++|+|.+++......+++.+++.++.|++.||+|||+. +++||||||+|||++.++.+|++|||.+.......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 999999999999987667899999999999999999999987 99999999999999999999999999876543222
Q ss_pred CCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHh
Q 043702 535 SPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTA 613 (711)
Q Consensus 535 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 613 (711)
........++..|+|||.+....++.++|||||||++|||++ |+.||..... ..+.+. ...+..
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~--------~~~~~~----~~~~~~--- 226 (266)
T cd05064 162 IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG--------QDVIKA----VEDGFR--- 226 (266)
T ss_pred hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH--------HHHHHH----HHCCCC---
Confidence 222222345678999999999999999999999999999875 9999965321 111111 111110
Q ss_pred hhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 614 ADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 614 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
..........+.+++.+||+.+|.+||+++++++.|..
T Consensus 227 ------~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 227 ------LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred ------CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 01122334567788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=354.61 Aligned_cols=240 Identities=24% Similarity=0.451 Sum_probs=202.3
Q ss_pred ccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCCCCCH
Q 043702 384 ANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSL 463 (711)
Q Consensus 384 ~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 463 (711)
..+-||.|+.|.||+|++ .++.||||+++.-+ ..+|+-|++|+||||+.+.|+|.....+|||||||+.|-|
T Consensus 128 ELeWlGSGaQGAVF~Grl--~netVAVKKV~elk------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRL--HNETVAVKKVRELK------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeec--cCceehhHHHhhhh------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 357899999999999999 57899999875322 2578899999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCcccccC
Q 043702 464 DKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAG 543 (711)
Q Consensus 464 ~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~g 543 (711)
++.|+. +..++......+..+||.||.|||.+ .|||||||.-||||..+..|||+|||.++...+. .....++|
T Consensus 200 ~~VLka-~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFaG 273 (904)
T KOG4721|consen 200 YEVLKA-GRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFAG 273 (904)
T ss_pred HHHHhc-cCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhhh
Confidence 999954 56788889999999999999999998 9999999999999999999999999999876543 33445789
Q ss_pred CCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccCCCc
Q 043702 544 TMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFD 623 (711)
Q Consensus 544 t~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 623 (711)
|..|||||++++.+.++|.||||||||||||+||.-||.+-+... .+|.+ .. + .+.-..+
T Consensus 274 TVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA-----------IIwGV-Gs-N-------sL~LpvP 333 (904)
T KOG4721|consen 274 TVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA-----------IIWGV-GS-N-------SLHLPVP 333 (904)
T ss_pred hHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe-----------eEEec-cC-C-------cccccCc
Confidence 999999999999999999999999999999999999997643211 11111 01 1 1122234
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 624 EAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
..+.+-+..|+.+||+..|..||++++++..|.-
T Consensus 334 stcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 334 STCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred ccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 5566778889999999999999999999999964
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=361.30 Aligned_cols=258 Identities=28% Similarity=0.427 Sum_probs=207.6
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCe---E-EEEEEccc----CCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGD---I-IAVKRCSH----NSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEI 451 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~---~-vavK~~~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 451 (711)
++....++||+|.||.||+|++...+. . ||+|.... ......+|++|.++|+.++|||||+++|++..+.++
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 445556899999999999999965422 3 89998874 234467899999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecC
Q 043702 452 LLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVE 531 (711)
Q Consensus 452 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~ 531 (711)
++|||+|+||+|.++|.+....++..++++++.+.|.||+|||+. +++||||.++|+|++.+..+||+||||++...
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGS 313 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence 999999999999999998877899999999999999999999998 99999999999999999999999999998653
Q ss_pred CCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCch
Q 043702 532 HDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRL 610 (711)
Q Consensus 532 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 610 (711)
.-. .......-+..|+|||.+..+.++.++|||||||++||+.+ |..||..... ..+..++ ...+
T Consensus 314 ~~~-~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~--------~~v~~kI---~~~~-- 379 (474)
T KOG0194|consen 314 QYV-MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN--------YEVKAKI---VKNG-- 379 (474)
T ss_pred cee-eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH--------HHHHHHH---HhcC--
Confidence 111 11111124679999999999999999999999999999999 8889876432 1111111 1111
Q ss_pred hHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCC
Q 043702 611 LTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEAEV 661 (711)
Q Consensus 611 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 661 (711)
..-..+......+..++.+||..+|++||+|.++.+.|+.....
T Consensus 380 -------~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 380 -------YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK 423 (474)
T ss_pred -------ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence 11122223445666777899999999999999999999765433
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=336.68 Aligned_cols=251 Identities=26% Similarity=0.420 Sum_probs=205.4
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCC
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMP 459 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 459 (711)
+.|+..+.||+|+||.||++.+. .+..+|+|.+.......+++.+|++++++++||||++++++|..++..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 35777889999999999999885 45689999987666667789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCcc
Q 043702 460 NGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDAT 539 (711)
Q Consensus 460 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 539 (711)
+|+|.+++......+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||+++...........
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05114 83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS 159 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceeccC
Confidence 9999999976666799999999999999999999987 9999999999999999999999999999865433222222
Q ss_pred cccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhc
Q 043702 540 VAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARL 618 (711)
Q Consensus 540 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 618 (711)
...++..|+|||.+....++.++||||||+++|||++ |+.||..... ...... ....... ..
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--------~~~~~~---i~~~~~~---~~--- 222 (256)
T cd05114 160 GAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--------YEVVEM---ISRGFRL---YR--- 222 (256)
T ss_pred CCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHH---HHCCCCC---CC---
Confidence 2345678999999988889999999999999999999 8999865321 111111 1111110 00
Q ss_pred cCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 043702 619 EGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655 (711)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L 655 (711)
+......+.+++.+||+.+|.+||++.++++.|
T Consensus 223 ----~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 223 ----PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ----CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 111234678899999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=340.37 Aligned_cols=257 Identities=17% Similarity=0.260 Sum_probs=203.4
Q ss_pred CccCHHHHHHHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCC----hhhhHHHHHHHHhcCCCCeeeeee
Q 043702 368 KEFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQG----KDEFLSELSIIGTLRHRNLVRLQG 443 (711)
Q Consensus 368 ~~~~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~Ei~~l~~l~H~niv~l~g 443 (711)
+.++.+++ .......||+|++|.||+|.+ +|+.||||++...... .+.+.+|+.+|++++||||++++|
T Consensus 13 ~~i~~~~i-----~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g 85 (283)
T PHA02988 13 KCIESDDI-----DKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85 (283)
T ss_pred eecCHHHc-----CCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEee
Confidence 34455555 223336799999999999998 6899999998764433 356779999999999999999999
Q ss_pred eeee----cCeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcE
Q 043702 444 WCHE----KGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNA 519 (711)
Q Consensus 444 ~~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~v 519 (711)
++.+ ....++||||+++|+|.+++.+ ...+++..+.+++.|++.||.|||+. .+++||||||+|||+++++.+
T Consensus 86 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~ 162 (283)
T PHA02988 86 FIIDIVDDLPRLSLILEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKL 162 (283)
T ss_pred eEEecccCCCceEEEEEeCCCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcE
Confidence 9876 3468999999999999999965 45799999999999999999999973 278899999999999999999
Q ss_pred EEeecCCceecCCCCCCCcccccCCCcccChhhhcc--CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccch
Q 043702 520 RLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLT--GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNL 597 (711)
Q Consensus 520 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l 597 (711)
||+|||+++.+.... ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 163 kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~----------- 227 (283)
T PHA02988 163 KIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT----------- 227 (283)
T ss_pred EEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH-----------
Confidence 999999998654322 23458899999999976 6789999999999999999999999975321
Q ss_pred HHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 598 VEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 598 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
.+........+. ....+......+.+++.+||+.||++|||++++++.|+..
T Consensus 228 ~~~~~~i~~~~~---------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 228 KEIYDLIINKNN---------SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred HHHHHHHHhcCC---------CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 111111111110 0111222345678899999999999999999999998753
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=341.63 Aligned_cols=250 Identities=25% Similarity=0.355 Sum_probs=202.7
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC----CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS----QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
.|+..+.||+|+||.||+|....+++.||+|++.... .....+.+|++++++++|+|++++++++.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3677889999999999999998899999999886522 223467899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 457 LMPNGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 457 y~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
|+++|+|..++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++........
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 999999998886533 4689999999999999999999997 999999999999999999999999999987643322
Q ss_pred CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhh
Q 043702 536 PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 615 (711)
.....||..|+|||++.+..++.++|||||||++|||++|+.||...... ...+-+......
T Consensus 158 --~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--------~~~~~~~~~~~~-------- 219 (285)
T cd05631 158 --VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER--------VKREEVDRRVKE-------- 219 (285)
T ss_pred --ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcc--------hhHHHHHHHhhc--------
Confidence 23346899999999999999999999999999999999999999753211 000101000000
Q ss_pred hhccCCCcHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH
Q 043702 616 ARLEGQFDEAEMRRVLLVGLACSHPDPLARPT-----MRGVVQ 653 (711)
Q Consensus 616 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~eVl~ 653 (711)
....+.......+.+|+.+||+.||.+||+ ++++++
T Consensus 220 --~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 220 --DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred --ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 011122233456778899999999999997 788886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=350.38 Aligned_cols=246 Identities=26% Similarity=0.394 Sum_probs=210.2
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC---ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ---GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
++|...+.||+|.||.||||+.+.+.+.||+|.+.+..+ +.+.+.+|++++++|+||||+.++++|+...++++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 467788899999999999999999999999999877443 34568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCC
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP 536 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~ 536 (711)
|+.+ +|..+|.. .+.++++.++.|+.++..||.|||+. +|+|||+||+||||+.++.+|+||||+||.+.... .
T Consensus 82 ~a~g-~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t-~ 155 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT-S 155 (808)
T ss_pred hhhh-hHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccCc-e
Confidence 9977 99999954 66799999999999999999999998 99999999999999999999999999999876643 3
Q ss_pred CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhh
Q 043702 537 DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADA 616 (711)
Q Consensus 537 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 616 (711)
..+...|||.|||||.+.++.|+..+|+||+||+|||+.+|++||... .+.+.+...+.+.
T Consensus 156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----------si~~Lv~~I~~d~-------- 216 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----------SITQLVKSILKDP-------- 216 (808)
T ss_pred eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----------HHHHHHHHHhcCC--------
Confidence 445567999999999999999999999999999999999999999642 2333333222221
Q ss_pred hccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 617 RLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 617 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
...+......+..++...+..||.+|.+-.+++.
T Consensus 217 ---v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 217 ---VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred ---CCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 1122345566778888889999999999999986
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=337.41 Aligned_cols=253 Identities=25% Similarity=0.405 Sum_probs=208.5
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCCC
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPN 460 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 460 (711)
+|...+.||+|++|.||+|.....++.||+|++........++.+|++++++++|+||++++++|..++..+++|||+++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 86 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCC
Confidence 47778899999999999999988899999999887665667899999999999999999999999999999999999999
Q ss_pred CCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCcc
Q 043702 461 GSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDAT 539 (711)
Q Consensus 461 gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 539 (711)
++|.+++.... ..+++..++.++.|+++||+|||+. +++||||||+||++++++.+||+|||+++...........
T Consensus 87 ~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~ 163 (263)
T cd05052 87 GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 163 (263)
T ss_pred CcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceeeccC
Confidence 99999996543 4689999999999999999999987 9999999999999999999999999999876543322222
Q ss_pred cccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhc
Q 043702 540 VAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARL 618 (711)
Q Consensus 540 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 618 (711)
...++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+. +.....+ .
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-----------~~~-~~~~~~~---------~ 222 (263)
T cd05052 164 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----------SQV-YELLEKG---------Y 222 (263)
T ss_pred CCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----------HHH-HHHHHCC---------C
Confidence 2234668999999998899999999999999999998 9999864311 111 1111111 1
Q ss_pred cCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 619 EGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
...........+.+++.+||+.+|++||++.+++++|+.
T Consensus 223 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 223 RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 111122234567789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=356.95 Aligned_cols=256 Identities=28% Similarity=0.417 Sum_probs=203.0
Q ss_pred hcCCcccceeecCCceEEEEEEe-----CCCCeEEEEEEcccCC--CChhhhHHHHHHHHhc-CCCCeeeeeeeeeecCe
Q 043702 379 TKCFNANRIIGHGAFGTVYKGIL-----PQNGDIIAVKRCSHNS--QGKDEFLSELSIIGTL-RHRNLVRLQGWCHEKGE 450 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~-----~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 450 (711)
.++|+..+.||+|+||.||+|+. .+++..||||++.... ...+.+.+|+.++..+ +||||++++++|...+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 34688899999999999999974 3456789999987532 3345788999999999 79999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhhCC-----------------------------------------------------------
Q 043702 451 ILLVYDLMPNGSLDKALFEAR----------------------------------------------------------- 471 (711)
Q Consensus 451 ~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------------- 471 (711)
.++|||||++|+|.+++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999986432
Q ss_pred ---------------CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCC
Q 043702 472 ---------------SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP 536 (711)
Q Consensus 472 ---------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~ 536 (711)
..+++..+++++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 2478899999999999999999997 9999999999999999999999999999876543321
Q ss_pred C-cccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhh
Q 043702 537 D-ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614 (711)
Q Consensus 537 ~-~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 614 (711)
. .....++..|+|||.+.+..++.++|||||||++|||++ |..||...... ..+..+ ...+..
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-------~~~~~~----~~~~~~---- 335 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-------SKFYKM----IKEGYR---- 335 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-------HHHHHH----HHhCcc----
Confidence 1 112335678999999999999999999999999999998 88888643210 111111 111110
Q ss_pred hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 615 DARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 615 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
...+.....++.+++.+||+.||++||++.||++.|+.
T Consensus 336 -----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 336 -----MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred -----CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 00111123467789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=343.83 Aligned_cols=260 Identities=22% Similarity=0.372 Sum_probs=201.8
Q ss_pred cCCcccceeecCCceEEEEEEeCC----------------CCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeee
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQ----------------NGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRL 441 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~----------------~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l 441 (711)
++|...++||+|+||.||+|.+.. ++..||+|.+.... ....++.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 468888999999999999998632 34479999887532 234578999999999999999999
Q ss_pred eeeeeecCeEEEEEEcCCCCCHHHHHhhCC------------------CCCChHHHHHHHHHHHHHHHHHHhccCCCeee
Q 043702 442 QGWCHEKGEILLVYDLMPNGSLDKALFEAR------------------SPLPWPHRSKILLGVASALAYLHQECENQVIH 503 (711)
Q Consensus 442 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~------------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH 503 (711)
++++.+.+..++||||+++|+|.+++.... ..++|..+.+++.||+.||.|||+. +|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence 999999999999999999999999985421 2478899999999999999999997 9999
Q ss_pred ccCCCCceEEcCCCcEEEeecCCceecCCCCCC-CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh--CCCC
Q 043702 504 RDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP-DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS--GRRP 580 (711)
Q Consensus 504 rDlkp~NILld~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt--G~~P 580 (711)
|||||+|||+++++.+||+|||+++.+...... ......++..|+|||++..+.++.++|||||||++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999876433221 1223346789999999998999999999999999999987 5567
Q ss_pred CccccccccccccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 043702 581 IEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLV 656 (711)
Q Consensus 581 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 656 (711)
|..... ....+.+.......... ............+.+++.+||+.||.+|||+.+|.+.|+
T Consensus 242 ~~~~~~--------~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTD--------EQVIENAGEFFRDQGRQ------VYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCH--------HHHHHHHHHHhhhcccc------ccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 654211 11222222211111000 000011123456788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=339.79 Aligned_cols=248 Identities=33% Similarity=0.575 Sum_probs=195.1
Q ss_pred ccceeecCCceEEEEEEeC----CCCeEEEEEEcccCCC--ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEc
Q 043702 384 ANRIIGHGAFGTVYKGILP----QNGDIIAVKRCSHNSQ--GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 384 ~~~~LG~G~fg~Vy~~~~~----~~~~~vavK~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
..+.||.|.||.||+|.+. ..+..|+||++..... ..+++.+|++.+++++||||++++|+|...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999996 3457899999965332 357899999999999999999999999988889999999
Q ss_pred CCCCCHHHHHhhC-CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC-
Q 043702 458 MPNGSLDKALFEA-RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS- 535 (711)
Q Consensus 458 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~- 535 (711)
+++|+|.++|... ...+++.++.+|+.||++||.|||+. +++|+||+++|||+++++.+||+|||+++.......
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 9999999999877 67799999999999999999999997 999999999999999999999999999987732221
Q ss_pred CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhh
Q 043702 536 PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 614 (711)
.......+...|+|||.+....++.++||||||+++|||++ |+.||..... .++...+ .++..
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~-----------~~~~~~~-~~~~~---- 223 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN-----------EEIIEKL-KQGQR---- 223 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH-----------HHHHHHH-HTTEE----
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc-----------ccccccc-ccccc----
Confidence 11222346778999999999999999999999999999999 7788754311 1111122 11111
Q ss_pred hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 043702 615 DARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655 (711)
Q Consensus 615 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L 655 (711)
..........+.+++.+||+.+|++||+++++++.|
T Consensus 224 -----~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 -----LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -----TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -----ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 112222345677899999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=337.36 Aligned_cols=270 Identities=21% Similarity=0.309 Sum_probs=204.6
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC---CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
++|+..+.||+|+||.||+|++..+++.||+|++.... ...+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36888999999999999999999889999999987532 334578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCC
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP 536 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~ 536 (711)
|++++.|..+. .....+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 81 YVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence 99987766544 4456799999999999999999999987 9999999999999999999999999999876543333
Q ss_pred CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccc---cccc-hHHHHHHhhhcCchhH
Q 043702 537 DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVG---VASN-LVEWVWSLHREGRLLT 612 (711)
Q Consensus 537 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~---~~~~-l~~~~~~~~~~~~~~~ 612 (711)
......|++.|+|||++.+..++.++|||||||++|||++|+.||........... .... ..++............
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236 (287)
T ss_pred cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence 33445689999999999988899999999999999999999999965321000000 0000 0000000001100000
Q ss_pred hhhhhccC------CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 613 AADARLEG------QFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 613 ~~d~~l~~------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
...+.... .+.......+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000 001112346889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=333.20 Aligned_cols=253 Identities=26% Similarity=0.405 Sum_probs=207.0
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCC
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMP 459 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 459 (711)
++|+..++||+|++|.||+|... ++..||+|++.......+.+.+|+.++++++|+||+++++++...+..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 46888899999999999999975 56779999987655566789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhC-CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCc
Q 043702 460 NGSLDKALFEA-RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDA 538 (711)
Q Consensus 460 ~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 538 (711)
+++|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+++..........
T Consensus 85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05072 85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR 161 (261)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCceecc
Confidence 99999999753 45689999999999999999999987 999999999999999999999999999987654332222
Q ss_pred ccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhh
Q 043702 539 TVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADAR 617 (711)
Q Consensus 539 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 617 (711)
....++..|+|||++..+.++.++|||||||++|||++ |+.||..... ......+ ..+..
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--------~~~~~~~----~~~~~------- 222 (261)
T cd05072 162 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN--------SDVMSAL----QRGYR------- 222 (261)
T ss_pred CCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH--------HHHHHHH----HcCCC-------
Confidence 23346778999999998889999999999999999998 9999864321 1111111 11100
Q ss_pred ccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 618 LEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 618 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
..........+.+++.+|++.+|++||+++++++.|+.
T Consensus 223 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 223 --MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred --CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 00111223457789999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=343.19 Aligned_cols=261 Identities=25% Similarity=0.379 Sum_probs=210.9
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcC
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
...+.++||+|-||+|.++... .+..||||+++... ...++|.+|+++|.+|+||||++|+|+|..++.+++|+|||
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred heehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 4566788999999999999984 46999999998743 34579999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCC-CChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC
Q 043702 459 PNGSLDKALFEARSP-LPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD 537 (711)
Q Consensus 459 ~~gsL~~~l~~~~~~-l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 537 (711)
++|+|..+|..+..+ +.-....+|+.|||.||+||.+. ++|||||.++|+|+|.++++||+|||++|.+-.+..+.
T Consensus 618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCcee
Confidence 999999999876444 35566778999999999999998 99999999999999999999999999999665544433
Q ss_pred c-ccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh--CCCCCccccccccccccccchHHHHHHhhhcCchhHhh
Q 043702 538 A-TVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS--GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614 (711)
Q Consensus 538 ~-~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt--G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 614 (711)
. ...+-+.+|||+|.+..++++.++|||+||+++||+++ ...||....+ ...++-.-.+.+.+...
T Consensus 695 vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~--------e~vven~~~~~~~~~~~--- 763 (807)
T KOG1094|consen 695 VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD--------EQVVENAGEFFRDQGRQ--- 763 (807)
T ss_pred eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH--------HHHHHhhhhhcCCCCcc---
Confidence 2 23456789999999999999999999999999999865 7788875433 12222222222221111
Q ss_pred hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC
Q 043702 615 DARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEA 659 (711)
Q Consensus 615 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~ 659 (711)
.....+.-+...+.+++++||..|-++||+++++...|+..+
T Consensus 764 ---~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 764 ---VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred ---eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 111223445677889999999999999999999999997653
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=354.50 Aligned_cols=256 Identities=27% Similarity=0.437 Sum_probs=201.9
Q ss_pred hcCCcccceeecCCceEEEEEEeCC-----CCeEEEEEEcccCC--CChhhhHHHHHHHHhc-CCCCeeeeeeeeeecCe
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQ-----NGDIIAVKRCSHNS--QGKDEFLSELSIIGTL-RHRNLVRLQGWCHEKGE 450 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 450 (711)
.++|+..+.||+|+||.||+|+... ++..||+|++.... ...+.+.+|+++++.+ +|+||++++++|...+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 3478889999999999999998633 33579999987532 2345688999999999 79999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhhCC-----------------------------------------------------------
Q 043702 451 ILLVYDLMPNGSLDKALFEAR----------------------------------------------------------- 471 (711)
Q Consensus 451 ~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------------- 471 (711)
.++||||+++|+|.++++...
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999999986421
Q ss_pred ----------CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC-ccc
Q 043702 472 ----------SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD-ATV 540 (711)
Q Consensus 472 ----------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~-~~~ 540 (711)
.++++.++++++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++......... ...
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 2478889999999999999999997 99999999999999999999999999998764432211 112
Q ss_pred ccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhcc
Q 043702 541 AAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLE 619 (711)
Q Consensus 541 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 619 (711)
..++..|||||++....++.++|||||||++|||++ |+.||...... .. .......+ ..
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~-------~~----~~~~~~~~---------~~ 333 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN-------SK----FYKMVKRG---------YQ 333 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc-------HH----HHHHHHcc---------cC
Confidence 235678999999999999999999999999999997 99998653210 00 01111111 00
Q ss_pred CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 620 GQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 620 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
..........+.+++.+||+.||.+||++.+|+++|+.
T Consensus 334 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 334 MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 00111123567788899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=332.21 Aligned_cols=254 Identities=29% Similarity=0.434 Sum_probs=207.3
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcC
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
.++|+..+.||+|++|.||+|... ++..||+|.+.......+++.+|++++++++|+|++++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 356888999999999999999975 4678999998776656778999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC
Q 043702 459 PNGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD 537 (711)
Q Consensus 459 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 537 (711)
++++|.+++.... ..+++..+.+++.|++.||.|||+. +++||||||+||++++++.+||+|||+++.........
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA 160 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc
Confidence 9999999997544 5689999999999999999999987 99999999999999999999999999998775332221
Q ss_pred cccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhhhh
Q 043702 538 ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADA 616 (711)
Q Consensus 538 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 616 (711)
......+..|+|||++.+..++.++||||||+++|||++ |+.||..... ..+. .....
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~----~~~~~--------- 219 (261)
T cd05068 161 REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN--------AEVL----QQVDQ--------- 219 (261)
T ss_pred cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH--------HHHH----HHHHc---------
Confidence 121223458999999998899999999999999999999 9999864321 0111 11111
Q ss_pred hccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 617 RLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 617 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
.............+.+++.+|++.+|.+||++.++++.|+.
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 220 GYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 00011122234568889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=331.75 Aligned_cols=250 Identities=28% Similarity=0.419 Sum_probs=204.1
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCCC
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPN 460 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 460 (711)
+|+..+.||+|+||.||+|.++ ++..+|+|++.......+++.+|++++++++||||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 4777889999999999999885 466899999876555567899999999999999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCccc
Q 043702 461 GSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATV 540 (711)
Q Consensus 461 gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 540 (711)
++|.+++......+++..+++++.|++.||+|||+. +++||||||+||++++++.+||+|||+++............
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (256)
T cd05059 84 GCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQG 160 (256)
T ss_pred CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccccCC
Confidence 999999987666899999999999999999999997 99999999999999999999999999998764332221122
Q ss_pred ccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhcc
Q 043702 541 AAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLE 619 (711)
Q Consensus 541 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 619 (711)
..++..|+|||.+.+..++.++|||||||++|||++ |+.||..... .... ... ..+ ..
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~---~~~-~~~---------~~ 219 (256)
T cd05059 161 TKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN--------SEVV---ESV-SAG---------YR 219 (256)
T ss_pred CCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH--------HHHH---HHH-HcC---------Cc
Confidence 224567999999999999999999999999999999 8999864321 0111 111 110 00
Q ss_pred CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 043702 620 GQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655 (711)
Q Consensus 620 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L 655 (711)
..........+.+++.+||+.+|++||++.++++.|
T Consensus 220 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 220 LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 111122345688899999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=336.97 Aligned_cols=254 Identities=26% Similarity=0.465 Sum_probs=206.1
Q ss_pred cCCcccceeecCCceEEEEEEeCCCC-----eEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNG-----DIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEIL 452 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~-----~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 452 (711)
++|+..+.||+|+||.||+|.....+ ..||+|.+.... ....++.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 35778899999999999999986544 679999886533 22456889999999999999999999999989999
Q ss_pred EEEEcCCCCCHHHHHhhCC---------------CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCC
Q 043702 453 LVYDLMPNGSLDKALFEAR---------------SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGF 517 (711)
Q Consensus 453 lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~ 517 (711)
++|||+++|+|.+++.... ..+++..++.++.|++.||.|||+. +++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 9999999999999996532 4588899999999999999999997 999999999999999999
Q ss_pred cEEEeecCCceecCCCCC-CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCcccccccccccccc
Q 043702 518 NARLGDFGLARQVEHDKS-PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVAS 595 (711)
Q Consensus 518 ~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~ 595 (711)
.+||+|||+++....... .......+++.|+|||.+..+.++.++|||||||++|||++ |..||..... .
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~--------~ 233 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN--------Q 233 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH--------H
Confidence 999999999986643322 12233456889999999998899999999999999999998 9999864321 1
Q ss_pred chHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 596 NLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 596 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
.+.. .+..+. ..........++.+|+.+||+.||.+||+++||++.|+.
T Consensus 234 ~~~~----~i~~~~---------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 234 EVIE----MIRSRQ---------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHH----HHHcCC---------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1111 111111 111223345678899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=349.79 Aligned_cols=254 Identities=23% Similarity=0.385 Sum_probs=211.0
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
-|...+.||+|+-|.|-+|++..+|+.+|||++... ......+.+|+-+|+.|.|||+++|++++.+..++|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 366778899999999999999999999999998764 2234567899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCC
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP 536 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~ 536 (711)
|+++|.|+++|.. ++++++.+..+++.||+.|+.|+|.. +|+||||||+|+|||.++++||+|||+|..-..+.
T Consensus 93 yv~gGELFdylv~-kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk-- 166 (786)
T KOG0588|consen 93 YVPGGELFDYLVR-KGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK-- 166 (786)
T ss_pred ecCCchhHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCCc--
Confidence 9999999999965 56799999999999999999999998 99999999999999999999999999998654443
Q ss_pred CcccccCCCcccChhhhccCCC-CccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhh
Q 043702 537 DATVAAGTMGYLAPEYLLTGRA-TEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615 (711)
Q Consensus 537 ~~~~~~gt~~y~APE~~~~~~~-s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 615 (711)
.....||.+.|.+||++.+.+| ..++||||+|||||.|++|+.||+++ ++.....+ ++.|..
T Consensus 167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd-----------Nir~LLlK-V~~G~f----- 229 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD-----------NIRVLLLK-VQRGVF----- 229 (786)
T ss_pred cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc-----------cHHHHHHH-HHcCcc-----
Confidence 2344689999999999999887 78999999999999999999999853 22221111 111111
Q ss_pred hhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH--HhCCCCCC
Q 043702 616 ARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM--LVGEAEVP 662 (711)
Q Consensus 616 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~--L~~~~~~p 662 (711)
+.+.....++.+|+.+|+..||.+|.|++||++. |.+-..++
T Consensus 230 -----~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~ 273 (786)
T KOG0588|consen 230 -----EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLP 273 (786)
T ss_pred -----cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCC
Confidence 1223344567788899999999999999999984 45544443
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=346.86 Aligned_cols=253 Identities=22% Similarity=0.276 Sum_probs=204.7
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
++|+..+.||+|+||.||+|++..+++.||+|++... ....+.+.+|++++..++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 3688899999999999999999888999999998752 233467889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
||+++|+|.+++.. ...+++.++..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 81 EYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 99999999999964 45689999999999999999999997 999999999999999999999999999986543
Q ss_pred CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhh
Q 043702 536 PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 615 (711)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .... .......... .
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~--------~~~~---~i~~~~~~~~--~ 219 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN--------ETWE---NLKYWKETLQ--R 219 (333)
T ss_pred -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH--------HHHH---HHHhcccccc--C
Confidence 223456999999999999999999999999999999999999999653210 0000 0100000000 0
Q ss_pred hhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 616 ARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 616 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
+.. ..........+.+++.+||..+|.+||+++++++.
T Consensus 220 ~~~-~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 220 PVY-DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCC-CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000 00001224567788899999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=343.93 Aligned_cols=255 Identities=25% Similarity=0.441 Sum_probs=203.9
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCe----EEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGD----IIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILL 453 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~----~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 453 (711)
.+|+..+.||+|+||.||+|++..+++ .||+|++.... ...+++.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 458889999999999999999765554 38999986532 3356788999999999999999999999765 5789
Q ss_pred EEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCC
Q 043702 454 VYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHD 533 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~ 533 (711)
++||+++|+|.+++......+++..+++++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.+...
T Consensus 86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccCC
Confidence 9999999999999987777899999999999999999999997 9999999999999999999999999999876543
Q ss_pred CCCC-cccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchh
Q 043702 534 KSPD-ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLL 611 (711)
Q Consensus 534 ~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 611 (711)
.... .....++..|+|||.+....++.++|||||||++|||++ |+.||..... ..+.. ....+...
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~--------~~~~~----~~~~~~~~ 230 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--------SEISS----ILEKGERL 230 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--------HHHHH----HHhCCCCC
Confidence 3221 112234678999999999999999999999999999998 9999865321 11111 11111100
Q ss_pred HhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC
Q 043702 612 TAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEA 659 (711)
Q Consensus 612 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~ 659 (711)
.........+.+++.+||+.+|.+||++.+++..|....
T Consensus 231 ---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 231 ---------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred ---------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 001112345778899999999999999999999887553
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=335.42 Aligned_cols=261 Identities=19% Similarity=0.307 Sum_probs=201.8
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEc
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
++|...++||+|+||.||+|....++..||+|++.... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888999999999999999998889999999886532 3345678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC
Q 043702 458 MPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD 537 (711)
Q Consensus 458 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 537 (711)
+++ +|.+++......+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++....... .
T Consensus 85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-~ 159 (288)
T cd07871 85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-T 159 (288)
T ss_pred CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-c
Confidence 975 99999877666789999999999999999999997 999999999999999999999999999986543222 2
Q ss_pred cccccCCCcccChhhhcc-CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhh----------
Q 043702 538 ATVAAGTMGYLAPEYLLT-GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHR---------- 606 (711)
Q Consensus 538 ~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~---------- 606 (711)
.....|++.|+|||.+.+ ..++.++||||+||++|||++|+.||...... ...........
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~--------~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK--------EELHLIFRLLGTPTEETWPGI 231 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHHHhCCCChHHhhcc
Confidence 233468999999999875 46899999999999999999999999653211 00110000000
Q ss_pred --cCchhHhhhhhccCCC----cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 607 --EGRLLTAADARLEGQF----DEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 607 --~~~~~~~~d~~l~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
.........+...... ......++.+++.+|++.||.+|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 232 TSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000000000000 0011245678999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd01951 lectin_L-type legume lectins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=322.61 Aligned_cols=202 Identities=31% Similarity=0.474 Sum_probs=169.8
Q ss_pred CCCeEEeCceEee--CCcEEeCCCCCCCCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecCCCCCCCCceEEEEcC
Q 043702 43 LASLKLLGDAHMN--NGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLNPSSIGAGLAFVITP 120 (711)
Q Consensus 43 ~~~~~~~g~a~~~--~g~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~GlaF~l~~ 120 (711)
.+++.++|||.+. ++.|+||++.. +++||++|++||++| ++|+|+|+|.|.+.. ..+||||||+|+|
T Consensus 13 ~~~~~~~G~A~~~~~~~~l~Lt~~~~---~~~G~~~~~~~i~~~-------~~F~~~F~f~i~~~~-~~~gdG~aF~l~~ 81 (223)
T cd01951 13 QSNWQLNGSATLTTDSGVLRLTPDTG---NQAGSAWYKTPIDLS-------KDFTTTFKFYLGTKG-TNGADGIAFVLQN 81 (223)
T ss_pred hhhcEEcccEEecCCCCEEEECCCCC---CcEEEEEECCcEecc-------CCEEEEEEEEEeCCC-CCCCCcEEEEEec
Confidence 4689999999998 78999999876 889999999999998 689999999999765 5689999999999
Q ss_pred CCCCC-CCCC--CcccccccCCCCcceEEEEeecccCCCCCCCCCCeeeEecCCCcccc--cccCCccccc--cCCCCeE
Q 043702 121 DGEQV-GSAG--GSLGLLDEKGAGLGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTE--VDNLDTINVD--LKSGDLV 193 (711)
Q Consensus 121 ~~~~~-~~~g--~~lgl~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~S~~--~~~~~~~~~~--~~~g~~~ 193 (711)
....+ +..| ++||+... ++.+|||||||+|.+++||+.+|||||+|+..+.. ........+. ..+|+.+
T Consensus 82 ~~~~~~~~~g~~~~lG~~~~----~~~~aVefDT~~N~~~~dp~~~higi~~n~~~~~~~~~~~~~~~~~~~~~~~g~~~ 157 (223)
T cd01951 82 DPAGALGGGGGGGGLGYGGI----GNSVAVEFDTYKNDDNNDPNGNHISIDVNGNGNNTALATSLGSASLPNGTGLGNEH 157 (223)
T ss_pred CCCCccccCCCCCccCcccc----CCeEEEEEeccccCCCCCCCCCEEEEEcCCCCCCcccccccceeeCCCccCCCCEE
Confidence 77543 3444 78886433 56899999999999888999999999999997541 1111112222 2239999
Q ss_pred EEEEEEcccccEEEEEEEecCCCCCcceeeEecCcccccccceeEEEeeeccCceeeEEEEeecccc
Q 043702 194 NSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGSTEIHSIEWWSFSS 260 (711)
Q Consensus 194 ~~~I~Y~~~~~~l~V~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastg~~~~~~~i~sW~f~s 260 (711)
+|||+|++.+++|+|++.+... +..++++..+||+.+++++||||||||||...|.|+|++|+|++
T Consensus 158 ~v~I~Y~~~~~~L~v~l~~~~~-~~~~~l~~~~~l~~~~~~~~yvGFTAsTG~~~~~h~V~~wsf~~ 223 (223)
T cd01951 158 TVRITYDPTTNTLTVYLDNGST-LTSLDITIPVDLIQLGPTKAYFGFTASTGGLTNLHDILNWSFTS 223 (223)
T ss_pred EEEEEEeCCCCEEEEEECCCCc-cccccEEEeeeecccCCCcEEEEEEcccCCCcceeEEEEEEecC
Confidence 9999999999999999987554 66789999999999999999999999999999999999999964
|
The L-type (legume-type) lectins are a highly diverse family of carbohydrate binding proteins that generally display no enzymatic activity toward the sugars they bind. This family includes arcelin, concanavalinA, the lectin-like receptor kinases, the ERGIC-53/VIP36/EMP46 type1 transmembrane proteins, and an alpha-amylase inhibitor. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=332.47 Aligned_cols=254 Identities=29% Similarity=0.461 Sum_probs=206.6
Q ss_pred cCCcccceeecCCceEEEEEEeCCC---CeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQN---GDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLV 454 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~---~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 454 (711)
++|+..+.||+|+||.||+|.+... ...||+|++.... ....++.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 5688899999999999999998643 4579999887533 2345788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCC
Q 043702 455 YDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~ 534 (711)
|||+++++|.+++......+++..+++++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 999999999999987667899999999999999999999997 99999999999999999999999999998775222
Q ss_pred C-CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhH
Q 043702 535 S-PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLT 612 (711)
Q Consensus 535 ~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 612 (711)
. .......++..|+|||.+....++.++||||||+++|||++ |..||..... ..+.+.. ..+.
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~--------~~~~~~~----~~~~--- 225 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN--------QDVIKAV----EDGY--- 225 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH--------HHHHHHH----HcCC---
Confidence 2 11222335678999999998899999999999999999998 9999854321 1111111 1110
Q ss_pred hhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 613 AADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 613 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
...........+.+++.+||+.+|++||++++|++.|+.
T Consensus 226 ------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 226 ------RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 001112234567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=331.41 Aligned_cols=252 Identities=29% Similarity=0.429 Sum_probs=204.6
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCC
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMP 459 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 459 (711)
++|...+.||+|+||.||+|.... +..+|+|.+.......+++.+|+.++++++||||++++++|...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 357778899999999999998753 5569999987655556789999999999999999999999999889999999999
Q ss_pred CCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCcc
Q 043702 460 NGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDAT 539 (711)
Q Consensus 460 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 539 (711)
+|+|.+++......+++.++++++.||+.||+|||+. +++|+||||+||++++++.+||+|||+++...........
T Consensus 83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05113 83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV 159 (256)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeecC
Confidence 9999999977666799999999999999999999987 9999999999999999999999999999876443322222
Q ss_pred cccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhc
Q 043702 540 VAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARL 618 (711)
Q Consensus 540 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 618 (711)
...++..|+|||.+....++.++|||||||++|||++ |+.||..... ....+ .. ..+...
T Consensus 160 ~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--------~~~~~---~~-~~~~~~------- 220 (256)
T cd05113 160 GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN--------SETVE---KV-SQGLRL------- 220 (256)
T ss_pred CCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH--------HHHHH---HH-hcCCCC-------
Confidence 2335678999999988889999999999999999999 9999864321 01111 11 111100
Q ss_pred cCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 043702 619 EGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLV 656 (711)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 656 (711)
.........+.+++.+||+.+|.+||++.++++.|+
T Consensus 221 --~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 --YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred --CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 001112356788999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=344.90 Aligned_cols=241 Identities=24% Similarity=0.311 Sum_probs=198.0
Q ss_pred ceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCCCC
Q 043702 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNG 461 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 461 (711)
+.||+|+||.||+++...+|+.||+|++... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999999889999999998752 233456788999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCcccc
Q 043702 462 SLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVA 541 (711)
Q Consensus 462 sL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 541 (711)
+|.+++.. ...+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~ 155 (323)
T cd05571 81 ELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTF 155 (323)
T ss_pred cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccccce
Confidence 99999865 45789999999999999999999998 99999999999999999999999999997543222 223345
Q ss_pred cCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccCC
Q 043702 542 AGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQ 621 (711)
Q Consensus 542 ~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 621 (711)
+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.. ....+. . .
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--------~~~~~----~~~~~~------~----~ 213 (323)
T cd05571 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFE----LILMEE------I----R 213 (323)
T ss_pred ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH--------HHHHH----HHHcCC------C----C
Confidence 799999999999999999999999999999999999999964321 01111 111111 0 1
Q ss_pred CcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 043702 622 FDEAEMRRVLLVGLACSHPDPLARP-----TMRGVVQ 653 (711)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVl~ 653 (711)
++......+.+++.+||+.||++|| ++.++++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 1222334577888999999999999 7999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=337.32 Aligned_cols=263 Identities=21% Similarity=0.295 Sum_probs=201.6
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
.++|+..+.||+|+||.||+|+...+++.||+|++.... .....+.+|+++++.++||||+++++++..+...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 367899999999999999999998889999999987533 233467899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCC
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP 536 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~ 536 (711)
|++ ++|.+++......+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...... .
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 158 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-H 158 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-c
Confidence 995 688888877667799999999999999999999998 99999999999999999999999999997653322 1
Q ss_pred CcccccCCCcccChhhhcc-CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCch-----
Q 043702 537 DATVAAGTMGYLAPEYLLT-GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRL----- 610 (711)
Q Consensus 537 ~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~----- 610 (711)
......|++.|+|||++.+ ..++.++|||||||++|||++|+.||...... ....+...........
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~ 231 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI-------QDQLERIFLVLGTPNEDTWPG 231 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH-------HHHHHHHHHHhCCCChhhccc
Confidence 2233568999999999875 45788999999999999999999999753210 0111111000000000
Q ss_pred -hH--hhhh-hcc--CCCcH-------HHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 611 -LT--AADA-RLE--GQFDE-------AEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 611 -~~--~~d~-~l~--~~~~~-------~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
.. ..++ ... ..... .....+.+++.+|++.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 232 VHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00 0000 000 00000 01235678889999999999999999987
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=320.48 Aligned_cols=197 Identities=26% Similarity=0.432 Sum_probs=181.4
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC----CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS----QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
++|+..+.||.|+||+|.+++++.+|..+|+|++...+ ...+...+|..+|+.+.||+++++.+-|.+.+.++|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 35777899999999999999999999999999987633 33456778999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
||+++|.|..+|++ .++++....+-++.||+.||+|||+. .|++|||||+|||||.+|.+||+|||+|+.+...
T Consensus 124 eyv~GGElFS~Lrk-~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-- 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRK-SGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-- 197 (355)
T ss_pred eccCCccHHHHHHh-cCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc--
Confidence 99999999999964 56799999999999999999999998 9999999999999999999999999999987542
Q ss_pred CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccc
Q 043702 536 PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKE 584 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~ 584 (711)
+...||||.|+|||++....+..++|-|||||++|||+.|.+||...
T Consensus 198 --T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~ 244 (355)
T KOG0616|consen 198 --TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDD 244 (355)
T ss_pred --EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCC
Confidence 56789999999999999999999999999999999999999999765
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=340.43 Aligned_cols=245 Identities=21% Similarity=0.258 Sum_probs=202.4
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC----CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS----QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
++|+..+.||+|+||.||+|....+++.||+|++.... ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888999999999999999998889999999986422 23456889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
||+++|+|.+++.. ...+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-- 154 (291)
T cd05612 81 EYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-- 154 (291)
T ss_pred eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence 99999999999965 45689999999999999999999997 9999999999999999999999999999866432
Q ss_pred CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhh
Q 043702 536 PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 615 (711)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||..... .+.... ...+..
T Consensus 155 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-----------~~~~~~-i~~~~~----- 215 (291)
T cd05612 155 --TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP-----------FGIYEK-ILAGKL----- 215 (291)
T ss_pred --cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----------HHHHHH-HHhCCc-----
Confidence 2235699999999999988899999999999999999999999965321 111111 111110
Q ss_pred hhccCCCcHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHHH
Q 043702 616 ARLEGQFDEAEMRRVLLVGLACSHPDPLARPT-----MRGVVQM 654 (711)
Q Consensus 616 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~eVl~~ 654 (711)
.++......+.+++.+||+.||.+||+ ++++++.
T Consensus 216 -----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 -----EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred -----CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 111122345778899999999999995 8888764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=344.99 Aligned_cols=245 Identities=22% Similarity=0.319 Sum_probs=202.6
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
++|...+.||+|+||.||+|++..+++.||+|++... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 4688899999999999999999988999999998652 233467889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
||+++|+|.+++.. ...+++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 98 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~- 172 (329)
T PTZ00263 98 EFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT- 172 (329)
T ss_pred cCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-
Confidence 99999999999965 45688999999999999999999997 99999999999999999999999999998764322
Q ss_pred CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhh
Q 043702 536 PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 615 (711)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+. ......+.+
T Consensus 173 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-----------~~~-~~~i~~~~~----- 232 (329)
T PTZ00263 173 ---FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP-----------FRI-YEKILAGRL----- 232 (329)
T ss_pred ---ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH-----------HHH-HHHHhcCCc-----
Confidence 235799999999999999999999999999999999999999964321 011 111111111
Q ss_pred hhccCCCcHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHHH
Q 043702 616 ARLEGQFDEAEMRRVLLVGLACSHPDPLARPT-----MRGVVQM 654 (711)
Q Consensus 616 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~eVl~~ 654 (711)
.++.....++.+++.+||+.||.+||+ ++++++.
T Consensus 233 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 233 -----KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred -----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 011112245678899999999999997 6777753
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=342.61 Aligned_cols=253 Identities=23% Similarity=0.340 Sum_probs=208.7
Q ss_pred HhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC----CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEE
Q 043702 378 ATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS----QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILL 453 (711)
Q Consensus 378 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 453 (711)
..++|+....||+|+||.||+|+.+.+|..+|+|++++.. .+.+.++.|-.+|...++|+||+|+-.|++...+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4578999999999999999999999999999999998743 445678899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCC-
Q 043702 454 VYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEH- 532 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~- 532 (711)
||||+|||++..+|.. .+.|++...+.++.+++.|+.-||+. |+|||||||+|+|||..|.+||+||||+.-+..
T Consensus 219 iMEylPGGD~mTLL~~-~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMR-KDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEEecCCccHHHHHHh-cCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 9999999999999964 56799999999999999999999998 999999999999999999999999999953211
Q ss_pred ---------------------CCCC-----Cc-------------------ccccCCCcccChhhhccCCCCccccchhH
Q 043702 533 ---------------------DKSP-----DA-------------------TVAAGTMGYLAPEYLLTGRATEKTDVFSY 567 (711)
Q Consensus 533 ---------------------~~~~-----~~-------------------~~~~gt~~y~APE~~~~~~~s~ksDVwSf 567 (711)
.... .. ...+|||.|||||++.+..|+..+|.||+
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 0000 00 12369999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCC
Q 043702 568 GAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPT 647 (711)
Q Consensus 568 Gvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 647 (711)
|||+||||.|.+||..+.+ .+....+..|...+.... ......+..+||.+|+. ||++|.-
T Consensus 375 G~ImyEmLvGyPPF~s~tp----~~T~rkI~nwr~~l~fP~--------------~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETP----QETYRKIVNWRETLKFPE--------------EVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhhhccCCC--------------cCcccHHHHHHHHHHhc-CHHHhcC
Confidence 9999999999999987654 234455666653322211 11122566788888888 9999986
Q ss_pred ---HHHHHH
Q 043702 648 ---MRGVVQ 653 (711)
Q Consensus 648 ---~~eVl~ 653 (711)
++||-+
T Consensus 436 ~~G~~EIK~ 444 (550)
T KOG0605|consen 436 SKGAEEIKK 444 (550)
T ss_pred cccHHHHhc
Confidence 555544
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=343.18 Aligned_cols=247 Identities=27% Similarity=0.389 Sum_probs=209.2
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEccc--CCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcC
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSH--NSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
.|+..+.||+|.||.||||.+..+++.||+|++.. .+.+.+++.+|+.+|.+++++||.+.+|.+..+..++++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 46667889999999999999999999999999876 4455678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCc
Q 043702 459 PNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDA 538 (711)
Q Consensus 459 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 538 (711)
.+|++.+.|.. ...+.+.....|+++++.||.|||.+ +.+|||||+.|||+..++.+||+|||.+..+.......
T Consensus 94 ~gGsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr- 168 (467)
T KOG0201|consen 94 GGGSVLDLLKS-GNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR- 168 (467)
T ss_pred cCcchhhhhcc-CCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhcc-
Confidence 99999998843 34457888888999999999999998 99999999999999999999999999998887655444
Q ss_pred ccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhc
Q 043702 539 TVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARL 618 (711)
Q Consensus 539 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 618 (711)
...+||+.|||||++....|+.|+||||||++.+||++|.+|+.+..+. +.+ -.+.+..-|.+
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm-------rvl----------flIpk~~PP~L 231 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM-------RVL----------FLIPKSAPPRL 231 (467)
T ss_pred ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc-------eEE----------EeccCCCCCcc
Confidence 5678999999999999889999999999999999999999999764320 000 01122223333
Q ss_pred cCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 619 EGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
.+ .....+.+++..||+.||+.||++.++++
T Consensus 232 ~~----~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 232 DG----DFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred cc----ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 33 33455778889999999999999999986
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=341.03 Aligned_cols=198 Identities=31% Similarity=0.439 Sum_probs=176.7
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEc
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
++|+..+.||+|+||.||++++..++..+|+|++.... ...+.+.+|++++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 57889999999999999999999899999999987532 2245789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC
Q 043702 458 MPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD 537 (711)
Q Consensus 458 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 537 (711)
+++|+|.+++.. ...+++..+..++.|++.||.|||+. .+|+||||||+|||+++++.+||+|||+++......
T Consensus 85 ~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 158 (331)
T cd06649 85 MDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 158 (331)
T ss_pred CCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc---
Confidence 999999999865 34689999999999999999999985 369999999999999999999999999998654322
Q ss_pred cccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCcc
Q 043702 538 ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEK 583 (711)
Q Consensus 538 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~ 583 (711)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 2334689999999999998999999999999999999999999964
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=328.64 Aligned_cols=247 Identities=28% Similarity=0.421 Sum_probs=199.7
Q ss_pred ceeecCCceEEEEEEeCCCCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCCCCCH
Q 043702 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSL 463 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 463 (711)
+.||+|+||.||+|++..+++.+|+|.+.... .....+.+|++++++++||||++++++|...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999998889999999876432 2346789999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC-ccccc
Q 043702 464 DKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD-ATVAA 542 (711)
Q Consensus 464 ~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~-~~~~~ 542 (711)
.+++......+++..++.++.|+++||.|||+. +++||||||+|||++.++.+||+|||+++......... .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 999976666799999999999999999999987 99999999999999999999999999998654321111 11112
Q ss_pred CCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccCC
Q 043702 543 GTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQ 621 (711)
Q Consensus 543 gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 621 (711)
.+..|+|||.+..+.++.++|||||||++|||++ |..||..... ... .. .........
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~--------~~~----~~---------~~~~~~~~~ 216 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN--------QQT----RE---------AIEQGVRLP 216 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH--------HHH----HH---------HHHcCCCCC
Confidence 3457999999999999999999999999999998 8888854321 000 01 111111111
Q ss_pred CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 043702 622 FDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLV 656 (711)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 656 (711)
........+.+++.+|++.+|++||++.+|+++|+
T Consensus 217 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 217 CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 22233456788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=333.48 Aligned_cols=256 Identities=29% Similarity=0.429 Sum_probs=202.6
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCe----EEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGD----IIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILL 453 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~----~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 453 (711)
+.|+..+.||+|+||.||+|.+..+++ .+++|.+.... ....++..|+..+++++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 356778899999999999999866665 47778775422 23356788888999999999999999885 456789
Q ss_pred EEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCC
Q 043702 454 VYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHD 533 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~ 533 (711)
++||+++|+|.+++......+++..+..++.||+.||.|||+. +++||||||+|||+++++.+||+|||+++.....
T Consensus 86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 9999999999999987777899999999999999999999987 9999999999999999999999999999876433
Q ss_pred CC-CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchh
Q 043702 534 KS-PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLL 611 (711)
Q Consensus 534 ~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 611 (711)
.. .......++..|+|||.+..+.++.++|||||||++|||++ |+.||..... ..+.+ ....+...
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--------~~~~~----~~~~~~~~ 230 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP--------HEVPD----LLEKGERL 230 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHH----HHHCCCcC
Confidence 22 22233457789999999999999999999999999999998 9999865321 11111 11221111
Q ss_pred HhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC
Q 043702 612 TAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEAE 660 (711)
Q Consensus 612 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 660 (711)
. .+ ......+.+++.+||..||.+||++.|+++.|.....
T Consensus 231 ~--~~-------~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 231 A--QP-------QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred C--CC-------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 1 01 1122346778899999999999999999999976543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=339.42 Aligned_cols=239 Identities=25% Similarity=0.303 Sum_probs=195.2
Q ss_pred eecCCceEEEEEEeCCCCeEEEEEEccc----CCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCCCCCH
Q 043702 388 IGHGAFGTVYKGILPQNGDIIAVKRCSH----NSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSL 463 (711)
Q Consensus 388 LG~G~fg~Vy~~~~~~~~~~vavK~~~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 463 (711)
||+|+||.||+|+...+++.||+|++.. .......+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 7999999999999988899999999864 233446788999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCcccccC
Q 043702 464 DKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAG 543 (711)
Q Consensus 464 ~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~g 543 (711)
.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ......+|
T Consensus 81 ~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~g 155 (312)
T cd05585 81 FHHLQR-EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCG 155 (312)
T ss_pred HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccC
Confidence 999965 45689999999999999999999997 99999999999999999999999999998643222 22334579
Q ss_pred CCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccCCCc
Q 043702 544 TMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFD 623 (711)
Q Consensus 544 t~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 623 (711)
|+.|+|||++.+..++.++|||||||++|||++|+.||..... .+........ . ..++
T Consensus 156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-----------~~~~~~~~~~-~----------~~~~ 213 (312)
T cd05585 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-----------NEMYRKILQE-P----------LRFP 213 (312)
T ss_pred CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-----------HHHHHHHHcC-C----------CCCC
Confidence 9999999999999999999999999999999999999964311 1111111111 0 0111
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCCC---HHHHHH
Q 043702 624 EAEMRRVLLVGLACSHPDPLARPT---MRGVVQ 653 (711)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPs---~~eVl~ 653 (711)
......+.+++.+||+.||.+||+ +.|+++
T Consensus 214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 223345678889999999999985 566654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=344.93 Aligned_cols=252 Identities=24% Similarity=0.309 Sum_probs=204.9
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC----CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS----QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
++|...+.||+|+||+||+++...+++.||+|++.... ...+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999999899999999987532 24456889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
||+++|+|.+++......+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 99999999999987667899999999999999999999998 999999999999999999999999999987755443
Q ss_pred CCcccccCCCcccChhhhc------cCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCc
Q 043702 536 PDATVAAGTMGYLAPEYLL------TGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGR 609 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~------~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 609 (711)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||..... ............
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-----------~~~~~~i~~~~~ 226 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS-----------AKTYNNIMNFQR 226 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH-----------HHHHHHHHcCCC
Confidence 3334457999999999987 45678999999999999999999999965321 111111111111
Q ss_pred hhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 610 LLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 610 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
..... ........+.+++..|++ +|.+||++.++++
T Consensus 227 ~~~~~-------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 227 FLKFP-------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred ccCCC-------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 11000 011123456678888997 9999999999986
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=332.97 Aligned_cols=273 Identities=29% Similarity=0.390 Sum_probs=204.7
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHh--cCCCCeeeeeeeeeecC----eEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGT--LRHRNLVRLQGWCHEKG----EILL 453 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~~~~----~~~l 453 (711)
......++||+|.||.||||.+ .++.||||++.. ++++.|++|-+|++. ++|+||++++++-.... +++|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~--~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPE--QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhc--cCceeEEEecCH--HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 3455677899999999999999 569999999874 456788888888776 56999999999876554 8999
Q ss_pred EEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhcc------CCCeeeccCCCCceEEcCCCcEEEeecCCc
Q 043702 454 VYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQEC------ENQVIHRDVKTSNIMLDEGFNARLGDFGLA 527 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~------~~~ivHrDlkp~NILld~~~~vkL~DFGla 527 (711)
|+||.++|+|.+||.. ..++|....+|+..+++||+|||+.. .++|+|||||++||||..|+++.|+|||||
T Consensus 286 Vt~fh~kGsL~dyL~~--ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKA--NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred EeeeccCCcHHHHHHh--ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 9999999999999954 56999999999999999999999863 468999999999999999999999999999
Q ss_pred eecCCCCCC-CcccccCCCcccChhhhccCC-CC-----ccccchhHHHHHHHHHhCCCCCccc-ccccc-----ccccc
Q 043702 528 RQVEHDKSP-DATVAAGTMGYLAPEYLLTGR-AT-----EKTDVFSYGAVVLEVASGRRPIEKE-ITGVG-----KVGVA 594 (711)
Q Consensus 528 ~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~-~s-----~ksDVwSfGvll~elltG~~P~~~~-~~~~~-----~~~~~ 594 (711)
..+...... +....+||.+|||||++.+.. +. .+.||||+|.|||||++...-++.. .+... ..+..
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h 443 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH 443 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence 988755432 334478999999999997653 22 3689999999999999965544311 11000 01111
Q ss_pred cchHHHHHHh-hhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCC
Q 043702 595 SNLVEWVWSL-HREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEAEVPI 663 (711)
Q Consensus 595 ~~l~~~~~~~-~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~~p~ 663 (711)
..+ +-++.+ .++..-..+.+.- .....+.-+.+.+..||++||+.|.|+.=|-+.+.....+..
T Consensus 444 Pt~-e~mq~~VV~kK~RP~~p~~W----~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 444 PTL-EEMQELVVRKKQRPKIPDAW----RKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred CCH-HHHHHHHHhhccCCCChhhh----hcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 111 112221 1111111111111 112446778889999999999999999999998877655544
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=330.85 Aligned_cols=254 Identities=25% Similarity=0.421 Sum_probs=209.0
Q ss_pred HhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC-ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 378 ATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ-GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 378 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
...+|+..++||.|+||.||+|.... +..+++|.+..... ...++.+|+++++.++|+||+++++++...+..++|||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 34568888999999999999999976 88999999876443 46788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 457 LMPNGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 457 y~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
|+++++|.+++.... ..+++.++++++.|++.||+|||+. +++||||||+||++++++.+||+|||++........
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 999999999997643 4689999999999999999999987 999999999999999999999999999987644322
Q ss_pred CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhh
Q 043702 536 PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 614 (711)
. .....++..|+|||.+....++.++||||||++++||++ |+.||..... ........
T Consensus 160 ~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~--------~~~~~~~~------------ 218 (261)
T cd05148 160 L-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN--------HEVYDQIT------------ 218 (261)
T ss_pred c-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH--------HHHHHHHH------------
Confidence 1 223346778999999998899999999999999999998 8999865321 11111111
Q ss_pred hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 615 DARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 615 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
..............+.+++.+||+.||.+||+++++++.|+.
T Consensus 219 -~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 219 -AGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred -hCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 111111122334567889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=341.00 Aligned_cols=246 Identities=25% Similarity=0.402 Sum_probs=193.5
Q ss_pred CcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC--ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCC
Q 043702 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ--GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMP 459 (711)
Q Consensus 382 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 459 (711)
|+..++||+|+||.||+|++..+++.||||++..... ..+.+.+|+++++.++|+||+++++++...+.+++||||++
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 4456789999999999999988899999999865332 24678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCcc
Q 043702 460 NGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDAT 539 (711)
Q Consensus 460 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 539 (711)
+|+|... ....+..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.+..... ...
T Consensus 156 ~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~ 226 (353)
T PLN00034 156 GGSLEGT-----HIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-PCN 226 (353)
T ss_pred CCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc-ccc
Confidence 9998653 2356778889999999999999997 999999999999999999999999999987653322 123
Q ss_pred cccCCCcccChhhhcc-----CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhh
Q 043702 540 VAAGTMGYLAPEYLLT-----GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614 (711)
Q Consensus 540 ~~~gt~~y~APE~~~~-----~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 614 (711)
...||..|+|||.+.. ...+.++|||||||++|||++|+.||..... .+|.......
T Consensus 227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~-----------~~~~~~~~~~------- 288 (353)
T PLN00034 227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ-----------GDWASLMCAI------- 288 (353)
T ss_pred ccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-----------ccHHHHHHHH-------
Confidence 3569999999998743 2345689999999999999999999973211 1111110000
Q ss_pred hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 615 DARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 615 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
...............+.+++.+||+.||++||++.|+++.
T Consensus 289 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 289 CMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred hccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000011122234567889999999999999999999985
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=319.19 Aligned_cols=280 Identities=23% Similarity=0.301 Sum_probs=213.4
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCCh---hhhHHHHHHHHhcCCCCeeeeeeeeee--cCeEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGK---DEFLSELSIIGTLRHRNLVRLQGWCHE--KGEILLV 454 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV 454 (711)
+.|+..+.|++|.||.||+|+++.+++.||+|+++...... -.-++||.+|.+++|||||.+..+... -+..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 45777889999999999999999999999999998654221 245799999999999999999888754 3569999
Q ss_pred EEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCC
Q 043702 455 YDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~ 534 (711)
||||+. +|..++....+++...++..+..|+++|++|||.. .|+|||||++|+|+...|.+||+||||||.+....
T Consensus 156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 999987 99999988888999999999999999999999997 99999999999999999999999999999987654
Q ss_pred CCCcccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhc------
Q 043702 535 SPDATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHRE------ 607 (711)
Q Consensus 535 ~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~------ 607 (711)
. ..+..+-|.+|+|||.+.+. .|+...|+||+|||+.||+++++-|.....- ..++-+..+...
T Consensus 232 k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~--------dQl~~If~llGtPte~iw 302 (419)
T KOG0663|consen 232 K-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEI--------DQLDKIFKLLGTPSEAIW 302 (419)
T ss_pred c-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchH--------HHHHHHHHHhCCCccccC
Confidence 3 35566789999999999876 5899999999999999999999988654321 111111111100
Q ss_pred --CchhHhh---------hhhccCCCcHH-HHHHHHHHHHhcCCCCCCCCCCHHHHHHHH-hCCCCCCCCCCCCCCcc
Q 043702 608 --GRLLTAA---------DARLEGQFDEA-EMRRVLLVGLACSHPDPLARPTMRGVVQML-VGEAEVPIVPRAKPSMT 672 (711)
Q Consensus 608 --~~~~~~~---------d~~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L-~~~~~~p~~p~~~p~~~ 672 (711)
-.....+ -..+...+... ..+.-++|+...+..||.+|-|+.|.++.= -.+.+.|..|-..|.+.
T Consensus 303 pg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~Pt~P 380 (419)
T KOG0663|consen 303 PGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMFPTWP 380 (419)
T ss_pred CCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhcCCCc
Confidence 0000000 01111112111 224556777888999999999999998742 22345555555555443
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=346.14 Aligned_cols=252 Identities=24% Similarity=0.303 Sum_probs=205.1
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
++|...+.||+|+||+||+|+...+++.||+|++... ......+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 3688899999999999999999888999999998752 234567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCC-
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK- 534 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~- 534 (711)
||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 999999999999765 6799999999999999999999997 99999999999999999999999999998765433
Q ss_pred ---------------------------CCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCcccccc
Q 043702 535 ---------------------------SPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITG 587 (711)
Q Consensus 535 ---------------------------~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~ 587 (711)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~- 235 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL- 235 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH-
Confidence 1122345699999999999999999999999999999999999999965321
Q ss_pred ccccccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCC-HHHHHHH
Q 043702 588 VGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPT-MRGVVQM 654 (711)
Q Consensus 588 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~eVl~~ 654 (711)
.+......... ..+...........+.+++.+|++ ||.+||+ ++++++.
T Consensus 236 ----------~~~~~~i~~~~-------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 236 ----------QETYNKIINWK-------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred ----------HHHHHHHhccC-------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 11111111100 000000001123556778889997 9999999 9999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=336.89 Aligned_cols=261 Identities=24% Similarity=0.355 Sum_probs=197.6
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC---CCChhhhHHHHHHHHhcCCCCeeeeeeeeeec-----CeEE
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN---SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEK-----GEIL 452 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~~ 452 (711)
+|+..++||+|+||.||+|+...++..||||++... ......+.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 478889999999999999999888999999998642 23345688999999999999999999988543 3589
Q ss_pred EEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCC
Q 043702 453 LVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEH 532 (711)
Q Consensus 453 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~ 532 (711)
+|||||. ++|.+++.. ...+++..+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 lv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 81 VVFELME-SDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEecCC-CCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 9999995 689988854 34699999999999999999999998 999999999999999999999999999986533
Q ss_pred CCCC--CcccccCCCcccChhhhcc--CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHh----
Q 043702 533 DKSP--DATVAAGTMGYLAPEYLLT--GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSL---- 604 (711)
Q Consensus 533 ~~~~--~~~~~~gt~~y~APE~~~~--~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~---- 604 (711)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+...
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~--------~~~~~~~~~~~~~~ 227 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV--------VHQLDLITDLLGTP 227 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh--------HHHHHHHHHHhCCC
Confidence 2211 1234569999999999876 6789999999999999999999999965321 0001111000
Q ss_pred -------hhcCchhHhh---hhhccCCCc---HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 605 -------HREGRLLTAA---DARLEGQFD---EAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 605 -------~~~~~~~~~~---d~~l~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.......... .+.....+. ......+.+++.+||+.||++||+++|+++.
T Consensus 228 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 228 SPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred CHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000000 000000000 0112456789999999999999999999973
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=325.84 Aligned_cols=252 Identities=29% Similarity=0.460 Sum_probs=204.3
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCC
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMP 459 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 459 (711)
++|+..++||+|++|.||+|... .+..+|+|.+.......+.+.+|+.++++++|+|++++++++. ....+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 46788899999999999999875 4667999998876666678999999999999999999999885 456899999999
Q ss_pred CCCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCc
Q 043702 460 NGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDA 538 (711)
Q Consensus 460 ~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 538 (711)
+++|.+++.... ..+++.++++++.|++.||.|||+. +++||||||+||++++++.+||+|||++..+........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05070 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccccc
Confidence 999999997543 4589999999999999999999997 999999999999999999999999999987654332222
Q ss_pred ccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhh
Q 043702 539 TVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADAR 617 (711)
Q Consensus 539 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 617 (711)
....++..|+|||.+....++.++||||||+++|||++ |+.||..... ....+. ... .
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--------~~~~~~---~~~----------~ 219 (260)
T cd05070 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN--------REVLEQ---VER----------G 219 (260)
T ss_pred cCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHH---HHc----------C
Confidence 22345678999999988889999999999999999999 8899864321 111111 111 1
Q ss_pred ccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 618 LEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 618 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
............+.+++.+|++.+|.+|||++++.+.|+.
T Consensus 220 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 220 YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1111122334568889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=326.95 Aligned_cols=252 Identities=27% Similarity=0.426 Sum_probs=204.5
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCC
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMP 459 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 459 (711)
++|++.++||+|+||.||+|++..+ ..||+|++.......+++.+|++++++++|+||+++++.+. .+..++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 4688899999999999999988654 56999998875555678999999999999999999999875 456899999999
Q ss_pred CCCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCc
Q 043702 460 NGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDA 538 (711)
Q Consensus 460 ~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 538 (711)
+|+|.+++.... ..+++..+..++.|+++||+|||+. +++||||||+||++++++.+||+|||+++.+........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~ 160 (262)
T cd05071 84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 160 (262)
T ss_pred CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccccc
Confidence 999999997543 4589999999999999999999997 999999999999999999999999999987654432222
Q ss_pred ccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhh
Q 043702 539 TVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADAR 617 (711)
Q Consensus 539 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 617 (711)
....++..|+|||...+..++.++|||||||++|||++ |+.||..... .. .......+
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~--------~~----~~~~~~~~--------- 219 (262)
T cd05071 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------RE----VLDQVERG--------- 219 (262)
T ss_pred cCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh--------HH----HHHHHhcC---------
Confidence 23346778999999998899999999999999999999 8888864321 00 01111111
Q ss_pred ccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 618 LEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 618 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
.......+....+.+++.+|++.+|++||++.++++.|+.
T Consensus 220 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 220 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 0011123345667899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=345.91 Aligned_cols=265 Identities=19% Similarity=0.191 Sum_probs=201.1
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCC
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMP 459 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 459 (711)
.+|...+.||+|+||.||++.+..+++.||+|+.. .+.+.+|++++++|+||||+++++++......++|+|++.
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~ 166 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK 166 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence 57999999999999999999999999999999753 3457899999999999999999999999999999999995
Q ss_pred CCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCcc
Q 043702 460 NGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDAT 539 (711)
Q Consensus 460 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 539 (711)
++|..++.. ...+++..++.++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++...........
T Consensus 167 -~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~ 241 (391)
T PHA03212 167 -TDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241 (391)
T ss_pred -CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccc
Confidence 689888854 35689999999999999999999997 9999999999999999999999999999764332222334
Q ss_pred cccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhh---------hcCch
Q 043702 540 VAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLH---------REGRL 610 (711)
Q Consensus 540 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~---------~~~~~ 610 (711)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...............+........ ....+
T Consensus 242 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~ 321 (391)
T PHA03212 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANL 321 (391)
T ss_pred cccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHH
Confidence 457999999999999999999999999999999999999887532211000000011111000000 00000
Q ss_pred hHhh---hhh------ccCCC--cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 611 LTAA---DAR------LEGQF--DEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 611 ~~~~---d~~------l~~~~--~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.... ... ..... ..+....+.+|+.+||+.||.+|||++|+++.
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 322 DEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred HHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000 000 00000 01224467889999999999999999999963
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=323.74 Aligned_cols=249 Identities=25% Similarity=0.407 Sum_probs=206.7
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC---CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEc
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN---SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
+|+..+.||+|++|.||+|....+++.|++|.+... ....+++.+|++++++++|||++++++++.+++..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 477789999999999999999888999999987642 34456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhC-CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCC
Q 043702 458 MPNGSLDKALFEA-RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP 536 (711)
Q Consensus 458 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~ 536 (711)
+++++|.+++... ...+++..+.+++.|++.||.|||+. +++||||||+||++++++.+||+|||+++........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 9999999999764 45799999999999999999999987 9999999999999999999999999999876543322
Q ss_pred CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhh
Q 043702 537 DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADA 616 (711)
Q Consensus 537 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 616 (711)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||..... .+..... ..+.
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----------~~~~~~~-~~~~------- 217 (256)
T cd08529 158 -ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ-----------GALILKI-IRGV------- 217 (256)
T ss_pred -hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-----------HHHHHHH-HcCC-------
Confidence 2334688999999999999999999999999999999999999965321 0101111 1111
Q ss_pred hccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 617 RLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 617 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
...........+.+++.+||+.+|++||++.++++.
T Consensus 218 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 218 --FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred --CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 111122334568889999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=339.92 Aligned_cols=242 Identities=23% Similarity=0.285 Sum_probs=197.8
Q ss_pred ceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCCCC
Q 043702 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNG 461 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 461 (711)
+.||+|+||.||++....+++.||+|++... ......+.+|+++++.++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999999889999999998752 233457889999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCcccc
Q 043702 462 SLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVA 541 (711)
Q Consensus 462 sL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 541 (711)
+|..++.. ...+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~ 155 (328)
T cd05593 81 ELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKTF 155 (328)
T ss_pred CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cccccc
Confidence 99988854 45689999999999999999999997 99999999999999999999999999997643222 122345
Q ss_pred cCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccCC
Q 043702 542 AGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQ 621 (711)
Q Consensus 542 ~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 621 (711)
+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.... ...+ +..+
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-----------~~~~~~-~~~~------~~~~--- 214 (328)
T cd05593 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----------EKLFEL-ILME------DIKF--- 214 (328)
T ss_pred cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH-----------HHHHHH-hccC------CccC---
Confidence 799999999999998999999999999999999999999964321 011111 1000 0111
Q ss_pred CcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHH
Q 043702 622 FDEAEMRRVLLVGLACSHPDPLARP-----TMRGVVQM 654 (711)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVl~~ 654 (711)
+......+.+++.+||+.||.+|| ++.|+++.
T Consensus 215 -p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 215 -PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred -CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 112234567888999999999997 89999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=344.60 Aligned_cols=254 Identities=26% Similarity=0.409 Sum_probs=216.0
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcC
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
..+....++||-|.||.||.|+++.....||||.++.+..+.++|++|..+|+.++|||+|+|+|+|..+..+|||.|||
T Consensus 266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred chheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 34567788999999999999999988899999999998899999999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC
Q 043702 459 PNGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD 537 (711)
Q Consensus 459 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 537 (711)
.+|+|.+||++.. ..++--..+.++.||+.||+||..+ ++|||||.++|+|+.++..||++||||+|++..+....
T Consensus 346 ~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA 422 (1157)
T KOG4278|consen 346 CYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA 422 (1157)
T ss_pred cCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCceec
Confidence 9999999998755 4577778899999999999999998 99999999999999999999999999999987654332
Q ss_pred cccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhhhh
Q 043702 538 ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADA 616 (711)
Q Consensus 538 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 616 (711)
.....-...|.|||.+....++.|+|||+|||+|||+.| |..||...+. .-++.+++.|
T Consensus 423 HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl------------SqVY~LLEkg-------- 482 (1157)
T KOG4278|consen 423 HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------------SQVYGLLEKG-------- 482 (1157)
T ss_pred ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH------------HHHHHHHhcc--------
Confidence 222334678999999999999999999999999999999 8888865321 1123333332
Q ss_pred hccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 043702 617 RLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLV 656 (711)
Q Consensus 617 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 656 (711)
.+-+-++.+...+.+|++.||+.+|.+||+++|+-+.++
T Consensus 483 -yRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafE 521 (1157)
T KOG4278|consen 483 -YRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFE 521 (1157)
T ss_pred -ccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence 222334456678889999999999999999998877654
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=339.76 Aligned_cols=241 Identities=24% Similarity=0.307 Sum_probs=196.6
Q ss_pred ceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCCCC
Q 043702 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNG 461 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 461 (711)
+.||+|+||.||+++...+|..||+|++... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999999889999999998752 233456778999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCcccc
Q 043702 462 SLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVA 541 (711)
Q Consensus 462 sL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 541 (711)
+|..++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~ 155 (323)
T cd05595 81 ELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTF 155 (323)
T ss_pred cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Cccccc
Confidence 99988864 34689999999999999999999997 99999999999999999999999999987543222 122345
Q ss_pred cCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccCC
Q 043702 542 AGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQ 621 (711)
Q Consensus 542 ~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 621 (711)
.||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..... . ...+. ..
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~--------~~~~~---~-~~~~~------~~---- 213 (323)
T cd05595 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFE---L-ILMEE------IR---- 213 (323)
T ss_pred cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH--------HHHHH---H-HhcCC------CC----
Confidence 699999999999999999999999999999999999999964321 01100 0 00000 01
Q ss_pred CcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 043702 622 FDEAEMRRVLLVGLACSHPDPLARP-----TMRGVVQ 653 (711)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVl~ 653 (711)
++......+.+++.+||+.||.+|| ++.++++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 1112234567888999999999998 8888876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=333.97 Aligned_cols=263 Identities=23% Similarity=0.322 Sum_probs=195.3
Q ss_pred cCCcccceeecCCceEEEEEEeC-CCCeEEEEEEcccCC---CChhhhHHHHHHHHhc---CCCCeeeeeeeeee-----
Q 043702 380 KCFNANRIIGHGAFGTVYKGILP-QNGDIIAVKRCSHNS---QGKDEFLSELSIIGTL---RHRNLVRLQGWCHE----- 447 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~----- 447 (711)
++|+..+.||+|+||.||+|+.. .++..||+|++.... .....+.+|+.+++.+ +||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999984 346889999886532 2234567788887776 59999999999852
Q ss_pred cCeEEEEEEcCCCCCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCC
Q 043702 448 KGEILLVYDLMPNGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGL 526 (711)
Q Consensus 448 ~~~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGl 526 (711)
...+++||||++ ++|.+++.... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456899999996 69999886543 4589999999999999999999997 999999999999999999999999999
Q ss_pred ceecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhh
Q 043702 527 ARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHR 606 (711)
Q Consensus 527 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~ 606 (711)
++..... .......||+.|+|||.+....++.++|||||||++|||++|++||...... +....+.+.... ..
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~----~~~~~i~~~~~~-~~ 229 (290)
T cd07862 157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV----DQLGKILDVIGL-PG 229 (290)
T ss_pred eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH----HHHHHHHHHhCC-CC
Confidence 9876543 2233456899999999999889999999999999999999999999754220 000011110000 00
Q ss_pred cCchh-------Hhhhhhcc---CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 607 EGRLL-------TAADARLE---GQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 607 ~~~~~-------~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
..... ....+... .....+....+.+++.+||+.||++||++.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00000 00000000 0000112345678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=347.58 Aligned_cols=257 Identities=27% Similarity=0.415 Sum_probs=204.3
Q ss_pred hcCCcccceeecCCceEEEEEEeCCC-----CeEEEEEEcccCC--CChhhhHHHHHHHHhcC-CCCeeeeeeeeeecCe
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQN-----GDIIAVKRCSHNS--QGKDEFLSELSIIGTLR-HRNLVRLQGWCHEKGE 450 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~-----~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~ 450 (711)
.++|.+.++||+|+||.||+|+.... +..||||++.... ...+.+.+|++++++++ ||||++++++|.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 45788899999999999999986432 3479999987532 23467899999999996 9999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhhCC-----------------------------------------------------------
Q 043702 451 ILLVYDLMPNGSLDKALFEAR----------------------------------------------------------- 471 (711)
Q Consensus 451 ~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------------- 471 (711)
.++|||||++|+|.++|....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 999999999999999886421
Q ss_pred ------------------------------------CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcC
Q 043702 472 ------------------------------------SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDE 515 (711)
Q Consensus 472 ------------------------------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~ 515 (711)
..+++..+.+++.|+++||+|||+. +|+||||||+|||+++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeC
Confidence 2478888999999999999999997 9999999999999999
Q ss_pred CCcEEEeecCCceecCCCCCC-CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCcccccccccccc
Q 043702 516 GFNARLGDFGLARQVEHDKSP-DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGV 593 (711)
Q Consensus 516 ~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~ 593 (711)
++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~------ 346 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD------ 346 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh------
Confidence 999999999999876433221 1222346788999999999899999999999999999997 99998643210
Q ss_pred ccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 594 ASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 594 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
..+ ......+. ...........+.+++.+||+.||++||++.+|+++|+..
T Consensus 347 -~~~----~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 347 -STF----YNKIKSGY---------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred -HHH----HHHHhcCC---------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 011 11111110 1111223345678899999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=331.10 Aligned_cols=255 Identities=26% Similarity=0.457 Sum_probs=202.6
Q ss_pred HhcCCcccceeecCCceEEEEEEeCC-----CCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCe
Q 043702 378 ATKCFNANRIIGHGAFGTVYKGILPQ-----NGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGE 450 (711)
Q Consensus 378 at~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 450 (711)
.+++|+..+.||+|+||.||+|.+.. .+..||+|++.... ....++.+|+.+++.++||||+++++++..++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45679999999999999999998642 35679999886532 234568899999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhhCC---------CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEE
Q 043702 451 ILLVYDLMPNGSLDKALFEAR---------SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARL 521 (711)
Q Consensus 451 ~~lV~Ey~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL 521 (711)
.++||||+++|+|.+++.... ..+++..++.++.|+++||.|||+. +++||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence 999999999999999986532 2367889999999999999999997 9999999999999999999999
Q ss_pred eecCCceecCCCCCC-CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHH
Q 043702 522 GDFGLARQVEHDKSP-DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVE 599 (711)
Q Consensus 522 ~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~ 599 (711)
+|||+++........ ......++..|+|||.+..+.++.++|||||||++|||++ |..||..... ....+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~--------~~~~~ 232 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN--------EQVLR 232 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHH
Confidence 999999765432221 1112345778999999998899999999999999999999 7888854311 11111
Q ss_pred HHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 043702 600 WVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLV 656 (711)
Q Consensus 600 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 656 (711)
....+... .........+.+++.+||+.+|++||++.|+++.|+
T Consensus 233 ----~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 233 ----FVMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred ----HHHcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 11111110 111223456788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=341.52 Aligned_cols=245 Identities=23% Similarity=0.321 Sum_probs=200.8
Q ss_pred cCCcccceeecCCceEEEEEEeCCCC-eEEEEEEcccC----CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNG-DIIAVKRCSHN----SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLV 454 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~-~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 454 (711)
++|...+.||+|+||.||+|.+...+ ..||+|++... ....+.+.+|+++++.++||||+++++++.+.+.+++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 46888999999999999999875544 68999988642 23456788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCC
Q 043702 455 YDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~ 534 (711)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 110 ~Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~- 184 (340)
T PTZ00426 110 LEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR- 184 (340)
T ss_pred EeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC-
Confidence 999999999999965 34689999999999999999999998 9999999999999999999999999999876432
Q ss_pred CCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhh
Q 043702 535 SPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614 (711)
Q Consensus 535 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 614 (711)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... . ........+..
T Consensus 185 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~----------~--~~~~~i~~~~~---- 245 (340)
T PTZ00426 185 ---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP----------L--LIYQKILEGII---- 245 (340)
T ss_pred ---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH----------H--HHHHHHhcCCC----
Confidence 2345799999999999988899999999999999999999999965321 0 11111111111
Q ss_pred hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHH
Q 043702 615 DARLEGQFDEAEMRRVLLVGLACSHPDPLARP-----TMRGVVQM 654 (711)
Q Consensus 615 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVl~~ 654 (711)
.++......+.+++.+|++.||.+|+ +++++++.
T Consensus 246 ------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 ------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 01111224467888999999999995 89998764
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=327.45 Aligned_cols=255 Identities=29% Similarity=0.484 Sum_probs=206.2
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCe---EEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGD---IIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLV 454 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~---~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 454 (711)
++|+..+.||+|+||.||+|++..++. .+|+|++.... ...+++.+|++++++++|+|++++.+++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 467888999999999999999865443 79999887542 2346789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCC
Q 043702 455 YDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~ 534 (711)
|||+++++|.+++......+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+|||++.......
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 999999999999987777899999999999999999999987 99999999999999999999999999998765432
Q ss_pred CCCcc--cccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchh
Q 043702 535 SPDAT--VAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLL 611 (711)
Q Consensus 535 ~~~~~--~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 611 (711)
..... ....+..|+|||++....++.++|||||||++|||++ |+.||..... .++..... .+
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-----------~~~~~~i~-~~--- 226 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-----------HEVMKAIN-DG--- 226 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-----------HHHHHHHh-cC---
Confidence 22111 1223457999999998889999999999999999998 9999854311 11111111 11
Q ss_pred HhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 612 TAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 612 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
.......+....+.+++.+||+.+|++||++.+|++.|++.
T Consensus 227 ------~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 ------FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01111122345678999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=346.50 Aligned_cols=254 Identities=23% Similarity=0.282 Sum_probs=203.0
Q ss_pred HhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEE
Q 043702 378 ATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILL 453 (711)
Q Consensus 378 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 453 (711)
..++|+..++||+|+||.||+++...+++.||+|++... ......+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 456789999999999999999999989999999998642 2334557889999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCC
Q 043702 454 VYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHD 533 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~ 533 (711)
||||+++|+|.+++.. ..++...+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 121 v~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 121 VMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999999854 3578888999999999999999997 9999999999999999999999999999876543
Q ss_pred CCCCcccccCCCcccChhhhccC----CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCc
Q 043702 534 KSPDATVAAGTMGYLAPEYLLTG----RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGR 609 (711)
Q Consensus 534 ~~~~~~~~~gt~~y~APE~~~~~----~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 609 (711)
........+||+.|+|||++... .++.++|||||||++|||++|+.||..... ............
T Consensus 196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----------~~~~~~i~~~~~ 264 (370)
T cd05596 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----------VGTYSKIMDHKN 264 (370)
T ss_pred CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH-----------HHHHHHHHcCCC
Confidence 33233345799999999998653 478999999999999999999999975321 111111111000
Q ss_pred hhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCC--CCCHHHHHHH
Q 043702 610 LLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLA--RPTMRGVVQM 654 (711)
Q Consensus 610 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~eVl~~ 654 (711)
... ... .......+.+++.+|++.+|.+ ||++.++++.
T Consensus 265 ~~~-----~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 265 SLT-----FPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred cCC-----CCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 000 000 0112356678889999999988 9999999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=342.65 Aligned_cols=266 Identities=22% Similarity=0.241 Sum_probs=200.8
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCC
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMP 459 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 459 (711)
.+|.+.+.||+|+||.||+|.+...++.||||... ...+.+|+++|++|+|+||+++++++..++..++|||++
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~- 242 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY- 242 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-
Confidence 36899999999999999999999889999999632 235678999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCC-Cc
Q 043702 460 NGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP-DA 538 (711)
Q Consensus 460 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~-~~ 538 (711)
.++|..++......++|.+++.|+.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++........ ..
T Consensus 243 ~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 319 (461)
T PHA03211 243 RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH 319 (461)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccccccc
Confidence 4799999876666799999999999999999999997 9999999999999999999999999999876443221 22
Q ss_pred ccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhh-cC--------c
Q 043702 539 TVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHR-EG--------R 609 (711)
Q Consensus 539 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~-~~--------~ 609 (711)
....||+.|+|||++.+..++.++|||||||+||||++|..|+-..............+...+..... .. +
T Consensus 320 ~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~ 399 (461)
T PHA03211 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSR 399 (461)
T ss_pred cccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchH
Confidence 34569999999999999999999999999999999999887653321110000001111111111000 00 0
Q ss_pred hhHhhhh----hccCCCc----H---HHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 610 LLTAADA----RLEGQFD----E---AEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 610 ~~~~~d~----~l~~~~~----~---~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
+...... ....... . .....+.+|+.+||+.||.+|||+.|+++.
T Consensus 400 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 400 LVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000000 0000000 0 112357789999999999999999999985
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=344.52 Aligned_cols=257 Identities=23% Similarity=0.264 Sum_probs=202.3
Q ss_pred HHHHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCe
Q 043702 375 LRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGE 450 (711)
Q Consensus 375 l~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 450 (711)
+....++|+..+.||+|+||.||++++..+++.+|+|++... ......+.+|+.+++.++||||+++++++..++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 344457899999999999999999999988999999998642 2234567899999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceec
Q 043702 451 ILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV 530 (711)
Q Consensus 451 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~ 530 (711)
+++||||+++|+|.+++.. ..+++.....++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++..
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceec
Confidence 9999999999999999854 3588999999999999999999997 9999999999999999999999999999876
Q ss_pred CCCCCCCcccccCCCcccChhhhccC----CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhh
Q 043702 531 EHDKSPDATVAAGTMGYLAPEYLLTG----RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHR 606 (711)
Q Consensus 531 ~~~~~~~~~~~~gt~~y~APE~~~~~----~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~ 606 (711)
...........+||+.|+|||++... .++.++|||||||++|||++|+.||..... .........
T Consensus 193 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~-----------~~~~~~i~~ 261 (370)
T cd05621 193 DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL-----------VGTYSKIMD 261 (370)
T ss_pred ccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH-----------HHHHHHHHh
Confidence 54333233456799999999999754 378899999999999999999999965321 111111111
Q ss_pred cCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCC--CCCHHHHHHH
Q 043702 607 EGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLA--RPTMRGVVQM 654 (711)
Q Consensus 607 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~eVl~~ 654 (711)
.... +...........+.+++..|+..++.+ ||++.|+++.
T Consensus 262 ~~~~-------~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 262 HKNS-------LNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCcc-------cCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1000 000011122345667778888755543 8999999985
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=354.94 Aligned_cols=249 Identities=22% Similarity=0.297 Sum_probs=202.0
Q ss_pred CCcccceeecCCceEEEEEEeCCC-CeEEEEEEcccCC-CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcC
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQN-GDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~-~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
.|...+.||+|++|.||+|....+ ++.||+|.+.... .....+.+|+.+++.++||||++++++|..++.+++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 488899999999999999998766 7788999765433 23346778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhh---CCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 459 PNGSLDKALFE---ARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 459 ~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
++|+|.++|.. ....+++..+..++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 99999998864 234688999999999999999999997 999999999999999999999999999987654322
Q ss_pred C-CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhh
Q 043702 536 P-DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614 (711)
Q Consensus 536 ~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 614 (711)
. .....+||++|+|||++.+..++.++|||||||++|||++|+.||..... .+....... +...
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-----------~~~~~~~~~-~~~~--- 289 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-----------REIMQQVLY-GKYD--- 289 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----------HHHHHHHHh-CCCC---
Confidence 1 23345799999999999999999999999999999999999999964311 111111111 1110
Q ss_pred hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 615 DARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 615 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
.........+.+++.+||+.||++||+++++++
T Consensus 290 ------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 ------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 011122345778899999999999999999874
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=341.45 Aligned_cols=250 Identities=24% Similarity=0.398 Sum_probs=213.3
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC---CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCe-EEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN---SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGE-ILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-~~lV~ 455 (711)
++|...+.+|+|+||.++..+++.++..+++|++... ..+.+...+|+.++++++|||||...+.+.+++. ++|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 5788899999999999999999999999999998763 3445578899999999999999999999999888 99999
Q ss_pred EcCCCCCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCC
Q 043702 456 DLMPNGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~ 534 (711)
+||+||+|.+.+.+.+ ..++++.+.+++.|++.|+.|||+. .|+|||||+.||+++.+..|||+|||+|+.+....
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 9999999999997666 5689999999999999999999987 99999999999999999999999999999887665
Q ss_pred CCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhh
Q 043702 535 SPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614 (711)
Q Consensus 535 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 614 (711)
. .....+||+.||.||++.+.+|..|+|||||||++|||++-+++|..... ...+.+..+
T Consensus 161 ~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m-----------~~Li~ki~~-------- 220 (426)
T KOG0589|consen 161 S-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM-----------SELILKINR-------- 220 (426)
T ss_pred h-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch-----------HHHHHHHhh--------
Confidence 3 23446899999999999999999999999999999999999999976432 122211111
Q ss_pred hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 615 DARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 615 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
......+.....++..++..|++.+|+.||++.+++.+
T Consensus 221 --~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 221 --GLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred --ccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 11122334445677788899999999999999999875
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=329.60 Aligned_cols=254 Identities=29% Similarity=0.425 Sum_probs=202.7
Q ss_pred hcCCcccceeecCCceEEEEEEeCC-----CCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQ-----NGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEI 451 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 451 (711)
+++|...+.||+|++|.||+|.+.. .+..||+|.+.... .....+.+|+.++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4678889999999999999999976 66789999887533 2345789999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhhCC------CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCC---cEEEe
Q 043702 452 LLVYDLMPNGSLDKALFEAR------SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGF---NARLG 522 (711)
Q Consensus 452 ~lV~Ey~~~gsL~~~l~~~~------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~---~vkL~ 522 (711)
++||||+++++|.+++...+ ..+++..+++++.||+.||+|||+. +++||||||+|||++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEec
Confidence 99999999999999997543 2589999999999999999999997 999999999999998654 59999
Q ss_pred ecCCceecCCCCCC-CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHH
Q 043702 523 DFGLARQVEHDKSP-DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEW 600 (711)
Q Consensus 523 DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~ 600 (711)
|||+++.+...... .......+..|+|||++.+..++.++|||||||++|||++ |+.||..... ..+.+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~--------~~~~~- 232 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN--------QEVME- 232 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHH-
Confidence 99999876322211 1112234568999999999999999999999999999997 9999865321 11111
Q ss_pred HHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 043702 601 VWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLV 656 (711)
Q Consensus 601 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 656 (711)
...... ...........+.+++.+|++.+|++||++.+|++.|+
T Consensus 233 --~~~~~~----------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 233 --FVTGGG----------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred --HHHcCC----------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 111111 11112223356778999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=328.52 Aligned_cols=251 Identities=25% Similarity=0.347 Sum_probs=203.2
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC----CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS----QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
+|+..++||+|+||+||++....+++.||+|++.... .....+.+|++++++++||||+++++++..++.+++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999998889999999986522 223457789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhC-CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 457 LMPNGSLDKALFEA-RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 457 y~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
|+++|+|.+++... ...+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||+++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 99999999988654 34699999999999999999999997 999999999999999999999999999987643322
Q ss_pred CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhh
Q 043702 536 PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 615 (711)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||..... ....+.+......
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~--------~~~~~~~~~~~~~-------- 219 (285)
T cd05605 158 --IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE--------KVKREEVERRVKE-------- 219 (285)
T ss_pred --cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch--------hhHHHHHHHHhhh--------
Confidence 2234689999999999988999999999999999999999999965321 0011111110100
Q ss_pred hhccCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHH
Q 043702 616 ARLEGQFDEAEMRRVLLVGLACSHPDPLARP-----TMRGVVQM 654 (711)
Q Consensus 616 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVl~~ 654 (711)
....+.......+.+++.+||+.||.+|| +++++++.
T Consensus 220 --~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 220 --DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred --cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 01112223445677899999999999999 88888663
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=328.68 Aligned_cols=253 Identities=26% Similarity=0.478 Sum_probs=204.6
Q ss_pred cCCcccceeecCCceEEEEEEeCC-----CCeEEEEEEcccCCC--ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQ-----NGDIIAVKRCSHNSQ--GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEIL 452 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 452 (711)
++|...+.||+|+||.||+|.... .+..||+|++..... ..+.+.+|+++++.++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457788999999999999998743 357899999876433 3568999999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhhCC-------------CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcE
Q 043702 453 LVYDLMPNGSLDKALFEAR-------------SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNA 519 (711)
Q Consensus 453 lV~Ey~~~gsL~~~l~~~~-------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~v 519 (711)
+||||+++++|.+++.... ..+++.++..++.|++.||.|||+. +++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 9999999999999996532 3478999999999999999999997 99999999999999999999
Q ss_pred EEeecCCceecCCCCC-CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccch
Q 043702 520 RLGDFGLARQVEHDKS-PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNL 597 (711)
Q Consensus 520 kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l 597 (711)
||+|||+++....... .......+++.|+|||.+..+.++.++|||||||++|||++ |+.||..... ...
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~--------~~~ 233 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN--------EEV 233 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH--------HHH
Confidence 9999999986543221 11223346788999999999999999999999999999998 9999864321 111
Q ss_pred HHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 043702 598 VEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLV 656 (711)
Q Consensus 598 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 656 (711)
.+. ...+... .........+.+++.+||+.||.+||++.||++.|+
T Consensus 234 ~~~----~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 234 IEC----ITQGRLL---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHH----HHcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 111 1111111 111223456788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=331.22 Aligned_cols=241 Identities=22% Similarity=0.332 Sum_probs=193.1
Q ss_pred ceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhc-CCCCeeeeeeeeeecCeEEEEEEcCCC
Q 043702 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTL-RHRNLVRLQGWCHEKGEILLVYDLMPN 460 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 460 (711)
+.||+|+||.||+|+...+++.||+|++... ....+.+..|..++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999888999999988752 23344566777777654 799999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCccc
Q 043702 461 GSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATV 540 (711)
Q Consensus 461 gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 540 (711)
|+|..++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~ 155 (316)
T cd05592 81 GDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAST 155 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccc
Confidence 999998865 34689999999999999999999997 99999999999999999999999999998654322 22334
Q ss_pred ccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccC
Q 043702 541 AAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEG 620 (711)
Q Consensus 541 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 620 (711)
.+||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .+........ ..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-----------~~~~~~i~~~-----------~~ 213 (316)
T cd05592 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-----------DELFDSILND-----------RP 213 (316)
T ss_pred ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-----------HHHHHHHHcC-----------CC
Confidence 5799999999999988999999999999999999999999965321 1111111110 01
Q ss_pred CCcHHHHHHHHHHHHhcCCCCCCCCCCHH-HHHH
Q 043702 621 QFDEAEMRRVLLVGLACSHPDPLARPTMR-GVVQ 653 (711)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-eVl~ 653 (711)
.++......+.+++.+||+.||.+||++. ++++
T Consensus 214 ~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 214 HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 11122234567888999999999999976 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=322.62 Aligned_cols=252 Identities=28% Similarity=0.443 Sum_probs=203.0
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCC
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMP 459 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 459 (711)
++|...+.||+|++|.||+|.+.. +..+|+|++.......+.+.+|++++++++|+|++++++++. .+..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNG-TTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcC-CceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 357788899999999999998854 456999988765555678899999999999999999999875 456899999999
Q ss_pred CCCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCc
Q 043702 460 NGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDA 538 (711)
Q Consensus 460 ~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 538 (711)
+++|.+++.... ..+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||+++..........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence 999999997543 4589999999999999999999987 999999999999999999999999999987644332222
Q ss_pred ccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhh
Q 043702 539 TVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADAR 617 (711)
Q Consensus 539 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 617 (711)
....++..|+|||...+..++.++|||||||++|||++ |+.||..... ....++. ..+
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~~----~~~--------- 219 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN--------REVLEQV----ERG--------- 219 (260)
T ss_pred CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHH----HcC---------
Confidence 22346778999999998899999999999999999999 8999865321 1111111 111
Q ss_pred ccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 618 LEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 618 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
............+.+++.+||+.||.+||++++|++.|+.
T Consensus 220 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 220 YRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0011122334567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=322.05 Aligned_cols=246 Identities=29% Similarity=0.458 Sum_probs=199.7
Q ss_pred ceeecCCceEEEEEEeCCCCeEEEEEEcccCCC--ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCCCCCH
Q 043702 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ--GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSL 463 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 463 (711)
++||+|+||.||+|... ++..+|+|++..... ....+.+|++++++++||||++++++|...+..++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 36999999999999875 578899999875432 234688999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCcccccC
Q 043702 464 DKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAG 543 (711)
Q Consensus 464 ~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~g 543 (711)
.+++......+++..+.+++.|++.+|.|||+. +++||||||+||++++++.+||+|||+++..............+
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 999977666789999999999999999999987 99999999999999999999999999998654332222222345
Q ss_pred CCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccCCC
Q 043702 544 TMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQF 622 (711)
Q Consensus 544 t~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 622 (711)
+..|+|||++..+.++.++|||||||++|||++ |..||..... .... .....+ .....
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~--------~~~~----~~~~~~---------~~~~~ 215 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN--------QQAR----EQVEKG---------YRMSC 215 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH--------HHHH----HHHHcC---------CCCCC
Confidence 678999999998899999999999999999998 9999864321 0111 111111 01111
Q ss_pred cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 043702 623 DEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLV 656 (711)
Q Consensus 623 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 656 (711)
.......+.+++.+|++.+|++||++.++++.|.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 216 PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 2223456888999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=322.48 Aligned_cols=252 Identities=27% Similarity=0.441 Sum_probs=206.1
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCC
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMP 459 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 459 (711)
..|+..+.||+|+||.||++.+. .+..+|+|++........++.+|++++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 35777899999999999999885 46789999987766666789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCcc
Q 043702 460 NGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDAT 539 (711)
Q Consensus 460 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 539 (711)
+++|.+++......+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++...........
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05112 83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcccccC
Confidence 9999999987667799999999999999999999987 9999999999999999999999999999866433221122
Q ss_pred cccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhc
Q 043702 540 VAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARL 618 (711)
Q Consensus 540 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 618 (711)
...++.+|+|||.+.++.++.++|||||||++|||++ |+.||..... .+.........+. ..+
T Consensus 160 ~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----------~~~~~~~~~~~~~---~~~-- 223 (256)
T cd05112 160 GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-----------SEVVETINAGFRL---YKP-- 223 (256)
T ss_pred CCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-----------HHHHHHHhCCCCC---CCC--
Confidence 2235678999999998899999999999999999998 9999864321 1111111111000 011
Q ss_pred cCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 043702 619 EGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLV 656 (711)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 656 (711)
......+.+++.+||+.+|++||++.+++++|.
T Consensus 224 -----~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 224 -----RLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred -----CCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 112356888999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=322.92 Aligned_cols=252 Identities=26% Similarity=0.419 Sum_probs=205.4
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCC
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMP 459 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 459 (711)
+.|...++||+|+||.||+|... +++.||+|.+........++.+|+.++++++|+|++++++++. .+..+++|||++
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME 83 (260)
T ss_pred HHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence 46888899999999999999875 5788999998876666788999999999999999999999874 457899999999
Q ss_pred CCCHHHHHhhC-CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCc
Q 043702 460 NGSLDKALFEA-RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDA 538 (711)
Q Consensus 460 ~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 538 (711)
+++|.+++... ...+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+|||++...........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05067 84 NGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccc
Confidence 99999998653 34689999999999999999999987 999999999999999999999999999987653332222
Q ss_pred ccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhh
Q 043702 539 TVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADAR 617 (711)
Q Consensus 539 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 617 (711)
....++..|+|||++....++.++||||||+++|||++ |+.||..... ...... . ..+
T Consensus 161 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~---~-~~~--------- 219 (260)
T cd05067 161 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN--------PEVIQN---L-ERG--------- 219 (260)
T ss_pred cCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh--------HHHHHH---H-HcC---------
Confidence 23346778999999998899999999999999999999 9999964321 111111 1 111
Q ss_pred ccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 618 LEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 618 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
............+.+++.+|++.+|++||+++++++.|+.
T Consensus 220 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 220 YRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0001111223468889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=326.40 Aligned_cols=254 Identities=24% Similarity=0.400 Sum_probs=204.5
Q ss_pred HHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhc-CCCCeeeeeeeeeec------C
Q 043702 377 SATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTL-RHRNLVRLQGWCHEK------G 449 (711)
Q Consensus 377 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~------~ 449 (711)
.+++.|+..+.||+|+||.||+|....+++.||+|++........++.+|+.+++++ +|+|++++++++... .
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 466788899999999999999999988899999999877666667899999999998 699999999998753 4
Q ss_pred eEEEEEEcCCCCCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCce
Q 043702 450 EILLVYDLMPNGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLAR 528 (711)
Q Consensus 450 ~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~ 528 (711)
..++||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 6899999999999999997643 4689999999999999999999997 99999999999999999999999999998
Q ss_pred ecCCCCCCCcccccCCCcccChhhhc-----cCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHH
Q 043702 529 QVEHDKSPDATVAAGTMGYLAPEYLL-----TGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWS 603 (711)
Q Consensus 529 ~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~ 603 (711)
....... ......|+..|+|||++. ...++.++|||||||++|||++|+.||..... ...+. .
T Consensus 160 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~----------~~~~~-~ 227 (272)
T cd06637 160 QLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP----------MRALF-L 227 (272)
T ss_pred ecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH----------HHHHH-H
Confidence 7643322 233456899999999986 33578899999999999999999999964321 00110 0
Q ss_pred hhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 604 LHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 604 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.... . .... ........+.+++.+||+.+|.+||++.++++.
T Consensus 228 ~~~~-~-----~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 228 IPRN-P-----APRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred HhcC-C-----CCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 0000 0 0001 111223457788999999999999999999863
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=336.77 Aligned_cols=199 Identities=29% Similarity=0.444 Sum_probs=176.2
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC--ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEc
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ--GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
++|+..++||+|+||.||++.+..++..+|+|++..... ....+.+|++++++++|+||++++++|..++..++||||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence 578999999999999999999988899999998875322 235788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC
Q 043702 458 MPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD 537 (711)
Q Consensus 458 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 537 (711)
+++|+|.+++.. ...+++.....++.|++.||.|||+. .+|+||||||+|||+++++.+||+|||++.......
T Consensus 85 ~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--- 158 (333)
T cd06650 85 MDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 158 (333)
T ss_pred CCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc---
Confidence 999999999965 34688999999999999999999974 379999999999999999999999999997653321
Q ss_pred cccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccc
Q 043702 538 ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKE 584 (711)
Q Consensus 538 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~ 584 (711)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 22346899999999999888999999999999999999999999643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=336.47 Aligned_cols=252 Identities=21% Similarity=0.278 Sum_probs=199.8
Q ss_pred CCcccceeecCCceEEEEEEeC---CCCeEEEEEEcccC-----CCChhhhHHHHHHHHhcC-CCCeeeeeeeeeecCeE
Q 043702 381 CFNANRIIGHGAFGTVYKGILP---QNGDIIAVKRCSHN-----SQGKDEFLSELSIIGTLR-HRNLVRLQGWCHEKGEI 451 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~---~~~~~vavK~~~~~-----~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~ 451 (711)
+|+..+.||+|+||.||+++.. .+++.||+|++... ....+.+.+|++++..++ |+||+++++++..++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4788899999999999998863 36789999998642 223456788999999995 99999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecC
Q 043702 452 LLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVE 531 (711)
Q Consensus 452 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~ 531 (711)
++||||+++|+|.+++.. +..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 999999999999999865 45689999999999999999999997 99999999999999999999999999998764
Q ss_pred CCCCCCcccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCch
Q 043702 532 HDKSPDATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRL 610 (711)
Q Consensus 532 ~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 610 (711)
...........||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .....+......
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--------~~~~~~~~~~~~--- 225 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGER--------NTQSEVSRRILK--- 225 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCC--------CCHHHHHHHHhc---
Confidence 4433334456799999999999865 4788999999999999999999999643211 111111111100
Q ss_pred hHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHH
Q 043702 611 LTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARP-----TMRGVVQM 654 (711)
Q Consensus 611 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVl~~ 654 (711)
.++.+ .......+.+++.+||+.||++|| +++++++.
T Consensus 226 ---~~~~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 226 ---CDPPF----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred ---CCCCC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 11111 112234567888999999999999 77788764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=331.85 Aligned_cols=258 Identities=25% Similarity=0.421 Sum_probs=205.6
Q ss_pred HHhcCCcccceeecCCceEEEEEEeCCC-----CeEEEEEEcccCC--CChhhhHHHHHHHHhc-CCCCeeeeeeeeeec
Q 043702 377 SATKCFNANRIIGHGAFGTVYKGILPQN-----GDIIAVKRCSHNS--QGKDEFLSELSIIGTL-RHRNLVRLQGWCHEK 448 (711)
Q Consensus 377 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~-----~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 448 (711)
...++|+..+.||+|+||.||++..... ...+|+|++.... ....++.+|++++.++ +|+||++++++|..+
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 3445688889999999999999987533 3689999887533 2335688999999999 799999999999999
Q ss_pred CeEEEEEEcCCCCCHHHHHhhC---------------CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEE
Q 043702 449 GEILLVYDLMPNGSLDKALFEA---------------RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIML 513 (711)
Q Consensus 449 ~~~~lV~Ey~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl 513 (711)
+..+++|||+++|+|..++... ...+++..+++++.|++.||+|||+. +|+||||||+|||+
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEE
Confidence 9999999999999999998642 34689999999999999999999987 99999999999999
Q ss_pred cCCCcEEEeecCCceecCCCCCC-CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCcccccccccc
Q 043702 514 DEGFNARLGDFGLARQVEHDKSP-DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKV 591 (711)
Q Consensus 514 d~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~ 591 (711)
++++.+||+|||+++.+...... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----- 240 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV----- 240 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH-----
Confidence 99999999999999876543221 1122335678999999998899999999999999999998 9888864321
Q ss_pred ccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 592 GVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 592 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
.+ +......+. ...........+.+++.+||+.+|.+|||+.++++.|+..
T Consensus 241 ------~~-~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 241 ------EE-LFKLLKEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred ------HH-HHHHHHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 01 111111111 1111223345678899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=327.75 Aligned_cols=248 Identities=22% Similarity=0.338 Sum_probs=210.3
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
.+|++.+.||+|.||+|-+++....|+.||||.+.++ +++.-.+.+||+||+.|+||||+.++.+|...+.+.+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4678888999999999999999888999999988763 344456789999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
||..+|.|++|+.+ ++.|++.+.+.+++||..|+.|+|.. +++|||||.+|||||+|+++||+||||+..+...+
T Consensus 133 EYaS~GeLYDYiSe-r~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k- 207 (668)
T KOG0611|consen 133 EYASGGELYDYISE-RGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK- 207 (668)
T ss_pred EecCCccHHHHHHH-hccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcccc-
Confidence 99999999999954 56799999999999999999999997 99999999999999999999999999998876544
Q ss_pred CCcccccCCCcccChhhhccCCC-CccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhh
Q 043702 536 PDATVAAGTMGYLAPEYLLTGRA-TEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 614 (711)
..+.+||++.|.+||++.+.+| .+..|.||+||+||.|+.|..||+..+- ..++. .+..|...
T Consensus 208 -fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh--------k~lvr----QIs~GaYr--- 271 (668)
T KOG0611|consen 208 -FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH--------KRLVR----QISRGAYR--- 271 (668)
T ss_pred -HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH--------HHHHH----Hhhccccc---
Confidence 3456899999999999999888 6899999999999999999999986421 11111 11112111
Q ss_pred hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 043702 615 DARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLV 656 (711)
Q Consensus 615 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 656 (711)
.++......-|+.|||..||++|-|+.+|.....
T Consensus 272 --------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 272 --------EPETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred --------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 1233345567889999999999999999998664
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=339.46 Aligned_cols=256 Identities=27% Similarity=0.416 Sum_probs=201.5
Q ss_pred cCCcccceeecCCceEEEEEEeCC-----CCeEEEEEEcccCC--CChhhhHHHHHHHHhc-CCCCeeeeeeeeeec-Ce
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQ-----NGDIIAVKRCSHNS--QGKDEFLSELSIIGTL-RHRNLVRLQGWCHEK-GE 450 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~-~~ 450 (711)
++|++.+.||+|+||.||+|...+ +++.||+|++.... ...+.+.+|++++.++ +|+||++++++|... ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 468889999999999999997533 34789999987532 2235678899999999 799999999988654 56
Q ss_pred EEEEEEcCCCCCHHHHHhhCC-----------------------------------------------------------
Q 043702 451 ILLVYDLMPNGSLDKALFEAR----------------------------------------------------------- 471 (711)
Q Consensus 451 ~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------------- 471 (711)
++++|||+++++|.+++....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 899999999999999985422
Q ss_pred -CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCC-CcccccCCCcccC
Q 043702 472 -SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP-DATVAAGTMGYLA 549 (711)
Q Consensus 472 -~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~A 549 (711)
..++|..+.+++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.+...... ......++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 2689999999999999999999987 9999999999999999999999999999876433221 1223446778999
Q ss_pred hhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHH
Q 043702 550 PEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMR 628 (711)
Q Consensus 550 PE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 628 (711)
||++.+..++.++|||||||++|||++ |+.||...... +........+.. ...+.....
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~-----------~~~~~~~~~~~~---------~~~~~~~~~ 303 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID-----------EEFCRRLKEGTR---------MRAPEYATP 303 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc-----------HHHHHHHhccCC---------CCCCccCCH
Confidence 999999999999999999999999998 99998642110 011111111111 011122335
Q ss_pred HHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 629 RVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 629 ~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
++.+++.+||+.+|++||++.||+++|+..
T Consensus 304 ~~~~l~~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 304 EIYSIMLDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 678899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=341.70 Aligned_cols=252 Identities=21% Similarity=0.288 Sum_probs=199.6
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
++|+..+.||+|+||+||+|+...+++.||||++... ......+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 3688899999999999999999988999999998752 233456788999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..+.....
T Consensus 81 E~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 81 EYLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 99999999999865 34699999999999999999999998 999999999999999999999999999976532110
Q ss_pred C-------------------------------------CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCC
Q 043702 536 P-------------------------------------DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGR 578 (711)
Q Consensus 536 ~-------------------------------------~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~ 578 (711)
. .....+||+.|+|||++....++.++|||||||++|||++|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 0 011246999999999999999999999999999999999999
Q ss_pred CCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCC---HHHHHHH
Q 043702 579 RPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPT---MRGVVQM 654 (711)
Q Consensus 579 ~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~eVl~~ 654 (711)
.||..... .+............. ... .......+.+++.+|+. +|.+|++ ++|+++.
T Consensus 237 ~Pf~~~~~-----------~~~~~~i~~~~~~~~-----~~~--~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 237 PPFCSDNP-----------QETYRKIINWKETLQ-----FPD--EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCH-----------HHHHHHHHcCCCccC-----CCC--CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 99965321 011111111000000 000 00112345567778886 9999998 9998873
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=343.84 Aligned_cols=200 Identities=26% Similarity=0.364 Sum_probs=174.8
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
.|...+.||+|+||+||+|++..+++.||+|++... ....+.+.+|++++++++||||+++++++.+.+.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 578889999999999999999999999999998652 2234568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC-
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS- 535 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~- 535 (711)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 82 ~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 82 YIPGGDMMSLLIR-MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred cCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 9999999999865 34688999999999999999999997 999999999999999999999999999864321000
Q ss_pred ---------------------------------------------CCcccccCCCcccChhhhccCCCCccccchhHHHH
Q 043702 536 ---------------------------------------------PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAV 570 (711)
Q Consensus 536 ---------------------------------------------~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvl 570 (711)
......+||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 00123469999999999998889999999999999
Q ss_pred HHHHHhCCCCCccc
Q 043702 571 VLEVASGRRPIEKE 584 (711)
Q Consensus 571 l~elltG~~P~~~~ 584 (711)
+|||++|+.||...
T Consensus 238 l~elltG~~Pf~~~ 251 (381)
T cd05626 238 LFEMLVGQPPFLAP 251 (381)
T ss_pred HHHHHhCCCCCcCC
Confidence 99999999999653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=323.25 Aligned_cols=257 Identities=23% Similarity=0.365 Sum_probs=208.0
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC----CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS----QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
++|+..+.||+|+||.||+|+...+++.||||++.... .....+.+|+++++.++|||++++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 47888999999999999999998889999999876422 22346889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhh---CCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCC
Q 043702 456 DLMPNGSLDKALFE---ARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEH 532 (711)
Q Consensus 456 Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~ 532 (711)
||+++|+|.+++.. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999988853 334588999999999999999999987 999999999999999999999999999987643
Q ss_pred CCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhH
Q 043702 533 DKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLT 612 (711)
Q Consensus 533 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 612 (711)
... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ...++....... .
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~---------~~~~~~~~~~~~-~--- 224 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---------NLFSLCQKIEQC-D--- 224 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc---------cHHHHHHHHhcC-C---
Confidence 321 12234688899999999888899999999999999999999999864321 111221111110 0
Q ss_pred hhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 613 AADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 613 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
.+ ..........+.+++.+||+.+|++||++.+|++.|++.
T Consensus 225 --~~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 225 --YP---PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred --CC---CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 00 111123345678899999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=322.57 Aligned_cols=246 Identities=24% Similarity=0.401 Sum_probs=196.9
Q ss_pred eeecCCceEEEEEEeC--CCCeEEEEEEcccCCC--ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCCCCC
Q 043702 387 IIGHGAFGTVYKGILP--QNGDIIAVKRCSHNSQ--GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGS 462 (711)
Q Consensus 387 ~LG~G~fg~Vy~~~~~--~~~~~vavK~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 462 (711)
.||+|+||.||+|.+. ..+..||+|++..... ..+++.+|+.++++++||||++++++|. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999774 4456799999876432 2456889999999999999999999886 457899999999999
Q ss_pred HHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCc--cc
Q 043702 463 LDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDA--TV 540 (711)
Q Consensus 463 L~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~--~~ 540 (711)
|.+++......+++..+++++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++.......... ..
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 9999977677899999999999999999999997 999999999999999999999999999986644332211 11
Q ss_pred ccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhcc
Q 043702 541 AAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLE 619 (711)
Q Consensus 541 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 619 (711)
..++..|+|||.+....++.++|||||||++|||++ |+.||..... .++. .....+. .
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----------~~~~-~~~~~~~---------~ 216 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG-----------PEVM-SFIEQGK---------R 216 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH-----------HHHH-HHHHCCC---------C
Confidence 224578999999988889999999999999999996 9999865321 1111 1111111 1
Q ss_pred CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 620 GQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 620 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
...+......+.+++.+||..+|++||++.+|.+.|+.
T Consensus 217 ~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 217 LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 11222334567789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=329.67 Aligned_cols=256 Identities=25% Similarity=0.456 Sum_probs=204.2
Q ss_pred cCCcccceeecCCceEEEEEEeC-----CCCeEEEEEEcccCC-CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILP-----QNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILL 453 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 453 (711)
++|...+.||+|+||+||++... .++..+|+|.+.... ...+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46788899999999999999852 345678999887533 335678999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhCC------------CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEE
Q 043702 454 VYDLMPNGSLDKALFEAR------------SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARL 521 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~~------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL 521 (711)
||||+++++|.+++.... ..+++..+++++.|++.||+|||+. +++||||||+|||+++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEe
Confidence 999999999999986432 2489999999999999999999997 9999999999999999999999
Q ss_pred eecCCceecCCCCC-CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHH
Q 043702 522 GDFGLARQVEHDKS-PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVE 599 (711)
Q Consensus 522 ~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~ 599 (711)
+|||+++....... .......++..|+|||.+....++.++|||||||++|||++ |+.||..... ....+
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~--------~~~~~ 233 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--------NEVIE 233 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHH
Confidence 99999986543221 11222345778999999998889999999999999999998 8999864321 11111
Q ss_pred HHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC
Q 043702 600 WVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEA 659 (711)
Q Consensus 600 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~ 659 (711)
....+.... . .......+.+++.+||+.||.+||++.+|++.|+...
T Consensus 234 ----~i~~~~~~~-----~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 234 ----CITQGRVLQ-----R----PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred ----HHHcCCcCC-----C----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 111111110 1 1112345788999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=337.80 Aligned_cols=243 Identities=26% Similarity=0.319 Sum_probs=196.6
Q ss_pred ceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCCCC
Q 043702 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNG 461 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 461 (711)
+.||+|+||.||++....+++.||+|++... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999999889999999998752 233456788999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCcccc
Q 043702 462 SLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVA 541 (711)
Q Consensus 462 sL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 541 (711)
+|..++.. ...+++..+..++.||+.||+|||+. .+|+||||||+|||+++++.+||+|||+++....... .....
T Consensus 81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~ 156 (325)
T cd05594 81 ELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKTF 156 (325)
T ss_pred cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-ccccc
Confidence 99998854 34689999999999999999999972 2999999999999999999999999999976432221 22335
Q ss_pred cCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccCC
Q 043702 542 AGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQ 621 (711)
Q Consensus 542 ~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 621 (711)
.||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.. ....+. ..
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~--------~~~~~----~i~~~~------~~---- 214 (325)
T cd05594 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFE----LILMEE------IR---- 214 (325)
T ss_pred cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH--------HHHHH----HHhcCC------CC----
Confidence 699999999999999999999999999999999999999964321 01111 111110 01
Q ss_pred CcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHH
Q 043702 622 FDEAEMRRVLLVGLACSHPDPLARP-----TMRGVVQM 654 (711)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVl~~ 654 (711)
++......+.+++.+||+.||++|+ ++.++++.
T Consensus 215 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 215 FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 1112234567888999999999996 89999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=335.16 Aligned_cols=244 Identities=22% Similarity=0.334 Sum_probs=195.7
Q ss_pred CcccceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHH---HhcCCCCeeeeeeeeeecCeEEEE
Q 043702 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSII---GTLRHRNLVRLQGWCHEKGEILLV 454 (711)
Q Consensus 382 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l---~~l~H~niv~l~g~~~~~~~~~lV 454 (711)
|+..+.||+|+||.||+|.+..+++.||||++... ....+.+.+|++++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 56788999999999999999888999999998752 23345667776665 566799999999999999999999
Q ss_pred EEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCC
Q 043702 455 YDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~ 534 (711)
|||+++|+|..++. ...+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 81 ~E~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 81 MEYAAGGDLMMHIH--TDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EcCCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence 99999999998884 35699999999999999999999997 99999999999999999999999999987543222
Q ss_pred CCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhh
Q 043702 535 SPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614 (711)
Q Consensus 535 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 614 (711)
......+|++.|+|||.+.+..++.++|||||||++|||++|+.||..... .+....... +.
T Consensus 156 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~-----------~~~~~~i~~-~~----- 217 (324)
T cd05589 156 -DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE-----------EEVFDSIVN-DE----- 217 (324)
T ss_pred -CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH-----------HHHHHHHHh-CC-----
Confidence 223345799999999999999999999999999999999999999965321 111111111 10
Q ss_pred hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 043702 615 DARLEGQFDEAEMRRVLLVGLACSHPDPLARP-----TMRGVVQ 653 (711)
Q Consensus 615 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVl~ 653 (711)
. .++......+.+++.+||+.||.+|| ++.++++
T Consensus 218 -~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 218 -V----RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -C----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 0 11112234567889999999999999 5666665
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=330.82 Aligned_cols=256 Identities=23% Similarity=0.445 Sum_probs=205.1
Q ss_pred CCcccceeecCCceEEEEEEeCC-----CCeEEEEEEcccCCC-ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEE
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQ-----NGDIIAVKRCSHNSQ-GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLV 454 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 454 (711)
+|...+.||+|+||.||+|+... ++..+++|++..... ..+.+.+|++++++++|+||+++++++...+..++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV 85 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence 57778899999999999998532 345689998865432 346789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhCC---------------CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcE
Q 043702 455 YDLMPNGSLDKALFEAR---------------SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNA 519 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~v 519 (711)
|||+++++|.+++.... ..+++..+++++.||+.||+|||+. +|+||||||+|||++.++.+
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLV 162 (291)
T ss_pred EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence 99999999999996532 3489999999999999999999987 99999999999999999999
Q ss_pred EEeecCCceecCCCCC-CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccch
Q 043702 520 RLGDFGLARQVEHDKS-PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNL 597 (711)
Q Consensus 520 kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l 597 (711)
||+|||+++....... .......++..|+|||.+....++.++|||||||++|||++ |+.||..... ...
T Consensus 163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--------~~~ 234 (291)
T cd05094 163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN--------TEV 234 (291)
T ss_pred EECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHH
Confidence 9999999976543221 11223446788999999999999999999999999999999 9999864321 111
Q ss_pred HHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC
Q 043702 598 VEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEAE 660 (711)
Q Consensus 598 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 660 (711)
. +....+.... ........+.+++.+||+.+|.+||++++|+++|+....
T Consensus 235 ~----~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 235 I----ECITQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred H----HHHhCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 1 1111111111 111234567899999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=328.36 Aligned_cols=254 Identities=24% Similarity=0.437 Sum_probs=201.3
Q ss_pred cCCcccceeecCCceEEEEEEeC----CCCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILP----QNGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILL 453 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~----~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 453 (711)
+.|+..+.||+|+||.||+|... ..+..+++|.+.... +...++.+|++++++++||||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 35777899999999999999852 345789999987532 223578899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhCC----------------CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCC
Q 043702 454 VYDLMPNGSLDKALFEAR----------------SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGF 517 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~~----------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~ 517 (711)
||||+++++|.+++.... ..+++.+.+.++.|++.||.|||+. +++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 999999999999985321 2478899999999999999999997 999999999999999999
Q ss_pred cEEEeecCCceecCCCCC-CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCcccccccccccccc
Q 043702 518 NARLGDFGLARQVEHDKS-PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVAS 595 (711)
Q Consensus 518 ~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~ 595 (711)
.+||+|||+++....... .......++..|+|||.+.++.++.++|||||||++|||++ |..||..... .
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--------~ 233 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--------Q 233 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--------H
Confidence 999999999986643321 11223346778999999988889999999999999999998 9889854211 1
Q ss_pred chHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 596 NLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 596 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
.+.+ ....+... .........+.+++.+||+.||.+||++.+|.++|..
T Consensus 234 ~~~~----~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 234 EVIE----MVRKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHH----HHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111 11111111 1111223567788899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=324.15 Aligned_cols=252 Identities=27% Similarity=0.463 Sum_probs=200.3
Q ss_pred CcccceeecCCceEEEEEEeCCC---CeEEEEEEcccCC---CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCe-----
Q 043702 382 FNANRIIGHGAFGTVYKGILPQN---GDIIAVKRCSHNS---QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGE----- 450 (711)
Q Consensus 382 f~~~~~LG~G~fg~Vy~~~~~~~---~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~----- 450 (711)
|.+.+.||+|+||.||+|.+..+ +..||+|++.... ...+.+.+|++.++.++|||++++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 46678999999999999998643 3789999987532 234578999999999999999999999876554
Q ss_pred -EEEEEEcCCCCCHHHHHhhC-----CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeec
Q 043702 451 -ILLVYDLMPNGSLDKALFEA-----RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDF 524 (711)
Q Consensus 451 -~~lV~Ey~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DF 524 (711)
.++++||+++|+|..++... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 79999999999999998543 23689999999999999999999997 9999999999999999999999999
Q ss_pred CCceecCCCCCCC-cccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHH
Q 043702 525 GLARQVEHDKSPD-ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVW 602 (711)
Q Consensus 525 Gla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~ 602 (711)
|+++......... .....++..|+|||.+....++.++|||||||++|||++ |..||..... ..+.++..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--------~~~~~~~~ 229 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--------HEIYDYLR 229 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHH
Confidence 9998765433221 122335678999999988889999999999999999999 8888854321 11112111
Q ss_pred HhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 603 SLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 603 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
.+.. ..........+.+++.+||+.||.+||++.||++.|+.
T Consensus 230 ----~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 230 ----HGNR---------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred ----cCCC---------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 1110 11122334568889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=327.54 Aligned_cols=257 Identities=26% Similarity=0.443 Sum_probs=204.6
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCe----EEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGD----IIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILL 453 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~----~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 453 (711)
+.|+..++||+|+||+||+|++..+++ .||+|++.... ...+++.+|+.+++.++|+||++++++|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence 467888999999999999999766655 48999886533 2346788999999999999999999999754 5789
Q ss_pred EEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCC
Q 043702 454 VYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHD 533 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~ 533 (711)
++||+++|+|.+++......+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.+...
T Consensus 86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 9999999999999987677899999999999999999999997 9999999999999999999999999999877543
Q ss_pred CCC-CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchh
Q 043702 534 KSP-DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLL 611 (711)
Q Consensus 534 ~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 611 (711)
... ......++..|+|||.+.+..++.++|||||||++|||++ |..||..... ..+..+. ..+..
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~~----~~~~~- 229 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--------REIPDLL----EKGER- 229 (279)
T ss_pred cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHH----HCCCc-
Confidence 221 1112235678999999998899999999999999999998 8999864321 1111211 11110
Q ss_pred HhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCC
Q 043702 612 TAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEAEV 661 (711)
Q Consensus 612 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 661 (711)
..........+.+++.+||+.||++||++.++++.|+..+..
T Consensus 230 --------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 230 --------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred --------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 011112334677889999999999999999999998765443
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=334.74 Aligned_cols=250 Identities=22% Similarity=0.330 Sum_probs=198.0
Q ss_pred ceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhc-CCCCeeeeeeeeeecCeEEEEEEcCCC
Q 043702 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTL-RHRNLVRLQGWCHEKGEILLVYDLMPN 460 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 460 (711)
+.||+|+||.||++....+++.+|+|++... ....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999999989999999998752 22345677899988877 799999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCccc
Q 043702 461 GSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATV 540 (711)
Q Consensus 461 gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 540 (711)
|+|..++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~~ 155 (329)
T cd05618 81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTST 155 (329)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Ccccc
Confidence 999988854 35699999999999999999999998 99999999999999999999999999997543222 12234
Q ss_pred ccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccC
Q 043702 541 AAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEG 620 (711)
Q Consensus 541 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 620 (711)
..||+.|+|||++.+..++.++|||||||++|||++|+.||....... .......++.......+..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~---~~~~~~~~~~~~~i~~~~~---------- 222 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD---NPDQNTEDYLFQVILEKQI---------- 222 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcC---CcccccHHHHHHHHhcCCC----------
Confidence 579999999999999999999999999999999999999996422110 0111223333332222111
Q ss_pred CCcHHHHHHHHHHHHhcCCCCCCCCCC------HHHHHH
Q 043702 621 QFDEAEMRRVLLVGLACSHPDPLARPT------MRGVVQ 653 (711)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs------~~eVl~ 653 (711)
.++......+.+++.+||+.||.+||+ +.++++
T Consensus 223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 223 RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 112223345678899999999999998 466654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=321.52 Aligned_cols=254 Identities=30% Similarity=0.460 Sum_probs=207.8
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcC
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
.++|.+.++||+|++|.||+|... ++..+|+|.+.......+++.+|++++++++|+||+++++++..+...++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 457888999999999999999985 4678999998876666788999999999999999999999999889999999999
Q ss_pred CCCCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC
Q 043702 459 PNGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD 537 (711)
Q Consensus 459 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 537 (711)
++++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||+++.+.......
T Consensus 84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (261)
T cd05034 84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA 160 (261)
T ss_pred CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhhhh
Confidence 9999999997644 4699999999999999999999987 99999999999999999999999999998765432222
Q ss_pred cccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhhhh
Q 043702 538 ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADA 616 (711)
Q Consensus 538 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 616 (711)
.....++..|+|||.+.+..++.++|||||||+++||++ |+.||..... ....+. ....
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--------~~~~~~---~~~~--------- 220 (261)
T cd05034 161 REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN--------REVLEQ---VERG--------- 220 (261)
T ss_pred hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHH---HHcC---------
Confidence 222235678999999998889999999999999999999 9999854311 111111 1100
Q ss_pred hccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 617 RLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 617 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
.....+......+.+++.+|++.+|++||+++++++.|+.
T Consensus 221 -~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 221 -YRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0001111224567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=338.59 Aligned_cols=201 Identities=25% Similarity=0.380 Sum_probs=176.9
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
++|+..+.||+|+||+||++....+++.||+|++... ......+.+|+.++.+++|+||+++++.+.+...+++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4688899999999999999999888999999998652 223456788999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
||+++|+|.+++.. ...+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 81 EFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred cCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 99999999999965 45799999999999999999999997 999999999999999999999999999975432110
Q ss_pred ----------------------------------CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCC
Q 043702 536 ----------------------------------PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPI 581 (711)
Q Consensus 536 ----------------------------------~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~ 581 (711)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0012357999999999999999999999999999999999999999
Q ss_pred ccc
Q 043702 582 EKE 584 (711)
Q Consensus 582 ~~~ 584 (711)
...
T Consensus 237 ~~~ 239 (363)
T cd05628 237 CSE 239 (363)
T ss_pred CCC
Confidence 653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=327.00 Aligned_cols=266 Identities=24% Similarity=0.379 Sum_probs=202.5
Q ss_pred CcccceeecCCceEEEEEEe----CCCCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeec--CeEEE
Q 043702 382 FNANRIIGHGAFGTVYKGIL----PQNGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEK--GEILL 453 (711)
Q Consensus 382 f~~~~~LG~G~fg~Vy~~~~----~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~l 453 (711)
|...+.||+|+||+||++.. ..++..||+|.+.... .....+.+|++++++++||||++++++|... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37788999999999988653 3457889999987543 2456788999999999999999999998754 45899
Q ss_pred EEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCC
Q 043702 454 VYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHD 533 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~ 533 (711)
||||+++++|.+++.. ..+++.++..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 86 v~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 86 IMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred EecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 9999999999999965 3599999999999999999999997 9999999999999999999999999999876543
Q ss_pred CCCC--cccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchh
Q 043702 534 KSPD--ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLL 611 (711)
Q Consensus 534 ~~~~--~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 611 (711)
.... .....++..|+|||.+....++.++|||||||++|||++|+.|+....... .....+.........+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~------~~~~~~~~~~~~~~~~~ 234 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF------EEMIGPKQGQMTVVRLI 234 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh------hhhhcccccccchhhhh
Confidence 2211 112235667999999988889999999999999999999999986432110 00000000000111111
Q ss_pred HhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 612 TAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 612 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
+..+..............+.+++.+||+.+|++||++++|++.|+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 12222221122223346788899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=354.71 Aligned_cols=256 Identities=25% Similarity=0.337 Sum_probs=205.5
Q ss_pred HHHHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC---CChhhhHHHHHHHHhcCCCCeeeeeeeeeecC--
Q 043702 375 LRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKG-- 449 (711)
Q Consensus 375 l~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-- 449 (711)
.+...++|...+.||+|+||+||+|+...+++.||||++.... .....+.+|+.++..++|+|++++++.+...+
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 3445578999999999999999999998889999999986532 33456788999999999999999988765432
Q ss_pred ------eEEEEEEcCCCCCHHHHHhhC---CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEE
Q 043702 450 ------EILLVYDLMPNGSLDKALFEA---RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNAR 520 (711)
Q Consensus 450 ------~~~lV~Ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vk 520 (711)
.+++||||+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEE
Confidence 368999999999999998643 34688999999999999999999997 999999999999999999999
Q ss_pred EeecCCceecCCCCC-CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHH
Q 043702 521 LGDFGLARQVEHDKS-PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVE 599 (711)
Q Consensus 521 L~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~ 599 (711)
|+|||+++.+..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~-----------~~~ 252 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-----------MEE 252 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----------HHH
Confidence 999999987653322 12334579999999999999999999999999999999999999996431 112
Q ss_pred HHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 600 WVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 600 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.+.... .+.. ...+......+.+++.+||+.||.+||++.++++.
T Consensus 253 ~~~~~~-~~~~---------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 253 VMHKTL-AGRY---------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHHHh-cCCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111111 1111 01122234567788999999999999999999864
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=329.24 Aligned_cols=254 Identities=25% Similarity=0.431 Sum_probs=202.1
Q ss_pred CCcccceeecCCceEEEEEEeCC-----CCeEEEEEEcccCCC--ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEE
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQ-----NGDIIAVKRCSHNSQ--GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILL 453 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 453 (711)
+|...+.||+|+||.||+|+... ....+++|.+..... ..+++.+|+.+++.++||||+++++.|..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 46778899999999999998742 235788998875432 34578899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhCC-----------------------CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCc
Q 043702 454 VYDLMPNGSLDKALFEAR-----------------------SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSN 510 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~N 510 (711)
++||+++++|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 999999999999986421 3478999999999999999999987 99999999999
Q ss_pred eEEcCCCcEEEeecCCceecCCCCCC-CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccc
Q 043702 511 IMLDEGFNARLGDFGLARQVEHDKSP-DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGV 588 (711)
Q Consensus 511 ILld~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~ 588 (711)
||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-- 235 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-- 235 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH--
Confidence 99999999999999999865433221 1222345778999999988889999999999999999998 9999864321
Q ss_pred cccccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 589 GKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 589 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
.. ++.....+ ............+.+++.+||+.+|.+||++.++++.|+..
T Consensus 236 ------~~----~~~~~~~~---------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 236 ------ER----LFNLLKTG---------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred ------HH----HHHHHhCC---------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 11 11211111 11111122335677899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=320.48 Aligned_cols=247 Identities=29% Similarity=0.482 Sum_probs=198.6
Q ss_pred ceeecCCceEEEEEEeCCCC---eEEEEEEcccCCC--ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCCC
Q 043702 386 RIIGHGAFGTVYKGILPQNG---DIIAVKRCSHNSQ--GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPN 460 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~~~~---~~vavK~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 460 (711)
++||+|+||.||+|+....+ ..+|+|.+..... ..+++.+|+++++.++|+|++++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999875544 7899999876543 4567899999999999999999999876 4568999999999
Q ss_pred CCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCcc-
Q 043702 461 GSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDAT- 539 (711)
Q Consensus 461 gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~- 539 (711)
|+|.+++.... .+++..+.+++.|++.||+|||.. +++||||||+|||++.++.+||+|||+++...........
T Consensus 80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 99999997544 789999999999999999999987 9999999999999999999999999999876544332111
Q ss_pred -cccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhh
Q 043702 540 -VAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADAR 617 (711)
Q Consensus 540 -~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 617 (711)
...++..|+|||.+....++.++|||||||++|||++ |+.||..... ..+..+.. .+..
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--------~~~~~~~~----~~~~------- 216 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--------AEVIAMLE----SGER------- 216 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--------HHHHHHHH----cCCc-------
Confidence 1223568999999998899999999999999999998 9999865321 11222211 1110
Q ss_pred ccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 618 LEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 618 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
..........+.+++.+||+.+|.+||++.+|++.|++.
T Consensus 217 --~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 217 --LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred --CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 011112235677899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=319.30 Aligned_cols=256 Identities=25% Similarity=0.412 Sum_probs=209.5
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
++|+..+.||+|++|.||+|....+++.||+|.++.. ....+.+.+|++++++++|+|++++++++..++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 5788999999999999999999888999999987641 223567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhh---CCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCC
Q 043702 456 DLMPNGSLDKALFE---ARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEH 532 (711)
Q Consensus 456 Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~ 532 (711)
||+++++|.+++.. ....+++.++.+++.+++.||.|||+. +++||||||+||++++++.+||+|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999864 235589999999999999999999997 999999999999999999999999999987644
Q ss_pred CCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhH
Q 043702 533 DKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLT 612 (711)
Q Consensus 533 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 612 (711)
... ......|+..|+|||.+.+..++.++|||||||++|||++|+.||.... ..+.+..... ..+.
T Consensus 159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---------~~~~~~~~~~-~~~~--- 224 (267)
T cd08224 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---------MNLYSLCKKI-EKCD--- 224 (267)
T ss_pred CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC---------ccHHHHHhhh-hcCC---
Confidence 322 2233468899999999998889999999999999999999999986432 1111111111 1111
Q ss_pred hhhhhccCCCc-HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 613 AADARLEGQFD-EAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 613 ~~d~~l~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
..... ......+.+++.+||+.+|++||++.+|+++|+..
T Consensus 225 ------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 225 ------YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred ------CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 11111 13345678899999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=330.37 Aligned_cols=253 Identities=26% Similarity=0.400 Sum_probs=200.1
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCe--EEEEEEcccC--CCChhhhHHHHHHHHhc-CCCCeeeeeeeeeecCeEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGD--IIAVKRCSHN--SQGKDEFLSELSIIGTL-RHRNLVRLQGWCHEKGEILLV 454 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~--~vavK~~~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 454 (711)
++|+..+.||+|+||.||+|....++. .+++|.+... ....+.+.+|+++++++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 468888999999999999999876654 4688887642 23346788999999999 699999999999999999999
Q ss_pred EEcCCCCCHHHHHhhCC---------------CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcE
Q 043702 455 YDLMPNGSLDKALFEAR---------------SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNA 519 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~v 519 (711)
+||+++++|.+++.... ..+++..+++++.|++.||+|||+. +|+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 99999999999996532 3488999999999999999999987 99999999999999999999
Q ss_pred EEeecCCceecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchH
Q 043702 520 RLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLV 598 (711)
Q Consensus 520 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~ 598 (711)
||+|||++....... .......+..|+|||.+....++.++|||||||++|||++ |+.||..... .
T Consensus 159 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~-----------~ 225 (297)
T cd05089 159 KIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC-----------A 225 (297)
T ss_pred EECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----------H
Confidence 999999987432211 1111223567999999998889999999999999999997 9999965321 1
Q ss_pred HHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 599 EWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 599 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
+..... ...............+.+++.+||+.+|.+||++.++++.|+..
T Consensus 226 ~~~~~~----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 275 (297)
T cd05089 226 ELYEKL----------PQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM 275 (297)
T ss_pred HHHHHH----------hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111111 11111111122335677899999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=326.21 Aligned_cols=244 Identities=25% Similarity=0.362 Sum_probs=196.4
Q ss_pred eecCCceEEEEEEeCCCCeEEEEEEcccCC----CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCCCCCH
Q 043702 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNS----QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSL 463 (711)
Q Consensus 388 LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 463 (711)
||+|+||+||++.+..+++.+|+|++.... ...+.+..|+++++.++|+||+++.+++..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999998889999999986522 2235678899999999999999999999999999999999999999
Q ss_pred HHHHhh---CCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCccc
Q 043702 464 DKALFE---ARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATV 540 (711)
Q Consensus 464 ~~~l~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 540 (711)
..++.. ....+++..+..++.||+.||.|||+. +|+||||||+||++++++.+||+|||+++.+..... ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 988754 234689999999999999999999997 999999999999999999999999999987654332 2233
Q ss_pred ccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccC
Q 043702 541 AAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEG 620 (711)
Q Consensus 541 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 620 (711)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ........... ... .
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-------~~~~~~~~~~~---------~~~--~ 218 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK-------VENKELKQRIL---------NDS--V 218 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcc-------hhHHHHHHhhc---------ccC--C
Confidence 56899999999999999999999999999999999999999653210 00001000000 000 0
Q ss_pred CCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 043702 621 QFDEAEMRRVLLVGLACSHPDPLARP-----TMRGVVQ 653 (711)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVl~ 653 (711)
.+.......+.+++.+||+.||++|| +++++++
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 219 TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 11223345677888999999999999 7778876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=322.08 Aligned_cols=258 Identities=23% Similarity=0.372 Sum_probs=205.7
Q ss_pred HHHHHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC-CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEE
Q 043702 374 ELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEIL 452 (711)
Q Consensus 374 el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 452 (711)
|++.+++++.....||+|+||.||+|.+..++..||+|.+.... ...+.+.+|++++++++|+||+++++++..++..+
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 34556777778889999999999999998888999999876533 34567899999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhhCCCCC--ChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcC-CCcEEEeecCCcee
Q 043702 453 LVYDLMPNGSLDKALFEARSPL--PWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDE-GFNARLGDFGLARQ 529 (711)
Q Consensus 453 lV~Ey~~~gsL~~~l~~~~~~l--~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~-~~~vkL~DFGla~~ 529 (711)
+|+||+++++|.+++......+ ++..+..++.||+.||.|||+. +|+||||||+||+++. ++.+||+|||++..
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 9999999999999998655555 8888999999999999999987 9999999999999976 67899999999986
Q ss_pred cCCCCCCCcccccCCCcccChhhhccCC--CCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhc
Q 043702 530 VEHDKSPDATVAAGTMGYLAPEYLLTGR--ATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHRE 607 (711)
Q Consensus 530 ~~~~~~~~~~~~~gt~~y~APE~~~~~~--~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~ 607 (711)
...... ......|++.|+|||++.... ++.++||||||+++|||++|+.||..... .....+.....
T Consensus 159 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~--------~~~~~~~~~~~-- 227 (268)
T cd06624 159 LAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE--------PQAAMFKVGMF-- 227 (268)
T ss_pred cccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccC--------hhhhHhhhhhh--
Confidence 643222 222345889999999987654 78899999999999999999999864211 00011100000
Q ss_pred CchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 608 GRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 608 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.....++.....++.+++.+||+.+|.+||++.|+++.
T Consensus 228 ---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 228 ---------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ---------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00111222334567788999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=328.87 Aligned_cols=255 Identities=22% Similarity=0.319 Sum_probs=205.3
Q ss_pred HhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC---------------CChhhhHHHHHHHHhcCCCCeeeee
Q 043702 378 ATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---------------QGKDEFLSELSIIGTLRHRNLVRLQ 442 (711)
Q Consensus 378 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---------------~~~~~~~~Ei~~l~~l~H~niv~l~ 442 (711)
..++|++.+.||+|.||.|-+|+...+++.||||++.+.+ ...+...+||.+|++++|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 3467999999999999999999999999999999987521 1125788999999999999999999
Q ss_pred eeeeec--CeEEEEEEcCCCCCHHHHHhhCCCC-CChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcE
Q 043702 443 GWCHEK--GEILLVYDLMPNGSLDKALFEARSP-LPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNA 519 (711)
Q Consensus 443 g~~~~~--~~~~lV~Ey~~~gsL~~~l~~~~~~-l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~v 519 (711)
++..+. +.+|||+|||..|.+...= .... |+..+.+++++++..||+|||.+ +||||||||+|+||++++.|
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcE
Confidence 998764 5799999999998875422 2334 89999999999999999999998 99999999999999999999
Q ss_pred EEeecCCceecCCCCCC----CcccccCCCcccChhhhccCC----CCccccchhHHHHHHHHHhCCCCCcccccccccc
Q 043702 520 RLGDFGLARQVEHDKSP----DATVAAGTMGYLAPEYLLTGR----ATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKV 591 (711)
Q Consensus 520 kL~DFGla~~~~~~~~~----~~~~~~gt~~y~APE~~~~~~----~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~ 591 (711)
||+|||.+......... .....+|||.|||||...++. .+.+.||||+||+||.|+.|+.||-.+..
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~----- 324 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE----- 324 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH-----
Confidence 99999999876332211 122357999999999988743 36788999999999999999999965421
Q ss_pred ccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 592 GVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 592 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
.+ + ...++...+.-....++.+++.+|++++|+.||++|.+..+|.....-
T Consensus 325 ------~~----l-----~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 325 ------LE----L-----FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred ------HH----H-----HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 11 1 122333333333334567788899999999999999999999887653
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=333.24 Aligned_cols=246 Identities=20% Similarity=0.331 Sum_probs=198.1
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhcCCC-CeeeeeeeeeecCeEEEEE
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTLRHR-NLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~-niv~l~g~~~~~~~~~lV~ 455 (711)
+|+..+.||+|+||.||+|+...+++.||+|++... ....+.+..|.+++..++|+ +|+++++++...+.+++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 478889999999999999999888999999998752 23456788899999999865 5888999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
||+++|+|..++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~- 155 (324)
T cd05587 81 EYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG- 155 (324)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-
Confidence 99999999998864 45689999999999999999999997 99999999999999999999999999987543222
Q ss_pred CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhh
Q 043702 536 PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 615 (711)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.. .. ....
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--------~~~~~---~i-~~~~------ 217 (324)
T cd05587 156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE--------DELFQ---SI-MEHN------ 217 (324)
T ss_pred CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHH---HH-HcCC------
Confidence 123345799999999999999999999999999999999999999965321 11111 11 1110
Q ss_pred hhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCH-----HHHHH
Q 043702 616 ARLEGQFDEAEMRRVLLVGLACSHPDPLARPTM-----RGVVQ 653 (711)
Q Consensus 616 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~eVl~ 653 (711)
..++......+.+++.+||+.||.+|++. +++++
T Consensus 218 ----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 218 ----VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred ----CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 11111223456788899999999999986 55554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=306.02 Aligned_cols=248 Identities=27% Similarity=0.408 Sum_probs=209.8
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
++|+..+.||+|-||.||.|+.+.++-.||+|++.+. .+...++.+|+++-+.|+||||+++++|+.+....||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 4688899999999999999999999999999998763 244578999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCC
Q 043702 456 DLMPNGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~ 534 (711)
||.++|+|...|+..+ .+++......++.|+|.||.|+|.. +|+||||||+|+|++.++..||+|||-+....
T Consensus 102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--- 175 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP--- 175 (281)
T ss_pred EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC---
Confidence 9999999999998544 4588999999999999999999997 99999999999999999999999999987543
Q ss_pred CCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhh
Q 043702 535 SPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614 (711)
Q Consensus 535 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 614 (711)
.......|||..|.+||...+...+...|+|++|++.||++.|.+||+....+ .. .+.+.. .+
T Consensus 176 ~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~--------et----YkrI~k---~~-- 238 (281)
T KOG0580|consen 176 SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS--------ET----YKRIRK---VD-- 238 (281)
T ss_pred CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH--------HH----HHHHHH---cc--
Confidence 23345678999999999999999999999999999999999999999764311 00 111110 11
Q ss_pred hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 043702 615 DARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655 (711)
Q Consensus 615 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L 655 (711)
-.++......+.+++.+|+..+|.+|.+..|+++.-
T Consensus 239 -----~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 239 -----LKFPSTISGGAADLISRLLVKNPIERLALTEVMDHP 274 (281)
T ss_pred -----ccCCcccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence 112233345677888999999999999999998754
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=332.44 Aligned_cols=201 Identities=28% Similarity=0.398 Sum_probs=178.4
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEccc----CCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSH----NSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
++|+..+.||+|+||.||+++...+++.||+|++.. .....+.+.+|+.++..++|+||+++++++.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 468889999999999999999988899999999864 2233456889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
||+++|+|.+++.+....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 99999999999977667799999999999999999999998 999999999999999999999999999987654443
Q ss_pred CCcccccCCCcccChhhhcc-----CCCCccccchhHHHHHHHHHhCCCCCcc
Q 043702 536 PDATVAAGTMGYLAPEYLLT-----GRATEKTDVFSYGAVVLEVASGRRPIEK 583 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~-----~~~s~ksDVwSfGvll~elltG~~P~~~ 583 (711)
.......||+.|+|||++.. +.++.++|||||||++|||++|+.||..
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 33334569999999999863 4578899999999999999999999965
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=328.69 Aligned_cols=240 Identities=21% Similarity=0.326 Sum_probs=193.7
Q ss_pred ceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhc-CCCCeeeeeeeeeecCeEEEEEEcCCC
Q 043702 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTL-RHRNLVRLQGWCHEKGEILLVYDLMPN 460 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 460 (711)
++||+|+||.||+|++..+|+.||+|++... ....+.+..|..++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999999989999999998752 23445677788888764 799999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCccc
Q 043702 461 GSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATV 540 (711)
Q Consensus 461 gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 540 (711)
|+|..++.. ...+++.+...++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (316)
T cd05620 81 GDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRAST 155 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cceec
Confidence 999998865 45689999999999999999999997 99999999999999999999999999987532222 22334
Q ss_pred ccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccC
Q 043702 541 AAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEG 620 (711)
Q Consensus 541 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 620 (711)
..||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+. +....+ .+.+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~--------~~~~----~~~~~~------~~~~-- 215 (316)
T cd05620 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--------DELF----ESIRVD------TPHY-- 215 (316)
T ss_pred cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHHH----HHHHhC------CCCC--
Confidence 5799999999999999999999999999999999999999965321 1111 111111 0111
Q ss_pred CCcHHHHHHHHHHHHhcCCCCCCCCCCHH-HHH
Q 043702 621 QFDEAEMRRVLLVGLACSHPDPLARPTMR-GVV 652 (711)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-eVl 652 (711)
+......+.+++.+||+.||.+||++. +++
T Consensus 216 --~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 216 --PRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred --CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 111234567888999999999999985 565
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=327.01 Aligned_cols=267 Identities=23% Similarity=0.377 Sum_probs=202.8
Q ss_pred cCCcccceeecCCceEEEEEEe----CCCCeEEEEEEcccCC-CChhhhHHHHHHHHhcCCCCeeeeeeeeee--cCeEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGIL----PQNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCHE--KGEIL 452 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~----~~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~ 452 (711)
++|+..+.||+|+||.||++.. ..++..||+|++.... ...+.+.+|++++++++||||+++++++.. ...++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4678889999999999999984 3467899999987533 335678999999999999999999998754 34689
Q ss_pred EEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCC
Q 043702 453 LVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEH 532 (711)
Q Consensus 453 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~ 532 (711)
+||||+++|+|.+++......+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||+++....
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 99999999999999977667799999999999999999999987 999999999999999999999999999987654
Q ss_pred CCCCC--cccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCcccccccccc-ccc---cchHHHHHHhhh
Q 043702 533 DKSPD--ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKV-GVA---SNLVEWVWSLHR 606 (711)
Q Consensus 533 ~~~~~--~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~-~~~---~~l~~~~~~~~~ 606 (711)
..... .....++..|+|||.+.+..++.++|||||||++|||++|..|+.......... +.. ......
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 234 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYH------ 234 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHH------
Confidence 33211 111223456999999998889999999999999999999887754322110000 000 000000
Q ss_pred cCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 607 EGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 607 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
+.+.+...............+.+++.+||+.+|++|||+++|++.|+..
T Consensus 235 ---~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 235 ---LIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred ---HHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0111111111111122345688899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=326.99 Aligned_cols=252 Identities=23% Similarity=0.375 Sum_probs=201.0
Q ss_pred CCcccceeecCCceEEEEEEeCC-----CCeEEEEEEcccCCCC--hhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEE
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQ-----NGDIIAVKRCSHNSQG--KDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILL 453 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~~~--~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 453 (711)
.|...+.||+|+||.||+|.... .+..||+|++...... .+.+.+|+.+++.++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 36667889999999999998743 2578999998764332 3568899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhC---------------CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCc
Q 043702 454 VYDLMPNGSLDKALFEA---------------RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFN 518 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~ 518 (711)
++||+++++|.+++... ...+++..+.+++.|++.||+|||+. +|+||||||+|||+++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 99999999999998532 23488889999999999999999987 9999999999999999999
Q ss_pred EEEeecCCceecCCCCCC-CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccc
Q 043702 519 ARLGDFGLARQVEHDKSP-DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASN 596 (711)
Q Consensus 519 vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~ 596 (711)
+||+|||+++........ ......+++.|+|||.+..+.++.++|||||||++|||++ |..||.....
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---------- 232 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---------- 232 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH----------
Confidence 999999999866433221 1222346789999999998899999999999999999998 8888754211
Q ss_pred hHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 043702 597 LVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLV 656 (711)
Q Consensus 597 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 656 (711)
.++... ...+.. ..+.......+.+++..||+.+|.+||++++|++.|+
T Consensus 233 -~~~~~~-i~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 233 -QDVIEM-IRNRQV---------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred -HHHHHH-HHcCCc---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 111111 111111 1112234456788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=320.77 Aligned_cols=251 Identities=22% Similarity=0.374 Sum_probs=204.1
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC------CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS------QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILL 453 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 453 (711)
++|...+.||+|++|.||++....+++.+|+|.+.... ...+.+.+|++++++++||||+++++++..++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57889999999999999999998889999999876432 123468889999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCC
Q 043702 454 VYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHD 533 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~ 533 (711)
|+||+++++|.+++.. ...+++..+.+++.|++.||.|||+. +++||||+|+||++++++.+||+|||+++.....
T Consensus 82 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 82 FMEYMPGGSVKDQLKA-YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEECCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 9999999999998864 34688999999999999999999997 9999999999999999999999999999865432
Q ss_pred CCCCc--ccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchh
Q 043702 534 KSPDA--TVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLL 611 (711)
Q Consensus 534 ~~~~~--~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 611 (711)
..... ....|+..|+|||.+.+..++.++|||||||++|||++|+.||..... ... ......
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----------~~~-~~~~~~----- 221 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA----------MAA-IFKIAT----- 221 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch----------HHH-HHHHhc-----
Confidence 22111 234578899999999998899999999999999999999999864311 000 011000
Q ss_pred HhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 612 TAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 612 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.......+......+.+++.+||+.+|.+||++.++++.
T Consensus 222 ----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 222 ----QPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ----cCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 001111222334567788999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=333.12 Aligned_cols=250 Identities=23% Similarity=0.343 Sum_probs=198.9
Q ss_pred ceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhc-CCCCeeeeeeeeeecCeEEEEEEcCCC
Q 043702 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTL-RHRNLVRLQGWCHEKGEILLVYDLMPN 460 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 460 (711)
++||+|+||.||++++..+++.||+|++... ....+.+.+|..++..+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999999989999999998752 22345678899999998 699999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCccc
Q 043702 461 GSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATV 540 (711)
Q Consensus 461 gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 540 (711)
|+|..++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 155 (329)
T cd05588 81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTST 155 (329)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC-Ccccc
Confidence 999988864 35799999999999999999999998 99999999999999999999999999997532221 22334
Q ss_pred ccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccC
Q 043702 541 AAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEG 620 (711)
Q Consensus 541 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 620 (711)
.+||+.|+|||++.+..++.++|||||||++|||++|+.||+...... .......++..+....+.. .+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~---~~~~~~~~~~~~~~~~~~~------~~-- 224 (329)
T cd05588 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSD---NPDQNTEDYLFQVILEKQI------RI-- 224 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccc---cccccchHHHHHHHHcCCC------CC--
Confidence 579999999999999999999999999999999999999996432110 0011222333332222211 11
Q ss_pred CCcHHHHHHHHHHHHhcCCCCCCCCCC------HHHHHH
Q 043702 621 QFDEAEMRRVLLVGLACSHPDPLARPT------MRGVVQ 653 (711)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs------~~eVl~ 653 (711)
+......+.+++.+||+.||.+||+ ++++++
T Consensus 225 --p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 225 --PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred --CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 1122345778889999999999997 677765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=339.74 Aligned_cols=261 Identities=24% Similarity=0.325 Sum_probs=200.6
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC---CChhhhHHHHHHHHhcCCCCeeeeeeeeeecC-----eEE
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKG-----EIL 452 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~ 452 (711)
+|+..+.||+|+||.||++....+++.||+|++.... ...+.+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999998889999999986532 23457889999999999999999999998776 789
Q ss_pred EEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCC
Q 043702 453 LVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEH 532 (711)
Q Consensus 453 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~ 532 (711)
+|+||+. ++|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 lv~e~~~-~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEeeccc-cCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 9999996 588887743 45799999999999999999999997 999999999999999999999999999987654
Q ss_pred CCCCCcccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCc--
Q 043702 533 DKSPDATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGR-- 609 (711)
Q Consensus 533 ~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~-- 609 (711)
..........+++.|+|||.+.+. .++.++|||||||++|||++|+.||...... ...+-+........
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~i~~~~g~~~~~ 227 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI--------QQLDLITDLLGTPSLE 227 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH--------HHHHHHHHHcCCCCHH
Confidence 433333445689999999998774 4789999999999999999999999654221 00000000000000
Q ss_pred --------hhHhhhhh-cc-------CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 610 --------LLTAADAR-LE-------GQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 610 --------~~~~~d~~-l~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
....+... .. ..........+.+++.+||+.||.+|||+.|+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 228 AMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000000 00 00111224567789999999999999999999974
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=324.55 Aligned_cols=254 Identities=28% Similarity=0.467 Sum_probs=204.5
Q ss_pred hcCCcccceeecCCceEEEEEEeCCC-----CeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQN-----GDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEI 451 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~-----~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 451 (711)
.++|...+.||+|+||.||+|..... +..||+|.+.... .....+.+|+.+++.++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 34688889999999999999988543 3789999987543 2345788999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhhCC---------CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEe
Q 043702 452 LLVYDLMPNGSLDKALFEAR---------SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLG 522 (711)
Q Consensus 452 ~lV~Ey~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~ 522 (711)
++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+. +++||||||+|||+++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence 99999999999999986422 2478899999999999999999987 99999999999999999999999
Q ss_pred ecCCceecCCCCC-CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHH
Q 043702 523 DFGLARQVEHDKS-PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEW 600 (711)
Q Consensus 523 DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~ 600 (711)
|||+++.+..... .......++..|+|||.+..+.++.++|||||||++|||++ |+.||..... .....+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--------~~~~~~ 233 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--------EEVLKF 233 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH--------HHHHHH
Confidence 9999986644322 12233456889999999998889999999999999999998 9999864321 111111
Q ss_pred HHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 043702 601 VWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLV 656 (711)
Q Consensus 601 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 656 (711)
...+... ..+......+.+++.+||+.+|.+|||+.++++.|+
T Consensus 234 ----~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 234 ----VIDGGHL---------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred ----HhcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 1111111 111222456788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=323.69 Aligned_cols=253 Identities=29% Similarity=0.483 Sum_probs=203.7
Q ss_pred CCcccceeecCCceEEEEEEeCCCCe---EEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGD---IIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~---~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
.|...+.||+|+||.||+|.+..++. .||+|++.... ....+|..|+.+++.++||||+++++++..++..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46788999999999999999876554 69999987532 23468999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
||+++++|.+++......+++.+++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.......
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 85 EFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred ecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence 99999999999987677899999999999999999999987 999999999999999999999999999986644322
Q ss_pred CCc-c-ccc--CCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCch
Q 043702 536 PDA-T-VAA--GTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRL 610 (711)
Q Consensus 536 ~~~-~-~~~--gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 610 (711)
... . ... .+..|+|||.+....++.++|||||||++|||++ |..||..... .....++. ....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~--------~~~~~~i~---~~~~- 229 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--------QDVINAIE---QDYR- 229 (269)
T ss_pred ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH--------HHHHHHHH---cCCc-
Confidence 111 1 111 2457999999998999999999999999999886 9999864321 11222211 0000
Q ss_pred hHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 611 LTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 611 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
.....+....+.+++.+||+.+|.+||++++|++.|+.
T Consensus 230 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 230 ---------LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred ---------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 01112234557789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=332.97 Aligned_cols=241 Identities=24% Similarity=0.348 Sum_probs=194.9
Q ss_pred ceeecCCceEEEEEEeC---CCCeEEEEEEcccC-----CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEc
Q 043702 386 RIIGHGAFGTVYKGILP---QNGDIIAVKRCSHN-----SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~---~~~~~vavK~~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
+.||+|+||.||+++.. ..++.||+|++... ......+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999863 46789999998642 22345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC
Q 043702 458 MPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD 537 (711)
Q Consensus 458 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 537 (711)
+++|+|.+++.. ...+.+..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 82 ~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 156 (323)
T cd05584 82 LSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-V 156 (323)
T ss_pred CCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-c
Confidence 999999999865 45678889999999999999999997 999999999999999999999999999986433222 2
Q ss_pred cccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhh
Q 043702 538 ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADAR 617 (711)
Q Consensus 538 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 617 (711)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........ .+..
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~-----------~~~~~~~~-~~~~------- 217 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR-----------KKTIDKIL-KGKL------- 217 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH-----------HHHHHHHH-cCCC-------
Confidence 2345799999999999988899999999999999999999999965321 11111111 1110
Q ss_pred ccCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 043702 618 LEGQFDEAEMRRVLLVGLACSHPDPLARP-----TMRGVVQ 653 (711)
Q Consensus 618 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVl~ 653 (711)
..+......+.+++.+||+.+|++|| ++.++++
T Consensus 218 ---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 218 ---NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred ---CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 11112234577889999999999999 7888876
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=320.14 Aligned_cols=245 Identities=25% Similarity=0.377 Sum_probs=195.7
Q ss_pred eeecCCceEEEEEEe--CCCCeEEEEEEcccCCC---ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCCCC
Q 043702 387 IIGHGAFGTVYKGIL--PQNGDIIAVKRCSHNSQ---GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNG 461 (711)
Q Consensus 387 ~LG~G~fg~Vy~~~~--~~~~~~vavK~~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 461 (711)
.||+|+||.||+|.+ ..++..+|+|++..... ..+++.+|+.+++.++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999965 34578899999865332 2467899999999999999999999986 45679999999999
Q ss_pred CHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC--cc
Q 043702 462 SLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD--AT 539 (711)
Q Consensus 462 sL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~--~~ 539 (711)
+|.+++.. ...+++..+.+++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.+....... ..
T Consensus 81 ~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 81 PLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 99999864 34689999999999999999999987 99999999999999999999999999998765433211 12
Q ss_pred cccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhc
Q 043702 540 VAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARL 618 (711)
Q Consensus 540 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 618 (711)
...++..|+|||.+....++.++|||||||++|||++ |+.||..... . ++.. ..+.+..
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~---~~~~-~i~~~~~-------- 216 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--------N---EVTQ-MIESGER-------- 216 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--------H---HHHH-HHHCCCC--------
Confidence 2234678999999988889999999999999999998 9999965321 1 1111 1111111
Q ss_pred cCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 619 EGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
...+......+.+++.+||+.||++||++.+|++.|++
T Consensus 217 -~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 217 -MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred -CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 11122234567789999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=344.12 Aligned_cols=203 Identities=23% Similarity=0.392 Sum_probs=171.0
Q ss_pred HHHHHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCC------Ceeeeeeeeee
Q 043702 374 ELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHR------NLVRLQGWCHE 447 (711)
Q Consensus 374 el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~------niv~l~g~~~~ 447 (711)
++...+++|.+.++||+|+||+||+|.+..+++.||||++.......+++..|++++..++|. +++++++++..
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 444567889999999999999999999988899999999875444455677788888887654 58889998875
Q ss_pred c-CeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCC---------
Q 043702 448 K-GEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGF--------- 517 (711)
Q Consensus 448 ~-~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~--------- 517 (711)
. +..++|||++ +++|.+++.+ ...+++..+..|+.||+.||+|||+. .+|+||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCccccccccc
Confidence 4 5789999988 7789888865 35799999999999999999999973 3899999999999998765
Q ss_pred -------cEEEeecCCceecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccc
Q 043702 518 -------NARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKE 584 (711)
Q Consensus 518 -------~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~ 584 (711)
.+||+|||++..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred ccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 499999998864322 233467999999999999999999999999999999999999999754
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=330.31 Aligned_cols=252 Identities=29% Similarity=0.428 Sum_probs=198.9
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCe--EEEEEEcccC--CCChhhhHHHHHHHHhc-CCCCeeeeeeeeeecCeEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGD--IIAVKRCSHN--SQGKDEFLSELSIIGTL-RHRNLVRLQGWCHEKGEILLV 454 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~--~vavK~~~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 454 (711)
++|+..+.||+|+||.||+|.+..++. .+|+|++... ....+.+.+|++++.++ +|+||+++++++..++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 467888999999999999999876664 4677776542 23345788999999999 799999999999999999999
Q ss_pred EEcCCCCCHHHHHhhCC---------------CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcE
Q 043702 455 YDLMPNGSLDKALFEAR---------------SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNA 519 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~v 519 (711)
|||+++++|.+++.... ..+++.+++.++.|++.||+|||+. +++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence 99999999999997532 2588999999999999999999987 99999999999999999999
Q ss_pred EEeecCCceecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchH
Q 043702 520 RLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLV 598 (711)
Q Consensus 520 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~ 598 (711)
||+|||+++...... ......++..|+|||.+....++.++|||||||++|||++ |..||..... .
T Consensus 164 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----------~ 230 (303)
T cd05088 164 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----------A 230 (303)
T ss_pred EeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh-----------H
Confidence 999999986432111 1112234678999999988889999999999999999998 9999864321 0
Q ss_pred HHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 599 EWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 599 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
+..... ..+ ............+.+++.+||+.+|++||++.++++.|+.
T Consensus 231 ~~~~~~-~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~ 279 (303)
T cd05088 231 ELYEKL-PQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 279 (303)
T ss_pred HHHHHH-hcC---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 111111 000 0001111123457789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=341.74 Aligned_cols=240 Identities=22% Similarity=0.323 Sum_probs=204.5
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEccc----CCCChhhhHHHHHHHHhcC-CCCeeeeeeeeeecCeEEE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSH----NSQGKDEFLSELSIIGTLR-HRNLVRLQGWCHEKGEILL 453 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~----~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~l 453 (711)
.++|...++||+|.||+|+++..+.+++.+|||.+++ .+++.+..+.|.+++.... ||.+++|+..++..+++++
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 4678999999999999999999999999999999987 3466778889999988886 9999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCC
Q 043702 454 VYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHD 533 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~ 533 (711)
||||+.||++..+ ...+.+++....-++..|+.||+|||+. +||+||||.+|||||.+|.+||+||||++..-..
T Consensus 447 vmey~~Ggdm~~~--~~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 447 VMEYVAGGDLMHH--IHTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred EEEecCCCcEEEE--EecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCCC
Confidence 9999999994333 3457799999999999999999999998 9999999999999999999999999999864322
Q ss_pred CCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHh
Q 043702 534 KSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTA 613 (711)
Q Consensus 534 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 613 (711)
...+.+.||||.|||||++.+..|+...|-|||||+||||+.|..||..++++ +.
T Consensus 522 -g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe------------------------e~ 576 (694)
T KOG0694|consen 522 -GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE------------------------EV 576 (694)
T ss_pred -CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH------------------------HH
Confidence 23566789999999999999999999999999999999999999999865431 11
Q ss_pred hhhhc--cCCCcHHHHHHHHHHHHhcCCCCCCCCCCH
Q 043702 614 ADARL--EGQFDEAEMRRVLLVGLACSHPDPLARPTM 648 (711)
Q Consensus 614 ~d~~l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 648 (711)
.|..+ ...|+.....+.+.++.+.+..+|++|.-+
T Consensus 577 FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 577 FDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 11111 112344455677788889999999999877
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=337.34 Aligned_cols=261 Identities=24% Similarity=0.291 Sum_probs=205.9
Q ss_pred HHHHHHHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhcCCCCeeeeeeeeee
Q 043702 372 YRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTLRHRNLVRLQGWCHE 447 (711)
Q Consensus 372 ~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 447 (711)
++++....++|+..+.||+|+||.||++.+..+++.+|+|++... ......+.+|+.+++.++||||+++++++..
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 555666778999999999999999999999999999999998642 2234567889999999999999999999999
Q ss_pred cCeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCc
Q 043702 448 KGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLA 527 (711)
Q Consensus 448 ~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla 527 (711)
++.+++||||+++|+|.+++.. ..++...+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 9999999999999999999854 3588889999999999999999998 9999999999999999999999999999
Q ss_pred eecCCCCCCCcccccCCCcccChhhhccC----CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHH
Q 043702 528 RQVEHDKSPDATVAAGTMGYLAPEYLLTG----RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWS 603 (711)
Q Consensus 528 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~ 603 (711)
+.............+||+.|+|||++... .++.++|||||||++|||++|+.||..... ......
T Consensus 190 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----------~~~~~~ 258 (371)
T cd05622 190 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----------VGTYSK 258 (371)
T ss_pred eEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH-----------HHHHHH
Confidence 87654333333456799999999998754 378999999999999999999999975321 111111
Q ss_pred hhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCC--CCCHHHHHHHH
Q 043702 604 LHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLA--RPTMRGVVQML 655 (711)
Q Consensus 604 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~eVl~~L 655 (711)
...........+ .......+.+++.+|+..++.+ ||++.++++..
T Consensus 259 i~~~~~~~~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 259 IMNHKNSLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred HHcCCCcccCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 111111011000 1122345667888899844443 78999998854
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=325.29 Aligned_cols=253 Identities=24% Similarity=0.441 Sum_probs=201.1
Q ss_pred cCCcccceeecCCceEEEEEEeC-----CCCeEEEEEEcccC-CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILP-----QNGDIIAVKRCSHN-SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILL 453 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 453 (711)
++|...++||+|+||.||++... ..+..+|+|.+... ....+.+.+|+++++.++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 35677889999999999999742 24568999987653 3345679999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhCC--------------CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcE
Q 043702 454 VYDLMPNGSLDKALFEAR--------------SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNA 519 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~v 519 (711)
+|||+++++|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence 999999999999987543 3588999999999999999999987 99999999999999999999
Q ss_pred EEeecCCceecCCCCCC-CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccch
Q 043702 520 RLGDFGLARQVEHDKSP-DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNL 597 (711)
Q Consensus 520 kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l 597 (711)
||+|||+++........ ......+++.|+|||.+....++.++|||||||++|||++ |++||..... ...
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~~ 233 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN--------TEA 233 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH--------HHH
Confidence 99999999865432211 1122335678999999999999999999999999999998 8999854321 011
Q ss_pred HHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 043702 598 VEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLV 656 (711)
Q Consensus 598 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 656 (711)
.... ..+. ...........+.+++.+||+.||.+||++++|++.|+
T Consensus 234 ---~~~~-~~~~---------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 234 ---IECI-TQGR---------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ---HHHH-HcCc---------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1111 1110 00111122345778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=332.34 Aligned_cols=242 Identities=23% Similarity=0.336 Sum_probs=196.1
Q ss_pred ceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhc-CCCCeeeeeeeeeecCeEEEEEEcCCC
Q 043702 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTL-RHRNLVRLQGWCHEKGEILLVYDLMPN 460 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 460 (711)
++||+|+||.||+|+...+++.||+|++... ....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999888999999998752 23345677899999876 699999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCccc
Q 043702 461 GSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATV 540 (711)
Q Consensus 461 gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 540 (711)
|+|..++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~~ 155 (321)
T cd05591 81 GDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTTT 155 (321)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc-cccc
Confidence 999998864 35689999999999999999999998 999999999999999999999999999986433222 2334
Q ss_pred ccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccC
Q 043702 541 AAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEG 620 (711)
Q Consensus 541 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 620 (711)
..||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+....... +..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~-----------~~~~~~i~~-~~~---------- 213 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-----------DDLFESILH-DDV---------- 213 (321)
T ss_pred cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH-----------HHHHHHHHc-CCC----------
Confidence 5699999999999998999999999999999999999999975421 111111111 110
Q ss_pred CCcHHHHHHHHHHHHhcCCCCCCCCC-------CHHHHHHH
Q 043702 621 QFDEAEMRRVLLVGLACSHPDPLARP-------TMRGVVQM 654 (711)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-------s~~eVl~~ 654 (711)
.++......+.+++..||+.||.+|| ++.++++.
T Consensus 214 ~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 214 LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 01111234567888999999999999 78888754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=322.64 Aligned_cols=254 Identities=30% Similarity=0.477 Sum_probs=204.2
Q ss_pred cCCcccceeecCCceEEEEEEeCCCC---eEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNG---DIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLV 454 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~---~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 454 (711)
.+|...+.||+|+||.||+|++..++ ..+|+|.+.... ...+.+.+|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46788899999999999999875333 479999886533 2345789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCC
Q 043702 455 YDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~ 534 (711)
|||+++++|.+++......+++.++++++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++.+....
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 999999999999987667799999999999999999999997 99999999999999999999999999998765433
Q ss_pred CCCcc--cccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchh
Q 043702 535 SPDAT--VAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLL 611 (711)
Q Consensus 535 ~~~~~--~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 611 (711)
..... ...++..|+|||.+....++.++|||||||++||+++ |+.||..... ....... ..+.
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~--------~~~~~~~----~~~~-- 226 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN--------QDVIKAI----EEGY-- 226 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH--------HHHHHHH----hCCC--
Confidence 22111 1223568999999998899999999999999999887 9999864321 1111111 1110
Q ss_pred HhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 612 TAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 612 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
...........+.+++.+|++.+|.+||+|.++++.|..
T Consensus 227 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 227 -------RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred -------cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 000111223567789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=318.72 Aligned_cols=251 Identities=25% Similarity=0.379 Sum_probs=207.5
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCC
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMP 459 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 459 (711)
++|+..+.||+|++|.||+|....++..+++|.+..... .+++.+|++++++++|+|++++++++..+...++++||++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 568889999999999999999988889999999876433 6789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCcc
Q 043702 460 NGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDAT 539 (711)
Q Consensus 460 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 539 (711)
+++|.+++......+++..+..++.|+++||.|||+. +++||||+|+||++++++.+||+|||++........ ...
T Consensus 82 ~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~ 157 (256)
T cd06612 82 AGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KRN 157 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-ccc
Confidence 9999999987777899999999999999999999997 999999999999999999999999999987654332 223
Q ss_pred cccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhcc
Q 043702 540 VAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLE 619 (711)
Q Consensus 540 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 619 (711)
...|+..|+|||++.+..++.++|||||||++|||++|+.||...... . ... ...... .+.
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~--------~--~~~--~~~~~~-----~~~-- 218 (256)
T cd06612 158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM--------R--AIF--MIPNKP-----PPT-- 218 (256)
T ss_pred cccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh--------h--hhh--hhccCC-----CCC--
Confidence 345889999999999889999999999999999999999998653211 0 000 000000 000
Q ss_pred CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 620 GQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 620 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
...+......+.+++.+||+.+|.+||++.||++.
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 219 LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 01112223567888999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=331.74 Aligned_cols=246 Identities=21% Similarity=0.336 Sum_probs=198.3
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhcC-CCCeeeeeeeeeecCeEEEEE
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTLR-HRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 455 (711)
+|...+.||+|+||.||+|+...+++.||+|++... ....+.+..|..++..+. |++|+++++++...+.+++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 477889999999999999999888999999998752 223345677888888875 899999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
||+++|+|..++.. ...+++.++..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~- 155 (323)
T cd05616 81 EYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG- 155 (323)
T ss_pred cCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-
Confidence 99999999998864 35689999999999999999999997 99999999999999999999999999998643222
Q ss_pred CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhh
Q 043702 536 PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 615 (711)
.......||+.|+|||++....++.++|||||||++|||++|+.||..... ..+.. .. ....
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~--------~~~~~---~i-~~~~------ 217 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQ---SI-MEHN------ 217 (323)
T ss_pred CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH--------HHHHH---HH-HhCC------
Confidence 123345799999999999999999999999999999999999999975321 11111 11 1111
Q ss_pred hhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCH-----HHHHH
Q 043702 616 ARLEGQFDEAEMRRVLLVGLACSHPDPLARPTM-----RGVVQ 653 (711)
Q Consensus 616 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~eVl~ 653 (711)
..++.....++.+++.+|++.||.+|++. .++.+
T Consensus 218 ----~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 218 ----VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred ----CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 11122234567788999999999999985 56543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=342.77 Aligned_cols=200 Identities=26% Similarity=0.357 Sum_probs=174.8
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
+|+..+.||+|+||.||+++...+++.||+|++... ......+.+|++++++++|+||+++++.+.+++.+++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 688999999999999999999888999999998642 2334568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCC--
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK-- 534 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~-- 534 (711)
|+++|+|.+++.. ...+++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 82 YIPGGDMMSLLIR-LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 9999999999965 35688899999999999999999997 99999999999999999999999999985331000
Q ss_pred ----------------------------------------CCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHH
Q 043702 535 ----------------------------------------SPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEV 574 (711)
Q Consensus 535 ----------------------------------------~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~el 574 (711)
.......+||+.|||||++.+..++.++|||||||++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 0011234799999999999999999999999999999999
Q ss_pred HhCCCCCccc
Q 043702 575 ASGRRPIEKE 584 (711)
Q Consensus 575 ltG~~P~~~~ 584 (711)
++|+.||...
T Consensus 238 l~G~~Pf~~~ 247 (376)
T cd05598 238 LVGQPPFLAD 247 (376)
T ss_pred hhCCCCCCCC
Confidence 9999999754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=326.74 Aligned_cols=270 Identities=20% Similarity=0.298 Sum_probs=201.6
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEc
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
++|...+.||+|+||.||+|+...+++.||+|++.... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46888999999999999999998889999999987532 2344678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC
Q 043702 458 MPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD 537 (711)
Q Consensus 458 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 537 (711)
+++ +|.+++......+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 160 (309)
T cd07872 86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-T 160 (309)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc-c
Confidence 975 89888877666789999999999999999999997 999999999999999999999999999986543222 1
Q ss_pred cccccCCCcccChhhhcc-CCCCccccchhHHHHHHHHHhCCCCCccccccccccccc---cchHHHHHHhhhcC-chhH
Q 043702 538 ATVAAGTMGYLAPEYLLT-GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVA---SNLVEWVWSLHREG-RLLT 612 (711)
Q Consensus 538 ~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~---~~l~~~~~~~~~~~-~~~~ 612 (711)
.....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||............. .......|...... ....
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN 240 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence 223457899999998865 457899999999999999999999996532110000000 00000001000000 0000
Q ss_pred hhhhhccC----CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 613 AADARLEG----QFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 613 ~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
...+.... .........+.+++.+|++.||.+|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 00000000 0001123456789999999999999999999973
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=332.04 Aligned_cols=241 Identities=22% Similarity=0.332 Sum_probs=195.3
Q ss_pred ceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhc-CCCCeeeeeeeeeecCeEEEEEEcCCC
Q 043702 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTL-RHRNLVRLQGWCHEKGEILLVYDLMPN 460 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 460 (711)
++||+|+||.||+|+...+++.||+|++... ....+.+..|..++..+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999888999999998642 23445677899998877 599999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCccc
Q 043702 461 GSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATV 540 (711)
Q Consensus 461 gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 540 (711)
|+|..++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...... .....
T Consensus 81 g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~~ 155 (320)
T cd05590 81 GDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTST 155 (320)
T ss_pred chHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Ccccc
Confidence 9999988653 5689999999999999999999997 99999999999999999999999999987643222 22334
Q ss_pred ccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccC
Q 043702 541 AAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEG 620 (711)
Q Consensus 541 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 620 (711)
..||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.... ...+..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-----------~~~~~~-i~~~~~---------- 213 (320)
T cd05590 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-----------DDLFEA-ILNDEV---------- 213 (320)
T ss_pred cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-----------HHHHHH-HhcCCC----------
Confidence 5799999999999988999999999999999999999999965321 111111 111111
Q ss_pred CCcHHHHHHHHHHHHhcCCCCCCCCCCH------HHHHH
Q 043702 621 QFDEAEMRRVLLVGLACSHPDPLARPTM------RGVVQ 653 (711)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~eVl~ 653 (711)
..+......+.+++.+||+.||.+||++ +++++
T Consensus 214 ~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~ 252 (320)
T cd05590 214 VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILR 252 (320)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHc
Confidence 0111123456788899999999999998 66654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=318.78 Aligned_cols=248 Identities=29% Similarity=0.459 Sum_probs=205.2
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCC
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMP 459 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 459 (711)
++|+..+.||.|++|.||+|.. .|+.||+|.+.......+++.+|+.++++++|+|++++++++...+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 4678889999999999999988 47899999998765556789999999999999999999999998899999999999
Q ss_pred CCCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCc
Q 043702 460 NGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDA 538 (711)
Q Consensus 460 ~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 538 (711)
+++|.+++.... ..+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||+++.......
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--- 157 (256)
T cd05039 84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--- 157 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc---
Confidence 999999997544 3699999999999999999999997 999999999999999999999999999987633221
Q ss_pred ccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhh
Q 043702 539 TVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADAR 617 (711)
Q Consensus 539 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 617 (711)
...++..|+|||.+..+.++.++||||||+++|||++ |+.||..... ..+.. ....+
T Consensus 158 -~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~----~~~~~--------- 215 (256)
T cd05039 158 -SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KDVVP----HVEKG--------- 215 (256)
T ss_pred -cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH--------HHHHH----HHhcC---------
Confidence 2335678999999998889999999999999999997 9999864321 11111 11111
Q ss_pred ccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 618 LEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 618 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
............+.+++.+||..+|++||++.+++++|+.
T Consensus 216 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 216 YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 0111122234567889999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=326.43 Aligned_cols=261 Identities=23% Similarity=0.371 Sum_probs=204.8
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCC----------------eEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeee
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNG----------------DIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVR 440 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~----------------~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~ 440 (711)
.++|+..+.||+|+||.||++.....+ ..||+|++.... ...+++.+|++++++++|||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 357888999999999999999875433 468999987543 33567889999999999999999
Q ss_pred eeeeeeecCeEEEEEEcCCCCCHHHHHhhCC----------CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCc
Q 043702 441 LQGWCHEKGEILLVYDLMPNGSLDKALFEAR----------SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSN 510 (711)
Q Consensus 441 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~N 510 (711)
++++|..++..++++||+++++|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 9999999999999999999999999997543 2689999999999999999999987 99999999999
Q ss_pred eEEcCCCcEEEeecCCceecCCCCCC-CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh--CCCCCcccccc
Q 043702 511 IMLDEGFNARLGDFGLARQVEHDKSP-DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS--GRRPIEKEITG 587 (711)
Q Consensus 511 ILld~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt--G~~P~~~~~~~ 587 (711)
|+++.++.+||+|||+++........ ......++..|+|||.+..+.++.++|||||||++|||++ +..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 99999999999999999865433221 1223456789999999998899999999999999999998 6677754211
Q ss_pred ccccccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 043702 588 VGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLV 656 (711)
Q Consensus 588 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 656 (711)
...........+....... .........++.+++.+||+.||.+||++.||++.|+
T Consensus 240 -------~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 -------QQVIENAGHFFRDDGRQIY------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred -------HHHHHHHHhcccccccccc------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1112222211111111100 0111122356889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=322.48 Aligned_cols=252 Identities=27% Similarity=0.445 Sum_probs=197.8
Q ss_pred CcccceeecCCceEEEEEEeCCCCe--EEEEEEcccC---CCChhhhHHHHHHHHhcCCCCeeeeeeeeeec------Ce
Q 043702 382 FNANRIIGHGAFGTVYKGILPQNGD--IIAVKRCSHN---SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEK------GE 450 (711)
Q Consensus 382 f~~~~~LG~G~fg~Vy~~~~~~~~~--~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~ 450 (711)
|...++||+|+||.||+|....++. .+|+|.+... ....+.+.+|+++++.++|+||++++++|... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3456889999999999999876664 6899987653 23346788999999999999999999988532 24
Q ss_pred EEEEEEcCCCCCHHHHHhhC-----CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecC
Q 043702 451 ILLVYDLMPNGSLDKALFEA-----RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFG 525 (711)
Q Consensus 451 ~~lV~Ey~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFG 525 (711)
.+++|||+++|+|.+++... ...+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 68999999999999987432 23489999999999999999999987 99999999999999999999999999
Q ss_pred CceecCCCCCC-CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHH
Q 043702 526 LARQVEHDKSP-DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWS 603 (711)
Q Consensus 526 la~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~ 603 (711)
+++.+...... ......+++.|+|||++....++.++|||||||++|||++ |+.||..... ..+ +.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~~----~~ 225 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--------SEI----YD 225 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--------HHH----HH
Confidence 99876543221 1122346778999999999899999999999999999999 8888854311 111 11
Q ss_pred hhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 604 LHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 604 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
....+... .........+.+++.+||+.||++||++.++++.|+.
T Consensus 226 ~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 226 YLRQGNRL---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred HHHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 11221111 0111233557889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=320.80 Aligned_cols=256 Identities=24% Similarity=0.389 Sum_probs=206.9
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC----CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS----QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
.+|+..+.||+|++|.||++....+++.+|||.+.... ....++.+|+++++.++|+||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 36778899999999999999998889999999876522 23457889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhh---CCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCC
Q 043702 456 DLMPNGSLDKALFE---ARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEH 532 (711)
Q Consensus 456 Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~ 532 (711)
||+++++|.+++.. ....+++..+..++.|+++||.|||+. +++|+||||+||+++.++.+||+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999998863 235689999999999999999999987 999999999999999999999999999987643
Q ss_pred CCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhH
Q 043702 533 DKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLT 612 (711)
Q Consensus 533 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 612 (711)
... ......|+..|+|||.+.+..++.++||||||+++|||++|..||..... ...++.... ..
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---------~~~~~~~~~------~~ 222 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---------NLYSLCKKI------EQ 222 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc---------hHHHHhhhh------hc
Confidence 322 12234688999999999988899999999999999999999999864321 111111110 00
Q ss_pred hhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 613 AADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 613 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
...+.. ........+.+++.+||+.+|.+||||.+|+++++.
T Consensus 223 ~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 223 CDYPPL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred CCCCCC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence 001111 112234567788899999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=330.99 Aligned_cols=242 Identities=20% Similarity=0.320 Sum_probs=197.1
Q ss_pred ceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhc-CCCCeeeeeeeeeecCeEEEEEEcCCC
Q 043702 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTL-RHRNLVRLQGWCHEKGEILLVYDLMPN 460 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 460 (711)
+.||+|+||+||+|++..+++.||+|++... ....+.+..|.+++..+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999888999999998752 23455677899999888 599999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCccc
Q 043702 461 GSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATV 540 (711)
Q Consensus 461 gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 540 (711)
|+|..++.. ...+++.++..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++....... ....
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 155 (318)
T cd05570 81 GDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTST 155 (318)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cccc
Confidence 999998864 34799999999999999999999997 999999999999999999999999999975332221 2233
Q ss_pred ccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccC
Q 043702 541 AAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEG 620 (711)
Q Consensus 541 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 620 (711)
.+|++.|+|||++.+..++.++|||||||++|||++|+.||..... .+.. .....+..
T Consensus 156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~-----------~~~~-~~i~~~~~---------- 213 (318)
T cd05570 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-----------DELF-QSILEDEV---------- 213 (318)
T ss_pred eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH-----------HHHH-HHHHcCCC----------
Confidence 5699999999999999999999999999999999999999964321 0111 11111110
Q ss_pred CCcHHHHHHHHHHHHhcCCCCCCCCCCH-----HHHHHH
Q 043702 621 QFDEAEMRRVLLVGLACSHPDPLARPTM-----RGVVQM 654 (711)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~eVl~~ 654 (711)
.++......+.+++.+||+.||.+||++ .++++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 214 RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 1112223567788999999999999999 888763
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=328.07 Aligned_cols=255 Identities=29% Similarity=0.435 Sum_probs=203.5
Q ss_pred cCCcccceeecCCceEEEEEEe-----CCCCeEEEEEEcccCC--CChhhhHHHHHHHHhc-CCCCeeeeeeeeeecCeE
Q 043702 380 KCFNANRIIGHGAFGTVYKGIL-----PQNGDIIAVKRCSHNS--QGKDEFLSELSIIGTL-RHRNLVRLQGWCHEKGEI 451 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~-----~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 451 (711)
++|...+.||+|+||.||++.. ...+..||+|++.... ...+.+.+|+++++++ +||||++++++|...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 4688899999999999999975 2345689999887533 2245788999999999 799999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhhCCC-CCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceec
Q 043702 452 LLVYDLMPNGSLDKALFEARS-PLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV 530 (711)
Q Consensus 452 ~lV~Ey~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~ 530 (711)
++||||+++|+|.+++..... .+++.++..++.|++.||+|||+. +|+|+||||+|||++.++.+||+|||+++..
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~ 191 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDI 191 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccccc
Confidence 999999999999999975443 489999999999999999999997 9999999999999999999999999999866
Q ss_pred CCCCCC-CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcC
Q 043702 531 EHDKSP-DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREG 608 (711)
Q Consensus 531 ~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 608 (711)
...... ......++..|+|||.+..+.++.++|||||||++|||++ |+.||...... ..... ....+
T Consensus 192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~-------~~~~~----~~~~~ 260 (302)
T cd05055 192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD-------SKFYK----LIKEG 260 (302)
T ss_pred cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch-------HHHHH----HHHcC
Confidence 443221 1112345778999999999999999999999999999998 99998653210 01111 11111
Q ss_pred chhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 609 RLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 609 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
...........++.+++.+||+.+|++||++.||++.|+.
T Consensus 261 ---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 261 ---------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred ---------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 0001111223567889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=305.61 Aligned_cols=258 Identities=25% Similarity=0.305 Sum_probs=207.9
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC-CChhhhHHHHHHHHhcCCCCeeeeeeeeeec-----CeEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCHEK-----GEILL 453 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~~l 453 (711)
++|.+.+.||+|||+.||+++.-.++..+|+|++.... ++.+..++|++..++++|||++++++++..+ ...||
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl 100 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL 100 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence 57889999999999999999988889999999988754 6678899999999999999999999988543 35899
Q ss_pred EEEcCCCCCHHHHHhh---CCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceec
Q 043702 454 VYDLMPNGSLDKALFE---ARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV 530 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~ 530 (711)
+++|...|+|.+.+.. ++..+++.+.++|+.+|++||++||+. .++++||||||.|||+.+.+.++|.|||.+...
T Consensus 101 l~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a 179 (302)
T KOG2345|consen 101 LLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQA 179 (302)
T ss_pred EeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcccc
Confidence 9999999999999864 334699999999999999999999997 567999999999999999999999999999765
Q ss_pred CCCCC--------CCcccccCCCcccChhhhcc---CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHH
Q 043702 531 EHDKS--------PDATVAAGTMGYLAPEYLLT---GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVE 599 (711)
Q Consensus 531 ~~~~~--------~~~~~~~gt~~y~APE~~~~---~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~ 599 (711)
.-.-. .+.....-|..|+|||.+.- ...++++|||||||+||+|+.|..||+....
T Consensus 180 ~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~------------- 246 (302)
T KOG2345|consen 180 PIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ------------- 246 (302)
T ss_pred ceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-------------
Confidence 32111 11122346889999998853 4568999999999999999999999986533
Q ss_pred HHHHhhhcCchhHh-hhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 600 WVWSLHREGRLLTA-ADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 600 ~~~~~~~~~~~~~~-~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
+.|.+.-+ ....+.-.-+....+.+.+++.+|++.||.+||++.+++..+..
T Consensus 247 ------~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~ 299 (302)
T KOG2345|consen 247 ------QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD 299 (302)
T ss_pred ------cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence 11111111 11111111122245678899999999999999999999998864
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=332.90 Aligned_cols=202 Identities=27% Similarity=0.389 Sum_probs=178.0
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEccc----CCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSH----NSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
++|+..++||+|+||.||+++...+++.+|+|++.. .......+.+|+.++..++|+||+++++++.+.+.+++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 468889999999999999999998899999999864 2223445788999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
||+++|+|.+++.+....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 99999999999987667899999999999999999999997 999999999999999999999999999986544333
Q ss_pred CCcccccCCCcccChhhhc-----cCCCCccccchhHHHHHHHHHhCCCCCccc
Q 043702 536 PDATVAAGTMGYLAPEYLL-----TGRATEKTDVFSYGAVVLEVASGRRPIEKE 584 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwSfGvll~elltG~~P~~~~ 584 (711)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~ 211 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence 3333457999999999986 346789999999999999999999999653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=329.71 Aligned_cols=241 Identities=21% Similarity=0.351 Sum_probs=194.0
Q ss_pred ceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHh-cCCCCeeeeeeeeeecCeEEEEEEcCCC
Q 043702 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGT-LRHRNLVRLQGWCHEKGEILLVYDLMPN 460 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 460 (711)
+.||+|+||+||+|++..+++.||+|++... ....+.+..|..++.. ++||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999999888999999998753 2334566778888876 4899999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCccc
Q 043702 461 GSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATV 540 (711)
Q Consensus 461 gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 540 (711)
|+|.+++.. ...+++.++..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (316)
T cd05619 81 GDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCT 155 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cceee
Confidence 999999864 35689999999999999999999997 99999999999999999999999999997543222 12234
Q ss_pred ccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccC
Q 043702 541 AAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEG 620 (711)
Q Consensus 541 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 620 (711)
..||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+... ...+ .+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--------~~~~~~----i~~~------~~~--- 214 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE--------EELFQS----IRMD------NPC--- 214 (316)
T ss_pred ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH--------HHHHHH----HHhC------CCC---
Confidence 5699999999999998999999999999999999999999965321 111111 1110 011
Q ss_pred CCcHHHHHHHHHHHHhcCCCCCCCCCCHH-HHHH
Q 043702 621 QFDEAEMRRVLLVGLACSHPDPLARPTMR-GVVQ 653 (711)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-eVl~ 653 (711)
++......+.+++.+||+.||.+||++. ++.+
T Consensus 215 -~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 215 -YPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred -CCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 1111234567888999999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=316.70 Aligned_cols=247 Identities=30% Similarity=0.495 Sum_probs=204.3
Q ss_pred ceeecCCceEEEEEEeCCC---CeEEEEEEcccCCCC--hhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCCC
Q 043702 386 RIIGHGAFGTVYKGILPQN---GDIIAVKRCSHNSQG--KDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPN 460 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~~~---~~~vavK~~~~~~~~--~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 460 (711)
+.||+|+||.||+|..... +..+++|++...... .+.+.+|+++++.++|+|++++++++..+...++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4699999999999999765 889999998874433 67899999999999999999999999999999999999999
Q ss_pred CCHHHHHhhC--------CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCC
Q 043702 461 GSLDKALFEA--------RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEH 532 (711)
Q Consensus 461 gsL~~~l~~~--------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~ 532 (711)
++|.+++... ...+++..+.+++.|++.||+|||+. +++||||||+||++++++.+||+|||.++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999775 47799999999999999999999997 999999999999999999999999999987754
Q ss_pred CCC-CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCch
Q 043702 533 DKS-PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRL 610 (711)
Q Consensus 533 ~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 610 (711)
... .......++..|+|||.+....++.++||||+||+++||++ |+.||..... ..+. .....+.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~----~~~~~~~- 224 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--------EEVL----EYLRKGY- 224 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--------HHHH----HHHHcCC-
Confidence 431 12233457889999999998899999999999999999999 6999865421 1111 1111111
Q ss_pred hHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 043702 611 LTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLV 656 (711)
Q Consensus 611 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 656 (711)
...........+.+++.+||+.+|.+||++.|+++.|+
T Consensus 225 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 --------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11112223467888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=322.08 Aligned_cols=268 Identities=26% Similarity=0.370 Sum_probs=207.9
Q ss_pred HHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHh--cCCCCeeeeeeeeeec----Ce
Q 043702 377 SATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGT--LRHRNLVRLQGWCHEK----GE 450 (711)
Q Consensus 377 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~~~----~~ 450 (711)
...+.....+.||+|.||+||+|.+ .|+.||||++.. .+++.+.+|.++++. |+|+||+.+++.-..+ .+
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~s--rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSS--RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred hhhheeEEEEEecCccccceeeccc--cCCceEEEEecc--cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 3446788899999999999999999 589999999874 456788899999887 6899999999875443 27
Q ss_pred EEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhc-----cCCCeeeccCCCCceEEcCCCcEEEeecC
Q 043702 451 ILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQE-----CENQVIHRDVKTSNIMLDEGFNARLGDFG 525 (711)
Q Consensus 451 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-----~~~~ivHrDlkp~NILld~~~~vkL~DFG 525 (711)
++||.+|.++|||++||.. ..++-+..+++++.+|.||++||.+ ..+.|.|||||+.|||+..++.+.|+|+|
T Consensus 284 LwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 8999999999999999954 6799999999999999999999974 35789999999999999999999999999
Q ss_pred CceecCCCCC---CCcccccCCCcccChhhhccCC------CCccccchhHHHHHHHHHhC----------CCCCccccc
Q 043702 526 LARQVEHDKS---PDATVAAGTMGYLAPEYLLTGR------ATEKTDVFSYGAVVLEVASG----------RRPIEKEIT 586 (711)
Q Consensus 526 la~~~~~~~~---~~~~~~~gt~~y~APE~~~~~~------~s~ksDVwSfGvll~elltG----------~~P~~~~~~ 586 (711)
||-....+.. ......+||.+|||||++...- .-..+||||||.++||++.. +.||.+..+
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 9976654422 1234468999999999996542 23468999999999999862 446654322
Q ss_pred cccccccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC
Q 043702 587 GVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEAE 660 (711)
Q Consensus 587 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 660 (711)
.. .+ .+-+.+..-..++...++.+ ..+.+.+..+.+++..||..+|..|-|+-.+-+.|.+...
T Consensus 442 ~D------Ps-~eeMrkVVCv~~~RP~ipnr---W~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 442 SD------PS-FEEMRKVVCVQKLRPNIPNR---WKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CC------CC-HHHHhcceeecccCCCCCcc---cccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 11 11 12222322222332222222 2345788899999999999999999999999888876544
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=340.59 Aligned_cols=252 Identities=22% Similarity=0.274 Sum_probs=196.7
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
++|...++||+|+||+||++....+++.||||++... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3688899999999999999999989999999988642 223456888999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
||+++|+|.+++.. ...+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 81 EFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 99999999999864 45688999999999999999999998 999999999999999999999999999964321000
Q ss_pred ------------C----------------------------------CcccccCCCcccChhhhccCCCCccccchhHHH
Q 043702 536 ------------P----------------------------------DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGA 569 (711)
Q Consensus 536 ------------~----------------------------------~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGv 569 (711)
. .....+||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 001246999999999999989999999999999
Q ss_pred HHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCC---C
Q 043702 570 VVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLAR---P 646 (711)
Q Consensus 570 ll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R---P 646 (711)
++|||++|+.||...... +............. +.. .......+.+++.+|+. +|.+| +
T Consensus 237 il~elltG~~Pf~~~~~~-----------~~~~~i~~~~~~~~-----~p~--~~~~s~~~~dli~~lL~-~~~~r~~r~ 297 (377)
T cd05629 237 IMFECLIGWPPFCSENSH-----------ETYRKIINWRETLY-----FPD--DIHLSVEAEDLIRRLIT-NAENRLGRG 297 (377)
T ss_pred hhhhhhcCCCCCCCCCHH-----------HHHHHHHccCCccC-----CCC--CCCCCHHHHHHHHHHhc-CHhhcCCCC
Confidence 999999999999653210 00011110000000 000 00112346677788887 66665 6
Q ss_pred CHHHHHHH
Q 043702 647 TMRGVVQM 654 (711)
Q Consensus 647 s~~eVl~~ 654 (711)
++.|+++.
T Consensus 298 ~~~~~l~h 305 (377)
T cd05629 298 GAHEIKSH 305 (377)
T ss_pred CHHHHhcC
Confidence 99999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=318.12 Aligned_cols=253 Identities=26% Similarity=0.432 Sum_probs=204.7
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcC
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
.++|...++||+|+||.||++... .+..+|+|.+.......+.+.+|++++++++|+|++++++.+.. ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 357888999999999999999874 46679999887655556789999999999999999999999887 7789999999
Q ss_pred CCCCHHHHHhhC-CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC
Q 043702 459 PNGSLDKALFEA-RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD 537 (711)
Q Consensus 459 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 537 (711)
++++|.+++... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 159 (260)
T cd05073 83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 159 (260)
T ss_pred CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCccc
Confidence 999999999753 34689999999999999999999987 99999999999999999999999999998765433222
Q ss_pred cccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhhhh
Q 043702 538 ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADA 616 (711)
Q Consensus 538 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 616 (711)
.....++..|+|||++..+.++.++|||||||++|||++ |+.||..... ..+..+. ..+..
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--------~~~~~~~----~~~~~------ 221 (260)
T cd05073 160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--------PEVIRAL----ERGYR------ 221 (260)
T ss_pred ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHH----hCCCC------
Confidence 223346678999999998889999999999999999999 9999864321 1111111 11110
Q ss_pred hccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 617 RLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 617 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
..........+.+++.+|++.+|++||++.++++.|+.
T Consensus 222 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 222 ---MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ---CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01112233567788899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=340.28 Aligned_cols=200 Identities=26% Similarity=0.375 Sum_probs=174.4
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC----CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS----QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
.|+..++||+|+||+||+|+...+++.||+|++.... .....+.+|++++++++||||+++++.+.+++.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788999999999999999999899999999986522 234578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCC--
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK-- 534 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~-- 534 (711)
||++|+|.+++... ..+++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 82 YIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 99999999998653 5688999999999999999999997 99999999999999999999999999985331000
Q ss_pred --------------------------------------------CCCcccccCCCcccChhhhccCCCCccccchhHHHH
Q 043702 535 --------------------------------------------SPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAV 570 (711)
Q Consensus 535 --------------------------------------------~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvl 570 (711)
.......+||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 000122469999999999999999999999999999
Q ss_pred HHHHHhCCCCCccc
Q 043702 571 VLEVASGRRPIEKE 584 (711)
Q Consensus 571 l~elltG~~P~~~~ 584 (711)
+|||++|+.||...
T Consensus 238 l~elltG~~Pf~~~ 251 (382)
T cd05625 238 LYEMLVGQPPFLAQ 251 (382)
T ss_pred HHHHHhCCCCCCCC
Confidence 99999999999653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=323.22 Aligned_cols=247 Identities=24% Similarity=0.323 Sum_probs=195.9
Q ss_pred eecCCceEEEEEEeCCCCeEEEEEEcccCC----CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCCCCCH
Q 043702 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNS----QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSL 463 (711)
Q Consensus 388 LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 463 (711)
||+|+||.||++..+.+|+.+|+|++.... .....+..|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999998889999999986421 2234566799999999999999999999999999999999999999
Q ss_pred HHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCccccc
Q 043702 464 DKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAA 542 (711)
Q Consensus 464 ~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~ 542 (711)
..++.... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++....... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence 98886533 4589999999999999999999997 99999999999999999999999999998765432 223346
Q ss_pred CCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccCCC
Q 043702 543 GTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQF 622 (711)
Q Consensus 543 gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 622 (711)
|+..|+|||++.+..++.++|||||||++|||++|+.||...... ....+....... ... . ..
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~-------~~~~~~~~~~~~-~~~----~--~~--- 218 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK-------VAKEELKRRTLE-DEV----K--FE--- 218 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch-------hhHHHHHHHhhc-ccc----c--cc---
Confidence 899999999999989999999999999999999999998643210 011111111110 000 0 00
Q ss_pred cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 043702 623 DEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLV 656 (711)
Q Consensus 623 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 656 (711)
.......+.+++.+||+.||++||+++|+++.+.
T Consensus 219 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 219 HQNFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred cccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 0112345678899999999999999987765443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=321.72 Aligned_cols=247 Identities=29% Similarity=0.437 Sum_probs=195.1
Q ss_pred ceeecCCceEEEEEEeCCCCe--EEEEEEcccC--CCChhhhHHHHHHHHhc-CCCCeeeeeeeeeecCeEEEEEEcCCC
Q 043702 386 RIIGHGAFGTVYKGILPQNGD--IIAVKRCSHN--SQGKDEFLSELSIIGTL-RHRNLVRLQGWCHEKGEILLVYDLMPN 460 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~~~~~--~vavK~~~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 460 (711)
+.||+|+||.||+|++.+++. .+++|.+... ....+.+.+|+++++++ +||||++++++|...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 369999999999999977665 4688887742 23446788999999999 799999999999999999999999999
Q ss_pred CCHHHHHhhCC---------------CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecC
Q 043702 461 GSLDKALFEAR---------------SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFG 525 (711)
Q Consensus 461 gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFG 525 (711)
|+|.+++.... ..+++.++.+++.|++.||+|||+. +++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 99999996532 2488999999999999999999987 99999999999999999999999999
Q ss_pred CceecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHh
Q 043702 526 LARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSL 604 (711)
Q Consensus 526 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~ 604 (711)
+++...... .......+..|+|||++....++.++|||||||++|||++ |..||..... .+.....
T Consensus 158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-----------~~~~~~~ 224 (270)
T cd05047 158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----------AELYEKL 224 (270)
T ss_pred Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH-----------HHHHHHH
Confidence 986432111 1111234667999999988889999999999999999997 9999864321 1111111
Q ss_pred hhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 605 HREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 605 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
..+ ............+.+++.+||+.+|.+||++.++++.|...
T Consensus 225 -~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 225 -PQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred -hCC---------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 110 00011112234677899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=329.23 Aligned_cols=237 Identities=27% Similarity=0.341 Sum_probs=190.5
Q ss_pred ceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHH-HHHhcCCCCeeeeeeeeeecCeEEEEEEcCCC
Q 043702 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELS-IIGTLRHRNLVRLQGWCHEKGEILLVYDLMPN 460 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 460 (711)
+.||+|+||+||+|++..+|+.||+|++... .....++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999999989999999998652 223345556655 46789999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCccc
Q 043702 461 GSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATV 540 (711)
Q Consensus 461 gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 540 (711)
|+|..++.. ...+++..+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (323)
T cd05575 81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTST 155 (323)
T ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Ccccc
Confidence 999998865 45689999999999999999999997 99999999999999999999999999997543222 22334
Q ss_pred ccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccC
Q 043702 541 AAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEG 620 (711)
Q Consensus 541 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 620 (711)
.+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+....... +. ..+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-----------~~~~~~i~~-~~------~~~~- 216 (323)
T cd05575 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-----------AEMYDNILN-KP------LRLK- 216 (323)
T ss_pred ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-----------HHHHHHHHc-CC------CCCC-
Confidence 5799999999999999999999999999999999999999965321 111111111 10 0111
Q ss_pred CCcHHHHHHHHHHHHhcCCCCCCCCCCHH
Q 043702 621 QFDEAEMRRVLLVGLACSHPDPLARPTMR 649 (711)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 649 (711)
......+.+++.+|++.||.+||+++
T Consensus 217 ---~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 217 ---PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred ---CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 12245577888999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=329.93 Aligned_cols=238 Identities=24% Similarity=0.345 Sum_probs=192.8
Q ss_pred ceeecCCceEEEEEEe---CCCCeEEEEEEcccCC---CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCC
Q 043702 386 RIIGHGAFGTVYKGIL---PQNGDIIAVKRCSHNS---QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMP 459 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~---~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 459 (711)
+.||+|+||.||+++. ..+|+.+|+|++.... .....+.+|++++++++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999876 3468899999987522 234567789999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCcc
Q 043702 460 NGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDAT 539 (711)
Q Consensus 460 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 539 (711)
+|+|.+++.. ...+++..+..++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++....... ...
T Consensus 82 ~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~~~ 156 (318)
T cd05582 82 GGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KAY 156 (318)
T ss_pred CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-cee
Confidence 9999999854 45689999999999999999999997 999999999999999999999999999986543322 233
Q ss_pred cccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhcc
Q 043702 540 VAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLE 619 (711)
Q Consensus 540 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 619 (711)
...|++.|+|||.+....++.++|||||||++|||++|+.||..... .+....... ..
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-----------~~~~~~i~~-~~---------- 214 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR-----------KETMTMILK-AK---------- 214 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH-----------HHHHHHHHc-CC----------
Confidence 45799999999999988899999999999999999999999965321 111111111 11
Q ss_pred CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHH
Q 043702 620 GQFDEAEMRRVLLVGLACSHPDPLARPTMRG 650 (711)
Q Consensus 620 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 650 (711)
...+......+.+++.+||+.||++||++.+
T Consensus 215 ~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 215 LGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 0111122345678889999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=332.07 Aligned_cols=201 Identities=26% Similarity=0.369 Sum_probs=178.4
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
++|...+.||+|+||.||+++...+++.||+|++... ......+.+|+.++..++|+||+++++++..++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4688899999999999999999888999999998642 223445788999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
||+++|+|.+++......+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 99999999999987667899999999999999999999997 999999999999999999999999999987654433
Q ss_pred CCcccccCCCcccChhhhcc-----CCCCccccchhHHHHHHHHHhCCCCCcc
Q 043702 536 PDATVAAGTMGYLAPEYLLT-----GRATEKTDVFSYGAVVLEVASGRRPIEK 583 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~-----~~~s~ksDVwSfGvll~elltG~~P~~~ 583 (711)
.......||+.|+|||++.. +.++.++|||||||++|||++|+.||..
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 33334579999999999875 5678899999999999999999999964
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=318.68 Aligned_cols=253 Identities=28% Similarity=0.456 Sum_probs=202.9
Q ss_pred CcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChh---hhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcC
Q 043702 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKD---EFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 382 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~---~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
|+..+.||+|+||+||+++...+++.+|+|++........ ...+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5678899999999999999999999999999987554333 3356999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCc
Q 043702 459 PNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDA 538 (711)
Q Consensus 459 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 538 (711)
++++|.+++. ....+++..+..++.|+++||.|||+. +++|+||||+||++++++.++|+|||.+.... ......
T Consensus 81 ~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~~ 155 (260)
T PF00069_consen 81 PGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNENF 155 (260)
T ss_dssp TTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSEB
T ss_pred cccccccccc-ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-cccccc
Confidence 9999999997 456789999999999999999999998 99999999999999999999999999998652 222234
Q ss_pred ccccCCCcccChhhhc-cCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhh
Q 043702 539 TVAAGTMGYLAPEYLL-TGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADAR 617 (711)
Q Consensus 539 ~~~~gt~~y~APE~~~-~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 617 (711)
....++..|+|||++. ...++.++||||+|+++++|++|+.||..... ........... . .......
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~--------~~~~~~~~~~~-~---~~~~~~~ 223 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS--------DDQLEIIEKIL-K---RPLPSSS 223 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH--------HHHHHHHHHHH-H---THHHHHT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccc--------hhhhhhhhhcc-c---ccccccc
Confidence 4566899999999998 78899999999999999999999999975410 00000000000 0 0000000
Q ss_pred ccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 618 LEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 618 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
. ........+.+++.+||+.||++||++.++++.
T Consensus 224 ~---~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 224 Q---QSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp T---SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred c---ccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 001112678889999999999999999999863
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=323.99 Aligned_cols=250 Identities=25% Similarity=0.367 Sum_probs=204.2
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC-CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcC
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
++|+..+.||+|++|.||+|+...+++.||+|.+.... ...+.+.+|+.+++.++|+|++++++.+..+...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 57888899999999999999998889999999887633 33567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCc
Q 043702 459 PNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDA 538 (711)
Q Consensus 459 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 538 (711)
++++|.+++.. ..+++.++..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 100 ~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~ 173 (296)
T cd06654 100 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR 173 (296)
T ss_pred CCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc-cc
Confidence 99999999854 4589999999999999999999998 999999999999999999999999999886543322 12
Q ss_pred ccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhc
Q 043702 539 TVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARL 618 (711)
Q Consensus 539 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 618 (711)
....|++.|+|||.+.+..++.++|||||||++|||++|+.||..... . .+.......+. +.+
T Consensus 174 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~----------~-~~~~~~~~~~~------~~~ 236 (296)
T cd06654 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP----------L-RALYLIATNGT------PEL 236 (296)
T ss_pred CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH----------H-HhHHHHhcCCC------CCC
Confidence 234688999999999988899999999999999999999999965321 0 11101111100 000
Q ss_pred cCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 619 EGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.........+.+++.+||..+|++||++.++++.
T Consensus 237 --~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 237 --QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred --CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 1112233557788999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=326.07 Aligned_cols=260 Identities=22% Similarity=0.359 Sum_probs=200.4
Q ss_pred cCCcccceeecCCceEEEEEEeCCC--------------CeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeee
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQN--------------GDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQG 443 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~--------------~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g 443 (711)
++|+..+.||+|+||.||+++.... ...||+|++.... ...+.+.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 4688889999999999999987432 2358999987532 23457889999999999999999999
Q ss_pred eeeecCeEEEEEEcCCCCCHHHHHhhCC-----------CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceE
Q 043702 444 WCHEKGEILLVYDLMPNGSLDKALFEAR-----------SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIM 512 (711)
Q Consensus 444 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~-----------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NIL 512 (711)
++...+..++||||+++++|.+++.... ..+++..+++++.|++.||+|||+. +++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence 9999999999999999999999986432 2378899999999999999999997 9999999999999
Q ss_pred EcCCCcEEEeecCCceecCCCCCC-CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh--CCCCCcccccccc
Q 043702 513 LDEGFNARLGDFGLARQVEHDKSP-DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS--GRRPIEKEITGVG 589 (711)
Q Consensus 513 ld~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt--G~~P~~~~~~~~~ 589 (711)
+++++.+||+|||+++........ ......++..|+|||.+..+.++.++|||||||+++||++ |..||.....
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~--- 238 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD--- 238 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh---
Confidence 999999999999999865433221 1122345778999999999999999999999999999998 5667654321
Q ss_pred ccccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 043702 590 KVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLV 656 (711)
Q Consensus 590 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 656 (711)
.............. +..............+.+++.+||+.+|.+||++.+|++.|+
T Consensus 239 -----~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 239 -----EQVIENTGEFFRNQ------GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred -----HHHHHHHHHhhhhc------cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 11111111111110 000000111122357889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=318.73 Aligned_cols=254 Identities=22% Similarity=0.327 Sum_probs=202.1
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC-CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcC
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
++|+..+.||+|+||.||+|+...+++.||+|++.... .....+.+|+.++++++||||+++++++..++..++|+||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 46888999999999999999998889999999987533 33456789999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCc
Q 043702 459 PNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDA 538 (711)
Q Consensus 459 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 538 (711)
++++|.+++.. ...+++..+..++.|+++||.|||+. +|+||||||+||++++++.+||+|||+++.+..... ..
T Consensus 89 ~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~ 163 (267)
T cd06646 89 GGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-KR 163 (267)
T ss_pred CCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc-cc
Confidence 99999998864 45689999999999999999999987 999999999999999999999999999987643221 12
Q ss_pred ccccCCCcccChhhhc---cCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhh
Q 043702 539 TVAAGTMGYLAPEYLL---TGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615 (711)
Q Consensus 539 ~~~~gt~~y~APE~~~---~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 615 (711)
....|++.|+|||.+. ...++.++|||||||++|||++|+.||........ .. ....... ..
T Consensus 164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-------~~-----~~~~~~~---~~ 228 (267)
T cd06646 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-------LF-----LMSKSNF---QP 228 (267)
T ss_pred CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-------he-----eeecCCC---CC
Confidence 2346889999999884 34578899999999999999999999854321100 00 0000000 00
Q ss_pred hhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 043702 616 ARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655 (711)
Q Consensus 616 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L 655 (711)
+.... .......+.+++.+||+.+|++||+++++++.|
T Consensus 229 ~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 229 PKLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 01100 112235677899999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=339.35 Aligned_cols=256 Identities=24% Similarity=0.386 Sum_probs=202.3
Q ss_pred hcCCcccceeecCCceEEEEEEeC-----CCCeEEEEEEcccCC--CChhhhHHHHHHHHhcC-CCCeeeeeeeeeecCe
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILP-----QNGDIIAVKRCSHNS--QGKDEFLSELSIIGTLR-HRNLVRLQGWCHEKGE 450 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~ 450 (711)
.++|...++||+|+||.||+|++. ..+..||+|++.... ...+.+.+|+++|.++. ||||++++++|...+.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 346778899999999999999864 235689999997632 22357889999999998 9999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhhCC-----------------------------------------------------------
Q 043702 451 ILLVYDLMPNGSLDKALFEAR----------------------------------------------------------- 471 (711)
Q Consensus 451 ~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------------- 471 (711)
.++||||+++|+|.++++..+
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 999999999999999996432
Q ss_pred --------------------------------------CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEE
Q 043702 472 --------------------------------------SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIML 513 (711)
Q Consensus 472 --------------------------------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl 513 (711)
..+++..+++++.|++.||+|||+. +++||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEE
Confidence 1367788899999999999999987 99999999999999
Q ss_pred cCCCcEEEeecCCceecCCCCC-CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCcccccccccc
Q 043702 514 DEGFNARLGDFGLARQVEHDKS-PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKV 591 (711)
Q Consensus 514 d~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~ 591 (711)
++++.+||+|||+++....... .......++..|+|||.+....++.++|||||||++|||++ |+.||.....
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~----- 347 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM----- 347 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc-----
Confidence 9999999999999986543221 11222357789999999998889999999999999999998 8889854311
Q ss_pred ccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 592 GVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 592 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
.+........+. ....+......+.+++.+||+.+|.+||++++|++.|+.
T Consensus 348 ------~~~~~~~~~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 398 (401)
T cd05107 348 ------NEQFYNAIKRGY---------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD 398 (401)
T ss_pred ------hHHHHHHHHcCC---------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 111111111111 001111223567788899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=323.14 Aligned_cols=257 Identities=26% Similarity=0.423 Sum_probs=202.8
Q ss_pred HhcCCcccceeecCCceEEEEEEeCC-----CCeEEEEEEcccCCC--ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCe
Q 043702 378 ATKCFNANRIIGHGAFGTVYKGILPQ-----NGDIIAVKRCSHNSQ--GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGE 450 (711)
Q Consensus 378 at~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 450 (711)
..++|+..++||+|+||.||+|..++ .+..||+|.+..... ....+.+|+.++++++||||+++++++.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45678899999999999999997642 245799998765332 23467889999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhhCC---------CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEE
Q 043702 451 ILLVYDLMPNGSLDKALFEAR---------SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARL 521 (711)
Q Consensus 451 ~~lV~Ey~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL 521 (711)
.++||||+++|+|.+++.... ..+++..+.+++.|++.||.|||+. +|+||||||+|||+++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEE
Confidence 999999999999999996422 3356788899999999999999987 9999999999999999999999
Q ss_pred eecCCceecCCCCCC-CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHH
Q 043702 522 GDFGLARQVEHDKSP-DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVE 599 (711)
Q Consensus 522 ~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~ 599 (711)
+|||+++........ ......++..|+|||.+..+.++.++|||||||++|||++ |..||..... .+
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~-----------~~ 229 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-----------EQ 229 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH-----------HH
Confidence 999999865432211 1122345678999999999999999999999999999999 7888854211 11
Q ss_pred HHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 600 WVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 600 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
+...... +.. ..........+.+++.+|++.+|++||++.++++.|+..
T Consensus 230 ~~~~~~~-~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 230 VLKFVMD-GGY---------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HHHHHHc-CCC---------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 1111111 110 011122235788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=322.30 Aligned_cols=257 Identities=24% Similarity=0.340 Sum_probs=200.9
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecC-----eEEEEE
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKG-----EILLVY 455 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~lV~ 455 (711)
.|...+++|.|.||.||+|+...+++.||||+...+.. .--+|+++|+.++|||||+|+-++.... .+.+||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r---~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR---YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC---cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 46778999999999999999999999999999876443 2347999999999999999999886432 357899
Q ss_pred EcCCCCCHHHHHhh---CCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCC-CcEEEeecCCceecC
Q 043702 456 DLMPNGSLDKALFE---ARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEG-FNARLGDFGLARQVE 531 (711)
Q Consensus 456 Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~-~~vkL~DFGla~~~~ 531 (711)
||||. +|.+.++. .+.+++...+.-+..||++||.|||+. +|+||||||+|+|+|.+ +.+||||||.|+.+.
T Consensus 102 eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 102 EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 99988 99998864 356788888889999999999999997 99999999999999976 899999999999887
Q ss_pred CCCCCCcccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcC--
Q 043702 532 HDKSPDATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREG-- 608 (711)
Q Consensus 532 ~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~-- 608 (711)
.+.... ...-|..|+|||.+.+. .|+.+.||||.||++.||+-|++-|.++.. ...+++.+.-+-...
T Consensus 178 ~~epni--SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~-------~dQL~eIik~lG~Pt~e 248 (364)
T KOG0658|consen 178 KGEPNI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS-------VDQLVEIIKVLGTPTRE 248 (364)
T ss_pred cCCCce--eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH-------HHHHHHHHHHhCCCCHH
Confidence 665443 33468899999999875 689999999999999999999999976432 123333332111110
Q ss_pred ch-------hHhhhhhccCC-----CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 609 RL-------LTAADARLEGQ-----FDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 609 ~~-------~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
++ .+...+.+... +......+.++++.++++.+|.+|.++.|++.
T Consensus 249 ~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 249 DIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred HHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 00 01111222111 22334567888999999999999999999986
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=323.78 Aligned_cols=265 Identities=23% Similarity=0.383 Sum_probs=204.0
Q ss_pred cCCcccceeecCCceEEEEEEe----CCCCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeec--CeE
Q 043702 380 KCFNANRIIGHGAFGTVYKGIL----PQNGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEK--GEI 451 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~----~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 451 (711)
+.|...+.||+|+||.||+++. ..++..||+|.+.... .....+.+|++++++++|||++++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3567889999999999999984 3457889999987532 2345789999999999999999999999875 568
Q ss_pred EEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecC
Q 043702 452 LLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVE 531 (711)
Q Consensus 452 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~ 531 (711)
++||||+++++|.+++......+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.+.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccccc
Confidence 999999999999999976656799999999999999999999987 99999999999999999999999999998765
Q ss_pred CCCCC--CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccc----cccccchHHHHHHhh
Q 043702 532 HDKSP--DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGK----VGVASNLVEWVWSLH 605 (711)
Q Consensus 532 ~~~~~--~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~----~~~~~~l~~~~~~~~ 605 (711)
..... ......++..|+|||.+.+..++.++|||||||++|||++++.|.......... .........++ ...
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 239 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV-RVL 239 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH-HHH
Confidence 43221 112345677899999998888999999999999999999988765332110000 00000111111 111
Q ss_pred hcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 606 REGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 606 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
..+. ...........+.+++.+||+.+|.+||++.++++.|+.
T Consensus 240 ~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 282 (284)
T cd05079 240 EEGK---------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282 (284)
T ss_pred HcCc---------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence 1111 011112234678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=315.86 Aligned_cols=262 Identities=23% Similarity=0.334 Sum_probs=203.3
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC---ChhhhHHHHHHHHhcCCCC-eeeeeeeeeecC------
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ---GKDEFLSELSIIGTLRHRN-LVRLQGWCHEKG------ 449 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~------ 449 (711)
..|...++||+|.||+||+|+.+.+|+.||+|++..... -.....+|+.+|++|+|+| |++|++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 446667889999999999999999999999999887543 2356789999999999999 999999998877
Q ss_pred eEEEEEEcCCCCCHHHHHhhCC---CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCC
Q 043702 450 EILLVYDLMPNGSLDKALFEAR---SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGL 526 (711)
Q Consensus 450 ~~~lV~Ey~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGl 526 (711)
.+++|+||+.. +|..++.... ..++...+..++.||+.||+|||++ +|+||||||+||||++++.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence 78999999955 9999997655 3577789999999999999999998 999999999999999999999999999
Q ss_pred ceecCCCCCCCcccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhh
Q 043702 527 ARQVEHDKSPDATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLH 605 (711)
Q Consensus 527 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~ 605 (711)
|+....... ..+..++|..|+|||++.+. .|+...||||+||++.||++++.-|....+ .....-+.+..
T Consensus 167 Ara~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se--------~~ql~~If~~l 237 (323)
T KOG0594|consen 167 ARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE--------IDQLFRIFRLL 237 (323)
T ss_pred HHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH--------HHHHHHHHHHc
Confidence 997654433 24456789999999999887 689999999999999999999988865432 11111111111
Q ss_pred hcCch------hHhhhh--hc---c--CCCcH---HHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 606 REGRL------LTAADA--RL---E--GQFDE---AEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 606 ~~~~~------~~~~d~--~l---~--~~~~~---~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
..-.. ....+- .. . ..... .......+++.+|++.+|.+|.|++.++++
T Consensus 238 GtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 238 GTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 11000 000000 00 0 00000 111367788899999999999999999986
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=315.86 Aligned_cols=249 Identities=20% Similarity=0.329 Sum_probs=204.1
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC--CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcC
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN--SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
+|+..+.||+|+||.||++....++..+|+|.+... ....+.+.+|+.+++.++|+|++++++.+..++.++++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 477889999999999999999888999999987642 334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhC-CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC
Q 043702 459 PNGSLDKALFEA-RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD 537 (711)
Q Consensus 459 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 537 (711)
++|+|.+++... ...+++.....++.|++.||.|||+. +|+|+||||+||++++++.++|+|||+++....... .
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~ 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-Y 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc-c
Confidence 999999988653 34588999999999999999999987 999999999999999999999999999987654322 2
Q ss_pred cccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhh
Q 043702 538 ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADAR 617 (711)
Q Consensus 538 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 617 (711)
.....|++.|+|||++.+..++.++||||||+++|+|++|+.||..... ........ .+...
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-----------~~~~~~~~-~~~~~------ 218 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-----------KNLILKVC-QGSYK------ 218 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-----------HHHHHHHh-cCCCC------
Confidence 2235689999999999988899999999999999999999999964321 11111111 11111
Q ss_pred ccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 618 LEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 618 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.........+.+++.+||+.||++||++.+++..
T Consensus 219 ---~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 ---PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ---CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1111223457788899999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=322.03 Aligned_cols=265 Identities=22% Similarity=0.353 Sum_probs=207.0
Q ss_pred CCcccceeecCCceEEEEEEeCC----CCeEEEEEEcccCCCC--hhhhHHHHHHHHhcCCCCeeeeeeeeee--cCeEE
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQ----NGDIIAVKRCSHNSQG--KDEFLSELSIIGTLRHRNLVRLQGWCHE--KGEIL 452 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~----~~~~vavK~~~~~~~~--~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~ 452 (711)
.|...+.||+|+||.||++.+.. .+..+|+|++...... .+++.+|+++++.++|+||+++++++.. +...+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 56677899999999999998743 3788999998875543 6789999999999999999999999987 55789
Q ss_pred EEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCC
Q 043702 453 LVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEH 532 (711)
Q Consensus 453 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~ 532 (711)
++|||+++++|.+++......+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 85 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred EEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 99999999999999987666799999999999999999999987 999999999999999999999999999987753
Q ss_pred CCCC--CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCcccccccccc----ccccchHHHHHHhhh
Q 043702 533 DKSP--DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKV----GVASNLVEWVWSLHR 606 (711)
Q Consensus 533 ~~~~--~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~----~~~~~l~~~~~~~~~ 606 (711)
.... ......++..|+|||.+....++.++||||||++++||++|+.|+.......... ........+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----- 236 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL----- 236 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH-----
Confidence 3221 1112235667999999998899999999999999999999999986432211000 0000011111
Q ss_pred cCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 607 EGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 607 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
+.+...............+.+++.+||+.+|.+||+|.||+++|+..
T Consensus 237 -----~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 237 -----ELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred -----HHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11111111111122335688899999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=326.34 Aligned_cols=256 Identities=24% Similarity=0.413 Sum_probs=203.8
Q ss_pred hcCCcccceeecCCceEEEEEEeC-------CCCeEEEEEEcccC--CCChhhhHHHHHHHHhc-CCCCeeeeeeeeeec
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILP-------QNGDIIAVKRCSHN--SQGKDEFLSELSIIGTL-RHRNLVRLQGWCHEK 448 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~-------~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 448 (711)
..+|...+.||+|+||.||+|+.. ..+..||+|.+... ....+++.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 456788899999999999999752 23457999988653 23456789999999999 799999999999999
Q ss_pred CeEEEEEEcCCCCCHHHHHhhCC---------------CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEE
Q 043702 449 GEILLVYDLMPNGSLDKALFEAR---------------SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIML 513 (711)
Q Consensus 449 ~~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl 513 (711)
+..++||||+++|+|.+++.... ..+++.++++++.||++||.|||+. +++||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEE
Confidence 99999999999999999997532 3578899999999999999999997 99999999999999
Q ss_pred cCCCcEEEeecCCceecCCCCCC-CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCcccccccccc
Q 043702 514 DEGFNARLGDFGLARQVEHDKSP-DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKV 591 (711)
Q Consensus 514 d~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~ 591 (711)
++++.+||+|||+++.+...... ......++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~------ 244 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------ 244 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC------
Confidence 99999999999999876543322 1222346678999999998889999999999999999998 788875421
Q ss_pred ccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 592 GVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 592 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
..++.... ..+.. ..........+.+++.+||+.+|.+||++.++++.|+..
T Consensus 245 -----~~~~~~~~-~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~ 296 (304)
T cd05101 245 -----VEELFKLL-KEGHR---------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296 (304)
T ss_pred -----HHHHHHHH-HcCCc---------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence 11211111 11110 011122345677889999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=322.19 Aligned_cols=249 Identities=27% Similarity=0.384 Sum_probs=200.6
Q ss_pred CcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC----CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEc
Q 043702 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS----QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 382 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
|+..++||+|+||.||++....+++.+|+|++.... ...+.+.+|+.++++++|+|++++++.+..++..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999999999999999886532 1234577899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCC
Q 043702 458 MPNGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP 536 (711)
Q Consensus 458 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~ 536 (711)
+++++|.+++.... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 157 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence 99999999886533 4689999999999999999999987 999999999999999999999999999976543322
Q ss_pred CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhh
Q 043702 537 DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADA 616 (711)
Q Consensus 537 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 616 (711)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||...... ... +-....... ...
T Consensus 158 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~-------~~~-~~~~~~~~~------~~~ 222 (285)
T cd05630 158 -IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK-------IKR-EEVERLVKE------VQE 222 (285)
T ss_pred -ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCcc-------chH-HHHHhhhhh------hhh
Confidence 12346899999999999999999999999999999999999999753210 000 000011000 000
Q ss_pred hccCCCcHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH
Q 043702 617 RLEGQFDEAEMRRVLLVGLACSHPDPLARPT-----MRGVVQ 653 (711)
Q Consensus 617 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~eVl~ 653 (711)
.+.......+.+++.+||+.||++||+ ++|+++
T Consensus 223 ----~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 223 ----EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred ----hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 111122345678889999999999999 888887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=315.24 Aligned_cols=247 Identities=30% Similarity=0.441 Sum_probs=199.3
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeee-ecCeEEEEEEcC
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCH-EKGEILLVYDLM 458 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~-~~~~~~lV~Ey~ 458 (711)
++|...+.||+|+||.||++.. .+..+|+|.+.... ..+.+.+|+.++++++|+|++++++++. .++..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 3678889999999999999987 47889999886433 3567899999999999999999999765 456789999999
Q ss_pred CCCCHHHHHhhCCC-CCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC
Q 043702 459 PNGSLDKALFEARS-PLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD 537 (711)
Q Consensus 459 ~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 537 (711)
++++|.+++.+... .+++..+.+++.|++.||+|||+. +++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 99999999976443 489999999999999999999987 99999999999999999999999999998654322
Q ss_pred cccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhhhh
Q 043702 538 ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADA 616 (711)
Q Consensus 538 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 616 (711)
....++..|+|||++....++.++|||||||++|||++ |+.||..... ..+.... ..+
T Consensus 157 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~--------~~~~~~~----~~~-------- 215 (256)
T cd05082 157 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KDVVPRV----EKG-------- 215 (256)
T ss_pred -CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHH----hcC--------
Confidence 12235678999999998889999999999999999998 9999864211 1111111 111
Q ss_pred hccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 617 RLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 617 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
............+.+++.+|++.+|++||++.++++.|+.
T Consensus 216 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 216 -YKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred -CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 0111112234567788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=347.69 Aligned_cols=254 Identities=23% Similarity=0.290 Sum_probs=203.6
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEccc-CCCChhhhHHHHHHHHhcC-CCCeeeeeeee-ee------cCeE
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSH-NSQGKDEFLSELSIIGTLR-HRNLVRLQGWC-HE------KGEI 451 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~-~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~-~~------~~~~ 451 (711)
++++.+.|.+|||+.||++.+...|..+|+|++-. ++...+.+.+||++|+.|+ |+|||.+++.. .. .-++
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev 117 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV 117 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence 45677899999999999999987779999998655 5556678999999999998 99999999932 11 2368
Q ss_pred EEEEEcCCCCCHHHHHhhC-CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceec
Q 043702 452 LLVYDLMPNGSLDKALFEA-RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV 530 (711)
Q Consensus 452 ~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~ 530 (711)
+|.||||++|.|-+++..+ ...|++.++++|+.|+++|+++||.. .++|||||||-+||||+.++..||||||.+.-.
T Consensus 118 llLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~ 196 (738)
T KOG1989|consen 118 LLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTK 196 (738)
T ss_pred EeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence 9999999999999999743 23499999999999999999999985 788999999999999999999999999998643
Q ss_pred CCCCC-C-------CcccccCCCcccChhhh---ccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHH
Q 043702 531 EHDKS-P-------DATVAAGTMGYLAPEYL---LTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVE 599 (711)
Q Consensus 531 ~~~~~-~-------~~~~~~gt~~y~APE~~---~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~ 599 (711)
..... . ......-|+.|+|||.+ .+...++|+|||+|||+||-|+....||+....
T Consensus 197 ~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~------------- 263 (738)
T KOG1989|consen 197 ILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK------------- 263 (738)
T ss_pred cCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-------------
Confidence 22221 0 01112368999999987 456789999999999999999999999986421
Q ss_pred HHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC
Q 043702 600 WVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEA 659 (711)
Q Consensus 600 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~ 659 (711)
..+++....-.-......++..||..||++||.+||++-||++.+...+
T Consensus 264 -----------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~ 312 (738)
T KOG1989|consen 264 -----------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA 312 (738)
T ss_pred -----------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence 1111111111112456778889999999999999999999998876543
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=323.83 Aligned_cols=263 Identities=24% Similarity=0.324 Sum_probs=195.4
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC---CChhhhHHHHHHHHhc---CCCCeeeeeeeeee-----cC
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---QGKDEFLSELSIIGTL---RHRNLVRLQGWCHE-----KG 449 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~-----~~ 449 (711)
+|+..+.||+|+||.||+|.+..+++.||+|.+.... .....+.+|+++++++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999999899999999887532 2234566788877766 69999999998864 34
Q ss_pred eEEEEEEcCCCCCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCce
Q 043702 450 EILLVYDLMPNGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLAR 528 (711)
Q Consensus 450 ~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~ 528 (711)
..++||||+++ +|..++.... ..+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccc
Confidence 58999999974 8988886543 4589999999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHH-----H
Q 043702 529 QVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVW-----S 603 (711)
Q Consensus 529 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~-----~ 603 (711)
....... .....||..|+|||++.+..++.++|||||||++|||++|++||...... +....+..+.. .
T Consensus 157 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~----~~~~~~~~~~~~~~~~~ 230 (288)
T cd07863 157 IYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA----DQLGKIFDLIGLPPEDD 230 (288)
T ss_pred cccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH----HHHHHHHHHhCCCChhh
Confidence 7643322 23346899999999999889999999999999999999999998653221 00000110000 0
Q ss_pred hhhcCchh-Hhhhhhc---cCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 604 LHREGRLL-TAADARL---EGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 604 ~~~~~~~~-~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
+....... ....+.. ......+....+.+++.+|++.||++||++.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000 0000000 00011122345778999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=313.43 Aligned_cols=269 Identities=24% Similarity=0.316 Sum_probs=202.5
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEccc---CCCChhhhHHHHHHHHhcCCCCeeeeeeeeee-----cCe
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSH---NSQGKDEFLSELSIIGTLRHRNLVRLQGWCHE-----KGE 450 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-----~~~ 450 (711)
...|...+.||+|++|.|+.+..+.+|+.||||++.. .....+.-.+|+++|+.++|+||+.+.+.+.. -+.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 3455667889999999999999999999999999884 23345677899999999999999999998865 357
Q ss_pred EEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceec
Q 043702 451 ILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV 530 (711)
Q Consensus 451 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~ 530 (711)
+|+|+|+| ..+|...++. +..|+..+...++.|+++||.|+|+. +|+||||||+|+|++.+...||+|||+||..
T Consensus 101 vYiV~elM-etDL~~iik~-~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKS-QQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYL 175 (359)
T ss_pred eEEehhHH-hhHHHHHHHc-CccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeec
Confidence 89999999 5699998853 44599999999999999999999998 9999999999999999999999999999987
Q ss_pred CCC-CCCCcccccCCCcccChhhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccccccccc---ccccchHHHHHHhh
Q 043702 531 EHD-KSPDATVAAGTMGYLAPEYLLT-GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKV---GVASNLVEWVWSLH 605 (711)
Q Consensus 531 ~~~-~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~---~~~~~l~~~~~~~~ 605 (711)
... .....+..+.|.+|+|||++.. ..|+...||||.||++.||++|++-|.+...-..-. +......+......
T Consensus 176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i 255 (359)
T KOG0660|consen 176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKI 255 (359)
T ss_pred cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHh
Confidence 543 2234466788999999999865 479999999999999999999999986543210000 00000000111111
Q ss_pred hcCchhHhhhhhc-------cCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 606 REGRLLTAADARL-------EGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 606 ~~~~~~~~~d~~l-------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
...+....+.... ...++ ......++|+.+||..||.+|+|++|.++
T Consensus 256 ~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 256 RSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred ccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 1111111111000 00011 12245678888999999999999999997
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=322.90 Aligned_cols=263 Identities=24% Similarity=0.345 Sum_probs=207.4
Q ss_pred cCHHHHHHHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhc-CCCCeeeeeeeee--
Q 043702 370 FSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTL-RHRNLVRLQGWCH-- 446 (711)
Q Consensus 370 ~~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~-- 446 (711)
+.++.+..+.++|+..+.||+|+||.||++....+++.+|+|++.......+++.+|+.+++++ +|||++++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 4456677788899999999999999999999988899999998876444456788999999999 6999999999884
Q ss_pred ---ecCeEEEEEEcCCCCCHHHHHhh---CCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEE
Q 043702 447 ---EKGEILLVYDLMPNGSLDKALFE---ARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNAR 520 (711)
Q Consensus 447 ---~~~~~~lV~Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vk 520 (711)
.++..++||||+++++|.+++.. ....+++..+..++.|+++||.|||+. +++||||||+||++++++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEE
Confidence 34578999999999999998753 335688999999999999999999997 999999999999999999999
Q ss_pred EeecCCceecCCCCCCCcccccCCCcccChhhhcc-----CCCCccccchhHHHHHHHHHhCCCCCcccccccccccccc
Q 043702 521 LGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLT-----GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVAS 595 (711)
Q Consensus 521 L~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~ 595 (711)
|+|||+++....... ......|++.|+|||++.. ..++.++|||||||++|||++|+.||.....
T Consensus 165 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~--------- 234 (286)
T cd06638 165 LVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP--------- 234 (286)
T ss_pred EccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch---------
Confidence 999999987643322 2233468999999999853 4478899999999999999999999864321
Q ss_pred chHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 043702 596 NLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655 (711)
Q Consensus 596 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L 655 (711)
..... ... .+......++ ......+.+++.+||+.||++||++.|+++.+
T Consensus 235 -~~~~~-~~~-~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 235 -MRALF-KIP-RNPPPTLHQP-------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred -hHHHh-hcc-ccCCCcccCC-------CCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 00000 000 0000000000 11124577889999999999999999999754
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=323.18 Aligned_cols=260 Identities=20% Similarity=0.366 Sum_probs=200.7
Q ss_pred cCCcccceeecCCceEEEEEEeCC----------------CCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeee
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQ----------------NGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRL 441 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~----------------~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l 441 (711)
++|+..+.||+|+||.||++.... ++..+|+|++.... ...+++.+|+++++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 468889999999999999986432 34579999987532 234678999999999999999999
Q ss_pred eeeeeecCeEEEEEEcCCCCCHHHHHhhCC----------CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCce
Q 043702 442 QGWCHEKGEILLVYDLMPNGSLDKALFEAR----------SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNI 511 (711)
Q Consensus 442 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NI 511 (711)
++++...+..++||||+++++|.+++.... ..+++.+.++++.|++.||+|||+. +++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence 999999999999999999999999986532 2477889999999999999999998 999999999999
Q ss_pred EEcCCCcEEEeecCCceecCCCCCCC-cccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh--CCCCCccccccc
Q 043702 512 MLDEGFNARLGDFGLARQVEHDKSPD-ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS--GRRPIEKEITGV 588 (711)
Q Consensus 512 Lld~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt--G~~P~~~~~~~~ 588 (711)
|+++++.+||+|||+++.+....... .....++..|+|||....+.++.++|||||||++|||++ |..||.....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~-- 239 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD-- 239 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh--
Confidence 99999999999999998654332211 122334678999999988899999999999999999998 7778754321
Q ss_pred cccccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 043702 589 GKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLV 656 (711)
Q Consensus 589 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 656 (711)
................. ............+.+++.+||+.||.+||++.+|++.|+
T Consensus 240 ------~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 240 ------EQVIENTGEFFRDQGRQ------VYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred ------HHHHHHHHHHHhhcccc------ccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11111111111110000 000011123356788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=326.45 Aligned_cols=255 Identities=24% Similarity=0.411 Sum_probs=202.3
Q ss_pred cCCcccceeecCCceEEEEEEeCC-------CCeEEEEEEcccCC--CChhhhHHHHHHHHhc-CCCCeeeeeeeeeecC
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQ-------NGDIIAVKRCSHNS--QGKDEFLSELSIIGTL-RHRNLVRLQGWCHEKG 449 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~-------~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 449 (711)
++|...+.||+|+||.||++.... ....+|+|.+.... ....++.+|+++++.+ +||||++++++|...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 468899999999999999998632 23469999987532 3345788999999999 7999999999999999
Q ss_pred eEEEEEEcCCCCCHHHHHhhCC---------------CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEc
Q 043702 450 EILLVYDLMPNGSLDKALFEAR---------------SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLD 514 (711)
Q Consensus 450 ~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld 514 (711)
..++||||+++|+|.+++.... ..+++.++++++.|++.||+|||+. +++||||||+|||++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEc
Confidence 9999999999999999997532 3489999999999999999999987 999999999999999
Q ss_pred CCCcEEEeecCCceecCCCCCCC-cccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccc
Q 043702 515 EGFNARLGDFGLARQVEHDKSPD-ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVG 592 (711)
Q Consensus 515 ~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~ 592 (711)
+++.+||+|||+++......... .....+++.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~------- 247 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------- 247 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC-------
Confidence 99999999999998664322111 112234568999999998889999999999999999998 888885421
Q ss_pred cccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 593 VASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 593 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
..+.... ...+. ...........+.+++.+||+.+|.+||++.+|++.|+..
T Consensus 248 ----~~~~~~~-~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 248 ----VEELFKL-LKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred ----HHHHHHH-HHcCC---------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 1111111 11111 1111223345677889999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=341.52 Aligned_cols=259 Identities=23% Similarity=0.336 Sum_probs=194.1
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeec--------Ce
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEK--------GE 450 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--------~~ 450 (711)
.++|...++||+|+||.||+|....+++.||||++.... ....+|+.+++.++||||+++++++... ..
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 457999999999999999999998889999999886432 2345799999999999999999876432 24
Q ss_pred EEEEEEcCCCCCHHHHHhh---CCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCC-cEEEeecCC
Q 043702 451 ILLVYDLMPNGSLDKALFE---ARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGF-NARLGDFGL 526 (711)
Q Consensus 451 ~~lV~Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~-~vkL~DFGl 526 (711)
+++||||+++ +|.+++.. ....+++..+..++.||+.||+|||+. +|+||||||+||||+.++ .+||+|||+
T Consensus 142 l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 142 LNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred EEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecccc
Confidence 6799999975 77776642 346799999999999999999999998 999999999999998664 699999999
Q ss_pred ceecCCCCCCCcccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhh
Q 043702 527 ARQVEHDKSPDATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLH 605 (711)
Q Consensus 527 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~ 605 (711)
++.+..... .....||+.|+|||++.+. .++.++|||||||++|||++|++||...... ..+..... ..
T Consensus 218 a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-------~~~~~i~~-~~ 287 (440)
T PTZ00036 218 AKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-------DQLVRIIQ-VL 287 (440)
T ss_pred chhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHHH-Hh
Confidence 987654332 2234689999999998764 6899999999999999999999999653210 11111110 00
Q ss_pred hcCch--hHhhh-------------hhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 606 REGRL--LTAAD-------------ARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 606 ~~~~~--~~~~d-------------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
..... ..... ..+...++.....++.+++.+||+.||.+|||+.|+++.
T Consensus 288 ~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 288 GTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00000 00000 000011111223567889999999999999999999863
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=320.40 Aligned_cols=251 Identities=25% Similarity=0.364 Sum_probs=199.7
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEc
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
++|+..++||+|+||.||+|.+..+++.||+|++.... ...+++.+|++++++++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 35778899999999999999998889999999986532 2345788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC
Q 043702 458 MPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD 537 (711)
Q Consensus 458 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 537 (711)
+++++|..+. .+++..+..++.|++.||.|||+. +|+|+||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--- 149 (279)
T cd06619 81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--- 149 (279)
T ss_pred CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---
Confidence 9999997642 478889999999999999999997 99999999999999999999999999998664322
Q ss_pred cccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhh
Q 043702 538 ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADAR 617 (711)
Q Consensus 538 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 617 (711)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||......... ....++.... ... ..+.
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~----~~~~~~~~~~-~~~-----~~~~ 219 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGS----LMPLQLLQCI-VDE-----DPPV 219 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccc----cchHHHHHHH-hcc-----CCCC
Confidence 22356899999999999889999999999999999999999999653221100 0000111000 000 0011
Q ss_pred ccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 618 LEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 618 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
+. ......++.+++.+|++.+|++||+++++++.
T Consensus 220 ~~---~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 220 LP---VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CC---CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 10 11123457788999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=329.03 Aligned_cols=237 Identities=26% Similarity=0.325 Sum_probs=189.5
Q ss_pred ceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHH-HHHhcCCCCeeeeeeeeeecCeEEEEEEcCCC
Q 043702 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELS-IIGTLRHRNLVRLQGWCHEKGEILLVYDLMPN 460 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 460 (711)
++||+|+||.||+|++..+++.||+|++... ......+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999988999999998642 222345555654 67889999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCccc
Q 043702 461 GSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATV 540 (711)
Q Consensus 461 gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 540 (711)
|+|..++.. ...+++.....++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (321)
T cd05603 81 GELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTST 155 (321)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Ccccc
Confidence 999988854 45688899999999999999999987 99999999999999999999999999987532222 22334
Q ss_pred ccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccC
Q 043702 541 AAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEG 620 (711)
Q Consensus 541 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 620 (711)
.+||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ......... +. .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----------~~~~~~i~~-~~----------~ 213 (321)
T cd05603 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-----------SQMYDNILH-KP----------L 213 (321)
T ss_pred ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-----------HHHHHHHhc-CC----------C
Confidence 5799999999999988999999999999999999999999965321 111111111 00 0
Q ss_pred CCcHHHHHHHHHHHHhcCCCCCCCCCCHH
Q 043702 621 QFDEAEMRRVLLVGLACSHPDPLARPTMR 649 (711)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 649 (711)
.++......+.+++.+||+.||.+||++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 214 QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 11222334577889999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=331.39 Aligned_cols=243 Identities=25% Similarity=0.317 Sum_probs=192.8
Q ss_pred ceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHH-HHHhcCCCCeeeeeeeeeecCeEEEEEEcCCC
Q 043702 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELS-IIGTLRHRNLVRLQGWCHEKGEILLVYDLMPN 460 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 460 (711)
++||+|+||+||+|+...+|+.+|+|++... .....++..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999999889999999998652 233345566655 46779999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCccc
Q 043702 461 GSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATV 540 (711)
Q Consensus 461 gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 540 (711)
|+|..++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...... .....
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~ 155 (325)
T cd05604 81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTTT 155 (325)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCccc
Confidence 999988864 45789999999999999999999997 99999999999999999999999999997543222 22334
Q ss_pred ccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccC
Q 043702 541 AAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEG 620 (711)
Q Consensus 541 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 620 (711)
.+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+....... +.+ .+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-----------~~~~~~~~~-~~~------~~~- 216 (325)
T cd05604 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV-----------AEMYDNILH-KPL------VLR- 216 (325)
T ss_pred ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH-----------HHHHHHHHc-CCc------cCC-
Confidence 5799999999999999999999999999999999999999965321 111111111 110 011
Q ss_pred CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 043702 621 QFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655 (711)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L 655 (711)
......+.+++.+|++.+|.+||++++.++.+
T Consensus 217 ---~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i 248 (325)
T cd05604 217 ---PGASLTAWSILEELLEKDRQRRLGAKEDFLEI 248 (325)
T ss_pred ---CCCCHHHHHHHHHHhccCHHhcCCCCCCHHHH
Confidence 12234566888999999999999986444433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=320.89 Aligned_cols=256 Identities=22% Similarity=0.355 Sum_probs=203.8
Q ss_pred hcCCcccceeecCCceEEEEEEeCC----CCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeee-cCeE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQ----NGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHE-KGEI 451 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~----~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~ 451 (711)
.++|...++||+|+||.||+|.+.. .+..|++|++.... ...+.+.+|+.++++++|+||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4578889999999999999999864 25789999886532 234668899999999999999999999876 4678
Q ss_pred EEEEEcCCCCCHHHHHhhCC-------CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeec
Q 043702 452 LLVYDLMPNGSLDKALFEAR-------SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDF 524 (711)
Q Consensus 452 ~lV~Ey~~~gsL~~~l~~~~-------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DF 524 (711)
++++||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence 99999999999999986532 4589999999999999999999987 9999999999999999999999999
Q ss_pred CCceecCCCCCC-CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHH
Q 043702 525 GLARQVEHDKSP-DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVW 602 (711)
Q Consensus 525 Gla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~ 602 (711)
|+++.+...... ......++..|+|||.+....++.++|||||||++||+++ |+.||..... ..+..+..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~ 233 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--------FEMAAYLK 233 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--------HHHHHHHH
Confidence 999865432211 1122346778999999998889999999999999999999 9999865321 11111111
Q ss_pred HhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 603 SLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 603 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
..... .........+.+++.+||+.+|++||++.+|++.|+..
T Consensus 234 ---~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 234 ---DGYRL----------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred ---cCCCC----------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 11010 01112235678899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=318.03 Aligned_cols=248 Identities=26% Similarity=0.406 Sum_probs=204.1
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcC
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
+|+..+.||.|++|.||+|.+..+++.||+|++.... .....+.+|+++++.++|+|++++++++.++..+++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 5778889999999999999998889999999987532 33467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCc
Q 043702 459 PNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDA 538 (711)
Q Consensus 459 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 538 (711)
++++|.+++... .+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||+++....... ..
T Consensus 82 ~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~ 155 (274)
T cd06609 82 GGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-KR 155 (274)
T ss_pred CCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc-cc
Confidence 999999998653 789999999999999999999987 999999999999999999999999999987754322 22
Q ss_pred ccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhc
Q 043702 539 TVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARL 618 (711)
Q Consensus 539 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 618 (711)
....|+..|+|||++.+..++.++|||||||++|||++|+.||..... ....... ..+ ..+.+
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~-----------~~~~~~~-~~~-----~~~~~ 218 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP-----------MRVLFLI-PKN-----NPPSL 218 (274)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch-----------HHHHHHh-hhc-----CCCCC
Confidence 334688899999999998899999999999999999999999964321 0111111 111 01111
Q ss_pred cCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 619 EGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
... .....+.+++.+||+.+|++||+++++++.
T Consensus 219 ~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 219 EGN---KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred ccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 111 023457788899999999999999999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=329.90 Aligned_cols=243 Identities=25% Similarity=0.306 Sum_probs=192.4
Q ss_pred ceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHH-HHHhcCCCCeeeeeeeeeecCeEEEEEEcCCC
Q 043702 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELS-IIGTLRHRNLVRLQGWCHEKGEILLVYDLMPN 460 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 460 (711)
+.||+|+||+||+|++..+++.||+|++... .....++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4699999999999999888999999998652 222334555544 56789999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCccc
Q 043702 461 GSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATV 540 (711)
Q Consensus 461 gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 540 (711)
|+|.+++.. ...+.+.....++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~~ 155 (325)
T cd05602 81 GELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTST 155 (325)
T ss_pred CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCccc
Confidence 999999865 34578888899999999999999997 99999999999999999999999999997543222 22334
Q ss_pred ccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccC
Q 043702 541 AAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEG 620 (711)
Q Consensus 541 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 620 (711)
.+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+....... .. .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----------~~~~~~i~~-~~--------~-- 213 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-----------AEMYDNILN-KP--------L-- 213 (325)
T ss_pred ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH-----------HHHHHHHHh-CC--------c--
Confidence 5799999999999999999999999999999999999999964321 111111111 00 0
Q ss_pred CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 043702 621 QFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655 (711)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L 655 (711)
.........+.+++.+|++.||.+||++.+.+..+
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i 248 (325)
T cd05602 214 QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 248 (325)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHH
Confidence 11112234567888999999999999987544443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=316.80 Aligned_cols=249 Identities=30% Similarity=0.433 Sum_probs=193.8
Q ss_pred ceeecCCceEEEEEEeCC---CCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeee-cCeEEEEEEcCC
Q 043702 386 RIIGHGAFGTVYKGILPQ---NGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHE-KGEILLVYDLMP 459 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~~---~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV~Ey~~ 459 (711)
+.||+|+||.||+|.+.. .+..+|+|++.... ...+.+.+|+.+++.++|||+++++++|.. ++..++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998643 34579999886422 234678899999999999999999998764 556899999999
Q ss_pred CCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC---C
Q 043702 460 NGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS---P 536 (711)
Q Consensus 460 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~---~ 536 (711)
+|+|.+++......+++..+..++.|+++||.|||+. +++||||||+|||+++++.+||+|||+++.+..... .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 9999999977666788889999999999999999987 999999999999999999999999999986543221 1
Q ss_pred CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhC-CCCCccccccccccccccchHHHHHHhhhcCchhHhhh
Q 043702 537 DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASG-RRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615 (711)
Q Consensus 537 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG-~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 615 (711)
......++..|+|||.+....++.++|||||||++|||++| .+||..... ..+...+ .....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--------~~~~~~~---~~~~~------ 220 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--------FDITVYL---LQGRR------ 220 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHH---hcCCC------
Confidence 11223467789999999988999999999999999999995 555543211 1111111 11100
Q ss_pred hhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 616 ARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 616 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
...+......+.+++.+||+.+|++||++.+|++.|+..
T Consensus 221 ----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 221 ----LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred ----CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 001111234677899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=322.34 Aligned_cols=255 Identities=26% Similarity=0.444 Sum_probs=203.3
Q ss_pred hcCCcccceeecCCceEEEEEEeCC-----CCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQ-----NGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEI 451 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 451 (711)
.++|+..+.||+|+||.||++.... ++..||+|++.... ...+++.+|+.++++++||||++++++|.+++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 3568888999999999999998743 56789999987533 2346788999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhhCC---------------------CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCc
Q 043702 452 LLVYDLMPNGSLDKALFEAR---------------------SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSN 510 (711)
Q Consensus 452 ~lV~Ey~~~gsL~~~l~~~~---------------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~N 510 (711)
++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+. +++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence 99999999999999996432 2478889999999999999999987 99999999999
Q ss_pred eEEcCCCcEEEeecCCceecCCCCCC-CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccc
Q 043702 511 IMLDEGFNARLGDFGLARQVEHDKSP-DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGV 588 (711)
Q Consensus 511 ILld~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~ 588 (711)
|++++++.+||+|||+++.+...... ......++..|+|||.+....++.++|||||||++|||++ |..||.....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~-- 238 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH-- 238 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 99999999999999999865433211 1122235678999999998899999999999999999998 8888854211
Q ss_pred cccccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 589 GKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 589 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
.++... ...+.... .......++.+++.+||+.+|.+||++.|+++.|+.
T Consensus 239 ---------~~~~~~-~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 ---------EEVIYY-VRDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ---------HHHHHH-HhcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 111111 11222110 111234567889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=324.29 Aligned_cols=262 Identities=26% Similarity=0.344 Sum_probs=203.7
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC--ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEc
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ--GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
++|+..+.||+|+||.||++.+..++..+|+|.+..... ...++.+|++++++++||||++++++|..++.+++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 368889999999999999999988899999998865322 235688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC
Q 043702 458 MPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD 537 (711)
Q Consensus 458 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 537 (711)
+++++|.+++... ..+++..+..++.|+++||.|||+. .+++||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 154 (308)
T cd06615 81 MDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 154 (308)
T ss_pred cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccccc---
Confidence 9999999999654 5689999999999999999999973 389999999999999999999999999987653322
Q ss_pred cccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhc----------
Q 043702 538 ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHRE---------- 607 (711)
Q Consensus 538 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~---------- 607 (711)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||...... ....+.......
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~ 226 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK--------ELEAMFGRPVSEGEAKESHRPV 226 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh--------hHHHhhcCccccccccCCcccc
Confidence 22346899999999998888999999999999999999999998643211 000000000000
Q ss_pred ----------CchhHhhhhhcc---CCCc-HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 043702 608 ----------GRLLTAADARLE---GQFD-EAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655 (711)
Q Consensus 608 ----------~~~~~~~d~~l~---~~~~-~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L 655 (711)
....+..+.... ...+ ......+.+++.+||+.+|++||++++|++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 000000000000 0000 01234578899999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=313.41 Aligned_cols=250 Identities=30% Similarity=0.516 Sum_probs=203.8
Q ss_pred CcccceeecCCceEEEEEEeCCCC----eEEEEEEcccCCC--ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 382 FNANRIIGHGAFGTVYKGILPQNG----DIIAVKRCSHNSQ--GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 382 f~~~~~LG~G~fg~Vy~~~~~~~~----~~vavK~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
|+..+.||.|+||.||+++....+ ..||+|++..... ..+.+.+|++++..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 356788999999999999997655 8899999876543 4678999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCC-CChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCC
Q 043702 456 DLMPNGSLDKALFEARSP-LPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~-l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~ 534 (711)
||+++++|.+++...... +++.++..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999999765544 99999999999999999999998 99999999999999999999999999998776543
Q ss_pred CCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHh
Q 043702 535 SPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTA 613 (711)
Q Consensus 535 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 613 (711)
........+++.|+|||.+....++.++||||+||+++||++ |+.||..... ..+.+. ...+...
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--------~~~~~~----~~~~~~~-- 223 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--------EEVLEY----LKKGYRL-- 223 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHH----HhcCCCC--
Confidence 322222337789999999988889999999999999999998 7888764211 111111 1111110
Q ss_pred hhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 043702 614 ADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655 (711)
Q Consensus 614 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L 655 (711)
.........+.+++.+|+..+|++|||+.|+++.|
T Consensus 224 -------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 -------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11112345677899999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=333.78 Aligned_cols=244 Identities=27% Similarity=0.458 Sum_probs=207.3
Q ss_pred eeecCCceEEEEEEeCCCCeEEEEEEccc-CCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCCCCCHHH
Q 043702 387 IIGHGAFGTVYKGILPQNGDIIAVKRCSH-NSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDK 465 (711)
Q Consensus 387 ~LG~G~fg~Vy~~~~~~~~~~vavK~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 465 (711)
+||+|.||+||.|++.++...+|||.+.. ..+..+.+.+||.+.++|+|+|||+.+|.|.+++.+-+.||.+|||+|..
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999999999999999999876 55667788999999999999999999999999999999999999999999
Q ss_pred HHhhCCCCC--ChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEc-CCCcEEEeecCCceecCCCCCCCccccc
Q 043702 466 ALFEARSPL--PWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLD-EGFNARLGDFGLARQVEHDKSPDATVAA 542 (711)
Q Consensus 466 ~l~~~~~~l--~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld-~~~~vkL~DFGla~~~~~~~~~~~~~~~ 542 (711)
+|+..=+++ .+...-.+.+||++||.|||+. .|||||||-.|||++ -.|.+||+|||.++.+..- ...+....
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~TETFT 737 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCTETFT 737 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccC-Cccccccc
Confidence 998877777 6778888999999999999987 999999999999995 5788999999999876433 34555678
Q ss_pred CCCcccChhhhccCC--CCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccC
Q 043702 543 GTMGYLAPEYLLTGR--ATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEG 620 (711)
Q Consensus 543 gt~~y~APE~~~~~~--~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 620 (711)
||..|||||++..+. |..++|||||||++.||.||++||...... ..-+ ...-.-+...
T Consensus 738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp----------qAAM---------FkVGmyKvHP 798 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP----------QAAM---------FKVGMYKVHP 798 (1226)
T ss_pred cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh----------hHhh---------hhhcceecCC
Confidence 999999999998774 899999999999999999999999654221 0000 0111111234
Q ss_pred CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 621 QFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
..+++...+...++++|..+||.+||+++++++
T Consensus 799 ~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 799 PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 556777788889999999999999999999997
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=312.89 Aligned_cols=249 Identities=24% Similarity=0.391 Sum_probs=203.2
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC---CChhhhHHHHHHHHhcCCCCeeeeeeeeee-cCeEEEEEE
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---QGKDEFLSELSIIGTLRHRNLVRLQGWCHE-KGEILLVYD 456 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV~E 456 (711)
+|+..+.||+|++|.||++....+++.+|+|++.... ...+.+.+|++++++++|+|++++++.+.. +..++++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788999999999999999998888999999986532 334578899999999999999999998764 446899999
Q ss_pred cCCCCCHHHHHhhC-CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 457 LMPNGSLDKALFEA-RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 457 y~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
|+++++|.+++... ...+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 99999999999764 34589999999999999999999997 999999999999999999999999999987644322
Q ss_pred CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhh
Q 043702 536 PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 615 (711)
......|++.|+|||.+.+..++.++|||||||+++||++|+.||.... ...+..... .+.+
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~-----------~~~~~~~~~-~~~~----- 219 (257)
T cd08223 158 -MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD-----------MNSLVYRII-EGKL----- 219 (257)
T ss_pred -ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-----------HHHHHHHHH-hcCC-----
Confidence 2234568999999999999999999999999999999999999986431 111111111 1111
Q ss_pred hhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 616 ARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 616 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
..........+.+++.+|++.+|++||++.++++.
T Consensus 220 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 ----PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ----CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11122334567889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=319.87 Aligned_cols=250 Identities=24% Similarity=0.359 Sum_probs=200.7
Q ss_pred CcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC-CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCCC
Q 043702 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPN 460 (711)
Q Consensus 382 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 460 (711)
|+..+.||+|+||.||+|....++..+++|.+.... ...+.+.+|+++++.++|||++++++++..++..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 566788999999999999998889999999986533 3456788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCccc
Q 043702 461 GSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATV 540 (711)
Q Consensus 461 gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 540 (711)
++|..++......+++..+..++.|+++||.|||+. +++||||||+|||++.++.+||+|||+++....... ....
T Consensus 87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~ 162 (282)
T cd06643 87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RRDS 162 (282)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc-cccc
Confidence 999998876667899999999999999999999997 999999999999999999999999999976533221 2223
Q ss_pred ccCCCcccChhhhc-----cCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhh
Q 043702 541 AAGTMGYLAPEYLL-----TGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615 (711)
Q Consensus 541 ~~gt~~y~APE~~~-----~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 615 (711)
..|+..|+|||++. ...++.++|||||||++|||++|+.||..... .+.+...... . .
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-----------~~~~~~~~~~-~-----~ 225 (282)
T cd06643 163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP-----------MRVLLKIAKS-E-----P 225 (282)
T ss_pred ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH-----------HHHHHHHhhc-C-----C
Confidence 46899999999984 34577899999999999999999999864321 0000010000 0 0
Q ss_pred hhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 616 ARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 616 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
+.+ ..+......+.+++.+||+.+|.+||++.++++.
T Consensus 226 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 226 PTL--AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred CCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0111223467788999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=319.98 Aligned_cols=249 Identities=24% Similarity=0.333 Sum_probs=199.7
Q ss_pred CcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC----CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEc
Q 043702 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS----QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 382 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
|+..+.||+|+||+||+|....+++.+|+|.+.... .....+.+|++++++++|+|++++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999998889999999986532 2234578899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCC
Q 043702 458 MPNGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP 536 (711)
Q Consensus 458 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~ 536 (711)
+++++|.+++.... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 157 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES- 157 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc-
Confidence 99999999886543 4699999999999999999999987 999999999999999999999999999976543221
Q ss_pred CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhh
Q 043702 537 DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADA 616 (711)
Q Consensus 537 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 616 (711)
.....|+..|+|||++.+..++.++|+|||||++|||++|+.||...... .....+ ......+.
T Consensus 158 -~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~-------~~~~~~-~~~~~~~~------- 221 (285)
T cd05632 158 -IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK-------VKREEV-DRRVLETE------- 221 (285)
T ss_pred -ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHH-HHhhhccc-------
Confidence 23346899999999999889999999999999999999999999643210 000111 11011100
Q ss_pred hccCCCcHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH
Q 043702 617 RLEGQFDEAEMRRVLLVGLACSHPDPLARPT-----MRGVVQ 653 (711)
Q Consensus 617 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~eVl~ 653 (711)
..+.......+.+++..|++.||++||+ +.++++
T Consensus 222 ---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 222 ---EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ---cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 1112223345678889999999999999 666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=312.34 Aligned_cols=246 Identities=30% Similarity=0.455 Sum_probs=199.6
Q ss_pred ceeecCCceEEEEEEeCCCCeEEEEEEcccCCC--ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCCCCCH
Q 043702 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ--GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSL 463 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 463 (711)
++||+|++|.||++.+.. ++.||+|++..... ....+.+|++++++++|+||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 469999999999999976 89999998876433 356789999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCc-cccc
Q 043702 464 DKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDA-TVAA 542 (711)
Q Consensus 464 ~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~-~~~~ 542 (711)
.+++......+++..+..++.+++.||+|||+. +++||||||+||+++.++.+||+|||+++.......... ....
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 999977666789999999999999999999987 999999999999999999999999999986542221111 1123
Q ss_pred CCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccCC
Q 043702 543 GTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQ 621 (711)
Q Consensus 543 gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 621 (711)
++..|+|||.+.++.++.++|||||||++|||++ |..||..... ...... ... .....
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~--------~~~~~~----~~~---------~~~~~ 215 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN--------QQTRER----IES---------GYRMP 215 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH--------HHHHHH----Hhc---------CCCCC
Confidence 4567999999998899999999999999999999 8888854321 011111 111 00111
Q ss_pred CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 043702 622 FDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLV 656 (711)
Q Consensus 622 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 656 (711)
.+......+.+++.+|++.+|.+||++.||++.|.
T Consensus 216 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 216 APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 12223456888999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=325.35 Aligned_cols=255 Identities=25% Similarity=0.432 Sum_probs=201.4
Q ss_pred cCCcccceeecCCceEEEEEEeC-------CCCeEEEEEEcccCC--CChhhhHHHHHHHHhc-CCCCeeeeeeeeeecC
Q 043702 380 KCFNANRIIGHGAFGTVYKGILP-------QNGDIIAVKRCSHNS--QGKDEFLSELSIIGTL-RHRNLVRLQGWCHEKG 449 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~-------~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 449 (711)
++|...+.||+|+||.||+++.. .....+|+|++.... ....++.+|+++++++ +||||++++++|..++
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 46788899999999999999753 234579999887533 2345788999999999 5999999999999999
Q ss_pred eEEEEEEcCCCCCHHHHHhhCC---------------CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEc
Q 043702 450 EILLVYDLMPNGSLDKALFEAR---------------SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLD 514 (711)
Q Consensus 450 ~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld 514 (711)
..+++|||+++|+|.+++.... ..+++.++.+++.|++.||.|||+. +++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEc
Confidence 9999999999999999996532 3488999999999999999999987 999999999999999
Q ss_pred CCCcEEEeecCCceecCCCCCCC-cccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccc
Q 043702 515 EGFNARLGDFGLARQVEHDKSPD-ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVG 592 (711)
Q Consensus 515 ~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~ 592 (711)
+++.+||+|||+++......... .....++..|+|||.+..+.++.++|||||||++|||++ |+.||.....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~------ 242 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV------ 242 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH------
Confidence 99999999999998664322211 112234567999999998899999999999999999999 8888854311
Q ss_pred cccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 593 VASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 593 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
..+. .....+.. ..........+.+++.+||+.+|.+||++.++++.|+..
T Consensus 243 --~~~~----~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 293 (314)
T cd05099 243 --EELF----KLLREGHR---------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293 (314)
T ss_pred --HHHH----HHHHcCCC---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 1111 11111111 011122234677899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=330.25 Aligned_cols=198 Identities=27% Similarity=0.359 Sum_probs=170.5
Q ss_pred HhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC---CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecC-----
Q 043702 378 ATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN---SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKG----- 449 (711)
Q Consensus 378 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----- 449 (711)
..++|...+.||+|+||.||++....+|..||+|++... ......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 357899999999999999999999888999999998653 233457889999999999999999999986543
Q ss_pred -eEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCce
Q 043702 450 -EILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLAR 528 (711)
Q Consensus 450 -~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~ 528 (711)
..++||||+++ +|...+. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 57999999965 6666653 3478899999999999999999997 99999999999999999999999999998
Q ss_pred ecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccc
Q 043702 529 QVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKE 584 (711)
Q Consensus 529 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~ 584 (711)
...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 172 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 172 TACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred ccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 653322 223356899999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=328.57 Aligned_cols=248 Identities=22% Similarity=0.323 Sum_probs=197.1
Q ss_pred ceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhc-CCCCeeeeeeeeeecCeEEEEEEcCCC
Q 043702 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTL-RHRNLVRLQGWCHEKGEILLVYDLMPN 460 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 460 (711)
++||+|+||+||+|+...+++.+|+|++... ....+.+.+|+.++.++ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999999989999999998753 23345678899999888 599999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCccc
Q 043702 461 GSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATV 540 (711)
Q Consensus 461 gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 540 (711)
|+|..++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (327)
T cd05617 81 GDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTST 155 (327)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cceec
Confidence 999988854 34699999999999999999999997 99999999999999999999999999997532221 12234
Q ss_pred ccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccC
Q 043702 541 AAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEG 620 (711)
Q Consensus 541 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 620 (711)
.+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......++..........
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~---------- 220 (327)
T cd05617 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDN-----PDMNTEDYLFQVILEKPI---------- 220 (327)
T ss_pred ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCC-----cccccHHHHHHHHHhCCC----------
Confidence 57999999999999999999999999999999999999999643211 011222333322221111
Q ss_pred CCcHHHHHHHHHHHHhcCCCCCCCCCCH------HHHHH
Q 043702 621 QFDEAEMRRVLLVGLACSHPDPLARPTM------RGVVQ 653 (711)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~eVl~ 653 (711)
.++......+.+++.+||+.||.+||++ .++++
T Consensus 221 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 259 (327)
T cd05617 221 RIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKS 259 (327)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHc
Confidence 1111223456688899999999999985 56654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=312.80 Aligned_cols=250 Identities=22% Similarity=0.357 Sum_probs=206.5
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC---CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEc
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN---SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
+|+..+.||.|+||.||.++...+++.+++|++... ....+++.+|++++++++|+||+++++++.+.+.++++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 478889999999999999999888999999987653 33456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhC-CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCC
Q 043702 458 MPNGSLDKALFEA-RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP 536 (711)
Q Consensus 458 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~ 536 (711)
+++++|.+++... ...+++.++..++.|+++||.|||+. +++||||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999999764 45689999999999999999999987 999999999999999999999999999987654332
Q ss_pred CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhh
Q 043702 537 DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADA 616 (711)
Q Consensus 537 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 616 (711)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||.... ..+...... .+...
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-----------~~~~~~~~~-~~~~~----- 219 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN-----------PLNLVVKIV-QGNYT----- 219 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC-----------HHHHHHHHH-cCCCC-----
Confidence 2234568999999999988888999999999999999999999986431 111111111 11111
Q ss_pred hccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 043702 617 RLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655 (711)
Q Consensus 617 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L 655 (711)
.........+.+++.+||+.+|.+||++.++++.+
T Consensus 220 ----~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 220 ----PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ----CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 01122335677888999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=306.00 Aligned_cols=251 Identities=25% Similarity=0.378 Sum_probs=206.0
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC---C--Ch----hhhHHHHHHHHhcC-CCCeeeeeeeeeec
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---Q--GK----DEFLSELSIIGTLR-HRNLVRLQGWCHEK 448 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~--~~----~~~~~Ei~~l~~l~-H~niv~l~g~~~~~ 448 (711)
-.+|...+.||.|..+.|-++.++.+|...|+|++.... + .. +.-.+|+.+|+++. ||+|+++.+.++.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 356888899999999999999999999999999886421 1 11 23457999999986 99999999999999
Q ss_pred CeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCce
Q 043702 449 GEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLAR 528 (711)
Q Consensus 449 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~ 528 (711)
..+++|+|.|+.|.|.++|.. .-.++++..++|++|+.+|++|||.. .||||||||+|||+|++.++||+|||+++
T Consensus 96 sF~FlVFdl~prGELFDyLts-~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~ 171 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFAC 171 (411)
T ss_pred chhhhhhhhcccchHHHHhhh-heeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceee
Confidence 999999999999999999953 45689999999999999999999998 99999999999999999999999999999
Q ss_pred ecCCCCCCCcccccCCCcccChhhhcc------CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHH
Q 043702 529 QVEHDKSPDATVAAGTMGYLAPEYLLT------GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVW 602 (711)
Q Consensus 529 ~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~ 602 (711)
.+..+. .....||||+|+|||.+.- ..|+...|+|++||++|.|+.|.+||..... -.+.
T Consensus 172 ~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ------------mlML 237 (411)
T KOG0599|consen 172 QLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ------------MLML 237 (411)
T ss_pred ccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH------------HHHH
Confidence 887654 3566899999999999853 3578899999999999999999999954311 0111
Q ss_pred HhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 603 SLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 603 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
.++.+|+.. .......+......+|+.+||+.||.+|.|++|+++
T Consensus 238 R~ImeGkyq------F~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 238 RMIMEGKYQ------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHHhcccc------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 222222211 111222344556788999999999999999999986
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=331.25 Aligned_cols=193 Identities=26% Similarity=0.355 Sum_probs=170.2
Q ss_pred HhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEc
Q 043702 378 ATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 378 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
...+|...+.||+|+||.||+|+...+++.||+|+... .....|+.++++++|+||+++++++...+..++|+||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK-----GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc-----cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 34579999999999999999999988889999997532 2345799999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC
Q 043702 458 MPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD 537 (711)
Q Consensus 458 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 537 (711)
+ .++|.+++......+++..+.+|+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 139 ~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~ 212 (357)
T PHA03209 139 Y-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--PA 212 (357)
T ss_pred c-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC--cc
Confidence 9 4699999877777899999999999999999999997 9999999999999999999999999999754322 12
Q ss_pred cccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCC
Q 043702 538 ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPI 581 (711)
Q Consensus 538 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~ 581 (711)
.....||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 213 FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 23456999999999999999999999999999999999866554
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=326.65 Aligned_cols=241 Identities=20% Similarity=0.329 Sum_probs=194.7
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhcC-CCCeeeeeeeeeecCeEEEEE
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTLR-HRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 455 (711)
+|+..+.||+|+||.||+|+...+++.||+|++... ....+.+..|..++..+. |++|+++++++...+.+++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 367789999999999999999889999999998752 233456788999998886 577888999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
||+++|+|..++.. ...+++.++..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 81 Ey~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 81 EYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence 99999999998864 35699999999999999999999997 999999999999999999999999999975432221
Q ss_pred CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhh
Q 043702 536 PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 615 (711)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.. ... .+.
T Consensus 157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--------~~~~~---~i~-~~~------ 217 (323)
T cd05615 157 -TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE--------DELFQ---SIM-EHN------ 217 (323)
T ss_pred -cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHH---HHH-hCC------
Confidence 22335699999999999998999999999999999999999999975321 11111 111 111
Q ss_pred hhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCH
Q 043702 616 ARLEGQFDEAEMRRVLLVGLACSHPDPLARPTM 648 (711)
Q Consensus 616 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 648 (711)
..++......+.+++.+||+.+|.+|++.
T Consensus 218 ----~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 218 ----VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ----CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 01112223456788899999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=317.04 Aligned_cols=247 Identities=30% Similarity=0.471 Sum_probs=196.9
Q ss_pred ceeecCCceEEEEEEeCCCC------eEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEc
Q 043702 386 RIIGHGAFGTVYKGILPQNG------DIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~~~~------~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
+.||+|+||.||+|+..... +.+|+|.+.... ....++.+|+++++.++||||++++++|...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 36999999999999985433 679999876533 3456889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhC------CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCC-----cEEEeecCC
Q 043702 458 MPNGSLDKALFEA------RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGF-----NARLGDFGL 526 (711)
Q Consensus 458 ~~~gsL~~~l~~~------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~-----~vkL~DFGl 526 (711)
+++++|.+++... ...+++.+++.++.|++.||+|||+. +++|+||||+||+++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999642 23488999999999999999999987 999999999999999877 899999999
Q ss_pred ceecCCCCCC-CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHh
Q 043702 527 ARQVEHDKSP-DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSL 604 (711)
Q Consensus 527 a~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~ 604 (711)
++........ ......++..|+|||++.++.++.++|||||||++|||++ |+.||..... ...... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--------~~~~~~---~ 226 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--------QEVLQH---V 226 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--------HHHHHH---H
Confidence 9865432211 1122345778999999999999999999999999999998 9999864321 111111 1
Q ss_pred hhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 043702 605 HREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLV 656 (711)
Q Consensus 605 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 656 (711)
..+. ...........+.+++.+||..+|.+||++++|++.|+
T Consensus 227 -~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 227 -TAGG---------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred -hcCC---------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1110 01112223456788999999999999999999999986
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=317.85 Aligned_cols=254 Identities=26% Similarity=0.433 Sum_probs=203.0
Q ss_pred cCCcccceeecCCceEEEEEEeCCC---CeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQN---GDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLV 454 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~---~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 454 (711)
++|...++||+|+||.||+|.+... ...||+|+..... ...+.+.+|+.++++++||||++++++|.. +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 4577889999999999999987543 3468999887643 334678999999999999999999999875 567899
Q ss_pred EEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCC
Q 043702 455 YDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~ 534 (711)
|||+++|+|.+++......+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 999999999999977666799999999999999999999987 99999999999999999999999999998765543
Q ss_pred CCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHh
Q 043702 535 SPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTA 613 (711)
Q Consensus 535 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 613 (711)
........++..|+|||.+....++.++|||||||++|||++ |+.||..... .....+ .......
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--------~~~~~~---~~~~~~~--- 227 (270)
T cd05056 162 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN--------NDVIGR---IENGERL--- 227 (270)
T ss_pred ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH--------HHHHHH---HHcCCcC---
Confidence 322223335568999999988889999999999999999996 9999965321 111111 1111000
Q ss_pred hhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 614 ADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 614 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
.........+.+++.+|+..+|.+||++.++++.|...
T Consensus 228 -------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 228 -------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred -------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 01122335677888999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=319.34 Aligned_cols=261 Identities=26% Similarity=0.371 Sum_probs=206.9
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEc
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
++|+..+.||+|+||+||++....+++.+|+|++.... ...+.+.+|+++++.++||||+++++++...+.+++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 45777889999999999999998889999999876532 3356789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC
Q 043702 458 MPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD 537 (711)
Q Consensus 458 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 537 (711)
+++++|.+++.. .+.+++..+..++.+++.||.|||+. ++++||||||+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~--- 158 (284)
T cd06620 85 MDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--- 158 (284)
T ss_pred CCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---
Confidence 999999998865 45689999999999999999999974 389999999999999999999999999987553221
Q ss_pred cccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhh
Q 043702 538 ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADAR 617 (711)
Q Consensus 538 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 617 (711)
.....|+..|+|||.+.++.++.++|||||||++|||++|+.||...............+.++........ .+.
T Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 232 (284)
T cd06620 159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------PPR 232 (284)
T ss_pred cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------CCC
Confidence 22346899999999998888999999999999999999999999754321111111112222222211110 011
Q ss_pred ccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 043702 618 LEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655 (711)
Q Consensus 618 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L 655 (711)
+. ..+....+.+++.+|++.||.+||++.|++++.
T Consensus 233 ~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 233 LP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 10 112345677899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=318.97 Aligned_cols=254 Identities=26% Similarity=0.432 Sum_probs=203.7
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCe----EEEEEEcccCCC--ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGD----IIAVKRCSHNSQ--GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILL 453 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~----~vavK~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 453 (711)
.+|...+.||+|+||.||+|....+++ .+|+|....... ...++.+|++++++++||||++++++|.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 457778999999999999999865554 589998776432 34678899999999999999999999987 78999
Q ss_pred EEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCC
Q 043702 454 VYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHD 533 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~ 533 (711)
||||+++|+|.+++......+++..+++++.|++.||+|||+. +++||||||+|||+++++.+||+|||+++.....
T Consensus 86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 9999999999999987777799999999999999999999997 9999999999999999999999999999876533
Q ss_pred CCCCc-ccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchh
Q 043702 534 KSPDA-TVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLL 611 (711)
Q Consensus 534 ~~~~~-~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 611 (711)
..... ....++..|+|||.+....++.++|||||||++|||++ |+.||..... .++.... ..+..
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----------~~~~~~~-~~~~~- 229 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-----------VEIPDLL-EKGER- 229 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH-----------HHHHHHH-hCCCC-
Confidence 32111 11224568999999988889999999999999999999 9999865321 1111111 11110
Q ss_pred HhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 612 TAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 612 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
...+......+.+++.+||..+|.+||++.++++.|...
T Consensus 230 --------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 230 --------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 011111224577888999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=319.21 Aligned_cols=261 Identities=23% Similarity=0.404 Sum_probs=208.3
Q ss_pred ccCHHHHHHHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhc-CCCCeeeeeeeeee
Q 043702 369 EFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTL-RHRNLVRLQGWCHE 447 (711)
Q Consensus 369 ~~~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~ 447 (711)
..++.++....+.|+..+.||+|+||.||+|.+...++.+|+|++........++..|+.++.++ +|+|++++++++..
T Consensus 5 ~~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 5 DIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 34667777788899999999999999999999988899999999876655567788999999998 69999999999853
Q ss_pred ------cCeEEEEEEcCCCCCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEE
Q 043702 448 ------KGEILLVYDLMPNGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNAR 520 (711)
Q Consensus 448 ------~~~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vk 520 (711)
....+++|||+++|+|.+++.... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+|
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEE
Confidence 457899999999999999987543 4588888999999999999999997 999999999999999999999
Q ss_pred EeecCCceecCCCCCCCcccccCCCcccChhhhc-----cCCCCccccchhHHHHHHHHHhCCCCCcccccccccccccc
Q 043702 521 LGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLL-----TGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVAS 595 (711)
Q Consensus 521 L~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~ 595 (711)
|+|||++........ ......|++.|+|||.+. ...++.++|||||||++|||++|+.||....+. .
T Consensus 162 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~-------~ 233 (282)
T cd06636 162 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM-------R 233 (282)
T ss_pred EeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH-------h
Confidence 999999876543221 123356899999999886 345788999999999999999999999643210 0
Q ss_pred chHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 596 NLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 596 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
... .. .....+... .......+.+++.+||+.||.+||++.|+++
T Consensus 234 ~~~----~~------~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 234 ALF----LI------PRNPPPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred hhh----hH------hhCCCCCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000 00 000001110 1123356788999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=320.26 Aligned_cols=262 Identities=27% Similarity=0.386 Sum_probs=208.2
Q ss_pred cCHHHHHHHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhc-CCCCeeeeeeeeeec
Q 043702 370 FSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTL-RHRNLVRLQGWCHEK 448 (711)
Q Consensus 370 ~~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 448 (711)
+...++..++++|...+.||+|+||.||++....+++.+|+|++........++.+|+.+++++ +|||++++++++...
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 4456677788999999999999999999999988899999999876544456788999999999 799999999998753
Q ss_pred -----CeEEEEEEcCCCCCHHHHHhh---CCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEE
Q 043702 449 -----GEILLVYDLMPNGSLDKALFE---ARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNAR 520 (711)
Q Consensus 449 -----~~~~lV~Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vk 520 (711)
+..++||||+++++|.+++.. ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEE
Confidence 358999999999999998853 345689999999999999999999987 999999999999999999999
Q ss_pred EeecCCceecCCCCCCCcccccCCCcccChhhhccCC-----CCccccchhHHHHHHHHHhCCCCCcccccccccccccc
Q 043702 521 LGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGR-----ATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVAS 595 (711)
Q Consensus 521 L~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-----~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~ 595 (711)
|+|||+++....... ......|+..|+|||.+.... ++.++|||||||++|||++|+.||...... .
T Consensus 169 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-------~ 240 (291)
T cd06639 169 LVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-------K 240 (291)
T ss_pred Eeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-------H
Confidence 999999986543221 122346889999999986543 688999999999999999999998653210 1
Q ss_pred chHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 596 NLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 596 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.+..+ .+ +.. +.+. ...+....+.+++.+||+.+|++||++.|+++.
T Consensus 241 ~~~~~----~~-~~~-----~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 241 TLFKI----PR-NPP-----PTLL--HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHHHH----hc-CCC-----CCCC--cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11111 00 000 0000 112233467889999999999999999999874
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=332.80 Aligned_cols=252 Identities=27% Similarity=0.475 Sum_probs=212.8
Q ss_pred cCCcccceeecCCceEEEEEEeCC----CCeEEEEEEccc--CCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQ----NGDIIAVKRCSH--NSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILL 453 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~----~~~~vavK~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 453 (711)
+.....++||.|.||.||+|.... ..-.||||.++. ...+.+.|+.|..+|+.++||||++|+|+|.+ ...++
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi 467 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI 467 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence 445567889999999999998732 234589998876 34557889999999999999999999999976 47899
Q ss_pred EEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCC
Q 043702 454 VYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHD 533 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~ 533 (711)
|||.++.|.|..||+.+...|+......++.||+.||.|||+. +.|||||..+|||+.....|||+||||+|.++++
T Consensus 468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD 544 (974)
T ss_pred EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence 9999999999999999889999999999999999999999998 9999999999999999999999999999999888
Q ss_pred CCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhH
Q 043702 534 KSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLT 612 (711)
Q Consensus 534 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 612 (711)
..+......-+..|||||.+.-.+++.++|||-|||++||++. |..||..-... ++..
T Consensus 545 ~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs---------------------DVI~ 603 (974)
T KOG4257|consen 545 AYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS---------------------DVIG 603 (974)
T ss_pred chhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc---------------------ceEE
Confidence 7777666566779999999999999999999999999999988 99999654221 1111
Q ss_pred hhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 043702 613 AADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLV 656 (711)
Q Consensus 613 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 656 (711)
.+...-+...++.++..+..|+.+||..+|.+||.+.|+...|.
T Consensus 604 ~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~ls 647 (974)
T KOG4257|consen 604 HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILS 647 (974)
T ss_pred EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHH
Confidence 11111122345566778889999999999999999999877663
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=307.82 Aligned_cols=252 Identities=25% Similarity=0.346 Sum_probs=204.9
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEccc---CCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSH---NSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
++.|+..+.||+|.|+.||++.+..+|+.+|+|++.. ...+.+++.+|++|.+.|+||||++|..-+.+.+..++|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 4568888899999999999999999999999998765 3456788999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEc---CCCcEEEeecCCceecCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLD---EGFNARLGDFGLARQVEH 532 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld---~~~~vkL~DFGla~~~~~ 532 (711)
|+|.|++|..-+-.. .-.++...-..++||+++|.|+|.. +|||||+||+|+||- ..-.+||+|||+|..+.
T Consensus 90 e~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~- 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN- 164 (355)
T ss_pred ecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeC-
Confidence 999999997766432 4466777888999999999999997 999999999999994 33458999999999887
Q ss_pred CCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhH
Q 043702 533 DKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLT 612 (711)
Q Consensus 533 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 612 (711)
........+|||+|||||+++..+|+..+|||+.||+||-|+.|++||.++.. ..+ ++.+..|...
T Consensus 165 -~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~--------~rl----ye~I~~g~yd- 230 (355)
T KOG0033|consen 165 -DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--------HRL----YEQIKAGAYD- 230 (355)
T ss_pred -CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH--------HHH----HHHHhccccC-
Confidence 33344556899999999999999999999999999999999999999976432 111 1111221110
Q ss_pred hhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 613 AADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 613 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
..+.+.....++..+|+.+||..||.+|.|+.|.++.
T Consensus 231 -----~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 231 -----YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred -----CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 1111122234556788899999999999999998763
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=313.01 Aligned_cols=253 Identities=25% Similarity=0.349 Sum_probs=206.1
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC-CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcC
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
++|+..+.||+|++|.||+|....+++.+++|.+.... ...+.+.+|++++++++||||+++++++..++.++++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57888999999999999999998888999999987633 34578899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCc
Q 043702 459 PNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDA 538 (711)
Q Consensus 459 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 538 (711)
++++|.+++......+++.++..++.|++.||.|||+. +++|+||||+||++++++.+||+|||++........ ..
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~ 158 (262)
T cd06613 83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-KR 158 (262)
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh-cc
Confidence 99999999977667899999999999999999999987 999999999999999999999999999976543221 12
Q ss_pred ccccCCCcccChhhhccC---CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhh
Q 043702 539 TVAAGTMGYLAPEYLLTG---RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615 (711)
Q Consensus 539 ~~~~gt~~y~APE~~~~~---~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 615 (711)
....++..|+|||.+... .++.++|||||||++|||++|+.||...... ..... . ..... ..
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~-------~~~~~----~-~~~~~---~~ 223 (262)
T cd06613 159 KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM-------RALFL----I-SKSNF---PP 223 (262)
T ss_pred ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH-------HHHHH----H-HhccC---CC
Confidence 234688899999999776 7899999999999999999999998643210 00000 0 00000 00
Q ss_pred hhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 616 ARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 616 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
+. ..........+.+++.+||+.+|.+||++.+|+.
T Consensus 224 ~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 224 PK--LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cc--ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 0112233456889999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=330.28 Aligned_cols=256 Identities=26% Similarity=0.402 Sum_probs=198.6
Q ss_pred cCCcccceeecCCceEEEEEEeC-----CCCeEEEEEEcccCC--CChhhhHHHHHHHHhc-CCCCeeeeeeeeeec-Ce
Q 043702 380 KCFNANRIIGHGAFGTVYKGILP-----QNGDIIAVKRCSHNS--QGKDEFLSELSIIGTL-RHRNLVRLQGWCHEK-GE 450 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~-~~ 450 (711)
++|...+.||+|+||.||+|.+. .+++.||||++.... ...+.+.+|+.++.++ +||||++++++|... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 46888999999999999999842 356789999987532 2345688999999999 589999999988654 56
Q ss_pred EEEEEEcCCCCCHHHHHhhCC-----------------------------------------------------------
Q 043702 451 ILLVYDLMPNGSLDKALFEAR----------------------------------------------------------- 471 (711)
Q Consensus 451 ~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------------- 471 (711)
.++||||+++|+|.+++....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 799999999999999986432
Q ss_pred -------CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC-CCcccccC
Q 043702 472 -------SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS-PDATVAAG 543 (711)
Q Consensus 472 -------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~-~~~~~~~g 543 (711)
..+++..+.+++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++....... .......+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 2368888999999999999999997 999999999999999999999999999986533221 11122345
Q ss_pred CCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccCCC
Q 043702 544 TMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQF 622 (711)
Q Consensus 544 t~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 622 (711)
+..|+|||.+.+..++.++|||||||++|||++ |..||...... .. .......+.... .
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~----~~~~~~~~~~~~-----~---- 303 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-------EE----FCRRLKEGTRMR-----A---- 303 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc-------HH----HHHHHhccCCCC-----C----
Confidence 678999999998899999999999999999997 99998543110 01 111111111100 0
Q ss_pred cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 623 DEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 623 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
+......+.+++.+||+.+|.+||++.+|++.|+..
T Consensus 304 ~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 304 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 011123577888999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=326.59 Aligned_cols=252 Identities=24% Similarity=0.326 Sum_probs=212.3
Q ss_pred HhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC----CChhhhHHHHHHHHhcC-CCCeeeeeeeeeecCeEE
Q 043702 378 ATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS----QGKDEFLSELSIIGTLR-HRNLVRLQGWCHEKGEIL 452 (711)
Q Consensus 378 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~ 452 (711)
....|+..+.||+|.||.||+++.+.+|+.+|+|.+.... ...+.+.+|+.+|+++. |||||.+.+.+.....++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3456888899999999999999999999999999987633 24468999999999999 999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCC----CcEEEeecCCce
Q 043702 453 LVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEG----FNARLGDFGLAR 528 (711)
Q Consensus 453 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~----~~vkL~DFGla~ 528 (711)
+|||++.+|.|.+.+... .+++.....++.|+++++.|||+. +|+||||||+|+|+... +.+|++|||++.
T Consensus 113 lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 999999999999999766 399999999999999999999997 99999999999999533 479999999999
Q ss_pred ecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcC
Q 043702 529 QVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREG 608 (711)
Q Consensus 529 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 608 (711)
.... .......+||+.|+|||++....|+.++||||+||++|.|++|..||..+... .... ....+
T Consensus 188 ~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~-------~~~~-----~i~~~ 253 (382)
T KOG0032|consen 188 FIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEF-------EIFL-----AILRG 253 (382)
T ss_pred EccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChh-------HHHH-----HHHcC
Confidence 8776 34556678999999999999999999999999999999999999999875421 0000 11111
Q ss_pred chhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 609 RLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 609 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
+. .............+.+++..|+..||.+|+++.++++.
T Consensus 254 ~~------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 254 DF------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CC------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11 12222333445677788999999999999999999995
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=333.60 Aligned_cols=201 Identities=25% Similarity=0.384 Sum_probs=176.6
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
++|+..+.||+|+||.||++....+++.||+|++... ......+.+|+.++..++|+||+++++.+.+++.+++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 3688899999999999999999989999999998642 233457888999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
||+++|+|.+++.. ...+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 81 EFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred eCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 99999999999864 45689999999999999999999997 999999999999999999999999999875432110
Q ss_pred ----------------------------------CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCC
Q 043702 536 ----------------------------------PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPI 581 (711)
Q Consensus 536 ----------------------------------~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~ 581 (711)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0112347999999999999999999999999999999999999999
Q ss_pred ccc
Q 043702 582 EKE 584 (711)
Q Consensus 582 ~~~ 584 (711)
...
T Consensus 237 ~~~ 239 (360)
T cd05627 237 CSE 239 (360)
T ss_pred CCC
Confidence 653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=313.13 Aligned_cols=248 Identities=23% Similarity=0.422 Sum_probs=200.9
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCC----------hhhhHHHHHHHHhcCCCCeeeeeeeeeecCe
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQG----------KDEFLSELSIIGTLRHRNLVRLQGWCHEKGE 450 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~----------~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 450 (711)
+|.....||+|++|.||+|....+++.+|+|.+...... .+.+.+|++++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 366778999999999999999888899999987653211 2457889999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceec
Q 043702 451 ILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV 530 (711)
Q Consensus 451 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~ 530 (711)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|||+++..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 99999999999999999653 5689999999999999999999987 9999999999999999999999999999876
Q ss_pred CCCCC-----CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhh
Q 043702 531 EHDKS-----PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLH 605 (711)
Q Consensus 531 ~~~~~-----~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~ 605 (711)
..... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||..... ... .....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----------~~~-~~~~~ 225 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ----------LQA-IFKIG 225 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH----------HHH-HHHHh
Confidence 53211 111234588999999999988899999999999999999999999965311 000 00000
Q ss_pred hcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 606 REGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 606 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
.. .....+......+.+++.+||+.||.+||++.|+++
T Consensus 226 ------~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 226 ------EN----ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ------cc----CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 00 111122233456778889999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=314.80 Aligned_cols=269 Identities=23% Similarity=0.296 Sum_probs=198.2
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC---CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEc
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
+|+..+.||+|++|.||+|+...++..||+|++.... ...+.+.+|+.++++++|||++++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999998889999999886532 2345788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCC--CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 458 MPNGSLDKALFEAR--SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 458 ~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
++ ++|.+++.... ..+++..+..++.|+++||.|||+. +++||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 68988886433 5689999999999999999999987 999999999999999999999999999986543321
Q ss_pred CCcccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccccccccccccc---cchHHHHHHhhhc-Cch
Q 043702 536 PDATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVA---SNLVEWVWSLHRE-GRL 610 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~---~~l~~~~~~~~~~-~~~ 610 (711)
......+++.|+|||.+.+. .++.++|||||||++|||++|+.||............. ....+-.|..... ...
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 157 -VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235 (285)
T ss_pred -cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence 12233578899999988654 47889999999999999999999997532100000000 0000000000000 000
Q ss_pred hHhhhhhccCC---CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 611 LTAADARLEGQ---FDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 611 ~~~~d~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
....+...... .......++.+++.+||+.||.+|||+++|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000000000 000123456789999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=352.49 Aligned_cols=256 Identities=21% Similarity=0.311 Sum_probs=200.8
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC----ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ----GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
++|+..++||+|+||.||+|++..+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 478899999999999999999988899999999875321 2357889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhC----------CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecC
Q 043702 456 DLMPNGSLDKALFEA----------RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFG 525 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~----------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFG 525 (711)
||+++|+|.+++... ...+++..+++++.||++||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 999999999998632 13466778899999999999999997 99999999999999999999999999
Q ss_pred CceecCCCCC-----------------CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccc
Q 043702 526 LARQVEHDKS-----------------PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGV 588 (711)
Q Consensus 526 la~~~~~~~~-----------------~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~ 588 (711)
+++....... ......+||+.|||||.+.+..++.++|||||||++|||++|+.||......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~- 237 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR- 237 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh-
Confidence 9987621110 0112246999999999999999999999999999999999999999653210
Q ss_pred cccccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHhC
Q 043702 589 GKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARP-TMRGVVQMLVG 657 (711)
Q Consensus 589 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~eVl~~L~~ 657 (711)
.. ... .......+... ..+....+.+++.+|++.||++|| +++++++.|+.
T Consensus 238 -------ki---~~~----~~i~~P~~~~p----~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~ 289 (932)
T PRK13184 238 -------KI---SYR----DVILSPIEVAP----YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP 289 (932)
T ss_pred -------hh---hhh----hhccChhhccc----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00 000 00000000000 012234567888999999999996 56666665543
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=324.37 Aligned_cols=254 Identities=28% Similarity=0.468 Sum_probs=201.9
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCe----EEEEEEcccCCC--ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGD----IIAVKRCSHNSQ--GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILL 453 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~----~vavK~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 453 (711)
++|+..+.||+|+||.||+|.+..++. .+|+|++..... ...++.+|+.+++.++||||++++++|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 456778899999999999999866665 478888765332 234688999999999999999999999754 5679
Q ss_pred EEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCC
Q 043702 454 VYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHD 533 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~ 533 (711)
++||+++|+|.+++......+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccCc
Confidence 9999999999999987777799999999999999999999987 9999999999999999999999999999876533
Q ss_pred CCC-CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchh
Q 043702 534 KSP-DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLL 611 (711)
Q Consensus 534 ~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 611 (711)
... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||..... ....+++ ..+...
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--------~~~~~~~----~~~~~~ 230 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--------REIPDLL----EKGERL 230 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHH----HCCCCC
Confidence 221 1222345778999999998899999999999999999997 8999864311 1112211 111110
Q ss_pred HhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 612 TAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 612 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
.........+.+++..||..+|++||+++++++.|...
T Consensus 231 ---------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 231 ---------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 00111234577889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=319.64 Aligned_cols=247 Identities=25% Similarity=0.393 Sum_probs=202.2
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcC
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
.|+..+.||+|+||.||+|.+..++..||+|.+.... ...+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3566778999999999999998889999999876432 33457889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCc
Q 043702 459 PNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDA 538 (711)
Q Consensus 459 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 538 (711)
++++|.+++.. ..+++..+..++.|+++||.|||+. +++|+||+|+||++++++.+||+|||++..+..... ..
T Consensus 85 ~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~ 158 (277)
T cd06642 85 GGGSALDLLKP--GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KR 158 (277)
T ss_pred CCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch-hh
Confidence 99999998853 5689999999999999999999987 999999999999999999999999999987654321 22
Q ss_pred ccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhc
Q 043702 539 TVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARL 618 (711)
Q Consensus 539 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 618 (711)
....|+..|+|||.+.+..++.++|||||||++|||++|+.|+...... ..... ...+ .
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-----------~~~~~-~~~~---------~ 217 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM-----------RVLFL-IPKN---------S 217 (277)
T ss_pred hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh-----------hHHhh-hhcC---------C
Confidence 2345888999999999888999999999999999999999998643210 00000 0110 1
Q ss_pred cCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 619 EGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
...........+.+++.+||+.+|.+||++.+|++.
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 218 PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 111222334567889999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=313.19 Aligned_cols=239 Identities=24% Similarity=0.400 Sum_probs=193.1
Q ss_pred ceeecCCceEEEEEEeCCCC----------eEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 386 RIIGHGAFGTVYKGILPQNG----------DIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~~~~----------~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
+.||+|+||.||+|.+...+ ..+++|.+.........+.+|+.+++.++||||++++++|.. ...++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 46999999999999997655 358888876644446789999999999999999999999988 7789999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCC-------cEEEeecCCce
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGF-------NARLGDFGLAR 528 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~-------~vkL~DFGla~ 528 (711)
||+++|+|.+++......+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+++
T Consensus 80 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~ 156 (259)
T cd05037 80 EYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156 (259)
T ss_pred EcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence 99999999999987666899999999999999999999987 999999999999999887 79999999998
Q ss_pred ecCCCCCCCcccccCCCcccChhhhccC--CCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhh
Q 043702 529 QVEHDKSPDATVAAGTMGYLAPEYLLTG--RATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLH 605 (711)
Q Consensus 529 ~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~ 605 (711)
.... .....++..|+|||++... .++.++|||||||++|||++ |..|+..... .++... .
T Consensus 157 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~-----------~~~~~~-~ 219 (259)
T cd05037 157 TVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS-----------SEKERF-Y 219 (259)
T ss_pred cccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc-----------hhHHHH-H
Confidence 6543 1123467789999999876 78999999999999999999 5777654311 011100 0
Q ss_pred hcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 043702 606 REGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLV 656 (711)
Q Consensus 606 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 656 (711)
..... ........+.+++.+||..+|.+||++.+|++.|.
T Consensus 220 ~~~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 220 QDQHR-----------LPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred hcCCC-----------CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00000 00011156778999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=319.72 Aligned_cols=252 Identities=23% Similarity=0.369 Sum_probs=202.8
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC-CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcC
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
+.|++.++||+|+||.||+|.+..++..+++|.+.... ...+.+.+|+++++.++|+|++++++.+..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56888899999999999999998889999999987643 33567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCc
Q 043702 459 PNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDA 538 (711)
Q Consensus 459 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 538 (711)
++++|..++.+....+++..+..++.|++.+|+|||+. +++||||||+||+++.++.+||+|||++....... ...
T Consensus 92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~~ 167 (292)
T cd06644 92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QRR 167 (292)
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc-ccc
Confidence 99999998877667799999999999999999999987 99999999999999999999999999987643322 122
Q ss_pred ccccCCCcccChhhhc-----cCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHh
Q 043702 539 TVAAGTMGYLAPEYLL-----TGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTA 613 (711)
Q Consensus 539 ~~~~gt~~y~APE~~~-----~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 613 (711)
....+++.|+|||++. ...++.++|||||||++|||++|+.||..... .+........ .
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----------~~~~~~~~~~-~---- 231 (292)
T cd06644 168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-----------MRVLLKIAKS-E---- 231 (292)
T ss_pred ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-----------HHHHHHHhcC-C----
Confidence 3345889999999885 34467899999999999999999999864311 0111111100 0
Q ss_pred hhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 614 ADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 614 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.+.. .........+.+++.+||+.+|++||++.++++.
T Consensus 232 -~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 232 -PPTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred -CccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000 0111223457788999999999999999999873
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=329.09 Aligned_cols=268 Identities=22% Similarity=0.243 Sum_probs=198.8
Q ss_pred HhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC---CChhhhHHHHHHHHhcCCCCeeeeeeeeeec------
Q 043702 378 ATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---QGKDEFLSELSIIGTLRHRNLVRLQGWCHEK------ 448 (711)
Q Consensus 378 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------ 448 (711)
..++|...+.||+|+||.||++.....++.||+|++.... .....+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4568999999999999999999998889999999987532 2345678899999999999999999988643
Q ss_pred CeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCce
Q 043702 449 GEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLAR 528 (711)
Q Consensus 449 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~ 528 (711)
...++||||+++ +|...+. ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcccc
Confidence 357999999965 6766663 3588999999999999999999997 99999999999999999999999999998
Q ss_pred ecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCcccccccccccc----ccchHHH----
Q 043702 529 QVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGV----ASNLVEW---- 600 (711)
Q Consensus 529 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~----~~~l~~~---- 600 (711)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||............ .....++
T Consensus 168 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 168 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred cCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 654322 223356899999999999889999999999999999999999999653210000000 0000000
Q ss_pred ---HHHhhhcC-chhHhhhhh-----c---cCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 601 ---VWSLHREG-RLLTAADAR-----L---EGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 601 ---~~~~~~~~-~~~~~~d~~-----l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
+....... .......+. + ...........+.+++.+|++.||++|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000000 000000000 0 000111123567889999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=314.48 Aligned_cols=240 Identities=23% Similarity=0.368 Sum_probs=189.5
Q ss_pred ceeecCCceEEEEEEeCCC------------CeEEEEEEcccCC-CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEE
Q 043702 386 RIIGHGAFGTVYKGILPQN------------GDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEIL 452 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~~~------------~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 452 (711)
+.||+|+||.||+|+.... ...|++|.+.... .....+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 3689999999999986322 2358889876533 23457888999999999999999999999998999
Q ss_pred EEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCc-------EEEeecC
Q 043702 453 LVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFN-------ARLGDFG 525 (711)
Q Consensus 453 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~-------vkL~DFG 525 (711)
+||||+++|+|..++......+++..+++++.||++||+|||+. +|+||||||+|||++.++. +|++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 99999999999999877667799999999999999999999997 9999999999999987664 8999999
Q ss_pred CceecCCCCCCCcccccCCCcccChhhhc-cCCCCccccchhHHHHHHHHH-hCCCCCccccccccccccccchHHHHHH
Q 043702 526 LARQVEHDKSPDATVAAGTMGYLAPEYLL-TGRATEKTDVFSYGAVVLEVA-SGRRPIEKEITGVGKVGVASNLVEWVWS 603 (711)
Q Consensus 526 la~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~s~ksDVwSfGvll~ell-tG~~P~~~~~~~~~~~~~~~~l~~~~~~ 603 (711)
++...... ....++..|+|||.+. ...++.++|||||||++|||+ .|+.|+..... .+.. .
T Consensus 158 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-----------~~~~-~ 220 (262)
T cd05077 158 IPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL-----------AEKE-R 220 (262)
T ss_pred CCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch-----------hHHH-H
Confidence 98765322 2235788999999887 456899999999999999998 58888754211 0100 0
Q ss_pred hhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 043702 604 LHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLV 656 (711)
Q Consensus 604 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 656 (711)
... +.. .. .......+.+++.+||+.||.+||++.++++.|+
T Consensus 221 ~~~-~~~------~~----~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 221 FYE-GQC------ML----VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred HHh-cCc------cC----CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 000 000 00 1112345778999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=326.57 Aligned_cols=256 Identities=25% Similarity=0.415 Sum_probs=202.8
Q ss_pred cCCcccceeecCCceEEEEEEeCC-------CCeEEEEEEcccCC--CChhhhHHHHHHHHhc-CCCCeeeeeeeeeecC
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQ-------NGDIIAVKRCSHNS--QGKDEFLSELSIIGTL-RHRNLVRLQGWCHEKG 449 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~-------~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 449 (711)
.+|.+.+.||+|+||.||++.... .+..||+|.+.... ...+++.+|+++++++ +||||++++++|..++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 357888999999999999998632 22368999877532 2346789999999999 7999999999999999
Q ss_pred eEEEEEEcCCCCCHHHHHhhCC---------------CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEc
Q 043702 450 EILLVYDLMPNGSLDKALFEAR---------------SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLD 514 (711)
Q Consensus 450 ~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld 514 (711)
..+++|||+++|+|.+++.... ..+++.++++++.|++.||.|||+. +++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEc
Confidence 9999999999999999996532 3588999999999999999999997 999999999999999
Q ss_pred CCCcEEEeecCCceecCCCCCC-CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccc
Q 043702 515 EGFNARLGDFGLARQVEHDKSP-DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVG 592 (711)
Q Consensus 515 ~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~ 592 (711)
+++.+||+|||+++........ ......++..|+|||.+....++.++|||||||++|||++ |..||....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------- 241 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP------- 241 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC-------
Confidence 9999999999999876543221 1122234568999999999999999999999999999998 888885431
Q ss_pred cccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC
Q 043702 593 VASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEA 659 (711)
Q Consensus 593 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~ 659 (711)
..++.... ..+. ...........+.+++.+||+.+|.+||++.|+++.|....
T Consensus 242 ----~~~~~~~~-~~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 242 ----VEELFKLL-KEGH---------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred ----HHHHHHHH-HcCC---------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 11211111 1111 01111223456778999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=311.69 Aligned_cols=247 Identities=28% Similarity=0.428 Sum_probs=198.9
Q ss_pred ceeecCCceEEEEEEeCC-CC--eEEEEEEcccCCC--ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCCC
Q 043702 386 RIIGHGAFGTVYKGILPQ-NG--DIIAVKRCSHNSQ--GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPN 460 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~~-~~--~~vavK~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 460 (711)
++||+|++|.||+|.+.. ++ ..||+|.+..... ..+.+.+|++++++++||||+++++.+.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999854 33 3689999877443 45688999999999999999999999988 889999999999
Q ss_pred CCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCC--C
Q 043702 461 GSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP--D 537 (711)
Q Consensus 461 gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~--~ 537 (711)
++|.+++.+.. ..+++.....++.|+++||+|||+. +++||||||+||+++.++.+||+|||+++.+...... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999997655 5789999999999999999999997 9999999999999999999999999999876543221 1
Q ss_pred cccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhhhh
Q 043702 538 ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADA 616 (711)
Q Consensus 538 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 616 (711)
.....++..|+|||++....++.++|||||||++|||++ |+.||..... .+........+..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----------~~~~~~~~~~~~~------ 219 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG-----------SQILKKIDKEGER------ 219 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH-----------HHHHHHHHhcCCc------
Confidence 122457789999999999899999999999999999999 9999854211 1111111111000
Q ss_pred hccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 043702 617 RLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLV 656 (711)
Q Consensus 617 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 656 (711)
..........+.+++.+|++.+|++||++.++++.|.
T Consensus 220 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 220 ---LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ---CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0111223456788999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=314.28 Aligned_cols=247 Identities=23% Similarity=0.383 Sum_probs=204.7
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcC
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
.|+..+.||+|+||.||+|.+..++..||+|++.... .....+.+|++++++++|+||+++++++.+++..++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4667788999999999999998889999999887532 33567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCc
Q 043702 459 PNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDA 538 (711)
Q Consensus 459 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 538 (711)
++++|.+++.. ..+++.+...++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 85 ~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~ 158 (277)
T cd06640 85 GGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KR 158 (277)
T ss_pred CCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-cc
Confidence 99999999853 4689999999999999999999987 999999999999999999999999999987654332 22
Q ss_pred ccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhc
Q 043702 539 TVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARL 618 (711)
Q Consensus 539 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 618 (711)
....++..|+|||++.+..++.++|||||||++|||++|+.||...... .. .. ......
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--------~~---~~----------~~~~~~ 217 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM--------RV---LF----------LIPKNN 217 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH--------hH---hh----------hhhcCC
Confidence 3346888999999999888999999999999999999999998653210 00 00 000011
Q ss_pred cCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 619 EGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
...........+.+++.+||+.+|.+||++.++++.
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 218 PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 122333456678899999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=312.73 Aligned_cols=251 Identities=25% Similarity=0.358 Sum_probs=190.5
Q ss_pred ceeecCCceEEEEEEeCC--CCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCCCC
Q 043702 386 RIIGHGAFGTVYKGILPQ--NGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNG 461 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~~--~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 461 (711)
+.||+|+||.||+|.... .+..+|+|++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 359999999999998643 34679999887643 23357889999999999999999999999999999999999999
Q ss_pred CHHHHHhhCC----CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCC-
Q 043702 462 SLDKALFEAR----SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP- 536 (711)
Q Consensus 462 sL~~~l~~~~----~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~- 536 (711)
+|.+++.... ...++..+.+++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999997532 2467788889999999999999997 9999999999999999999999999999754332221
Q ss_pred CcccccCCCcccChhhhccC-------CCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcC
Q 043702 537 DATVAAGTMGYLAPEYLLTG-------RATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREG 608 (711)
Q Consensus 537 ~~~~~~gt~~y~APE~~~~~-------~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 608 (711)
......|+..|+|||++... .++.++|||||||++|||++ |+.||..... .....+. ..+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~--------~~~~~~~----~~~ 225 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD--------EQVLTYT----VRE 225 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh--------HHHHHHH----hhc
Confidence 12234578899999998642 35789999999999999996 9999964321 1111110 011
Q ss_pred chhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 043702 609 RLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLV 656 (711)
Q Consensus 609 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 656 (711)
......++.+.. .....+.+++..|+ .+|++||++++|++.|.
T Consensus 226 ~~~~~~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 226 QQLKLPKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred ccCCCCCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 111111222211 12234566778898 58999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=319.45 Aligned_cols=249 Identities=26% Similarity=0.355 Sum_probs=203.5
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC-CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcC
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
++|+..+.||+|++|.||+|....+++.||+|.+.... ...+.+.+|+.+++.++|+|++++++++..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 67889999999999999999998889999999987533 33466789999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCc
Q 043702 459 PNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDA 538 (711)
Q Consensus 459 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 538 (711)
++++|.+++.+ ..+++.++..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++......... .
T Consensus 99 ~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~-~ 172 (297)
T cd06656 99 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-R 172 (297)
T ss_pred CCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCccC-c
Confidence 99999999854 4588999999999999999999997 9999999999999999999999999999876443322 2
Q ss_pred ccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhc
Q 043702 539 TVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARL 618 (711)
Q Consensus 539 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 618 (711)
....+++.|+|||.+.+..++.++|||||||++|+|++|+.||....... .+. .....+. +.+
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~-------~~~----~~~~~~~------~~~ 235 (297)
T cd06656 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-------ALY----LIATNGT------PEL 235 (297)
T ss_pred CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch-------hee----eeccCCC------CCC
Confidence 33468899999999999889999999999999999999999996532210 000 0000000 000
Q ss_pred cCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 619 EGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
.........+.+++.+||+.+|.+||+++++++
T Consensus 236 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 236 --QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred --CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011122345677889999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=317.85 Aligned_cols=240 Identities=22% Similarity=0.367 Sum_probs=190.4
Q ss_pred ceeecCCceEEEEEEeCCCCe-------EEEEEEcccCC-CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEc
Q 043702 386 RIIGHGAFGTVYKGILPQNGD-------IIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~~~~~-------~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
+.||+|+||.||+|.....+. .+++|.+.... ...+++.+|+.+++.++|||++++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999998855443 48888876532 3346788999999999999999999999998999999999
Q ss_pred CCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCc--------EEEeecCCcee
Q 043702 458 MPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFN--------ARLGDFGLARQ 529 (711)
Q Consensus 458 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~--------vkL~DFGla~~ 529 (711)
+++|+|..++......+++..+++++.||+.||.|||+. +|+||||||+|||++.++. +|++|||++..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 999999999987666799999999999999999999997 9999999999999987765 69999999875
Q ss_pred cCCCCCCCcccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCC-CCCccccccccccccccchHHHHHHhhhc
Q 043702 530 VEHDKSPDATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGR-RPIEKEITGVGKVGVASNLVEWVWSLHRE 607 (711)
Q Consensus 530 ~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~-~P~~~~~~~~~~~~~~~~l~~~~~~~~~~ 607 (711)
.... ....++..|+|||++.+. .++.++|||||||++|||++|. .|+..... .... .....
T Consensus 158 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~-----------~~~~-~~~~~ 220 (258)
T cd05078 158 VLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS-----------QKKL-QFYED 220 (258)
T ss_pred cCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH-----------HHHH-HHHHc
Confidence 4321 224578899999999864 5799999999999999999995 55433211 0000 00110
Q ss_pred CchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 043702 608 GRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLV 656 (711)
Q Consensus 608 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 656 (711)
...++......+.+++.+||+.||++||+++++++.|+
T Consensus 221 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 -----------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -----------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 01111122345788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=327.70 Aligned_cols=198 Identities=26% Similarity=0.330 Sum_probs=171.0
Q ss_pred HhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC---CChhhhHHHHHHHHhcCCCCeeeeeeeeeec------
Q 043702 378 ATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---QGKDEFLSELSIIGTLRHRNLVRLQGWCHEK------ 448 (711)
Q Consensus 378 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------ 448 (711)
..++|...+.||+|+||.||+++....++.||||++.... .....+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3568999999999999999999998889999999987532 2345788999999999999999999987543
Q ss_pred CeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCce
Q 043702 449 GEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLAR 528 (711)
Q Consensus 449 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~ 528 (711)
...++||||+++ +|...+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH---hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 357999999965 7777764 3488899999999999999999997 99999999999999999999999999998
Q ss_pred ecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccc
Q 043702 529 QVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKE 584 (711)
Q Consensus 529 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~ 584 (711)
...... ......||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 175 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 175 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred ccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 654322 223356899999999999999999999999999999999999999653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=319.84 Aligned_cols=249 Identities=25% Similarity=0.365 Sum_probs=203.6
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC-CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcC
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
++|+..+.||.|++|.||+|....+++.|++|.+.... ...+.+.+|+++++.++|||++++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 46888999999999999999998889999999886533 34567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCc
Q 043702 459 PNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDA 538 (711)
Q Consensus 459 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 538 (711)
++++|..++.. ..+++.++..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++........ ..
T Consensus 99 ~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~ 172 (296)
T cd06655 99 AGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KR 172 (296)
T ss_pred CCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc-cC
Confidence 99999998854 3589999999999999999999998 999999999999999999999999999886544332 12
Q ss_pred ccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhc
Q 043702 539 TVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARL 618 (711)
Q Consensus 539 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 618 (711)
....|+..|+|||.+.+..++.++|||||||++|||++|+.||...... +........ .. +.+
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~-----------~~~~~~~~~-~~-----~~~ 235 (296)
T cd06655 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-----------RALYLIATN-GT-----PEL 235 (296)
T ss_pred CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----------HHHHHHHhc-CC-----ccc
Confidence 2346889999999999888999999999999999999999999654210 000000000 00 000
Q ss_pred cCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 619 EGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
.........+.+++.+||+.||.+||++.++++
T Consensus 236 --~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 236 --QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred --CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 011122345678889999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=310.60 Aligned_cols=249 Identities=23% Similarity=0.373 Sum_probs=204.9
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC---CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEc
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN---SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
+|+..+.||+|+||.||++....+++.+|+|++... ....+++.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 478889999999999999999888999999988652 23346789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCC
Q 043702 458 MPNGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP 536 (711)
Q Consensus 458 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~ 536 (711)
+++++|.+++.... ..+++.++++++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 99999999987643 3589999999999999999999987 999999999999999999999999999987644321
Q ss_pred CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhh
Q 043702 537 DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADA 616 (711)
Q Consensus 537 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 616 (711)
......|++.|+|||++.++..+.++|||||||+++||++|+.||.... ..+.+...... ..
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-----------~~~~~~~~~~~-~~------ 218 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN-----------MKNLVLKIIRG-SY------ 218 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC-----------HHHHHHHHhcC-CC------
Confidence 1223458899999999998899999999999999999999999986431 11111111111 10
Q ss_pred hccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 617 RLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 617 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
..........+.+++.+||+.+|.+||++++|++.
T Consensus 219 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 219 ---PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred ---CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11122334567889999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=318.40 Aligned_cols=195 Identities=24% Similarity=0.366 Sum_probs=161.9
Q ss_pred cceeecCCceEEEEEEeCC--CCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeee--cCeEEEEEEcCCC
Q 043702 385 NRIIGHGAFGTVYKGILPQ--NGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHE--KGEILLVYDLMPN 460 (711)
Q Consensus 385 ~~~LG~G~fg~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~Ey~~~ 460 (711)
.++||+|+||+||+|+... +++.+|+|++.... ....+.+|++++++++||||+++++++.. +...+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE- 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-
Confidence 4579999999999999753 56889999886533 23567899999999999999999998854 456899999985
Q ss_pred CCHHHHHhhC--------CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEE----cCCCcEEEeecCCce
Q 043702 461 GSLDKALFEA--------RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIML----DEGFNARLGDFGLAR 528 (711)
Q Consensus 461 gsL~~~l~~~--------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl----d~~~~vkL~DFGla~ 528 (711)
++|.+++... ...+++..+..++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 4888877532 13588999999999999999999997 99999999999999 456789999999998
Q ss_pred ecCCCCC--CCcccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccc
Q 043702 529 QVEHDKS--PDATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKE 584 (711)
Q Consensus 529 ~~~~~~~--~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~ 584 (711)
....... .......||+.|+|||++.+. .++.++||||+||++|||++|++||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 7654322 122345789999999998774 5899999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=318.26 Aligned_cols=261 Identities=20% Similarity=0.327 Sum_probs=201.0
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEc
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
+.|...+.||+|+||.||+|+...+++.||+|.+.... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46888999999999999999998889999999886532 2345678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC
Q 043702 458 MPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD 537 (711)
Q Consensus 458 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 537 (711)
++ ++|..++......+++..+..++.|+++||.|||+. +|+||||||+|||+++++.+||+|||++........ .
T Consensus 86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~ 160 (301)
T cd07873 86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-T 160 (301)
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-c
Confidence 97 599999877667799999999999999999999997 999999999999999999999999999976543222 1
Q ss_pred cccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHH-----------HHh-
Q 043702 538 ATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWV-----------WSL- 604 (711)
Q Consensus 538 ~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~-----------~~~- 604 (711)
.....+++.|+|||.+.+. .++.++|||||||++|||++|+.||...... ...... |..
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~--------~~~~~~~~~~~~~~~~~~~~~ 232 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE--------EQLHFIFRILGTPTEETWPGI 232 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHHHcCCCChhhchhh
Confidence 2233578899999998754 4788999999999999999999999653210 000000 000
Q ss_pred hhcCchhHhhhhhccCC----CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 605 HREGRLLTAADARLEGQ----FDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 605 ~~~~~~~~~~d~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
...........+..... ........+.+++.+|++.||.+|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 233 LSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred hccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000000000000000 00112345678999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=315.13 Aligned_cols=254 Identities=22% Similarity=0.370 Sum_probs=203.2
Q ss_pred cCCcccceeecCCceEEEEEEeCC-----CCeEEEEEEcccCCCC--hhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQ-----NGDIIAVKRCSHNSQG--KDEFLSELSIIGTLRHRNLVRLQGWCHEKGEIL 452 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~~~--~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 452 (711)
++|...+.||+|+||.||+|+.+. ....+++|.+...... .+++.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 467888999999999999999743 3467999988664432 467999999999999999999999999989999
Q ss_pred EEEEcCCCCCHHHHHhhCC--------CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeec
Q 043702 453 LVYDLMPNGSLDKALFEAR--------SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDF 524 (711)
Q Consensus 453 lV~Ey~~~gsL~~~l~~~~--------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DF 524 (711)
+||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999997543 1589999999999999999999987 9999999999999999999999999
Q ss_pred CCceecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHH
Q 043702 525 GLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWS 603 (711)
Q Consensus 525 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~ 603 (711)
|+++..............++..|+|||.+.+...+.++||||||+++|||++ |..||..... .....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~--------~~~~~---- 229 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD--------EEVLN---- 229 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch--------HHHHH----
Confidence 9987554333223333456788999999988889999999999999999999 7888854211 11111
Q ss_pred hhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 043702 604 LHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLV 656 (711)
Q Consensus 604 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 656 (711)
....+... ..........+.+++.+||+.+|.+||++.|+++.|.
T Consensus 230 ~~~~~~~~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 230 RLQAGKLE--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHHcCCcC--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 11111111 0011122356788999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=317.39 Aligned_cols=239 Identities=22% Similarity=0.384 Sum_probs=188.2
Q ss_pred eeecCCceEEEEEEeCCC------------------------CeEEEEEEcccCCC-ChhhhHHHHHHHHhcCCCCeeee
Q 043702 387 IIGHGAFGTVYKGILPQN------------------------GDIIAVKRCSHNSQ-GKDEFLSELSIIGTLRHRNLVRL 441 (711)
Q Consensus 387 ~LG~G~fg~Vy~~~~~~~------------------------~~~vavK~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l 441 (711)
+||+|+||.||+|.+..+ ...|++|++..... ...++.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 599999999999985321 23588898865332 23578889999999999999999
Q ss_pred eeeeeecCeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCC----
Q 043702 442 QGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGF---- 517 (711)
Q Consensus 442 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~---- 517 (711)
+++|......++||||+++|+|..++......+++..+.+++.||++||+|||+. +|+||||||+|||+++++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999977677899999999999999999999987 999999999999997643
Q ss_pred ---cEEEeecCCceecCCCCCCCcccccCCCcccChhhhcc-CCCCccccchhHHHHHHHHH-hCCCCCccccccccccc
Q 043702 518 ---NARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLT-GRATEKTDVFSYGAVVLEVA-SGRRPIEKEITGVGKVG 592 (711)
Q Consensus 518 ---~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ell-tG~~P~~~~~~~~~~~~ 592 (711)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||.....
T Consensus 159 ~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------ 227 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP------ 227 (274)
T ss_pred ccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh------
Confidence 3799999998654321 12347788999998875 56899999999999999995 69999864321
Q ss_pred cccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 043702 593 VASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLV 656 (711)
Q Consensus 593 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 656 (711)
.....+ ... ...+ .......+.+++.+||+.+|.+||++.+|++.|.
T Consensus 228 --~~~~~~----~~~-------~~~~----~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 228 --SEKERF----YEK-------KHRL----PEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred --HHHHHH----HHh-------ccCC----CCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 011111 000 0001 1111235778999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=311.90 Aligned_cols=252 Identities=29% Similarity=0.407 Sum_probs=204.1
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC---CChhhhHHHHHHHHhcCCCCeeeeeeeeee--cCeEEEEE
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---QGKDEFLSELSIIGTLRHRNLVRLQGWCHE--KGEILLVY 455 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~ 455 (711)
+|+..+.||.|+||.||++....++..+|+|++.... ...+.+.+|++++++++|+|++++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4778899999999999999998889999999886532 234568889999999999999999998764 45689999
Q ss_pred EcCCCCCHHHHHhhC---CCCCChHHHHHHHHHHHHHHHHHHhcc--CCCeeeccCCCCceEEcCCCcEEEeecCCceec
Q 043702 456 DLMPNGSLDKALFEA---RSPLPWPHRSKILLGVASALAYLHQEC--ENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV 530 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~aL~yLH~~~--~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~ 530 (711)
||+++++|.+++... ...+++..++.++.|++.||.|||..+ ..+++|+||||+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998653 467999999999999999999999332 349999999999999999999999999999876
Q ss_pred CCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCch
Q 043702 531 EHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRL 610 (711)
Q Consensus 531 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 610 (711)
...... .....|++.|+|||.+....++.++||||||+++++|++|+.||..... ..+.+. ...+.
T Consensus 161 ~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~----~~~~~- 226 (265)
T cd08217 161 GHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ--------LQLASK----IKEGK- 226 (265)
T ss_pred cCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH--------HHHHHH----HhcCC-
Confidence 544321 2234689999999999988899999999999999999999999965321 111111 11111
Q ss_pred hHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 611 LTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 611 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
...........+.+++.+|++.+|.+||++++|+++
T Consensus 227 --------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 227 --------FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred --------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 112233445678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=331.52 Aligned_cols=249 Identities=26% Similarity=0.399 Sum_probs=207.1
Q ss_pred CcccceeecCCceEEEEEEeCCC-C--eEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 382 FNANRIIGHGAFGTVYKGILPQN-G--DIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 382 f~~~~~LG~G~fg~Vy~~~~~~~-~--~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
....++||+|.||.|++|.+... | ..||||.+.... ...++|++|+.+|.+|+|+|+++|+|...+ ....||+|
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 44567899999999999999643 2 458999988744 357899999999999999999999999987 67899999
Q ss_pred cCCCCCHHHHHhh-CCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 457 LMPNGSLDKALFE-ARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 457 y~~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
.++.|+|.+.|++ .+..|.......++.|||.||.||.++ ++|||||..+|+||-....|||+||||.|.+.....
T Consensus 191 LaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred hcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 9999999999987 456688899999999999999999998 999999999999999999999999999998876543
Q ss_pred CC-cc-cccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhH
Q 043702 536 PD-AT-VAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLT 612 (711)
Q Consensus 536 ~~-~~-~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 612 (711)
.. +. ...-...|+|||.++..+++.++|||+|||+||||++ |..||-... .-.+++
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~---------------------g~qIL~ 326 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR---------------------GIQILK 326 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC---------------------HHHHHH
Confidence 22 11 1223567999999999999999999999999999999 788875431 112344
Q ss_pred hhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 043702 613 AADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655 (711)
Q Consensus 613 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L 655 (711)
.+|..-+-.-...+.+++.++++.||.++|++||++..+.+.+
T Consensus 327 ~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 327 NIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred hccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 4443333334566788999999999999999999999998544
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=318.99 Aligned_cols=267 Identities=25% Similarity=0.373 Sum_probs=204.5
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC---CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN---SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
++|+..+.||+|++|.||+|.+..+++.||+|++... ....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 3688899999999999999999888999999988653 2334678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCC
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP 536 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~ 536 (711)
|++++.|..++ .....+++.++..++.|++.||.|||+. +++||||+|+||++++++.+||+|||++.........
T Consensus 81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 81 YVERTLLELLE-ASPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence 99987776655 3445689999999999999999999997 9999999999999999999999999999877654432
Q ss_pred CcccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHH-------HHhh-hc
Q 043702 537 DATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWV-------WSLH-RE 607 (711)
Q Consensus 537 ~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~-------~~~~-~~ 607 (711)
......++..|+|||++.+. .++.++||||||+++|||++|+.||...... +....+.... +... ..
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI----DQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHhCCCCHHHhhhcccC
Confidence 33445688999999999888 7899999999999999999999998643210 0000000000 0000 00
Q ss_pred Cch-----hHhhhhh-ccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 608 GRL-----LTAADAR-LEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 608 ~~~-----~~~~d~~-l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
... ....++. ....+.......+.+++.+||+.+|++||+++++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000 0000000 0001111225678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=311.52 Aligned_cols=249 Identities=22% Similarity=0.388 Sum_probs=195.5
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC------CChhhhHHHHHHHHhcCCCCeeeeeeeeee--cCeE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS------QGKDEFLSELSIIGTLRHRNLVRLQGWCHE--KGEI 451 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~ 451 (711)
.+|...+.||+|+||.||+|....++..|++|++.... +..+.+.+|++++++++||||+++++++.+ ++..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36888999999999999999998889999999876421 123467889999999999999999998875 3578
Q ss_pred EEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecC
Q 043702 452 LLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVE 531 (711)
Q Consensus 452 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~ 531 (711)
++++||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 82 ~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 9999999999999998653 4589999999999999999999987 99999999999999999999999999998654
Q ss_pred CCCC--CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCc
Q 043702 532 HDKS--PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGR 609 (711)
Q Consensus 532 ~~~~--~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 609 (711)
.... .......++..|+|||.+.+..++.++|||||||++|||++|+.||..... . ..........
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~----------~-~~~~~~~~~~- 225 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA----------M-AAIFKIATQP- 225 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch----------H-HHHHHHhcCC-
Confidence 3211 112234588999999999988899999999999999999999999964311 0 0011110000
Q ss_pred hhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 610 LLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 610 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
....++......+..++ +||..+|++||+++||++
T Consensus 226 --------~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 --------TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred --------CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 01111222223344444 688899999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=314.34 Aligned_cols=255 Identities=26% Similarity=0.398 Sum_probs=204.7
Q ss_pred HHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhc-CCCCeeeeeeeeeecC------
Q 043702 377 SATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTL-RHRNLVRLQGWCHEKG------ 449 (711)
Q Consensus 377 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~------ 449 (711)
.++++|+..+.||+|++|.||+|....+++.+++|++.......+++.+|+++++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 456789999999999999999999988889999999887666667899999999999 6999999999997644
Q ss_pred eEEEEEEcCCCCCHHHHHhhC---CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCC
Q 043702 450 EILLVYDLMPNGSLDKALFEA---RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGL 526 (711)
Q Consensus 450 ~~~lV~Ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGl 526 (711)
.+++||||+++++|.+++... ...+++..+..++.|+++||.|||+. +++|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcc
Confidence 489999999999999988643 36799999999999999999999997 999999999999999999999999999
Q ss_pred ceecCCCCCCCcccccCCCcccChhhhcc-----CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHH
Q 043702 527 ARQVEHDKSPDATVAAGTMGYLAPEYLLT-----GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWV 601 (711)
Q Consensus 527 a~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~ 601 (711)
+........ ......|+..|+|||.+.. ..++.++|||||||+++||++|+.||...... ..+.
T Consensus 160 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~--- 228 (275)
T cd06608 160 SAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-------RALF--- 228 (275)
T ss_pred ceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-------HHHH---
Confidence 986543222 2233468999999998854 34678999999999999999999999643110 0111
Q ss_pred HHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 602 WSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 602 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.... + ..+.+ .........+.+++.+||..||++|||+.++++.
T Consensus 229 -~~~~-~-----~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 229 -KIPR-N-----PPPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred -Hhhc-c-----CCCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0000 0 00011 1112234567889999999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=316.29 Aligned_cols=270 Identities=23% Similarity=0.303 Sum_probs=201.4
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC---CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
++|+..+.||+|++|.||+|++..+++.||+|++.... ...+.+.+|++++++++|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36888899999999999999998889999999886532 233567899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCC
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP 536 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~ 536 (711)
|++++.|..++.. ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07847 81 YCDHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD- 155 (286)
T ss_pred ccCccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence 9999888877643 44699999999999999999999997 999999999999999999999999999987654332
Q ss_pred CcccccCCCcccChhhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccccccccccccc---chHHHHHHhhhcCchh-
Q 043702 537 DATVAAGTMGYLAPEYLLT-GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVAS---NLVEWVWSLHREGRLL- 611 (711)
Q Consensus 537 ~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~---~l~~~~~~~~~~~~~~- 611 (711)
......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.............. .+..............
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07847 156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235 (286)
T ss_pred cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence 2223457889999999876 4578999999999999999999999965322100000000 0000000000000000
Q ss_pred HhhhhhccCCCc-----HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 612 TAADARLEGQFD-----EAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 612 ~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
....+......+ ......+.+++.+||+.+|++||++.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000000000000 1123567889999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=314.31 Aligned_cols=262 Identities=20% Similarity=0.271 Sum_probs=204.4
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC---CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEc
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
+|+..+.||+|++|.||+|.+..+|+.||+|++.... .....+.+|+.++++++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778899999999999999998889999999987533 2346789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC
Q 043702 458 MPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD 537 (711)
Q Consensus 458 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 537 (711)
+ +++|.+++......+++.++++++.||++||+|||+. +++|+||||+||++++++.++|+|||++..........
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL 156 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence 9 9999999977667899999999999999999999997 99999999999999999999999999998765443222
Q ss_pred cccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCch------
Q 043702 538 ATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRL------ 610 (711)
Q Consensus 538 ~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~------ 610 (711)
.....|+..|+|||.+.+. .++.++||||+||+++||++|++||...... ....+..........
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07832 157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI--------EQLAIVFRTLGTPNEETWPGL 228 (286)
T ss_pred cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH--------HHHHHHHHHcCCCChHHHhhc
Confidence 3345689999999988654 4689999999999999999998887543210 111111110000000
Q ss_pred ------hHhhhhhc----cCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 611 ------LTAADARL----EGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 611 ------~~~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.....+.. ......+....+.+++.+|++.+|++||+++++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 229 TSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000 000001223678889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=310.84 Aligned_cols=246 Identities=30% Similarity=0.437 Sum_probs=198.4
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCC
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMP 459 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 459 (711)
++|+..+.||+|+||.||+|.. .++.+|+|++.... ..+.+.+|+.++++++|||++++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4578889999999999999976 67889999886532 346789999999999999999999998764 4799999999
Q ss_pred CCCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCc
Q 043702 460 NGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDA 538 (711)
Q Consensus 460 ~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 538 (711)
+++|.+++.... ..+++..+++++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---- 154 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---- 154 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence 999999997543 3589999999999999999999987 99999999999999999999999999997653321
Q ss_pred ccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhh
Q 043702 539 TVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADAR 617 (711)
Q Consensus 539 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 617 (711)
.....+..|+|||.+..+.++.++|||||||++|||++ |+.||..... .+.. .....+.
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----------~~~~-~~~~~~~-------- 214 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL-----------KEVK-ECVEKGY-------- 214 (254)
T ss_pred CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH-----------HHHH-HHHhCCC--------
Confidence 11234568999999998899999999999999999998 9999864321 1111 1111111
Q ss_pred ccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 618 LEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 618 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
...........+.+++.+||+.+|.+||+++++++.|+.
T Consensus 215 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 215 -RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 111112234567789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=312.15 Aligned_cols=252 Identities=27% Similarity=0.416 Sum_probs=200.9
Q ss_pred CCcccceeecCCceEEEEEEeCC-CCeEEEEEEcccC-----------CCChhhhHHHHHHHHh-cCCCCeeeeeeeeee
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQ-NGDIIAVKRCSHN-----------SQGKDEFLSELSIIGT-LRHRNLVRLQGWCHE 447 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~-~~~~vavK~~~~~-----------~~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~ 447 (711)
+|+..+.||+|+||.||+|.+.. .++.+|+|.+... .....++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778899999999999999976 5788999987531 1123457788888875 789999999999999
Q ss_pred cCeEEEEEEcCCCCCHHHHHhh---CCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeec
Q 043702 448 KGEILLVYDLMPNGSLDKALFE---ARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDF 524 (711)
Q Consensus 448 ~~~~~lV~Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DF 524 (711)
++..+++|||+++++|.+++.. ....+++..+++++.|++.||.|||+. .+++|+||||+||++++++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999988743 345689999999999999999999963 38999999999999999999999999
Q ss_pred CCceecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHh
Q 043702 525 GLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSL 604 (711)
Q Consensus 525 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~ 604 (711)
|++....... ......|+..|+|||.+.++.++.++||||||+++|||++|+.||..... .......
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~-----------~~~~~~~ 225 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM-----------LSLATKI 225 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH-----------HHHHHHH
Confidence 9998765433 23345689999999999988899999999999999999999999864311 1111111
Q ss_pred hhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 043702 605 HREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLV 656 (711)
Q Consensus 605 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 656 (711)
. .+... ..........+.+++.+||+.||++||++.||..++.
T Consensus 226 ~-~~~~~--------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 226 V-EAVYE--------PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred h-hccCC--------cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1 11110 0001112345778889999999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=317.08 Aligned_cols=253 Identities=24% Similarity=0.360 Sum_probs=203.9
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC-CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEc
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
.++|++.+.||+|++|.||+|.+..++..+|+|.+.... ...+.+.+|++++++++|+|++++++.+..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 356888899999999999999998889999999986533 3345788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC
Q 043702 458 MPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD 537 (711)
Q Consensus 458 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 537 (711)
+++++|.+++......+++..+.+++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++........ .
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~ 159 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-K 159 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc-c
Confidence 999999999987667899999999999999999999998 999999999999999999999999999876543222 2
Q ss_pred cccccCCCcccChhhhc-----cCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhH
Q 043702 538 ATVAAGTMGYLAPEYLL-----TGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLT 612 (711)
Q Consensus 538 ~~~~~gt~~y~APE~~~-----~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 612 (711)
.....|++.|+|||.+. ...++.++|||||||++|||++|+.||..... .+...... .+..
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~-----------~~~~~~~~-~~~~-- 225 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP-----------MRVLLKIL-KSEP-- 225 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH-----------HHHHHHHh-cCCC--
Confidence 23346899999999985 33467899999999999999999999865321 01111111 1100
Q ss_pred hhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 613 AADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 613 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
+.+ ..+......+.+++..||+.+|.+||++.++++.
T Consensus 226 ---~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 226 ---PTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ---CCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 000 0111223457788899999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=316.35 Aligned_cols=266 Identities=23% Similarity=0.338 Sum_probs=201.7
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC---ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ---GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
++|+..++||+|+||.||+|.+..+++.||+|++..... ..+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 368888999999999999999988899999998765322 24568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCC
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP 536 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~ 536 (711)
|+++++|..+... ...+++.+++.++.|+++||.|||+. +++||||+|+||++++++.+||+|||++....... .
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~ 155 (286)
T cd07846 81 FVDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-E 155 (286)
T ss_pred cCCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-c
Confidence 9999999887643 34589999999999999999999997 99999999999999999999999999998765433 2
Q ss_pred CcccccCCCcccChhhhcc-CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHh-------hhcC
Q 043702 537 DATVAAGTMGYLAPEYLLT-GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSL-------HREG 608 (711)
Q Consensus 537 ~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~-------~~~~ 608 (711)
......++..|+|||++.+ ..++.++|||||||++|||++|++||...... .....+..+...+ ....
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI----DQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH----HHHHHHHHHhCCCchhhHHHhccc
Confidence 2233458899999999875 34788999999999999999999998643210 0000111110000 0000
Q ss_pred chhH-hhhhhccCC-----CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 609 RLLT-AADARLEGQ-----FDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 609 ~~~~-~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.... ...+..... ........+.+++.+||+.+|.+||++.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0000 000000000 001224568889999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=308.25 Aligned_cols=248 Identities=23% Similarity=0.360 Sum_probs=202.6
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC---CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEc
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN---SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
+|+..+.||+|++|.||++....+++.+|+|++... ....+.+.+|++++++++|||++++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 478889999999999999999888999999988653 23456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCC-CcEEEeecCCceecCCCCC
Q 043702 458 MPNGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEG-FNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 458 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~-~~vkL~DFGla~~~~~~~~ 535 (711)
+++++|.+++.... ..+++..+.+++.|++++|.|||+. +++||||||+||+++++ ..+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 99999999997643 4589999999999999999999997 99999999999999855 4589999999987654322
Q ss_pred CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhh
Q 043702 536 PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 615 (711)
.....|+..|+|||.+....++.++||||||+++|+|++|+.||..... ...+...... .
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-----------~~~~~~~~~~-~------ 217 (256)
T cd08220 158 --AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL-----------PALVLKIMSG-T------ 217 (256)
T ss_pred --ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch-----------HHHHHHHHhc-C------
Confidence 2234688999999999988899999999999999999999999864321 1111111110 0
Q ss_pred hhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 616 ARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 616 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
...........+.+++.+||+.+|.+||+++|+++.
T Consensus 218 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 218 ---FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ---CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 011111234567789999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=323.92 Aligned_cols=259 Identities=22% Similarity=0.282 Sum_probs=197.2
Q ss_pred HHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC---CChhhhHHHHHHHHhcCCCCeeeeeeeeeec-----
Q 043702 377 SATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---QGKDEFLSELSIIGTLRHRNLVRLQGWCHEK----- 448 (711)
Q Consensus 377 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~----- 448 (711)
...++|...+.||+|+||.||+|....+++.||||++.... ...+.+.+|++++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 34577899999999999999999998889999999987532 2345677899999999999999999987543
Q ss_pred -CeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCc
Q 043702 449 -GEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLA 527 (711)
Q Consensus 449 -~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla 527 (711)
...++++|++ +++|.+++. ...+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||++
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccc
Confidence 4579999998 779988774 34699999999999999999999997 9999999999999999999999999999
Q ss_pred eecCCCCCCCcccccCCCcccChhhhcc-CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHh--
Q 043702 528 RQVEHDKSPDATVAAGTMGYLAPEYLLT-GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSL-- 604 (711)
Q Consensus 528 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~-- 604 (711)
+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+..+....
T Consensus 166 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~~~~~~~~~~~ 234 (343)
T cd07878 166 RQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-------DQLKRIMEVVGT 234 (343)
T ss_pred eecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHHHhCC
Confidence 875432 233468999999999876 46899999999999999999999999643210 0011100000
Q ss_pred --------hhcCchhHhhhhhccCCCcH--------HHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 605 --------HREGRLLTAADARLEGQFDE--------AEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 605 --------~~~~~~~~~~d~~l~~~~~~--------~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.......... ..+ ..... .....+.+++.+|++.||.+|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 235 PSPEVLKKISSEHARKYI-QSL-PHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CCHHHHHhcchhhHHHHh-hcc-ccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000 000 00000 011246789999999999999999999964
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=311.98 Aligned_cols=253 Identities=21% Similarity=0.331 Sum_probs=200.8
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC-CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcC
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
++|...+.||+|+||.||+|+...+++.||+|.+.... .....+.+|+.+++.++||||+++++.+..++..++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46777889999999999999998889999999887543 33456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCc
Q 043702 459 PNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDA 538 (711)
Q Consensus 459 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 538 (711)
++++|.+++.. ...+++.+++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++....... ...
T Consensus 89 ~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~~ 163 (267)
T cd06645 89 GGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AKR 163 (267)
T ss_pred CCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-ccc
Confidence 99999998854 45799999999999999999999997 99999999999999999999999999997664322 222
Q ss_pred ccccCCCcccChhhhc---cCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhh
Q 043702 539 TVAAGTMGYLAPEYLL---TGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615 (711)
Q Consensus 539 ~~~~gt~~y~APE~~~---~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 615 (711)
....|+..|+|||.+. .+.++.++|||||||++|||++|+.||...... ......... ... .
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~-----------~~~~~~~~~-~~~---~ 228 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM-----------RALFLMTKS-NFQ---P 228 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch-----------hhHHhhhcc-CCC---C
Confidence 3456899999999974 456888999999999999999999998543210 000000000 000 0
Q ss_pred hhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 616 ARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 616 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
+..... ......+.+++.+|++.+|++||++++|++.
T Consensus 229 ~~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 229 PKLKDK--MKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred Cccccc--CCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 000000 0112356788999999999999999998863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=313.66 Aligned_cols=262 Identities=21% Similarity=0.321 Sum_probs=199.5
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC---CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEc
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
+|+..+.||+|++|.||+|+...+|+.+|+|++.... .....+.+|++++++++|||++++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778899999999999999999899999999986532 2235678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC
Q 043702 458 MPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD 537 (711)
Q Consensus 458 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 537 (711)
++ ++|.+++......+++..++.++.||++||.|||+. +|+||||||+||+++.++.+||+|||+++....... .
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-C 155 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-C
Confidence 96 588888876667799999999999999999999997 999999999999999999999999999986543322 1
Q ss_pred cccccCCCcccChhhhccCC-CCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCc------h
Q 043702 538 ATVAAGTMGYLAPEYLLTGR-ATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGR------L 610 (711)
Q Consensus 538 ~~~~~gt~~y~APE~~~~~~-~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~------~ 610 (711)
.....++..|+|||.+.+.. ++.++|||||||++|||++|+.|+...... ....+.......... +
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-------DDQLKRIFRLLGTPTEESWPGV 228 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH-------HHHHHHHHHHhCCCChHHhHHh
Confidence 22345788999999987654 689999999999999999999986432110 000000000000000 0
Q ss_pred hHhhhhh----ccC-----CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 611 LTAADAR----LEG-----QFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 611 ~~~~d~~----l~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
....+.. ... .........+.+++.+||+.||.+|||++++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0000000 000 0011223567789999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=330.43 Aligned_cols=263 Identities=25% Similarity=0.309 Sum_probs=199.3
Q ss_pred hcCCcccceeecCCceEEEEEEeCC--CCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQ--NGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
..+|...+.||+|+||.||++...+ .+..||+|.+... +...+|++++++++||||+++++++...+..++|||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 3468999999999999999997643 4578999987643 345689999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC-
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS- 535 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~- 535 (711)
++. ++|.+++ .....+++.+++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 167 ~~~-~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~ 241 (392)
T PHA03207 167 KYK-CDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241 (392)
T ss_pred hcC-CCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence 995 6888888 4456799999999999999999999997 999999999999999999999999999986654322
Q ss_pred CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhh-------hcC
Q 043702 536 PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLH-------REG 608 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~-------~~~ 608 (711)
.......||+.|+|||++....++.++|||||||++|||++|+.||....... ....+......+. ...
T Consensus 242 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~----~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS----SSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCC----cHHHHHHHHHHhccCccccCCcc
Confidence 22234579999999999999999999999999999999999999996543211 0001111000000 000
Q ss_pred --chhHh---hhhhccCCCc-------HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 609 --RLLTA---ADARLEGQFD-------EAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 609 --~~~~~---~d~~l~~~~~-------~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.+... ........+. ......+.+++.+||+.||++||++.|++..
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000 0000000000 0112356678899999999999999999985
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=312.82 Aligned_cols=262 Identities=22% Similarity=0.339 Sum_probs=199.5
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEc
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
++|+..+.||+|++|.||+|+.+.+++.||+|.+.... .....+.+|++++++++|+||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 56888999999999999999998889999999986532 2234577899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC
Q 043702 458 MPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD 537 (711)
Q Consensus 458 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 537 (711)
+++ +|.+++......+++.....++.|+++||.|||+. +|+||||||+||++++++.+||+|||+++....... .
T Consensus 85 ~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~ 159 (291)
T cd07844 85 LDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-T 159 (291)
T ss_pred CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCc-c
Confidence 975 99999877667889999999999999999999997 999999999999999999999999999875432211 1
Q ss_pred cccccCCCcccChhhhcc-CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcC---chhHh
Q 043702 538 ATVAAGTMGYLAPEYLLT-GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREG---RLLTA 613 (711)
Q Consensus 538 ~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~---~~~~~ 613 (711)
.....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... .....-.+...... .....
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV-------EDQLHKIFRVLGTPTEETWPGV 232 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH-------HHHHHHHHHhcCCCChhhhhhh
Confidence 122346889999999875 45789999999999999999999999643210 00000001100000 00000
Q ss_pred --------------hhhhccCCC-cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 614 --------------ADARLEGQF-DEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 614 --------------~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
....+.... .......+.+++.+|++.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000000000 0011256678999999999999999999886
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=312.57 Aligned_cols=202 Identities=26% Similarity=0.418 Sum_probs=173.9
Q ss_pred HhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 378 ATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 378 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
++++|...+.||+|+||.||+|....++..||+|++.... .....+.+|+++++.++|+||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4578999999999999999999998889999999986533 22346789999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
||+. ++|.+++......+++..+..++.|++.||.|||+. +|+||||||+|||++.++++||+|||+++.......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 9995 688877766566788999999999999999999997 999999999999999999999999999976433221
Q ss_pred CCcccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccc
Q 043702 536 PDATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKE 584 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~ 584 (711)
......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~ 207 (291)
T cd07870 159 -TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV 207 (291)
T ss_pred -CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 12234578999999998754 4788999999999999999999999753
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=313.53 Aligned_cols=263 Identities=23% Similarity=0.295 Sum_probs=200.8
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC------ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEE
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ------GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLV 454 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 454 (711)
+|...+.||+|++|.||+|....+++.||+|++..... ....+..|++++++++|+||+++++++...+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 47778899999999999999988899999999876332 234567899999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCC
Q 043702 455 YDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~ 534 (711)
|||+ +|+|.+++......+++..+.+++.||++||.|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 9999999976555799999999999999999999998 99999999999999999999999999998765432
Q ss_pred CCCcccccCCCcccChhhhcc-CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHH-------HHHhhh
Q 043702 535 SPDATVAAGTMGYLAPEYLLT-GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEW-------VWSLHR 606 (711)
Q Consensus 535 ~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~-------~~~~~~ 606 (711)
. ......+++.|+|||.+.+ ..++.++|||||||+++||++|.+||...... ......... .|. .
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~--~ 229 (298)
T cd07841 157 R-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI----DQLGKIFEALGTPTEENWP--G 229 (298)
T ss_pred c-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH----HHHHHHHHHcCCCchhhhh--h
Confidence 2 1222346788999998865 45789999999999999999998887643210 000000000 000 0
Q ss_pred cCchhHhhhhhccCCC-----cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 607 EGRLLTAADARLEGQF-----DEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 607 ~~~~~~~~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
................ .......+.+++.+||+.+|.+||++.|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000000000001 11224567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=321.49 Aligned_cols=197 Identities=23% Similarity=0.314 Sum_probs=167.0
Q ss_pred ccceeecC--CceEEEEEEeCCCCeEEEEEEcccCC---CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcC
Q 043702 384 ANRIIGHG--AFGTVYKGILPQNGDIIAVKRCSHNS---QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 384 ~~~~LG~G--~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
..++||+| +|++||++..+.+|+.||+|++.... ...+.+.+|+++++.++||||++++++|..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35789999 78999999999999999999987532 22346778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhC-CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC-C
Q 043702 459 PNGSLDKALFEA-RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS-P 536 (711)
Q Consensus 459 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~-~ 536 (711)
++|+|.+++... ...+++..+++++.|++.||+|||+. +|+||||||+|||++.++.++++||+.......... .
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999998654 34589999999999999999999987 999999999999999999999999987654321111 0
Q ss_pred -----CcccccCCCcccChhhhcc--CCCCccccchhHHHHHHHHHhCCCCCcc
Q 043702 537 -----DATVAAGTMGYLAPEYLLT--GRATEKTDVFSYGAVVLEVASGRRPIEK 583 (711)
Q Consensus 537 -----~~~~~~gt~~y~APE~~~~--~~~s~ksDVwSfGvll~elltG~~P~~~ 583 (711)
......++..|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 0112346778999999976 4588999999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=327.00 Aligned_cols=240 Identities=26% Similarity=0.315 Sum_probs=188.4
Q ss_pred eecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhc---CCCCeeeeeeeeeecCeEEEEEEcCCC
Q 043702 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTL---RHRNLVRLQGWCHEKGEILLVYDLMPN 460 (711)
Q Consensus 388 LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~~~~~lV~Ey~~~ 460 (711)
||+|+||+||+|+...+++.||+|++... ......+..|..++.++ +||||+++++++...+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999888999999998642 12233455677777665 699999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCccc
Q 043702 461 GSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATV 540 (711)
Q Consensus 461 gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 540 (711)
|+|..++.. ...+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~~ 155 (330)
T cd05586 81 GELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTNT 155 (330)
T ss_pred ChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-CccC
Confidence 999998864 45689999999999999999999997 999999999999999999999999999975433222 2334
Q ss_pred ccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhcc
Q 043702 541 AAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLE 619 (711)
Q Consensus 541 ~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 619 (711)
.+||+.|+|||.+.+. .++.++|||||||++|||++|+.||..... .+. ......+.. .+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~-----------~~~-~~~i~~~~~------~~~ 217 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT-----------QQM-YRNIAFGKV------RFP 217 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH-----------HHH-HHHHHcCCC------CCC
Confidence 5799999999998765 479999999999999999999999965321 111 111111111 010
Q ss_pred CCCcHHHHHHHHHHHHhcCCCCCCCCC----CHHHHHH
Q 043702 620 GQFDEAEMRRVLLVGLACSHPDPLARP----TMRGVVQ 653 (711)
Q Consensus 620 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP----s~~eVl~ 653 (711)
. ......+.+++.+||+.||.+|| ++.++++
T Consensus 218 ~---~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 218 K---NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred C---ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 0 11234566788999999999998 4566655
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=311.41 Aligned_cols=252 Identities=28% Similarity=0.402 Sum_probs=205.6
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcC
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
+|+..+.||+|++|.||++.+..+++.+|+|++.... ...+++.+|++++++++||||+++++.+..++..++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5777889999999999999998889999999987643 34467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHh-ccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC
Q 043702 459 PNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQ-ECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD 537 (711)
Q Consensus 459 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 537 (711)
++++|.+++......+++..+.+++.|+++||+|||+ . +++||||||+||++++++.+||+|||++.........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~- 157 (265)
T cd06605 82 DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK- 157 (265)
T ss_pred CCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh-
Confidence 9999999997766789999999999999999999998 6 9999999999999999999999999998765432211
Q ss_pred cccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhh
Q 043702 538 ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADAR 617 (711)
Q Consensus 538 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 617 (711)
...++..|+|||.+.+..++.++||||||+++|+|++|+.||...... .....+.+.......
T Consensus 158 --~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~--------- 220 (265)
T cd06605 158 --TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP------PDGIFELLQYIVNEP--------- 220 (265)
T ss_pred --cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc------cccHHHHHHHHhcCC---------
Confidence 156889999999999989999999999999999999999999654210 011112111111110
Q ss_pred ccCCCcHH-HHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 618 LEGQFDEA-EMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 618 l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
....... ....+.+++.+||..+|.+||++.++++.
T Consensus 221 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 221 -PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred -CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 0011111 34557788999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=315.00 Aligned_cols=251 Identities=25% Similarity=0.388 Sum_probs=201.1
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcC
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
+|+..+.||+|+||.||++....++..||+|.+.... ...+.+.+|++++++++|+||+++++.+...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5778899999999999999998889999999886532 23457889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhC--CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCC
Q 043702 459 PNGSLDKALFEA--RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP 536 (711)
Q Consensus 459 ~~gsL~~~l~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~ 536 (711)
++++|..++... ...+++..+..++.|++.||.|||+. .+|+||||||+||+++.++.+||+|||++..+....
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 157 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-- 157 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc--
Confidence 999999988654 24689999999999999999999963 389999999999999999999999999997654322
Q ss_pred CcccccCCCcccChhhhccCC------CCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCch
Q 043702 537 DATVAAGTMGYLAPEYLLTGR------ATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRL 610 (711)
Q Consensus 537 ~~~~~~gt~~y~APE~~~~~~------~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 610 (711)
.....++..|+|||.+.+.. ++.++|||||||++|||++|+.||..... .......
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--------~~~~~~~--------- 219 (286)
T cd06622 158 -AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY--------ANIFAQL--------- 219 (286)
T ss_pred -cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch--------hhHHHHH---------
Confidence 22345888999999986543 48899999999999999999999964311 0111100
Q ss_pred hHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 611 LTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 611 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
....+. .......+....+.+++.+||+.+|.+||+++++++.
T Consensus 220 ~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 220 SAIVDG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred HHHhhc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 001110 0111223345667789999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=308.26 Aligned_cols=255 Identities=26% Similarity=0.351 Sum_probs=206.2
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEc
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
++|+..+.||.|++|+||+|....++..+++|++.... ...+.+.+|+++++.++|+|++++++.+..++..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999998889999999986532 3457889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhC--CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 458 MPNGSLDKALFEA--RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 458 ~~~gsL~~~l~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
+++++|.+++... ...+++.....++.|++.||.|||+. +++||||||+||++++++.+||+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 9999999999754 24689999999999999999999987 999999999999999999999999999987654332
Q ss_pred C---CcccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchh
Q 043702 536 P---DATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLL 611 (711)
Q Consensus 536 ~---~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 611 (711)
. ......|+..|+|||++... .++.++|||||||++|||++|+.||...... ...... ...
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-------~~~~~~----~~~---- 222 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM-------KVLMLT----LQN---- 222 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh-------hhHHHH----hcC----
Confidence 2 22334689999999999877 7899999999999999999999999654220 111111 111
Q ss_pred HhhhhhccCCC-cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 612 TAADARLEGQF-DEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 612 ~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
..+.+.... .......+.+++.+||+.||++||++.++++.
T Consensus 223 --~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 223 --DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred --CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 001111100 11234567789999999999999999999863
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=312.17 Aligned_cols=250 Identities=27% Similarity=0.372 Sum_probs=187.8
Q ss_pred eeecCCceEEEEEEeCC--CCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCCCCC
Q 043702 387 IIGHGAFGTVYKGILPQ--NGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGS 462 (711)
Q Consensus 387 ~LG~G~fg~Vy~~~~~~--~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 462 (711)
.||+|+||.||+|.... ....+++|.+.... .....+.+|+++++.++|+||+++++.|......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 59999999999997532 34578899876432 234578899999999999999999999999999999999999999
Q ss_pred HHHHHhhCCC----CCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCC-C
Q 043702 463 LDKALFEARS----PLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP-D 537 (711)
Q Consensus 463 L~~~l~~~~~----~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~-~ 537 (711)
|.+++..... ..++.....++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++........ .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999976432 356788899999999999999997 9999999999999999999999999998754332211 1
Q ss_pred cccccCCCcccChhhhcc-------CCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCc
Q 043702 538 ATVAAGTMGYLAPEYLLT-------GRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGR 609 (711)
Q Consensus 538 ~~~~~gt~~y~APE~~~~-------~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 609 (711)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||..... ... .......+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--------~~~---~~~~~~~~~ 227 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD--------EQV---LKQVVREQD 227 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH--------HHH---HHHHhhccC
Confidence 122346778999999753 356889999999999999999 7888854321 011 111111111
Q ss_pred hhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 043702 610 LLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLV 656 (711)
Q Consensus 610 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 656 (711)
....++.+ +......+.+++..|+ .||++||++++|++.|.
T Consensus 228 -~~~~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 228 -IKLPKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred -ccCCCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11111222 1223344556777888 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=310.53 Aligned_cols=254 Identities=25% Similarity=0.405 Sum_probs=200.4
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC----C-------ChhhhHHHHHHHHhcCCCCeeeeeeeeeecC
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS----Q-------GKDEFLSELSIIGTLRHRNLVRLQGWCHEKG 449 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~-------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 449 (711)
+|...+.||+|++|.||+|....+++.+|+|++.... . ..+.+.+|+++++.++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667789999999999999998889999999875311 1 1235788999999999999999999999999
Q ss_pred eEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCcee
Q 043702 450 EILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQ 529 (711)
Q Consensus 450 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~ 529 (711)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||+++.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 999999999999999999654 5789999999999999999999987 999999999999999999999999999986
Q ss_pred cCCCCC-CCcccccCCCcccChhhhccCC--CCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhh
Q 043702 530 VEHDKS-PDATVAAGTMGYLAPEYLLTGR--ATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHR 606 (711)
Q Consensus 530 ~~~~~~-~~~~~~~gt~~y~APE~~~~~~--~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~ 606 (711)
...... .......|+..|+|||.+.... ++.++||||||+++|||++|..||..... . +.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----------~-~~~~~~~~ 226 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA----------I-AAMFKLGN 226 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch----------H-HHHHHhhc
Confidence 543221 1223346889999999987655 78999999999999999999999854311 1 11111111
Q ss_pred cCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 607 EGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 607 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
. ........ ....+....+.+++.+||+.+|.+||++++|++.
T Consensus 227 ~-~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 227 K-RSAPPIPP----DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred c-ccCCcCCc----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 1 00111111 1112234567788899999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=314.95 Aligned_cols=195 Identities=24% Similarity=0.375 Sum_probs=161.3
Q ss_pred cceeecCCceEEEEEEeCC--CCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeee--cCeEEEEEEcCCC
Q 043702 385 NRIIGHGAFGTVYKGILPQ--NGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHE--KGEILLVYDLMPN 460 (711)
Q Consensus 385 ~~~LG~G~fg~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~Ey~~~ 460 (711)
..+||+|+||.||+|+... .+..||+|++.... ....+.+|++++++++||||+++++++.. +...++||||+++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 3579999999999999754 45789999886543 23467899999999999999999998853 5678999999865
Q ss_pred CCHHHHHhhC--------CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEE----cCCCcEEEeecCCce
Q 043702 461 GSLDKALFEA--------RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIML----DEGFNARLGDFGLAR 528 (711)
Q Consensus 461 gsL~~~l~~~--------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl----d~~~~vkL~DFGla~ 528 (711)
+|.+++... ...+++..+..++.||+.||.|||+. +|+||||||+|||+ ++++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 787776421 23488999999999999999999997 99999999999999 566789999999998
Q ss_pred ecCCCCC--CCcccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccc
Q 043702 529 QVEHDKS--PDATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKE 584 (711)
Q Consensus 529 ~~~~~~~--~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~ 584 (711)
....... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 7654322 122345689999999998764 5799999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=308.33 Aligned_cols=250 Identities=21% Similarity=0.342 Sum_probs=198.1
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC------CChhhhHHHHHHHHhcCCCCeeeeeeeeeec--CeE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS------QGKDEFLSELSIIGTLRHRNLVRLQGWCHEK--GEI 451 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 451 (711)
.+|+..++||+|+||.||+|....++..||+|++.... ...+.+.+|++++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888999999999999999998889999999875321 1234678899999999999999999988763 468
Q ss_pred EEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecC
Q 043702 452 LLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVE 531 (711)
Q Consensus 452 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~ 531 (711)
+++|||+++++|.+++... ..+++...++++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++...
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 8999999999999998643 4588999999999999999999987 99999999999999999999999999998654
Q ss_pred CCCC--CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCc
Q 043702 532 HDKS--PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGR 609 (711)
Q Consensus 532 ~~~~--~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 609 (711)
.... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||..... .... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----------~~~~-~~~~~--- 223 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA----------MAAI-FKIAT--- 223 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch----------HHHH-HHHhc---
Confidence 3211 112334689999999999888899999999999999999999999864311 0010 00000
Q ss_pred hhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 610 LLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 610 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.......+......+.+++.+|+. +|.+||++++|++.
T Consensus 224 ------~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 224 ------QPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred ------CCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 001122233444566677788885 99999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=306.88 Aligned_cols=247 Identities=29% Similarity=0.475 Sum_probs=201.5
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC------CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEE
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS------QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLV 454 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 454 (711)
+|...+.||+|++|.||+|....+++.|++|.+.... +..+.+.+|+++++.++|+|++++++++..+..++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667789999999999999998789999999876532 2345788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCC
Q 043702 455 YDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~ 534 (711)
+||+++++|.+++... ..+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 81 LELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 9999999999998654 4689999999999999999999987 99999999999999999999999999998764433
Q ss_pred CCCcccccCCCcccChhhhccCC-CCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHh
Q 043702 535 SPDATVAAGTMGYLAPEYLLTGR-ATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTA 613 (711)
Q Consensus 535 ~~~~~~~~gt~~y~APE~~~~~~-~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 613 (711)
......|+..|+|||.+.... ++.++|+|||||++|||++|+.||..... .+..+........
T Consensus 157 --~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~-----------~~~~~~~~~~~~~--- 220 (258)
T cd06632 157 --FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-----------VAAVFKIGRSKEL--- 220 (258)
T ss_pred --cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH-----------HHHHHHHHhcccC---
Confidence 223456889999999998776 89999999999999999999999865321 1111111111111
Q ss_pred hhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 614 ADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 614 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
..........+.+++.+||+.+|.+||++.++++
T Consensus 221 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 221 ------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1112223355678889999999999999999986
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=306.57 Aligned_cols=251 Identities=28% Similarity=0.450 Sum_probs=202.3
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC---ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEc
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ---GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
+|...+.||+|++|.||+|....+++.|++|.+..... ..+.+.+|++++++++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 47788999999999999999988899999999876443 456889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC
Q 043702 458 MPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD 537 (711)
Q Consensus 458 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 537 (711)
+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++..........
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 81 CSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred CCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 9999999998653 4588999999999999999999997 99999999999999999999999999998765433322
Q ss_pred cc---cccCCCcccChhhhccCC---CCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchh
Q 043702 538 AT---VAAGTMGYLAPEYLLTGR---ATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLL 611 (711)
Q Consensus 538 ~~---~~~gt~~y~APE~~~~~~---~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 611 (711)
.. ...++..|+|||.+.... .+.++||||||+++|||++|+.||..... .......... +.
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~----------~~~~~~~~~~-~~-- 223 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN----------EFQIMFHVGA-GH-- 223 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc----------hHHHHHHHhc-CC--
Confidence 11 346788999999998766 88999999999999999999999964311 0011111000 00
Q ss_pred HhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 612 TAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 612 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
.+.+.. .......+.+++.+||+.+|.+||++.+++.
T Consensus 224 ---~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 ---KPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ---CCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 001100 0112445678889999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=328.23 Aligned_cols=196 Identities=24% Similarity=0.382 Sum_probs=175.8
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcC-C-----CCeeeeeeeeeecCeEEEE
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLR-H-----RNLVRLQGWCHEKGEILLV 454 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~-H-----~niv~l~g~~~~~~~~~lV 454 (711)
+|++.+.||+|.||.|.+|.+..+++.||||+++....-.++...|+.+|..|+ | -|+|++++++..++++|||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 789999999999999999999999999999999988777788889999999998 4 4899999999999999999
Q ss_pred EEcCCCCCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCC--CcEEEeecCCceecC
Q 043702 455 YDLMPNGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEG--FNARLGDFGLARQVE 531 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~--~~vkL~DFGla~~~~ 531 (711)
+|.+. -+|+++|..++ ..++...++.++.||+.||..||+. +|||+||||+||||.+- ..+||+|||.++...
T Consensus 267 fELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~ 342 (586)
T KOG0667|consen 267 FELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFES 342 (586)
T ss_pred ehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccccC
Confidence 99994 49999997654 4599999999999999999999987 99999999999999653 369999999998754
Q ss_pred CCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccc
Q 043702 532 HDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKE 584 (711)
Q Consensus 532 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~ 584 (711)
... ...+-+..|+|||++.+.+|..+.||||||||+.||++|.+-|.++
T Consensus 343 q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 343 QRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred Ccc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 322 2456788999999999999999999999999999999998777544
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=309.42 Aligned_cols=248 Identities=25% Similarity=0.419 Sum_probs=201.4
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC--CCChhhhHHHHHHHHhcC---CCCeeeeeeeeeecCeEEEEE
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN--SQGKDEFLSELSIIGTLR---HRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV~ 455 (711)
.|+..+.||+|+||.||+|.+..+++.+|+|.+... .....++.+|++++++++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999999888999999988653 334567889999999997 999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
||+++++|.+++.. ..+++.....++.|++.||.|||+. +++||||+|+||++++++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 82 EYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred ecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 99999999999854 3789999999999999999999987 999999999999999999999999999987654432
Q ss_pred CCcccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhh
Q 043702 536 PDATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 614 (711)
......|+..|+|||.+..+ .++.++|||||||++|||++|+.||..... ..+... .... .
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-----------~~~~~~-~~~~-----~ 218 (277)
T cd06917 157 -KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA-----------FRAMML-IPKS-----K 218 (277)
T ss_pred -ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh-----------hhhhhc-cccC-----C
Confidence 22334689999999998764 468899999999999999999999965321 111100 0000 0
Q ss_pred hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 615 DARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 615 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.+.+... .....+.+++.+||+.||.+||++.++++.
T Consensus 219 ~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 219 PPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 0111111 133567788899999999999999999873
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=307.81 Aligned_cols=249 Identities=29% Similarity=0.471 Sum_probs=198.2
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC-------ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEE
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ-------GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILL 453 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 453 (711)
+|...+.||+|+||+||+|... +++.+|+|.+..... ..+.+.+|++++++++|+||++++++|.+.+..++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 3677889999999999999874 688999998764321 12458889999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCC
Q 043702 454 VYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHD 533 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~ 533 (711)
+|||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+|+||+|+||++++++.+||+|||+++.....
T Consensus 80 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 80 FMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 99999999999999643 4688999999999999999999987 9999999999999999999999999999865321
Q ss_pred C-----CCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcC
Q 043702 534 K-----SPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREG 608 (711)
Q Consensus 534 ~-----~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 608 (711)
. ........|+..|+|||.+.+..++.++|||||||++|||++|+.||..... ...........+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~----------~~~~~~~~~~~~ 225 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR----------LAAMFYIGAHRG 225 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh----------HHHHHHhhhccC
Confidence 1 1112234689999999999988899999999999999999999999964311 111000000000
Q ss_pred chhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 609 RLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 609 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
. .+.+ .......+.+++.+||+.+|.+||++.++++
T Consensus 226 ~-----~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 226 L-----MPRL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred C-----CCCC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 0111 1223355778889999999999999999876
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=334.37 Aligned_cols=252 Identities=27% Similarity=0.420 Sum_probs=208.7
Q ss_pred cccceeecCCceEEEEEEeCCCCe----EEEEEEcccC--CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 383 NANRIIGHGAFGTVYKGILPQNGD----IIAVKRCSHN--SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 383 ~~~~~LG~G~fg~Vy~~~~~~~~~----~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
...++||+|+||+||+|.+-..|+ +||+|++... .+...++++|..+|.+|+|||+++|+|+|.... +.||.+
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 446789999999999999854454 5888887763 344678999999999999999999999998765 899999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCC
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP 536 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~ 536 (711)
|||.|+|.+|++.++..+.....+.|..|||+||.|||.+ +++||||.++||||.+-..+||.|||+++.+..+...
T Consensus 778 ~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred hcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 9999999999999999999999999999999999999987 9999999999999999999999999999988765543
Q ss_pred Cc-ccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhh
Q 043702 537 DA-TVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614 (711)
Q Consensus 537 ~~-~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 614 (711)
-. ....-.+.|||-|.+....++.++|||||||++||++| |..|++.... +-+-++.+.|.-
T Consensus 855 y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~------------~eI~dlle~geR---- 918 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA------------EEIPDLLEKGER---- 918 (1177)
T ss_pred ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH------------HHhhHHHhcccc----
Confidence 22 22234568999999999999999999999999999999 9999876432 112222222221
Q ss_pred hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC
Q 043702 615 DARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEA 659 (711)
Q Consensus 615 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~ 659 (711)
-..++-+..++..++.+||..|+..||+++++...+...+
T Consensus 919 -----LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 919 -----LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred -----CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 2234455677888999999999999999999998776543
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=309.16 Aligned_cols=247 Identities=24% Similarity=0.411 Sum_probs=202.1
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcC
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
-|...+.||+|+||.||+|....+++.+|+|++.... ...+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4667889999999999999998889999999876432 33467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCc
Q 043702 459 PNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDA 538 (711)
Q Consensus 459 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 538 (711)
++++|.+++.. ..+++..+..++.|++.+|.|||+. +++|+||||+||+++.++.++|+|||++..+..... ..
T Consensus 85 ~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~~ 158 (277)
T cd06641 85 GGGSALDLLEP--GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KR 158 (277)
T ss_pred CCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh-hh
Confidence 99999999853 4689999999999999999999987 999999999999999999999999999987644321 22
Q ss_pred ccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhc
Q 043702 539 TVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARL 618 (711)
Q Consensus 539 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 618 (711)
....|+..|+|||.+....++.++|||||||++|||++|..||..... ..+.... ..+.
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----------~~~~~~~-~~~~--------- 217 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP-----------MKVLFLI-PKNN--------- 217 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch-----------HHHHHHH-hcCC---------
Confidence 234688899999999888889999999999999999999999864211 0111111 1110
Q ss_pred cCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 619 EGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
...........+.+++.+||+.+|.+||++.++++.
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 218 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 111222334567788999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=348.63 Aligned_cols=256 Identities=24% Similarity=0.396 Sum_probs=200.8
Q ss_pred HHHHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC---CCChhhhHHHHHHHHhcCCCCeeeeeeeeee--cC
Q 043702 375 LRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN---SQGKDEFLSELSIIGTLRHRNLVRLQGWCHE--KG 449 (711)
Q Consensus 375 l~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~ 449 (711)
.....+.|.+.+.||+|+||+||++.+...+..+|+|.+... ......+..|+.++++|+||||+++++++.. ..
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 334556899999999999999999999988999999988753 2334678899999999999999999998854 35
Q ss_pred eEEEEEEcCCCCCHHHHHhhC---CCCCChHHHHHHHHHHHHHHHHHHhcc----CCCeeeccCCCCceEEcCC------
Q 043702 450 EILLVYDLMPNGSLDKALFEA---RSPLPWPHRSKILLGVASALAYLHQEC----ENQVIHRDVKTSNIMLDEG------ 516 (711)
Q Consensus 450 ~~~lV~Ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~aL~yLH~~~----~~~ivHrDlkp~NILld~~------ 516 (711)
.++|||||+++|+|.++|... ...+++..++.|+.||+.||.|||+.. ..+|+||||||+||||+.+
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 689999999999999998642 356999999999999999999999852 1369999999999999643
Q ss_pred -----------CcEEEeecCCceecCCCCCCCcccccCCCcccChhhhcc--CCCCccccchhHHHHHHHHHhCCCCCcc
Q 043702 517 -----------FNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLT--GRATEKTDVFSYGAVVLEVASGRRPIEK 583 (711)
Q Consensus 517 -----------~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~s~ksDVwSfGvll~elltG~~P~~~ 583 (711)
..+||+|||+++.+.... ......||+.|+|||++.. ..++.++|||||||+||||++|+.||..
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 348999999998764332 2234569999999999864 4588999999999999999999999964
Q ss_pred ccccccccccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 584 EITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 584 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
.. .....+..+ ..+. .+.. ......+.+|+..||+.+|.+||++.|+++
T Consensus 246 ~~----------~~~qli~~l-k~~p-------~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 246 AN----------NFSQLISEL-KRGP-------DLPI---KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CC----------cHHHHHHHH-hcCC-------CCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 31 111111111 1110 0100 112345778899999999999999999984
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=315.85 Aligned_cols=251 Identities=24% Similarity=0.287 Sum_probs=202.4
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC----CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS----QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
++|+..+.||+|++|.||+|....+++.+|+|.+.... ...+.+.+|+++++.++|+||+++++.+...+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999998889999999987633 23456889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhC-CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCC
Q 043702 456 DLMPNGSLDKALFEA-RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~ 534 (711)
||+.+++|.+++... ...+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 999999999998754 35699999999999999999999987 99999999999999999999999999987653221
Q ss_pred CC----------------------------CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccc
Q 043702 535 SP----------------------------DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEIT 586 (711)
Q Consensus 535 ~~----------------------------~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~ 586 (711)
.. ......|+..|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 10 11123588999999999988899999999999999999999999964321
Q ss_pred cccccccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCC----HHHHHH
Q 043702 587 GVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPT----MRGVVQ 653 (711)
Q Consensus 587 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs----~~eVl~ 653 (711)
. ..+ ....+..............+.+++.+||+.||++||+ ++|+++
T Consensus 238 ~----------~~~----------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 238 D----------ETF----------SNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred H----------HHH----------HHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 0 000 0111111111111113567888999999999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=300.79 Aligned_cols=250 Identities=27% Similarity=0.416 Sum_probs=205.9
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC-ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCC
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ-GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMP 459 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 459 (711)
.|+..+.||+|++|.||++....+++.+++|++..... ..+++.+|++++++++|+|++++++++...+..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 36778899999999999999988899999999876443 56789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCcc
Q 043702 460 NGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDAT 539 (711)
Q Consensus 460 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 539 (711)
+++|.+++......+++..+..++.|+++||.|||+. +++||||+|+||++++++.+||+|||.+........ ..
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~ 155 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RN 155 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--cc
Confidence 9999999976656899999999999999999999997 999999999999999999999999999987654432 23
Q ss_pred cccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhcc
Q 043702 540 VAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLE 619 (711)
Q Consensus 540 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 619 (711)
...++..|+|||.+....++.++||||||+++++|++|+.||..... .+....... ..... +.
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----------~~~~~~~~~-~~~~~-----~~ 218 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP-----------MKALFKIAT-NGPPG-----LR 218 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch-----------HHHHHHHHh-cCCCC-----cC
Confidence 45688999999999988899999999999999999999999865321 011100000 00000 00
Q ss_pred CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 620 GQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 620 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
........+.+++.+||+.||.+||++.++++.
T Consensus 219 --~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 219 --NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred --cccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 011113567888999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=306.34 Aligned_cols=252 Identities=25% Similarity=0.402 Sum_probs=202.9
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC-------ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEE
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ-------GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILL 453 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 453 (711)
+|+..+.||+|++|.||+|....+++.+|+|++..... ..+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 47788999999999999999988899999998865321 23578899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCC-cEEEeecCCceecCC
Q 043702 454 VYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGF-NARLGDFGLARQVEH 532 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~-~vkL~DFGla~~~~~ 532 (711)
||||+++++|.+++.+ ...+++..+..++.|++.||.|||+. +++||||||+||+++.++ .+||+|||++.....
T Consensus 81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 81 FVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 9999999999999865 34689999999999999999999997 999999999999998775 599999999987653
Q ss_pred CCC---CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCc
Q 043702 533 DKS---PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGR 609 (711)
Q Consensus 533 ~~~---~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 609 (711)
... .......|+..|+|||.+.+..++.++||||+||+++||++|+.||..... ............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~~~~--- 225 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH--------SNHLALIFKIAS--- 225 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC--------cchHHHHHHHhc---
Confidence 321 112234688999999999888899999999999999999999999864321 111111111100
Q ss_pred hhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 610 LLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 610 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
.......+......+.+++.+|++.+|.+||++.++++
T Consensus 226 ------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 226 ------ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ------cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00112233344466788999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=310.94 Aligned_cols=265 Identities=26% Similarity=0.358 Sum_probs=202.1
Q ss_pred CcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC---CChhhhHHHHHHHHhcCCCCeeeeeeeeeec--CeEEEEEE
Q 043702 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---QGKDEFLSELSIIGTLRHRNLVRLQGWCHEK--GEILLVYD 456 (711)
Q Consensus 382 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~E 456 (711)
|+..+.||+|++|.||+|+...+++.+|+|++.... ...+.+.+|++++++++|+|++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567789999999999999998889999999987642 2345688999999999999999999999888 88999999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCC
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP 536 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~ 536 (711)
|+++ +|.+++......+++..++.++.|+++||+|||+. +++|+||||+||++++++.+||+|||++.........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence 9975 89998876656799999999999999999999997 9999999999999999999999999999877654432
Q ss_pred CcccccCCCcccChhhhcc-CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHH-------HHhh---
Q 043702 537 DATVAAGTMGYLAPEYLLT-GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWV-------WSLH--- 605 (711)
Q Consensus 537 ~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~-------~~~~--- 605 (711)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ....+.+.. |...
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE----QLEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCchhhccccccc
Confidence 2334457889999998765 457899999999999999999999996543210 000000000 0000
Q ss_pred ---hcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 606 ---REGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 606 ---~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
............+...+...+...+.+++.+||+.+|.+||+++++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0000000000001011111124578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=309.82 Aligned_cols=250 Identities=28% Similarity=0.390 Sum_probs=194.9
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC--CChhhhHHHHHH-HHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS--QGKDEFLSELSI-IGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~Ei~~-l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
++|+..+.||+|+||.||++++..+|+.||+|++.... ....++..|+.+ ++.++|||++++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36888899999999999999998889999999987643 234456667765 566789999999999999999999999
Q ss_pred cCCCCCHHHHHhh---CCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCC
Q 043702 457 LMPNGSLDKALFE---ARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHD 533 (711)
Q Consensus 457 y~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~ 533 (711)
|++ |+|.+++.. ....+++..++.++.|++.||+|||+. .+++||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 688888754 235689999999999999999999974 38999999999999999999999999999866432
Q ss_pred CCCCcccccCCCcccChhhhcc----CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCc
Q 043702 534 KSPDATVAAGTMGYLAPEYLLT----GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGR 609 (711)
Q Consensus 534 ~~~~~~~~~gt~~y~APE~~~~----~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 609 (711)
. ......|+..|+|||.+.. ..++.++|+|||||++|||++|+.||..... .. +.......
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---------~~-~~~~~~~~--- 222 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT---------PF-QQLKQVVE--- 222 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc---------CH-HHHHHHHh---
Confidence 2 1223458899999998864 4468899999999999999999999864211 00 10111100
Q ss_pred hhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 610 LLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 610 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
...+.+. .......+.+++.+||..+|.+||++.++++
T Consensus 223 ---~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 223 ---EPSPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred ---cCCCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0001110 1112345778999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=308.38 Aligned_cols=259 Identities=26% Similarity=0.301 Sum_probs=203.5
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeec--CeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEK--GEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 455 (711)
++|+..+.||.|++|.||++.+..+++.+|+|++.... ....++.+|++++++++||||++++++|... +.+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36788899999999999999998889999999987533 2456789999999999999999999998653 4689999
Q ss_pred EcCCCCCHHHHHhh---CCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCC
Q 043702 456 DLMPNGSLDKALFE---ARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEH 532 (711)
Q Consensus 456 Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~ 532 (711)
||+++++|.+++.. ....+++.....++.|+++||.|||+. +++|+||+|+||++++++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999988753 345688999999999999999999997 999999999999999999999999999876543
Q ss_pred CCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhH
Q 043702 533 DKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLT 612 (711)
Q Consensus 533 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 612 (711)
... ....++..|+|||.+.+..++.++|||||||++|||++|+.||...... ......+..+... .....
T Consensus 158 ~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~----~~~~~ 227 (287)
T cd06621 158 SLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP---PLGPIELLSYIVN----MPNPE 227 (287)
T ss_pred ccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC---CCChHHHHHHHhc----CCchh
Confidence 221 2345788999999999999999999999999999999999999754220 0111122222111 01111
Q ss_pred hhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 613 AADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 613 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
..+ .. .........+.+++.+||+.+|.+|||+.|+++.
T Consensus 228 ~~~-~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 228 LKD-EP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred hcc-CC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 100 00 0011234567899999999999999999999983
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=304.42 Aligned_cols=251 Identities=25% Similarity=0.393 Sum_probs=207.7
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcC
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
+|+..+.||+|++|.||+++...+++.|++|++.... ...+++.+|++.+++++|+|++++++++...+.+++||||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 6788899999999999999998889999999987643 34578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHh-ccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC
Q 043702 459 PNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQ-ECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD 537 (711)
Q Consensus 459 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 537 (711)
++++|.+++... ..+++..+++++.|+++||+|||+ . +++||||+|+||+++.++.+||+|||++.........
T Consensus 82 ~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~- 156 (264)
T cd06623 82 DGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ- 156 (264)
T ss_pred CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCc-
Confidence 999999999654 678999999999999999999998 7 9999999999999999999999999999876543322
Q ss_pred cccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhh
Q 043702 538 ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADAR 617 (711)
Q Consensus 538 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 617 (711)
.....++..|+|||.+....++.++||||||+++|||++|+.||...... ....+..+.. ..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-----~~~~~~~~~~---~~---------- 218 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP-----SFFELMQAIC---DG---------- 218 (264)
T ss_pred ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc-----CHHHHHHHHh---cC----------
Confidence 22345889999999999999999999999999999999999999654210 0011111111 00
Q ss_pred ccCCCcHH-HHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 618 LEGQFDEA-EMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 618 l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
........ ....+.+++.+||+++|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 219 PPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00111222 34678889999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=305.93 Aligned_cols=249 Identities=24% Similarity=0.394 Sum_probs=203.1
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC---CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEc
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN---SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
+|...+.||+|+||.||+|....++..+|+|.+... ..+.+.+.+|+++++.++|+|++++++.+...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 477889999999999999999988999999998653 23456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCC-cEEEeecCCceecCCCCC
Q 043702 458 MPNGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGF-NARLGDFGLARQVEHDKS 535 (711)
Q Consensus 458 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~-~vkL~DFGla~~~~~~~~ 535 (711)
+++++|.+++.... ..+++..+..++.|+++||.|||+. +++|+||||+||++++++ .+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 99999999986543 3589999999999999999999987 999999999999998885 469999999987643322
Q ss_pred CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhh
Q 043702 536 PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 615 (711)
......|++.|+|||.+....++.++|||||||+++||++|+.||.... ..++....... ..
T Consensus 158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----------~~~~~~~~~~~-~~----- 219 (257)
T cd08225 158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-----------LHQLVLKICQG-YF----- 219 (257)
T ss_pred -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----------HHHHHHHHhcc-cC-----
Confidence 2223458999999999988889999999999999999999999986421 12222221111 11
Q ss_pred hhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 616 ARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 616 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
..........+.+++.+||+.+|++||++.++++.
T Consensus 220 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 220 ----APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ----CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 01111223457788899999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=311.13 Aligned_cols=244 Identities=25% Similarity=0.361 Sum_probs=201.8
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
++|+..+.||+|++|.||++....+++.+|+|++... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 3688899999999999999999888999999988652 233467889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
||+++++|.+++... ..+++..+..++.|+++||.|||+. +++||||+|+|||+++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 999999999998654 5789999999999999999999997 9999999999999999999999999999876543
Q ss_pred CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhh
Q 043702 536 PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 615 (711)
.....|++.|+|||.+.....+.++||||||+++|||++|+.||..... .........+..
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------------~~~~~~~~~~~~----- 215 (290)
T cd05580 155 --TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP------------IQIYEKILEGKV----- 215 (290)
T ss_pred --CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH------------HHHHHHHhcCCc-----
Confidence 2334689999999999888889999999999999999999999864321 001111111110
Q ss_pred hhccCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 043702 616 ARLEGQFDEAEMRRVLLVGLACSHPDPLARP-----TMRGVVQ 653 (711)
Q Consensus 616 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVl~ 653 (711)
.++......+.+++.+||..||.+|| +++++++
T Consensus 216 -----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 216 -----RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred -----cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 11112235677888999999999999 6777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=307.50 Aligned_cols=249 Identities=25% Similarity=0.380 Sum_probs=212.1
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCCC
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPN 460 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 460 (711)
-|.+.++||+|.||.||++.++..|..+|||++... .+.+++.+|+.+|++.+.|++|+.+|.+.....+++|||||.-
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 366778899999999999999999999999998754 3578899999999999999999999999888999999999999
Q ss_pred CCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCccc
Q 043702 461 GSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATV 540 (711)
Q Consensus 461 gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 540 (711)
|++.+.++.++..|++.++..+++..+.||+|||.. .-+|||||+.||||+.+|.+||+|||.|-.+.+... ....
T Consensus 113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA-KRNT 188 (502)
T KOG0574|consen 113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA-KRNT 188 (502)
T ss_pred CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHH-hhCc
Confidence 999999998899999999999999999999999998 889999999999999999999999999987654332 2334
Q ss_pred ccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCch-hHhhhhhcc
Q 043702 541 AAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRL-LTAADARLE 619 (711)
Q Consensus 541 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~-~~~~d~~l~ 619 (711)
+.||+-|||||++..-.|..++||||+|++..||..|++||.+.-+- ..+ +-...|...
T Consensus 189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM--------------------RAIFMIPT~PPPT 248 (502)
T KOG0574|consen 189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM--------------------RAIFMIPTKPPPT 248 (502)
T ss_pred cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc--------------------ceeEeccCCCCCC
Confidence 67999999999999999999999999999999999999999653220 000 001111111
Q ss_pred CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 620 GQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 620 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
-.-+++...++-+++..||-.+|++|-|+.++++.
T Consensus 249 F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 249 FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 12244556788899999999999999999998874
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=313.73 Aligned_cols=247 Identities=28% Similarity=0.415 Sum_probs=199.8
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC----CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS----QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
+.|...+.||+|+||.||+|+...+++.||+|++.... ...+++.+|+++++.++|||+++++++|..++..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 56888899999999999999998889999999886422 22356889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
||++ |+|.+++......+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-- 168 (307)
T cd06607 95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-- 168 (307)
T ss_pred HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence 9996 588887766666799999999999999999999987 9999999999999999999999999999765432
Q ss_pred CCcccccCCCcccChhhhc---cCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhH
Q 043702 536 PDATVAAGTMGYLAPEYLL---TGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLT 612 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~---~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 612 (711)
....++..|+|||.+. .+.++.++||||||+++|||++|+.||..... .......... .
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~-----------~~~~~~~~~~-~--- 230 (307)
T cd06607 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----------MSALYHIAQN-D--- 230 (307)
T ss_pred ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH-----------HHHHHHHhcC-C---
Confidence 2345788999999874 45688999999999999999999999864321 0111111100 0
Q ss_pred hhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 043702 613 AADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655 (711)
Q Consensus 613 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L 655 (711)
.+.+ ........+.+++.+||+.+|.+||++.+|++..
T Consensus 231 --~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 231 --SPTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred --CCCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 0001 1122345678899999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=309.37 Aligned_cols=255 Identities=27% Similarity=0.404 Sum_probs=208.2
Q ss_pred HHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 377 SATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 377 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
..++.|+..+.||+|++|.||+|.+...+..+++|++.......+.+.+|+++++.++|+|++++++.+...+..++|+|
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 45667888899999999999999998788999999987655456788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCC
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP 536 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~ 536 (711)
|+++++|.+++......+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++........
T Consensus 96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 171 (286)
T cd06614 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS- 171 (286)
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-
Confidence 9999999999987655799999999999999999999997 999999999999999999999999999876543221
Q ss_pred CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhh
Q 043702 537 DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADA 616 (711)
Q Consensus 537 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 616 (711)
......++..|++||.+.+..++.++|||||||++|||++|+.||..... . ........ .....
T Consensus 172 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~----------~-~~~~~~~~-~~~~~---- 235 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP----------L-RALFLITT-KGIPP---- 235 (286)
T ss_pred hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH----------H-HHHHHHHh-cCCCC----
Confidence 12234578899999999888899999999999999999999999864321 0 00000000 00000
Q ss_pred hccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 617 RLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 617 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
. .........+.+++.+|++.+|.+||++.++++.
T Consensus 236 -~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 236 -L--KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred -C--cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0 0011133567789999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=306.29 Aligned_cols=250 Identities=21% Similarity=0.326 Sum_probs=187.8
Q ss_pred eeecCCceEEEEEEeCCC--CeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCCCCC
Q 043702 387 IIGHGAFGTVYKGILPQN--GDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGS 462 (711)
Q Consensus 387 ~LG~G~fg~Vy~~~~~~~--~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 462 (711)
.||+|+||.||+|..... ...+++|.+.... ...+.+.+|+.+++.++||||+++++.|......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999976432 2356677766532 345689999999999999999999999999999999999999999
Q ss_pred HHHHHhhCC---CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCC-CCCc
Q 043702 463 LDKALFEAR---SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK-SPDA 538 (711)
Q Consensus 463 L~~~l~~~~---~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~-~~~~ 538 (711)
|.+++.+.. ..+++.....++.||+.||+|||+. +++||||||+|||++.++.+||+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999997542 3466777889999999999999987 99999999999999999999999999986432211 1122
Q ss_pred ccccCCCcccChhhhcc-------CCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCch
Q 043702 539 TVAAGTMGYLAPEYLLT-------GRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRL 610 (711)
Q Consensus 539 ~~~~gt~~y~APE~~~~-------~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 610 (711)
....++..|+|||++.. ..++.++|||||||++|||++ |..||..... .+........ ..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-----------~~~~~~~~~~-~~ 226 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-----------REVLNHVIKD-QQ 226 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-----------HHHHHHHHhh-cc
Confidence 33568899999998753 245789999999999999997 5667753211 1111122111 11
Q ss_pred hHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 043702 611 LTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLV 656 (711)
Q Consensus 611 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 656 (711)
....++.+...++ ..+.+++..|| .+|++||++++|++.|.
T Consensus 227 ~~~~~~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 227 VKLFKPQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cccCCCccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 2222333332223 34566778899 57999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=310.29 Aligned_cols=266 Identities=22% Similarity=0.301 Sum_probs=201.7
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC---ChhhhHHHHHHHHhcCCCCeeeeeeeeeec--CeEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ---GKDEFLSELSIIGTLRHRNLVRLQGWCHEK--GEILLV 454 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV 454 (711)
++|+..+.||+|++|.||+|....+++.+|+|.+..... ....+.+|++++++++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 468888999999999999999988899999999875322 223567899999999999999999999877 889999
Q ss_pred EEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCC
Q 043702 455 YDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~ 534 (711)
|||++ ++|.+++......+++..+++++.|++.||+|||+. +++||||||+||++++++.+||+|||+++......
T Consensus 85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 99997 499998876666799999999999999999999997 99999999999999999999999999998765432
Q ss_pred CCCcccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHH-------HHHHhhh
Q 043702 535 SPDATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVE-------WVWSLHR 606 (711)
Q Consensus 535 ~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~-------~~~~~~~ 606 (711)
. ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...... .....+.. ..|....
T Consensus 161 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 161 K-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI----DQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred c-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHHHhCCCchHHHHHhh
Confidence 2 12234578899999998765 4689999999999999999999999653210 00000000 0010000
Q ss_pred c------CchhHhhhhhccCCCcHH-HHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 607 E------GRLLTAADARLEGQFDEA-EMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 607 ~------~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
. ..........+...+... ....+.+++.+||+.+|++||++.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 000000111111112111 24557788999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=310.20 Aligned_cols=250 Identities=26% Similarity=0.355 Sum_probs=203.5
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC-CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcC
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN-SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
++|...+.||+|+||.||++....++..||+|.+... ....+.+.+|+.+++.++|||++++++.|...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 5788889999999999999998878899999998653 334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCc
Q 043702 459 PNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDA 538 (711)
Q Consensus 459 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 538 (711)
++++|.+++.+ ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++........ ..
T Consensus 99 ~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~~ 172 (293)
T cd06647 99 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR 172 (293)
T ss_pred CCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-cc
Confidence 99999999854 3588999999999999999999997 999999999999999999999999999876544322 22
Q ss_pred ccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhc
Q 043702 539 TVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARL 618 (711)
Q Consensus 539 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 618 (711)
....|++.|+|||.+..+.++.++|||||||++|||++|+.||...... +.+......+. .
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~-----------~~~~~~~~~~~--------~ 233 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-----------RALYLIATNGT--------P 233 (293)
T ss_pred ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh-----------hheeehhcCCC--------C
Confidence 2346889999999998888999999999999999999999999654221 00000000000 0
Q ss_pred cCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 619 EGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
...........+.+++.+||+.+|.+||++.+++++
T Consensus 234 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 234 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000111223457788999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=314.64 Aligned_cols=246 Identities=24% Similarity=0.345 Sum_probs=198.1
Q ss_pred ccceeecCCceEEEEEEeCCCCeEEEEEEcccCC-CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCCCCC
Q 043702 384 ANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGS 462 (711)
Q Consensus 384 ~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 462 (711)
....||+|+||.||++....++..||||++.... ...+.+.+|+.+++.++|+|++++++.+...+..++||||+++++
T Consensus 26 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~ 105 (292)
T cd06658 26 SFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105 (292)
T ss_pred hhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence 3466999999999999998889999999986533 335578899999999999999999999999999999999999999
Q ss_pred HHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCccccc
Q 043702 463 LDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAA 542 (711)
Q Consensus 463 L~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~ 542 (711)
|.+++.. ..+++.++..++.||+.||.|||+. +|+||||||+||++++++.+||+|||++........ ......
T Consensus 106 L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~ 179 (292)
T cd06658 106 LTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKSLV 179 (292)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCceee
Confidence 9998843 4689999999999999999999997 999999999999999999999999999976543322 223356
Q ss_pred CCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccCCC
Q 043702 543 GTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQF 622 (711)
Q Consensus 543 gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 622 (711)
|+..|+|||.+.+..++.++|||||||++|||++|+.||..... .+-.... .....+.+..
T Consensus 180 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-----------~~~~~~~------~~~~~~~~~~-- 240 (292)
T cd06658 180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP-----------LQAMRRI------RDNLPPRVKD-- 240 (292)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----------HHHHHHH------HhcCCCcccc--
Confidence 89999999999888899999999999999999999999864321 0000000 0011111111
Q ss_pred cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 623 DEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 623 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.......+..++.+|++.||.+||+++++++.
T Consensus 241 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11123356678889999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=311.98 Aligned_cols=255 Identities=20% Similarity=0.257 Sum_probs=202.0
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC----CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS----QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
++|+..+.||+|+||.||++.+...++.|++|.+.... ...+.+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888899999999999999999889999999887532 23457889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
||+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.......
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 81 EYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 999999999999654 5689999999999999999999997 999999999999999999999999999874211100
Q ss_pred --------------CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHH
Q 043702 536 --------------PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWV 601 (711)
Q Consensus 536 --------------~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~ 601 (711)
.......|+..|+|||.+....++.++|||||||++|||++|+.||..... .++.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~-----------~~~~ 225 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-----------EELF 225 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----------HHHH
Confidence 011124578899999999888899999999999999999999999864311 1111
Q ss_pred HHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 602 WSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 602 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
..... +.. ..+... ......+.+++.+||+.+|++||++.++.+.|+.
T Consensus 226 ~~~~~-~~~---~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 226 GQVIS-DDI---EWPEGD----EALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHHHh-ccc---CCCCcc----ccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 11111 100 001100 1123456789999999999999997767666653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=313.15 Aligned_cols=253 Identities=22% Similarity=0.358 Sum_probs=216.1
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC---ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ---GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
..-|...+.||+|.|..|-++++-.+|+.||||++.+.+. ....+.+|++.|+.++|||||+|+++......+|||.
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 3457788899999999999999999999999999987443 3457899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEE-cCCCcEEEeecCCceecCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIML-DEGFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl-d~~~~vkL~DFGla~~~~~~~ 534 (711)
|.-.+|+|++||.+....+.+....+++.||+.|+.|+|+. .+|||||||+||.+ ..-|-|||.|||++..+..+.
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 99999999999999999999999999999999999999998 99999999999976 667889999999998877655
Q ss_pred CCCcccccCCCcccChhhhccCCC-CccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHh
Q 043702 535 SPDATVAAGTMGYLAPEYLLTGRA-TEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTA 613 (711)
Q Consensus 535 ~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 613 (711)
. .+..||.+.|-|||++.+..| .++.||||+||+||-|++|++||+...+. ..+..+
T Consensus 174 k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS--------------------ETLTmI 231 (864)
T KOG4717|consen 174 K--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS--------------------ETLTMI 231 (864)
T ss_pred h--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch--------------------hhhhhh
Confidence 3 455789999999999999887 56889999999999999999999764321 112223
Q ss_pred hhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--HHhCC
Q 043702 614 ADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ--MLVGE 658 (711)
Q Consensus 614 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~--~L~~~ 658 (711)
+|-.. ..+.....++.+|+..||..||.+|-+.++|+. +|+..
T Consensus 232 mDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~ 276 (864)
T KOG4717|consen 232 MDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAG 276 (864)
T ss_pred hcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCC
Confidence 33222 234556678889999999999999999999986 45443
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=307.77 Aligned_cols=253 Identities=25% Similarity=0.434 Sum_probs=197.6
Q ss_pred CcccceeecCCceEEEEEEeCC---CCeEEEEEEcccCC---CChhhhHHHHHHHHhcCCCCeeeeeeeeeecC------
Q 043702 382 FNANRIIGHGAFGTVYKGILPQ---NGDIIAVKRCSHNS---QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKG------ 449 (711)
Q Consensus 382 f~~~~~LG~G~fg~Vy~~~~~~---~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 449 (711)
|...+.||+|+||.||+|.+.. +++.||||++.... ...+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 5567889999999999998643 46889999887532 23457889999999999999999999886532
Q ss_pred eEEEEEEcCCCCCHHHHHhhCC-----CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeec
Q 043702 450 EILLVYDLMPNGSLDKALFEAR-----SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDF 524 (711)
Q Consensus 450 ~~~lV~Ey~~~gsL~~~l~~~~-----~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DF 524 (711)
..++++||+++|+|..++.... ..+++...++++.|++.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 3478999999999998875321 2478899999999999999999987 9999999999999999999999999
Q ss_pred CCceecCCCCCC-CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHH
Q 043702 525 GLARQVEHDKSP-DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVW 602 (711)
Q Consensus 525 Gla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~ 602 (711)
|+++........ ......+++.|++||.+....++.++|||||||++|||++ |+.||..... ..+..+..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--------~~~~~~~~ 229 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--------SEIYNYLI 229 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--------HHHHHHHH
Confidence 999876433221 1122345678999999998889999999999999999999 8888864321 11222111
Q ss_pred HhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 603 SLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 603 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
..... .........+.+++.+||+.+|.+||++.++++.|++.
T Consensus 230 ---~~~~~----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 230 ---KGNRL----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ---cCCcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11100 01112335788899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=305.04 Aligned_cols=258 Identities=24% Similarity=0.312 Sum_probs=197.3
Q ss_pred CcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC--CChhhhHHHHHHHHhcC-CCCeeeeeeeeeec--CeEEEEEE
Q 043702 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS--QGKDEFLSELSIIGTLR-HRNLVRLQGWCHEK--GEILLVYD 456 (711)
Q Consensus 382 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~--~~~~lV~E 456 (711)
|+..+.||+|+||.||+|....+++.+|+|++.... .......+|+.++.++. |+|++++++++.+. +.+++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 566788999999999999998889999999987632 22334567999999986 99999999999987 88999999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCC
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP 536 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~ 536 (711)
|++ ++|.+.+......+++..+..++.|++.||+|||+. +++||||||+||+++. +.+||+|||+++........
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~ 155 (282)
T cd07831 81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY 155 (282)
T ss_pred cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence 996 588888876667799999999999999999999997 9999999999999999 99999999999876443222
Q ss_pred CcccccCCCcccChhhhcc-CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhh----------
Q 043702 537 DATVAAGTMGYLAPEYLLT-GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLH---------- 605 (711)
Q Consensus 537 ~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~---------- 605 (711)
....++..|+|||.+.. +.++.++|||||||++|||++|+.||..... .....+.....
T Consensus 156 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~~~ 225 (282)
T cd07831 156 --TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE--------LDQIAKIHDVLGTPDAEVLKK 225 (282)
T ss_pred --CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH--------HHHHHHHHHHcCCCCHHHHHh
Confidence 23457899999998754 4578899999999999999999999965321 11111111110
Q ss_pred -hcCchhHhhhhhccC----CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 606 -REGRLLTAADARLEG----QFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 606 -~~~~~~~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
..........+.... .........+.+++.+||+.+|++||+++++++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 226 FRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred hcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000000000000000 0011235678899999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=313.42 Aligned_cols=246 Identities=24% Similarity=0.344 Sum_probs=198.3
Q ss_pred ccceeecCCceEEEEEEeCCCCeEEEEEEcccC-CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCCCCC
Q 043702 384 ANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN-SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGS 462 (711)
Q Consensus 384 ~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 462 (711)
....||+|+||.||++....+++.||+|++... ....+.+.+|+.+++.++|||++++++++..++..++|+||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 345699999999999999888999999998653 3345678899999999999999999999999999999999999999
Q ss_pred HHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCccccc
Q 043702 463 LDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAA 542 (711)
Q Consensus 463 L~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~ 542 (711)
|..++.. ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++........ ......
T Consensus 105 L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~ 178 (297)
T cd06659 105 LTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSLV 178 (297)
T ss_pred HHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-ccccee
Confidence 9998743 4689999999999999999999987 999999999999999999999999999976543322 223356
Q ss_pred CCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccCCC
Q 043702 543 GTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQF 622 (711)
Q Consensus 543 gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 622 (711)
|+..|+|||++.+..++.++|||||||++|||++|+.||..... .+..... .... .+... .
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----------~~~~~~~-~~~~-----~~~~~--~ 239 (297)
T cd06659 179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP-----------VQAMKRL-RDSP-----PPKLK--N 239 (297)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----------HHHHHHH-hccC-----CCCcc--c
Confidence 89999999999988999999999999999999999999864321 0101111 0000 00000 0
Q ss_pred cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 623 DEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 623 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.......+.+++.+||+.+|.+||++.++++.
T Consensus 240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 240 AHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 11123456788899999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=305.88 Aligned_cols=247 Identities=26% Similarity=0.347 Sum_probs=203.4
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC----CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS----QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
+|+..+.||.|+||.||+|.+..++..+|+|.+.... ...+.+.+|++++++++||||+++++.+...+..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999998889999999987532 345688999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCC
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP 536 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~ 536 (711)
|+++++|.+++... ..+++.....++.|+++||.|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-- 154 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence 99999999998654 5789999999999999999999987 99999999999999999999999999998764432
Q ss_pred CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhh
Q 043702 537 DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADA 616 (711)
Q Consensus 537 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 616 (711)
......|+..|+|||.+....++.++|+||||+++|+|++|+.||...... ..++.......
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---------~~~~~~~~~~~--------- 216 (258)
T cd05578 155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT---------IRDQIRAKQET--------- 216 (258)
T ss_pred cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc---------HHHHHHHHhcc---------
Confidence 223345888999999999888999999999999999999999999754210 11111111110
Q ss_pred hccCCCcHHHHHHHHHHHHhcCCCCCCCCCCH--HHHH
Q 043702 617 RLEGQFDEAEMRRVLLVGLACSHPDPLARPTM--RGVV 652 (711)
Q Consensus 617 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~--~eVl 652 (711)
.....+......+.+++.+||+.||.+||++ +|++
T Consensus 217 -~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 217 -ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 0111222334677789999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=304.62 Aligned_cols=266 Identities=23% Similarity=0.245 Sum_probs=211.4
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC----CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS----QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
.|+..+.||+|.-|+||++.+.+++..+|+|++.+.. ........|-+||+.++||.+..|+..++.++..||+||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 4566788999999999999999989999999998632 334567789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCC---
Q 043702 457 LMPNGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEH--- 532 (711)
Q Consensus 457 y~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~--- 532 (711)
||+||+|..++++.. ..++....+-++..++-||+|||-. |||.|||||+||||.++|.+.|+||.|+.....
T Consensus 158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 999999999987544 5699999999999999999999998 999999999999999999999999998754210
Q ss_pred ------------------------------C-CC---------------------CCcccccCCCcccChhhhccCCCCc
Q 043702 533 ------------------------------D-KS---------------------PDATVAAGTMGYLAPEYLLTGRATE 560 (711)
Q Consensus 533 ------------------------------~-~~---------------------~~~~~~~gt~~y~APE~~~~~~~s~ 560 (711)
. .. ......+||-.|+|||++.+...+.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 0 00 0012246999999999999999999
Q ss_pred cccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCC
Q 043702 561 KTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHP 640 (711)
Q Consensus 561 ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~ 640 (711)
+.|-|+|||+||||+.|..||...... . .+..++...+.-....+....+.+||...|.+
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~~-------~-------------Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvK 374 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNNK-------E-------------TLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVK 374 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCch-------h-------------hHHHHhcCCCcCCCCCcchhHHHHHHHHHhcc
Confidence 999999999999999999999765321 1 12222222222222234556788899999999
Q ss_pred CCCCCCC----HHHHHHH---------HhCCCCCCCCCCCCC
Q 043702 641 DPLARPT----MRGVVQM---------LVGEAEVPIVPRAKP 669 (711)
Q Consensus 641 dP~~RPs----~~eVl~~---------L~~~~~~p~~p~~~p 669 (711)
||.+|.. +.||-+. |.....+|.+|....
T Consensus 375 dP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~d 416 (459)
T KOG0610|consen 375 DPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPVD 416 (459)
T ss_pred ChhhhhccccchHHhhcCccccCCChhheeccCCCcCCCccc
Confidence 9999998 7777552 233345566555443
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=306.96 Aligned_cols=262 Identities=24% Similarity=0.352 Sum_probs=198.1
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC---CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEc
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
+|+..+.||.|++|.||+|+...+++.||||++.... ...+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999998889999999886532 2235788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhC-CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCC
Q 043702 458 MPNGSLDKALFEA-RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP 536 (711)
Q Consensus 458 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~ 536 (711)
+. ++|.+++... ...+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence 95 6899888654 35689999999999999999999987 999999999999999999999999999986543322
Q ss_pred CcccccCCCcccChhhhccCC-CCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhc-C------
Q 043702 537 DATVAAGTMGYLAPEYLLTGR-ATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHRE-G------ 608 (711)
Q Consensus 537 ~~~~~~gt~~y~APE~~~~~~-~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~-~------ 608 (711)
......++..|+|||.+.+.. ++.++|||||||++|||++|+.||...... ..+.......... .
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-------DQLFRIFRTLGTPDEVVWPGV 228 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHHHhCCCChhhhhhh
Confidence 122335788999999887654 588999999999999999999999643210 0111110000000 0
Q ss_pred -chhHhhh--hhc-cCC---CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 609 -RLLTAAD--ARL-EGQ---FDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 609 -~~~~~~d--~~l-~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.+..... +.. ... ........+.+++.+||+.||.+||+++++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 229 TSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000000 000 000 000112456788999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=299.29 Aligned_cols=251 Identities=26% Similarity=0.437 Sum_probs=207.4
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC---CChhhhHHHHHHHHhcCCCCeeeeeeeeeec--CeEEEEE
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---QGKDEFLSELSIIGTLRHRNLVRLQGWCHEK--GEILLVY 455 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 455 (711)
+|...+.||+|++|.||+|....+++.|++|++.... ...+.+.+|++++++++|+||+++++.+... +..++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999998889999999987644 3467889999999999999999999999988 8899999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
||+++++|.+++.... .+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.+||+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 9999999999997644 899999999999999999999997 999999999999999999999999999987765432
Q ss_pred C-CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhh
Q 043702 536 P-DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614 (711)
Q Consensus 536 ~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 614 (711)
. ......++..|+|||.+.....+.++||||||+++++|++|+.||.... ......+......
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----------~~~~~~~~~~~~~------ 220 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG----------NPMAALYKIGSSG------ 220 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----------chHHHHHhccccC------
Confidence 1 1233568899999999988889999999999999999999999996542 1111111111100
Q ss_pred hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 615 DARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 615 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
............+.+++.+|++.+|.+||++.++++.
T Consensus 221 ---~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 221 ---EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred ---CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 1111222335678888999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=307.78 Aligned_cols=247 Identities=23% Similarity=0.349 Sum_probs=200.7
Q ss_pred CcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC-CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCCC
Q 043702 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPN 460 (711)
Q Consensus 382 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 460 (711)
|...+.||+|++|.||++....+++.+++|++.... ...+.+.+|+.+++.++|||++++++++...+..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 445578999999999999998889999999886533 3345688999999999999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCccc
Q 043702 461 GSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATV 540 (711)
Q Consensus 461 gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 540 (711)
++|.+++.. .++++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||+|||++........ ....
T Consensus 101 ~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~ 174 (285)
T cd06648 101 GALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRKS 174 (285)
T ss_pred CCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-cccc
Confidence 999999865 5689999999999999999999997 999999999999999999999999999876543322 2233
Q ss_pred ccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccC
Q 043702 541 AAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEG 620 (711)
Q Consensus 541 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 620 (711)
..|++.|+|||.+.+..++.++|||||||++|||++|+.||..... ........ .+. .+.+.
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-----------~~~~~~~~-~~~-----~~~~~- 236 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-----------LQAMKRIR-DNL-----PPKLK- 236 (285)
T ss_pred ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-----------HHHHHHHH-hcC-----CCCCc-
Confidence 4689999999999888899999999999999999999999864321 11111111 110 01110
Q ss_pred CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 621 QFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
........+.+++.+||+.+|++||++.++++
T Consensus 237 -~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 237 -NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred -ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 01112356888999999999999999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=311.29 Aligned_cols=249 Identities=26% Similarity=0.392 Sum_probs=199.8
Q ss_pred CcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC----CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEc
Q 043702 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS----QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 382 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
|...+.||+|+||.||+++...++..+|+|++.... ....++.+|++++++++|||+++++++|..++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 556788999999999999998889999999986532 1234688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC
Q 043702 458 MPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD 537 (711)
Q Consensus 458 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 537 (711)
++ |+|.+++......+++.++..++.|++.||.|||+. +|+||||+|+||+++.++.+||+|||++......
T Consensus 107 ~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---- 178 (317)
T cd06635 107 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---- 178 (317)
T ss_pred CC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc----
Confidence 96 588888876667799999999999999999999987 9999999999999999999999999998754322
Q ss_pred cccccCCCcccChhhhc---cCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhh
Q 043702 538 ATVAAGTMGYLAPEYLL---TGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614 (711)
Q Consensus 538 ~~~~~gt~~y~APE~~~---~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 614 (711)
....|++.|+|||.+. .+.++.++|||||||++|||++|+.||..... ..........+.
T Consensus 179 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-----------~~~~~~~~~~~~----- 241 (317)
T cd06635 179 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----------MSALYHIAQNES----- 241 (317)
T ss_pred -ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH-----------HHHHHHHHhccC-----
Confidence 2345889999999974 45688999999999999999999999864311 010111111110
Q ss_pred hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC
Q 043702 615 DARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEA 659 (711)
Q Consensus 615 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~ 659 (711)
+ ..........+.+++.+||+.+|.+||++.++++.+....
T Consensus 242 -~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 242 -P---TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred -C---CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 0 0111123345778899999999999999999998765433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=308.74 Aligned_cols=265 Identities=26% Similarity=0.335 Sum_probs=201.2
Q ss_pred HHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC---CChhhhHHHHHHHHhcCCCCeeeeeeeeeecC----
Q 043702 377 SATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKG---- 449 (711)
Q Consensus 377 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~---- 449 (711)
...++|+..+.||+|+||.||+|.+..+++.||+|++.... .....+.+|++++++++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999998889999999987532 23356788999999999999999999987654
Q ss_pred ------eEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEee
Q 043702 450 ------EILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGD 523 (711)
Q Consensus 450 ------~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~D 523 (711)
.+++|+||+++ +|...+......+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCc
Confidence 78999999976 78787766566799999999999999999999997 999999999999999999999999
Q ss_pred cCCceecCCCCCCCcccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHH
Q 043702 524 FGLARQVEHDKSPDATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVW 602 (711)
Q Consensus 524 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~ 602 (711)
||++...............++..|+|||.+.+. .++.++|||||||++|||++|++||..... ....+-+.
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~--------~~~~~~~~ 231 (302)
T cd07864 160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE--------LAQLELIS 231 (302)
T ss_pred ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHH
Confidence 999987654432222233467889999988654 568899999999999999999999964321 00011111
Q ss_pred HhhhcCc---hhHh--------hhh------hccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 603 SLHREGR---LLTA--------ADA------RLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 603 ~~~~~~~---~~~~--------~d~------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
....... .... .+. ...... ......+.+++.+||+.+|.+||+++++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 232 RLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HHhCCCChhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1000000 0000 000 000000 0123567889999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=309.98 Aligned_cols=270 Identities=22% Similarity=0.286 Sum_probs=198.9
Q ss_pred CCcccceeecCCceEEEEEEeCC--CCeEEEEEEcccCC----CChhhhHHHHHHHHhcCCCCeeeeeeeeeec--CeEE
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQ--NGDIIAVKRCSHNS----QGKDEFLSELSIIGTLRHRNLVRLQGWCHEK--GEIL 452 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~--~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~ 452 (711)
+|...+.||+|++|.||+|+... .+..||+|.+.... ...+.+.+|+.++++++||||+++++++... +.++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47788899999999999999987 78999999987632 2245678899999999999999999999988 7899
Q ss_pred EEEEcCCCCCHHHHHhhC----CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcC----CCcEEEeec
Q 043702 453 LVYDLMPNGSLDKALFEA----RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDE----GFNARLGDF 524 (711)
Q Consensus 453 lV~Ey~~~gsL~~~l~~~----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~----~~~vkL~DF 524 (711)
+||||+++ +|.+++... ...++...+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 676666432 23688999999999999999999998 9999999999999999 999999999
Q ss_pred CCceecCCCCC--CCcccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccccccccccc--cccchHH
Q 043702 525 GLARQVEHDKS--PDATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVG--VASNLVE 599 (711)
Q Consensus 525 Gla~~~~~~~~--~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~--~~~~l~~ 599 (711)
|+++....... .......++..|+|||.+.+. .++.++|||||||+++||++|+.||........... ....+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987654332 122334678999999988764 578999999999999999999999975433210000 0000111
Q ss_pred HHHHhh-----------hcCchhHhhhhhccCCCc---------H--HHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 600 WVWSLH-----------REGRLLTAADARLEGQFD---------E--AEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 600 ~~~~~~-----------~~~~~~~~~d~~l~~~~~---------~--~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.+..+. .........+......+. . ....++.+++.+||+.||++|||+.|+++.
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 110000 000000000000000111 0 223468889999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=321.85 Aligned_cols=245 Identities=29% Similarity=0.419 Sum_probs=204.9
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC-C---ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS-Q---GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
.|...+.||.|.||.||-+++..+.+.||||+++... + ..+++.+|+..|.+++|||++...|++..+...+||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 3666778999999999999999999999999998632 2 24689999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCC
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP 536 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~ 536 (711)
|| -|+-.++|.-.+.++.+..+..|+.+.+.||+|||+. +.||||||+.||||++.+.|||+|||.|......
T Consensus 107 YC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA--- 179 (948)
T KOG0577|consen 107 YC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA--- 179 (948)
T ss_pred HH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch---
Confidence 99 5588888877788899999999999999999999998 9999999999999999999999999999766443
Q ss_pred CcccccCCCcccChhhhc---cCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHh
Q 043702 537 DATVAAGTMGYLAPEYLL---TGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTA 613 (711)
Q Consensus 537 ~~~~~~gt~~y~APE~~~---~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 613 (711)
..++|||.|||||++. .|.|+-|+||||+|++-.||.-.++|+-.+.. ..-++. +...
T Consensus 180 --nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-----------MSALYH------IAQN 240 (948)
T KOG0577|consen 180 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----------MSALYH------IAQN 240 (948)
T ss_pred --hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-----------HHHHHH------HHhc
Confidence 3468999999999985 57899999999999999999999999754321 111111 1111
Q ss_pred hhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 614 ADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 614 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
-.|.+. ..+....+..++..||+.-|.+|||..++++.
T Consensus 241 esPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 241 ESPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 122222 34566778889999999999999999988763
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=314.86 Aligned_cols=262 Identities=23% Similarity=0.309 Sum_probs=198.5
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC--CCChhhhHHHHHHHHhcCCCCeeeeeeeeeec-----CeE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN--SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEK-----GEI 451 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~ 451 (711)
+++|...++||+|+||.||+|++..+|+.||+|++... ......+.+|+.++++++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46899999999999999999999888999999998642 23345688899999999999999999987654 358
Q ss_pred EEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecC
Q 043702 452 LLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVE 531 (711)
Q Consensus 452 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~ 531 (711)
++|+||+++ +|..++. ...+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~lv~e~~~~-~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 84 YIVQELMET-DLYKLIK--TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEehhccc-CHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 999999965 8888774 35699999999999999999999997 99999999999999999999999999998764
Q ss_pred CCCCC--CcccccCCCcccChhhhcc-CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcC
Q 043702 532 HDKSP--DATVAAGTMGYLAPEYLLT-GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREG 608 (711)
Q Consensus 532 ~~~~~--~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 608 (711)
..... ......|++.|+|||.+.+ ..++.++|||||||++|||++|+.||..... .....+........
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~--------~~~~~~~~~~~~~~ 229 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY--------LHQLNLILGVLGTP 229 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHHHcCCC
Confidence 32221 1223468999999998765 4688999999999999999999999964321 01111111111100
Q ss_pred c---hhHhhhhh-------c--cCCC-----cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 609 R---LLTAADAR-------L--EGQF-----DEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 609 ~---~~~~~d~~-------l--~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
. .....+.. . .... .......+.+++.+||+.+|++||++.|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 230 SQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred CHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 00000000 0 0000 01123567899999999999999999999985
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=304.52 Aligned_cols=261 Identities=25% Similarity=0.343 Sum_probs=198.1
Q ss_pred CcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC---CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcC
Q 043702 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 382 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
|+..+.||.|++|.||+|.+..+|..||+|++.... ...+.+.+|++++++++|||++++++++.+++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999998889999999987533 22356889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC
Q 043702 459 PNGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD 537 (711)
Q Consensus 459 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 537 (711)
+ ++|.+++.... ..+++..+.+++.|+++||+|||+. +++||||+|+||++++++.+||+|||+++........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~- 155 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT- 155 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-
Confidence 5 68999886544 4689999999999999999999987 9999999999999999999999999999765433221
Q ss_pred cccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcC--------
Q 043702 538 ATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREG-------- 608 (711)
Q Consensus 538 ~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~-------- 608 (711)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||...... ..+...........
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI-------DQLFRIFRTLGTPDEDVWPGVT 228 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHHHhCCCChHHhhhhh
Confidence 1223568899999988664 5688999999999999999999999653220 01111110000000
Q ss_pred chhHhhh--hhc----cCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 609 RLLTAAD--ARL----EGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 609 ~~~~~~d--~~l----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.+.+... +.. ...........+.+++.+|++.+|.+||+++|+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 229 SLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000000 000 000011122467789999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=289.90 Aligned_cols=247 Identities=28% Similarity=0.431 Sum_probs=198.6
Q ss_pred cceeecCCceEEEEEEeCCCCeEEEEEEccc--CCCChhhhHHHHHHHHhcC-CCCeeeeeeeeeecCeEEEEEEcCCCC
Q 043702 385 NRIIGHGAFGTVYKGILPQNGDIIAVKRCSH--NSQGKDEFLSELSIIGTLR-HRNLVRLQGWCHEKGEILLVYDLMPNG 461 (711)
Q Consensus 385 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~g 461 (711)
...||.|..|.|++++.+.+|..+|||.+.. +..+.+.++..+.++..-+ +|.||+.+|||..+....+.||.| ..
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~ 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-ST 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-HH
Confidence 4569999999999999999999999999876 3344567778888877665 999999999999999999999998 44
Q ss_pred CHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCcccc
Q 043702 462 SLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVA 541 (711)
Q Consensus 462 sL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 541 (711)
.++++|.....++++...-++...+..||.||.++ ++|+|||+||+|||+|+.|++||||||++-.+.+... .+..
T Consensus 176 C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA--htrs 251 (391)
T KOG0983|consen 176 CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA--HTRS 251 (391)
T ss_pred HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeecccc--cccc
Confidence 77888877778899999999999999999999987 6999999999999999999999999999987755443 3445
Q ss_pred cCCCcccChhhhcc---CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhc
Q 043702 542 AGTMGYLAPEYLLT---GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARL 618 (711)
Q Consensus 542 ~gt~~y~APE~~~~---~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 618 (711)
.|-+.|||||.+.- ..|..++||||||+.|+||+||+.||.....+. .. +-. +.....|.+
T Consensus 252 AGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF-------e~---ltk------vln~ePP~L 315 (391)
T KOG0983|consen 252 AGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF-------EV---LTK------VLNEEPPLL 315 (391)
T ss_pred cCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH-------HH---HHH------HHhcCCCCC
Confidence 68999999999864 468889999999999999999999997643210 00 111 111111333
Q ss_pred cCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 619 EGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.+. ......+.+++..||+.|+.+||...++++.
T Consensus 316 ~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 316 PGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred Ccc--cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 221 1134567788889999999999999999874
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=310.13 Aligned_cols=253 Identities=30% Similarity=0.411 Sum_probs=196.4
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC--CChhhhHHHHHHHHhcC-CCCeeeeeeeeeecCeEEEEEEc
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS--QGKDEFLSELSIIGTLR-HRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
+|...+.||+|+||.||++.+..+++.+|+|++.... .....+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4555678999999999999999889999999987532 33457889999999997 99999999999999999999999
Q ss_pred CCCCCHHHHH---hh-CCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCC
Q 043702 458 MPNGSLDKAL---FE-ARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHD 533 (711)
Q Consensus 458 ~~~gsL~~~l---~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~ 533 (711)
+.. +|.++. .. ....+++..+.+++.|++.||+|||+. .+++||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 554433 22 236799999999999999999999974 38999999999999999999999999999765433
Q ss_pred CCCCcccccCCCcccChhhhccC---CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCch
Q 043702 534 KSPDATVAAGTMGYLAPEYLLTG---RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRL 610 (711)
Q Consensus 534 ~~~~~~~~~gt~~y~APE~~~~~---~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 610 (711)
.. .....|++.|+|||.+... .++.++|||||||++|||++|+.||.... ...+........
T Consensus 162 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----------~~~~~~~~~~~~--- 226 (288)
T cd06616 162 IA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN----------SVFDQLTQVVKG--- 226 (288)
T ss_pred Cc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc----------hHHHHHhhhcCC---
Confidence 21 2233588999999999776 68999999999999999999999986431 111111111110
Q ss_pred hHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 611 LTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 611 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
..+.+...........+.+++.+||+.+|.+||++++|++.
T Consensus 227 ---~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 227 ---DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred ---CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01111111112234567889999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=302.85 Aligned_cols=263 Identities=23% Similarity=0.338 Sum_probs=199.8
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcC
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
+|+..+.||.|++|.||+|+...+|..||+|++.... ...+.+.+|++++++++|+||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788899999999999999998889999999987633 23456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCC--CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCC
Q 043702 459 PNGSLDKALFEAR--SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP 536 (711)
Q Consensus 459 ~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~ 536 (711)
++ +|.+++.... ..+++..+.+++.|+++||.|||+. +++||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 8988886544 4689999999999999999999987 999999999999999999999999999976543222
Q ss_pred CcccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHH-------HHHhhhcC
Q 043702 537 DATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEW-------VWSLHREG 608 (711)
Q Consensus 537 ~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~-------~~~~~~~~ 608 (711)
......++..|++||.+.+. .++.++|||||||++|||++|+.||....... ....+.+. .|+.....
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED----QLLKIFRIMGTPTESTWPGISQL 231 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH----HHHHHHHHhCCCChhhHHHHhcC
Confidence 12234578899999998664 56889999999999999999999997542210 00000000 00000000
Q ss_pred c-hh----HhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 609 R-LL----TAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 609 ~-~~----~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
. .. ...+... ....+.....+.+++.+|++.||.+||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 232 PEYKPTFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred chhcccccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 00 0000000 0011122456778999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=300.31 Aligned_cols=247 Identities=21% Similarity=0.376 Sum_probs=204.6
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC---CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEc
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN---SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
+|+..++||+|++|.||++....+++.+++|++... .....++.+|+++++.++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 477889999999999999999888999999998753 23345788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhC---CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCC
Q 043702 458 MPNGSLDKALFEA---RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 458 ~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~ 534 (711)
+++++|.+++... ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||+++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 9999999998652 35689999999999999999999987 99999999999999999999999999998765542
Q ss_pred CCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhh
Q 043702 535 SPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614 (711)
Q Consensus 535 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 614 (711)
.....++..|++||.+.+..++.++|+||||+++|||++|+.||..... .+.... ...
T Consensus 158 ---~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----------~~~~~~-~~~------- 215 (256)
T cd08530 158 ---AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM-----------QDLRYK-VQR------- 215 (256)
T ss_pred ---cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----------HHHHHH-Hhc-------
Confidence 2224588999999999998899999999999999999999999864321 011101 111
Q ss_pred hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 615 DARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 615 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
............++.+++.+|++.+|.+||++.++++.
T Consensus 216 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 216 --GKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred --CCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11112223445668899999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=298.91 Aligned_cols=249 Identities=25% Similarity=0.429 Sum_probs=206.4
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC---CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEc
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
+|...+.||.|++|.||++....++..+++|++.... ...+++.+|+++++.++|+|++++++.+..++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999998889999999987643 3456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhC---CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCC
Q 043702 458 MPNGSLDKALFEA---RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 458 ~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~ 534 (711)
+++++|.+++... ...+++..+..++.++++||.|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999999765 36799999999999999999999997 99999999999999999999999999998765443
Q ss_pred CCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhh
Q 043702 535 SPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614 (711)
Q Consensus 535 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 614 (711)
.......|++.|+|||.+....++.++||||+|+++++|++|+.||..... .+........ ..
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----------~~~~~~~~~~-~~---- 220 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-----------LELALKILKG-QY---- 220 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-----------HHHHHHHhcC-CC----
Confidence 222334688999999999888899999999999999999999999864321 1111111111 10
Q ss_pred hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 615 DARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 615 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
..........+.+++.+||..+|++||++.++++.
T Consensus 221 -----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 221 -----PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11111233567788999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=307.02 Aligned_cols=260 Identities=23% Similarity=0.322 Sum_probs=197.2
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC---CChhhhHHHHHHHHhcCCCCeeeeeeeeeecC-------
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKG------- 449 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------- 449 (711)
++|+..++||+|+||.||+|....+++.||+|++.... .....+.+|++++++++||||++++++|...+
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 46889999999999999999998889999999886532 22335678999999999999999999987643
Q ss_pred -eEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCce
Q 043702 450 -EILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLAR 528 (711)
Q Consensus 450 -~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~ 528 (711)
..++||||+.+ +|.+++......+++.++..++.|+++||.|||+. +++|+||||+||+++.++.+||+|||++.
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 45999999964 88888876666799999999999999999999997 99999999999999999999999999998
Q ss_pred ecCCCCCC---CcccccCCCcccChhhhccCC-CCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHh
Q 043702 529 QVEHDKSP---DATVAAGTMGYLAPEYLLTGR-ATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSL 604 (711)
Q Consensus 529 ~~~~~~~~---~~~~~~gt~~y~APE~~~~~~-~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~ 604 (711)
........ ......++..|+|||.+.+.. ++.++||||||+++|||++|+.||...... .........
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~--------~~~~~~~~~ 239 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ--------HQLTLISQL 239 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHHH
Confidence 76433221 122345788999999886653 688999999999999999999998653211 011111000
Q ss_pred h--------hc-------------CchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 605 H--------RE-------------GRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 605 ~--------~~-------------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
. .. ..........+... .....+.+++.+||+.||.+||+++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~---~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 240 CGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPY---VKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hCCCChhhcccccchhhhhhccCCCccchhhHHhcccc---cCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0 00 00000001111000 012356689999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=301.52 Aligned_cols=242 Identities=22% Similarity=0.293 Sum_probs=197.5
Q ss_pred eecCCceEEEEEEeCCCCeEEEEEEcccCC----CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCCCCCH
Q 043702 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNS----QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSL 463 (711)
Q Consensus 388 LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 463 (711)
||.|++|.||+++...+++.+|+|++.... ...+.+.+|+++++.++||||+++++++.+++..++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999998889999999986532 3346789999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCcccccC
Q 043702 464 DKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAG 543 (711)
Q Consensus 464 ~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~g 543 (711)
.+++.+. ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||+++...... ......|
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~ 154 (262)
T cd05572 81 WTILRDR-GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCG 154 (262)
T ss_pred HHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccC
Confidence 9999653 4589999999999999999999997 99999999999999999999999999998765432 2233468
Q ss_pred CCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccCCCc
Q 043702 544 TMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFD 623 (711)
Q Consensus 544 t~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 623 (711)
+..|++||.+....++.++|+||||+++|||++|+.||..... +..+...... +......++
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---------~~~~~~~~~~---------~~~~~~~~~ 216 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE---------DPMEIYNDIL---------KGNGKLEFP 216 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC---------CHHHHHHHHh---------ccCCCCCCC
Confidence 8999999999888899999999999999999999999965421 0111111111 001111222
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH
Q 043702 624 EAEMRRVLLVGLACSHPDPLARPT-----MRGVVQ 653 (711)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPs-----~~eVl~ 653 (711)
......+.+++.+||+.+|++||+ ++|+++
T Consensus 217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 223467888999999999999999 666665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=303.09 Aligned_cols=264 Identities=25% Similarity=0.337 Sum_probs=202.3
Q ss_pred CcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC---ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcC
Q 043702 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ---GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 382 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
|+..+.||+|++|.||+|....+++.+++|++..... ....+.+|++++++++|+||+++++++..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 4567889999999999999988899999999875332 3467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCc
Q 043702 459 PNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDA 538 (711)
Q Consensus 459 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 538 (711)
++ +|..++......+++..+..++.|+++||.|||+. +|+|+||||+||++++++.+||+|||.+........ ..
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~-~~ 155 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-PY 155 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-cc
Confidence 75 89888877667899999999999999999999997 999999999999999999999999999987755431 12
Q ss_pred ccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHH-------HHHHhhhc-Cc
Q 043702 539 TVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVE-------WVWSLHRE-GR 609 (711)
Q Consensus 539 ~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~-------~~~~~~~~-~~ 609 (711)
....++..|+|||.+.+. .++.++||||||+++|+|++|+.||...... +......+ ..|..... ..
T Consensus 156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI----DQLFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHcCCCchHhcccchhhhh
Confidence 234578899999998876 7899999999999999999999998653210 00000000 00000000 00
Q ss_pred --hhHhhhhhc--cCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 610 --LLTAADARL--EGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 610 --~~~~~d~~l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.....+... ...........+.+++.+||+.||.+||++++++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000000000 001112335678899999999999999999999863
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=306.66 Aligned_cols=268 Identities=24% Similarity=0.321 Sum_probs=199.8
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC---ChhhhHHHHHHHHhcCCCCeeeeeeeeeec--CeEEE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ---GKDEFLSELSIIGTLRHRNLVRLQGWCHEK--GEILL 453 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~l 453 (711)
.++|+..+.||+|+||.||+|....+|+.||+|++..... ....+.+|+.++++++|+|++++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 3578899999999999999999988899999999865322 223567899999999999999999998754 56899
Q ss_pred EEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCC
Q 043702 454 VYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHD 533 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~ 533 (711)
||||+.+ +|.+++......+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.....
T Consensus 86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 9999964 89988876667799999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCCCcccccCCCcccChhhhcc-CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHH-------HHHHhh
Q 043702 534 KSPDATVAAGTMGYLAPEYLLT-GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVE-------WVWSLH 605 (711)
Q Consensus 534 ~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~-------~~~~~~ 605 (711)
.. ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...... +....+.. ..|...
T Consensus 162 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 162 AK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI----EQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred cC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHhcCCCChhhchhh
Confidence 21 1222346788999999875 45789999999999999999999999653221 00000000 000000
Q ss_pred hcCchhHhh--hhhccCCCc---HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 043702 606 REGRLLTAA--DARLEGQFD---EAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655 (711)
Q Consensus 606 ~~~~~~~~~--d~~l~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L 655 (711)
+........ ......... ......+.+++.+|++.||++||+++++++.-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~ 291 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS 291 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 000000000 000000000 01134567899999999999999999999743
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=304.65 Aligned_cols=263 Identities=22% Similarity=0.290 Sum_probs=196.0
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC---CChhhhHHHHHHHHhcC-CCCeeeeeeeeeecCe-----
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---QGKDEFLSELSIIGTLR-HRNLVRLQGWCHEKGE----- 450 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~----- 450 (711)
++|+..+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36888999999999999999998889999999876532 22357889999999996 6999999999987665
Q ss_pred EEEEEEcCCCCCHHHHHhhC----CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcC-CCcEEEeecC
Q 043702 451 ILLVYDLMPNGSLDKALFEA----RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDE-GFNARLGDFG 525 (711)
Q Consensus 451 ~~lV~Ey~~~gsL~~~l~~~----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~-~~~vkL~DFG 525 (711)
.++||||+++ +|.+++... ...+++..++.++.||++||.|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 898888643 23589999999999999999999997 9999999999999998 8899999999
Q ss_pred CceecCCCCCCCcccccCCCcccChhhhcc-CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHh
Q 043702 526 LARQVEHDKSPDATVAAGTMGYLAPEYLLT-GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSL 604 (711)
Q Consensus 526 la~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~ 604 (711)
+++....... ......+++.|+|||++.+ ..++.++|||||||++|||++|..||...... ..+.......
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~-------~~~~~~~~~~ 228 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL-------QQLLHIFKLL 228 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH-------HHHHHHHHHh
Confidence 9986543221 1122356889999998865 45789999999999999999999999653210 0000000000
Q ss_pred hhc-C-------chhHhhh-hhcc----CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 605 HRE-G-------RLLTAAD-ARLE----GQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 605 ~~~-~-------~~~~~~d-~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
... . ....... +... ....+.....+.+++.+||+.||.+||++.|++..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 229 GTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred CCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000 0 0000000 0000 00001234567789999999999999999999863
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=304.36 Aligned_cols=242 Identities=24% Similarity=0.312 Sum_probs=189.0
Q ss_pred eeecCCceEEEEEEeCCCCeEEEEEEcccCCC----ChhhhHHHHHHHHh---cCCCCeeeeeeeeeecCeEEEEEEcCC
Q 043702 387 IIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ----GKDEFLSELSIIGT---LRHRNLVRLQGWCHEKGEILLVYDLMP 459 (711)
Q Consensus 387 ~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~Ei~~l~~---l~H~niv~l~g~~~~~~~~~lV~Ey~~ 459 (711)
.||+|+||.||++....+++.+|+|.+..... ....+.+|..+++. .+|||++.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999999988899999998865321 12234455544443 469999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCcc
Q 043702 460 NGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDAT 539 (711)
Q Consensus 460 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 539 (711)
+|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~ 153 (279)
T cd05633 81 GGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PH 153 (279)
T ss_pred CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---cc
Confidence 9999998864 35699999999999999999999997 99999999999999999999999999997654322 12
Q ss_pred cccCCCcccChhhhcc-CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhc
Q 043702 540 VAAGTMGYLAPEYLLT-GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARL 618 (711)
Q Consensus 540 ~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 618 (711)
...|+..|+|||.+.+ ..++.++|||||||+++||++|+.||...... . ......... ..
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--------~-~~~~~~~~~----------~~ 214 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--------D-KHEIDRMTL----------TV 214 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCc--------C-HHHHHHHhh----------cC
Confidence 3468999999999874 45789999999999999999999999653211 0 011111100 01
Q ss_pred cCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHH
Q 043702 619 EGQFDEAEMRRVLLVGLACSHPDPLARP-----TMRGVVQM 654 (711)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVl~~ 654 (711)
....+.....++.+++.+||+.||.+|| +++++++.
T Consensus 215 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 215 NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 1112223345677888999999999999 69999885
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=296.52 Aligned_cols=247 Identities=27% Similarity=0.488 Sum_probs=204.3
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC---CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEc
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
+|+..+.||+|++|.||+++....++.+++|.+.... ...+.+.+|++++++++|+|++++++++...+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4777899999999999999998888999999987644 3456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC
Q 043702 458 MPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD 537 (711)
Q Consensus 458 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 537 (711)
+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (254)
T cd06627 81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD- 155 (254)
T ss_pred CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence 9999999998654 6799999999999999999999987 9999999999999999999999999999877544322
Q ss_pred cccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhh
Q 043702 538 ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADAR 617 (711)
Q Consensus 538 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 617 (711)
.....++..|+|||......++.++|||++|++++||++|+.||..... ... .+.....
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~----------~~~-~~~~~~~---------- 214 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP----------MAA-LFRIVQD---------- 214 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH----------HHH-HHHHhcc----------
Confidence 2334688999999999888889999999999999999999999864321 111 1111100
Q ss_pred ccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 618 LEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 618 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
.....+......+.+++.+||+.+|++||++.+++.
T Consensus 215 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 215 DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 001112222456778889999999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=312.18 Aligned_cols=268 Identities=22% Similarity=0.237 Sum_probs=199.4
Q ss_pred HhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC---CCChhhhHHHHHHHHhcCCCCeeeeeeeeeec------
Q 043702 378 ATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN---SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEK------ 448 (711)
Q Consensus 378 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------ 448 (711)
..++|+..+.||+|+||.||+|....+++.||+|++... ....+++.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457799999999999999999999889999999998642 22345677899999999999999999988643
Q ss_pred CeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCce
Q 043702 449 GEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLAR 528 (711)
Q Consensus 449 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~ 528 (711)
...++||||+. ++|.+.+... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 166 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccce
Confidence 35799999995 5888877532 88999999999999999999997 99999999999999999999999999998
Q ss_pred ecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccc----cccchHHHHHH-
Q 043702 529 QVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVG----VASNLVEWVWS- 603 (711)
Q Consensus 529 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~----~~~~l~~~~~~- 603 (711)
....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||........... ......++...
T Consensus 167 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T cd07850 167 TAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL 244 (353)
T ss_pred eCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 7643322 2334588999999999999999999999999999999999999964321000000 00000000000
Q ss_pred ------hhhcC------chhHhhhhhcc----CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 604 ------LHREG------RLLTAADARLE----GQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 604 ------~~~~~------~~~~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
..... .+.+.....+. ..........+.+++.+||+.||++||++.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 00000000000 00011234567889999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=334.08 Aligned_cols=200 Identities=24% Similarity=0.333 Sum_probs=162.2
Q ss_pred HhcCCcccceeecCCceEEEEEEeCCCCe-EEEE------------------EEcccCCCChhhhHHHHHHHHhcCCCCe
Q 043702 378 ATKCFNANRIIGHGAFGTVYKGILPQNGD-IIAV------------------KRCSHNSQGKDEFLSELSIIGTLRHRNL 438 (711)
Q Consensus 378 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~-~vav------------------K~~~~~~~~~~~~~~Ei~~l~~l~H~ni 438 (711)
..++|...+.||+|+||+||++..+.... ..++ |++.........+.+|+++|++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 34689999999999999999987643221 1111 1222222234568899999999999999
Q ss_pred eeeeeeeeecCeEEEEEEcCCCCCHHHHHhhCC----CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEc
Q 043702 439 VRLQGWCHEKGEILLVYDLMPNGSLDKALFEAR----SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLD 514 (711)
Q Consensus 439 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld 514 (711)
+++++++...+..++|+|++. ++|.+++.... ......+..+|+.||+.||+|||+. +|+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 999999999999999999984 57877775432 2234566788999999999999997 999999999999999
Q ss_pred CCCcEEEeecCCceecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCC
Q 043702 515 EGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPI 581 (711)
Q Consensus 515 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~ 581 (711)
.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|..++
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 9999999999999887654433344467999999999999999999999999999999999987643
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=314.23 Aligned_cols=250 Identities=24% Similarity=0.389 Sum_probs=202.0
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEccc---CCCChhhhHHHHHHHHhcC-CCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSH---NSQGKDEFLSELSIIGTLR-HRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 455 (711)
..|++.++||+||.++||++... +...+|+|++.. +.+..+-|.+|+.+|.+|+ |.+|++|++|-..++.+||||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 45888899999999999999874 456778887654 3445678999999999998 999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
||- ..+|..+|.+....++...++.+..|++.|+.++|++ +|||.||||.|+|+-. |++||+|||+|..+..+..
T Consensus 440 E~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred ecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCcccc
Confidence 986 5699999988776666448889999999999999998 9999999999999965 5899999999998866543
Q ss_pred C-CcccccCCCcccChhhhccC-----------CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHH
Q 043702 536 P-DATVAAGTMGYLAPEYLLTG-----------RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWS 603 (711)
Q Consensus 536 ~-~~~~~~gt~~y~APE~~~~~-----------~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~ 603 (711)
. .....+||+.||+||.+... +.+.++||||+||+||+|+.|+.||..... .|
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n------------~~--- 579 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN------------QI--- 579 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH------------HH---
Confidence 2 23346899999999998543 256789999999999999999999965321 11
Q ss_pred hhhcCchhHhhhhhccCCCcH-HHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 604 LHREGRLLTAADARLEGQFDE-AEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 604 ~~~~~~~~~~~d~~l~~~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.++..+.||...-+|+. ....++++++..||..||.+||+..++++.
T Consensus 580 ----aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 580 ----AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ----HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 13455566654333332 112238899999999999999999999984
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=304.07 Aligned_cols=266 Identities=22% Similarity=0.279 Sum_probs=196.0
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC---CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
++|+..+.||+|++|.||+|....+++.||+|++.... ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888999999999999999998889999999886532 234578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcC-CCcEEEeecCCceecCCCC
Q 043702 457 LMPNGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDE-GFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 457 y~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~-~~~vkL~DFGla~~~~~~~ 534 (711)
|++ ++|.+++.... ..+++.....++.||+.||+|||+. +++||||+|+||+++. +..+||+|||+++......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 996 58888775433 2367888889999999999999987 9999999999999985 5679999999998654322
Q ss_pred CCCcccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHH----hhhc-C
Q 043702 535 SPDATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWS----LHRE-G 608 (711)
Q Consensus 535 ~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~----~~~~-~ 608 (711)
. ......+++.|+|||++.+. .++.++|||||||++|||++|+.||...... +.......+... .+.. .
T Consensus 158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 232 (294)
T PLN00009 158 R-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI----DELFKIFRILGTPNEETWPGVT 232 (294)
T ss_pred c-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHhCCCChhhccccc
Confidence 1 12234578899999998764 5789999999999999999999999653210 000000000000 0000 0
Q ss_pred chhHhh--hhhccCC----CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 609 RLLTAA--DARLEGQ----FDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 609 ~~~~~~--d~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.+.... .+..... ........+.+++.+|++.+|++||++.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 0000000 011123457789999999999999999999973
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=298.20 Aligned_cols=249 Identities=22% Similarity=0.365 Sum_probs=198.4
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC------CCChhhhHHHHHHHHhcCCCCeeeeeeeeeec--CeE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN------SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEK--GEI 451 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 451 (711)
.+|...+.||+|++|.||+|.+..++..||+|++... .+....+.+|++++++++|+||+++++++.+. +.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688899999999999999999888999999987532 12335788999999999999999999998764 468
Q ss_pred EEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecC
Q 043702 452 LLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVE 531 (711)
Q Consensus 452 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~ 531 (711)
++++||+++++|.+++... ..+++....+++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++...
T Consensus 82 ~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 9999999999999998653 4588999999999999999999987 99999999999999999999999999998654
Q ss_pred CCC--CCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCc
Q 043702 532 HDK--SPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGR 609 (711)
Q Consensus 532 ~~~--~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 609 (711)
... ........|+..|+|||.+.+..++.++|||||||+++||++|+.||..... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----------~~~---------- 217 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA----------MAA---------- 217 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH----------HHH----------
Confidence 321 1112234689999999999888899999999999999999999999864311 000
Q ss_pred hhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 610 LLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 610 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
+............+......+.+++.+||+ +|.+||+..+++.
T Consensus 218 ~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 218 IFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 001111111122233344567788899999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=301.57 Aligned_cols=243 Identities=26% Similarity=0.366 Sum_probs=193.6
Q ss_pred eecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCCCCCH
Q 043702 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSL 463 (711)
Q Consensus 388 LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 463 (711)
||+|+||+||++....+|+.+|+|.+... ......+.+|++++++++|||++++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999999888999999988642 22344667899999999999999999999999999999999999999
Q ss_pred HHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCccccc
Q 043702 464 DKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAA 542 (711)
Q Consensus 464 ~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~ 542 (711)
.+++.... ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||+++...... ......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccccc
Confidence 99997644 3689999999999999999999997 99999999999999999999999999998664322 222345
Q ss_pred CCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccCCC
Q 043702 543 GTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQF 622 (711)
Q Consensus 543 gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 622 (711)
++..|+|||.+.++.++.++|||||||+++||++|+.||...... .. .+........ .....
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~-~~~~~~~~~~----------~~~~~ 217 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK-------VE-KEELKRRTLE----------MAVEY 217 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc-------cc-HHHHHhcccc----------ccccC
Confidence 788999999998888999999999999999999999999653210 00 0000000000 00111
Q ss_pred cHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 043702 623 DEAEMRRVLLVGLACSHPDPLARP-----TMRGVVQ 653 (711)
Q Consensus 623 ~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVl~ 653 (711)
.......+.+++.+||+.+|.+|| ++.++++
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 218 PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 122245577889999999999999 5555654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=300.19 Aligned_cols=245 Identities=26% Similarity=0.370 Sum_probs=197.5
Q ss_pred eecCCceEEEEEEeCCCCeEEEEEEcccCC----CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCCCCCH
Q 043702 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNS----QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSL 463 (711)
Q Consensus 388 LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 463 (711)
||+|+||.||++++..+++.+++|++.... ...+.+.+|++++++++||||+++++.+..++..+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999998889999999986533 2356788999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC-------C
Q 043702 464 DKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS-------P 536 (711)
Q Consensus 464 ~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~-------~ 536 (711)
.+++.... .+++..+.+++.|+++||+|||+. +++||||+|+||++++++.+||+|||++........ .
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 99996544 789999999999999999999987 999999999999999999999999999876543321 1
Q ss_pred CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhh
Q 043702 537 DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADA 616 (711)
Q Consensus 537 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 616 (711)
......++..|+|||.+.....+.++||||||++++||++|+.||..... .+....... +...
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----------~~~~~~~~~-~~~~----- 219 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP-----------EEIFQNILN-GKIE----- 219 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-----------HHHHHHHhc-CCcC-----
Confidence 22334578899999999888899999999999999999999999965321 111111111 1110
Q ss_pred hccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 043702 617 RLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLV 656 (711)
Q Consensus 617 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 656 (711)
..........+.+++.+||+.+|.+||++.++.+.|+
T Consensus 220 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 220 ---WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred ---CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0000012456778999999999999999966666664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=310.56 Aligned_cols=267 Identities=26% Similarity=0.349 Sum_probs=198.9
Q ss_pred HhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC---CCChhhhHHHHHHHHhc-CCCCeeeeeeeeeec--CeE
Q 043702 378 ATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN---SQGKDEFLSELSIIGTL-RHRNLVRLQGWCHEK--GEI 451 (711)
Q Consensus 378 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~--~~~ 451 (711)
..++|+..+.||+|+||.||+|.+..+++.+|+|++... ......+.+|+.+++++ +||||++++++|... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 456788899999999999999999888999999987542 23345677899999999 999999999998653 468
Q ss_pred EEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecC
Q 043702 452 LLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVE 531 (711)
Q Consensus 452 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~ 531 (711)
++||||++ ++|..++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 85 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred EEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 99999997 5999988653 789999999999999999999997 99999999999999999999999999998764
Q ss_pred CCCC----CCcccccCCCcccChhhhcc-CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHH-----
Q 043702 532 HDKS----PDATVAAGTMGYLAPEYLLT-GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWV----- 601 (711)
Q Consensus 532 ~~~~----~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~----- 601 (711)
.... .......|+..|+|||.+.. ..++.++|||||||++|||++|+.||........ ...+..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~----~~~~~~~~~~~~~ 234 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ----LEKIIEVIGPPSA 234 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHHHhCCCCH
Confidence 4332 12233568999999998765 4578899999999999999999999964322100 00000000
Q ss_pred --HHhhhcCchhHhhhh---hcc---CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 602 --WSLHREGRLLTAADA---RLE---GQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 602 --~~~~~~~~~~~~~d~---~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
+............+. .-. ..........+.+++.+||+.+|.+||++.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000000000000 000 00001124567889999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=305.72 Aligned_cols=262 Identities=25% Similarity=0.342 Sum_probs=197.0
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC---CChhhhHHHHHHHHhcCCCCeeeeeeeeeec-------
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---QGKDEFLSELSIIGTLRHRNLVRLQGWCHEK------- 448 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------- 448 (711)
.++|+..++||+|++|.||+|....+++.+|+|++.... .....+.+|++++++++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999998889999999886522 2234678999999999999999999987543
Q ss_pred -CeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCc
Q 043702 449 -GEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLA 527 (711)
Q Consensus 449 -~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla 527 (711)
..+++|+||+.+ +|...+......+++.++..++.|+++||.|||+. +|+||||||+||++++++.+||+|||++
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccc
Confidence 346999999965 78887766666799999999999999999999998 9999999999999999999999999999
Q ss_pred eecCCCCCC----------CcccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccccccccccccccc
Q 043702 528 RQVEHDKSP----------DATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASN 596 (711)
Q Consensus 528 ~~~~~~~~~----------~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~ 596 (711)
+........ ..+...|++.|+|||.+.+. .++.++|||||||++|||++|++||...... .
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~--------~ 234 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI--------D 234 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH--------H
Confidence 865432211 11234578899999988654 5789999999999999999999999653221 0
Q ss_pred hHHHHHHhhhc---------CchhHh--------hhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 597 LVEWVWSLHRE---------GRLLTA--------ADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 597 l~~~~~~~~~~---------~~~~~~--------~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
..+-.+..... ..+... ..+.+...+ ......+.+++.+|++.||.+|||+.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 235 QLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHc-ccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 00000000000 000000 000000000 111256788999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=308.39 Aligned_cols=272 Identities=25% Similarity=0.325 Sum_probs=200.8
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC---CChhhhHHHHHHHHhcCCCCeeeeeeeeee----cCeE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---QGKDEFLSELSIIGTLRHRNLVRLQGWCHE----KGEI 451 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~ 451 (711)
..+|+..+.||+|++|.||+|....+++.||+|++.... ...+.+.+|+.++++++||||+++++++.. ...+
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 367888999999999999999998889999999987532 334567889999999999999999998753 3568
Q ss_pred EEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecC
Q 043702 452 LLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVE 531 (711)
Q Consensus 452 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~ 531 (711)
++||||+. ++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 84 ~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEEEehhh-hhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 99999995 689888854 34599999999999999999999987 99999999999999999999999999998764
Q ss_pred CCCCC---CcccccCCCcccChhhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccccccccc---ccccchHHHHHHh
Q 043702 532 HDKSP---DATVAAGTMGYLAPEYLLT-GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKV---GVASNLVEWVWSL 604 (711)
Q Consensus 532 ~~~~~---~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~---~~~~~l~~~~~~~ 604 (711)
..... ......|+..|+|||.+.. ..++.++|||||||++|||++|+.||.......... ..........+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~ 238 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence 33221 1223468999999999866 458899999999999999999999996532100000 0000000000000
Q ss_pred hhcCchhHhhhhh-ccCCC-----cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 043702 605 HREGRLLTAADAR-LEGQF-----DEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655 (711)
Q Consensus 605 ~~~~~~~~~~d~~-l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L 655 (711)
...+.+....+.. ..... .......+.+++.+||+.+|++||++.++++.-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 0011111111100 00000 112346788999999999999999999999743
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=305.50 Aligned_cols=253 Identities=28% Similarity=0.423 Sum_probs=197.5
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC--CChhhhHHHHHHHHhcC-CCCeeeeeeeeeecCeEEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS--QGKDEFLSELSIIGTLR-HRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 456 (711)
++|+..+.||+|++|.||+|.+..+++.||||++.... ....++..|+.++.++. |+||++++++|..+...+++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 46788899999999999999998889999999987532 23456677888777776 9999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCC
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP 536 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~ 536 (711)
|++ ++|..++......+++..+.+++.|++.||+|||+. ++|+||||+|+||++++++.+||+|||++..+......
T Consensus 95 ~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~ 171 (296)
T cd06618 95 LMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK 171 (296)
T ss_pred ccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcc
Confidence 985 478887766566899999999999999999999973 38999999999999999999999999999766433221
Q ss_pred CcccccCCCcccChhhhccCC----CCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhH
Q 043702 537 DATVAAGTMGYLAPEYLLTGR----ATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLT 612 (711)
Q Consensus 537 ~~~~~~gt~~y~APE~~~~~~----~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 612 (711)
....++..|+|||.+.+.. ++.++||||||+++|||++|+.||...... .+......... .
T Consensus 172 --~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----------~~~~~~~~~~~-~-- 236 (296)
T cd06618 172 --TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE----------FEVLTKILQEE-P-- 236 (296)
T ss_pred --cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH----------HHHHHHHhcCC-C--
Confidence 2235788999999987554 788999999999999999999998642110 11111111110 0
Q ss_pred hhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 043702 613 AADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655 (711)
Q Consensus 613 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L 655 (711)
+... ........+.+++.+||+.||.+||++.++++..
T Consensus 237 ---~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 237 ---PSLP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred ---CCCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 0000 0011235678899999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=309.73 Aligned_cols=266 Identities=22% Similarity=0.291 Sum_probs=199.9
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC---CCChhhhHHHHHHHHhcCCCCeeeeeeeeeec-----Ce
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN---SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEK-----GE 450 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~ 450 (711)
.++|...+.||+|+||+||+|+...+++.||||++... ......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 35688899999999999999999888999999988652 23345678899999999999999999988644 35
Q ss_pred EEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceec
Q 043702 451 ILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV 530 (711)
Q Consensus 451 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~ 530 (711)
.++||||+. ++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 84 ~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 899999996 689888854 45699999999999999999999997 9999999999999999999999999999876
Q ss_pred CCCCCCCcccccCCCcccChhhhcc-CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHH-------HH
Q 043702 531 EHDKSPDATVAAGTMGYLAPEYLLT-GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEW-------VW 602 (711)
Q Consensus 531 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~-------~~ 602 (711)
.... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||...... .....+.+. .+
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07858 159 SEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV----HQLKLITELLGSPSEEDL 233 (337)
T ss_pred CCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH----HHHHHHHHHhCCCChHHh
Confidence 4432 12233457889999998865 46889999999999999999999999653210 000000000 00
Q ss_pred HhhhcCchhHhhhhhc---c---CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 603 SLHREGRLLTAADARL---E---GQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 603 ~~~~~~~~~~~~d~~l---~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
...........+.... . ..........+.+++.+||+.+|++||+++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 234 GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0001111111110000 0 00011234567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=301.77 Aligned_cols=267 Identities=22% Similarity=0.324 Sum_probs=198.7
Q ss_pred CcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC--ChhhhHHHHHHHHhcC-CCCeeeeeeeeeecCeEEEEEEcC
Q 043702 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ--GKDEFLSELSIIGTLR-HRNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 382 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
|...+.||+|++|+||+|+...+++.|+||++..... +.....+|+..+++++ |+|++++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 5677899999999999999988899999999876433 2334567999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC
Q 043702 459 PNGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD 537 (711)
Q Consensus 459 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 537 (711)
+|+|.+++.... ..+++.++..++.|++.+|.|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-- 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence 889999887654 5789999999999999999999987 999999999999999999999999999987644322
Q ss_pred cccccCCCcccChhhhcc-CCCCccccchhHHHHHHHHHhCCCCCccccccccccc---ccc--chHHHHHHhhhcCchh
Q 043702 538 ATVAAGTMGYLAPEYLLT-GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVG---VAS--NLVEWVWSLHREGRLL 611 (711)
Q Consensus 538 ~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~---~~~--~l~~~~~~~~~~~~~~ 611 (711)
.....++..|+|||.+.. ..++.++||||||++++||++|+.||........... ... .-..|...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 223458889999998754 4578999999999999999999999864321000000 000 0000110000000000
Q ss_pred Hhhhhhcc---CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 612 TAADARLE---GQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 612 ~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
........ ..........+.+++.+||+.+|++||+++|++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00000000 00001113568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=317.63 Aligned_cols=248 Identities=22% Similarity=0.373 Sum_probs=197.1
Q ss_pred ccceeecCCceEEEEEEeCCCCeEEEEEEc-----ccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecC--eEEEEEE
Q 043702 384 ANRIIGHGAFGTVYKGILPQNGDIIAVKRC-----SHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKG--EILLVYD 456 (711)
Q Consensus 384 ~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~-----~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV~E 456 (711)
...+||+|.|-+||||.+..+|..||--.+ .......+.|..|+.+|+.|+||||++++.+..+.. ...+|.|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 345799999999999999888988874322 223344578999999999999999999999887654 4889999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcC-CCcEEEeecCCceecCCCCC
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDE-GFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~-~~~vkL~DFGla~~~~~~~~ 535 (711)
.|..|+|..|+.+ .+.++.+....|++||++||.|||++ +++|||||||.+||+|+. -|.|||+|+|||.......
T Consensus 124 L~TSGtLr~Y~kk-~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~- 200 (632)
T KOG0584|consen 124 LFTSGTLREYRKK-HRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH- 200 (632)
T ss_pred cccCCcHHHHHHH-hccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc-
Confidence 9999999999965 45688899999999999999999997 889999999999999975 5789999999998775433
Q ss_pred CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhh
Q 043702 536 PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 615 (711)
...+.|||.|||||.+. ..|.+..||||||++++||+|+..||..- .+-.+ +++....|.....+.
T Consensus 201 --aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC----------~n~AQ-IYKKV~SGiKP~sl~ 266 (632)
T KOG0584|consen 201 --AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC----------TNPAQ-IYKKVTSGIKPAALS 266 (632)
T ss_pred --cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh----------CCHHH-HHHHHHcCCCHHHhh
Confidence 23368999999999876 78999999999999999999999998643 22222 233333333332222
Q ss_pred hhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--HHhC
Q 043702 616 ARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ--MLVG 657 (711)
Q Consensus 616 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~--~L~~ 657 (711)
. .. ..++.+++..|+.. ..+|||+.|+|+ +|..
T Consensus 267 k-----V~---dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 267 K-----VK---DPEVREFIEKCLAT-KSERLSAKELLKDPFFDE 301 (632)
T ss_pred c-----cC---CHHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence 1 11 12455778899999 999999999997 4443
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=314.70 Aligned_cols=249 Identities=21% Similarity=0.301 Sum_probs=207.9
Q ss_pred HhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCC---hhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEE
Q 043702 378 ATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQG---KDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLV 454 (711)
Q Consensus 378 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 454 (711)
-...|.+...||+|.|++|.+|++..++..||||.+.+..-+ .+.+.+|+++|..|+|||||+++.+......+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 345788999999999999999999999999999998874432 34588999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCC
Q 043702 455 YDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~ 534 (711)
|||+.+|.++++|.+.. .+.......++.|+..|++|||++ .|+|||||++||||+.+.++||+|||++..+...
T Consensus 134 ~eya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~- 208 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYG- 208 (596)
T ss_pred EEeccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeeccc-
Confidence 99999999999997654 455588899999999999999998 9999999999999999999999999999988643
Q ss_pred CCCcccccCCCcccChhhhccCCC-CccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHh
Q 043702 535 SPDATVAAGTMGYLAPEYLLTGRA-TEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTA 613 (711)
Q Consensus 535 ~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 613 (711)
......+|++.|.|||++.+..| .+++|+||+|++||-|++|..||+...- .+.
T Consensus 209 -~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l------------------------k~L 263 (596)
T KOG0586|consen 209 -LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL------------------------KEL 263 (596)
T ss_pred -ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc------------------------ccc
Confidence 34556789999999999998776 7899999999999999999999975321 111
Q ss_pred hhhhccCCCcH--HHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 043702 614 ADARLEGQFDE--AEMRRVLLVGLACSHPDPLARPTMRGVVQMLV 656 (711)
Q Consensus 614 ~d~~l~~~~~~--~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 656 (711)
-++.+.+.+.. -...++.+++++++-.+|.+|++++++.+.-.
T Consensus 264 r~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W 308 (596)
T KOG0586|consen 264 RPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRW 308 (596)
T ss_pred cchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhcc
Confidence 11122222211 11235667888899999999999999987543
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=297.14 Aligned_cols=259 Identities=24% Similarity=0.313 Sum_probs=196.4
Q ss_pred CcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC---ChhhhHHHHHHHHhc---CCCCeeeeeeeeeecCe-----
Q 043702 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ---GKDEFLSELSIIGTL---RHRNLVRLQGWCHEKGE----- 450 (711)
Q Consensus 382 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~~~----- 450 (711)
|+..+.||+|+||.||+|+...+++.+|+|++..... ....+.+|+.+++++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5677899999999999999988899999999875322 234566788877766 59999999999988776
Q ss_pred EEEEEEcCCCCCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCcee
Q 043702 451 ILLVYDLMPNGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQ 529 (711)
Q Consensus 451 ~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~ 529 (711)
.+++|||+++ +|.+++.... ..+++..+..++.|+++||.|||+. +++|+||+|+||++++++.+||+|||++..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCccee
Confidence 9999999974 8998886543 3699999999999999999999997 999999999999999999999999999987
Q ss_pred cCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCc
Q 043702 530 VEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGR 609 (711)
Q Consensus 530 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 609 (711)
....... ....++..|+|||.+.+..++.++|||||||++|||++|++||...... ..+..+.......+.
T Consensus 157 ~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~ 227 (287)
T cd07838 157 YSFEMAL--TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-------DQLDKIFDVIGLPSE 227 (287)
T ss_pred ccCCccc--ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH-------HHHHHHHHHcCCCCh
Confidence 6543221 2234788999999999999999999999999999999999998653221 011111100000000
Q ss_pred h---------hHhhhhhcc---CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 610 L---------LTAADARLE---GQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 610 ~---------~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
. ......... .....+....+.+++.+||+.||.+||+++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 228 EEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred HhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0 000000000 0111123456778999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=300.77 Aligned_cols=248 Identities=23% Similarity=0.328 Sum_probs=203.1
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhcC-CCCeeeeeeeeeecCeEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTLR-HRNLVRLQGWCHEKGEILLV 454 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV 454 (711)
++|...+.||+|++|.||+|+...+++.||+|++... ....+.+.+|++++++++ |+||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 3688889999999999999999888999999998652 233467889999999999 99999999999999999999
Q ss_pred EEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCC
Q 043702 455 YDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~ 534 (711)
|||+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.+++++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 81 LEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 9999999999999654 4799999999999999999999987 99999999999999999999999999998764433
Q ss_pred C-------------------CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCcccccccccccccc
Q 043702 535 S-------------------PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVAS 595 (711)
Q Consensus 535 ~-------------------~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~ 595 (711)
. .......|+..|+|||.+....++.++||||||++++|+++|+.||..... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~ 228 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE--------Y 228 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH--------H
Confidence 2 122234578999999999988899999999999999999999999875321 0
Q ss_pred chHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCH----HHHHH
Q 043702 596 NLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTM----RGVVQ 653 (711)
Q Consensus 596 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~----~eVl~ 653 (711)
.... .. . .....+.......+.+++.+||+.+|.+||++ +++++
T Consensus 229 ~~~~---~~---------~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 229 LTFQ---KI---------L--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHH---HH---------H--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0000 00 0 01111222234567889999999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=304.20 Aligned_cols=247 Identities=28% Similarity=0.415 Sum_probs=198.4
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC----CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS----QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
.|...+.||+|++|.||+|+...+++.+|+|.+.... ...+++.+|+++++.++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3666788999999999999998889999999886421 223567899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCC
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP 536 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~ 536 (711)
|+. |+|.+++......+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 96 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 96 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred ccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 996 688888766666789999999999999999999987 9999999999999999999999999999865432
Q ss_pred CcccccCCCcccChhhhc---cCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHh
Q 043702 537 DATVAAGTMGYLAPEYLL---TGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTA 613 (711)
Q Consensus 537 ~~~~~~gt~~y~APE~~~---~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 613 (711)
....|++.|+|||.+. ...++.++|||||||++|||++|+.||..... .+........ ..
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----------~~~~~~~~~~-~~--- 231 (308)
T cd06634 169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----------MSALYHIAQN-ES--- 231 (308)
T ss_pred --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH-----------HHHHHHHhhc-CC---
Confidence 2345889999999975 34678899999999999999999999854311 0111111110 00
Q ss_pred hhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 043702 614 ADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLV 656 (711)
Q Consensus 614 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 656 (711)
+.. ........+.+++.+||+.+|.+||++.++++...
T Consensus 232 --~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 232 --PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred --CCc---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 011 11123355778899999999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=302.55 Aligned_cols=244 Identities=23% Similarity=0.348 Sum_probs=197.0
Q ss_pred cceeecCCceEEEEEEeCCCCeEEEEEEcccCC-CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCCCCCH
Q 043702 385 NRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSL 463 (711)
Q Consensus 385 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 463 (711)
..+||+|+||.||++....+++.||+|++.... ...+.+.+|+.+++.++|+|++++++++...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 356999999999999998889999999886533 3345688999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCcccccC
Q 043702 464 DKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAG 543 (711)
Q Consensus 464 ~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~g 543 (711)
.+++.. ..+++.....++.|++.||+|||+. +++||||+|+||++++++.++|+|||++........ ......|
T Consensus 105 ~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~ 178 (292)
T cd06657 105 TDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVG 178 (292)
T ss_pred HHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-ccccccc
Confidence 998743 4589999999999999999999997 999999999999999999999999999876643321 2233568
Q ss_pred CCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccCCCc
Q 043702 544 TMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFD 623 (711)
Q Consensus 544 t~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 623 (711)
++.|+|||.+....++.++|||||||++|||++|..||..... ......... ...+.+.. .
T Consensus 179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--------~~~~~~~~~---------~~~~~~~~--~ 239 (292)
T cd06657 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--------LKAMKMIRD---------NLPPKLKN--L 239 (292)
T ss_pred CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHh---------hCCcccCC--c
Confidence 9999999999888899999999999999999999999864321 001110000 00011100 0
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 624 EAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
......+.+++.+||+.+|.+||++.++++
T Consensus 240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 240 HKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred ccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 112345667889999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=305.94 Aligned_cols=264 Identities=21% Similarity=0.309 Sum_probs=197.1
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC---CCChhhhHHHHHHHHhcCCCCeeeeeeeeeec------C
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN---SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEK------G 449 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~ 449 (711)
.++|...+.||+|+||.||+|+...+++.||+|++... ......+.+|+.+++.++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 37899999999999999999999888999999988652 22235688999999999999999999998654 3
Q ss_pred eEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCcee
Q 043702 450 EILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQ 529 (711)
Q Consensus 450 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~ 529 (711)
..++|+||+.. +|..++ ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 94 ~~~lv~e~~~~-~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred eEEEEeccccc-CHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 56999999964 777665 34689999999999999999999997 999999999999999999999999999976
Q ss_pred cCCCCCCCcccccCCCcccChhhhcc-CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHH-------
Q 043702 530 VEHDKSPDATVAAGTMGYLAPEYLLT-GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWV------- 601 (711)
Q Consensus 530 ~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~------- 601 (711)
.... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ..+....
T Consensus 167 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~-------~~~~~~~~~~~~~~ 235 (342)
T cd07879 167 ADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-------DQLTQILKVTGVPG 235 (342)
T ss_pred CCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHHhcCCCC
Confidence 5322 223457889999999876 45889999999999999999999999653210 0000000
Q ss_pred ---HHhhhcCchhHhhh--hhc-cCCC---cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--HHhCCCC
Q 043702 602 ---WSLHREGRLLTAAD--ARL-EGQF---DEAEMRRVLLVGLACSHPDPLARPTMRGVVQ--MLVGEAE 660 (711)
Q Consensus 602 ---~~~~~~~~~~~~~d--~~l-~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~--~L~~~~~ 660 (711)
.............. +.. .... .......+.+++.+||+.||.+||++.++++ .+++..+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 236 PEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 00000000000000 000 0000 0012345778999999999999999999995 4665544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=294.57 Aligned_cols=250 Identities=19% Similarity=0.239 Sum_probs=194.9
Q ss_pred HHHHHHhcCCccccee--ecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhc-CCCCeeeeeeeeeecC
Q 043702 373 RELRSATKCFNANRII--GHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTL-RHRNLVRLQGWCHEKG 449 (711)
Q Consensus 373 ~el~~at~~f~~~~~L--G~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 449 (711)
.+.....++|++.+.+ |+|+||.||+++.+.++..+|+|.+....... .|+.....+ +|||++++++++...+
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----IEPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence 3444555677777776 99999999999998899999999986532211 123333323 6999999999999999
Q ss_pred eEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCC-cEEEeecCCce
Q 043702 450 EILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGF-NARLGDFGLAR 528 (711)
Q Consensus 450 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~-~vkL~DFGla~ 528 (711)
..++||||+++++|.+++.... .+++.++..++.|+++||.|||+. +++||||||+||+++.++ .++|+|||+++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~ 158 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCK 158 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence 9999999999999999996543 899999999999999999999997 999999999999999988 99999999998
Q ss_pred ecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcC
Q 043702 529 QVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREG 608 (711)
Q Consensus 529 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 608 (711)
...... ...|+..|+|||++.+..++.++|||||||++|||++|+.||...... ......+.... .
T Consensus 159 ~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~--~- 224 (267)
T PHA03390 159 IIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE------ELDLESLLKRQ--Q- 224 (267)
T ss_pred ecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc------hhhHHHHHHhh--c-
Confidence 664322 235889999999999989999999999999999999999999743221 11122222111 0
Q ss_pred chhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCC-HHHHHH
Q 043702 609 RLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPT-MRGVVQ 653 (711)
Q Consensus 609 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~eVl~ 653 (711)
... .........+.+++.+||+.+|.+||+ ++|+++
T Consensus 225 -------~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 225 -------KKL--PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred -------ccC--CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 000 111123456778889999999999996 688875
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=300.09 Aligned_cols=257 Identities=16% Similarity=0.216 Sum_probs=185.2
Q ss_pred cCCcccceeecCCceEEEEEEeCCC---CeEEEEEEcccCCCCh------------hhhHHHHHHHHhcCCCCeeeeeee
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQN---GDIIAVKRCSHNSQGK------------DEFLSELSIIGTLRHRNLVRLQGW 444 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~---~~~vavK~~~~~~~~~------------~~~~~Ei~~l~~l~H~niv~l~g~ 444 (711)
+.|.+.++||+|+||.||+|....+ +..+|+|+........ .....+...+..++|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 5788999999999999999998766 5667777643322111 112233345566789999999997
Q ss_pred eeecC----eEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEE
Q 043702 445 CHEKG----EILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNAR 520 (711)
Q Consensus 445 ~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vk 520 (711)
+.... ..++++|++.. ++.+.+.. ....++..+..|+.|+++||+|||+. +|+||||||+|||++.++.+|
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~~ 166 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGY 166 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcEE
Confidence 76543 34778887743 66666543 33467888999999999999999997 999999999999999999999
Q ss_pred EeecCCceecCCCCC------CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccc
Q 043702 521 LGDFGLARQVEHDKS------PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVA 594 (711)
Q Consensus 521 L~DFGla~~~~~~~~------~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~ 594 (711)
|+|||+++.+..... .......||+.|+|||++.+..++.++|||||||+++||++|+.||......... ..
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~--~~ 244 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL--IH 244 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH--HH
Confidence 999999987643221 1122346999999999999999999999999999999999999999754211000 00
Q ss_pred cchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 043702 595 SNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655 (711)
Q Consensus 595 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L 655 (711)
....++.... ..++ +. .......+.+++..|++.+|++||++.++++.|
T Consensus 245 ~~~~~~~~~~-~~~~--------~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 245 AAKCDFIKRL-HEGK--------IK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HhHHHHHHHh-hhhh--------hc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 0001111111 1111 10 011235677888999999999999999999876
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=317.52 Aligned_cols=251 Identities=23% Similarity=0.343 Sum_probs=204.5
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEccc-CCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCC
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSH-NSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMP 459 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 459 (711)
.+++...||.|+||+||++..+.++...|.|.+.. ...+.++++-||+||....||+||+|++.|..++.++++.|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 45667789999999999999988777788888876 44567899999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCcc
Q 043702 460 NGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDAT 539 (711)
Q Consensus 460 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 539 (711)
||-.+.++.+-...|+..++..+++|++.||.|||+. .|||||||+.|||++-+|.++|+|||.+...... .....
T Consensus 113 GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~qkRD 188 (1187)
T KOG0579|consen 113 GGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-RQKRD 188 (1187)
T ss_pred CchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhH-Hhhhc
Confidence 9999999988888999999999999999999999998 9999999999999999999999999998543211 11233
Q ss_pred cccCCCcccChhhhc-----cCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhh
Q 043702 540 VAAGTMGYLAPEYLL-----TGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614 (711)
Q Consensus 540 ~~~gt~~y~APE~~~-----~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 614 (711)
.+.|||+|||||++. ..+|..++||||||++|.||..+.+|-....+ ...++. .. ..-
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp-------MRVllK----ia------KSe 251 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP-------MRVLLK----IA------KSE 251 (1187)
T ss_pred cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch-------HHHHHH----Hh------hcC
Confidence 467999999999874 45789999999999999999999999653211 011111 00 000
Q ss_pred hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 615 DARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 615 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.|.+. .+......+.++..+||..||..||++.++++.
T Consensus 252 PPTLl--qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 252 PPTLL--QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred CCccc--CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 11111 133455677888899999999999999998863
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=331.15 Aligned_cols=255 Identities=27% Similarity=0.446 Sum_probs=208.2
Q ss_pred cCCcccceeecCCceEEEEEEeCC-------CCeEEEEEEcccC--CCChhhhHHHHHHHHhcC-CCCeeeeeeeeeecC
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQ-------NGDIIAVKRCSHN--SQGKDEFLSELSIIGTLR-HRNLVRLQGWCHEKG 449 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~-------~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~ 449 (711)
++..+.+.||+|.||.|++|.... ....||||.+... ..+.+.+..|+++|+.+. |+|++.++|+|..++
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 344556689999999999998631 1457999998863 345778999999999986 999999999999999
Q ss_pred eEEEEEEcCCCCCHHHHHhhCC---------------CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEc
Q 043702 450 EILLVYDLMPNGSLDKALFEAR---------------SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLD 514 (711)
Q Consensus 450 ~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld 514 (711)
.+++|.||+..|+|.++|+..+ ..|+..+.+.++.|||.|++||++. +++||||.++|||+.
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLIT 452 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEec
Confidence 9999999999999999998777 3489999999999999999999998 999999999999999
Q ss_pred CCCcEEEeecCCceecCCCCCCCcccccC--CCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCcccccccccc
Q 043702 515 EGFNARLGDFGLARQVEHDKSPDATVAAG--TMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKV 591 (711)
Q Consensus 515 ~~~~vkL~DFGla~~~~~~~~~~~~~~~g--t~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~ 591 (711)
++..+||+|||+||...+...+....-.| ...|||||.+....|+.|+|||||||+||||++ |..||.....
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~----- 527 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP----- 527 (609)
T ss_pred CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc-----
Confidence 99999999999999766555443332223 446999999999999999999999999999999 8888854210
Q ss_pred ccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 592 GVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 592 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
...+ ++..++|..++. +..+..++.++++.||+.+|++||++.++++.+..
T Consensus 528 --~~~l----~~~l~~G~r~~~---------P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 528 --TEEL----LEFLKEGNRMEQ---------PEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred --HHHH----HHHHhcCCCCCC---------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 1122 233444433222 22335667789999999999999999999999976
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=302.54 Aligned_cols=244 Identities=27% Similarity=0.416 Sum_probs=196.0
Q ss_pred CcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC----CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEc
Q 043702 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS----QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 382 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
|...+.||+|+||+||+|+...+++.|++|++.... ...+.+.+|+++++.++|||++++++++.++...++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 556678999999999999998889999999986522 2234678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC
Q 043702 458 MPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD 537 (711)
Q Consensus 458 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 537 (711)
+. |+|.+++......+++.++..++.|++.||.|||+. +++||||+|+||++++++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----- 173 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----- 173 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence 95 588888876667799999999999999999999987 999999999999999999999999999864322
Q ss_pred cccccCCCcccChhhhc---cCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhh
Q 043702 538 ATVAAGTMGYLAPEYLL---TGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614 (711)
Q Consensus 538 ~~~~~gt~~y~APE~~~---~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 614 (711)
.....|+..|+|||++. .+.++.++|||||||++|||++|+.||..... ........... .
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~-----------~~~~~~~~~~~-~---- 237 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----------MSALYHIAQND-S---- 237 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-----------HHHHHHHHhcC-C----
Confidence 22346889999999984 45688899999999999999999999865321 11111111110 0
Q ss_pred hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 615 DARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 615 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
+.. ........+.+++.+||+.+|.+||++.++++.
T Consensus 238 -~~~---~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 238 -PTL---QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -CCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 111122457788899999999999999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=304.25 Aligned_cols=258 Identities=21% Similarity=0.287 Sum_probs=193.1
Q ss_pred ceeecC--CceEEEEEEeCCCCeEEEEEEcccCCC---ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCCC
Q 043702 386 RIIGHG--AFGTVYKGILPQNGDIIAVKRCSHNSQ---GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPN 460 (711)
Q Consensus 386 ~~LG~G--~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 460 (711)
..||+| +||+||++++..+|+.||+|++..... ..+.+.+|+.+++.++||||++++++|..++..++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 457776 999999999988999999999875332 235688899999999999999999999999999999999999
Q ss_pred CCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC--
Q 043702 461 GSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD-- 537 (711)
Q Consensus 461 gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~-- 537 (711)
++|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+|||++.++.+|++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 99999987543 3589999999999999999999987 99999999999999999999999998654332211110
Q ss_pred ----cccccCCCcccChhhhccC--CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHH---------
Q 043702 538 ----ATVAAGTMGYLAPEYLLTG--RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVW--------- 602 (711)
Q Consensus 538 ----~~~~~gt~~y~APE~~~~~--~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~--------- 602 (711)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||....... .......
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~ 233 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ-------MLLQKLKGPPYSPLDI 233 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH-------HHHHHhcCCCCCCccc
Confidence 0112356679999999764 47899999999999999999999996542110 0000000
Q ss_pred -------Hhh----------------hcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 603 -------SLH----------------REGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 603 -------~~~----------------~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
... ..+......+..+...........+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 234 TTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred cccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 000 000000001111111122334567889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=297.26 Aligned_cols=242 Identities=24% Similarity=0.327 Sum_probs=188.5
Q ss_pred eeecCCceEEEEEEeCCCCeEEEEEEcccCCC----ChhhhHHHHH---HHHhcCCCCeeeeeeeeeecCeEEEEEEcCC
Q 043702 387 IIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ----GKDEFLSELS---IIGTLRHRNLVRLQGWCHEKGEILLVYDLMP 459 (711)
Q Consensus 387 ~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~Ei~---~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 459 (711)
.||+|+||.||++....+++.||+|.+..... ....+..|.. .++..+||||+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999999988899999998865321 1222444444 3444579999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCcc
Q 043702 460 NGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDAT 539 (711)
Q Consensus 460 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 539 (711)
+|+|..++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~~ 153 (278)
T cd05606 81 GGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PH 153 (278)
T ss_pred CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---Cc
Confidence 9999998854 45799999999999999999999997 99999999999999999999999999997654322 12
Q ss_pred cccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhc
Q 043702 540 VAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARL 618 (711)
Q Consensus 540 ~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 618 (711)
...|+..|+|||.+.++ .++.++||||+||++|||++|+.||...... .. ......... ...
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~--------~~-~~~~~~~~~------~~~-- 216 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--------DK-HEIDRMTLT------MAV-- 216 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCcc--------ch-HHHHHHhhc------cCC--
Confidence 34689999999999755 5889999999999999999999999754210 00 001111000 011
Q ss_pred cCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHH
Q 043702 619 EGQFDEAEMRRVLLVGLACSHPDPLARP-----TMRGVVQM 654 (711)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVl~~ 654 (711)
..+......+.+++.+|+..+|.+|| ++.++++.
T Consensus 217 --~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 217 --ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred --CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 11112235677888999999999999 99999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=303.64 Aligned_cols=250 Identities=26% Similarity=0.387 Sum_probs=205.7
Q ss_pred HHHHHh-cCCcccceeecCCceEEEEEEeCCCCeEEEEEEccc----CCCChhhhHHHHHHHHhcCCCCeeeeeeeeeec
Q 043702 374 ELRSAT-KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSH----NSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEK 448 (711)
Q Consensus 374 el~~at-~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 448 (711)
|....| +.|..-++||+||||.||-+.-+.+|+.+|+|++.+ .++.+...++|-.+|.+++.+.||.+--.++..
T Consensus 178 E~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTk 257 (591)
T KOG0986|consen 178 ELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETK 257 (591)
T ss_pred HhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCC
Confidence 344444 457888999999999999999999999999998765 334556788999999999999999999999999
Q ss_pred CeEEEEEEcCCCCCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCc
Q 043702 449 GEILLVYDLMPNGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLA 527 (711)
Q Consensus 449 ~~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla 527 (711)
+.+|||+..|.||+|.-+|.+.+ ..+++...+-++.+|+.||++||+. +||.|||||+|||||+.|.++|+|+|||
T Consensus 258 d~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLA 334 (591)
T KOG0986|consen 258 DALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLA 334 (591)
T ss_pred CceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceE
Confidence 99999999999999999997655 4599999999999999999999998 9999999999999999999999999999
Q ss_pred eecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhc
Q 043702 528 RQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHRE 607 (711)
Q Consensus 528 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~ 607 (711)
..+..+.. ....+||.+|||||++.++.|+...|-||+||+||||+.|+.||...... +.
T Consensus 335 vei~~g~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK----------vk-------- 394 (591)
T KOG0986|consen 335 VEIPEGKP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK----------VK-------- 394 (591)
T ss_pred EecCCCCc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh----------hh--------
Confidence 98876554 33347999999999999999999999999999999999999999754221 01
Q ss_pred CchhHhhhhhc---cCCCcHHHHHHHHHHHHhcCCCCCCCCCCHH
Q 043702 608 GRLLTAADARL---EGQFDEAEMRRVLLVGLACSHPDPLARPTMR 649 (711)
Q Consensus 608 ~~~~~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 649 (711)
.+-+|.+. ..++++...++...+....|+.||.+|.--+
T Consensus 395 ---~eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 395 ---REEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred ---HHHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 11122221 1234444455566666777889999996543
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=303.15 Aligned_cols=271 Identities=25% Similarity=0.328 Sum_probs=204.8
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC---CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecC-----eEE
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN---SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKG-----EIL 452 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~ 452 (711)
+|...+.||.|++|.||+|+...+++.+|+|++... ....+.+.+|+++++.++|+||+++++++...+ .++
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 477889999999999999999888999999988763 234567899999999999999999999998765 789
Q ss_pred EEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCC
Q 043702 453 LVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEH 532 (711)
Q Consensus 453 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~ 532 (711)
++|||++ ++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 lv~e~~~-~~l~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 81 IVTELME-TDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEecchh-hhHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 9999997 4898888543 4899999999999999999999997 999999999999999999999999999987654
Q ss_pred CCC--CCcccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHH-------H
Q 043702 533 DKS--PDATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWV-------W 602 (711)
Q Consensus 533 ~~~--~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~-------~ 602 (711)
... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||....... ....+.... +
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~ 231 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID----QLNLIVEVLGTPSEEDL 231 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH----HHHHHHHhcCCCChhHh
Confidence 431 122334578899999999887 78999999999999999999999996542100 000000000 0
Q ss_pred HhhhcCchhHhhhhh-ccC-----CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH--HhCCCC
Q 043702 603 SLHREGRLLTAADAR-LEG-----QFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM--LVGEAE 660 (711)
Q Consensus 603 ~~~~~~~~~~~~d~~-l~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~--L~~~~~ 660 (711)
...........+... ... .........+.+++.+||+.+|.+||+++++++. +++...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 000000011111100 000 0011124567889999999999999999999984 554433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=295.00 Aligned_cols=244 Identities=25% Similarity=0.304 Sum_probs=190.8
Q ss_pred ceeecCCceEEEEEEeCCCCeEEEEEEcccCC----CChhhhHHHHHHH-HhcCCCCeeeeeeeeeecCeEEEEEEcCCC
Q 043702 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS----QGKDEFLSELSII-GTLRHRNLVRLQGWCHEKGEILLVYDLMPN 460 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l-~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 460 (711)
+.||+|++|.||+|....+++.||+|++.... .....+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46999999999999998889999999986532 1123345555544 445799999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCccc
Q 043702 461 GSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATV 540 (711)
Q Consensus 461 gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 540 (711)
++|.+++.. ...+++..+.+++.|++.||.|||+. +++||||+|+||++++++.+||+|||+++.... ...
T Consensus 82 ~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~ 152 (260)
T cd05611 82 GDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKK 152 (260)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----ccc
Confidence 999999864 34689999999999999999999997 999999999999999999999999999986433 223
Q ss_pred ccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccC
Q 043702 541 AAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEG 620 (711)
Q Consensus 541 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 620 (711)
..|+..|+|||.+.+..++.++||||||+++|||++|..||..... .+ .+.....+... ...
T Consensus 153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----------~~-~~~~~~~~~~~------~~~ 214 (260)
T cd05611 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP-----------DA-VFDNILSRRIN------WPE 214 (260)
T ss_pred CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH-----------HH-HHHHHHhcccC------CCC
Confidence 4588899999999888889999999999999999999999964321 01 11111111110 000
Q ss_pred CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 043702 621 QFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLV 656 (711)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 656 (711)
.........+.+++.+||+.+|++||++.++.+.|.
T Consensus 215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 111123456788999999999999998876666553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=294.06 Aligned_cols=248 Identities=23% Similarity=0.338 Sum_probs=196.4
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEccc------CCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEE
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSH------NSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLV 454 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~------~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 454 (711)
+|.+.++||+|+||.||+++....+..+++|.+.. ......++..|+.+++.++|||++++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47788999999999999999876666666665543 122334577899999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhh---CCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecC
Q 043702 455 YDLMPNGSLDKALFE---ARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVE 531 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~ 531 (711)
|||+++++|..++.. ....+++.+++.++.|+++||.|||+. +++|+||||+||++++ +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998864 345699999999999999999999997 9999999999999976 469999999998764
Q ss_pred CCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchh
Q 043702 532 HDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLL 611 (711)
Q Consensus 532 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 611 (711)
.... ......|++.|+|||.+....++.++|+||||+++|+|++|+.||.... ......... .+.
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-----------~~~~~~~~~-~~~-- 221 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-----------FLSVVLRIV-EGP-- 221 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----------HHHHHHHHH-cCC--
Confidence 3322 2223458889999999988888999999999999999999999985421 111111111 111
Q ss_pred HhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 612 TAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 612 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
....+......+.+++.+||+.+|++||++.++++.
T Consensus 222 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 222 -------TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred -------CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 111223344567889999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=296.79 Aligned_cols=264 Identities=23% Similarity=0.323 Sum_probs=201.1
Q ss_pred CcccceeecCCceEEEEEEeCCCCeEEEEEEcccC---CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcC
Q 043702 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN---SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 382 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
|+..+.||+|++|.||+|+...+++.+|+|++... ....+.+.+|++++++++|+|++++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 45677899999999999999888999999998764 233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCc
Q 043702 459 PNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDA 538 (711)
Q Consensus 459 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 538 (711)
+ ++|.+++......+++..+.+++.|++.||.|||+. +|+||||+|+||++++++.+||+|||+++....... ..
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~ 155 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TY 155 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-cc
Confidence 7 599999977656799999999999999999999997 999999999999999999999999999987654332 12
Q ss_pred ccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchH-------HHHHHhhhcCch
Q 043702 539 TVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLV-------EWVWSLHREGRL 610 (711)
Q Consensus 539 ~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~-------~~~~~~~~~~~~ 610 (711)
....++..|+|||.+... .++.++|||||||++|||++|+.||...... +....+. +..|.....-..
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI----DQLFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH----HHHHHHHHHhCCCcHHHHHhhccccc
Confidence 223467889999998776 7899999999999999999999999654210 0000000 001100000000
Q ss_pred hHhhhhhccC----CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 611 LTAADARLEG----QFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 611 ~~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
....-+.... .........+.+++.+||+.+|++||++.+++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0000000000 0000113568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=301.43 Aligned_cols=273 Identities=21% Similarity=0.270 Sum_probs=203.1
Q ss_pred CccCHHHHHHHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC---CChhhhHHHHHHHHhcCCCCeeeeeee
Q 043702 368 KEFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---QGKDEFLSELSIIGTLRHRNLVRLQGW 444 (711)
Q Consensus 368 ~~~~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~ 444 (711)
++....++..++++|...+.||+|+||.||+|....+++.||+|++.... ...+.+.+|++++++++||||++++++
T Consensus 5 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~ 84 (345)
T cd07877 5 RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84 (345)
T ss_pred hhhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeee
Confidence 34445677788899999999999999999999998889999999987532 224567889999999999999999998
Q ss_pred eeec------CeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCc
Q 043702 445 CHEK------GEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFN 518 (711)
Q Consensus 445 ~~~~------~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~ 518 (711)
+... ...++++|++ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.
T Consensus 85 ~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~ 158 (345)
T cd07877 85 FTPARSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCE 158 (345)
T ss_pred eeecccccccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCC
Confidence 8643 3468888887 7899888753 4589999999999999999999997 9999999999999999999
Q ss_pred EEEeecCCceecCCCCCCCcccccCCCcccChhhhcc-CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccch
Q 043702 519 ARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLT-GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNL 597 (711)
Q Consensus 519 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l 597 (711)
+||+|||+++..... .....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...... .....+
T Consensus 159 ~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~----~~~~~~ 230 (345)
T cd07877 159 LKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI----DQLKLI 230 (345)
T ss_pred EEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHH
Confidence 999999999865332 223467899999999876 46788999999999999999999999643210 000000
Q ss_pred HH-------HHHHhhhcCch---hHhhhhhccCCCc---HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 598 VE-------WVWSLHREGRL---LTAADARLEGQFD---EAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 598 ~~-------~~~~~~~~~~~---~~~~d~~l~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.. ........... ...........+. ......+.+++.+|++.||.+||++.++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 231 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00 00000000000 0000000000000 0113457789999999999999999999874
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=297.96 Aligned_cols=255 Identities=23% Similarity=0.324 Sum_probs=200.5
Q ss_pred CCcccceeecCCceEEEEEEeC---CCCeEEEEEEcccC-----CCChhhhHHHHHHHHhcC-CCCeeeeeeeeeecCeE
Q 043702 381 CFNANRIIGHGAFGTVYKGILP---QNGDIIAVKRCSHN-----SQGKDEFLSELSIIGTLR-HRNLVRLQGWCHEKGEI 451 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~---~~~~~vavK~~~~~-----~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~ 451 (711)
+|+..+.||+|++|.||+++.. .+++.||+|.+... ....+.+.+|++++.+++ ||||+++++.+..++..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 3677899999999999999863 35688999988642 223456889999999995 99999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecC
Q 043702 452 LLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVE 531 (711)
Q Consensus 452 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~ 531 (711)
++||||+++|+|.+++.. ...+++.....++.|++++|.|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 81 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 999999999999999864 34688999999999999999999987 99999999999999999999999999998765
Q ss_pred CCCCCCcccccCCCcccChhhhccCC--CCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCc
Q 043702 532 HDKSPDATVAAGTMGYLAPEYLLTGR--ATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGR 609 (711)
Q Consensus 532 ~~~~~~~~~~~gt~~y~APE~~~~~~--~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 609 (711)
...........|+..|+|||.+.+.. .+.++||||||+++|||++|..||...... ....+........
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-------~~~~~~~~~~~~~-- 227 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-------NSQSEISRRILKS-- 227 (288)
T ss_pred cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-------chHHHHHHHHHcc--
Confidence 44333333456899999999987665 788999999999999999999998542110 0111111111110
Q ss_pred hhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 610 LLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 610 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
.+ .........+.+++.+||+.+|++|||++++.+.|+.
T Consensus 228 -----~~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 -----KP----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred -----CC----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 01 1111223456788899999999999999988887753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=316.34 Aligned_cols=198 Identities=32% Similarity=0.487 Sum_probs=174.1
Q ss_pred CcccceeecCCceEEEEEEeCCCCeEEEEEEccc--CCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecC------eEEE
Q 043702 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSH--NSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKG------EILL 453 (711)
Q Consensus 382 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------~~~l 453 (711)
+...+.||+|+||.||+|+.+.+|+.||||.+.. .....+...+|+++|++|+|+|||++++.-.... ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 4556789999999999999999999999999887 3455677889999999999999999999765443 5689
Q ss_pred EEEcCCCCCHHHHHhhCC--CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEc--CCC--cEEEeecCCc
Q 043702 454 VYDLMPNGSLDKALFEAR--SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLD--EGF--NARLGDFGLA 527 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld--~~~--~vkL~DFGla 527 (711)
|||||.+|||+..|.+.. ..|++.+.+.++.+++.||.|||+. +|+||||||.||++- +++ .-||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 999999999999997543 4699999999999999999999986 999999999999983 333 3699999999
Q ss_pred eecCCCCCCCcccccCCCcccChhhhcc-CCCCccccchhHHHHHHHHHhCCCCCccc
Q 043702 528 RQVEHDKSPDATVAAGTMGYLAPEYLLT-GRATEKTDVFSYGAVVLEVASGRRPIEKE 584 (711)
Q Consensus 528 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~elltG~~P~~~~ 584 (711)
|.++++. ..+..+||..|++||.+.. +.|+...|.|||||++||++||..||...
T Consensus 172 rel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 172 RELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred ccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 9887655 5566789999999999984 88999999999999999999999999765
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=301.94 Aligned_cols=271 Identities=22% Similarity=0.273 Sum_probs=199.7
Q ss_pred HHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC---ChhhhHHHHHHHHhcCCCCeeeeeeeeeecC----
Q 043702 377 SATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ---GKDEFLSELSIIGTLRHRNLVRLQGWCHEKG---- 449 (711)
Q Consensus 377 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~---- 449 (711)
...++|...+.||+|+||.||++....++..||+|++..... ....+.+|++++++++||||+++++++..+.
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 356789999999999999999999988899999999864322 2356889999999999999999999987543
Q ss_pred --eEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCc
Q 043702 450 --EILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLA 527 (711)
Q Consensus 450 --~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla 527 (711)
..++||||+ +++|.+++.. ..+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 458999999 7799888753 5689999999999999999999997 9999999999999999999999999999
Q ss_pred eecCCCCCCCcccccCCCcccChhhhcc-CCCCccccchhHHHHHHHHHhCCCCCccccccccccc----cccchHHHHH
Q 043702 528 RQVEHDKSPDATVAAGTMGYLAPEYLLT-GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVG----VASNLVEWVW 602 (711)
Q Consensus 528 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~----~~~~l~~~~~ 602 (711)
+..... .....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||........... ......+|..
T Consensus 166 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07880 166 RQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ 241 (343)
T ss_pred cccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 865432 223457889999999876 4588999999999999999999999964321000000 0000001110
Q ss_pred HhhhcCchhHhhh--hhcc----CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--HHhCC
Q 043702 603 SLHREGRLLTAAD--ARLE----GQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ--MLVGE 658 (711)
Q Consensus 603 ~~~~~~~~~~~~d--~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~--~L~~~ 658 (711)
.+ .......... +... ..........+.+++.+|++.||.+||++.++++ .++..
T Consensus 242 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 242 KL-QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred hh-cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 00 0000000000 0000 0001112335778999999999999999999994 44443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=295.70 Aligned_cols=251 Identities=22% Similarity=0.306 Sum_probs=197.5
Q ss_pred CCcccceeecCCceEEEEEEeC---CCCeEEEEEEcccCC-----CChhhhHHHHHHHHhcC-CCCeeeeeeeeeecCeE
Q 043702 381 CFNANRIIGHGAFGTVYKGILP---QNGDIIAVKRCSHNS-----QGKDEFLSELSIIGTLR-HRNLVRLQGWCHEKGEI 451 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~---~~~~~vavK~~~~~~-----~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~ 451 (711)
+|+..+.||+|+||.||+++.. .+|..||+|++.... ...+.+.+|++++++++ |+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4778899999999999999874 368899999986522 22456788999999995 99999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecC
Q 043702 452 LLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVE 531 (711)
Q Consensus 452 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~ 531 (711)
++||||+++++|.+++.. ...+++.....++.|+++||.|||+. +++||||||+|||+++++.+||+|||+++...
T Consensus 81 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 999999999999999865 35688999999999999999999997 99999999999999999999999999998765
Q ss_pred CCCCCCcccccCCCcccChhhhccC--CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCc
Q 043702 532 HDKSPDATVAAGTMGYLAPEYLLTG--RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGR 609 (711)
Q Consensus 532 ~~~~~~~~~~~gt~~y~APE~~~~~--~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 609 (711)
...........|+..|+|||.+... .++.++||||||+++|||++|+.||..... .....++........
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-------~~~~~~~~~~~~~~~- 228 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-------KNSQAEISRRILKSE- 228 (290)
T ss_pred cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-------cccHHHHHHHhhccC-
Confidence 4433333345689999999998753 467899999999999999999999863211 011122221111110
Q ss_pred hhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 043702 610 LLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARP-----TMRGVVQ 653 (711)
Q Consensus 610 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVl~ 653 (711)
..++......+.+++.+||+.||.+|| ++.+++.
T Consensus 229 ----------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 ----------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ----------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 111222334567888999999999997 6677665
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=338.77 Aligned_cols=255 Identities=27% Similarity=0.384 Sum_probs=206.4
Q ss_pred HHHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC---CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEE
Q 043702 376 RSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN---SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEIL 452 (711)
Q Consensus 376 ~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 452 (711)
+..+-++.....||.|.||.||-|...++|+..|+|.+... ....+.+.+|+.++..|+|||+|+.+|+-.+++..+
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 34456777888999999999999999999999999977652 334567889999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCC
Q 043702 453 LVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEH 532 (711)
Q Consensus 453 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~ 532 (711)
|.||||++|+|.+.+.. .+.+++.....+..|++.|+.|||+. +||||||||.||+|+.+|-+|++|||.|..+..
T Consensus 1311 IFMEyC~~GsLa~ll~~-gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHHHhccCcHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecC
Confidence 99999999999999854 34466667777889999999999998 999999999999999999999999999998765
Q ss_pred CCC---CCcccccCCCcccChhhhccCC---CCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHH-Hhh
Q 043702 533 DKS---PDATVAAGTMGYLAPEYLLTGR---ATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVW-SLH 605 (711)
Q Consensus 533 ~~~---~~~~~~~gt~~y~APE~~~~~~---~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~-~~~ 605 (711)
... .......||+.|||||++.+.. -..++||||+|||++||+||++||...+. +|.- ..+
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn------------e~aIMy~V 1454 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN------------EWAIMYHV 1454 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc------------hhHHHhHH
Confidence 421 1223457999999999996543 45689999999999999999999976532 2321 111
Q ss_pred hcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 043702 606 REGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655 (711)
Q Consensus 606 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L 655 (711)
..|. ...+++....+-.+++..|+..||++|.++.|+++.=
T Consensus 1455 ~~gh---------~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1455 AAGH---------KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred hccC---------CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 1221 2334444455566788899999999999999888754
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=297.86 Aligned_cols=256 Identities=21% Similarity=0.270 Sum_probs=188.8
Q ss_pred eeecCCceEEEEEEeCCCCeEEEEEEcccC---CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCCCCCH
Q 043702 387 IIGHGAFGTVYKGILPQNGDIIAVKRCSHN---SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSL 463 (711)
Q Consensus 387 ~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 463 (711)
.+|.|++ ||.++...+++.||+|++... ....+.+.+|+++++.++|+||+++++++.+.+..+++|||+++|+|
T Consensus 9 ~~~~~~~--v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 9 CFEDLMI--VHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred hhcCCce--EEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 3444444 454445557999999998753 33456789999999999999999999999999999999999999999
Q ss_pred HHHHhhC-CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC------C
Q 043702 464 DKALFEA-RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS------P 536 (711)
Q Consensus 464 ~~~l~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~------~ 536 (711)
.+++... ...+++.....++.|+++||.|||+. +|+||||||+||+++.++.+||+|||.+..+..... .
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 9999754 34688999999999999999999998 999999999999999999999999999876532211 1
Q ss_pred CcccccCCCcccChhhhccC--CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHH----hhhcC--
Q 043702 537 DATVAAGTMGYLAPEYLLTG--RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWS----LHREG-- 608 (711)
Q Consensus 537 ~~~~~~gt~~y~APE~~~~~--~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~----~~~~~-- 608 (711)
......++..|+|||++... .++.++|||||||++|||++|+.||...... ..+.+.... .....
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~ 236 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT-------QMLLEKVRGTVPCLLDKSTY 236 (314)
T ss_pred ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhccCccccccCch
Confidence 11233577889999998763 5789999999999999999999999753211 001010000 00000
Q ss_pred -----chhH----hhhhh----ccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 609 -----RLLT----AADAR----LEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 609 -----~~~~----~~d~~----l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.... ..++. ...........++.+++.+||+.||++||+++++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000 00000 0011122334567889999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=303.53 Aligned_cols=262 Identities=23% Similarity=0.302 Sum_probs=196.9
Q ss_pred cCCc-ccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCCh---------------hhhHHHHHHHHhcCCCCeeeeee
Q 043702 380 KCFN-ANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGK---------------DEFLSELSIIGTLRHRNLVRLQG 443 (711)
Q Consensus 380 ~~f~-~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~---------------~~~~~Ei~~l~~l~H~niv~l~g 443 (711)
++|. ..+.||+|+||.||+|.+...++.||+|++....... ..+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3454 3467999999999999998889999999886532211 24779999999999999999999
Q ss_pred eeeecCeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEee
Q 043702 444 WCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGD 523 (711)
Q Consensus 444 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~D 523 (711)
++..++..++||||++ |+|.+++.. ...+++.....++.|++.||+|||+. +++||||+|+||+++.++.+||+|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~d 162 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIAD 162 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECC
Confidence 9999999999999996 699998853 45689999999999999999999987 999999999999999999999999
Q ss_pred cCCceecCCCC-------------CCCcccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCcccccccc
Q 043702 524 FGLARQVEHDK-------------SPDATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKEITGVG 589 (711)
Q Consensus 524 FGla~~~~~~~-------------~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~ 589 (711)
||+++...... ........+++.|+|||.+.+. .++.++|||||||++|||++|+.||......
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~-- 240 (335)
T PTZ00024 163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI-- 240 (335)
T ss_pred ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--
Confidence 99998664111 1111223468899999998764 4689999999999999999999999754321
Q ss_pred ccccccchHHHHHHhhhcCc---hhHh--------h----hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 590 KVGVASNLVEWVWSLHREGR---LLTA--------A----DARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 590 ~~~~~~~l~~~~~~~~~~~~---~~~~--------~----d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.....+........ .... . .+... .........+.+++.+||+.+|++||++.|++..
T Consensus 241 ------~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 241 ------DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred ------HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 11111111110000 0000 0 00000 0001123567789999999999999999999974
Q ss_pred H
Q 043702 655 L 655 (711)
Q Consensus 655 L 655 (711)
-
T Consensus 314 ~ 314 (335)
T PTZ00024 314 E 314 (335)
T ss_pred c
Confidence 4
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=302.99 Aligned_cols=270 Identities=23% Similarity=0.275 Sum_probs=201.0
Q ss_pred HHHHHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC---CCChhhhHHHHHHHHhcCCCCeeeeeeeeee-cC
Q 043702 374 ELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN---SQGKDEFLSELSIIGTLRHRNLVRLQGWCHE-KG 449 (711)
Q Consensus 374 el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~ 449 (711)
++..++++|+..+.||.|+||.||++....+++.||+|++... ....+.+.+|++++++++||||+++.+++.. ..
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 3445778899999999999999999999889999999987542 2234678899999999999999999998865 56
Q ss_pred eEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCcee
Q 043702 450 EILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQ 529 (711)
Q Consensus 450 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~ 529 (711)
..++++||+ +++|..++.. ..+++.....++.|+++||.|||+. +|+||||+|+||++++++.+||+|||+++.
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred cEEEEeehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccc
Confidence 789999998 5689888753 4578888999999999999999998 999999999999999999999999999975
Q ss_pred cCCCCCCCcccccCCCcccChhhhcc-CCCCccccchhHHHHHHHHHhCCCCCccccccccccc----cccchHHHHHHh
Q 043702 530 VEHDKSPDATVAAGTMGYLAPEYLLT-GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVG----VASNLVEWVWSL 604 (711)
Q Consensus 530 ~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~----~~~~l~~~~~~~ 604 (711)
.... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||........... ......+|....
T Consensus 158 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 158 QDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred cCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 4322 123457889999998766 5689999999999999999999999964321000000 000001111111
Q ss_pred hhcCchhHhhh-hhccCCCcH-----HHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 605 HREGRLLTAAD-ARLEGQFDE-----AEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 605 ~~~~~~~~~~d-~~l~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
... ...+... .......+. .....+.+++.+||+.+|++||++.+++..
T Consensus 234 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 234 CSE-NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred cch-hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 111 1111100 000011111 123567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=301.30 Aligned_cols=261 Identities=23% Similarity=0.309 Sum_probs=193.3
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC-CChhhhHHHHHHHHhcCCCCeeeeeeeeeec----------
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCHEK---------- 448 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~---------- 448 (711)
.+|...+.||.|+||.||+|....++..||+|++.... ...+.+.+|++++++++||||+++++.+...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 57889999999999999999998889999999886633 3456788999999999999999999776543
Q ss_pred ----CeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEc-CCCcEEEee
Q 043702 449 ----GEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLD-EGFNARLGD 523 (711)
Q Consensus 449 ----~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld-~~~~vkL~D 523 (711)
...++||||++ ++|.+++.. ..+++.....++.||++||.|||+. +|+||||||+||+++ ++..+||+|
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECC
Confidence 35799999997 589888743 4689999999999999999999987 999999999999997 456789999
Q ss_pred cCCceecCCCCCC--CcccccCCCcccChhhhcc-CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHH
Q 043702 524 FGLARQVEHDKSP--DATVAAGTMGYLAPEYLLT-GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEW 600 (711)
Q Consensus 524 FGla~~~~~~~~~--~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~ 600 (711)
||+++.+...... ......|+..|+|||.+.. ..++.++|||||||++|||++|+.||...... ......
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~-------~~~~~~ 231 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL-------EQMQLI 231 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHH
Confidence 9999866432211 1122357889999998755 45788999999999999999999999653210 000000
Q ss_pred HHHhh-----hcCc----hhHhhh-hhccCC-----CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 601 VWSLH-----REGR----LLTAAD-ARLEGQ-----FDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 601 ~~~~~-----~~~~----~~~~~d-~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
..... .... ...... ...... .......++.+++.+||+.||.+||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 232 LESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 00000 0000 000000 000000 00112345778999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=326.55 Aligned_cols=255 Identities=25% Similarity=0.370 Sum_probs=195.6
Q ss_pred HHHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC--CCChhhhHHHHHHHHhcCCCCeeeeeeeeee------
Q 043702 376 RSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN--SQGKDEFLSELSIIGTLRHRNLVRLQGWCHE------ 447 (711)
Q Consensus 376 ~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~------ 447 (711)
.+....|+..++||+||||.|||++.+-+|+.+|||++... ......+.+|++.|++|+|||+|+++....+
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 45667899999999999999999999999999999999875 4445678899999999999999997542100
Q ss_pred --------------------------------------------------------------------------------
Q 043702 448 -------------------------------------------------------------------------------- 447 (711)
Q Consensus 448 -------------------------------------------------------------------------------- 447 (711)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -------------------------c--------CeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHH
Q 043702 448 -------------------------K--------GEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLH 494 (711)
Q Consensus 448 -------------------------~--------~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH 494 (711)
+ ..+|+-||||+...|..++..+...-.-...++++++|++||.|+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 0 1357889999998888887654322246778899999999999999
Q ss_pred hccCCCeeeccCCCCceEEcCCCcEEEeecCCceecC-----------------CCCCCCcccccCCCcccChhhhccC-
Q 043702 495 QECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVE-----------------HDKSPDATVAAGTMGYLAPEYLLTG- 556 (711)
Q Consensus 495 ~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~-----------------~~~~~~~~~~~gt~~y~APE~~~~~- 556 (711)
+. +||||||||.||+||++..|||+|||+|.... .......+..+||.-|+|||++.+.
T Consensus 715 ~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 DQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred hC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 98 99999999999999999999999999998721 0111244667899999999999765
Q ss_pred --CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHH
Q 043702 557 --RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVG 634 (711)
Q Consensus 557 --~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~ 634 (711)
+|+.|+|+||+||||+||+. ||...- .-+. +..-.+.+.+... ..+....+..-..++
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM----------ERa~-iL~~LR~g~iP~~------~~f~~~~~~~e~slI 851 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSM----------ERAS-ILTNLRKGSIPEP------ADFFDPEHPEEASLI 851 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCchH----------HHHH-HHHhcccCCCCCC------cccccccchHHHHHH
Confidence 49999999999999999996 454310 0001 1112234443332 223334445556788
Q ss_pred HhcCCCCCCCCCCHHHHHH
Q 043702 635 LACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 635 ~~Cl~~dP~~RPs~~eVl~ 653 (711)
.+++++||.+|||+.|+++
T Consensus 852 ~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 852 RWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHhcCCCccCCCHHHHhh
Confidence 9999999999999999986
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=302.39 Aligned_cols=263 Identities=22% Similarity=0.306 Sum_probs=199.0
Q ss_pred HHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC---CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCe---
Q 043702 377 SATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN---SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGE--- 450 (711)
Q Consensus 377 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~--- 450 (711)
...++|...+.||+|++|.||+|+...+++.||+|++... ....+.+.+|+.++++++|+|++++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 3456899999999999999999999888999999998652 2234567789999999999999999998866554
Q ss_pred ---EEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCc
Q 043702 451 ---ILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLA 527 (711)
Q Consensus 451 ---~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla 527 (711)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||.|||+. +|+||||||+||++++++.+||+|||++
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccc
Confidence 89999998 6699998854 4699999999999999999999997 9999999999999999999999999999
Q ss_pred eecCCCCCCCcccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccccccccccccccch--------H
Q 043702 528 RQVEHDKSPDATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNL--------V 598 (711)
Q Consensus 528 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l--------~ 598 (711)
...... .....++..|+|||.+.+. .++.++|||||||++|||++|+.||...... .....+ .
T Consensus 166 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~----~~~~~i~~~~~~~~~ 237 (343)
T cd07851 166 RHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI----DQLKRIMNLVGTPDE 237 (343)
T ss_pred cccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHHhcCCCCH
Confidence 865432 2234578899999998653 6789999999999999999999999643210 000000 0
Q ss_pred HHHHHhhhcCchhHhhhh---hccCCCc---HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 599 EWVWSLHREGRLLTAADA---RLEGQFD---EAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 599 ~~~~~~~~~~~~~~~~d~---~l~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.+....... .....+.. .....+. ......+.+++.+||+.+|.+|||+.+|++.
T Consensus 238 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 238 ELLQKISSE-SARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHHhhccch-hHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 011000000 00000000 0000000 0124568899999999999999999999873
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=281.15 Aligned_cols=265 Identities=20% Similarity=0.260 Sum_probs=204.8
Q ss_pred hcCCccc-ceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcC-CCCeeeeeeeeee----cCeEE
Q 043702 379 TKCFNAN-RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLR-HRNLVRLQGWCHE----KGEIL 452 (711)
Q Consensus 379 t~~f~~~-~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~----~~~~~ 452 (711)
|++|.+. ++||-|-.|+|-.+.++.+++.+|+|++.. .....+|+++.-... |||||.+++++.. ...+.
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLL 135 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLL 135 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeE
Confidence 4455544 579999999999999999999999999864 345678888866655 9999999998754 45789
Q ss_pred EEEEcCCCCCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEc---CCCcEEEeecCCce
Q 043702 453 LVYDLMPNGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLD---EGFNARLGDFGLAR 528 (711)
Q Consensus 453 lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld---~~~~vkL~DFGla~ 528 (711)
+|||.|+||.|...+.+++ ..+++.+.-.|+.||+.|+.|||+. +|.||||||+|+|.. .|-.+||+|||+|+
T Consensus 136 iVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK 212 (400)
T KOG0604|consen 136 IVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAK 212 (400)
T ss_pred eeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccccccc
Confidence 9999999999999998655 4699999999999999999999998 999999999999995 45568999999998
Q ss_pred ecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcC
Q 043702 529 QVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREG 608 (711)
Q Consensus 529 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 608 (711)
..... ......+-|+.|.|||++...+|....|+||+||++|-|++|.+||..... ..+..-+...++.|
T Consensus 213 ~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg--------~aispgMk~rI~~g 282 (400)
T KOG0604|consen 213 ETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG--------LAISPGMKRRIRTG 282 (400)
T ss_pred ccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC--------ccCChhHHhHhhcc
Confidence 75542 334556889999999999999999999999999999999999999975421 11111122222222
Q ss_pred chhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--HHhCCCCCCCCCC
Q 043702 609 RLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ--MLVGEAEVPIVPR 666 (711)
Q Consensus 609 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~--~L~~~~~~p~~p~ 666 (711)
... +.........+...+++...|..+|.+|.|+.+++. ++.+...+|..|.
T Consensus 283 qy~------FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl 336 (400)
T KOG0604|consen 283 QYE------FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPL 336 (400)
T ss_pred Ccc------CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCc
Confidence 110 001111233456677888999999999999999997 4444444454443
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=279.15 Aligned_cols=264 Identities=20% Similarity=0.341 Sum_probs=205.1
Q ss_pred CHHHHHHHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC-CChhhhHHHHHHHHhcC-CCCeeeeeeeeeec
Q 043702 371 SYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLR-HRNLVRLQGWCHEK 448 (711)
Q Consensus 371 ~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~ 448 (711)
++.++...|+ ++||+|+++.|--++...+|..+|||++.+.. .....+.+|++++.+.+ |+||++|++|++++
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 3566666665 67999999999999998899999999998743 34567899999999987 99999999999999
Q ss_pred CeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCC---cEEEeecC
Q 043702 449 GEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGF---NARLGDFG 525 (711)
Q Consensus 449 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~---~vkL~DFG 525 (711)
...|||||-|.||.|..+|++ +..+++.+..++.++|+.||.+||.+ +|.||||||+|||-.+-. -+|||||.
T Consensus 149 ~~FYLVfEKm~GGplLshI~~-~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfD 224 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQK-RKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFD 224 (463)
T ss_pred ceEEEEEecccCchHHHHHHH-hhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccc
Confidence 999999999999999999965 45689999999999999999999998 999999999999996543 48999998
Q ss_pred CceecCCCC------CCCcccccCCCcccChhhhc-----cCCCCccccchhHHHHHHHHHhCCCCCccccccccccccc
Q 043702 526 LARQVEHDK------SPDATVAAGTMGYLAPEYLL-----TGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVA 594 (711)
Q Consensus 526 la~~~~~~~------~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~ 594 (711)
|..-..... .......+|+..|||||+.. ...|..+.|.||+||+||-|++|.+||........+++..
T Consensus 225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrG 304 (463)
T KOG0607|consen 225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRG 304 (463)
T ss_pred cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCC
Confidence 876443221 22334568999999999873 3357899999999999999999999998765533333222
Q ss_pred cch---HHHHHHhhhcCchhHhhhhhccCCCcHHH----HHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 595 SNL---VEWVWSLHREGRLLTAADARLEGQFDEAE----MRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 595 ~~l---~~~~~~~~~~~~~~~~~d~~l~~~~~~~~----~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
..- ..-+.+-+.+|.. ++++++ ..+..+++...+..|+.+|.++.++++
T Consensus 305 e~Cr~CQ~~LFesIQEGkY----------eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 305 EVCRVCQNKLFESIQEGKY----------EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CccHHHHHHHHHHHhccCC----------cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 221 1111222222221 233333 234455666777799999999999987
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=284.36 Aligned_cols=236 Identities=26% Similarity=0.350 Sum_probs=193.7
Q ss_pred eecCCceEEEEEEeCCCCeEEEEEEcccCCC----ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCCCCCH
Q 043702 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ----GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSL 463 (711)
Q Consensus 388 LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 463 (711)
||+|++|.||++....+++.+|+|++..... ..+.+..|++++++++|+|++++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 6899999999999988899999998875322 345788999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCcccccC
Q 043702 464 DKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAG 543 (711)
Q Consensus 464 ~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~g 543 (711)
.+++... ..+++.....++.|+++||.|||+. +++|+||+|+||+++.++.++|+|||++....... .......+
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~ 155 (250)
T cd05123 81 FSHLSKE-GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCG 155 (250)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcC
Confidence 9999654 3689999999999999999999997 99999999999999999999999999998765432 12334568
Q ss_pred CCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccCCCc
Q 043702 544 TMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFD 623 (711)
Q Consensus 544 t~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 623 (711)
+..|++||...+...+.++|+||||+++|||++|+.||..... .+....... + ...++
T Consensus 156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----------~~~~~~~~~-~----------~~~~~ 213 (250)
T cd05123 156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----------KEIYEKILK-D----------PLRFP 213 (250)
T ss_pred CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----------HHHHHHHhc-C----------CCCCC
Confidence 8899999999888889999999999999999999999964321 111111111 0 01112
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCCCHHH
Q 043702 624 EAEMRRVLLVGLACSHPDPLARPTMRG 650 (711)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPs~~e 650 (711)
......+.+++.+||..||++||++.+
T Consensus 214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 214 EFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 222456778899999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=280.41 Aligned_cols=202 Identities=25% Similarity=0.396 Sum_probs=171.2
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCC----eEEEEEEcccCCCC---hhhhHHHHHHHHhcCCCCeeeeeeeeee-cCe
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNG----DIIAVKRCSHNSQG---KDEFLSELSIIGTLRHRNLVRLQGWCHE-KGE 450 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~----~~vavK~~~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~ 450 (711)
...|+....||+|.+|.||+|....++ ..+|+|+++..+.. .....+|+.+++.|+|||++.|..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 356888899999999999999765443 36899998864322 3567899999999999999999999877 788
Q ss_pred EEEEEEcCCCCCHHHHHhhCC----CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCC----CcEEEe
Q 043702 451 ILLVYDLMPNGSLDKALFEAR----SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEG----FNARLG 522 (711)
Q Consensus 451 ~~lV~Ey~~~gsL~~~l~~~~----~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~----~~vkL~ 522 (711)
++|++||.+. +|...++-.+ ..++-..+..|+.||+.|+.|||+. -|+||||||.||||..+ |+|||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEee
Confidence 9999999987 8998886432 4688999999999999999999997 89999999999999877 999999
Q ss_pred ecCCceecCCCCCC--CcccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccc
Q 043702 523 DFGLARQVEHDKSP--DATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKE 584 (711)
Q Consensus 523 DFGla~~~~~~~~~--~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~ 584 (711)
|+|++|.+...-.. ....++-|..|+|||.+.+. .||.+.|||+.||++.||++-++-|...
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 99999988654432 23446689999999999876 5899999999999999999998888654
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=293.02 Aligned_cols=267 Identities=21% Similarity=0.260 Sum_probs=193.1
Q ss_pred CCcccceeecCCceEEEEEEeCCC--CeEEEEEEcccCC---CChhhhHHHHHHHHhcC-CCCeeeeeeeeeec----Ce
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQN--GDIIAVKRCSHNS---QGKDEFLSELSIIGTLR-HRNLVRLQGWCHEK----GE 450 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~--~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~----~~ 450 (711)
+|+..+.||+|+||.||++..... +..||+|++.... ...+.+.+|++++++++ ||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 477889999999999999999877 8899999886522 22456788999999995 99999999976432 45
Q ss_pred EEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceec
Q 043702 451 ILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV 530 (711)
Q Consensus 451 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~ 530 (711)
.++++||+. ++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++.+
T Consensus 81 ~~~~~e~~~-~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred EEEEEeccc-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 788899985 689988853 45689999999999999999999997 9999999999999999999999999999876
Q ss_pred CCCCCC---CcccccCCCcccChhhhcc-CCCCccccchhHHHHHHHHHhCCCCCccccccccccc----cccchHHHHH
Q 043702 531 EHDKSP---DATVAAGTMGYLAPEYLLT-GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVG----VASNLVEWVW 602 (711)
Q Consensus 531 ~~~~~~---~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~----~~~~l~~~~~ 602 (711)
...... ......|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||........... ......++..
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 433221 1223468999999998866 4688999999999999999999999865321000000 0000000110
Q ss_pred HhhhcCchhHhhh---hhcc---CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 603 SLHREGRLLTAAD---ARLE---GQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 603 ~~~~~~~~~~~~d---~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
..... ....... ..-. ..........+.+++.+|++.||.+||++.++++
T Consensus 236 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 236 RIGSP-KAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred hhhhh-hHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000 0000000 0000 0000111346778999999999999999999975
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=283.91 Aligned_cols=247 Identities=23% Similarity=0.316 Sum_probs=199.3
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
++|...++||+|.||+|.+++.+.+++.+|+|++++. +.+...-+.|-++|+..+||.+..|.-.++..+.+|+||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 5678889999999999999999999999999998863 233444567999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
||..||.|.-+|.. ...+++...+-+-..|..||.|||+. +||.||||.+|.|||.+|.+||+||||++.--. ..
T Consensus 248 eyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~-~g 322 (516)
T KOG0690|consen 248 EYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK-YG 322 (516)
T ss_pred EEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhccc-cc
Confidence 99999999998854 44588888888899999999999997 999999999999999999999999999985332 23
Q ss_pred CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhh
Q 043702 536 PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 615 (711)
..+...||||.|+|||++....|....|-|.+||++|||++|+.||...+. ..+.+. + -.-|
T Consensus 323 ~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh--------~kLFeL----I------l~ed 384 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH--------EKLFEL----I------LMED 384 (516)
T ss_pred ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch--------hHHHHH----H------Hhhh
Confidence 345668999999999999999999999999999999999999999975421 111111 1 1111
Q ss_pred hhccCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 043702 616 ARLEGQFDEAEMRRVLLVGLACSHPDPLARP-----TMRGVVQ 653 (711)
Q Consensus 616 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVl~ 653 (711)
-+ ++.....+...|..-.|..||.+|. .++||.+
T Consensus 385 ~k----FPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 385 LK----FPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred cc----CCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 11 2222233344555667789999996 3566654
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=309.89 Aligned_cols=265 Identities=18% Similarity=0.218 Sum_probs=175.1
Q ss_pred HhcCCcccceeecCCceEEEEEEeCCC----CeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeee------eee
Q 043702 378 ATKCFNANRIIGHGAFGTVYKGILPQN----GDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGW------CHE 447 (711)
Q Consensus 378 at~~f~~~~~LG~G~fg~Vy~~~~~~~----~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~------~~~ 447 (711)
..++|...++||+|+||.||+|++..+ +..||+|++..... .+....| .+....+.+++.++.. +..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~ 206 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKK 206 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-hHHHHHH--HHHhhchhhHHHHHHhhhccccccc
Confidence 567899999999999999999999888 89999998764221 1111111 1222223333322221 245
Q ss_pred cCeEEEEEEcCCCCCHHHHHhhCCCC-------------------CChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCC
Q 043702 448 KGEILLVYDLMPNGSLDKALFEARSP-------------------LPWPHRSKILLGVASALAYLHQECENQVIHRDVKT 508 (711)
Q Consensus 448 ~~~~~lV~Ey~~~gsL~~~l~~~~~~-------------------l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp 508 (711)
+...++||||+++++|.+++...... .....+..++.||+.||+|||+. +|+||||||
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP 283 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKP 283 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCH
Confidence 67899999999999999998653311 11234567999999999999997 999999999
Q ss_pred CceEEcC-CCcEEEeecCCceecCCCCCCCcccccCCCcccChhhhccC----------------------CCCccccch
Q 043702 509 SNIMLDE-GFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTG----------------------RATEKTDVF 565 (711)
Q Consensus 509 ~NILld~-~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~----------------------~~s~ksDVw 565 (711)
+|||+++ ++.+||+|||+++.+............+++.|||||.+... .+..++|||
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw 363 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 363 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence 9999985 57899999999987655444444556799999999976432 234567999
Q ss_pred hHHHHHHHHHhCCCCCccccccccc--cccccchHHHHHHhhhcCchhHhhhhhccCCC--cHHHHHHHHHHHHhcCCCC
Q 043702 566 SYGAVVLEVASGRRPIEKEITGVGK--VGVASNLVEWVWSLHREGRLLTAADARLEGQF--DEAEMRRVLLVGLACSHPD 641 (711)
Q Consensus 566 SfGvll~elltG~~P~~~~~~~~~~--~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~--~~~~~~~l~~l~~~Cl~~d 641 (711)
||||+||||+++..|++........ ......+..|....... ..+.+...+ .........+|+.+||+.|
T Consensus 364 SlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 364 SAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred HHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 9999999999987765432100000 00001122221111000 000000000 0011223457999999999
Q ss_pred CCCCCCHHHHHHH
Q 043702 642 PLARPTMRGVVQM 654 (711)
Q Consensus 642 P~~RPs~~eVl~~ 654 (711)
|++|||++|+++.
T Consensus 438 P~kR~ta~e~L~H 450 (566)
T PLN03225 438 GRQRISAKAALAH 450 (566)
T ss_pred cccCCCHHHHhCC
Confidence 9999999999984
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=316.22 Aligned_cols=145 Identities=27% Similarity=0.378 Sum_probs=132.0
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC----CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS----QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
++|.+.++||+|+||.||+|.+...++.||||++.... .....+.+|+.++..++||||+++++++...+..++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57889999999999999999998889999999987532 12357888999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCce
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLAR 528 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~ 528 (711)
||+++++|.+++.. ...+++...++|+.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999864 34688999999999999999999997 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=315.37 Aligned_cols=210 Identities=28% Similarity=0.384 Sum_probs=190.4
Q ss_pred CHHHHHHHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhcCCCCeeeeeeeee
Q 043702 371 SYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTLRHRNLVRLQGWCH 446 (711)
Q Consensus 371 ~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~ 446 (711)
..++++.-.++|.+.++||+|+||.|..++++.+++.+|+|++++. ..+..-|..|-.+|..-+.+-|++|+-.|.
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 3567777788999999999999999999999999999999999872 334456888999999999999999999999
Q ss_pred ecCeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCC
Q 043702 447 EKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGL 526 (711)
Q Consensus 447 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGl 526 (711)
+..++|+|||||+||+|-.++.+.. ++++...+-++..|..||.-||+. |+|||||||+|||||..|.+||+|||.
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchh
Confidence 9999999999999999999997655 899999999999999999999998 999999999999999999999999999
Q ss_pred ceecCCCCCCCcccccCCCcccChhhhcc-----CCCCccccchhHHHHHHHHHhCCCCCccc
Q 043702 527 ARQVEHDKSPDATVAAGTMGYLAPEYLLT-----GRATEKTDVFSYGAVVLEVASGRRPIEKE 584 (711)
Q Consensus 527 a~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~s~ksDVwSfGvll~elltG~~P~~~~ 584 (711)
|-.+..+..-.....+|||.|++||++.. +.|+..+|-||+||++|||+.|..||..+
T Consensus 222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad 284 (1317)
T KOG0612|consen 222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD 284 (1317)
T ss_pred HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH
Confidence 98887666656667789999999999962 57899999999999999999999999764
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=278.57 Aligned_cols=221 Identities=22% Similarity=0.214 Sum_probs=178.6
Q ss_pred CCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCCCCCHHHHHhhC
Q 043702 391 GAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEA 470 (711)
Q Consensus 391 G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~ 470 (711)
|.+|.||++++..+++.+|+|++.... .+.+|...+....|||++++++++.+.+..++||||+++|+|.+++...
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 899999999999999999999987543 2345555666667999999999999999999999999999999998653
Q ss_pred CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCcccccCCCcccCh
Q 043702 471 RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAP 550 (711)
Q Consensus 471 ~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~AP 550 (711)
..+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+|++|||++....... ....++..|+||
T Consensus 80 -~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y~aP 151 (237)
T cd05576 80 -LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMYCAP 151 (237)
T ss_pred -cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCccccCC
Confidence 4599999999999999999999987 99999999999999999999999999887654321 223457789999
Q ss_pred hhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHH
Q 043702 551 EYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRV 630 (711)
Q Consensus 551 E~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 630 (711)
|.+....++.++||||+||++|||++|+.|+....... .. ... ...+......+
T Consensus 152 E~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------------~~-----~~~----~~~~~~~~~~~ 205 (237)
T cd05576 152 EVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------------NT-----HTT----LNIPEWVSEEA 205 (237)
T ss_pred cccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------------cc-----ccc----cCCcccCCHHH
Confidence 99988889999999999999999999998875321100 00 000 00111123456
Q ss_pred HHHHHhcCCCCCCCCCCHH
Q 043702 631 LLVGLACSHPDPLARPTMR 649 (711)
Q Consensus 631 ~~l~~~Cl~~dP~~RPs~~ 649 (711)
.+++.+|++.||.+||++.
T Consensus 206 ~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 206 RSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHHccCCHHHhcCCC
Confidence 7888999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-34 Score=281.47 Aligned_cols=248 Identities=30% Similarity=0.390 Sum_probs=193.8
Q ss_pred cceeecCCceEEEEEEeCCCCeEEEEEEcccC--CCChhhhHHHHHHHHh-cCCCCeeeeeeeeeecCeEEEEEEcCCCC
Q 043702 385 NRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN--SQGKDEFLSELSIIGT-LRHRNLVRLQGWCHEKGEILLVYDLMPNG 461 (711)
Q Consensus 385 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 461 (711)
...||.|.||+|+|-.++..|+..|||+++.. ..+.++++.|.+...+ -+.||||+++|.+..++..++.||.| ..
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~ 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DI 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hh
Confidence 45699999999999999999999999999863 3456678889887555 45999999999999999999999999 44
Q ss_pred CHHHHHh---h-CCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC
Q 043702 462 SLDKALF---E-ARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD 537 (711)
Q Consensus 462 sL~~~l~---~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 537 (711)
+|+.+-. . ....+++...-+|.....+||.||... ..|||||+||+|||||..|.+||||||++-.+..+- .
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si--A 223 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI--A 223 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHHH--H
Confidence 7765432 2 345689999999999999999999986 589999999999999999999999999998765432 2
Q ss_pred cccccCCCcccChhhhccC--CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhh
Q 043702 538 ATVAAGTMGYLAPEYLLTG--RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615 (711)
Q Consensus 538 ~~~~~gt~~y~APE~~~~~--~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 615 (711)
.+.-.|-..|||||.+... .|.-++||||+|++|+|+.||+.||.... ++.+.+..... -|
T Consensus 224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~----------svfeql~~Vv~-------gd 286 (361)
T KOG1006|consen 224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD----------SVFEQLCQVVI-------GD 286 (361)
T ss_pred hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH----------HHHHHHHHHHc-------CC
Confidence 3445688899999998643 48899999999999999999999997532 12222211111 11
Q ss_pred hhc-cCC-CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 616 ARL-EGQ-FDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 616 ~~l-~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
+.+ ... -..+....+...+..|+..|-.+||...++.++
T Consensus 287 pp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 287 PPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 211 111 112234567788889999999999999998764
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=298.25 Aligned_cols=242 Identities=26% Similarity=0.339 Sum_probs=198.1
Q ss_pred HhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcC-CCCeeeeeeeeeecCeEEEEEE
Q 043702 378 ATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLR-HRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 378 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 456 (711)
.++.|.....+|.|.|+.|-++.+..+++..++|++... ..+..+|+.++...+ ||||+++.+.+.++.+.++|||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~---~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR---ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc---ccccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 355677778899999999999999999999999999765 334557887766664 9999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEE-cCCCcEEEeecCCceecCCCCC
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIML-DEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl-d~~~~vkL~DFGla~~~~~~~~ 535 (711)
.+.++-|.+.+..... .. .++..|+.+|+.|+.|||++ +++||||||+|||+ ++.+.++|+|||.++....+
T Consensus 397 ~l~g~ell~ri~~~~~-~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPE-FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred hccccHHHHHHHhcch-hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 9999988887764432 22 67778999999999999997 99999999999999 58999999999999987654
Q ss_pred CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhh
Q 043702 536 PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 615 (711)
....+-|..|.|||++....|++++|+||||++||||++|+.||.....+ .+ ....+
T Consensus 470 --~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~----------~e-i~~~i---------- 526 (612)
T KOG0603|consen 470 --CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG----------IE-IHTRI---------- 526 (612)
T ss_pred --hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch----------HH-HHHhh----------
Confidence 22345688999999999999999999999999999999999999764321 00 11111
Q ss_pred hhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 616 ARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 616 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
..+.+.........+|+.+||+.||.+||+|.++...
T Consensus 527 --~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 527 --QMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred --cCCccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 1223334445567788899999999999999999864
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.5e-33 Score=290.77 Aligned_cols=195 Identities=27% Similarity=0.470 Sum_probs=174.0
Q ss_pred cceeecCCceEEEEEEeCCCCeEEEEEEccc---CCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCCCC
Q 043702 385 NRIIGHGAFGTVYKGILPQNGDIIAVKRCSH---NSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNG 461 (711)
Q Consensus 385 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 461 (711)
.+.||.|.||+||-|+++.+|+.||||++.+ ....+.++.+|+.||+.++||.||.|...|+..+..++|||-+.+.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 4789999999999999999999999999876 3345678999999999999999999999999999999999999655
Q ss_pred CHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCC---CcEEEeecCCceecCCCCCCCc
Q 043702 462 SLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEG---FNARLGDFGLARQVEHDKSPDA 538 (711)
Q Consensus 462 sL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~---~~vkL~DFGla~~~~~~~~~~~ 538 (711)
-|+..|....++|++....-++.||+.||.|||.+ +|+|+||||+||||.+. -.+||||||+||.+.+... .
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF--R 723 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF--R 723 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhh--h
Confidence 55555666778899999999999999999999998 99999999999999543 4699999999999876543 3
Q ss_pred ccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccc
Q 043702 539 TVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKE 584 (711)
Q Consensus 539 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~ 584 (711)
..++||+.|+|||+++.+.|...-|+||.||++|--++|..||..+
T Consensus 724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd 769 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED 769 (888)
T ss_pred hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc
Confidence 4467999999999999999999999999999999999999999754
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-31 Score=270.19 Aligned_cols=238 Identities=29% Similarity=0.386 Sum_probs=194.0
Q ss_pred CceEEEEEEeCCCCeEEEEEEcccCCC-C-hhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCCCCCHHHHHhh
Q 043702 392 AFGTVYKGILPQNGDIIAVKRCSHNSQ-G-KDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFE 469 (711)
Q Consensus 392 ~fg~Vy~~~~~~~~~~vavK~~~~~~~-~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~ 469 (711)
+||.||+|+...+++.+++|++..... . .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999988899999999876432 2 57899999999999999999999999999999999999999999999865
Q ss_pred CCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCcccccCCCcccC
Q 043702 470 ARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLA 549 (711)
Q Consensus 470 ~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~A 549 (711)
... +++..+..++.+++++|.|||+. +++|+||+|+||++++++.++|+|||++....... ......++..|++
T Consensus 81 ~~~-~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~ 154 (244)
T smart00220 81 RGR-LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMA 154 (244)
T ss_pred ccC-CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCC
Confidence 433 89999999999999999999997 99999999999999999999999999998775542 2334568889999
Q ss_pred hhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHH
Q 043702 550 PEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRR 629 (711)
Q Consensus 550 PE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 629 (711)
||.+....++.++|||+||++++||++|..||..... ...+.++. ..+.... ..........
T Consensus 155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~-------~~~~~~~~----~~~~~~~-------~~~~~~~~~~ 216 (244)
T smart00220 155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ-------LLELFKKI----GKPKPPF-------PPPEWKISPE 216 (244)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-------HHHHHHHH----hccCCCC-------ccccccCCHH
Confidence 9999988899999999999999999999999865211 01111111 1111000 0000003356
Q ss_pred HHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 630 VLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 630 l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
+.+++.+|+..+|++||++.++++
T Consensus 217 ~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 217 AKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHccCCchhccCHHHHhh
Confidence 888999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.6e-34 Score=275.39 Aligned_cols=272 Identities=23% Similarity=0.372 Sum_probs=203.1
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEccc--CCCC-hhhhHHHHHHHHhcCCCCeeeeeeeeee--------c
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSH--NSQG-KDEFLSELSIIGTLRHRNLVRLQGWCHE--------K 448 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~--~~~~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~--------~ 448 (711)
..|+...+||+|.||+||+|+.+.+|+.||+|++.. .+.+ .....+|+++|..|+|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 346667789999999999999999999999987643 2222 3467899999999999999999999854 3
Q ss_pred CeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCce
Q 043702 449 GEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLAR 528 (711)
Q Consensus 449 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~ 528 (711)
..+++||++|+. +|.-+|.....+++..++.+++.++.+||.|+|.. .|+|||+|+.|+||+.++.+||+|||++|
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccccc
Confidence 458999999977 99999977778899999999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCC---CCcccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccccccccc---cccccchHHHH
Q 043702 529 QVEHDKS---PDATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGK---VGVASNLVEWV 601 (711)
Q Consensus 529 ~~~~~~~---~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~---~~~~~~l~~~~ 601 (711)
.+..... ...+..+-|..|++||.+.+. .|+++.|||.-||++.||.++.+-+....+...- .+...++..-+
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence 7754332 233445679999999998765 5899999999999999999999888654331100 00001111112
Q ss_pred HHhhhcCchhHhh--hhhccCCCc--HHHH------HHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 043702 602 WSLHREGRLLTAA--DARLEGQFD--EAEM------RRVLLVGLACSHPDPLARPTMRGVVQML 655 (711)
Q Consensus 602 ~~~~~~~~~~~~~--d~~l~~~~~--~~~~------~~l~~l~~~Cl~~dP~~RPs~~eVl~~L 655 (711)
|.-...-.+.+.+ .|...+.+. .+.+ .+.++|+..++..||.+|+.+.+++..-
T Consensus 253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 2222222222222 111111111 1111 2566777888999999999999998743
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.3e-32 Score=299.43 Aligned_cols=262 Identities=23% Similarity=0.348 Sum_probs=216.9
Q ss_pred cCHHHHHHHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcC-CCCeeeeeeeeee-
Q 043702 370 FSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLR-HRNLVRLQGWCHE- 447 (711)
Q Consensus 370 ~~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~- 447 (711)
..++.+..-+..|++.+.||.|.+|.||+++...+++..|+|+........+++..|.++|+.+. |||++.++|++..
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 34555556678899999999999999999999999999999999888888888999999999986 9999999999864
Q ss_pred ----cCeEEEEEEcCCCCCHHHHHhhC-CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEe
Q 043702 448 ----KGEILLVYDLMPNGSLDKALFEA-RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLG 522 (711)
Q Consensus 448 ----~~~~~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~ 522 (711)
+++++||||||.+|+.-+++... +.++.|..+..|++.++.||.+||.. .++|||||-.||||+.++.|||+
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEe
Confidence 46899999999999999998643 46799999999999999999999987 99999999999999999999999
Q ss_pred ecCCceecCCCCCCCcccccCCCcccChhhhccC-----CCCccccchhHHHHHHHHHhCCCCCccccccccccccccch
Q 043702 523 DFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTG-----RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNL 597 (711)
Q Consensus 523 DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l 597 (711)
|||.+..+...... .....||+.|||||++.-. .|+.++|+||+|++..||.-|.+|+-++-+.
T Consensus 166 DFGvSaQldsT~gr-RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm---------- 234 (953)
T KOG0587|consen 166 DFGVSAQLDSTVGR-RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM---------- 234 (953)
T ss_pred eeeeeeeeeccccc-ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh----------
Confidence 99999987654433 3345799999999998543 4677899999999999999999998654220
Q ss_pred HHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 598 VEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 598 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
+.+. .+.. .|.....-+....+.+.+.+..||..|-++||++.++++.
T Consensus 235 ----raLF---~IpR--NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 235 ----RALF---LIPR--NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ----hhhc---cCCC--CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 0000 0111 1222222355677889999999999999999999988763
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=273.10 Aligned_cols=261 Identities=20% Similarity=0.282 Sum_probs=205.4
Q ss_pred HHHHHHHhcCCcccceeecCCceEEEEEEeCCCC-----eEEEEEEcccC--CCChhhhHHHHHHHHhcCCCCeeeeeee
Q 043702 372 YRELRSATKCFNANRIIGHGAFGTVYKGILPQNG-----DIIAVKRCSHN--SQGKDEFLSELSIIGTLRHRNLVRLQGW 444 (711)
Q Consensus 372 ~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~-----~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~ 444 (711)
.+++.....+++...++-+|.||.||+|.+.+.+ +.|-+|.++.. .-....+..|-.++..+.|||+..+.+.
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 3455556677888899999999999999886433 34566766543 2334568889999999999999999999
Q ss_pred eeec-CeEEEEEEcCCCCCHHHHHhhCC-------CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCC
Q 043702 445 CHEK-GEILLVYDLMPNGSLDKALFEAR-------SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEG 516 (711)
Q Consensus 445 ~~~~-~~~~lV~Ey~~~gsL~~~l~~~~-------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~ 516 (711)
+.++ ...+++|.++.-|+|..+|...+ +.++-.+...++.|++.|++|||+. +|||.||.++|++||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence 9765 46799999999999999997322 3467778889999999999999998 99999999999999999
Q ss_pred CcEEEeecCCceecCCCCCC-CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccc
Q 043702 517 FNARLGDFGLARQVEHDKSP-DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVA 594 (711)
Q Consensus 517 ~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~ 594 (711)
.++||+|=.++|.+-..+.. -......+..||+||.+....|+.++|||||||+||||+| |+.|+...++
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP-------- 504 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP-------- 504 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH--------
Confidence 99999999999976443322 1222345678999999999999999999999999999999 9999865432
Q ss_pred cchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 043702 595 SNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLV 656 (711)
Q Consensus 595 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 656 (711)
. .+....++|. +-..+..++.++..++.-||..+|++||+.+|++.-|.
T Consensus 505 ---f-Em~~ylkdGy---------RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLs 553 (563)
T KOG1024|consen 505 ---F-EMEHYLKDGY---------RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLS 553 (563)
T ss_pred ---H-HHHHHHhccc---------eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence 1 1222223322 11223456778899999999999999999999998774
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=247.76 Aligned_cols=196 Identities=27% Similarity=0.471 Sum_probs=172.3
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCC---hhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEc
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQG---KDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
+|...++||+|.+|+||+|+..++++.||+|+++.++.+ .....+|+-+|+.++|+|||++++..+.++.+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 466678899999999999999999999999998764433 35788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC
Q 043702 458 MPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD 537 (711)
Q Consensus 458 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 537 (711)
|.. +|.++...-.+.++.+..+.++.|+++||.++|++ ++.|||+||.|.||+.++..||+|||++|.+.-....
T Consensus 83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvrc- 157 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC- 157 (292)
T ss_pred hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceEe-
Confidence 955 89998887788899999999999999999999998 9999999999999999999999999999987654322
Q ss_pred cccccCCCcccChhhhccCC-CCccccchhHHHHHHHHHhCCCCC
Q 043702 538 ATVAAGTMGYLAPEYLLTGR-ATEKTDVFSYGAVVLEVASGRRPI 581 (711)
Q Consensus 538 ~~~~~gt~~y~APE~~~~~~-~s~ksDVwSfGvll~elltG~~P~ 581 (711)
....+-|..|.+|+++.+.+ |+...|+||-||++.|+....+|.
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrpl 202 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCC
Confidence 22345789999999998765 788999999999999999855543
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-32 Score=282.52 Aligned_cols=257 Identities=23% Similarity=0.344 Sum_probs=199.5
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCCh--------hhhHHHHHHHHhcCCCCeeeeeeeeeec-C
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGK--------DEFLSELSIIGTLRHRNLVRLQGWCHEK-G 449 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~~~-~ 449 (711)
.++|-..++||+|||+.||++.+....+.||||+-..++... +...+|.+|.+.|.||.||++++|+.-+ +
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 356888899999999999999998888999999865433221 3467899999999999999999999754 5
Q ss_pred eEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEc---CCCcEEEeecCC
Q 043702 450 EILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLD---EGFNARLGDFGL 526 (711)
Q Consensus 450 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld---~~~~vkL~DFGl 526 (711)
.+|-|+|||+|.+|+-||.. ...+++.+.+.|+.||+.||.||.+. .++|||-||||.||||. ..|.+||.||||
T Consensus 542 sFCTVLEYceGNDLDFYLKQ-hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQ-HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred cceeeeeecCCCchhHHHHh-hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 68999999999999999965 45689999999999999999999987 78999999999999994 457799999999
Q ss_pred ceecCCCCCC------CcccccCCCcccChhhhccC----CCCccccchhHHHHHHHHHhCCCCCccccccccccccccc
Q 043702 527 ARQVEHDKSP------DATVAAGTMGYLAPEYLLTG----RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASN 596 (711)
Q Consensus 527 a~~~~~~~~~------~~~~~~gt~~y~APE~~~~~----~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~ 596 (711)
++.++.+... .+....||.+|++||++.-+ +.+.|.||||.||++|..+.|+.||...... ..
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ-------Qd 692 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ-------QD 692 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH-------HH
Confidence 9988755432 22345799999999998644 4688999999999999999999999764221 11
Q ss_pred hHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 597 LVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 597 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
+ +....+...-.-.+. ..+....+...++.+||+..-++|-...++..
T Consensus 693 I-------LqeNTIlkAtEVqFP--~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 693 I-------LQENTILKATEVQFP--PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred H-------HhhhchhcceeccCC--CCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 1 122222222211111 11122334556788999999999988776653
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-31 Score=292.28 Aligned_cols=264 Identities=17% Similarity=0.255 Sum_probs=182.6
Q ss_pred HhcCCcccceeecCCceEEEEEEeC----------------CCCeEEEEEEcccCCCC---------------hhhhHHH
Q 043702 378 ATKCFNANRIIGHGAFGTVYKGILP----------------QNGDIIAVKRCSHNSQG---------------KDEFLSE 426 (711)
Q Consensus 378 at~~f~~~~~LG~G~fg~Vy~~~~~----------------~~~~~vavK~~~~~~~~---------------~~~~~~E 426 (711)
..++|++.++||+|+||.||+|.+. ..++.||||++....+. .+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4668999999999999999999752 23467999998653321 1234457
Q ss_pred HHHHHhcCCCCe-----eeeeeeeee--------cCeEEEEEEcCCCCCHHHHHhhCC----------------------
Q 043702 427 LSIIGTLRHRNL-----VRLQGWCHE--------KGEILLVYDLMPNGSLDKALFEAR---------------------- 471 (711)
Q Consensus 427 i~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lV~Ey~~~gsL~~~l~~~~---------------------- 471 (711)
+.++.+++|.++ ++++++|.. ++..+|||||+++++|.++++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 778888876654 678888753 356899999999999999986421
Q ss_pred -CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCcccccCCCcccCh
Q 043702 472 -SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAP 550 (711)
Q Consensus 472 -~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~AP 550 (711)
..++|..+..++.|++++|.|||+. +|+||||||+|||++.++.+||+|||+++..............+++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 1346778899999999999999997 999999999999999999999999999976644332222223458899999
Q ss_pred hhhccCCC----------------------CccccchhHHHHHHHHHhCCC-CCccccccccc-cccccchHHHHHHhhh
Q 043702 551 EYLLTGRA----------------------TEKTDVFSYGAVVLEVASGRR-PIEKEITGVGK-VGVASNLVEWVWSLHR 606 (711)
Q Consensus 551 E~~~~~~~----------------------s~ksDVwSfGvll~elltG~~-P~~~~~~~~~~-~~~~~~l~~~~~~~~~ 606 (711)
|.+..... ..+.||||+||+++||++|.. |+.....-... ......+..|. ...
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r--~~~ 457 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR--MYK 457 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH--hhc
Confidence 98864321 234799999999999999876 66432110000 00011122221 111
Q ss_pred cCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCC---CCCCCHHHHHHH
Q 043702 607 EGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDP---LARPTMRGVVQM 654 (711)
Q Consensus 607 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP---~~RPs~~eVl~~ 654 (711)
.... +-. ..........+++.+|+..+| .+|+|++|++++
T Consensus 458 ~~~~----~~~----~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 458 GQKY----DFS----LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred ccCC----Ccc----cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 1111 000 111223456677777887655 789999999875
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=274.16 Aligned_cols=268 Identities=22% Similarity=0.298 Sum_probs=206.4
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCC--C----CeeeeeeeeeecCeEE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRH--R----NLVRLQGWCHEKGEIL 452 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H--~----niv~l~g~~~~~~~~~ 452 (711)
+++|.+..++|+|.||.|-.+.+...+..||||+++.-..-.+..+-|+++|+++.+ | .+|.+.+|+.-.++.|
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC 167 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC 167 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence 678999999999999999999998889999999998766666778889999999952 2 4788999999999999
Q ss_pred EEEEcCCCCCHHHHHhhC-CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcC----------------
Q 043702 453 LVYDLMPNGSLDKALFEA-RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDE---------------- 515 (711)
Q Consensus 453 lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~---------------- 515 (711)
+|+|.+ |-+++++|..+ ..+++..+++.|+.|+++++++||+. +++|.||||+|||+.+
T Consensus 168 ivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~~~ 243 (415)
T KOG0671|consen 168 IVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVCFI 243 (415)
T ss_pred EEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCcccee
Confidence 999998 66999999764 45799999999999999999999998 9999999999999831
Q ss_pred ----CCcEEEeecCCceecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccc-
Q 043702 516 ----GFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGK- 590 (711)
Q Consensus 516 ----~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~- 590 (711)
+..+||+|||.|....... ...+.|..|+|||++.+-.++.++||||+||||.||.+|..-|...+..+..
T Consensus 244 r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLa 319 (415)
T KOG0671|consen 244 RPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLA 319 (415)
T ss_pred ccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHH
Confidence 3458999999998754433 4467899999999999999999999999999999999999988654321100
Q ss_pred ------cccccchHHH--HHHhhhcCchh-----------Hhhhhhc----cCCCcHHHHHHHHHHHHhcCCCCCCCCCC
Q 043702 591 ------VGVASNLVEW--VWSLHREGRLL-----------TAADARL----EGQFDEAEMRRVLLVGLACSHPDPLARPT 647 (711)
Q Consensus 591 ------~~~~~~l~~~--~~~~~~~~~~~-----------~~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 647 (711)
.+.......- ..+....|++. ...++.. .-.....+..++++|+..+|..||.+|+|
T Consensus 320 MMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiT 399 (415)
T KOG0671|consen 320 MMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRIT 399 (415)
T ss_pred HHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccccc
Confidence 0000000000 00111111110 0011000 11123456678999999999999999999
Q ss_pred HHHHHHH
Q 043702 648 MRGVVQM 654 (711)
Q Consensus 648 ~~eVl~~ 654 (711)
++|+++.
T Consensus 400 l~EAL~H 406 (415)
T KOG0671|consen 400 LREALSH 406 (415)
T ss_pred HHHHhcC
Confidence 9999874
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=275.01 Aligned_cols=242 Identities=20% Similarity=0.325 Sum_probs=195.6
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhcC-CCCeeeeeeeeeecCeEEE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTLR-HRNLVRLQGWCHEKGEILL 453 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~l 453 (711)
..+|....+||+|+||+|.+|..+++.+.+|||+++++ ..+.+--+.|-++|.... -|.+++|..+++.-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 34689999999999999999999999999999998763 233444567888887765 7889999999999999999
Q ss_pred EEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCC
Q 043702 454 VYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHD 533 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~ 533 (711)
||||+.+|+|--++++ -+++.+....-++..||-||-+||++ +|+.||||..|||||.++.+||+|||+++.---+
T Consensus 428 VMEyvnGGDLMyhiQQ-~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQ-VGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD 503 (683)
T ss_pred EEEEecCchhhhHHHH-hcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccccC
Confidence 9999999999888854 45688889999999999999999998 9999999999999999999999999999853322
Q ss_pred CCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHh
Q 043702 534 KSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTA 613 (711)
Q Consensus 534 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 613 (711)
...+...+|||.|+|||++...+|+...|-|||||+||||+.|++||+.++++ .+ . ..+
T Consensus 504 -~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~--------el----F--------~aI 562 (683)
T KOG0696|consen 504 -GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--------EL----F--------QAI 562 (683)
T ss_pred -CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH--------HH----H--------HHH
Confidence 23455689999999999999999999999999999999999999999876441 11 1 111
Q ss_pred hhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCC
Q 043702 614 ADARLEGQFDEAEMRRVLLVGLACSHPDPLARPT 647 (711)
Q Consensus 614 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 647 (711)
.+... .++.....+...+...-+...|.+|..
T Consensus 563 ~ehnv--syPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 563 MEHNV--SYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred HHccC--cCcccccHHHHHHHHHHhhcCCccccC
Confidence 12111 233334445556666677788888843
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-30 Score=268.44 Aligned_cols=267 Identities=23% Similarity=0.322 Sum_probs=200.4
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcC-----C---CCeeeeeeeeee----
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLR-----H---RNLVRLQGWCHE---- 447 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~-----H---~niv~l~g~~~~---- 447 (711)
.+|...++||+|.|++||++.+..+.+.||+|+.+....-.+..+.||++|++++ | ..||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN 157 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN 157 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence 5788999999999999999999999999999998876666677889999999986 2 479999999975
Q ss_pred cCeEEEEEEcCCCCCHHHHHhhC-CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCC----------
Q 043702 448 KGEILLVYDLMPNGSLDKALFEA-RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEG---------- 516 (711)
Q Consensus 448 ~~~~~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~---------- 516 (711)
+.++|||+|++ |-+|..+|... .+.++...+.+|++||+.||.|||.+| +|||.||||+||||..+
T Consensus 158 G~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~~~~~~ 234 (590)
T KOG1290|consen 158 GQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPAKDARE 234 (590)
T ss_pred CcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchhhhhhh
Confidence 45899999999 66888888654 456999999999999999999999997 99999999999999411
Q ss_pred --------------------------------------------------------------------------------
Q 043702 517 -------------------------------------------------------------------------------- 516 (711)
Q Consensus 517 -------------------------------------------------------------------------------- 516 (711)
T Consensus 235 a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~ 314 (590)
T KOG1290|consen 235 AGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNES 314 (590)
T ss_pred hccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcccc
Confidence
Q ss_pred ----------------------------------------------------------------------------CcEE
Q 043702 517 ----------------------------------------------------------------------------FNAR 520 (711)
Q Consensus 517 ----------------------------------------------------------------------------~~vk 520 (711)
.+||
T Consensus 315 ~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vK 394 (590)
T KOG1290|consen 315 TVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVK 394 (590)
T ss_pred chhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEE
Confidence 0134
Q ss_pred EeecCCceecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchH--
Q 043702 521 LGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLV-- 598 (711)
Q Consensus 521 L~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~-- 598 (711)
|+|||-|+.+.... +.-..|..|+|||++.+..|+..+||||++|+++||+||..-|+...... ....+..+.
T Consensus 395 IaDlGNACW~~khF----T~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~-Y~rDEDHiA~i 469 (590)
T KOG1290|consen 395 IADLGNACWVHKHF----TEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGEN-YSRDEDHIALI 469 (590)
T ss_pred Eeeccchhhhhhhh----chhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCC-CCccHHHHHHH
Confidence 44444444332211 11234778999999999999999999999999999999999997653221 111111222
Q ss_pred -HHH----HHhhhcCchhH-hhh-----------------hhcc--CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 599 -EWV----WSLHREGRLLT-AAD-----------------ARLE--GQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 599 -~~~----~~~~~~~~~~~-~~d-----------------~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
+.+ +.+...|+... ..+ ..+. =++..++...+.+++.-||+.+|++|||+.+.++
T Consensus 470 ~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~ 549 (590)
T KOG1290|consen 470 MELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLK 549 (590)
T ss_pred HHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhc
Confidence 111 22223332111 111 1111 2356788899999999999999999999999997
Q ss_pred H
Q 043702 654 M 654 (711)
Q Consensus 654 ~ 654 (711)
.
T Consensus 550 h 550 (590)
T KOG1290|consen 550 H 550 (590)
T ss_pred C
Confidence 4
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=281.43 Aligned_cols=249 Identities=21% Similarity=0.294 Sum_probs=202.9
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEccc----CCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSH----NSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
++++....||-||||.|=+.........+|+|++++ .....+.+..|-.+|...+.|.||+|+--+.+.+.+|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 344555679999999999998865555588888765 3344567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
|-|-||.|+..|++ ++.++.....-++..+++|++|||++ +||.|||||+|.|||.+|-+||.|||+|+.+..+.
T Consensus 500 EaClGGElWTiLrd-Rg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~- 574 (732)
T KOG0614|consen 500 EACLGGELWTILRD-RGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR- 574 (732)
T ss_pred HhhcCchhhhhhhh-cCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccCC-
Confidence 99999999999964 56788888999999999999999998 99999999999999999999999999999886544
Q ss_pred CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhh
Q 043702 536 PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 615 (711)
.+-..|||+.|.|||++..+....++|.||+|+++|||++|.+||...++- ..| . .++..+|
T Consensus 575 -KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm----------ktY--n-----~ILkGid 636 (732)
T KOG0614|consen 575 -KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM----------KTY--N-----LILKGID 636 (732)
T ss_pred -ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH----------HHH--H-----HHHhhhh
Confidence 456689999999999999999999999999999999999999999765331 111 0 1111222
Q ss_pred hhccCCCcHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHHH
Q 043702 616 ARLEGQFDEAEMRRVLLVGLACSHPDPLARPT-----MRGVVQM 654 (711)
Q Consensus 616 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~eVl~~ 654 (711)
. -.++....+...+|+++.+..+|.+|.- +.++-+.
T Consensus 637 ~---i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 637 K---IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred h---hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 1 1233344556677888888899999986 5666553
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=290.83 Aligned_cols=244 Identities=27% Similarity=0.403 Sum_probs=188.3
Q ss_pred CCcccceeecCCceE-EEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcC-CCCeeeeeeeeeecCeEEEEEEcC
Q 043702 381 CFNANRIIGHGAFGT-VYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLR-HRNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~-Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
-|...+++|.|+.|+ ||+|.. .|+.||||++-... .+-..+|+..|+.-+ |||||+.++.-.++..+|+..|.|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~--~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEF--FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eeccHHHcccCCCCcEEEEEee--CCceehHHHHhhHh--HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 466678899999875 699999 68899999986432 234568999999986 999999999888899999999999
Q ss_pred CCCCHHHHHhhCCCC---CChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcC-----CCcEEEeecCCceec
Q 043702 459 PNGSLDKALFEARSP---LPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDE-----GFNARLGDFGLARQV 530 (711)
Q Consensus 459 ~~gsL~~~l~~~~~~---l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~-----~~~vkL~DFGla~~~ 530 (711)
..+|.+++...... ..-...+.++.|+++||++||+. +||||||||.||||+. ..+++|+|||+++.+
T Consensus 586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 55999999763111 11144577899999999999998 9999999999999965 357999999999988
Q ss_pred CCCCCCC--cccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhC-CCCCccccccccccccccchHHHHHHhhhc
Q 043702 531 EHDKSPD--ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASG-RRPIEKEITGVGKVGVASNLVEWVWSLHRE 607 (711)
Q Consensus 531 ~~~~~~~--~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG-~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~ 607 (711)
..+...- .....||-||+|||.+.....+.+.||||+||++|..++| .+||.+.-. ++
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~-------------------R~ 722 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE-------------------RQ 722 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH-------------------hh
Confidence 7665432 3345699999999999999889999999999999999995 999976421 11
Q ss_pred CchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 608 GRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 608 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
.++.........-....++ +..+|+.+|++++|..||++.+|+.
T Consensus 723 ~NIl~~~~~L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 723 ANILTGNYTLVHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred hhhhcCccceeeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 1111110000000011111 6678899999999999999999985
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=274.50 Aligned_cols=216 Identities=26% Similarity=0.370 Sum_probs=183.3
Q ss_pred CccCHHHHHHHh---cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhcCCCCeee
Q 043702 368 KEFSYRELRSAT---KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTLRHRNLVR 440 (711)
Q Consensus 368 ~~~~~~el~~at---~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~ 440 (711)
++-+|..|+.+. ..|...+.||-|+||+|.++...++...+|+|.+.+. +......+.|-.||..-+.+-||+
T Consensus 614 KESnYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVr 693 (1034)
T KOG0608|consen 614 KESNYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVR 693 (1034)
T ss_pred hhhhHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEE
Confidence 345566666664 5688889999999999999998888889999988762 233456788999999999999999
Q ss_pred eeeeeeecCeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEE
Q 043702 441 LQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNAR 520 (711)
Q Consensus 441 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vk 520 (711)
|+--|.+++.+|+||||++||++-.+|.+ .+-+.+...+.++..+..|+++.|.. |+|||||||+|||||.+|.+|
T Consensus 694 LyySFQDkdnLYFVMdYIPGGDmMSLLIr-mgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIK 769 (1034)
T KOG0608|consen 694 LYYSFQDKDNLYFVMDYIPGGDMMSLLIR-MGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIK 769 (1034)
T ss_pred EEEEeccCCceEEEEeccCCccHHHHHHH-hccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCcee
Confidence 99999999999999999999999998865 34678888888999999999999998 999999999999999999999
Q ss_pred EeecCCceec---------CCCCC----------------C----------------CcccccCCCcccChhhhccCCCC
Q 043702 521 LGDFGLARQV---------EHDKS----------------P----------------DATVAAGTMGYLAPEYLLTGRAT 559 (711)
Q Consensus 521 L~DFGla~~~---------~~~~~----------------~----------------~~~~~~gt~~y~APE~~~~~~~s 559 (711)
|+|||||.-+ ..+.. . .....+||+.|+|||++....++
T Consensus 770 LTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~ 849 (1034)
T KOG0608|consen 770 LTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT 849 (1034)
T ss_pred eeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc
Confidence 9999998522 11000 0 00124699999999999999999
Q ss_pred ccccchhHHHHHHHHHhCCCCCcccccc
Q 043702 560 EKTDVFSYGAVVLEVASGRRPIEKEITG 587 (711)
Q Consensus 560 ~ksDVwSfGvll~elltG~~P~~~~~~~ 587 (711)
..+|.||.|||||||+.|+.||....++
T Consensus 850 q~cdwws~gvil~em~~g~~pf~~~tp~ 877 (1034)
T KOG0608|consen 850 QLCDWWSVGVILYEMLVGQPPFLADTPG 877 (1034)
T ss_pred ccchhhHhhHHHHHHhhCCCCccCCCCC
Confidence 9999999999999999999999877654
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=246.33 Aligned_cols=196 Identities=34% Similarity=0.465 Sum_probs=168.4
Q ss_pred ccceeecCCceEEEEEEeCCCCeEEEEEEccc--CCCChhhhHHHHHHHHh-cCCCCeeeeeeeeeecCeEEEEEEcCCC
Q 043702 384 ANRIIGHGAFGTVYKGILPQNGDIIAVKRCSH--NSQGKDEFLSELSIIGT-LRHRNLVRLQGWCHEKGEILLVYDLMPN 460 (711)
Q Consensus 384 ~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 460 (711)
....||+|++|.|-+-++..+|...|+|++.. ..++.+..++|+.+..+ ..+|.+|.++|........++.||.| .
T Consensus 50 ~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~ 128 (282)
T KOG0984|consen 50 GIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-D 128 (282)
T ss_pred hhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-h
Confidence 34569999999999999999999999999876 55666778889988655 46999999999999999999999999 4
Q ss_pred CCHHHHHh---hCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC
Q 043702 461 GSLDKALF---EARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD 537 (711)
Q Consensus 461 gsL~~~l~---~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 537 (711)
.+|+.+-. +.+..+++...-+|+..+..||.|||++ -.++|||+||+|||++.+|++|+||||.+-.+.++-.
T Consensus 129 tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA-- 204 (282)
T KOG0984|consen 129 TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA-- 204 (282)
T ss_pred hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhhH--
Confidence 48877643 4667899999999999999999999997 5899999999999999999999999999987754432
Q ss_pred cccccCCCcccChhhhcc----CCCCccccchhHHHHHHHHHhCCCCCccc
Q 043702 538 ATVAAGTMGYLAPEYLLT----GRATEKTDVFSYGAVVLEVASGRRPIEKE 584 (711)
Q Consensus 538 ~~~~~gt~~y~APE~~~~----~~~s~ksDVwSfGvll~elltG~~P~~~~ 584 (711)
.+...|-..|||||.+.. ..|+-|+||||+|+.+.||.+++.||+..
T Consensus 205 kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 205 KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 233457889999999853 36889999999999999999999999754
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-30 Score=256.15 Aligned_cols=250 Identities=22% Similarity=0.314 Sum_probs=201.4
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEccc----CCCChhhhHHHHHHHHhc-CCCCeeeeeeeeeecCeEEE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSH----NSQGKDEFLSELSIIGTL-RHRNLVRLQGWCHEKGEILL 453 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~----~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 453 (711)
.++|...++||+|.|.+|.+++++.+.+.+|+|++++ ...+.+-.+.|..+..+- +||.+|.|..+++.+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 4678999999999999999999999999999999876 334455567788777776 49999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCC
Q 043702 454 VYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHD 533 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~ 533 (711)
|.||+++|+|--+++. ..+|++++.+-+...|+.||.|||+. +||.||||..|||||.++.+||.|+|+++.--..
T Consensus 329 vieyv~ggdlmfhmqr-qrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP 404 (593)
T ss_pred EEEEecCcceeeehhh-hhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence 9999999999877754 45799999999999999999999998 9999999999999999999999999999854332
Q ss_pred CCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHh
Q 043702 534 KSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTA 613 (711)
Q Consensus 534 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 613 (711)
...+...+|||.|+|||++++..|....|-|++||+++||+.|+.||+--..+ ....+..+|+.+.+-+..+.-
T Consensus 405 -gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~----n~d~ntedylfqvilekqiri- 478 (593)
T KOG0695|consen 405 -GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMD----NPDMNTEDYLFQVILEKQIRI- 478 (593)
T ss_pred -CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCC----CcccchhHHHHHHHhhhcccc-
Confidence 23455689999999999999999999999999999999999999999754321 122455566655443322211
Q ss_pred hhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCC
Q 043702 614 ADARLEGQFDEAEMRRVLLVGLACSHPDPLARPT 647 (711)
Q Consensus 614 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 647 (711)
+....-+...+...-+..||.+|..
T Consensus 479 ---------prslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 479 ---------PRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred ---------cceeehhhHHHHHHhhcCCcHHhcC
Confidence 1111223345566778889998853
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=241.89 Aligned_cols=210 Identities=33% Similarity=0.534 Sum_probs=185.8
Q ss_pred eecCCceEEEEEEeCCCCeEEEEEEcccCCC--ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCCCCCHHH
Q 043702 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ--GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDK 465 (711)
Q Consensus 388 LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 465 (711)
||+|.+|.||++....+++.+++|++..... ..+.+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999977799999999886544 25789999999999999999999999999899999999999999999
Q ss_pred HHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcC-CCcEEEeecCCceecCCCCCCCcccccCC
Q 043702 466 ALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDE-GFNARLGDFGLARQVEHDKSPDATVAAGT 544 (711)
Q Consensus 466 ~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~-~~~vkL~DFGla~~~~~~~~~~~~~~~gt 544 (711)
++......+++..+..++.+++++|+|||+. +++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~ 156 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGT 156 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCC
Confidence 9976545789999999999999999999998 9999999999999999 89999999999987654321 12334578
Q ss_pred CcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccCCCc
Q 043702 545 MGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFD 623 (711)
Q Consensus 545 ~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 623 (711)
..|++||.+... ..+.+.|+|++|+++++|
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------- 187 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------- 187 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------------
Confidence 899999999887 788999999999999998
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 624 EAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 624 ~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
..+.+++..|++.+|.+||++.++++.
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 346678889999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-31 Score=258.21 Aligned_cols=197 Identities=27% Similarity=0.463 Sum_probs=171.1
Q ss_pred CcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC---ChhhhHHHHHHHHhcCCCCeeeeeeeeeec-----CeEEE
Q 043702 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ---GKDEFLSELSIIGTLRHRNLVRLQGWCHEK-----GEILL 453 (711)
Q Consensus 382 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~~l 453 (711)
.+..+-||.|.||.||...++.+|+.||+|++..-.+ ..+.+.+|+++|+.++|.|++..+++..-. .++|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 3456789999999999999999999999999876332 346788999999999999999998876543 24688
Q ss_pred EEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCC
Q 043702 454 VYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHD 533 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~ 533 (711)
+.|.|.. +|.+.+. ..+.|+-+++.-++.||++||+|||+. +|.||||||.|.|++.|...||||||++|..+.+
T Consensus 135 ~TELmQS-DLHKIIV-SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIV-SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHHHh-hhhheec-cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchh
Confidence 8888844 7877764 356789999999999999999999998 9999999999999999999999999999988877
Q ss_pred CCCCcccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCcc
Q 043702 534 KSPDATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEK 583 (711)
Q Consensus 534 ~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~ 583 (711)
....++..+-|..|+|||++++. .|+.+.||||.||++.||+..+--|..
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQA 260 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQA 260 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhc
Confidence 77777778889999999999876 589999999999999999988877754
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=238.83 Aligned_cols=199 Identities=32% Similarity=0.488 Sum_probs=174.7
Q ss_pred CcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC--ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCC
Q 043702 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ--GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMP 459 (711)
Q Consensus 382 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 459 (711)
|...+.||+|++|.||++....+++.+++|.+..... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567889999999999999987789999999876443 46788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCcc
Q 043702 460 NGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDAT 539 (711)
Q Consensus 460 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 539 (711)
+++|.+++......+++..+..++.+++.+|.|||+. +++|+||+|+||+++.++.++|+|||++............
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 9999999976544489999999999999999999997 9999999999999999999999999999887554311223
Q ss_pred cccCCCcccChhhh-ccCCCCccccchhHHHHHHHHHhCCCCCcc
Q 043702 540 VAAGTMGYLAPEYL-LTGRATEKTDVFSYGAVVLEVASGRRPIEK 583 (711)
Q Consensus 540 ~~~gt~~y~APE~~-~~~~~s~ksDVwSfGvll~elltG~~P~~~ 583 (711)
...++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 34678899999998 666778899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=261.67 Aligned_cols=195 Identities=23% Similarity=0.349 Sum_probs=171.9
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC---------ChhhhHHHHHHHHhcC---CCCeeeeeeeeeec
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ---------GKDEFLSELSIIGTLR---HRNLVRLQGWCHEK 448 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~ 448 (711)
.|...+.+|.|+||.|++|.++.+...|+||.+.+.+- ..-.+..||.||..|+ |+||++++++|+++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 58889999999999999999999989999998876432 2224667999999998 99999999999999
Q ss_pred CeEEEEEEcC-CCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCc
Q 043702 449 GEILLVYDLM-PNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLA 527 (711)
Q Consensus 449 ~~~~lV~Ey~-~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla 527 (711)
+.+||++|-. ++-+|.+++. .+..+++.+..-|++||+.|+++||+. +|||||||-+||.+|.+|-+||+|||.+
T Consensus 642 d~yyl~te~hg~gIDLFd~IE-~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgsa 717 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIE-FKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGSA 717 (772)
T ss_pred CeeEEEecCCCCCcchhhhhh-ccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccch
Confidence 9999999975 5668999984 456799999999999999999999998 9999999999999999999999999999
Q ss_pred eecCCCCCCCcccccCCCcccChhhhccCCC-CccccchhHHHHHHHHHhCCCCCc
Q 043702 528 RQVEHDKSPDATVAAGTMGYLAPEYLLTGRA-TEKTDVFSYGAVVLEVASGRRPIE 582 (711)
Q Consensus 528 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwSfGvll~elltG~~P~~ 582 (711)
.....+ .....+||.+|.|||++.+.+| ...-|||++|++||.++....||.
T Consensus 718 a~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 718 AYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 876543 2345679999999999998877 667899999999999999998875
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.2e-28 Score=230.65 Aligned_cols=257 Identities=21% Similarity=0.281 Sum_probs=194.9
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcC-CCCeeeeeeeeeec--CeEEEEE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLR-HRNLVRLQGWCHEK--GEILLVY 455 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~--~~~~lV~ 455 (711)
.++|++.+++|+|-+++||.|..-.+++.++||+++.-+ .+.+.+|+.+|..|+ ||||++|++...+. ....||+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF 114 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF 114 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence 367888999999999999999987889999999987533 567899999999999 99999999998765 4578999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCC-CcEEEeecCCceecCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEG-FNARLGDFGLARQVEHDK 534 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~-~~vkL~DFGla~~~~~~~ 534 (711)
||+.+.+...+- ..|+...+...+.+++.||.|+|+. ||.|||+||.||++|.. ...+|+|+|||.++..+.
T Consensus 115 E~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~ 187 (338)
T KOG0668|consen 115 EYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
T ss_pred hhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence 999998766544 3577788899999999999999998 99999999999999865 469999999999887665
Q ss_pred CCCcccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhH-
Q 043702 535 SPDATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLT- 612 (711)
Q Consensus 535 ~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~- 612 (711)
... ..+.+..|--||.+..- .|...-|+|||||+|.+|+..+.||-.... ....++..+.-+ ....+..
T Consensus 188 eYn--VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d------N~DQLVkIakVL-Gt~el~~Y 258 (338)
T KOG0668|consen 188 EYN--VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD------NYDQLVKIAKVL-GTDELYAY 258 (338)
T ss_pred eee--eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC------CHHHHHHHHHHh-ChHHHHHH
Confidence 443 33567788999998765 467778999999999999999999854211 112333322111 1111111
Q ss_pred ------hhhhhccC---CCc-------------HHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 613 ------AADARLEG---QFD-------------EAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 613 ------~~d~~l~~---~~~-------------~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
.+|++... ... .-...+.++++...|..|-++|||++|.+.
T Consensus 259 l~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 259 LNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 01222111 000 001245677778888899999999999886
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=239.64 Aligned_cols=265 Identities=23% Similarity=0.244 Sum_probs=195.5
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC---CCChhhhHHHHHHHHhcCCCCeeeeeeeeeec------Ce
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN---SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEK------GE 450 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~ 450 (711)
.+|...+.+|.|.- .|..+.+.-.++.||+|+.... ....+...+|..++..++|+|+++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666777888888 7888888778899999987653 33456678999999999999999999998654 35
Q ss_pred EEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceec
Q 043702 451 ILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV 530 (711)
Q Consensus 451 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~ 530 (711)
.|+|||+| ..+|...+. -.++-.....|+.|++.|++|||+. +|+||||||+||++..+..+||.|||+|+.-
T Consensus 96 ~y~v~e~m-~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVIL---MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HHHHHHhh-hhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhccc
Confidence 79999999 558888875 3466778889999999999999998 9999999999999999999999999999875
Q ss_pred CCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccc-----------cccccccchHH
Q 043702 531 EHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGV-----------GKVGVASNLVE 599 (711)
Q Consensus 531 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~-----------~~~~~~~~l~~ 599 (711)
..+ ...+..+.|..|.|||++.+..+.+.+||||.||++.||++|+--|.+.+.-. ........+..
T Consensus 169 ~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~ 246 (369)
T KOG0665|consen 169 DTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP 246 (369)
T ss_pred Ccc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence 544 45667789999999999999889999999999999999999998886432100 00000011111
Q ss_pred HHHHhhhcCc------hhHhh-hhhcc--CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 600 WVWSLHREGR------LLTAA-DARLE--GQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 600 ~~~~~~~~~~------~~~~~-d~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
-+....+... ..+.. |.... .+.+.-....+.+++.+||-.||++|-+++++++.
T Consensus 247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 1111111000 00000 00000 01111223456678899999999999999999973
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-28 Score=255.45 Aligned_cols=203 Identities=24% Similarity=0.268 Sum_probs=175.9
Q ss_pred HHHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcC------CCCeeeeeeeeeecC
Q 043702 376 RSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLR------HRNLVRLQGWCHEKG 449 (711)
Q Consensus 376 ~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~------H~niv~l~g~~~~~~ 449 (711)
+.....|......|+|-|++|.+|.+...|..||||++..++.-.+.=+.|+++|++|+ .-++++|+-.|...+
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn 507 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN 507 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence 34556888889999999999999999888999999999987776777789999999996 347899999999999
Q ss_pred eEEEEEEcCCCCCHHHHHhhCCC--CCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCC-cEEEeecCC
Q 043702 450 EILLVYDLMPNGSLDKALFEARS--PLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGF-NARLGDFGL 526 (711)
Q Consensus 450 ~~~lV~Ey~~~gsL~~~l~~~~~--~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~-~vkL~DFGl 526 (711)
++|||+|-+ ..+|.++|.+-+. .|....+..++.|+.-||..|... +|+|.||||.|||+++.. .+||||||.
T Consensus 508 HLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 508 HLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred eeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCcc
Confidence 999999988 5599999976443 478889999999999999999987 999999999999998765 479999999
Q ss_pred ceecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCcccc
Q 043702 527 ARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEI 585 (711)
Q Consensus 527 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~ 585 (711)
|....... .+...-+.-|.|||++.+..|....|+||.||+||||.||+--|.+..
T Consensus 584 A~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T 639 (752)
T KOG0670|consen 584 ASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT 639 (752)
T ss_pred cccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence 98765543 333445667999999999999999999999999999999999886543
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-27 Score=229.94 Aligned_cols=254 Identities=20% Similarity=0.326 Sum_probs=191.3
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcC-CCCeeeeeee-eeecCeEEEEEE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLR-HRNLVRLQGW-CHEKGEILLVYD 456 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~-~~~~~~~~lV~E 456 (711)
.+.|.+.+.||+|.||.+-++.+++....+++|-+.......++|.+|...--.|. |.||+.-++. ++..+..++++|
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 35688899999999999999999999999999999887777899999988766665 9999987775 455677889999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEE--cCCCcEEEeecCCceecCCCC
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIML--DEGFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl--d~~~~vkL~DFGla~~~~~~~ 534 (711)
|+|.|+|.+-+.. ..+.+....+++.|++.|+.|+|++ ++||||||.+|||| .+..++||||||+.+..+.-.
T Consensus 103 ~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV 177 (378)
T KOG1345|consen 103 FAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV 177 (378)
T ss_pred cCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCcee
Confidence 9999999987743 4577888899999999999999998 99999999999999 345589999999998654322
Q ss_pred CCCcccccCCCcccChhhhccC-----CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCc
Q 043702 535 SPDATVAAGTMGYLAPEYLLTG-----RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGR 609 (711)
Q Consensus 535 ~~~~~~~~gt~~y~APE~~~~~-----~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 609 (711)
....-+..|.+||..... ...+.+|||.||++++.++||+.||.... .......+|. .+..+.
T Consensus 178 ----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~------~~d~~Y~~~~--~w~~rk 245 (378)
T KOG1345|consen 178 ----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS------IMDKPYWEWE--QWLKRK 245 (378)
T ss_pred ----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh------ccCchHHHHH--HHhccc
Confidence 122346679999987543 24678999999999999999999997431 1223334443 333332
Q ss_pred hhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 043702 610 LLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655 (711)
Q Consensus 610 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L 655 (711)
.... |..-..+. .+++++-.+-+.++|++|=-..++.++.
T Consensus 246 ~~~~--P~~F~~fs----~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 246 NPAL--PKKFNPFS----EKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred CccC--chhhcccC----HHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 2211 11222233 3344555678889999995555555443
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-27 Score=280.70 Aligned_cols=197 Identities=16% Similarity=0.190 Sum_probs=142.5
Q ss_pred HhcCC-CCeeeeeeee-------eecCeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCee
Q 043702 431 GTLRH-RNLVRLQGWC-------HEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVI 502 (711)
Q Consensus 431 ~~l~H-~niv~l~g~~-------~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iv 502 (711)
+.++| +||++++++| .+...+++++||+ +++|.++|......+++.+++.++.||++||.|||+. +|+
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---gIv 102 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQ---GIV 102 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 34566 6888888887 2334678889987 6699999976667799999999999999999999987 999
Q ss_pred eccCCCCceEEcC-------------------CCcEEEeecCCceecCCCC---------------CCCcccccCCCccc
Q 043702 503 HRDVKTSNIMLDE-------------------GFNARLGDFGLARQVEHDK---------------SPDATVAAGTMGYL 548 (711)
Q Consensus 503 HrDlkp~NILld~-------------------~~~vkL~DFGla~~~~~~~---------------~~~~~~~~gt~~y~ 548 (711)
||||||+||||+. ++.+|++|||+++...... ........||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999954 4456666666665421100 00011245889999
Q ss_pred ChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHH
Q 043702 549 APEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMR 628 (711)
Q Consensus 549 APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 628 (711)
|||++.+..++.++|||||||+||||++|..|+..... .+..+... ...+.. .....
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---------~~~~~~~~---------~~~~~~-----~~~~~ 239 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---------TMSSLRHR---------VLPPQI-----LLNWP 239 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---------HHHHHHHh---------hcChhh-----hhcCH
Confidence 99999999999999999999999999999888643210 00011000 001110 11123
Q ss_pred HHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 629 RVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 629 ~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
....++.+||+++|.+||+|.|+++.
T Consensus 240 ~~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 240 KEASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHHHHhCCCChhhCcChHHHhhc
Confidence 34577889999999999999999863
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-27 Score=257.57 Aligned_cols=251 Identities=22% Similarity=0.323 Sum_probs=200.1
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC-CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcC
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
++|+....+|.|.+|.|||+++...++..|+|+++... .+..-+.+|+-+++..+||||+.++|-+..++.+++.||||
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc 94 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC 94 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence 46888899999999999999999999999999988743 45567788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCc
Q 043702 459 PNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDA 538 (711)
Q Consensus 459 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 538 (711)
.+|+|.+.-+ ..+++++.+....++..++||+|||+. +-+|||||-.|||+++.+.+|++|||.+..+...- ...
T Consensus 95 gggslQdiy~-~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati-~Kr 169 (829)
T KOG0576|consen 95 GGGSLQDIYH-VTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATI-AKR 169 (829)
T ss_pred CCCcccceee-ecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhh-hhh
Confidence 9999998654 456799999999999999999999998 88999999999999999999999999987654322 223
Q ss_pred ccccCCCcccChhhh---ccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhh
Q 043702 539 TVAAGTMGYLAPEYL---LTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615 (711)
Q Consensus 539 ~~~~gt~~y~APE~~---~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 615 (711)
....||+.|||||+. +.+.|..++|||+.|+...|+---++|.-+.-+ . . +..+... . ..+
T Consensus 170 ksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp---------m--r-~l~LmTk-S---~~q 233 (829)
T KOG0576|consen 170 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP---------M--R-ALFLMTK-S---GFQ 233 (829)
T ss_pred hcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch---------H--H-HHHHhhc-c---CCC
Confidence 446799999999986 467799999999999999999888877432110 0 0 0011111 0 011
Q ss_pred -hhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 616 -ARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 616 -~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
+.+. -.......+-+++..|+-.+|.+||+++.+++
T Consensus 234 pp~lk--Dk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 234 PPTLK--DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCccc--CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1111 12234456677889999999999999876553
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=241.39 Aligned_cols=204 Identities=27% Similarity=0.428 Sum_probs=170.5
Q ss_pred HHHHhcCCcccceeecCCceEEEEEEeCC---CCeEEEEEEcccCCCChhhhHHHHHHHHhcC-CCCeeeeeeeeeecCe
Q 043702 375 LRSATKCFNANRIIGHGAFGTVYKGILPQ---NGDIIAVKRCSHNSQGKDEFLSELSIIGTLR-HRNLVRLQGWCHEKGE 450 (711)
Q Consensus 375 l~~at~~f~~~~~LG~G~fg~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~ 450 (711)
+....+.|...++||+|.|++||++.+.. .++.||+|.+.... ....+.+|+++|..+. +.||+++.+++...++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 33455678899999999999999999876 67899999886533 2456889999999998 9999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcC-CCcEEEeecCCcee
Q 043702 451 ILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDE-GFNARLGDFGLARQ 529 (711)
Q Consensus 451 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~-~~~vkL~DFGla~~ 529 (711)
.++|+||++.....+++.. ++...+..+++.++.||.++|.. |||||||||+|+|.+. -++-.|.|||||..
T Consensus 110 v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred eEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHH
Confidence 9999999999998888743 66889999999999999999998 9999999999999974 45689999999972
Q ss_pred cCCCC-------------------------------------------CCCcccccCCCcccChhhhccC-CCCccccch
Q 043702 530 VEHDK-------------------------------------------SPDATVAAGTMGYLAPEYLLTG-RATEKTDVF 565 (711)
Q Consensus 530 ~~~~~-------------------------------------------~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVw 565 (711)
.+... ........||+||.|||++... ..+.+.|||
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw 262 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW 262 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence 11000 0001124699999999998765 578999999
Q ss_pred hHHHHHHHHHhCCCCCccccc
Q 043702 566 SYGAVVLEVASGRRPIEKEIT 586 (711)
Q Consensus 566 SfGvll~elltG~~P~~~~~~ 586 (711)
|.||+++.+++++.||-...+
T Consensus 263 s~GVI~Lslls~~~PFf~a~d 283 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFKAKD 283 (418)
T ss_pred eccceeehhhccccccccCcc
Confidence 999999999999999976544
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=217.00 Aligned_cols=166 Identities=22% Similarity=0.173 Sum_probs=126.6
Q ss_pred CCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCccc
Q 043702 461 GSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATV 540 (711)
Q Consensus 461 gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 540 (711)
|+|.+++...+..+++.+++.|+.|++.||+|||+. + ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc------
Confidence 789999987677799999999999999999999997 4 999999999999999 99998765432
Q ss_pred ccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccC
Q 043702 541 AAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEG 620 (711)
Q Consensus 541 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 620 (711)
..||+.|||||++.+..++.++|||||||++|||++|+.||...... ...+..+....... ++. ..
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~------~~~~~~~~~~~~~~-------~~~-~~ 129 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL------SAILEILLNGMPAD-------DPR-DR 129 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh------cHHHHHHHHHhccC-------Ccc-cc
Confidence 25899999999999999999999999999999999999998643210 01111111110000 000 00
Q ss_pred CCcHHHH--HHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 621 QFDEAEM--RRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 621 ~~~~~~~--~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
....... ..+.+++.+||+.+|.+||++.|+++.+..
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 0111122 258899999999999999999999998753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=223.73 Aligned_cols=169 Identities=20% Similarity=0.206 Sum_probs=132.5
Q ss_pred HHHHHhcCCcccceeecCCceEEEEEEeCC-CCeEEEEEEcccCC------CChhhhHHHHHHHHhcCCCCeeeeeeeee
Q 043702 374 ELRSATKCFNANRIIGHGAFGTVYKGILPQ-NGDIIAVKRCSHNS------QGKDEFLSELSIIGTLRHRNLVRLQGWCH 446 (711)
Q Consensus 374 el~~at~~f~~~~~LG~G~fg~Vy~~~~~~-~~~~vavK~~~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~ 446 (711)
.......+|...+.||+|+||+||+|++.. +++.+|||++.... ...+.+.+|+++|++++|+|+++.+..
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~-- 89 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA-- 89 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE--
Confidence 344566789999999999999999998865 67888999865321 124568899999999999999853322
Q ss_pred ecCeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccC-CCCceEEcCCCcEEEeecC
Q 043702 447 EKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDV-KTSNIMLDEGFNARLGDFG 525 (711)
Q Consensus 447 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDl-kp~NILld~~~~vkL~DFG 525 (711)
.+..++||||+++++|.. + .... ...++.|++++|.|||+. +|+|||| ||+|||++.++++||+|||
T Consensus 90 -~~~~~LVmE~~~G~~L~~-~-~~~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 90 -TGKDGLVRGWTEGVPLHL-A-RPHG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred -cCCcEEEEEccCCCCHHH-h-Cccc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 246799999999999973 2 1111 256789999999999997 9999999 9999999999999999999
Q ss_pred CceecCCCCC-------CCcccccCCCcccChhhhccC
Q 043702 526 LARQVEHDKS-------PDATVAAGTMGYLAPEYLLTG 556 (711)
Q Consensus 526 la~~~~~~~~-------~~~~~~~gt~~y~APE~~~~~ 556 (711)
+++.+..... ...+...+++.|+|||++...
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9997754321 112345688999999998643
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.6e-24 Score=209.37 Aligned_cols=242 Identities=21% Similarity=0.315 Sum_probs=188.7
Q ss_pred cceeecCCceEEEEEEeCCCCeEEEEEEccc---CCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCCCC
Q 043702 385 NRIIGHGAFGTVYKGILPQNGDIIAVKRCSH---NSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNG 461 (711)
Q Consensus 385 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 461 (711)
.-+|.+...|+.|+|++. |..+++|++.. .....++|..|.-.|+.+.||||+.++|.|....++.++..||+.|
T Consensus 195 ~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence 345889999999999995 44466676654 2344568999999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCC-CCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEe--ecCCceecCCCCCCCc
Q 043702 462 SLDKALFEARS-PLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLG--DFGLARQVEHDKSPDA 538 (711)
Q Consensus 462 sL~~~l~~~~~-~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~--DFGla~~~~~~~~~~~ 538 (711)
+|+..|++... ..+-.+..++++++|+|++|||+. ++-|..--|.+..|++|++.++||+ |--++.. .
T Consensus 273 slynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfq--------e 343 (448)
T KOG0195|consen 273 SLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ--------E 343 (448)
T ss_pred HHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeee--------c
Confidence 99999987554 367788999999999999999997 5556666799999999999998875 3222211 1
Q ss_pred ccccCCCcccChhhhccCCC---CccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhh
Q 043702 539 TVAAGTMGYLAPEYLLTGRA---TEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615 (711)
Q Consensus 539 ~~~~gt~~y~APE~~~~~~~---s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 615 (711)
....-.+.||+||.++..+- -.++|+|||.++||||.|...||.+..+-+. -+++.-
T Consensus 344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec--------------------gmkial 403 (448)
T KOG0195|consen 344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC--------------------GMKIAL 403 (448)
T ss_pred cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh--------------------hhhhhh
Confidence 11224678999999987653 4578999999999999999999976433110 012222
Q ss_pred hhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 616 ARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 616 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
+.++..+++.....+.+|+.-|+..||.+||.+..|+-.|+.
T Consensus 404 eglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilek 445 (448)
T KOG0195|consen 404 EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEK 445 (448)
T ss_pred ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence 334444555566778888899999999999999999988875
|
|
| >cd07308 lectin_leg-like legume-like lectins: ERGIC-53, ERGL, VIP36, VIPL, EMP46, and EMP47 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.4e-21 Score=194.57 Aligned_cols=190 Identities=22% Similarity=0.241 Sum_probs=136.9
Q ss_pred CCCeEEeCceEeeCCcEEeCCCCCCCCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecCCCCCCCCceEEEEcCCC
Q 043702 43 LASLKLLGDAHMNNGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLNPSSIGAGLAFVITPDG 122 (711)
Q Consensus 43 ~~~~~~~g~a~~~~g~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~GlaF~l~~~~ 122 (711)
.+++.+.|+|.+.++.|+||++.. ++.|+++|+.|+++ .+|+|+|+|+|.+.. ..+||||||+|++..
T Consensus 19 ~~~w~~~G~a~~~~~~i~LT~~~~---~~~G~~~~~~pi~~--------~~F~~~f~F~i~~~~-~~~gdG~af~~~~~~ 86 (218)
T cd07308 19 IGNWTVGGSTVITKNYIRLTPDVP---SQSGSLWSRVPIPA--------KDFEIEVEFSIHGGS-GLGGDGFAFWYTEEP 86 (218)
T ss_pred cCCeEEcCCeEEeCCEEEeCCCCC---CCEeEEEeCCCccC--------CCEEEEEEEEEeCCC-CCCCCEEEEEEECCC
Confidence 468999999999999999999876 78999999999998 479999999998753 568999999999865
Q ss_pred CCCCCCCCcccccccCCCCcceEEEEeecccCCCCCCCCCCeeeEecCCC-cccc------cccCCccccccCC-CCeEE
Q 043702 123 EQVGSAGGSLGLLDEKGAGLGFVAVEFDTLMDVEFSDINGNHVGLDLNSM-VSTE------VDNLDTINVDLKS-GDLVN 194 (711)
Q Consensus 123 ~~~~~~g~~lgl~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~-~S~~------~~~~~~~~~~~~~-g~~~~ 194 (711)
.. .|+.+|.-+. .+-+||||||+.|. +-...+|.+-+|.- .+.. ........+...+ +...+
T Consensus 87 ~~---~g~~~G~~~~----~~Glai~fdt~~n~---~~~~p~i~~~~Ndg~~~~~~~~d~~~~~~~~c~~~~~~~~~~~~ 156 (218)
T cd07308 87 GS---DGPLFGGPDK----FKGLAIFFDTYDND---GKGFPSISVFLNDGTKSYDYETDGEKLELASCSLKFRNSNAPTT 156 (218)
T ss_pred CC---CCcccccCCC----CCEEEEEEEcCCCC---CCCCCeEEEEEeCCCceecccCCCccccccceeEecccCCCCeE
Confidence 43 4445554322 34589999999985 22334455433322 1211 1112222333333 68999
Q ss_pred EEEEEcccccEEEEEEEecCCCCCcceeeEecCcccccccceeEEEeeeccCceeeEEEEeeccc
Q 043702 195 SWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGSTEIHSIEWWSFS 259 (711)
Q Consensus 195 ~~I~Y~~~~~~l~V~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastg~~~~~~~i~sW~f~ 259 (711)
++|.|+ .+.|.|.+.+....... ....++. ..+|+..|+||||+||...+.|+|++|.+.
T Consensus 157 ~~I~y~--~~~l~v~i~~~~~~~~~--~c~~~~~-~~l~~~~y~G~sA~tg~~~d~~dIls~~~~ 216 (218)
T cd07308 157 LRISYL--NNTLKVDITYSEGNNWK--ECFTVED-VILPSQGYFGFSAQTGDLSDNHDILSVHTY 216 (218)
T ss_pred EEEEEE--CCEEEEEEeCCCCCCcc--EEEEcCC-cccCCCCEEEEEeccCCCcCcEEEEEEEee
Confidence 999999 67899988764322222 3333332 257789999999999999999999999864
|
The legume-like (leg-like) lectins are eukaryotic intracellular sugar transport proteins with a carbohydrate recognition domain similar to that of the legume lectins. This domain binds high-mannose-type oligosaccharides for transport from the endoplasmic reticulum to the Golgi complex. These leg-like lectins include ERGIC-53, ERGL, VIP36, VIPL, EMP46, EMP47, and the UIP5 (ULP1-interacting protein 5) precursor protein. Leg-like lectins have different intracellular distributions and dynamics in the endoplasmic reticulum-Golgi system of the secretory pathway and interact with N-glycans of glycoproteins in a calcium-dependent manner, suggesting a role in glycoprotein sorting and trafficking. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "ba |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-21 Score=208.01 Aligned_cols=257 Identities=21% Similarity=0.241 Sum_probs=189.9
Q ss_pred CCcccceeecCCceEEEEEEeCCCC-eEEEEEEcccCCC-ChhhhHHHHHHHHhcCC----CCeeeeeeee-eecCeEEE
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNG-DIIAVKRCSHNSQ-GKDEFLSELSIIGTLRH----RNLVRLQGWC-HEKGEILL 453 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~-~~vavK~~~~~~~-~~~~~~~Ei~~l~~l~H----~niv~l~g~~-~~~~~~~l 453 (711)
+|...++||+|+||.||++.....+ ..+|+|....... ....+..|..++..+.. +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 7899999999999999999986654 5788887665322 22378899999999973 5888888888 46778899
Q ss_pred EEEcCCCCCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCC-----CcEEEeecCCc
Q 043702 454 VYDLMPNGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEG-----FNARLGDFGLA 527 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~-----~~vkL~DFGla 527 (711)
||+.+ +.+|.++..... +.++....++|+.|++.+|++||+. +++||||||.|+++... ..+.|.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99988 779999875544 7899999999999999999999998 99999999999999754 46899999999
Q ss_pred e--ecCCCCC----CC---cccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchH
Q 043702 528 R--QVEHDKS----PD---ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLV 598 (711)
Q Consensus 528 ~--~~~~~~~----~~---~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~ 598 (711)
+ .+..... .. .....||..|.+++...+...+.+.|+||++.++.|++.|..||....... ....+.
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~----~~~~~~ 250 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTD----LKSKFE 250 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccc----hHHHHH
Confidence 8 3222211 11 223459999999999999999999999999999999999999996542210 000000
Q ss_pred HHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 599 EWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 599 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
....... ... .....+.+... +...+-..+..++|....+...|+..
T Consensus 251 ~~~~~~~--------~~~--~~~~~~~~~~~---~~~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 251 KDPRKLL--------TDR--FGDLKPEEFAK---ILEYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred HHhhhhc--------ccc--ccCCChHHHHH---HHHHhhccCCcCCCCHHHHHHHHHHH
Confidence 0000000 000 11122333333 33344447899999999998887554
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.9e-21 Score=200.21 Aligned_cols=258 Identities=30% Similarity=0.453 Sum_probs=196.1
Q ss_pred CcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC----ChhhhHHHHHHHHhcCCC-CeeeeeeeeeecCeEEEEEE
Q 043702 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ----GKDEFLSELSIIGTLRHR-NLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 382 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~Ei~~l~~l~H~-niv~l~g~~~~~~~~~lV~E 456 (711)
|...+.||.|+||.||++.+. ..+++|.+..... ....+.+|+.+++.+.|+ +++++.+.+......++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 566788999999999999985 7789998876332 356899999999999988 79999999977777899999
Q ss_pred cCCCCCHHHHHhhCC--CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCC-cEEEeecCCceecCCC
Q 043702 457 LMPNGSLDKALFEAR--SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGF-NARLGDFGLARQVEHD 533 (711)
Q Consensus 457 y~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~-~vkL~DFGla~~~~~~ 533 (711)
|+.+++|.+++.... ..+.......++.|++.++.|+|+. +++|||+||+||+++... .+|++|||+++.....
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 999999997775444 2789999999999999999999998 899999999999999988 7999999999866544
Q ss_pred CCC-----CcccccCCCcccChhhhcc---CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhh
Q 043702 534 KSP-----DATVAAGTMGYLAPEYLLT---GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLH 605 (711)
Q Consensus 534 ~~~-----~~~~~~gt~~y~APE~~~~---~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~ 605 (711)
... ......|+..|+|||.+.. ..+....|+|++|++++++++|..||...... .......+..+...
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~----~~~~~~~~~~~~~~ 231 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS----SATSQTLKIILELP 231 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc----ccHHHHHHHHHhcC
Confidence 322 2355679999999999987 57889999999999999999999997543210 00011111111111
Q ss_pred hcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 606 REGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 606 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.. .... .............+.+++..|+..+|..|.++.+....
T Consensus 232 ~~-~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 232 TP-SLAS----PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred Cc-cccc----ccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00 0000 00000001223456678888999999999999987764
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.4e-20 Score=187.33 Aligned_cols=200 Identities=20% Similarity=0.312 Sum_probs=174.2
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcC-CCCeeeeeeeeeecCeEEEEEEcCC
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLR-HRNLVRLQGWCHEKGEILLVYDLMP 459 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~ 459 (711)
+|...++||+|.||..+.|+.--+++.||||.-. .+.+..++..|.+.++.|. .++|...+-+-.++.+-.||+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEP-rkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL- 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEP-RKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL- 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEecc-ccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence 5778899999999999999988899999999644 3445678889999999987 789999988888888889999998
Q ss_pred CCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcC-----CCcEEEeecCCceecCCCC
Q 043702 460 NGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDE-----GFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 460 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~-----~~~vkL~DFGla~~~~~~~ 534 (711)
|-+|+++..-.++.++.+.+.-|+.|++.-++|+|++ .+|.|||||+|+||.. ...+.|+|||+|+.+.+..
T Consensus 107 GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~ 183 (449)
T KOG1165|consen 107 GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPK 183 (449)
T ss_pred CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcc
Confidence 7799998877888999999999999999999999998 9999999999999953 3358899999999886554
Q ss_pred CC------CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCcccc
Q 043702 535 SP------DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEI 585 (711)
Q Consensus 535 ~~------~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~ 585 (711)
.. +.....||.+||+-....+...+.+.|+=|+|-++...+-|..||....
T Consensus 184 TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 184 TKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred ccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 32 2234569999999998889999999999999999999999999997643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.6e-22 Score=225.44 Aligned_cols=253 Identities=21% Similarity=0.268 Sum_probs=188.5
Q ss_pred cccceeecCCceEEEEEEeCCCCeEEEEEEcc----cCCCCh---hhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 383 NANRIIGHGAFGTVYKGILPQNGDIIAVKRCS----HNSQGK---DEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 383 ~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~----~~~~~~---~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
...+++|.|.+|.|+........+..+.|... ....+. ..+..|+-+-..++|+|++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45678999999988888776555555555433 211111 12556777788899999999888887776666669
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
|||++ +|...+... ..+...++..++.|++.|++|||+. +|.|||+|++|++++.++.+||+|||.+........
T Consensus 401 E~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 99999 999988543 4788899999999999999999998 999999999999999999999999999987654433
Q ss_pred ---CCcccccCCCcccChhhhccCCCCc-cccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchh
Q 043702 536 ---PDATVAAGTMGYLAPEYLLTGRATE-KTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLL 611 (711)
Q Consensus 536 ---~~~~~~~gt~~y~APE~~~~~~~s~-ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 611 (711)
......+|+..|+|||++....|.+ ..||||.|+++..|++|+.||.......... ....-..|. +..
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-~~~~~~~~~-------~~~ 547 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-KTNNYSDQR-------NIF 547 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-hhhcccccc-------ccc
Confidence 3445678999999999999988865 5799999999999999999997543211100 000000000 000
Q ss_pred HhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 612 TAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 612 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
.- ..........+...++.++|+.||.+|-|+++|++
T Consensus 548 ~~-----~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 548 EG-----PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cC-----hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00 00112334566778889999999999999999987
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-20 Score=182.86 Aligned_cols=202 Identities=24% Similarity=0.328 Sum_probs=172.4
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCC-CCeeeeeeeeeecCeEEEEEEc
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRH-RNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~Ey 457 (711)
..+|...++||.|+||.+|.|..-..|+.||||.-+.. ....++.-|.++...|++ ..|..+..|..++..-.+|||.
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL 92 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK-AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL 92 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc-CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence 35689999999999999999999999999999986542 334578889999999984 6777888888888889999999
Q ss_pred CCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcC---CCcEEEeecCCceecCCCC
Q 043702 458 MPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDE---GFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 458 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~---~~~vkL~DFGla~~~~~~~ 534 (711)
+ +-+|+++..-....++...++-++-|++.-++|+|.. +++||||||+|+|..- ...+.|+||||++.+.+..
T Consensus 93 L-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~ 168 (341)
T KOG1163|consen 93 L-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIR 168 (341)
T ss_pred c-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhcccc
Confidence 8 7799998877778899999999999999999999998 9999999999999954 3468899999998765433
Q ss_pred C------CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCcccc
Q 043702 535 S------PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEI 585 (711)
Q Consensus 535 ~------~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~ 585 (711)
. .......||.+|.+-....+...+.+.|+=|+|.+|..+.-|..||....
T Consensus 169 t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk 225 (341)
T KOG1163|consen 169 TRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK 225 (341)
T ss_pred ccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc
Confidence 2 12344679999999887777788999999999999999999999997653
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.9e-20 Score=181.47 Aligned_cols=139 Identities=17% Similarity=0.215 Sum_probs=108.5
Q ss_pred cceeecCCceEEEEEEeCCCCeEEEEEEcccCCC---C-------hhhh-----------------HHHHHHHHhcCCCC
Q 043702 385 NRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ---G-------KDEF-----------------LSELSIIGTLRHRN 437 (711)
Q Consensus 385 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~-------~~~~-----------------~~Ei~~l~~l~H~n 437 (711)
...||+|++|.||+|.+. +|+.||||++..... . ...| ..|++.+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 457999999999999996 799999999875321 1 1122 34999999998877
Q ss_pred eeeeeeeeeecCeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHH-HhccCCCeeeccCCCCceEEcCC
Q 043702 438 LVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYL-HQECENQVIHRDVKTSNIMLDEG 516 (711)
Q Consensus 438 iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yL-H~~~~~~ivHrDlkp~NILld~~ 516 (711)
+.....+.. ...++||||+++++|...+.. ...+++....+++.|++.+|.|| |+. +|+||||||+|||++ +
T Consensus 81 v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~ 153 (190)
T cd05147 81 IPCPEPILL--KSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCCcEEEe--cCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-C
Confidence 644333222 223899999998877654322 35788999999999999999999 676 999999999999998 4
Q ss_pred CcEEEeecCCceecC
Q 043702 517 FNARLGDFGLARQVE 531 (711)
Q Consensus 517 ~~vkL~DFGla~~~~ 531 (711)
+.++|+|||++....
T Consensus 154 ~~v~LiDFG~a~~~~ 168 (190)
T cd05147 154 GKLYIIDVSQSVEHD 168 (190)
T ss_pred CcEEEEEccccccCC
Confidence 789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.7e-20 Score=201.10 Aligned_cols=216 Identities=22% Similarity=0.327 Sum_probs=162.6
Q ss_pred HHhcCCCCeeeeeeeeeecCeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCC
Q 043702 430 IGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTS 509 (711)
Q Consensus 430 l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~ 509 (711)
|+.+.|.|+.+++|.|.++...+.|.+||..|+|.+.+......++|.-...++++|+.||.|||.. +-..|+.++++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeeeccc
Confidence 3568899999999999999999999999999999999988788899999999999999999999986 23399999999
Q ss_pred ceEEcCCCcEEEeecCCceecCCCC-CCCcccccCCCcccChhhhccC-------CCCccccchhHHHHHHHHHhCCCCC
Q 043702 510 NIMLDEGFNARLGDFGLARQVEHDK-SPDATVAAGTMGYLAPEYLLTG-------RATEKTDVFSYGAVVLEVASGRRPI 581 (711)
Q Consensus 510 NILld~~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~-------~~s~ksDVwSfGvll~elltG~~P~ 581 (711)
|+++|..+.+||+|||+........ ........-..-|.|||.+... ..+.++||||||++++|+++.+.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 9999999999999999998764311 0111111123469999998763 1467899999999999999999999
Q ss_pred ccccccccccccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 582 EKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 582 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
+....... ...++.++.. .+. ...-|.+... .+...++..++.+||..+|.+||++++|-..++..
T Consensus 159 ~~~~~~~~----~~eii~~~~~---~~~--~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 159 DLRNLVED----PDEIILRVKK---GGS--NPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred ccccccCC----hHHHHHHHHh---cCC--CCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 76432111 1122222221 011 1111111100 13334688899999999999999999998887654
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.1e-20 Score=184.13 Aligned_cols=177 Identities=12% Similarity=0.128 Sum_probs=136.3
Q ss_pred CHHHHHH--HhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhh----------hHHHHHHHHhcCCCCe
Q 043702 371 SYRELRS--ATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDE----------FLSELSIIGTLRHRNL 438 (711)
Q Consensus 371 ~~~el~~--at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~----------~~~Ei~~l~~l~H~ni 438 (711)
.|.++.. ..++|...++||.|+||.||+... ++..+|+|.+.......+. +.+|++.+.+++|++|
T Consensus 20 ~~~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI 97 (232)
T PRK10359 20 KYKEIFDDFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGL 97 (232)
T ss_pred cHHHHHHHHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCC
Confidence 3455433 467899999999999999999655 4668999998753322222 5789999999999999
Q ss_pred eeeeeeeeec--------CeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCc
Q 043702 439 VRLQGWCHEK--------GEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSN 510 (711)
Q Consensus 439 v~l~g~~~~~--------~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~N 510 (711)
..+..++... +..+|+|||++|.+|.++.. ++. ....+++.+|..||+. +++|||+||+|
T Consensus 98 ~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~N 165 (232)
T PRK10359 98 ASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQH---GMVSGDPHKGN 165 (232)
T ss_pred CcceEeeeecccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHc---CCccCCCChHH
Confidence 9998885532 35899999999999988641 222 3466999999999998 99999999999
Q ss_pred eEEcCCCcEEEeecCCceecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHH
Q 043702 511 IMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVA 575 (711)
Q Consensus 511 ILld~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ell 575 (711)
|+++.++ ++|+|||.......+...+ .++....+..++|+|+||+.+.-+.
T Consensus 166 ili~~~g-i~liDfg~~~~~~e~~a~d-------------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 166 FIVSKNG-LRIIDLSGKRCTAQRKAKD-------------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEeCCC-EEEEECCCcccccchhhHH-------------HHHHHhHhcccccccceeEeehHHH
Confidence 9999988 9999999887653322111 1344455667999999999987654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.6e-19 Score=177.12 Aligned_cols=140 Identities=18% Similarity=0.190 Sum_probs=111.2
Q ss_pred cceeecCCceEEEEEEeCCCCeEEEEEEcccCCCC---------------------------hhhhHHHHHHHHhcCCCC
Q 043702 385 NRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQG---------------------------KDEFLSELSIIGTLRHRN 437 (711)
Q Consensus 385 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---------------------------~~~~~~Ei~~l~~l~H~n 437 (711)
...||+|++|.||+|.+. +|+.||||++...... ...+..|.+.+.+++|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 467999999999999986 7999999998764211 011357899999999998
Q ss_pred eeeeeeeeeecCeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHh-ccCCCeeeccCCCCceEEcCC
Q 043702 438 LVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQ-ECENQVIHRDVKTSNIMLDEG 516 (711)
Q Consensus 438 iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivHrDlkp~NILld~~ 516 (711)
+.....+... ..+|||||++++++..... ....++.....+++.|++.+|.+||+ . +|+||||||+|||++ +
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l-~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~ 153 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRL-KDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-D 153 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhh-hhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-C
Confidence 7554444333 2489999999886544322 23457888999999999999999999 6 999999999999999 7
Q ss_pred CcEEEeecCCceecCC
Q 043702 517 FNARLGDFGLARQVEH 532 (711)
Q Consensus 517 ~~vkL~DFGla~~~~~ 532 (711)
+.++|+|||++.....
T Consensus 154 ~~~~liDFG~a~~~~~ 169 (190)
T cd05145 154 GKPYIIDVSQAVELDH 169 (190)
T ss_pred CCEEEEEcccceecCC
Confidence 8999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.5e-20 Score=214.17 Aligned_cols=249 Identities=22% Similarity=0.221 Sum_probs=182.2
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC--CChhhhHHHHHH--HHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS--QGKDEFLSELSI--IGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~Ei~~--l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
++...+.||.+.|=+|.+|+++. |. |+||++-+.. -..+.|.++++- ...++|||.+++.-+-..++..|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 46667889999999999999953 54 8899876533 334555554443 445679999999888777777889999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCcee--cCCCC
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQ--VEHDK 534 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~--~~~~~ 534 (711)
|..+ +|++.|. .+.-|...+++.|+.|++.||.-+|.. +|+|||||.+||||+.-.-+.|+||.--+. +.+++
T Consensus 102 yvkh-nLyDRlS-TRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 102 YVKH-NLYDRLS-TRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred HHhh-hhhhhhc-cchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 9866 8888883 455688889999999999999999998 999999999999999998999999976653 23333
Q ss_pred CCCccccc----CCCcccChhhhccC-----------CCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchH
Q 043702 535 SPDATVAA----GTMGYLAPEYLLTG-----------RATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLV 598 (711)
Q Consensus 535 ~~~~~~~~----gt~~y~APE~~~~~-----------~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~ 598 (711)
..+.+..- .-.+|+|||.+... ..+++.||||+||++.||++ |++||+- ..+.
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L-----------SQL~ 245 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL-----------SQLL 245 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH-----------HHHH
Confidence 32222222 23479999998652 15778999999999999999 6888753 2233
Q ss_pred HHHHHhhhcCc--hhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC
Q 043702 599 EWVWSLHREGR--LLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEA 659 (711)
Q Consensus 599 ~~~~~~~~~~~--~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~ 659 (711)
.|. .|. ..+.+-..+. -..+..+++.|++.||.+|.++++.++.-.|..
T Consensus 246 aYr-----~~~~~~~e~~Le~Ie-------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~ 296 (1431)
T KOG1240|consen 246 AYR-----SGNADDPEQLLEKIE-------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLV 296 (1431)
T ss_pred hHh-----ccCccCHHHHHHhCc-------CccHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence 322 111 1111111111 125678889999999999999999999865543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=7.9e-19 Score=172.55 Aligned_cols=187 Identities=16% Similarity=0.064 Sum_probs=143.0
Q ss_pred cccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChh-----hhHHHHHHHHhcC-CCCeeeeeeeeeecCeEEEEEE
Q 043702 383 NANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKD-----EFLSELSIIGTLR-HRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 383 ~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~-----~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 456 (711)
.....|++|+||+||.+.. .+.+++.+.+.......+ .+.+|+++|++|+ |+++.+++++ +..+++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 3467899999999997765 577888887776544333 5789999999996 5889999886 34699999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccC-CCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDV-KTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDl-kp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
|+.+.+|...+.. ....++.|++++|.++|+. +|+|||| ||+|||++.++.++|+|||++........
T Consensus 79 yI~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 79 YLAGAAMYQRPPR--------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred eecCccHHhhhhh--------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 9999998764421 1245788999999999998 9999999 79999999999999999999986543321
Q ss_pred C----C--------cccccCCCcccChhhhccC-CCC-ccccchhHHHHHHHHHhCCCCCccccc
Q 043702 536 P----D--------ATVAAGTMGYLAPEYLLTG-RAT-EKTDVFSYGAVVLEVASGRRPIEKEIT 586 (711)
Q Consensus 536 ~----~--------~~~~~gt~~y~APE~~~~~-~~s-~ksDVwSfGvll~elltG~~P~~~~~~ 586 (711)
. . ......++.|++|+...-. ..+ ...+-++-|.-+|.++|++.+...+.+
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 0 0 0112368889999865432 223 467889999999999999998765433
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.4e-18 Score=179.28 Aligned_cols=196 Identities=23% Similarity=0.280 Sum_probs=138.8
Q ss_pred CCCCeeeeeeeeee---------------------------cCeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHH
Q 043702 434 RHRNLVRLQGWCHE---------------------------KGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGV 486 (711)
Q Consensus 434 ~H~niv~l~g~~~~---------------------------~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i 486 (711)
+|||||+++++|.+ ...+|+||.-.+. +|..++... ..+...+.-|+.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~--~~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR--HRSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC--CCchHHHHHHHHHH
Confidence 49999999887632 3467999988755 899998643 35667788899999
Q ss_pred HHHHHHHHhccCCCeeeccCCCCceEE--cCCCc--EEEeecCCceecCCC-----CCCCcccccCCCcccChhhhccCC
Q 043702 487 ASALAYLHQECENQVIHRDVKTSNIML--DEGFN--ARLGDFGLARQVEHD-----KSPDATVAAGTMGYLAPEYLLTGR 557 (711)
Q Consensus 487 a~aL~yLH~~~~~~ivHrDlkp~NILl--d~~~~--vkL~DFGla~~~~~~-----~~~~~~~~~gt~~y~APE~~~~~~ 557 (711)
++|+.|||.+ +|.|||+|++|||| |+|.. ..|+|||++-..+.. .........|.-.-||||+....+
T Consensus 351 LEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 9999999998 99999999999999 44443 678999998643321 112223345888899999986432
Q ss_pred ------CCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHH
Q 043702 558 ------ATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVL 631 (711)
Q Consensus 558 ------~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 631 (711)
.-.|+|.|+.|.+.||++....||....+ +.- .... +++.++ |. .++.....+.
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe--m~L----~~r~-----Yqe~qL-----Pa----lp~~vpp~~r 487 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE--MLL----DTRT-----YQESQL-----PA----LPSRVPPVAR 487 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccch--hee----chhh-----hhhhhC-----CC----CcccCChHHH
Confidence 24689999999999999999999976321 100 0000 111111 11 2233344566
Q ss_pred HHHHhcCCCCCCCCCCHHHHHHHH
Q 043702 632 LVGLACSHPDPLARPTMRGVVQML 655 (711)
Q Consensus 632 ~l~~~Cl~~dP~~RPs~~eVl~~L 655 (711)
+|+...++.||.+||+..-....|
T Consensus 488 qlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 488 QLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHHHHhcCCccccCCccHHHhHH
Confidence 788888999999999976655544
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.8e-18 Score=178.65 Aligned_cols=231 Identities=20% Similarity=0.250 Sum_probs=150.1
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC----CChhhhHHHHHHHHhcCC----------CCeeeeeeeee
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS----QGKDEFLSELSIIGTLRH----------RNLVRLQGWCH 446 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~H----------~niv~l~g~~~ 446 (711)
.+...+.||.|+++.||.+++.++|+.+|+|++.... .+.+++++|.-....+.+ -.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3455678999999999999999999999999876422 334566666655555332 12222222221
Q ss_pred ---------ec---C-----eEEEEEEcCCCCCHHHHHh---hCCC---CCChHHHHHHHHHHHHHHHHHHhccCCCeee
Q 043702 447 ---------EK---G-----EILLVYDLMPNGSLDKALF---EARS---PLPWPHRSKILLGVASALAYLHQECENQVIH 503 (711)
Q Consensus 447 ---------~~---~-----~~~lV~Ey~~~gsL~~~l~---~~~~---~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH 503 (711)
.. . ..+++|+-+ .++|.+++. .... .+....++.+..|+++.+++||+. +++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEe
Confidence 11 1 236778877 568887753 2222 244566788889999999999998 9999
Q ss_pred ccCCCCceEEcCCCcEEEeecCCceecCCCCCCCcccccCCCcccChhhhccC--------CCCccccchhHHHHHHHHH
Q 043702 504 RDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTG--------RATEKTDVFSYGAVVLEVA 575 (711)
Q Consensus 504 rDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~--------~~s~ksDVwSfGvll~ell 575 (711)
+||||+|++++.+|.++|+||+.....+..... ...+..|.+||..... .++.+.|.|++|+++|.|.
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 999999999999999999999887654332111 2345789999977442 4688999999999999999
Q ss_pred hCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCC
Q 043702 576 SGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLAR 645 (711)
Q Consensus 576 tG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R 645 (711)
||+.||+........ +| .-..+. +..+.+..|+..+|+.||++|
T Consensus 245 C~~lPf~~~~~~~~~--------~~-----------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADP--------EW-----------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTS--------GG-----------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCccccc--------cc-----------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999765331100 00 112334 556777888899999999988
|
|
| >cd06901 lectin_VIP36_VIPL VIP36 and VIPL type 1 transmembrane proteins, lectin domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.1e-17 Score=166.91 Aligned_cols=195 Identities=17% Similarity=0.199 Sum_probs=131.0
Q ss_pred CCCCeEEeCceEeeCCcEEeCCCCCCCCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecCCCCCCCCceEEEEcCC
Q 043702 42 TLASLKLLGDAHMNNGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLNPSSIGAGLAFVITPD 121 (711)
Q Consensus 42 ~~~~~~~~g~a~~~~g~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~GlaF~l~~~ 121 (711)
..+++.+.|+|.+.++.|+||++.+ ++.|++||+.|+++ .+|+++|+|+|.+.....+||||||+++..
T Consensus 18 ~i~~w~~~G~a~v~~~~IrLTp~~~---~~~G~~w~~~p~~~--------~~F~~~f~F~I~~~~~~~~GdGlAfw~t~~ 86 (248)
T cd06901 18 SMPLWDFLGSTMVTSQYIRLTPDHQ---SKQGSIWNRVPCYL--------RDWEMHVHFKVHGSGKNLFGDGFAIWYTKE 86 (248)
T ss_pred CCCCEEEcceEEEcCCeEEECCCCC---CCEEEEeccCCccC--------CCEEEEEEEEEeCCCCCCCCCEEEEEEEcC
Confidence 3579999999999989999999877 67999999999998 579999999999876667899999999986
Q ss_pred CCCCCCCCCcccccccCCCCcceEEEEeecccCCCCC-CCCCCee-eEecCCCccccccc------CCcccccc-CCCCe
Q 043702 122 GEQVGSAGGSLGLLDEKGAGLGFVAVEFDTLMDVEFS-DINGNHV-GLDLNSMVSTEVDN------LDTINVDL-KSGDL 192 (711)
Q Consensus 122 ~~~~~~~g~~lgl~~~~~~~~~~vaVEFDt~~n~~~~-d~~~~Hv-gid~ns~~S~~~~~------~~~~~~~~-~~g~~ 192 (711)
... .|..+|-.+. ..=+||-|||+.|.+-. .....-| ++-.|+........ .+.-...+ ..+..
T Consensus 87 ~~~---~G~~fG~~~~----f~Gl~I~~Dt~~n~~~~~~~~~P~i~~~~NDGt~~yd~~~Dg~~~~~~~C~~~~rn~~~~ 159 (248)
T cd06901 87 RMQ---PGPVFGSKDN----FHGLAIFFDTYSNQNGEHEHVHPYISAMVNNGSLSYDHDRDGTHTELAGCSAPFRNKDHD 159 (248)
T ss_pred CCc---cCcccccCCC----CceEEEEEECCCCCCCcccCCCceEEEEEcCCCeeecccCCCchhhcCceeeeccCCCCC
Confidence 542 3444443222 12379999999885310 0111223 22223322211111 11101223 23456
Q ss_pred EEEEEEEcccccEEEEEEEecCCCCCcceeeEecCccc-ccccceeEEEeeeccCceeeEEEEeecccc
Q 043702 193 VNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQ-YVNDFMYVGFSGSTQGSTEIHSIEWWSFSS 260 (711)
Q Consensus 193 ~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~ls~~vdL~~-~l~~~~~vGFsastg~~~~~~~i~sW~f~s 260 (711)
.+++|.|... .+.|.+...+......|+ +... .||...|+||||+||...+.|+|++=.+..
T Consensus 160 t~~rI~Y~~~--~l~v~vd~~~~~~w~~Cf----~~~~v~LP~~~yfGiSA~Tg~~sd~hdIlsv~~~~ 222 (248)
T cd06901 160 TFVAIRYSKG--RLTVMTDIDGKNEWKECF----DVTGVRLPTGYYFGASAATGDLSDNHDIISMKLYE 222 (248)
T ss_pred eEEEEEEECC--eEEEEEecCCCCceeeeE----EeCCeecCCCCEEEEEecCCCCCCcEEEEEEEEec
Confidence 7899999964 577777654422223332 2222 467779999999999999999999976644
|
The vesicular integral protein of 36 kDa (VIP36) is a type 1 transmembrane protein of the mammalian early secretory pathway that acts as a cargo receptor transporting high mannose type glycoproteins between the Golgi and the endoplasmic reticulum (ER). Lectins of the early secretory pathway are involved in the selective transport of newly synthesized glycoproteins from the ER to the ER-Golgi intermediate compartment (ERGIC). The most prominent cycling lectin is the mannose-binding type1 membrane protein ERGIC-53, which functions as a cargo receptor to facilitate export of glycoproteins from the ER. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded she |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=7e-18 Score=168.56 Aligned_cols=136 Identities=18% Similarity=0.219 Sum_probs=107.7
Q ss_pred CcccceeecCCceEEEEEEeCCCCeEEEEEEcccC-CCChhhhHHHHHHHHhc-----CCCCeeeeeeeeeecC---e-E
Q 043702 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN-SQGKDEFLSELSIIGTL-----RHRNLVRLQGWCHEKG---E-I 451 (711)
Q Consensus 382 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~Ei~~l~~l-----~H~niv~l~g~~~~~~---~-~ 451 (711)
+...+.||+|+||.||. ++.++.. +||++... ....+++.+|+.+++.+ +||||++++|++..+. . .
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 34567899999999996 6666655 68987653 33456799999999999 5799999999998763 4 3
Q ss_pred EEEEEc--CCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHH-HHHHhccCCCeeeccCCCCceEEcC----CCcEEEeec
Q 043702 452 LLVYDL--MPNGSLDKALFEARSPLPWPHRSKILLGVASAL-AYLHQECENQVIHRDVKTSNIMLDE----GFNARLGDF 524 (711)
Q Consensus 452 ~lV~Ey--~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL-~yLH~~~~~~ivHrDlkp~NILld~----~~~vkL~DF 524 (711)
.+|+|| +++|+|.+++.+. .+++. ..++.+++.++ +|||+. +|+||||||+|||++. +.+++|+||
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 478999 6689999999553 35555 35678888888 999998 9999999999999974 347999995
Q ss_pred CCc
Q 043702 525 GLA 527 (711)
Q Consensus 525 Gla 527 (711)
+-+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 444
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=5.7e-19 Score=193.08 Aligned_cols=186 Identities=25% Similarity=0.378 Sum_probs=155.2
Q ss_pred eeecCCceEEEEEEe---CCCCeEEEEEEcccCC---CChhhhHHHHHHHHhcC-CCCeeeeeeeeeecCeEEEEEEcCC
Q 043702 387 IIGHGAFGTVYKGIL---PQNGDIIAVKRCSHNS---QGKDEFLSELSIIGTLR-HRNLVRLQGWCHEKGEILLVYDLMP 459 (711)
Q Consensus 387 ~LG~G~fg~Vy~~~~---~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~ 459 (711)
.+|+|.||.|+++.- .+.|..+|+|...... ........|-.++..++ ||.++++.-.++.+..++++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 378999999987543 2356778888766521 11224567888899998 9999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCcc
Q 043702 460 NGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDAT 539 (711)
Q Consensus 460 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 539 (711)
+|+|...+.+ ...++..........++-+++++|+. +|+|||+|++||+++.+|.+|+.|||+++..-..+..
T Consensus 81 gg~lft~l~~-~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--- 153 (612)
T KOG0603|consen 81 GGDLFTRLSK-EVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--- 153 (612)
T ss_pred cchhhhcccc-CCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc---
Confidence 9999988843 34566777777888899999999998 9999999999999999999999999999876443322
Q ss_pred cccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCcc
Q 043702 540 VAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEK 583 (711)
Q Consensus 540 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~ 583 (711)
|||..|||||++. .....+|-||||++++||++|..||..
T Consensus 154 --cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 --CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred --ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 8999999999998 567789999999999999999999965
|
|
| >cd06902 lectin_ERGIC-53_ERGL ERGIC-53 and ERGL type 1 transmembrane proteins, N-terminal lectin domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.1e-16 Score=155.47 Aligned_cols=194 Identities=20% Similarity=0.198 Sum_probs=133.9
Q ss_pred CCCeEEeCceEeeCCcEEeCCCCCCCCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecCCCCCCCCceEEEEcCCC
Q 043702 43 LASLKLLGDAHMNNGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLNPSSIGAGLAFVITPDG 122 (711)
Q Consensus 43 ~~~~~~~g~a~~~~g~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~GlaF~l~~~~ 122 (711)
.+++.+.|+|.+.++.|+||++.+ ++.|.+|.+.|++. .+|+.+|+|+|.+.. ..+||||||+++...
T Consensus 21 i~~W~~~G~t~~~~~~IrLTp~~~---~~~G~iw~~~~~~~--------~~w~ie~~Fri~g~~-~~~gdG~a~W~t~~~ 88 (225)
T cd06902 21 VPFWSHGGDAIASLEQVRLTPSLR---SKKGSVWTKNPFSF--------ENWEVEVTFRVTGRG-RIGADGLAIWYTKER 88 (225)
T ss_pred CCceEecccEEecCCEEEECCCCC---CCEEEEeeCCCcCC--------CCEEEEEEEEEecCC-CCCCCEEEEEEECCC
Confidence 478999999999999999999877 88999999999984 469999999999754 356899999999764
Q ss_pred CCCCCCCCcccccccCCCCcceEEEEeecccCCCCCCCCCCeeeEecC-CCcccccccC------CccccccCC-CCeEE
Q 043702 123 EQVGSAGGSLGLLDEKGAGLGFVAVEFDTLMDVEFSDINGNHVGLDLN-SMVSTEVDNL------DTINVDLKS-GDLVN 194 (711)
Q Consensus 123 ~~~~~~g~~lgl~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~n-s~~S~~~~~~------~~~~~~~~~-g~~~~ 194 (711)
. ..|+.+|.-+.- .=+||.|||+.|.+ ..+...|-+-+| +......... +.-...+.+ ..+.+
T Consensus 89 ~---~~G~~~G~~~~f----~Gl~I~~Dt~~n~~--~~~~p~i~~~~NDGt~~yd~~~D~~~~~~~~C~~~~rn~~~p~~ 159 (225)
T cd06902 89 G---EEGPVFGSSDKW----NGVGIFFDSFDNDG--KKNNPAILVVGNDGTKSYDHQNDGLTQALGSCLRDFRNKPYPVR 159 (225)
T ss_pred C---CCCCccCCCCcc----cEEEEEEECCCCCC--CCCCcEEEEEECCCCeeccccCCCcccccceEEEeccCCCCCeE
Confidence 3 245555543322 23799999998743 233345644333 3222221111 110223333 56889
Q ss_pred EEEEEcccccEEEEEEEecCCCCCcceeeEecCccc-ccccceeEEEeeeccCceeeEEEEeecccc
Q 043702 195 SWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQ-YVNDFMYVGFSGSTQGSTEIHSIEWWSFSS 260 (711)
Q Consensus 195 ~~I~Y~~~~~~l~V~~~~~~~~~~~~~ls~~vdL~~-~l~~~~~vGFsastg~~~~~~~i~sW~f~s 260 (711)
++|.|.. ..|.|.++.... +...-....+++.. .||...|+||||+||...+.|+|++|+|.+
T Consensus 160 ~rI~Y~~--~~l~V~~d~~~~-~~~~~~~~Cf~~~~v~LP~~~yfGiSA~Tg~l~d~hDIls~~~~s 223 (225)
T cd06902 160 AKITYYQ--NVLTVSINNGFT-PNKDDYELCTRVENMVLPPNGYFGVSAATGGLADDHDVLSFLTFS 223 (225)
T ss_pred EEEEEEC--CeEEEEEeCCcC-CCCCcccEEEecCCeeCCCCCEEEEEecCCCCCCcEeEEEEEEec
Confidence 9999988 468888864221 11111233344444 477889999999999999999999999864
|
ERGIC-53 and ERGL, N-terminal carbohydrate recognition domain. ERGIC-53 and ERGL are eukaryotic mannose-binding type 1 transmembrane proteins of the early secretory pathway that transport newly synthesized glycoproteins from the endoplasmic reticulum (ER) to the ER-Golgi intermediate compartment (ERGIC). ERGIC-53 and ERGL have an N-terminal lectin-like carbohydrate recognition domain (represented by this alignment model) as well as a C-terminal transmembrane domain. ERGIC-53 functions as a 'cargo receptor' to facilitate the export of glycoproteins with different characteristics from the ER, while the ERGIC-53-like protein (ERGL) which may act as a regulator of ERGIC-53. In mammals, ERGIC-53 forms a complex with MCFD2 (multi-coagulation factor deficiency 2) which then recruits blood coagulation factors V and VIII. Mutations in either MCFD2 or ERGIC-53 cause a mild form of inherite |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.4e-17 Score=184.74 Aligned_cols=140 Identities=19% Similarity=0.247 Sum_probs=114.0
Q ss_pred HHHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEc-cc-CC-------CChhhhHHHHHHHHhcCCCCeeeeeeeee
Q 043702 376 RSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRC-SH-NS-------QGKDEFLSELSIIGTLRHRNLVRLQGWCH 446 (711)
Q Consensus 376 ~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~-~~-~~-------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~ 446 (711)
......|...++||+|+||+||+|.+... .+++|+. .. .. ...+.+.+|+++++.++|++++....++.
T Consensus 329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~ 406 (535)
T PRK09605 329 EEVKRRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDV 406 (535)
T ss_pred cccccccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEE
Confidence 34445667789999999999999988543 3344432 11 11 11245789999999999999998888888
Q ss_pred ecCeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCC
Q 043702 447 EKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGL 526 (711)
Q Consensus 447 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGl 526 (711)
.....++||||+++++|.+++. .+.+++.+++++|.|||+. +++||||||+|||+ +++.++|+|||+
T Consensus 407 ~~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGl 473 (535)
T PRK09605 407 DPEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGL 473 (535)
T ss_pred eCCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcc
Confidence 7778899999999999999884 4678999999999999997 99999999999999 677999999999
Q ss_pred ceec
Q 043702 527 ARQV 530 (711)
Q Consensus 527 a~~~ 530 (711)
++..
T Consensus 474 a~~~ 477 (535)
T PRK09605 474 GKYS 477 (535)
T ss_pred cccC
Confidence 9763
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.7e-17 Score=166.36 Aligned_cols=142 Identities=15% Similarity=0.176 Sum_probs=111.1
Q ss_pred CCcccceeecCCceEEEEEE-eCCCCeEEEEEEcccCCCC-------------------------hhhhHHHHHHHHhcC
Q 043702 381 CFNANRIIGHGAFGTVYKGI-LPQNGDIIAVKRCSHNSQG-------------------------KDEFLSELSIIGTLR 434 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~-~~~~~~~vavK~~~~~~~~-------------------------~~~~~~Ei~~l~~l~ 434 (711)
.|.+.+.||+|++|.||+|. +..+|+.||+|++...... ...+..|++++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788899999999999998 5567999999988753210 012467999999998
Q ss_pred CCC--eeeeeeeeeecCeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCC-eeeccCCCCce
Q 043702 435 HRN--LVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQ-VIHRDVKTSNI 511 (711)
Q Consensus 435 H~n--iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~-ivHrDlkp~NI 511 (711)
+.. +.+++++ ...++||||+++++|...+.. ...+...+...++.|++.+|++||+. + ++||||||+||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NI 180 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNI 180 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhE
Confidence 633 3344443 235899999999888765432 23455666789999999999999998 8 99999999999
Q ss_pred EEcCCCcEEEeecCCceecC
Q 043702 512 MLDEGFNARLGDFGLARQVE 531 (711)
Q Consensus 512 Lld~~~~vkL~DFGla~~~~ 531 (711)
+++ +++++|+|||++....
T Consensus 181 li~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEE-CCCEEEEEChhhhccC
Confidence 999 8899999999987543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=9.7e-17 Score=161.17 Aligned_cols=133 Identities=21% Similarity=0.291 Sum_probs=113.2
Q ss_pred ceeecCCceEEEEEEeCCCCeEEEEEEcccCCC---------ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ---------GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
+.||+|++|.||+|.. .|..+++|+...... ....+.+|++++..++|+++.....++...+..+++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999988 567888997553221 12357789999999999999888888777788899999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCcee
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQ 529 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~ 529 (711)
|+++++|.+++.... + .+..++.+++.+|.+||+. +++|||++|.|||++ ++.++|+|||+++.
T Consensus 80 ~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999999885432 2 8889999999999999998 999999999999999 78999999999875
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.9e-17 Score=187.50 Aligned_cols=202 Identities=20% Similarity=0.206 Sum_probs=159.2
Q ss_pred HHHHHHHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcC---CCCeeeeeeeeeec
Q 043702 372 YRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLR---HRNLVRLQGWCHEK 448 (711)
Q Consensus 372 ~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~ 448 (711)
..+++...+.|.+.+.||+|+||+||+|...+ |+.||+|+-...... +|.--.+++.+|+ -+-|..+.....-.
T Consensus 690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~W--EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPW--EFYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred cceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCce--eeeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 34455556789999999999999999999975 999999986653322 2322334455555 23344444444455
Q ss_pred CeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEc-------CCCcEEE
Q 043702 449 GEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLD-------EGFNARL 521 (711)
Q Consensus 449 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld-------~~~~vkL 521 (711)
+.-+||+||.+.|+|.+++. ..+.++|.....++.|+++-++.||.. +|||+||||+|+||. ++.-++|
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred CcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEE
Confidence 67799999999999999996 566799999999999999999999998 999999999999993 3445899
Q ss_pred eecCCceecCCCC-CCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCC
Q 043702 522 GDFGLARQVEHDK-SPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRP 580 (711)
Q Consensus 522 ~DFGla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P 580 (711)
+|||.+..+..-. .......++|-.+--+|...+..++...|.|.+.-+++-||.|+.-
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 9999997654221 1234456788899999999999999999999999999999999753
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.5e-16 Score=158.52 Aligned_cols=144 Identities=17% Similarity=0.230 Sum_probs=112.1
Q ss_pred HHHHHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCC-----------------------hhhhHHHHHHH
Q 043702 374 ELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQG-----------------------KDEFLSELSII 430 (711)
Q Consensus 374 el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~Ei~~l 430 (711)
++......|...+.||+|+||.||++... +|+.||||++...... ...+..|+.++
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 33333344778899999999999999885 6899999986542210 11356789999
Q ss_pred HhcCCCC--eeeeeeeeeecCeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCC
Q 043702 431 GTLRHRN--LVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKT 508 (711)
Q Consensus 431 ~~l~H~n--iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp 508 (711)
..+.|++ +...++. ...++||||+++++|...... .....++.+++.++.++|+. +|+||||||
T Consensus 88 ~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p 153 (198)
T cd05144 88 KALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKH---GIIHGDLSE 153 (198)
T ss_pred HHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCc
Confidence 9998874 4444432 345899999999999775421 34567899999999999997 999999999
Q ss_pred CceEEcCCCcEEEeecCCceecCC
Q 043702 509 SNIMLDEGFNARLGDFGLARQVEH 532 (711)
Q Consensus 509 ~NILld~~~~vkL~DFGla~~~~~ 532 (711)
+||++++++.++|+|||++.....
T Consensus 154 ~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 154 FNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred ccEEEcCCCcEEEEECCccccCCC
Confidence 999999999999999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.8e-16 Score=157.82 Aligned_cols=129 Identities=21% Similarity=0.317 Sum_probs=106.3
Q ss_pred eeecCCceEEEEEEeCCCCeEEEEEEcccCC--C-------ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEc
Q 043702 387 IIGHGAFGTVYKGILPQNGDIIAVKRCSHNS--Q-------GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 387 ~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~-------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
.||+|++|.||+|.+ .+..+++|+..... . ....+.+|++++..++|+++.....++...+..++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999986 56788999854321 1 124567899999999988766665566666778999999
Q ss_pred CCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCcee
Q 043702 458 MPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQ 529 (711)
Q Consensus 458 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~ 529 (711)
+++++|.+++..... .++.+++.+|.+||+. +++|||++|.||+++ ++.+++.|||+++.
T Consensus 79 ~~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND--------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH--------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999998754221 8899999999999998 999999999999999 78999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.69 E-value=9.5e-18 Score=180.32 Aligned_cols=122 Identities=26% Similarity=0.448 Sum_probs=108.4
Q ss_pred CeEEEEEEcCCCCCHHHHHhhC--CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCC
Q 043702 449 GEILLVYDLMPNGSLDKALFEA--RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGL 526 (711)
Q Consensus 449 ~~~~lV~Ey~~~gsL~~~l~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGl 526 (711)
..+++.|++|...+|.++|... ....++...+.++.|++.|++| + +.+|||+||.||+...+..+||+|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 3589999999999999999643 3568899999999999999999 4 899999999999999999999999999
Q ss_pred ceecCCCC-----CCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh
Q 043702 527 ARQVEHDK-----SPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS 576 (711)
Q Consensus 527 a~~~~~~~-----~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt 576 (711)
........ ....+...||..||+||.+.+..|+.|+||||+|++|+||+.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 98766544 234566789999999999999999999999999999999998
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.2e-17 Score=187.37 Aligned_cols=212 Identities=26% Similarity=0.337 Sum_probs=144.4
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCC
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMP 459 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 459 (711)
.+|+..++|-.|++|.||..+++.+.+.+|+|+ ++.. .+.+- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~----lilRn--ilt~a~npfvv-------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN----LILRN--ILTFAGNPFVV-------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcc-cccc----hhhhc--cccccCCccee--------------------
Confidence 578889999999999999999988888999843 3211 11111 22222333333
Q ss_pred CCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCC-----
Q 043702 460 NGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK----- 534 (711)
Q Consensus 460 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~----- 534 (711)
|+-...+. .-+.++... +.+++|||+. +|+|||+||+|.+|+.-|.+|+.|||+.+......
T Consensus 136 -gDc~tllk-~~g~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~ 202 (1205)
T KOG0606|consen 136 -GDCATLLK-NIGPLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK 202 (1205)
T ss_pred -chhhhhcc-cCCCCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence 44444442 223344332 7899999998 99999999999999999999999999987532111
Q ss_pred ---------CCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhh
Q 043702 535 ---------SPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLH 605 (711)
Q Consensus 535 ---------~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~ 605 (711)
......++||+.|+|||++....|....|.|++|+++||.+.|+.||..+.+..--.......++|.
T Consensus 203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wp---- 278 (1205)
T KOG0606|consen 203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP---- 278 (1205)
T ss_pred hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccc----
Confidence 0112346899999999999999999999999999999999999999987644211111111111110
Q ss_pred hcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHH
Q 043702 606 REGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRG 650 (711)
Q Consensus 606 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 650 (711)
+-++....+..+++.+.|+.+|..|--...
T Consensus 279 ---------------E~dea~p~Ea~dli~~LL~qnp~~Rlgt~g 308 (1205)
T KOG0606|consen 279 ---------------EEDEALPPEAQDLIEQLLRQNPLCRLGTGG 308 (1205)
T ss_pred ---------------ccCcCCCHHHHHHHHHHHHhChHhhcccch
Confidence 112222344556667778899999964443
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.4e-15 Score=140.12 Aligned_cols=135 Identities=19% Similarity=0.192 Sum_probs=115.9
Q ss_pred ccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCC--CCeeeeeeeeeecCeEEEEEEcCCCC
Q 043702 384 ANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRH--RNLVRLQGWCHEKGEILLVYDLMPNG 461 (711)
Q Consensus 384 ~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~lV~Ey~~~g 461 (711)
+.+.||+|.++.||++... +..+++|....... ...+.+|+.++..++| .++.+++++...++..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 3567999999999999984 47899998865443 5678999999999986 58999999888888899999999987
Q ss_pred CHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCcee
Q 043702 462 SLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQ 529 (711)
Q Consensus 462 sL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~ 529 (711)
.+..+ +......++.+++++|.+||.....+++|+|++|+||++++++.+++.|||+++.
T Consensus 79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77653 5667788999999999999986555899999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.1e-15 Score=148.42 Aligned_cols=136 Identities=18% Similarity=0.260 Sum_probs=97.8
Q ss_pred cceeecCCceEEEEEEeCCCCeEEEEEEcccCCCCh---hhh----------------------HHHHHHHHhcCCCC--
Q 043702 385 NRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGK---DEF----------------------LSELSIIGTLRHRN-- 437 (711)
Q Consensus 385 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~----------------------~~Ei~~l~~l~H~n-- 437 (711)
.+.||+|+||.||+|.+. +++.||||++....... ..+ ..|.+.+.++.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999986 78999999876532211 111 34566666665432
Q ss_pred eeeeeeeeeecCeEEEEEEcCCCCCHHH-HHhhCCCCCChHHHHHHHHHHHHHHHHHHh-ccCCCeeeccCCCCceEEcC
Q 043702 438 LVRLQGWCHEKGEILLVYDLMPNGSLDK-ALFEARSPLPWPHRSKILLGVASALAYLHQ-ECENQVIHRDVKTSNIMLDE 515 (711)
Q Consensus 438 iv~l~g~~~~~~~~~lV~Ey~~~gsL~~-~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivHrDlkp~NILld~ 515 (711)
+.+.+++ ...++||||++++.+.. .+.... .. ....+++.+++.++.++|. . +|+||||||+||+++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~- 149 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD- 149 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-
Confidence 3334432 24689999999954321 111111 11 6678899999999999998 5 999999999999999
Q ss_pred CCcEEEeecCCceecCC
Q 043702 516 GFNARLGDFGLARQVEH 532 (711)
Q Consensus 516 ~~~vkL~DFGla~~~~~ 532 (711)
++.++|+|||.+.....
T Consensus 150 ~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred CCcEEEEECcccccccC
Confidence 88999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd06903 lectin_EMP46_EMP47 EMP46 and EMP47 type 1 transmembrane proteins, N-terminal lectin domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.1e-13 Score=136.00 Aligned_cols=183 Identities=16% Similarity=0.210 Sum_probs=123.8
Q ss_pred CCCeEEeCceEeeCCcEEeCCCCCCCCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecCCCCCCCCceEEEEcCCC
Q 043702 43 LASLKLLGDAHMNNGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLNPSSIGAGLAFVITPDG 122 (711)
Q Consensus 43 ~~~~~~~g~a~~~~g~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~GlaF~l~~~~ 122 (711)
.+++.+.|+|.+.++.|+||++ + ++.|.+|-+.|+++-+ +|+.+|+|+|..+.. .+||||||.++...
T Consensus 20 i~~W~~~G~t~v~~~~IrLTp~-~---s~~G~iWs~~pl~~~~-------~w~ie~~Fri~G~~~-~~gdGla~W~t~~~ 87 (215)
T cd06903 20 IPNWQTSGNPKLESGRIILTPP-G---NQRGSLWLKKPLSLKD-------EWTIEWTFRSTGPEG-RSGGGLNFWLVKDG 87 (215)
T ss_pred CCCeEEcCcEEeeCCeEEECCC-C---CceEeEeeCCcCCCCC-------CEEEEEEEEecccCC-cCCCEEEEEEECCC
Confidence 4689999999999999999999 7 8899999999998742 699999999987543 67999999999764
Q ss_pred CCCCCCC-CcccccccCCCCcceEEEEeecccCCCCCCCCCCeeeEecCCCccccccc-----CCcccccc-CCCCeEEE
Q 043702 123 EQVGSAG-GSLGLLDEKGAGLGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDN-----LDTINVDL-KSGDLVNS 195 (711)
Q Consensus 123 ~~~~~~g-~~lgl~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~S~~~~~-----~~~~~~~~-~~g~~~~~ 195 (711)
... .| ...|-.+. ..=+||.|||+.|.. | ...++--++........ .+.=.+.. ..+...++
T Consensus 88 ~~~--~g~~~fG~~~~----f~Gl~I~~Dt~~n~~---p--~i~~~~NDGt~~yd~~~d~~~~~g~C~~~~rn~~~p~~i 156 (215)
T cd06903 88 NAD--VGTSSIYGPSK----FDGLQLLIDNNGGSG---G--SLRGFLNDGSKDYKNEDVDSLAFGSCLFAYQDSGVPSTI 156 (215)
T ss_pred ccc--CCccccCCCCC----CcEEEEEEECCCCCC---c--eEEEEECCCCeeccccCCcccccceeeEeccCCCCCEEE
Confidence 321 11 22222111 112799999998731 2 12222223333322211 11102232 34668999
Q ss_pred EEEEcccccEEEEEEEecCCCCCcceee-EecCcccccc-cceeEEEeeeccCceeeEEEEeecc
Q 043702 196 WIEYDGLTRAFNISVSYSNLKPKVPILS-FTLDLDQYVN-DFMYVGFSGSTQGSTEIHSIEWWSF 258 (711)
Q Consensus 196 ~I~Y~~~~~~l~V~~~~~~~~~~~~~ls-~~vdL~~~l~-~~~~vGFsastg~~~~~~~i~sW~f 258 (711)
+|.|......|+|.++. ..|+. ..|. || .-.|+||||+||...+.|+|++-.+
T Consensus 157 ri~Y~~~~~~l~v~vd~------~~Cf~~~~v~----lP~~~y~fGiSAaTg~~~d~hdIl~~~~ 211 (215)
T cd06903 157 RLSYDALNSLFKVQVDN------RLCFQTDKVQ----LPQGGYRFGITAANADNPESFEILKLKV 211 (215)
T ss_pred EEEEECCCCEEEEEECC------CEEEecCCee----cCCCCCEEEEEEcCCCCCCcEEEEEEEE
Confidence 99999877889998842 12322 1223 55 4567999999999999999998654
|
EMP46 and EMP47, N-terminal carbohydrate recognition domain. EMP46 and EMP47 are fungal type-I transmembrane proteins that cycle between the endoplasmic reticulum and the golgi apparatus and are thought to function as cargo receptors that transport newly synthesized glycoproteins. EMP47 is a receptor for EMP46 responsible for the selective transport of EMP46 by forming hetero-oligomerization between the two proteins. EMP46 and EMP47 have an N-terminal lectin-like carbohydrate recognition domain (represented by this alignment model) as well as a C-terminal transmembrane domain. EMP46 and EMP47 are 45% sequence-identical to one another and have sequence homology to a class of intracellular lectins defined by ERGIC-53 and VIP36. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat s |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.5e-14 Score=145.42 Aligned_cols=134 Identities=19% Similarity=0.226 Sum_probs=105.3
Q ss_pred cceee-cCCceEEEEEEeCCCCeEEEEEEcccCC--------------CChhhhHHHHHHHHhcCCCCe--eeeeeeeee
Q 043702 385 NRIIG-HGAFGTVYKGILPQNGDIIAVKRCSHNS--------------QGKDEFLSELSIIGTLRHRNL--VRLQGWCHE 447 (711)
Q Consensus 385 ~~~LG-~G~fg~Vy~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~Ei~~l~~l~H~ni--v~l~g~~~~ 447 (711)
...|| .||.|+||+... .+..++||++.... .....+.+|++++.+|+|+++ ++.++++..
T Consensus 36 ~~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 35688 899999999988 46788999775311 123457889999999998875 677776544
Q ss_pred cC----eEEEEEEcCCC-CCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEe
Q 043702 448 KG----EILLVYDLMPN-GSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLG 522 (711)
Q Consensus 448 ~~----~~~lV~Ey~~~-gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~ 522 (711)
+. ..++|+|++++ .+|.+++.. ..++.. .+.+++.+|.+||+. +|+||||||.|||++.++.++|+
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQE--APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhc--CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEE
Confidence 32 23599999997 699988854 234433 367899999999998 99999999999999998899999
Q ss_pred ecCCcee
Q 043702 523 DFGLARQ 529 (711)
Q Consensus 523 DFGla~~ 529 (711)
|||.++.
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9999875
|
|
| >PF03388 Lectin_leg-like: Legume-like lectin family; InterPro: IPR005052 Lectins are structurally diverse proteins that bind to specific carbohydrates | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.5e-13 Score=135.79 Aligned_cols=190 Identities=22% Similarity=0.228 Sum_probs=123.0
Q ss_pred CCeEEeCceEeeCCcEEeCCCCCCCCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecCCCCCCCCceEEEEcCCCC
Q 043702 44 ASLKLLGDAHMNNGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLNPSSIGAGLAFVITPDGE 123 (711)
Q Consensus 44 ~~~~~~g~a~~~~g~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~GlaF~l~~~~~ 123 (711)
+++.+.|+|.+.++.|+||++.+ ++.|.+|.+.|++. .+|+.+|+|+|........||||||+++....
T Consensus 22 ~~W~~~G~t~i~~~~IrLTp~~~---~~~G~iws~~~~~~--------~~w~i~~~Fri~g~~~~~~g~G~a~W~t~~~~ 90 (229)
T PF03388_consen 22 PNWDIGGSTVITDNFIRLTPDRQ---SQSGSIWSRKPIPF--------DNWEIEFTFRISGQEKGLGGDGMAFWYTKDPG 90 (229)
T ss_dssp TTEEEEET-EEESSEEEEE-SST---TEEEEEEESS-BEE--------SEEEEEEEEEEESS-SSS-S-EEEEEEESSSS
T ss_pred CCEEECCeEEecCCEEEECCCcc---cCEEEEEEcCCCCc--------cCEEEEEEEEEeccccCcCCCeEEEEEEcCcc
Confidence 58999999999999999999988 88999999999998 47999999999987556689999999997554
Q ss_pred CCCCCCCcccccccCCCCcceEEEEeecccCCCCC-CCCCCeeeEecCCC-cccccccC------CccccccC-CCCeEE
Q 043702 124 QVGSAGGSLGLLDEKGAGLGFVAVEFDTLMDVEFS-DINGNHVGLDLNSM-VSTEVDNL------DTINVDLK-SGDLVN 194 (711)
Q Consensus 124 ~~~~~g~~lgl~~~~~~~~~~vaVEFDt~~n~~~~-d~~~~Hvgid~ns~-~S~~~~~~------~~~~~~~~-~g~~~~ 194 (711)
. .|..+|.-+. ..=+||=||||.|.+-. ......|.+-+|.- .+...... +.-..+++ .+...+
T Consensus 91 ~---~G~~fG~~~~----f~Gl~i~idt~~N~~~~~~~~~p~i~~~~NDGt~~~~~~~dg~~~~~~~C~~~~rn~~~p~~ 163 (229)
T PF03388_consen 91 S---DGPVFGGPDK----FDGLGIFIDTYDNDEGGHKRGFPYISAMLNDGTKSYDHDNDGKDQSLGSCSADYRNSDVPTR 163 (229)
T ss_dssp S---SCSBTTB-SS-----EEEEEEEEES-TTCTTCTSTSSEEEEEEEESSS---GGGTTTTT-SEEEE---BTESSEEE
T ss_pred c---cccccCCCcc----cceEEEEEEcccCCCcccccccceEEEEecCCCccccccccCcccccccceeccCcCCCCEE
Confidence 3 4555554222 12379999999985421 12334455544422 22111111 11123333 356789
Q ss_pred EEEEEcccccEEEEEEEe---cCCCCCcceeeEecCcccccccceeEEEeeeccCceeeEEEEee
Q 043702 195 SWIEYDGLTRAFNISVSY---SNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGSTEIHSIEWW 256 (711)
Q Consensus 195 ~~I~Y~~~~~~l~V~~~~---~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastg~~~~~~~i~sW 256 (711)
++|.|... .+.|.+.. .+......|+... .-.||+..|+||||+||...+.|+|++=
T Consensus 164 ~ri~Y~~~--~l~v~id~~~~~~~~~~~~Cf~~~---~v~LP~~~yfGvSA~Tg~~~d~hdi~s~ 223 (229)
T PF03388_consen 164 IRISYSKN--TLTVSIDSNYLKNQDDWELCFTTD---GVDLPEGYYFGVSAATGELSDNHDILSV 223 (229)
T ss_dssp EEEEEETT--EEEEEEETSCCSECCTTEEEEEES---TEEGGSSBEEEEEEEESSSGGEEEEEEE
T ss_pred EEEEEECC--eEEEEEecccccCCcCCcEEEEcC---CeecCCCCEEEEEecCCCCCCcEEEEEE
Confidence 99999874 57777762 2223334444421 1246788899999999999999999974
|
This family includes the VIP36 and ERGIC-53 lectins. These two proteins were the first members of the family of animal lectins similar to the leguminous plant lectins []. The alignment for this family is towards the N terminus, where the similarity of VIP36 and ERGIC-53 is greatest. Although they have been identified as a family of animal lectins, this alignment also includes yeast sequences[]. ERGIC-53 is a 53kDa protein, localised to the intermediate region between the endoplasmic reticulum and the Golgi apparatus (ER-Golgi-Intermediate Compartment, ERGIC). It was identified as a calcium-dependent, mannose-specific lectin []. Its dysfunction has been associated with combined factors V and VIII deficiency, suggesting an important and substrate-specific role for ERGIC-53 in the glycoprotein-secreting pathway [,]. The L-type lectin-like domain has an overall globular shape composed of a beta-sandwich of two major twisted antiparallel beta-sheets. The beta-sandwich comprises a major concave beta-sheet and a minor convex beta-sheet, in a variation of the jelly roll fold [, , , ]. ; GO: 0016020 membrane; PDB: 3A4U_A 3LCP_B 2A6Z_A 2A71_C 2A70_B 2A6Y_A 2A6X_A 2A6W_B 2A6V_B 2E6V_B .... |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.1e-15 Score=175.19 Aligned_cols=253 Identities=23% Similarity=0.262 Sum_probs=188.2
Q ss_pred CCcccceeecCCceEEEEEEeCC-CCeEEEEEEcccCCCC---hhhhHHHHHHHHhcC-CCCeeeeeeeeeecCeEEEEE
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQ-NGDIIAVKRCSHNSQG---KDEFLSELSIIGTLR-HRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~-~~~~vavK~~~~~~~~---~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 455 (711)
.|...+.||+|.|+.|-...... ....+|+|.+...... ......|..+-..+. |+|++.+++.....+..+++.
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 45666779999999998877633 3456777776654322 234455888888887 999999999999999999999
Q ss_pred EcCCCCCHHHHH-hhCCCCCChHHHHHHHHHHHHHHHHHH-hccCCCeeeccCCCCceEEcCCC-cEEEeecCCceecCC
Q 043702 456 DLMPNGSLDKAL-FEARSPLPWPHRSKILLGVASALAYLH-QECENQVIHRDVKTSNIMLDEGF-NARLGDFGLARQVEH 532 (711)
Q Consensus 456 Ey~~~gsL~~~l-~~~~~~l~~~~~~~i~~~ia~aL~yLH-~~~~~~ivHrDlkp~NILld~~~-~vkL~DFGla~~~~~ 532 (711)
||..++++.+-+ .......+.......+.|+..++.|+| .. ++.||||||+|.+++..+ ..|++|||+|..+..
T Consensus 101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred CcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999988 433336777788889999999999999 65 999999999999999999 999999999987765
Q ss_pred --CCCCCcccccC-CCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcC
Q 043702 533 --DKSPDATVAAG-TMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREG 608 (711)
Q Consensus 533 --~~~~~~~~~~g-t~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 608 (711)
+........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++...... .....|.... +
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~------~~~~~~~~~~---~ 248 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD------GRYSSWKSNK---G 248 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc------ccceeecccc---c
Confidence 33333445678 9999999998874 55778999999999999999999987543211 1111221110 0
Q ss_pred chhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 609 RLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 609 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
... ............++...|+..+|..|.+.+++..
T Consensus 249 ~~~--------~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 249 RFT--------QLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ccc--------cCccccCChhhhhcccccccCCchhccccccccc
Confidence 000 0011112234456667788899999999988764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.37 E-value=6.5e-13 Score=145.99 Aligned_cols=247 Identities=26% Similarity=0.297 Sum_probs=184.5
Q ss_pred CCcccceeec--CCceEEEEEEe--CCCCeEEEEEEcccC---CCChhhhHHHHHHHHhcC-CCCeeeeeeeeeecCeEE
Q 043702 381 CFNANRIIGH--GAFGTVYKGIL--PQNGDIIAVKRCSHN---SQGKDEFLSELSIIGTLR-HRNLVRLQGWCHEKGEIL 452 (711)
Q Consensus 381 ~f~~~~~LG~--G~fg~Vy~~~~--~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~ 452 (711)
.|...+.+|. |.+|.||.+.. +..+..+|+|+-+.. ......=.+|+....+++ |+|.++.......++.++
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4556778999 99999999998 778889999985442 222333456777777776 999999888888999999
Q ss_pred EEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHH----HHHHHHhccCCCeeeccCCCCceEEcCC-CcEEEeecCCc
Q 043702 453 LVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVAS----ALAYLHQECENQVIHRDVKTSNIMLDEG-FNARLGDFGLA 527 (711)
Q Consensus 453 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~----aL~yLH~~~~~~ivHrDlkp~NILld~~-~~vkL~DFGla 527 (711)
+-.|+|. .+|..+.+.....++....+.++.+..+ ||.++|+. .++|-|+||.||++..+ ..++++|||+.
T Consensus 195 iqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred eeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCccee
Confidence 9999984 7999988776666778888888888888 99999997 99999999999999999 88999999999
Q ss_pred eecCCCCCC----CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHH
Q 043702 528 RQVEHDKSP----DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWS 603 (711)
Q Consensus 528 ~~~~~~~~~----~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~ 603 (711)
..+...... ......|...|++||.. .+.++..+|+|++|.+++|..++..+...... .. |.
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~-----------~~--W~ 336 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKN-----------SS--WS 336 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCC-----------CC--cc
Confidence 987655421 12233578889999965 55688899999999999999998766532100 01 11
Q ss_pred hhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 604 LHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 604 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
..+.+.+ ..++...-..++..++.++++.+|..|++.+.+..
T Consensus 337 ~~r~~~i--------p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 337 QLRQGYI--------PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ccccccC--------chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 1222111 11111111233444778899999999999888765
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.36 E-value=4.2e-13 Score=136.30 Aligned_cols=152 Identities=24% Similarity=0.405 Sum_probs=117.2
Q ss_pred HHHHhcCCCCeeeeeeeeeecC-----eEEEEEEcCCCCCHHHHHhhC---CCCCChHHHHHHHHHHHHHHHHHHhccCC
Q 043702 428 SIIGTLRHRNLVRLQGWCHEKG-----EILLVYDLMPNGSLDKALFEA---RSPLPWPHRSKILLGVASALAYLHQECEN 499 (711)
Q Consensus 428 ~~l~~l~H~niv~l~g~~~~~~-----~~~lV~Ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~aL~yLH~~~~~ 499 (711)
.-|-++-|.|||+++.|..+.+ ...++.|||..|+|..+|++. ...+......+++.||+.||.|||+ |.+
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence 3455566999999999986543 578999999999999999753 3457788889999999999999999 589
Q ss_pred CeeeccCCCCceEEcCCCcEEEeecCCcee---cCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh
Q 043702 500 QVIHRDVKTSNIMLDEGFNARLGDFGLARQ---VEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS 576 (711)
Q Consensus 500 ~ivHrDlkp~NILld~~~~vkL~DFGla~~---~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt 576 (711)
+|+|+++..+-|++..++-+|++----... .............+-++|.+||+-.....+..+|||+||+..+||.-
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 999999999999999998888853211100 00001111223347789999998777778889999999999999988
Q ss_pred CCCC
Q 043702 577 GRRP 580 (711)
Q Consensus 577 G~~P 580 (711)
+.--
T Consensus 278 lEiq 281 (458)
T KOG1266|consen 278 LEIQ 281 (458)
T ss_pred heec
Confidence 7643
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.34 E-value=6.8e-12 Score=139.58 Aligned_cols=140 Identities=16% Similarity=0.178 Sum_probs=99.9
Q ss_pred cceeecCCceEEEEEEeCCCCeEEEEEEcccCCCC-----------------------------------------hhhh
Q 043702 385 NRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQG-----------------------------------------KDEF 423 (711)
Q Consensus 385 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~-----------------------------------------~~~~ 423 (711)
.+.||.|++|.||+|+++ +|+.||||+....-.. +-+|
T Consensus 122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 367999999999999996 6899999987542100 0124
Q ss_pred HHHHHHHHhcC----CCCeeeeeeeee-ecCeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHH-HHHHHHhcc
Q 043702 424 LSELSIIGTLR----HRNLVRLQGWCH-EKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVAS-ALAYLHQEC 497 (711)
Q Consensus 424 ~~Ei~~l~~l~----H~niv~l~g~~~-~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~-aL~yLH~~~ 497 (711)
.+|.+.+.+++ |.+-+.+-..+. .....+|||||++|++|.++........ .+.+++..++. .+..+|..
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~- 276 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRD- 276 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhC-
Confidence 45555555553 333334333332 2345799999999999988765322222 34567777766 46778876
Q ss_pred CCCeeeccCCCCceEEcCCCcEEEeecCCceecC
Q 043702 498 ENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVE 531 (711)
Q Consensus 498 ~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~ 531 (711)
+++|+|+||.||+++++++++++|||++..+.
T Consensus 277 --g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 --GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred --CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.30 E-value=9.3e-12 Score=120.24 Aligned_cols=130 Identities=15% Similarity=0.064 Sum_probs=98.0
Q ss_pred ceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCee-eeeeeeeecCeEEEEEEcCCCCCHH
Q 043702 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLV-RLQGWCHEKGEILLVYDLMPNGSLD 464 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lV~Ey~~~gsL~ 464 (711)
+.|+.|.++.||++.. .+..+++|+..........+.+|.++++.+.+.+++ +++.+. ....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEE--CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 5688999999999987 477899998765443344678899999999765554 344433 23458999999998876
Q ss_pred HHHhhCCCCCChHHHHHHHHHHHHHHHHHHhcc--CCCeeeccCCCCceEEcCCCcEEEeecCCcee
Q 043702 465 KALFEARSPLPWPHRSKILLGVASALAYLHQEC--ENQVIHRDVKTSNIMLDEGFNARLGDFGLARQ 529 (711)
Q Consensus 465 ~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~--~~~ivHrDlkp~NILld~~~~vkL~DFGla~~ 529 (711)
.. ......++.+++++|+.||+.. ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 80 ~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TE---------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cc---------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 42 0112346788999999999872 22369999999999999 66899999998853
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3839 consensus Lectin VIP36, involved in the transport of glycoproteins carrying high mannose-type glycans [Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.25 E-value=2.7e-10 Score=115.80 Aligned_cols=200 Identities=18% Similarity=0.218 Sum_probs=141.7
Q ss_pred eeeecCCCC--CCCeEEeCceEeeCCcEEeCCCCCCCCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecCCCCCCC
Q 043702 34 TEFDFGTLT--LASLKLLGDAHMNNGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLNPSSIG 111 (711)
Q Consensus 34 ~~f~~~~f~--~~~~~~~g~a~~~~g~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g 111 (711)
++=.|.+-. ..++.+.|.+.+....++||.+.+ ++.|.++-..||... +|..-+.|.|..+.+...|
T Consensus 60 L~~Py~g~g~r~~~W~~~Gstvv~~~~irLT~d~q---sk~GAv~n~~Pv~s~--------~wev~v~fkv~~~s~~lfg 128 (351)
T KOG3839|consen 60 LSKPYQGVGGRQPNWNLSGSTVVTSNYIRLTPDEQ---SKSGAVWNRQPVFSR--------DWEVLVHFKVHGQSKNLFG 128 (351)
T ss_pred cccccccccccccCccccccEEEEeeeeecccccc---ccccccccCCCcccc--------ceeEEEEEEEecCCCcccc
Confidence 444444332 468999999999999999999999 889999999999864 5999999999999888999
Q ss_pred CceEEEEcCCCCCCCCCCCcccccccCCCCcceEEEEeecccCCCCCCCCCCe--ee-EecCCCccccccc------CCc
Q 043702 112 AGLAFVITPDGEQVGSAGGSLGLLDEKGAGLGFVAVEFDTLMDVEFSDINGNH--VG-LDLNSMVSTEVDN------LDT 182 (711)
Q Consensus 112 ~GlaF~l~~~~~~~~~~g~~lgl~~~~~~~~~~vaVEFDt~~n~~~~d~~~~H--vg-id~ns~~S~~~~~------~~~ 182 (711)
||||+.++-.... .|..+|-++. .+.+||=.|||-|.+ +-+..-| |. .+.|+..|..... ++.
T Consensus 129 dG~Aiw~t~Er~q---~GPvFG~~dk----F~GL~vfidtY~n~~-g~~~~v~P~isvmv~~gs~sYD~~~Dg~~tel~g 200 (351)
T KOG3839|consen 129 DGMAIWYTKERAQ---PGPVFGSKDK----FTGLAVFIDTYGNHN-GPHEHVFPYISVMVNIGSLSYDHSKDGTHTELAG 200 (351)
T ss_pred cceEEEeeccccc---CCCCCCCccc----ceeEEEEEeccCCcC-CCcccceeeEEEEeccCCcccccCCCCCcccccc
Confidence 9999999976654 4555665433 345899999998854 1222212 22 2333434433222 111
Q ss_pred cccccCCCC-eEEEEEEEcccccEEEEEEEecCCCCCcceeeEecCcccc-cccceeEEEeeeccCceeeEEEEeecc
Q 043702 183 INVDLKSGD-LVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQY-VNDFMYVGFSGSTQGSTEIHSIEWWSF 258 (711)
Q Consensus 183 ~~~~~~~g~-~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~ls~~vdL~~~-l~~~~~vGFsastg~~~~~~~i~sW~f 258 (711)
-..++++.. ...+.|.|+. +.|++..+..+. . ......+|..+ +|.--|+|+||+||...+.|+|.|=.+
T Consensus 201 c~a~~rn~~~dt~~~iry~~--~~l~~~~dl~~~--~--~~~~c~~~n~v~lp~g~~fg~SasTGdlSd~HdivS~kl 272 (351)
T KOG3839|consen 201 CTANFRNLPHDTLVVIRYEK--KTLSISIDLEGP--N--EWIDCFSLNNVELPLGYFFGVSASTGDLSDSHDIVSLKL 272 (351)
T ss_pred ceeeeccCCCcceeEEEecC--CceEEEEecCCC--c--eeeeeeeecceecccceEEeeeeccCccchhhHHHHhhh
Confidence 123344332 3457799988 677777765542 1 35667788776 788889999999999999999998654
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.21 E-value=3e-11 Score=136.17 Aligned_cols=147 Identities=14% Similarity=0.165 Sum_probs=94.6
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCC-----------------------------------h----
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQG-----------------------------------K---- 420 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~-----------------------------------~---- 420 (711)
..|+. +.||+|++|.||+|+++++|+.||||+....-.. .
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45666 7899999999999999877999999988643100 0
Q ss_pred --hhhHHHHHHHHhcC----CCCeeeeeeeeee-cCeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHH
Q 043702 421 --DEFLSELSIIGTLR----HRNLVRLQGWCHE-KGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYL 493 (711)
Q Consensus 421 --~~~~~Ei~~l~~l~----H~niv~l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yL 493 (711)
-++.+|...+.+++ +.+.+.+-..+.+ ....+|||||++|+.|.++-.-.....+ +..++...++. |+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d---~~~la~~~v~~--~~ 273 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTD---MKLLAERGVEV--FF 273 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCC---HHHHHHHHHHH--HH
Confidence 12444554444443 3333443333332 3456899999999999874321111111 22222222221 22
Q ss_pred HhccCCCeeeccCCCCceEEcCCC----cEEEeecCCceecCC
Q 043702 494 HQECENQVIHRDVKTSNIMLDEGF----NARLGDFGLARQVEH 532 (711)
Q Consensus 494 H~~~~~~ivHrDlkp~NILld~~~----~vkL~DFGla~~~~~ 532 (711)
++....+++|+|+||.||+++.++ ++++.|||++..+..
T Consensus 274 ~Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 274 TQVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 222234999999999999999888 999999999987654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.12 E-value=6.6e-10 Score=109.44 Aligned_cols=137 Identities=13% Similarity=0.102 Sum_probs=98.4
Q ss_pred ceeecCCceEEEEEEeCC------CCeEEEEEEcccCC-----------CC------------hhhhH----HHHHHHHh
Q 043702 386 RIIGHGAFGTVYKGILPQ------NGDIIAVKRCSHNS-----------QG------------KDEFL----SELSIIGT 432 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~~------~~~~vavK~~~~~~-----------~~------------~~~~~----~Ei~~l~~ 432 (711)
..||.|--+.||.|...+ .+..+|||+.+... ++ .+.+. +|.+.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998643 25789999765310 00 11223 79999999
Q ss_pred cCC--CCeeeeeeeeeecCeEEEEEEcCCCCCHHH-HHhhCCCCCChHHHHHHHHHHHHHHHHH-HhccCCCeeeccCCC
Q 043702 433 LRH--RNLVRLQGWCHEKGEILLVYDLMPNGSLDK-ALFEARSPLPWPHRSKILLGVASALAYL-HQECENQVIHRDVKT 508 (711)
Q Consensus 433 l~H--~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~-~l~~~~~~l~~~~~~~i~~~ia~aL~yL-H~~~~~~ivHrDlkp 508 (711)
+.. -++.+++++ ..-+|||||+.++.+.. .+. ...++..+..++..+++.+|..| |.. +++|+||++
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk--d~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs~ 153 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK--DAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLSE 153 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh--ccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCCH
Confidence 873 345555553 45689999997654422 222 12344556678889999999999 766 999999999
Q ss_pred CceEEcCCCcEEEeecCCceecCC
Q 043702 509 SNIMLDEGFNARLGDFGLARQVEH 532 (711)
Q Consensus 509 ~NILld~~~~vkL~DFGla~~~~~ 532 (711)
.|||+++ +.++|+|||.+....+
T Consensus 154 ~NIL~~~-~~v~iIDF~qav~~~h 176 (197)
T cd05146 154 YNMLWHD-GKVWFIDVSQSVEPTH 176 (197)
T ss_pred HHEEEEC-CcEEEEECCCceeCCC
Confidence 9999974 6899999999876544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.11 E-value=4.8e-10 Score=112.96 Aligned_cols=141 Identities=17% Similarity=0.243 Sum_probs=110.8
Q ss_pred ceeecCCceEEEEEEeCCCCeEEEEEEcccCCC--ChhhhHHHHHHHHhcCC--CCeeeeeeeeeecC---eEEEEEEcC
Q 043702 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ--GKDEFLSELSIIGTLRH--RNLVRLQGWCHEKG---EILLVYDLM 458 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~---~~~lV~Ey~ 458 (711)
+.|+.|..+.||++... +|+.+++|+...... ...++..|.++++.+++ .++.+++.++.... ..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 56899999999999884 367899998765433 45678999999999986 34567777776542 568999999
Q ss_pred CCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhcc-----------------------------------------
Q 043702 459 PNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQEC----------------------------------------- 497 (711)
Q Consensus 459 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~----------------------------------------- 497 (711)
++.++...+.. ..++..++..++.++++.|.+||+..
T Consensus 83 ~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 83 DGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 99888775421 35677788888889999999888521
Q ss_pred ------------CCCeeeccCCCCceEEcC--CCcEEEeecCCcee
Q 043702 498 ------------ENQVIHRDVKTSNIMLDE--GFNARLGDFGLARQ 529 (711)
Q Consensus 498 ------------~~~ivHrDlkp~NILld~--~~~vkL~DFGla~~ 529 (711)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 56689999998863
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3838 consensus Mannose lectin ERGIC-53, involved in glycoprotein traffic [Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.10 E-value=5.3e-09 Score=107.81 Aligned_cols=188 Identities=19% Similarity=0.236 Sum_probs=128.4
Q ss_pred CeEEeCceEeeCCcEEeCCCCCCCCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecCCCCCCCCceEEEEcCCCCC
Q 043702 45 SLKLLGDAHMNNGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLNPSSIGAGLAFVITPDGEQ 124 (711)
Q Consensus 45 ~~~~~g~a~~~~g~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~GlaF~l~~~~~~ 124 (711)
-+...|||..+...|||++.-. ++.|-+|-+..+++ -.|..+-.|+|+++. .-++|||||.-+....
T Consensus 55 FW~~~GdAIas~eqvRlaPSmr---srkGavWtka~~~f--------e~weVev~~rVtGrG-RiGAdGlaiWYt~~~G- 121 (497)
T KOG3838|consen 55 FWSHHGDAIASSEQVRLAPSMR---SRKGAVWTKASVPF--------ENWEVEVQFRVTGRG-RIGADGLAIWYTRGRG- 121 (497)
T ss_pred eeeecCcccccccceeeccccc---cccCceeecccCCc--------ccceEEEEEEecccc-cccCCceEEEEecCCC-
Confidence 4888999988889999999766 77898877777666 459999999999875 4679999999876432
Q ss_pred CCCCCCcccccccCCCCcceEEEEeecccCCCCCCCCCCeeeEecCC-CcccccccCCcc------ccccCCC-CeEEEE
Q 043702 125 VGSAGGSLGLLDEKGAGLGFVAVEFDTLMDVEFSDINGNHVGLDLNS-MVSTEVDNLDTI------NVDLKSG-DLVNSW 196 (711)
Q Consensus 125 ~~~~g~~lgl~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns-~~S~~~~~~~~~------~~~~~~g-~~~~~~ 196 (711)
..|..+|-.+.= | -+++=||.|-|.+ .-|+.-|.+-.|. -.+......+.. -++++|. -+++|+
T Consensus 122 --~~GpVfGg~d~W---n-GigiffDSfdnD~--qknnP~Is~~lndGt~~ydh~~DGasQ~LssCqrDFRNkPyPvRar 193 (497)
T KOG3838|consen 122 --HVGPVFGGLDSW---N-GIGIFFDSFDNDG--QKNNPAISVLLNDGTIPYDHPGDGASQGLSSCQRDFRNKPYPVRAR 193 (497)
T ss_pred --cccccccccccc---c-ceEEEeecccccC--CcCCccEEEEecCCcccccCCCccHHHHHHHhhHHhccCCCCceEE
Confidence 233333332221 1 1699999998743 3344556665443 334333222211 3566654 588999
Q ss_pred EEEcccccEEEEEEEecCCCCCcceeeEecCccc-ccccceeEEEeeeccCceeeEEEEeec
Q 043702 197 IEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQ-YVNDFMYVGFSGSTQGSTEIHSIEWWS 257 (711)
Q Consensus 197 I~Y~~~~~~l~V~~~~~~~~~~~~~ls~~vdL~~-~l~~~~~vGFsastg~~~~~~~i~sW~ 257 (711)
|+|-. ++|+|.+..+-+.... ....++... .||..-|+|.||+||....-|+|++..
T Consensus 194 ItY~~--nvLtv~innGmtp~d~--yE~C~rve~~~lp~nGyFGvSAATGgLADDHDVl~Fl 251 (497)
T KOG3838|consen 194 ITYYG--NVLTVMINNGMTPSDD--YEFCVRVENLLLPPNGYFGVSAATGGLADDHDVLSFL 251 (497)
T ss_pred EEEec--cEEEEEEcCCCCCCCC--cceeEeccceeccCCCeeeeeecccccccccceeeeE
Confidence 99965 7888888654322112 223344433 578899999999999999999999875
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=5.9e-10 Score=123.91 Aligned_cols=169 Identities=20% Similarity=0.298 Sum_probs=126.9
Q ss_pred EEEeCCCCeEEEEEEcccCCCC-hhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCCCCCHHHHHhhCCCCCCh
Q 043702 398 KGILPQNGDIIAVKRCSHNSQG-KDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPW 476 (711)
Q Consensus 398 ~~~~~~~~~~vavK~~~~~~~~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~ 476 (711)
.|..+.++.+|.|........+ .....+-++.|+.+|||||++++.....++.+|||.|-+. -|..++.+ +..
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~----l~~ 103 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE----LGK 103 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH----hHH
Confidence 4566667888888877654332 3456778899999999999999999999999999999873 35556643 225
Q ss_pred HHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCcccccCCCcccChhhhccC
Q 043702 477 PHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTG 556 (711)
Q Consensus 477 ~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~ 556 (711)
......+.||+.||.+||+.| +++|++|....|++++.|..||++|-++........ ......---.|..|+.+...
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCcc
Confidence 566678899999999999764 899999999999999999999999988865432221 11111122346677754332
Q ss_pred CCCccccchhHHHHHHHHHhC
Q 043702 557 RATEKTDVFSYGAVVLEVASG 577 (711)
Q Consensus 557 ~~s~ksDVwSfGvll~elltG 577 (711)
. -..|.|-|||+++|++.|
T Consensus 181 ~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred c--cchhhhhHHHHHHHHhCc
Confidence 2 346999999999999999
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.09 E-value=7.9e-11 Score=129.69 Aligned_cols=249 Identities=22% Similarity=0.202 Sum_probs=173.5
Q ss_pred HHHHhcCCcccceeecCCceEEEEEEeC-CCCeEEEEEEcccCCCC---hhhhHHHHHHHHhcC-CCCeeeeeeeeeecC
Q 043702 375 LRSATKCFNANRIIGHGAFGTVYKGILP-QNGDIIAVKRCSHNSQG---KDEFLSELSIIGTLR-HRNLVRLQGWCHEKG 449 (711)
Q Consensus 375 l~~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~~vavK~~~~~~~~---~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~ 449 (711)
....+..|.....||.|.|+.|++...+ .++..+++|........ ...-..|+.+...+. |.++++.........
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 3344567888999999999999998765 67788999987663322 112346777777765 888888766666666
Q ss_pred eEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCC-CcEEEeecCCce
Q 043702 450 EILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEG-FNARLGDFGLAR 528 (711)
Q Consensus 450 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~-~~vkL~DFGla~ 528 (711)
+.++--|||+++++...+ .....++...++++..|++.++.++|+. .++|+|+||+||++..+ +..+++|||++.
T Consensus 340 ~~~ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred cccCchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccccc
Confidence 777999999999887665 2234577788999999999999999987 99999999999999875 888999999986
Q ss_pred ecCCCCCCCcccccCCCccc--ChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhh
Q 043702 529 QVEHDKSPDATVAAGTMGYL--APEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHR 606 (711)
Q Consensus 529 ~~~~~~~~~~~~~~gt~~y~--APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~ 606 (711)
.+.-. .....+.-+++ +++......+-.+.|++|||.-+.|.+++..--.. ...| ...+
T Consensus 416 ~~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~-------------~~~~--~~i~ 476 (524)
T KOG0601|consen 416 RLAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES-------------GVQS--LTIR 476 (524)
T ss_pred cccee----cccccccccccccchhhccccccccccccccccccccccccCcccCcc-------------cccc--eeee
Confidence 42111 11112233444 55555666788999999999999999988653221 1111 1111
Q ss_pred cCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 043702 607 EGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLV 656 (711)
Q Consensus 607 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 656 (711)
.+... .+.+ .. +.+..+...+..+++..||.+.++..+..
T Consensus 477 ~~~~p-----~~~~----~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 477 SGDTP-----NLPG----LK-LQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred ccccc-----CCCc----hH-HhhhhhhhhhcCCccccchhhhhhcccch
Confidence 22111 1111 11 33445556678899999999988776543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.04 E-value=5.3e-09 Score=112.92 Aligned_cols=168 Identities=20% Similarity=0.271 Sum_probs=133.6
Q ss_pred CceEEEEEEeCCCCeEEEEEEcccCC-CChhhhHHHHHHHHhcCCCCeeeeeeeee----ecCeEEEEEEcCCC-CCHHH
Q 043702 392 AFGTVYKGILPQNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCH----EKGEILLVYDLMPN-GSLDK 465 (711)
Q Consensus 392 ~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~----~~~~~~lV~Ey~~~-gsL~~ 465 (711)
.-.+.||+...-+|..|++||++..+ +.......-++.++++.|.|+|++.+++. .+..+++||+|.|+ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 44788999999999999999995433 33335566789999999999999998876 34578999999986 57777
Q ss_pred HHhhC--------------CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecC
Q 043702 466 ALFEA--------------RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVE 531 (711)
Q Consensus 466 ~l~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~ 531 (711)
+-+.. ....++...+.++.|+..||.++|+. |+.-+-|.+++||++.+.+++|+.+|....+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence 65421 12467788999999999999999998 99999999999999999999999999887766
Q ss_pred CCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCC
Q 043702 532 HDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRP 580 (711)
Q Consensus 532 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P 580 (711)
.+... -+. -..+-|.=-||.+++.|.||..-
T Consensus 445 ~d~~~---------------~le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDPTE---------------PLE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCCc---------------chh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 54411 111 12356888999999999999654
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=4.3e-09 Score=100.42 Aligned_cols=130 Identities=26% Similarity=0.325 Sum_probs=99.5
Q ss_pred ceeecCCceEEEEEEeCCCCeEEEEEE-cccCCC--C------hhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 386 RIIGHGAFGTVYKGILPQNGDIIAVKR-CSHNSQ--G------KDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~~~~~~vavK~-~~~~~~--~------~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
..+++|+-+.+|.+.+ -|..+++|. +.+.-. + ...-.+|.+++.+++--.|.-..-+..+.+...++||
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 3588999999999977 344566663 333211 1 1245679999999876555555555666777899999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCcee
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQ 529 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~ 529 (711)
|+++..|.+.+... +..++..+-.-+.-||.. +|+|+||.++||++..+. +.++||||+..
T Consensus 80 ~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA--------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999888654 366777888888999987 999999999999998764 99999999974
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.95 E-value=5.7e-09 Score=99.06 Aligned_cols=141 Identities=18% Similarity=0.237 Sum_probs=105.1
Q ss_pred ccceeecCCceEEEEEEeCCCCeEEEEEE-cccCC--------CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEE
Q 043702 384 ANRIIGHGAFGTVYKGILPQNGDIIAVKR-CSHNS--------QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLV 454 (711)
Q Consensus 384 ~~~~LG~G~fg~Vy~~~~~~~~~~vavK~-~~~~~--------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 454 (711)
....|-+|+-+.|+++.+ .|+...||. +.+.- -.....++|.++|.+++--.|....-++.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 567899999999999998 577777773 33211 1234577899999998755555544555566667899
Q ss_pred EEcCCC-CCHHHHHhhCCCCCChHHH-HHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCC---cEEEeecCCcee
Q 043702 455 YDLMPN-GSLDKALFEARSPLPWPHR-SKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGF---NARLGDFGLARQ 529 (711)
Q Consensus 455 ~Ey~~~-gsL~~~l~~~~~~l~~~~~-~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~---~vkL~DFGla~~ 529 (711)
|||+++ -++.+++......-..+.. ...+.+|-+.+.-||.. .|+|+||..+||+|..++ .+.++|||++..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 999976 4788888765443333333 78899999999999987 999999999999996554 358999999864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.92 E-value=2.6e-10 Score=131.61 Aligned_cols=205 Identities=23% Similarity=0.277 Sum_probs=148.0
Q ss_pred HhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEccc----CCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEE
Q 043702 378 ATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSH----NSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILL 453 (711)
Q Consensus 378 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 453 (711)
.-+.+.+.+-+-.|.++.++.+.-...|...++|.... .....+....+-.++-..+||-++...--+.-....+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 44566667778889999999887766665555554332 11223333344444444456666655544455678899
Q ss_pred EEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCC-
Q 043702 454 VYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEH- 532 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~- 532 (711)
+++|..+++|...|+... ..+.+..+..+..+..+++|||.. .+.|||++|.|.|...++..+++|||+......
T Consensus 882 ~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred hhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccc
Confidence 999999999999987654 344444555666778899999996 699999999999999999999999984432210
Q ss_pred --------------------CCC---------CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCcc
Q 043702 533 --------------------DKS---------PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEK 583 (711)
Q Consensus 533 --------------------~~~---------~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~ 583 (711)
... .......||+.|.+||.+.+......+|.|+.|++++|.++|..||..
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 000 012234689999999999999999999999999999999999999987
Q ss_pred ccc
Q 043702 584 EIT 586 (711)
Q Consensus 584 ~~~ 586 (711)
...
T Consensus 1038 ~tp 1040 (1205)
T KOG0606|consen 1038 ETP 1040 (1205)
T ss_pred cch
Confidence 644
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.84 E-value=7.9e-08 Score=99.88 Aligned_cols=139 Identities=13% Similarity=0.075 Sum_probs=101.5
Q ss_pred ceeecCCceEEEEEEeCCCCeEEEEEEcccCC------------CChhhhHHHHHHHHhcCCCCe--eeeeeeeee----
Q 043702 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS------------QGKDEFLSELSIIGTLRHRNL--VRLQGWCHE---- 447 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------------~~~~~~~~Ei~~l~~l~H~ni--v~l~g~~~~---- 447 (711)
+.+-......|++... +|+.+.||+..... .....+.+|...+.+|...+| ..++++...
T Consensus 28 e~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 28 EVFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred cEEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 4455555556778776 57889999764322 111247899999988863333 344555433
Q ss_pred -cCeEEEEEEcCCCC-CHHHHHhhC-CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcC-------CC
Q 043702 448 -KGEILLVYDLMPNG-SLDKALFEA-RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDE-------GF 517 (711)
Q Consensus 448 -~~~~~lV~Ey~~~g-sL~~~l~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~-------~~ 517 (711)
...-+||+|++++. +|.+++... ....+...+..++.+++..+.-||.. +|+|+|++++|||++. +.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCc
Confidence 23578999999886 899888532 23455677889999999999999998 9999999999999975 56
Q ss_pred cEEEeecCCcee
Q 043702 518 NARLGDFGLARQ 529 (711)
Q Consensus 518 ~vkL~DFGla~~ 529 (711)
.+.|+||+.++.
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 899999998863
|
|
| >cd06900 lectin_VcfQ VcfQ bacterial pilus biogenesis protein, lectin domain | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.1e-06 Score=86.69 Aligned_cols=190 Identities=19% Similarity=0.222 Sum_probs=113.9
Q ss_pred eeCCcEEeCCCCCCCCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecCCCCCCCCceEEEEcCCC--CCCCCCCCc
Q 043702 54 MNNGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLNPSSIGAGLAFVITPDG--EQVGSAGGS 131 (711)
Q Consensus 54 ~~~g~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~GlaF~l~~~~--~~~~~~g~~ 131 (711)
+.+|.||||++.. +++|-+.|.+++|--+. -...+|.+..-.. ...++||+||||.-.. ..++..||-
T Consensus 29 i~~g~LRLT~~~~---nqata~~~~~~FPs~~n------~v~veFd~yayg~-~g~GADGia~vLsDasv~p~~G~fGGs 98 (255)
T cd06900 29 VVNNRLRLTDASG---NQATAVTLQRLFPSAGN------YVEVEFDYYAYGS-GGNGADGVALVLSDASVTPQAGAFGGS 98 (255)
T ss_pred cccCeEEeccCcc---CcceeEEEeeeeccCCC------eEEEEEEEEEecC-CCCCCceEEEEEeCCCcCCcCCCcCcc
Confidence 4589999999888 88999999999986321 2777888877654 4678999999998433 345888999
Q ss_pred ccccccC--CCC--cceEEEEeecccCCCC-CCCC-------CCeeeEecCCCcccccccCC--------ccccccCC--
Q 043702 132 LGLLDEK--GAG--LGFVAVEFDTLMDVEF-SDIN-------GNHVGLDLNSMVSTEVDNLD--------TINVDLKS-- 189 (711)
Q Consensus 132 lgl~~~~--~~~--~~~vaVEFDt~~n~~~-~d~~-------~~Hvgid~ns~~S~~~~~~~--------~~~~~~~~-- 189 (711)
||+--.. ..| ..+++|-||-|-|..- .+-. .+-|+|= +.-+. +..+. ...++..+
T Consensus 99 LGYa~~~~~~~GfaGGwLGiGlDEyGNFsn~~eg~~~~~g~r~~sV~vR--Gsg~g-~~gY~yl~gt~~~~~~id~~~~~ 175 (255)
T cd06900 99 LGYAQRNDGVPGFAGGWLGIGLDEYGNFSNPNEGRNGFSGRRPQSVTVR--GSGSG-YTGYKYITGTGVLPPGIDNNSTS 175 (255)
T ss_pred cccccccCCCCccccceEEEEEeccccccCCCCCccCCcccccceEEEE--CCCCC-CcCceEecccCCCCcccccCCCC
Confidence 9997553 233 5689999999876321 1111 1234331 11110 01110 01111111
Q ss_pred --CCeEEEEEEEccc-c--cEEEEEEEecCCCCCcceee--EecCcc--cccccceeEEEeeeccCceeeEEEEee
Q 043702 190 --GDLVNSWIEYDGL-T--RAFNISVSYSNLKPKVPILS--FTLDLD--QYVNDFMYVGFSGSTQGSTEIHSIEWW 256 (711)
Q Consensus 190 --g~~~~~~I~Y~~~-~--~~l~V~~~~~~~~~~~~~ls--~~vdL~--~~l~~~~~vGFsastg~~~~~~~i~sW 256 (711)
.-.++-+|.-|+. . ..|+|.-+..+..-..+++. ..++.. .-+|+..+++|++|||...-.|+|...
T Consensus 176 ~~~~~hrY~i~Ids~~~~~~~vsV~R~~~~gg~~~~~I~~~d~~~~~~q~avP~~f~lS~TgSTGgstN~HEIdnf 251 (255)
T cd06900 176 TPAPGHRYRITIDSTNGDNAWLSVERDIGNGGAYFVVILTFDALAEQNQDAIPENFYLSFTGSTGGSTNTHEIDNF 251 (255)
T ss_pred CCCCceEEEEEEecCCCCceEEEEEEEccCCceeEEeecceeeccccCCCCCCccEEEEEEecCCCcccceeecce
Confidence 1235556666655 2 23444444322211222221 122333 468999999999999999999999653
|
This family includes bacterial proteins homologous to the VcfQ (also known as MshQ) bacterial pilus biogenesis protein. VcfQ is encoded by the vcfQ gene of the type IV pilus gene cluster of Vibrio cholerae and is essential for type IV pilus assembly. VcfQ has a Laminin G-like domain as well as an L-type lectin domain. |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.69 E-value=2.1e-07 Score=91.32 Aligned_cols=125 Identities=20% Similarity=0.311 Sum_probs=81.5
Q ss_pred EEEEEEeCCCCeEEEEEEcccCC--------------C--------C-----hhhhHHHHHHHHhcCCC--Ceeeeeeee
Q 043702 395 TVYKGILPQNGDIIAVKRCSHNS--------------Q--------G-----KDEFLSELSIIGTLRHR--NLVRLQGWC 445 (711)
Q Consensus 395 ~Vy~~~~~~~~~~vavK~~~~~~--------------~--------~-----~~~~~~Ei~~l~~l~H~--niv~l~g~~ 445 (711)
.||.|... +|..+|+|+..... . . .....+|.+.|.++..- ++.+++.+-
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 48999884 58899999765310 0 0 11356799999999865 455555442
Q ss_pred eecCeEEEEEEcCC--CCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHH-HhccCCCeeeccCCCCceEEcCCCcEEEe
Q 043702 446 HEKGEILLVYDLMP--NGSLDKALFEARSPLPWPHRSKILLGVASALAYL-HQECENQVIHRDVKTSNIMLDEGFNARLG 522 (711)
Q Consensus 446 ~~~~~~~lV~Ey~~--~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yL-H~~~~~~ivHrDlkp~NILld~~~~vkL~ 522 (711)
.-+|||||++ +..+..+... . ++......++.+++..+..+ |.. +|+|+||.+.|||++++ .+.|+
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~-~--~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDV-D--LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHC-G--GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE-
T ss_pred ----CCEEEEEecCCCccchhhHHhc-c--ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEE
Confidence 2379999998 5445443321 1 12455677888888866664 565 99999999999999988 99999
Q ss_pred ecCCceecC
Q 043702 523 DFGLARQVE 531 (711)
Q Consensus 523 DFGla~~~~ 531 (711)
|||.+....
T Consensus 149 Df~qav~~~ 157 (188)
T PF01163_consen 149 DFGQAVDSS 157 (188)
T ss_dssp -GTTEEETT
T ss_pred ecCcceecC
Confidence 999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.4e-06 Score=87.42 Aligned_cols=107 Identities=21% Similarity=0.258 Sum_probs=85.0
Q ss_pred hhhhHHHHHHHHhcCCC--CeeeeeeeeeecC----eEEEEEEcCCCC-CHHHHHhhCCCCCChHHHHHHHHHHHHHHHH
Q 043702 420 KDEFLSELSIIGTLRHR--NLVRLQGWCHEKG----EILLVYDLMPNG-SLDKALFEARSPLPWPHRSKILLGVASALAY 492 (711)
Q Consensus 420 ~~~~~~Ei~~l~~l~H~--niv~l~g~~~~~~----~~~lV~Ey~~~g-sL~~~l~~~~~~l~~~~~~~i~~~ia~aL~y 492 (711)
.....+|...+.+|... ...+.+++..... .-++|+|++++. +|.+++..... ++...+..++.++++.+.-
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAK 133 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHH
Confidence 45678899988888633 3455666655432 458999999884 79998865322 6667788999999999999
Q ss_pred HHhccCCCeeeccCCCCceEEcCCC---cEEEeecCCceec
Q 043702 493 LHQECENQVIHRDVKTSNIMLDEGF---NARLGDFGLARQV 530 (711)
Q Consensus 493 LH~~~~~~ivHrDlkp~NILld~~~---~vkL~DFGla~~~ 530 (711)
||.. +|+|+|+++.|||++.+. .+.++||+-++..
T Consensus 134 lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 134 LHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9998 999999999999998887 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.47 E-value=5.4e-08 Score=108.99 Aligned_cols=150 Identities=21% Similarity=0.317 Sum_probs=99.6
Q ss_pred HHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC--------cccccCCCcccChhhhcc
Q 043702 484 LGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD--------ATVAAGTMGYLAPEYLLT 555 (711)
Q Consensus 484 ~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~--------~~~~~gt~~y~APE~~~~ 555 (711)
.+++.||.|+|.. .++||++|.|++|.++.++..||+.|+++.......... .....-...|.|||++..
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 3455999999986 799999999999999999999999999886544321111 011224567999999999
Q ss_pred CCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHH
Q 043702 556 GRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVG 634 (711)
Q Consensus 556 ~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~ 634 (711)
...+.++|+||+||++|-+.. |+.-+.... ....+... ...+..-...+..+...++.+=+
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~----------~~~~~~~~--------~~~~~~~~~~~s~~~p~el~~~l 245 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANG----------GLLSYSFS--------RNLLNAGAFGYSNNLPSELRESL 245 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccC----------Ccchhhhh--------hcccccccccccccCcHHHHHHH
Confidence 888999999999999999985 444433221 11111100 00011111112223334455555
Q ss_pred HhcCCCCCCCCCCHHHHHH
Q 043702 635 LACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 635 ~~Cl~~dP~~RPs~~eVl~ 653 (711)
.+.+..++..||++.++..
T Consensus 246 ~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 246 KKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HHHhcCCcccCcchhhhhc
Confidence 6788899999998877764
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.43 E-value=4.9e-06 Score=82.40 Aligned_cols=136 Identities=21% Similarity=0.204 Sum_probs=103.7
Q ss_pred eecCCceEEEEEEeCCCCeEEEEEEccc----C---CCChhhhHHHHHHHHhcCCC--Ceeeeeeeeeec-----CeEEE
Q 043702 388 IGHGAFGTVYKGILPQNGDIIAVKRCSH----N---SQGKDEFLSELSIIGTLRHR--NLVRLQGWCHEK-----GEILL 453 (711)
Q Consensus 388 LG~G~fg~Vy~~~~~~~~~~vavK~~~~----~---~~~~~~~~~Ei~~l~~l~H~--niv~l~g~~~~~-----~~~~l 453 (711)
-|+||-+.|++-.+ .|..+-+|+-.. . .-....|.+|+..|.+|... .+.+++ ++... -.-+|
T Consensus 26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 46799999999877 455788997652 1 33567899999999999732 244444 33321 24689
Q ss_pred EEEcCCC-CCHHHHHhhC-CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCc--EEEeecCCcee
Q 043702 454 VYDLMPN-GSLDKALFEA-RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFN--ARLGDFGLARQ 529 (711)
Q Consensus 454 V~Ey~~~-gsL~~~l~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~--vkL~DFGla~~ 529 (711)
|+|-+++ -+|.+++.+. ..+.+...+..++.+++..+.-||+. ++.|+|+.+.|||++.++. ++++||.-++.
T Consensus 103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 9997764 5898888543 24567788899999999999999998 9999999999999986667 99999976653
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.9e-06 Score=87.25 Aligned_cols=136 Identities=19% Similarity=0.214 Sum_probs=97.1
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC-----------------------CChhhhHHHHHHHHhcCCC-
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS-----------------------QGKDEFLSELSIIGTLRHR- 436 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----------------------~~~~~~~~Ei~~l~~l~H~- 436 (711)
-..+...||-|--+.||.|..+ .|.++|||.-.... -......+|.++|.+|...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred HHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 3556688999999999999996 68899999432110 0012456899999999855
Q ss_pred -CeeeeeeeeeecCeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcC
Q 043702 437 -NLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDE 515 (711)
Q Consensus 437 -niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~ 515 (711)
.+.+.+++ +.-.+||||+++--|...- ++.+....|+..|++-+.-+-.. ||||+|+.+-||++++
T Consensus 171 ~~VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~ 237 (304)
T COG0478 171 VKVPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEec
Confidence 66666665 3458999999886665421 12334444555555555544444 9999999999999999
Q ss_pred CCcEEEeecCCceec
Q 043702 516 GFNARLGDFGLARQV 530 (711)
Q Consensus 516 ~~~vkL~DFGla~~~ 530 (711)
|+.+.++||--+...
T Consensus 238 dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 238 DGDIVVIDWPQAVPI 252 (304)
T ss_pred CCCEEEEeCcccccC
Confidence 999999999766543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.35 E-value=6.9e-06 Score=87.20 Aligned_cols=192 Identities=15% Similarity=0.177 Sum_probs=127.8
Q ss_pred cccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhc-CCCCeeeeeeee-------eecCeEEEE
Q 043702 383 NANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTL-RHRNLVRLQGWC-------HEKGEILLV 454 (711)
Q Consensus 383 ~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~-------~~~~~~~lV 454 (711)
...+.||+|+-+.+|-.-. -+.. +.|+.....-..+ .+.+..|... .||-+-.-+.|= ......-+.
T Consensus 14 ~~gr~LgqGgea~ly~l~e--~~d~-VAKIYh~Pppa~~--aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE--VRDQ-VAKIYHAPPPAAQ--AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecch--hhch-hheeecCCCchHH--HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 3457799999999996433 1222 3466654322111 1223333333 365443322221 112236677
Q ss_pred EEcCCCCCHHHHHhh------CCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCce
Q 043702 455 YDLMPNGSLDKALFE------ARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLAR 528 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~ 528 (711)
|..+++..--..+.. ......|.-.++.++.+|.+.+-||.. |.+-+|+.++|+|+.++..|.|.|-..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence 887766532222321 123488999999999999999999998 99999999999999999999999854433
Q ss_pred ecCCCCCCCcccccCCCcccChhhhc-----cCCCCccccchhHHHHHHHHHhC-CCCCccc
Q 043702 529 QVEHDKSPDATVAAGTMGYLAPEYLL-----TGRATEKTDVFSYGAVVLEVASG-RRPIEKE 584 (711)
Q Consensus 529 ~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwSfGvll~elltG-~~P~~~~ 584 (711)
.. .+.......+|...|.+||.-. +..-+...|-|.+||++++|+.| ++||...
T Consensus 166 i~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 166 IN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred ec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 32 2223334467899999999754 23446789999999999999986 9999754
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.6e-07 Score=103.92 Aligned_cols=186 Identities=20% Similarity=0.164 Sum_probs=135.6
Q ss_pred CcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCC-eeeeeeeeeecCeEEEEEEcCCC
Q 043702 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRN-LVRLQGWCHEKGEILLVYDLMPN 460 (711)
Q Consensus 382 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~~~~lV~Ey~~~ 460 (711)
+..-+-+++|+.+++||.+...+. ....+.+... ....-++++|.+++||| .+..++-+..+...+++++++..
T Consensus 244 s~~fh~fvK~altknpKkRptaek-lL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~ 318 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEK-LLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST 318 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhh-heeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence 344456889999999998764433 2335554432 45567899999999999 77777777777889999999987
Q ss_pred C-CHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCcc
Q 043702 461 G-SLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDAT 539 (711)
Q Consensus 461 g-sL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 539 (711)
+ +-..........+...+...+++.-+++|+|||+. .=+||| ||+..+ ...|..||+....+.... ...
T Consensus 319 ~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~ 388 (829)
T KOG0576|consen 319 GRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPR 388 (829)
T ss_pred CccccccCChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--ccc
Confidence 7 22111111112233344556677778899999986 458998 777766 578999999998776544 334
Q ss_pred cccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCc
Q 043702 540 VAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIE 582 (711)
Q Consensus 540 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~ 582 (711)
...+++.|+|||+.....+..+-|+|+.|+-..++.-|-+|-.
T Consensus 389 t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 389 TAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 4569999999999999999999999999988778877777753
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.5e-05 Score=81.10 Aligned_cols=137 Identities=14% Similarity=0.181 Sum_probs=85.5
Q ss_pred ceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCC--eeeeeeeeeecCeEEEEEEcCCCCC-
Q 043702 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRN--LVRLQGWCHEKGEILLVYDLMPNGS- 462 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~~~~~~~~~lV~Ey~~~gs- 462 (711)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.++++...+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 56899999999984 24456788876533 3456789999999987443 4667777777777889999998863
Q ss_pred HHHHH---------------------hhCC-CCCChHHHHH-HHH----------HHHH-HHHHHHhc-cCCCeeeccCC
Q 043702 463 LDKAL---------------------FEAR-SPLPWPHRSK-ILL----------GVAS-ALAYLHQE-CENQVIHRDVK 507 (711)
Q Consensus 463 L~~~l---------------------~~~~-~~l~~~~~~~-i~~----------~ia~-aL~yLH~~-~~~~ivHrDlk 507 (711)
+...+ +.-. .......+.. +.. .+.+ ...+|... ....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 21111 1100 0111111110 000 0111 12222211 13467899999
Q ss_pred CCceEEcCCCcEEEeecCCce
Q 043702 508 TSNIMLDEGFNARLGDFGLAR 528 (711)
Q Consensus 508 p~NILld~~~~vkL~DFGla~ 528 (711)
|.||++++++ +.|+||+.+.
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCcEEEcCCC-cEEEechhcC
Confidence 9999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.21 E-value=4e-06 Score=94.37 Aligned_cols=141 Identities=16% Similarity=0.196 Sum_probs=92.4
Q ss_pred ceeecCCceEEEEEEeCCCCeEEEEEEcccCCC---------------------------C--------------hhhhH
Q 043702 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ---------------------------G--------------KDEFL 424 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---------------------------~--------------~~~~~ 424 (711)
+-|+.++-|.||+|+++. |+.||||+...+-. . +-++.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 568999999999999964 99999998754210 0 01234
Q ss_pred HHHHHHHhcC----CCCeeeeeeeeee-cCeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCC
Q 043702 425 SELSIIGTLR----HRNLVRLQGWCHE-KGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECEN 499 (711)
Q Consensus 425 ~Ei~~l~~l~----H~niv~l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~ 499 (711)
+|...+.+++ ...-+++-..|.+ .+...|+|||++|-.+.+........++.+ .++..++++ |+-+....
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k---~ia~~~~~~--f~~q~~~d 284 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRK---ELAELLVRA--FLRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHH---HHHHHHHHH--HHHHHHhc
Confidence 4555555543 2222333333332 356799999999998888754333445533 333333332 11111123
Q ss_pred CeeeccCCCCceEEcCCCcEEEeecCCceecCC
Q 043702 500 QVIHRDVKTSNIMLDEGFNARLGDFGLARQVEH 532 (711)
Q Consensus 500 ~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~ 532 (711)
++.|.|..|.||+++.++++.+.|||+...+..
T Consensus 285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 999999999999999999999999999987654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.12 E-value=2.1e-05 Score=79.48 Aligned_cols=142 Identities=20% Similarity=0.217 Sum_probs=85.8
Q ss_pred cceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCC--Ceeeeeeeeee---cCeEEEEEEcCC
Q 043702 385 NRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHR--NLVRLQGWCHE---KGEILLVYDLMP 459 (711)
Q Consensus 385 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~--niv~l~g~~~~---~~~~~lV~Ey~~ 459 (711)
.+.|+.|..+.||+....+ ..+++|..... .....+.+|..+++.+... .+.+++.++.. ....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3568999999999999854 58899986654 3456788999999988733 34566664432 345799999999
Q ss_pred CCCHHH----------------HH---hhC---CCCCChHH---------HHHH------------HHHHHH-HHHHHHh
Q 043702 460 NGSLDK----------------AL---FEA---RSPLPWPH---------RSKI------------LLGVAS-ALAYLHQ 495 (711)
Q Consensus 460 ~gsL~~----------------~l---~~~---~~~l~~~~---------~~~i------------~~~ia~-aL~yLH~ 495 (711)
+..+.. .+ +.. ...+.+.. .... ...+.+ .+..+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988777 11 111 11111111 0000 111222 3334433
Q ss_pred c----cCCCeeeccCCCCceEEc-CCCcEEEeecCCcee
Q 043702 496 E----CENQVIHRDVKTSNIMLD-EGFNARLGDFGLARQ 529 (711)
Q Consensus 496 ~----~~~~ivHrDlkp~NILld-~~~~vkL~DFGla~~ 529 (711)
. ....++|+|+.+.|||++ +++++.|.||+.+..
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2 245799999999999999 666678999988753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.12 E-value=3.2e-05 Score=79.50 Aligned_cols=137 Identities=18% Similarity=0.144 Sum_probs=85.0
Q ss_pred eecCCc-eEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcC-CCCeeeeeeeeeecCeEEEEEEcCCCCCHHH
Q 043702 388 IGHGAF-GTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLR-HRNLVRLQGWCHEKGEILLVYDLMPNGSLDK 465 (711)
Q Consensus 388 LG~G~f-g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 465 (711)
|-.|.. ..||+.... +..+.+|+..... ..++.+|+++++.+. +--+.+++++....+..++|||+++|.+|..
T Consensus 6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC--CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 444555 889998763 4678888875433 456788999999886 4445577777776667899999999987764
Q ss_pred HH-------------------hhCC---CCCC--hHHHHHHHH--------------------HHHHHHHHHHhc----c
Q 043702 466 AL-------------------FEAR---SPLP--WPHRSKILL--------------------GVASALAYLHQE----C 497 (711)
Q Consensus 466 ~l-------------------~~~~---~~l~--~~~~~~i~~--------------------~ia~aL~yLH~~----~ 497 (711)
.. +... ..+. ...+..... .+...+..|-.. .
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 32 1000 0111 001110000 011112222111 1
Q ss_pred CCCeeeccCCCCceEEcCCCcEEEeecCCce
Q 043702 498 ENQVIHRDVKTSNIMLDEGFNARLGDFGLAR 528 (711)
Q Consensus 498 ~~~ivHrDlkp~NILld~~~~vkL~DFGla~ 528 (711)
.+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 3469999999999999998778899998775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.98 E-value=6.6e-05 Score=75.56 Aligned_cols=154 Identities=17% Similarity=0.192 Sum_probs=98.7
Q ss_pred ccCHHHHHHHhcCCcccce---eecCCceEEEEEEeCCCCeEEEEEEcccCCCC--------------------hhh---
Q 043702 369 EFSYRELRSATKCFNANRI---IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQG--------------------KDE--- 422 (711)
Q Consensus 369 ~~~~~el~~at~~f~~~~~---LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~--------------------~~~--- 422 (711)
..++..+........+... |.+|--+.||+|.. .++..+|+|+....... .++
T Consensus 34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~ 112 (268)
T COG1718 34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVF 112 (268)
T ss_pred hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHH
Confidence 3445556666555555555 45677889999877 45889999987642211 111
Q ss_pred --hHHHHHHHHhcC--CCCeeeeeeeeeecCeEEEEEEcCCCCC-HHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhcc
Q 043702 423 --FLSELSIIGTLR--HRNLVRLQGWCHEKGEILLVYDLMPNGS-LDKALFEARSPLPWPHRSKILLGVASALAYLHQEC 497 (711)
Q Consensus 423 --~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~lV~Ey~~~gs-L~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~ 497 (711)
..+|+.-|.++. +-.+.+.+++. .-.|||||+.... -.-.|. .-.+...+...+..++++.+.-|-..
T Consensus 113 ~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk--Dv~~e~~e~~~~~~~~v~~~~~l~~~- 185 (268)
T COG1718 113 AWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK--DVPLELEEAEGLYEDVVEYMRRLYKE- 185 (268)
T ss_pred HHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc--cCCcCchhHHHHHHHHHHHHHHHHHh-
Confidence 235677777664 33333444433 2389999986531 111111 11233335667777888888877763
Q ss_pred CCCeeeccCCCCceEEcCCCcEEEeecCCceecCC
Q 043702 498 ENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEH 532 (711)
Q Consensus 498 ~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~ 532 (711)
.++||+||+.-|||+. ++.+.|+|||-|....+
T Consensus 186 -a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 186 -AGLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred -cCcccccchhhheEEE-CCeEEEEECccccccCC
Confidence 3999999999999999 78999999998865543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.96 E-value=0.0001 Score=73.45 Aligned_cols=137 Identities=12% Similarity=0.127 Sum_probs=92.1
Q ss_pred HhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC-Chh---------hhHHHHHHHHhcCC---CCeeeeeee
Q 043702 378 ATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ-GKD---------EFLSELSIIGTLRH---RNLVRLQGW 444 (711)
Q Consensus 378 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~---------~~~~Ei~~l~~l~H---~niv~l~g~ 444 (711)
..++|...+++-......|.+-.. +|..+.+|....... ..+ ...+++..+.+++. -..+.++.+
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 456788888888888788887766 678899997665221 111 22344554555542 233333333
Q ss_pred eee-----cCeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcE
Q 043702 445 CHE-----KGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNA 519 (711)
Q Consensus 445 ~~~-----~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~v 519 (711)
+.. ....+|+|||++|..|.++.. ++. .++..+.+++.-||.. |+.|+|..|.|++++++ .+
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~-~i 173 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN-GI 173 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC-cE
Confidence 322 234578999999988766431 221 3455677889999998 99999999999999865 49
Q ss_pred EEeecCCcee
Q 043702 520 RLGDFGLARQ 529 (711)
Q Consensus 520 kL~DFGla~~ 529 (711)
++.||+..+.
T Consensus 174 ~iID~~~k~~ 183 (229)
T PF06176_consen 174 RIIDTQGKRM 183 (229)
T ss_pred EEEECccccc
Confidence 9999987764
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.90 E-value=4.2e-05 Score=75.34 Aligned_cols=102 Identities=22% Similarity=0.220 Sum_probs=82.3
Q ss_pred HHHHHHHhcCC-CCeeeeeeeeeecCeEEEEEEcCCCCCHHHHHh--hCCCCCChHHHHHHHHHHHHHHHHHHhccCCCe
Q 043702 425 SELSIIGTLRH-RNLVRLQGWCHEKGEILLVYDLMPNGSLDKALF--EARSPLPWPHRSKILLGVASALAYLHQECENQV 501 (711)
Q Consensus 425 ~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~i 501 (711)
.|.-+++.+++ +++.+++|.|- .++|.||.+.+++...-. ..-..-+|..|.+|+.++++.+.+|++.....+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 58888999986 69999999994 377899998776643100 011246899999999999999999998655568
Q ss_pred eeccCCCCceEEcCCCcEEEeecCCceec
Q 043702 502 IHRDVKTSNIMLDEGFNARLGDFGLARQV 530 (711)
Q Consensus 502 vHrDlkp~NILld~~~~vkL~DFGla~~~ 530 (711)
.-.|++++|+-+++++++|+.|...+...
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcchh
Confidence 89999999999999999999999877543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.85 E-value=5.7e-05 Score=84.93 Aligned_cols=142 Identities=18% Similarity=0.197 Sum_probs=91.4
Q ss_pred ceeecCCceEEEEEEeCCCCeEEEEEEcccCCCC--------------------------------------hhhhHHHH
Q 043702 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQG--------------------------------------KDEFLSEL 427 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~--------------------------------------~~~~~~Ei 427 (711)
+-||.-..|.||+|+++. |+.||||+-+..-+. +=+|.+|.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 569999999999999975 999999976532100 01244454
Q ss_pred HHHHhc----CCCC---eeeeeeeeee-cCeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCC
Q 043702 428 SIIGTL----RHRN---LVRLQGWCHE-KGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECEN 499 (711)
Q Consensus 428 ~~l~~l----~H~n---iv~l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~ 499 (711)
+-..+. .|-+ -|.+-.++.+ .....|+||||+|..+.+...-....++... |+..+.++ |++.....
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~---i~~~l~~~--~~~qIf~~ 320 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHD---ILNKLVEA--YLEQIFKT 320 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHH---HHHHHHHH--HHHHHHhc
Confidence 443333 3444 1222222222 2467999999999877766443344455543 33333332 33333345
Q ss_pred CeeeccCCCCceEEcC----CCcEEEeecCCceecCCC
Q 043702 500 QVIHRDVKTSNIMLDE----GFNARLGDFGLARQVEHD 533 (711)
Q Consensus 500 ~ivHrDlkp~NILld~----~~~vkL~DFGla~~~~~~ 533 (711)
|++|.|=.|.||+++. ++.+.+-|||+...+.+.
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 8999999999999984 678999999999876543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00018 Score=87.03 Aligned_cols=78 Identities=13% Similarity=0.284 Sum_probs=57.7
Q ss_pred cceeecCCceEEEEEEeCCCC--eEEEEEEcccCC--CChhhhHHHHHHHHhcC-CCCe--eeeeeeeeec---CeEEEE
Q 043702 385 NRIIGHGAFGTVYKGILPQNG--DIIAVKRCSHNS--QGKDEFLSELSIIGTLR-HRNL--VRLQGWCHEK---GEILLV 454 (711)
Q Consensus 385 ~~~LG~G~fg~Vy~~~~~~~~--~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~-H~ni--v~l~g~~~~~---~~~~lV 454 (711)
.+.|+.|.+..+|+......+ ..+++|+..... .....+.+|.++|+.+. |.++ .+++.+|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 456899999999998775432 467788765432 23457889999999996 6654 7788888764 467899
Q ss_pred EEcCCCCC
Q 043702 455 YDLMPNGS 462 (711)
Q Consensus 455 ~Ey~~~gs 462 (711)
|||+++..
T Consensus 123 ME~v~G~~ 130 (822)
T PLN02876 123 MEYLEGRI 130 (822)
T ss_pred EEecCCcc
Confidence 99998754
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00033 Score=69.00 Aligned_cols=124 Identities=27% Similarity=0.422 Sum_probs=91.3
Q ss_pred cCCcccceeecCCc-eEEEEEEeCCCCeEEEEEEccc---C-------C------------CChhhhHHHHHHHHhcC--
Q 043702 380 KCFNANRIIGHGAF-GTVYKGILPQNGDIIAVKRCSH---N-------S------------QGKDEFLSELSIIGTLR-- 434 (711)
Q Consensus 380 ~~f~~~~~LG~G~f-g~Vy~~~~~~~~~~vavK~~~~---~-------~------------~~~~~~~~Ei~~l~~l~-- 434 (711)
..++..+.||.|.- |.||+++. +|..+|+|.+.. . . .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 67788899999999 99999999 688999999321 0 0 01235788999888886
Q ss_pred -CCCe--eeeeeeeeec------------------CeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHH
Q 043702 435 -HRNL--VRLQGWCHEK------------------GEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYL 493 (711)
Q Consensus 435 -H~ni--v~l~g~~~~~------------------~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yL 493 (711)
+..+ |+.+||..-. ....+|.||++... .+ ..+-+.+|.+-|..+
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~----~~~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PL----QIRDIPQMLRDLKIL 180 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------cc----chhHHHHHHHHHHHH
Confidence 4466 9999997432 12467888876633 12 223345667778889
Q ss_pred HhccCCCeeeccCCCCceEEcCCCcEEEeecCCc
Q 043702 494 HQECENQVIHRDVKTSNIMLDEGFNARLGDFGLA 527 (711)
Q Consensus 494 H~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla 527 (711)
|.. +|+-+|+++.|.. .-||+|||.+
T Consensus 181 ~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHC---CeeeccCcccccc-----CCEEEecccC
Confidence 987 9999999999984 5689999864
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00021 Score=73.12 Aligned_cols=73 Identities=14% Similarity=0.090 Sum_probs=45.6
Q ss_pred ceeecCCce-EEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCC---Ceeeeeeeeeec---CeEEEEEEcC
Q 043702 386 RIIGHGAFG-TVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHR---NLVRLQGWCHEK---GEILLVYDLM 458 (711)
Q Consensus 386 ~~LG~G~fg-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~---niv~l~g~~~~~---~~~~lV~Ey~ 458 (711)
+.|+.|+.. .||+. +..+++|.... .....++.+|.+++..|... .+.+.++.+... ...+++||++
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 457777776 48975 23466776543 23355788999999888632 233344433322 2358899999
Q ss_pred CCCCHH
Q 043702 459 PNGSLD 464 (711)
Q Consensus 459 ~~gsL~ 464 (711)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 987663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00052 Score=72.84 Aligned_cols=78 Identities=12% Similarity=0.055 Sum_probs=56.7
Q ss_pred cccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCC---CCeeeeeeeeee---cCeEEEEEE
Q 043702 383 NANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRH---RNLVRLQGWCHE---KGEILLVYD 456 (711)
Q Consensus 383 ~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H---~niv~l~g~~~~---~~~~~lV~E 456 (711)
...+.||.|..+.||+....+ + .+.+|..+ .......+..|.+.|+.|.- -.+.+++++|.. .+..+||||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~-~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQ-G-NPMPLMAR-SFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred heeeecCCccceeEEEEEcCC-C-CEEEEEec-ccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 345669999999999986632 3 45666633 22234588999999999863 367788888754 366899999
Q ss_pred cCCCCCH
Q 043702 457 LMPNGSL 463 (711)
Q Consensus 457 y~~~gsL 463 (711)
+++++++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998754
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00058 Score=69.60 Aligned_cols=74 Identities=20% Similarity=0.232 Sum_probs=48.3
Q ss_pred ceeecCCceEEEEEEeCC-CCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCe-eeeeeeeeecCeEEEEEEcCCCCCH
Q 043702 386 RIIGHGAFGTVYKGILPQ-NGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNL-VRLQGWCHEKGEILLVYDLMPNGSL 463 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~~gsL 463 (711)
+.|..|-...+|+..... .+..+++|+........-+..+|+.+++.+...++ .++++.+. + .++|||+++.++
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~~l 79 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGRTL 79 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCCcC
Confidence 457778888999987642 25678888765433222334579999999864333 34443332 2 479999988765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00063 Score=65.08 Aligned_cols=127 Identities=17% Similarity=0.240 Sum_probs=87.3
Q ss_pred ccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeee-eeeeeeecCeEEEEEEcCCCCC
Q 043702 384 ANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVR-LQGWCHEKGEILLVYDLMPNGS 462 (711)
Q Consensus 384 ~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~-l~g~~~~~~~~~lV~Ey~~~gs 462 (711)
..+.|++|.+|.||+|.+ .|..+|+|+-.. +.....+..|.++|..+.--++.+ ++.|-. -.+.|||+.|-.
T Consensus 26 v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~-ds~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~ 98 (201)
T COG2112 26 VEKELAKGTTSVVYLGEW--RGGEVALKVRRR-DSPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhcccccEEEEeec--cCceEEEEEecC-CcchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcc
Confidence 456799999999999999 466889987554 334678899999999998666544 444332 244599998888
Q ss_pred HHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCC-C-CceEEcCCCcEEEeecCCcee
Q 043702 463 LDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVK-T-SNIMLDEGFNARLGDFGLARQ 529 (711)
Q Consensus 463 L~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk-p-~NILld~~~~vkL~DFGla~~ 529 (711)
|.+.-... + .+-+..+++.---|... +|-|+.|. | .||++.+. .+.|+||.-|..
T Consensus 99 L~~~~~~~----~----rk~l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~-~~~iIDFd~At~ 155 (201)
T COG2112 99 LGKLEIGG----D----RKHLLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDR-DVYIIDFDSATF 155 (201)
T ss_pred hhhhhhcc----c----HHHHHHHHHHHHHHHHh---ccchhhhcCCceeEEecCC-cEEEEEccchhh
Confidence 87754321 1 22334455553344444 89998887 3 45555554 999999998874
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.0011 Score=65.67 Aligned_cols=128 Identities=20% Similarity=0.260 Sum_probs=90.0
Q ss_pred ccceeecCCceEEEEEEeCCCCeEEEEEEcccCC-----------------CChhhhHHHHHHHHhcC------CCCeee
Q 043702 384 ANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS-----------------QGKDEFLSELSIIGTLR------HRNLVR 440 (711)
Q Consensus 384 ~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----------------~~~~~~~~Ei~~l~~l~------H~niv~ 440 (711)
....||+|+.-.||. ++. +....||+..... ...++..+|+.....+. +..|.+
T Consensus 5 ~~~~i~~G~~R~cy~--HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r 81 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR 81 (199)
T ss_pred CCcccccCCCceEEE--CCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence 456799999999996 443 4556788776543 23467778887777766 789999
Q ss_pred eeeeeeecCeEEEEEEcCCC------CCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEc
Q 043702 441 LQGWCHEKGEILLVYDLMPN------GSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLD 514 (711)
Q Consensus 441 l~g~~~~~~~~~lV~Ey~~~------gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld 514 (711)
++|+.+.+.-+-+|+|.+.+ -+|.+++.+ +.++. ...+.+. +-.+||-+. .|+.+|++|.||++.
T Consensus 82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~--~~~~~-~~~~~L~---~f~~~l~~~---~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE--GGLTE-ELRQALD---EFKRYLLDH---HIVIRDLNPHNIVVQ 152 (199)
T ss_pred EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc--CCccH-HHHHHHH---HHHHHHHHc---CCeecCCCcccEEEE
Confidence 99999998889999998643 258888843 33444 3333333 334566555 899999999999994
Q ss_pred CC---C-cEEEee
Q 043702 515 EG---F-NARLGD 523 (711)
Q Consensus 515 ~~---~-~vkL~D 523 (711)
.. . .+.|+|
T Consensus 153 ~~~~~~~~lvlID 165 (199)
T PF10707_consen 153 RRDSGEFRLVLID 165 (199)
T ss_pred ecCCCceEEEEEe
Confidence 32 2 466776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00057 Score=72.31 Aligned_cols=140 Identities=20% Similarity=0.165 Sum_probs=86.4
Q ss_pred cceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCC--eeeeeee------eeecCeEEEEEE
Q 043702 385 NRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRN--LVRLQGW------CHEKGEILLVYD 456 (711)
Q Consensus 385 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~------~~~~~~~~lV~E 456 (711)
.+.|..|....+|+.... +..+++|+... ........|++++..|++.. +.+++.. ....+..++|+|
T Consensus 19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD--SGRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC--CCcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 455777877899998763 44688888764 34556778888888886432 3444332 123455689999
Q ss_pred cCCCCCHHH-----------H---HhhCC----------CCCChHHHHH----------HHHHHHHHHHHHHh----ccC
Q 043702 457 LMPNGSLDK-----------A---LFEAR----------SPLPWPHRSK----------ILLGVASALAYLHQ----ECE 498 (711)
Q Consensus 457 y~~~gsL~~-----------~---l~~~~----------~~l~~~~~~~----------i~~~ia~aL~yLH~----~~~ 498 (711)
|++|..+.. . ++... ....|..... ....+..++.++.. ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 998866421 1 11100 0122222110 11123344555543 123
Q ss_pred CCeeeccCCCCceEEcCCCcEEEeecCCce
Q 043702 499 NQVIHRDVKTSNIMLDEGFNARLGDFGLAR 528 (711)
Q Consensus 499 ~~ivHrDlkp~NILld~~~~vkL~DFGla~ 528 (711)
.+++|+|+.|.|||++++..+.|.||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 579999999999999998777899998875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0025 Score=68.20 Aligned_cols=154 Identities=18% Similarity=0.178 Sum_probs=84.5
Q ss_pred CHHHHHHHhcCCcc-----cceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCC--eeeeee
Q 043702 371 SYRELRSATKCFNA-----NRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRN--LVRLQG 443 (711)
Q Consensus 371 ~~~el~~at~~f~~-----~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g 443 (711)
+..++....+.|.. .+.|+.|....+|+.... +| .+++|+.. ....++...|+.++..|...+ +.+.+.
T Consensus 8 s~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~-~g-~~vLK~~~--~~~~~~l~~~~~~l~~L~~~glpvP~~i~ 83 (319)
T PRK05231 8 SDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTT-QG-EYVLTLFE--RLTAEDLPFFLGLMQHLAARGVPVPAPVA 83 (319)
T ss_pred CHHHHHHHHHhcCCchhhccchhccccccceEEEEeC-CC-cEEEEEec--cCChHHhHHHHHHHHHHHHCCCCCCccee
Confidence 34455444444543 244667777899998763 33 68889875 223445556666766664222 222222
Q ss_pred ------eeeecCeEEEEEEcCCCCCHH-----------HHH---hhCCC----------CCCh-HHHHH-----------
Q 043702 444 ------WCHEKGEILLVYDLMPNGSLD-----------KAL---FEARS----------PLPW-PHRSK----------- 481 (711)
Q Consensus 444 ------~~~~~~~~~lV~Ey~~~gsL~-----------~~l---~~~~~----------~l~~-~~~~~----------- 481 (711)
+....+..++++||++|..+. +.| +.... .+.| .....
T Consensus 84 ~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (319)
T PRK05231 84 RRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQA 163 (319)
T ss_pred CCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHH
Confidence 122345679999999887431 111 11110 1112 11111
Q ss_pred -HHHH-HHHHHHHHHhc----cCCCeeeccCCCCceEEcCCCcEEEeecCCce
Q 043702 482 -ILLG-VASALAYLHQE----CENQVIHRDVKTSNIMLDEGFNARLGDFGLAR 528 (711)
Q Consensus 482 -i~~~-ia~aL~yLH~~----~~~~ivHrDlkp~NILld~~~~vkL~DFGla~ 528 (711)
.+.+ +...++.+... ...++||+|+.+.|||++.+...-|.||+.+.
T Consensus 164 ~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 164 ALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred HHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 1111 11122333211 24589999999999999976556899999885
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.00057 Score=81.39 Aligned_cols=195 Identities=18% Similarity=0.145 Sum_probs=134.4
Q ss_pred HHHHHHHHhcCCCCeeeeeeeeeecCeE----EEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCC
Q 043702 424 LSELSIIGTLRHRNLVRLQGWCHEKGEI----LLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECEN 499 (711)
Q Consensus 424 ~~Ei~~l~~l~H~niv~l~g~~~~~~~~----~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~ 499 (711)
.-|++.+..+.|+|++.+++|-.++... .+..|++..-++...+. .-..++....+.+..++.+||.|+|+.
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q-~v~~i~~~~~r~~~~~~~~GL~~~h~~--- 305 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ-SVGSIPLETLRILHQKLLEGLAYLHSL--- 305 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh-hccccCHHHHHHHHHHHhhhHHHHHHh---
Confidence 3467778888999999999998765433 34457888878877774 345688888999999999999999987
Q ss_pred CeeeccCCCC---ceEEcCCCcEEEe--ecCCceecCCCCCCCcccccCCCcccChhhhccCCCCc--cccchhHHHHHH
Q 043702 500 QVIHRDVKTS---NIMLDEGFNARLG--DFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATE--KTDVFSYGAVVL 572 (711)
Q Consensus 500 ~ivHrDlkp~---NILld~~~~vkL~--DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~--ksDVwSfGvll~ 572 (711)
...|.-+..+ +...+.++.+.++ ||+..+.+....... ...-+..|.+||......+.. ..|+|.+|.++.
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~--~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~ 383 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF--SDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL 383 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCCcccch--hhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence 5555555444 4455666777777 888887665433222 122455678888877665544 479999999999
Q ss_pred HHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHH
Q 043702 573 EVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVV 652 (711)
Q Consensus 573 elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl 652 (711)
.+..|..+-..... .....+ ... ...+.+....|+..++++|+++.+++
T Consensus 384 ~~~~~~~i~~~~~~-----------------------~~~~l~----~~~----~~~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 384 QLSQGEDISEKSAV-----------------------PVSLLD----VLS----TSELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred hhhhcCcccccccc-----------------------hhhhhc----ccc----chhhhhhhhhhcchhhhhccchhhhh
Confidence 99998766322100 000111 001 11345566789999999999999999
Q ss_pred HHH
Q 043702 653 QML 655 (711)
Q Consensus 653 ~~L 655 (711)
...
T Consensus 433 ~~~ 435 (1351)
T KOG1035|consen 433 THP 435 (1351)
T ss_pred hch
Confidence 865
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0011 Score=68.65 Aligned_cols=135 Identities=15% Similarity=0.116 Sum_probs=78.3
Q ss_pred eecCCceEEEEEEeCCCCeEEEEEEcccCCCCh-hhhHHHHHHHHhcCCCCee-eeeeeeeecCeEEEEEEcCCCCCHHH
Q 043702 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGK-DEFLSELSIIGTLRHRNLV-RLQGWCHEKGEILLVYDLMPNGSLDK 465 (711)
Q Consensus 388 LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lV~Ey~~~gsL~~ 465 (711)
+..|-...+|+... ++..+++|+........ -+..+|.++++.+....++ +++..+. -.+||||++|..+..
T Consensus 4 ~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 4 LSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred CCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 45677889998874 56778888765432222 2467899999998744333 3343332 268999998866532
Q ss_pred --------------H---HhhCC---CCCChHHH-HHHHHHH---------HHHHHHHHhc-----cCCCeeeccCCCCc
Q 043702 466 --------------A---LFEAR---SPLPWPHR-SKILLGV---------ASALAYLHQE-----CENQVIHRDVKTSN 510 (711)
Q Consensus 466 --------------~---l~~~~---~~l~~~~~-~~i~~~i---------a~aL~yLH~~-----~~~~ivHrDlkp~N 510 (711)
. |+... .+++...+ .....++ ...+..+-.. ....++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 11111 11222111 1111111 1112222111 13468999999999
Q ss_pred eEEcCCCcEEEeecCCcee
Q 043702 511 IMLDEGFNARLGDFGLARQ 529 (711)
Q Consensus 511 ILld~~~~vkL~DFGla~~ 529 (711)
|++++++ ++|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999876 78999988753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0017 Score=69.04 Aligned_cols=139 Identities=24% Similarity=0.290 Sum_probs=83.8
Q ss_pred ceeecCCceEEEEEEeCC------CCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCee-eeeeeeeecCeEEEEEEcC
Q 043702 386 RIIGHGAFGTVYKGILPQ------NGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLV-RLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~~------~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lV~Ey~ 458 (711)
+.|..|-...+|+..... .++.+++|+.........+..+|.+++..+....+. ++++++. + .+|+||+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~i 79 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEFI 79 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhee
Confidence 345667777999987643 257888998766444445677899999988743333 4555443 2 3589999
Q ss_pred CCCCHHHH-----------------HhhCCCCC----------ChHHHHHH--------------------------HHH
Q 043702 459 PNGSLDKA-----------------LFEARSPL----------PWPHRSKI--------------------------LLG 485 (711)
Q Consensus 459 ~~gsL~~~-----------------l~~~~~~l----------~~~~~~~i--------------------------~~~ 485 (711)
+|..+... ++...... -|....++ ...
T Consensus 80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (302)
T cd05156 80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED 159 (302)
T ss_pred CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence 88765321 11111100 01111111 112
Q ss_pred HHHHHHHHHh------ccCCCeeeccCCCCceEEcCC----CcEEEeecCCce
Q 043702 486 VASALAYLHQ------ECENQVIHRDVKTSNIMLDEG----FNARLGDFGLAR 528 (711)
Q Consensus 486 ia~aL~yLH~------~~~~~ivHrDlkp~NILld~~----~~vkL~DFGla~ 528 (711)
+..-+..|-. .....++|+|+.+.|||++++ +.++++||..+.
T Consensus 160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 2222334432 134579999999999999885 889999998875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0098 Score=63.38 Aligned_cols=141 Identities=17% Similarity=0.169 Sum_probs=82.7
Q ss_pred cceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCC--eeeeeeee------eecCeEEEEEE
Q 043702 385 NRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRN--LVRLQGWC------HEKGEILLVYD 456 (711)
Q Consensus 385 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~~------~~~~~~~lV~E 456 (711)
.+.++.|....+|+.... ++ .+++|+..... ..++...|++++..|.... +.+++... ...+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~-~~-~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTD-VG-RYILTLYEKRV-KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeC-CC-cEEEEEecCCC-CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 345677777899998653 33 57788765422 2445667788888775322 33443321 22456789999
Q ss_pred cCCCCCHH-----------HH---HhhCCCC-----------CChHHHH------------HHHHHHHHHHHHHHh----
Q 043702 457 LMPNGSLD-----------KA---LFEARSP-----------LPWPHRS------------KILLGVASALAYLHQ---- 495 (711)
Q Consensus 457 y~~~gsL~-----------~~---l~~~~~~-----------l~~~~~~------------~i~~~ia~aL~yLH~---- 495 (711)
|++|..+. .. ++..... -.|.... .....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 99885431 11 1110000 1121110 011123344555543
Q ss_pred ccCCCeeeccCCCCceEEcCCCcEEEeecCCce
Q 043702 496 ECENQVIHRDVKTSNIMLDEGFNARLGDFGLAR 528 (711)
Q Consensus 496 ~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~ 528 (711)
....+++|+|+.+.||++++++.+.|.||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 224689999999999999988777899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.014 Score=64.04 Aligned_cols=75 Identities=15% Similarity=0.147 Sum_probs=53.4
Q ss_pred ceeecCCceEEEEEEeCCCCeEEEEEEcccC--------CCChhhhHHHHHHHHhcC---CCCeeeeeeeeeecCeEEEE
Q 043702 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHN--------SQGKDEFLSELSIIGTLR---HRNLVRLQGWCHEKGEILLV 454 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--------~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV 454 (711)
+.||.|.+..||++...++++.++||.-... ....+.+..|.+.|..+. ...+.+++.+. .+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEEE
Confidence 5699999999999998654468999975421 123456778888888864 24566677663 3557899
Q ss_pred EEcCCCCC
Q 043702 455 YDLMPNGS 462 (711)
Q Consensus 455 ~Ey~~~gs 462 (711)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998743
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.00029 Score=85.40 Aligned_cols=159 Identities=13% Similarity=0.011 Sum_probs=114.6
Q ss_pred hHHHHHHHHhcCCCCeeeeeeeee--ecCeEEEEEEcCCCCCHHHHHhhCCCC---CChHHHHHHHHHHHHHHHHHHhcc
Q 043702 423 FLSELSIIGTLRHRNLVRLQGWCH--EKGEILLVYDLMPNGSLDKALFEARSP---LPWPHRSKILLGVASALAYLHQEC 497 (711)
Q Consensus 423 ~~~Ei~~l~~l~H~niv~l~g~~~--~~~~~~lV~Ey~~~gsL~~~l~~~~~~---l~~~~~~~i~~~ia~aL~yLH~~~ 497 (711)
...|...++...|+++.....-.. +..+.+.+++|+..|.+...|.+...+ +...-+...-.+...+..-+|+..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 445555666678888776554332 234568899999999999998764433 333323333333345555555543
Q ss_pred --CCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHH
Q 043702 498 --ENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVA 575 (711)
Q Consensus 498 --~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ell 575 (711)
.+-.+|+++|+-|.+|..+.++|++++|+.+...+. ........+++.|+.|++...-.++.++|+|..|+.+|++.
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~-~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV-LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCch-HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 345799999999999999999999999999843322 22233456788999999999999999999999999999999
Q ss_pred hCCCCCc
Q 043702 576 SGRRPIE 582 (711)
Q Consensus 576 tG~~P~~ 582 (711)
.|..+|-
T Consensus 1435 ~~n~~fi 1441 (2724)
T KOG1826|consen 1435 DGNAYFI 1441 (2724)
T ss_pred cccHHHH
Confidence 9888764
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.013 Score=61.40 Aligned_cols=31 Identities=26% Similarity=0.440 Sum_probs=25.9
Q ss_pred CCeeeccCCCCceEEcCCCc-EEEeecCCcee
Q 043702 499 NQVIHRDVKTSNIMLDEGFN-ARLGDFGLARQ 529 (711)
Q Consensus 499 ~~ivHrDlkp~NILld~~~~-vkL~DFGla~~ 529 (711)
..++|+|+++.|||++++++ .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997555 46999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.023 Score=61.67 Aligned_cols=139 Identities=19% Similarity=0.223 Sum_probs=81.0
Q ss_pred eeecCCceEEEEEEeCC----CCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCee-eeeeeeeecCeEEEEEEcCCCC
Q 043702 387 IIGHGAFGTVYKGILPQ----NGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLV-RLQGWCHEKGEILLVYDLMPNG 461 (711)
Q Consensus 387 ~LG~G~fg~Vy~~~~~~----~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lV~Ey~~~g 461 (711)
.|-.|-.-.+|+..... .++.+++|+........-+-.+|..+++.+...++. ++++.+.. + .|+||+++.
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~g~ 118 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIHAR 118 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeCCC
Confidence 35457778889887532 236788998765433222346799999988754444 44554432 2 579999776
Q ss_pred CHHHH-----------------HhhCC---C--CCChHHHHHHHHH-----------------HHHHHHHHHh-----cc
Q 043702 462 SLDKA-----------------LFEAR---S--PLPWPHRSKILLG-----------------VASALAYLHQ-----EC 497 (711)
Q Consensus 462 sL~~~-----------------l~~~~---~--~l~~~~~~~i~~~-----------------ia~aL~yLH~-----~~ 497 (711)
+|... +|... . ...|.+..++..+ +...+..|.. ..
T Consensus 119 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~ 198 (344)
T PLN02236 119 TLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQ 198 (344)
T ss_pred CCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCC
Confidence 65321 11111 0 1123333233211 1112222221 12
Q ss_pred CCCeeeccCCCCceEEcC-CCcEEEeecCCcee
Q 043702 498 ENQVIHRDVKTSNIMLDE-GFNARLGDFGLARQ 529 (711)
Q Consensus 498 ~~~ivHrDlkp~NILld~-~~~vkL~DFGla~~ 529 (711)
...++|+|+++.|||+++ +..++++||..+..
T Consensus 199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 347899999999999986 46899999988753
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.039 Score=58.65 Aligned_cols=133 Identities=17% Similarity=0.206 Sum_probs=77.3
Q ss_pred eEEEEEEeCCCCeEEEEEEccc---CCCChhhhHHHHHHHHhcCC--CCeeeeeeeeeecC--eEEEEEEcCCCCCHHHH
Q 043702 394 GTVYKGILPQNGDIIAVKRCSH---NSQGKDEFLSELSIIGTLRH--RNLVRLQGWCHEKG--EILLVYDLMPNGSLDKA 466 (711)
Q Consensus 394 g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~--~~~lV~Ey~~~gsL~~~ 466 (711)
-.+|.... .++.+++. ... .........+|.++|+.+.- --..+.+++|.++. ..+.||+|+++..+...
T Consensus 39 n~t~~~~~--~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~ 115 (321)
T COG3173 39 NDTFRLGD--TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSA 115 (321)
T ss_pred cceEEEec--CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCc
Confidence 34444444 26677777 321 22234556778888888752 34455677887766 67999999988432221
Q ss_pred ------------------Hhh---C---C-------------CCCChHHHHHHH--------HHHHHHHHHHHhcc----
Q 043702 467 ------------------LFE---A---R-------------SPLPWPHRSKIL--------LGVASALAYLHQEC---- 497 (711)
Q Consensus 467 ------------------l~~---~---~-------------~~l~~~~~~~i~--------~~ia~aL~yLH~~~---- 497 (711)
|.. - . +.-.|...++.+ -....-..+|+...
T Consensus 116 ~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~ 195 (321)
T COG3173 116 LPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWA 195 (321)
T ss_pred CCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcC
Confidence 110 0 0 001111112110 01122234444432
Q ss_pred -CCCeeeccCCCCceEEcCCCcEEEeecCCcee
Q 043702 498 -ENQVIHRDVKTSNIMLDEGFNARLGDFGLARQ 529 (711)
Q Consensus 498 -~~~ivHrDlkp~NILld~~~~vkL~DFGla~~ 529 (711)
...++|+|+.+.|++++.+..+=+.||+++..
T Consensus 196 ~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 196 GPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred CCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 34699999999999999988899999999865
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.07 E-value=0.021 Score=60.16 Aligned_cols=75 Identities=19% Similarity=0.313 Sum_probs=49.1
Q ss_pred cccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcC---CCCeeeeeeeeeecCeEEEEEEcCC
Q 043702 383 NANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLR---HRNLVRLQGWCHEKGEILLVYDLMP 459 (711)
Q Consensus 383 ~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV~Ey~~ 459 (711)
+..+.++.|....+|+.. .+++.+.||.-. ......|..|.+-|+.|. --.+.+++++...++..+||+||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 445678999999999977 467888999865 334467889999999885 3456788888877777799999998
Q ss_pred CC
Q 043702 460 NG 461 (711)
Q Consensus 460 ~g 461 (711)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 76
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.01 E-value=0.034 Score=59.23 Aligned_cols=142 Identities=15% Similarity=0.166 Sum_probs=93.0
Q ss_pred cccceeecCCceEEEEEEeCCCCeEEEEEEcccCC----------------------CChhh-----hHHHHHHHHhcCC
Q 043702 383 NANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS----------------------QGKDE-----FLSELSIIGTLRH 435 (711)
Q Consensus 383 ~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----------------------~~~~~-----~~~Ei~~l~~l~H 435 (711)
++...|..|--+.||.+... +|..+|||+.+.+- ...+. ...|++-|.+|+.
T Consensus 147 ~inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 34556889999999999874 68889999765310 00011 2357777888875
Q ss_pred CCeeeeeeeeeecCeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcC
Q 043702 436 RNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDE 515 (711)
Q Consensus 436 ~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~ 515 (711)
..|...--+.. ..-.|||+|+.. +=+-.=.-..-.++......+-.|++.-|.-|-+.| ++||.||.--|+|+-+
T Consensus 226 aGIP~PePIlL--k~hVLVM~FlGr-dgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyhd 300 (520)
T KOG2270|consen 226 AGIPCPEPILL--KNHVLVMEFLGR-DGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHD 300 (520)
T ss_pred cCCCCCCceee--ecceEeeeeccC-CCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEEC
Confidence 44332211111 234799999853 211111112234666667777788888888888876 8999999999999854
Q ss_pred CCcEEEeecCCceecC
Q 043702 516 GFNARLGDFGLARQVE 531 (711)
Q Consensus 516 ~~~vkL~DFGla~~~~ 531 (711)
|.+.|+|-+-+....
T Consensus 301 -G~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 301 -GKLYIIDVSQSVEHD 315 (520)
T ss_pred -CEEEEEEccccccCC
Confidence 589999987765443
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.90 E-value=0.0098 Score=62.21 Aligned_cols=136 Identities=17% Similarity=0.153 Sum_probs=89.6
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC---------C--------C------hhhhHHHHHHHHhcC-CC
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---------Q--------G------KDEFLSELSIIGTLR-HR 436 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---------~--------~------~~~~~~Ei~~l~~l~-H~ 436 (711)
-+...+.||-|--+.||.+... .|...++|.-...+ . . .-...+|...|+.|. |.
T Consensus 93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 4677899999999999999884 57888888422110 0 0 113457888888886 33
Q ss_pred C-eeeeeeeeeecCeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcC
Q 043702 437 N-LVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDE 515 (711)
Q Consensus 437 n-iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~ 515 (711)
. +.+.++++ ..++|||++.+-.|...-+ ..+...++.-+. .-+.-|.. +|+||+|..--||++++
T Consensus 172 fpVPkpiD~~----RH~Vvmelv~g~Pl~~v~~----v~d~~~ly~~lm---~~Iv~la~---~GlIHgDFNEFNimv~d 237 (465)
T KOG2268|consen 172 FPVPKPIDHN----RHCVVMELVDGYPLRQVRH----VEDPPTLYDDLM---GLIVRLAN---HGLIHGDFNEFNIMVKD 237 (465)
T ss_pred CCCCCccccc----ceeeHHHhhcccceeeeee----cCChHHHHHHHH---HHHHHHHH---cCceecccchheeEEec
Confidence 2 33445443 4589999998866654321 122233333222 22333444 49999999999999999
Q ss_pred CCcEEEeecCCceecC
Q 043702 516 GFNARLGDFGLARQVE 531 (711)
Q Consensus 516 ~~~vkL~DFGla~~~~ 531 (711)
+..++++||--+....
T Consensus 238 d~~i~vIDFPQmvS~s 253 (465)
T KOG2268|consen 238 DDKIVVIDFPQMVSTS 253 (465)
T ss_pred CCCEEEeechHhhccC
Confidence 9999999997655443
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.83 E-value=0.065 Score=57.77 Aligned_cols=139 Identities=19% Similarity=0.215 Sum_probs=79.4
Q ss_pred eeecCCceEEEEEEeCCC---CeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCee-eeeeeeeecCeEEEEEEcCCCCC
Q 043702 387 IIGHGAFGTVYKGILPQN---GDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLV-RLQGWCHEKGEILLVYDLMPNGS 462 (711)
Q Consensus 387 ~LG~G~fg~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lV~Ey~~~gs 462 (711)
.|..|=.-.+|+....+. +..|++|+........-+-.+|..+++.+..-++. ++++++. .+ +|.+|+++..
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g~~ 96 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINART 96 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcCCC
Confidence 354466778888865432 23788888765433223345789999998765554 4555542 22 4899997765
Q ss_pred HHH--------------H---HhhCC---C--CCChHHHHHHHHHH----------------------HHHHHHHHhc--
Q 043702 463 LDK--------------A---LFEAR---S--PLPWPHRSKILLGV----------------------ASALAYLHQE-- 496 (711)
Q Consensus 463 L~~--------------~---l~~~~---~--~l~~~~~~~i~~~i----------------------a~aL~yLH~~-- 496 (711)
|.. . +|... . .-.|....++..++ .+-+..+...
T Consensus 97 l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~~ 176 (330)
T PLN02421 97 LTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEITD 176 (330)
T ss_pred CChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHhc
Confidence 421 1 11111 0 11233322222221 1112222211
Q ss_pred ---cCCCeeeccCCCCceEEcC-CCcEEEeecCCcee
Q 043702 497 ---CENQVIHRDVKTSNIMLDE-GFNARLGDFGLARQ 529 (711)
Q Consensus 497 ---~~~~ivHrDlkp~NILld~-~~~vkL~DFGla~~ 529 (711)
.....+|.|+.+.|||+++ ++.++++||..|..
T Consensus 177 ~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 177 SLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred cCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1234899999999999974 57899999988853
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.78 E-value=0.13 Score=54.72 Aligned_cols=30 Identities=23% Similarity=0.307 Sum_probs=26.0
Q ss_pred CCCeeeccCCCCceEEcCCCcEEEeecCCce
Q 043702 498 ENQVIHRDVKTSNIMLDEGFNARLGDFGLAR 528 (711)
Q Consensus 498 ~~~ivHrDlkp~NILld~~~~vkL~DFGla~ 528 (711)
..+++|+|+.+.||+++. +.+.|.||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 358999999999999988 578999998764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.69 E-value=0.11 Score=55.51 Aligned_cols=32 Identities=19% Similarity=0.253 Sum_probs=28.5
Q ss_pred CCCeeeccCCCCceEEcCCCcEEEeecCCcee
Q 043702 498 ENQVIHRDVKTSNIMLDEGFNARLGDFGLARQ 529 (711)
Q Consensus 498 ~~~ivHrDlkp~NILld~~~~vkL~DFGla~~ 529 (711)
..+++|+|+.+.|||++.++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 45799999999999999999999999988753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.69 E-value=0.037 Score=61.24 Aligned_cols=160 Identities=24% Similarity=0.333 Sum_probs=89.4
Q ss_pred hhhHHHHHHHHhcCCCCeeeeeeeeeec-CeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCC
Q 043702 421 DEFLSELSIIGTLRHRNLVRLQGWCHEK-GEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECEN 499 (711)
Q Consensus 421 ~~~~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~ 499 (711)
.++.....+++.+.|+|+...+.+.... ....+|+|++ +.+|++.+..+. +-.. +++ - +
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~--l~~~----------s~~--~-----~ 86 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN--LKDE----------SLL--A-----H 86 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc--cchh----------hhc--c-----c
Confidence 4566778889999999999998887644 3478899998 669999885432 1111 011 1 1
Q ss_pred CeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCC
Q 043702 500 QVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRR 579 (711)
Q Consensus 500 ~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~ 579 (711)
++.|- |+ .+++| -++ . . | |- ...+|+|||++|.++.|+.-|..
T Consensus 87 ~~~~~-----~~-------~~~td-~~~---t--~------------~--~~-----~~~pKsdVwsl~~i~~el~L~~~ 129 (725)
T KOG1093|consen 87 GVLHL-----NI-------IYITD-HFL---T--K------------Y--PS-----PIGPKSDVWSLGFIILELYLGIS 129 (725)
T ss_pred cccee-----hh-------hhccc-ccc---c--c------------C--CC-----CCCcchhhhhHHHHHHHHHHhhH
Confidence 33331 22 22333 000 0 0 0 00 01149999999999999999876
Q ss_pred CCccccccccccccccchHHHHHHhhh-cCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCH
Q 043702 580 PIEKEITGVGKVGVASNLVEWVWSLHR-EGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTM 648 (711)
Q Consensus 580 P~~~~~~~~~~~~~~~~l~~~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 648 (711)
-+..... .+..+....+.. ++......... .+..+..+..+++...|+-..|..||..
T Consensus 130 l~~~~~~--------s~~l~~i~k~~~~d~~~~~~a~e~---~~~~~~d~~~~~~~~~c~~~~~~ir~l~ 188 (725)
T KOG1093|consen 130 LEAELTE--------SEYLEILLKYYTDDQELLSTAMEH---LIQLLADKKRLPLLKKCLWLEPIIRPLP 188 (725)
T ss_pred HHHHHHH--------HHHHHHHHHhccCchhHHHHHHHH---HHHHhhhHhHHHHhccCCccccccccch
Confidence 5533211 111122222211 11121111111 2233455677888899999999988754
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.62 E-value=0.16 Score=55.76 Aligned_cols=72 Identities=11% Similarity=0.138 Sum_probs=50.0
Q ss_pred cceeecCCceEEEEEEeCCCCeEEEEEEccc-----CC---CChhhhHHHHHHHHhcC---CCCeeeeeeeeeecCeEEE
Q 043702 385 NRIIGHGAFGTVYKGILPQNGDIIAVKRCSH-----NS---QGKDEFLSELSIIGTLR---HRNLVRLQGWCHEKGEILL 453 (711)
Q Consensus 385 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~-----~~---~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~l 453 (711)
.+.||.|..-.||+... .+..++||+-.. .. ...+.-..|.+.|+.+. ..++.+++.+|.+ .-++
T Consensus 37 ~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vl 112 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALI 112 (418)
T ss_pred EEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEE
Confidence 45689999999999876 345688997652 11 13334455667776664 3477788888874 4578
Q ss_pred EEEcCCC
Q 043702 454 VYDLMPN 460 (711)
Q Consensus 454 V~Ey~~~ 460 (711)
+|||+++
T Consensus 113 vME~L~~ 119 (418)
T PLN02756 113 GMRYLEP 119 (418)
T ss_pred EEeecCC
Confidence 8999976
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 711 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 9e-61 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-60 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-44 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-43 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-35 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-35 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-34 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-33 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-23 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-22 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-22 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-22 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-22 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-22 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-22 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-22 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-22 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-22 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-22 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-22 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-22 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-22 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-22 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-22 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-22 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-22 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-21 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-21 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-21 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-21 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-21 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-21 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-21 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-21 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-21 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-21 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 7e-21 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 9e-21 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-20 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-19 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-19 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-19 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-19 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-19 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-19 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-19 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-19 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-19 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-19 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-18 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-18 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-18 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-18 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-18 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-18 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-18 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-18 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-18 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-18 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-18 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-18 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-18 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-18 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-18 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-18 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-18 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-18 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-18 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-18 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-18 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-18 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-18 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-18 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-18 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-18 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-18 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-18 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-18 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-18 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 8e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-18 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 8e-18 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-18 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-18 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 9e-18 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-17 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-17 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-17 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-17 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-17 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-17 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-17 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-17 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-17 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-17 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-17 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-17 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-17 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-17 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-17 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-17 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-17 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 7e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-17 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-17 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-16 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-16 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-16 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-16 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-16 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-16 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-16 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-16 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-16 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-16 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-16 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-16 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-16 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-16 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-16 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-16 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-16 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-16 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-16 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-16 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-16 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-16 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-16 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-16 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-16 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-16 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-16 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-16 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-16 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 9e-16 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 9e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-15 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-15 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-15 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-15 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-15 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-15 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-15 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-15 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-15 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-15 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-15 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-15 | ||
| 2pel_A | 236 | Peanut Lectin Length = 236 | 4e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-15 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-15 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-15 | ||
| 1bzw_A | 232 | Peanut Lectin Complexed With C-Lactose Length = 232 | 5e-15 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-15 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-15 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-15 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-15 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-15 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-15 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-15 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-15 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-15 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-15 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-15 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-15 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 7e-15 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-15 | ||
| 3ujo_A | 281 | Galactose-Specific Seed Lectin From Dolichos Lablab | 7e-15 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-15 | ||
| 2e7q_A | 237 | Crystal Structure Of Basic Winged Bean Lectin In Co | 7e-15 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-15 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-15 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 8e-15 | ||
| 1wbf_A | 242 | Winged Bean Lectin, Saccharide Free Form Length = 2 | 8e-15 | ||
| 1wbl_A | 241 | Winged Bean Lectin Complexed With Methyl-Alpha-D-Ga | 9e-15 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 9e-15 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-14 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-14 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-14 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-14 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-14 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-14 | ||
| 1g8w_A | 233 | Improved Structure Of Phytohemagglutinin-L From The | 2e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-14 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-14 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-14 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-14 | ||
| 1fat_A | 252 | Phytohemagglutinin-L Length = 252 | 2e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-14 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-14 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-14 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-14 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-14 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-14 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-14 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-14 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-14 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-14 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-14 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-14 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-14 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-14 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-14 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-14 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-14 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-14 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-14 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-14 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-14 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-14 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-14 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-14 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 6e-14 | ||
| 1bjq_A | 253 | The Dolichos Biflorus Seed Lectin In Complex With A | 6e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 7e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-14 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 7e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-14 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-14 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 8e-14 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 9e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 9e-14 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 9e-14 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 9e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-13 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-13 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-13 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-13 | ||
| 1gnz_A | 257 | Lectin I-B4 From Griffonia Simplicifolia (Gs I-B4)m | 1e-13 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-13 | ||
| 1hql_A | 257 | The Xenograft Antigen In Complex With The B4 Isolec | 2e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-13 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-13 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-13 | ||
| 3usu_B | 242 | Crystal Structure Of Butea Monosperma Seed Lectin L | 2e-13 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-13 | ||
| 3usu_A | 256 | Crystal Structure Of Butea Monosperma Seed Lectin L | 2e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-13 | ||
| 3ipv_A | 251 | Crystal Structure Of Spatholobus Parviflorus Seed L | 3e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-13 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-13 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 7e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 7e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 7e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-13 | ||
| 3ipv_B | 239 | Crystal Structure Of Spatholobus Parviflorus Seed L | 8e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 8e-13 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-12 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-12 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-12 | ||
| 2bqp_A | 234 | The Structure Of The Pea Lectin-D-Glucopyranose Com | 2e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-12 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-12 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-12 | ||
| 1lul_A | 253 | Db58, A Legume Lectin From Dolichos Biflorus Length | 3e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-12 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-12 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-12 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-12 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-12 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-12 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 9e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 9e-12 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 9e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 9e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 9e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-11 | ||
| 2fmd_A | 240 | Structural Basis Of Carbohydrate Recognition By Bow | 1e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-11 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-11 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-11 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-11 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-11 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-11 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 7e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-11 | ||
| 1lgc_A | 181 | Interaction Of A Legume Lectin With The N2 Fragment | 7e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 7e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-11 | ||
| 2eig_A | 234 | Lotus Tetragonolobus Seed Lectin (Isoform) Length = | 8e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 8e-11 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 9e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-11 | ||
| 1fay_A | 238 | Winged Bean Acidic Lectin Complexed With Methyl-Alp | 9e-11 | ||
| 1fny_A | 237 | Legume Lectin Of The Bark Of Robinia Pseudoacacia. | 9e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-10 | ||
| 1lgb_A | 181 | Interaction Of A Legume Lectin With The N2 Fragment | 1e-10 | ||
| 1gsl_A | 243 | Lectin (Fourth Isolated From (Griffonia Simplicifol | 1e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-10 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-10 | ||
| 1lof_C | 181 | X-Ray Structure Of A Biantennary Octasaccharide-Lec | 3e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-10 | ||
| 1loa_A | 181 | Three-Dimensional Structures Of Complexes Of Lathyr | 4e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-10 | ||
| 3zvx_A | 261 | Structure Of The Lectin From Platypodium Elegans In | 7e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 8e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 9e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-09 | ||
| 2sba_A | 253 | Soybean Agglutinin Complexed With 2,6-Pentasacchari | 1e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-09 | ||
| 2ltn_A | 181 | Design, Expression, And Crystallization Of Recombin | 2e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-09 | ||
| 1ofs_A | 187 | Pea Lectin-sucrose Complex Length = 187 | 2e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-09 | ||
| 2lal_A | 181 | Crystal Structure Determination And Refinement At 2 | 2e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-09 | ||
| 1dbn_A | 239 | Maackia Amurensis Leukoagglutinin (Lectin) With Sia | 4e-09 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-09 | ||
| 1fx5_A | 242 | Crystal Structure Analysis Of Ulex Europaeus Lectin | 6e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 7e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-09 | ||
| 1rin_A | 180 | X-Ray Crystal Structure Of A Pea Lectin-Trimannosid | 7e-09 | ||
| 1qnw_A | 242 | Lectin Ii From Ulex Europaeus Length = 242 | 7e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 8e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 8e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 8e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 8e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 8e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 8e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 8e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 9e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 9e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 9e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 9e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-08 | ||
| 1n47_A | 233 | Isolectin B4 From Vicia Villosa In Complex With The | 1e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-08 | ||
| 1avb_A | 226 | Arcelin-1 From Phaseolus Vulgaris L Length = 226 | 2e-08 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-08 | ||
| 1dhk_B | 223 | Structure Of Porcine Pancreatic Alpha-Amylase Lengt | 2e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-08 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-08 | ||
| 1viw_B | 205 | Tenebrio Molitor Alpha-Amylase-Inhibitor Complex Le | 4e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 5e-08 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-08 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 5e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-08 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-08 | ||
| 1qmo_E | 133 | Structure Of Fril, A Legume Lectin That Delays Hema | 7e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 8e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 8e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 9e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 9e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 9e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 9e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 9e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 9e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-07 | ||
| 2b7y_A | 182 | Fava Bean Lectin-Glucose Complex Length = 182 | 2e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-07 | ||
| 1gz9_A | 239 | High-Resolution Crystal Structure Of Erythrina Cris | 2e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-07 | ||
| 3n35_A | 242 | Erythrina Corallodendron Lectin Mutant (Y106g) With | 5e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-07 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2PEL|A Chain A, Peanut Lectin Length = 236 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1BZW|A Chain A, Peanut Lectin Complexed With C-Lactose Length = 232 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3UJO|A Chain A, Galactose-Specific Seed Lectin From Dolichos Lablab In Complex With Adenine And Galactose Length = 281 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2E7Q|A Chain A, Crystal Structure Of Basic Winged Bean Lectin In Complex With B Blood Group Trisaccharide Length = 237 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1WBF|A Chain A, Winged Bean Lectin, Saccharide Free Form Length = 242 | Back alignment and structure |
|
| >pdb|1WBL|A Chain A, Winged Bean Lectin Complexed With Methyl-Alpha-D-Galactose Length = 241 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1G8W|A Chain A, Improved Structure Of Phytohemagglutinin-L From The Kidney Bean Length = 233 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1FAT|A Chain A, Phytohemagglutinin-L Length = 252 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1BJQ|A Chain A, The Dolichos Biflorus Seed Lectin In Complex With Adenine Length = 253 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1GNZ|A Chain A, Lectin I-B4 From Griffonia Simplicifolia (Gs I-B4)metal Free Form Length = 257 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1HQL|A Chain A, The Xenograft Antigen In Complex With The B4 Isolectin Of Griffonia Simplicifolia Lectin-1 Length = 257 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3USU|B Chain B, Crystal Structure Of Butea Monosperma Seed Lectin Length = 242 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3USU|A Chain A, Crystal Structure Of Butea Monosperma Seed Lectin Length = 256 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3IPV|A Chain A, Crystal Structure Of Spatholobus Parviflorus Seed Lectin Length = 251 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3IPV|B Chain B, Crystal Structure Of Spatholobus Parviflorus Seed Lectin Length = 239 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BQP|A Chain A, The Structure Of The Pea Lectin-D-Glucopyranose Complex Length = 234 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1LUL|A Chain A, Db58, A Legume Lectin From Dolichos Biflorus Length = 253 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2FMD|A Chain A, Structural Basis Of Carbohydrate Recognition By Bowringia Milbraedii Seed Agglutinin Length = 240 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1LGC|A Chain A, Interaction Of A Legume Lectin With The N2 Fragment Of Human Lactotransferrin Or With The Isolated Biantennary Glycopeptide: Role Of The Fucose Moiety Length = 181 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2EIG|A Chain A, Lotus Tetragonolobus Seed Lectin (Isoform) Length = 234 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1FAY|A Chain A, Winged Bean Acidic Lectin Complexed With Methyl-Alpha-D-Galactose (Monoclinic Form) Length = 238 | Back alignment and structure |
|
| >pdb|1FNY|A Chain A, Legume Lectin Of The Bark Of Robinia Pseudoacacia. Length = 237 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1LGB|A Chain A, Interaction Of A Legume Lectin With The N2 Fragment Of Human Lactotransferrin Or With The Isolated Biantennary Glycopeptide: Role Of The Fucose Moiety Length = 181 | Back alignment and structure |
|
| >pdb|1GSL|A Chain A, Lectin (Fourth Isolated From (Griffonia Simplicifolia)) Complex With Y Human Blood Group Determinant Length = 243 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1LOF|C Chain C, X-Ray Structure Of A Biantennary Octasaccharide-Lectin Complex At 2.3 Angstroms Resolution Length = 181 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1LOA|A Chain A, Three-Dimensional Structures Of Complexes Of Lathyrus Ochrus Isolectin I With Glucose And Mannose: Fine Specificity Of The Monosaccharide-Binding Site Length = 181 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3ZVX|A Chain A, Structure Of The Lectin From Platypodium Elegans In Complex With A Trimannoside Length = 261 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2SBA|A Chain A, Soybean Agglutinin Complexed With 2,6-Pentasaccharide Length = 253 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2LTN|A Chain A, Design, Expression, And Crystallization Of Recombinant Lectin From The Garden Pea (Pisum Sativum) Length = 181 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1OFS|A Chain A, Pea Lectin-sucrose Complex Length = 187 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2LAL|A Chain A, Crystal Structure Determination And Refinement At 2.3 Angstroms Resolution Of The Lentil Lectin Length = 181 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1DBN|A Chain A, Maackia Amurensis Leukoagglutinin (Lectin) With Sialyllactose Length = 239 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1FX5|A Chain A, Crystal Structure Analysis Of Ulex Europaeus Lectin I Length = 242 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1RIN|A Chain A, X-Ray Crystal Structure Of A Pea Lectin-Trimannoside Complex At 2.6 Angstroms Resolution Length = 180 | Back alignment and structure |
|
| >pdb|1QNW|A Chain A, Lectin Ii From Ulex Europaeus Length = 242 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1N47|A Chain A, Isolectin B4 From Vicia Villosa In Complex With The Tn Antigen Length = 233 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1AVB|A Chain A, Arcelin-1 From Phaseolus Vulgaris L Length = 226 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1DHK|B Chain B, Structure Of Porcine Pancreatic Alpha-Amylase Length = 223 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1VIW|B Chain B, Tenebrio Molitor Alpha-Amylase-Inhibitor Complex Length = 205 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1QMO|E Chain E, Structure Of Fril, A Legume Lectin That Delays Hematopoietic Progenitor Maturation Length = 133 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2B7Y|A Chain A, Fava Bean Lectin-Glucose Complex Length = 182 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1GZ9|A Chain A, High-Resolution Crystal Structure Of Erythrina Cristagalli Lectin In Complex With 2'-Alpha-L-Fucosyllactose Length = 239 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3N35|A Chain A, Erythrina Corallodendron Lectin Mutant (Y106g) With N- Acetylgalactosamine Length = 242 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 401 bits (1034), Expect = e-136
Identities = 126/298 (42%), Positives = 183/298 (61%), Gaps = 9/298 (3%)
Query: 367 PKEFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS-QGKD-EFL 424
K FS REL+ A+ F+ I+G G FG VYKG L +G ++AVKR QG + +F
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQ 75
Query: 425 SELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFE---ARSPLPWPHRSK 481
+E+ +I HRNL+RL+G+C E LLVY M NGS+ L E ++ PL WP R +
Sbjct: 76 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 482 ILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVA 541
I LG A LAYLH C+ ++IHRDVK +NI+LDE F A +GDFGLA+ +++ + T
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV 195
Query: 542 AGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWV 601
GT+G++APEYL TG+++EKTDVF YG ++LE+ +G+R + L++WV
Sbjct: 196 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD---LARLANDDDVMLLDWV 252
Query: 602 WSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEA 659
L +E +L D L+G + + E+ +++ V L C+ P+ RP M VV+ML G+
Sbjct: 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 364 bits (937), Expect = e-121
Identities = 110/315 (34%), Positives = 167/315 (53%), Gaps = 14/315 (4%)
Query: 346 FSKRYKHVKKSESFTSDIIRMPKEFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNG 405
+SK + + S + + +L AT F+ +IGHG FG VYKG+L +G
Sbjct: 5 YSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DG 63
Query: 406 DIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLD 464
+A+KR + S QG +EF +E+ + RH +LV L G+C E+ E++L+Y M NG+L
Sbjct: 64 AKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123
Query: 465 KALF---EARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARL 521
+ L+ + W R +I +G A L YLH +IHRDVK+ NI+LDE F ++
Sbjct: 124 RHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKI 180
Query: 522 GDFGLARQV-EHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRP 580
DFG++++ E D++ +TV GT+GY+ PEY + GR TEK+DV+S+G V+ EV R
Sbjct: 181 TDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240
Query: 581 IEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHP 640
I + + V NL EW H G+L D L + +R+ + C
Sbjct: 241 IVQSLPR-EMV----NLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLAL 295
Query: 641 DPLARPTMRGVVQML 655
RP+M V+ L
Sbjct: 296 SSEDRPSMGDVLWKL 310
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 354 bits (912), Expect = e-118
Identities = 96/304 (31%), Positives = 152/304 (50%), Gaps = 29/304 (9%)
Query: 367 PKEFSYRELRSATKCFN------ANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS--- 417
FS+ EL++ T F+ +G G FG VYKG + N +AVK+ +
Sbjct: 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDIT 69
Query: 418 --QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALF--EARSP 473
+ K +F E+ ++ +H NLV L G+ + ++ LVY MPNGSL L + P
Sbjct: 70 TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129
Query: 474 LPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV-EH 532
L W R KI G A+ + +LH EN IHRD+K++NI+LDE F A++ DFGLAR +
Sbjct: 130 LSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 533 DKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVG 592
++ + GT Y+APE L G T K+D++S+G V+LE+ +G +++
Sbjct: 187 AQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEH-------R 238
Query: 593 VASNLVEWVWSLHREGRLLTA-ADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGV 651
L++ + E + + D ++ D + + V C H RP ++ V
Sbjct: 239 EPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKV 297
Query: 652 VQML 655
Q+L
Sbjct: 298 QQLL 301
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 1e-69
Identities = 65/310 (20%), Positives = 113/310 (36%), Gaps = 32/310 (10%)
Query: 369 EFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELS 428
+ L + + G FG V+K L + +AVK + + E+
Sbjct: 13 DLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVY 70
Query: 429 IIGTLRHRNLVRLQGWC----HEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILL 484
+ ++H N+++ G ++ L+ GSL L + + W I
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK--ANVVSWNELCHIAE 128
Query: 485 GVASALAYLHQECENQ-------VIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP- 536
+A LAYLH++ + HRD+K+ N++L A + DFGLA + E KS
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAG 188
Query: 537 DATVAAGTMGYLAPEYL-----LTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKV 591
D GT Y+APE L A + D+++ G V+ E+AS + +
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD----- 243
Query: 592 GVASNLVEWVWSLHREGRLLTAADAR-----LEGQFDEAEMRRVLL-VGLACSHPDPLAR 645
E + + + L + + +L C D AR
Sbjct: 244 EYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEAR 303
Query: 646 PTMRGVVQML 655
+ V + +
Sbjct: 304 LSAGCVGERI 313
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 1e-55
Identities = 72/319 (22%), Positives = 122/319 (38%), Gaps = 39/319 (12%)
Query: 369 EFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELS 428
E + E +IG G +G VYKG L + +AVK S + F++E +
Sbjct: 2 EAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFS--FANRQNFINEKN 57
Query: 429 IIGT--LRHRNLVRLQGWCHE-----KGEILLVYDLMPNGSLDKALFEARSPLPWPHRSK 481
I + H N+ R + E LLV + PNGSL K L W +
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS--LHTSDWVSSCR 115
Query: 482 ILLGVASALAYLHQE------CENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK- 534
+ V LAYLH E + + HRD+ + N+++ + DFGL+ ++ ++
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 535 ------SPDATVAAGTMGYLAPEYL-------LTGRATEKTDVFSYGAVVLEVASGRRPI 581
A GT+ Y+APE L A ++ D+++ G + E+ R
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM-RCTD 234
Query: 582 EKEITGVGKVGVA-SNLVEWVWSLHREGRLLTAADARLE----GQFDEAEMRRVLLVGLA 636
V + +A V + L++ R + + + +R +
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294
Query: 637 CSHPDPLARPTMRGVVQML 655
C D AR T + + +
Sbjct: 295 CWDQDAEARLTAQXAEERM 313
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 1e-54
Identities = 74/278 (26%), Positives = 116/278 (41%), Gaps = 41/278 (14%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWC 445
++G GAFG V K +A+K+ S+ + F+ EL + + H N+V+L G C
Sbjct: 14 EVVGRGAFGVVCKAKW--RAKDVAIKQIESESE-RKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 446 HEKGEILLVYDLMPNGSLDKALFEARSP--LPWPHRSKILLGVASALAYLHQECENQVIH 503
+ LV + GSL L A H L + +AYLH +IH
Sbjct: 71 LNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 504 RDVKTSNIMLDEGFN-ARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKT 562
RD+K N++L G ++ DFG A D T G+ ++APE +EK
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKC 184
Query: 563 DVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD-----AR 617
DVFS+G ++ EV + R+P + + +W++H R +
Sbjct: 185 DVFSWGIILWEVITRRKPFD---------EIGGPAFRIMWAVHNGTRPPLIKNLPKPIES 235
Query: 618 LEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655
L M R C DP RP+M +V+++
Sbjct: 236 L--------MTR-------CWSKDPSQRPSMEEIVKIM 258
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 2e-54
Identities = 66/292 (22%), Positives = 122/292 (41%), Gaps = 54/292 (18%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRC--------SHNSQGKDEFLSELSIIGTLRHRN 437
+ IG G FG V+KG L ++ ++A+K + + EF E+ I+ L H N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 438 LVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQEC 497
+V+L G H +V + +P G L L + P+ W + +++L +A + Y+
Sbjct: 85 IVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN-Q 141
Query: 498 ENQVIHRDVKTSNIMLDEG-----FNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEY 552
++HRD+++ NI L A++ DFGL++Q H + G ++APE
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH----SVSGLLGNFQWMAPE- 196
Query: 553 LLTGRA---TEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGR 609
+ TEK D +S+ ++ + +G P + + ++++ + EG
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPFD---------EYSYGKIKFINMIREEGL 247
Query: 610 LLTAAD------ARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655
T + + + C DP RP +V+ L
Sbjct: 248 RPTIPEDCPPRLRNV--------IEL-------CWSGDPKKRPHFSYIVKEL 284
|
| >3ipv_A Lectin alpha chain; galactose binding, SEED lectin, hemagglutinin, legume lectin fungal, sugar binding protein; 2.04A {Spatholobus parviflorus} PDB: 3ipv_B 3usu_B* 3usu_A* Length = 251 | Back alignment and structure |
|---|
Score = 186 bits (472), Expect = 3e-54
Identities = 77/245 (31%), Positives = 110/245 (44%), Gaps = 17/245 (6%)
Query: 31 STATEFDFGTLTL--ASLKLLGDAH-MNNGSVRLTRDV---TVPYDGAGKALYSKPVRFR 84
+ T F F +L L GDA G ++LT G+A YS P+
Sbjct: 1 AEETSFVFSKFKPLEPNLILQGDALVTVAGVLQLTNVDKNGVPEPSSLGRATYSAPINIW 60
Query: 85 LPGTHTPASFSTFFSFSITNLNPSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAG--L 142
T ASF+T F F+I N ++I GLAF + P S GG LGL D +G
Sbjct: 61 DSATGLVASFATSFRFTIYAPNIATIADGLAFFLAPVASAPDSGGGFLGLFDSAVSGSTY 120
Query: 143 GFVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGL 202
VAVEFDT + F+D H+G D+NS+ S T+ L +G+ I Y+
Sbjct: 121 QTVAVEFDTYENTVFTDPPYTHIGFDVNSISSI-----KTVKWSLANGEAAKVLITYNSA 175
Query: 203 TRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGST---QGSTEIHSIEWWSFS 259
+ S+ Y + IL+ +DL + +++ VGFS +T G E H + WSF+
Sbjct: 176 VKLLVASLVYPS-SKTSFILADIVDLSSVLPEWVRVGFSAATGASGGKIETHDVFSWSFA 234
Query: 260 SSFES 264
S
Sbjct: 235 SKLAG 239
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 7e-54
Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSH-NSQGKDEFLSELSIIGTLRHRNLVRLQGW 444
++G G FG K + G+++ +K + + + FL E+ ++ L H N+++ G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 445 CHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHR 504
++ + + + + G+L + S PW R +AS +AYLH +IHR
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHR 132
Query: 505 DVKTSNIMLDEGFNARLGDFGLARQVEHDKS-------------PDATVAAGTMGYLAPE 551
D+ + N ++ E N + DFGLAR + +K+ G ++APE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 552 YLLTGRATEKTDVFSYGAVVLEVASGRRP 580
+ EK DVFS+G V+ E+
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEIIGRVNA 221
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 7e-54
Identities = 72/281 (25%), Positives = 134/281 (47%), Gaps = 41/281 (14%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKR---CSHNSQGKDEFLSELSIIGTLRHRNLVRLQ 442
IG G+FGTV++ +G +AVK +++ +EFL E++I+ LRH N+V
Sbjct: 43 EKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 443 GWCHEKGEILLVYDLMPNGSLDKALF--EARSPLPWPHRSKILLGVASALAYLHQECENQ 500
G + + +V + + GSL + L AR L R + VA + YLH
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPP 159
Query: 501 VIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATE 560
++HR++K+ N+++D+ + ++ DFGL+R ++ + AAGT ++APE L + E
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSR-LKASTFLSSKSAAGTPEWMAPEVLRDEPSNE 218
Query: 561 KTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD----- 615
K+DV+S+G ++ E+A+ ++P + N + V ++ + + L
Sbjct: 219 KSDVYSFGVILWELATLQQPWG----NL-------NPAQVVAAVGFKCKRLEIPRNLNPQ 267
Query: 616 -ARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655
A + + C +P RP+ ++ +L
Sbjct: 268 VAAI--------IEG-------CWTNEPWKRPSFATIMDLL 293
|
| >1v6i_A Agglutinin, PNA, galactose-binding lectin; open quaternary association, orthorhombic, carbohydrate specificity, protein crystallography; HET: GAL GLC; 2.15A {Arachis hypogaea} SCOP: b.29.1.1 PDB: 1bzw_A* 1v6j_A* 1v6k_A* 1v6l_A* 1v6m_A 1v6n_A 1v6o_A 2dva_A* 1cq9_A 1ciw_A* 1qf3_A* 1rir_A* 1rit_A* 2dh1_A 1cr7_A* 2dv9_A* 2dvb_A* 2dvd_A* 2dvf_A 2dvg_A* ... Length = 232 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 2e-53
Identities = 66/240 (27%), Positives = 115/240 (47%), Gaps = 15/240 (6%)
Query: 31 STATEFDFGTLTLA--SLKLLGDAH-MNNGSVRLTRDVTVPYDGAGKALYSKPVRFRLPG 87
+ F+F + + ++ GD ++NG+++LT + G+ LY+ PVR
Sbjct: 1 AETVSFNFNSFSEGNPAINFQGDVTVLSNGNIQLTNLNK--VNSVGRVLYAMPVRIWSSA 58
Query: 88 THTPASFSTFFSFSITNLNPSSIGAGLAFVITPDGEQVGSAGGSLGLL--DEKGAGLGFV 145
T ASF T FSF + ++ G+ F I P+ Q+ + G L + FV
Sbjct: 59 TGNVASFLTSFSFEMKDIKDYDPADGIIFFIAPEDTQIPAGSIGGGTLGVSDTKGAGHFV 118
Query: 146 AVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLTRA 205
VEFDT + E++D +HVG+D+NS+ S + + SG +V + YD T+
Sbjct: 119 GVEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVPW-----NSVSGAVVKVTVIYDSSTKT 173
Query: 206 FNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGST-QGSTEIHSIEWWSFSSSFES 264
+++V+ + ++ +DL + + + GFS S G +IH I WSF+S+ +
Sbjct: 174 LSVAVTND--NGDITTIAQVVDLKAKLPERVKFGFSASGSLGGRQIHLIRSWSFTSTLIT 231
|
| >1hql_A Lectin; xenograft antigen, sugar BI protein; HET: GLA MBG NAG; 2.20A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1gnz_A* Length = 257 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 6e-53
Identities = 77/259 (29%), Positives = 119/259 (45%), Gaps = 16/259 (6%)
Query: 31 STATEFD---FGTLTLASLKLLGDAHMNNGSVRLTRDVTVPY---DGAGKALYSKPVRFR 84
S + F F + S+ GDA+ G+++L + AG+ALYS PV+
Sbjct: 2 SDSVSFTFPNFWSDVEDSIIFQGDANTTAGTLQLCKTNQYGTPLQWSAGRALYSDPVQLW 61
Query: 85 LPGTHTPASFSTFFSFSITNLNPSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAGLG- 143
T + ASF T F+F + + GLAF + P V AG LGL ++ A
Sbjct: 62 DNKTESVASFYTEFTFFLKI-TGNGPADGLAFFLAPPDSDVKDAGEYLGLFNKSTATQPS 120
Query: 144 ---FVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYD 200
VAVEFDT + F + + H+G+++NS+VS + + D+ SG + + I YD
Sbjct: 121 KNQVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVATKRWE--DSDIFSGKIATARISYD 178
Query: 201 GLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGST-EIHSIEWWSFS 259
G ++V S ILS ++D+ Q + + + VG S ST + I W FS
Sbjct: 179 GSAE--ILTVVLSYPDGSDYILSHSVDMRQNLPESVRVGISASTGNNQFLTVYILSWRFS 236
Query: 260 SSFESNSGTGSGSAPPPPT 278
S+ +S S + T
Sbjct: 237 SNLQSTSVKAAMEPEITRT 255
|
| >1g7y_A Stem/LEAF lectin DB58; jelly roll fold, sugar binding protein; HET: NAG FUC FUL; 2.50A {Vigna unguiculata subsp} SCOP: b.29.1.1 PDB: 1lul_A 1lu1_A* 1bjq_A* 1lu2_A* Length = 253 | Back alignment and structure |
|---|
Score = 182 bits (462), Expect = 6e-53
Identities = 73/260 (28%), Positives = 120/260 (46%), Gaps = 20/260 (7%)
Query: 31 STATEFDFGTLTLASLKLLGDAHMNNGSVRLTRDVT---VPYDGAGKALYSKPVRFRLPG 87
+ F F +S L GDA +++ +RLT+ G+A YS P++
Sbjct: 1 ADIQSFSFKNFNSSSFILQGDATVSSSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIYDKS 60
Query: 88 THTPASFSTFFSFSITNLNPSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAGLG--FV 145
T AS++T F+ +I N SS G+AF + P G + S G LG+ D V
Sbjct: 61 TGAVASWATSFTANIFAPNKSSSADGIAFALVPVGSEPKSNSGFLGVFDSDVYDNSAQTV 120
Query: 146 AVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLTRA 205
AVEFDT + ++ D H+G+D+NS+ S T + L +G I Y+ T
Sbjct: 121 AVEFDTFSNTDW-DPTSRHIGIDVNSIKSIR-----TASWGLANGQNAEILITYNAATSL 174
Query: 206 FNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGST---QGSTEIHSIEWWSFSSSF 262
S+ + + + I+S +D+ + +++ +GFS +T +G TE H + WSF+S
Sbjct: 175 LVASLVHPS-RRTSYIVSERVDITNELPEYVSIGFSATTGLSEGYTETHDVLSWSFASKL 233
Query: 263 ESNSGTGSGSAPPPPTASLM 282
+ + P AS +
Sbjct: 234 PDD-----STTEPLDIASYL 248
|
| >1fat_A Phytohemagglutinin-L; glycoprotein, plant defense protein, lectin; HET: NAG; 2.80A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1g8w_A* Length = 252 | Back alignment and structure |
|---|
Score = 182 bits (462), Expect = 7e-53
Identities = 81/258 (31%), Positives = 122/258 (47%), Gaps = 19/258 (7%)
Query: 31 STATEFDFGTLTLASLKLLGDAH-MNNGSVRLTRD---VTVPYDGAGKALYSKPVRFRLP 86
S F+F +L L DA ++G +RLT G+A YS P++
Sbjct: 1 SNDIYFNFQRFNETNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIWDN 60
Query: 87 GTHTPASFSTFFSFSITNLNPSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAGLGFVA 146
T T ASF+T F+F+I N + GLAF + P G Q GG LGL D + VA
Sbjct: 61 TTGTVASFATSFTFNIQVPNNAGPADGLAFALVPVGSQPKDKGGFLGLFDGSNSNFHTVA 120
Query: 147 VEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLTRAF 206
VEFDTL + ++ D H+G+D+NS+ S T D +G+ I YD T
Sbjct: 121 VEFDTLYNKDW-DPTERHIGIDVNSIRSI-----KTTRWDFVNGENAEVLITYDSSTNLL 174
Query: 207 NISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGST---QGSTEIHSIEWWSFSSSFE 263
S+ Y + + I+S T+DL + +++ VGFS +T +G+ E + + WSF+S
Sbjct: 175 VASLVYPS-QKTSFIVSDTVDLKSVLPEWVSVGFSATTGINKGNVETNDVLSWSFASKLS 233
Query: 264 SNSGTGSGSAPPPPTASL 281
++ A+L
Sbjct: 234 DE-----TTSEGLNLANL 246
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 2e-52
Identities = 74/289 (25%), Positives = 121/289 (41%), Gaps = 52/289 (17%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRC-----SHNSQGKDEFLSELSIIGTLRHRNLVR 440
IIG G FG VY+ GD +AVK SQ + E + L+H N++
Sbjct: 13 EIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 441 LQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQ 500
L+G C ++ + LV + G L++ L + +P + +A + YLH E
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQIARGMNYLHDEAIVP 128
Query: 501 VIHRDVKTSNIMLDEGFNAR--------LGDFGLARQVEHDKSPDATVAAGTMGYLAPEY 552
+IHRD+K+SNI++ + + DFGLAR+ AAG ++APE
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT---TKMSAAGAYAWMAPEV 185
Query: 553 LLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLT 612
+ ++ +DV+SYG ++ E+ +G P I G + + + L
Sbjct: 186 IRASMFSKGSDVWSYGVLLWELLTGEVPFR-GIDG----------LAVAYGVAMNKLALP 234
Query: 613 AAD------ARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655
A+L M C +PDP +RP+ ++ L
Sbjct: 235 IPSTCPEPFAKL--------MED-------CWNPDPHSRPSFTNILDQL 268
|
| >2eig_A Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG binding protein; HET: NAG; 2.00A {Lotus tetragonolobus} Length = 234 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 8e-52
Identities = 70/231 (30%), Positives = 113/231 (48%), Gaps = 13/231 (5%)
Query: 44 ASLKLLGDAH-MNNGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSI 102
SL GDA +G + + D V ALY+ PV T ASF T FSF +
Sbjct: 12 GSLIFQGDAKIWTDGRLAMPTDPLVNR-TTSHALYATPVPIWDSATGNVASFITSFSFIV 70
Query: 103 TNLNPSSIGAGLAFVITPDGEQV--GSAGGSLGLLDEKGAGLGFVAVEFDTLMDV-EFSD 159
+N+ G+ F + P G ++ S GG LG+ D + FVAVEFD+ +V +
Sbjct: 71 SNVQRYPPTDGVVFFLAPWGTEIPPNSQGGYLGITDSSNSQNQFVAVEFDSHPNVWDPKS 130
Query: 160 INGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLTRAFNISVSYSNLKPKV 219
+ +H+G+D+NS++S + +N + SG L + I YD T+ + +++ N ++
Sbjct: 131 LRSSHIGIDVNSIMSLK-----AVNWNRVSGSLEKATIIYDSDTKILTVVMTHQN--GQI 183
Query: 220 PILSFTLDLDQYVNDFMYVGFSGSTQG-STEIHSIEWWSFSSSFESNSGTG 269
+S +DL + + + VGFS +T E H I WSF+S+ +
Sbjct: 184 TTISQEIDLKTVLPEKVSVGFSATTWNPERERHDIYSWSFTSTLKEPEEQA 234
|
| >2bqp_A Protein (PEA lectin); D-glucopyranose complex, sugar binding protein; HET: GLC; 1.90A {Pisum sativum} SCOP: b.29.1.1 Length = 234 | Back alignment and structure |
|---|
Score = 178 bits (452), Expect = 1e-51
Identities = 66/241 (27%), Positives = 106/241 (43%), Gaps = 17/241 (7%)
Query: 31 STATEFDFG--TLTLASLKLLGDAHMNNGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGT 88
+ T F + +L GD + + LT+ V + G+ALYS P+ T
Sbjct: 1 TETTSFLITKFSPDQQNLIFQGDGYTTKEKLTLTKAVK---NTVGRALYSSPIHIWDRET 57
Query: 89 HTPASFSTFFSFSITNLNPSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAGL--GFVA 146
A+F T F+F I N ++ G F I P + + GG LG+ + VA
Sbjct: 58 GNVANFVTSFTFVINAPNSYNVADGFTFFIAPVDTKPQTGGGYLGVFNSAEYDKTTQTVA 117
Query: 147 VEFDTLMDVEFSDIN-GNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLTRA 205
VEFDT + + N H+G+D+NS+ S T + L++G+ N I ++ T
Sbjct: 118 VEFDTFYNAAWDPSNRDRHIGIDVNSIKSVN-----TKSWKLQNGEEANVVIAFNAATNV 172
Query: 206 FNISVSYSN----LKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGSTEIHSIEWWSFSSS 261
+S++Y N + LS + L V +++ +GFS +T H + WSF S
Sbjct: 173 LTVSLTYPNNSLEEEVTSYTLSDVVSLKDVVPEWVRIGFSATTGAEYAAHEVLSWSFHSE 232
Query: 262 F 262
Sbjct: 233 L 233
|
| >1gsl_A Griffonia simplicifolia lectin 4; glycoprotein, manganese; HET: FUC GAL MAG NAG BMA; 2.00A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1lec_A* 1led_A* Length = 243 | Back alignment and structure |
|---|
Score = 178 bits (451), Expect = 2e-51
Identities = 70/238 (29%), Positives = 110/238 (46%), Gaps = 14/238 (5%)
Query: 36 FDFGTLTLASLKLLGDAHMNNGSVRLTRDVTVP---YDGAGKALYSKPVRFRLPGTHTPA 92
+ + + LGDA G+++LT+ AG+A YS+PV T A
Sbjct: 12 WSYSLKNGTEITFLGDATRIPGALQLTKTDANGNPVRSSAGQASYSEPVFLW-DSTGKAA 70
Query: 93 SFSTFFSFSITNLNPSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGA----GLGFVAVE 148
SF T F+F + N + GLAF + P V GG LGL + A VAVE
Sbjct: 71 SFYTSFTFLLKNYGAPT-ADGLAFFLAPVDSSVKDYGGFLGLFRHETAADPSKNQVVAVE 129
Query: 149 FDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLTRAFNI 208
FDT ++ +++D H+G+D+NS+VS + N D + + I YD ++ +
Sbjct: 130 FDTWINKDWNDPPYPHIGIDVNSIVSVATTRWE--NDDAYGSSIATAHITYDARSK--IL 185
Query: 209 SVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGSTEIHSIEWWSFSSSFESNS 266
+V S + ILS +DL + + + +GFS G E+ I W F S+ + +
Sbjct: 186 TVLLSYEHGRDYILSHVVDLAKVLPQKVRIGFSAGV-GYDEVTYILSWHFFSTLDGTN 242
|
| >1fx5_A UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HOMO-dimer, fucose specific lectin, SUG binding protein; HET: NAG FUC BMA MAN; 2.20A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1jxn_A* Length = 242 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 2e-51
Identities = 68/245 (27%), Positives = 112/245 (45%), Gaps = 13/245 (5%)
Query: 31 STATEFDFGTLTL--ASLKLLGDAH-MNNGSVRLTRDVT-VPYDGAGKALYSKPVRFRLP 86
S F F + L G+A + G ++L + +P + G A Y P+
Sbjct: 1 SDDLSFKFKNFSQNGKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIWNC 60
Query: 87 GTHTPASFSTFFSFSI-TNLNPSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAGL--G 143
T ASF T FSF + T+ NP + GL F + P + AGG GL ++
Sbjct: 61 NTGELASFITSFSFFMETSANPKAATDGLTFFLAPPDSPLRRAGGYFGLFNDTKCDSSYQ 120
Query: 144 FVAVEFDTLMD-VEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGL 202
VAVEFDT+ V F D H+G+D+N + S + + ++ N I Y+
Sbjct: 121 TVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAERWNK---RYGLNNVANVEIIYEAS 177
Query: 203 TRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGST-QGSTEIHSIEWWSFSSS 261
++ S++Y + ++ +DL + + +++ VGFSGST G H + W F+S+
Sbjct: 178 SKTLTASLTYPS-DQTSISVTSIVDLKEILPEWVSVGFSGSTYIGRQATHEVLNWYFTST 236
Query: 262 FESNS 266
F + +
Sbjct: 237 FINTN 241
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 3e-51
Identities = 66/277 (23%), Positives = 120/277 (43%), Gaps = 30/277 (10%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRC---SHNSQGKDEFLSELSIIGTLRHRNLVRLQ 442
+ IG G+FGTVYKG +GD+ AVK + Q F +E+ ++ RH N++
Sbjct: 30 QRIGSGSFGTVYKGKW--HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 443 GWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVI 502
G+ ++ +V SL L + + I A + YLH +I
Sbjct: 87 GYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA---KSII 142
Query: 503 HRDVKTSNIMLDEGFNARLGDFGLARQVEH-DKSPDATVAAGTMGYLAPEYLL---TGRA 558
HRD+K++NI L E ++GDFGLA + S +G++ ++APE + +
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 559 TEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARL 618
+ ++DV+++G V+ E+ +G+ P I ++ + + R + R
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYS-NINNRDQI---------IEMVGRGSLSPDLSKVRS 252
Query: 619 EGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655
M+R++ C RP+ ++ +
Sbjct: 253 NCP---KRMKRLM---AECLKKKRDERPSFPRILAEI 283
|
| >1sbf_A Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {Glycine max} SCOP: b.29.1.1 PDB: 1sbd_A* 1sbe_A* 1g9f_A* 2sba_A* Length = 253 | Back alignment and structure |
|---|
Score = 174 bits (441), Expect = 7e-50
Identities = 69/254 (27%), Positives = 114/254 (44%), Gaps = 16/254 (6%)
Query: 31 STATEFDFGTLTL--ASLKLLGDAH-MNNGSVRLTRD---VTVPYDGAGKALYSKPVRFR 84
+ F + ++ L GDA ++G ++L + T G+ALYS P+
Sbjct: 1 AETVSFSWNKFVPKQPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIW 60
Query: 85 LPGTHTPASFSTFFSFSITNLNPSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAGLGF 144
T + ASF+ F+F+ + + GLAF + P + + G LGL +E +G
Sbjct: 61 DKETGSVASFAASFNFTFYAPDTKRLADGLAFFLAPIDTKPQTHAGYLGLFNENESGDQV 120
Query: 145 VAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLTR 204
VAVEFDT + D H+G+++NS+ S + T + DL + + I YD T
Sbjct: 121 VAVEFDTFRNSW--DPPNPHIGINVNSIRSIK-----TTSWDLANNKVAKVLITYDASTS 173
Query: 205 AFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGST--EIHSIEWWSFSSSF 262
S+ Y + + ILS +DL + +++ +GFS +T E H + WSF+S+
Sbjct: 174 LLVASLVYPS-QRTSNILSDVVDLKTSLPEWVRIGFSAATGLDIPGESHDVLSWSFASNL 232
Query: 263 ESNSGTGSGSAPPP 276
S
Sbjct: 233 PHASSNIDPLDLTS 246
|
| >1fny_A BARK lectin, BARK agglutinin I,polypeptide A; legume lectin, jelly roll, sugar binding protein; 1.81A {Robinia pseudoacacia} SCOP: b.29.1.1 PDB: 1fnz_A* Length = 237 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 2e-49
Identities = 68/243 (27%), Positives = 114/243 (46%), Gaps = 17/243 (6%)
Query: 31 STATEFDFGTLT--LASLKLLGDAH-MNNGSVRLTRDVTVP--YDGAGKALYSKPVRFRL 85
+ + F F L GDA + G ++LT V G+ALY+ P +
Sbjct: 1 TGSLSFSFPKFAPNQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWD 60
Query: 86 PGTHTPASFSTFFSFSITNLNPSSIGAGLAFVITPDGEQVGSAGGSLGLLDEK--GAGLG 143
T ASF T F+F I NP++ GLAF + P Q GG LG+ +
Sbjct: 61 STTGNVASFVTSFTFIIQAPNPATTADGLAFFLAPVDTQPLDLGGMLGIFKDGYFNKSNQ 120
Query: 144 FVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLT 203
VAVEFDT + ++ D G H+G+++NS+ S T+ + +G++ N +I Y+ T
Sbjct: 121 IVAVEFDTFSNGDW-DPKGRHLGINVNSIESI-----KTVPWNWTNGEVANVFISYEAST 174
Query: 204 RAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGST---QGSTEIHSIEWWSFSS 260
++ S+ Y + I+ +D+ + +++ GFS +T +G + + + WSF S
Sbjct: 175 KSLTASLVYPS-LETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGYVQTNDVLSWSFES 233
Query: 261 SFE 263
+
Sbjct: 234 NLP 236
|
| >3zyr_A Lectin; sugar binding protein, N-glycan; HET: NAG BMA MAN GOL; 1.65A {Platypodium elegans} PDB: 3zvx_A* 1ukg_A* 1q8o_A* 1q8q_A* 1q8s_A* 1q8v_A* 1q8p_A* 2auy_A* 2gme_A 2gmm_A* 2gmp_A* 2gn3_A* 2gn7_A* 2gnb_A* 2gnd_A* 2gnm_A* 2gnt_A 2phf_A* 2phr_A* 2pht_A* ... Length = 261 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 3e-49
Identities = 71/250 (28%), Positives = 120/250 (48%), Gaps = 22/250 (8%)
Query: 31 STATEFDFGTLTL--ASLKLLGDAH-MNNGSVRLTRDVT---VPYDGAGKALYSKPVRFR 84
+ + F F +L GDAH N ++LTR + G+ L+S VR
Sbjct: 9 TDSLSFSFINFDRDERNLIFQGDAHTSRNNILQLTRTDSNGAPVRSTVGRILHSAQVRLW 68
Query: 85 LPGTHTPASFSTFFSFSITNLNPSSIGAGLAFVITPDGEQV--GSAGGSLGLLDEKGAGL 142
T+ A+ T FSF +++ S+ G+AF I P + GSAGG LGL + + A
Sbjct: 69 EKSTNRVANLQTQFSFFLSS-PLSNPADGIAFFIAPPDTTIPSGSAGGLLGLFNPRTALN 127
Query: 143 G----FVAVEFDTLMD--VEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSW 196
+AVEFDT D N H+G+D+NS+ S++ + + + G +N
Sbjct: 128 ESANQVLAVEFDTFFAQNSNTWDPNYQHIGIDVNSIRSSK-----VVRWERREGKTLNVL 182
Query: 197 IEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGSTEIHSIEWW 256
+ Y+ TR ++ +Y + + LS +DL + +++ VGFS ++ + H++E W
Sbjct: 183 VTYNPSTRTIDVVATYPD--GQRYQLSHVVDLTTILPEWVRVGFSAASGEQFQTHNLESW 240
Query: 257 SFSSSFESNS 266
SF+S+ +
Sbjct: 241 SFTSTLLYTA 250
|
| >1avb_A Arcelin-1; lectin-like glycoprotein, plant defense, insecticidal activi lectin; HET: NAG; 1.90A {Phaseolus vulgaris} SCOP: b.29.1.1 Length = 226 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 6e-49
Identities = 71/238 (29%), Positives = 108/238 (45%), Gaps = 19/238 (7%)
Query: 31 STATEFDFGTLTLASLKLLGDAH-MNNGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTH 89
S F+ T +L L GDA + G + LT D G+A YS P++
Sbjct: 1 SNDASFNVETFNKTNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQINDRTID 60
Query: 90 TPASFSTFFSFSITNLNPSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAGLG--FVAV 147
ASFST F+F I N + GLAF + P G + G LGL + VAV
Sbjct: 61 NLASFSTNFTFRINAKNIENSAYGLAFALVPVGSRPKLKGRYLGLFNTTNYDRDAHTVAV 120
Query: 148 EFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLTRAFN 207
FDT N + +D+NS+ ++ N +G+ I YD
Sbjct: 121 VFDT---------VSNRIEIDVNSIRPIATESC---NFGHNNGEKAEVRITYDSPKNDLR 168
Query: 208 ISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGST---QGSTEIHSIEWWSFSSSF 262
+S+ Y + + +S T+ L++ V D++ VGFS ++ + +TE H++ WSFSS+F
Sbjct: 169 VSLLYPS-SEEKCHVSATVPLEKEVEDWVSVGFSATSGSKKETTETHNVLSWSFSSNF 225
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 1e-48
Identities = 58/286 (20%), Positives = 108/286 (37%), Gaps = 43/286 (15%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRC---SHNSQGKDEFLSELSIIGTLRHRNLVRLQ 442
+IG G FG VY G +G++ A++ N F E+ RH N+V
Sbjct: 39 ELIGKGRFGQVYHGRW--HGEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 443 GWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVI 502
G C + ++ L +L + +A+ L +I + + YLH ++
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGIL 152
Query: 503 HRDVKTSNIMLDEGFNARLGDFGLAR----QVEHDKSPDATVAAGTMGYLAPEYLLTGRA 558
H+D+K+ N+ D G + DFGL + + G + +LAPE +
Sbjct: 153 HKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211
Query: 559 ---------TEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGR 609
++ +DVF+ G + E+ + P + + +W + +
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ-----------PAEAIIWQMGTGMK 260
Query: 610 LLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655
+ + + E+ +L L C + RPT ++ ML
Sbjct: 261 PNLS-----QIGMGK-EISDIL---LFCWAFEQEERPTFTKLMDML 297
|
| >1wbf_A Protein (agglutinin); lectin (agglutinin), legume lectin, protein crystallography, group specificity, saccharide free form; HET: NAG; 2.30A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 2d3s_A* 2dtw_A* 1wbl_A* 2dty_A* 2du0_A* 2du1_A* 2e51_A* 2e53_A* 2zmk_A* 2zml_A* 2zmn_A* 2e7t_A* 2e7q_A* Length = 242 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-48
Identities = 81/247 (32%), Positives = 120/247 (48%), Gaps = 22/247 (8%)
Query: 33 ATEFDFGTLT--LASLKLLGDAH-MNNGSVRLTRDV--TVPYDGAGKALYSKPVRFRLPG 87
F+F LKL DA +N + LT+ V ++ G+ALY+KPV+
Sbjct: 3 TISFNFNQFHQNEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDST 62
Query: 88 THTPASFSTFFSFSITNLNPSSIGA-GLAFVITPDGEQVGSAGGSLGLLDEKGAGLGFVA 146
T ASF T FSFSI P A GL F I P Q G GG G+ + FVA
Sbjct: 63 TGNVASFETRFSFSIRQPFPRPHPADGLVFFIAPPNTQTGEGGGYFGIYNPLSPY-PFVA 121
Query: 147 VEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLTRAF 206
VEFDT + D H+G+D+NS++ST T+ L +G + N I+YD T+
Sbjct: 122 VEFDTFRNTW--DPQIPHIGIDVNSVIST-----KTVPFTLDNGGIANVVIKYDASTKIL 174
Query: 207 NISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGST-------QGSTEIHSIEWWSFS 259
++ + + + + ++ +DL Q + + + VGFS +T + +TE H I WSFS
Sbjct: 175 HVVLVFPS-LGTIYTIADIVDLKQVLPESVNVGFSAATGDPSGKQRNATETHDILSWSFS 233
Query: 260 SSFESNS 266
+S +
Sbjct: 234 ASLPGTN 240
|
| >1gzc_A Erythrina crista-galli lectin; carbohydrate, sugar binding protein, saccharide, protein-carbohydrate interactions, lactose, glycoprotein; HET: LAT; 1.58A {Erythrina crista-galli} SCOP: b.29.1.1 PDB: 1gz9_A* 1fyu_A* 1ax0_A* 1ax1_A* 1ax2_A* 1axy_A* 1axz_A* 1lte_A* 1sfy_A* 1v00_A* 1uzz_A 1uzy_A* 3n35_A* 3n36_A* 3n3h_A* Length = 239 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 9e-48
Identities = 69/242 (28%), Positives = 113/242 (46%), Gaps = 19/242 (7%)
Query: 33 ATEFDFGTLTLAS--LKLLGDAH-MNNGSVRLTRDV---TVPYDGAGKALYSKPVRFRLP 86
F F + L L G A +G ++LT+ +D G+ LY+KPV
Sbjct: 3 TISFSFSEFEPGNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMWDS 62
Query: 87 GTHTPASFSTFFSFSITNLNPSSIGA-GLAFVITPDGEQVGSAGGSLGLLDEKGAGLGF- 144
T T ASF T FSFSI + A GL F + P + G LG+ + +
Sbjct: 63 TTGTVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKPAQGYGYLGVFNNSKQDNSYQ 122
Query: 145 -VAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLT 203
+AVEFDT + + H+G+D+NS+ S + T L +G + N I+YD +
Sbjct: 123 TLAVEFDTFSN-PWDPPQVPHIGIDVNSIRS-----IKTQPFQLDNGQVANVVIKYDAPS 176
Query: 204 RAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGST---QGSTEIHSIEWWSFSS 260
+ ++ + Y + + ++ +D+ Q + D++ VG SG+T + + E H + WSF +
Sbjct: 177 KILHVVLVYPS-SGAIYTIAEIVDVKQVLPDWVDVGLSGATGAQRDAAETHDVYSWSFQA 235
Query: 261 SF 262
S
Sbjct: 236 SL 237
|
| >1n47_A Isolectin B4; cancer antigen, vicia villosa lectin, glycoprotein TN-bindin protein, carbohydrate recognition, sugar binding protein; HET: NAG FUC TNR; 2.70A {Vicia villosa} SCOP: b.29.1.1 Length = 233 | Back alignment and structure |
|---|
Score = 167 bits (423), Expect = 1e-47
Identities = 74/242 (30%), Positives = 110/242 (45%), Gaps = 20/242 (8%)
Query: 31 STATEFDFGTLTL--ASLKLLGDAH-MNNGSVRLTRDVTVPY--DGAGKALYSKPVRFRL 85
+ +T F F +L L DA + G++ LT D G+ALY+ P+
Sbjct: 1 TESTSFSFTNFNPNQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIH- 59
Query: 86 PGTHTPASFSTFFSFSITNLNPSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAGL--G 143
T ASF+T FSF + +++ GLAF + P Q + GG LGL ++
Sbjct: 60 -DNTTLASFTTSFSFVMAAPAAAAVADGLAFFLAPPDTQPQARGGFLGLFADRAHDASYQ 118
Query: 144 FVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLT 203
VAVEFDT + D N H+G+D N + S + T D+ G+ N I Y T
Sbjct: 119 TVAVEFDTYSNAW--DPNYTHIGIDTNGIESKK-----TTPFDMVYGEKANIVITYQAST 171
Query: 204 RAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGST---QGSTEIHSIEWWSFSS 260
+A S+ + +S +DL + +++ VGFS +T G E H I WSF+
Sbjct: 172 KALAASLVFPV-SQTSYAVSARVDLRDILPEYVRVGFSATTGLNAGVVETHDIVSWSFAV 230
Query: 261 SF 262
S
Sbjct: 231 SL 232
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 1e-47
Identities = 57/287 (19%), Positives = 104/287 (36%), Gaps = 54/287 (18%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSH---NSQGKDEFLSELSIIGTLRHRNLVRLQ 442
+ G ++KG G+ I VK +++ +F E + H N++ +
Sbjct: 16 TKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 443 GWCHE--KGEILLVYDLMPNGSLDKALFEARS-PLPWPHRSKILLGVASALAYLHQECEN 499
G C L+ MP GSL L E + + K L +A +A+LH E
Sbjct: 74 GACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-LEP 132
Query: 500 QVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRA- 558
+ + + ++M+DE AR+ + S + ++APE L +
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPAWVAPE-ALQKKPE 185
Query: 559 ---TEKTDVFSYGAVVL-EVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614
D++S+ V+L E+ + P +++ +E + EG T
Sbjct: 186 DTNRRSADMWSFA-VLLWELVTREVPFA-DLSN----------MEIGMKVALEGLRPTIP 233
Query: 615 D------ARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655
++L M+ C + DP RP +V +L
Sbjct: 234 PGISPHVSKL--------MKI-------CMNEDPAKRPKFDMIVPIL 265
|
| >1dbn_A MAL, protein (leukoagglutinin); plant lectin, carbohydrate binding, sialyllactose, sugar BIN protein; HET: NAG SIA GAL BGC; 2.75A {Maackia amurensis} SCOP: b.29.1.1 Length = 239 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 3e-47
Identities = 72/245 (29%), Positives = 112/245 (45%), Gaps = 19/245 (7%)
Query: 31 STATEFDFG--TLTLASLKLLGDAH-MNNGSVRLTRDV--TVPYDGAGKALYSKPVRFRL 85
S F A L G+A + G ++LT+ G+ALY+ PVR
Sbjct: 1 SDELSFTINNFVPNEADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIWG 60
Query: 86 PGTHTPASFSTFFSFSITNLNPSSIGAGLAFVITPDGEQV--GSAGGSLGLLDEKGAG-- 141
T + ASFST F+F + NP GLAF + P Q+ GS LGL + +
Sbjct: 61 NTTGSVASFSTSFTFVVKAPNPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSNSDSS 120
Query: 142 LGFVAVEFDTLMDVEF--SDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEY 199
VAVEFDT + D N H+G+D+N + S + T+ D +G + + I Y
Sbjct: 121 NQIVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIESIK-----TVQWDWINGGVAFATITY 175
Query: 200 DGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGST--EIHSIEWWS 257
+ S+ Y + ++ ++DL + + +++ VGFS +T T E H + WS
Sbjct: 176 LAPNKTLIASLVYPS-NQTTFSVAASVDLKEILPEWVRVGFSAATGYPTEVETHDVLSWS 234
Query: 258 FSSSF 262
F+S+
Sbjct: 235 FTSTL 239
|
| >1f9k_A Acidic lectin; legume lectin, glycosylated protein, H-antigenic specificity agglutinin, sugar binding protein; HET: NAG MAN AMG; 3.00A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 1fay_A* Length = 238 | Back alignment and structure |
|---|
Score = 165 bits (418), Expect = 6e-47
Identities = 74/241 (30%), Positives = 117/241 (48%), Gaps = 19/241 (7%)
Query: 36 FDFGTLTLASLKLLGDAH-MNNGSVRLTRDV---TVPYDGAGKALYSKPVRFRLPGTHTP 91
FD L L A +NG + LT+ + G+ALY++P++ T
Sbjct: 7 FDHFEENSKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWDSTTGNV 66
Query: 92 ASFSTFFSFSITNLNPSSI-GAGLAFVITPDGEQVGSAGGSLGLLDEKGAGLGFVAVEFD 150
ASF T FSF+IT GL F + P G GG+LG+ AVEFD
Sbjct: 67 ASFETRFSFNITQPYAYPEPADGLTFFMVPPNSPQGEDGGNLGVFKPPEGD-NAFAVEFD 125
Query: 151 TLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLTRAFNISV 210
T + D H+G+D+NS+VS++ T++ L++G + N I+YD T+ N+ +
Sbjct: 126 TFQNTW--DPQVPHIGIDVNSIVSSK-----TLHFQLENGGVANVVIKYDSPTKILNVVL 178
Query: 211 SYSNLKPKVPILSFTLDLDQYV--NDFMYVGFSGST---QGSTEIHSIEWWSFSSSFESN 265
++ + V LS +DL Q ++++ VG S +T + + E H I WSF+SS +
Sbjct: 179 AFHS-VGTVYTLSNIVDLKQEFPNSEWVNVGLSATTGYQKNAVETHEIISWSFTSSLQET 237
Query: 266 S 266
+
Sbjct: 238 N 238
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 3e-46
Identities = 65/299 (21%), Positives = 116/299 (38%), Gaps = 44/299 (14%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGT--LRHRNLVRLQG 443
+G G +G V++G G+ +AVK +S+ + + E + T LRH N++
Sbjct: 14 ECVGKGRYGEVWRGSW--QGENVAVKI--FSSRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 444 WC----HEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQE--- 496
H ++ L+ GSL L + L +I+L +AS LA+LH E
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 497 --CENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD---ATVAAGTMGYLAPE 551
+ + HRD+K+ NI++ + + D GLA + GT Y+APE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 552 ------YLLTGRATEKTDVFSYGAVVLEVASGRRPI----EKEITGVGKVGVASNLVEWV 601
+ + ++ D++++G V+ EVA + + V + +
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMR 247
Query: 602 WSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLA-----CSHPDPLARPTMRGVVQML 655
+ + + R L LA C + +P AR T + + L
Sbjct: 248 KVVCVDQQ-------RPN--IPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297
|
| >2fmd_A Lectin, agglutinin, BMA; legume lectin, beta sandwich, protein-carbohydrate complex, sugar binding protein; HET: MAN; 1.90A {Bowringia mildbraedii} Length = 240 | Back alignment and structure |
|---|
Score = 163 bits (413), Expect = 4e-46
Identities = 69/246 (28%), Positives = 114/246 (46%), Gaps = 18/246 (7%)
Query: 31 STATEFDFGTLT--LASLKLLGDAH-MNNGSVRLTRDVTVP---YDGAGKALYSKPVRFR 84
+ + F F L GDA +N +++LT+ + G+ALY+ P+R
Sbjct: 1 ANSVCFTFTDFESGQQDLIFQGDASVGSNKALQLTKVDSKGNPQGGSVGRALYTAPIRLW 60
Query: 85 LPGTHTPASFSTFFSFSITNLNPSSIGAGLAFVITPDGE-QVGSAGGSLGLLDEKGAGLG 143
+ ASF T F+FSI+ + + A F+ +PD + GS G LGL
Sbjct: 61 -QSSSLVASFETTFTFSISQGSSTPADALTFFIASPDTKIPSGSGGRLLGLFGSSNNAGS 119
Query: 144 ---FVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYD 200
V+VEFDT + + D N H+G+D+NS+ S D ++G + I Y+
Sbjct: 120 DNGVVSVEFDTYPNTDIGDPNYRHIGIDVNSIRSK-----AASKWDWQNGKTATAHISYN 174
Query: 201 GLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGSTEIHSIEWWSFSS 260
++ +SV S ++SF ++L+ B++ VGFS +T T+ ++I WSF S
Sbjct: 175 SASK--RLSVVSSYPNSSPVVVSFDVELNNVBPBWVRVGFSATTGQYTQTNNILAWSFRS 232
Query: 261 SFESNS 266
S
Sbjct: 233 SLMGYQ 238
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 5e-46
Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 13/202 (6%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVK--RCSHNSQGKDEFLSELSIIGTLRHRNLVRLQG 443
IG G FG V+ G L + ++AVK R + K +FL E I+ H N+VRL G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 444 WCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIH 503
C +K I +V +L+ G L + L +++ A+ + YL IH
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIH 236
Query: 504 RDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGY----LAPEYLLTGRAT 559
RD+ N ++ E ++ DFG++R+ + G APE L GR +
Sbjct: 237 RDLAARNCLVTEKNVLKISDFGMSREEADG---VYAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 560 EKTDVFSYGAVVLEVAS-GRRP 580
++DV+S+G ++ E S G P
Sbjct: 294 SESDVWSFGILLWETFSLGASP 315
|
| >1ioa_A Arcelin-5A, ARC5A; lectin-like proteins, plant defense proteins, lectin; HET: NAG FUC; 2.70A {Phaseolus vulgaris} SCOP: b.29.1.1 Length = 240 | Back alignment and structure |
|---|
Score = 160 bits (405), Expect = 4e-45
Identities = 63/248 (25%), Positives = 107/248 (43%), Gaps = 25/248 (10%)
Query: 31 STATEFDF-GTLTLASLKLLGDAH-MNNGSVRLTRDVT---VPYDGAGKALYSKPVRFRL 85
+T T F+F T L L G+A + G ++LT + D G+A YS P++ +
Sbjct: 1 ATETSFNFPNFHTDDKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIK- 59
Query: 86 PGTHTPASFSTFFSFSITNLNPSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKG--AGLG 143
++ ASF+T F+F I N S GLAF + P LG+ +
Sbjct: 60 -DSNNVASFNTNFTFIIRAKNQSISAYGLAFALVPVNSPPQKKQEFLGIFNTNNPEPNAR 118
Query: 144 FVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLT 203
VAV F+T + D + N + +N +G+ + I YD
Sbjct: 119 TVAVVFNTFKNRI--DFDKNFIKPYVNENCD----------FHKYNGEKTDVQITYDSSN 166
Query: 204 RAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGST---QGSTEIHSIEWWSFSS 260
+ + ++ +S T+ L++ V++++ VGFS ++ + +TE H + WSFSS
Sbjct: 167 NDLRVFLHFTV-SQVKCSVSATVHLEKEVDEWVSVGFSPTSGLTEDTTETHDVLSWSFSS 225
Query: 261 SFESNSGT 268
F +
Sbjct: 226 KFRNKLSN 233
|
| >1qnw_A Chitin binding lectin, UEA-II; carbohydrate binding; HET: NAG; 2.35A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1dzq_A* 1qoo_A* 1qos_A* 1qot_A* Length = 242 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-44
Identities = 69/247 (27%), Positives = 119/247 (48%), Gaps = 18/247 (7%)
Query: 31 STATEFDFGTLT--LASLKLLGDAH-MNNGSVRLTRDVTVPYDGAGKALYSKPVRFRLPG 87
S F+F ++ GDA G +++T+ G+ALY+ P++
Sbjct: 3 SDDLSFNFDKFVPNQKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIWDSI 62
Query: 88 THTPASFSTFFSFSITNLNPSSIGAGLAFVITPDGEQV--GSAGGSLGLLDEKGAGL--G 143
T ASF+T FSF + + S GLAF + P Q+ GS+ G GL +
Sbjct: 63 TGKVASFATSFSFVVKA-DKSDGVDGLAFFLAPANSQIPSGSSAGMFGLFSSSDSKSSNQ 121
Query: 144 FVAVEFDTLMDVEF--SDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDG 201
+AVEFDT + D + H+G+D+NS+ S T+ D ++G++ + I Y
Sbjct: 122 IIAVEFDTYFGKAYNPWDPDFKHIGIDVNSIKSI-----KTVKWDWRNGEVADVVITYRA 176
Query: 202 LTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGST--EIHSIEWWSFS 259
T++ + +SY + I++ ++DL + +++ VGFSG + E H + W F+
Sbjct: 177 PTKSLTVCLSYPSDGTS-NIITASVDLKAILPEWVSVGFSGGVGNAAEFETHDVLSWYFT 235
Query: 260 SSFESNS 266
S+ E+N+
Sbjct: 236 SNLEANN 242
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 9e-44
Identities = 69/298 (23%), Positives = 115/298 (38%), Gaps = 44/298 (14%)
Query: 387 IIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGT--LRHRNLVRLQGW 444
IG G FG V++G G+ +AVK S S+ + + E I T LRH N++
Sbjct: 49 SIGKGRFGEVWRGKW--RGEEVAVKIFS--SREERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 445 CHEKG----EILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQ 500
++ ++ LV D +GSL L R + K+ L AS LA+LH E
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 162
Query: 501 -----VIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD---ATVAAGTMGYLAPEY 552
+ HRD+K+ NI++ + + D GLA + + GT Y+APE
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 222
Query: 553 LL------TGRATEKTDVFSYGAVVLEVASGRRPI----EKEITGVGKVGVASNLVEWVW 602
L + ++ D+++ G V E+A + ++ V ++ E
Sbjct: 223 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 282
Query: 603 SLHREGRLLTAADARLEGQFDEAEMRRVLLVGLA-----CSHPDPLARPTMRGVVQML 655
+ + R L +A C + + AR T + + L
Sbjct: 283 VVCEQKL-------RPN--IPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331
|
| >1dhk_B Bean lectin-like inhibitor, porcine pancreatic alpha-amylase; CO (hydrolase-inhibitor), complex (hydrolase-inhibitor) comple; HET: NAG; 1.85A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1viw_B* Length = 223 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 9e-44
Identities = 67/244 (27%), Positives = 109/244 (44%), Gaps = 36/244 (14%)
Query: 31 STATEFDFGTLTLASLKLLGDAH-MNNGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTH 89
+T T F +L L GDA +NG+++L+ + D +A YS P++ R T
Sbjct: 1 ATETSFIIDAFNKTNLILQGDATVSSNGNLQLSYNSY---DSMSRAFYSAPIQIRDSTTG 57
Query: 90 TPASFSTFFSFSITNLNPSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAGLGFVAVEF 149
ASF T F+ +I ++ GL FV+ P + + V VEF
Sbjct: 58 NVASFDTNFTMNIRTHRQANSAVGLDFVLVPVQPE---------------SKGDTVTVEF 102
Query: 150 DTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLTRAFNIS 209
DT + + + +D+N+ V +V G I Y+ T+ F++S
Sbjct: 103 DTFL---------SRISIDVNNNDIKSV----PWDVHDYDGQNAEVRITYNSSTKVFSVS 149
Query: 210 VSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGST---QGSTEIHSIEWWSFSSSFESNS 266
+S + K +S T++L++ V D++ VGFS ++ Q S E H + WSFSS F +
Sbjct: 150 LSNPS-TGKSNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHDVLSWSFSSKFINLK 208
Query: 267 GTGS 270
S
Sbjct: 209 DQKS 212
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-43
Identities = 63/300 (21%), Positives = 107/300 (35%), Gaps = 46/300 (15%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGT--LRHRNLVRLQG 443
+ IG G +G V+ G G+ +AVK + + + E I T +RH N++
Sbjct: 43 KQIGKGRYGEVWMGKW--RGEKVAVKV--FFTTEEASWFRETEIYQTVLMRHENILGFIA 98
Query: 444 WCHEKG----EILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQE--- 496
+ ++ L+ D NGSL L + L K+ S L +LH E
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 497 --CENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD---ATVAAGTMGYLAPE 551
+ + HRD+K+ NI++ + + D GLA + D + GT Y+ PE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216
Query: 552 YLLTGR-------ATEKTDVFSYGAVVLEVASGRRPIEKEITG----VGKVGVASNLVEW 600
+L + D++S+G ++ EVA V + +
Sbjct: 217 -VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDM 275
Query: 601 VWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLA-----CSHPDPLARPTMRGVVQML 655
+ + R F L + C +P +R T V + L
Sbjct: 276 REIVCIKKL-------RPS--FPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-43
Identities = 58/200 (29%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 386 RIIGHGAFGTVYKGILPQNGDI-IAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGW 444
+ +G G FG V G G +AVK S +DEF E + L H LV+ G
Sbjct: 14 KELGSGQFGVVKLGKW--KGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 445 CHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHR 504
C ++ I +V + + NG L L L ++ V +A+L +Q IHR
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHR 128
Query: 505 DVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTM---GYLAPEYLLTGRATEK 561
D+ N ++D ++ DFG+ R V D + GT + APE + + K
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDD---QYVSSVGTKFPVKWSAPEVFHYFKYSSK 185
Query: 562 TDVFSYGAVVLEVAS-GRRP 580
+DV+++G ++ EV S G+ P
Sbjct: 186 SDVWAFGILMWEVFSLGKMP 205
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 156 bits (398), Expect = 1e-43
Identities = 64/199 (32%), Positives = 97/199 (48%), Gaps = 11/199 (5%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWC 445
+ IG G FG V+ G N D +A+K + +++F+ E ++ L H LV+L G C
Sbjct: 14 QEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 446 HEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRD 505
E+ I LV + M +G L L R + L V +AYL E VIHRD
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRD 129
Query: 506 VKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTM---GYLAPEYLLTGRATEKT 562
+ N ++ E ++ DFG+ R V D T + GT + +PE R + K+
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLDD---QYTSSTGTKFPVKWASPEVFSFSRYSSKS 186
Query: 563 DVFSYGAVVLEVAS-GRRP 580
DV+S+G ++ EV S G+ P
Sbjct: 187 DVWSFGVLMWEVFSEGKIP 205
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 6e-43
Identities = 57/200 (28%), Positives = 99/200 (49%), Gaps = 13/200 (6%)
Query: 386 RIIGHGAFGTVYKGILPQNGDI-IAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGW 444
+ +G G FG V G G +A+K S +DEF+ E ++ L H LV+L G
Sbjct: 30 KELGTGQFGVVKYGKW--RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 445 CHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHR 504
C ++ I ++ + M NG L L E R ++ V A+ YL Q +HR
Sbjct: 88 CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHR 144
Query: 505 DVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTM---GYLAPEYLLTGRATEK 561
D+ N ++++ ++ DFGL+R V D + T + G+ + PE L+ + + K
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDD---EYTSSVGSKFPVRWSPPEVLMYSKFSSK 201
Query: 562 TDVFSYGAVVLEVAS-GRRP 580
+D++++G ++ E+ S G+ P
Sbjct: 202 SDIWAFGVLMWEIYSLGKMP 221
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-42
Identities = 54/205 (26%), Positives = 104/205 (50%), Gaps = 16/205 (7%)
Query: 386 RIIGHGAFGTVYKGILPQNGD----IIAVKRC--SHNSQGKDEFLSELSIIGTLRHRNLV 439
+++G GAFGTVYKG+ G+ +A+K + + + E L E ++ ++ + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 440 RLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECEN 499
RL G C + L+ LMP G L + E + + + + +A + YL +
Sbjct: 81 RLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DR 136
Query: 500 QVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTM---GYLAPEYLLTG 556
+++HRD+ N+++ + ++ DFGLA+ + ++ A G ++A E +L
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWMALESILHR 194
Query: 557 RATEKTDVFSYGAVVLEVAS-GRRP 580
T ++DV+SYG V E+ + G +P
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 7e-42
Identities = 55/204 (26%), Positives = 97/204 (47%), Gaps = 16/204 (7%)
Query: 386 RIIGHGAFGTVYKGIL--PQNGDI-IAVKRC--SHNSQGKDEFLSELSIIGTLRHRNLVR 440
R IG G FG V++GI P+N + +A+K C + +++FL E + H ++V+
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 441 LQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQ 500
L G + + ++ +L G L L + L +++ALAYL +
Sbjct: 81 LIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKR 136
Query: 501 VIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTM---GYLAPEYLLTGR 557
+HRD+ N+++ +LGDFGL+R +E A+ ++APE + R
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS---TYYKASKGKLPIKWMAPESINFRR 193
Query: 558 ATEKTDVFSYGAVVLEVAS-GRRP 580
T +DV+ +G + E+ G +P
Sbjct: 194 FTSASDVWMFGVCMWEILMHGVKP 217
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 8e-42
Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 16/204 (7%)
Query: 386 RIIGHGAFGTVYKGIL-PQNGDII--AVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVR 440
RI+G G FG VY+G+ G+ I AVK C + K++F+SE I+ L H ++V+
Sbjct: 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 441 LQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQ 500
L G E+ ++ +L P G L L ++ L L + A+AYL
Sbjct: 78 LIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SIN 133
Query: 501 VIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTM---GYLAPEYLLTGR 557
+HRD+ NI++ +LGDFGL+R +E + D A+ T +++PE + R
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDE---DYYKASVTRLPIKWMSPESINFRR 190
Query: 558 ATEKTDVFSYGAVVLEVAS-GRRP 580
T +DV+ + + E+ S G++P
Sbjct: 191 FTTASDVWMFAVCMWEILSFGKQP 214
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 5e-41
Identities = 58/203 (28%), Positives = 101/203 (49%), Gaps = 17/203 (8%)
Query: 388 IGHGAFGTVYKGILPQNGDII--AVKRCSHNSQGKD--EFLSELSIIGTLRHRNLVRLQG 443
+G G FG+V +G+ I A+K ++ D E + E I+ L + +VRL G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 444 WCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIH 503
C + ++LV ++ G L K L R +P + +++L V+ + YL E +H
Sbjct: 78 VCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVH 133
Query: 504 RDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYL-----APEYLLTGRA 558
RD+ N++L A++ DFGL++ + D D+ A + G APE + +
Sbjct: 134 RDLAARNVLLVNRHYAKISDFGLSKALGAD---DSYYTARSAGKWPLKWYAPECINFRKF 190
Query: 559 TEKTDVFSYGAVVLEVAS-GRRP 580
+ ++DV+SYG + E S G++P
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQKP 213
|
| >2ltn_A PEA lectin, alpha chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1bqp_A* 1hkd_A 1ofs_A* 1rin_A* 1lof_C* 1len_A 1lem_A 1les_A* 2lal_A 1loe_A 1loa_A* 1loc_A* 1lod_A* 1lob_A 1lof_A* 1log_A* 1lgc_A* 1lgb_A* 2b7y_A* Length = 181 | Back alignment and structure |
|---|
Score = 147 bits (371), Expect = 5e-41
Identities = 53/189 (28%), Positives = 85/189 (44%), Gaps = 13/189 (6%)
Query: 31 STATEFDFGTLT--LASLKLLGDAHMNNGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGT 88
+ T F + +L GD + + LT+ V + G+ALYS P+ T
Sbjct: 1 TETTSFLITKFSPDQQNLIFQGDGYTTKEKLTLTKAVK---NTVGRALYSSPIHIWDRET 57
Query: 89 HTPASFSTFFSFSITNLNPSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAGL--GFVA 146
A+F T F+F I N ++ G F I P + + GG LG+ + VA
Sbjct: 58 GNVANFVTSFTFVINAPNSYNVADGFTFFIAPVDTKPQTGGGYLGVFNSAEYDKTTQTVA 117
Query: 147 VEFDTLMDVEFSDIN-GNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLTRA 205
VEFDT + + N H+G+D+NS+ S T + L++G+ N I ++ T
Sbjct: 118 VEFDTFYNAAWDPSNRDRHIGIDVNSIKSVN-----TKSWKLQNGEEANVVIAFNAATNV 172
Query: 206 FNISVSYSN 214
+S++Y N
Sbjct: 173 LTVSLTYPN 181
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 6e-41
Identities = 62/208 (29%), Positives = 91/208 (43%), Gaps = 19/208 (9%)
Query: 386 RIIGHGAFGTVYKGILPQNGDI---IAVKRCSHNSQGKD--EFLSELSIIGTLRHRNLVR 440
+IG G FG VY G L N AVK + + + +FL+E I+ H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 441 LQGWC-HEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECEN 499
L G C +G L+V M +G L + L VA + YL
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SK 147
Query: 500 QVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYL------APEYL 553
+ +HRD+ N MLDE F ++ DFGLAR + + G A E L
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK---EYYSVHNKTGAKLPVKWMALESL 204
Query: 554 LTGRATEKTDVFSYGAVVLEVAS-GRRP 580
T + T K+DV+S+G ++ E+ + G P
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 7e-41
Identities = 64/208 (30%), Positives = 105/208 (50%), Gaps = 20/208 (9%)
Query: 386 RIIGHGAFGTVYKGILPQNGDI----IAVKRCSHN--SQGKDEFLSELSIIGTLRHRNLV 439
++IG G FG VYKG+L + +A+K + + +FL E I+G H N++
Sbjct: 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 440 RLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECEN 499
RL+G + ++++ + M NG+LDK L E +L G+A+ + YL
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NM 166
Query: 500 QVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAG------TMGYLAPEYL 553
+HRD+ NI+++ ++ DFGL+R +E D T + G T APE +
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT----APEAI 222
Query: 554 LTGRATEKTDVFSYGAVVLEVAS-GRRP 580
+ T +DV+S+G V+ EV + G RP
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-40
Identities = 64/207 (30%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 386 RIIGHGAFGTVYKGIL--PQNGDI-IAVKRCSHN--SQGKDEFLSELSIIGTLRHRNLVR 440
+IIG G G V G L P D+ +A+K + + +FLSE SI+G H N++R
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 441 LQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQ 500
L+G ++V + M NGSLD L +L GV + + YL +
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLG 171
Query: 501 VIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGT------MGYLAPEYLL 554
+HRD+ N+++D ++ DFGL+R +E D A G APE +
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE-DDPDAAYTTTGGKIPIRWT---APEAIA 227
Query: 555 TGRATEKTDVFSYGAVVLEVAS-GRRP 580
+ +DV+S+G V+ EV + G RP
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 60/208 (28%), Positives = 91/208 (43%), Gaps = 19/208 (9%)
Query: 386 RIIGHGAFGTVYKGIL--PQNGDI-IAVKRCSHNSQGKD--EFLSELSIIGTLRHRNLVR 440
R+IG G FG VY G I A+K S ++ + FL E ++ L H N++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 441 LQGWC-HEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECEN 499
L G +G ++ M +G L + + + L VA + YL E
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---EQ 143
Query: 500 QVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYL------APEYL 553
+ +HRD+ N MLDE F ++ DFGLAR + + A E L
Sbjct: 144 KFVHRDLAARNCMLDESFTVKVADFGLARDILDR---EYYSVQQHRHARLPVKWTALESL 200
Query: 554 LTGRATEKTDVFSYGAVVLEVAS-GRRP 580
T R T K+DV+S+G ++ E+ + G P
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 2e-40
Identities = 55/202 (27%), Positives = 98/202 (48%), Gaps = 15/202 (7%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWC 445
+G G +G VY+G+ + +AVK ++ +EFL E +++ ++H NLV+L G C
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 446 HEKGEILLVYDLMPNGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHR 504
+ ++ + M G+L L E + + ++SA+ YL + IHR
Sbjct: 79 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHR 135
Query: 505 DVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYL-----APEYLLTGRAT 559
D+ N ++ E ++ DFGL+R + D T A APE L + +
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGD-----TYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 560 EKTDVFSYGAVVLEVAS-GRRP 580
K+DV+++G ++ E+A+ G P
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSP 212
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 2e-40
Identities = 53/197 (26%), Positives = 99/197 (50%), Gaps = 5/197 (2%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWC 445
+G G +G VY+G+ + +AVK ++ +EFL E +++ ++H NLV+L G C
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 446 HEKGEILLVYDLMPNGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHR 504
+ ++ + M G+L L E + + ++SA+ YL + IHR
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHR 342
Query: 505 DVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDV 564
++ N ++ E ++ DFGL+R + D A + + APE L + + K+DV
Sbjct: 343 NLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 402
Query: 565 FSYGAVVLEVAS-GRRP 580
+++G ++ E+A+ G P
Sbjct: 403 WAFGVLLWEIATYGMSP 419
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 2e-40
Identities = 59/207 (28%), Positives = 105/207 (50%), Gaps = 19/207 (9%)
Query: 385 NRIIGHGAFGTVYKGILPQNGDII--AVKRCSHNS---QGKDEFLSELSIIGTLRHRNLV 439
++ +G G FGTV KG + AVK + + KDE L+E +++ L + +V
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 440 RLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECEN 499
R+ G C E +LV ++ G L+K L + + + +++ V+ + YL E E+
Sbjct: 82 RMIGIC-EAESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYL--E-ES 136
Query: 500 QVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYL-----APEYLL 554
+HRD+ N++L A++ DFGL++ + D + A T G APE +
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD---ENYYKAQTHGKWPVKWYAPECIN 193
Query: 555 TGRATEKTDVFSYGAVVLEVAS-GRRP 580
+ + K+DV+S+G ++ E S G++P
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 4e-40
Identities = 54/205 (26%), Positives = 104/205 (50%), Gaps = 16/205 (7%)
Query: 386 RIIGHGAFGTVYKGILPQNGD----IIAVKRC--SHNSQGKDEFLSELSIIGTLRHRNLV 439
+++G GAFGTVYKG+ G+ +A+K + + + E L E ++ ++ + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 440 RLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECEN 499
RL G C + L+ LMP G L + E + + + + +A + YL +
Sbjct: 81 RLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DR 136
Query: 500 QVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTM---GYLAPEYLLTG 556
+++HRD+ N+++ + ++ DFGLA+ + ++ A G ++A E +L
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWMALESILHR 194
Query: 557 RATEKTDVFSYGAVVLEVAS-GRRP 580
T ++DV+SYG V E+ + G +P
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 5e-40
Identities = 74/302 (24%), Positives = 120/302 (39%), Gaps = 24/302 (7%)
Query: 295 SLAPSGSST----TQKSSKSSSCHNQLCKQGAGAVAGVVTASAFFAIFAGVLIWFFSKRY 350
+ P G +++S ++ G + + S AG +F
Sbjct: 3 PIDPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGAN 62
Query: 351 KHVKKSESFTSDIIRMPKEFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDI--- 407
+ ++++ + N +IG G FG VY G L N
Sbjct: 63 TVHIDLSALNPELVQAVQHVVIGPSSLIVHF---NEVIGRGHFGCVYHGTLLDNDGKKIH 119
Query: 408 IAVKRCSHNSQGKD--EFLSELSIIGTLRHRNLVRLQGWC-HEKGEILLVYDLMPNGSLD 464
AVK + + + +FL+E I+ H N++ L G C +G L+V M +G L
Sbjct: 120 CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 179
Query: 465 KALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDF 524
+ L VA + +L + +HRD+ N MLDE F ++ DF
Sbjct: 180 NFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADF 236
Query: 525 GLARQVEHDKSPDATVAAGTMGYL-----APEYLLTGRATEKTDVFSYGAVVLEVAS-GR 578
GLAR + +DK D+ T L A E L T + T K+DV+S+G ++ E+ + G
Sbjct: 237 GLARDM-YDKEFDSVH-NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 294
Query: 579 RP 580
P
Sbjct: 295 PP 296
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 8e-40
Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 386 RIIGHGAFGTVYKGILPQNGDII----AVKRC--SHNSQGKDEFLSELSIIGTLRHRNLV 439
+++G G FGTV+KG+ G+ I +K Q + IG+L H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 440 RLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECEN 499
RL G C + LV +P GSL + + R L + +A + YL E+
Sbjct: 79 RLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EH 134
Query: 500 QVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTM---GYLAPEYLLTG 556
++HR++ N++L ++ DFG+A + D + + ++A E + G
Sbjct: 135 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK--QLLYSEAKTPIKWMALESIHFG 192
Query: 557 RATEKTDVFSYGAVVLEVAS-GRRP 580
+ T ++DV+SYG V E+ + G P
Sbjct: 193 KYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 8e-40
Identities = 65/203 (32%), Positives = 104/203 (51%), Gaps = 11/203 (5%)
Query: 386 RIIGHGAFGTVYKGIL--PQNGDI-IAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVR 440
+++G G FG V G L P +I +A+K + + +FL E SI+G H N++R
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 441 LQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQ 500
L+G + +++V + M NGSLD L + + +L G+AS + YL +
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMG 167
Query: 501 VIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYL--APEYLLTGRA 558
+HRD+ NI+++ ++ DFGL R +E D T G + +PE + +
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 559 TEKTDVFSYGAVVLEVAS-GRRP 580
T +DV+SYG V+ EV S G RP
Sbjct: 228 TSASDVWSYGIVLWEVMSYGERP 250
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-39
Identities = 65/309 (21%), Positives = 121/309 (39%), Gaps = 20/309 (6%)
Query: 282 MNPTANSVKSPPPSLAPSGSSTTQKSSKSSSCHNQLCKQGAGAVAGVVTASAFFAIFAGV 341
+ S S+ + ++ + H + + +
Sbjct: 241 LKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARIT 300
Query: 342 LIWFFSKRYKHVKKSESFTSDIIRMPKEFSYRELRSATKCFNANRIIGHGAFGTVYKGIL 401
ES SD + + R A+ +G G FG+V +G+
Sbjct: 301 SPDKPRPMPMDTSVFESPFSDPEELKDKK-LFLKRD--NLLIADIELGCGNFGSVRQGVY 357
Query: 402 PQNGDII--AVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457
I A+K + +E + E I+ L + +VRL G C + ++LV ++
Sbjct: 358 RMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEM 416
Query: 458 MPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGF 517
G L K L R +P + +++L V+ + YL E +HR++ N++L
Sbjct: 417 AGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARNVLLVNRH 473
Query: 518 NARLGDFGLARQVEHDKSPDATVAAGTMGYL-----APEYLLTGRATEKTDVFSYGAVVL 572
A++ DFGL++ + D D+ A + G APE + + + ++DV+SYG +
Sbjct: 474 YAKISDFGLSKALGAD---DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMW 530
Query: 573 EVAS-GRRP 580
E S G++P
Sbjct: 531 EALSYGQKP 539
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 19/203 (9%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWC 445
+G G FG V+ G + + AVK S D FL+E +++ L+H+ LVRL
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 446 HEKGEILLVYDLMPNGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHR 504
++ I ++ + M NGSL L L + +A +A++ E IHR
Sbjct: 78 TQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHR 133
Query: 505 DVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGT------MGYLAPEYLLTGRA 558
D++ +NI++ + + ++ DFGLAR +E + + T G APE + G
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDN---EYTAREGAKFPIKWT---APEAINYGTF 187
Query: 559 TEKTDVFSYGAVVLEVAS-GRRP 580
T K+DV+S+G ++ E+ + GR P
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIP 210
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-39
Identities = 60/229 (26%), Positives = 102/229 (44%), Gaps = 19/229 (8%)
Query: 361 SDIIRMPKEFSYRELRSATKCFNANRIIGHGAFGTVYKGIL--PQNGDI-IAVKRC--SH 415
D MP Y R R IG G FG V++GI P+N + +A+K C
Sbjct: 374 EDTYTMPSTRDYEIQRE---RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT 430
Query: 416 NSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLP 475
+ +++FL E + H ++V+L G + + ++ +L G L L + L
Sbjct: 431 SDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLD 489
Query: 476 WPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535
+++ALAYL + +HRD+ N+++ +LGDFGL+R +E
Sbjct: 490 LASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-- 544
Query: 536 PDATVAAGTM---GYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRP 580
A+ ++APE + R T +DV+ +G + E+ G +P
Sbjct: 545 -TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 8e-39
Identities = 61/197 (30%), Positives = 97/197 (49%), Gaps = 7/197 (3%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWC 445
+G G FG V+ G + A+K + + FL E ++ LRH LV+L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 446 HEKGEILLVYDLMPNGSLDKALFE-ARSPLPWPHRSKILLGVASALAYLHQECENQVIHR 504
E+ I +V + M GSL L L P + +AS +AY+ +HR
Sbjct: 249 SEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 505 DVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDV 564
D++ +NI++ E ++ DFGLAR +E ++ A + + APE L GR T K+DV
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 565 FSYGAVVLEVAS-GRRP 580
+S+G ++ E+ + GR P
Sbjct: 365 WSFGILLTELTTKGRVP 381
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-38
Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 386 RIIGHGAFGTVYKGIL-PQNGDII--AVKRC----SHNSQGKDEFLSELSIIGTLRHRNL 438
+G G+FG V +G +G + AVK + D+F+ E++ + +L HRNL
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 439 VRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECE 498
+RL G + +V +L P GSL L + + S+ + VA + YL
Sbjct: 84 IRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---S 139
Query: 499 NQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGY----LAPEYLL 554
+ IHRD+ N++L ++GDFGL R + + D V APE L
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN--DDHYVMQEHRKVPFAWCAPESLK 197
Query: 555 TGRATEKTDVFSYGAVVLEVAS-GRRP 580
T + +D + +G + E+ + G+ P
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-38
Identities = 60/240 (25%), Positives = 102/240 (42%), Gaps = 27/240 (11%)
Query: 367 PKEFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGD----IIAVKRCSHNSQGKD- 421
P F R L+ R +G G FG V GD +AVK S G
Sbjct: 15 PTHFEKRFLK-------RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI 67
Query: 422 -EFLSELSIIGTLRHRNLVRLQGWCHEKGE--ILLVYDLMPNGSLDKALFEARSPLPWPH 478
+ E+ I+ L H N+V+ +G C E G I L+ + +P+GSL + L + ++ +
Sbjct: 68 ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQ 127
Query: 479 RSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDA 538
+ K + + + YL Q +HRD+ N++++ ++GDFGL + +E DK
Sbjct: 128 QLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE--- 181
Query: 539 TVAAGTMGYL-----APEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVG 592
APE L+ + +DV+S+G + E+ + + +G
Sbjct: 182 YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIG 241
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-38
Identities = 68/243 (27%), Positives = 105/243 (43%), Gaps = 14/243 (5%)
Query: 345 FFSKRYKHVKKSESFTSDIIRMPKEFSYRELRSAT---KCFNANRIIGHGAFGTVYKGIL 401
+F ++ + SF + + Y R + + F +GHG++G V+K
Sbjct: 19 YFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRS 78
Query: 402 PQNGDIIAVKRCSHNSQGKDE---FLSELSIIGTL-RHRNLVRLQGWCHEKGEILLVYDL 457
++G + AVKR +G + L+E+ + +H VRL+ E G + L +L
Sbjct: 79 KEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTEL 138
Query: 458 MPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGF 517
SL + + LP L ALA+LH ++H DVK +NI L
Sbjct: 139 C-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRG 194
Query: 518 NARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASG 577
+LGDFGL ++ + + G Y+APE LL G DVFS G +LEVA
Sbjct: 195 RCKLGDFGLLVELGTAGAGEVQE--GDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACN 251
Query: 578 RRP 580
Sbjct: 252 MEL 254
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-38
Identities = 49/216 (22%), Positives = 93/216 (43%), Gaps = 32/216 (14%)
Query: 386 RIIGHGAFGTVYKGILPQNGDI-------IAVKRCSHNS-QGKDEFLSELSIIGTLRHRN 437
+G G F ++KG+ + GD + +K + F S++ L H++
Sbjct: 14 ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 438 LVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQEC 497
LV G C E +LV + + GSLD L + ++ + + ++ +A+A+ +L
Sbjct: 74 LVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE--- 130
Query: 498 ENQVIHRDVKTSNIMLDEGFNAR--------LGDFGLARQVEHD---KSPDATVAAGTMG 546
EN +IH +V NI+L + + L D G++ V + +
Sbjct: 131 ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQER--------IP 182
Query: 547 YLAPEYLLTGRA-TEKTDVFSYGAVVLEVAS-GRRP 580
++ PE + + TD +S+G + E+ S G +P
Sbjct: 183 WVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-38
Identities = 68/203 (33%), Positives = 101/203 (49%), Gaps = 23/203 (11%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWC 445
+ IG G FG V G G+ +AVK +++ + FL+E S++ LRH NLV+L G
Sbjct: 27 QTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQA-FLAEASVMTQLRHSNLVQLLGVI 83
Query: 446 -HEKGEILLVYDLMPNGSLDKAL-FEARSPLPWPHRSKILLGVASALAYLHQECENQVIH 503
EKG + +V + M GSL L RS L K L V A+ YL N +H
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 140
Query: 504 RDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYL-----APEYLLTGRA 558
RD+ N+++ E A++ DFGL ++ + G L APE L +
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQD---------TGKLPVKWTAPEALREKKF 191
Query: 559 TEKTDVFSYGAVVLEVAS-GRRP 580
+ K+DV+S+G ++ E+ S GR P
Sbjct: 192 STKSDVWSFGILLWEIYSFGRVP 214
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 6e-38
Identities = 58/200 (29%), Positives = 101/200 (50%), Gaps = 13/200 (6%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWC 445
+ +G G FG V+ ++ + AVK S + FL+E +++ TL+H LV+L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 446 HEKGEILLVYDLMPNGSLDKALFE-ARSPLPWPHRSKILLGVASALAYLHQECENQVIHR 504
++ I ++ + M GSL L S P P +A +A++ + IHR
Sbjct: 253 TKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHR 308
Query: 505 DVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMG---YLAPEYLLTGRATEK 561
D++ +NI++ ++ DFGLAR +E + + T G + APE + G T K
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIEDN---EYTAREGAKFPIKWTAPEAINFGSFTIK 365
Query: 562 TDVFSYGAVVLEVAS-GRRP 580
+DV+S+G +++E+ + GR P
Sbjct: 366 SDVWSFGILLMEIVTYGRIP 385
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 6e-38
Identities = 55/227 (24%), Positives = 97/227 (42%), Gaps = 26/227 (11%)
Query: 367 PKEFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGD----IIAVKRCSHNS-QGKD 421
P F R L+ +G G FG+V GD ++AVK+ H+ +
Sbjct: 17 PTIFEERHLK-------YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR 69
Query: 422 EFLSELSIIGTLRHRNLVRLQGWCHEKGE--ILLVYDLMPNGSLDKALFEARSPLPWPHR 479
+F E+ I+ L +V+ +G + G + LV + +P+G L L R+ L
Sbjct: 70 DFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRL 129
Query: 480 SKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDAT 539
+ + YL + +HRD+ NI+++ + ++ DFGLA+ + DK
Sbjct: 130 LLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD---Y 183
Query: 540 VAAGTMGYL-----APEYLLTGRATEKTDVFSYGAVVLEVAS-GRRP 580
G APE L + ++DV+S+G V+ E+ + +
Sbjct: 184 YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 230
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 7e-38
Identities = 61/197 (30%), Positives = 97/197 (49%), Gaps = 7/197 (3%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWC 445
+G G FG V+ G + A+K + + FL E ++ LRH LV+L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 446 HEKGEILLVYDLMPNGSLDKALFE-ARSPLPWPHRSKILLGVASALAYLHQECENQVIHR 504
E+ I +V + M GSL L L P + +AS +AY+ +HR
Sbjct: 332 SEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 387
Query: 505 DVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDV 564
D++ +NI++ E ++ DFGLAR +E ++ A + + APE L GR T K+DV
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 447
Query: 565 FSYGAVVLEVAS-GRRP 580
+S+G ++ E+ + GR P
Sbjct: 448 WSFGILLTELTTKGRVP 464
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 58/239 (24%), Positives = 108/239 (45%), Gaps = 26/239 (10%)
Query: 367 PKEFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGD----IIAVKRCSHNS-QGKD 421
P +F R L+ + +G G FG+V D ++AVK+ H++ +
Sbjct: 4 PTQFEERHLK-------FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR 56
Query: 422 EFLSELSIIGTLRHRNLVRLQGWCHEKGE--ILLVYDLMPNGSLDKALFEARSPLPWPHR 479
+F E+ I+ +L+H N+V+ +G C+ G + L+ + +P GSL L + + +
Sbjct: 57 DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL 116
Query: 480 SKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDAT 539
+ + + YL + IHRD+ T NI+++ ++GDFGL + + DK
Sbjct: 117 LQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE---F 170
Query: 540 VAAGTMGYL-----APEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVG 592
G APE L + + +DV+S+G V+ E+ + + + +G
Sbjct: 171 FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 229
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 60/218 (27%), Positives = 102/218 (46%), Gaps = 29/218 (13%)
Query: 385 NRIIGHGAFGTVYKG----ILPQNGDI-IAVKRC--SHNSQGKDEFLSELSIIGTLRHRN 437
+R +G G+FG VY+G ++ + +A+K + + + + EFL+E S++ +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 438 LVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKIL---------LGVAS 488
+VRL G + L++ +LM G L L R + +A
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 489 ALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYL 548
+AYL+ N+ +HRD+ N M+ E F ++GDFG+ R + D G G L
Sbjct: 150 GMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET---DYYR-KGGKGLL 202
Query: 549 -----APEYLLTGRATEKTDVFSYGAVVLEVAS-GRRP 580
+PE L G T +DV+S+G V+ E+A+ +P
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 29/218 (13%)
Query: 385 NRIIGHGAFGTVYKGILPQNGDI---IAVKRC---SHNSQGKDEFLSELSIIGTLRHRNL 438
+I+G G FG+V +G L Q +AVK + + + +EFLSE + + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 439 VRLQGWC-----HEKGEILLVYDLMPNGSLDKALFEAR-----SPLPWPHRSKILLGVAS 488
+RL G C + +++ M G L L +R +P K ++ +A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 489 ALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYL 548
+ YL +HRD+ N ML + + DFGL++++ D G + +
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSG---DYYR-QGRIAKM 211
Query: 549 -----APEYLLTGRATEKTDVFSYGAVVLEVAS-GRRP 580
A E L T K+DV+++G + E+A+ G P
Sbjct: 212 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-37
Identities = 47/199 (23%), Positives = 90/199 (45%), Gaps = 8/199 (4%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDE---FLSELSIIGTLRHRNLVRLQ 442
+ IG G+FG ++G +K + + E E++++ ++H N+V+ +
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 443 GWCHEKGEILLVYDLMPNGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQV 501
E G + +V D G L K + + + + AL ++H + ++
Sbjct: 90 ESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKI 146
Query: 502 IHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEK 561
+HRD+K+ NI L + +LGDFG+AR + GT YL+PE K
Sbjct: 147 LHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARAC-IGTPYYLSPEICENKPYNNK 205
Query: 562 TDVFSYGAVVLEVASGRRP 580
+D+++ G V+ E+ + +
Sbjct: 206 SDIWALGCVLYELCTLKHA 224
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 58/239 (24%), Positives = 108/239 (45%), Gaps = 26/239 (10%)
Query: 367 PKEFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGD----IIAVKRCSHNS-QGKD 421
P +F R L+ + +G G FG+V D ++AVK+ H++ +
Sbjct: 35 PTQFEERHLK-------FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR 87
Query: 422 EFLSELSIIGTLRHRNLVRLQGWCHEKGE--ILLVYDLMPNGSLDKALFEARSPLPWPHR 479
+F E+ I+ +L+H N+V+ +G C+ G + L+ + +P GSL L + + +
Sbjct: 88 DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL 147
Query: 480 SKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDAT 539
+ + + YL + IHRD+ T NI+++ ++GDFGL + + DK
Sbjct: 148 LQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE---Y 201
Query: 540 VAAGTMGYL-----APEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVG 592
G APE L + + +DV+S+G V+ E+ + + + +G
Sbjct: 202 YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 260
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-37
Identities = 67/217 (30%), Positives = 94/217 (43%), Gaps = 29/217 (13%)
Query: 386 RIIGHGAFGTVYKGIL----PQNGDI-IAVKRCSHNSQGKD--EFLSELSIIGTLRHRNL 438
R +GHGAFG VY+G + + +AVK +D +FL E II H+N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 439 VRLQGWCHEKGEILLVYDLMPNGSLDKALFEAR------SPLPWPHRSKILLGVASALAY 492
VR G + ++ +LM G L L E R S L + +A Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 493 LHQECENQVIHRDVKTSNIMLD---EGFNARLGDFGLARQVEHDKSPDATVAAGTMGYL- 548
L EN IHRD+ N +L G A++GDFG+AR + G L
Sbjct: 156 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA---SYY-RKGGCAMLP 208
Query: 549 ----APEYLLTGRATEKTDVFSYGAVVLEVAS-GRRP 580
PE + G T KTD +S+G ++ E+ S G P
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 5e-37
Identities = 66/222 (29%), Positives = 99/222 (44%), Gaps = 38/222 (17%)
Query: 386 RIIGHGAFGTVYKGILPQNGDII--AVKRC--SHNSQGKDEFLSELSIIGTL-RHRNLVR 440
+IG G FG V K + ++G + A+KR + +F EL ++ L H N++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 441 LQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRS---------------KILLG 485
L G C +G + L + P+G+L L ++R P +
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 486 VASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTM 545
VA + YL + Q IHRD+ NI++ E + A++ DFGL+R E TM
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV-------KKTM 200
Query: 546 GYL-----APEYLLTGRATEKTDVFSYGAVVL-EVAS-GRRP 580
G L A E L T +DV+SYG V+L E+ S G P
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYG-VLLWEIVSLGGTP 241
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 6e-37
Identities = 53/224 (23%), Positives = 92/224 (41%), Gaps = 37/224 (16%)
Query: 386 RIIGHGAFGTVYKG----ILPQNGDI-IAVKRC--SHNSQGKDEFLSELSIIGTLRHRNL 438
+G FG VYKG P +A+K ++EF E + L+H N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 439 VRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRS---------------KIL 483
V L G + + +++ +G L + L ++
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 484 LGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAG 543
+A+ + YL + V+H+D+ T N+++ + N ++ D GL R+V
Sbjct: 135 AQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYA----ADYYKLL 187
Query: 544 TMGYL-----APEYLLTGRATEKTDVFSYGAVVL-EVAS-GRRP 580
L APE ++ G+ + +D++SYG VVL EV S G +P
Sbjct: 188 GNSLLPIRWMAPEAIMYGKFSIDSDIWSYG-VVLWEVFSYGLQP 230
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 8e-37
Identities = 66/198 (33%), Positives = 99/198 (50%), Gaps = 13/198 (6%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWC 445
+ IG G FG V G G+ +AVK +++ + FL+E S++ LRH NLV+L G
Sbjct: 199 QTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQA-FLAEASVMTQLRHSNLVQLLGVI 255
Query: 446 -HEKGEILLVYDLMPNGSLDKALFE-ARSPLPWPHRSKILLGVASALAYLHQECENQVIH 503
EKG + +V + M GSL L RS L K L V A+ YL N +H
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 312
Query: 504 RDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTD 563
RD+ N+++ E A++ DFGL ++ + APE L + + K+D
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTKE-ASSTQDTGKLPVKWT---APEALREKKFSTKSD 368
Query: 564 VFSYGAVVLEVAS-GRRP 580
V+S+G ++ E+ S GR P
Sbjct: 369 VWSFGILLWEIYSFGRVP 386
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 9e-37
Identities = 50/202 (24%), Positives = 99/202 (49%), Gaps = 11/202 (5%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCS----HNSQGKDEFLSELSIIGTLRHRNLVRL 441
+ IG G F VY+ +G +A+K+ +++ + + + E+ ++ L H N+++
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97
Query: 442 QGWCHEKGEILLVYDLMPNGSLD---KALFEARSPLPWPHRSKILLGVASALAYLHQECE 498
E E+ +V +L G L K + + +P K + + SAL ++H
Sbjct: 98 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---S 154
Query: 499 NQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRA 558
+V+HRD+K +N+ + +LGD GL R + ++ GT Y++PE +
Sbjct: 155 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL-VGTPYYMSPERIHENGY 213
Query: 559 TEKTDVFSYGAVVLEVASGRRP 580
K+D++S G ++ E+A+ + P
Sbjct: 214 NFKSDIWSLGCLLYEMAALQSP 235
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-36
Identities = 53/219 (24%), Positives = 88/219 (40%), Gaps = 30/219 (13%)
Query: 385 NRIIGHGAFGTVYKGILPQNGD---IIAVKRCSHNSQGKDE---FLSELSIIGTLRHRNL 438
R++G G FG+V + L Q +AVK + + FL E + + H ++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 439 VRLQGWCHEKG------EILLVYDLMPNGSLDKALFEAR-----SPLPWPHRSKILLGVA 487
+L G +++ M +G L L +R LP + ++ +A
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 488 SALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGY 547
+ YL IHRD+ N ML E + DFGL+R++ D G
Sbjct: 148 CGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSG---DYYR-QGCASK 200
Query: 548 L-----APEYLLTGRATEKTDVFSYGAVVLEVAS-GRRP 580
L A E L T +DV+++G + E+ + G+ P
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 60/241 (24%), Positives = 97/241 (40%), Gaps = 29/241 (12%)
Query: 367 PKEFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGD----IIAVKRC--SHNSQGK 420
P F R L+ R +G G FG V D ++AVK Q +
Sbjct: 25 PTVFHKRYLK-------KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHR 77
Query: 421 DEFLSELSIIGTLRHRNLVRLQGWCHEKGE--ILLVYDLMPNGSLDKALFEARSPLPWPH 478
+ E+ I+ TL H ++++ +G C + G + LV + +P GSL L R +
Sbjct: 78 SGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL--PRHSIGLAQ 135
Query: 479 RSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDA 538
+ +AYLH IHRD+ N++LD ++GDFGLA+ V +
Sbjct: 136 LLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH--EY 190
Query: 539 TVAAGTMGYL-----APEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVG 592
G APE L + +DV+S+G + E+ + + +G
Sbjct: 191 YR-VREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIG 249
Query: 593 V 593
+
Sbjct: 250 I 250
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-36
Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 13/206 (6%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKR---CSHNSQGKDEFLSELSIIGTLRHRNLVRLQ 442
IG G++G K +G I+ K S K +SE++++ L+H N+VR
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 443 GWCHEK--GEILLVYDLMPNGSLD---KALFEARSPLPWPHRSKILLGVASALAYLHQ-- 495
++ + +V + G L + R L +++ + AL H+
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 496 ECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLT 555
+ + V+HRD+K +N+ LD N +LGDFGLAR + HD S A GT Y++PE +
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF-AKTFVGTPYYMSPE-QMN 189
Query: 556 GRA-TEKTDVFSYGAVVLEVASGRRP 580
+ EK+D++S G ++ E+ + P
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 4e-36
Identities = 67/217 (30%), Positives = 94/217 (43%), Gaps = 29/217 (13%)
Query: 386 RIIGHGAFGTVYKGILPQNGD-----IIAVKRCSHNSQGKD--EFLSELSIIGTLRHRNL 438
R +GHGAFG VY+G + + +AVK +D +FL E II H+N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 439 VRLQGWCHEKGEILLVYDLMPNGSLDKALFEAR------SPLPWPHRSKILLGVASALAY 492
VR G + ++ +LM G L L E R S L + +A Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 493 LHQECENQVIHRDVKTSNIMLD---EGFNARLGDFGLARQVEHDKSPDATVAAGTMGYL- 548
L EN IHRD+ N +L G A++GDFG+AR + G L
Sbjct: 197 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA---GYY-RKGGCAMLP 249
Query: 549 ----APEYLLTGRATEKTDVFSYGAVVLEVAS-GRRP 580
PE + G T KTD +S+G ++ E+ S G P
Sbjct: 250 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-36
Identities = 60/222 (27%), Positives = 105/222 (47%), Gaps = 35/222 (15%)
Query: 386 RIIGHGAFGTVYKG----ILPQNGDI-IAVKRC-SHNSQGKDEFLSELSIIGTLRHRNLV 439
+G GAFG V+ +LP+ + +AVK + + +F E ++ L+H+++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 440 RLQGWCHEKGEILLVYDLMPNGSLDKALFEAR--------------SPLPWPHRSKILLG 485
R G C E +L+V++ M +G L++ L PL +
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 486 VASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTM 545
VA+ + YL +HRD+ T N ++ +G ++GDFG++R + D G
Sbjct: 167 VAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST---DYY-RVGGR 219
Query: 546 GYL-----APEYLLTGRATEKTDVFSYGAVVL-EVAS-GRRP 580
L PE +L + T ++DV+S+G VVL E+ + G++P
Sbjct: 220 TMLPIRWMPPESILYRKFTTESDVWSFG-VVLWEIFTYGKQP 260
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 8e-36
Identities = 55/223 (24%), Positives = 98/223 (43%), Gaps = 36/223 (16%)
Query: 386 RIIGHGAFGTVYKG----ILPQNGDII-AVKRC-SHNSQGKDEFLSELSIIGTLRHRNLV 439
R +G GAFG V+ + P ++ AVK + +F E ++ L+H ++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 440 RLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRS---------------KILL 484
+ G C + +++V++ M +G L+K L I
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 485 GVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGT 544
+AS + YL +HRD+ T N ++ ++GDFG++R V D G
Sbjct: 141 QIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYST---DYY-RVGG 193
Query: 545 MGYL-----APEYLLTGRATEKTDVFSYGAVVL-EVAS-GRRP 580
L PE ++ + T ++DV+S+G V+L E+ + G++P
Sbjct: 194 HTMLPIRWMPPESIMYRKFTTESDVWSFG-VILWEIFTYGKQP 235
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 59/236 (25%), Positives = 98/236 (41%), Gaps = 18/236 (7%)
Query: 354 KKSESFTSDIIRMPKEFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRC 413
++ DI + + + + + + IG G+F TVYKG+ + +A
Sbjct: 2 EERNQQQDDIEELETKAV--GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCEL 59
Query: 414 SHNSQGKDE---FLSELSIIGTLRHRNLVRLQG----WCHEKGEILLVYDLMPNGSLDKA 466
K E F E ++ L+H N+VR K I+LV +LM +G+L K
Sbjct: 60 QDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTL-KT 118
Query: 467 LFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLD--EGFNARLGDF 524
+ + + L +LH +IHRD+K NI + G + ++GD
Sbjct: 119 YLKRFKVMKIKVLRSWCRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTG-SVKIGDL 176
Query: 525 GLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRP 580
GLA + GT ++APE E DV+++G +LE+A+ P
Sbjct: 177 GLATLKRASFAKA---VIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYP 228
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 45/213 (21%), Positives = 95/213 (44%), Gaps = 27/213 (12%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRL---- 441
+IG G FG V+K +G +KR +N++ + E+ + L H N+V
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE---KAEREVKALAKLDHVNIVHYNGCW 73
Query: 442 ------------QGWCHEKGEILLVYDLMPNGSLDKALFEARS-PLPWPHRSKILLGVAS 488
+ + + + G+L++ + + R L ++ +
Sbjct: 74 DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITK 133
Query: 489 ALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYL 548
+ Y+H ++I+RD+K SNI L + ++GDFGL +++D T + GT+ Y+
Sbjct: 134 GVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG--KRTRSKGTLRYM 188
Query: 549 APEYLLTGRA-TEKTDVFSYGAVVLEVASGRRP 580
+PE ++ + ++ D+++ G ++ E+
Sbjct: 189 SPE-QISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 2e-35
Identities = 57/239 (23%), Positives = 97/239 (40%), Gaps = 13/239 (5%)
Query: 347 SKRYKHVKKSESFTSDIIRMPKEFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGD 406
+K + ++E ++ + E R +G G+FG V++ Q G
Sbjct: 25 AKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGF 84
Query: 407 IIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKA 466
AVK+ + EL L +V L G E + + +L+ GSL
Sbjct: 85 QCAVKKVRLEVFRVE----ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL-GQ 139
Query: 467 LFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLD-EGFNARLGDFG 525
L + LP L L YLH +++H DVK N++L +G A L DFG
Sbjct: 140 LIKQMGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFG 196
Query: 526 LARQVEHDKSPDATVAAGTM-G---YLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRP 580
A ++ D + + + G ++APE ++ K D++S ++L + +G P
Sbjct: 197 HALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 48/216 (22%), Positives = 86/216 (39%), Gaps = 32/216 (14%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVK--RCSHNSQGKDEFLSELSIIGTLRHRNLVRL-- 441
+ +G G FG V++ + A+K R + +++ + E+ + L H +VR
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70
Query: 442 -------QGWCHEKGEILLVYDLM---PNGSLDKALFEARSPLPWPHRS--KILLGVASA 489
+ +Y M +L + + I L +A A
Sbjct: 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEA 130
Query: 490 LAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS-----------PDA 538
+ +LH ++HRD+K SNI ++GDFGL ++ D+
Sbjct: 131 VEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187
Query: 539 TVAAGTMGYLAPEYLLTGRA-TEKTDVFSYGAVVLE 573
T GT Y++PE + G + + K D+FS G ++ E
Sbjct: 188 TGQVGTKLYMSPE-QIHGNSYSHKVDIFSLGLILFE 222
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-35
Identities = 77/299 (25%), Positives = 126/299 (42%), Gaps = 58/299 (19%)
Query: 386 RIIGHGAFGTVYKG----ILPQNGDI-IAVK--RCSHNSQGKDEFLSELSIIGTL-RHRN 437
+ +G GAFG V + + ++ + +AVK + + ++ K+ +SEL I+ L +H N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 438 LVRLQGWCHEKGEILLVYDLMPNGSL-------------DKALFEARSPLPWPHRSKILL 484
+V L G C G +L++ + G L D A A S
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 485 GVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGT 544
VA +A+L IHRDV N++L G A++GDFGLAR + +D +
Sbjct: 172 QVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND---SNYI-VKG 224
Query: 545 MGYL-----APEYLLTGRATEKTDVFSYGAVVL-EVAS-GRRPIEKEITGVGKVGVASNL 597
L APE + T ++DV+SYG ++L E+ S G P G+ N
Sbjct: 225 NARLPVKWMAPESIFDCVYTVQSDVWSYG-ILLWEIFSLGLNPYP---------GILVN- 273
Query: 598 VEWVWSLHREGRLLTAADARLEG-QFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655
+ L ++G ++ F + ++ AC +P RPT + + L
Sbjct: 274 -SKFYKLVKDGY-------QMAQPAFAPKNIYSIM---QACWALEPTHRPTFQQICSFL 321
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 57/207 (27%), Positives = 103/207 (49%), Gaps = 22/207 (10%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCS-HNSQGKDEFLSELSIIGTLRHRNLVRLQGW 444
++G G +G VY G N IA+K +S+ E+++ L+H+N+V+ G
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG- 86
Query: 445 CHEKGEILLVY-DLMPNGSLDKALFEARSPLPWPHR------SKILLGVASALAYLHQEC 497
+ + ++ + +P GSL L PL + +IL G L YLH
Sbjct: 87 SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEG----LKYLH--- 139
Query: 498 ENQVIHRDVKTSNIMLD--EGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLT 555
+NQ++HRD+K N++++ G ++ DFG ++++ T GT+ Y+APE +
Sbjct: 140 DNQIVHRDIKGDNVLINTYSG-VLKISDFGTSKRLAGINPCTETF-TGTLQYMAPEIIDK 197
Query: 556 GR--ATEKTDVFSYGAVVLEVASGRRP 580
G + D++S G ++E+A+G+ P
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-34
Identities = 70/298 (23%), Positives = 106/298 (35%), Gaps = 63/298 (21%)
Query: 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKR---CSHNSQGKDEFLSELSIIGTL-R 434
T F+ IG G FG+V+K + +G I A+KR S + L E+ L +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 435 HRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEAR---SPLPWPHRSKILLGVASALA 491
H ++VR E +L+ + GSL A+ E S +LL V L
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 492 YLHQECENQVIHRDVKTSNIMLDE-------------------GFNARLGDFGLARQVEH 532
Y+H ++H D+K SNI + ++GD G ++
Sbjct: 130 YIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 533 DKSPDATVAAGTMGYLAPEYLLTGRA-TEKTDVFSYGAVVLEVASGRRPIEKEITGVGKV 591
+ G +LA E L K D+F+ V+ A
Sbjct: 187 PQV-----EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL----------- 230
Query: 592 GVASNLVEWVWSLH--REGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPT 647
N +W H R+GRL R+ + E +L HPDP RP+
Sbjct: 231 --PRNGDQW----HEIRQGRL-----PRIPQVLSQ-EFTELL---KVMIHPDPERRPS 273
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-34
Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 8/224 (3%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVK--RCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWC 445
+G G G V+K +G ++A K +++ + EL ++ +V G
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 446 HEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRD 505
+ GEI + + M GSLD+ + + +P K+ + V L YL ++ ++++HRD
Sbjct: 101 YSDGEISICMEHMDGGSLDQ-VLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRD 157
Query: 506 VKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVF 565
VK SNI+++ +L DFG++ Q+ A GT Y++PE L + ++D++
Sbjct: 158 VKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIW 214
Query: 566 SYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGR 609
S G ++E+A GR PI ++ + R
Sbjct: 215 SMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 258
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-34
Identities = 60/232 (25%), Positives = 103/232 (44%), Gaps = 45/232 (19%)
Query: 386 RIIGHGAFGTVYKG----ILPQNGDII-AVKRC--SHNSQGKDEFLSELSIIGTLRHRNL 438
+ +G G FG V K + + G AVK + + + LSE +++ + H ++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 439 VRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLG------------- 485
++L G C + G +LL+ + GSL L E+R P S
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 486 ----------VASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535
++ + YL E +++HRD+ NI++ EG ++ DFGL+R V +
Sbjct: 149 MGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE-- 203
Query: 536 PDATVAAGTMGYL-----APEYLLTGRATEKTDVFSYGAVVL-EVAS-GRRP 580
D+ V + G + A E L T ++DV+S+G V+L E+ + G P
Sbjct: 204 -DSYV-KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFG-VLLWEIVTLGGNP 252
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 77/302 (25%), Positives = 124/302 (41%), Gaps = 60/302 (19%)
Query: 386 RIIGHGAFGTVYKG----ILPQNGDII-AVK--RCSHNSQGKDEFLSELSIIGTL-RHRN 437
+ +G GAFG V + ++ + + AVK + S + ++ +SEL ++ L H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 438 LVRLQGWCHEKGEILLVYDLMPNGSL-------------DKALFEARSPLPWPHRSKILL 484
+V L G C G L++ + G L K + LL
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 485 G----VASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATV 540
VA +A+L IHRD+ NI+L G ++ DFGLAR +++D V
Sbjct: 149 SFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKND---SNYV 202
Query: 541 AAGTMGYL-----APEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVA 594
L APE + T ++DV+SYG + E+ S G P G+
Sbjct: 203 -VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP---------GMP 252
Query: 595 SNLVEWVWSLHREGRLLTAADARLEG-QFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653
+ + + +EG R+ + AEM ++ C DPL RPT + +VQ
Sbjct: 253 VD--SKFYKMIKEGF-------RMLSPEHAPAEMYDIM---KTCWDADPLKRPTFKQIVQ 300
Query: 654 ML 655
++
Sbjct: 301 LI 302
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 60/232 (25%), Positives = 99/232 (42%), Gaps = 45/232 (19%)
Query: 386 RIIGHGAFGTVYKG----ILPQNGDII-AVKRC--SHNSQGKDEFLSELSIIGTLRHRNL 438
R IG GAFG V++ +LP + AVK ++ + +F E +++ + N+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 439 VRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRS------------------ 480
V+L G C + L+++ M G L++ L
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 481 -----KILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535
I VA+ +AYL E + +HRD+ T N ++ E ++ DFGL+R +
Sbjct: 173 CAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA-- 227
Query: 536 PDATVAAGTMGYL-----APEYLLTGRATEKTDVFSYGAVVL-EVAS-GRRP 580
D A + PE + R T ++DV++YG VVL E+ S G +P
Sbjct: 228 -DYYK-ADGNDAIPIRWMPPESIFYNRYTTESDVWAYG-VVLWEIFSYGLQP 276
|
| >1qmo_E Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 Length = 133 | Back alignment and structure |
|---|
Score = 124 bits (311), Expect = 2e-33
Identities = 38/129 (29%), Positives = 70/129 (54%), Gaps = 7/129 (5%)
Query: 144 FVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLT 203
VAVEFDT ++ ++ D N H+G+D+NS+ S T D ++G + + I Y+ ++
Sbjct: 3 VVAVEFDTYLNPDYGDPNYIHIGIDVNSIRSK-----VTAKWDWQNGKIATAHISYNSVS 57
Query: 204 RAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGSTEIHSIEWWSFSSSFE 263
+ +++ Y+ KP LS+ ++L + +++ VG S ST E +++ WSF+SS
Sbjct: 58 KRLSVTSYYAGSKP--ATLSYDIELHTVLPEWVRVGLSASTGQDKERNTVHSWSFTSSLW 115
Query: 264 SNSGTGSGS 272
+N
Sbjct: 116 TNVAKKENE 124
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 72/308 (23%), Positives = 114/308 (37%), Gaps = 67/308 (21%)
Query: 386 RIIGHGAFGTVYKG----ILPQNGDII-AVKRC--SHNSQGKDEFLSELSIIGTL-RHRN 437
+++G GAFG V I I AVK +S ++ +SEL ++ L H N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 438 LVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLG------------ 485
+V L G C G I L+++ G L L R
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 486 ----------VASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535
VA + +L +HRD+ N+++ G ++ DFGLAR + D
Sbjct: 171 FEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD-- 225
Query: 536 PDATVAAGTMGYL-----APEYLLTGRATEKTDVFSYGAVVL-EVAS-GRRPIEKEITGV 588
V L APE L G T K+DV+SYG ++L E+ S G P
Sbjct: 226 -SNYV-VRGNARLPVKWMAPESLFEGIYTIKSDVWSYG-ILLWEIFSLGVNPYP------ 276
Query: 589 GKVGVASNLVEWVWSLHREGRLLTAADARLEG-QFDEAEMRRVLLVGLACSHPDPLARPT 647
G+ + + L + G +++ + E+ ++ +C D RP+
Sbjct: 277 ---GIPVD--ANFYKLIQNGF-------KMDQPFYATEEIYIIM---QSCWAFDSRKRPS 321
Query: 648 MRGVVQML 655
+ L
Sbjct: 322 FPNLTSFL 329
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 54/227 (23%), Positives = 97/227 (42%), Gaps = 40/227 (17%)
Query: 386 RIIGHGAFGTVYKGIL-------PQNGDIIAVK--RCSHNSQGKDEFLSELSIIGTL-RH 435
+ +G GAFG V P+ +AVK + + + +SE+ ++ + +H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 436 RNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLG---------- 485
+N++ L G C + G + ++ + G+L + L R P +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 486 -----VASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATV 540
+A + YL + IHRD+ N+++ E ++ DFGLAR + +
Sbjct: 161 SCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID----YY 213
Query: 541 AAGTMGYL-----APEYLLTGRATEKTDVFSYGAVVL-EVAS-GRRP 580
T G L APE L T ++DV+S+G V++ E+ + G P
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG-VLMWEIFTLGGSP 259
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 4e-33
Identities = 73/301 (24%), Positives = 115/301 (38%), Gaps = 59/301 (19%)
Query: 386 RIIGHGAFGTVYKGILPQNGD-----IIAVKRC--SHNSQGKDEFLSELSIIGTL-RHRN 437
+ +G GAFG V + +AVK +SEL I+ + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 438 LVRLQGWCHEKGE-ILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLG----------- 485
+V L G C + G ++++ + G+L L R+ + L
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 486 ----VASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVA 541
VA + +L + IHRD+ NI+L E ++ DFGLAR + D
Sbjct: 153 YSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP----DYV 205
Query: 542 AGTMGYL-----APEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVAS 595
L APE + T ++DV+S+G ++ E+ S G P GV
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP---------GVKI 256
Query: 596 NLVEWVWSLHREGRLLTAADARLEG-QFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654
+ E +EG R+ + EM + + L C H +P RPT +V+
Sbjct: 257 D--EEFCRRLKEGT-------RMRAPDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEH 304
Query: 655 L 655
L
Sbjct: 305 L 305
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 8e-33
Identities = 54/227 (23%), Positives = 96/227 (42%), Gaps = 40/227 (17%)
Query: 386 RIIGHGAFGTVYKGIL-------PQNGDIIAVKRC--SHNSQGKDEFLSELSIIGTL-RH 435
+ +G G FG V P+ +AVK + + +SE+ ++ + +H
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 436 RNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLG---------- 485
+N++ L G C + G + ++ + G+L + L R P +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 486 -----VASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATV 540
+A + YL + IHRD+ N+++ E ++ DFGLAR + + D
Sbjct: 207 SCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI---DYYK 260
Query: 541 AAGTMGYL-----APEYLLTGRATEKTDVFSYGAVVL-EVAS-GRRP 580
T G L APE L T ++DV+S+G V++ E+ + G P
Sbjct: 261 -KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG-VLMWEIFTLGGSP 305
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 8e-33
Identities = 57/228 (25%), Positives = 97/228 (42%), Gaps = 40/228 (17%)
Query: 385 NRIIGHGAFGTVYKGIL-------PQNGDIIAVK--RCSHNSQGKDEFLSELSIIGTL-R 434
+ +G GAFG V P +AVK + + + +SE+ ++ + +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 435 HRNLVRLQGWCHEKGEILLVYDLMPNGSL-----------DKALFEARSPLPWPHRSKIL 483
H+N++ L G C + G + ++ + G+L + + SK L
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 484 LG----VASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDAT 539
+ VA + YL + IHRD+ N+++ E ++ DFGLAR + H
Sbjct: 194 VSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID----Y 246
Query: 540 VAAGTMGYL-----APEYLLTGRATEKTDVFSYGAVVL-EVAS-GRRP 580
T G L APE L T ++DV+S+G V+L E+ + G P
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG-VLLWEIFTLGGSP 293
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-32
Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 15/209 (7%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVK--RCSHNSQGKDEFLSELSII-GTLRHRNLVRLQGW 444
+G GA+G V K +G I+AVK R + NSQ + L +L I T+ V G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 445 CHEKGEILLVYDLMPNGSLD---KALFEARSPLPWPHRSKILLGVASALAYLHQECENQV 501
+G++ + +LM + SLD K + + +P KI + + AL +LH + V
Sbjct: 75 LFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSV 131
Query: 502 IHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRA--- 558
IHRDVK SN++++ ++ DFG++ + + AG Y+APE +
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISGYLVD--DVAKDIDAGCKPYMAPERINPELNQKG 189
Query: 559 -TEKTDVFSYGAVVLEVASGRRPIEKEIT 586
+ K+D++S G ++E+A R P + T
Sbjct: 190 YSVKSDIWSLGITMIELAILRFPYDSWGT 218
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 58/216 (26%), Positives = 92/216 (42%), Gaps = 32/216 (14%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQG-W 444
++G GAFG V K + A+K+ H + LSE+ ++ +L H+ +VR W
Sbjct: 12 AVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 445 CHE------------KGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAY 492
K + + + NG+L + ++ + AL+Y
Sbjct: 72 LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSY 131
Query: 493 LHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP-------------DAT 539
+H +IHRD+K NI +DE N ++GDFGLA+ V + T
Sbjct: 132 IHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLT 188
Query: 540 VAAGTMGYLAPEYLLTGRAT--EKTDVFSYGAVVLE 573
A GT Y+A E +L G EK D++S G + E
Sbjct: 189 SAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFE 223
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 64/204 (31%), Positives = 105/204 (51%), Gaps = 16/204 (7%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVK--RCSHNSQGKDEFLSELSII-GTLRHRNLVRLQGW 444
IG GA+G+V K + +G I+AVK R + + + + + L +L ++ + +V+ G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 445 CHEKGEILLVYDLMPNGSLDKALFEARS----PLPWPHRSKILLGVASALAYLHQECENQ 500
+G+ + +LM + S DK S +P KI L AL +L + +
Sbjct: 90 LFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LK 146
Query: 501 VIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRA-- 558
+IHRD+K SNI+LD N +L DFG++ Q+ S T AG Y+APE + +
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGISGQLVD--SIAKTRDAGCRPYMAPERIDPSASRQ 204
Query: 559 --TEKTDVFSYGAVVLEVASGRRP 580
++DV+S G + E+A+GR P
Sbjct: 205 GYDVRSDVWSLGITLYELATGRFP 228
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-32
Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 23/217 (10%)
Query: 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDE--FLSELSIIGTLRHRNLV 439
+ + I+G GA V++G + GD+ A+K ++ S + + E ++ L H+N+V
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 440 RLQG--WCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHR--SKILLGVASALAYLHQ 495
+L +L+ + P GSL L E + P +L V + +L
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR- 129
Query: 496 ECENQVIHRDVKTSNIML----DEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPE 551
EN ++HR++K NIM D +L DFG AR++E D+ GT YL P+
Sbjct: 130 --ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ--FVSLYGTEEYLHPD 185
Query: 552 YLLTGRA--------TEKTDVFSYGAVVLEVASGRRP 580
D++S G A+G P
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-32
Identities = 59/201 (29%), Positives = 100/201 (49%), Gaps = 13/201 (6%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVK--RCSHNSQGKDEFLSELSII-GTLRHRNLVRLQGW 444
+G G G V+K + G +IAVK R S N + L +L ++ + +V+ G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 445 CHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHR 504
++ + +LM +K + P+P K+ + + AL YL ++ + VIHR
Sbjct: 93 FITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK--HGVIHR 149
Query: 505 DVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATE---- 560
DVK SNI+LDE +L DFG++ ++ +AG Y+APE + T+
Sbjct: 150 DVKPSNILLDERGQIKLCDFGISGRL--VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYD 207
Query: 561 -KTDVFSYGAVVLEVASGRRP 580
+ DV+S G ++E+A+G+ P
Sbjct: 208 IRADVWSLGISLVELATGQFP 228
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 55/215 (25%), Positives = 85/215 (39%), Gaps = 24/215 (11%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKR-CSHNSQGKDEFLSELSIIGTLRHRNLVRLQGW 444
+ +G G F V +G A+KR H Q ++E E + H N++RL +
Sbjct: 35 QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94
Query: 445 CHE----KGEILLVYDLMPNGSLD---KALFEARSPLPWPHRSKILLGVASALAYLHQEC 497
C K E L+ G+L + L + + L +LLG+ L +H
Sbjct: 95 CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA-- 152
Query: 498 ENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAA--------GTMGYLA 549
HRD+K +NI+L + L D G Q T+ Y A
Sbjct: 153 -KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 550 PEYLLTGRA----TEKTDVFSYGAVVLEVASGRRP 580
PE L + ++ E+TDV+S G V+ + G P
Sbjct: 212 PE-LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 57/224 (25%), Positives = 106/224 (47%), Gaps = 13/224 (5%)
Query: 366 MPKEFSYRELRSA---TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGK-D 421
M K Y +R + + +G GAFG VYK + G + A K S+ + +
Sbjct: 2 MRKSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE 61
Query: 422 EFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSK 481
+++ E+ I+ T H +V+L G + G++ ++ + P G++D + E L P
Sbjct: 62 DYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV 121
Query: 482 ILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVA 541
+ + AL +LH ++IHRD+K N+++ + RL DFG++ + +
Sbjct: 122 VCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF- 177
Query: 542 AGTMGYLAPEYLLTGRATE-----KTDVFSYGAVVLEVASGRRP 580
GT ++APE ++ + K D++S G ++E+A P
Sbjct: 178 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-31
Identities = 64/210 (30%), Positives = 95/210 (45%), Gaps = 18/210 (8%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDE--FLSELSIIGTLRHRNLVRL-- 441
+G G FG V + I G+ +A+K+C K+ + E+ I+ L H N+V
Sbjct: 20 ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 79
Query: 442 ----QGWCHEKGEILLVYDLMPNGSLDKAL--FEARSPLPWPHRSKILLGVASALAYLHQ 495
LL + G L K L FE L +L ++SAL YLH
Sbjct: 80 VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH- 138
Query: 496 ECENQVIHRDVKTSNIMLDEGFNAR---LGDFGLARQVEHDKSPDATVAAGTMGYLAPEY 552
EN++IHRD+K NI+L G + D G A++++ + T GT+ YLAPE
Sbjct: 139 --ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL--CTEFVGTLQYLAPEL 194
Query: 553 LLTGRATEKTDVFSYGAVVLEVASGRRPIE 582
L + T D +S+G + E +G RP
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGFRPFL 224
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 9e-31
Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 11/202 (5%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGK----DEFLSELSIIGTLRHRNLVRL 441
R +G G F ++ ++ A K + K ++ E+SI +L H+++V
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 442 QGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQV 501
G+ + + +V +L SL + + R L P L + YLH+ N+V
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELH-KRRKALTEPEARYYLRQIVLGCQYLHR---NRV 162
Query: 502 IHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRA-TE 560
IHRD+K N+ L+E ++GDFGLA +VE+D + GT Y+APE +L+ + +
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-CGTPNYIAPE-VLSKKGHSF 220
Query: 561 KTDVFSYGAVVLEVASGRRPIE 582
+ DV+S G ++ + G+ P E
Sbjct: 221 EVDVWSIGCIMYTLLVGKPPFE 242
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 11/202 (5%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVK----RCSHNSQGKDEFLSELSIIGTLRHRNLVRL 441
R +G G F ++ ++ A K +++ E+SI +L H+++V
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 442 QGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQV 501
G+ + + +V +L SL + + R L P L + YLH+ N+V
Sbjct: 81 HGFFEDNDFVFVVLELCRRRSLLELH-KRRKALTEPEARYYLRQIVLGCQYLHR---NRV 136
Query: 502 IHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRA-TE 560
IHRD+K N+ L+E ++GDFGLA +VE+D + GT Y+APE +L+ + +
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-CGTPNYIAPE-VLSKKGHSF 194
Query: 561 KTDVFSYGAVVLEVASGRRPIE 582
+ DV+S G ++ + G+ P E
Sbjct: 195 EVDVWSIGCIMYTLLVGKPPFE 216
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-30
Identities = 56/217 (25%), Positives = 90/217 (41%), Gaps = 31/217 (14%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDE--FLSELSIIGTLRHRNLVRLQG 443
I+G GA V++G + GD+ A+K ++ S + + E ++ L H+N+V+L
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL-- 72
Query: 444 WCHE------KGEILLVYDLMPNGSLDKALFEARSPLPWPHR--SKILLGVASALAYLHQ 495
+L+ + P GSL L E + P +L V + +L
Sbjct: 73 --FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR- 129
Query: 496 ECENQVIHRDVKTSNIML----DEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPE 551
EN ++HR++K NIM D +L DFG AR++E D+ GT YL P+
Sbjct: 130 --ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ--FVSLYGTEEYLHPD 185
Query: 552 YLLTGRA--------TEKTDVFSYGAVVLEVASGRRP 580
D++S G A+G P
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 47/192 (24%), Positives = 92/192 (47%), Gaps = 11/192 (5%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVK----RCSHNSQGKDEFLSELSIIGTLRHRNLVRL 441
++G G+F VY+ G +A+K + + + +E+ I L+H +++ L
Sbjct: 17 NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76
Query: 442 QGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQV 501
+ + + LV ++ NG +++ L P + + + + YLH + +
Sbjct: 77 YNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS---HGI 133
Query: 502 IHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRA-TE 560
+HRD+ SN++L N ++ DFGLA Q++ T+ GT Y++PE + T A
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL-CGTPNYISPE-IATRSAHGL 191
Query: 561 KTDVFSYGAVVL 572
++DV+S G +
Sbjct: 192 ESDVWSLG-CMF 202
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 9e-30
Identities = 51/213 (23%), Positives = 86/213 (40%), Gaps = 24/213 (11%)
Query: 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKR----CSHNSQGKDEFLSELSIIGTLRHRN 437
F ++GHGA GT+ + + +AVKR C + + + L E H N
Sbjct: 26 FCPKDVLGHGAEGTIVYRGM-FDNRDVAVKRILPECFSFADREVQLLRESD-----EHPN 79
Query: 438 LVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQEC 497
++R ++ + +L +L + + + +L S LA+LH
Sbjct: 80 VIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH--- 135
Query: 498 ENQVIHRDVKTSNIMLDE-----GFNARLGDFGLARQVEHDKSPDATV--AAGTMGYLAP 550
++HRD+K NI++ A + DFGL +++ + + GT G++AP
Sbjct: 136 SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 551 EYL---LTGRATEKTDVFSYGAVVLEVASGRRP 580
E L T D+FS G V V S
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 59/229 (25%), Positives = 102/229 (44%), Gaps = 17/229 (7%)
Query: 365 RMPKEFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFL 424
R E LR F ++G+G +G VYKG + G + A+K ++E
Sbjct: 9 RSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIK 68
Query: 425 SELSIIGTL-RHRNLVRLQG------WCHEKGEILLVYDLMPNGSL-DKALFEARSPLPW 476
E++++ HRN+ G ++ LV + GS+ D + L
Sbjct: 69 QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE 128
Query: 477 PHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP 536
+ I + L++LH +++VIHRD+K N++L E +L DFG++ Q++
Sbjct: 129 EWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR 185
Query: 537 DATVAAGTMGYLAPEYLLTGRATE-----KTDVFSYGAVVLEVASGRRP 580
T GT ++APE + + K+D++S G +E+A G P
Sbjct: 186 RNTF-IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 55/195 (28%), Positives = 99/195 (50%), Gaps = 9/195 (4%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQG-KDEFLSELSIIGTLRHRNLVRLQGWCH 446
IG GA GTVY + G +A+++ + Q K+ ++E+ ++ ++ N+V +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD-SY 86
Query: 447 EKGEIL-LVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRD 505
G+ L +V + + GSL + + + + + AL +LH NQVIHRD
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHS---NQVIHRD 141
Query: 506 VKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVF 565
+K+ NI+L + +L DFG Q+ ++S +T+ GT ++APE + K D++
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 566 SYGAVVLEVASGRRP 580
S G + +E+ G P
Sbjct: 201 SLGIMAIEMIEGEPP 215
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 2e-29
Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 13/204 (6%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCS----HNSQGKDEFLSELSIIGTLRHRNLVRL 441
R +G G FG VY Q+ I+A+K + + + E+ I LRH N++RL
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 442 QGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQV 501
G+ H+ + L+ + P G++ + L + S + + +A+AL+Y H +V
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHS---KRV 130
Query: 502 IHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRA-TE 560
IHRD+K N++L ++ DFG + + T GT+ YL PE ++ GR E
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGTLDYLPPE-MIEGRMHDE 186
Query: 561 KTDVFSYGAVVLEVASGRRPIEKE 584
K D++S G + E G+ P E
Sbjct: 187 KVDLWSLGVLCYEFLVGKPPFEAN 210
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 61/223 (27%), Positives = 105/223 (47%), Gaps = 11/223 (4%)
Query: 364 IRMPKEFSYRELRSA------TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS 417
+R P ++L + F+ +G G++G+VYK I + G I+A+K+ S
Sbjct: 7 LRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES 66
Query: 418 QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWP 477
E + E+SI+ ++V+ G + ++ +V + GS+ + L
Sbjct: 67 D-LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTED 125
Query: 478 HRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD 537
+ IL L YLH + IHRD+K NI+L+ +A+L DFG+A Q+ +
Sbjct: 126 EIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR 182
Query: 538 ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRP 580
TV GT ++APE + D++S G +E+A G+ P
Sbjct: 183 NTV-IGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 5e-29
Identities = 45/203 (22%), Positives = 83/203 (40%), Gaps = 21/203 (10%)
Query: 386 RIIGHGAFGTVYKGI-LPQNGDIIAVK--RCSHNSQGKDEFLSELSIIGTLRHRNLVRL- 441
I HG G +Y + NG + +K S +++ + ++E + + H ++V++
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 442 ----QGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQEC 497
H +V + + SL ++ LP LL + AL+YLH
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSK---GQKLPVAEAIAYLLEILPALSYLH--- 199
Query: 498 ENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGR 557
+++ D+K NIML E +L D G ++ GT G+ APE ++
Sbjct: 200 SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN-----SFGYLYGTPGFQAPE-IVRTG 252
Query: 558 ATEKTDVFSYGAVVLEVASGRRP 580
T TD+++ G + +
Sbjct: 253 PTVATDIYTVGRTLAALTLDLPT 275
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-29
Identities = 54/194 (27%), Positives = 92/194 (47%), Gaps = 7/194 (3%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFL-SELSIIGTLRHRNLVRLQGWCH 446
IG G+ G V +G +AVK Q + E L +E+ I+ +H N+V +
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 447 EKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDV 506
E+ ++ + + G+L + ++ L + + V ALAYLH VIHRD+
Sbjct: 113 VGEELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLHA---QGVIHRDI 167
Query: 507 KTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFS 566
K+ +I+L +L DFG Q+ D ++ GT ++APE + + D++S
Sbjct: 168 KSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL-VGTPYWMAPEVISRSLYATEVDIWS 226
Query: 567 YGAVVLEVASGRRP 580
G +V+E+ G P
Sbjct: 227 LGIMVIEMVDGEPP 240
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 56/203 (27%), Positives = 86/203 (42%), Gaps = 16/203 (7%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVK----RCSHNSQGKDEFLSELSIIGTLRHRNLVRL 441
R++G G G VY+ I+A+K S + + E G L+ ++V +
Sbjct: 40 RLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 442 QGWCHEKGEI----LLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQEC 497
H+ GEI + L+ L A+ + PL P I+ + SAL H
Sbjct: 100 ----HDFGEIDGQLYVDMRLINGVDL-AAMLRRQGPLAPPRAVAIVRQIGSALDAAHA-- 152
Query: 498 ENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGR 557
HRDVK NI++ A L DFG+A +K GT+ Y+APE
Sbjct: 153 -AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESH 211
Query: 558 ATEKTDVFSYGAVVLEVASGRRP 580
AT + D+++ V+ E +G P
Sbjct: 212 ATYRADIYALTCVLYECLTGSPP 234
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 55/196 (28%), Positives = 92/196 (46%), Gaps = 10/196 (5%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCS--HNSQGKDEFLSELSIIGTLRHRNLVRLQGWC 445
IG G+FG V+KGI + ++A+K ++ E++++ + + G
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG-S 88
Query: 446 HEKGEIL-LVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHR 504
+ K L ++ + + GS L E PL + IL + L YLH + IHR
Sbjct: 89 YLKDTKLWIIMEYLGGGSAL-DLLEPG-PLDETQIATILREILKGLDYLH---SEKKIHR 143
Query: 505 DVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDV 564
D+K +N++L E +L DFG+A Q+ + T GT ++APE + K D+
Sbjct: 144 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF-VGTPFWMAPEVIKQSAYDSKADI 202
Query: 565 FSYGAVVLEVASGRRP 580
+S G +E+A G P
Sbjct: 203 WSLGITAIELARGEPP 218
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 8e-28
Identities = 60/248 (24%), Positives = 114/248 (45%), Gaps = 23/248 (9%)
Query: 351 KHVKKSESFTSDIIRMPKEFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAV 410
+++ F D+ P F + ++ + + +G GA+G V A+
Sbjct: 8 SSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAI 67
Query: 411 K---RCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKAL 467
K + S ++ + L E++++ L H N+++L + +K LV + G L
Sbjct: 68 KIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGE----L 123
Query: 468 FE---ARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIML---DEGFNARL 521
F+ R + I+ V S + YLH+ + ++HRD+K N++L ++ ++
Sbjct: 124 FDEIIHRMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKI 180
Query: 522 GDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPI 581
DFGL+ E+ K + GT Y+APE +L + EK DV+S G ++ + +G P
Sbjct: 181 VDFGLSAVFENQKKMKERL--GTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPPF 237
Query: 582 ----EKEI 585
++EI
Sbjct: 238 GGQTDQEI 245
|
| >1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... Length = 237 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 34/119 (28%), Positives = 62/119 (52%), Gaps = 7/119 (5%)
Query: 144 FVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLT 203
VAVE DT + + D + H+G+D+ S+ S + ++++G + + I Y+ +
Sbjct: 4 IVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAKW-----NMQNGKVGTAHIIYNSVD 58
Query: 204 RAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGSTEIHSIEWWSFSSSF 262
+ + VSY N +S+ +DLD + +++ VG S ST E ++I WSF+S
Sbjct: 59 KRLSAVVSYPN--ADSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSKL 115
|
| >1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... Length = 237 | Back alignment and structure |
|---|
Score = 64.9 bits (157), Expect = 8e-12
Identities = 26/108 (24%), Positives = 42/108 (38%), Gaps = 7/108 (6%)
Query: 36 FDFGTLTLASLKLLGDAHMNNGSVRLTR---DVTVPYDGAGKALYSKPVRFRLPGTHTPA 92
F + +G++ LTR + + G+AL+ PV + A
Sbjct: 131 NQFSKDQKDLILQGDATTGTDGNLELTRVSSNGSPQGSSVGRALFYAPVHIW-ESSAVVA 189
Query: 93 SFSTFFSFSITNLNPSSIGAGLAFVITPDGEQV--GSAGGSLGLLDEK 138
SF F+F I + + G+AF I+ + GS G LGL +
Sbjct: 190 SFEATFTFLIKSPDSHP-ADGIAFFISNIDSSIPSGSTGRLLGLFPDA 236
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 27/232 (11%), Positives = 54/232 (23%), Gaps = 44/232 (18%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVK----RCSHNSQGKDEFLSELSIIGTLRHRNLVRL 441
+ G V+ + + A+K ++ + L +
Sbjct: 68 EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127
Query: 442 QGWCH--------------------------EKGEILLVY-----DLMPNGSLDKALFEA 470
+ LL+ DL S ++
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVF 187
Query: 471 RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV 530
R + + A L ++H N+ + LGD +V
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244
Query: 531 EHDKSPDATVAAGTMGYLAPEYLLTGRA--TEKTDVFSYGAVVLEVASGRRP 580
++ + Y E+L A T + + G + V P
Sbjct: 245 ----GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-27
Identities = 66/233 (28%), Positives = 106/233 (45%), Gaps = 20/233 (8%)
Query: 358 SFTSDIIRMPKEFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVK----RC 413
S + P F + + R++G G+FG V G AVK R
Sbjct: 4 SMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQ 63
Query: 414 SHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFE---A 470
K+ L E+ ++ L H N+++L + +KG LV ++ G LF+ +
Sbjct: 64 VKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE----LFDEIIS 119
Query: 471 RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIML---DEGFNARLGDFGLA 527
R ++I+ V S + Y+H+ N+++HRD+K N++L + N R+ DFGL+
Sbjct: 120 RKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLS 176
Query: 528 RQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRP 580
E K GT Y+APE +L G EK DV+S G ++ + SG P
Sbjct: 177 THFEASKK--MKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 43/257 (16%), Positives = 86/257 (33%), Gaps = 27/257 (10%)
Query: 347 SKRYKHVKKSESFTSDIIRMPKEFSYRELRSATKCFNANRIIGHGAFGTVYKGI-----L 401
S K V + ++P E + +K + ++G GAF VY+
Sbjct: 32 SGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLND 91
Query: 402 PQNGDIIAVKRCSHNSQGKDEFL-SELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPN 460
+N +K + + + + ++ + +LV +L
Sbjct: 92 AKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSY 151
Query: 461 GSLDKALFEARS----PLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIML--- 513
G+L A+ ++ +P + + + +H + ++IH D+K N +L
Sbjct: 152 GTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNG 208
Query: 514 --------DEGFNARLGDFGLARQVE-HDKSPDATVAAGTMGYLAPEYLLTGRA-TEKTD 563
D L D G + ++ K T T G+ E +L+ + + D
Sbjct: 209 FLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVE-MLSNKPWNYQID 267
Query: 564 VFSYGAVVLEVASGRRP 580
F A V + G
Sbjct: 268 YFGVAATVYCMLFGTYM 284
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 49/253 (19%), Positives = 103/253 (40%), Gaps = 28/253 (11%)
Query: 347 SKRYKHVKKSESFTSDIIRMPKEFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGD 406
+K + S +D + + + ++ + IG G V++ L +
Sbjct: 23 AKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQV-LNEKKQ 81
Query: 407 IIAVKRCSHNSQGKDE---FLSELSIIGTLRHRNL--VRLQGWCHEKGEILLVYDLM--P 459
I A+K + + +E++ + L+ + +RL + I +V M
Sbjct: 82 IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV---MECG 138
Query: 460 NGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNA 519
N L+ L + + + R + A+ +HQ + ++H D+K +N ++ +G
Sbjct: 139 NIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVDG-ML 193
Query: 520 RLGDFGLARQVEHD-KSPDATVAAGTMGYLAPEYLL-----------TGRATEKTDVFSY 567
+L DFG+A Q++ D S G + Y+ PE + + + K+DV+S
Sbjct: 194 KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 253
Query: 568 GAVVLEVASGRRP 580
G ++ + G+ P
Sbjct: 254 GCILYYMTYGKTP 266
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 48/212 (22%), Positives = 96/212 (45%), Gaps = 24/212 (11%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKR---CSHNSQGKDEFLSELSIIGTLRHRNL--VR 440
+ IG G V++ L + I A+K ++Q D + +E++ + L+ + +R
Sbjct: 34 KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 92
Query: 441 LQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQ 500
L + I +V + N L+ L + + + R + A+ +HQ +
Sbjct: 93 LYDYEITDQYIYMVMECG-NIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIHQ---HG 147
Query: 501 VIHRDVKTSNIMLDEGFNARLGDFGLARQVEHD-KSPDATVAAGTMGYLAPEYLL----- 554
++H D+K +N ++ +G +L DFG+A Q++ D S GT+ Y+ PE +
Sbjct: 148 IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 206
Query: 555 ------TGRATEKTDVFSYGAVVLEVASGRRP 580
+ + K+DV+S G ++ + G+ P
Sbjct: 207 RENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 13/202 (6%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVK--RCSHNSQGKDE--FLSELSIIGTLRHRNLVRL 441
R +G G FG VY QN I+A+K S + E E+ I LRH N++R+
Sbjct: 20 RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 442 QGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQV 501
+ H++ I L+ + P G L K L + + + +A AL Y H+ +V
Sbjct: 80 YNYFHDRKRIYLMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCHE---RKV 135
Query: 502 IHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRA-TE 560
IHRD+K N+++ ++ DFG + + GT+ YL PE ++ G+ E
Sbjct: 136 IHRDIKPENLLMGYKGELKIADFGWSVHAPSLR---RRTMCGTLDYLPPE-MIEGKTHDE 191
Query: 561 KTDVFSYGAVVLEVASGRRPIE 582
K D++ G + E G P +
Sbjct: 192 KVDLWCAGVLCYEFLVGMPPFD 213
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-27
Identities = 48/212 (22%), Positives = 96/212 (45%), Gaps = 24/212 (11%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVK---RCSHNSQGKDEFLSELSIIGTLRHRNL--VR 440
+ IG G V++ L + I A+K ++Q D + +E++ + L+ + +R
Sbjct: 15 KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 73
Query: 441 LQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQ 500
L + I +V + N L+ L + + + R + A+ +HQ +
Sbjct: 74 LYDYEITDQYIYMVMEC-GNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIHQ---HG 128
Query: 501 VIHRDVKTSNIMLDEGFNARLGDFGLARQVEHD-KSPDATVAAGTMGYLAPEYLL----- 554
++H D+K +N ++ +G +L DFG+A Q++ D S GT+ Y+ PE +
Sbjct: 129 IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 187
Query: 555 ------TGRATEKTDVFSYGAVVLEVASGRRP 580
+ + K+DV+S G ++ + G+ P
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 6e-27
Identities = 59/231 (25%), Positives = 97/231 (41%), Gaps = 40/231 (17%)
Query: 382 FNANRIIGHGAFGTV-YKGILPQNGDIIAVKRCSHNSQGKDEFLSELSI-IGTLRHRNLV 439
+ +I+G+G+ GTV ++G G +AVKR D L E+ + + H N++
Sbjct: 17 VVSEKILGYGSSGTVVFQGSF--QGRPVAVKRM--LIDFCDIALMEIKLLTESDDHPNVI 72
Query: 440 RLQGWCHEKGEILLVYDLMPNGSLD------KALFEARSPLPWPHRSKILLGVASALAYL 493
R + + +L N +L E + +L +AS +A+L
Sbjct: 73 RYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 494 HQECENQVIHRDVKTSNIMLD-------------EGFNARLGDFGLARQVEHDKSPDATV 540
H ++IHRD+K NI++ E + DFGL ++++ +S T
Sbjct: 132 H---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 541 ---AAGTMGYLAPEYLL-------TGRATEKTDVFSYGAVVLEVAS-GRRP 580
+GT G+ APE L R T D+FS G V + S G+ P
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 8e-27
Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 19/200 (9%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEF----LSELSIIGTLRHRNLVRLQG 443
+G G++G V K G I+A+K+ S + E+ ++ LRH NLV L
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKF-LESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 444 WCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIH 503
C +K LV++ + + ++ L + L + K L + + + + H + +IH
Sbjct: 92 VCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS---HNIIH 147
Query: 504 RDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDAT----VAAGTMGYLAPEYLLTGRA- 558
RD+K NI++ + +L DFG AR + +P VA T Y APE L+
Sbjct: 148 RDIKPENILVSQSGVVKLCDFGFARTL---AAPGEVYDDEVA--TRWYRAPELLVGDVKY 202
Query: 559 TEKTDVFSYGAVVLEVASGR 578
+ DV++ G +V E+ G
Sbjct: 203 GKAVDVWAIGCLVTEMFMGE 222
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 47/207 (22%), Positives = 75/207 (36%), Gaps = 17/207 (8%)
Query: 388 IGHGA--FGTVYKGILPQNGDIIAVKRCSHNSQGKDEF---LSELSIIGTLRHRNLVRLQ 442
IG G TV G+ + V+R + + + EL + H N+V +
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92
Query: 443 GWCHEKGEILLVYDLMPNGSL-DKALFEARSPLPWPHRSKILLGVASALAYLHQECENQV 501
E+ +V M GS D + + IL GV AL Y+H
Sbjct: 93 ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH---MGY 149
Query: 502 IHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATV------AAGTMGYLAPEYLLT 555
+HR VK S+I++ L + V + + +L+PE L
Sbjct: 150 VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ 209
Query: 556 GRA--TEKTDVFSYGAVVLEVASGRRP 580
K+D++S G E+A+G P
Sbjct: 210 NLQGYDAKSDIYSVGITACELANGHVP 236
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 46/199 (23%), Positives = 78/199 (39%), Gaps = 8/199 (4%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVK----RCSHNSQGKDEFLSELSIIGTLRHRNLVRL 441
+G G TVY +A+K + F E+ L H+N+V +
Sbjct: 17 DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 442 QGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQV 501
E LV + + +L E+ PL + + + H ++
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTL-SEYIESHGPLSVDTAINFTNQILDGIKHAHD---MRI 132
Query: 502 IHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEK 561
+HRD+K NI++D ++ DFG+A+ + GT+ Y +PE E
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDEC 192
Query: 562 TDVFSYGAVVLEVASGRRP 580
TD++S G V+ E+ G P
Sbjct: 193 TDIYSIGIVLYEMLVGEPP 211
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 56/200 (28%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEF----LSELSIIGTLRHRNLVRLQG 443
IG G++G V+K G I+A+K+ S+ L E+ ++ L+H NLV L
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 444 WCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIH 503
K + LV++ + ++ L + +P I A+ + H+ + IH
Sbjct: 70 VFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK---HNCIH 125
Query: 504 RDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDAT----VAAGTMGYLAPEYLLTGRA- 558
RDVK NI++ + +L DFG AR + P VA T Y +PE L+
Sbjct: 126 RDVKPENILITKHSVIKLCDFGFARLL---TGPSDYYDDEVA--TRWYRSPELLVGDTQY 180
Query: 559 TEKTDVFSYGAVVLEVASGR 578
DV++ G V E+ SG
Sbjct: 181 GPPVDVWAIGCVFAELLSGV 200
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 16/209 (7%)
Query: 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLS----ELSIIGTLR 434
K F+ R IGHG+FG VY +N +++A+K+ S++ + +E E+ + LR
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 435 HRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLH 494
H N ++ +G + LV + + D L + PL + + G LAYLH
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASD-LLEVHKKPLQEVEIAAVTHGALQGLAYLH 171
Query: 495 QECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLL 554
+ +IHRDVK NI+L E +LGDFG A + +P + GT ++APE +L
Sbjct: 172 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANSF-VGTPYWMAPEVIL 223
Query: 555 TGRATE---KTDVFSYGAVVLEVASGRRP 580
+ K DV+S G +E+A + P
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 53/203 (26%), Positives = 91/203 (44%), Gaps = 19/203 (9%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEF----LSELSIIGTLRHRNLVRLQG 443
IG G +GTV+K + +I+A+KR + + L E+ ++ L+H+N+VRL
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 444 WCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIH 503
H ++ LV++ L K L L + L + H V+H
Sbjct: 69 VLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLH 124
Query: 504 RDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDAT----VAAGTMGYLAPEYLLTGRA- 558
RD+K N++++ +L +FGLAR P V T+ Y P+ L +
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAFG---IPVRCYSAEVV--TLWYRPPDVLFGAKLY 179
Query: 559 TEKTDVFSYGAVVLEVASGRRPI 581
+ D++S G + E+A+ RP+
Sbjct: 180 STSIDMWSAGCIFAELANAGRPL 202
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 32/236 (13%), Positives = 61/236 (25%), Gaps = 44/236 (18%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLS----ELSIIGTLRH------ 435
++G + + G+ V + + E+ + LR
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 436 ----------RNLVRLQGWCH--------EKGEILLVYDLMP-----NGSLDKALFE--- 469
+LV+ +L + L P + + L
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 470 ARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQ 529
L R ++ L V LA LH ++H ++ +I+LD+ L F +
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 530 VEHDKSPDATVAAGTMGYLAPEYLL-----TGRATEKTDVFSYGAVVLEVASGRRP 580
A L T D ++ G + + P
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 50/222 (22%), Positives = 89/222 (40%), Gaps = 26/222 (11%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKR-CSHNSQGKDEFLSELSIIGTLR-HRNLVRL-- 441
R++ G F VY+ +G A+KR S+ + + E+ + L H N+V+
Sbjct: 34 RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 442 ------QGWCHEKGEILLVYDLMPNGSLDKAL-FEARSPLPWPHRSKILLGVASALAYLH 494
+ + E LL+ +L ++ E+R PL KI A+ ++H
Sbjct: 94 AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 495 QECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAA-----------G 543
+ + +IHRD+K N++L +L DFG A + H +
Sbjct: 154 R-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 544 TMGYLAPEYLLTGR---ATEKTDVFSYGAVVLEVASGRRPIE 582
T Y PE + EK D+++ G ++ + + P E
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-26
Identities = 58/232 (25%), Positives = 102/232 (43%), Gaps = 30/232 (12%)
Query: 354 KKSESFTSDIIRMPKEFSYRELRSATKCFNAN------RIIGHGAFGTVYKGILPQNGDI 407
K++ + DI P F +R + + N+ I+G G FG V+K G
Sbjct: 57 KRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLK 116
Query: 408 IAVK--RCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSL-- 463
+A K + + K+E +E+S++ L H NL++L K +I+LV + + G L
Sbjct: 117 LAAKIIKTRG-MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFD 175
Query: 464 -----DKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIML--DEG 516
L E + + + + ++HQ ++H D+K NI+ +
Sbjct: 176 RIIDESYNLTELDT-------ILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDA 225
Query: 517 FNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYG 568
++ DFGLAR+ + + V GT +LAPE + + TD++S G
Sbjct: 226 KQIKIIDFGLARRYKPREK--LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVG 275
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 58/207 (28%), Positives = 86/207 (41%), Gaps = 17/207 (8%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCS--HNSQGKDEFLSELSIIGTLRHRNLVRLQGWC 445
IG GA V + +A+KR + DE L E+ + H N+V
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 446 HEKGEILLVYDLMPNGSL-------DKALFEARSPLPWPHRSKILLGVASALAYLHQECE 498
K E+ LV L+ GS+ L + IL V L YLH +
Sbjct: 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---K 139
Query: 499 NQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTM-G---YLAPEYLL 554
N IHRDVK NI+L E + ++ DFG++ + T G ++APE +
Sbjct: 140 NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVME 199
Query: 555 TGRA-TEKTDVFSYGAVVLEVASGRRP 580
R K D++S+G +E+A+G P
Sbjct: 200 QVRGYDFKADIWSFGITAIELATGAAP 226
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 52/199 (26%), Positives = 94/199 (47%), Gaps = 28/199 (14%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDE-FLSELSIIGTLRHRNLVRLQGW 444
++G GAF V+ G + A+K + +D +E++++ ++H N+V L+
Sbjct: 15 EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 445 CHEKGEILLVYDLMPNGSL-----DKALF---EARSPLPWPHRSKILLGVASALAYLHQE 496
LV L+ G L ++ ++ +A S ++ V SA+ YLH
Sbjct: 75 YESTTHYYLVMQLVSGGELFDRILERGVYTEKDA---------SLVIQQVLSAVKYLH-- 123
Query: 497 CENQVIHRDVKTSNIML---DEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYL 553
EN ++HRD+K N++ +E + DFGL++ ++ + A GT GY+APE L
Sbjct: 124 -ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI---MSTACGTPGYVAPEVL 179
Query: 554 LTGRATEKTDVFSYGAVVL 572
++ D +S G V+
Sbjct: 180 AQKPYSKAVDCWSIG-VIT 197
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 54/196 (27%), Positives = 93/196 (47%), Gaps = 20/196 (10%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVK---RCSHNSQGKDEFLSELSIIGTLRHRNLVRLQ 442
++G G+FG V K AVK + S ++ L E+ ++ L H N+++L
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 443 GWCHEKGEILLVYDLMPNGSLDKALFE---ARSPLPWPHRSKILLGVASALAYLHQECEN 499
+ +V +L G LF+ R ++I+ V S + Y+H+ +
Sbjct: 88 EILEDSSSFYIVGELYTGGE----LFDEIIKRKRFSEHDAARIIKQVFSGITYMHK---H 140
Query: 500 QVIHRDVKTSNIML---DEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTG 556
++HRD+K NI+L ++ + ++ DFGL+ + + GT Y+APE +L G
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--MKDRIGTAYYIAPE-VLRG 197
Query: 557 RATEKTDVFSYGAVVL 572
EK DV+S G V+L
Sbjct: 198 TYDEKCDVWSAG-VIL 212
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-26
Identities = 58/247 (23%), Positives = 103/247 (41%), Gaps = 30/247 (12%)
Query: 354 KKSESFTSDIIRMPKEFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVK-- 411
+ + I P + ++ + + R +G GA+G V A+K
Sbjct: 10 GRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVI 69
Query: 412 ------------RCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMP 459
+ + +E +E+S++ +L H N+++L +K LV +
Sbjct: 70 KKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYE 129
Query: 460 NGSLDKALFE---ARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIML--- 513
G LFE R + I+ + S + YLH+ + ++HRD+K NI+L
Sbjct: 130 GGE----LFEQIINRHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENK 182
Query: 514 DEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLE 573
+ N ++ DFGL+ D + GT Y+APE +L + EK DV+S G ++
Sbjct: 183 NSLLNIKIVDFGLSSFFSKDYKLRDRL--GTAYYIAPE-VLKKKYNEKCDVWSCGVIMYI 239
Query: 574 VASGRRP 580
+ G P
Sbjct: 240 LLCGYPP 246
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 48/197 (24%), Positives = 82/197 (41%), Gaps = 23/197 (11%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVK-------RCSHNSQGKDEFLSELSIIGTLRHRNL 438
+G G F V K G A K R S ++E E+SI+ + H N+
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 439 VRLQGWCHEKGEILLVYDLMPNGSLDKALFE---ARSPLPWPHRSKILLGVASALAYLHQ 495
+ L + +++L+ +L+ G LF+ + L + + + + YLH
Sbjct: 78 ITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 496 ECENQVIHRDVKTSNIML----DEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPE 551
++ H D+K NIML + +L DFGLA ++E GT ++APE
Sbjct: 134 ---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--FKNIFGTPEFVAPE 188
Query: 552 YLLTGRATEKTDVFSYG 568
+ + D++S G
Sbjct: 189 IVNYEPLGLEADMWSIG 205
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 48/197 (24%), Positives = 82/197 (41%), Gaps = 23/197 (11%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVK-------RCSHNSQGKDEFLSELSIIGTLRHRNL 438
+G G F V K G A K R S ++E E+SI+ + H N+
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 439 VRLQGWCHEKGEILLVYDLMPNGSLDKALFE---ARSPLPWPHRSKILLGVASALAYLHQ 495
+ L + +++L+ +L+ G LF+ + L + + + + YLH
Sbjct: 78 ITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 496 ECENQVIHRDVKTSNIML----DEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPE 551
++ H D+K NIML + +L DFGLA ++E GT ++APE
Sbjct: 134 ---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--FKNIFGTPEFVAPE 188
Query: 552 YLLTGRATEKTDVFSYG 568
+ + D++S G
Sbjct: 189 IVNYEPLGLEADMWSIG 205
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 50/205 (24%), Positives = 85/205 (41%), Gaps = 14/205 (6%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVK----RCSHNSQGKDEFLSELSIIGTLRHRNLVRL 441
I+G G V+ ++ +AVK + + F E L H +V +
Sbjct: 18 EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 442 --QGWCHEKGEIL--LVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQEC 497
G L +V + + +L + + P+ +++ AL + H
Sbjct: 78 YDTGEAETPAGPLPYIVMEYVDGVTL-RDIVHTEGPMTPKRAIEVIADACQALNFSH--- 133
Query: 498 ENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP--DATVAAGTMGYLAPEYLLT 555
+N +IHRDVK +NIM+ ++ DFG+AR + + GT YL+PE
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 556 GRATEKTDVFSYGAVVLEVASGRRP 580
++DV+S G V+ EV +G P
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 50/202 (24%), Positives = 93/202 (46%), Gaps = 15/202 (7%)
Query: 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVK--RCSHNSQGKDEFLSELSIIGTLRHR 436
F R +G GAFG V+ +G +K + ++ +E+ ++ +L H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 437 NLVRLQGWCHEKGEILLVYDLMPNGSL-DKALFEARSPLPWPHR--SKILLGVASALAYL 493
N++++ + + +V + G L ++ + ++++ + +ALAY
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 494 HQECENQVIHRDVKTSNIML---DEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAP 550
H V+H+D+K NI+ ++ DFGLA + D+ +T AAGT Y+AP
Sbjct: 141 HS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH--STNAAGTALYMAP 195
Query: 551 EYLLTGRATEKTDVFSYGAVVL 572
E + T K D++S G VV+
Sbjct: 196 E-VFKRDVTFKCDIWSAG-VVM 215
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 54/220 (24%), Positives = 96/220 (43%), Gaps = 21/220 (9%)
Query: 376 RSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRH 435
R F R+ G G FGTV G G +A+K+ + + ++ L + + L H
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHH 78
Query: 436 RNLVRLQGWCHEKGE-------ILLVYDLMPNGSLD-----KALFEARSPLPWPHRSKIL 483
N+V+LQ + + GE + +V + +P + + + P L
Sbjct: 79 PNIVQLQSYFYTLGERDRRDIYLNVVMEYVP---DTLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 484 LGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNA-RLGDFGLARQVEHDKSPDATVAA 542
+ ++ LH N V HRD+K N++++E +L DFG A+++ + A +
Sbjct: 136 FQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC- 193
Query: 543 GTMGYLAPEYLLTGRA-TEKTDVFSYGAVVLEVASGRRPI 581
+ Y APE + + T D++S G + E+ G PI
Sbjct: 194 -SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-EPI 231
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-25
Identities = 55/204 (26%), Positives = 97/204 (47%), Gaps = 19/204 (9%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVK---RCSHNSQGKDEFLSELSIIGTLRHRNLVRLQ 442
++G G+FG V K AVK + S ++ L E+ ++ L H N+++L
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 443 GWCHEKGEILLVYDLMPNGSLDKALFE---ARSPLPWPHRSKILLGVASALAYLHQECEN 499
+ +V +L G LF+ R ++I+ V S + Y+H+ +
Sbjct: 88 EILEDSSSFYIVGELYTGGE----LFDEIIKRKRFSEHDAARIIKQVFSGITYMHK---H 140
Query: 500 QVIHRDVKTSNIML---DEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTG 556
++HRD+K NI+L ++ + ++ DFGL+ + + + GT Y+APE +L G
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPE-VLRG 197
Query: 557 RATEKTDVFSYGAVVLEVASGRRP 580
EK DV+S G ++ + SG P
Sbjct: 198 TYDEKCDVWSAGVILYILLSGTPP 221
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 31/243 (12%), Positives = 68/243 (27%), Gaps = 57/243 (23%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVK-----------------------------RCSHN 416
++G + + G+ V +
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 417 SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMP-----NGSLDKALFE-- 469
++ F+ ++ + + ++R++ +L + L P + + L
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLD-ERDMWVLSRFFLYPRMQSNLQTFGEVLLSHS 197
Query: 470 -ARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLAR 528
L R ++ L V LA LH ++H ++ +I+LD+ L F
Sbjct: 198 STHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 254
Query: 529 QVEHDKSPDATVAAGTMGYLAPEYLLT-----------GRATEKTDVFSYGAVVLEVASG 577
+ + G+ PE T D ++ G V+ +
Sbjct: 255 RDGARVVSS-----VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
Query: 578 RRP 580
P
Sbjct: 310 DLP 312
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 4e-25
Identities = 48/197 (24%), Positives = 82/197 (41%), Gaps = 23/197 (11%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVK-------RCSHNSQGKDEFLSELSIIGTLRHRNL 438
+G G F V K G A K S ++E E++I+ +RH N+
Sbjct: 11 EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70
Query: 439 VRLQGWCHEKGEILLVYDLMPNGSLDKALFE---ARSPLPWPHRSKILLGVASALAYLHQ 495
+ L K +++L+ +L+ G LF+ + L ++ L + + YLH
Sbjct: 71 ITLHDIFENKTDVVLILELVSGGE----LFDFLAEKESLTEDEATQFLKQILDGVHYLHS 126
Query: 496 ECENQVIHRDVKTSNIML----DEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPE 551
++ H D+K NIML +L DFG+A ++E GT ++APE
Sbjct: 127 ---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE--FKNIFGTPEFVAPE 181
Query: 552 YLLTGRATEKTDVFSYG 568
+ + D++S G
Sbjct: 182 IVNYEPLGLEADMWSIG 198
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-25
Identities = 57/196 (29%), Positives = 91/196 (46%), Gaps = 18/196 (9%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVK---RCSHNSQGKDEFLSELSIIGTLRHRNLVRLQ 442
+G GAF V + + G A +++ + E I L+H N+VRL
Sbjct: 17 EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76
Query: 443 GWCHEKGEILLVYDLMPNGSLDKALFE---ARSPLPWPHRSKILLGVASALAYLHQECEN 499
E+G L++DL+ G LFE AR S + + A+ + H +
Sbjct: 77 DSISEEGHHYLIFDLVTGGE----LFEDIVAREYYSEADASHCIQQILEAVLHCH---QM 129
Query: 500 QVIHRDVKTSNIML---DEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTG 556
V+HR++K N++L +G +L DFGLA +VE ++ AGT GYL+PE L
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGF-AGTPGYLSPEVLRKD 188
Query: 557 RATEKTDVFSYGAVVL 572
+ D+++ G V+L
Sbjct: 189 PYGKPVDLWACG-VIL 203
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 52/199 (26%), Positives = 84/199 (42%), Gaps = 17/199 (8%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVK------RCSHNSQGKDEFLSELSIIGTLRHRNLV 439
+IG G F V + I + G AVK S ++ E SI L+H ++V
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 440 RLQGWCHEKGEILLVYDLMPNGSL-DKALFEARSPLPWPHR--SKILLGVASALAYLHQE 496
L G + +V++ M L + + A + + S + + AL Y H
Sbjct: 90 ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH-- 147
Query: 497 CENQVIHRDVKTSNIML---DEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYL 553
+N +IHRDVK ++L + +LG FG+A Q+ GT ++APE +
Sbjct: 148 -DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR-VGTPHFMAPEVV 205
Query: 554 LTGRATEKTDVFSYGAVVL 572
+ DV+ G V+L
Sbjct: 206 KREPYGKPVDVWGCG-VIL 223
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 54/194 (27%), Positives = 87/194 (44%), Gaps = 18/194 (9%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCS-HNSQGKDEFLSELSIIGTLRHRNLVRLQGW 444
IG G++G V + A K+ + + D F E+ I+ +L H N++RL
Sbjct: 15 NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 74
Query: 445 CHEKGEILLVYDLMPNGSLDKALFE---ARSPLPWPHRSKILLGVASALAYLHQECENQV 501
+ +I LV +L G LFE + ++I+ V SA+AY H+ V
Sbjct: 75 FEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAARIMKDVLSAVAYCHK---LNV 127
Query: 502 IHRDVKTSNIML---DEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRA 558
HRD+K N + +L DFGLA + + K GT Y++P+ +L G
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM--MRTKVGTPYYVSPQ-VLEGLY 184
Query: 559 TEKTDVFSYGAVVL 572
+ D +S G V++
Sbjct: 185 GPECDEWSAG-VMM 197
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 7e-25
Identities = 48/228 (21%), Positives = 91/228 (39%), Gaps = 26/228 (11%)
Query: 355 KSESFTSDIIRMPKEFSYRELRSATKCFNAN----RIIGHGAFGTVYKGILPQNGDIIAV 410
K + + K++ + + +G GAFG V++ + G +
Sbjct: 22 KINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVA 81
Query: 411 KRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSL------ 463
K + K +E+SI+ L H L+ L +K E++L+ + + G L
Sbjct: 82 KFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA 141
Query: 464 -DKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIML--DEGFNAR 520
D + EA + L ++H+ + ++H D+K NIM + + +
Sbjct: 142 EDYKMSEAEV-------INYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVK 191
Query: 521 LGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYG 568
+ DFGLA ++ D+ V T + APE + TD+++ G
Sbjct: 192 IIDFGLATKLNPDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIG 237
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-25
Identities = 47/206 (22%), Positives = 87/206 (42%), Gaps = 27/206 (13%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEF----LSELSIIGTLRHRNLVRLQG 443
+G G +G VYK I + +A+KR + ++ + E+S++ L+HRN++ L+
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKS 100
Query: 444 WCHEKGEILLVYDLMPNGSLD-KALFEARSPLPWPHRSKILLGVASALAYLHQECENQVI 502
H + L+++ D K + + L + + + + H + +
Sbjct: 101 VIHHNHRLHLIFEYA---ENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS---RRCL 154
Query: 503 HRDVKTSNIMLDEGFNAR-----LGDFGLARQVEHDKSPDAT----VAAGTMGYLAPEYL 553
HRD+K N++L + +GDFGLAR P + T+ Y PE L
Sbjct: 155 HRDLKPQNLLLSVSDASETPVLKIGDFGLARAF---GIPIRQFTHEII--TLWYRPPEIL 209
Query: 554 LTGRA-TEKTDVFSYGAVVLEVASGR 578
L R + D++S + E+
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 9e-25
Identities = 58/196 (29%), Positives = 92/196 (46%), Gaps = 19/196 (9%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVK---RCSHNSQGKDEFLSELSIIGTLRHRNLVRLQ 442
+G GAF V + + G A K +++ + E I L+H N+VRL
Sbjct: 12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 443 GWCHEKGEILLVYDLMPNGSLDKALFE---ARSPLPWPHRSKILLGVASALAYLHQECEN 499
E+ LV+DL+ G LFE AR S + + ++AY H N
Sbjct: 72 DSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILESIAYCH---SN 124
Query: 500 QVIHRDVKTSNIML---DEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTG 556
++HR++K N++L +G +L DFGLA +V ++ AGT GYL+PE L
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--WHGFAGTPGYLSPEVLKKD 182
Query: 557 RATEKTDVFSYGAVVL 572
++ D+++ G V+L
Sbjct: 183 PYSKPVDIWACG-VIL 197
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 47/197 (23%), Positives = 84/197 (42%), Gaps = 23/197 (11%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVK-------RCSHNSQGKDEFLSELSIIGTLRHRNL 438
+G G F V K G A K + S +++ E+SI+ ++H N+
Sbjct: 17 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 439 VRLQGWCHEKGEILLVYDLMPNGSLDKALFE---ARSPLPWPHRSKILLGVASALAYLHQ 495
+ L K +++L+ +L+ G LF+ + L ++ L + + + YLH
Sbjct: 77 ITLHEVYENKTDVILILELVAGGE----LFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 496 ECENQVIHRDVKTSNIML----DEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPE 551
Q+ H D+K NIML ++ DFGLA +++ GT ++APE
Sbjct: 133 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEFVAPE 187
Query: 552 YLLTGRATEKTDVFSYG 568
+ + D++S G
Sbjct: 188 IVNYEPLGLEADMWSIG 204
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 1e-24
Identities = 65/207 (31%), Positives = 96/207 (46%), Gaps = 25/207 (12%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVK--RCSHNSQGKDEF----LSELSIIGTLRHRNLVRL 441
+G G F TVYK I+A+K + H S+ KD L E+ ++ L H N++ L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 442 QGWCHEKGEILLVYDLMPNGSLD-KALFEARS-PLPWPHRSKILLGVASALAYLHQECEN 499
K I LV+D M D + + + S L H +L L YLHQ +
Sbjct: 78 LDAFGHKSNISLVFDFME---TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ---H 131
Query: 500 QVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDAT----VAAGTMGYLAPEYLLT 555
++HRD+K +N++LDE +L DFGLA+ SP+ V T Y APE L
Sbjct: 132 WILHRDLKPNNLLLDENGVLKLADFGLAKSF---GSPNRAYTHQVV--TRWYRAPELLFG 186
Query: 556 GRA-TEKTDVFSYGAVVLEVASGRRPI 581
R D+++ G ++ E+ R P
Sbjct: 187 ARMYGVGVDMWAVGCILAELLL-RVPF 212
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 52/198 (26%), Positives = 87/198 (43%), Gaps = 27/198 (13%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWC 445
+G GA VY+ A+K + K +E+ ++ L H N+++L+
Sbjct: 59 SELGRGATSIVYRCKQKGTQKPYALKVLK-KTVDKKIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 446 HEKGEILLVYDLMPNGSL-----DKALF---EARSPLPWPHRSKILLGVASALAYLHQEC 497
EI LV +L+ G L +K + +A + + + A+AYLH
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGYYSERDA---------ADAVKQILEAVAYLH--- 165
Query: 498 ENQVIHRDVKTSNIML---DEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLL 554
EN ++HRD+K N++ ++ DFGL++ VEH GT GY APE L
Sbjct: 166 ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL--MKTVCGTPGYCAPEILR 223
Query: 555 TGRATEKTDVFSYGAVVL 572
+ D++S G ++
Sbjct: 224 GCAYGPEVDMWSVG-IIT 240
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 48/227 (21%), Positives = 90/227 (39%), Gaps = 32/227 (14%)
Query: 386 RIIGHGAFGTVY---------------KGILPQNGDIIAVKRCSHNSQGKDEFLS-ELSI 429
R + G F + K +L + D + + K + EL I
Sbjct: 37 RTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 430 IGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKAL-------FEARSPLPWPHRSKI 482
I +++ + +G E+ ++Y+ M N S+ K +P I
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 483 LLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAA 542
+ V ++ +Y+H E + HRDVK SNI++D+ +L DFG + + K +
Sbjct: 157 IKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK---IKGSR 211
Query: 543 GTMGYLAPEYLLTGRAT---EKTDVFSYGAVVLEVASGRRPIEKEIT 586
GT ++ PE + ++ K D++S G + + P +I+
Sbjct: 212 GTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 38/185 (20%), Positives = 76/185 (41%), Gaps = 7/185 (3%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWC 445
+G G FG V++ + + K + E+SI+ RHRN++ L
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 446 HEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRD 505
E++++++ + + + + + L + V AL +LH + + H D
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFD 127
Query: 506 VKTSNIML--DEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTD 563
++ NI+ ++ +FG ARQ++ + + Y APE + TD
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--FRLLFTAPEYYAPEVHQHDVVSTATD 185
Query: 564 VFSYG 568
++S G
Sbjct: 186 MWSLG 190
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 19/215 (8%)
Query: 367 PKEFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVK---RCSHNSQGKDEF 423
EF + ++ +G GAF V + + G A K +++ +
Sbjct: 16 GSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKL 75
Query: 424 LSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFE---ARSPLPWPHRS 480
E I L+H N+VRL E+ LV+DL+ G LFE AR S
Sbjct: 76 EREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADAS 131
Query: 481 KILLGVASALAYLHQECENQVIHRDVKTSNIML---DEGFNARLGDFGLARQVEHDKSPD 537
+ + ++AY H N ++HR++K N++L +G +L DFGLA +V ++
Sbjct: 132 HCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-- 186
Query: 538 ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVL 572
AGT GYL+PE L ++ D+++ G V+L
Sbjct: 187 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACG-VIL 220
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 65/218 (29%), Positives = 109/218 (50%), Gaps = 23/218 (10%)
Query: 376 RSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRH 435
R + ++IG+G+FG VY+ L +G+++A+K+ Q K EL I+ L H
Sbjct: 50 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQDKRFKNRELQIMRKLDH 106
Query: 436 RNLVRLQGWCHEKGE------ILLVYDLMPN--GSLDKALFEARSPLPWPHRSKILLGVA 487
N+VRL+ + + GE + LV D +P + + A+ LP + + +
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 488 SALAYLHQECENQVIHRDVKTSNIMLDEGFNA-RLGDFGLARQVEHDKSPDATVAAGTMG 546
+LAY+H + HRD+K N++LD +L DFG A+Q+ + + + +
Sbjct: 167 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRY 221
Query: 547 YLAPEYLLTGRATEKT---DVFSYGAVVLEVASGRRPI 581
Y APE + AT+ T DV+S G V+ E+ G +PI
Sbjct: 222 YRAPELIFG--ATDYTSSIDVWSAGCVLAELLLG-QPI 256
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-24
Identities = 51/222 (22%), Positives = 93/222 (41%), Gaps = 12/222 (5%)
Query: 354 KKSESFTSDIIRMPKEFSYRELRSATKCFNA----NRIIGHGAFGTVYKGILPQNGDIIA 409
S ++ + + + K++ + + + +G GAFG V++ G+ A
Sbjct: 127 TVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFA 186
Query: 410 VKRCSH-NSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALF 468
K + K+ E+ + LRH LV L + E++++Y+ M G L + +
Sbjct: 187 AKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA 246
Query: 469 EARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIML--DEGFNARLGDFGL 526
+ + + + + V L ++H EN +H D+K NIM +L DFGL
Sbjct: 247 DEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGL 303
Query: 527 ARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYG 568
++ +S V GT + APE TD++S G
Sbjct: 304 TAHLDPKQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVG 343
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 54/200 (27%), Positives = 85/200 (42%), Gaps = 30/200 (15%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTL-RHRNLVRLQGW 444
IG G++ + I AVK + K + E+ I+ +H N++ L+
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVKII---DKSKRDPTEEIEILLRYGQHPNIITLKDV 84
Query: 445 CHEKGEILLVYDLMPNGSL-----DKALF---EARSPLPWPHRSKILLGVASALAYLHQE 496
+ + +V +LM G L + F EA S +L + + YLH
Sbjct: 85 YDDGKYVYVVTELMKGGELLDKILRQKFFSEREA---------SAVLFTITKTVEYLH-- 133
Query: 497 CENQVIHRDVKTSNIML-DEGFNA---RLGDFGLARQVEHDKSPDATVAAGTMGYLAPEY 552
V+HRD+K SNI+ DE N R+ DFG A+Q+ + T T ++APE
Sbjct: 134 -AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTP-CYTANFVAPEV 191
Query: 553 LLTGRATEKTDVFSYGAVVL 572
L D++S G V+L
Sbjct: 192 LERQGYDAACDIWSLG-VLL 210
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 55/198 (27%), Positives = 98/198 (49%), Gaps = 16/198 (8%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCS-HNSQGKDE-FLSELSIIGTLRHRNLVRLQGWC 445
+G G + TVYKG +++A+K + +G + E+S++ L+H N+V L
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 446 HEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRD 505
H + + LV++ + L + L + + + + L + LAY H+ +V+HRD
Sbjct: 70 HTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRD 125
Query: 506 VKTSNIMLDEGFNARLGDFGLARQVEHDKSPDAT----VAAGTMGYLAPEYLLTGRA-TE 560
+K N++++E +L DFGLAR P T V T+ Y P+ LL +
Sbjct: 126 LKPQNLLINERGELKLADFGLARAK---SIPTKTYDNEVV--TLWYRPPDILLGSTDYST 180
Query: 561 KTDVFSYGAVVLEVASGR 578
+ D++ G + E+A+GR
Sbjct: 181 QIDMWGVGCIFYEMATGR 198
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 6e-24
Identities = 53/248 (21%), Positives = 94/248 (37%), Gaps = 37/248 (14%)
Query: 343 IWFFSKRYKHVKKSESFTSDIIRMPKEFSYRELRSATKCFNANRIIGHGAFGTVYKGILP 402
I R K + D PK + ++ +G GA G V
Sbjct: 106 IALSLSRNKVFVFFDLTVDDQSVYPKAL--------RDEYIMSKTLGSGACGEVKLAFER 157
Query: 403 QNGDIIAVK---------RCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILL 453
+ +A++ + + +E+ I+ L H +++++ + + + +
Sbjct: 158 KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYI 216
Query: 454 VYDLMPNGSLDKALFE---ARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSN 510
V +LM G LF+ L + A+ YLH EN +IHRD+K N
Sbjct: 217 VLELMEGGE----LFDKVVGNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPEN 269
Query: 511 IML---DEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRA---TEKTDV 564
++L +E ++ DFG ++ + GT YLAPE L++ D
Sbjct: 270 VLLSSQEEDCLIKITDFGHSKILGETSLM--RTLCGTPTYLAPEVLVSVGTAGYNRAVDC 327
Query: 565 FSYGAVVL 572
+S G V+L
Sbjct: 328 WSLG-VIL 334
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 58/247 (23%), Positives = 94/247 (38%), Gaps = 55/247 (22%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVK------RCSHNSQGKDEFLSELSIIGTLRHRNLV 439
IG G++G V I Q I A+K N + + +E+ ++ L H N+
Sbjct: 32 GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91
Query: 440 RLQGWCHEKGEILLVYDLMPNGSL-------------DKALFEARSPLPWPHR------- 479
RL ++ I LV +L G L A+ ++ +
Sbjct: 92 RLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAIN 151
Query: 480 -------------------SKILLGVASALAYLHQECENQVIHRDVKTSNIML--DEGFN 518
S I+ + SAL YLH + HRD+K N + ++ F
Sbjct: 152 GSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFE 208
Query: 519 ARLGDFGLARQVEHDKSPDA---TVAAGTMGYLAPEYLLTGRA--TEKTDVFSYGAVVLE 573
+L DFGL+++ + + T AGT ++APE L T K D +S G ++
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHL 268
Query: 574 VASGRRP 580
+ G P
Sbjct: 269 LLMGAVP 275
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 53/212 (25%), Positives = 86/212 (40%), Gaps = 40/212 (18%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVK----------RCSHNSQGKDEFLSELSIIGTL-R 434
I+G G V + I AVK + ++ L E+ I+ +
Sbjct: 23 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82
Query: 435 HRNLVRLQGWCHEKGEILLVYDLMPNGSL-----DKALF---EARSPLPWPHRSKILLGV 486
H N+++L+ LV+DLM G L +K E R KI+ +
Sbjct: 83 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR---------KIMRAL 133
Query: 487 ASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMG 546
+ LH + ++HRD+K NI+LD+ N +L DFG + Q++ + GT
Sbjct: 134 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPS 188
Query: 547 YLAPEYLLTGRATEKT------DVFSYGAVVL 572
YLAPE + D++S G V++
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTG-VIM 219
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 5e-23
Identities = 57/204 (27%), Positives = 104/204 (50%), Gaps = 23/204 (11%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEF----LSELSIIGTLRHRNLVRLQG 443
+G+G + TVYKG+ G +A+K +S ++ + E+S++ L+H N+VRL
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYD 70
Query: 444 WCHEKGEILLVYDLMPN---GSLD-KALFEARSPLPWPHRSKILLGVASALAYLHQECEN 499
H + ++ LV++ M N +D + + L + LA+ H+ N
Sbjct: 71 VIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---N 127
Query: 500 QVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDAT----VAAGTMGYLAPEYLLT 555
+++HRD+K N+++++ +LGDFGLAR P T V T+ Y AP+ L+
Sbjct: 128 KILHRDLKPQNLLINKRGQLKLGDFGLARAF---GIPVNTFSSEVV--TLWYRAPDVLMG 182
Query: 556 GRA-TEKTDVFSYGAVVLEVASGR 578
R + D++S G ++ E+ +G+
Sbjct: 183 SRTYSTSIDIWSCGCILAEMITGK 206
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 6e-23
Identities = 54/226 (23%), Positives = 107/226 (47%), Gaps = 32/226 (14%)
Query: 367 PKEFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSE 426
+E +Y + +IG+G+FG V++ L ++ + +A+K+ Q K E
Sbjct: 37 QREIAYTNCK----------VIGNGSFGVVFQAKLVESDE-VAIKKV---LQDKRFKNRE 82
Query: 427 LSIIGTLRHRNLVRLQGWCHEKGE------ILLVYDLMPNGSLDKAL---FEARSPLPWP 477
L I+ ++H N+V L+ + + G+ + LV + +P ++ +A + + +P
Sbjct: 83 LQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPML 141
Query: 478 HRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNA-RLGDFGLARQVEHDKSP 536
+ + +LAY+H + HRD+K N++LD +L DFG A+ + +
Sbjct: 142 LIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN 198
Query: 537 DATVAAGTMGYLAPEYLLTGRA-TEKTDVFSYGAVVLEVASGRRPI 581
+ + + Y APE + T D++S G V+ E+ G +P+
Sbjct: 199 VSYIC--SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG-QPL 241
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 7e-23
Identities = 55/200 (27%), Positives = 99/200 (49%), Gaps = 20/200 (10%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEF----LSELSIIGTLRHRNLVRLQG 443
+G G +G VYK G I+A+KR +++ + + E+S++ L H N+V L
Sbjct: 29 VGEGTYGVVYKAK-DSQGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 444 WCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIH 503
H + + LV++ M L K L E ++ L L + +A+ HQ ++++H
Sbjct: 87 VIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ---HRILH 142
Query: 504 RDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDAT----VAAGTMGYLAPEYLLTGRA- 558
RD+K N++++ +L DFGLAR P + V T+ Y AP+ L+ +
Sbjct: 143 RDLKPQNLLINSDGALKLADFGLARAF---GIPVRSYTHEVV--TLWYRAPDVLMGSKKY 197
Query: 559 TEKTDVFSYGAVVLEVASGR 578
+ D++S G + E+ +G+
Sbjct: 198 STSVDIWSIGCIFAEMITGK 217
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 46/191 (24%), Positives = 83/191 (43%), Gaps = 13/191 (6%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVK--RCSHNSQG-KDEFLSELSIIGTLRHR-NLVRL 441
+ +G G F V + I G A K + Q + E L E++++ + ++ L
Sbjct: 35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94
Query: 442 QGWCHEKGEILLVYDLMPNGSL-DKALFEARSPLPWPHRSKILLGVASALAYLHQECENQ 500
EI+L+ + G + L E + +++ + + YLH +N
Sbjct: 95 HEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNN 151
Query: 501 VIHRDVKTSNIML---DEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGR 557
++H D+K NI+L + ++ DFG++R++ H GT YLAPE L
Sbjct: 152 IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE--LREIMGTPEYLAPEILNYDP 209
Query: 558 ATEKTDVFSYG 568
T TD+++ G
Sbjct: 210 ITTATDMWNIG 220
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 53/200 (26%), Positives = 91/200 (45%), Gaps = 28/200 (14%)
Query: 385 NRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLR-HRNLVRLQG 443
++ +G G+F K + ++ AVK + + + E++ + H N+V+L
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVK--IISKRMEANTQKEITALKLCEGHPNIVKLHE 73
Query: 444 WCHEKGEILLVYDLMPNGSL-----DKALF---EARSPLPWPHRSKILLGVASALAYLHQ 495
H++ LV +L+ G L K F EA S I+ + SA++++H
Sbjct: 74 VFHDQLHTFLVMELLNGGELFERIKKKKHFSETEA---------SYIMRKLVSAVSHMH- 123
Query: 496 ECENQVIHRDVKTSNIML---DEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEY 552
+ V+HRD+K N++ ++ ++ DFG AR D P T T+ Y APE
Sbjct: 124 --DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP-CFTLHYAAPEL 180
Query: 553 LLTGRATEKTDVFSYGAVVL 572
L E D++S G V+L
Sbjct: 181 LNQNGYDESCDLWSLG-VIL 199
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-22
Identities = 54/211 (25%), Positives = 85/211 (40%), Gaps = 39/211 (18%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVK---------RCSHNSQGKDEFLSELSIIGTLR-H 435
+IG G V + + G AVK + ++ E I+ + H
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159
Query: 436 RNLVRLQGWCHEKGEILLVYDLMPNGSL-----DKALF---EARSPLPWPHRSKILLGVA 487
+++ L + LV+DLM G L +K E R I+ +
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETR---------SIMRSLL 210
Query: 488 SALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGY 547
A+++LH N ++HRD+K NI+LD+ RL DFG + +E + GT GY
Sbjct: 211 EAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK--LRELCGTPGY 265
Query: 548 LAPEYLLTGRATEKT------DVFSYGAVVL 572
LAPE L D+++ G V+L
Sbjct: 266 LAPEILKCSMDETHPGYGKEVDLWACG-VIL 295
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 1e-22
Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 20/200 (10%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEF----LSELSIIGTLRHRNLVRLQG 443
IG G +G VYK G+ A+K+ + + + E+SI+ L+H N+V+L
Sbjct: 10 IGEGTYGVVYKAQ-NNYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 444 WCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIH 503
H K ++LV++ + L K L L LL + + +AY H +V+H
Sbjct: 68 VIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLH 123
Query: 504 RDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDAT----VAAGTMGYLAPEYLLTGRA- 558
RD+K N++++ ++ DFGLAR P + T+ Y AP+ L+ +
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAF---GIPVRKYTHEIV--TLWYRAPDVLMGSKKY 178
Query: 559 TEKTDVFSYGAVVLEVASGR 578
+ D++S G + E+ +G
Sbjct: 179 STTIDIWSVGCIFAEMVNGT 198
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 2e-22
Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 26/211 (12%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVK--RCSHNSQGKDEF----LSELSIIGTLR---HRNL 438
IG GA+GTVYK P +G +A+K R + G + E++++ L H N+
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 439 VRLQGWCHEKGE-----ILLVYDLMPNGSLD-KALFEARSP--LPWPHRSKILLGVASAL 490
VRL C + LV++ + D + + P LP ++ L
Sbjct: 77 VRLMDVCATSRTDREIKVTLVFEHV---DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGL 133
Query: 491 AYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAP 550
+LH N ++HRD+K NI++ G +L DFGLAR + + V T+ Y AP
Sbjct: 134 DFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV--TLWYRAP 188
Query: 551 EYLLTGRATEKTDVFSYGAVVLEVASGRRPI 581
E LL D++S G + E+ R+P+
Sbjct: 189 EVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 218
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-22
Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 26/212 (12%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEF----LSELSIIGTLRHRNLVRLQG 443
IG G FG V+K + G +A+K+ ++ K+ F L E+ I+ L+H N+V L
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIE 83
Query: 444 WCHEK--------GEILLVYDLMPNGSLD-KALFEARS-PLPWPHRSKILLGVASALAYL 493
C K G I LV+D D L +++ + + L Y+
Sbjct: 84 ICRTKASPYNRCKGSIYLVFDFC---EHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYI 140
Query: 494 HQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQ---VEHDKSPDATVAAGTMGYLAP 550
H+ N+++HRD+K +N+++ +L DFGLAR ++ + T T+ Y P
Sbjct: 141 HR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 197
Query: 551 EYLLTGRA-TEKTDVFSYGAVVLEVASGRRPI 581
E LL R D++ G ++ E+ + R PI
Sbjct: 198 ELLLGERDYGPPIDLWGAGCIMAEMWT-RSPI 228
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 3e-22
Identities = 43/224 (19%), Positives = 81/224 (36%), Gaps = 21/224 (9%)
Query: 368 KEFSYRELRSATKCFNANRIIGHGAF-----GTVYKGILPQNGDIIAVKRCSHNSQGKDE 422
+E RE+++ K + + A+ + + + + D
Sbjct: 48 REKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDA 107
Query: 423 FLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRS-- 480
++ + +N V K + + L +L + S H
Sbjct: 108 PSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCL 167
Query: 481 KILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS----- 535
I + +A A+ +LH ++HRD+K SNI ++GDFGL ++ D+
Sbjct: 168 HIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 224
Query: 536 ------PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLE 573
T GT Y++PE + + K D+FS G ++ E
Sbjct: 225 TPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFE 268
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 3e-22
Identities = 55/244 (22%), Positives = 93/244 (38%), Gaps = 37/244 (15%)
Query: 365 RMPKEFSYRELRSATKCFNANRI----IGHGAFGTVYKGI--LPQNGDIIAVKR-----C 413
+M +F + + + +G G +G VYK ++ A+K+
Sbjct: 2 KMDYDFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI 61
Query: 414 SHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGE--ILLV-----YDLMP--NGSLD 464
S ++ + L EL +H N++ LQ + + L+ +DL
Sbjct: 62 SMSACREIALLREL------KHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRA 115
Query: 465 KALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNAR---- 520
+ LP +L + + YLH N V+HRD+K +NI++ R
Sbjct: 116 SKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVK 172
Query: 521 LGDFGLAR--QVEHDKSPDATVAAGTMGYLAPEYLLTGRA-TEKTDVFSYGAVVLEVASG 577
+ D G AR D T Y APE LL R T+ D+++ G + E+ +
Sbjct: 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT- 231
Query: 578 RRPI 581
PI
Sbjct: 232 SEPI 235
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 48/205 (23%), Positives = 85/205 (41%), Gaps = 29/205 (14%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVK---------RCSHNSQGKDEFLSELSIIGTLRHR 436
+ +G GA G V + +A+K + + +E+ I+ L H
Sbjct: 16 KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 437 NLVRLQGWCHEKGEILLVYDLMPNGSLDKALFE---ARSPLPWPHRSKILLGVASALAYL 493
+++++ + + + +V +LM G LF+ L + A+ YL
Sbjct: 76 CIIKIKNF-FDAEDYYIVLELMEGGE----LFDKVVGNKRLKEATCKLYFYQMLLAVQYL 130
Query: 494 HQECENQVIHRDVKTSNIML---DEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAP 550
H EN +IHRD+K N++L +E ++ DFG ++ + GT YLAP
Sbjct: 131 H---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL--MRTLCGTPTYLAP 185
Query: 551 EYLLTGRA---TEKTDVFSYGAVVL 572
E L++ D +S G V+L
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLG-VIL 209
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 6e-22
Identities = 54/208 (25%), Positives = 88/208 (42%), Gaps = 30/208 (14%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEF---------LSELSIIGTLRHR 436
+ IG GA G V +A+K+ S F EL ++ + H+
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKLS------RPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 437 NLVRL------QGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASAL 490
N++ L Q E ++ +V +LM +L + + + L S +L + +
Sbjct: 85 NIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI---QMELDHERMSYLLYQMLCGI 140
Query: 491 AYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAP 550
+LH +IHRD+K SNI++ ++ DFGLAR S T T Y AP
Sbjct: 141 KHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAP 195
Query: 551 EYLLTGRATEKTDVFSYGAVVLEVASGR 578
E +L E D++S G ++ E+ G
Sbjct: 196 EVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 6e-22
Identities = 50/210 (23%), Positives = 86/210 (40%), Gaps = 37/210 (17%)
Query: 387 IIGHGAFGTVYKGILPQNGDIIAVKRCS-HNSQGKDEFLSELSIIGTLR-HRNLVRLQGW 444
++G GA V I AVK + E+ ++ + HRN++ L +
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 445 CHEKGEILLVYDLMPNGSL-----DKALF---EARSPLPWPHRSKILLGVASALAYLHQE 496
E+ LV++ M GS+ + F EA S ++ VASAL +LH
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEA---------SVVVQDVASALDFLH-- 128
Query: 497 CENQVIHRDVKTSNIML---DEGFNARLGDFGLARQVEHDK------SPDATVAAGTMGY 547
+ HRD+K NI+ ++ ++ DF L ++ + +P+ G+ Y
Sbjct: 129 -NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187
Query: 548 LAPEYLLTGRATEKT-----DVFSYGAVVL 572
+APE + D++S G V+L
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLG-VIL 216
|
| >1qmo_A Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 Length = 113 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 2e-21
Identities = 32/113 (28%), Positives = 45/113 (39%), Gaps = 6/113 (5%)
Query: 31 STATEFDFGT--LTLASLKLLGDAHMNNGSVRLTRDVTVPY---DGAGKALYSKPVRFRL 85
+ + F F L G A N +++T+ + AG+ LYS P+R
Sbjct: 1 AQSLSFSFTKFDPNQEDLIFQGHATSTNNVLQVTKLDSAGNPVSSSAGRVLYSAPLRLW- 59
Query: 86 PGTHTPASFSTFFSFSITNLNPSSIGAGLAFVITPDGEQVGSAGGSLGLLDEK 138
+ SF T +F I+ S I GLAF I P + GG LGL
Sbjct: 60 EDSAVLTSFDTIINFEISTPYTSRIADGLAFFIAPPDSVISYHGGFLGLFPNA 112
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 3e-21
Identities = 55/201 (27%), Positives = 87/201 (43%), Gaps = 24/201 (11%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVK---------RCSHNSQGKDEFLSELSIIGTLRHR 436
+G GAFG V+ + + + VK C + E++I+ + H
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 437 NLVRLQGWCHEKGEILLVYDLMPNGSLDKALF---EARSPLPWPHRSKILLGVASALAYL 493
N++++ +G LV + +G LF + L P S I + SA+ YL
Sbjct: 90 NIIKVLDIFENQGFFQLVMEKHGSG---LDLFAFIDRHPRLDEPLASYIFRQLVSAVGYL 146
Query: 494 HQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYL 553
+IHRD+K NI++ E F +L DFG A +E K GT+ Y APE +
Sbjct: 147 RL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFY--TFCGTIEYCAPE-V 200
Query: 554 LTGRATE--KTDVFSYGAVVL 572
L G + +++S G V L
Sbjct: 201 LMGNPYRGPELEMWSLG-VTL 220
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 4e-21
Identities = 49/204 (24%), Positives = 90/204 (44%), Gaps = 23/204 (11%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCS----HNSQGKDEFLSELSIIGTLRHRNLVRL 441
+G GA+G+V I ++G+ +A+K+ S K EL ++ ++H N++ L
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK-RAYRELLLLKHMQHENVIGL 88
Query: 442 ------QGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQ 495
+ LV M L K + ++ + L Y+H
Sbjct: 89 LDVFTPASSLRNFYDFYLVMPFMQT-DLQKIM---GLKFSEEKIQYLVYQMLKGLKYIH- 143
Query: 496 ECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLT 555
V+HRD+K N+ ++E ++ DFGLAR + + + V T Y APE +L+
Sbjct: 144 --SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGY--VV--TRWYRAPEVILS 197
Query: 556 -GRATEKTDVFSYGAVVLEVASGR 578
+ D++S G ++ E+ +G+
Sbjct: 198 WMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 6e-21
Identities = 49/237 (20%), Positives = 96/237 (40%), Gaps = 31/237 (13%)
Query: 348 KRYKHVKKSESFTSDIIRMPKEFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDI 407
+ H S PK+++ + +K +++G G G V + + G
Sbjct: 2 AHHHHHHSSGLEVLFQGPEPKKYAVTDDYQLSK-----QVLGLGVNGKVLECFHRRTGQK 56
Query: 408 IAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWC----HEKGEILLVYDLMPNGSL 463
A+K + + + E G ++V + H K +L++ + M G
Sbjct: 57 CALKLLYDSPKARQEVDHHWQASG---GPHIVCILDVYENMHHGKRCLLIIMECMEGGE- 112
Query: 464 DKALFE---ARSPLPWPHR--SKILLGVASALAYLHQECENQVIHRDVKTSNIML---DE 515
LF R + R ++I+ + +A+ +LH + + HRDVK N++ ++
Sbjct: 113 ---LFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEK 166
Query: 516 GFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVL 572
+L DFG A++ + T Y+APE L + + D++S G V++
Sbjct: 167 DAVLKLTDFGFAKETTQNALQT---PCYTPYYVAPEVLGPEKYDKSCDMWSLG-VIM 219
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 1e-20
Identities = 54/203 (26%), Positives = 90/203 (44%), Gaps = 20/203 (9%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCS----HNSQGKDEFLSELSIIGTLRHRNLVRL 441
+ IG GA G V +A+K+ S + + K EL ++ + H+N++ L
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK-RAYRELVLMKCVNHKNIISL 126
Query: 442 ------QGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQ 495
Q E ++ LV +LM +L + + + L S +L + + +LH
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELMDA-NLCQVI---QMELDHERMSYLLYQMLCGIKHLH- 181
Query: 496 ECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLT 555
+IHRD+K SNI++ ++ DFGLAR S T T Y APE +L
Sbjct: 182 --SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILG 237
Query: 556 GRATEKTDVFSYGAVVLEVASGR 578
E D++S G ++ E+ +
Sbjct: 238 MGYKENVDIWSVGCIMGEMVRHK 260
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 50/211 (23%), Positives = 88/211 (41%), Gaps = 23/211 (10%)
Query: 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEF---------LSELSIIGT 432
F +I+G G+F TV A+K K E ++
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILE-----KRHIIKENKVPYVTRERDVMSR 86
Query: 433 LRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARS-PLPWPHRSKILLG-VASAL 490
L H V+L + ++ NG L K + + S ++ + SAL
Sbjct: 87 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---CTRFYTAEIVSAL 143
Query: 491 AYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVA-AGTMGYLA 549
YLH +IHRD+K NI+L+E + ++ DFG A+ + + + GT Y++
Sbjct: 144 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 200
Query: 550 PEYLLTGRATEKTDVFSYGAVVLEVASGRRP 580
PE L A + +D+++ G ++ ++ +G P
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-20
Identities = 59/216 (27%), Positives = 90/216 (41%), Gaps = 33/216 (15%)
Query: 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVK-----RCSHNSQGKDEF---LSELSIIGTL 433
F R IG G+FG V + A+K +C ++E EL I+ L
Sbjct: 17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKC----VERNEVRNVFKELQIMQGL 72
Query: 434 RHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALF-----EARSPLPWPHRSKILLG-VA 487
H LV L ++ ++ +V DL+ G L K+ + +
Sbjct: 73 EHPFLVNLWYSFQDEEDMFMVVDLLLGGDL----RYHLQQNVHFKEE---TVKLFICELV 125
Query: 488 SALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGY 547
AL YL ++IHRD+K NI+LDE + + DF +A + + T AGT Y
Sbjct: 126 MALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ--ITTMAGTKPY 180
Query: 548 LAPEYLLTGRATEKT---DVFSYGAVVLEVASGRRP 580
+APE + + + D +S G E+ GRRP
Sbjct: 181 MAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 3e-20
Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 19/209 (9%)
Query: 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVK--RCSHNSQGKDEF--LSE---LSIIGTLR 434
F+ +RIIG G FG VY G + A+K + E L+E LS++ T
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 435 HRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARS-PLPWPHRSKILLG-VASALAY 492
+V + H ++ + DLM G L L + + + L +
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA---DMRFYAAEIILGLEH 307
Query: 493 LHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEY 552
+H V++RD+K +NI+LDE + R+ D GLA K + GT GY+APE
Sbjct: 308 MHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEV 361
Query: 553 LLTGRATEKT-DVFSYGAVVLEVASGRRP 580
L G A + + D FS G ++ ++ G P
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 3e-20
Identities = 63/306 (20%), Positives = 116/306 (37%), Gaps = 38/306 (12%)
Query: 348 KRYKHVKKSESFTSDIIRMPKEFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDI 407
+R K++ + + +++R + F ++IG GAFG V L +
Sbjct: 47 RREKNILEYLEWAKPFTS-----KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKV 101
Query: 408 IAVK--RCSHNSQGKDE--FLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSL 463
A+K + + F E ++ + + L + + LV D G L
Sbjct: 102 FAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDL 161
Query: 464 DKALFEARSPLPWPHRSKILLG-VASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLG 522
L + LP ++ L + A+ +HQ +HRD+K NI++D + RL
Sbjct: 162 LTLLSKFEDRLP-EEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLA 217
Query: 523 DFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKT-----DVFSYGAVVLEVASG 577
DFG ++ D + ++VA GT Y++PE L + D +S G + E+ G
Sbjct: 218 DFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277
Query: 578 RRP---------IEKEITGVGKVGVASNLVEWVWSLHREGR-----LLTAADARLEGQFD 623
P K + + V + + L+ + + RL GQ
Sbjct: 278 ETPFYAESLVETYGKIMNHKERF----QFPTQVTDVSENAKDLIRRLICSREHRL-GQNG 332
Query: 624 EAEMRR 629
+ ++
Sbjct: 333 IEDFKK 338
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 4e-20
Identities = 61/231 (26%), Positives = 102/231 (44%), Gaps = 11/231 (4%)
Query: 356 SESFTSDIIRMPKEFSYRELRSATK-CFNANRIIGHGAFGTVYKGILPQNGDIIAVK--R 412
++ S ++ + E + TK F R++G G FG V + G + A K
Sbjct: 159 ADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLE 218
Query: 413 CSHNSQGKDEF--LSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEA 470
+ K E L+E I+ + R +V L K + LV LM G L ++
Sbjct: 219 KKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM 278
Query: 471 RSPLPWPHRSKILLG-VASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQ 529
R+ + L LH ++++RD+K NI+LD+ + R+ D GLA
Sbjct: 279 GQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVH 335
Query: 530 VEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRP 580
V ++ V GT+GY+APE + R T D ++ G ++ E+ +G+ P
Sbjct: 336 VPEGQTIKGRV--GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 1e-19
Identities = 46/238 (19%), Positives = 97/238 (40%), Gaps = 51/238 (21%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWC 445
+ +G G+FG V + ++G A+K+ + + K EL I+ L H N+++L +
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK---NRELDIMKVLDHVNIIKLVDYF 69
Query: 446 HEKGEIL--------------------------------------LVYDLMPN--GSLDK 465
+ G+ ++ + +P+ + K
Sbjct: 70 YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLK 129
Query: 466 ALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLD-EGFNARLGDF 524
+ + +P S + + A+ ++H + HRD+K N++++ + +L DF
Sbjct: 130 SFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKDNTLKLCDF 186
Query: 525 GLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRA-TEKTDVFSYGAVVLEVASGRRPI 581
G A+++ + A + + Y APE +L T D++S G V E+ +P+
Sbjct: 187 GSAKKLIPSEPSVAYIC--SRFYRAPELMLGATEYTPSIDLWSIGCVFGELI-LGKPL 241
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 26/210 (12%)
Query: 388 IGHGAFGTVYKGI-LPQNGDIIAVKRCSHNSQGKDEF----LSELSIIGTLR---HRNLV 439
IG GA+G V+K L G +A+KR G++ + E++++ L H N+V
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 440 RLQGWCH-----EKGEILLVYDLMPNGSLD-KALFEARSP--LPWPHRSKILLGVASALA 491
RL C + ++ LV++ + D + +P ++ + L
Sbjct: 78 RLFDVCTVSRTDRETKLTLVFEHV---DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 134
Query: 492 YLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPE 551
+LH ++V+HRD+K NI++ +L DFGLAR + + V T+ Y APE
Sbjct: 135 FLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAPE 189
Query: 552 YLLTGRATEKTDVFSYGAVVLEVASGRRPI 581
LL D++S G + E+ R+P+
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 47/203 (23%), Positives = 83/203 (40%), Gaps = 20/203 (9%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLR-HRNLVRLQGW 444
R +G G + V++ I N + + VK K + E+ I+ LR N++ L
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKIL--KPVKKKKIKREIKILENLRGGPNIITLADI 99
Query: 445 CH---EKGEILLVYDLMPNGSLD-KALFEARSPLPWPHRSKILLGVASALAYLHQECENQ 500
+ L+ + + D K L++ L + + AL Y H
Sbjct: 100 VKDPVSRTPALVFEHVN---NTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHS---MG 150
Query: 501 VIHRDVKTSNIMLD-EGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRA- 558
++HRDVK N+M+D E RL D+GLA + + V + + PE L+ +
Sbjct: 151 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELLVDYQMY 208
Query: 559 TEKTDVFSYGAVVLEVASGRRPI 581
D++S G ++ + + P
Sbjct: 209 DYSLDMWSLGCMLASMIFRKEPF 231
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 2e-19
Identities = 48/225 (21%), Positives = 92/225 (40%), Gaps = 54/225 (24%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEF---------LSELSIIGTLRHR 436
+IG G++G V + ++A+K+ F L E++I+ L H
Sbjct: 59 HLIGTGSYGHVCEAYDKLEKRVVAIKKIL------RVFEDLIDCKRILREIAILNRLNHD 112
Query: 437 NLVRLQ-----GWCHEKGEILLVYDLMPNGSLD-KALFEARSPLPWPHRSKILLGVASAL 490
++V++ + E+ +V ++ D K LF L H +L + +
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIAD---SDFKKLFRTPVYLTELHIKTLLYNLLVGV 169
Query: 491 AYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMG---- 546
Y+H ++HRD+K +N ++++ + ++ DFGLAR V++ ++ ++ +
Sbjct: 170 KYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 547 ----------------------YLAPEYLLTGRA-TEKTDVFSYG 568
Y APE +L TE DV+S G
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIG 271
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 3e-19
Identities = 58/242 (23%), Positives = 95/242 (39%), Gaps = 27/242 (11%)
Query: 355 KSESFTSDIIRMPKEFS--YRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKR 412
+ + + K+ R+LR + + ++IG GAFG V + A+K
Sbjct: 42 RKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKL 101
Query: 413 CSHNSQGKDE---------FLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSL 463
S K E F E I+ +V+L + + +V + MP G L
Sbjct: 102 LS-----KFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL 156
Query: 464 DKALFEARSPLPWPHRSKILLG-VASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLG 522
+ P ++ V AL +H IHRDVK N++LD+ + +L
Sbjct: 157 VNLMSNYDVPEK---WARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLA 210
Query: 523 DFGLARQVEHDKSPDATVAAGTMGYLAPEYLLT----GRATEKTDVFSYGAVVLEVASGR 578
DFG ++ + A GT Y++PE L + G + D +S G + E+ G
Sbjct: 211 DFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
Query: 579 RP 580
P
Sbjct: 271 TP 272
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 6e-19
Identities = 51/214 (23%), Positives = 89/214 (41%), Gaps = 26/214 (12%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEF------------LSELSIIGTL 433
R I G++G V G+ G +A+KR + L E+ ++
Sbjct: 28 RFISSGSYGAVCAGV-DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF 86
Query: 434 RHRNLVRLQ-----GWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVAS 488
H N++ L+ ++ LV +LM L + + + R + H + +
Sbjct: 87 HHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILL 145
Query: 489 ALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYL 548
L LH E V+HRD+ NI+L + + + DF LAR+ D + V Y
Sbjct: 146 GLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT--HRWYR 200
Query: 549 APEYLLT-GRATEKTDVFSYGAVVLEVASGRRPI 581
APE ++ T+ D++S G V+ E+ R+ +
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEMF-NRKAL 233
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 6e-19
Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 24/207 (11%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCS---HNSQGKDEFLSELSIIGTLRHRNLVRLQ 442
IG GA+G V N +A+K+ S H + + L E+ I+ RH N++ +
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ-RTLREIKILLRFRHENIIGIN 91
Query: 443 -----GWCHEKGEILLVYDLMPNGSLDKALFEARS-PLPWPHRSKILLGVASALAYLHQE 496
+ ++ +V DLM L K L ++ L H L + L Y+H
Sbjct: 92 DIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KTQHLSNDHICYFLYQILRGLKYIH-- 145
Query: 497 CENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV--EHDKSPDAT--VAAGTMGYLAPEY 552
V+HRD+K SN++L+ + ++ DFGLAR +HD + T VA T Y APE
Sbjct: 146 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA--TRWYRAPEI 202
Query: 553 LLTGRA-TEKTDVFSYGAVVLEVASGR 578
+L + T+ D++S G ++ E+ S R
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 6e-19
Identities = 52/204 (25%), Positives = 89/204 (43%), Gaps = 22/204 (10%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCS----HNSQGKDEFLSELSIIGTLRHRNLVRL 441
+ +G GA+G V + + G +A+K+ K EL ++ +RH N++ L
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK-RAYRELRLLKHMRHENVIGL 89
Query: 442 ------QGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQ 495
+ + LV M L K + L ++ + L Y+H
Sbjct: 90 LDVFTPDETLDDFTDFYLVMPFMGT-DLGKLM--KHEKLGEDRIQFLVYQMLKGLRYIH- 145
Query: 496 ECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLT 555
+IHRD+K N+ ++E ++ DFGLARQ + T T Y APE +L
Sbjct: 146 --AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA----DSEMTGYVVTRWYRAPEVILN 199
Query: 556 -GRATEKTDVFSYGAVVLEVASGR 578
R T+ D++S G ++ E+ +G+
Sbjct: 200 WMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 7e-19
Identities = 58/233 (24%), Positives = 100/233 (42%), Gaps = 12/233 (5%)
Query: 356 SESFTSDIIRMPKEFSYRELRSAT-KCFNANRIIGHGAFGTVYKGILPQNGDIIAVK--R 412
E S ++ + E + F R++G G FG V+ + G + A K
Sbjct: 160 QEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLN 219
Query: 413 CSHNSQGKDEF--LSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEA 470
+ K + E I+ + R +V L K ++ LV +M G + ++
Sbjct: 220 KKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNV 279
Query: 471 RSPLPW--PHRSKILLG-VASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLA 527
P R+ + S L +LH + +I+RD+K N++LD+ N R+ D GLA
Sbjct: 280 DEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLA 336
Query: 528 RQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRP 580
+++ ++ AGT G++APE LL D F+ G + E+ + R P
Sbjct: 337 VELKAGQTKTKGY-AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 7e-19
Identities = 45/200 (22%), Positives = 82/200 (41%), Gaps = 27/200 (13%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTL-RHRNLVRLQGW 444
+++G G G V + + + A+K + E+ + + ++VR+
Sbjct: 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDV 123
Query: 445 CHE----KGEILLVYDLMPNGSLDKALFE---ARSPLPWPHR--SKILLGVASALAYLHQ 495
+ +L+V + + G LF R + R S+I+ + A+ YLH
Sbjct: 124 YENLYAGRKCLLIVMECLDGGE----LFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH- 178
Query: 496 ECENQVIHRDVKTSNIML---DEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEY 552
+ HRDVK N++ +L DFG A++ S T T Y+APE
Sbjct: 179 --SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPCYTPYYVAPEV 234
Query: 553 LLTGRATEKTDVFSYGAVVL 572
L + + D++S G V++
Sbjct: 235 LGPEKYDKSCDMWSLG-VIM 253
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 9e-19
Identities = 52/199 (26%), Positives = 85/199 (42%), Gaps = 27/199 (13%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVK---RCSHNSQGKDEFLSELSIIGTLRHRNLVRLQ 442
+ IG G F V G +A+K + N + E+ I+ L H N+V+L
Sbjct: 21 KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL- 79
Query: 443 GWCHE----KGEILLVYDLMPNGSLDKALFE---ARSPLPWPHRSKILLGVASALAYLHQ 495
E + + L+ + G + F+ A + + SA+ Y HQ
Sbjct: 80 ---FEVIETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ 132
Query: 496 ECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLT 555
+++HRD+K N++LD N ++ DFG + + DA G Y APE L
Sbjct: 133 ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC--GAPPYAAPE-LFQ 186
Query: 556 GRATE--KTDVFSYGAVVL 572
G+ + + DV+S G V+L
Sbjct: 187 GKKYDGPEVDVWSLG-VIL 204
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 52/216 (24%), Positives = 90/216 (41%), Gaps = 33/216 (15%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCS--HNSQGKDEFLSELSIIGTLRHRNLVRL-- 441
+ +G G G V+ + +A+K+ K L E+ II L H N+V++
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVK-HALREIKIIRRLDHDNIVKVFE 75
Query: 442 ------------QGWCHEKGEILLVYDLMPNGSLDKALFEARS-PLPWPHRSKILLGVAS 488
G E + +V + M L L PL H + +
Sbjct: 76 ILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVL---EQGPLLEEHARLFMYQLLR 131
Query: 489 ALAYLHQECENQVIHRDVKTSNIMLD-EGFNARLGDFGLARQVEHDKSPDAT----VAAG 543
L Y+H V+HRD+K +N+ ++ E ++GDFGLAR ++ S +
Sbjct: 132 GLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV-- 186
Query: 544 TMGYLAPEYLLTGRA-TEKTDVFSYGAVVLEVASGR 578
T Y +P LL+ T+ D+++ G + E+ +G+
Sbjct: 187 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-18
Identities = 35/288 (12%), Positives = 77/288 (26%), Gaps = 55/288 (19%)
Query: 388 IGHGAFGTVYKGILPQNGDIIAVK----RCSHNSQGKDEFLSELSIIGTLRHRNLVRLQG 443
G ++ + +A+ + E LS + + + R+
Sbjct: 39 HGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLD 98
Query: 444 WCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIH 503
H + L+V + + GSL + + + + +A+A H+ V
Sbjct: 99 VVHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGAIRAMQSLAAAADAAHR---AGVAL 152
Query: 504 RDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTD 563
S + + + L + A + D
Sbjct: 153 SIDHPSRVRVSIDGDVVLAYP---------------------ATMPD-------ANPQDD 184
Query: 564 VFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFD 623
+ GA + + R P+ + + A G+ + AD +
Sbjct: 185 IRGIGASLYALLVNRWPLPEA-GVRSGLAPAER--------DTAGQPIEPADIDRDI--- 232
Query: 624 EAEMRRVLLVGLACSHPDPLARP--TMRGVVQMLVGEAEVPIVPRAKP 669
++ V + D R T+ ++Q A+ V
Sbjct: 233 PFQISAVAARSVQ---GDGGIRSASTLLNLMQQATAVADRTEVLGPID 277
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 43/200 (21%), Positives = 85/200 (42%), Gaps = 20/200 (10%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVK-----RCSHNSQGKDEFLSELSIIGTLRHRNLVR 440
++G G++G V + + + AVK + G+ E+ ++ LRH+N+++
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 441 L-QGWCHE-KGEILLVYDLMPNGSLDKALFE--ARSPLPWPHRSKILLGVASALAYLHQE 496
L +E K ++ +V + G + + + P + L YLH
Sbjct: 71 LVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS- 127
Query: 497 CENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDA-TVAAGTMGYLAPEYLLT 555
++H+D+K N++L G ++ G+A + + D + G+ + PE +
Sbjct: 128 --QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE-IAN 184
Query: 556 GRAT---EKTDVFSYGAVVL 572
G T K D++S G V L
Sbjct: 185 GLDTFSGFKVDIWSAG-VTL 203
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-18
Identities = 54/204 (26%), Positives = 92/204 (45%), Gaps = 22/204 (10%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDE---FLSELSIIGTLRHRNLVRL- 441
+G GA+G+V + G +AVK+ S Q EL ++ ++H N++ L
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 442 -----QGWCHEKGEILLVYDLMPNGSLDKALFEARS-PLPWPHRSKILLGVASALAYLHQ 495
E ++ LV LM L+ + + L H ++ + L Y+H
Sbjct: 95 DVFTPARSLEEFNDVYLVTHLMGA-DLNNIV---KCQKLTDDHVQFLIYQILRGLKYIHS 150
Query: 496 ECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLT 555
+IHRD+K SN+ ++E ++ DFGLAR + + T T Y APE +L
Sbjct: 151 ---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT----ADEMTGYVATRWYRAPEIMLN 203
Query: 556 -GRATEKTDVFSYGAVVLEVASGR 578
+ D++S G ++ E+ +GR
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 5e-18
Identities = 53/214 (24%), Positives = 95/214 (44%), Gaps = 26/214 (12%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCS---HNSQGKDEFLSELSIIGTLRHRNLVRLQ 442
++G GA+G V G+I+A+K+ L E+ I+ +H N++ +
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFAL-RTLREIKILKHFKHENIITIF 75
Query: 443 -----GWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQEC 497
E+ ++ +LM L + + + L H + A+ LH
Sbjct: 76 NIQRPDSFENFNEVYIIQELMQT-DLHRVI--STQMLSDDHIQYFIYQTLRAVKVLH--- 129
Query: 498 ENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAG---------TMGYL 548
+ VIHRD+K SN++++ + ++ DFGLAR ++ + ++ T Y
Sbjct: 130 GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYR 189
Query: 549 APEYLLTGRA-TEKTDVFSYGAVVLEVASGRRPI 581
APE +LT + DV+S G ++ E+ RRPI
Sbjct: 190 APEVMLTSAKYSRAMDVWSCGCILAELF-LRRPI 222
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 6e-18
Identities = 54/229 (23%), Positives = 94/229 (41%), Gaps = 23/229 (10%)
Query: 355 KSESFTSDIIRMPKEFS--YRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKR 412
+ + +D ++ + +E+R F ++IG GAF V + Q G + A+K
Sbjct: 34 AQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKI 93
Query: 413 CSHNSQGKDE---------FLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSL 463
+ K + F E ++ R + +L ++ + LV + G L
Sbjct: 94 MN-----KWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDL 148
Query: 464 DKALFEARSPLPWPHRSKILLG-VASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLG 522
L + +P ++ L + A+ +H+ +HRD+K NI+LD + RL
Sbjct: 149 LTLLSKFGERIP-AEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLA 204
Query: 523 DFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVV 571
DFG ++ D + + VA GT YL+PE L SYG
Sbjct: 205 DFGSCLKLRADGTVRSLVAVGTPDYLSPEILQ--AVGGGPGTGSYGPEC 251
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 47/203 (23%), Positives = 79/203 (38%), Gaps = 28/203 (13%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVK---RCSHNSQGKDEFLS----ELSIIGTLRHR-- 436
++G G FG+VY GI + +A+K + + G+ + E+ ++ +
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108
Query: 437 NLVRLQGWCHEKGEILLVYDLMPNGSLDKALF---EARSPLPWPHRSKILLGVASALAYL 493
++RL W +L+ + + LF R L V A+ +
Sbjct: 109 GVIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 165
Query: 494 HQECENQVIHRDVKTSNIMLD-EGFNARLGDFGLARQVEHDKSPDA--TVAAGTMGYLAP 550
H V+HRD+K NI++D +L DFG D T GT Y P
Sbjct: 166 HN---CGVLHRDIKDENILIDLNRGELKLIDFGSG-----ALLKDTVYTDFDGTRVYSPP 217
Query: 551 EYLLTGR-ATEKTDVFSYGAVVL 572
E++ R V+S G ++L
Sbjct: 218 EWIRYHRYHGRSAAVWSLG-ILL 239
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-17
Identities = 53/243 (21%), Positives = 96/243 (39%), Gaps = 59/243 (24%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEF---------LSELSIIGTLRHR 436
+IG G++G VY +A+K+ + F L E++I+ L+
Sbjct: 32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVN------RMFEDLIDCKRILREITILNRLKSD 85
Query: 437 NLVRLQ-----GWCHEKGEILLVYDLMPNGSLD-KALFEARSPLPWPHRSKILLGVASAL 490
++RL + E+ +V ++ + D K LF+ L H IL +
Sbjct: 86 YIIRLYDLIIPDDLLKFDELYIVLEIADS---DLKKLFKTPIFLTEEHIKTILYNLLLGE 142
Query: 491 AYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAG------- 543
++H E+ +IHRD+K +N +L++ + ++ DFGLAR + +K +
Sbjct: 143 NFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGP 199
Query: 544 --------------TMGYLAPEYLLTGRA-TEKTDVFSYG----------AVVLEVASGR 578
T Y APE +L T+ D++S G + + R
Sbjct: 200 HNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR 259
Query: 579 RPI 581
P+
Sbjct: 260 FPL 262
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 47/226 (20%), Positives = 87/226 (38%), Gaps = 53/226 (23%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVK----------------------RCSHNSQGKDEF 423
IG G++G V + A+K R + +
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 424 LS-----ELSIIGTLRHRNLVRLQGWCHE------KGEILLVYDLMPNGSLDKALFE--A 470
E++I+ L H N+V+L E + + +V++L+ G + E
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKL----VEVLDDPNEDHLYMVFELVNQGPV----MEVPT 130
Query: 471 RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV 530
PL + + YLH ++IHRD+K SN+++ E + ++ DFG++ +
Sbjct: 131 LKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187
Query: 531 EHDKSPDATVAAGTMGYLAPEYLLTGRATE----KTDVFSYGAVVL 572
+ + + GT ++APE L+ DV++ G V L
Sbjct: 188 KGSDALLSN-TVGTPAFMAPE-SLSETRKIFSGKALDVWAMG-VTL 230
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 47/203 (23%), Positives = 80/203 (39%), Gaps = 26/203 (12%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVK---RCSHNSQGKDEFLS----ELSIIGTLR---- 434
++G G FGTV+ G + +A+K R E++++ +
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 435 HRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALF---EARSPLPWPHRSKILLGVASALA 491
H ++RL W + +LV + + LF + PL V +A+
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPA---QDLFDYITEKGPLGEGPSRCFFGQVVAAIQ 153
Query: 492 YLHQECENQVIHRDVKTSNIMLD-EGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAP 550
+ H V+HRD+K NI++D A+L DFG + T GT Y P
Sbjct: 154 HCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALL---HDEPYTDFDGTRVYSPP 207
Query: 551 EYLLTGR-ATEKTDVFSYGAVVL 572
E++ + V+S G ++L
Sbjct: 208 EWISRHQYHALPATVWSLG-ILL 229
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 1e-16
Identities = 56/199 (28%), Positives = 85/199 (42%), Gaps = 25/199 (12%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLS-------ELSIIGTLRHRNL 438
+ +G GA+G V + + +AVK + E+ I L H N+
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVD-----MKRAVDCPENIKKEICINKMLNHENV 67
Query: 439 VRLQGWCHEKGEILLVYDLMPNGSL-DKALFEARSPLPWPHRSKILLGVASALAYLHQEC 497
V+ G E L + G L D+ E +P P + + + + YLH
Sbjct: 68 VKFYGHRREGNIQYLFLEYCSGGELFDR--IEPDIGMPEPDAQRFFHQLMAGVVYLHG-- 123
Query: 498 ENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD--ATVAAGTMGYLAPEYLLT 555
+ HRD+K N++LDE N ++ DFGLA ++ GT+ Y+APE LL
Sbjct: 124 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPE-LLK 180
Query: 556 GR--ATEKTDVFSYGAVVL 572
R E DV+S G +VL
Sbjct: 181 RREFHAEPVDVWSCG-IVL 198
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 3e-16
Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 42/207 (20%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVK---RCSHNSQGKDEFLS-ELSIIGTLRHRNLVRL 441
+G G FG V G G +AVK R S + E+ + RH ++++L
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 442 QGWCHE----KGEILLVYDLMPNGSLDKALFE---ARSPLPWPHRSKILLGVASALAYLH 494
++ + +V + + G L F+ + ++ + SA+ Y H
Sbjct: 77 ----YQVISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEARRLFQQILSAVDYCH 128
Query: 495 QECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK-------SPDATVAAGTMGY 547
+ + V+HRD+K N++LD NA++ DFGL+ + + SP+ Y
Sbjct: 129 R---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN---------Y 176
Query: 548 LAPEYLLTGRATE--KTDVFSYGAVVL 572
APE +++GR + D++S G V+L
Sbjct: 177 AAPE-VISGRLYAGPEVDIWSCG-VIL 201
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 5e-16
Identities = 56/199 (28%), Positives = 85/199 (42%), Gaps = 25/199 (12%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLS-------ELSIIGTLRHRNL 438
+ +G GA+G V + + +AVK + E+ I L H N+
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVD-----MKRAVDCPENIKKEICINKMLNHENV 67
Query: 439 VRLQGWCHEKGEILLVYDLMPNGSL-DKALFEARSPLPWPHRSKILLGVASALAYLHQEC 497
V+ G E L + G L D+ E +P P + + + + YLH
Sbjct: 68 VKFYGHRREGNIQYLFLEYCSGGELFDR--IEPDIGMPEPDAQRFFHQLMAGVVYLHG-- 123
Query: 498 ENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD--ATVAAGTMGYLAPEYLLT 555
+ HRD+K N++LDE N ++ DFGLA ++ GT+ Y+APE LL
Sbjct: 124 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPE-LLK 180
Query: 556 GR--ATEKTDVFSYGAVVL 572
R E DV+S G +VL
Sbjct: 181 RREFHAEPVDVWSCG-IVL 198
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 51/198 (25%), Positives = 79/198 (39%), Gaps = 26/198 (13%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWC 445
+ IG G FG +++AVK + + E+ +LRH N+VR
Sbjct: 26 KDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRF---- 81
Query: 446 HE----KGEILLVYDLMPNGSLDKALFE---ARSPLPWPHRSKILLGVASALAYLHQECE 498
E + ++ + G L +E + S ++Y H
Sbjct: 82 KEVILTPTHLAIIMEYASGGEL----YERICNAGRFSEDEARFFFQQLLSGVSYCHS--- 134
Query: 499 NQVIHRDVKTSNIMLDEGFNARL--GDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTG 556
Q+ HRD+K N +LD RL DFG ++ P +TV GT Y+APE +L
Sbjct: 135 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPAYIAPE-VLLR 191
Query: 557 R--ATEKTDVFSYGAVVL 572
+ + DV+S G V L
Sbjct: 192 QEYDGKIADVWSCG-VTL 208
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 34/162 (20%), Positives = 65/162 (40%), Gaps = 24/162 (14%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTL-RHRNLVRLQGW 444
+++G G G V + + + A+K + E+ + + ++VR+
Sbjct: 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQ----DCPKARREVELHWRASQCPHIVRIVDV 79
Query: 445 CHE----KGEILLVYDLMPNGSLDKALFE---ARSPLPWPHR--SKILLGVASALAYLHQ 495
+ +L+V + + G LF R + R S+I+ + A+ YLH
Sbjct: 80 YENLYAGRKCLLIVMECLDGGE----LFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH- 134
Query: 496 ECENQVIHRDVKTSNIML---DEGFNARLGDFGLARQVEHDK 534
+ HRDVK N++ +L DFG A++ +K
Sbjct: 135 --SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEK 174
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 5e-15
Identities = 50/207 (24%), Positives = 91/207 (43%), Gaps = 42/207 (20%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLS----ELSIIGTLRHRNLVRL 441
+G G FG V G G +AVK + + + E+ + RH ++++L
Sbjct: 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 442 QGWCHE----KGEILLVYDLMPNGSLDKALFE---ARSPLPWPHRSKILLGVASALAYLH 494
++ +I +V + + G L F+ L ++ + S + Y H
Sbjct: 82 ----YQVISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESRRLFQQILSGVDYCH 133
Query: 495 QECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK-------SPDATVAAGTMGY 547
+ + V+HRD+K N++LD NA++ DFGL+ + + SP+ Y
Sbjct: 134 R---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN---------Y 181
Query: 548 LAPEYLLTGRATE--KTDVFSYGAVVL 572
APE +++GR + D++S G V+L
Sbjct: 182 AAPE-VISGRLYAGPEVDIWSSG-VIL 206
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 7e-15
Identities = 57/230 (24%), Positives = 98/230 (42%), Gaps = 48/230 (20%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEF---------LSELSIIGTLR-H 435
+ +G GA+G V+K I + G+++AVK+ D F E+ I+ L H
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIF------DAFQNSTDAQRTFREIMILTELSGH 68
Query: 436 RNLVRLQGWCHEKG--EILLVYDLMPNGSLDKALFEARS-PLPWPHRSKILLGVASALAY 492
N+V L ++ LV+D M L + R+ L H+ ++ + + Y
Sbjct: 69 ENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVI---RANILEPVHKQYVVYQLIKVIKY 124
Query: 493 LHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMG------ 546
LH ++HRD+K SNI+L+ + ++ DFGL+R + + +
Sbjct: 125 LH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
Query: 547 --------------YLAPEYLLTGRA-TEKTDVFSYGAVVLEVASGRRPI 581
Y APE LL T+ D++S G ++ E+ +PI
Sbjct: 182 DDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL-CGKPI 230
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 7e-15
Identities = 48/177 (27%), Positives = 73/177 (41%), Gaps = 35/177 (19%)
Query: 486 VASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTM 545
VA + +L + IHRD+ NI+L E ++ DFGLAR + D
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP----DYVRKGD 254
Query: 546 GYL-----APEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVE 599
L APE + T ++DV+S+G ++ E+ S G P GV + E
Sbjct: 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP---------GVKID--E 303
Query: 600 WVWSLHREGRLLTAADARLEG-QFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655
+EG R+ + EM + + L C H +P RPT +V+ L
Sbjct: 304 EFCRRLKEGT-------RMRAPDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 350
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 63.8 bits (155), Expect = 6e-11
Identities = 24/95 (25%), Positives = 39/95 (41%), Gaps = 9/95 (9%)
Query: 386 RIIGHGAFGTVYKGIL-----PQNGDIIAVK--RCSHNSQGKDEFLSELSIIGTL-RHRN 437
+ +G GAFG V + +AVK + +SEL I+ + H N
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 438 LVRLQGWC-HEKGEILLVYDLMPNGSLDKALFEAR 471
+V L G C G ++++ + G+L L R
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR 122
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 8e-15
Identities = 47/213 (22%), Positives = 92/213 (43%), Gaps = 55/213 (25%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVK---RCSHNSQGKDEFLS-ELSIIGTLRHRNLVRL 441
+G G+FG V + +A+K R + E+S + LRH ++++L
Sbjct: 15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 442 QGWCHE----KGEILLV--------YD-LMPNGSLDKALFEARSPLPWPHRSKILLGVAS 488
++ +I++V +D ++ + + E R + +
Sbjct: 75 ----YDVITTPTDIVMVIEYAGGELFDYIVEKKRMTED--EGR---------RFFQQIIC 119
Query: 489 ALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK-------SPDATVA 541
A+ Y H+ ++++HRD+K N++LD+ N ++ DFGL+ + SP+
Sbjct: 120 AIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPN---- 172
Query: 542 AGTMGYLAPEYLLTGRATE--KTDVFSYGAVVL 572
Y APE ++ G+ + DV+S G +VL
Sbjct: 173 -----YAAPE-VINGKLYAGPEVDVWSCG-IVL 198
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 50/246 (20%), Positives = 100/246 (40%), Gaps = 41/246 (16%)
Query: 356 SESFTSDIIRMPKEFSYRELRSATK-----CFNANRIIGHGAFGTVYKGILPQNGDIIAV 410
ES + + ++F + + F+ + +G G+FG V ++G+ A+
Sbjct: 12 QESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAM 71
Query: 411 KRCSHNSQGKDEF---------LSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNG 461
K K + L+E I+ + LV+L+ + + +V + + G
Sbjct: 72 KILD-----KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 462 SL-----DKALFEARSPLPWPHRSKILLG-VASALAYLHQECENQVIHRDVKTSNIMLDE 515
+ F ++ + YLH +I+RD+K N+++D+
Sbjct: 127 EMFSHLRRIGRFS-------EPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQ 176
Query: 516 GFNARLGDFGLARQVEHDKSPDATVA-AGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEV 574
++ DFG A++V+ T GT LAPE +L+ + D ++ G ++ E+
Sbjct: 177 QGYIQVTDFGFAKRVK-----GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEM 231
Query: 575 ASGRRP 580
A+G P
Sbjct: 232 AAGYPP 237
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 41/215 (19%), Positives = 88/215 (40%), Gaps = 29/215 (13%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVK----RCSHNSQGKDE--FLSELSIIGTLRH---- 435
R +G G F TV+ N +A+K + +DE L ++ +
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 436 -RNLVRLQGWCHEKGE----ILLVYDLMPNGSLDKALFEAR-SPLPWPHRSKILLGVASA 489
++++L + KG +++V++++ +L + + +P + +I +
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLG 143
Query: 490 LAYLHQECENQVIHRDVKTSNIMLDEG------FNARLGDFGLARQVEHDKSPDATVAAG 543
L Y+H+ C +IH D+K N++++ ++ D G A + +
Sbjct: 144 LDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ---- 197
Query: 544 TMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGR 578
T Y +PE LL D++S ++ E+ +G
Sbjct: 198 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >1gv9_A P58/ergic-53; lectin, carbohydrate binding; 1.46A {Rattus norvegicus} SCOP: b.29.1.13 PDB: 1r1z_A 3a4u_A 3lcp_A Length = 260 | Back alignment and structure |
|---|
Score = 69.9 bits (170), Expect = 2e-13
Identities = 42/240 (17%), Positives = 72/240 (30%), Gaps = 43/240 (17%)
Query: 47 KLLGDAHMNNGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLN 106
G+A + +R+ + G F ++ +F +T
Sbjct: 52 AHAGNAIPSADQIRIAPSL---KSQRGSVWTKTKAAFE--------NWEVEVTFRVTGRG 100
Query: 107 PSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAGLGFVAVEFDTLMDVEFSDINGNHVG 166
GLA T + G GS + + V + FD+ D +G
Sbjct: 101 RIG-ADGLAIWYTENQGLDGPVFGSADMWN-------GVGIFFDS------FDNDGKKNN 146
Query: 167 LDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLTRAFNISVSYSNLKPKVPI-LSFT 225
+ + + N D N D + L + ++ ++Y V I FT
Sbjct: 147 PAIVVVGNNGQINYDHQN-DGATQALASCQRDFRNKPYPVRAKITYYQKTLTVMINNGFT 205
Query: 226 LDLDQYVNDF----------MYVGFSGSTQGSTEIHSIEWWSFSSSFESNSGTGSGSAPP 275
D + Y + G S +T G + H + SF + T G PP
Sbjct: 206 PDKNDYEFCAKVENMVIPTQGHFGISAATGGLADDHDV------LSFLTFQLTEPGKEPP 259
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 70.6 bits (174), Expect = 2e-13
Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 36/215 (16%)
Query: 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEF---------LSELSIIGT 432
F R +G G+FG V+ NG A+K K+ E ++
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLK-----KEIVVRLKQVEHTNDERLMLSI 62
Query: 433 LRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALF-----EARSPLPWPHRSKILLG-V 486
+ H ++R+ G + +I ++ D + G L F R P P +K V
Sbjct: 63 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL----FSLLRKSQRFPNP---VAKFYAAEV 115
Query: 487 ASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVA-AGTM 545
AL YLH +I+RD+K NI+LD+ + ++ DFG A+ V PD T GT
Sbjct: 116 CLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV-----PDVTYTLCGTP 167
Query: 546 GYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRP 580
Y+APE + T + D +S+G ++ E+ +G P
Sbjct: 168 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 3e-13
Identities = 65/235 (27%), Positives = 94/235 (40%), Gaps = 20/235 (8%)
Query: 356 SESFTSDIIRMPKEFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCS- 414
S S S M + + R F +++G G FG V G A+K
Sbjct: 124 SPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKK 183
Query: 415 HNSQGKDEF---LSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALF--- 468
KDE L+E ++ RH L L+ + V + G LF
Sbjct: 184 EVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE----LFFHL 239
Query: 469 --EARSPLPWPHRSKILLG-VASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFG 525
E R++ + SAL YLH E V++RD+K N+MLD+ + ++ DFG
Sbjct: 240 SRERVFSED---RARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFG 294
Query: 526 LARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRP 580
L ++ D + T GT YLAPE L D + G V+ E+ GR P
Sbjct: 295 LCKEGIKDGATMKTF-CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >2dur_A VIP36;, vesicular integral-membrane protein VIP36; beta sandwich, carbohydrate binding protein, cargo receptor, transport; HET: MAN; 1.65A {Canis lupus familiaris} PDB: 2dup_A 2duq_A* 2duo_A* 2e6v_A* Length = 253 | Back alignment and structure |
|---|
Score = 68.0 bits (165), Expect = 8e-13
Identities = 38/241 (15%), Positives = 76/241 (31%), Gaps = 36/241 (14%)
Query: 37 DFGTLTLASLKLLGDAHMNNGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTHTPASFST 96
G+ ++ G + + VRLT D G +P + +
Sbjct: 18 GVGSSSMPLWDFQGSTILTSQYVRLTPD---ERSKEGSIWNHQPCFLK--------DWEM 66
Query: 97 FFSFSITNLNPSSIGA-GLAFVITPDGEQVGSAGGSLGLLDEKGAGLGFVAVEFDTLMDV 155
F + ++ G+A T D G GS +A+ DT +
Sbjct: 67 HVHFKVHGTGKKNLHGDGIALWYTRDRLVPGPVFGSKDNFH-------GLAIFLDTYPND 119
Query: 156 EFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLTRAFNISVSYSNL 215
E ++ ++ + +N+ S D+ + D + +L ++ ++V YS
Sbjct: 120 ETTERVFPYISVMVNN-GSLSYDH----SKDGRWTELAGCTADFRNRDHDTFLAVRYSRG 174
Query: 216 KPKVPILSFTLDLDQYVNDF----------MYVGFSGSTQGSTEIHSIEWWSFSSSFESN 265
+ V D +++ N Y G S T ++ H I +
Sbjct: 175 RLTVMT--DLEDKNEWKNCIDITGVRLPTGYYFGASAGTGDLSDNHDIISMKLFQLMVEH 232
Query: 266 S 266
+
Sbjct: 233 T 233
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 1e-12
Identities = 57/217 (26%), Positives = 100/217 (46%), Gaps = 31/217 (14%)
Query: 381 CFNANRIIGHGAFGTVY---KGILPQNGDIIAVK--RCSHNSQGKDEF---LSELSIIGT 432
CF R++G G +G V+ K G I A+K + + + + +E +I+
Sbjct: 18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEE 77
Query: 433 LRHRNLVRLQGWC---HEKGEILLVYDLMPNGSLDKALF-----EARSPLPWPHRSKILL 484
++H +V L + K + L+ + + G L F E + L
Sbjct: 78 VKHPFIVDLI-YAFQTGGK--LYLILEYLSGGEL----FMQLEREGIFMED---TACFYL 127
Query: 485 G-VASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAG 543
++ AL +LH + +I+RD+K NIML+ + +L DFGL ++ HD + T G
Sbjct: 128 AEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTF-CG 183
Query: 544 TMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRP 580
T+ Y+APE L+ D +S GA++ ++ +G P
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 46/212 (21%), Positives = 81/212 (38%), Gaps = 37/212 (17%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVK----RCSHNSQGKDE--FLSELSIIGTLRHRNLV 439
++IG G+FG V K + +A+K + Q +E L L N++
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 440 RLQGWCHEKGEILLVYDLMPNGSLDKALFEAR-----SPLPWPHRSKILLGVASALAYLH 494
+ + I + ++L L L+E P K + L LH
Sbjct: 163 HMLENFTFRNHICMTFEL-----LSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH 217
Query: 495 QECENQVIHRDVKTSNIMLDEGFNA--RLGDFGLARQVEHDKSPDATVAAGTMGYL---- 548
+ N++IH D+K NI+L + + ++ DFG + Y+
Sbjct: 218 K---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYT----------YIQSRF 264
Query: 549 --APEYLLTGRATEKTDVFSYGAVVLEVASGR 578
APE +L R D++S G ++ E+ +G
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 3e-12
Identities = 60/219 (27%), Positives = 105/219 (47%), Gaps = 37/219 (16%)
Query: 381 CFNANRIIGHGAFGTVY---KGILPQNGDIIAVK--RCSHNSQGKDEF--LSELSIIGTL 433
F +++G G+FG V+ K + A+K + + +D E I+ +
Sbjct: 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV-RDRVRTKMERDILVEV 83
Query: 434 RHRNLVRL----QGWCHEKGEILLVYDLMPNGSLDKALF-----EARSPLPWPHRSKILL 484
H +V+L Q +G++ L+ D + G L F E K L
Sbjct: 84 NHPFIVKLHYAFQ----TEGKLYLILDFLRGGDL----FTRLSKEVMFTEE---DVKFYL 132
Query: 485 G-VASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQ-VEHDKSPDATVAA 542
+A AL +LH +I+RD+K NI+LDE + +L DFGL+++ ++H+K A
Sbjct: 133 AELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFC 187
Query: 543 GTMGYLAPEYLLTGRATEKT-DVFSYGAVVLEVASGRRP 580
GT+ Y+APE ++ R ++ D +S+G ++ E+ +G P
Sbjct: 188 GTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 45/219 (20%), Positives = 88/219 (40%), Gaps = 35/219 (15%)
Query: 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVK----RCSHNSQGKDE--FLSELSIIGT 432
+ + +IG G+FG V K + +A+K + + +Q + E L ++ T
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDT 112
Query: 433 LRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEA-----RSPLPWPHRSKILLGVA 487
+V L+ + + LV+++ L L++ + K +
Sbjct: 113 EMKYYIVHLKRHFMFRNHLCLVFEM-----LSYNLYDLLRNTNFRGVSLNLTRKFAQQMC 167
Query: 488 SALAYLHQECENQVIHRDVKTSNIMLDEGFNA--RLGDFGLARQVEHDKSPDATVAAGTM 545
+AL +L E +IH D+K NI+L + ++ DFG + Q+
Sbjct: 168 TALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ--------- 217
Query: 546 GYL------APEYLLTGRATEKTDVFSYGAVVLEVASGR 578
Y+ +PE LL D++S G +++E+ +G
Sbjct: 218 -YIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 7e-12
Identities = 54/217 (24%), Positives = 99/217 (45%), Gaps = 27/217 (12%)
Query: 381 CFNANRIIGHGAFGTVY---KGILPQNGDIIAVK-----RCSHNSQGKDEFLSELSIIGT 432
F +++G GA+G V+ K G + A+K ++ + +E ++
Sbjct: 55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 114
Query: 433 LRHRN-LVRLQGWCHEKGEILLVYDLMPNGSLDKALF-----EARSPLPWPHRSKILLG- 485
+R LV L + ++ L+ D + G L F R +I +G
Sbjct: 115 IRQSPFLVTLHYAFQTETKLHLILDYINGGEL----FTHLSQRERFTEH---EVQIYVGE 167
Query: 486 VASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTM 545
+ AL +LH + +I+RD+K NI+LD + L DFGL+++ D++ A GT+
Sbjct: 168 IVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 224
Query: 546 GYLAPEYLLTGRA--TEKTDVFSYGAVVLEVASGRRP 580
Y+AP+ + G + + D +S G ++ E+ +G P
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 66.5 bits (162), Expect = 8e-12
Identities = 51/259 (19%), Positives = 86/259 (33%), Gaps = 69/259 (26%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLR--------HRN 437
R +G G F TV+ Q +A+K + L E+ ++ ++R
Sbjct: 43 RKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREM 102
Query: 438 LVRLQGWCHEKGE----ILLVYDLM-PNGSLDKALFEARSPLPWPHRSKILLGVASALAY 492
+V+L G I +V++++ + + LP P KI+ V L Y
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQ-GLPLPCVKKIIQQVLQGLDY 161
Query: 493 LHQECENQVIHRDVKTSNIML--------------------------------------- 513
LH +C ++IH D+K NI+L
Sbjct: 162 LHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGN 219
Query: 514 ----------DEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTD 563
E ++ D G A V + D T Y + E L+ D
Sbjct: 220 FLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ----TRQYRSLEVLIGSGYNTPAD 275
Query: 564 VFSYGAVVLEVASGRRPIE 582
++S + E+A+G E
Sbjct: 276 IWSTACMAFELATGDYLFE 294
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 3e-11
Identities = 59/210 (28%), Positives = 88/210 (41%), Gaps = 21/210 (10%)
Query: 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVK--RCSHNSQGKDEF---LSELSIIGTLRH 435
F+ +++G G FG V G A+K R KDE ++E ++ RH
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA-KDEVAHTVTESRVLQNTRH 64
Query: 436 RNLVRLQGWCHEKGEILLVYDLMPNGSLDKALF----EARSPLPWPHRSKILLG-VASAL 490
L L+ + V + G L F E R++ + SAL
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEE---RARFYGAEIVSAL 118
Query: 491 AYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAP 550
YLH V++RD+K N+MLD+ + ++ DFGL ++ D + T GT YLAP
Sbjct: 119 EYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF-CGTPEYLAP 174
Query: 551 EYLLTGRATEKTDVFSYGAVVLEVASGRRP 580
E L D + G V+ E+ GR P
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 65.0 bits (158), Expect = 5e-11
Identities = 49/216 (22%), Positives = 88/216 (40%), Gaps = 32/216 (14%)
Query: 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRN--- 437
FN ++G G+FG V ++ AVK KD + + + T+ +
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK-----KDVVIQDDDVECTMVEKRVLA 396
Query: 438 -------LVRLQGWCHEKGEILLVYDLMPNGSLDKALF----EARSPLPWPHRSKILLG- 485
L +L + V + + G L ++ R P +
Sbjct: 397 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEP---HAVFYAAE 450
Query: 486 VASALAYLHQECENQVIHRDVKTSNIMLD-EGFNARLGDFGLARQVEHDKSPDATVAAGT 544
+A L +L +I+RD+K N+MLD EG ++ DFG+ ++ D T GT
Sbjct: 451 IAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTF-CGT 505
Query: 545 MGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRP 580
Y+APE + + D +++G ++ E+ +G+ P
Sbjct: 506 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 62.6 bits (151), Expect = 1e-10
Identities = 40/267 (14%), Positives = 72/267 (26%), Gaps = 72/267 (26%)
Query: 361 SDIIRMPKEFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRC------- 413
+ +L+ K IG G FG V++ I + +A+K
Sbjct: 8 KGPVPFSHCLPTEKLQRCEK-------IGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDL 58
Query: 414 --SHNSQGKDEFLSE---------LSIIGTLRHRNLVRLQGWCHEKG----EILLVYDL- 457
+ + +E L E LS R + L +G +L +D
Sbjct: 59 VNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHY 118
Query: 458 ------------------------MPNGSLDKALFEARSPLPWPHRSKILLGVASALAYL 493
G +D IL + ++LA
Sbjct: 119 NSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-TKLSSLATAKSILHQLTASLAVA 177
Query: 494 HQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEH----------DKSPDATVAAG 543
+ HRD+ N++L + +L + D + G
Sbjct: 178 EASL--RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG 235
Query: 544 TMGYL---APEYLLTGRATEKTDVFSY 567
+ + E L TG + D++
Sbjct: 236 IVVFCDVSMDEDLFTGDGDYQFDIYRL 262
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 36/95 (37%), Positives = 49/95 (51%), Gaps = 4/95 (4%)
Query: 486 VASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTM 545
+ASAL YLH +++RD+K NI+LD + L DFGL ++ S +T GT
Sbjct: 148 IASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTF-CGTP 203
Query: 546 GYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRP 580
YLAPE L D + GAV+ E+ G P
Sbjct: 204 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >2ltn_B PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1hkd_B 1rin_B* 1ofs_B* 1bqp_B* 1loe_B 1loa_B* 1loc_B* 1lod_B* 1lob_B 1lof_B* 1log_B* 1lof_D* 1les_B* 2b7y_B* 1lgc_B* 1lgb_B* 1len_B 1lem_B 2lal_B Length = 52 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 2e-10
Identities = 14/49 (28%), Positives = 22/49 (44%)
Query: 220 PILSFTLDLDQYVNDFMYVGFSGSTQGSTEIHSIEWWSFSSSFESNSGT 268
LS + L V +++ +GFS +T H + WSF S S +
Sbjct: 4 YTLSDVVSLKDVVPEWVRIGFSATTGAEYAAHEVLSWSFHSELSGTSSS 52
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 6e-10
Identities = 28/169 (16%), Positives = 52/169 (30%), Gaps = 31/169 (18%)
Query: 386 RIIGHGAFGTVYKGILPQNGDI--------IAVKRCSHNSQGKDEFLSELSIIGTLRHRN 437
G +Y+ ++K + + + +E L+
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 438 LVRLQG----------WC--HEKGEILLVYDLMPNG-SLDKALFEARSPLPWPHRSKILL 484
+L H+ LV + G SL + RS + +
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQS-ALDVSPKHVLSERSVLQV 164
Query: 485 GV--ASALAYLHQECENQVIHRDVKTSNIMLDEGFNAR--LGDFGLARQ 529
AL +LH EN+ +H +V NI +D ++ L +G A +
Sbjct: 165 ACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 7e-10
Identities = 29/96 (30%), Positives = 51/96 (53%), Gaps = 6/96 (6%)
Query: 486 VASALAYLHQECENQVIHRDVKTSNIMLD-EGFNARLGDFGLARQVEHDKSPDATVAAGT 544
+ L +LH +++RD+K NI+LD +G ++ DFG+ ++ + T GT
Sbjct: 127 IILGLQFLH---SKGIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNTF-CGT 181
Query: 545 MGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRP 580
Y+APE LL + D +S+G ++ E+ G+ P
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 8e-10
Identities = 30/98 (30%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 486 VASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAA--G 543
+ SAL +LH + +I+RD+K N++LD + +L DFG+ ++ T A G
Sbjct: 133 IISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE---GICNGVTTATFCG 186
Query: 544 TMGYLAPEYLLTGRATEKT-DVFSYGAVVLEVASGRRP 580
T Y+APE +L D ++ G ++ E+ G P
Sbjct: 187 TPDYIAPE-ILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 8e-10
Identities = 54/252 (21%), Positives = 98/252 (38%), Gaps = 35/252 (13%)
Query: 347 SKRYKHVKKSESFTSDIIRMPKEFSYRELRSAT-KCFNANRIIGHGAFGTVYKGILPQNG 405
Y + M S + S + F+ R+IG G++ V L +
Sbjct: 18 ENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTD 77
Query: 406 DIIAVKRCSHNSQGKDEFLSELSIIGTLRHRN----------LVRLQGWCHEKGEILLVY 455
I A++ K+ + I ++ LV L + + V
Sbjct: 78 RIYAMRVVK-----KELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 132
Query: 456 DLMPNGSLDKALF----EARSPLPWPHRSKILLG-VASALAYLHQECENQVIHRDVKTSN 510
+ + G L +F + + P ++ ++ AL YLH E +I+RD+K N
Sbjct: 133 EYVNGGDL---MFHMQRQRKLPEE---HARFYSAEISLALNYLH---ERGIIYRDLKLDN 183
Query: 511 IMLDEGFNARLGDFGLARQVEHDKSPDATVAA--GTMGYLAPEYLLTGRATEKTDVFSYG 568
++LD + +L D+G+ ++ P T + GT Y+APE L D ++ G
Sbjct: 184 VLLDSEGHIKLTDYGMCKE---GLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALG 240
Query: 569 AVVLEVASGRRP 580
++ E+ +GR P
Sbjct: 241 VLMFEMMAGRSP 252
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 9e-10
Identities = 29/96 (30%), Positives = 51/96 (53%), Gaps = 6/96 (6%)
Query: 486 VASALAYLHQECENQVIHRDVKTSNIMLD-EGFNARLGDFGLARQVEHDKSPDATVAAGT 544
+A L +L +I+RD+K N+MLD EG ++ DFG+ ++ D T GT
Sbjct: 130 IAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTF-CGT 184
Query: 545 MGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRP 580
Y+APE + + D +++G ++ E+ +G+ P
Sbjct: 185 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 51/216 (23%), Positives = 91/216 (42%), Gaps = 34/216 (15%)
Query: 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRN---- 437
F+ R+IG G++ V L + I A+K K+ + I ++
Sbjct: 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVK-----KELVNDDEDIDWVQTEKHVFEQ 65
Query: 438 ------LVRLQGWCHEKGEILLVYDLMPNGSLDKALF----EARSPLPWPHRSKILLG-V 486
LV L + + V + + G L +F + + P ++ +
Sbjct: 66 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEE---HARFYSAEI 119
Query: 487 ASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAA--GT 544
+ AL YLH E +I+RD+K N++LD + +L D+G+ ++ P T + GT
Sbjct: 120 SLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE---GLRPGDTTSTFCGT 173
Query: 545 MGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRP 580
Y+APE L D ++ G ++ E+ +GR P
Sbjct: 174 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 46/223 (20%), Positives = 83/223 (37%), Gaps = 43/223 (19%)
Query: 386 RIIGHGAFGTVYKGI-LPQNGDIIAVK----RCSHNSQGKDEFLSELSIIGTLRHR---- 436
+G G FG V + + + +A+K + + E ++++ ++ +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE----INVLKKIKEKDKEN 80
Query: 437 --NLVRLQGWCHEKGEILLVYDLMPNGSLDKALFE-----ARSPLPWPHRSKILLGVASA 489
V + W + G + + ++L L K FE P P PH + + A
Sbjct: 81 KFLCVLMSDWFNFHGHMCIAFEL-----LGKNTFEFLKENNFQPYPLPHVRHMAYQLCHA 135
Query: 490 LAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD--------ATVA 541
L +LH ENQ+ H D+K NI+ L + + + + K+ AT
Sbjct: 136 LRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFD 192
Query: 542 AGTMG-------YLAPEYLLTGRATEKTDVFSYGAVVLEVASG 577
Y PE +L + DV+S G ++ E G
Sbjct: 193 HEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 50/227 (22%), Positives = 82/227 (36%), Gaps = 47/227 (20%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVK----RCSHNSQGKDEFLSELSIIGTLRHR----- 436
R +G G FG V N AVK + K E I+ +++
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI----EADILKKIQNDDINNN 96
Query: 437 NLVRLQGWCHEKGEILLVYDLMPNGSLDKALFE-----ARSPLPWPHRSKILLGVASALA 491
N+V+ G + L+++ L +L+E + + + AL
Sbjct: 97 NIVKYHGKFMYYDHMCLIFEP-----LGPSLYEIITRNNYNGFHIEDIKLYCIEILKALN 151
Query: 492 YLHQECENQVIHRDVKTSNIMLDEG------FNARLGDFGLARQVEHDKSPD-------- 537
YL + + H D+K NI+LD+ R G Q+ KS
Sbjct: 152 YLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC 208
Query: 538 ATVAAGTMG-------YLAPEYLLTGRATEKTDVFSYGAVVLEVASG 577
AT + G Y APE +L +D++S+G V+ E+ +G
Sbjct: 209 ATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 6e-09
Identities = 47/223 (21%), Positives = 83/223 (37%), Gaps = 43/223 (19%)
Query: 386 RIIGHGAFGTVYKGI-LPQNGDIIAVK----RCSHNSQGKDEFLSELSIIGTLRHR---- 436
+G GAFG V + I G +AVK + + E + ++ L
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSE----IQVLEHLNTTDPNS 75
Query: 437 --NLVRLQGWCHEKGEILLVYDLMPNGSLDKALFE-----ARSPLPWPHRSKILLGVASA 489
V++ W G I +V++L L + ++ P H K+ + +
Sbjct: 76 TFRCVQMLEWFEHHGHICIVFEL-----LGLSTYDFIKENGFLPFRLDHIRKMAYQICKS 130
Query: 490 LAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD--------ATVA 541
+ +LH N++ H D+K NI+ + + + R +PD AT
Sbjct: 131 VNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYD 187
Query: 542 AGTMG-------YLAPEYLLTGRATEKTDVFSYGAVVLEVASG 577
Y APE +L ++ DV+S G +++E G
Sbjct: 188 DEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 32/170 (18%), Positives = 56/170 (32%), Gaps = 36/170 (21%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCS----HNSQGKDEF-----LSELSIIGTLRHR 436
+ IG G FG +Y + A N E +++ I R
Sbjct: 43 KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIER 102
Query: 437 NLVRLQG-----WC--HEKGEI---LLVYDLMPNG-SLDKALFEARSPLPWPHRSKILLG 485
+ G E +V + + G L K + +L
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQK-ISGQNGTFK----KSTVLQ 155
Query: 486 VA----SALAYLHQECENQVIHRDVKTSNIMLDEGFNAR--LGDFGLARQ 529
+ L Y+H EN+ +H D+K +N++L + L D+GL+ +
Sbjct: 156 LGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYR 202
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 6e-07
Identities = 36/160 (22%), Positives = 65/160 (40%), Gaps = 31/160 (19%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVK---RCSHNSQGKDEFLSELSIIGTLRHRNLVRLQ 442
+ IG G FG + G + +A+K S Q E+ + + ++
Sbjct: 15 KKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSG---DGIPQVY 71
Query: 443 GWCHEKGEILLVYDLMPNG-SLDKALFEARSPLPWPHRS---KILLGVA----SALAYLH 494
+ +V +L+ G SL+ LF+ R+ K +L +A S + Y+H
Sbjct: 72 YFGPCGKYNAMVLELL--GPSLED-LFD------LCDRTFSLKTVLMIAIQLISRMEYVH 122
Query: 495 QECENQVIHRDVKTSNIMLDEGFNAR-----LGDFGLARQ 529
+ +I+RDVK N ++ N + DF LA++
Sbjct: 123 SKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 37/160 (23%), Positives = 68/160 (42%), Gaps = 31/160 (19%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVK---RCSHNSQGKDEFLSELSIIGTLRHRNLVRLQ 442
R IG G+FG +++G N +A+K R S Q +DE+ + + G + +
Sbjct: 16 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGC---TGIPNVY 72
Query: 443 GWCHEKGEILLVYDLMPNG-SLDKALFEARSPLPWPHRS---KILLGVA----SALAYLH 494
+ E +LV DL+ G SL+ L + R K + A + + +H
Sbjct: 73 YFGQEGLHNVLVIDLL--GPSLED-LLD------LCGRKFSVKTVAMAAKQMLARVQSIH 123
Query: 495 QECENQVIHRDVKTSNIMLDEGFNAR-----LGDFGLARQ 529
E +++RD+K N ++ + + DFG+ +
Sbjct: 124 ---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 37/175 (21%), Positives = 65/175 (37%), Gaps = 43/175 (24%)
Query: 386 RIIGHGAFGTVYKGILPQNGDI-----IAVKRCSH-NSQGKDEF-----LSELSIIGTLR 434
IG G FG +Y + + + VK N E ++ I
Sbjct: 41 LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100
Query: 435 HRNLVRLQG-----WC--HEKGEI---LLVYDLMPNG-SLDKALFEARS---PLPWPHRS 480
++ G H+K ++ D G L K ++EA +
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQK-IYEANAKRFSR------ 151
Query: 481 KILLGVA----SALAYLHQECENQVIHRDVKTSNIMLDEGFNAR--LGDFGLARQ 529
K +L ++ L Y+H E++ +H D+K SN++L+ + L D+GLA +
Sbjct: 152 KTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYR 203
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 44/166 (26%), Positives = 68/166 (40%), Gaps = 45/166 (27%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRH--RNLVRLQG 443
R IG G+FG +Y G G+ +A+K ++ L + +QG
Sbjct: 15 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-----------QLHIESKIYKMMQG 63
Query: 444 --------WC-HEKGEILLVYDLMPNG-SLDKALFEARSPLPWPHRS---KILLGVA--- 487
WC E ++V +L+ G SL+ LF + R K +L +A
Sbjct: 64 GVGIPTIRWCGAEGDYNVMVMELL--GPSLED-LFN------FCSRKFSLKTVLLLADQM 114
Query: 488 -SALAYLHQECENQVIHRDVKTSNIMLDEGFNA---RLGDFGLARQ 529
S + Y+H IHRDVK N ++ G + DFGLA++
Sbjct: 115 ISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 41/162 (25%), Positives = 67/162 (41%), Gaps = 37/162 (22%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVK---RCSHNSQGKDEFLSELSIIGTLRHRNLVRLQ 442
R IG G+FG +Y G Q + +A+K + + Q E + LQ
Sbjct: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYES------------KIYRILQ 60
Query: 443 G--------WC-HEKGEILLVYDLMPNG-SLDKALFEARSPLPWPHRSKILLGV--ASAL 490
G W E +LV DL+ G SL+ LF ++ ++L + +
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLL--GPSLED-LFN-FCSRKLSLKTVLMLADQMINRV 116
Query: 491 AYLHQECENQVIHRDVKTSNIMLDEGFNAR---LGDFGLARQ 529
++H +HRD+K N ++ G A + DFGLA++
Sbjct: 117 EFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.8 bits (105), Expect = 1e-04
Identities = 42/276 (15%), Positives = 84/276 (30%), Gaps = 59/276 (21%)
Query: 4 FSCKIL-TSLNLSLVFCLFVINNAVITISTATEFDFGTLTLA-SLKLLGDAHMNNGSVRL 61
SCKIL T+ + L I++ + TLT LL ++ L
Sbjct: 264 LSCKILLTTRFKQVTDFLSAATTTHISL----DHHSMTLTPDEVKSLLLKY-LDCRPQDL 318
Query: 62 TRDV--TVPY--DGAGKALYSKPVR---FRLPGTHTPASFSTFFSFSITNLNPSSIGAGL 114
R+V T P +++ ++ +T S+ L P+
Sbjct: 319 PREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDK---LTTIIESSLNVLEPAEYRKMF 375
Query: 115 -AFVITPDG----EQVGSAGGSLGLL--DEKGAGLGFVAVEFDTLMDVEFSDINGNHVGL 167
+ P + L L+ D + + V + VE + + +
Sbjct: 376 DRLSVFPPSAHIPTIL------LSLIWFDVIKSDVMVVVNKLHKYSLVE-KQPKESTISI 428
Query: 168 -DLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTL 226
+ + +++N ++ S +++ + + F+ +L P
Sbjct: 429 PSIYLELKVKLENEYALH---------RSIVDHYNIPKTFD----SDDLIPPY------- 468
Query: 227 DLDQYVNDFMYVGFSGSTQGSTEIHSIEWWSFSSSF 262
LDQY + ++G E F F
Sbjct: 469 -LDQYF--YSHIGHHLKNIEHPE----RMTLFRMVF 497
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 711 | |||
| 3ujo_A | 281 | Legume lectin; carbohydrate-binding, galactose, ad | 100.0 | |
| 3ipv_A | 251 | Lectin alpha chain; galactose binding, SEED lectin | 100.0 | |
| 3zyr_A | 261 | Lectin; sugar binding protein, N-glycan; HET: NAG | 100.0 | |
| 1fny_A | 237 | BARK lectin, BARK agglutinin I,polypeptide A; legu | 100.0 | |
| 1fx5_A | 242 | UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HO | 100.0 | |
| 1dbn_A | 239 | MAL, protein (leukoagglutinin); plant lectin, carb | 100.0 | |
| 1gzc_A | 239 | Erythrina crista-galli lectin; carbohydrate, sugar | 100.0 | |
| 1v6i_A | 232 | Agglutinin, PNA, galactose-binding lectin; open qu | 100.0 | |
| 1g7y_A | 253 | Stem/LEAF lectin DB58; jelly roll fold, sugar bind | 100.0 | |
| 1sbf_A | 253 | Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {G | 100.0 | |
| 2eig_A | 234 | Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG bin | 100.0 | |
| 1hql_A | 257 | Lectin; xenograft antigen, sugar BI protein; HET: | 100.0 | |
| 1gsl_A | 243 | Griffonia simplicifolia lectin 4; glycoprotein, ma | 100.0 | |
| 1fat_A | 252 | Phytohemagglutinin-L; glycoprotein, plant defense | 100.0 | |
| 2bqp_A | 234 | Protein (PEA lectin); D-glucopyranose complex, sug | 100.0 | |
| 1qnw_A | 242 | Chitin binding lectin, UEA-II; carbohydrate bindin | 100.0 | |
| 1f9k_A | 238 | Acidic lectin; legume lectin, glycosylated protein | 100.0 | |
| 1wbf_A | 242 | Protein (agglutinin); lectin (agglutinin), legume | 100.0 | |
| 1n47_A | 233 | Isolectin B4; cancer antigen, vicia villosa lectin | 100.0 | |
| 2fmd_A | 240 | Lectin, agglutinin, BMA; legume lectin, beta sandw | 100.0 | |
| 1avb_A | 226 | Arcelin-1; lectin-like glycoprotein, plant defense | 100.0 | |
| 1ioa_A | 240 | Arcelin-5A, ARC5A; lectin-like proteins, plant def | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1dhk_B | 223 | Bean lectin-like inhibitor, porcine pancreatic alp | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2ltn_A | 181 | PEA lectin, alpha chain; 1.70A {Pisum sativum} SCO | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 1qmo_E | 133 | Mannose binding lectin, FRIL; crosslink, hematopoi | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2dur_A | 253 | VIP36;, vesicular integral-membrane protein VIP36; | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1gv9_A | 260 | P58/ergic-53; lectin, carbohydrate binding; 1.46A | 100.0 | |
| 1nls_A | 237 | Concanavalin A; lectin, agglutinin; 0.94A {Canaval | 99.98 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 1qmo_A | 113 | Mannose binding lectin, FRIL; crosslink, hematopoi | 99.94 | |
| 2a6y_A | 256 | EMP47P (FORM1); beta sandwich, carbohydrate bindin | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 1nls_A | 237 | Concanavalin A; lectin, agglutinin; 0.94A {Canaval | 99.87 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 2a6z_A | 222 | EMP47P (FORM2); beta sandwich, carbohydrate bindin | 99.77 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.6 | |
| 2a6v_A | 226 | EMP46P; beta sandwich, carbohydrate binding protei | 99.54 | |
| 2ltn_B | 52 | PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP | 99.49 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.31 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.14 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.02 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.84 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.48 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.43 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.32 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.27 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.26 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.16 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.98 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.97 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.65 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.47 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.34 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.33 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.28 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.24 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.05 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.05 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.92 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.81 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.69 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.27 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.21 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.9 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.26 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 90.94 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 88.25 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 87.39 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 86.98 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 85.98 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 81.87 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 81.37 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 81.34 |
| >3ujo_A Legume lectin; carbohydrate-binding, galactose, adenine binding protein; HET: ADE GAL; 2.00A {Dolichos lablab} PDB: 3ujq_A* 3uk9_A* 3ul2_A* 1fat_A* 1g8w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-63 Score=504.76 Aligned_cols=244 Identities=31% Similarity=0.459 Sum_probs=205.7
Q ss_pred HHHHHHHHHHHhhccccCCccceeeecCCCCCCCeEEeCceEeeCCcEEeCCCCCC---CCCceEEEEeCCceeccCCCC
Q 043702 12 LNLSLVFCLFVINNAVITISTATEFDFGTLTLASLKLLGDAHMNNGSVRLTRDVTV---PYDGAGKALYSKPVRFRLPGT 88 (711)
Q Consensus 12 ~~~~~~~~~~~~~~~~~~~~~~~~f~~~~f~~~~~~~~g~a~~~~g~~~Lt~~~~~---~~~~~Gr~~y~~pv~l~~~~~ 88 (711)
++|++++||++++.+ .++.+++|+|++|...|++|+|||.+.+|.|+||++..+ ..+++|||+|++||+|||+++
T Consensus 7 ~~~~~~~fl~l~~~~--~sa~~~sF~f~~F~~~nL~l~GdA~i~~g~L~LT~~~~~~~p~~~s~Gra~Y~~Pi~l~d~~t 84 (281)
T 3ujo_A 7 TMKRIVLFLILLTKA--ASANLISFTFKKFNETNLILQRDATVSSGKLRITKAAENGVPTAGSLGRAFYSTPIQIWDNTT 84 (281)
T ss_dssp -------------------CEEEEEEESSCCSTTEEECSSCCCBTTBEECSCCCSSCCCCSSCEEEEEESSCEECBCSSS
T ss_pred HHHHHHHHHHHHccc--CcCCcceEEcCCCCccCEEEecceEEeCCEEEeCCCCCCCcccCCceEEEEECCCEEcccCCC
Confidence 344455555544433 346778999999998999999999999999999997652 124899999999999999999
Q ss_pred CCceeeEEEEEEEEecCCCCCCCCceEEEEcCCCCCCCCCCCcccccccCCCC--cceEEEEeecccCCCCCCCCCCeee
Q 043702 89 HTPASFSTFFSFSITNLNPSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAG--LGFVAVEFDTLMDVEFSDINGNHVG 166 (711)
Q Consensus 89 ~~~~sF~t~F~f~i~~~~~~~~g~GlaF~l~~~~~~~~~~g~~lgl~~~~~~~--~~~vaVEFDt~~n~~~~d~~~~Hvg 166 (711)
|+++||+|+|+|.|.+++...+||||||||+|.+..+++.||||||+|.+++. +++|||||||++|++| ||++||||
T Consensus 85 g~vaSFsTsFsF~I~~~~~~~~gdGlAF~laP~~~~p~~~gg~LGL~n~~~~~~~n~~vAVEFDT~~N~e~-Dp~~nHVG 163 (281)
T 3ujo_A 85 GTVASWATSFTFNLQAPNAASPADGLAFALVPVGSQPKDKGGFLGLFDSKNYASSNQTVAVEFDTFYNGGW-DPTERHIG 163 (281)
T ss_dssp CCBEEEEEEEEEECCCSSTTSCCEEEEEEEEETTCCCCCCGGGTTTCSCSSCCTTSCCEEEEECCSCCCSS-CCSSSEEE
T ss_pred CCceeEEEEEEEEEecCCCCCCCCceEEEEecCCCCCCCCcceeeeccccCCCccCcEEEEEEeccccccC-CCCCCeEE
Confidence 99999999999999988777899999999999887677889999999876433 8999999999999888 99999999
Q ss_pred EecCCCcccccccCCccccccCCCCeEEEEEEEcccccEEEEEEEecCCCCCcceeeEecCcccccccceeEEEeeeccC
Q 043702 167 LDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQG 246 (711)
Q Consensus 167 id~ns~~S~~~~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastg~ 246 (711)
|||||+.|.++.+ |++.+|+.++|||+||+.+++|+|++++.+. ++.|+|++.|||+++|||+||||||||||.
T Consensus 164 IDvNSi~S~~t~~-----~~l~~G~~~~vwI~Yd~~tk~L~V~l~~~~~-~~~~~lS~~vDL~~~L~e~v~VGFSAsTG~ 237 (281)
T 3ujo_A 164 IDVNSIKSIKTTS-----WDFANGENAEVLITYDSSTNLLVASLVHPSQ-KTSFIVSERVDLTSVLPEWVSVGFSATTGL 237 (281)
T ss_dssp EEESSSCCSCEEE-----CCCCSSCCEEEEEEECTTTCEEEEEEECTTT-CCCEEEEEECCSTTTSCSEEEEEEEEEECS
T ss_pred EEcCCCCcccccc-----ccccCCCEEEEEEEEeCCCCEEEEEEecCCC-CCCceEEEEechHHhccCcEEEEEEeecCC
Confidence 9999999987654 5678999999999999999999999998663 457899999999999999999999999996
Q ss_pred ---ceeeEEEEeeccccccCc
Q 043702 247 ---STEIHSIEWWSFSSSFES 264 (711)
Q Consensus 247 ---~~~~~~i~sW~f~s~~~~ 264 (711)
..|.|+|++|+|++++..
T Consensus 238 ~~~~~e~H~IlsWSFss~l~~ 258 (281)
T 3ujo_A 238 SKGYVETNEVLSWSFASKLSI 258 (281)
T ss_dssp STTSCCCCEEEEEEEEEEECS
T ss_pred CCcccceeEEEEEEEEEEcCC
Confidence 689999999999999853
|
| >3ipv_A Lectin alpha chain; galactose binding, SEED lectin, hemagglutinin, legume lectin fungal, sugar binding protein; 2.04A {Spatholobus parviflorus} PDB: 3ipv_B 3usu_B* 3usu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-61 Score=487.69 Aligned_cols=227 Identities=33% Similarity=0.472 Sum_probs=205.1
Q ss_pred cceeeecCCCC--CCCeEEeCceEe-eCCcEEeCCCCCC---CCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecC
Q 043702 32 TATEFDFGTLT--LASLKLLGDAHM-NNGSVRLTRDVTV---PYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNL 105 (711)
Q Consensus 32 ~~~~f~~~~f~--~~~~~~~g~a~~-~~g~~~Lt~~~~~---~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~ 105 (711)
.+++|+|++|. ..||+|+|||.+ .+|.|+||++..+ ..+++|||+|++||+|||+++|+++||+|+|+|.|.++
T Consensus 2 ~~~sF~f~~F~~~~~nl~l~GdA~v~~~g~L~LT~~~~~~~~~~~s~Gra~Y~~Pi~l~d~~tg~vaSFsT~F~F~I~~~ 81 (251)
T 3ipv_A 2 EETSFVFSKFKPLEPNLILQGDALVTVAGVLQLTNVDKNGVPEPSSLGRATYSAPINIWDSATGLVASFATSFRFTIYAP 81 (251)
T ss_dssp EEEEEEESSCCSSCTTEEEEETCEECTTSCEESSCBCTTSCBCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCS
T ss_pred cceEEEeCCCCCCCCCeEEeccEEecCCCeEEcCCCCCCCcccCCcEEEEEECCCEEeecCCCCceeeEEEEEEEEEeCC
Confidence 45799999998 689999999999 5899999997652 12489999999999999999999999999999999988
Q ss_pred CCCCCCCceEEEEcCCCCCCCCCCCcccccccCCC--CcceEEEEeecccCCCCCCCCCCeeeEecCCCcccccccCCcc
Q 043702 106 NPSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGA--GLGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTI 183 (711)
Q Consensus 106 ~~~~~g~GlaF~l~~~~~~~~~~g~~lgl~~~~~~--~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~S~~~~~~~~~ 183 (711)
+...+||||||||+|....++..||||||+|..++ .+++|||||||++|.+|+||++|||||||||+.|.++.+
T Consensus 82 ~~~~~gdGlAF~lap~~~~~~~~gg~LGL~n~~~~~~~n~~vAVEFDT~~n~~~~Dp~~nHVGIdvNsi~S~~t~~---- 157 (251)
T 3ipv_A 82 NIATIADGLAFFLAPVASAPDSGGGFLGLFDSAVSGSTYQTVAVEFDTYENTVFTDPPYTHIGFDVNSISSIKTVK---- 157 (251)
T ss_dssp STTSCCEEEEEEEEETTCCCCCCGGGTTTCSSSSCCTTSCCEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEE----
T ss_pred CCCCCCCceEEEEecCCCCCCCCCceeeeccccCCCccCcEEEEEEecccccccCCCCCCeEEEEcCCCcccccce----
Confidence 77789999999999988766678999999987643 389999999999999999999999999999999987654
Q ss_pred ccccCCCCeEEEEEEEcccccEEEEEEEecCCCCCcceeeEecCcccccccceeEEEeeeccCc---eeeEEEEeecccc
Q 043702 184 NVDLKSGDLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGS---TEIHSIEWWSFSS 260 (711)
Q Consensus 184 ~~~~~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastg~~---~~~~~i~sW~f~s 260 (711)
+++.+|+.++|||+||+.+++|+|+|++.+. +..|+|++.|||+++|||+|||||||+||.. .|.|+|++|+|++
T Consensus 158 -~~l~~G~~~~v~I~Yd~~tk~L~V~l~~~~~-~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~e~h~IlsWsF~s 235 (251)
T 3ipv_A 158 -WSLANGEAAKVLITYNSAVKLLVASLVYPSS-KTSFILADIVDLSSVLPEWVRVGFSAATGASGGKIETHDVFSWSFAS 235 (251)
T ss_dssp -CCCCTTCEEEEEEEEETTTTEEEEEEECTTT-CCEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCCCCCEEEEEEEEE
T ss_pred -eEecCCCEEEEEEEEeCCCCEEEEEEecCCC-CccceEEEEechHHhCCCcEEEEEEEecCCCccccceeEEEEEEEEE
Confidence 5688999999999999999999999998664 5678999999999999999999999999998 9999999999999
Q ss_pred ccCc
Q 043702 261 SFES 264 (711)
Q Consensus 261 ~~~~ 264 (711)
++..
T Consensus 236 ~l~~ 239 (251)
T 3ipv_A 236 KLAG 239 (251)
T ss_dssp EECC
T ss_pred ECCC
Confidence 9853
|
| >3zyr_A Lectin; sugar binding protein, N-glycan; HET: NAG BMA MAN GOL; 1.65A {Platypodium elegans} SCOP: b.29.1.1 PDB: 3zvx_A* 1ukg_A* 1q8o_A* 1q8q_A* 1q8s_A* 1q8v_A* 1q8p_A* 2auy_A* 2gme_A 2gmm_A* 2gmp_A* 2gn3_A* 2gn7_A* 2gnb_A* 2gnd_A* 2gnm_A* 2gnt_A 2phf_A* 2phr_A* 2pht_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-60 Score=477.80 Aligned_cols=226 Identities=32% Similarity=0.485 Sum_probs=202.8
Q ss_pred CCccceeeecCCCC--CCCeEEeCceEe-eCCcEEeCCCCCC---CCCceEEEEeCCceeccCCCCCCceeeEEEEEEEE
Q 043702 29 TISTATEFDFGTLT--LASLKLLGDAHM-NNGSVRLTRDVTV---PYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSI 102 (711)
Q Consensus 29 ~~~~~~~f~~~~f~--~~~~~~~g~a~~-~~g~~~Lt~~~~~---~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i 102 (711)
.++.+++|+|++|. ..+|+|+|||.+ .+|.|+||++..+ ...++|||+|++||+|||+++|+++||+|+|+|.|
T Consensus 7 ~sa~~~sF~f~~F~~~~~~l~l~GdA~i~~~g~L~LT~~~~~~~~~~~s~Gra~Y~~Pv~l~d~~tg~vaSFsT~F~F~I 86 (261)
T 3zyr_A 7 NSTDSLSFSFINFDRDERNLIFQGDAHTSRNNILQLTRTDSNGAPVRSTVGRILHSAQVRLWEKSTNRVANLQTQFSFFL 86 (261)
T ss_dssp -CCEEEEEEESSCCSCCTTEEEEETCEECTTSCEECSCBCTTSCBCSSEEEEEEESSCEECBCTTTCCBEEEEEEEEEEE
T ss_pred CcCcccEEEcCCCCCCCCCeEEeccEEecCCCeEEeCCCCCCCccccCCEEEEEECCCEEeecCCCCCceeEEEEEEEEE
Confidence 34678999999998 679999999999 5899999997542 22679999999999999999999999999999999
Q ss_pred ecCCCCCCCCceEEEEcCCCCC--CCCCCCcccccccCCCC----cceEEEEeecc---cCCCCCCCCCCeeeEecCCCc
Q 043702 103 TNLNPSSIGAGLAFVITPDGEQ--VGSAGGSLGLLDEKGAG----LGFVAVEFDTL---MDVEFSDINGNHVGLDLNSMV 173 (711)
Q Consensus 103 ~~~~~~~~g~GlaF~l~~~~~~--~~~~g~~lgl~~~~~~~----~~~vaVEFDt~---~n~~~~d~~~~Hvgid~ns~~ 173 (711)
.+. ...+||||||||+|.+.. .++.||||||+|..+++ |++|||||||+ +|.+| ||++|||||||||+.
T Consensus 87 ~~~-~~~~gdGlAF~lap~~~~~p~~~~g~~LGL~n~~~~g~~~~n~~vAVEFDT~~~~~n~~~-Dp~~nHVGIdvNsi~ 164 (261)
T 3zyr_A 87 SSP-LSNPADGIAFFIAPPDTTIPSGSAGGLLGLFNPRTALNESANQVLAVEFDTFFAQNSNTW-DPNYQHIGIDVNSIR 164 (261)
T ss_dssp ECS-SSSCCCEEEEEEECTTCCCCTTCCGGGTTTCCTTTTTCGGGCCCEEEEEECCCCTTTCTT-SCSSCEEEEEESSSS
T ss_pred ecC-CCCCCccEEEEEccCCCCCCCCCCCceeeeecccccCCCccCcEEEEEEeccccccCcCC-CCCCCeEEEEcCCCC
Confidence 986 567899999999998764 47889999999987653 69999999999 99888 999999999999999
Q ss_pred ccccccCCccccccCCCCeEEEEEEEcccccEEEEEEEecCCCCCcceeeEecCcccccccceeEEEeeeccCceeeEEE
Q 043702 174 STEVDNLDTINVDLKSGDLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGSTEIHSI 253 (711)
Q Consensus 174 S~~~~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastg~~~~~~~i 253 (711)
|.++.+ +.+.+|+.++|||+||+.+++|+|+|++.+. ..|+|++.|||+++|||+|||||||+||...|.|+|
T Consensus 165 S~~s~~-----~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~e~h~I 237 (261)
T 3zyr_A 165 SSKVVR-----WERREGKTLNVLVTYNPSTRTIDVVATYPDG--QRYQLSHVVDLTTILPEWVRVGFSAASGEQFQTHNL 237 (261)
T ss_dssp CSEEEE-----CCCCTTCCEEEEEEEETTTTEEEEEEECTTC--CEEEEEEECCGGGTSCSEEEEEEEEEESSSCCEEEE
T ss_pred cccccc-----ccccCCceEEEEEEEcCCCCEEEEEEEcCCC--CCeEEEEEechHHhCcCcEEEEEEecCCCccceEEE
Confidence 987654 5678999999999999999999999998763 378999999999999999999999999999999999
Q ss_pred EeeccccccC
Q 043702 254 EWWSFSSSFE 263 (711)
Q Consensus 254 ~sW~f~s~~~ 263 (711)
++|+|++++.
T Consensus 238 lsWsF~s~l~ 247 (261)
T 3zyr_A 238 ESWSFTSTLL 247 (261)
T ss_dssp EEEEEEEEEC
T ss_pred EEEEEEEEcC
Confidence 9999999985
|
| >1fny_A BARK lectin, BARK agglutinin I,polypeptide A; legume lectin, jelly roll, sugar binding protein; 1.81A {Robinia pseudoacacia} SCOP: b.29.1.1 PDB: 1fnz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-59 Score=471.12 Aligned_cols=223 Identities=30% Similarity=0.492 Sum_probs=199.1
Q ss_pred ceeeecCCCC--CCCeEEeCceEee-CCcEEeCCCCCC--CCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecCCC
Q 043702 33 ATEFDFGTLT--LASLKLLGDAHMN-NGSVRLTRDVTV--PYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLNP 107 (711)
Q Consensus 33 ~~~f~~~~f~--~~~~~~~g~a~~~-~g~~~Lt~~~~~--~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~ 107 (711)
+++|+|++|. ..+|+|+|||.+. +|.|+||++... ..+++|||+|++||+|||+.+|+++||+|+|+|.|.+++.
T Consensus 3 ~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pi~l~d~~tg~vaSFsT~F~F~I~~~~~ 82 (237)
T 1fny_A 3 SLSFSFPKFAPNQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWDSTTGNVASFVTSFTFIIQAPNP 82 (237)
T ss_dssp EEEEEESSCCTTCTTEEEEETCEECTTSCEECSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCSST
T ss_pred ceEEEcCCCCCCCCCeEEcccEEeccCCeEEecCCcCCCcccCceEEEEeCCCEecccCCCCCccceEEEEEEEEeCCCC
Confidence 5789999998 6799999999996 799999987510 1278999999999999999999999999999999998777
Q ss_pred CCCCCceEEEEcCCCCCCCCCCCcccccccCCCC--cceEEEEeecccCCCCCCCCCCeeeEecCCCcccccccCCcccc
Q 043702 108 SSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAG--LGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINV 185 (711)
Q Consensus 108 ~~~g~GlaF~l~~~~~~~~~~g~~lgl~~~~~~~--~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~S~~~~~~~~~~~ 185 (711)
..+||||||||+|...++++.||||||+|..++. +++|||||||++|.+| ||++|||||||||+.|.++.++
T Consensus 83 ~~~gdGlAF~l~p~~~~~~~~g~~LGl~n~~~~~~~~~~vAVEFDT~~n~~~-Dp~~nHVGIdvNsi~S~~~~~~----- 156 (237)
T 1fny_A 83 ATTADGLAFFLAPVDTQPLDLGGMLGIFKDGYFNKSNQIVAVEFDTFSNGDW-DPKGRHLGINVNSIESIKTVPW----- 156 (237)
T ss_dssp TSCCEEEEEEEEETTCCCCCCGGGTTTCC---CCTTSCCEEEEEECSCCTTT-CCSSSEEEEEESSSSCSEEEEC-----
T ss_pred CCCCCCEEEEeccCCCCCCCCCCcccccccCCCCccccEEEEEeecccCccc-CCCCCceEEecCCccccccccc-----
Confidence 7889999999999877777889999999865332 8999999999999885 9999999999999999876554
Q ss_pred ccCCCCeEEEEEEEcccccEEEEEEEecCCCCCcceeeEecCcccccccceeEEEeeeccCc---eeeEEEEeecccccc
Q 043702 186 DLKSGDLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGS---TEIHSIEWWSFSSSF 262 (711)
Q Consensus 186 ~~~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastg~~---~~~~~i~sW~f~s~~ 262 (711)
++.+|+.++|||+||+.+++|+|+|++.+. |..|+|+..|||+++|||+|||||||+||.. .|.|+|++|+|++++
T Consensus 157 ~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~-~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~~~h~IlsWsF~s~l 235 (237)
T 1fny_A 157 NWTNGEVANVFISYEASTKSLTASLVYPSL-ETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGYVQTNDVLSWSFESNL 235 (237)
T ss_dssp CCCTTCCEEEEEEEEGGGTEEEEEEEETTT-TEEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCCCCCEEEEEEEEEEE
T ss_pred cccCCCEEEEEEEEeCCCcEEEEEEecCCC-CCcceEEEEechHHhCCCcEEEEEEEeeCCCCcccceeEEEEEEEEEec
Confidence 688999999999999999999999998653 5678999999999999999999999999999 999999999999875
|
| >1fx5_A UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HOMO-dimer, fucose specific lectin, SUG binding protein; HET: NAG FUC BMA MAN; 2.20A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1jxn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-58 Score=467.10 Aligned_cols=225 Identities=28% Similarity=0.441 Sum_probs=201.9
Q ss_pred cceeeecCCCC--CCCeEEeCceEee-CCcEEeCCCCCCCCCceEE-EEeCCceeccCCCCCCceeeEEEEEEEEecC-C
Q 043702 32 TATEFDFGTLT--LASLKLLGDAHMN-NGSVRLTRDVTVPYDGAGK-ALYSKPVRFRLPGTHTPASFSTFFSFSITNL-N 106 (711)
Q Consensus 32 ~~~~f~~~~f~--~~~~~~~g~a~~~-~g~~~Lt~~~~~~~~~~Gr-~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~-~ 106 (711)
.+++|+|++|. ..+|+|+|||.+. +|.|+||++......++|| |+|++||+|||+.+|+++||+|+|+|.|.++ +
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~Gr~a~y~~Pv~l~~~~tg~vaSFsT~F~F~I~~~~~ 81 (242)
T 1fx5_A 2 DDLSFKFKNFSQNGKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIWNCNTGELASFITSFSFFMETSAN 81 (242)
T ss_dssp CEEEEEESSCCTTCSSEEEEETCEECTTSCEESCCCSSSSCSEEEEEEEESSCEECEETTTTEECEEEEEEEEEEEESSC
T ss_pred cceEEEcCCCCCCCCCeEEcccEEeccCCcEEecCCCCcccCCccCEEEeCCCEEeecCCCCCccceEEEEEEEEecCCC
Confidence 45789999998 6799999999996 7999999976212378999 9999999999999999999999999999987 5
Q ss_pred CCCCCCceEEEEcCCCCCCCCCCCcccccccCCCC--cceEEEEeecccCCCC-CCCCCCeeeEecCCCcccccccCCcc
Q 043702 107 PSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAG--LGFVAVEFDTLMDVEF-SDINGNHVGLDLNSMVSTEVDNLDTI 183 (711)
Q Consensus 107 ~~~~g~GlaF~l~~~~~~~~~~g~~lgl~~~~~~~--~~~vaVEFDt~~n~~~-~d~~~~Hvgid~ns~~S~~~~~~~~~ 183 (711)
...+||||||||+|....+++.||||||+|.+++. +++|||||||++|.++ +||++||||||+||+.|.++.+
T Consensus 82 ~~~~gdGlAF~l~p~~~~~~~~g~~LGl~n~~~~~~~n~~vAVEFDT~~N~~~~~Dp~~nHVGIdvNs~~S~~~~~---- 157 (242)
T 1fx5_A 82 PKAATDGLTFFLAPPDSPLRRAGGYFGLFNDTKCDSSYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAER---- 157 (242)
T ss_dssp GGGCCCEEEEEEECTTCCCCBCGGGTTTBSSSCCCGGGCCEEEEEECCCTTTSTTSCSSCEEEEEESSSSCSEEEE----
T ss_pred CCCCCCcEEEEEecCCCCCCCCCCcccccccCCCCccCcEEEEEeccccCcccccCCCCCeEEEecCCccccceec----
Confidence 66789999999999877777889999999865433 8999999999999986 7999999999999999987655
Q ss_pred ccccCCC--CeEEEEEEEcccccEEEEEEEecCCCCCcceeeEecCcccccccceeEEEeeec--cCceeeEEEEeeccc
Q 043702 184 NVDLKSG--DLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGST--QGSTEIHSIEWWSFS 259 (711)
Q Consensus 184 ~~~~~~g--~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsast--g~~~~~~~i~sW~f~ 259 (711)
+++.+| +.++|||+||+.+++|+|+|++.+. |..|+|++.|||+++|||+|||||||+| |.. |.|+|++|+|+
T Consensus 158 -~~l~~G~~~~~~v~I~Yd~~~~~L~V~l~~~~~-~~~~~ls~~vdL~~~l~e~v~VGFSAsT~~G~~-~~h~IlsWsF~ 234 (242)
T 1fx5_A 158 -WNKRYGLNNVANVEIIYEASSKTLTASLTYPSD-QTSISVTSIVDLKEILPEWVSVGFSGSTYIGRQ-ATHEVLNWYFT 234 (242)
T ss_dssp -CCCCCSGGGCEEEEEEEETTTTEEEEEEEETTT-TEEEEEEEECCGGGTSCSEEEEEEEEEEETTSC-EEEEEEEEEEE
T ss_pred -ccccCCCceeEEEEEEEeCCCCEEEEEEecCCC-CccceeeEEechHHhCCccEEEEEEecccCCCc-ceeEEEEEEeE
Confidence 468899 9999999999999999999998653 5678999999999999999999999999 999 99999999999
Q ss_pred cccC
Q 043702 260 SSFE 263 (711)
Q Consensus 260 s~~~ 263 (711)
+++.
T Consensus 235 s~l~ 238 (242)
T 1fx5_A 235 STFI 238 (242)
T ss_dssp EESS
T ss_pred eecc
Confidence 9874
|
| >1dbn_A MAL, protein (leukoagglutinin); plant lectin, carbohydrate binding, sialyllactose, sugar BIN protein; HET: NAG SIA GAL BGC; 2.75A {Maackia amurensis} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-58 Score=467.19 Aligned_cols=223 Identities=31% Similarity=0.456 Sum_probs=199.1
Q ss_pred cceeeecCCCC--CCCeEEeCceEee-CCcEEeCCCCCC--CCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecCC
Q 043702 32 TATEFDFGTLT--LASLKLLGDAHMN-NGSVRLTRDVTV--PYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLN 106 (711)
Q Consensus 32 ~~~~f~~~~f~--~~~~~~~g~a~~~-~g~~~Lt~~~~~--~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~ 106 (711)
.+++|+|++|. ..+|+|+|||.+. +|.|+||++... ..+++|||+|++||+|||+.+|+++||+|+|+|.|.+++
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pi~l~~~~tg~vaSFsT~F~F~I~~~~ 81 (239)
T 1dbn_A 2 DELSFTINNFVPNEADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIWGNTTGSVASFSTSFTFVVKAPN 81 (239)
T ss_dssp CEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCSS
T ss_pred cceEEEcCCCCCCCCCeEEcccEEecCCCcEEeCCCCCCCcccCceEEEEeCCCEecccCCCCCccceEEEEEEEEeCCC
Confidence 45789999998 6799999999996 799999987510 127899999999999999999999999999999999877
Q ss_pred CCCCCCceEEEEcCCCCC--CCCCCCcccccccCCCC--cceEEEEeecccC---CCCCCCCCCeeeEecCCCccccccc
Q 043702 107 PSSIGAGLAFVITPDGEQ--VGSAGGSLGLLDEKGAG--LGFVAVEFDTLMD---VEFSDINGNHVGLDLNSMVSTEVDN 179 (711)
Q Consensus 107 ~~~~g~GlaF~l~~~~~~--~~~~g~~lgl~~~~~~~--~~~vaVEFDt~~n---~~~~d~~~~Hvgid~ns~~S~~~~~ 179 (711)
...+||||||||+|.... .++.||||||+|..++. +++|||||||++| .+ +||++||||||+||+.|.++.+
T Consensus 82 ~~~~gdGlAF~l~p~~~~~p~~~~g~~LGl~n~~~~~~~~~~vAVEFDT~~n~~~~~-~Dp~~nHVGIdvNs~~S~~~~~ 160 (239)
T 1dbn_A 82 PDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSNSDSSNQIVAVEFDTYFAHSYDP-WDPNYRHIGIDVNGIESIKTVQ 160 (239)
T ss_dssp TTSCCEEEEEEEECTTCCCCSSSCGGGTTSCSSSCCCTTSCCEEEEEECCCCTTTCT-TSCSSCEEEEEESSSSCSEEEE
T ss_pred CCCCCCCEEEEEecCCCCCCcCCCCCcccccccCCCCccccEEEEEEeccccCcccc-cCCCCCcEEEecCCccccceEc
Confidence 778899999999998753 47889999999865332 8999999999999 77 4999999999999999987655
Q ss_pred CCccccccCCCCeEEEEEEEcccccEEEEEEEecCCCCCcceeeEecCcccccccceeEEEeeeccCc--eeeEEEEeec
Q 043702 180 LDTINVDLKSGDLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGS--TEIHSIEWWS 257 (711)
Q Consensus 180 ~~~~~~~~~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastg~~--~~~~~i~sW~ 257 (711)
+++.+|+.++|||+||+.+++|+|+|++.+. +..|+|+..|||+++|||+|||||||+||.. .|.|+|++|+
T Consensus 161 -----~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~-~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~~h~IlsWs 234 (239)
T 1dbn_A 161 -----WDWINGGVAFATITYLAPNKTLIASLVYPSN-QTTFSVAASVDLKEILPEWVRVGFSAATGYPTEVETHDVLSWS 234 (239)
T ss_dssp -----CCCCTTCCEEEEEEEEGGGTEEEEEEEETTT-TEEEEEEEECCHHHHSCSEEEEEEEEEECSGGGCCCCEEEEEE
T ss_pred -----ccccCCCEEEEEEEEeCCCcEEEEEEccCCC-CCcceEEEEechHHhCCccEEEEEEeccCCCccceeeEEEEEE
Confidence 4688999999999999999999999998653 4678999999999999999999999999999 9999999999
Q ss_pred cccc
Q 043702 258 FSSS 261 (711)
Q Consensus 258 f~s~ 261 (711)
|+++
T Consensus 235 F~s~ 238 (239)
T 1dbn_A 235 FTST 238 (239)
T ss_dssp EEEE
T ss_pred eEec
Confidence 9875
|
| >1gzc_A Erythrina crista-galli lectin; carbohydrate, sugar binding protein, saccharide, protein-carbohydrate interactions, lactose, glycoprotein; HET: LAT; 1.58A {Erythrina crista-galli} SCOP: b.29.1.1 PDB: 1gz9_A* 1fyu_A* 1ax0_A* 1ax1_A* 1ax2_A* 1axy_A* 1axz_A* 1lte_A* 1sfy_A* 1v00_A* 1uzz_A 1uzy_A* 3n35_A* 3n36_A* 3n3h_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-58 Score=465.64 Aligned_cols=224 Identities=30% Similarity=0.497 Sum_probs=200.6
Q ss_pred cceeeecCCCC--CCCeEEeCceEee-CCcEEeCCCCCCC---CCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecC
Q 043702 32 TATEFDFGTLT--LASLKLLGDAHMN-NGSVRLTRDVTVP---YDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNL 105 (711)
Q Consensus 32 ~~~~f~~~~f~--~~~~~~~g~a~~~-~g~~~Lt~~~~~~---~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~ 105 (711)
.+++|+|++|. ..+|+|+|||.+. +|.|+||++..++ .+++|||+|++||+|||+.+|+++||+|+|+|.|.++
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pi~l~~~~tg~vaSFsT~F~F~I~~~ 81 (239)
T 1gzc_A 2 ETISFSFSEFEPGNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMWDSTTGTVASFETRFSFSIEQP 81 (239)
T ss_dssp EEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCBCTTSCBCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCC
T ss_pred eeEEEEeCCCCCCCCCeEEcccEEEcCCCcEEeCCCCcCCcccCCceEEEEeCCCEecccCCCCCccceEEEEEEEEeCC
Confidence 35789999998 6799999999996 7999999976321 3789999999999999999999999999999999987
Q ss_pred C-CCCCCCceEEEEcCCCCCCCCCCCcccccccCCCC--cceEEEEeecccCCCCCCCCCCeeeEecCCCcccccccCCc
Q 043702 106 N-PSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAG--LGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDT 182 (711)
Q Consensus 106 ~-~~~~g~GlaF~l~~~~~~~~~~g~~lgl~~~~~~~--~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~S~~~~~~~~ 182 (711)
+ ...+||||||||+|...++++.||||||+|..++. +++|||||||++|. |+||++||||||+||+.|.++.+
T Consensus 82 ~~~~~~gdGlAF~l~p~~~~~~~~g~~LGl~n~~~~~~~~~~vAVEFDT~~n~-~dDp~~nHVGIdvns~~S~~~~~--- 157 (239)
T 1gzc_A 82 YTRPLPADGLVFFMGPTKSKPAQGYGYLGVFNNSKQDNSYQTLAVEFDTFSNP-WDPPQVPHIGIDVNSIRSIKTQP--- 157 (239)
T ss_dssp CSSSCCCEEEEEEEECSSCCCCCCGGGTTTCSSSSCCGGGCCEEEEEECSCCT-TSCSSSSEEEEEESSSSCSEEEE---
T ss_pred CCCCCCCCcEEEEEecCCCCCCCCCCcccccccCCCCccccEEEEEEeccccc-CCCCCCCeEEEecCCcccccccc---
Confidence 6 67789999999999877778889999999865433 89999999999998 87799999999999999987655
Q ss_pred cccccCCCCeEEEEEEEcccccEEEEEEEecCCCCCcceeeEecCcccccccceeEEEeeeccC---ceeeEEEEeeccc
Q 043702 183 INVDLKSGDLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQG---STEIHSIEWWSFS 259 (711)
Q Consensus 183 ~~~~~~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastg~---~~~~~~i~sW~f~ 259 (711)
+++.+|+.++|||+||+.+++|+|+|++.+. +..|+|++.|||+++|||+|||||||+||. ..|.|+|++|+|+
T Consensus 158 --~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~-~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~~~h~IlsWsF~ 234 (239)
T 1gzc_A 158 --FQLDNGQVANVVIKYDAPSKILHVVLVYPSS-GAIYTIAEIVDVKQVLPDWVDVGLSGATGAQRDAAETHDVYSWSFQ 234 (239)
T ss_dssp --CCCCTTCEEEEEEEEETTTTEEEEEEECTTT-CCEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCCCCCEEEEEEEE
T ss_pred --ccccCCCEEEEEEEEeCCCcEEEEEEecCCC-CccceEEEEechHHhCCCceEEEEEeccCCCccccceEEEEEEEeE
Confidence 4688999999999999999999999998653 467899999999999999999999999997 4999999999999
Q ss_pred ccc
Q 043702 260 SSF 262 (711)
Q Consensus 260 s~~ 262 (711)
+++
T Consensus 235 s~l 237 (239)
T 1gzc_A 235 ASL 237 (239)
T ss_dssp EEE
T ss_pred Eec
Confidence 875
|
| >1v6i_A Agglutinin, PNA, galactose-binding lectin; open quaternary association, orthorhombic, carbohydrate specificity, protein crystallography; HET: GAL GLC; 2.15A {Arachis hypogaea} SCOP: b.29.1.1 PDB: 1bzw_A* 1v6j_A* 1v6k_A* 1v6l_A* 1v6m_A 1v6n_A 1v6o_A 2dva_A* 1cq9_A 1ciw_A* 1qf3_A* 1rir_A* 1rit_A* 2dh1_A 1cr7_A* 2dv9_A* 2dvb_A* 2dvd_A* 2dvf_A 2dvg_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-58 Score=461.98 Aligned_cols=220 Identities=31% Similarity=0.546 Sum_probs=199.7
Q ss_pred cceeeecCCCC--CCCeEEeCceEee-CCcEEeCCC-CCCCCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecCCC
Q 043702 32 TATEFDFGTLT--LASLKLLGDAHMN-NGSVRLTRD-VTVPYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLNP 107 (711)
Q Consensus 32 ~~~~f~~~~f~--~~~~~~~g~a~~~-~g~~~Lt~~-~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~ 107 (711)
.+++|+|++|. ..+|+|+|||.+. +|.|+||++ .. +++|||+|++||+|||+.+|+++||+|+|+|.|.+++.
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~---~~~Gra~y~~Pi~l~~~~tg~vaSFsT~F~F~I~~~~~ 78 (232)
T 1v6i_A 2 ETVSFNFNSFSEGNPAINFQGDVTVLSNGNIQLTNLNKV---NSVGRVLYAMPVRIWSSATGNVASFLTSFSFEMKDIKD 78 (232)
T ss_dssp EEEEEEESSCCTTCTTEEEEESCEECTTSCEECSCTTST---TCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECCSS
T ss_pred cceEEEcCCCCCCCCCeEEcccEEEccCCcEEeCCCCCC---CceEEEEeCCCEEeecCCCCCccceEEEEEEEEecCCC
Confidence 35789999998 6799999999996 799999998 55 78999999999999999999999999999999998777
Q ss_pred CCCCCceEEEEcCCCC--CCCC-CCCcccccccCCCCcceEEEEeecccCCCCCCCCCCeeeEecCCCcccccccCCccc
Q 043702 108 SSIGAGLAFVITPDGE--QVGS-AGGSLGLLDEKGAGLGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTIN 184 (711)
Q Consensus 108 ~~~g~GlaF~l~~~~~--~~~~-~g~~lgl~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~S~~~~~~~~~~ 184 (711)
..+||||||||+|... +.++ .||||||+|. +..+++|||||||++|.+++||++||||||+||+.|.++.+
T Consensus 79 ~~~gdGlAF~l~p~~~~~p~~~~~g~~LGl~n~-~~~~~~vAVEFDT~~n~~~~Dp~~nHVGIdvns~~S~~~~~----- 152 (232)
T 1v6i_A 79 YDPADGIIFFIAPEDTQIPAGSIGGGTLGVSDT-KGAGHFVGVEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVP----- 152 (232)
T ss_dssp SBCCCEEEEEEEETTCCCCTTCCCGGGTTTSCT-TSEEEEEEEEEECSCCGGGTCCSSCEEEEEEEESSCSEEEE-----
T ss_pred CCCCCCEEEEEecCCCCCCCCcCCCcccccccC-CCcccEEEEEeecccccccCCCCCCeEEEEcCCcccccccc-----
Confidence 7789999999999864 3467 8999999987 33489999999999999988999999999999999987655
Q ss_pred cccCCCCeEEEEEEEcccccEEEEEEEecCCCCCcceeeEecCcccccccceeEEEeeeccC--ceeeEEEEeecccccc
Q 043702 185 VDLKSGDLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQG--STEIHSIEWWSFSSSF 262 (711)
Q Consensus 185 ~~~~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastg~--~~~~~~i~sW~f~s~~ 262 (711)
+++.+|+.++|||+||+.+++|+|+|++ + .|..|+|+..|||+++|||+|||||| |||. ..|.|+|++|+|++++
T Consensus 153 ~~l~~G~~~~v~I~Yd~~~~~L~V~l~~-~-~~~~~~ls~~vdL~~~l~e~v~VGFS-sTG~~~~~~~h~IlsWsF~s~l 229 (232)
T 1v6i_A 153 WNSVSGAVVKVTVIYDSSTKTLSVAVTN-D-NGDITTIAQVVDLKAKLPERVKFGFS-ASGSLGGRQIHLIRSWSFTSTL 229 (232)
T ss_dssp CCCCTTCEEEEEEEEETTTTEEEEEEEC-T-TSCEEEEEEECCHHHHSCSEEEEEEE-EECCSSBCCEEEEEEEEEEEEE
T ss_pred ccccCCCEEEEEEEEeCCCcEEEEEEec-C-CCCcceEEEEechHHhCCccEEEEEE-ecCCCccccEEEEEEEEEEeec
Confidence 4688999999999999999999999998 4 46789999999999999999999999 9998 6999999999999876
Q ss_pred C
Q 043702 263 E 263 (711)
Q Consensus 263 ~ 263 (711)
.
T Consensus 230 ~ 230 (232)
T 1v6i_A 230 I 230 (232)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >1g7y_A Stem/LEAF lectin DB58; jelly roll fold, sugar binding protein; HET: NAG FUC FUL; 2.50A {Vigna unguiculata subsp} SCOP: b.29.1.1 PDB: 1lul_A 1lu1_A* 1bjq_A* 1lu2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-58 Score=466.18 Aligned_cols=225 Identities=31% Similarity=0.446 Sum_probs=203.2
Q ss_pred cceeeecCCCCCCCeEEeCceEeeCCcEEeCCCCCCC---CCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecCCCC
Q 043702 32 TATEFDFGTLTLASLKLLGDAHMNNGSVRLTRDVTVP---YDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLNPS 108 (711)
Q Consensus 32 ~~~~f~~~~f~~~~~~~~g~a~~~~g~~~Lt~~~~~~---~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~ 108 (711)
.+++|+|++|...+|+|+|||.+.+|.|+||++..++ .+++|||+|++||+|||+.+|+++||+|+|+|.|.+++..
T Consensus 2 ~~~~F~f~~F~~~~l~l~GdA~v~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg~vaSFsT~F~F~I~~~~~~ 81 (253)
T 1g7y_A 2 DIQSFSFKNFNSSSFILQGDATVSSSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIYDKSTGAVASWATSFTANIFAPNKS 81 (253)
T ss_dssp EEEEEEESSCCSSCEEEEETCEEETTEEECSCBCTTSCBCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCSSGG
T ss_pred cceEEEcCCCCcCCEEEecceEEeCCEEEeCCCCCCCccccCCeEEEEECCCEEeecCCCCCccceEEEEEEEEecCCCC
Confidence 4578999999989999999999999999999976321 3789999999999999999999999999999999987667
Q ss_pred CCCCceEEEEcCCCCCCCCCCCcccccccCCCC--cceEEEEeecccCCCCCCCCCCeeeEecCCCcccccccCCccccc
Q 043702 109 SIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAG--LGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVD 186 (711)
Q Consensus 109 ~~g~GlaF~l~~~~~~~~~~g~~lgl~~~~~~~--~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~S~~~~~~~~~~~~ 186 (711)
.+||||||||+|...++++.||||||+|.+++. +++|||||||++|.+ +||++||||||+||+.|.++.+ ++
T Consensus 82 ~~gdGlAF~l~p~~~~~~~~g~~LGl~n~~~~~~~n~~vAVEFDT~~N~~-~Dp~~nHVGIdvns~~S~~t~~-----~~ 155 (253)
T 1g7y_A 82 SSADGIAFALVPVGSEPKSNSGFLGVFDSDVYDNSAQTVAVEFDTFSNTD-WDPTSRHIGIDVNSIKSIRTAS-----WG 155 (253)
T ss_dssp GCCCEEEEEEEETTCCCCCCGGGTTTCSCSSCCGGGCCEEEEEECSCCTT-TCCSSCEEEEEESSSSCSEEEE-----CC
T ss_pred CCCCcEEEEEecCCCCCCCCCCcccccccCCCCccCceEEEEecceeccC-cCCCCCcEeeccCCccccceec-----cc
Confidence 789999999999877778889999999865433 899999999999988 4999999999999999987655 46
Q ss_pred cCCCCeEEEEEEEcccccEEEEEEEecCCCCCcceeeEecCcccccccceeEEEeeeccCc---eeeEEEEeeccccccC
Q 043702 187 LKSGDLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGS---TEIHSIEWWSFSSSFE 263 (711)
Q Consensus 187 ~~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastg~~---~~~~~i~sW~f~s~~~ 263 (711)
+.+|+.++|||+||+.+++|+|+|++.+. |..|+|+..|||+.+|||+|||||||+||.. .|.|+|++|+|++++.
T Consensus 156 l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~-~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~~~~~~H~IlsWsF~s~l~ 234 (253)
T 1g7y_A 156 LANGQNAEILITYNAATSLLVASLVHPSR-RTSYIVSERVDITNELPEYVSIGFSATTGLSEGYTETHDVLSWSFASKLP 234 (253)
T ss_dssp CCTTSEEEEEEEEETTTTEEEEEEEETTT-TEEEEEEEECCHHHHSCSEEEEEEEEECCSSSSCCCCCEEEEEEEEEEEC
T ss_pred cCCCCeEEEEEEEeCCCCEEEEEEecCCC-CCcceEEEEechHHhCCCceEEEEEeCcCCCCcccceeEEEEEEEEeeCC
Confidence 88999999999999999999999998653 5678999999999999999999999999999 9999999999999874
|
| >1sbf_A Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {Glycine max} SCOP: b.29.1.1 PDB: 1sbd_A* 1sbe_A* 1g9f_A* 2sba_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-57 Score=462.59 Aligned_cols=224 Identities=29% Similarity=0.471 Sum_probs=201.9
Q ss_pred cceeeecCCCC--CCCeEEeCceEee-CCcEEeCCCCCCC---CCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecC
Q 043702 32 TATEFDFGTLT--LASLKLLGDAHMN-NGSVRLTRDVTVP---YDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNL 105 (711)
Q Consensus 32 ~~~~f~~~~f~--~~~~~~~g~a~~~-~g~~~Lt~~~~~~---~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~ 105 (711)
.+++|+|++|. ..+|+|+|||.+. +|.|+||++..++ .+++|||+|++||+|||+.+|+++||+|+|+|.|.++
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~GdA~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg~vaSFsT~F~F~I~~~ 81 (253)
T 1sbf_A 2 ETVSFSWNKFVPKQPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIWDKETGSVASFAASFNFTFYAP 81 (253)
T ss_dssp EEEEEEESSCCTTCTTEEEEETCEECTTSCEECSCBCTTSCBCTTCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECS
T ss_pred cceEEEcCCCCCCCCCeEEcccEEEcCCCeEEeCCCccCCcccCCCeEEEEECCCEecccCCCCcccceEEEEEEEEeCC
Confidence 45789999998 6799999999996 7999999976321 3789999999999999999999999999999999988
Q ss_pred CCCCCCCceEEEEcCCCCCCCCCCCcccccccCCCCcceEEEEeecccCCCCCCCCCCeeeEecCCCcccccccCCcccc
Q 043702 106 NPSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAGLGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINV 185 (711)
Q Consensus 106 ~~~~~g~GlaF~l~~~~~~~~~~g~~lgl~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~S~~~~~~~~~~~ 185 (711)
+...+||||||||+|...++++.||||||+|.++..+++|||||||++|. +||++||||||+||+.|.++.+ +
T Consensus 82 ~~~~~gdGlAF~l~p~~~~~~~~g~~LGL~n~~~~~n~~vAVEFDT~~N~--~Dp~~nHVGIdvNs~~S~~t~~-----~ 154 (253)
T 1sbf_A 82 DTKRLADGLAFFLAPIDTKPQTHAGYLGLFNENESGDQVVAVEFDTFRNS--WDPPNPHIGINVNSIRSIKTTS-----W 154 (253)
T ss_dssp STTSCCEEEEEEEEETTCCCCCCGGGTTTCCTTSCCCSCEEEEEECSCCT--TCCSSSEEEEEESSSSCSEEEE-----C
T ss_pred CCCCCCCcEEEEEecCCCCCCCCCCccccccCCCcccceEEEEeccccCC--CCCCCCcEEEEcCCccccceec-----c
Confidence 77788999999999987767888999999987634489999999999997 5999999999999999987655 4
Q ss_pred ccCCCCeEEEEEEEcccccEEEEEEEecCCCCCcceeeEecCcccccccceeEEEeeeccCc--eeeEEEEeeccccccC
Q 043702 186 DLKSGDLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGS--TEIHSIEWWSFSSSFE 263 (711)
Q Consensus 186 ~~~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastg~~--~~~~~i~sW~f~s~~~ 263 (711)
++.+|+.++|||+||+.+++|+|+|++.+. |..|+|+..|||+.+|||+||||||||||.. .|.|+|++|+|++++.
T Consensus 155 ~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~-~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~~~~~H~IlsWsF~s~l~ 233 (253)
T 1sbf_A 155 DLANNKVAKVLITYDASTSLLVASLVYPSQ-RTSNILSDVVDLKTSLPEWVRIGFSAATGLDIPGESHDVLSWSFASNLP 233 (253)
T ss_dssp CCCTTCCEEEEEEEETTTTEEEEEEEETTT-TEEEEEEEECCHHHHSCSEEEEEEEEEECSSSCCCEEEEEEEEEEEEEC
T ss_pred cccCCCeeEEEEEEeCCCcEEEEEEecCCC-CCcceEEEEechHHhCCCceEEEEEeccCCCccceeeEEEEEEeEeecC
Confidence 688999999999999999999999998653 5678999999999999999999999999999 9999999999999874
|
| >2eig_A Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG binding protein; HET: NAG; 2.00A {Lotus tetragonolobus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-57 Score=456.19 Aligned_cols=217 Identities=33% Similarity=0.508 Sum_probs=197.3
Q ss_pred eeeecCCCC-CCCeEEeCceEee-CCcEEeCCC--CCCCCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecCCCCC
Q 043702 34 TEFDFGTLT-LASLKLLGDAHMN-NGSVRLTRD--VTVPYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLNPSS 109 (711)
Q Consensus 34 ~~f~~~~f~-~~~~~~~g~a~~~-~g~~~Lt~~--~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~ 109 (711)
++|+|++|. ..+|+|+|||.+. +|.|+||++ .. +++|||+|++||+|||+.+|+++||+|+|+|.|.+++...
T Consensus 1 ~sF~f~~F~~~~~l~l~G~A~v~~~g~l~LT~~~~~~---~~~Gra~y~~Pv~l~~~~tg~vaSFsT~F~F~I~~~~~~~ 77 (234)
T 2eig_A 1 VSFNYTRFKDDGSLIFQGDAKIWTDGRLAMPTDPLVN---RTTSHALYATPVPIWDSATGNVASFITSFSFIVSNVQRYP 77 (234)
T ss_dssp CEEEESSCCSSSSEEEEETCEEEGGGEEESSSCGGGS---SEEEEEEESSCEECBCTTTCCBCEEEEEEEEEEEECTTSC
T ss_pred CeEEcCCCCCCCCeEEcccEEEcCCCCeeeCCCCCcc---CceEEEEeCCCEEeecCCCCCccceEEEEEEEEeCCCCCC
Confidence 479999998 8899999999996 799999997 44 7899999999999999999999999999999999887778
Q ss_pred CCCceEEEEcCCCC--CCCCCCCcccccccCCCCcceEEEEeecccCCCCCCCCC---CeeeEecCCCcccccccCCccc
Q 043702 110 IGAGLAFVITPDGE--QVGSAGGSLGLLDEKGAGLGFVAVEFDTLMDVEFSDING---NHVGLDLNSMVSTEVDNLDTIN 184 (711)
Q Consensus 110 ~g~GlaF~l~~~~~--~~~~~g~~lgl~~~~~~~~~~vaVEFDt~~n~~~~d~~~---~Hvgid~ns~~S~~~~~~~~~~ 184 (711)
+||||||||+|... +.++.||||||+|.++..+++|||||||++|. +||++ ||||||+||+.|.++.+
T Consensus 78 ~gdGlAF~l~p~~~~~p~~~~g~~LGl~n~~~~~~~~vAVEFDT~~N~--~Dp~~~~~nHVGIdvNsi~S~~~~~----- 150 (234)
T 2eig_A 78 PTDGVVFFLAPWGTEIPPNSQGGYLGITDSSNSQNQFVAVEFDSHPNV--WDPKSLRSSHIGIDVNSIMSLKAVN----- 150 (234)
T ss_dssp CCCEEEEEEEETTCCCCTTCCGGGTTTCCTTCSCCCCEEEEEECSCCT--TSCTTTCSSEEEEEESSSSCSEEEE-----
T ss_pred CCCcEEEEEecCCCCCCcCCCCCccccccCCCccccEEEEEeccccCc--cCCCCCCCCceEEecCCccccceec-----
Confidence 89999999999864 44688999999987633489999999999997 49999 99999999999987655
Q ss_pred cccCCCCeEEEEEEEcccccEEEEEEEecCCCCCcceeeEecCcccccccceeEEEeeec--cCceeeEEEEeecccccc
Q 043702 185 VDLKSGDLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGST--QGSTEIHSIEWWSFSSSF 262 (711)
Q Consensus 185 ~~~~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsast--g~~~~~~~i~sW~f~s~~ 262 (711)
+++.+|+.++|||+||+.+++|+|+|++ + .|..|+|+..|||+++|||+|||||||+| |.. |.|+|++|+|++++
T Consensus 151 ~~l~~g~~~~v~I~Yd~~~~~L~V~l~~-~-~~~~~~ls~~vdL~~~l~e~v~VGFSAsT~~G~~-~~h~IlsWsF~s~l 227 (234)
T 2eig_A 151 WNRVSGSLEKATIIYDSDTKILTVVMTH-Q-NGQITTISQEIDLKTVLPEKVSVGFSATTWNPER-ERHDIYSWSFTSTL 227 (234)
T ss_dssp CCCCTTCCEEEEEEEETTTTEEEEEEEE-T-TSCEEEEEEECCHHHHSCSEEEEEEEEEECSSCC-EEEEEEEEEEEEEC
T ss_pred ccccCCCEEEEEEEEeCCCcEEEEEEec-C-CCCcceEeEeechHHhcCCceEEEEEeeecCCCc-ceeEEEEEEEEecC
Confidence 4688999999999999999999999999 4 46679999999999999999999999999 998 99999999999987
Q ss_pred C
Q 043702 263 E 263 (711)
Q Consensus 263 ~ 263 (711)
.
T Consensus 228 ~ 228 (234)
T 2eig_A 228 K 228 (234)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1hql_A Lectin; xenograft antigen, sugar BI protein; HET: GLA MBG NAG; 2.20A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1gnz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-57 Score=462.82 Aligned_cols=227 Identities=32% Similarity=0.472 Sum_probs=202.0
Q ss_pred cceeeecCCCC---CCCeEEeCceEeeCCcEEeCCCCCC---CCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecC
Q 043702 32 TATEFDFGTLT---LASLKLLGDAHMNNGSVRLTRDVTV---PYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNL 105 (711)
Q Consensus 32 ~~~~f~~~~f~---~~~~~~~g~a~~~~g~~~Lt~~~~~---~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~ 105 (711)
.+++|+|++|. ..+|+|+|||.+.+|.|+||++..+ ..+++|||+|++||+|||+.+|+++||+|+|+|.|.++
T Consensus 3 ~~~~F~f~~F~~~~~~~l~l~GdA~v~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg~vasFsT~F~F~I~~~ 82 (257)
T 1hql_A 3 DSVSFTFPNFWSDVEDSIIFQGDANTTAGTLQLCKTNQYGTPLQWSAGRALYSDPVQLWDNKTESVASFYTEFTFFLKIT 82 (257)
T ss_dssp -CCEEEESCSCSCGGGTEEEEETCEEETTEEECSCBCTTSCBCSSCEEEEEESSCEECCCSTTCCCCEEEEEEEEEEEEC
T ss_pred cceEEEcCCCCCCCCCCEEEccceEecCCcEEecCCccCCcccCCCeEEEEECCCEecccCCCCCeeceEEEEEEEEecC
Confidence 45789999998 6799999999999999999997632 13789999999999999999999999999999999987
Q ss_pred CCCCCCCceEEEEcCCCCCCCCCCCcccccccCCC-C---cceEEEEeecccCCCCCCCCCCeeeEecCCCcccccccCC
Q 043702 106 NPSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGA-G---LGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLD 181 (711)
Q Consensus 106 ~~~~~g~GlaF~l~~~~~~~~~~g~~lgl~~~~~~-~---~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~S~~~~~~~ 181 (711)
...+||||||||+|....+++.|+||||+|.+++ + +++|||||||++|.+|+||++||||||+||+.|.++.++.
T Consensus 83 -~~~~gdGlAF~l~p~~~~~~~~g~~LGl~n~~~~~~~~~n~~vAVEFDT~~N~~~~Dp~~nHVGIdvNs~~S~~s~~~~ 161 (257)
T 1hql_A 83 -GNGPADGLAFFLAPPDSDVKDAGEYLGLFNKSTATQPSKNQVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVATKRWE 161 (257)
T ss_dssp -SSCCCCEEEEEEECTTCCCCCCGGGTTTSCTTTTTCGGGCCCEEEEEECSCCSSSCCCSSCEEEEEESSSSCSEEEECC
T ss_pred -CCCCCCcEEEEEecCCCCCCCCCccccccccccccCCccCceEEEEecccccccccCCCCCceeeeeCCccccceeccC
Confidence 6778999999999987777888999999987642 2 8999999999999999999999999999999998876653
Q ss_pred ccccccCCCCeEEEEEEEcccccEEEEEEEecCCCCCcceeeEecCcccccccceeEEEeeecc-CceeeEEEEeecccc
Q 043702 182 TINVDLKSGDLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQ-GSTEIHSIEWWSFSS 260 (711)
Q Consensus 182 ~~~~~~~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastg-~~~~~~~i~sW~f~s 260 (711)
. .+|.+|+.++|||+||+.+++|+|+|++.+. ..|+|+..|||+.+|||+|||||||||| ...|.|+|++|+|++
T Consensus 162 ~--~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~ls~~vdL~~~l~e~~~vGFSAsTG~~~~~~H~IlsWsF~s 237 (257)
T 1hql_A 162 D--SDIFSGKIATARISYDGSAEILTVVLSYPDG--SDYILSHSVDMRQNLPESVRVGISASTGNNQFLTVYILSWRFSS 237 (257)
T ss_dssp H--HHHTSCSCEEEEEEEETTTTEEEEEEEETTT--EEEEEEEECCGGGTSCSEEEEEEEEECCSCCCEEEEEEEEEEEE
T ss_pred c--ccccCCceEEEEEEEeCCCCEEEEEEecCCC--CceeeEEeechHHhcCCceEEEEEeccCCCccceeEEEEEEeEe
Confidence 1 1355699999999999999999999998654 4689999999999999999999999999 999999999999999
Q ss_pred ccC
Q 043702 261 SFE 263 (711)
Q Consensus 261 ~~~ 263 (711)
++.
T Consensus 238 ~~~ 240 (257)
T 1hql_A 238 NLQ 240 (257)
T ss_dssp EC-
T ss_pred cCC
Confidence 863
|
| >1gsl_A Griffonia simplicifolia lectin 4; glycoprotein, manganese; HET: FUC GAL MAG NAG BMA; 2.00A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1lec_A* 1led_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-57 Score=458.75 Aligned_cols=222 Identities=31% Similarity=0.482 Sum_probs=199.6
Q ss_pred cceeeecCCC----C--CCCeEEeCceEeeCCcEEeCCCCCCC---CCceEEEEeCCceeccCCCCCCceeeEEEEEEEE
Q 043702 32 TATEFDFGTL----T--LASLKLLGDAHMNNGSVRLTRDVTVP---YDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSI 102 (711)
Q Consensus 32 ~~~~f~~~~f----~--~~~~~~~g~a~~~~g~~~Lt~~~~~~---~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i 102 (711)
.+++|+|++| . ..+|+|+|||.+.+|.|+||++..++ .+++|||+|++||+||| .+|+++||+|+|+|.|
T Consensus 2 ~~~~F~f~~F~~~~~~~~~~l~l~GdA~i~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~~-~tg~vasFsT~F~F~I 80 (243)
T 1gsl_A 2 NTVNFTYPDFWSYSLKNGTEITFLGDATRIPGALQLTKTDANGNPVRSSAGQASYSEPVFLWD-STGKAASFYTSFTFLL 80 (243)
T ss_dssp CCCEEEESCCCCTTCCTTSSEEEEETCEEETTEEECSCBCTTSCBCSSEEEEEEESSCEECBC-TTSCBCEEEEEEEEEE
T ss_pred cceEEEcCCCccccCCCCCCEEEccceEecCCcEEecCCccCCcccCCCeEEEEECCCEEccC-CCCCcCceEEEEEEEE
Confidence 3578999999 6 57999999999999999999976321 37899999999999999 9999999999999999
Q ss_pred ecCCCCCCCCceEEEEcCCCCCCCCCCCcccccccCCC-C---cceEEEEeecccCCCCCCCCCCeeeEecCCCcccccc
Q 043702 103 TNLNPSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGA-G---LGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVD 178 (711)
Q Consensus 103 ~~~~~~~~g~GlaF~l~~~~~~~~~~g~~lgl~~~~~~-~---~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~S~~~~ 178 (711)
.++ ...+||||||||+|...++++.|+||||+|.+++ + +++|||||||++|.+|+||++||||||+|++.|.++.
T Consensus 81 ~~~-~~~~gdGlAF~l~p~~~~~~~~g~~LGl~n~~~~~~~~~n~~vAVEFDT~~N~~~~Dp~~nHvGIdvns~~S~~~~ 159 (243)
T 1gsl_A 81 KNY-GAPTADGLAFFLAPVDSSVKDYGGFLGLFRHETAADPSKNQVVAVEFDTWINKDWNDPPYPHIGIDVNSIVSVATT 159 (243)
T ss_dssp EES-SSSCBCEEEEEEEETTCCCCCCGGGTTTSCTTTTTCGGGCCCEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEE
T ss_pred ecC-CCCCCCCEEEEEecCCCCCCCCCCcccccccccccCCccCcEEEEEeccccccccCCCCCCceeeccCCcccccee
Confidence 987 6678999999999987777888999999987653 3 8999999999999999999999999999999998765
Q ss_pred cCCccccccCC---CCeEEEEEEEcccccEEEEEEEecCCCCCcceeeEecCcccccccceeEEEeeeccCceeeEEEEe
Q 043702 179 NLDTINVDLKS---GDLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGSTEIHSIEW 255 (711)
Q Consensus 179 ~~~~~~~~~~~---g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastg~~~~~~~i~s 255 (711)
++ ++.+ |+.++|||+||+.+++|+|+|++.+. ..|+|+..|||+.+|||+|||||||+|| ..|.|+|++
T Consensus 160 ~~-----~l~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~ls~~vdL~~~l~~~~~vGFSAsTG-~~~~h~Ils 231 (243)
T 1gsl_A 160 RW-----ENDDAYGSSIATAHITYDARSKILTVLLSYEHG--RDYILSHVVDLAKVLPQKVRIGFSAGVG-YDEVTYILS 231 (243)
T ss_dssp EC-----CHHHHTSCCEEEEEEEEETTTTEEEEEEEETTS--CEEEEEEECCHHHHSCSEEEEEEEEEEC-BSEEEEEEE
T ss_pred ee-----EEeccCCCcEEEEEEEEeCCCCEEEEEEecCCC--CceeEEEEechHHhCCCceEEEEEeccC-CcceeEEEE
Confidence 54 4666 99999999999999999999998654 4689999999999999999999999999 999999999
Q ss_pred eccccccC
Q 043702 256 WSFSSSFE 263 (711)
Q Consensus 256 W~f~s~~~ 263 (711)
|+|++++.
T Consensus 232 WsF~s~l~ 239 (243)
T 1gsl_A 232 WHFFSTLD 239 (243)
T ss_dssp EEEEEECT
T ss_pred EEEEeecc
Confidence 99999874
|
| >1fat_A Phytohemagglutinin-L; glycoprotein, plant defense protein, lectin; HET: NAG; 2.80A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1g8w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-58 Score=464.06 Aligned_cols=225 Identities=34% Similarity=0.491 Sum_probs=202.9
Q ss_pred cceeeecCCCCCCCeEEeCceEee-CCcEEeCCCCCC---CCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecCCC
Q 043702 32 TATEFDFGTLTLASLKLLGDAHMN-NGSVRLTRDVTV---PYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLNP 107 (711)
Q Consensus 32 ~~~~f~~~~f~~~~~~~~g~a~~~-~g~~~Lt~~~~~---~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~ 107 (711)
.+++|+|++|...+|+|+|||.+. +|.|+||++..+ ..+++|||+|++||+|||+.+|+++||+|+|+|.|.+++.
T Consensus 2 ~~~~F~f~~F~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg~vaSFsT~F~F~I~~~~~ 81 (252)
T 1fat_A 2 NDIYFNFQRFNETNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIWDNTTGTVASFATSFTFNIQVPNN 81 (252)
T ss_dssp CCEEEEESSCCGGGEEEEETCEECTTSCEECSCCC-CCCCCTTCEEEEEEEEEEECEETTTTEEEEEEEEEEEECCCCSS
T ss_pred cceEEEcCCCCcCCEEEeccEEECCCCEEEeCCCCCCCccccCCEEEEEECCCEecccCCCCcccceEEEEEEEEeCCCC
Confidence 457899999998899999999996 799999997632 1378999999999999999999999999999999998766
Q ss_pred CCCCCceEEEEcCCCCCCCCCCCcccccccCCCCcceEEEEeecccCCCCCCCCCCeeeEecCCCcccccccCCcccccc
Q 043702 108 SSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAGLGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDL 187 (711)
Q Consensus 108 ~~~g~GlaF~l~~~~~~~~~~g~~lgl~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~S~~~~~~~~~~~~~ 187 (711)
..+||||||||+|...++++.||||||+|..+..+++||||||||+|.+ +||++||||||+|++.|.++.+ +++
T Consensus 82 ~~~gdGlAF~l~p~~~~~~~~g~~LGl~n~~~~~~~~vAVEFDT~~N~~-~Dp~~nHVGIdvNs~~S~~~~~-----~~l 155 (252)
T 1fat_A 82 AGPADGLAFALVPVGSQPKDKGGFLGLFDGSNSNFHTVAVEFDTLYNKD-WDPTERHIGIDVNSIRSIKTTR-----WDF 155 (252)
T ss_dssp CBCCEEEEEEEEETTCCCCCSGGGTTTCCSSCCCCCCEEEEEECSCCTT-TCCSSCEEEEEESSSSCSEEEE-----CCC
T ss_pred CCCCCcEEEEEccCCCCCCCCCccccccccCCccCcEEEEEeecccCCC-CCCCCCeEEEecCCccccceec-----ccc
Confidence 7789999999999877778889999999876334899999999999988 5999999999999999987655 468
Q ss_pred CCCCeEEEEEEEcccccEEEEEEEecCCCCCcceeeEecCcccccccceeEEEeeeccCc---eeeEEEEeeccccccC
Q 043702 188 KSGDLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGS---TEIHSIEWWSFSSSFE 263 (711)
Q Consensus 188 ~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastg~~---~~~~~i~sW~f~s~~~ 263 (711)
.+|+.++|||+||+.+++|+|+|++.+. |..|+|+..|||+.+|||+|||||||+||.. .|.|+|++|+|++++.
T Consensus 156 ~~G~~~~v~I~Yd~~~~~L~V~l~~~~~-~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~~~~~~H~IlsWsF~s~l~ 233 (252)
T 1fat_A 156 VNGENAEVLITYDSSTNLLVASLVYPSQ-KTSFIVSDTVDLKSVLPEWVSVGFSATTGINKGNVETNDVLSWSFASKLS 233 (252)
T ss_dssp CTTCEEEEEEEEETTTTEEEEEEEETTT-TEEEEEEEECCHHHHSCSEEEEEEEEEECSSTTBCCCCEEEEEEEEEEEC
T ss_pred cCCCEEEEEEEEeCCCCEEEEEEecCCC-CCcceEEEEechHHhCCCceEEEEEeccCCCCcccceEEEEEEEEEeeCC
Confidence 8999999999999999999999998653 5678999999999999999999999999999 9999999999999874
|
| >2bqp_A Protein (PEA lectin); D-glucopyranose complex, sugar binding protein; HET: GLC; 1.90A {Pisum sativum} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-57 Score=454.38 Aligned_cols=222 Identities=29% Similarity=0.492 Sum_probs=200.7
Q ss_pred cceeeecCCCC--CCCeEEeCceEeeCCcEEeCCCCCCCCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecCCCCC
Q 043702 32 TATEFDFGTLT--LASLKLLGDAHMNNGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLNPSS 109 (711)
Q Consensus 32 ~~~~f~~~~f~--~~~~~~~g~a~~~~g~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~ 109 (711)
.+++|+|++|. ..+|+|+|||...+|.|+||++.+ ++.|||+|++||+|||+.+|+++||+|+|+|+|.+++...
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~~~~g~l~LT~~~~---~~~G~a~y~~Pv~l~~~~~~~~~sFst~F~F~I~~~~~~~ 78 (234)
T 2bqp_A 2 ETTSFLITKFSPDQQNLIFQGDGYTTKEKLTLTKAVK---NTVGRALYSSPIHIWDRETGNVANFVTSFTFVINAPNSYN 78 (234)
T ss_dssp EEEEEEESSBCTTCTTEEEEETCEEETBEEEEECSCT---TCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECSSTTS
T ss_pred cceEEEcCCCCCCCCCEEEeeceecCCCEEEeCCCCC---CCEEEEEECCCEEcccCCCCceeeEEEEEEEEEeCCCCCC
Confidence 45789999998 679999999996689999999877 8899999999999999999999999999999999877778
Q ss_pred CCCceEEEEcCCCCCCCCCCCcccccccCCCC--cceEEEEeecccCCCCCCCC--CCeeeEecCCCcccccccCCcccc
Q 043702 110 IGAGLAFVITPDGEQVGSAGGSLGLLDEKGAG--LGFVAVEFDTLMDVEFSDIN--GNHVGLDLNSMVSTEVDNLDTINV 185 (711)
Q Consensus 110 ~g~GlaF~l~~~~~~~~~~g~~lgl~~~~~~~--~~~vaVEFDt~~n~~~~d~~--~~Hvgid~ns~~S~~~~~~~~~~~ 185 (711)
+||||||+|+|....+++.|+||||+|.+++. +++|||||||++|.+| ||+ +||||||||++.|.++.+ +
T Consensus 79 ~gdGlAF~l~p~~~~p~~~g~~LGl~n~~~~~~~~~~vAVEFDT~~N~~~-Dp~~~~nHVgIdvns~~S~~s~~-----~ 152 (234)
T 2bqp_A 79 VADGFTFFIAPVDTKPQTGGGYLGVFNSAEYDKTTQTVAVEFDTFYNAAW-DPSNRDRHIGIDVNSIKSVNTKS-----W 152 (234)
T ss_dssp CCCEEEEEEEETTCCCCCCGGGTTTCSCSSCCGGGCCEEEEEECSCCTTT-SCTTCCCEEEEEESSSSCSEEEE-----C
T ss_pred CCCcEEEEEecCCCCCCCCCCccccccccCCCCCCcEEEEEEecccCccc-CCCCCCCceeEeeCCccccceEe-----e
Confidence 99999999999876666889999999876433 8999999999999884 999 999999999999987654 4
Q ss_pred ccCCCCeEEEEEEEcccccEEEEEEEecCC----CCCcceeeEecCcccccccceeEEEeeeccCceeeEEEEeeccccc
Q 043702 186 DLKSGDLVNSWIEYDGLTRAFNISVSYSNL----KPKVPILSFTLDLDQYVNDFMYVGFSGSTQGSTEIHSIEWWSFSSS 261 (711)
Q Consensus 186 ~~~~g~~~~~~I~Y~~~~~~l~V~~~~~~~----~~~~~~ls~~vdL~~~l~~~~~vGFsastg~~~~~~~i~sW~f~s~ 261 (711)
++.+|+.++|||+||+.+++|+|+|++.+. +|..|+|+..|||+.+|||+||||||||||...|.|+|++|+|+++
T Consensus 153 ~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~p~~~~ls~~vdL~~~l~~~~yvGFSAsTG~~~~~H~IlsWsF~s~ 232 (234)
T 2bqp_A 153 KLQNGEEANVVIAFNAATNVLTVSLTYPNNSLEEEVTSYTLSDVVSLKDVVPEWVRIGFSATTGAEYAAHEVLSWSFHSE 232 (234)
T ss_dssp CCCTTCEEEEEEEEETTTTEEEEEEEECC------CEEEEEEEECCGGGTSCSEEEEEEEEECSSSCCEEEEEEEEEEEE
T ss_pred EEcCCCEEEEEEEEeCCCCEEEEEEecCCCCcccCCCcceEEEEechHHhCCCceEEEEEeccCCCcccEEEEEEEEEee
Confidence 688999999999999999999999998653 4678999999999999999999999999999999999999999886
Q ss_pred c
Q 043702 262 F 262 (711)
Q Consensus 262 ~ 262 (711)
+
T Consensus 233 l 233 (234)
T 2bqp_A 233 L 233 (234)
T ss_dssp E
T ss_pred c
Confidence 4
|
| >1qnw_A Chitin binding lectin, UEA-II; carbohydrate binding; HET: NAG; 2.35A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1dzq_A* 1qoo_A* 1qos_A* 1qot_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-57 Score=456.96 Aligned_cols=224 Identities=29% Similarity=0.496 Sum_probs=199.0
Q ss_pred ccceeeecCCCC--CCCeEEeCceEee-CCcEEeCCCCCCCCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecCCC
Q 043702 31 STATEFDFGTLT--LASLKLLGDAHMN-NGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLNP 107 (711)
Q Consensus 31 ~~~~~f~~~~f~--~~~~~~~g~a~~~-~g~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~ 107 (711)
+.+++|+|++|. ..+|+|+|||.+. +|.|+||++.....+++|||+|++||+|||+.+|+++||+|+|+|.|.++ .
T Consensus 3 ~~~~~F~f~~F~~~~~~l~l~G~A~i~~~g~l~LT~~~~~~~~~~Gra~y~~Pv~l~~~~tg~vasFsT~F~F~I~~~-~ 81 (242)
T 1qnw_A 3 SDDLSFNFDKFVPNQKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIWDSITGKVASFATSFSFVVKAD-K 81 (242)
T ss_dssp CCSEEEEESSCCTTCTTEEEEETCEECTTSCEESSCCC--CCCEEEEEEESSCEECBCTTTCCBCEEEEEEEEECCBS-S
T ss_pred ccceEEEcCCCCCCCCCeEEccceEEccCCcEEecCCCCcccCCeEEEEeCCCEeeecCCCCCcccEEEEEEEEEecC-C
Confidence 456899999998 6799999999996 79999999862112789999999999999999999999999999999987 6
Q ss_pred CCCCCceEEEEcCCCC--CCCCCCCcccccccCCCC--cceEEEEeecc----cCCCCCCCCCCeeeEecCCCccccccc
Q 043702 108 SSIGAGLAFVITPDGE--QVGSAGGSLGLLDEKGAG--LGFVAVEFDTL----MDVEFSDINGNHVGLDLNSMVSTEVDN 179 (711)
Q Consensus 108 ~~~g~GlaF~l~~~~~--~~~~~g~~lgl~~~~~~~--~~~vaVEFDt~----~n~~~~d~~~~Hvgid~ns~~S~~~~~ 179 (711)
..+||||||||+|... +.++.||||||+|..++. +++|||||||+ +|. +||++||||||+|++.|.++.+
T Consensus 82 ~~~gdGlAF~l~p~~~~~p~~~~g~~LGl~n~~~~~~~~~~vAVEFDT~~~~~~N~--~Dp~~nHVGIdvNs~~S~~~~~ 159 (242)
T 1qnw_A 82 SDGVDGLAFFLAPANSQIPSGSSAGMFGLFSSSDSKSSNQIIAVEFDTYFGKAYNP--WDPDFKHIGIDVNSIKSIKTVK 159 (242)
T ss_dssp SCCCCEEEEEEEETTCCCCTTCCGGGTTTCSSSSCCTTSCCEEEEEECCCCTTTCT--TSCSSCEEEEEESSSSCSEEEE
T ss_pred CCCCCCEEEEEecCCCCCCcCCCCCcccccccCCCCccccEEEEEeecccccccCC--CCCCCCcEEEecCCccccceec
Confidence 7789999999999864 447889999999865332 89999999999 887 5999999999999999987655
Q ss_pred CCccccccCCCCeEEEEEEEcccccEEEEEEEecCCCCCcceeeEecCcccccccceeEEEeeeccCc--eeeEEEEeec
Q 043702 180 LDTINVDLKSGDLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGS--TEIHSIEWWS 257 (711)
Q Consensus 180 ~~~~~~~~~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastg~~--~~~~~i~sW~ 257 (711)
+++.+|+.++|||+||+.+++|+|+|++.+. |..|+|+..|||+++|||+|||||||+||.. .|.|+|++|+
T Consensus 160 -----~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~-~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~~h~IlsWs 233 (242)
T 1qnw_A 160 -----WDWRNGEVADVVITYRAPTKSLTVCLSYPSD-GTSNIITASVDLKAILPEWVSVGFSGGVGNAAEFETHDVLSWY 233 (242)
T ss_dssp -----CCCCTTCCEEEEEEEEGGGTEEEEEEECTTT-CCEEEEEEECCHHHHSCSEEEEEEEEEESCGGGCBCCEEEEEE
T ss_pred -----ccccCCCEEEEEEEEeCCCcEEEEEEecCCC-CcceeEEEeechHHhcCCceEEEEEeccCCCccceEEEEEEEE
Confidence 4688999999999999999999999998653 5678999999999999999999999999999 9999999999
Q ss_pred cccccC
Q 043702 258 FSSSFE 263 (711)
Q Consensus 258 f~s~~~ 263 (711)
|++++.
T Consensus 234 F~s~l~ 239 (242)
T 1qnw_A 234 FTSNLE 239 (242)
T ss_dssp EEEEC-
T ss_pred eEeecC
Confidence 998863
|
| >1f9k_A Acidic lectin; legume lectin, glycosylated protein, H-antigenic specificity agglutinin, sugar binding protein; HET: NAG MAN AMG; 3.00A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 1fay_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-57 Score=453.96 Aligned_cols=222 Identities=33% Similarity=0.527 Sum_probs=199.8
Q ss_pred ceeeecCCCC--CCCeEEeCceEee-CCcEEeCCCCCCC---CCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecC-
Q 043702 33 ATEFDFGTLT--LASLKLLGDAHMN-NGSVRLTRDVTVP---YDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNL- 105 (711)
Q Consensus 33 ~~~f~~~~f~--~~~~~~~g~a~~~-~g~~~Lt~~~~~~---~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~- 105 (711)
+++|+|++|. ..+|+|+|||.+. +|.|+||++..++ .+++|||+|++||+|||+.+|+++||+|+|+|.|.++
T Consensus 2 ~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~~g~vasFsT~F~F~I~~~~ 81 (238)
T 1f9k_A 2 TQSFNFDHFEENSKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWDSTTGNVASFETRFSFNITQPY 81 (238)
T ss_dssp EEEEEESSCCSSCTTEEEEETCEECTTSCEECSCSEETTEECCSCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECCC
T ss_pred CeEEEcCCCCCCCCCeEEccceEECcCCcEEecCccccCccccCCEEEEEECCCEEeecCCCCCeeeEEEEEEEEEecCC
Confidence 4789999998 6799999999996 7999999976211 3789999999999999999999999999999999987
Q ss_pred CCCCCCCceEEEEcCCCCCCCCCCCcccccccCCCCcceEEEEeecccCCCCCCCCCCeeeEecCCCcccccccCCcccc
Q 043702 106 NPSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAGLGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINV 185 (711)
Q Consensus 106 ~~~~~g~GlaF~l~~~~~~~~~~g~~lgl~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~S~~~~~~~~~~~ 185 (711)
+...+||||||||+|....+++.||||||+|..+. +++|||||||++|. +||++||||||||++.|.++.+ +
T Consensus 82 ~~~~~gdGlAF~l~p~~~~~~~~g~~LGl~n~~~~-~~~vAVEFDT~~N~--~Dp~~nHVgIdvns~~S~~s~~-----~ 153 (238)
T 1f9k_A 82 AYPEPADGLTFFMVPPNSPQGEDGGNLGVFKPPEG-DNAFAVEFDTFQNT--WDPQVPHIGIDVNSIVSSKTLH-----F 153 (238)
T ss_dssp SSSCCCEEEEEEEECTTCCCCCSGGGTTTCCSSCC-SCCEEEEEECSCCT--TCCSSSEEEEEESSSSCSEEEE-----C
T ss_pred CCCCCCCcEEEEEccCCCCCCCCCCcccccccCCC-CcEEEEEEecccCC--CCCCCCeEEEecCCccccceEe-----e
Confidence 66778999999999987777888999999987644 89999999999997 5999999999999999987654 4
Q ss_pred ccCCCCeEEEEEEEcccccEEEEEEEecCCCCCcceeeEecCccccccc--ceeEEEeeeccCc---eeeEEEEeecccc
Q 043702 186 DLKSGDLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVND--FMYVGFSGSTQGS---TEIHSIEWWSFSS 260 (711)
Q Consensus 186 ~~~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~ls~~vdL~~~l~~--~~~vGFsastg~~---~~~~~i~sW~f~s 260 (711)
++.+|+.++|||+||+.+++|+|+|++.+. +..|+|+..|||+.+||| +||||||||||.. .|.|+|++|+|++
T Consensus 154 ~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~-~~~~~ls~~vdL~~~l~~~~~~~vGFSAsTG~~~~~~~~h~IlsWsF~s 232 (238)
T 1f9k_A 154 QLENGGVANVVIKYDSPTKILNVVLAFHSV-GTVYTLSNIVDLKQEFPNSEWVNVGLSATTGYQKNAVETHEIISWSFTS 232 (238)
T ss_dssp CCCTTCCEEEEEEEETTTTEEEEEEEETTT-TEEEEEEEECCHHHHSTTCSEEEEEEEEEECSSTTCCCEEEEEEEEEEE
T ss_pred cccCCCEEEEEEEEeCCCCEEEEEEecCCC-CCceeEEEEechHHhCCCCceEEEEEEeCcCCCCcccceEEEEEeEeEe
Confidence 688999999999999999999999998653 557899999999999999 9999999999999 9999999999998
Q ss_pred ccC
Q 043702 261 SFE 263 (711)
Q Consensus 261 ~~~ 263 (711)
++.
T Consensus 233 ~~~ 235 (238)
T 1f9k_A 233 SLQ 235 (238)
T ss_dssp EC-
T ss_pred ecc
Confidence 763
|
| >1wbf_A Protein (agglutinin); lectin (agglutinin), legume lectin, protein crystallography, group specificity, saccharide free form; HET: NAG; 2.30A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 2d3s_A* 2dtw_A* 1wbl_A* 2dty_A* 2du0_A* 2du1_A* 2e51_A* 2e53_A* 2zmk_A* 2zml_A* 2zmn_A* 2e7t_A* 2e7q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-57 Score=455.56 Aligned_cols=222 Identities=36% Similarity=0.565 Sum_probs=199.3
Q ss_pred ceeeecCCCC--CCCeEEeCceEee-CCcEEeCCCCC-C-CCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecC-C
Q 043702 33 ATEFDFGTLT--LASLKLLGDAHMN-NGSVRLTRDVT-V-PYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNL-N 106 (711)
Q Consensus 33 ~~~f~~~~f~--~~~~~~~g~a~~~-~g~~~Lt~~~~-~-~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~-~ 106 (711)
+++|+|++|. ..+|+|+|||.+. +|.|+||++.. . ..+++|||+|++||+|||+.+|+++||+|+|+|.|.++ +
T Consensus 3 ~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg~vaSFsT~F~F~I~~~~~ 82 (242)
T 1wbf_A 3 TISFNFNQFHQNEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDSTTGNVASFETRFSFSIRQPFP 82 (242)
T ss_dssp EEEEEESSCCTTCTTEEEEETCEECTTSCEESSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCSCC
T ss_pred ceEEEcCCCCCCCCCeEEccceEEccCCcEEecCcccCCcccCCeEEEEECCCEecccCCCCCeeeEEEEEEEEEeCCCC
Confidence 5789999998 6799999999996 79999998751 0 12789999999999999999999999999999999987 5
Q ss_pred CCCCCCceEEEEcCCCCCCCCCCCcccccccCCCCcceEEEEeecccCCCCCCCCCCeeeEecCCCcccccccCCccccc
Q 043702 107 PSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAGLGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVD 186 (711)
Q Consensus 107 ~~~~g~GlaF~l~~~~~~~~~~g~~lgl~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~S~~~~~~~~~~~~ 186 (711)
...+||||||||+|....+++.||||||+|.+ ..+++|||||||++|. +||++||||||+|++.|.++.+ ++
T Consensus 83 ~~~~gdGlAF~l~p~~~~~~~~g~~LGl~n~~-~~~~~vAVEFDT~~N~--~Dp~~nHVGIdvNs~~S~~~~~-----~~ 154 (242)
T 1wbf_A 83 RPHPADGLVFFIAPPNTQTGEGGGYFGIYNPL-SPYPFVAVEFDTFRNT--WDPQIPHIGIDVNSVISTKTVP-----FT 154 (242)
T ss_dssp SSCCCEEEEEEEECSSCCCCCCGGGTTTCCTT-SCCCCEEEEEECSCCT--TCCSSSEEEEEESSSSCSEEEE-----CC
T ss_pred CCCCCCcEEEEEecCCCCCCCCCCccccccCC-CcCcEEEEEeccccCC--CCCCCCeEEEECCCccccceee-----eE
Confidence 67789999999999877778889999999875 4489999999999997 5999999999999999987654 46
Q ss_pred cCCCCeEEEEEEEcccccEEEEEEEecCCCCCcceeeEecCcccccccceeEEEeeec----cCc---eeeEEEEeeccc
Q 043702 187 LKSGDLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGST----QGS---TEIHSIEWWSFS 259 (711)
Q Consensus 187 ~~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsast----g~~---~~~~~i~sW~f~ 259 (711)
+.+|+.++|||+||+.+++|+|+|++.+. +..|+|+..|||+++|||+||||||||| |.. .|.|+|++|+|+
T Consensus 155 l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~-~~~~~ls~~vdL~~~l~e~v~VGFSAsTg~~~G~~~~~~~~h~IlsWsF~ 233 (242)
T 1wbf_A 155 LDNGGIANVVIKYDASTKILHVVLVFPSL-GTIYTIADIVDLKQVLPESVNVGFSAATGDPSGKQRNATETHDILSWSFS 233 (242)
T ss_dssp CCTTSCEEEEEEEETTTTEEEEEEEETTT-TEEEEEEEECCHHHHSCSEEEEEEEEEECCGGGCCTTCCCCCEEEEEEEE
T ss_pred ecCCCEEEEEEEEeCCCCEEEEEEccCCC-CCcceEEEEechHHhcCCceEEEEEEeecCcCCccccccceEEEEEEEeE
Confidence 88999999999999999999999998653 4578999999999999999999999999 888 999999999999
Q ss_pred cccC
Q 043702 260 SSFE 263 (711)
Q Consensus 260 s~~~ 263 (711)
+++.
T Consensus 234 s~l~ 237 (242)
T 1wbf_A 234 ASLP 237 (242)
T ss_dssp EECC
T ss_pred ecCC
Confidence 9874
|
| >1n47_A Isolectin B4; cancer antigen, vicia villosa lectin, glycoprotein TN-bindin protein, carbohydrate recognition, sugar binding protein; HET: NAG FUC TNR; 2.70A {Vicia villosa} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-56 Score=452.14 Aligned_cols=221 Identities=33% Similarity=0.499 Sum_probs=196.6
Q ss_pred cceeeecCCCC--CCCeEEeCceEee-CCcEEeCCCCCC--CCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecCC
Q 043702 32 TATEFDFGTLT--LASLKLLGDAHMN-NGSVRLTRDVTV--PYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLN 106 (711)
Q Consensus 32 ~~~~f~~~~f~--~~~~~~~g~a~~~-~g~~~Lt~~~~~--~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~ 106 (711)
.+++|+|++|. ..+|+|+|||.+. +|.|+||++... ..+++|||+|++||+|||+.+ ++||+|+|+|.|.+++
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pi~l~d~~~--~~sFsT~F~F~I~~~~ 79 (233)
T 1n47_A 2 ESTSFSFTNFNPNQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIHDNTT--LASFTTSFSFVMAAPA 79 (233)
T ss_dssp EEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCBSSSSBCTTCEEEEEESSCEECBCSSC--BCEEEEEEEEECCCSS
T ss_pred cceEEEcCCCCCCCCCeEEccceEEccCCcEEeccCcCCCccCCCeEEEEECCCEeccCCCC--cCCEEEEEEEEEeCCC
Confidence 45789999998 6799999999996 799999997621 126899999999999999877 9999999999999877
Q ss_pred CCCCCCceEEEEcCCCCCCCCCCCcccccccCCCC--cceEEEEeecccCCCCCCCCCCeeeEecCCCcccccccCCccc
Q 043702 107 PSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAG--LGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTIN 184 (711)
Q Consensus 107 ~~~~g~GlaF~l~~~~~~~~~~g~~lgl~~~~~~~--~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~S~~~~~~~~~~ 184 (711)
...+||||||||+|....+++.||||||+|.+++. +++|||||||++|. +||++||||||+||+.|.++.+
T Consensus 80 ~~~~gdGlAF~l~p~~~~p~~~g~~LGl~n~~~~~~~n~~vAVEFDT~~N~--~Dp~~nHvGIdvns~~S~~~~~----- 152 (233)
T 1n47_A 80 AAAVADGLAFFLAPPDTQPQARGGFLGLFADRAHDASYQTVAVEFDTYSNA--WDPNYTHIGIDTNGIESKKTTP----- 152 (233)
T ss_dssp TTSCCEEEEEEEECTTCCCCCCGGGTTTCSSSSCCGGGCCEEEEEECSCCT--TSCSSCEEEEEESSSSCSEEEE-----
T ss_pred CCCCCCcEEEEEecCCCCCCCCCCcccccccCCCCccCceEEEEeccccCC--CCCCCCcEEEccCCcccccccc-----
Confidence 67789999999999876667889999999875333 89999999999997 4999999999999999987654
Q ss_pred cccCCCCeEEEEEEEcccccEEEEEEEecCCCCCcceeeEecCcccccccceeEEEeeeccCc---eeeEEEEeeccccc
Q 043702 185 VDLKSGDLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGS---TEIHSIEWWSFSSS 261 (711)
Q Consensus 185 ~~~~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastg~~---~~~~~i~sW~f~s~ 261 (711)
+++.+|+.++|||+||+.+++|+|+|++.+.+ ..|+|+..|||+.+|||+|||||||+||.. .|.|+|++|+|+++
T Consensus 153 ~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~-~~~~ls~~vdL~~~l~~~~~vGFSAsTG~~~~~~~~h~IlsWsF~s~ 231 (233)
T 1n47_A 153 FDMVYGEKANIVITYQASTKALAASLVFPVSQ-TSYAVSARVDLRDILPEYVRVGFSATTGLNAGVVETHDIVSWSFAVS 231 (233)
T ss_dssp CCCCTTSCEEEEEEEETTTTEEEEEEEETTTT-EEEEEEEECCGGGTSCSEEEEEEEEEECSSTTCCCCCEEEEEEEEEE
T ss_pred ccccCCCEEEEEEEEeCCCCEEEEEEecCCCC-CcceEEEEechHHhCCCceEEEEEeccCCCccccceeEEEEEEEEee
Confidence 46889999999999999999999999986533 578999999999999999999999999998 99999999999886
Q ss_pred c
Q 043702 262 F 262 (711)
Q Consensus 262 ~ 262 (711)
+
T Consensus 232 l 232 (233)
T 1n47_A 232 L 232 (233)
T ss_dssp E
T ss_pred c
Confidence 4
|
| >2fmd_A Lectin, agglutinin, BMA; legume lectin, beta sandwich, protein-carbohydrate complex, sugar binding protein; HET: MAN; 1.90A {Bowringia mildbraedii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-56 Score=451.11 Aligned_cols=223 Identities=31% Similarity=0.510 Sum_probs=199.2
Q ss_pred cceeeecCCCC--CCCeEEeCceEee-CCcEEeCCCCCC---CCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecC
Q 043702 32 TATEFDFGTLT--LASLKLLGDAHMN-NGSVRLTRDVTV---PYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNL 105 (711)
Q Consensus 32 ~~~~f~~~~f~--~~~~~~~g~a~~~-~g~~~Lt~~~~~---~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~ 105 (711)
.+++|+|++|. ..+|+|+|||.+. +|.|+||++.++ ..++.|||+|++||+|||+ +|+++||+|+|+|+|.++
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~G~a~y~~Pv~l~~~-~g~~~sFst~F~F~I~~~ 80 (240)
T 2fmd_A 2 NSVCFTFTDFESGQQDLIFQGDASVGSNKALQLTKVDSKGNPQGGSVGRALYTAPIRLWQS-SSLVASFETTFTFSISQG 80 (240)
T ss_dssp CEEEEEESSCCTTCTTEEEEETCEECTTSCEECSCBCTTSCBCSSCEEEEEESSCEECCCT-TCSEEEEEEEEEEECCBS
T ss_pred cceEEEcCCCCCCCCCeEEccceEEcCCCCEEeCCCCcCCcccCCCeEEEEECCCEEeeCC-CCCcCcEEEEEEEEEecC
Confidence 45789999998 6799999999996 799999997642 1267999999999999999 999999999999999987
Q ss_pred CCCCCCCceEEEEcCCCCCCC--CCCCcccccccCCCC---cceEEEEeecccCCCCCCCCCCeeeEecCCCcccccccC
Q 043702 106 NPSSIGAGLAFVITPDGEQVG--SAGGSLGLLDEKGAG---LGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNL 180 (711)
Q Consensus 106 ~~~~~g~GlaF~l~~~~~~~~--~~g~~lgl~~~~~~~---~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~S~~~~~~ 180 (711)
...+||||||+|+|....++ +.|+||||+|.++++ +++|||||||++|.+++||++||||||+|++.|.++.+
T Consensus 81 -~~~~gdGlAF~l~p~~~~p~~g~~g~~LGl~n~~~~~~~~n~~vAVEfDT~~N~~~~Dp~~nHvgIdvns~~S~~s~~- 158 (240)
T 2fmd_A 81 -SSTPADALTFFIASPDTKIPSGSGGRLLGLFGSSNNAGSDNGVVSVEFDTYPNTDIGDPNYRHIGIDVNSIRSKAASK- 158 (240)
T ss_dssp -SSSCCCEEEEEEECTTCCCCTTCCGGGTTTCSCCC----CCCEEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEE-
T ss_pred -CCCCCCcEEEEEecCCCCCCccCCCCcccccccCcCCCCcCcEEEEEeccccccccCCCCCCceeeccccccccceeE-
Confidence 67789999999999876553 889999999876533 89999999999999877999999999999999987654
Q ss_pred CccccccCCCCeEEEEEEEcccccEEEEEEEecCCCCCcceeeEecCcccccccceeEEEeeeccCceeeEEEEeecccc
Q 043702 181 DTINVDLKSGDLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGSTEIHSIEWWSFSS 260 (711)
Q Consensus 181 ~~~~~~~~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastg~~~~~~~i~sW~f~s 260 (711)
+++.+|+.++|||+||+.+++|+|+|++.+. ..|+|+..|||+.+||++|||||||+||...|.|+|++|+|++
T Consensus 159 ----~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~ls~~vdL~~~l~~~~yvGFSAsTG~~~~~H~IlsWsF~s 232 (240)
T 2fmd_A 159 ----WDWQNGKTATAHISYNSASKRLSVVSSYPNS--SPVVVSFDVELNNVBPBWVRVGFSATTGQYTQTNNILAWSFRS 232 (240)
T ss_dssp ----CCCCSSCEEEEEEEEETTTTEEEEEEECTTS--CCEEEEEECCGGGTSCSEEEEEEEEECCSSCBCCEEEEEEEEE
T ss_pred ----EEeeCCCEEEEEEEEeCCCCEEEEEEecCCC--CceEEEEEechHHhCCCceEEEEEeccCCccccEEEEEEEeEe
Confidence 4688999999999999999999999998654 4789999999999999999999999999999999999999999
Q ss_pred ccC
Q 043702 261 SFE 263 (711)
Q Consensus 261 ~~~ 263 (711)
++.
T Consensus 233 ~~~ 235 (240)
T 2fmd_A 233 SLM 235 (240)
T ss_dssp EEE
T ss_pred cCC
Confidence 874
|
| >1avb_A Arcelin-1; lectin-like glycoprotein, plant defense, insecticidal activi lectin; HET: NAG; 1.90A {Phaseolus vulgaris} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-56 Score=445.53 Aligned_cols=218 Identities=32% Similarity=0.485 Sum_probs=194.5
Q ss_pred cceeeecCCCCCCCeEEeCceEee-CCcEEeCCCCCCCCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecCCCCCC
Q 043702 32 TATEFDFGTLTLASLKLLGDAHMN-NGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLNPSSI 110 (711)
Q Consensus 32 ~~~~f~~~~f~~~~~~~~g~a~~~-~g~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~ 110 (711)
.+++|+|++|...||+|+|||.+. +|.|+||++.....+++|||+|++||+|||+.+|+++||+|+|+|.|.+++...+
T Consensus 2 ~~~~F~f~~F~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~Gra~y~~Pv~l~~~~~g~vaSFsT~F~F~I~~~~~~~~ 81 (226)
T 1avb_A 2 NDASFNVETFNKTNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQINDRTIDNLASFSTNFTFRINAKNIENS 81 (226)
T ss_dssp EEEEEEESSCCGGGEEEEETCEECTTSCEECSCSSSCCTTCEEEEEESSCEECEEGGGTEEEEEEEEEEEEEEESSTTSC
T ss_pred cceEEEcCCCCccCEEEeccEEECCCCEEEeCCCCCCccCCeEEEEeCCCEEeecCCCCCcccEEEEEEEEEeCCCCCCC
Confidence 357899999998899999999996 8999999983112278999999999999999999999999999999998877789
Q ss_pred CCceEEEEcCCCCCCCCCCCcccccccCCCC--cceEEEEeecccCCCCCCCCCCeeeEecCCCcccccccCCccccccC
Q 043702 111 GAGLAFVITPDGEQVGSAGGSLGLLDEKGAG--LGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLK 188 (711)
Q Consensus 111 g~GlaF~l~~~~~~~~~~g~~lgl~~~~~~~--~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~S~~~~~~~~~~~~~~ 188 (711)
||||||||+|....+++.||||||+|.+++. +++|||||||+ +||||||+||+.|.++.++ ...+.
T Consensus 82 gdGlAF~l~p~~~~p~~~g~~LGl~n~~~~~~~~~~vAVEFDT~---------~nHVGIdvNs~~S~~t~~~---~~~l~ 149 (226)
T 1avb_A 82 AYGLAFALVPVGSRPKLKGRYLGLFNTTNYDRDAHTVAVVFDTV---------SNRIEIDVNSIRPIATESC---NFGHN 149 (226)
T ss_dssp CEEEEEEEEETTCCCCCCGGGTTTCSCSSCCGGGCCEEEEEETT---------TTEEEEEESSSSCSEEEEC---CSGGG
T ss_pred CCcEEEEEecCCCCCCCCCCcccccccCCCCCcccEEEEEecCc---------CCccceeecCcccCccccC---Ccccc
Confidence 9999999999876666889999999875433 89999999998 6899999999999887765 35677
Q ss_pred CCCeEEEEEEEcccccEEEEEEEecCCCCCcceeeEecCcccccccceeEEEeeeccCc---eeeEEEEeecccccc
Q 043702 189 SGDLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGS---TEIHSIEWWSFSSSF 262 (711)
Q Consensus 189 ~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastg~~---~~~~~i~sW~f~s~~ 262 (711)
+|+.++|||+||+.+++|+|+|++.+. ++.|+|+..|||+++|||+|||||||+||.. .|.|+|++|+|++++
T Consensus 150 ~g~~~~v~I~Yd~~~~~L~V~l~~~~~-~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~~~~~~h~IlsWsF~s~l 225 (226)
T 1avb_A 150 NGEKAEVRITYDSPKNDLRVSLLYPSS-EEKCHVSATVPLEKEVEDWVSVGFSATSGSKKETTETHNVLSWSFSSNF 225 (226)
T ss_dssp TTCEEEEEEEEEGGGTEEEEEEEETTT-TEEEEEEEECCHHHHSCSEEEEEEEEEECSSGGGCEEEEEEEEEEEEEE
T ss_pred CCCeEEEEEEEeCCCcEEEEEEeecCC-CccceEEEEechHHhCCCceEEEEEeccCCCCcccceeEEEEEEEEeec
Confidence 999999999999999999999998653 2478999999999999999999999999999 999999999998764
|
| >1ioa_A Arcelin-5A, ARC5A; lectin-like proteins, plant defense proteins, lectin; HET: NAG FUC; 2.70A {Phaseolus vulgaris} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-54 Score=437.55 Aligned_cols=217 Identities=29% Similarity=0.438 Sum_probs=193.1
Q ss_pred cceeeecCCCCCCC-eEEeCceEee-CCcEEeCCCCCC---CCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecCC
Q 043702 32 TATEFDFGTLTLAS-LKLLGDAHMN-NGSVRLTRDVTV---PYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLN 106 (711)
Q Consensus 32 ~~~~f~~~~f~~~~-~~~~g~a~~~-~g~~~Lt~~~~~---~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~ 106 (711)
.+++|+|++|...| |+|+|||.+. +|.|+||++.++ ..+++|||+|++||+|||+. +++||+|+|+|.|.+++
T Consensus 2 ~~~~F~f~~F~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~s~Gra~y~~Pi~l~d~~--~vaSFsT~F~F~I~~~~ 79 (240)
T 1ioa_A 2 TETSFNFPNFHTDDKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIKDSN--NVASFNTNFTFIIRAKN 79 (240)
T ss_dssp CCCEEEESSCCTTSSEEEEETCEECTTSCEETTCBCTTSSBCSSCBEEEEESSCEECBCSS--CBEEEEEEEEEECCBSC
T ss_pred cceEEEcCCCCCCCcEEEccceEECCCCeEEeCCCCCCCccccCceEEEEECCCEEccCCC--ccccEEEEEEEEEeCCC
Confidence 35789999999889 9999999996 899999987642 22679999999999999986 89999999999999887
Q ss_pred CCCCCCceEEEEcCCCCCCCCCCCcccccccCCCC--cceEEEEeecccCCCCCCCCCCeeeEecCCCcccccccCCccc
Q 043702 107 PSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAG--LGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTIN 184 (711)
Q Consensus 107 ~~~~g~GlaF~l~~~~~~~~~~g~~lgl~~~~~~~--~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~S~~~~~~~~~~ 184 (711)
...+||||||||+|....+++.||||||+|.+++. +++|||||||+ +|||||||||+.|.++.++ .
T Consensus 80 ~~~~gdGlAF~l~p~~~~p~~~g~~LGL~n~~~~~~~~~~vAVEFDT~---------~nHVGIdvNs~~S~~t~~~---~ 147 (240)
T 1ioa_A 80 QSISAYGLAFALVPVNSPPQKKQEFLGIFNTNNPEPNARTVAVVFNTF---------KNRIDFDKNFIKPYVNENC---D 147 (240)
T ss_dssp TTSCCEEEEEEEEETTCCCCCCGGGTTTCCCSSCCGGGCCEEEEEETT---------TTEEEEEESSSSCSEEEEC---C
T ss_pred CCCCCCcEEEEEecCCCCCCCCCCcccccccCCCCCcCcEEEEEecCc---------CCceeeeeCCccccccccC---C
Confidence 77889999999999876666889999999875333 89999999998 6899999999999887765 3
Q ss_pred cccCCCCeEEEEEEEcccccEEEEEEEecCCCCCcceeeEecCcccccccceeEEEeeeccCc---eeeEEEEeeccccc
Q 043702 185 VDLKSGDLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGS---TEIHSIEWWSFSSS 261 (711)
Q Consensus 185 ~~~~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastg~~---~~~~~i~sW~f~s~ 261 (711)
..+.+|+.++|||+||+.+++|+|+|++.+. ++.|+|+..|||+++|||+|||||||+||.. .|.|+|++|+|+++
T Consensus 148 ~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~-~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~~~H~IlsWsF~s~ 226 (240)
T 1ioa_A 148 FHKYNGEKTDVQITYDSSNNDLRVFLHFTVS-QVKCSVSATVHLEKEVDEWVSVGFSPTSGLTEDTTETHDVLSWSFSSK 226 (240)
T ss_dssp HHHHCSSCEEEEEEEETTTTEEEEEEEETTT-CCEEEEEEECCGGGTSCSEEEEEEEEEECSSTTTCBCCEEEEEEEEEE
T ss_pred ccccCCCEEEEEEEEeCCCcEEEEEEecCCC-CccceeEEEechHHhCCCceEEEEEeccCCCCcccceeEEEEEEEEee
Confidence 5677999999999999999999999998653 3478999999999999999999999999999 99999999999987
Q ss_pred cC
Q 043702 262 FE 263 (711)
Q Consensus 262 ~~ 263 (711)
+.
T Consensus 227 ~~ 228 (240)
T 1ioa_A 227 FR 228 (240)
T ss_dssp EC
T ss_pred CC
Confidence 63
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-54 Score=460.08 Aligned_cols=258 Identities=25% Similarity=0.442 Sum_probs=204.9
Q ss_pred cCCcccceeecCCceEEEEEEeCC-----CCeEEEEEEcccCC-CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQ-----NGDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILL 453 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 453 (711)
++|...++||+|+||+||+|++.. +++.||||++.... ...++|.+|+++|++++|||||+++|+|.+.+.++|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 356778899999999999998752 57899999997633 345689999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhCC--------------CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcE
Q 043702 454 VYDLMPNGSLDKALFEAR--------------SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNA 519 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~v 519 (711)
|||||++|+|.++|+... .+++|.++++|+.|||+||+|||+. +|+||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcE
Confidence 999999999999997532 4599999999999999999999997 99999999999999999999
Q ss_pred EEeecCCceecCCCCC-CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccch
Q 043702 520 RLGDFGLARQVEHDKS-PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNL 597 (711)
Q Consensus 520 kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l 597 (711)
||+|||+++.+..... ......+||+.|||||++.+..++.++|||||||+||||+| |+.||..... ..+
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~--------~~~ 269 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN--------TEA 269 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH--------HHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH--------HHH
Confidence 9999999997654432 23344679999999999999999999999999999999999 8999975321 111
Q ss_pred HHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCC
Q 043702 598 VEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEAEV 661 (711)
Q Consensus 598 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 661 (711)
. ..+..+. ....+.....++.+|+.+||+.||++||||+||+++|+...+.
T Consensus 270 ~----~~i~~g~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 270 I----DCITQGR---------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp H----HHHHHTC---------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred H----HHHHcCC---------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 1 1111111 1112223345678899999999999999999999999876443
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-54 Score=453.50 Aligned_cols=254 Identities=24% Similarity=0.397 Sum_probs=209.8
Q ss_pred CCcccceeecCCceEEEEEEeC-----CCCeEEEEEEcccC--CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEE
Q 043702 381 CFNANRIIGHGAFGTVYKGILP-----QNGDIIAVKRCSHN--SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILL 453 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 453 (711)
.+++.++||+|+||+||+|++. .+++.||||++... ....++|.+|+.++++++|||||+++|+|.+++.++|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 4566789999999999999974 25688999998763 3345789999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhCC---------------CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCc
Q 043702 454 VYDLMPNGSLDKALFEAR---------------SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFN 518 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~ 518 (711)
|||||++|+|.++|.... ..++|.++++|+.|||+||+|||+. +||||||||+||||++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCC
Confidence 999999999999996532 3599999999999999999999998 9999999999999999999
Q ss_pred EEEeecCCceecCCCCC-CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccc
Q 043702 519 ARLGDFGLARQVEHDKS-PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASN 596 (711)
Q Consensus 519 vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~ 596 (711)
+||+|||+++.+..... ......+||++|||||++.++.++.++|||||||+||||+| |+.||..... ..
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~--------~~ 255 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--------QD 255 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH--------HH
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH--------HH
Confidence 99999999987654332 23345679999999999999999999999999999999998 8999975321 11
Q ss_pred hHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 597 LVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 597 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
+.+ .+..+.. ...+.+....+.+|+.+||+.||++||||+||++.|+.-
T Consensus 256 ~~~----~i~~~~~---------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 256 VVE----MIRNRQV---------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHH----HHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHH----HHHcCCC---------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 211 1222221 112333456688899999999999999999999999853
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-54 Score=454.77 Aligned_cols=255 Identities=25% Similarity=0.451 Sum_probs=209.3
Q ss_pred cCCcccceeecCCceEEEEEEeC-----CCCeEEEEEEcccCC-CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILP-----QNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILL 453 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 453 (711)
++|.+.+.||+|+||+||+|++. .++..||||+++... ...++|.+|+++|++++|||||+++|+|.+++.++|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46788899999999999999874 247889999997643 345689999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhCC------------CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEE
Q 043702 454 VYDLMPNGSLDKALFEAR------------SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARL 521 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~~------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL 521 (711)
|||||++|+|.++|+..+ ..++|.++++|+.|||+||+|||+. +|+||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEE
Confidence 999999999999997532 4699999999999999999999997 9999999999999999999999
Q ss_pred eecCCceecCCCCCC-CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHH
Q 043702 522 GDFGLARQVEHDKSP-DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVE 599 (711)
Q Consensus 522 ~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~ 599 (711)
+|||+|+........ ......||+.|||||++.++.++.++|||||||+||||+| |+.||..... ..+.
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~--------~~~~- 240 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--------NEVI- 240 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--------HHHH-
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------HHHH-
Confidence 999999876543322 2233469999999999999999999999999999999999 8999975321 1111
Q ss_pred HHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 600 WVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 600 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
..+..+.. ...+.....++.+|+.+||+.||++||||+||+++|+..
T Consensus 241 ---~~i~~~~~---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 241 ---ECITQGRV---------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp ---HHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHcCCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11122211 112223445678899999999999999999999999764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-53 Score=447.81 Aligned_cols=256 Identities=25% Similarity=0.375 Sum_probs=202.4
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC---CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
+++...++||+|+||+||+|++.. .||||+++... +..++|.+|+++|++++|||||+++|+|.+ +.++||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 467788999999999999998842 58999987533 234679999999999999999999999865 56899999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCC-C
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK-S 535 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~-~ 535 (711)
||++|+|.++|+.....++|.++++|+.|||+||+|||+. +||||||||+||||++++.+||+|||+|+...... .
T Consensus 112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 9999999999988778899999999999999999999997 99999999999999999999999999998765433 2
Q ss_pred CCcccccCCCcccChhhhcc---CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhH
Q 043702 536 PDATVAAGTMGYLAPEYLLT---GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLT 612 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~---~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 612 (711)
......+||+.|||||++.. +.|+.++|||||||+||||+||+.||..... ...+......+..
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~-----------~~~~~~~~~~~~~-- 255 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN-----------RDQIIFMVGRGYA-- 255 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----------HHHHHHHHHTTCC--
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh-----------HHHHHHHHhcCCC--
Confidence 23445689999999999964 4689999999999999999999999965321 1111111111111
Q ss_pred hhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 613 AADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 613 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
.+.+ .....+....+.+|+.+||+.||++||||.||++.|+..
T Consensus 256 --~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 256 --SPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp --CCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred --CCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1111 112223445678899999999999999999999988654
|
| >1dhk_B Bean lectin-like inhibitor, porcine pancreatic alpha-amylase; CO (hydrolase-inhibitor), complex (hydrolase-inhibitor) comple; HET: NAG; 1.85A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1viw_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-51 Score=408.47 Aligned_cols=200 Identities=32% Similarity=0.468 Sum_probs=175.0
Q ss_pred cceeeecCCCCCCCeEEeCceEee-CCcEEeCCCCCCCCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecCCCCCC
Q 043702 32 TATEFDFGTLTLASLKLLGDAHMN-NGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLNPSSI 110 (711)
Q Consensus 32 ~~~~f~~~~f~~~~~~~~g~a~~~-~g~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~ 110 (711)
.+++|+|++|...||+|+|||.+. +|.|+||++.. +++|||+|++||+|||+.+|+++||+|+|+|.|.+++...+
T Consensus 2 ~~~~F~f~~F~~~~l~l~G~A~v~~~g~l~LT~~~~---~~~Gra~y~~Pi~l~~~~~g~vaSFsT~F~F~I~~~~~~~~ 78 (223)
T 1dhk_B 2 TETSFIIDAFNKTNLILQGDATVSSNGNLQLSYNSY---DSMSRAFYSAPIQIRDSTTGNVASFDTNFTMNIRTHRQANS 78 (223)
T ss_dssp CCCEEEESSCCGGGEEEESSEEECTTSCEEESSSCS---SEEEEEEESSCEESEETTTTEECEEEEEEEEEEECCC---C
T ss_pred cceEEEcCCCCcCCEEEeccEEECCCCEEEcCCCCC---CCEEEEEECCCEEeecCCCCCccceEEEEEEEEeCCCCCCC
Confidence 357899999998899999999996 89999998766 78999999999999999999999999999999998877788
Q ss_pred CCceEEEEcCCCCCCCCCCCcccccccCCCCcceEEEEeecccCCCCCCCCCCeeeEecCCCcccccccCCccccccCCC
Q 043702 111 GAGLAFVITPDGEQVGSAGGSLGLLDEKGAGLGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSG 190 (711)
Q Consensus 111 g~GlaF~l~~~~~~~~~~g~~lgl~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~S~~~~~~~~~~~~~~~g 190 (711)
||||||||+|....++ +++|||||||+ +||||||+||+ |.++.++ ...+.+|
T Consensus 79 gdGlAF~l~p~~~~p~---------------~~~vAVEFDT~---------~nHVGIdvNsi-S~~~~~~---~~~l~~g 130 (223)
T 1dhk_B 79 AVGLDFVLVPVQPESK---------------GDTVTVEFDTF---------LSRISIDVNNN-DIKSVPW---DVHDYDG 130 (223)
T ss_dssp CSEEEEEEEEC---------------------CCEEEEEETT---------TTEEEEEETTE-EEEEEEC---CGGGTTT
T ss_pred CCceEEEEecCCCCCC---------------ccEEEEEecCC---------CCcccccCCcc-ccccccC---CccccCC
Confidence 9999999999765322 24799999998 68999999999 9887765 3677799
Q ss_pred CeEEEEEEEcccccEEEEEEEecCCCCCcceeeEecCcccccccceeEEEeeeccCc---eeeEEEEeeccccccC
Q 043702 191 DLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGS---TEIHSIEWWSFSSSFE 263 (711)
Q Consensus 191 ~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastg~~---~~~~~i~sW~f~s~~~ 263 (711)
+.++|||+||+.+++|+|++++.+. ++.|+|+..|||+++|||+|||||||+||.. .|.|+|++|+|++++.
T Consensus 131 ~~~~v~I~Yd~~~~~L~V~l~~~~~-~~~~~ls~~vdLs~~l~e~~~VGFSAsTG~~~~~~~~H~IlsWsF~s~~~ 205 (223)
T 1dhk_B 131 QNAEVRITYNSSTKVFSVSLSNPST-GKSNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHDVLSWSFSSKFI 205 (223)
T ss_dssp SCEEEEEEEETTTTEEEEEEECTTT-CCEEEEEEECCCCSGGGSEEEEEEEEEECSGGGSCCEEEEEEEEEEEEC-
T ss_pred CEEEEEEEEeCCCCEEEEEEecCCC-CccceEEEEechHHhCCCceEEEEEeccCCCccccceEEEEEEEEEeccc
Confidence 9999999999999999999998653 3478999999999999999999999999999 9999999999998763
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-51 Score=435.44 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=209.9
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEccc-CCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcC
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSH-NSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
+.|+..++||+|+||+||+|+++.+|+.||||++.. .....+.+.+|+++|++++|||||++++++.+++.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 468889999999999999999999999999999875 3345667899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCc
Q 043702 459 PNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDA 538 (711)
Q Consensus 459 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 538 (711)
++|+|.+++.+ ..+++.+...++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+|+.+..... ..
T Consensus 154 ~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~ 227 (346)
T 4fih_A 154 EGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RR 227 (346)
T ss_dssp TTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CB
T ss_pred CCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-cc
Confidence 99999999965 4699999999999999999999998 999999999999999999999999999998755432 34
Q ss_pred ccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhc
Q 043702 539 TVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARL 618 (711)
Q Consensus 539 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 618 (711)
...+||+.|||||++.+..|+.++|||||||++|||++|+.||..... .+.. ..+..+ ..+.+
T Consensus 228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----------~~~~-~~i~~~-----~~~~~ 290 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-----------LKAM-KMIRDN-----LPPRL 290 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----------HHHH-HHHHHS-----SCCCC
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----------HHHH-HHHHcC-----CCCCC
Confidence 456899999999999999999999999999999999999999975321 1111 111111 01111
Q ss_pred cCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 619 EGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
........++.+|+.+||+.||++|||+.|+++.
T Consensus 291 --~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 291 --KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp --SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1111223567788999999999999999999873
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-52 Score=444.81 Aligned_cols=249 Identities=22% Similarity=0.359 Sum_probs=203.1
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC---ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ---GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
++|+..+.||+|+||+||+|++..+|+.||||++..... ..+.+.+|+++|++|+|||||++++++.+++.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 579999999999999999999999999999999876432 34578999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 457 LMPNGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 457 y~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
||++|+|.++|...+ ..+++.+.+.|+.||+.||+|||+. +|+||||||+||||++++.+||+|||+|+.+....
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV- 179 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence 999999999997544 4578999999999999999999998 99999999999999999999999999998764321
Q ss_pred CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhh
Q 043702 536 PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 615 (711)
......+||+.|||||++.+..|+.++|||||||+||||++|+.||.... ..+....... +..
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~-----------~~~~~~~i~~-~~~----- 242 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS-----------MKNLVLKIIS-GSF----- 242 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-----------HHHHHHHHHH-TCC-----
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-----------HHHHHHHHHc-CCC-----
Confidence 12344679999999999999999999999999999999999999997532 1122222111 111
Q ss_pred hhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 616 ARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 616 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
+.+ .......+.+|+.+||+.||++|||++|+++
T Consensus 243 ~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 243 PPV----SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCC----CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111 1222345778899999999999999999986
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-51 Score=432.85 Aligned_cols=271 Identities=24% Similarity=0.265 Sum_probs=202.9
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecC----eEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKG----EILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~lV~ 455 (711)
++|.+.++||+|+||+||+|++ +|+.||||++.........+..|+..+.+++|||||+++|+|.+++ .++|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4577889999999999999998 5899999998754322223334566667899999999999998764 689999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhcc-----CCCeeeccCCCCceEEcCCCcEEEeecCCceec
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQEC-----ENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV 530 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-----~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~ 530 (711)
|||++|+|.++|+. ..++|..+.+++.|+|+||+|||+.+ .++|+||||||+||||++++.+||+|||+++..
T Consensus 81 Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp ECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred cCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 99999999999975 45999999999999999999999863 458999999999999999999999999999977
Q ss_pred CCCCCC---CcccccCCCcccChhhhccC------CCCccccchhHHHHHHHHHhCCCCCcccccccccccc---ccchH
Q 043702 531 EHDKSP---DATVAAGTMGYLAPEYLLTG------RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGV---ASNLV 598 (711)
Q Consensus 531 ~~~~~~---~~~~~~gt~~y~APE~~~~~------~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~---~~~l~ 598 (711)
...... .....+||+.|||||++.+. .++.++|||||||+||||+||+.|+............ .....
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~ 238 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence 544321 22345799999999999764 3678999999999999999999887543321110000 00111
Q ss_pred HHHHHhhhcCchhHhhhhhccCC-CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 599 EWVWSLHREGRLLTAADARLEGQ-FDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 599 ~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
+.+......+.+ ++.+... ...+....+.+|+.+||+.||++||||.||++.|+..
T Consensus 239 ~~~~~~~~~~~~----rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 239 EEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp HHHHHHHTTSCC----CCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHhcccC----CCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 111111111111 1111111 1235667888999999999999999999999999754
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-51 Score=434.75 Aligned_cols=251 Identities=23% Similarity=0.261 Sum_probs=204.8
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCC
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMP 459 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 459 (711)
+.|...++||+|+||+||+|+++.+|+.||||+++... ...+|+.++++++|||||++++++.+++.+|||||||+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~ 133 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 133 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence 46788899999999999999999999999999987532 23579999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCC-cEEEeecCCceecCCCCCC--
Q 043702 460 NGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGF-NARLGDFGLARQVEHDKSP-- 536 (711)
Q Consensus 460 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~-~vkL~DFGla~~~~~~~~~-- 536 (711)
+|+|.++|.+ .+.+++.+...++.||+.||+|||+. +|+||||||+||||+.++ .+||+|||+|+.+..+...
T Consensus 134 gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~ 209 (336)
T 4g3f_A 134 GGSLGQLIKQ-MGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS 209 (336)
T ss_dssp TCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC--------
T ss_pred CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccc
Confidence 9999999965 35799999999999999999999997 999999999999999987 6999999999987644321
Q ss_pred --CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhh
Q 043702 537 --DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614 (711)
Q Consensus 537 --~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 614 (711)
.....+||+.|||||++.+..|+.++|||||||+||||++|+.||...... .+.. ........
T Consensus 210 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~--------~~~~---~i~~~~~~---- 274 (336)
T 4g3f_A 210 LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG--------PLCL---KIASEPPP---- 274 (336)
T ss_dssp ----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS--------CCHH---HHHHSCCG----
T ss_pred eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--------HHHH---HHHcCCCC----
Confidence 123357999999999999999999999999999999999999999754321 1111 11111000
Q ss_pred hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 615 DARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 615 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
...++......+.+++.+||+.||.+|||+.|+++.|..
T Consensus 275 ----~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 275 ----IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp ----GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 011222334567788999999999999999999987753
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=422.43 Aligned_cols=246 Identities=24% Similarity=0.361 Sum_probs=198.1
Q ss_pred cccceeecCCceEEEEEEeCCCCeEEEEEEcccCC---CChhhhHHHHHHHHhcCCCCeeeeeeeeee----cCeEEEEE
Q 043702 383 NANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---QGKDEFLSELSIIGTLRHRNLVRLQGWCHE----KGEILLVY 455 (711)
Q Consensus 383 ~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 455 (711)
...++||+|+||+||+|.+..++..||+|++.... ...+.|.+|+++|++|+|||||+++++|.. ++.++|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 56678999999999999999999999999987532 234578999999999999999999999865 35689999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEc-CCCcEEEeecCCceecCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLD-EGFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld-~~~~vkL~DFGla~~~~~~~ 534 (711)
|||++|+|.++|.+ ...+++..+..++.||+.||+|||+. +++|+||||||+||||+ .++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~-- 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-- 184 (290)
T ss_dssp ECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT--
T ss_pred eCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC--
Confidence 99999999999965 45799999999999999999999987 22499999999999998 478999999999986432
Q ss_pred CCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhh
Q 043702 535 SPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614 (711)
Q Consensus 535 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 614 (711)
......+||+.|||||++. +.|+.++|||||||+||||+||+.||..... ... +......+......
T Consensus 185 -~~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~----------~~~-~~~~i~~~~~~~~~ 251 (290)
T 3fpq_A 185 -SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN----------AAQ-IYRRVTSGVKPASF 251 (290)
T ss_dssp -TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----------HHH-HHHHHTTTCCCGGG
T ss_pred -CccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCc----------HHH-HHHHHHcCCCCCCC
Confidence 2344568999999999886 4699999999999999999999999964321 111 11112222111111
Q ss_pred hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 615 DARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 615 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
+ .. ...++.+|+.+||+.||++|||++|+++
T Consensus 252 ~----~~----~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 252 D----KV----AIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp G----GC----CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C----cc----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 11 1235778899999999999999999987
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-51 Score=429.23 Aligned_cols=247 Identities=21% Similarity=0.273 Sum_probs=209.0
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEccc----CCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSH----NSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
++|+..+.||+|+||+||+|++..+|+.||||++.. .....+.+.+|+++|++|+|||||++++++.+++.+|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 358899999999999999999999999999999874 3345678999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
|||++|+|.++|.+ .+.+++.+...++.||+.||+|||+. +|+||||||+||||++++.+||+|||+|+.+.....
T Consensus 112 Ey~~gG~L~~~i~~-~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 112 SYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp CCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred ecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 99999999999965 45799999999999999999999998 999999999999999999999999999998764432
Q ss_pred -CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhh
Q 043702 536 -PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614 (711)
Q Consensus 536 -~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 614 (711)
......+||+.|||||++.+..|+.++||||+||+||||++|+.||..... .+.... +..+..
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----------~~~~~~-i~~~~~---- 251 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-----------GLIFAK-IIKLEY---- 251 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHHHH-HHHTCC----
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----------HHHHHH-HHcCCC----
Confidence 334567899999999999999999999999999999999999999975321 111111 111111
Q ss_pred hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHH
Q 043702 615 DARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVV 652 (711)
Q Consensus 615 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl 652 (711)
.++.....++.+|+.+||+.||++|||++|++
T Consensus 252 ------~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 ------DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp ------CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred ------CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 11222234577899999999999999999874
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-51 Score=440.32 Aligned_cols=261 Identities=26% Similarity=0.376 Sum_probs=211.8
Q ss_pred HHHHHhcCCcccceeecCCceEEEEEEeCCC-----CeEEEEEEcccCCC--ChhhhHHHHHHHHhcCC-CCeeeeeeee
Q 043702 374 ELRSATKCFNANRIIGHGAFGTVYKGILPQN-----GDIIAVKRCSHNSQ--GKDEFLSELSIIGTLRH-RNLVRLQGWC 445 (711)
Q Consensus 374 el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~-----~~~vavK~~~~~~~--~~~~~~~Ei~~l~~l~H-~niv~l~g~~ 445 (711)
+.+...++|++.+.||+|+||+||+|.+... ++.||||++..... +.++|.+|+++|++++| ||||+++|+|
T Consensus 58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~ 137 (353)
T 4ase_A 58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 137 (353)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEE
Confidence 3444457899999999999999999997543 36899999876432 34679999999999975 8999999999
Q ss_pred eec-CeEEEEEEcCCCCCHHHHHhhC---------------CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCC
Q 043702 446 HEK-GEILLVYDLMPNGSLDKALFEA---------------RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTS 509 (711)
Q Consensus 446 ~~~-~~~~lV~Ey~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~ 509 (711)
.+. +.+++|||||++|+|.++|+.. ...++|.+++.++.|||+||+|||+. +||||||||+
T Consensus 138 ~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~ 214 (353)
T 4ase_A 138 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAAR 214 (353)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred EecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCcc
Confidence 764 5689999999999999999753 23589999999999999999999998 9999999999
Q ss_pred ceEEcCCCcEEEeecCCceecCCCCCC-CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCcccccc
Q 043702 510 NIMLDEGFNARLGDFGLARQVEHDKSP-DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITG 587 (711)
Q Consensus 510 NILld~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~ 587 (711)
||||++++.+||+|||+|+.+..+... .....+||+.|||||++.++.|+.++|||||||+||||+| |+.||.....
T Consensus 215 NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~- 293 (353)
T 4ase_A 215 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI- 293 (353)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC-
T ss_pred ceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH-
Confidence 999999999999999999977554432 2344679999999999999999999999999999999998 9999965321
Q ss_pred ccccccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 588 VGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 588 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
.+.+......+. ....+.....++.+++.+||+.||++|||+.||++.|+.
T Consensus 294 ----------~~~~~~~i~~g~---------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ 344 (353)
T 4ase_A 294 ----------DEEFCRRLKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 344 (353)
T ss_dssp ----------SHHHHHHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----------HHHHHHHHHcCC---------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 111222222221 111222234567788999999999999999999998864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-50 Score=437.52 Aligned_cols=250 Identities=24% Similarity=0.352 Sum_probs=210.1
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC-CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcC
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN-SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
+.|+..++||+|+||+||+|+++.+|+.||||++... ....+.+.+|+++|++++|||||++++++.+++.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 5699999999999999999999999999999999763 344567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCc
Q 043702 459 PNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDA 538 (711)
Q Consensus 459 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 538 (711)
++|+|.+++.. ..+++.++..|+.||+.||+|||+. +||||||||+||||+.++.+||+|||+|+.+..... ..
T Consensus 231 ~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~ 304 (423)
T 4fie_A 231 EGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RR 304 (423)
T ss_dssp TTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-CB
T ss_pred CCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-cc
Confidence 99999999965 4599999999999999999999998 999999999999999999999999999998765433 34
Q ss_pred ccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhc
Q 043702 539 TVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARL 618 (711)
Q Consensus 539 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 618 (711)
...+||+.|||||++.+..|+.++|||||||++|||++|+.||..... .+.. ..+..+ ..+.+
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----------~~~~-~~i~~~-----~~~~~ 367 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-----------LKAM-KMIRDN-----LPPRL 367 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----------HHHH-HHHHHS-----CCCCC
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----------HHHH-HHHHcC-----CCCCC
Confidence 456899999999999999999999999999999999999999965321 1111 111111 01111
Q ss_pred cCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 619 EGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
. ........+.+|+.+||+.||++|||+.|+++.
T Consensus 368 ~--~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 368 K--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp S--CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred c--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1 111223457788999999999999999999873
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-50 Score=414.59 Aligned_cols=248 Identities=22% Similarity=0.355 Sum_probs=193.9
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
++|+..+.||+|+||+||+|++..+|+.||||++... ....+.+.+|+++|++++|||||++++++.+++.+++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5799999999999999999999999999999998753 233457899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
||| +|+|.+++.+ ...+++.+...++.||+.||+|||+. +|+||||||+||||++++++||+|||+|+......
T Consensus 93 Ey~-~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~- 166 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN- 166 (275)
T ss_dssp ECC-CEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred eCC-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCC-
Confidence 999 6899999865 45799999999999999999999998 99999999999999999999999999998765433
Q ss_pred CCcccccCCCcccChhhhccCCC-CccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhh
Q 043702 536 PDATVAAGTMGYLAPEYLLTGRA-TEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 614 (711)
.....+||+.|||||++.+..+ +.++||||+||++|||++|+.||..... .+... ....+..
T Consensus 167 -~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~-----------~~~~~-~i~~~~~---- 229 (275)
T 3hyh_A 167 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI-----------PVLFK-NISNGVY---- 229 (275)
T ss_dssp ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHHH-HHHHTCC----
T ss_pred -ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH-----------HHHHH-HHHcCCC----
Confidence 2334689999999999988776 5799999999999999999999965321 11111 1111111
Q ss_pred hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--HHh
Q 043702 615 DARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ--MLV 656 (711)
Q Consensus 615 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~--~L~ 656 (711)
. ++......+.+++.+||+.||++|||++|+++ +++
T Consensus 230 --~----~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k 267 (275)
T 3hyh_A 230 --T----LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFK 267 (275)
T ss_dssp --C----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHH
T ss_pred --C----CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCcccc
Confidence 1 11122345678899999999999999999998 454
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-50 Score=420.34 Aligned_cols=247 Identities=23% Similarity=0.317 Sum_probs=196.9
Q ss_pred cCCcccceeecCCceEEEEEEeC---CCCeEEEEEEcccC---CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILP---QNGDIIAVKRCSHN---SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILL 453 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~---~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 453 (711)
++|++.+.||+|+||+||+|+.. .+++.||||++... ......+.+|+++|++++|||||++++++.+++.+|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46999999999999999999873 45789999998752 2234568899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCC
Q 043702 454 VYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHD 533 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~ 533 (711)
|||||++|+|.++|.+ ...+++.+...++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 104 vmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EECCCTTCEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEcCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 9999999999999965 45799999999999999999999998 9999999999999999999999999999875443
Q ss_pred CCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHh
Q 043702 534 KSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTA 613 (711)
Q Consensus 534 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 613 (711)
.. .....+||+.|||||++.+..|+.++||||+||+||||++|+.||..... .+...... .+..
T Consensus 180 ~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-----------~~~~~~i~-~~~~--- 243 (304)
T 3ubd_A 180 EK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR-----------KETMTMIL-KAKL--- 243 (304)
T ss_dssp -C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHHHHHH-HCCC---
T ss_pred Cc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH-----------HHHHHHHH-cCCC---
Confidence 32 23446899999999999999999999999999999999999999975321 11111111 1111
Q ss_pred hhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH
Q 043702 614 ADARLEGQFDEAEMRRVLLVGLACSHPDPLARPT-----MRGVVQ 653 (711)
Q Consensus 614 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~eVl~ 653 (711)
.++.....++.+|+.+||+.||++||| ++|+++
T Consensus 244 -------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 244 -------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred -------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 111222345778899999999999998 467765
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=412.14 Aligned_cols=248 Identities=23% Similarity=0.369 Sum_probs=189.4
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC--ChhhhHHHHHHHHhcCCCCeeeeeeeeeecC--------
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ--GKDEFLSELSIIGTLRHRNLVRLQGWCHEKG-------- 449 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-------- 449 (711)
++|+..+.||+|+||+||+|+++.+|+.||||++..... ..+.+.+|+++|++|+|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 458899999999999999999999999999999875432 2457899999999999999999999987644
Q ss_pred ----eEEEEEEcCCCCCHHHHHhhCCC--CCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEee
Q 043702 450 ----EILLVYDLMPNGSLDKALFEARS--PLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGD 523 (711)
Q Consensus 450 ----~~~lV~Ey~~~gsL~~~l~~~~~--~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~D 523 (711)
.+|+|||||++|+|.+++..... ..++..++.|+.||++||+|||+. +|+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence 37999999999999999975432 356677889999999999999998 999999999999999999999999
Q ss_pred cCCceecCCCCCC-----------CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccc
Q 043702 524 FGLARQVEHDKSP-----------DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVG 592 (711)
Q Consensus 524 FGla~~~~~~~~~-----------~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~ 592 (711)
||+|+.+...... ..+..+||+.|||||++.+..|+.++|||||||+||||++ ||.....
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~------ 232 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME------ 232 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH------
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH------
Confidence 9999977543321 1234579999999999999999999999999999999996 7753211
Q ss_pred cccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 593 VASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 593 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
..... ........... ..+....+.+++.+||+.||.+|||+.|+++
T Consensus 233 ----~~~~~-~~~~~~~~p~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 233 ----RVRTL-TDVRNLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp ----HHHHH-HHHHTTCCCHH---------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----HHHHH-HHHhcCCCCCC---------CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00101 11111111111 1122334567899999999999999999987
|
| >2ltn_A PEA lectin, alpha chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1bqp_A* 1hkd_A 1ofs_A* 1rin_A* 1lof_C* 1len_A 1lem_A 1les_A* 2lal_A 1loe_A 1loa_A* 1loc_A* 1lod_A* 1lob_A 1lof_A* 1log_A* 1lgc_A* 1lgb_A* 2b7y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-47 Score=362.95 Aligned_cols=173 Identities=29% Similarity=0.499 Sum_probs=156.0
Q ss_pred cceeeecCCCC--CCCeEEeCceEeeCCcEEeCCCCCCCCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecCCCCC
Q 043702 32 TATEFDFGTLT--LASLKLLGDAHMNNGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLNPSS 109 (711)
Q Consensus 32 ~~~~f~~~~f~--~~~~~~~g~a~~~~g~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~ 109 (711)
.+++|+|++|. ..+|+|+|||...+|.|+||++.. .++|||+|++||+|||+.+|+++||+|+|+|.|.+.+...
T Consensus 2 ~~~sF~f~~F~~~~~~l~l~G~A~~~~g~l~LT~~~~---~~~Gra~y~~Pv~l~d~~tg~vaSFsT~F~F~I~~~~~~~ 78 (181)
T 2ltn_A 2 ETTSFLITKFSPDQQNLIFQGDGYTTKEKLTLTKAVK---NTVGRALYSSPIHIWDRETGNVANFVTSFTFVINAPNSYN 78 (181)
T ss_dssp EEEEEEESSCCSSCTTEEEEETCEECSSSEEEECSCS---SCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECSSTTS
T ss_pred cceEEEcCCCCCCCCCEEEeccccCCCCCeEcCCCCC---CCEEEEEECCCEEeecCCCCCccceEEEEEEEEecCCCCC
Confidence 45789999998 679999999995589999999876 7899999999999999999999999999999999877778
Q ss_pred CCCceEEEEcCCCCCCCCCCCcccccccCCCC--cceEEEEeecccCCCCCCCC--CCeeeEecCCCcccccccCCcccc
Q 043702 110 IGAGLAFVITPDGEQVGSAGGSLGLLDEKGAG--LGFVAVEFDTLMDVEFSDIN--GNHVGLDLNSMVSTEVDNLDTINV 185 (711)
Q Consensus 110 ~g~GlaF~l~~~~~~~~~~g~~lgl~~~~~~~--~~~vaVEFDt~~n~~~~d~~--~~Hvgid~ns~~S~~~~~~~~~~~ 185 (711)
+||||||||+|....+++.||||||+|.+++. +++|||||||++|.+ +||+ +|||||||||+.|.++.++
T Consensus 79 ~gdGlAF~l~p~~~~p~~~g~~LGL~n~~~~~~~n~~vAVEFDT~~n~~-~Dp~~~~nHVGIdvNs~~S~~t~~~----- 152 (181)
T 2ltn_A 79 VADGFTFFIAPVDTKPQTGGGYLGVFNSAEYDKTTQTVAVEFDTFYNAA-WDPSNRDRHIGIDVNSIKSVNTKSW----- 152 (181)
T ss_dssp CCCEEEEEEEETTCCCCCCGGGTTTCSCSSCCTTSCCEEEEEECSCCTT-TSCTTCCCEEEEEESSSSCSEEEEC-----
T ss_pred CCCceEEEEecCCCCCCCCCccccccccCCCCccccEEEEEeccccccc-cCCCCCCCEEEEEcCCccccceecc-----
Confidence 89999999999876566889999999875332 899999999999988 5999 9999999999999876554
Q ss_pred ccCCCCeEEEEEEEcccccEEEEEEEec
Q 043702 186 DLKSGDLVNSWIEYDGLTRAFNISVSYS 213 (711)
Q Consensus 186 ~~~~g~~~~~~I~Y~~~~~~l~V~~~~~ 213 (711)
++.+|+.++|||+||+.+++|+|+|+|+
T Consensus 153 ~l~~G~~~~v~I~Yd~~~~~L~V~l~~~ 180 (181)
T 2ltn_A 153 KLQNGEEANVVIAFNAATNVLTVSLTYP 180 (181)
T ss_dssp CCCTTCCEEEEEEEETTTTEEEEEEEEC
T ss_pred ccCCCCEEEEEEEEECCCCEEEEEEecC
Confidence 6889999999999999999999999875
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=399.58 Aligned_cols=292 Identities=43% Similarity=0.773 Sum_probs=255.0
Q ss_pred CCCccCHHHHHHHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeee
Q 043702 366 MPKEFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQG 443 (711)
Q Consensus 366 ~~~~~~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g 443 (711)
..+.+++.++..++++|...+.||+|+||.||+|... +++.||||++.... .....+.+|+++++.++||||+++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 3567999999999999999999999999999999864 58899999987633 33457899999999999999999999
Q ss_pred eeeecCeEEEEEEcCCCCCHHHHHhhCC---CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEE
Q 043702 444 WCHEKGEILLVYDLMPNGSLDKALFEAR---SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNAR 520 (711)
Q Consensus 444 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vk 520 (711)
+|...+..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+.++|+||||||+|||++.++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 9999999999999999999999997543 3499999999999999999999998777999999999999999999999
Q ss_pred EeecCCceecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHH
Q 043702 521 LGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEW 600 (711)
Q Consensus 521 L~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~ 600 (711)
|+|||+++..............||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........+|
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~ 251 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA---NDDDVMLLDW 251 (326)
T ss_dssp ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHT---TTSCSBHHHH
T ss_pred eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccc---cccchhHHHH
Confidence 9999999987655554455567999999999999999999999999999999999999999643221 1223567788
Q ss_pred HHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCC
Q 043702 601 VWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEAEV 661 (711)
Q Consensus 601 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 661 (711)
+........+....+..+...+..+....+.+++.+||+.||.+|||++||+++|++....
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~ 312 (326)
T 3uim_A 252 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312 (326)
T ss_dssp HTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCS
T ss_pred HHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchh
Confidence 8877788888888888888888899999999999999999999999999999999976443
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=407.34 Aligned_cols=262 Identities=24% Similarity=0.341 Sum_probs=201.6
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCC---hhhhHHHHHHHHhcCCCCeeeeeeeeee------cCe
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQG---KDEFLSELSIIGTLRHRNLVRLQGWCHE------KGE 450 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~------~~~ 450 (711)
++|+..+.||+|+||+||+|++..+|+.||||++...... .+.+.+|+++|++|+|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 4699999999999999999999999999999999764332 3567899999999999999999998764 367
Q ss_pred EEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceec
Q 043702 451 ILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV 530 (711)
Q Consensus 451 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~ 530 (711)
+|||||||+ |+|.+++.. .+.+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+.+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp EEEEEECCS-EEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred EEEEEeCCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeec
Confidence 999999995 689999864 56799999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCC---CCCcccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhh
Q 043702 531 EHDK---SPDATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHR 606 (711)
Q Consensus 531 ~~~~---~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~ 606 (711)
.... .......+||+.|||||++.+. .++.++||||+||++|||++|++||..... ......+.....
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~--------~~~l~~I~~~~g 280 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY--------VHQLQLIMMVLG 280 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH--------HHHHHHHHHHHC
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH--------HHHHHHHHHhcC
Confidence 4322 2234457899999999998875 569999999999999999999999975422 011111100000
Q ss_pred c-----------CchhHhhhhhc-cCCCc-----HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 607 E-----------GRLLTAADARL-EGQFD-----EAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 607 ~-----------~~~~~~~d~~l-~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
. ........... ....+ ......+.+|+.+||+.||.+|||++|+++.
T Consensus 281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 281 TPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp CCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 00000000000 00000 0112457789999999999999999999973
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=394.49 Aligned_cols=200 Identities=27% Similarity=0.392 Sum_probs=172.9
Q ss_pred HHhcCCcccceeecCCceEEEEEEeC---CCCeEEEEEEcccCCCChhhhHHHHHHHHhc-CCCCeeeeeeeeeecCeEE
Q 043702 377 SATKCFNANRIIGHGAFGTVYKGILP---QNGDIIAVKRCSHNSQGKDEFLSELSIIGTL-RHRNLVRLQGWCHEKGEIL 452 (711)
Q Consensus 377 ~at~~f~~~~~LG~G~fg~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 452 (711)
...+.|++.++||+|+||+||+|+++ .+++.||+|++.... ....+.+|+++|+.+ +||||+++++++.+.+.++
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 45678999999999999999999874 357899999886543 355788999999998 5999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCC-CcEEEeecCCceecC
Q 043702 453 LVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEG-FNARLGDFGLARQVE 531 (711)
Q Consensus 453 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~-~~vkL~DFGla~~~~ 531 (711)
+|||||++|+|.+++. .+++.+...++.||+.||+|||+. +|+||||||+|||++.+ +.+||+|||+|+...
T Consensus 97 lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~ 169 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH 169 (361)
T ss_dssp EEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred EEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence 9999999999999983 489999999999999999999998 99999999999999877 799999999998654
Q ss_pred CCCC---------------------------CCcccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCcc
Q 043702 532 HDKS---------------------------PDATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEK 583 (711)
Q Consensus 532 ~~~~---------------------------~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~ 583 (711)
.... ......+||+.|||||++.+. .++.++||||+||++|||++|+.||..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 3221 112345799999999999875 589999999999999999999999964
Q ss_pred c
Q 043702 584 E 584 (711)
Q Consensus 584 ~ 584 (711)
.
T Consensus 250 ~ 250 (361)
T 4f9c_A 250 A 250 (361)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=389.12 Aligned_cols=281 Identities=37% Similarity=0.677 Sum_probs=240.5
Q ss_pred ccCHHHHHHHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC-CChhhhHHHHHHHHhcCCCCeeeeeeeeee
Q 043702 369 EFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCHE 447 (711)
Q Consensus 369 ~~~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 447 (711)
++++.++..++++|+..+.||+|+||.||+|++. +++.||||++.... ...+.+.+|++++++++||||++++++|.+
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE 106 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 3444556678889999999999999999999975 58899999987643 445789999999999999999999999999
Q ss_pred cCeEEEEEEcCCCCCHHHHHhhCC---CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeec
Q 043702 448 KGEILLVYDLMPNGSLDKALFEAR---SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDF 524 (711)
Q Consensus 448 ~~~~~lV~Ey~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DF 524 (711)
.+..++||||+++|+|.+++.... ..+++..+++++.|+++||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Df 183 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDF 183 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCC
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeec
Confidence 999999999999999999986543 3599999999999999999999997 9999999999999999999999999
Q ss_pred CCceecCCCC-CCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHH
Q 043702 525 GLARQVEHDK-SPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWS 603 (711)
Q Consensus 525 Gla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~ 603 (711)
|+++...... ........||+.|+|||.+.++.++.++|||||||++|||++|+.||..... .......+|...
T Consensus 184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~-----~~~~~~~~~~~~ 258 (321)
T 2qkw_B 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP-----REMVNLAEWAVE 258 (321)
T ss_dssp TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSS-----SSCCCHHHHTHH
T ss_pred ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCc-----HHHHHHHHHhhh
Confidence 9998754332 2223345689999999999999999999999999999999999999976432 122456677766
Q ss_pred hhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 604 LHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 604 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
....+.+...+++.+......+....+.+++.+||+.||++|||+.||++.|+..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 259 SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp HHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 6667777777777777777888999999999999999999999999999999754
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=418.89 Aligned_cols=253 Identities=22% Similarity=0.311 Sum_probs=210.6
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC-CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEc
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
.++|++.+.||+|+||+||+|+++.+|+.||+|++.... .+.+.+.+|+++|+.|+|||||++++++.+++.++|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 367999999999999999999999999999999987633 3356788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCC--CcEEEeecCCceecCCCCC
Q 043702 458 MPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEG--FNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 458 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~--~~vkL~DFGla~~~~~~~~ 535 (711)
|++|+|.++|......+++.+...++.||+.||+|||+. +|+||||||+|||++.+ +.+||+|||+|+.+....
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~- 311 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ- 311 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS-
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCC-
Confidence 999999999977777899999999999999999999998 99999999999999854 889999999999875433
Q ss_pred CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhh
Q 043702 536 PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 615 (711)
.....+||+.|||||++.+..|+.++||||+||++|||++|+.||..... .+..... ..+..
T Consensus 312 -~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~-----------~~~~~~i-~~~~~----- 373 (573)
T 3uto_A 312 -SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-----------DETLRNV-KSCDW----- 373 (573)
T ss_dssp -EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-----------HHHHHHH-HTTCC-----
T ss_pred -ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----------HHHHHHH-HhCCC-----
Confidence 33456899999999999999999999999999999999999999975422 1111111 11110
Q ss_pred hhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 616 ARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 616 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.+...........+.+|+.+||+.||.+|||+.|+++.
T Consensus 374 -~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 374 -NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp -CCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000011123456788999999999999999999983
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=411.21 Aligned_cols=248 Identities=26% Similarity=0.338 Sum_probs=201.5
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHH---HHHHHhcCCCCeeeeeeeeeecCeEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSE---LSIIGTLRHRNLVRLQGWCHEKGEIL 452 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~E---i~~l~~l~H~niv~l~g~~~~~~~~~ 452 (711)
++|++.++||+|+||+||+|+++.+|+.||||++... ......+.+| +.+++.++|||||++++++.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 5799999999999999999999999999999998642 2333334444 56677788999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCC
Q 043702 453 LVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEH 532 (711)
Q Consensus 453 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~ 532 (711)
||||||+||+|..+|.+ .+.+++.....++.||+.||+|||+. +||||||||+||||+.++.+||+|||+|+.+..
T Consensus 269 lVmEy~~GGdL~~~l~~-~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp EEECCCCSCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 99999999999999975 45799999999999999999999998 999999999999999999999999999998754
Q ss_pred CCCCCcccccCCCcccChhhhcc-CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchh
Q 043702 533 DKSPDATVAAGTMGYLAPEYLLT-GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLL 611 (711)
Q Consensus 533 ~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 611 (711)
.. ....+||+.|||||++.. ..|+.++||||+||+||||++|+.||...... ...+.. .......
T Consensus 345 ~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~--------~~~~i~-~~i~~~~-- 410 (689)
T 3v5w_A 345 KK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--------DKHEID-RMTLTMA-- 410 (689)
T ss_dssp CC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC--------CHHHHH-HHHHHCC--
T ss_pred CC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--------HHHHHH-HhhcCCC--
Confidence 43 334689999999999975 47999999999999999999999999754221 111111 1110100
Q ss_pred HhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH
Q 043702 612 TAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPT-----MRGVVQ 653 (711)
Q Consensus 612 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~eVl~ 653 (711)
..++.....++.+|+.+||+.||.+|++ ++||++
T Consensus 411 --------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 411 --------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred --------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 1112223345778899999999999998 688875
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=378.35 Aligned_cols=257 Identities=24% Similarity=0.394 Sum_probs=212.1
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC-CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcC
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN-SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
++|...++||+|+||+||+|.+..+++.||+|++... ....+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 5688899999999999999999989999999988653 334567999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC-
Q 043702 459 PNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD- 537 (711)
Q Consensus 459 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~- 537 (711)
++|+|.+++......+++.++..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (310)
T 3s95_A 90 KGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166 (310)
T ss_dssp TTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence 99999999988778899999999999999999999998 99999999999999999999999999998765433211
Q ss_pred ------------cccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhh
Q 043702 538 ------------ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLH 605 (711)
Q Consensus 538 ------------~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~ 605 (711)
.....||+.|+|||.+.+..++.++|||||||++|||++|..|+.......... ....
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~--~~~~-------- 236 (310)
T 3s95_A 167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF--GLNV-------- 236 (310)
T ss_dssp -------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS--SBCH--------
T ss_pred ccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH--hhhh--------
Confidence 114579999999999999999999999999999999999999986543211110 0111
Q ss_pred hcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 606 REGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 606 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
....+..... .....+.+++.+||+.||++|||+.++++.|+..
T Consensus 237 -----~~~~~~~~~~----~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l 280 (310)
T 3s95_A 237 -----RGFLDRYCPP----NCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280 (310)
T ss_dssp -----HHHHHHTCCT----TCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----hccccccCCC----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1111111111 2224577889999999999999999999999764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=367.37 Aligned_cols=251 Identities=25% Similarity=0.351 Sum_probs=209.5
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEccc-CCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEc
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSH-NSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
.++|+..+.||+|+||+||+|.+..+++.||+|++.. .....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 4579999999999999999999988999999999865 334456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC
Q 043702 458 MPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD 537 (711)
Q Consensus 458 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 537 (711)
+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 99 ~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 172 (297)
T 3fxz_A 99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (297)
T ss_dssp CTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred CCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-c
Confidence 9999999999654 589999999999999999999998 999999999999999999999999999987654433 2
Q ss_pred cccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhh
Q 043702 538 ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADAR 617 (711)
Q Consensus 538 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 617 (711)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .+........+..
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----------~~~~~~~~~~~~~------- 234 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-----------LRALYLIATNGTP------- 234 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----------HHHHHHHHHHCSC-------
T ss_pred cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----------HHHHHHHHhCCCC-------
Confidence 3445799999999999999999999999999999999999999965321 1111111111100
Q ss_pred ccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 618 LEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 618 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
...........+.+++.+||+.||.+|||++|+++.
T Consensus 235 -~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 235 -ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp -CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 011122233557788999999999999999999973
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=362.39 Aligned_cols=278 Identities=34% Similarity=0.579 Sum_probs=228.5
Q ss_pred CCccCHHHHHHHhcCCccc------ceeecCCceEEEEEEeCCCCeEEEEEEcccC-----CCChhhhHHHHHHHHhcCC
Q 043702 367 PKEFSYRELRSATKCFNAN------RIIGHGAFGTVYKGILPQNGDIIAVKRCSHN-----SQGKDEFLSELSIIGTLRH 435 (711)
Q Consensus 367 ~~~~~~~el~~at~~f~~~------~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~Ei~~l~~l~H 435 (711)
...|++.++..++++|... +.||+|+||.||+|.. +++.||+|++... ....+.+.+|++++++++|
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 4679999999999999888 8999999999999987 5789999998652 2234678899999999999
Q ss_pred CCeeeeeeeeeecCeEEEEEEcCCCCCHHHHHhhC--CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEE
Q 043702 436 RNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEA--RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIML 513 (711)
Q Consensus 436 ~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl 513 (711)
|||+++++++.+.+..++||||+++++|.+++... ...+++..+++++.|++.||.|||+. +|+||||||+|||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEE
Confidence 99999999999999999999999999999999643 35699999999999999999999998 99999999999999
Q ss_pred cCCCcEEEeecCCceecCCCCCC-CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccc
Q 043702 514 DEGFNARLGDFGLARQVEHDKSP-DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVG 592 (711)
Q Consensus 514 d~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~ 592 (711)
++++.+||+|||+++........ ......||+.|+|||.+.+ .++.++|||||||++|||++|+.||......
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----- 240 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP----- 240 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS-----
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch-----
Confidence 99999999999999876543322 2233569999999998764 5889999999999999999999999764321
Q ss_pred cccchHHHHHHhhhc-CchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 593 VASNLVEWVWSLHRE-GRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 593 ~~~~l~~~~~~~~~~-~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
..+..+....... ..+...+++.+ ..........+.+++.+||+.||.+||++++|++.|+..
T Consensus 241 --~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 241 --QLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp --SBTTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred --HHHHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 1222332222222 22333444433 344667778899999999999999999999999999764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=364.79 Aligned_cols=254 Identities=28% Similarity=0.422 Sum_probs=213.0
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCC
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMP 459 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 459 (711)
++|+..+.||+|+||.||+|.+. +++.||+|++.......+++.+|++++++++||||+++++++.+++..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 56888999999999999999986 57889999998877777889999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCcc
Q 043702 460 NGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDAT 539 (711)
Q Consensus 460 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 539 (711)
+++|.+++......+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++...........
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 165 (269)
T 4hcu_A 89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 165 (269)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccccccc
Confidence 9999999987777899999999999999999999998 9999999999999999999999999999876443322233
Q ss_pred cccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhc
Q 043702 540 VAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARL 618 (711)
Q Consensus 540 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 618 (711)
...+|+.|+|||.+....++.++|||||||++|||++ |+.||..... .+....... + .
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~-----------~~~~~~~~~-~---------~ 224 (269)
T 4hcu_A 166 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-----------SEVVEDIST-G---------F 224 (269)
T ss_dssp STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----------HHHHHHHHT-T---------C
T ss_pred CcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH-----------HHHHHHHhc-C---------c
Confidence 3457888999999999999999999999999999999 9999965321 111111111 1 1
Q ss_pred cCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 619 EGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
....+......+.+++.+||+.||.+||+++++++.|+..
T Consensus 225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 225 RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 1111112234577889999999999999999999999753
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=377.53 Aligned_cols=256 Identities=28% Similarity=0.428 Sum_probs=208.7
Q ss_pred cCCcccceeecCCceEEEEEEeCCCC---eEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNG---DIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLV 454 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~---~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 454 (711)
++|...+.||+|+||.||+|.+..++ ..||||++.... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 46888999999999999999997544 469999987633 2346789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCC
Q 043702 455 YDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~ 534 (711)
|||+++|+|.+++......+++.+++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 205 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205 (325)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence 999999999999987777899999999999999999999998 99999999999999999999999999999875443
Q ss_pred CCC--cccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchh
Q 043702 535 SPD--ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLL 611 (711)
Q Consensus 535 ~~~--~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 611 (711)
... .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... ..+.. .. .
T Consensus 206 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--------~~~~~---~~-~----- 268 (325)
T 3kul_A 206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN--------RDVIS---SV-E----- 268 (325)
T ss_dssp -CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH--------HHHHH---HH-H-----
T ss_pred cceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH--------HHHHH---HH-H-----
Confidence 222 222346788999999999999999999999999999999 9999965321 11111 11 1
Q ss_pred HhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC
Q 043702 612 TAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEA 659 (711)
Q Consensus 612 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~ 659 (711)
..............+.+++.+||+.||.+||++.+|++.|+...
T Consensus 269 ----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~ 312 (325)
T 3kul_A 269 ----EGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312 (325)
T ss_dssp ----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----cCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11111122233456788999999999999999999999998753
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=393.25 Aligned_cols=265 Identities=22% Similarity=0.267 Sum_probs=216.1
Q ss_pred cCHHHHHHHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEccc----CCCChhhhHHHHHHHHhcCCCCeeeeeeee
Q 043702 370 FSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSH----NSQGKDEFLSELSIIGTLRHRNLVRLQGWC 445 (711)
Q Consensus 370 ~~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~ 445 (711)
+.+++++..+++|+..++||+|+||+||+|++..+++.||+|++.. .....+.+.+|+.++..++||||++++++|
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 4466777778999999999999999999999998999999999865 233445689999999999999999999999
Q ss_pred eecCeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecC
Q 043702 446 HEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFG 525 (711)
Q Consensus 446 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFG 525 (711)
.+.+.+++|||||++|+|.+++......+++..++.++.||+.||+|||+. +|+||||||+||||+.++.+||+|||
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchh
Confidence 999999999999999999999987677899999999999999999999998 99999999999999999999999999
Q ss_pred CceecCCCCCCCcccccCCCcccChhhhc-----cCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHH
Q 043702 526 LARQVEHDKSPDATVAAGTMGYLAPEYLL-----TGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEW 600 (711)
Q Consensus 526 la~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~ 600 (711)
+++.............+||+.|+|||++. .+.++.++|||||||++|||++|+.||..... .+.
T Consensus 221 la~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~-----------~~~ 289 (437)
T 4aw2_A 221 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-----------VET 289 (437)
T ss_dssp TCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH-----------HHH
T ss_pred hhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh-----------hHH
Confidence 99877655444444568999999999997 45789999999999999999999999975321 111
Q ss_pred HHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCC--CCCHHHHHHH
Q 043702 601 VWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLA--RPTMRGVVQM 654 (711)
Q Consensus 601 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~eVl~~ 654 (711)
........ ....+ ..........+.+++.+||..+|++ ||+++|+++.
T Consensus 290 ~~~i~~~~-----~~~~~-p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 290 YGKIMNHK-----ERFQF-PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HHHHHTHH-----HHCCC-CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred HHhhhhcc-----ccccC-CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 11111000 00000 0000112345677888999888888 9999999973
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=362.00 Aligned_cols=256 Identities=25% Similarity=0.355 Sum_probs=214.0
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcC
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
.++|+..+.||+|+||.||+|.+. ++..||+|++.......+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 457889999999999999999886 5778999999887777788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCc
Q 043702 459 PNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDA 538 (711)
Q Consensus 459 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 538 (711)
++++|.+++......+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..........
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 162 (268)
T 3sxs_A 86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS 162 (268)
T ss_dssp TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEEC
T ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhhcc
Confidence 99999999987666799999999999999999999998 999999999999999999999999999987755443333
Q ss_pred ccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhh
Q 043702 539 TVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADAR 617 (711)
Q Consensus 539 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 617 (711)
....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... .+........ .
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----------~~~~~~~~~~-~-------- 222 (268)
T 3sxs_A 163 VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN-----------SEVVLKVSQG-H-------- 222 (268)
T ss_dssp CSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH-----------HHHHHHHHTT-C--------
T ss_pred cCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh-----------HHHHHHHHcC-C--------
Confidence 33456778999999999899999999999999999999 9999965321 1111111111 0
Q ss_pred ccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC
Q 043702 618 LEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEA 659 (711)
Q Consensus 618 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~ 659 (711)
....+......+.+++.+||+.||.+|||+.++++.|+...
T Consensus 223 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 223 -RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp -CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred -CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 00011112345778899999999999999999999998754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=364.68 Aligned_cols=264 Identities=23% Similarity=0.334 Sum_probs=215.8
Q ss_pred CCCccCHHHHHHHhcC----------CcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC-CChhhhHHHHHHHHhcC
Q 043702 366 MPKEFSYRELRSATKC----------FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLR 434 (711)
Q Consensus 366 ~~~~~~~~el~~at~~----------f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~ 434 (711)
.+..+++++++.+++. |...+.||+|+||.||+|++..+|+.||||++.... ...+.+.+|+.++++++
T Consensus 21 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~ 100 (321)
T 2c30_A 21 QSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ 100 (321)
T ss_dssp ----CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCC
T ss_pred cCCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCC
Confidence 3457889999988865 777789999999999999998889999999987643 44567899999999999
Q ss_pred CCCeeeeeeeeeecCeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEc
Q 043702 435 HRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLD 514 (711)
Q Consensus 435 H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld 514 (711)
||||+++++++...+..++||||+++++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++
T Consensus 101 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLT 175 (321)
T ss_dssp CTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEC
T ss_pred CCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEC
Confidence 99999999999999999999999999999999853 4699999999999999999999997 999999999999999
Q ss_pred CCCcEEEeecCCceecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccc
Q 043702 515 EGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVA 594 (711)
Q Consensus 515 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~ 594 (711)
.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~-------- 246 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP-------- 246 (321)
T ss_dssp TTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------
T ss_pred CCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------
Confidence 999999999999987654332 23445799999999999999999999999999999999999999965321
Q ss_pred cchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 595 SNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 595 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.+..... .... .+.+. ........+.+++.+||+.||++||++.|+++.
T Consensus 247 ---~~~~~~~-~~~~-----~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 247 ---VQAMKRL-RDSP-----PPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp ---HHHHHHH-HHSS-----CCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ---HHHHHHH-hcCC-----CCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111111 1110 01110 011123457788899999999999999999984
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=379.14 Aligned_cols=256 Identities=23% Similarity=0.422 Sum_probs=209.7
Q ss_pred hcCCcccceeecCCceEEEEEEeC-------CCCeEEEEEEcccCCC--ChhhhHHHHHHHHhc-CCCCeeeeeeeeeec
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILP-------QNGDIIAVKRCSHNSQ--GKDEFLSELSIIGTL-RHRNLVRLQGWCHEK 448 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~-------~~~~~vavK~~~~~~~--~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 448 (711)
.++|...+.||+|+||.||+|++. .++..||||++..... ..+++.+|+++++++ +||||++++++|...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 357889999999999999999863 2456899999876432 345789999999999 899999999999999
Q ss_pred CeEEEEEEcCCCCCHHHHHhhCC---------------CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEE
Q 043702 449 GEILLVYDLMPNGSLDKALFEAR---------------SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIML 513 (711)
Q Consensus 449 ~~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl 513 (711)
+.+++||||+++|+|.+++.... ..+++.++++++.||+.||+|||+. +|+||||||+||||
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence 99999999999999999997643 3589999999999999999999998 99999999999999
Q ss_pred cCCCcEEEeecCCceecCCCCC-CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCcccccccccc
Q 043702 514 DEGFNARLGDFGLARQVEHDKS-PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKV 591 (711)
Q Consensus 514 d~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~ 591 (711)
+.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~----- 311 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV----- 311 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH-----
Confidence 9999999999999997654332 22334467889999999999999999999999999999999 9999965321
Q ss_pred ccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 592 GVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 592 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
..+... ...+. ....+......+.+++.+||+.||.+||++.|+++.|+..
T Consensus 312 ---~~~~~~----~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 312 ---EELFKL----LKEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp ---GGHHHH----HHTTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHH----HhcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111111 11111 1112223345678899999999999999999999999753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=371.33 Aligned_cols=257 Identities=27% Similarity=0.425 Sum_probs=201.0
Q ss_pred HHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCC---hhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEE
Q 043702 377 SATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQG---KDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILL 453 (711)
Q Consensus 377 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 453 (711)
...++|+..+.||+|+||+||+|+. .++.||||++...... .+++.+|++++++++||||+++++++...+..++
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI 111 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence 3456789999999999999999988 5889999998764432 3578899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhCCC--CCChHHHHHHHHHHHHHHHHHHhccCCC--eeeccCCCCceEEcCCCcEEEeecCCcee
Q 043702 454 VYDLMPNGSLDKALFEARS--PLPWPHRSKILLGVASALAYLHQECENQ--VIHRDVKTSNIMLDEGFNARLGDFGLARQ 529 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~~~--~l~~~~~~~i~~~ia~aL~yLH~~~~~~--ivHrDlkp~NILld~~~~vkL~DFGla~~ 529 (711)
||||+++|+|.+++..... .+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||+|||+++.
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 9999999999999975432 399999999999999999999997 7 99999999999999999999999999986
Q ss_pred cCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCc
Q 043702 530 VEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGR 609 (711)
Q Consensus 530 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 609 (711)
..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ..... ......
T Consensus 189 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~--------~~~~~---~~~~~~- 255 (309)
T 3p86_A 189 KASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP--------AQVVA---AVGFKC- 255 (309)
T ss_dssp --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH--------HHHHH---HHHHSC-
T ss_pred ccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHH---HHHhcC-
Confidence 54332 223345799999999999999999999999999999999999999975321 11111 110000
Q ss_pred hhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC
Q 043702 610 LLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEA 659 (711)
Q Consensus 610 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~ 659 (711)
.....+......+.+++.+||+.||.+|||+.++++.|+...
T Consensus 256 --------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~ 297 (309)
T 3p86_A 256 --------KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297 (309)
T ss_dssp --------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 011112223345778999999999999999999999997653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=382.02 Aligned_cols=255 Identities=27% Similarity=0.450 Sum_probs=199.1
Q ss_pred cCCcccceeecCCceEEEEEEeC---CCCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILP---QNGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLV 454 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~---~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 454 (711)
++|...+.||+|+||.||+|++. ..+..||||++.... ...+++.+|++++++++||||++++++|.+.+..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 57899999999999999999886 356789999987643 2346799999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCC
Q 043702 455 YDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~ 534 (711)
|||+++|+|.+++......+++.+++.++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 201 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201 (373)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence 999999999999987777899999999999999999999998 99999999999999999999999999998765433
Q ss_pred CCC--cccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchh
Q 043702 535 SPD--ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLL 611 (711)
Q Consensus 535 ~~~--~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 611 (711)
... .....+++.|+|||++....++.++|||||||++|||++ |+.||..... ..+.
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~--------~~~~------------- 260 (373)
T 2qol_A 202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN--------QDVI------------- 260 (373)
T ss_dssp ------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH--------HHHH-------------
T ss_pred ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH--------HHHH-------------
Confidence 221 122345778999999999999999999999999999998 9999965321 1111
Q ss_pred HhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 612 TAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 612 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
..++..............+.+++.+||+.||.+||++.+|++.|+..
T Consensus 261 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 261 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp HHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 11111111122223446688899999999999999999999999764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=384.71 Aligned_cols=256 Identities=26% Similarity=0.399 Sum_probs=210.2
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
.++|...+.||+|+||.||+|++..+++.||||++.... ...+++.+|++++++++||||++++++|..++..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 357888999999999999999998889999999987532 224578999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCC
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP 536 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~ 536 (711)
|+++|+|.+++......+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 9999999999987667799999999999999999999998 9999999999999999999999999999865432211
Q ss_pred C-cccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhh
Q 043702 537 D-ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614 (711)
Q Consensus 537 ~-~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 614 (711)
. .....+++.|+|||.+..+.++.++|||||||++|||++ |+.||..... ... ......+.
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~--------~~~----~~~~~~~~----- 332 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN--------QQT----REFVEKGG----- 332 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH--------HHH----HHHHHTTC-----
T ss_pred ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHH----HHHHHcCC-----
Confidence 1 111235778999999999999999999999999999998 9999865321 111 11111111
Q ss_pred hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 615 DARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 615 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
....+......+.+++.+||+.||.+|||+++|++.|+..
T Consensus 333 ----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 333 ----RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 1111222345677899999999999999999999999753
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=395.07 Aligned_cols=256 Identities=25% Similarity=0.397 Sum_probs=215.9
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcC
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
.++|...++||+|+||.||+|.+..++..||||++.......++|.+|+++|++++||||++++++|...+.+++|||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~ 298 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 298 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence 34688889999999999999999888999999999887777889999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhC-CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC
Q 043702 459 PNGSLDKALFEA-RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD 537 (711)
Q Consensus 459 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 537 (711)
++|+|.+++... ...+++..++.++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++.........
T Consensus 299 ~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 375 (495)
T 1opk_A 299 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 375 (495)
T ss_dssp TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEEC
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCceee
Confidence 999999999864 35699999999999999999999998 99999999999999999999999999999765433222
Q ss_pred cccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhhhh
Q 043702 538 ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADA 616 (711)
Q Consensus 538 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 616 (711)
.....+++.|+|||++....++.++|||||||+||||++ |+.||..... ..+.+. +..
T Consensus 376 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~--------~~~~~~-------------~~~ 434 (495)
T 1opk_A 376 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------SQVYEL-------------LEK 434 (495)
T ss_dssp CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG--------GGHHHH-------------HHT
T ss_pred cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH--------HHHHHH-------------HHc
Confidence 233456789999999999999999999999999999999 9999865321 111111 111
Q ss_pred hccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 617 RLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 617 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
......+......+.+|+.+||+.||.+||++.+|++.|+..
T Consensus 435 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~ 476 (495)
T 1opk_A 435 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476 (495)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 111122223345678899999999999999999999999875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=371.89 Aligned_cols=271 Identities=24% Similarity=0.322 Sum_probs=208.7
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecC----eEEEE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKG----EILLV 454 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~lV 454 (711)
.++|+..++||+|+||+||+|++. ++.||||++.........+.+|+.++++++||||+++++++.... .+++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 357889999999999999999984 799999999765555556777999999999999999999998754 47999
Q ss_pred EEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhcc-------CCCeeeccCCCCceEEcCCCcEEEeecCCc
Q 043702 455 YDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQEC-------ENQVIHRDVKTSNIMLDEGFNARLGDFGLA 527 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-------~~~ivHrDlkp~NILld~~~~vkL~DFGla 527 (711)
|||+++|+|.+++.. ..+++..+..++.|+++||+|||+.+ .++|+||||||+|||++.++.+||+|||++
T Consensus 101 ~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a 178 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178 (322)
T ss_dssp EECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcc
Confidence 999999999999965 35999999999999999999999752 338999999999999999999999999999
Q ss_pred eecCCCCCC-CcccccCCCcccChhhhccC-----CCCccccchhHHHHHHHHHhCCCCCcccccccccc-----ccccc
Q 043702 528 RQVEHDKSP-DATVAAGTMGYLAPEYLLTG-----RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKV-----GVASN 596 (711)
Q Consensus 528 ~~~~~~~~~-~~~~~~gt~~y~APE~~~~~-----~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~-----~~~~~ 596 (711)
+........ ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.......... .....
T Consensus 179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 258 (322)
T 3soc_A 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS 258 (322)
T ss_dssp EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCC
T ss_pred cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCc
Confidence 877554332 23345799999999999863 45668899999999999999999997643211100 00001
Q ss_pred hHHHHHHhhhcCchhHhhhhhccCC-CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 597 LVEWVWSLHREGRLLTAADARLEGQ-FDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 597 l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
..++....... .. .+.+... ........+.+++.+||+.||++|||+.||++.|+..
T Consensus 259 ~~~~~~~~~~~-~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 259 LEDMQEVVVHK-KK----RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp HHHHHHHHTTS-CC----CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hhhhhhhhhcc-cC----CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11111111110 00 0111110 1224566789999999999999999999999999753
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=363.58 Aligned_cols=254 Identities=25% Similarity=0.404 Sum_probs=209.2
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcC
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
.++|...+.||+|+||.||+|.+. ++..||+|++.......+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 346888999999999999999986 5788999999887777788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCc
Q 043702 459 PNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDA 538 (711)
Q Consensus 459 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 538 (711)
++++|.+++......+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..........
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 178 (283)
T 3gen_A 102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 178 (283)
T ss_dssp TTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHST
T ss_pred CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccccccc
Confidence 99999999987667799999999999999999999998 999999999999999999999999999987644322222
Q ss_pred ccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhh
Q 043702 539 TVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADAR 617 (711)
Q Consensus 539 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 617 (711)
....+|+.|+|||.+....++.++|||||||++|||++ |+.||..... .+...... . .
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~-----------~~~~~~~~-~---------~ 237 (283)
T 3gen_A 179 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-----------SETAEHIA-Q---------G 237 (283)
T ss_dssp TSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----------HHHHHHHH-T---------T
T ss_pred cCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh-----------hHHHHHHh-c---------c
Confidence 33457888999999999999999999999999999998 9999965321 01111111 1 1
Q ss_pred ccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 618 LEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 618 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
.....+......+.+++.+||+.||.+||+++++++.|+.
T Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 277 (283)
T 3gen_A 238 LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 277 (283)
T ss_dssp CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred cCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 1111111223567789999999999999999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=371.10 Aligned_cols=254 Identities=24% Similarity=0.414 Sum_probs=202.9
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeE----EEEEEccc--CCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDI----IAVKRCSH--NSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILL 453 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~----vavK~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 453 (711)
++|+..++||+|+||+||+|++..+++. ||+|++.. .....+++.+|++++++++||||++++++|.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 4688899999999999999998766654 58888764 2345678999999999999999999999998754 789
Q ss_pred EEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCC
Q 043702 454 VYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHD 533 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~ 533 (711)
|+||+++|+|.+++......+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence 9999999999999988888899999999999999999999998 9999999999999999999999999999877544
Q ss_pred CCC-CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchh
Q 043702 534 KSP-DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLL 611 (711)
Q Consensus 534 ~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 611 (711)
... ......||+.|+|||.+.+..++.++|||||||++|||++ |+.||..... ..+...
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~~~~~----------- 231 (327)
T 3poz_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--------SEISSI----------- 231 (327)
T ss_dssp CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--------GGHHHH-----------
T ss_pred cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH--------HHHHHH-----------
Confidence 322 2233457889999999999999999999999999999999 9999975422 111111
Q ss_pred HhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 612 TAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 612 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
+...............+.+++.+||+.||.+||+++|+++.|+..
T Consensus 232 --~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 232 --LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp --HHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred --HHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 111111112223345678899999999999999999999998654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=368.04 Aligned_cols=253 Identities=19% Similarity=0.234 Sum_probs=211.2
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcC
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
.++|...+.||+|+||.||+|.+..+++.+|+|.+.........+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 46799999999999999999999999999999998866556677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcC--CCcEEEeecCCceecCCCCCC
Q 043702 459 PNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDE--GFNARLGDFGLARQVEHDKSP 536 (711)
Q Consensus 459 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~--~~~vkL~DFGla~~~~~~~~~ 536 (711)
++|+|.+++......+++.++..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++......
T Consensus 84 ~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~-- 158 (321)
T 1tki_A 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-- 158 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC--
Confidence 99999999977667899999999999999999999998 9999999999999987 7899999999998875433
Q ss_pred CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhh
Q 043702 537 DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADA 616 (711)
Q Consensus 537 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 616 (711)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+........ .... +.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----------~~~~~~i~~~-~~~~--~~ 224 (321)
T 1tki_A 159 NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-----------QQIIENIMNA-EYTF--DE 224 (321)
T ss_dssp EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-----------HHHHHHHHHT-CCCC--CH
T ss_pred ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH-----------HHHHHHHHcC-CCCC--Ch
Confidence 23445799999999999988899999999999999999999999965321 1111111111 1000 00
Q ss_pred hccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 617 RLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 617 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.... .....+.+++.+||+.||.+|||+.|+++.
T Consensus 225 ~~~~----~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 225 EAFK----EISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhhc----cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0001 123467789999999999999999999983
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=368.71 Aligned_cols=248 Identities=21% Similarity=0.326 Sum_probs=207.1
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC---CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
.++|...+.||+|+||.||+|.+..+|+.||||++.... ...+.+.+|+++++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 467999999999999999999998899999999987633 23456889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
||+++|+|.+++... ..+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 94 e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 168 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG- 168 (328)
T ss_dssp CCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC-
T ss_pred ECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC-
Confidence 999999999999653 5699999999999999999999998 99999999999999999999999999998765432
Q ss_pred CCcccccCCCcccChhhhccCCCC-ccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhh
Q 043702 536 PDATVAAGTMGYLAPEYLLTGRAT-EKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~~~s-~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 614 (711)
.....+||+.|+|||++.+..+. .++|||||||++|||++|+.||..... .+...... .+..
T Consensus 169 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----------~~~~~~i~-~~~~---- 231 (328)
T 3fe3_A 169 -KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL-----------KELRERVL-RGKY---- 231 (328)
T ss_dssp -GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHHHHHH-HCCC----
T ss_pred -ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH-----------HHHHHHHH-hCCC----
Confidence 33456799999999999888764 799999999999999999999975321 11111111 1111
Q ss_pred hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 615 DARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 615 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
..+......+.+++.+||+.||.+|||++|+++.
T Consensus 232 ------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 ------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1111123456788999999999999999999974
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=363.42 Aligned_cols=267 Identities=21% Similarity=0.359 Sum_probs=206.6
Q ss_pred cCCcccceeecCCceEEEEEE----eCCCCeEEEEEEcccCC-CChhhhHHHHHHHHhcCCCCeeeeeeeeee--cCeEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGI----LPQNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCHE--KGEIL 452 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~----~~~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~ 452 (711)
++|+..+.||+|+||+||+|+ ...+++.||||++.... ...+.+.+|++++++++||||++++++|.. ....+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 578899999999999999998 45578999999987643 334678999999999999999999999865 35689
Q ss_pred EEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCC
Q 043702 453 LVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEH 532 (711)
Q Consensus 453 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~ 532 (711)
+||||+++|+|.+++......+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166 (295)
T ss_dssp EEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred EEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence 99999999999999988777799999999999999999999997 999999999999999999999999999987654
Q ss_pred CCCC--CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccc----cccccchHHHHHHhhh
Q 043702 533 DKSP--DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGK----VGVASNLVEWVWSLHR 606 (711)
Q Consensus 533 ~~~~--~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~----~~~~~~l~~~~~~~~~ 606 (711)
.... ......++..|+|||.+.+..++.++|||||||++|||++|..|+......... ..........
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 240 (295)
T 3ugc_A 167 DKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH------ 240 (295)
T ss_dssp ---------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH------
T ss_pred CcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH------
Confidence 3321 222345778899999999999999999999999999999999998653221000 0000000001
Q ss_pred cCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 607 EGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 607 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
+...+........+......+.+++.+||+.||.+|||++|+++.|+..
T Consensus 241 ---~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 241 ---LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp ---HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1111111111222233446688899999999999999999999998753
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=365.13 Aligned_cols=257 Identities=25% Similarity=0.403 Sum_probs=217.2
Q ss_pred HHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 377 SATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 377 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
...++|+..+.||+|+||.||+|.+..++..||+|++.......+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 34567899999999999999999998889999999998777777889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhC-CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 457 LMPNGSLDKALFEA-RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 457 y~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
|+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 166 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166 (288)
T ss_dssp CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence 99999999999764 35699999999999999999999998 999999999999999999999999999987665443
Q ss_pred CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhh
Q 043702 536 PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 614 (711)
.......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ....+..
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~--------~~~~~~~------------- 225 (288)
T 3kfa_A 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------SQVYELL------------- 225 (288)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--------GGHHHHH-------------
T ss_pred ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHH-------------
Confidence 33444557889999999999999999999999999999999 9999865321 1111111
Q ss_pred hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 615 DARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 615 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
...............+.+++.+||+.||.+||++.++++.|+.
T Consensus 226 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~ 268 (288)
T 3kfa_A 226 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 268 (288)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHH
Confidence 1111111222334567889999999999999999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=366.09 Aligned_cols=245 Identities=29% Similarity=0.388 Sum_probs=197.4
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCC---hhhhHHHHHHHHhc-CCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQG---KDEFLSELSIIGTL-RHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 455 (711)
++|+..++||+|+||+||+|++..+++.||||++...... ..++..|+..+.++ +||||++++++|.+++.+++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 6799999999999999999999988999999998654332 23455666666555 8999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
||+ +++|.+++......+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~- 211 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG- 211 (311)
T ss_dssp ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccCC-
Confidence 999 7799999987777899999999999999999999998 99999999999999999999999999998765432
Q ss_pred CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhh
Q 043702 536 PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 615 (711)
......||++|+|||++.+ .++.++|||||||++|||++|..|+..... +.....+.......
T Consensus 212 -~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---------------~~~~~~~~~~~~~~ 274 (311)
T 3p1a_A 212 -AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---------------WQQLRQGYLPPEFT 274 (311)
T ss_dssp ----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---------------HHHHTTTCCCHHHH
T ss_pred -CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---------------HHHHhccCCCcccc
Confidence 2334569999999998875 789999999999999999999776643211 11111211111111
Q ss_pred hhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 616 ARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 616 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
. .....+.+++.+||+.||++|||++|+++.
T Consensus 275 ----~----~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 275 ----A----GLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp ----T----TSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ----c----CCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 1 123567889999999999999999999974
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=361.62 Aligned_cols=260 Identities=20% Similarity=0.273 Sum_probs=206.6
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC----ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ----GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLV 454 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 454 (711)
.++|+..+.||+|+||.||+|++..+++.||+|++..... ..+.+.+|+.++++++||||+++++++..++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 3578999999999999999999988999999999865322 235788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCC
Q 043702 455 YDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~ 534 (711)
|||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 90 ~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 9999999999999653 4799999999999999999999998 99999999999999999999999999998765544
Q ss_pred CCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhh
Q 043702 535 SPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614 (711)
Q Consensus 535 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 614 (711)
........||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .+.......... .. .
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-----------~~~~~~~~~~~~-~~-~ 232 (294)
T 4eqm_A 166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA-----------VSIAIKHIQDSV-PN-V 232 (294)
T ss_dssp ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH-----------HHHHHHHHSSCC-CC-H
T ss_pred ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-----------HHHHHHHhhccC-CC-c
Confidence 3444456799999999999999999999999999999999999999975321 111111111111 00 0
Q ss_pred hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHhCCC
Q 043702 615 DARLEGQFDEAEMRRVLLVGLACSHPDPLARP-TMRGVVQMLVGEA 659 (711)
Q Consensus 615 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~eVl~~L~~~~ 659 (711)
.... ..+....+.+++.+||+.||.+|| +++++.+.|....
T Consensus 233 ~~~~----~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 233 TTDV----RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp HHHS----CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred chhc----ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 0111 112235677889999999999999 9999999998653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=361.14 Aligned_cols=270 Identities=23% Similarity=0.281 Sum_probs=215.7
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC--CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecC--eEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN--SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKG--EILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV~ 455 (711)
++|...++||+|+||+||+|.+..+++.||||++... ....+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 5688999999999999999999988999999998753 244577889999999999999999999998765 789999
Q ss_pred EcCCCCCHHHHHhhCC--CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEE----cCCCcEEEeecCCcee
Q 043702 456 DLMPNGSLDKALFEAR--SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIML----DEGFNARLGDFGLARQ 529 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl----d~~~~vkL~DFGla~~ 529 (711)
||+++++|.+++.... ..+++.+++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 9999999999997543 3399999999999999999999998 99999999999999 7888899999999988
Q ss_pred cCCCCCCCcccccCCCcccChhhhc--------cCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHH
Q 043702 530 VEHDKSPDATVAAGTMGYLAPEYLL--------TGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWV 601 (711)
Q Consensus 530 ~~~~~~~~~~~~~gt~~y~APE~~~--------~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~ 601 (711)
...... .....||+.|+|||++. +..++.++|||||||++|||++|+.||...... ....+.+
T Consensus 166 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~~~~~~ 236 (319)
T 4euu_A 166 LEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP-------RRNKEVM 236 (319)
T ss_dssp CCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCG-------GGCHHHH
T ss_pred cCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc-------chhHHHH
Confidence 755432 23456999999999986 467899999999999999999999999753221 1112222
Q ss_pred HHhhhcCch---h---Hhh--------hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCC
Q 043702 602 WSLHREGRL---L---TAA--------DARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEAEV 661 (711)
Q Consensus 602 ~~~~~~~~~---~---~~~--------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 661 (711)
......... . ... +......+.......+.+++.+||+.||++|||++|+++...+++..
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~ 310 (319)
T 4euu_A 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (319)
T ss_dssp HHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-
T ss_pred HHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhc
Confidence 222111100 0 000 00111234567777888999999999999999999999999876543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=387.03 Aligned_cols=260 Identities=26% Similarity=0.429 Sum_probs=213.0
Q ss_pred HHHHHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEE
Q 043702 374 ELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILL 453 (711)
Q Consensus 374 el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 453 (711)
+.+...++|...+.||+|+||.||+|.+. .+..||||++.......++|.+|+++|++++||||+++++++. .+..++
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l 259 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI 259 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence 34445678999999999999999999995 4788999999877677889999999999999999999999987 567899
Q ss_pred EEEcCCCCCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCC
Q 043702 454 VYDLMPNGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEH 532 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~ 532 (711)
|||||++|+|.+++.... ..+++..+++++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++....
T Consensus 260 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp EECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 999999999999997433 3689999999999999999999998 999999999999999999999999999987643
Q ss_pred CCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchh
Q 043702 533 DKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLL 611 (711)
Q Consensus 533 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 611 (711)
..........++..|+|||++..+.++.++|||||||+||||++ |+.||..... ..+.. .. ..+
T Consensus 337 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~--------~~~~~---~i-~~~--- 401 (454)
T 1qcf_A 337 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--------PEVIR---AL-ERG--- 401 (454)
T ss_dssp HHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHHHH---HH-HHT---
T ss_pred CceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH--------HHHHH---HH-HcC---
Confidence 22111223346789999999999999999999999999999999 9999965321 11111 11 111
Q ss_pred HhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC
Q 043702 612 TAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEA 659 (711)
Q Consensus 612 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~ 659 (711)
.....+......+.+++.+||+.||.+|||+++|++.|+...
T Consensus 402 ------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 402 ------YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp ------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred ------CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 111112233456788999999999999999999999998753
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=368.19 Aligned_cols=255 Identities=25% Similarity=0.394 Sum_probs=205.6
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeE----EEEEEcccC--CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDI----IAVKRCSHN--SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILL 453 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~----vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 453 (711)
++|...++||+|+||+||+|.+..+++. ||+|.+... ....+.+.+|+.++++++||||++++++|. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 4688899999999999999998777664 788877542 344567889999999999999999999986 467899
Q ss_pred EEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCC
Q 043702 454 VYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHD 533 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~ 533 (711)
||||+++|+|.+++......+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168 (325)
T ss_dssp EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence 9999999999999987767899999999999999999999998 9999999999999999999999999999977544
Q ss_pred CCC-CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchh
Q 043702 534 KSP-DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLL 611 (711)
Q Consensus 534 ~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 611 (711)
... ......||..|+|||.+..+.++.++|||||||++|||++ |+.||..... ..+.+.+ ..+.
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~----~~~~-- 234 (325)
T 3kex_A 169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL--------AEVPDLL----EKGE-- 234 (325)
T ss_dssp TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT--------THHHHHH----HTTC--
T ss_pred cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH--------HHHHHHH----HcCC--
Confidence 322 2344568889999999999999999999999999999999 9999975321 1111111 1111
Q ss_pred HhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC
Q 043702 612 TAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEA 659 (711)
Q Consensus 612 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~ 659 (711)
...........+.+++.+||+.||.+||+++++++.|+...
T Consensus 235 -------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 235 -------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp -------BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred -------CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 01111112234667889999999999999999999997654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=374.25 Aligned_cols=265 Identities=26% Similarity=0.392 Sum_probs=212.4
Q ss_pred cCHHHHHHHhcCCcccceeecCCceEEEEEE-----eCCCCeEEEEEEcccCCC--ChhhhHHHHHHHHhc-CCCCeeee
Q 043702 370 FSYRELRSATKCFNANRIIGHGAFGTVYKGI-----LPQNGDIIAVKRCSHNSQ--GKDEFLSELSIIGTL-RHRNLVRL 441 (711)
Q Consensus 370 ~~~~el~~at~~f~~~~~LG~G~fg~Vy~~~-----~~~~~~~vavK~~~~~~~--~~~~~~~Ei~~l~~l-~H~niv~l 441 (711)
+...+.....++|...+.||+|+||.||+|+ ...+++.||||++..... ..+.+.+|++++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 4455666677899999999999999999998 445678999999976432 245789999999999 69999999
Q ss_pred eeeeeecC-eEEEEEEcCCCCCHHHHHhhCCC------------------------------------------------
Q 043702 442 QGWCHEKG-EILLVYDLMPNGSLDKALFEARS------------------------------------------------ 472 (711)
Q Consensus 442 ~g~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~------------------------------------------------ 472 (711)
+++|.+.+ ..++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 99998755 48999999999999999976432
Q ss_pred -----------------CCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 473 -----------------PLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 473 -----------------~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
.+++..++.++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 189999999999999999999998 999999999999999999999999999987644332
Q ss_pred C-CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHh
Q 043702 536 P-DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTA 613 (711)
Q Consensus 536 ~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 613 (711)
. ......||+.|+|||++.+..++.++|||||||++|||++ |+.||...... +........+.
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----------~~~~~~~~~~~---- 313 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-----------EEFCRRLKEGT---- 313 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-----------HHHHHHHHHTC----
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh-----------HHHHHHHHcCC----
Confidence 2 2334568999999999999999999999999999999998 99999653211 11111111111
Q ss_pred hhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 614 ADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 614 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
...........+.+++.+||+.||.+||++.||+++|+.
T Consensus 314 -----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 352 (359)
T 3vhe_A 314 -----RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 352 (359)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -----CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 111112223457788999999999999999999999975
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=355.39 Aligned_cols=254 Identities=28% Similarity=0.407 Sum_probs=212.1
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCC
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMP 459 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 459 (711)
++|...+.||+|+||.||+|.+. +++.||+|++.......+++.+|++++++++||||+++++++.+.+..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 56888999999999999999986 57889999998877677889999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCcc
Q 043702 460 NGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDAT 539 (711)
Q Consensus 460 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 539 (711)
+++|.+++......+++..+..++.|+++||.|||+. +++||||||+||+++.++.+||+|||+++...........
T Consensus 87 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 163 (267)
T 3t9t_A 87 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 163 (267)
T ss_dssp TCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred CCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccccccc
Confidence 9999999988777899999999999999999999998 9999999999999999999999999999876432222223
Q ss_pred cccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhc
Q 043702 540 VAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARL 618 (711)
Q Consensus 540 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 618 (711)
...+++.|+|||.+....++.++||||||+++|||++ |+.||..... .+..... ..+.
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----------~~~~~~i-~~~~--------- 222 (267)
T 3t9t_A 164 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-----------SEVVEDI-STGF--------- 222 (267)
T ss_dssp STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----------HHHHHHH-HTTC---------
T ss_pred cccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH-----------HHHHHHH-hcCC---------
Confidence 3457889999999999999999999999999999999 8999865321 1111111 1110
Q ss_pred cCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 619 EGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
....+......+.+++.+||+.||.+||+++++++.|+..
T Consensus 223 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 223 RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0011112234577889999999999999999999999753
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=365.93 Aligned_cols=254 Identities=24% Similarity=0.348 Sum_probs=204.8
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
.++|+..+.||+|+||+||+|++..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 357999999999999999999999899999999986532 334678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCC-C
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK-S 535 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~-~ 535 (711)
|+++|+|.+++.. ...+++.+++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+.... .
T Consensus 86 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 86 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 9999999998853 45699999999999999999999997 99999999999999999999999999998764332 1
Q ss_pred CCcccccCCCcccChhhhccCCC-CccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhh
Q 043702 536 PDATVAAGTMGYLAPEYLLTGRA-TEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 614 (711)
.......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... ......|. .......
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~~~~----~~~~~~~-- 229 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS------CQEYSDWK----EKKTYLN-- 229 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT------SHHHHHHH----TTCTTST--
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH------HHHHHHHh----cccccCC--
Confidence 22334679999999999987765 78999999999999999999999754221 01111111 1100000
Q ss_pred hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 043702 615 DARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655 (711)
Q Consensus 615 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L 655 (711)
........+.+++.+||+.||.+|||+.|+++.-
T Consensus 230 -------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~ 263 (323)
T 3tki_A 230 -------PWKKIDSAPLALLHKILVENPSARITIPDIKKDR 263 (323)
T ss_dssp -------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred -------ccccCCHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 0111234567889999999999999999998754
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=358.85 Aligned_cols=254 Identities=24% Similarity=0.401 Sum_probs=196.4
Q ss_pred hcCCcccceeecCCceEEEEEEeCCC---CeEEEEEEcccCCC--ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQN---GDIIAVKRCSHNSQ--GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILL 453 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~---~~~vavK~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 453 (711)
.++|+..+.||+|+||.||+|.+..+ +..||+|++..... ..+.+.+|+.++++++||||+++++++. ++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 45788999999999999999998543 46799999876332 3457889999999999999999999985 457899
Q ss_pred EEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCC
Q 043702 454 VYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHD 533 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~ 533 (711)
||||+++|+|.+++......+++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169 (281)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCcc
Confidence 9999999999999987777899999999999999999999998 9999999999999999999999999999877554
Q ss_pred CCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhH
Q 043702 534 KSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLT 612 (711)
Q Consensus 534 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 612 (711)
.........+++.|+|||.+....++.++|||||||++|||++ |+.||..... ......+ ..+.
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~--------~~~~~~i----~~~~--- 234 (281)
T 1mp8_A 170 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--------NDVIGRI----ENGE--- 234 (281)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG--------GGHHHHH----HTTC---
T ss_pred cccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH--------HHHHHHH----HcCC---
Confidence 4333444567889999999999999999999999999999997 9999975422 1111111 1111
Q ss_pred hhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 613 AADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 613 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
...........+.+++.+||+.||.+||++.|+++.|+.
T Consensus 235 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 273 (281)
T 1mp8_A 235 ------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 273 (281)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 011122234567789999999999999999999999875
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=376.72 Aligned_cols=256 Identities=28% Similarity=0.400 Sum_probs=206.0
Q ss_pred cCCcccceeecCCceEEEEEEe-----CCCCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGIL-----PQNGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEIL 452 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~-----~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 452 (711)
++|...+.||+|+||+||+|++ ..+++.||||++.... ....++.+|+.++++++||||+++++++...+..+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 5688899999999999999995 3457789999987532 33457889999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhhCC------CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCC---cEEEee
Q 043702 453 LVYDLMPNGSLDKALFEAR------SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGF---NARLGD 523 (711)
Q Consensus 453 lV~Ey~~~gsL~~~l~~~~------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~---~vkL~D 523 (711)
+||||+++|+|.+++...+ ..+++.+++.++.||+.||+|||+. +|+||||||+|||++.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECC
Confidence 9999999999999997543 4599999999999999999999998 999999999999999554 599999
Q ss_pred cCCceecCCCC-CCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHH
Q 043702 524 FGLARQVEHDK-SPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWV 601 (711)
Q Consensus 524 FGla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~ 601 (711)
||+++...... ........||+.|+|||++.+..++.++|||||||++|||++ |+.||..... ..+.+
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~--------~~~~~-- 297 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--------QEVLE-- 297 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHHHH--
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHH--
Confidence 99998653222 122334568999999999999999999999999999999998 9999965321 11111
Q ss_pred HHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC
Q 043702 602 WSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEA 659 (711)
Q Consensus 602 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~ 659 (711)
.. ..+. ...........+.+++.+||+.||.+||++.+|++.|+...
T Consensus 298 -~i-~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 298 -FV-TSGG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp -HH-HTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HH-HcCC---------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 11 1111 11112223345778999999999999999999999997653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=362.32 Aligned_cols=248 Identities=23% Similarity=0.286 Sum_probs=207.1
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEccc----CCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSH----NSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
++|+..+.||+|+||+||+|+...+|+.||+|++.. .......+.+|+++++.++||||+++++++...+.+++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 578999999999999999999998999999999865 3345667899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
||+++|+|..++.. ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 85 E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~- 159 (337)
T 1o6l_A 85 EYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG- 159 (337)
T ss_dssp ECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-
T ss_pred eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCC-
Confidence 99999999999865 35689999999999999999999998 99999999999999999999999999998643322
Q ss_pred CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhh
Q 043702 536 PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 615 (711)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+...... .+..
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----------~~~~~~i~-~~~~----- 222 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----------ERLFELIL-MEEI----- 222 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHHHHHH-HCCC-----
T ss_pred CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH-----------HHHHHHHH-cCCC-----
Confidence 233456799999999999999999999999999999999999999965321 11111111 1110
Q ss_pred hhccCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHH
Q 043702 616 ARLEGQFDEAEMRRVLLVGLACSHPDPLARP-----TMRGVVQM 654 (711)
Q Consensus 616 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVl~~ 654 (711)
.++......+.+++.+||+.||.+|| +++|+++.
T Consensus 223 -----~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 223 -----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -----CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 11122234577888999999999999 89999863
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=369.93 Aligned_cols=259 Identities=26% Similarity=0.422 Sum_probs=211.1
Q ss_pred HHhcCCcccceeecCCceEEEEEEeCC-----CCeEEEEEEcccCCC--ChhhhHHHHHHHHhcCCCCeeeeeeeeeecC
Q 043702 377 SATKCFNANRIIGHGAFGTVYKGILPQ-----NGDIIAVKRCSHNSQ--GKDEFLSELSIIGTLRHRNLVRLQGWCHEKG 449 (711)
Q Consensus 377 ~at~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 449 (711)
...++|...+.||+|+||.||+|++.. +++.||+|++..... ..+.+.+|++++++++||||++++++|.+.+
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 345789999999999999999999863 458999999876432 2467899999999999999999999999999
Q ss_pred eEEEEEEcCCCCCHHHHHhhCC-----------------------CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccC
Q 043702 450 EILLVYDLMPNGSLDKALFEAR-----------------------SPLPWPHRSKILLGVASALAYLHQECENQVIHRDV 506 (711)
Q Consensus 450 ~~~lV~Ey~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDl 506 (711)
..++||||+++|+|.+++.... ..+++.+++.++.||++||.|||+. +|+||||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dl 200 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDL 200 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 9999999999999999997642 5699999999999999999999998 9999999
Q ss_pred CCCceEEcCCCcEEEeecCCceecCCCCC-CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccc
Q 043702 507 KTSNIMLDEGFNARLGDFGLARQVEHDKS-PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKE 584 (711)
Q Consensus 507 kp~NILld~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~ 584 (711)
||+|||++.++.+||+|||+++....... .......||+.|+|||.+....++.++|||||||++|||++ |+.||...
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence 99999999999999999999987643321 22234568899999999999999999999999999999999 99999653
Q ss_pred cccccccccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC
Q 043702 585 ITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEA 659 (711)
Q Consensus 585 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~ 659 (711)
.. .+.. .....+... ..+......+.+++.+||+.||.+||++.+|++.|+...
T Consensus 281 ~~-----------~~~~-~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~ 334 (343)
T 1luf_A 281 AH-----------EEVI-YYVRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 334 (343)
T ss_dssp CH-----------HHHH-HHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred Ch-----------HHHH-HHHhCCCcC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence 21 1111 111122111 112223356788999999999999999999999998753
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=355.80 Aligned_cols=261 Identities=16% Similarity=0.174 Sum_probs=211.6
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhc-CCCCeeeeeeeeeecCeEEEEEEc
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTL-RHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
.++|...+.||+|+||.||+|.+..+++.||+|++.... ..+.+.+|+++++++ +|+|++++++++......++||||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 357999999999999999999998899999999986533 446788999999999 699999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCc-----EEEeecCCceecCC
Q 043702 458 MPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFN-----ARLGDFGLARQVEH 532 (711)
Q Consensus 458 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~-----vkL~DFGla~~~~~ 532 (711)
+ +++|.+++......+++..+.+++.||++||+|||+. +|+||||||+|||++.++. +||+|||+++....
T Consensus 88 ~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~ 163 (298)
T 1csn_A 88 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163 (298)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred c-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccc
Confidence 9 9999999987777899999999999999999999987 9999999999999987776 99999999998765
Q ss_pred CCCC------CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhh
Q 043702 533 DKSP------DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHR 606 (711)
Q Consensus 533 ~~~~------~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~ 606 (711)
.... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ...+.......
T Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--------~~~~~~~~~~~ 235 (298)
T 1csn_A 164 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA--------TNKQKYERIGE 235 (298)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC--------CHHHHHHHHHH
T ss_pred ccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcc--------ccHHHHHHHHh
Confidence 4321 234457999999999999999999999999999999999999999764221 01111111100
Q ss_pred cCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 607 EGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 607 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
. ..... .+.+.. .....+.+++.+||+.||.+||++++|++.|+..
T Consensus 236 ~-~~~~~-~~~~~~----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 236 K-KQSTP-LRELCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp H-HHHSC-HHHHTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred h-ccCcc-HHHHHh----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence 0 00000 000111 1235677899999999999999999999998754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=381.32 Aligned_cols=255 Identities=27% Similarity=0.422 Sum_probs=204.8
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcC
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
.++|...++||+|+||.||+|.+.. +..||||++.......++|.+|+++|++++||||+++++++.+ +..++||||+
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 3567888999999999999999964 5779999998766667889999999999999999999999976 6789999999
Q ss_pred CCCCHHHHHhhC-CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC
Q 043702 459 PNGSLDKALFEA-RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD 537 (711)
Q Consensus 459 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 537 (711)
++|+|.+++... ...+++.++..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.........
T Consensus 261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 337 (452)
T 1fmk_A 261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337 (452)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCceec
Confidence 999999999653 34699999999999999999999998 99999999999999999999999999998765443323
Q ss_pred cccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhhhh
Q 043702 538 ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADA 616 (711)
Q Consensus 538 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 616 (711)
.....++..|+|||.+..+.++.++|||||||++|||++ |+.||..... ..+.+ . ...+
T Consensus 338 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--------~~~~~---~-i~~~-------- 397 (452)
T 1fmk_A 338 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLD---Q-VERG-------- 397 (452)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHH---H-HHTT--------
T ss_pred ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH--------HHHHH---H-HHcC--------
Confidence 333457889999999999999999999999999999999 9999965321 11111 1 1111
Q ss_pred hccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC
Q 043702 617 RLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEA 659 (711)
Q Consensus 617 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~ 659 (711)
.....+......+.+++.+||+.||++|||+++|++.|+...
T Consensus 398 -~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 398 -YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred -CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 111122233456788999999999999999999999998753
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=355.11 Aligned_cols=251 Identities=27% Similarity=0.497 Sum_probs=205.1
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCC--------hhhhHHHHHHHHhcCCCCeeeeeeeeeecCeE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQG--------KDEFLSELSIIGTLRHRNLVRLQGWCHEKGEI 451 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 451 (711)
++|+..+.||+|+||+||+|++..+++.||+|++...... .+.+.+|++++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 5788899999999999999999889999999998653221 167889999999999999999999997665
Q ss_pred EEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCC--eeeccCCCCceEEcCCCc-----EEEeec
Q 043702 452 LLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQ--VIHRDVKTSNIMLDEGFN-----ARLGDF 524 (711)
Q Consensus 452 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~--ivHrDlkp~NILld~~~~-----vkL~DF 524 (711)
++||||+++|+|.+++......+++..++.++.|++.||+|||+. + |+||||||+|||++.++. +||+||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 799999999999999988778899999999999999999999997 7 999999999999988776 999999
Q ss_pred CCceecCCCCCCCcccccCCCcccChhhhc--cCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHH
Q 043702 525 GLARQVEHDKSPDATVAAGTMGYLAPEYLL--TGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVW 602 (711)
Q Consensus 525 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~--~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~ 602 (711)
|+++.... ......||+.|+|||.+. ...++.++|||||||++|||++|+.||...... -..+..
T Consensus 174 g~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---------~~~~~~ 240 (287)
T 4f0f_A 174 GLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG---------KIKFIN 240 (287)
T ss_dssp TTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC---------HHHHHH
T ss_pred Cccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc---------HHHHHH
Confidence 99985433 233457999999999984 455789999999999999999999999654221 111111
Q ss_pred HhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 603 SLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 603 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
.... ..............+.+++.+||+.||.+||+++|+++.|+.
T Consensus 241 ~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 241 MIRE---------EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HHHH---------SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHhc---------cCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 1111 111112223334567889999999999999999999999975
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=361.95 Aligned_cols=259 Identities=17% Similarity=0.203 Sum_probs=210.3
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhc-CCCCeeeeeeeeeecCeEEEEEEc
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTL-RHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
.++|...+.||+|+||+||+|+...+++.||||++.... ..+.+.+|+++++++ +||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 357899999999999999999998899999999987543 345789999999999 899999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCc-----EEEeecCCceecCC
Q 043702 458 MPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFN-----ARLGDFGLARQVEH 532 (711)
Q Consensus 458 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~-----vkL~DFGla~~~~~ 532 (711)
+ +++|.+++......+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++.+..
T Consensus 87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~ 162 (330)
T 2izr_A 87 L-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162 (330)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence 9 9999999987777899999999999999999999998 9999999999999998887 99999999997654
Q ss_pred CCCC------CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhh
Q 043702 533 DKSP------DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHR 606 (711)
Q Consensus 533 ~~~~------~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~ 606 (711)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.+......
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~--------~~~~~~~~~i~- 233 (330)
T 2izr_A 163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA--------DTLKERYQKIG- 233 (330)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--------SSHHHHHHHHH-
T ss_pred CCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc--------ccHHHHHHHHH-
Confidence 3321 12356799999999999999999999999999999999999999976422 11111111110
Q ss_pred cCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 607 EGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 607 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
........ ..+... .. .+.+++.+||+.||.+||++++|++.|+.
T Consensus 234 ~~~~~~~~-~~~~~~----~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~ 278 (330)
T 2izr_A 234 DTKRATPI-EVLCEN----FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTD 278 (330)
T ss_dssp HHHHHSCH-HHHTTT----CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred hhhccCCH-HHHhcc----Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHH
Confidence 00000000 000111 12 67888999999999999999999998864
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=377.01 Aligned_cols=249 Identities=29% Similarity=0.415 Sum_probs=205.3
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecC-eEEEEEEc
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKG-EILLVYDL 457 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~lV~Ey 457 (711)
.++|...+.||+|+||.||+|.+ .++.||||++.... ..+.|.+|+++|++++||||++++++|.+.+ ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 35688899999999999999998 47899999987644 5678999999999999999999999987765 79999999
Q ss_pred CCCCCHHHHHhhCCC-CCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCC
Q 043702 458 MPNGSLDKALFEARS-PLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP 536 (711)
Q Consensus 458 ~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~ 536 (711)
|++|+|.+++..... .+++..++.++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 343 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 343 (450)
T ss_dssp CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc--
Confidence 999999999986544 479999999999999999999998 99999999999999999999999999998653321
Q ss_pred CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhhh
Q 043702 537 DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615 (711)
Q Consensus 537 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 615 (711)
....++..|+|||.+....++.++|||||||++|||++ |+.||..... ..+... ...+
T Consensus 344 --~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--------~~~~~~----i~~~------- 402 (450)
T 1k9a_A 344 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KDVVPR----VEKG------- 402 (450)
T ss_dssp -----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT--------TTHHHH----HHTT-------
T ss_pred --cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHH----HHcC-------
Confidence 22357889999999999999999999999999999998 9999975422 111111 1111
Q ss_pred hhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 616 ARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 616 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
.....+......+.+++.+||+.||.+|||+.++++.|+..
T Consensus 403 --~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 403 --YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11112223345678899999999999999999999998753
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=378.39 Aligned_cols=264 Identities=23% Similarity=0.262 Sum_probs=213.4
Q ss_pred cCHHHHHHHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhcCCCCeeeeeeee
Q 043702 370 FSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTLRHRNLVRLQGWC 445 (711)
Q Consensus 370 ~~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~ 445 (711)
+.+++++...++|+..++||+|+||+||+++.+.+++.||+|++... ....+.+.+|..++..++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 44566666788999999999999999999999989999999998652 23345688999999999999999999999
Q ss_pred eecCeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecC
Q 043702 446 HEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFG 525 (711)
Q Consensus 446 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFG 525 (711)
.+.+.+++||||+++|+|.+++......+++..++.++.||+.||+|||+. +|+||||||+||||+.++.+||+|||
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeech
Confidence 999999999999999999999987666899999999999999999999998 99999999999999999999999999
Q ss_pred CceecCCCCCCCcccccCCCcccChhhhc-------cCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchH
Q 043702 526 LARQVEHDKSPDATVAAGTMGYLAPEYLL-------TGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLV 598 (711)
Q Consensus 526 la~~~~~~~~~~~~~~~gt~~y~APE~~~-------~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~ 598 (711)
+++.............+||+.|+|||++. ...++.++|||||||++|||++|+.||..... .
T Consensus 208 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----------~ 276 (412)
T 2vd5_A 208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST-----------A 276 (412)
T ss_dssp TCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH-----------H
T ss_pred hheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH-----------H
Confidence 99887654433334568999999999997 35689999999999999999999999965321 1
Q ss_pred HHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCC---CCHHHHHHH
Q 043702 599 EWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLAR---PTMRGVVQM 654 (711)
Q Consensus 599 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Ps~~eVl~~ 654 (711)
+.......... ....+. ........+.+++.+||. +|.+| |+++|+++.
T Consensus 277 ~~~~~i~~~~~--~~~~p~----~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 277 ETYGKIVHYKE--HLSLPL----VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHHHHHHTHHH--HCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HHHHHHHhccc--CcCCCc----cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 11111110000 000010 111223567788899999 99998 699999873
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=370.79 Aligned_cols=256 Identities=25% Similarity=0.419 Sum_probs=209.6
Q ss_pred hcCCcccceeecCCceEEEEEEeCC-------CCeEEEEEEcccCCC--ChhhhHHHHHHHHhc-CCCCeeeeeeeeeec
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQ-------NGDIIAVKRCSHNSQ--GKDEFLSELSIIGTL-RHRNLVRLQGWCHEK 448 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~-------~~~~vavK~~~~~~~--~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 448 (711)
.++|...+.||+|+||.||+|++.. .+..||+|++..... ..+++.+|+++++++ +||||++++++|..+
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 3578889999999999999999642 346799999876433 236788999999999 899999999999999
Q ss_pred CeEEEEEEcCCCCCHHHHHhhCC---------------CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEE
Q 043702 449 GEILLVYDLMPNGSLDKALFEAR---------------SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIML 513 (711)
Q Consensus 449 ~~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl 513 (711)
+..++||||+++|+|.+++.... ..+++..+++++.||+.||+|||+. +|+||||||+||||
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEE
Confidence 99999999999999999997654 3599999999999999999999998 99999999999999
Q ss_pred cCCCcEEEeecCCceecCCCCC-CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCcccccccccc
Q 043702 514 DEGFNARLGDFGLARQVEHDKS-PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKV 591 (711)
Q Consensus 514 d~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~ 591 (711)
++++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~----- 299 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV----- 299 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----
Confidence 9999999999999987654332 22334567889999999999999999999999999999999 9999865321
Q ss_pred ccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 592 GVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 592 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
.+. ......+. ...........+.+++.+||+.||.+||+++||++.|+..
T Consensus 300 ------~~~-~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 350 (382)
T 3tt0_A 300 ------EEL-FKLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350 (382)
T ss_dssp ------HHH-HHHHHTTC---------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------HHH-HHHHHcCC---------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111 11111111 1111222335677899999999999999999999999765
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=360.95 Aligned_cols=253 Identities=21% Similarity=0.285 Sum_probs=207.3
Q ss_pred HhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC-------ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCe
Q 043702 378 ATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ-------GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGE 450 (711)
Q Consensus 378 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 450 (711)
..+.|...+.||+|+||.||+|.+..+|+.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 34679999999999999999999998999999999876322 24678999999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCC----cEEEeecCC
Q 043702 451 ILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGF----NARLGDFGL 526 (711)
Q Consensus 451 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~----~vkL~DFGl 526 (711)
.++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||+++++ .+||+|||+
T Consensus 90 ~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 9999999999999999954 45799999999999999999999998 999999999999998877 799999999
Q ss_pred ceecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhh
Q 043702 527 ARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHR 606 (711)
Q Consensus 527 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~ 606 (711)
++...... .....+||+.|+|||++....++.++|||||||++|||++|+.||..... .+..... .
T Consensus 166 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~-----------~~~~~~i-~ 231 (361)
T 2yab_A 166 AHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-----------QETLANI-T 231 (361)
T ss_dssp CEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-----------HHHHHHH-H
T ss_pred ceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-----------HHHHHHH-H
Confidence 98875533 23345799999999999999999999999999999999999999965321 1111111 1
Q ss_pred cCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 607 EGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 607 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.+... .++.... .....+.+++.+||+.||.+|||+.|+++.
T Consensus 232 ~~~~~--~~~~~~~----~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 232 AVSYD--FDEEFFS----QTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp TTCCC--CCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hcCCC--CCchhcc----CCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11100 0000001 113457788999999999999999999863
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=376.83 Aligned_cols=260 Identities=23% Similarity=0.280 Sum_probs=211.8
Q ss_pred HHHHHHHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEccc----CCCChhhhHHHHHHHHhcCCCCeeeeeeeeee
Q 043702 372 YRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSH----NSQGKDEFLSELSIIGTLRHRNLVRLQGWCHE 447 (711)
Q Consensus 372 ~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 447 (711)
+++++...++|+..++||+|+||+||+|++..+++.||+|++.. .....+.+.+|+.+++.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 44556667899999999999999999999999999999999865 23445678899999999999999999999999
Q ss_pred cCeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCc
Q 043702 448 KGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLA 527 (711)
Q Consensus 448 ~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla 527 (711)
.+.+++|||||++|+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||++
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a 215 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTC 215 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEecccee
Confidence 9999999999999999999965 3589999999999999999999998 9999999999999999999999999999
Q ss_pred eecCCCCCCCcccccCCCcccChhhhccCC----CCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHH
Q 043702 528 RQVEHDKSPDATVAAGTMGYLAPEYLLTGR----ATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWS 603 (711)
Q Consensus 528 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~----~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~ 603 (711)
+.............+||+.|+|||++.... ++.++|||||||++|||++|+.||..... .+....
T Consensus 216 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----------~~~~~~ 284 (410)
T 3v8s_A 216 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----------VGTYSK 284 (410)
T ss_dssp EECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH-----------HHHHHH
T ss_pred EeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh-----------hhHHHH
Confidence 877554333334568999999999998765 78999999999999999999999975321 111111
Q ss_pred hhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCC--CCCHHHHHHH
Q 043702 604 LHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLA--RPTMRGVVQM 654 (711)
Q Consensus 604 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~eVl~~ 654 (711)
.... . ..+.-.........+.+|+.+||+.+|.+ ||+++||++.
T Consensus 285 i~~~-~------~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 285 IMNH-K------NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HHTH-H------HHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred HHhc-c------ccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 1110 0 00000000112345778889999999988 9999999974
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=360.33 Aligned_cols=250 Identities=21% Similarity=0.329 Sum_probs=199.9
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC--CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecC-------
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN--SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKG------- 449 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------- 449 (711)
.++|+..+.||+|+||.||+|++..+++.||||++... ....+.+.+|++++++++||||++++++|.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 45789999999999999999999889999999998753 334578999999999999999999999986543
Q ss_pred --------------------------------------------------eEEEEEEcCCCCCHHHHHhhCCC--CCChH
Q 043702 450 --------------------------------------------------EILLVYDLMPNGSLDKALFEARS--PLPWP 477 (711)
Q Consensus 450 --------------------------------------------------~~~lV~Ey~~~gsL~~~l~~~~~--~l~~~ 477 (711)
..++|||||++|+|.+++..... ..++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 38999999999999999976432 35677
Q ss_pred HHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC-----------CCcccccCCCc
Q 043702 478 HRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS-----------PDATVAAGTMG 546 (711)
Q Consensus 478 ~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~-----------~~~~~~~gt~~ 546 (711)
.+++++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....... .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 7899999999999999998 999999999999999999999999999998765421 12233569999
Q ss_pred ccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccCCCcHHH
Q 043702 547 YLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAE 626 (711)
Q Consensus 547 y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 626 (711)
|+|||.+.+..++.++|||||||++|||++|..|+.... .. ........... .....
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~-------------~~-~~~~~~~~~~~---------~~~~~ 298 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV-------------RI-ITDVRNLKFPL---------LFTQK 298 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH-------------HH-HHHHHTTCCCH---------HHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH-------------HH-HHHhhccCCCc---------ccccC
Confidence 999999999999999999999999999999987753211 00 01111111111 11223
Q ss_pred HHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 627 MRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 627 ~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
...+.+++.+||+.||.+||+++|+++.
T Consensus 299 ~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 299 YPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp CHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred ChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 3456789999999999999999999974
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=360.06 Aligned_cols=266 Identities=21% Similarity=0.367 Sum_probs=209.2
Q ss_pred cCCcccceeecCCceEEEEEE----eCCCCeEEEEEEcccC--CCChhhhHHHHHHHHhcCCCCeeeeeeeeeec--CeE
Q 043702 380 KCFNANRIIGHGAFGTVYKGI----LPQNGDIIAVKRCSHN--SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEK--GEI 451 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~----~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 451 (711)
+.|+..+.||+|+||.||+|+ ...+++.||+|++... ....+.+.+|++++++++||||+++++++... +..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 357888999999999999999 4567899999998753 33457899999999999999999999999876 668
Q ss_pred EEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecC
Q 043702 452 LLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVE 531 (711)
Q Consensus 452 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~ 531 (711)
++||||+++|+|.+++......+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccccccc
Confidence 999999999999999977777899999999999999999999998 99999999999999999999999999998876
Q ss_pred CCCC--CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHh---hh
Q 043702 532 HDKS--PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSL---HR 606 (711)
Q Consensus 532 ~~~~--~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~---~~ 606 (711)
.... .......||..|+|||.+.+..++.++|||||||++|||++|+.|+...... ........ ..
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---------~~~~~~~~~~~~~ 248 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL---------FLKMIGPTHGQMT 248 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH---------HHHHHCSCCGGGH
T ss_pred CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH---------HhhccCCcccccC
Confidence 5432 1223356888999999999999999999999999999999999987533110 00000000 00
Q ss_pred cCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 607 EGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 607 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
...+...................+.+++.+||+.||.+|||+.++++.|+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 249 VTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 001111111111122223334568889999999999999999999999974
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=355.45 Aligned_cols=251 Identities=22% Similarity=0.298 Sum_probs=206.4
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC-------ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ-------GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEI 451 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 451 (711)
.+.|...+.||+|+||.||+|.+..+++.||+|++..... ..+.+.+|+.++++++||||+++++++...+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3568899999999999999999998999999999875321 356789999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCC----cEEEeecCCc
Q 043702 452 LLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGF----NARLGDFGLA 527 (711)
Q Consensus 452 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~----~vkL~DFGla 527 (711)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||++
T Consensus 90 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp EEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 999999999999999954 45799999999999999999999998 999999999999999887 8999999999
Q ss_pred eecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhc
Q 043702 528 RQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHRE 607 (711)
Q Consensus 528 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~ 607 (711)
+....... .....||+.|+|||++....++.++|||||||++|||++|+.||..... .+........
T Consensus 166 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----------~~~~~~~~~~ 232 (326)
T 2y0a_A 166 HKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-----------QETLANVSAV 232 (326)
T ss_dssp EECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-----------HHHHHHHHHT
T ss_pred eECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH-----------HHHHHHHHhc
Confidence 88754332 2345799999999999999999999999999999999999999965321 0111111100
Q ss_pred -CchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 608 -GRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 608 -~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
..... .... .....+.+++.+||+.||.+|||+.|+++.
T Consensus 233 ~~~~~~----~~~~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 233 NYEFED----EYFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp CCCCCH----HHHT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCcCc----cccc----cCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00000 0001 113457788999999999999999999984
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=367.80 Aligned_cols=266 Identities=16% Similarity=0.204 Sum_probs=207.7
Q ss_pred HhcCCcccceeecCCceEEEEEEeCCC-----CeEEEEEEcccCCCC------------hhhhHHHHHHHHhcCCCCeee
Q 043702 378 ATKCFNANRIIGHGAFGTVYKGILPQN-----GDIIAVKRCSHNSQG------------KDEFLSELSIIGTLRHRNLVR 440 (711)
Q Consensus 378 at~~f~~~~~LG~G~fg~Vy~~~~~~~-----~~~vavK~~~~~~~~------------~~~~~~Ei~~l~~l~H~niv~ 440 (711)
..++|...+.||+|+||.||+|.+..+ ++.||||++...... ...+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 345799999999999999999998654 478999998654311 123445666777788999999
Q ss_pred eeeeeeec----CeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEc--
Q 043702 441 LQGWCHEK----GEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLD-- 514 (711)
Q Consensus 441 l~g~~~~~----~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld-- 514 (711)
+++++... ...++||||+ +++|.+++......+++..++.|+.||+.||+|||+. +|+||||||+||||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESS
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecC
Confidence 99998764 4589999999 9999999988778899999999999999999999998 999999999999999
Q ss_pred CCCcEEEeecCCceecCCCCCC------CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccc
Q 043702 515 EGFNARLGDFGLARQVEHDKSP------DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGV 588 (711)
Q Consensus 515 ~~~~vkL~DFGla~~~~~~~~~------~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~ 588 (711)
.++.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~- 267 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD- 267 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC-
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC-
Confidence 8899999999999876543221 123345999999999999999999999999999999999999999753221
Q ss_pred cccccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 589 GKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 589 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
.....+..... ...+....++.+... .....+.+++..||+.||.+||++++|++.|+..
T Consensus 268 ------~~~~~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 268 ------PKYVRDSKIRY-RENIASLMDKCFPAA---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp ------HHHHHHHHHHH-HHCHHHHHHHHSCTT---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred ------HHHHHHHHHHh-hhhHHHHHHHhcccc---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 11222221111 123444444443211 1234677888999999999999999999988653
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=355.62 Aligned_cols=263 Identities=24% Similarity=0.348 Sum_probs=202.1
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHh--cCCCCeeeeeeeeeec----CeEE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGT--LRHRNLVRLQGWCHEK----GEIL 452 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~~~----~~~~ 452 (711)
.++|...+.||+|+||+||+|++ +++.||||++... ..+.+.+|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR--DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG--GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc--cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46799999999999999999998 6899999998643 34566777777777 7899999999997653 4689
Q ss_pred EEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhcc-----CCCeeeccCCCCceEEcCCCcEEEeecCCc
Q 043702 453 LVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQEC-----ENQVIHRDVKTSNIMLDEGFNARLGDFGLA 527 (711)
Q Consensus 453 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-----~~~ivHrDlkp~NILld~~~~vkL~DFGla 527 (711)
+||||+++|+|.+++. ...+++..+++++.|++.||+|||... ..+|+||||||+|||++.++.+||+|||++
T Consensus 83 lv~e~~~~g~L~~~l~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 160 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA 160 (301)
T ss_dssp EEECCCTTCBHHHHHT--TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EehhhccCCCHHHHHh--hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence 9999999999999994 457999999999999999999999211 239999999999999999999999999999
Q ss_pred eecCCCCCC---CcccccCCCcccChhhhccC------CCCccccchhHHHHHHHHHhC----------CCCCccccccc
Q 043702 528 RQVEHDKSP---DATVAAGTMGYLAPEYLLTG------RATEKTDVFSYGAVVLEVASG----------RRPIEKEITGV 588 (711)
Q Consensus 528 ~~~~~~~~~---~~~~~~gt~~y~APE~~~~~------~~s~ksDVwSfGvll~elltG----------~~P~~~~~~~~ 588 (711)
+........ ......||+.|+|||.+.+. .++.++|||||||++|||++| +.||.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~ 240 (301)
T 3q4u_A 161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240 (301)
T ss_dssp EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence 876543322 12234799999999999876 445799999999999999999 77775432210
Q ss_pred cccccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 589 GKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 589 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
.............+..... ............+.+++.+||+.||.+|||+.||++.|+.
T Consensus 241 ------~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 241 ------PSFEDMRKVVCVDQQRPNI----PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp ------CCHHHHHHHHTTSCCCCCC----CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred ------cchhhhhHHHhccCCCCCC----ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 1111111111111110000 0111234566789999999999999999999999999975
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=357.13 Aligned_cols=262 Identities=23% Similarity=0.323 Sum_probs=203.0
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC---ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ---GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
.++|+..++||+|+||+||+|++. +++.||+|++..... ..+.+.+|++++++++||||+++++++..++..++||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 467899999999999999999995 589999999875332 2367889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
||++ |+|.+++......+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 99 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 174 (311)
T 3niz_A 99 EFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR 174 (311)
T ss_dssp ECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred cCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence 9997 489998887777899999999999999999999998 999999999999999999999999999987654322
Q ss_pred CCcccccCCCcccChhhhcc-CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCc-----
Q 043702 536 PDATVAAGTMGYLAPEYLLT-GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGR----- 609 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~----- 609 (711)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+........
T Consensus 175 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~i~~~~~~~~~~~~~ 245 (311)
T 3niz_A 175 -SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD--------DQLPKIFSILGTPNPREWP 245 (311)
T ss_dssp ----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT--------THHHHHHHHHCCCCTTTSG
T ss_pred -cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH--------HHHHHHHHHHCCCChHHhh
Confidence 2334568999999999876 56899999999999999999999999754321 11111111111000
Q ss_pred ----hhHhhhhhc--cCC-----CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 610 ----LLTAADARL--EGQ-----FDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 610 ----~~~~~d~~l--~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
+....+... ... .......++.+++.+||+.||.+|||++|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000000000 000 001122467789999999999999999999973
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=359.40 Aligned_cols=255 Identities=25% Similarity=0.423 Sum_probs=209.0
Q ss_pred hcCCcccceeecCCceEEEEEEe-----CCCCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGIL-----PQNGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEI 451 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~-----~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 451 (711)
.++|...+.||+|+||.||+|.+ ..++..||+|++.... ...+.+.+|++++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 46788999999999999999987 3455899999987643 2346788999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhhCC-----------------------CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCC
Q 043702 452 LLVYDLMPNGSLDKALFEAR-----------------------SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKT 508 (711)
Q Consensus 452 ~lV~Ey~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp 508 (711)
++||||+++|+|.+++.... ..+++.++++++.||++||+|||+. +|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccch
Confidence 99999999999999997643 2388999999999999999999998 999999999
Q ss_pred CceEEcCCCcEEEeecCCceecCCCCCC-CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccc
Q 043702 509 SNIMLDEGFNARLGDFGLARQVEHDKSP-DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEIT 586 (711)
Q Consensus 509 ~NILld~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~ 586 (711)
+|||+++++.+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999876543321 2233457889999999999999999999999999999999 9999965422
Q ss_pred cccccccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 587 GVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 587 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
..+... ...+. ...........+.+++.+||+.||.+||++.++++.|+.
T Consensus 259 --------~~~~~~----~~~~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~ 308 (314)
T 2ivs_A 259 --------ERLFNL----LKTGH---------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEK 308 (314)
T ss_dssp --------GGHHHH----HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --------HHHHHH----hhcCC---------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 111111 11111 111122234567889999999999999999999999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=363.84 Aligned_cols=258 Identities=26% Similarity=0.423 Sum_probs=209.3
Q ss_pred HhcCCcccceeecCCceEEEEEEe-----CCCCeEEEEEEcccC--CCChhhhHHHHHHHHhc-CCCCeeeeeeeeeecC
Q 043702 378 ATKCFNANRIIGHGAFGTVYKGIL-----PQNGDIIAVKRCSHN--SQGKDEFLSELSIIGTL-RHRNLVRLQGWCHEKG 449 (711)
Q Consensus 378 at~~f~~~~~LG~G~fg~Vy~~~~-----~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 449 (711)
..++|...+.||+|+||.||+|.+ ...+..||+|++... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 457899999999999999999997 235678999998753 34457899999999999 8999999999999999
Q ss_pred eEEEEEEcCCCCCHHHHHhhCCC----------------------CCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCC
Q 043702 450 EILLVYDLMPNGSLDKALFEARS----------------------PLPWPHRSKILLGVASALAYLHQECENQVIHRDVK 507 (711)
Q Consensus 450 ~~~lV~Ey~~~gsL~~~l~~~~~----------------------~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk 507 (711)
..++||||+++|+|.+++..... .+++..++.++.||+.||+|||+. +|+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCC
Confidence 99999999999999999976543 379999999999999999999998 99999999
Q ss_pred CCceEEcCCCcEEEeecCCceecCCCCCC-CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCcccc
Q 043702 508 TSNIMLDEGFNARLGDFGLARQVEHDKSP-DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEI 585 (711)
Q Consensus 508 p~NILld~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~ 585 (711)
|+|||++.++.+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 99999999999999999999876544332 2233457889999999999999999999999999999998 999996542
Q ss_pred ccccccccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 586 TGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 586 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
.. ..+ ......+ .....+......+.+++.+||+.||.+||++.+|++.|+..
T Consensus 280 ~~-------~~~----~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 332 (344)
T 1rjb_A 280 VD-------ANF----YKLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 332 (344)
T ss_dssp CS-------HHH----HHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cH-------HHH----HHHHhcC---------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 11 111 1111111 11111222345677899999999999999999999999764
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=362.48 Aligned_cols=251 Identities=24% Similarity=0.312 Sum_probs=204.3
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC------CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN------SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILL 453 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 453 (711)
+.|+..+.||+|+||.||+|.+..+++.||||++... ....+.+.+|+++++.++||||+++++++.+++..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4688999999999999999999989999999998531 2246789999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhC---CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCc---EEEeecCCc
Q 043702 454 VYDLMPNGSLDKALFEA---RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFN---ARLGDFGLA 527 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~---vkL~DFGla 527 (711)
|||||++|+|.+++... ...+++..+..++.||++||+|||+. +|+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 99999999998887542 34589999999999999999999998 9999999999999987655 999999999
Q ss_pred eecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhc
Q 043702 528 RQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHRE 607 (711)
Q Consensus 528 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~ 607 (711)
+....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+ ......
T Consensus 181 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~~----~~~i~~ 246 (351)
T 3c0i_A 181 IQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE---------RL----FEGIIK 246 (351)
T ss_dssp EECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH---------HH----HHHHHH
T ss_pred eEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH---------HH----HHHHHc
Confidence 87754332 23345799999999999999999999999999999999999999965311 11 111111
Q ss_pred CchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 608 GRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 608 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
+.... .+.... .....+.+++.+||+.||.+||++.|+++
T Consensus 247 ~~~~~--~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 247 GKYKM--NPRQWS----HISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp TCCCC--CHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCC--Cccccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11100 000001 11346778899999999999999999986
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=350.57 Aligned_cols=251 Identities=27% Similarity=0.481 Sum_probs=194.9
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC-----CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS-----QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLV 454 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 454 (711)
++|+..+.||+|+||.||+|.+ .++.||+|++.... ...+.+.+|+++++.++||||+++++++..++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 5788999999999999999998 48899999987532 2346788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcC--------CCcEEEeecCC
Q 043702 455 YDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDE--------GFNARLGDFGL 526 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~--------~~~vkL~DFGl 526 (711)
|||+++++|.+++. ...+++..+..++.|+++||+|||+....+|+||||||+|||++. ++.+||+|||+
T Consensus 85 ~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 85 MEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp EECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred EEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 99999999999984 457999999999999999999999981122999999999999986 77899999999
Q ss_pred ceecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhh
Q 043702 527 ARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHR 606 (711)
Q Consensus 527 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~ 606 (711)
++....... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .........
T Consensus 163 ~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----------~~~~~~~~~ 228 (271)
T 3dtc_A 163 AREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG-----------LAVAYGVAM 228 (271)
T ss_dssp ----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH-----------HHHHHHHHT
T ss_pred ccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----------HHHHHhhhc
Confidence 986644322 234699999999999999999999999999999999999999965321 011111111
Q ss_pred cCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 607 EGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 607 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
. .............+.+++.+||+.||.+|||+.|+++.|+.
T Consensus 229 ~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 229 N---------KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp S---------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred C---------CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 1 11111222334567889999999999999999999999974
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=351.00 Aligned_cols=263 Identities=21% Similarity=0.320 Sum_probs=205.1
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC---ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ---GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
++|+..++||+|+||+||+|.+..+++.||+|++..... ..+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 478899999999999999999998999999999876332 23678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCC
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP 536 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~ 536 (711)
|+++ +|.+++......+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 156 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR- 156 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS-
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCccc-
Confidence 9975 77777777677899999999999999999999998 999999999999999999999999999987654332
Q ss_pred CcccccCCCcccChhhhccCC-CCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCc------
Q 043702 537 DATVAAGTMGYLAPEYLLTGR-ATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGR------ 609 (711)
Q Consensus 537 ~~~~~~gt~~y~APE~~~~~~-~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~------ 609 (711)
......||+.|+|||++.+.. ++.++|||||||++|||++|+.|+...... ......+........
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~-------~~~~~~i~~~~~~~~~~~~~~ 229 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-------DDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH-------HHHHHHHHHHHCCCCTTTCTT
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH-------HHHHHHHHHHhCCCChhhhhh
Confidence 233457899999999998766 799999999999999999998886432110 111111111110000
Q ss_pred hhHhhhh---------hccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 610 LLTAADA---------RLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 610 ~~~~~d~---------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.....+. .............+.+++.+||+.||++|||++|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000000 00001111233567789999999999999999999974
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=354.58 Aligned_cols=254 Identities=26% Similarity=0.408 Sum_probs=208.8
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcC
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
.++|...+.||+|+||.||+|... ++..||+|++.......+.+.+|++++++++||||+++++++.. +..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence 457889999999999999999985 57789999998776677889999999999999999999999874 5689999999
Q ss_pred CCCCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC
Q 043702 459 PNGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD 537 (711)
Q Consensus 459 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 537 (711)
++++|.+++.... ..+++..+.+++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.........
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 166 (279)
T 1qpc_A 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (279)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCccccc
Confidence 9999999996432 2699999999999999999999998 99999999999999999999999999998876543333
Q ss_pred cccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhhhh
Q 043702 538 ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADA 616 (711)
Q Consensus 538 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 616 (711)
.....++..|+|||.+..+.++.++|||||||++|||++ |+.||..... .+..... ..+
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----------~~~~~~~-~~~-------- 226 (279)
T 1qpc_A 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-----------PEVIQNL-ERG-------- 226 (279)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----------HHHHHHH-HTT--------
T ss_pred ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH-----------HHHHHHH-hcc--------
Confidence 334457889999999998899999999999999999999 9999865321 1111111 111
Q ss_pred hccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 617 RLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 617 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
............+.+++.+||+.||++||++.++++.|+..
T Consensus 227 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 227 -YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -cCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 11111122235677899999999999999999999998753
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=354.33 Aligned_cols=259 Identities=22% Similarity=0.360 Sum_probs=192.4
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
.++|+..+.||+|+||.||+|....+++.||+|++.... ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 457889999999999999999998889999999987532 345678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCC-----CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecC
Q 043702 457 LMPNGSLDKALFEAR-----SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVE 531 (711)
Q Consensus 457 y~~~gsL~~~l~~~~-----~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~ 531 (711)
|++ |+|.+++.... ..+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 59999886432 4589999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCCCcccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhc---
Q 043702 532 HDKSPDATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHRE--- 607 (711)
Q Consensus 532 ~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~--- 607 (711)
.... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .....+......
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~i~~~~~~~~~ 230 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE--------EQLKLIFDIMGTPNE 230 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHHHCSCCT
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--------HHHHHHHHHhCCCCh
Confidence 4322 22345689999999999764 6899999999999999999999999754221 111111111000
Q ss_pred ---------------------CchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 608 ---------------------GRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 608 ---------------------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
..+.....+..... ....+.+++.+||+.||++|||++|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 231 SLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEP----LDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp TTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSC----CCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hHhhhhhhhhhcccccccccchhHHHhhccccccc----CCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 00111111111111 23467889999999999999999999873
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=367.45 Aligned_cols=257 Identities=21% Similarity=0.323 Sum_probs=205.4
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhc-CCCCeeeeeeeeeecCeEEE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTL-RHRNLVRLQGWCHEKGEILL 453 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 453 (711)
.++|+..++||+|+||+||+|+++.+++.||+|++... ....+.+.+|..++.++ +||||+++++++...+.+++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 35799999999999999999999999999999998752 23345688999999887 79999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCC
Q 043702 454 VYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHD 533 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~ 533 (711)
||||+++|+|..++.. ...+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 131 V~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEcCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 9999999999999965 35699999999999999999999998 9999999999999999999999999999863322
Q ss_pred CCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHh
Q 043702 534 KSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTA 613 (711)
Q Consensus 534 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 613 (711)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... .....+++......+.+
T Consensus 207 ~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~---~~~~~~~~~~~i~~~~~--- 279 (396)
T 4dc2_A 207 G-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP---DQNTEDYLFQVILEKQI--- 279 (396)
T ss_dssp T-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC---------CCHHHHHHHHHHCCC---
T ss_pred C-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccccccc---chhhHHHHHHHHhcccc---
Confidence 2 2344568999999999999999999999999999999999999999643211000 01111222222211111
Q ss_pred hhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCH------HHHHH
Q 043702 614 ADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTM------RGVVQ 653 (711)
Q Consensus 614 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~eVl~ 653 (711)
.++......+.+++.+||+.||.+||++ .|+++
T Consensus 280 -------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 280 -------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred -------CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 1222233457788999999999999995 67765
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=360.57 Aligned_cols=256 Identities=24% Similarity=0.410 Sum_probs=202.7
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeE----EEEEEccc--CCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDI----IAVKRCSH--NSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILL 453 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~----vavK~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 453 (711)
++|+..++||+|+||.||+|.+..+++. ||+|.+.. .....+.+.+|+.++++++||||++++++|.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 5788999999999999999998777664 57777654 3345678999999999999999999999998754 889
Q ss_pred EEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCC
Q 043702 454 VYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHD 533 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~ 533 (711)
|+||+++|+|.+++......+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 94 v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~ 170 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence 9999999999999988888899999999999999999999998 9999999999999999999999999999876543
Q ss_pred CC-CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchh
Q 043702 534 KS-PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLL 611 (711)
Q Consensus 534 ~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 611 (711)
.. .......||+.|+|||.+.+..++.++|||||||++|||++ |+.||..... ..+...+
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--------~~~~~~~---------- 232 (327)
T 3lzb_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--------SEISSIL---------- 232 (327)
T ss_dssp ---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--------GGHHHHH----------
T ss_pred cccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH--------HHHHHHH----------
Confidence 32 22233457889999999999999999999999999999999 9999975422 1111111
Q ss_pred HhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC
Q 043702 612 TAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEAE 660 (711)
Q Consensus 612 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 660 (711)
...............+.+++.+||+.||.+||++.|+++.|+....
T Consensus 233 ---~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 233 ---EKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp ---HTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred ---HcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1111111122233457789999999999999999999999987543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=358.56 Aligned_cols=257 Identities=28% Similarity=0.431 Sum_probs=210.1
Q ss_pred hcCCcccceeecCCceEEEEEEe-----CCCCeEEEEEEcccCCC--ChhhhHHHHHHHHhc-CCCCeeeeeeeeeecCe
Q 043702 379 TKCFNANRIIGHGAFGTVYKGIL-----PQNGDIIAVKRCSHNSQ--GKDEFLSELSIIGTL-RHRNLVRLQGWCHEKGE 450 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~-----~~~~~~vavK~~~~~~~--~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 450 (711)
.++|...+.||+|+||.||+|++ ..+++.||+|++..... ..+.+.+|+++++++ +||||+++++++...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 45788999999999999999985 34678999999876432 346789999999999 89999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhhCCC-----------------CCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEE
Q 043702 451 ILLVYDLMPNGSLDKALFEARS-----------------PLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIML 513 (711)
Q Consensus 451 ~~lV~Ey~~~gsL~~~l~~~~~-----------------~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl 513 (711)
.++||||+++|+|.+++..... .+++..+++++.|+++||+|||+. +|+||||||+|||+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEE
Confidence 9999999999999999976543 489999999999999999999998 99999999999999
Q ss_pred cCCCcEEEeecCCceecCCCCCCC-cccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCcccccccccc
Q 043702 514 DEGFNARLGDFGLARQVEHDKSPD-ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKV 591 (711)
Q Consensus 514 d~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~ 591 (711)
+.++.+||+|||+++......... .....||+.|+|||.+.+..++.++|||||||++|||++ |+.||......
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---- 254 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD---- 254 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS----
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch----
Confidence 999999999999998775543321 223457889999999999999999999999999999999 99999654211
Q ss_pred ccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 592 GVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 592 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
... ...... .............+.+++.+||+.||.+||++.|+++.|+..
T Consensus 255 ---~~~----~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 255 ---SKF----YKMIKE---------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp ---HHH----HHHHHH---------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---hHH----HHHhcc---------CCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 111 111111 111111222335678899999999999999999999999753
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=363.61 Aligned_cols=261 Identities=24% Similarity=0.390 Sum_probs=194.6
Q ss_pred HHHhcCCcccceeecCCceEEEEEEeCCCCe---EEEEEEcccC---CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecC
Q 043702 376 RSATKCFNANRIIGHGAFGTVYKGILPQNGD---IIAVKRCSHN---SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKG 449 (711)
Q Consensus 376 ~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~---~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 449 (711)
....++|...+.||+|+||.||+|.+..++. .||||++... ....+.+.+|++++++++||||+++++++....
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 3445689999999999999999999876654 8999998763 334567999999999999999999999998766
Q ss_pred eE------EEEEEcCCCCCHHHHHhhCC-----CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCc
Q 043702 450 EI------LLVYDLMPNGSLDKALFEAR-----SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFN 518 (711)
Q Consensus 450 ~~------~lV~Ey~~~gsL~~~l~~~~-----~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~ 518 (711)
.. ++||||+++|+|.+++.... ..+++..+++++.|+++||+|||+. +|+||||||+|||+++++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCC
Confidence 54 99999999999999986422 2599999999999999999999998 9999999999999999999
Q ss_pred EEEeecCCceecCCCCCC-CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccc
Q 043702 519 ARLGDFGLARQVEHDKSP-DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASN 596 (711)
Q Consensus 519 vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~ 596 (711)
+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||..... ..
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--------~~ 247 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN--------AE 247 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--------GG
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh--------HH
Confidence 999999999876543321 2223457889999999999999999999999999999999 9999975422 11
Q ss_pred hHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC
Q 043702 597 LVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEAE 660 (711)
Q Consensus 597 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 660 (711)
+... .... . ...........+.+++.+||+.||.+|||+.++++.|+....
T Consensus 248 ~~~~---~~~~-~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 248 IYNY---LIGG-N---------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp HHHH---HHTT-C---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHH---HhcC-C---------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1111 1111 0 111122233567889999999999999999999999987543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=363.20 Aligned_cols=210 Identities=23% Similarity=0.307 Sum_probs=187.4
Q ss_pred CCccCHHHHHHHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcC-----CCCeeee
Q 043702 367 PKEFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLR-----HRNLVRL 441 (711)
Q Consensus 367 ~~~~~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~-----H~niv~l 441 (711)
...+++++.....++|...++||+|+||+||+|++..+++.||||++.......+.+..|+++++.++ ||||+++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 34566777777788999999999999999999999889999999999765555667888999999997 9999999
Q ss_pred eeeeeecCeEEEEEEcCCCCCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcC-----
Q 043702 442 QGWCHEKGEILLVYDLMPNGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDE----- 515 (711)
Q Consensus 442 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~----- 515 (711)
++++...+..++||||+ +++|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCE
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccc
Confidence 99999999999999999 999999997654 4599999999999999999999998 9999999999999975
Q ss_pred --------------------CCcEEEeecCCceecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHH
Q 043702 516 --------------------GFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVA 575 (711)
Q Consensus 516 --------------------~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ell 575 (711)
++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 253 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY 253 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence 7899999999998754322 3456899999999999999999999999999999999
Q ss_pred hCCCCCccc
Q 043702 576 SGRRPIEKE 584 (711)
Q Consensus 576 tG~~P~~~~ 584 (711)
+|+.||...
T Consensus 254 ~g~~pf~~~ 262 (360)
T 3llt_A 254 TGSLLFRTH 262 (360)
T ss_dssp HSSCSCCCS
T ss_pred HCCCCCCCC
Confidence 999999653
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=351.62 Aligned_cols=261 Identities=23% Similarity=0.358 Sum_probs=200.7
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC---CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
++|...+.||+|+||+||+|+. .+++.||+|++.... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 4788999999999999999998 568999999986533 234678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCC
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP 536 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~ 536 (711)
|+++ +|.+++......+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 155 (288)
T 1ob3_A 81 HLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR- 155 (288)
T ss_dssp CCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred ecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-
Confidence 9975 99999987777899999999999999999999998 999999999999999999999999999987643222
Q ss_pred CcccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCch-----
Q 043702 537 DATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRL----- 610 (711)
Q Consensus 537 ~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~----- 610 (711)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+.. ..........
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-------~~~~~-~~~~~~~~~~~~~~~ 227 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA-------DQLMR-IFRILGTPNSKNWPN 227 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHH-HHHHHCCCCTTTSTT
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHH-HHHHHCCCChhhchh
Confidence 22335689999999999764 5899999999999999999999999653210 01111 1111000000
Q ss_pred -h--Hhhhhhcc-------CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 611 -L--TAADARLE-------GQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 611 -~--~~~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
. ...++... ..+.......+.+++.+||+.||++|||++|+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0 00000000 00011123557789999999999999999999873
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=355.17 Aligned_cols=248 Identities=21% Similarity=0.327 Sum_probs=197.8
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC---------------------------CChhhhHHHHHHHHh
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---------------------------QGKDEFLSELSIIGT 432 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---------------------------~~~~~~~~Ei~~l~~ 432 (711)
++|...+.||+|+||.||+|++..+++.||||++.... ...+.+.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 57899999999999999999998899999999986532 123568899999999
Q ss_pred cCCCCeeeeeeeeee--cCeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCc
Q 043702 433 LRHRNLVRLQGWCHE--KGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSN 510 (711)
Q Consensus 433 l~H~niv~l~g~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~N 510 (711)
++||||+++++++.+ .+..++||||+++++|.+++ ....+++.++..++.||++||+|||+. +|+||||||+|
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~N 167 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP--TLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSN 167 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS--CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGG
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHH
Confidence 999999999999986 56899999999999998865 345799999999999999999999998 99999999999
Q ss_pred eEEcCCCcEEEeecCCceecCCCCCCCcccccCCCcccChhhhccCC---CCccccchhHHHHHHHHHhCCCCCcccccc
Q 043702 511 IMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGR---ATEKTDVFSYGAVVLEVASGRRPIEKEITG 587 (711)
Q Consensus 511 ILld~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~---~s~ksDVwSfGvll~elltG~~P~~~~~~~ 587 (711)
||++.++.+||+|||+++....... ......||+.|+|||.+.... ++.++|||||||++|||++|+.||.....
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~- 245 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI- 245 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH-
T ss_pred EEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH-
Confidence 9999999999999999987654322 223457999999999997665 37889999999999999999999965321
Q ss_pred ccccccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 588 VGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 588 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
..+.... ..+.. ...........+.+++.+||+.||++||++.|+++
T Consensus 246 ----------~~~~~~~-~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 246 ----------MCLHSKI-KSQAL--------EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp ----------HHHHHHH-HHCCC--------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ----------HHHHHHH-hcccC--------CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 1111111 11110 00001112345778899999999999999999975
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=352.98 Aligned_cols=244 Identities=25% Similarity=0.328 Sum_probs=205.6
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
++|+..+.||+|+||+||+++...+|+.||+|++... ....+.+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 5788999999999999999999989999999998652 344567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-- 159 (318)
T 1fot_A 86 DYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 159 (318)
T ss_dssp CCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc--
Confidence 99999999999975 45699999999999999999999997 9999999999999999999999999999876432
Q ss_pred CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhh
Q 043702 536 PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 615 (711)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+........ .
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----------~~~~~~i~~~-~------ 219 (318)
T 1fot_A 160 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-----------MKTYEKILNA-E------ 219 (318)
T ss_dssp --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----------HHHHHHHHHC-C------
T ss_pred --cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----------HHHHHHHHhC-C------
Confidence 2345799999999999999999999999999999999999999965321 1111111111 1
Q ss_pred hhccCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 043702 616 ARLEGQFDEAEMRRVLLVGLACSHPDPLARP-----TMRGVVQ 653 (711)
Q Consensus 616 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVl~ 653 (711)
+ .++......+.+++.+||+.||.+|| +++++++
T Consensus 220 --~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 220 --L--RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp --C--CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --C--CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 0 11112234577888999999999999 8999985
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=352.55 Aligned_cols=255 Identities=27% Similarity=0.442 Sum_probs=203.8
Q ss_pred HhcCCcccceeecCCceEEEEEEeCC---CCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEE
Q 043702 378 ATKCFNANRIIGHGAFGTVYKGILPQ---NGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEIL 452 (711)
Q Consensus 378 at~~f~~~~~LG~G~fg~Vy~~~~~~---~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 452 (711)
..++|...+.||+|+||.||+|.+.. .+..||+|++.... ...+.+.+|++++++++||||+++++++.++ ..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence 34678999999999999999998643 34569999987643 2356789999999999999999999998754 568
Q ss_pred EEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCC
Q 043702 453 LVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEH 532 (711)
Q Consensus 453 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~ 532 (711)
+||||+++++|.+++......+++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 89 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred EEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 99999999999999987777899999999999999999999998 999999999999999999999999999987655
Q ss_pred CCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchh
Q 043702 533 DKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLL 611 (711)
Q Consensus 533 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 611 (711)
..........+++.|+|||.+....++.++|||||||++|||++ |+.||..... ....... ..+.
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~--------~~~~~~~----~~~~-- 231 (281)
T 3cc6_A 166 EDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN--------KDVIGVL----EKGD-- 231 (281)
T ss_dssp -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG--------GGHHHHH----HHTC--
T ss_pred ccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh--------HHHHHHH----hcCC--
Confidence 44333444567889999999999999999999999999999998 9999964321 1111111 1110
Q ss_pred HhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 612 TAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 612 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
...........+.+++.+||+.||.+||++.|+++.|+.
T Consensus 232 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 270 (281)
T 3cc6_A 232 -------RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSD 270 (281)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -------CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHH
Confidence 001111223457788999999999999999999999875
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=364.90 Aligned_cols=270 Identities=22% Similarity=0.307 Sum_probs=212.9
Q ss_pred cCCcccceeecCCceEEEEEE----eCCCCeEEEEEEcccCC-CChhhhHHHHHHHHhcCCCCeeeeeeeee--ecCeEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGI----LPQNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCH--EKGEIL 452 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~----~~~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~--~~~~~~ 452 (711)
++|+..+.||+|+||.||+|+ ...+++.||||++.... ...+.+.+|++++++++||||+++++++. +.+..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 578889999999999999999 45678999999987643 33456899999999999999999999886 456789
Q ss_pred EEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCC
Q 043702 453 LVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEH 532 (711)
Q Consensus 453 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~ 532 (711)
+||||+++++|.+++......+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 99999999999999987666799999999999999999999997 999999999999999999999999999997754
Q ss_pred CCCC--CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCch
Q 043702 533 DKSP--DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRL 610 (711)
Q Consensus 533 ~~~~--~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 610 (711)
.... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......... ..+.........+
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~------~~~~~~~~~~~~~ 253 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM------MGCERDVPALSRL 253 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH------CC----CCHHHHH
T ss_pred CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhh------cccccccccHHHH
Confidence 3321 2233458889999999999999999999999999999999999986532210000 0000000000111
Q ss_pred hHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 611 LTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 611 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
...................+.+++.+||+.||.+|||++|+++.|+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 301 (327)
T 3lxl_A 254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301 (327)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC
T ss_pred HHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 222222222223334456788899999999999999999999999865
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=364.35 Aligned_cols=253 Identities=23% Similarity=0.329 Sum_probs=206.5
Q ss_pred HhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC---ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEE
Q 043702 378 ATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ---GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLV 454 (711)
Q Consensus 378 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 454 (711)
..++|...+.||+|+||.||+|.+..+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 35679999999999999999999998999999999876432 335688999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCC---cEEEeecCCceecC
Q 043702 455 YDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGF---NARLGDFGLARQVE 531 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~---~vkL~DFGla~~~~ 531 (711)
|||+++|+|.+++.. ...+++..+..++.||++||.|||+. +|+||||||+|||++.++ .+||+|||+++...
T Consensus 107 ~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 107 FDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp ECCCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred EecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 999999999999864 45699999999999999999999998 999999999999998654 59999999998765
Q ss_pred CCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchh
Q 043702 532 HDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLL 611 (711)
Q Consensus 532 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 611 (711)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+ ......+...
T Consensus 183 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--------~~~----~~~i~~~~~~ 248 (362)
T 2bdw_A 183 DSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--------HRL----YAQIKAGAYD 248 (362)
T ss_dssp TCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHH----HHHHHHTCCC
T ss_pred CCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHH----HHHHHhCCCC
Confidence 432 23345799999999999998999999999999999999999999965321 111 1111111110
Q ss_pred HhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 612 TAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 612 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
. ...........+.+++.+||+.||.+||++.|+++.
T Consensus 249 ~------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 249 Y------PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp C------CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred C------CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 000001123457788999999999999999999864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=356.02 Aligned_cols=251 Identities=21% Similarity=0.325 Sum_probs=203.6
Q ss_pred cCCcccceeecCCceEEEEEEeCCCC-------eEEEEEEcccC-CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNG-------DIIAVKRCSHN-SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEI 451 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~-------~~vavK~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 451 (711)
++|...+.||+|+||.||+|.+..++ ..||+|++... ....+.+.+|++++++++||||+++++++..++..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 57888999999999999999987655 47999998653 34456799999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCc--------EEEee
Q 043702 452 LLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFN--------ARLGD 523 (711)
Q Consensus 452 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~--------vkL~D 523 (711)
++||||+++|+|.+++......+++..++.++.||+.||+|||+. +|+||||||+|||++.++. +||+|
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D 164 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred EEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeecc
Confidence 999999999999999987766799999999999999999999998 9999999999999998887 99999
Q ss_pred cCCceecCCCCCCCcccccCCCcccChhhhcc-CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHH
Q 043702 524 FGLARQVEHDKSPDATVAAGTMGYLAPEYLLT-GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVW 602 (711)
Q Consensus 524 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~ 602 (711)
||+++.... .....||+.|+|||.+.+ ..++.++|||||||++|||++|..|+..... ......
T Consensus 165 fg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~----------~~~~~~ 229 (289)
T 4fvq_A 165 PGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD----------SQRKLQ 229 (289)
T ss_dssp CCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC----------HHHHHH
T ss_pred CcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc----------hHHHHH
Confidence 999865422 233458999999999987 6789999999999999999996555432211 000000
Q ss_pred HhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC
Q 043702 603 SLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEAE 660 (711)
Q Consensus 603 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 660 (711)
..... ..+ +......+.+++.+||+.||.+|||++++++.|+....
T Consensus 230 ~~~~~--------~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 230 FYEDR--------HQL----PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HHHTT--------CCC----CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred Hhhcc--------CCC----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 00000 001 11112346788899999999999999999999997654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=368.66 Aligned_cols=253 Identities=21% Similarity=0.291 Sum_probs=208.7
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC-CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEc
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
.+.|...+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 467999999999999999999999899999999987543 2345788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcC--CCcEEEeecCCceecCCCCC
Q 043702 458 MPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDE--GFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 458 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~--~~~vkL~DFGla~~~~~~~~ 535 (711)
+++|+|.+++......+++..+..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++......
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~- 205 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 205 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCc-
Confidence 999999999976666899999999999999999999998 9999999999999974 5779999999999875433
Q ss_pred CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhh
Q 043702 536 PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 615 (711)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+........ ..
T Consensus 206 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-----------~~~~~~i~~~-~~----- 267 (387)
T 1kob_A 206 -IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-----------LETLQNVKRC-DW----- 267 (387)
T ss_dssp -CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-----------HHHHHHHHHC-CC-----
T ss_pred -ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH-----------HHHHHHHHhC-CC-----
Confidence 23345799999999999999999999999999999999999999975321 1111111110 00
Q ss_pred hhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 616 ARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 616 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.............+.+++.+||+.||.+|||+.|+++.
T Consensus 268 -~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 268 -EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp -CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00011111223467789999999999999999999984
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=365.06 Aligned_cols=248 Identities=21% Similarity=0.312 Sum_probs=201.6
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhc-CCCCeeeeeeeeeecCeEEE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTL-RHRNLVRLQGWCHEKGEILL 453 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 453 (711)
.++|+..++||+|+||+||+|++..+++.||||++... ....+.+.+|.++++.+ +||||+++++++...+.+++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 36799999999999999999999989999999998752 33456788999999998 69999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCC
Q 043702 454 VYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHD 533 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~ 533 (711)
||||+++|+|..++... ..+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 102 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 99999999999999653 5699999999999999999999998 9999999999999999999999999999864332
Q ss_pred CCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHh
Q 043702 534 KSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTA 613 (711)
Q Consensus 534 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 613 (711)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+...... .+.
T Consensus 178 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----------~~~~~~i~-~~~---- 240 (353)
T 3txo_A 178 G-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE-----------DDLFEAIL-NDE---- 240 (353)
T ss_dssp ---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHHHHHH-HCC----
T ss_pred C-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH-----------HHHHHHHH-cCC----
Confidence 2 233456799999999999998999999999999999999999999975421 11111111 111
Q ss_pred hhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCH------HHHHH
Q 043702 614 ADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTM------RGVVQ 653 (711)
Q Consensus 614 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~eVl~ 653 (711)
..++......+.+++.+||+.||.+||++ +|+++
T Consensus 241 ------~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 241 ------VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ------CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 01122233457788999999999999998 77775
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=363.50 Aligned_cols=260 Identities=28% Similarity=0.435 Sum_probs=210.0
Q ss_pred HHHHhcCCcccceeecCCceEEEEEEeCCCC-----eEEEEEEcccCC--CChhhhHHHHHHHHhc-CCCCeeeeeeeee
Q 043702 375 LRSATKCFNANRIIGHGAFGTVYKGILPQNG-----DIIAVKRCSHNS--QGKDEFLSELSIIGTL-RHRNLVRLQGWCH 446 (711)
Q Consensus 375 l~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~-----~~vavK~~~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~ 446 (711)
++...++|...+.||+|+||.||+|.+...+ ..||+|++.... ...+.+.+|+++++++ +||||++++++|.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 4445678999999999999999999986554 379999987643 2346789999999999 8999999999999
Q ss_pred ecCeEEEEEEcCCCCCHHHHHhhC-------------CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEE
Q 043702 447 EKGEILLVYDLMPNGSLDKALFEA-------------RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIML 513 (711)
Q Consensus 447 ~~~~~~lV~Ey~~~gsL~~~l~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl 513 (711)
..+..++||||+++|+|.+++... ...+++..++.++.||+.||+|||+. +|+||||||+|||+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEE
Confidence 999999999999999999999643 34689999999999999999999998 99999999999999
Q ss_pred cCCCcEEEeecCCceecCCCCCC-CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCcccccccccc
Q 043702 514 DEGFNARLGDFGLARQVEHDKSP-DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKV 591 (711)
Q Consensus 514 d~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~ 591 (711)
+.++.+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---- 273 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN---- 273 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS----
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh----
Confidence 99999999999999876543322 1223457889999999999999999999999999999999 99998653210
Q ss_pred ccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 592 GVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 592 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
..+ ......+ .....+......+.+++.+||+.||.+||++.||++.|+.
T Consensus 274 ---~~~----~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 323 (333)
T 2i1m_A 274 ---SKF----YKLVKDG---------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 323 (333)
T ss_dssp ---HHH----HHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---HHH----HHHHhcC---------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence 111 1111111 1111111223567789999999999999999999999975
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=364.27 Aligned_cols=254 Identities=20% Similarity=0.264 Sum_probs=198.0
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcC
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
.++|...+.||+|+||+||+++...+++.||||++.......+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 35789999999999999999999989999999999876666778999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCc--EEEeecCCceecCCCCCC
Q 043702 459 PNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFN--ARLGDFGLARQVEHDKSP 536 (711)
Q Consensus 459 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~--vkL~DFGla~~~~~~~~~ 536 (711)
++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++......
T Consensus 99 ~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~-- 172 (361)
T 3uc3_A 99 SGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 172 (361)
T ss_dssp CSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccC--
Confidence 99999999865 34699999999999999999999997 9999999999999987765 9999999998543222
Q ss_pred CcccccCCCcccChhhhccCCCCcc-ccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhh
Q 043702 537 DATVAAGTMGYLAPEYLLTGRATEK-TDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615 (711)
Q Consensus 537 ~~~~~~gt~~y~APE~~~~~~~s~k-sDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 615 (711)
......||+.|+|||++.+..+..+ +|||||||++|||++|+.||...... .............
T Consensus 173 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------~~~~~~~~~~~~~-------- 237 (361)
T 3uc3_A 173 QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-------RDYRKTIQRILSV-------- 237 (361)
T ss_dssp --------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C-------CCHHHHHHHHHTT--------
T ss_pred CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH-------HHHHHHHHHHhcC--------
Confidence 2233569999999999988887655 89999999999999999999754221 1111111111110
Q ss_pred hhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 616 ARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 616 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.............+.+++.+||+.||.+|||+.|+++.
T Consensus 238 -~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 238 -KYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp -CCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred -CCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 00000001123457789999999999999999999974
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=360.58 Aligned_cols=255 Identities=27% Similarity=0.481 Sum_probs=200.8
Q ss_pred cCCcccceeecCCceEEEEEEeCCCC----eEEEEEEcccCCC--ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNG----DIIAVKRCSHNSQ--GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILL 453 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~----~~vavK~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 453 (711)
++|...+.||+|+||.||+|.+..++ ..||+|++..... ....+.+|++++++++||||+++++++...+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 46777899999999999999885442 4699999876432 34568899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCC
Q 043702 454 VYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHD 533 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~ 533 (711)
||||+++|+|.+++......+++.+++.++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 200 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200 (333)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence 9999999999999988778899999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCC--CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCch
Q 043702 534 KSP--DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRL 610 (711)
Q Consensus 534 ~~~--~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 610 (711)
... ......+|+.|+|||.+....++.++|||||||++|||++ |+.||..... ..+. .....+
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--------~~~~----~~~~~~-- 266 (333)
T 1mqb_A 201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--------HEVM----KAINDG-- 266 (333)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHH----HHHHTT--
T ss_pred cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH--------HHHH----HHHHCC--
Confidence 221 1222346789999999999999999999999999999999 9999964321 1111 111111
Q ss_pred hHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 611 LTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 611 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
............+.+++.+||+.||.+||++.++++.|+..
T Consensus 267 -------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 267 -------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp -------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 01111122345677899999999999999999999998754
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=366.99 Aligned_cols=252 Identities=19% Similarity=0.271 Sum_probs=193.3
Q ss_pred cCCccc-ceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHh-cCCCCeeeeeeeeee----cCeEEE
Q 043702 380 KCFNAN-RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGT-LRHRNLVRLQGWCHE----KGEILL 453 (711)
Q Consensus 380 ~~f~~~-~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~----~~~~~l 453 (711)
++|... ++||+|+||+||+|.+..+++.||||++.. ...+.+|++++.+ .+||||+++++++.. .+.+++
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l 136 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 136 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence 345555 689999999999999998999999999863 3567889998754 579999999999875 567899
Q ss_pred EEEcCCCCCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcC---CCcEEEeecCCcee
Q 043702 454 VYDLMPNGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDE---GFNARLGDFGLARQ 529 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~---~~~vkL~DFGla~~ 529 (711)
|||||++|+|.+++.... ..+++..+..|+.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++.
T Consensus 137 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~ 213 (400)
T 1nxk_A 137 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213 (400)
T ss_dssp EEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccc
Confidence 999999999999997643 4699999999999999999999997 9999999999999987 78999999999987
Q ss_pred cCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCc
Q 043702 530 VEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGR 609 (711)
Q Consensus 530 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 609 (711)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ........ ...+.
T Consensus 214 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~~~~~~~----i~~~~ 283 (400)
T 1nxk_A 214 TTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA----ISPGMKTR----IRMGQ 283 (400)
T ss_dssp CC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCS----SCCSHHHH----HHHTC
T ss_pred cCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccc----ccHHHHHH----HHcCc
Confidence 65332 2344679999999999999999999999999999999999999997542210 00111111 11111
Q ss_pred hhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 610 LLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 610 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.. ............+.+++.+||+.||.+|||+.|+++.
T Consensus 284 ~~------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 284 YE------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp CC------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cc------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 10 0000001223457789999999999999999999984
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=357.83 Aligned_cols=244 Identities=21% Similarity=0.309 Sum_probs=206.1
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
++|+..+.||+|+||.||++++..+|+.||+|++... ....+.+.+|+++++.++||||+++++++.+.+.+++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 5788999999999999999999989999999998652 344567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
||+++|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp ECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC--
Confidence 999999999999753 4699999999999999999999998 9999999999999999999999999999876432
Q ss_pred CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhh
Q 043702 536 PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 615 (711)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+..... ..+..
T Consensus 195 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----------~~~~~~i-~~~~~----- 255 (350)
T 1rdq_E 195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-----------IQIYEKI-VSGKV----- 255 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHHHHH-HHCCC-----
T ss_pred --cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH-----------HHHHHHH-HcCCC-----
Confidence 2345799999999999999999999999999999999999999965321 1111111 11111
Q ss_pred hhccCCCcHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH
Q 043702 616 ARLEGQFDEAEMRRVLLVGLACSHPDPLARPT-----MRGVVQ 653 (711)
Q Consensus 616 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~eVl~ 653 (711)
.++......+.+++.+||+.||.+||+ ++++++
T Consensus 256 -----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 256 -----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -----CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 111222355778899999999999998 888876
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=354.36 Aligned_cols=251 Identities=27% Similarity=0.469 Sum_probs=196.9
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCC
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMP 459 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 459 (711)
++|+..+.||+|+||.||+|++ .++.||+|++... ...+.+.+|++++++++||||+++++++.+ ..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 4688899999999999999998 4789999998643 345789999999999999999999999874 4799999999
Q ss_pred CCCHHHHHhhCCC--CCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCc-EEEeecCCceecCCCCCC
Q 043702 460 NGSLDKALFEARS--PLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFN-ARLGDFGLARQVEHDKSP 536 (711)
Q Consensus 460 ~gsL~~~l~~~~~--~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~-vkL~DFGla~~~~~~~~~ 536 (711)
+|+|.+++..... .+++..++.++.|+++||+|||+....+|+||||||+|||++.++. +||+|||+++.....
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999975443 4789999999999999999999943349999999999999998887 799999999765432
Q ss_pred CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhh
Q 043702 537 DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADA 616 (711)
Q Consensus 537 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 616 (711)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ......+..... .
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---------~~~~~~~~~~~~-~------- 221 (307)
T 2eva_A 160 -MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGG---------PAFRIMWAVHNG-T------- 221 (307)
T ss_dssp ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCS---------SHHHHHHHHHTT-C-------
T ss_pred -cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCc---------cHHHHHHHHhcC-C-------
Confidence 2234699999999999999999999999999999999999999964321 111111111111 1
Q ss_pred hccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 617 RLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 617 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
...........+.+++.+||+.||.+|||++++++.|+..
T Consensus 222 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 261 (307)
T 2eva_A 222 --RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261 (307)
T ss_dssp --CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 0111112234577889999999999999999999999764
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=346.65 Aligned_cols=262 Identities=19% Similarity=0.242 Sum_probs=205.9
Q ss_pred HhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeee-eecCeEEEEEE
Q 043702 378 ATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWC-HEKGEILLVYD 456 (711)
Q Consensus 378 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~-~~~~~~~lV~E 456 (711)
..++|...+.||+|+||.||+|++..+++.||||++.... ..+++.+|+++++.++|++++..++++ ...+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 4578999999999999999999998899999999865433 345688999999999988877777766 56678899999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEE---cCCCcEEEeecCCceecCCC
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIML---DEGFNARLGDFGLARQVEHD 533 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl---d~~~~vkL~DFGla~~~~~~ 533 (711)
|+ +++|.+++......+++..++.++.||+.||+|||+. +|+||||||+|||+ ++++.+||+|||+++.....
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp CC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 99 9999999987777899999999999999999999998 99999999999999 78999999999999987554
Q ss_pred CCC------CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhc
Q 043702 534 KSP------DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHRE 607 (711)
Q Consensus 534 ~~~------~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~ 607 (711)
... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ....+.........
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~- 236 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT----KRQKYERISEKKMS- 236 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS----SSSHHHHHHHHHHH-
T ss_pred ccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhh----hhhhhhhhhccccc-
Confidence 331 2234579999999999999999999999999999999999999997543211 00111111100000
Q ss_pred CchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 608 GRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 608 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
.. .+.+...+ ...+.+++.+||+.||++||++++|++.|+..
T Consensus 237 ----~~-~~~~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 237 ----TP-IEVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp ----SC-HHHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred ----ch-hhhhhccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 00 00011111 34677899999999999999999999998754
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=363.05 Aligned_cols=251 Identities=20% Similarity=0.331 Sum_probs=206.2
Q ss_pred HHHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhc-CCCCeeeeeeeeeecCe
Q 043702 376 RSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTL-RHRNLVRLQGWCHEKGE 450 (711)
Q Consensus 376 ~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 450 (711)
....++|...+.||+|+||.||+|+++.+++.||+|++... ....+.+..|.+++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 34567899999999999999999999989999999998753 34556788999999987 89999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceec
Q 043702 451 ILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV 530 (711)
Q Consensus 451 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~ 530 (711)
+++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 9999999999999999965 34699999999999999999999998 9999999999999999999999999999864
Q ss_pred CCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCch
Q 043702 531 EHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRL 610 (711)
Q Consensus 531 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 610 (711)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+..... ..+.
T Consensus 169 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----------~~~~~~i-~~~~- 234 (345)
T 1xjd_A 169 MLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-----------EELFHSI-RMDN- 234 (345)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHHHHH-HHCC-
T ss_pred ccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH-----------HHHHHHH-HhCC-
Confidence 3322 224456899999999999999999999999999999999999999965321 1111111 1111
Q ss_pred hHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHH-HHHH
Q 043702 611 LTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMR-GVVQ 653 (711)
Q Consensus 611 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-eVl~ 653 (711)
+ .++......+.+++.+||+.||.+||++. ++++
T Consensus 235 -----~----~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 235 -----P----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp -----C----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -----C----CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 1 11112234577888999999999999997 7653
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=350.47 Aligned_cols=254 Identities=24% Similarity=0.407 Sum_probs=206.7
Q ss_pred cCCcccc-eeecCCceEEEEEEeC--CCCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEE
Q 043702 380 KCFNANR-IIGHGAFGTVYKGILP--QNGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLV 454 (711)
Q Consensus 380 ~~f~~~~-~LG~G~fg~Vy~~~~~--~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 454 (711)
++|...+ .||+|+||.||+|.+. .++..||+|++.... ...+.+.+|++++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4555665 8999999999999863 457889999987643 2356789999999999999999999999 55679999
Q ss_pred EEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCC
Q 043702 455 YDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~ 534 (711)
|||+++++|.+++......+++..+.+++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 164 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164 (287)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence 999999999999987777899999999999999999999998 99999999999999999999999999998775433
Q ss_pred CC--CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchh
Q 043702 535 SP--DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLL 611 (711)
Q Consensus 535 ~~--~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 611 (711)
.. ......||+.|+|||.+....++.++|||||||++|||++ |+.||..... ..+.. ....+.
T Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~~~~----~i~~~~-- 230 (287)
T 1u59_A 165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------PEVMA----FIEQGK-- 230 (287)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--------HHHHH----HHHTTC--
T ss_pred ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH--------HHHHH----HHhcCC--
Confidence 21 1223457889999999998899999999999999999998 9999965321 11111 111111
Q ss_pred HhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 612 TAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 612 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
....+......+.+++.+||+.||.+||++.++++.|+..
T Consensus 231 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 231 -------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp -------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1112223345678899999999999999999999998754
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=365.22 Aligned_cols=247 Identities=23% Similarity=0.281 Sum_probs=199.1
Q ss_pred ccceeecCCceEEEEEEeCCCCeEEEEEEcccCC-CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCCCCC
Q 043702 384 ANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGS 462 (711)
Q Consensus 384 ~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 462 (711)
..+.||+|+||.||+|....+|+.||+|++.... ...+++.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 3568999999999999998899999999987643 345689999999999999999999999999999999999999999
Q ss_pred HHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEE--cCCCcEEEeecCCceecCCCCCCCccc
Q 043702 463 LDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIML--DEGFNARLGDFGLARQVEHDKSPDATV 540 (711)
Q Consensus 463 L~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl--d~~~~vkL~DFGla~~~~~~~~~~~~~ 540 (711)
|.+++......+++..+..++.||++||+|||+. +|+||||||+|||+ +.++.+||+|||+++....... ...
T Consensus 173 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~~ 247 (373)
T 2x4f_A 173 LFDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKV 247 (373)
T ss_dssp EHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CCC
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--ccc
Confidence 9999987777799999999999999999999998 99999999999999 6778999999999998754332 233
Q ss_pred ccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccC
Q 043702 541 AAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEG 620 (711)
Q Consensus 541 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 620 (711)
..||+.|+|||++....++.++|||||||++|||++|+.||..... .+.......... .+..
T Consensus 248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-----------~~~~~~i~~~~~-------~~~~ 309 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND-----------AETLNNILACRW-------DLED 309 (373)
T ss_dssp CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH-----------HHHHHHHHHTCC-------CSCS
T ss_pred ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----------HHHHHHHHhccC-------CCCh
Confidence 4699999999999988999999999999999999999999965321 111111111100 0000
Q ss_pred CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 621 QFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
.........+.+++.+||+.||.+||++.|+++
T Consensus 310 ~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 310 EEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000112346778999999999999999999997
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=371.07 Aligned_cols=254 Identities=24% Similarity=0.310 Sum_probs=206.3
Q ss_pred HhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC---ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEE
Q 043702 378 ATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ---GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLV 454 (711)
Q Consensus 378 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 454 (711)
..++|+..+.||+|+||.||+|.+..+|+.+|+|++..... ..+.+.+|++++++++||||+++++++.+++..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 45679999999999999999999999999999999876432 345688999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEc---CCCcEEEeecCCceecC
Q 043702 455 YDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLD---EGFNARLGDFGLARQVE 531 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld---~~~~vkL~DFGla~~~~ 531 (711)
|||+++|+|.+++... ..+++..+..++.||++||.|||+. +|+||||||+|||++ .++.+||+|||+++...
T Consensus 89 ~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 89 FDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp ECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 9999999999998754 5699999999999999999999998 999999999999998 56789999999998765
Q ss_pred CCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchh
Q 043702 532 HDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLL 611 (711)
Q Consensus 532 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 611 (711)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+ ......+...
T Consensus 165 ~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~--------~~~----~~~i~~~~~~ 231 (444)
T 3soa_A 165 GEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ--------HRL----YQQIKAGAYD 231 (444)
T ss_dssp TTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHH----HHHHHHTCCC
T ss_pred CCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH--------HHH----HHHHHhCCCC
Confidence 4332 23346799999999999999999999999999999999999999965321 111 1111111110
Q ss_pred HhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 612 TAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 612 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
............+.+++.+||+.||.+|||+.|+++.
T Consensus 232 ------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 232 ------FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp ------CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ------CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0000001223457788999999999999999999984
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=360.66 Aligned_cols=253 Identities=23% Similarity=0.315 Sum_probs=191.7
Q ss_pred HhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEc
Q 043702 378 ATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 378 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
..+.|+..+.||+|+||.||+|++..+++.||||++.... ..+.+.+|++++++++||||+++++++...+..++||||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 3467899999999999999999999889999999987543 356788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcC---CCcEEEeecCCceecCCCC
Q 043702 458 MPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDE---GFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 458 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~---~~~vkL~DFGla~~~~~~~ 534 (711)
+++|+|.+++.. ...+++.++..++.||++||.|||+. +|+||||||+|||++. ++.+||+|||+++......
T Consensus 130 ~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 205 (349)
T 2w4o_A 130 VTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV 205 (349)
T ss_dssp CCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred CCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence 999999999864 45699999999999999999999998 9999999999999975 8899999999998764432
Q ss_pred CCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhh
Q 043702 535 SPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614 (711)
Q Consensus 535 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 614 (711)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +........+...
T Consensus 206 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----------~~~~~~i~~~~~~--- 269 (349)
T 2w4o_A 206 --LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD-----------QFMFRRILNCEYY--- 269 (349)
T ss_dssp ---------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH-----------HHHHHHHHTTCCC---
T ss_pred --ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc-----------HHHHHHHHhCCCc---
Confidence 223457999999999999999999999999999999999999999653210 1111111111100
Q ss_pred hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 615 DARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 615 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.......+....+.+++.+||+.||++|||+.|+++.
T Consensus 270 ---~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 270 ---FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp ---CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0001111233567789999999999999999999984
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=361.06 Aligned_cols=246 Identities=22% Similarity=0.320 Sum_probs=203.7
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEccc----CCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSH----NSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
++|...+.||+|+||.||+|.+..+++.||+|++.. .......+.+|+++++.++||||+++++++...+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 578999999999999999999988999999999864 2334567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
||+ +|+|.+++... ..+++.++..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 89 E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~ 163 (336)
T 3h4j_B 89 EYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF 163 (336)
T ss_dssp CCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT
T ss_pred ECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc
Confidence 999 78999988653 5699999999999999999999998 999999999999999999999999999987654332
Q ss_pred CCcccccCCCcccChhhhccCCC-CccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhh
Q 043702 536 PDATVAAGTMGYLAPEYLLTGRA-TEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 614 (711)
....+||+.|+|||.+.+..+ +.++|||||||++|||++|+.||......... .. ...+.
T Consensus 164 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~----~~--------i~~~~----- 224 (336)
T 3h4j_B 164 --LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF----KK--------VNSCV----- 224 (336)
T ss_dssp --TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB----CC--------CCSSC-----
T ss_pred --cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH----HH--------HHcCC-----
Confidence 234579999999999987776 78999999999999999999999754221000 00 00000
Q ss_pred hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 615 DARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 615 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
...+......+.+++.+||+.||.+|||++|+++.
T Consensus 225 -----~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 225 -----YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp -----CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred -----CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 01111123456788999999999999999999973
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=356.66 Aligned_cols=261 Identities=23% Similarity=0.284 Sum_probs=205.4
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC-CChhhhHHHHHHHHhcCCCCeeeeeeeeee----cCeEEE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCHE----KGEILL 453 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~l 453 (711)
.++|...+.||+|+||.||+++...+++.||+|++.... ...+.+.+|+++++.++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 357889999999999999999998899999999886533 345678999999999999999999999873 347899
Q ss_pred EEEcCCCCCHHHHHhh---CCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceec
Q 043702 454 VYDLMPNGSLDKALFE---ARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV 530 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~ 530 (711)
||||+++|+|.+++.. ....+++..++.++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 9999999999999875 456799999999999999999999998 9999999999999999999999999998865
Q ss_pred CCCCCC--------CcccccCCCcccChhhhccCC---CCccccchhHHHHHHHHHhCCCCCccccccccccccccchHH
Q 043702 531 EHDKSP--------DATVAAGTMGYLAPEYLLTGR---ATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVE 599 (711)
Q Consensus 531 ~~~~~~--------~~~~~~gt~~y~APE~~~~~~---~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~ 599 (711)
...... ......||+.|+|||.+.... ++.++|||||||++|||++|+.||....... ..+..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~ 258 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG------DSVAL 258 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT------SCHHH
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc------chhhH
Confidence 321111 012245799999999987554 6889999999999999999999996432110 01111
Q ss_pred HHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCC
Q 043702 600 WVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEAEV 661 (711)
Q Consensus 600 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 661 (711)
.. .. .............+.+++.+||+.||.+||+++++++.|+...+.
T Consensus 259 ~~----~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 259 AV----QN---------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp HH----HC---------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred Hh----hc---------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 00 00 010011112235678899999999999999999999999876543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=361.19 Aligned_cols=266 Identities=25% Similarity=0.428 Sum_probs=214.0
Q ss_pred cCHHHHHHHhcCCcccceeecCCceEEEEEEeC-----CCCeEEEEEEcccCCC--ChhhhHHHHHHHHhcCCCCeeeee
Q 043702 370 FSYRELRSATKCFNANRIIGHGAFGTVYKGILP-----QNGDIIAVKRCSHNSQ--GKDEFLSELSIIGTLRHRNLVRLQ 442 (711)
Q Consensus 370 ~~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~ 442 (711)
+...+++...++|...+.||+|+||.||+|++. ..++.||+|++..... ....+.+|++++++++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 344455566788999999999999999999875 2467899999875432 345688999999999999999999
Q ss_pred eeeeecCeEEEEEEcCCCCCHHHHHhhCC---------CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEE
Q 043702 443 GWCHEKGEILLVYDLMPNGSLDKALFEAR---------SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIML 513 (711)
Q Consensus 443 g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl 513 (711)
+++.+.+..++||||+++|+|.+++.... ..+++..+++++.||+.||+|||+. +|+||||||+|||+
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEE
Confidence 99999999999999999999999986422 4579999999999999999999998 99999999999999
Q ss_pred cCCCcEEEeecCCceecCCCCCC-CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCcccccccccc
Q 043702 514 DEGFNARLGDFGLARQVEHDKSP-DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKV 591 (711)
Q Consensus 514 d~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~ 591 (711)
+.++.+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||++ |+.||.....
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----- 246 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN----- 246 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-----
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH-----
Confidence 99999999999999866433221 2223457889999999999999999999999999999999 8999865321
Q ss_pred ccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC
Q 043702 592 GVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEA 659 (711)
Q Consensus 592 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~ 659 (711)
.+.. .....+.. ..........+.+++.+||+.||.+||++.|+++.|+...
T Consensus 247 ------~~~~-~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 247 ------EQVL-RFVMEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp ------HHHH-HHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred ------HHHH-HHHHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 1111 11111111 0111223355778999999999999999999999998753
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=363.79 Aligned_cols=249 Identities=26% Similarity=0.364 Sum_probs=205.8
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEccc----CCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSH----NSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
++|...+.||+|+||.||++....+++.||+|++.. .....+.+.+|+++++.++||||+++++++...+.+++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 568899999999999999999999999999999864 2345678899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
||+++|+|..++.. ...+++..+..++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++.+....
T Consensus 95 e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~- 169 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET- 169 (384)
T ss_dssp CCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC-
T ss_pred ecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCCC-
Confidence 99999999999964 45699999999999999999999998 99999999999999999999999999998765432
Q ss_pred CCcccccCCCcccChhhhcc---CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhH
Q 043702 536 PDATVAAGTMGYLAPEYLLT---GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLT 612 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~---~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 612 (711)
.....+||+.|+|||++.. ..++.++|||||||++|||++|+.||..... ....+...... ..
T Consensus 170 -~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~--------~~~~~~~~~~~-~~---- 235 (384)
T 4fr4_A 170 -QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS--------TSSKEIVHTFE-TT---- 235 (384)
T ss_dssp -CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTT--------SCHHHHHHHHH-HC----
T ss_pred -ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCC--------ccHHHHHHHHh-hc----
Confidence 3345679999999999974 4589999999999999999999999964321 11111111110 00
Q ss_pred hhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCC-HHHHHH
Q 043702 613 AADARLEGQFDEAEMRRVLLVGLACSHPDPLARPT-MRGVVQ 653 (711)
Q Consensus 613 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~eVl~ 653 (711)
...++......+.+++.+||+.||.+||+ +++|++
T Consensus 236 ------~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 236 ------VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ------ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 01122223356788999999999999998 777765
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=385.94 Aligned_cols=254 Identities=27% Similarity=0.425 Sum_probs=209.0
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcC
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
.++|...++||+|+||.||+|.+.. +..||||++.......++|.+|+++|++++||||++++++|.+ +..++|||||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 4568889999999999999999964 5779999998766667889999999999999999999999976 6789999999
Q ss_pred CCCCHHHHHhhC-CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC
Q 043702 459 PNGSLDKALFEA-RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD 537 (711)
Q Consensus 459 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 537 (711)
++|+|.++|... ...+++.++++|+.||++||+|||+. +|+||||||+||||++++.+||+|||+++.........
T Consensus 344 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 420 (535)
T 2h8h_A 344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 420 (535)
T ss_dssp TTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHT
T ss_pred cCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceec
Confidence 999999999653 34699999999999999999999998 99999999999999999999999999998664322111
Q ss_pred cccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhhhh
Q 043702 538 ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADA 616 (711)
Q Consensus 538 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 616 (711)
.....++..|+|||++..+.++.++|||||||+||||++ |+.||..... ..+.+ ....+
T Consensus 421 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~--------~~~~~----~i~~~-------- 480 (535)
T 2h8h_A 421 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLD----QVERG-------- 480 (535)
T ss_dssp TCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH--------HHHHH----HHHTT--------
T ss_pred ccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHH----HHHcC--------
Confidence 223346789999999999999999999999999999999 9999965321 11111 11111
Q ss_pred hccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 617 RLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 617 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
............+.+|+.+||+.||++||++++|+++|+..
T Consensus 481 -~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~ 521 (535)
T 2h8h_A 481 -YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521 (535)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11111223345678899999999999999999999999875
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=359.83 Aligned_cols=247 Identities=29% Similarity=0.425 Sum_probs=203.4
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCC----hhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQG----KDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
+.|...+.||+|+||.||+|+...+++.||||++...... .+++.+|++++++++||||+++++++..++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588889999999999999999889999999998754322 356889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
||++ |+|.+++......+++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 207 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence 9997 689888876677899999999999999999999998 9999999999999999999999999999865432
Q ss_pred CCcccccCCCcccChhhhc---cCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhH
Q 043702 536 PDATVAAGTMGYLAPEYLL---TGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLT 612 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~---~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 612 (711)
....||+.|+|||++. .+.++.++|||||||++|||++|+.||..... .+..........
T Consensus 208 ---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~-----------~~~~~~~~~~~~--- 270 (348)
T 1u5q_A 208 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----------MSALYHIAQNES--- 270 (348)
T ss_dssp ---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----------HHHHHHHHHSCC---
T ss_pred ---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-----------HHHHHHHHhcCC---
Confidence 2356999999999985 56789999999999999999999999864321 111222211110
Q ss_pred hhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 043702 613 AADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655 (711)
Q Consensus 613 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L 655 (711)
+... .......+.+++.+||+.||.+|||++++++..
T Consensus 271 ---~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 271 ---PALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp ---CCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred ---CCCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 1111 111234567888999999999999999999743
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=386.20 Aligned_cols=252 Identities=23% Similarity=0.405 Sum_probs=202.0
Q ss_pred CCcccc-eeecCCceEEEEEEeC--CCCeEEEEEEcccC--CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 381 CFNANR-IIGHGAFGTVYKGILP--QNGDIIAVKRCSHN--SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 381 ~f~~~~-~LG~G~fg~Vy~~~~~--~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
++...+ .||+|+||.||+|.+. .++..||||++... ....+++.+|+++|++++||||++++++|.. +.+++||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 344444 7999999999999875 34567999999763 3456789999999999999999999999976 5699999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
|||++|+|.+++......+++..+..++.||+.||+|||+. +|+||||||+||||++++.+||+|||+++.+.....
T Consensus 415 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~ 491 (613)
T 2ozo_A 415 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491 (613)
T ss_dssp ECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred EeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence 99999999999987777899999999999999999999998 999999999999999999999999999987654332
Q ss_pred CC--cccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhH
Q 043702 536 PD--ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLT 612 (711)
Q Consensus 536 ~~--~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 612 (711)
.. .....+++.|+|||++..+.++.++|||||||+||||++ |+.||..... ..+.+ .+..+.
T Consensus 492 ~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--------~~~~~----~i~~~~--- 556 (613)
T 2ozo_A 492 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------PEVMA----FIEQGK--- 556 (613)
T ss_dssp ----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS--------HHHHH----HHHTTC---
T ss_pred eeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH--------HHHHH----HHHcCC---
Confidence 21 122346789999999999999999999999999999998 9999975422 11111 111111
Q ss_pred hhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 613 AADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 613 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
....+......+.+++.+||+.||.+||++.+|++.|+.
T Consensus 557 ------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 595 (613)
T 2ozo_A 557 ------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 595 (613)
T ss_dssp ------CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred ------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 112223344668889999999999999999999999875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=358.11 Aligned_cols=256 Identities=24% Similarity=0.420 Sum_probs=207.0
Q ss_pred hcCCcccceeecCCceEEEEEEeC-------CCCeEEEEEEcccCCC--ChhhhHHHHHHHHhc-CCCCeeeeeeeeeec
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILP-------QNGDIIAVKRCSHNSQ--GKDEFLSELSIIGTL-RHRNLVRLQGWCHEK 448 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~-------~~~~~vavK~~~~~~~--~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 448 (711)
.++|...+.||+|+||.||+|.+. .++..||+|++..... ..+.+.+|+++++++ +||||++++++|...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 467899999999999999999975 3567899999876432 345788999999999 899999999999999
Q ss_pred CeEEEEEEcCCCCCHHHHHhhCC---------------CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEE
Q 043702 449 GEILLVYDLMPNGSLDKALFEAR---------------SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIML 513 (711)
Q Consensus 449 ~~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl 513 (711)
+..++||||+++|+|.+++.... ..+++..+++++.||++||.|||+. +|+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence 99999999999999999997643 2489999999999999999999998 99999999999999
Q ss_pred cCCCcEEEeecCCceecCCCCCC-CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCcccccccccc
Q 043702 514 DEGFNARLGDFGLARQVEHDKSP-DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKV 591 (711)
Q Consensus 514 d~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~ 591 (711)
+.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----- 265 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV----- 265 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH-----
Confidence 99999999999999876543321 2233457889999999999899999999999999999999 9999865321
Q ss_pred ccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 592 GVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 592 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
.+.. .....+. ...........+.+++.+||+.||.+||++.|+++.|+..
T Consensus 266 ------~~~~-~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 266 ------EELF-KLLKEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp ------HHHH-HHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------HHHH-HHHhcCC---------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1111 1111111 1111222335677889999999999999999999998764
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=346.15 Aligned_cols=261 Identities=20% Similarity=0.243 Sum_probs=208.8
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeee-eecCeEEEEEEc
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWC-HEKGEILLVYDL 457 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~-~~~~~~~lV~Ey 457 (711)
.++|...+.||+|+||.||+|++..+++.||+|++.... ..+++.+|+++++.++|++++..++++ ...+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEe
Confidence 468999999999999999999998899999999986543 345789999999999998877766666 556788999999
Q ss_pred CCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEE---cCCCcEEEeecCCceecCCCC
Q 043702 458 MPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIML---DEGFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 458 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl---d~~~~vkL~DFGla~~~~~~~ 534 (711)
+ +++|.+++......+++..++.++.|++.||+|||+. +|+||||||+|||+ ++++.+||+|||+++......
T Consensus 87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 87 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred c-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 9 9999999987777899999999999999999999998 99999999999999 588899999999999876543
Q ss_pred CC------CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcC
Q 043702 535 SP------DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREG 608 (711)
Q Consensus 535 ~~------~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 608 (711)
.. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ....+.........
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~-- 236 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT----KRQKYERISEKKMS-- 236 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS----SSSHHHHHHHHHHH--
T ss_pred cccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchh----hhhhhhhhcccccC--
Confidence 31 1234579999999999999999999999999999999999999997542210 00111111110000
Q ss_pred chhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 609 RLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 609 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
. ..+.+...+ ...+.+++.+||+.||.+||++.+|++.|+..
T Consensus 237 ---~-~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 237 ---T-PIEVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp ---S-CHHHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred ---C-chHHHHhhC----CHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 0 000111122 24577899999999999999999999999754
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=352.11 Aligned_cols=263 Identities=24% Similarity=0.306 Sum_probs=201.6
Q ss_pred HhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC------CChhhhHHHHHHHHhcC---CCCeeeeeeeeeec
Q 043702 378 ATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS------QGKDEFLSELSIIGTLR---HRNLVRLQGWCHEK 448 (711)
Q Consensus 378 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~ 448 (711)
.+++|+..++||+|+||+||+|++..+++.||+|++.... .....+.+|++++++++ ||||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4578999999999999999999998899999999987422 22346778888887775 99999999999875
Q ss_pred C-----eEEEEEEcCCCCCHHHHHhhCCC-CCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEe
Q 043702 449 G-----EILLVYDLMPNGSLDKALFEARS-PLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLG 522 (711)
Q Consensus 449 ~-----~~~lV~Ey~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~ 522 (711)
. ..++||||+. ++|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEe
Confidence 5 5899999997 599999976543 499999999999999999999998 99999999999999999999999
Q ss_pred ecCCceecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHH
Q 043702 523 DFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVW 602 (711)
Q Consensus 523 DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~ 602 (711)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.
T Consensus 163 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--------~~~~~i~ 232 (308)
T 3g33_A 163 DFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA--------DQLGKIF 232 (308)
T ss_dssp SCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH--------HHHHHHH
T ss_pred eCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHH
Confidence 999998664332 234567999999999999999999999999999999999999999654221 1111111
Q ss_pred HhhhcCchhHh------hhhhcc-------CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 603 SLHREGRLLTA------ADARLE-------GQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 603 ~~~~~~~~~~~------~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
........... ...... .....+....+.+++.+||+.||.+|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 233 DLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp HHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 11000000000 000000 00001123567789999999999999999999874
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=346.60 Aligned_cols=250 Identities=21% Similarity=0.365 Sum_probs=187.0
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLV 454 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 454 (711)
.++|...+.||+|+||.||+|+...+++.||+|++... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35788999999999999999999888999999998642 23346789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCC
Q 043702 455 YDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~ 534 (711)
|||+++++|.+++......+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 999999999999987767899999999999999999999998 99999999999999999999999999998765332
Q ss_pred CCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhh
Q 043702 535 SPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614 (711)
Q Consensus 535 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 614 (711)
. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ....... .
T Consensus 167 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----------~~~~~~~-~------ 227 (278)
T 3cok_A 167 E-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN-----------TLNKVVL-A------ 227 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------------CCS-S------
T ss_pred C-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH-----------HHHHHhh-c------
Confidence 2 2233568999999999998889999999999999999999999997542210 0000000 0
Q ss_pred hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 615 DARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 615 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
+... +......+.+++.+||+.||.+||+++++++.
T Consensus 228 ~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 228 DYEM----PSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp CCCC----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccCC----ccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 0011 11123456788999999999999999999873
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=347.71 Aligned_cols=250 Identities=22% Similarity=0.310 Sum_probs=202.1
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC---ChhhhHHHHHHHHhcCCCCeeeeeeeeeec--CeEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ---GKDEFLSELSIIGTLRHRNLVRLQGWCHEK--GEILLV 454 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV 454 (711)
++|...+.||+|+||.||+|++ .++.||+|++..... ..+.+.+|+.++++++||||+++++++... +..++|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 4688899999999999999999 488999999876432 245789999999999999999999999876 788999
Q ss_pred EEcCCCCCHHHHHhhCCC-CCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCC
Q 043702 455 YDLMPNGSLDKALFEARS-PLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHD 533 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~ 533 (711)
|||+++|+|.+++..... .+++..++.++.|++.||+|||+. +..|+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~- 165 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS- 165 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS-SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC-CCceecCCCccceEEEcCCcceeEEeccceeeecc-
Confidence 999999999999976544 599999999999999999999987 12299999999999999999999999998764322
Q ss_pred CCCCcccccCCCcccChhhhccCCCCc---cccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCch
Q 043702 534 KSPDATVAAGTMGYLAPEYLLTGRATE---KTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRL 610 (711)
Q Consensus 534 ~~~~~~~~~gt~~y~APE~~~~~~~s~---ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 610 (711)
....||+.|+|||.+.+..++. ++|||||||++|||++|+.||..... .+........+
T Consensus 166 -----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----------~~~~~~~~~~~-- 227 (271)
T 3kmu_A 166 -----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN-----------MEIGMKVALEG-- 227 (271)
T ss_dssp -----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH-----------HHHHHHHHHSC--
T ss_pred -----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh-----------HHHHHHHHhcC--
Confidence 2346899999999998765444 79999999999999999999965321 11111111111
Q ss_pred hHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 611 LTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 611 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
.....+......+.+++.+||+.||.+|||++++++.|+..
T Consensus 228 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 228 -------LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 11112222345677889999999999999999999999754
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=363.51 Aligned_cols=203 Identities=23% Similarity=0.318 Sum_probs=178.2
Q ss_pred hcCCcccceeecC--CceEEEEEEeCCCCeEEEEEEcccCCC---ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEE
Q 043702 379 TKCFNANRIIGHG--AFGTVYKGILPQNGDIIAVKRCSHNSQ---GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILL 453 (711)
Q Consensus 379 t~~f~~~~~LG~G--~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 453 (711)
.++|+..++||+| +||+||+|++..+++.||||++..... ..+.+.+|++++++++||||+++++++..++..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3578999999999 999999999998999999999876432 23567889999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhC-CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCC
Q 043702 454 VYDLMPNGSLDKALFEA-RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEH 532 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~ 532 (711)
|||||++|+|.+++... ...+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||++.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 99999999999999764 35699999999999999999999998 999999999999999999999999999875432
Q ss_pred CC------CCCcccccCCCcccChhhhcc--CCCCccccchhHHHHHHHHHhCCCCCccc
Q 043702 533 DK------SPDATVAAGTMGYLAPEYLLT--GRATEKTDVFSYGAVVLEVASGRRPIEKE 584 (711)
Q Consensus 533 ~~------~~~~~~~~gt~~y~APE~~~~--~~~s~ksDVwSfGvll~elltG~~P~~~~ 584 (711)
.. ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 240 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence 21 111223468999999999987 57899999999999999999999999754
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=357.45 Aligned_cols=263 Identities=23% Similarity=0.342 Sum_probs=187.7
Q ss_pred cceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcC-CCCeeeeeeeeeecCeEEEEEEcCCCCCH
Q 043702 385 NRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLR-HRNLVRLQGWCHEKGEILLVYDLMPNGSL 463 (711)
Q Consensus 385 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 463 (711)
.+.||+|+||.||+|.+..+++.||||++... ....+.+|+.+++.++ ||||+++++++.+++..++||||+++|+|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 37899999999999999989999999998643 3567889999999998 99999999999999999999999999999
Q ss_pred HHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCC---cEEEeecCCceecCCCCCCCccc
Q 043702 464 DKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGF---NARLGDFGLARQVEHDKSPDATV 540 (711)
Q Consensus 464 ~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~---~vkL~DFGla~~~~~~~~~~~~~ 540 (711)
.+++.. ...+++.++..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+++....... ....
T Consensus 94 ~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~ 168 (325)
T 3kn6_A 94 FERIKK-KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PLKT 168 (325)
T ss_dssp HHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--------
T ss_pred HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-cccc
Confidence 999976 45799999999999999999999998 999999999999997665 899999999987654332 2334
Q ss_pred ccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccC
Q 043702 541 AAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEG 620 (711)
Q Consensus 541 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 620 (711)
.+||+.|+|||++.+..++.++|||||||++|||++|+.||........ .....+.. .....+... ...
T Consensus 169 ~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----~~~~~~~~-~~i~~~~~~------~~~ 237 (325)
T 3kn6_A 169 PCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT----CTSAVEIM-KKIKKGDFS------FEG 237 (325)
T ss_dssp ---------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-----------CCCHHHHH-HHHTTTCCC------CCS
T ss_pred cCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc----cccHHHHH-HHHHcCCCC------CCc
Confidence 5689999999999999999999999999999999999999976432110 01111111 111111110 000
Q ss_pred CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--HHhCCCCCCCCC
Q 043702 621 QFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ--MLVGEAEVPIVP 665 (711)
Q Consensus 621 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~--~L~~~~~~p~~p 665 (711)
.........+.+++.+||+.||.+|||++|+++ ++++....+..|
T Consensus 238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~~~~~ 284 (325)
T 3kn6_A 238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNP 284 (325)
T ss_dssp HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCCCCSC
T ss_pred ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccCCCCC
Confidence 000122356788999999999999999999986 444444443333
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=356.13 Aligned_cols=253 Identities=28% Similarity=0.425 Sum_probs=203.6
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEE--EEEEccc--CCCChhhhHHHHHHHHhc-CCCCeeeeeeeeeecCeEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDII--AVKRCSH--NSQGKDEFLSELSIIGTL-RHRNLVRLQGWCHEKGEILLV 454 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~v--avK~~~~--~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 454 (711)
++|...+.||+|+||.||+|++..++..+ |+|++.. .....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57888999999999999999998778755 9998875 334456799999999999 899999999999999999999
Q ss_pred EEcCCCCCHHHHHhhCC---------------CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcE
Q 043702 455 YDLMPNGSLDKALFEAR---------------SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNA 519 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~v 519 (711)
|||+++|+|.+++.... ..+++.+++.++.||++||+|||+. +|+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 99999999999997543 4699999999999999999999998 99999999999999999999
Q ss_pred EEeecCCceecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchH
Q 043702 520 RLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLV 598 (711)
Q Consensus 520 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~ 598 (711)
||+|||+++...... ......+++.|+|||.+....++.++|||||||++|||++ |+.||..... .
T Consensus 182 kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-----------~ 248 (327)
T 1fvr_A 182 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----------A 248 (327)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----------H
T ss_pred EEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH-----------H
Confidence 999999997543221 2233457889999999998889999999999999999998 9999965321 1
Q ss_pred HHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 599 EWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 599 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
+.... ...+ ............+.+++.+||+.||.+||++.|+++.|+..
T Consensus 249 ~~~~~-~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 298 (327)
T 1fvr_A 249 ELYEK-LPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298 (327)
T ss_dssp HHHHH-GGGT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHH-hhcC---------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11111 1111 11111122235677899999999999999999999988753
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=370.87 Aligned_cols=247 Identities=24% Similarity=0.302 Sum_probs=195.6
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEccc----CCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSH----NSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
++|+..++||+|+||.||+|....+++.||||++.. .......+.+|+++++.++||||++++++|...+.+++||
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 227 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence 468889999999999999999999999999999874 2344567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHh-ccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQ-ECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~ 534 (711)
||+++|+|..++.. ...+++..+..++.||+.||+|||+ . +|+||||||+||||+.++.+||+|||+++......
T Consensus 228 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 303 (446)
T 4ejn_A 228 EYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 303 (446)
T ss_dssp CCCSSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred eeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence 99999999999865 3479999999999999999999998 6 99999999999999999999999999998643322
Q ss_pred CCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhh
Q 043702 535 SPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614 (711)
Q Consensus 535 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 614 (711)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.+ .... +.
T Consensus 304 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~---~i~~-~~----- 365 (446)
T 4ejn_A 304 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFE---LILM-EE----- 365 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHH---HHHH-CC-----
T ss_pred -cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--------HHHHH---HHHh-CC-----
Confidence 223446799999999999999999999999999999999999999965321 11111 1111 00
Q ss_pred hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 043702 615 DARLEGQFDEAEMRRVLLVGLACSHPDPLARP-----TMRGVVQ 653 (711)
Q Consensus 615 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVl~ 653 (711)
. .++......+.+++.+||+.||.+|| +++|+++
T Consensus 366 -~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 366 -I----RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp -C----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -C----CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 0 11122234577889999999999999 9999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=350.93 Aligned_cols=258 Identities=24% Similarity=0.393 Sum_probs=194.9
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC---ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ---GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
.++|...++||+|+||.||+|++. ..||+|++..... ..+.+.+|++++++++||||+++++++. .+..++||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~lv~ 98 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVT 98 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEEEE
Confidence 357899999999999999999874 3599999876433 2457889999999999999999999764 45689999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCC-
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK- 534 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~- 534 (711)
||+++++|.+++......+++..+++++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 99 QWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred EecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccccc
Confidence 99999999999987777899999999999999999999998 99999999999999999999999999998654322
Q ss_pred CCCcccccCCCcccChhhhc---cCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchh
Q 043702 535 SPDATVAAGTMGYLAPEYLL---TGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLL 611 (711)
Q Consensus 535 ~~~~~~~~gt~~y~APE~~~---~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 611 (711)
........||+.|+|||.+. ...++.++|||||||++|||++|+.||...... ..+ ......+...
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~----~~~~~~~~~~ 244 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-------DQI----IEMVGRGSLS 244 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH-------HHH----HHHHHHTSCC
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH-------HHH----HHHhcccccC
Confidence 22233456999999999986 567888999999999999999999999653210 111 1111111111
Q ss_pred HhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC
Q 043702 612 TAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEA 659 (711)
Q Consensus 612 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~ 659 (711)
... ..........+.+++.+||+.||.+||++.++++.|+...
T Consensus 245 ~~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 245 PDL-----SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CCT-----TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cch-----hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 100 1112223456888999999999999999999999998754
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=346.04 Aligned_cols=247 Identities=27% Similarity=0.425 Sum_probs=202.7
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLV 454 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 454 (711)
.++|...+.||+|+||.||+|.+..++..||+|++... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 46789999999999999999999989999999998642 23356788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCC
Q 043702 455 YDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~ 534 (711)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 88 ~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~ 163 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163 (279)
T ss_dssp ECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence 9999999999998653 5699999999999999999999987 99999999999999999999999999986543322
Q ss_pred CCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhh
Q 043702 535 SPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614 (711)
Q Consensus 535 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 614 (711)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||..... .+..... ..
T Consensus 164 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----------~~~~~~~-~~------- 221 (279)
T 3fdn_A 164 ---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-----------QETYKRI-SR------- 221 (279)
T ss_dssp -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----------HHHHHHH-HH-------
T ss_pred ---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH-----------HHHHHHH-Hh-------
Confidence 2345689999999999999999999999999999999999999965321 1111111 10
Q ss_pred hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 615 DARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 615 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
....++......+.+++.+||+.||.+||+++|+++.
T Consensus 222 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 222 ---VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ---TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ---CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0111122223456788999999999999999999973
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=353.12 Aligned_cols=253 Identities=22% Similarity=0.311 Sum_probs=195.6
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCC----hhhhHHHHHHHHhcCCCCeeeeeeeeeecC----e
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQG----KDEFLSELSIIGTLRHRNLVRLQGWCHEKG----E 450 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~ 450 (711)
.++|+..+.||+|+||.||+|++..+++.||||++...... ...+.+|++++++++||||+++++++.... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 35799999999999999999999889999999998764322 246889999999999999999999987654 3
Q ss_pred EEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceec
Q 043702 451 ILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV 530 (711)
Q Consensus 451 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~ 530 (711)
.++||||+++++|.+++... ..+++.+++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred cEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 49999999999999999653 4699999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCC--CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcC
Q 043702 531 EHDKS--PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREG 608 (711)
Q Consensus 531 ~~~~~--~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 608 (711)
..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .+..+......
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-----------~~~~~~~~~~~ 235 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP-----------VSVAYQHVRED 235 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----------HHHHHHHHHCC
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-----------HHHHHHHhcCC
Confidence 54322 223345699999999999999999999999999999999999999965321 11122222221
Q ss_pred chhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 609 RLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 609 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
...... ... .....+.+++.+||+.||.+||++.++++
T Consensus 236 ~~~~~~---~~~----~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 236 PIPPSA---RHE----GLSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp CCCHHH---HST----TCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred CCCccc---ccC----CCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 111100 001 12345778899999999999997776654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=355.23 Aligned_cols=259 Identities=24% Similarity=0.253 Sum_probs=203.5
Q ss_pred HHHHHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC------CCChhhhHHHHHHHHhcCCCCeeeeeeeeee
Q 043702 374 ELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN------SQGKDEFLSELSIIGTLRHRNLVRLQGWCHE 447 (711)
Q Consensus 374 el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 447 (711)
++....++|...+.||+|+||.||+|....+++.||+|++... ....+.+.+|++++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 3556677899999999999999999999989999999988642 3445789999999999999999999999999
Q ss_pred cCeEEEEEEcCCCCCHHHHHhhC---------------------------------------CCCCChHHHHHHHHHHHH
Q 043702 448 KGEILLVYDLMPNGSLDKALFEA---------------------------------------RSPLPWPHRSKILLGVAS 488 (711)
Q Consensus 448 ~~~~~lV~Ey~~~gsL~~~l~~~---------------------------------------~~~l~~~~~~~i~~~ia~ 488 (711)
.+..++||||+++|+|.+++... ...+++..+..++.||++
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999999999998410 112356778899999999
Q ss_pred HHHHHHhccCCCeeeccCCCCceEEcCCC--cEEEeecCCceecCCCCC---CCcccccCCCcccChhhhcc--CCCCcc
Q 043702 489 ALAYLHQECENQVIHRDVKTSNIMLDEGF--NARLGDFGLARQVEHDKS---PDATVAAGTMGYLAPEYLLT--GRATEK 561 (711)
Q Consensus 489 aL~yLH~~~~~~ivHrDlkp~NILld~~~--~vkL~DFGla~~~~~~~~---~~~~~~~gt~~y~APE~~~~--~~~s~k 561 (711)
||+|||+. +|+||||||+|||++.++ .+||+|||+++.+..... .......||+.|+|||.+.. ..++.+
T Consensus 180 ~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 99999998 999999999999998776 899999999987644222 22345679999999999975 678999
Q ss_pred ccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCC
Q 043702 562 TDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPD 641 (711)
Q Consensus 562 sDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~d 641 (711)
+|||||||++|||++|+.||..... .+............. .+ ........+.+++.+||+.|
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~-----------~~~~~~~~~~~~~~~--~~-----~~~~~~~~~~~li~~~l~~~ 318 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVND-----------ADTISQVLNKKLCFE--NP-----NYNVLSPLARDLLSNLLNRN 318 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHHHHHHHCCCCTT--SG-----GGGGSCHHHHHHHHHHSCSC
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCCh-----------HHHHHHHHhcccccC--Cc-----ccccCCHHHHHHHHHHcCCC
Confidence 9999999999999999999965321 111111111111000 00 00112345778899999999
Q ss_pred CCCCCCHHHHHH
Q 043702 642 PLARPTMRGVVQ 653 (711)
Q Consensus 642 P~~RPs~~eVl~ 653 (711)
|.+||++.|+++
T Consensus 319 p~~Rps~~~~l~ 330 (345)
T 3hko_A 319 VDERFDAMRALQ 330 (345)
T ss_dssp TTTSCCHHHHHH
T ss_pred hhHCCCHHHHhc
Confidence 999999999998
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=344.73 Aligned_cols=249 Identities=24% Similarity=0.322 Sum_probs=198.3
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC--CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEc
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN--SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
++|...+.||+|+||.||++....++..+|+|++... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 5688999999999999999999888999999998763 33457899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhC---CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEE---cCCCcEEEeecCCceecC
Q 043702 458 MPNGSLDKALFEA---RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIML---DEGFNARLGDFGLARQVE 531 (711)
Q Consensus 458 ~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl---d~~~~vkL~DFGla~~~~ 531 (711)
+++|+|.+++... ...+++..+.+++.|+++||+|||+. +|+||||||+|||+ +.++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999998643 46799999999999999999999998 99999999999999 456789999999998765
Q ss_pred CCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchh
Q 043702 532 HDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLL 611 (711)
Q Consensus 532 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 611 (711)
... ......||+.|+|||.+. +.++.++|||||||++|||++|+.||..... .+.........
T Consensus 179 ~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~-----------~~~~~~~~~~~--- 241 (285)
T 3is5_A 179 SDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL-----------EEVQQKATYKE--- 241 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHHHHHHHCC---
T ss_pred Ccc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH-----------HHHHhhhccCC---
Confidence 432 233456999999999875 5689999999999999999999999965321 11111100000
Q ss_pred HhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 612 TAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 612 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
+..... .......+.+++.+||+.||.+||++.|+++
T Consensus 242 ----~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 242 ----PNYAVE-CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ----CCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ----cccccc-cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000 0011245678899999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=345.54 Aligned_cols=250 Identities=22% Similarity=0.383 Sum_probs=207.1
Q ss_pred HhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeee----------
Q 043702 378 ATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHE---------- 447 (711)
Q Consensus 378 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~---------- 447 (711)
..++|+..+.||+|+||.||+|.+..+++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 3457899999999999999999998889999999987543 568899999999999999999998864
Q ss_pred ------cCeEEEEEEcCCCCCHHHHHhhC-CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEE
Q 043702 448 ------KGEILLVYDLMPNGSLDKALFEA-RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNAR 520 (711)
Q Consensus 448 ------~~~~~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vk 520 (711)
....++||||+++|+|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+|||+++++.+|
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCEE
Confidence 44589999999999999999754 35799999999999999999999998 999999999999999999999
Q ss_pred EeecCCceecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHH
Q 043702 521 LGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEW 600 (711)
Q Consensus 521 L~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~ 600 (711)
|+|||+++....... .....||+.|+|||.+.+..++.++|||||||++|||++|..|+.... .+
T Consensus 163 l~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-------------~~ 227 (284)
T 2a19_B 163 IGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-------------KF 227 (284)
T ss_dssp ECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-------------HH
T ss_pred ECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-------------HH
Confidence 999999987755432 233469999999999999999999999999999999999998874321 01
Q ss_pred HHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCC
Q 043702 601 VWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEAEV 661 (711)
Q Consensus 601 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 661 (711)
+.....+ .+...++ ..+.+++.+||+.||.+||++.|+++.|.....-
T Consensus 228 -~~~~~~~--------~~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 228 -FTDLRDG--------IISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp -HHHHHTT--------CCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred -HHHhhcc--------cccccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 1111111 1112222 3467888999999999999999999999765443
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=354.24 Aligned_cols=263 Identities=15% Similarity=0.176 Sum_probs=200.2
Q ss_pred cCCcccceeecCCceEEEEEEeCC---CCeEEEEEEcccCCC------------ChhhhHHHHHHHHhcCCCCeeeeeee
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQ---NGDIIAVKRCSHNSQ------------GKDEFLSELSIIGTLRHRNLVRLQGW 444 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~---~~~~vavK~~~~~~~------------~~~~~~~Ei~~l~~l~H~niv~l~g~ 444 (711)
++|...+.||+|+||.||+|.+.. .+..+|+|+...... ....+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 568889999999999999999976 678899999876432 12346788899999999999999999
Q ss_pred eee----cCeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCC--c
Q 043702 445 CHE----KGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGF--N 518 (711)
Q Consensus 445 ~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~--~ 518 (711)
+.. ....++||||+ +++|.+++.... .+++.++++++.||+.||+|||+. +|+||||||+|||++.++ .
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~ 191 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQ 191 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTTS
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCCc
Confidence 988 67899999999 999999996544 799999999999999999999998 999999999999999887 9
Q ss_pred EEEeecCCceecCCCCC------CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccc
Q 043702 519 ARLGDFGLARQVEHDKS------PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVG 592 (711)
Q Consensus 519 vkL~DFGla~~~~~~~~------~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~ 592 (711)
+||+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~----- 266 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD----- 266 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC-----
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc-----
Confidence 99999999987653321 1124457999999999999999999999999999999999999999643211
Q ss_pred cccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 593 VASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 593 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
............. .+.......... ......+.+++.+||+.||.+||++++|++.|+..
T Consensus 267 --~~~~~~~~~~~~~-~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 267 --PVAVQTAKTNLLD-ELPQSVLKWAPS---GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp --HHHHHHHHHHHHH-TTTHHHHHHSCT---TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred --cHHHHHHHHhhcc-cccHHHHhhccc---cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 0111111111110 111111111100 02234677888999999999999999999999864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=360.90 Aligned_cols=202 Identities=28% Similarity=0.467 Sum_probs=166.1
Q ss_pred HHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC---CChhhhHHHHHHHHhcC-CCCeeeeeeeeeecC--e
Q 043702 377 SATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---QGKDEFLSELSIIGTLR-HRNLVRLQGWCHEKG--E 450 (711)
Q Consensus 377 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~--~ 450 (711)
...++|...+.||+|+||.||+|.+..+++.||||++.... ...+.+.+|+.+++++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 34578999999999999999999999999999999986532 23456789999999998 999999999997544 7
Q ss_pred EEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceec
Q 043702 451 ILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV 530 (711)
Q Consensus 451 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~ 530 (711)
+++|||||+ |+|..++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+
T Consensus 86 ~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 899999997 699999865 4689999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCC--------------------CCCcccccCCCcccChhhhcc-CCCCccccchhHHHHHHHHHhCCCCCccc
Q 043702 531 EHDK--------------------SPDATVAAGTMGYLAPEYLLT-GRATEKTDVFSYGAVVLEVASGRRPIEKE 584 (711)
Q Consensus 531 ~~~~--------------------~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~elltG~~P~~~~ 584 (711)
.... ....+..+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 4311 112334579999999999986 67899999999999999999999999654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=351.57 Aligned_cols=270 Identities=24% Similarity=0.329 Sum_probs=203.8
Q ss_pred HHHHHHHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhc--CCCCeeeeeeeeeec-
Q 043702 372 YRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTL--RHRNLVRLQGWCHEK- 448 (711)
Q Consensus 372 ~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l--~H~niv~l~g~~~~~- 448 (711)
...-....++|...+.||+|+||.||+|++ .++.||||++.... ...+..|.+++..+ +||||+++++++...
T Consensus 29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTE--EASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp HHHHTTHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred cccccccccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccc--cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 333445567899999999999999999998 48999999986432 34556666666665 899999999999887
Q ss_pred ---CeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhcc-----CCCeeeccCCCCceEEcCCCcEE
Q 043702 449 ---GEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQEC-----ENQVIHRDVKTSNIMLDEGFNAR 520 (711)
Q Consensus 449 ---~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-----~~~ivHrDlkp~NILld~~~~vk 520 (711)
...++||||+++|+|.+++... .+++..++.++.|++.||+|||+.+ .++|+||||||+|||++.++.+|
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 182 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC 182 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred CCCCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence 7899999999999999999653 6999999999999999999999752 34899999999999999999999
Q ss_pred EeecCCceecCCCCCCC---cccccCCCcccChhhhccCCCCcc------ccchhHHHHHHHHHhC----------CCCC
Q 043702 521 LGDFGLARQVEHDKSPD---ATVAAGTMGYLAPEYLLTGRATEK------TDVFSYGAVVLEVASG----------RRPI 581 (711)
Q Consensus 521 L~DFGla~~~~~~~~~~---~~~~~gt~~y~APE~~~~~~~s~k------sDVwSfGvll~elltG----------~~P~ 581 (711)
|+|||+++......... .....||+.|+|||.+.+.....+ +|||||||++|||++| +.||
T Consensus 183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~ 262 (337)
T 3mdy_A 183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262 (337)
T ss_dssp ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence 99999998765433221 124579999999999988776665 9999999999999999 4555
Q ss_pred ccccccccccccccchHHHHHHhhhcCchhHhhhhhccCC-CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 582 EKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQ-FDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 582 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
...... ................. +..... ...+....+.+++.+||+.||.+|||+.||++.|+..
T Consensus 263 ~~~~~~-------~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 263 HDLVPS-------DPSYEDMREIVCIKKLR----PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp TTTSCS-------SCCHHHHHHHHTTSCCC----CCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hhhcCC-------CCchhhhHHHHhhhccC----ccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 432111 00111111111111110 111111 1235677889999999999999999999999999764
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=364.64 Aligned_cols=254 Identities=30% Similarity=0.425 Sum_probs=194.4
Q ss_pred CCcccceeecCCceEEEEEEeCCC---CeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeee-cCeEEEE
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQN---GDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHE-KGEILLV 454 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~---~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV 454 (711)
.|...+.||+|+||.||+|.+..+ +..||+|.+.... ...+++.+|+.++++++||||++++++|.+ ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 467788999999999999987433 2468999987532 335679999999999999999999998754 4678999
Q ss_pred EEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCC
Q 043702 455 YDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~ 534 (711)
|||+++|+|.+++......+++..++.++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 999999999999987777899999999999999999999998 99999999999999999999999999998764332
Q ss_pred CC---CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCch
Q 043702 535 SP---DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRL 610 (711)
Q Consensus 535 ~~---~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 610 (711)
.. ......+|+.|+|||.+.+..++.++|||||||++|||++ |.+||..... ......+ ..+..
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~--------~~~~~~~----~~~~~ 314 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--------FDITVYL----LQGRR 314 (373)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS--------SCHHHHH----HTTCC
T ss_pred cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH--------HHHHHHH----HcCCC
Confidence 11 2233457889999999999999999999999999999999 6777754321 1111111 11110
Q ss_pred hHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 611 LTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 611 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
...+......+.+++.+||+.||.+||++.|+++.|+..
T Consensus 315 ---------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i 353 (373)
T 3c1x_A 315 ---------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353 (373)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 001112234677889999999999999999999999764
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=357.13 Aligned_cols=256 Identities=22% Similarity=0.321 Sum_probs=204.5
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC----CChhhhHHHHHHHHhc-CCCCeeeeeeeeeecCeEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS----QGKDEFLSELSIIGTL-RHRNLVRLQGWCHEKGEILLV 454 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 454 (711)
++|+..+.||+|+||.||+|+++.+++.||+|++.... ...+.+.+|..++.++ +||||+++++++...+.+++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 56889999999999999999999899999999987632 1234578899999988 799999999999999999999
Q ss_pred EEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCC
Q 043702 455 YDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~ 534 (711)
|||+++|+|..++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 89 ~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp ECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred EeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence 9999999999999653 4699999999999999999999998 99999999999999999999999999998643222
Q ss_pred CCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhh
Q 043702 535 SPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614 (711)
Q Consensus 535 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 614 (711)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..............+..
T Consensus 165 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~~~~~~~~~~~i~~~~~---- 236 (345)
T 3a8x_A 165 -DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP---DQNTEDYLFQVILEKQI---- 236 (345)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC----------CHHHHHHHHHHCCC----
T ss_pred -CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccc---ccccHHHHHHHHHcCCC----
Confidence 2334567999999999999999999999999999999999999999643211000 00111122221111111
Q ss_pred hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCH------HHHHH
Q 043702 615 DARLEGQFDEAEMRRVLLVGLACSHPDPLARPTM------RGVVQ 653 (711)
Q Consensus 615 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~eVl~ 653 (711)
.++......+.+++.+||+.||.+||++ .|+++
T Consensus 237 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 237 ------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred ------CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 1122233457788999999999999995 67765
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=348.67 Aligned_cols=255 Identities=28% Similarity=0.385 Sum_probs=203.1
Q ss_pred CCcccceeecCCceEEEEEEeCCCC---eEEEEEEcccCCC--ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeE-EEE
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNG---DIIAVKRCSHNSQ--GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEI-LLV 454 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~---~~vavK~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~-~lV 454 (711)
.|...++||+|+||+||+|.+..++ ..+|+|++..... ..+.+.+|++++++++||||+++++++...+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4566789999999999999975443 3799999876332 346788999999999999999999999876655 999
Q ss_pred EEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCC
Q 043702 455 YDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~ 534 (711)
|||+.+|+|.+++......+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 999999999999987777899999999999999999999998 99999999999999999999999999998654321
Q ss_pred ---CCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchh
Q 043702 535 ---SPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLL 611 (711)
Q Consensus 535 ---~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 611 (711)
........+++.|+|||.+.+..++.++|||||||++|||++|..|+..... ...+..... .+.
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~-------~~~~~~~~~----~~~-- 245 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID-------PFDLTHFLA----QGR-- 245 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-------GGGHHHHHH----TTC--
T ss_pred ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC-------HHHHHHHhh----cCC--
Confidence 1222335688999999999999999999999999999999996666533211 011111111 110
Q ss_pred HhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 612 TAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 612 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
...........+.+++.+||+.||.+|||++++++.|+..
T Consensus 246 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 246 -------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1111122234677899999999999999999999998764
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=351.89 Aligned_cols=257 Identities=25% Similarity=0.361 Sum_probs=206.4
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC---CChhhhHHHHHHHHhcCCCCeeeeeeeeee--cCeEEE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---QGKDEFLSELSIIGTLRHRNLVRLQGWCHE--KGEILL 453 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~l 453 (711)
.++|+..+.||+|+||.||+|....+++.||+|++.... ...+.+.+|++++++++||||+++++++.. .+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 457899999999999999999999899999999987643 234578899999999999999999998854 578999
Q ss_pred EEEcCCCCCHHHHHhhC---CCCCChHHHHHHHHHHHHHHHHHHhccCCC-----eeeccCCCCceEEcCCCcEEEeecC
Q 043702 454 VYDLMPNGSLDKALFEA---RSPLPWPHRSKILLGVASALAYLHQECENQ-----VIHRDVKTSNIMLDEGFNARLGDFG 525 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~-----ivHrDlkp~NILld~~~~vkL~DFG 525 (711)
||||+++++|.+++... ...+++..+++++.|++.||+|||+. + |+||||||+|||++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 99999999999999643 34599999999999999999999998 6 9999999999999999999999999
Q ss_pred CceecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhh
Q 043702 526 LARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLH 605 (711)
Q Consensus 526 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~ 605 (711)
+++....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ..+. ...
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~----~~i 228 (279)
T 2w5a_A 162 LARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--------KELA----GKI 228 (279)
T ss_dssp HHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHH----HHH
T ss_pred hheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH--------HHHH----HHH
Confidence 9987643321 12234689999999999999999999999999999999999999965321 1111 111
Q ss_pred hcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC
Q 043702 606 REGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEAE 660 (711)
Q Consensus 606 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 660 (711)
..+.. ...+......+.+++.+||+.||.+||++.||++.+...++
T Consensus 229 ~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 229 REGKF---------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp HHTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred hhccc---------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 11111 11112233567788999999999999999999998765433
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=355.84 Aligned_cols=266 Identities=26% Similarity=0.391 Sum_probs=212.1
Q ss_pred cCHHHHHHHhcCCcccceeecCCceEEEEEEe-----CCCCeEEEEEEcccCCC--ChhhhHHHHHHHHhc-CCCCeeee
Q 043702 370 FSYRELRSATKCFNANRIIGHGAFGTVYKGIL-----PQNGDIIAVKRCSHNSQ--GKDEFLSELSIIGTL-RHRNLVRL 441 (711)
Q Consensus 370 ~~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~-----~~~~~~vavK~~~~~~~--~~~~~~~Ei~~l~~l-~H~niv~l 441 (711)
+...+.....++|...+.||+|+||.||+|.+ ..+++.||||++..... ..+.+.+|++++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 34455556678999999999999999999985 34578999999876433 345788999999999 69999999
Q ss_pred eeeeeecC-eEEEEEEcCCCCCHHHHHhhCCCC---------------CChHHHHHHHHHHHHHHHHHHhccCCCeeecc
Q 043702 442 QGWCHEKG-EILLVYDLMPNGSLDKALFEARSP---------------LPWPHRSKILLGVASALAYLHQECENQVIHRD 505 (711)
Q Consensus 442 ~g~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~---------------l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrD 505 (711)
++++...+ ..++||||+++|+|.+++...... +++..++.++.|+++||.|||+. +|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence 99988754 589999999999999999765432 88999999999999999999998 999999
Q ss_pred CCCCceEEcCCCcEEEeecCCceecCCCCCC-CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCcc
Q 043702 506 VKTSNIMLDEGFNARLGDFGLARQVEHDKSP-DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEK 583 (711)
Q Consensus 506 lkp~NILld~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~ 583 (711)
|||+|||++.++.+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||++ |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 9999999999999999999999876543322 2233567899999999999999999999999999999998 9999965
Q ss_pred ccccccccccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 584 EITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 584 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
.... .. .......+.. ..........+.+++.+||+.||.+||++.|+++.|+..
T Consensus 254 ~~~~-------~~----~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 254 VKID-------EE----FCRRLKEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp CCCS-------HH----HHHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cchh-------HH----HHHHhccCcc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 3210 11 1111111110 111112234577888999999999999999999998753
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=342.08 Aligned_cols=251 Identities=24% Similarity=0.306 Sum_probs=205.5
Q ss_pred HhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEccc-CCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 378 ATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSH-NSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 378 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
..++|...+.||+|+||.||+|.+..++..+|+|++.. .....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 34679999999999999999999998899999999876 34556789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEE---cCCCcEEEeecCCceecCCC
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIML---DEGFNARLGDFGLARQVEHD 533 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl---d~~~~vkL~DFGla~~~~~~ 533 (711)
|+++++|.+++.. ...+++..+.+++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||++......
T Consensus 87 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 87 LCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp CCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred ccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 9999999998865 35699999999999999999999998 99999999999999 88899999999999876543
Q ss_pred CCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHh
Q 043702 534 KSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTA 613 (711)
Q Consensus 534 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 613 (711)
. ......||+.|+|||.+.+ .++.++|||||||++|||++|+.||..... .+..... ..+.....
T Consensus 163 ~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----------~~~~~~~-~~~~~~~~ 227 (277)
T 3f3z_A 163 K--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTD-----------SEVMLKI-REGTFTFP 227 (277)
T ss_dssp S--CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHHHHH-HHCCCCCC
T ss_pred c--chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCH-----------HHHHHHH-HhCCCCCC
Confidence 3 2334569999999998865 489999999999999999999999965321 1111111 11111000
Q ss_pred hhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 614 ADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 614 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
.. ... .....+.+++.+||+.||.+||++.++++
T Consensus 228 ~~--~~~----~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 228 EK--DWL----NVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HH--HHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ch--hhh----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 000 12346778899999999999999999986
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=345.90 Aligned_cols=252 Identities=21% Similarity=0.293 Sum_probs=206.9
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC-------ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ-------GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEI 451 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 451 (711)
.+.|...+.||+|+||.||+|.+..+|+.||+|++..... ..+++.+|++++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 4568999999999999999999998899999999875321 246789999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCC----cEEEeecCCc
Q 043702 452 LLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGF----NARLGDFGLA 527 (711)
Q Consensus 452 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~----~vkL~DFGla 527 (711)
++||||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp EEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred EEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 999999999999999964 45789999999999999999999998 999999999999999888 7999999999
Q ss_pred eecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhc
Q 043702 528 RQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHRE 607 (711)
Q Consensus 528 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~ 607 (711)
+....... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .+...... .
T Consensus 167 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----------~~~~~~i~-~ 232 (321)
T 2a2a_A 167 HEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-----------QETLANIT-S 232 (321)
T ss_dssp EECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-----------HHHHHHHH-T
T ss_pred eecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH-----------HHHHHHHH-h
Confidence 87754332 2345699999999999999999999999999999999999999965321 11111111 1
Q ss_pred CchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 608 GRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 608 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
... ..++..... ....+.+++.+||+.||.+|||+.|+++.
T Consensus 233 ~~~--~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 233 VSY--DFDEEFFSH----TSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp TCC--CCCHHHHTT----CCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred ccc--ccChhhhcc----cCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 000001111 12457788999999999999999999984
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=347.77 Aligned_cols=258 Identities=22% Similarity=0.275 Sum_probs=199.8
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC----ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ----GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLV 454 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 454 (711)
.++|...+.||+|+||.||+|.+..+++.||+|++..... ..+.+.+|+.++++++||||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 3679999999999999999999988899999999875322 236788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCC
Q 043702 455 YDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~ 534 (711)
|||+++++|.+++... ..+++..++.++.|+++||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 113 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp EECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred EEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 9999999999999653 5699999999999999999999998 99999999999999999999999999998765544
Q ss_pred CCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhh
Q 043702 535 SPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614 (711)
Q Consensus 535 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 614 (711)
........|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ............ .
T Consensus 189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------------~~~~~~~~~~~~-~-- 253 (309)
T 2h34_A 189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL------------SVMGAHINQAIP-R-- 253 (309)
T ss_dssp --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH------------HHHHHHHHSCCC-C--
T ss_pred cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH------------HHHHHHhccCCC-C--
Confidence 3334455799999999999999999999999999999999999999975321 011111111100 0
Q ss_pred hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHhCCC
Q 043702 615 DARLEGQFDEAEMRRVLLVGLACSHPDPLARP-TMRGVVQMLVGEA 659 (711)
Q Consensus 615 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~eVl~~L~~~~ 659 (711)
...........+.+++.+||+.||++|| +++++++.|+...
T Consensus 254 ----~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l 295 (309)
T 2h34_A 254 ----PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL 295 (309)
T ss_dssp ----GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred ----ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence 0011112234577889999999999999 9999999998653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=356.01 Aligned_cols=261 Identities=20% Similarity=0.318 Sum_probs=198.9
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEc
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
++|...+.||+|+||+||+|+...+++.||+|++.... .....+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 47889999999999999999998889999999987533 2234567899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC
Q 043702 458 MPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD 537 (711)
Q Consensus 458 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 537 (711)
++ |+|.+++......+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~ 156 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-T 156 (324)
T ss_dssp CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-c
Confidence 97 599999988777899999999999999999999998 999999999999999999999999999986543322 2
Q ss_pred cccccCCCcccChhhhcc-CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCc---hhHh
Q 043702 538 ATVAAGTMGYLAPEYLLT-GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGR---LLTA 613 (711)
Q Consensus 538 ~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~---~~~~ 613 (711)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+........ ....
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--------~~~~~~i~~~~~~~~~~~~~~~ 228 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV--------EEQLHFIFRILGTPTEETWPGI 228 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHHHCCCCTTTSTTG
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHHHhCCCChHhchhh
Confidence 233568999999999876 5689999999999999999999999975422 111111111111000 0000
Q ss_pred h------h---hhccCC----CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 614 A------D---ARLEGQ----FDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 614 ~------d---~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
. . +..... ........+.+++.+||+.||.+|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 229 LSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp GGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0 0 000000 00112245678999999999999999999998
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=351.08 Aligned_cols=261 Identities=21% Similarity=0.310 Sum_probs=199.1
Q ss_pred cCCccc-ceeecCCceEEEEEEeCCCCeEEEEEEcccCC-CChhhhHHHHHHHHhc-CCCCeeeeeeeeeecCeEEEEEE
Q 043702 380 KCFNAN-RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS-QGKDEFLSELSIIGTL-RHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 380 ~~f~~~-~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 456 (711)
+.|... ++||+|+||.||+|....+++.||||++.... ...+.+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 457764 78999999999999998889999999987643 4467889999999985 69999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCc---EEEeecCCceecCCC
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFN---ARLGDFGLARQVEHD 533 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~---vkL~DFGla~~~~~~ 533 (711)
|+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+|||+++.....
T Consensus 92 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 92 KMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp CCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred cCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 99999999999753 5689999999999999999999998 9999999999999988776 999999999865432
Q ss_pred CC------CCcccccCCCcccChhhhcc-----CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccch---HH
Q 043702 534 KS------PDATVAAGTMGYLAPEYLLT-----GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNL---VE 599 (711)
Q Consensus 534 ~~------~~~~~~~gt~~y~APE~~~~-----~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l---~~ 599 (711)
.. ......+||+.|+|||++.. ..++.++|||||||++|||++|+.||................ ..
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 247 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247 (316)
T ss_dssp --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence 21 11223469999999999975 457899999999999999999999997643221111100000 01
Q ss_pred HHHHhhhcCchhHhhhhhccCCCcH----HHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 600 WVWSLHREGRLLTAADARLEGQFDE----AEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 600 ~~~~~~~~~~~~~~~d~~l~~~~~~----~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
........+.. .++. .....+.+++.+||+.||.+|||+.|+++.
T Consensus 248 ~~~~~i~~~~~----------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 248 MLFESIQEGKY----------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHCCC----------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHhccCc----------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11111111111 1111 123467889999999999999999999984
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=357.15 Aligned_cols=251 Identities=22% Similarity=0.361 Sum_probs=197.2
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCC---hhhhHHHHHHHHhcCC--CCeeeeeeeeeecCeEEE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQG---KDEFLSELSIIGTLRH--RNLVRLQGWCHEKGEILL 453 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~l 453 (711)
.+.|+..+.||+|+||.||++... +++.||||++...... .+.+.+|++++.+++| +||+++++++..++..++
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 356899999999999999999985 5889999998764332 3578899999999986 999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCC
Q 043702 454 VYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHD 533 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~ 533 (711)
||| +.+++|.+++.. ...+++.++..++.||+.||+|||+. +|+||||||+|||++ ++.+||+|||+++.....
T Consensus 87 v~e-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EEC-CCSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EEe-CCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 999 568899999976 45799999999999999999999998 999999999999997 578999999999876543
Q ss_pred CCC-CcccccCCCcccChhhhcc-----------CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHH
Q 043702 534 KSP-DATVAAGTMGYLAPEYLLT-----------GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWV 601 (711)
Q Consensus 534 ~~~-~~~~~~gt~~y~APE~~~~-----------~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~ 601 (711)
... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||..... .. .
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---------~~-~-- 228 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN---------QI-S-- 228 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS---------HH-H--
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh---------HH-H--
Confidence 322 2334579999999999875 6789999999999999999999999964311 11 1
Q ss_pred HHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 043702 602 WSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655 (711)
Q Consensus 602 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L 655 (711)
.+....++.....++......+.+++.+||+.||.+|||+.|+++..
T Consensus 229 -------~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 229 -------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp -------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred -------HHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 11122222222222222234677889999999999999999999743
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=355.43 Aligned_cols=244 Identities=24% Similarity=0.341 Sum_probs=205.4
Q ss_pred HhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC---------ChhhhHHHHHHHHhcCCCCeeeeeeeeeec
Q 043702 378 ATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ---------GKDEFLSELSIIGTLRHRNLVRLQGWCHEK 448 (711)
Q Consensus 378 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 448 (711)
..++|...+.||+|+||.||+|.+..+++.||||++..... ..+.+.+|++++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 35689999999999999999999998999999999876432 345688999999999999999999999999
Q ss_pred CeEEEEEEcCCCC-CHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCc
Q 043702 449 GEILLVYDLMPNG-SLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLA 527 (711)
Q Consensus 449 ~~~~lV~Ey~~~g-sL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla 527 (711)
+..++||||+.+| +|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred CEEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccc
Confidence 9999999999777 99998864 45699999999999999999999998 9999999999999999999999999999
Q ss_pred eecCCCCCCCcccccCCCcccChhhhccCCC-CccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhh
Q 043702 528 RQVEHDKSPDATVAAGTMGYLAPEYLLTGRA-TEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHR 606 (711)
Q Consensus 528 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~ 606 (711)
+....... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.......
T Consensus 178 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------------------ 237 (335)
T 3dls_A 178 AYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV------------------ 237 (335)
T ss_dssp EECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT------------------
T ss_pred eECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH------------------
Confidence 87754432 334579999999999988876 889999999999999999999996532100
Q ss_pred cCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 043702 607 EGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655 (711)
Q Consensus 607 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L 655 (711)
..... .+......+.+++.+||+.||.+|||+.++++.-
T Consensus 238 --------~~~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp 276 (335)
T 3dls_A 238 --------EAAIH--PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDP 276 (335)
T ss_dssp --------TTCCC--CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCT
T ss_pred --------hhccC--CCcccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 00000 0001124577888999999999999999999853
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=348.41 Aligned_cols=262 Identities=23% Similarity=0.301 Sum_probs=199.8
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCC---hhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQG---KDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
++|+..+.||+|+||+||+|.+..+++.||+|++...... .+.+.+|++++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 5789999999999999999999988999999998764433 3567899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCC
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP 536 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~ 536 (711)
|+++++|..++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~~~~~l~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 157 (311)
T 4agu_A 83 YCDHTVLHELDRY-QRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD- 157 (311)
T ss_dssp CCSEEHHHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred eCCCchHHHHHhh-hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-
Confidence 9999999988754 45699999999999999999999998 999999999999999999999999999987654332
Q ss_pred CcccccCCCcccChhhhcc-CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHh-----------
Q 043702 537 DATVAAGTMGYLAPEYLLT-GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSL----------- 604 (711)
Q Consensus 537 ~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~----------- 604 (711)
......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...... .....+...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~~~~~ 229 (311)
T 4agu_A 158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDV--------DQLYLIRKTLGDLIPRHQQV 229 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHHHCSCCHHHHHH
T ss_pred ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHHHhcccccccccc
Confidence 2234568999999999976 56899999999999999999999999654221 011111000
Q ss_pred hhcCchhHhhh-hhccCCCc-----HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 605 HREGRLLTAAD-ARLEGQFD-----EAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 605 ~~~~~~~~~~d-~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
........... +....... ......+.+++.+||+.||.+|||++|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp HHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000000000 00000000 1123457789999999999999999999974
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=349.16 Aligned_cols=255 Identities=29% Similarity=0.421 Sum_probs=200.9
Q ss_pred cCCcccceeecCCceEEEEEEeCCC---CeEEEEEEcccCCC--ChhhhHHHHHHHHhcCCCCeeeeeeeee-ecCeEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQN---GDIIAVKRCSHNSQ--GKDEFLSELSIIGTLRHRNLVRLQGWCH-EKGEILL 453 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~---~~~vavK~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~-~~~~~~l 453 (711)
..|...++||+|+||.||+|.+..+ ...+|+|++..... ..+.+.+|++++++++||||++++++|. .++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 4688889999999999999997543 34689998876332 3467889999999999999999999865 4567899
Q ss_pred EEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCC
Q 043702 454 VYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHD 533 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~ 533 (711)
||||+++|+|.+++......+++..++.++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccccccc
Confidence 9999999999999987777899999999999999999999998 9999999999999999999999999999876433
Q ss_pred CC---CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCc
Q 043702 534 KS---PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGR 609 (711)
Q Consensus 534 ~~---~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 609 (711)
.. .......||+.|+|||.+.+..++.++|||||||++|||++ |.+||..... ....... ... .
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~--------~~~~~~~---~~~-~ 249 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--------FDITVYL---LQG-R 249 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT--------TTHHHHH---HTT-C
T ss_pred chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH--------HHHHHHH---hcC-C
Confidence 21 12233457889999999999999999999999999999999 5555543211 1111111 111 0
Q ss_pred hhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 610 LLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 610 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
....+......+.+++.+||+.||.+||+++|+++.|+..
T Consensus 250 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 289 (298)
T 3f66_A 250 ---------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289 (298)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0011111234577889999999999999999999999764
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=349.06 Aligned_cols=253 Identities=26% Similarity=0.385 Sum_probs=203.1
Q ss_pred hcCCcccc-eeecCCceEEEEEEe--CCCCeEEEEEEcccCCC---ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEE
Q 043702 379 TKCFNANR-IIGHGAFGTVYKGIL--PQNGDIIAVKRCSHNSQ---GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEIL 452 (711)
Q Consensus 379 t~~f~~~~-~LG~G~fg~Vy~~~~--~~~~~~vavK~~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 452 (711)
.++|...+ .||+|+||.||+|.+ ...++.||||++..... ..+++.+|+++++.++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 45677777 999999999999954 55678999999876432 246789999999999999999999999 567789
Q ss_pred EEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCC
Q 043702 453 LVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEH 532 (711)
Q Consensus 453 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~ 532 (711)
+||||+++++|.+++.. ...+++..++.++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 94 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169 (291)
T ss_dssp EEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence 99999999999999976 45699999999999999999999998 999999999999999999999999999987754
Q ss_pred CCCCC--cccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCc
Q 043702 533 DKSPD--ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGR 609 (711)
Q Consensus 533 ~~~~~--~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 609 (711)
..... .....+++.|+|||.+....++.++||||||+++|||++ |+.||..... ..+. .....+.
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~----~~~~~~~ 237 (291)
T 1xbb_A 170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SEVT----AMLEKGE 237 (291)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHH----HHHHTTC
T ss_pred CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH--------HHHH----HHHHcCC
Confidence 43221 222346789999999998889999999999999999999 9999965321 1111 1111111
Q ss_pred hhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 610 LLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 610 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
....+......+.+++.+||+.||.+||++.+|++.|+.
T Consensus 238 ---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 276 (291)
T 1xbb_A 238 ---------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 276 (291)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 111222334567889999999999999999999999875
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=356.79 Aligned_cols=248 Identities=21% Similarity=0.310 Sum_probs=205.5
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEccc----CCCChhhhHHHHHHHHhc-CCCCeeeeeeeeeecCeEEE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSH----NSQGKDEFLSELSIIGTL-RHRNLVRLQGWCHEKGEILL 453 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~----~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 453 (711)
.++|+..+.||+|+||+||+|+...+++.||+|++.. .....+.+..|..++..+ +||||+++++++...+.+++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 4679999999999999999999988899999999875 234556788999999988 79999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCC
Q 043702 454 VYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHD 533 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~ 533 (711)
||||+++|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 99 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 99999999999999653 4699999999999999999999998 9999999999999999999999999999864322
Q ss_pred CCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHh
Q 043702 534 KSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTA 613 (711)
Q Consensus 534 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 613 (711)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+....... +.
T Consensus 175 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----------~~~~~~i~~-~~---- 237 (353)
T 2i0e_A 175 G-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----------DELFQSIME-HN---- 237 (353)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHHHHHHH-CC----
T ss_pred C-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH-----------HHHHHHHHh-CC----
Confidence 2 234456799999999999999999999999999999999999999975321 111111111 11
Q ss_pred hhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH
Q 043702 614 ADARLEGQFDEAEMRRVLLVGLACSHPDPLARPT-----MRGVVQ 653 (711)
Q Consensus 614 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~eVl~ 653 (711)
..++......+.+++.+||+.||.+||+ ++++++
T Consensus 238 ------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 238 ------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred ------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 0112223356778899999999999995 577775
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=357.37 Aligned_cols=266 Identities=23% Similarity=0.344 Sum_probs=206.9
Q ss_pred CcccceeecCCceEEEEEEe----CCCCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeec--CeEEE
Q 043702 382 FNANRIIGHGAFGTVYKGIL----PQNGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEK--GEILL 453 (711)
Q Consensus 382 f~~~~~LG~G~fg~Vy~~~~----~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~l 453 (711)
|+..+.||+|+||+||++.. ..+++.||||++.... ...+.+.+|++++++++||||+++++++.+. ..+++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 48889999999999988764 3468899999987643 2346789999999999999999999999874 67899
Q ss_pred EEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCC
Q 043702 454 VYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHD 533 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~ 533 (711)
||||+++|+|.+++... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 113 v~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp EECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred EEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 99999999999999653 499999999999999999999998 9999999999999999999999999999987554
Q ss_pred CCC--CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchh
Q 043702 534 KSP--DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLL 611 (711)
Q Consensus 534 ~~~--~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 611 (711)
... ......||..|+|||.+.+..++.++|||||||++|||++|+.||........ ....+.........+.
T Consensus 188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~~ 261 (318)
T 3lxp_A 188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL------ELIGIAQGQMTVLRLT 261 (318)
T ss_dssp CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH------HHHCSCCHHHHHHHHH
T ss_pred ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh------hhhcccccchhHHHHH
Confidence 321 22334588899999999999999999999999999999999999865322100 0000000000111122
Q ss_pred HhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 612 TAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 612 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
..++..............+.+++.+||+.||.+||+++|+++.|+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 22222222223334456788999999999999999999999999753
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=364.58 Aligned_cols=249 Identities=21% Similarity=0.345 Sum_probs=196.8
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC---ChhhhHHHHHHHHhcC--CCCeeeeeeeeeecCeEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ---GKDEFLSELSIIGTLR--HRNLVRLQGWCHEKGEILLV 454 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~lV 454 (711)
+.|...+.||+|+||.||+|.... ++.||||++..... ..+.+.+|+++|++++ ||||+++++++...+.+++|
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 458999999999999999999865 89999999876432 3467899999999997 59999999999999999999
Q ss_pred EEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCC
Q 043702 455 YDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~ 534 (711)
|| +.+++|.+++... ..+++.++..++.||+.||.|||+. +|+||||||+|||++ ++.+||+|||+++.+....
T Consensus 135 ~E-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EE-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred Ee-cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 99 5688999999764 4789999999999999999999997 999999999999996 5789999999998765433
Q ss_pred CC-CcccccCCCcccChhhhcc-----------CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHH
Q 043702 535 SP-DATVAAGTMGYLAPEYLLT-----------GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVW 602 (711)
Q Consensus 535 ~~-~~~~~~gt~~y~APE~~~~-----------~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~ 602 (711)
.. .....+||+.|+|||++.. ..++.++|||||||++|||++|+.||..... .....
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~----------~~~~~- 277 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN----------QISKL- 277 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC----------HHHHH-
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH----------HHHHH-
Confidence 22 2334579999999999875 4689999999999999999999999964311 11111
Q ss_pred HhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 603 SLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 603 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
....++.....++......+.+++.+||+.||.+||++.|+++.
T Consensus 278 --------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 278 --------HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp --------HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --------HHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 11222222112222223467788999999999999999999974
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=343.91 Aligned_cols=255 Identities=23% Similarity=0.318 Sum_probs=206.8
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC---ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ---GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
.++|+..+.||+|+||.||+|.+..+++.||+|++..... ..+.+.+|++++++++||||+++++++...+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4689999999999999999999998999999999876332 3456889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCc---EEEeecCCceecCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFN---ARLGDFGLARQVEH 532 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~---vkL~DFGla~~~~~ 532 (711)
||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++. +||+|||++.....
T Consensus 85 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 999999999988653 5699999999999999999999998 9999999999999986655 99999999987654
Q ss_pred CCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhH
Q 043702 533 DKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLT 612 (711)
Q Consensus 533 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 612 (711)
... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ..... ....+....
T Consensus 161 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--------~~~~~----~~~~~~~~~ 226 (284)
T 3kk8_A 161 SEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--------HRLYA----QIKAGAYDY 226 (284)
T ss_dssp SCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHH----HHHHTCCCC
T ss_pred Ccc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch--------hHHHH----HHHhccccC
Confidence 332 2335699999999999999999999999999999999999999965321 01111 111111000
Q ss_pred hhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--HHhC
Q 043702 613 AADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ--MLVG 657 (711)
Q Consensus 613 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~--~L~~ 657 (711)
...........+.+++.+||+.||.+|||+.|+++ .+..
T Consensus 227 ------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (284)
T 3kk8_A 227 ------PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 267 (284)
T ss_dssp ------CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHS
T ss_pred ------CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccC
Confidence 00000112345778899999999999999999997 4443
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=344.17 Aligned_cols=245 Identities=28% Similarity=0.414 Sum_probs=200.9
Q ss_pred HhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC---CCChhhhHHHHHHHHhc-CCCCeeeeeeeeeecCeEEE
Q 043702 378 ATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN---SQGKDEFLSELSIIGTL-RHRNLVRLQGWCHEKGEILL 453 (711)
Q Consensus 378 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 453 (711)
..++|+..+.||+|+||.||+|.+..+++.||+|++... .....++.+|+..+..+ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 346799999999999999999999888999999998753 23356788999999999 89999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhC---CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcC---------------
Q 043702 454 VYDLMPNGSLDKALFEA---RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDE--------------- 515 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~--------------- 515 (711)
||||+++++|.+++... ...+++..++.++.||++||+|||+. +|+||||||+|||++.
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 99999999999999753 25699999999999999999999998 9999999999999984
Q ss_pred ----CCcEEEeecCCceecCCCCCCCcccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccccccccc
Q 043702 516 ----GFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGK 590 (711)
Q Consensus 516 ----~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~ 590 (711)
...+||+|||++....... ...||+.|+|||.+.+. .++.++|||||||++|||++|++|+....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----- 235 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD----- 235 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH-----
T ss_pred ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh-----
Confidence 4479999999998765432 23589999999999876 56789999999999999999998764321
Q ss_pred cccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 591 VGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 591 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
. +.....+.. +.+ +......+.+++.+||+.||.+||++.|+++.
T Consensus 236 -----~-----~~~~~~~~~-----~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 236 -----Q-----WHEIRQGRL-----PRI----PQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -----H-----HHHHHTTCC-----CCC----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -----H-----HHHHHcCCC-----CCC----CcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 0 111111111 111 11223457788999999999999999999874
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=352.35 Aligned_cols=270 Identities=21% Similarity=0.371 Sum_probs=209.1
Q ss_pred cCCcccceeecCCceEEEEEEe----CCCCeEEEEEEcccCC-CChhhhHHHHHHHHhcCCCCeeeeeeeeeecC--eEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGIL----PQNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKG--EIL 452 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~----~~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~ 452 (711)
++|+..+.||+|+||.||+|+. ..+++.||+|++.... ...+.+.+|++++++++||||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 4688899999999999999984 4578999999987643 33467899999999999999999999987644 689
Q ss_pred EEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCC
Q 043702 453 LVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEH 532 (711)
Q Consensus 453 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~ 532 (711)
+||||+++++|.+++......+++..+++++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 121 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp EEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred EEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence 99999999999999988777899999999999999999999997 999999999999999999999999999998754
Q ss_pred CCCC--CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCcccccccccc-ccccchHHHHHHhhhcCc
Q 043702 533 DKSP--DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKV-GVASNLVEWVWSLHREGR 609 (711)
Q Consensus 533 ~~~~--~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~-~~~~~l~~~~~~~~~~~~ 609 (711)
.... ......++..|+|||.+.+..++.++|||||||++|||++|+.|+.......... ..... ..+. ...
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~-~~~~-----~~~ 271 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ-GQMI-----VFH 271 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCC-THHH-----HHH
T ss_pred cccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccc-hhhh-----HHH
Confidence 4321 1223457788999999999889999999999999999999999986431100000 00000 0000 000
Q ss_pred hhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 610 LLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 610 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
+.+.+...............+.+++.+||+.||.+||++.||++.|+..
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 272 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111111111112223345688899999999999999999999998753
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=346.52 Aligned_cols=248 Identities=25% Similarity=0.432 Sum_probs=207.0
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC--CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEc
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN--SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
+.|...+.||+|+||.||+|....+++.||+|++... ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 4688899999999999999999888999999998753 34457899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC
Q 043702 458 MPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD 537 (711)
Q Consensus 458 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 537 (711)
+++++|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++....... .
T Consensus 102 ~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 175 (303)
T 3a7i_A 102 LGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-K 175 (303)
T ss_dssp CTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-C
T ss_pred CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcccc-c
Confidence 999999999853 5699999999999999999999998 999999999999999999999999999987654332 2
Q ss_pred cccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhh
Q 043702 538 ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADAR 617 (711)
Q Consensus 538 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 617 (711)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .+.... ...+. .+.
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----------~~~~~~-~~~~~-----~~~ 238 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP-----------MKVLFL-IPKNN-----PPT 238 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----------HHHHHH-HHHSC-----CCC
T ss_pred cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH-----------HHHHHH-hhcCC-----CCC
Confidence 3345699999999999999999999999999999999999999864321 011111 11110 111
Q ss_pred ccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 618 LEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 618 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
+...+ ...+.+++.+||+.||.+||++.++++.
T Consensus 239 ~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 239 LEGNY----SKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CCSSC----CHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred Ccccc----CHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 12222 3457788999999999999999999874
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=351.41 Aligned_cols=259 Identities=24% Similarity=0.382 Sum_probs=198.4
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC----CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS----QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
++|...+.||+|+||.||+|....+++.||+|++.... ...+.+.+|++++++++||||+++++++...+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 46888999999999999999998889999999987522 23457889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhh---CCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCC
Q 043702 456 DLMPNGSLDKALFE---ARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEH 532 (711)
Q Consensus 456 Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~ 532 (711)
||+++++|.+++.. ....+++..+++++.|+++||.|||+. +++||||||+|||++.++.+||+|||+++....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999864 456799999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhH
Q 043702 533 DKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLT 612 (711)
Q Consensus 533 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 612 (711)
... ......|++.|+|||.+.+..++.++|||||||++|||++|+.||..... ......... ..+...
T Consensus 189 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---------~~~~~~~~~-~~~~~~- 256 (310)
T 2wqm_A 189 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---------NLYSLCKKI-EQCDYP- 256 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C---------CHHHHHHHH-HTTCSC-
T ss_pred CCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch---------hHHHHHHHh-hcccCC-
Confidence 322 22335689999999999999999999999999999999999999964321 111111111 111110
Q ss_pred hhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC
Q 043702 613 AADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEAE 660 (711)
Q Consensus 613 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 660 (711)
.. ........+.+++.+||+.||.+||++++|++.|+....
T Consensus 257 ----~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~ 297 (310)
T 2wqm_A 257 ----PL---PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA 297 (310)
T ss_dssp ----CC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CC---cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 00 011223457788999999999999999999999987543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=354.44 Aligned_cols=253 Identities=23% Similarity=0.329 Sum_probs=203.6
Q ss_pred HhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhc-CCCCeeeeeeeeeecCeEEEEEE
Q 043702 378 ATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTL-RHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 378 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 456 (711)
..++|+..+.||+|+||.||+|.++.+++.||+|++.... ....+|++++.++ +||||+++++++.+++..++|||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK---RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT---CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc---CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 3567999999999999999999999899999999987543 2456799999888 69999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCC----CcEEEeecCCceecCC
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEG----FNARLGDFGLARQVEH 532 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~----~~vkL~DFGla~~~~~ 532 (711)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||+.++ +.+||+|||+++....
T Consensus 97 ~~~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 97 LMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp CCCSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred CCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 9999999999865 45699999999999999999999998 99999999999998443 3499999999987654
Q ss_pred CCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhH
Q 043702 533 DKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLT 612 (711)
Q Consensus 533 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 612 (711)
... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....+.. .....+...
T Consensus 173 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~~-~~i~~~~~~- 241 (342)
T 2qr7_A 173 ENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD--------DTPEEIL-ARIGSGKFS- 241 (342)
T ss_dssp TTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT--------SCHHHHH-HHHHHCCCC-
T ss_pred CCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc--------CCHHHHH-HHHccCCcc-
Confidence 432 23346799999999999888889999999999999999999999975321 1111111 111111111
Q ss_pred hhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 613 AADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 613 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
+...........+.+++.+||+.||++||++.|+++
T Consensus 242 -----~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 242 -----LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp -----CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -----cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111111223356778899999999999999999987
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=342.43 Aligned_cols=250 Identities=23% Similarity=0.384 Sum_probs=199.4
Q ss_pred CcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC-CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCCC
Q 043702 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPN 460 (711)
Q Consensus 382 f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 460 (711)
|....+||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 103 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPG 103 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCC
Confidence 445568999999999999998889999999987643 3457789999999999999999999999999999999999999
Q ss_pred CCHHHHHhhCCC--CCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcC-CCcEEEeecCCceecCCCCCCC
Q 043702 461 GSLDKALFEARS--PLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDE-GFNARLGDFGLARQVEHDKSPD 537 (711)
Q Consensus 461 gsL~~~l~~~~~--~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~-~~~vkL~DFGla~~~~~~~~~~ 537 (711)
++|.+++..... .+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++....... .
T Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-~ 179 (295)
T 2clq_A 104 GSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-C 179 (295)
T ss_dssp EEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----
T ss_pred CCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-c
Confidence 999999976543 467888999999999999999998 9999999999999987 89999999999987654322 2
Q ss_pred cccccCCCcccChhhhccCC--CCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhh
Q 043702 538 ATVAAGTMGYLAPEYLLTGR--ATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615 (711)
Q Consensus 538 ~~~~~gt~~y~APE~~~~~~--~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 615 (711)
.....|++.|+|||++.... ++.++|||||||++|||++|+.||...... . .. ..... .
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~-~~-~~~~~---------~ 240 (295)
T 2clq_A 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP--------Q-AA-MFKVG---------M 240 (295)
T ss_dssp -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH--------H-HH-HHHHH---------H
T ss_pred ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch--------h-HH-HHhhc---------c
Confidence 23456899999999997654 789999999999999999999999643210 0 00 00000 0
Q ss_pred hhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 616 ARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 616 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.......+......+.+++.+||+.||++||++.++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 241 FKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp HCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 001111222234567788999999999999999999863
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=362.35 Aligned_cols=267 Identities=23% Similarity=0.285 Sum_probs=212.3
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC--CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecC--eEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN--SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKG--EILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV~ 455 (711)
++|...++||+|+||+||+|.+..+++.||||++... ....+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 5688999999999999999999988999999998753 244577889999999999999999999998755 789999
Q ss_pred EcCCCCCHHHHHhhCC--CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEE----cCCCcEEEeecCCcee
Q 043702 456 DLMPNGSLDKALFEAR--SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIML----DEGFNARLGDFGLARQ 529 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl----d~~~~vkL~DFGla~~ 529 (711)
||+++|+|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 9999999999996533 2399999999999999999999998 99999999999999 7788899999999987
Q ss_pred cCCCCCCCcccccCCCcccChhhhcc--------CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHH
Q 043702 530 VEHDKSPDATVAAGTMGYLAPEYLLT--------GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWV 601 (711)
Q Consensus 530 ~~~~~~~~~~~~~gt~~y~APE~~~~--------~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~ 601 (711)
...... .....||+.|+|||++.. ..++.++|||||||++|||++|+.||...... ....+.+
T Consensus 166 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~-------~~~~~~~ 236 (396)
T 4eut_A 166 LEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP-------RRNKEVM 236 (396)
T ss_dssp CCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCT-------TTCHHHH
T ss_pred ccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcc-------cchHHHH
Confidence 654332 233569999999999875 56788999999999999999999999753221 1111222
Q ss_pred HHhhhcCchh------Hhh--------hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 602 WSLHREGRLL------TAA--------DARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 602 ~~~~~~~~~~------~~~--------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
.......... ... +..............+.+++.+||+.||++||+++|+++.+...
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp HHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence 2222111000 000 00111234466777888999999999999999999999988664
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=351.61 Aligned_cols=247 Identities=23% Similarity=0.337 Sum_probs=194.4
Q ss_pred cCCcccceeecCCceEEEEEEeC---CCCeEEEEEEcccCC-----CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILP---QNGDIIAVKRCSHNS-----QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEI 451 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~---~~~~~vavK~~~~~~-----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 451 (711)
++|+..+.||+|+||.||+++.. .+++.||+|++.... .....+.+|++++++++||||+++++++...+.+
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 57899999999999999999984 578999999987532 2345678999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecC
Q 043702 452 LLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVE 531 (711)
Q Consensus 452 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~ 531 (711)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 97 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 97 YLILEYLSGGELFMQLER-EGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp EEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred EEEEeCCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 999999999999999965 34689999999999999999999998 99999999999999999999999999998643
Q ss_pred CCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchh
Q 043702 532 HDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLL 611 (711)
Q Consensus 532 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 611 (711)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+........ .
T Consensus 173 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----------~~~~~~i~~~-~-- 237 (327)
T 3a62_A 173 HDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR-----------KKTIDKILKC-K-- 237 (327)
T ss_dssp -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----------HHHHHHHHHT-C--
T ss_pred cCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH-----------HHHHHHHHhC-C--
Confidence 3222 23345799999999999999999999999999999999999999975321 1111111110 0
Q ss_pred HhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 043702 612 TAADARLEGQFDEAEMRRVLLVGLACSHPDPLARP-----TMRGVVQ 653 (711)
Q Consensus 612 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVl~ 653 (711)
..++......+.+++.+||+.||.+|| ++.|+++
T Consensus 238 --------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 238 --------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp --------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred --------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 011122235677889999999999999 7888886
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=365.98 Aligned_cols=251 Identities=21% Similarity=0.349 Sum_probs=208.2
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
++|...+.||+|+||.||+|++..+|+.||||++... ....+.+.+|+++++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 5788999999999999999999889999999998652 234567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 96 E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~- 170 (476)
T 2y94_A 96 EYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE- 170 (476)
T ss_dssp ECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC-
T ss_pred eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccccc-
Confidence 99999999999964 45799999999999999999999997 99999999999999999999999999999765432
Q ss_pred CCcccccCCCcccChhhhccCCC-CccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhh
Q 043702 536 PDATVAAGTMGYLAPEYLLTGRA-TEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 614 (711)
.....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... .+.... ...+..
T Consensus 171 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-----------~~~~~~-i~~~~~---- 233 (476)
T 2y94_A 171 -FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV-----------PTLFKK-ICDGIF---- 233 (476)
T ss_dssp -CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS-----------HHHHHH-HHTTCC----
T ss_pred -cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH-----------HHHHHH-HhcCCc----
Confidence 2334579999999999988765 7899999999999999999999975321 111111 111111
Q ss_pred hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--HHhCC
Q 043702 615 DARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ--MLVGE 658 (711)
Q Consensus 615 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~--~L~~~ 658 (711)
..+......+.+++.+||+.||.+|||++|+++ .+...
T Consensus 234 ------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 234 ------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred ------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 011112245778899999999999999999997 55543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=351.02 Aligned_cols=261 Identities=25% Similarity=0.435 Sum_probs=198.4
Q ss_pred HHHHHhcCCcccceeecCCceEEEEEEeCC---CCeEEEEEEcccCCC---ChhhhHHHHHHHHhcCCCCeeeeeeeeee
Q 043702 374 ELRSATKCFNANRIIGHGAFGTVYKGILPQ---NGDIIAVKRCSHNSQ---GKDEFLSELSIIGTLRHRNLVRLQGWCHE 447 (711)
Q Consensus 374 el~~at~~f~~~~~LG~G~fg~Vy~~~~~~---~~~~vavK~~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 447 (711)
++....++|...+.||+|+||.||+|.... ++..||+|++..... ..+.+.+|+.++++++||||+++++++.+
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 333455789999999999999999998754 456899999876432 23568899999999999999999999987
Q ss_pred cC-----eEEEEEEcCCCCCHHHHHhh-----CCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCC
Q 043702 448 KG-----EILLVYDLMPNGSLDKALFE-----ARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGF 517 (711)
Q Consensus 448 ~~-----~~~lV~Ey~~~gsL~~~l~~-----~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~ 517 (711)
.+ ..++||||+++|+|.+++.. ....+++..+++++.||++||.|||+. +|+||||||+|||++.++
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDM 184 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTS
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCC
Confidence 54 35999999999999999853 335699999999999999999999997 999999999999999999
Q ss_pred cEEEeecCCceecCCCCC-CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCcccccccccccccc
Q 043702 518 NARLGDFGLARQVEHDKS-PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVAS 595 (711)
Q Consensus 518 ~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~ 595 (711)
.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||..... .
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~ 256 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN--------H 256 (313)
T ss_dssp CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--------G
T ss_pred cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH--------H
Confidence 999999999987654332 12233457889999999999999999999999999999999 8899865322 1
Q ss_pred chHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 596 NLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 596 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
.+.... . .+. ...........+.+++.+||+.||.+||++.++++.|+..
T Consensus 257 ~~~~~~---~-~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 257 EMYDYL---L-HGH---------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp GHHHHH---H-TTC---------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHH---H-cCC---------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111111 1 110 1111222335678899999999999999999999999754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=340.55 Aligned_cols=245 Identities=26% Similarity=0.395 Sum_probs=205.2
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
++|...+.||+|+||.||+|....+++.||+|++... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 5788999999999999999999888999999998642 334567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
||+++|+|.+++... ..+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 94 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~- 168 (284)
T 2vgo_A 94 EFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR- 168 (284)
T ss_dssp CCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC-
T ss_pred EeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcccc-
Confidence 999999999999654 4689999999999999999999997 99999999999999999999999999997654322
Q ss_pred CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhh
Q 043702 536 PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 615 (711)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||..... .+....... . +
T Consensus 169 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----------~~~~~~~~~-~------~ 228 (284)
T 2vgo_A 169 --RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH-----------TETHRRIVN-V------D 228 (284)
T ss_dssp --BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----------HHHHHHHHT-T------C
T ss_pred --cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH-----------hHHHHHHhc-c------c
Confidence 2345699999999999999999999999999999999999999965321 111111111 0 1
Q ss_pred hhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 616 ARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 616 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
. .++......+.+++.+||+.||.+||+++++++
T Consensus 229 ~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 229 L----KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp C----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c----CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 1 111222345778899999999999999999997
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=342.66 Aligned_cols=253 Identities=24% Similarity=0.351 Sum_probs=205.4
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC--CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN--SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
.++|+..+.||+|+||.||+|....+++.||+|++... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 45789999999999999999999888999999998653 2345678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC-
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS- 535 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~- 535 (711)
|+++++|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 86 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 86 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred ecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 9999999998853 45699999999999999999999998 999999999999999999999999999987643221
Q ss_pred CCcccccCCCcccChhhhccCCC-CccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhh
Q 043702 536 PDATVAAGTMGYLAPEYLLTGRA-TEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 614 (711)
.......|++.|+|||.+.+..+ +.++|||||||++|||++|+.||...... ......|. .......
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~----~~~~~~~-- 229 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS------CQEYSDWK----EKKTYLN-- 229 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT------SHHHHHHH----TTCTTST--
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH------HHHHHHhh----hcccccC--
Confidence 22334568999999999987665 78999999999999999999999754221 01111111 1100000
Q ss_pred hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 615 DARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 615 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
........+.+++.+||+.||.+|||++|+++.
T Consensus 230 -------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 230 -------PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp -------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 001123456788999999999999999999874
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=352.29 Aligned_cols=267 Identities=25% Similarity=0.302 Sum_probs=201.9
Q ss_pred HHHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC------ChhhhHHHHHHHHhcCCCCeeeeeeeeeecC
Q 043702 376 RSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ------GKDEFLSELSIIGTLRHRNLVRLQGWCHEKG 449 (711)
Q Consensus 376 ~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 449 (711)
....++|...+.||+|+||.||+|++..+|+.||||++..... ..+.+.+|++++++++||||+++++++...+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 3445789999999999999999999988899999999875221 1356889999999999999999999999999
Q ss_pred eEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCcee
Q 043702 450 EILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQ 529 (711)
Q Consensus 450 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~ 529 (711)
..++||||+++ +|..++......+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 99999999976 89999977777899999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCCCcccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcC
Q 043702 530 VEHDKSPDATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREG 608 (711)
Q Consensus 530 ~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 608 (711)
...... ......||+.|+|||.+.+. .++.++|||||||++|||++|.+||...... ..+.. ........
T Consensus 162 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~-------~~~~~-i~~~~~~~ 232 (346)
T 1ua2_A 162 FGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-------DQLTR-IFETLGTP 232 (346)
T ss_dssp TTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHH-HHHHHCCC
T ss_pred ccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-------HHHHH-HHHHcCCC
Confidence 654332 23345789999999999764 5899999999999999999999998654210 01111 11100000
Q ss_pred chhHh------hhh---hccCCCc-----HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 043702 609 RLLTA------ADA---RLEGQFD-----EAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655 (711)
Q Consensus 609 ~~~~~------~d~---~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L 655 (711)
..... .+. ....... ......+.+++.+||+.||.+|||+.|+++.-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 233 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp CTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred ChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 00000 000 0000000 11235678899999999999999999999854
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=336.42 Aligned_cols=250 Identities=23% Similarity=0.312 Sum_probs=202.0
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC-------CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS-------QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEIL 452 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 452 (711)
++|...+.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|++++++++||||+++++++...+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56889999999999999999998889999999886532 13567899999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCC----cEEEeecCCce
Q 043702 453 LVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGF----NARLGDFGLAR 528 (711)
Q Consensus 453 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~----~vkL~DFGla~ 528 (711)
+||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++ .+||+|||+++
T Consensus 85 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 99999999999999965 35699999999999999999999998 999999999999998877 89999999998
Q ss_pred ecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcC
Q 043702 529 QVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREG 608 (711)
Q Consensus 529 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 608 (711)
....... .....|++.|+|||.+....++.++||||||+++|||++|+.||..... .+..... ...
T Consensus 161 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----------~~~~~~~-~~~ 226 (283)
T 3bhy_A 161 KIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK-----------QETLTNI-SAV 226 (283)
T ss_dssp ECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH-----------HHHHHHH-HTT
T ss_pred eccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch-----------HHHHHHh-Hhc
Confidence 7654332 2335689999999999999999999999999999999999999965321 0111111 110
Q ss_pred chhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 609 RLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 609 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
... ....... .....+.+++.+||+.||.+||++.|+++
T Consensus 227 ~~~--~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 227 NYD--FDEEYFS----NTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp CCC--CCHHHHT----TCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccC--Ccchhcc----cCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 000 0000001 11345778999999999999999999997
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=354.73 Aligned_cols=256 Identities=28% Similarity=0.415 Sum_probs=202.0
Q ss_pred cCCcccceeecCCceEEEEEEe-----CCCCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGIL-----PQNGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEIL 452 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~-----~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 452 (711)
++|...+.||+|+||.||+|++ ..++..||||++.... ....++.+|+.++++++||||+++++++...+..+
T Consensus 30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (327)
T 2yfx_A 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 109 (327)
T ss_dssp GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcE
Confidence 5788999999999999999994 4567889999987532 33457889999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhhCC------CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcC---CCcEEEee
Q 043702 453 LVYDLMPNGSLDKALFEAR------SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDE---GFNARLGD 523 (711)
Q Consensus 453 lV~Ey~~~gsL~~~l~~~~------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~---~~~vkL~D 523 (711)
+||||+++|+|.+++.... ..+++..++.++.|++.||.|||+. +|+||||||+|||++. +..+||+|
T Consensus 110 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~D 186 (327)
T 2yfx_A 110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGD 186 (327)
T ss_dssp EEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEECc
Confidence 9999999999999998654 4589999999999999999999998 9999999999999984 45699999
Q ss_pred cCCceecCCCCC-CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHH
Q 043702 524 FGLARQVEHDKS-PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWV 601 (711)
Q Consensus 524 FGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~ 601 (711)
||+++....... .......||+.|+|||.+.+..++.++|||||||++|||++ |+.||..... ..+.+.
T Consensus 187 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~~~~~- 257 (327)
T 2yfx_A 187 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--------QEVLEF- 257 (327)
T ss_dssp CHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHHHHH-
T ss_pred cccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH--------HHHHHH-
Confidence 999986543322 22234568999999999999999999999999999999998 9999865321 111111
Q ss_pred HHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC
Q 043702 602 WSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEA 659 (711)
Q Consensus 602 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~ 659 (711)
...+.. ..........+.+++.+||+.||.+||++.++++.|+...
T Consensus 258 ---~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 258 ---VTSGGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp ---HHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HhcCCC---------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 111110 1111222346778999999999999999999999987643
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=344.09 Aligned_cols=249 Identities=29% Similarity=0.426 Sum_probs=197.0
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeec-CeEEEEEEc
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEK-GEILLVYDL 457 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~lV~Ey 457 (711)
.++|+..+.||+|+||.||+|.. .++.||+|++.... ..+.+.+|++++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 45789999999999999999988 48899999987543 467899999999999999999999997654 478999999
Q ss_pred CCCCCHHHHHhhCCC-CCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCC
Q 043702 458 MPNGSLDKALFEARS-PLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP 536 (711)
Q Consensus 458 ~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~ 536 (711)
+++++|.+++..... .+++..+.+++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 171 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 171 (278)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence 999999999975432 388999999999999999999998 99999999999999999999999999998654322
Q ss_pred CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhhh
Q 043702 537 DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615 (711)
Q Consensus 537 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 615 (711)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+.. . ...+
T Consensus 172 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--------~~~~~---~-~~~~------- 230 (278)
T 1byg_A 172 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KDVVP---R-VEKG------- 230 (278)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--------GGHHH---H-HTTT-------
T ss_pred --cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHH---H-HhcC-------
Confidence 22357889999999999999999999999999999998 9999865321 11111 1 1111
Q ss_pred hhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 616 ARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 616 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
............+.+++.+||+.||.+||++.|+++.|+..
T Consensus 231 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 231 --YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 11111222345677889999999999999999999998753
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=356.42 Aligned_cols=254 Identities=24% Similarity=0.332 Sum_probs=187.8
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC-CChhhhHHHHHHHHhcC-CCCeeeeeeeee--------ec
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLR-HRNLVRLQGWCH--------EK 448 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~--------~~ 448 (711)
..+|...++||+|+||.||+|++..+++.||+|++.... ...+.+.+|+.++.++. ||||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 347889999999999999999998899999999886543 33467889999999996 999999999984 34
Q ss_pred CeEEEEEEcCCCCCHHHHHhh--CCCCCChHHHHHHHHHHHHHHHHHHhccCCC--eeeccCCCCceEEcCCCcEEEeec
Q 043702 449 GEILLVYDLMPNGSLDKALFE--ARSPLPWPHRSKILLGVASALAYLHQECENQ--VIHRDVKTSNIMLDEGFNARLGDF 524 (711)
Q Consensus 449 ~~~~lV~Ey~~~gsL~~~l~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~--ivHrDlkp~NILld~~~~vkL~DF 524 (711)
...++||||+. |+|.+++.. ....+++..+++++.||+.||+|||+. + |+||||||+|||++.++.+||+||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecC
Confidence 45899999995 799998864 456799999999999999999999997 7 999999999999999999999999
Q ss_pred CCceecCCCCCC-----------CcccccCCCcccChhhh---ccCCCCccccchhHHHHHHHHHhCCCCCccccccccc
Q 043702 525 GLARQVEHDKSP-----------DATVAAGTMGYLAPEYL---LTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGK 590 (711)
Q Consensus 525 Gla~~~~~~~~~-----------~~~~~~gt~~y~APE~~---~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~ 590 (711)
|+++........ ......||+.|+|||++ ....++.++|||||||++|||++|+.||......
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--- 259 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL--- 259 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH---
Confidence 999876543221 11234689999999998 5667899999999999999999999999653210
Q ss_pred cccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC
Q 043702 591 VGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEAE 660 (711)
Q Consensus 591 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 660 (711)
.. ... . ............+.+++.+||+.||.+||++.|+++.|+....
T Consensus 260 -----~~---~~~-----~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 260 -----RI---VNG-----K--------YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp ---------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----Hh---hcC-----c--------ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 00 000 0 0000001111236678899999999999999999999977543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=352.63 Aligned_cols=261 Identities=24% Similarity=0.413 Sum_probs=204.4
Q ss_pred ccCHHHHHHHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhc-CCCCeeeeeeeeee
Q 043702 369 EFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTL-RHRNLVRLQGWCHE 447 (711)
Q Consensus 369 ~~~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~ 447 (711)
.+.+.++....++|+..+.||+|+||.||+|++..+++.||||++.......+.+.+|+.+++++ +||||+++++++..
T Consensus 13 ~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp ---CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred hccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 34455566677899999999999999999999988899999999987666778899999999999 79999999999987
Q ss_pred ------cCeEEEEEEcCCCCCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEE
Q 043702 448 ------KGEILLVYDLMPNGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNAR 520 (711)
Q Consensus 448 ------~~~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vk 520 (711)
.+..++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+|
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEE
Confidence 468999999999999999997643 5699999999999999999999998 999999999999999999999
Q ss_pred EeecCCceecCCCCCCCcccccCCCcccChhhhc-----cCCCCccccchhHHHHHHHHHhCCCCCcccccccccccccc
Q 043702 521 LGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLL-----TGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVAS 595 (711)
Q Consensus 521 L~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~ 595 (711)
|+|||++........ ......||+.|+|||.+. ...++.++|||||||++|||++|+.||.....
T Consensus 170 l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------- 239 (326)
T 2x7f_A 170 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP--------- 239 (326)
T ss_dssp ECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH---------
T ss_pred EeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH---------
Confidence 999999987643321 223356999999999987 56789999999999999999999999964321
Q ss_pred chHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 596 NLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 596 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
.......... . .+... .......+.+++.+||+.||.+||++.++++
T Consensus 240 --~~~~~~~~~~-~-----~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 240 --MRALFLIPRN-P-----APRLK---SKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp --HHHHHHHHHS-C-----CCCCS---CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred --HHHHHHhhcC-c-----cccCC---ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0111111111 0 01110 1112345778889999999999999999997
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=355.06 Aligned_cols=255 Identities=22% Similarity=0.299 Sum_probs=206.1
Q ss_pred cCCcccceeecCCceEEEEEEeC---CCCeEEEEEEcccC-----CCChhhhHHHHHHHHhc-CCCCeeeeeeeeeecCe
Q 043702 380 KCFNANRIIGHGAFGTVYKGILP---QNGDIIAVKRCSHN-----SQGKDEFLSELSIIGTL-RHRNLVRLQGWCHEKGE 450 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~---~~~~~vavK~~~~~-----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 450 (711)
++|...+.||+|+||.||+|+.. .+++.||||++... ....+.+.+|+++++++ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 57899999999999999999984 47899999998652 23456788999999999 59999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceec
Q 043702 451 ILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV 530 (711)
Q Consensus 451 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~ 530 (711)
.++||||+++|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++..
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred EEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 99999999999999999753 4699999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCCCcccccCCCcccChhhhccC--CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcC
Q 043702 531 EHDKSPDATVAAGTMGYLAPEYLLTG--RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREG 608 (711)
Q Consensus 531 ~~~~~~~~~~~~gt~~y~APE~~~~~--~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 608 (711)
...........+||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .............
T Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-------~~~~~~~~~~~~~- 281 (355)
T 1vzo_A 210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK-------NSQAEISRRILKS- 281 (355)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC-------CCHHHHHHHHHHC-
T ss_pred ccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCcc-------chHHHHHHHHhcc-
Confidence 54433334456799999999999863 4789999999999999999999999753221 1111211111110
Q ss_pred chhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHHh
Q 043702 609 RLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARP-----TMRGVVQMLV 656 (711)
Q Consensus 609 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVl~~L~ 656 (711)
...++.+....+.+++.+||+.||.+|| +++|+++...
T Consensus 282 ----------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 282 ----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp ----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred ----------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 1112223335577889999999999999 9999998653
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=358.89 Aligned_cols=246 Identities=25% Similarity=0.302 Sum_probs=193.4
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC----CChhhhHHHHHH-HHhcCCCCeeeeeeeeeecCeEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS----QGKDEFLSELSI-IGTLRHRNLVRLQGWCHEKGEILLV 454 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~-l~~l~H~niv~l~g~~~~~~~~~lV 454 (711)
++|+..+.||+|+||+||+|+++.+++.||+|++.... .....+.+|..+ ++.++||||+++++++...+.+++|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 46888999999999999999999999999999987532 234456777776 5778999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCC
Q 043702 455 YDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~ 534 (711)
|||+++|+|..++.. ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 118 ~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~ 193 (373)
T 2r5t_A 118 LDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 193 (373)
T ss_dssp EECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence 999999999999965 34688999999999999999999998 99999999999999999999999999998643322
Q ss_pred CCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhh
Q 043702 535 SPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614 (711)
Q Consensus 535 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 614 (711)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+....... +.
T Consensus 194 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----------~~~~~~i~~-~~----- 255 (373)
T 2r5t_A 194 -STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-----------AEMYDNILN-KP----- 255 (373)
T ss_dssp -CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH-----------HHHHHHHHH-SC-----
T ss_pred -CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----------HHHHHHHHh-cc-----
Confidence 234456899999999999999999999999999999999999999965321 111111111 11
Q ss_pred hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHH
Q 043702 615 DARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVV 652 (711)
Q Consensus 615 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl 652 (711)
+ .+.......+.+++.+||+.||.+||++.+.+
T Consensus 256 ---~--~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 256 ---L--QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp ---C--CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred ---c--CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 1 11112234577888999999999999985433
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=345.14 Aligned_cols=252 Identities=25% Similarity=0.384 Sum_probs=204.1
Q ss_pred HhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEc
Q 043702 378 ATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 378 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
..+.|+..+.||+|+||.||+|.+..+|+.||+|++.... ..+++.+|++++++++||||+++++++...+..++||||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY 105 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence 3467999999999999999999998889999999987643 457899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC
Q 043702 458 MPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD 537 (711)
Q Consensus 458 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 537 (711)
+++++|.+++......+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++........ .
T Consensus 106 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~ 181 (314)
T 3com_A 106 CGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-K 181 (314)
T ss_dssp CTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-C
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-c
Confidence 999999999976677899999999999999999999998 999999999999999999999999999987654322 2
Q ss_pred cccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhh
Q 043702 538 ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADAR 617 (711)
Q Consensus 538 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 617 (711)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||..... .......... . .+.
T Consensus 182 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----------~~~~~~~~~~-~-----~~~ 244 (314)
T 3com_A 182 RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP-----------MRAIFMIPTN-P-----PPT 244 (314)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH-----------HHHHHHHHHS-C-----CCC
T ss_pred cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh-----------HHHHHHHhcC-C-----Ccc
Confidence 3345689999999999999999999999999999999999999965321 0111111111 0 000
Q ss_pred ccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 618 LEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 618 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
. .........+.+++.+||+.||.+||++.++++
T Consensus 245 ~--~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 245 F--RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp C--SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred c--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0 011112346778999999999999999999987
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=365.19 Aligned_cols=263 Identities=22% Similarity=0.246 Sum_probs=196.9
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC---CChhhhHHHHHHHHhcCCCCeeeeeeeeeec------C
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---QGKDEFLSELSIIGTLRHRNLVRLQGWCHEK------G 449 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~ 449 (711)
.++|+..+.||+|+||+||+|++..+++.||||++.... ...+.+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 468999999999999999999999999999999987532 2346788999999999999999999999654 4
Q ss_pred eEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCcee
Q 043702 450 EILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQ 529 (711)
Q Consensus 450 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~ 529 (711)
..++||||+++ +|.+.+. ..+++.++..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++.
T Consensus 141 ~~~lv~E~~~~-~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp EEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred eEEEEEeCCCC-CHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 67999999976 5666663 3489999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHH--------H-
Q 043702 530 VEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVE--------W- 600 (711)
Q Consensus 530 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~--------~- 600 (711)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+.+ +
T Consensus 214 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~----~~~~i~~~lg~p~~~~~ 287 (464)
T 3ttj_A 214 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID----QWNKVIEQLGTPCPEFM 287 (464)
T ss_dssp ---CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHHHCSCCHHHH
T ss_pred cCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHhcCCCCHHHH
Confidence 65432 2345679999999999999999999999999999999999999997542100 0000000 0
Q ss_pred ------HHHhhhcC------chhHhhhhhcc---CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 601 ------VWSLHREG------RLLTAADARLE---GQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 601 ------~~~~~~~~------~~~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
........ .........+. ..........+.+|+.+||+.||.+|||++|+++.
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 00000000000 00111224578899999999999999999999974
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=373.80 Aligned_cols=252 Identities=26% Similarity=0.391 Sum_probs=208.6
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEccc----CCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSH----NSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLV 454 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 454 (711)
.++|...++||+|+||.||+|++..+|+.||+|++.. .......+.+|+++|+.++||||+++++++.+.+.+++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 3568999999999999999999998999999999865 234456788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCC
Q 043702 455 YDLMPNGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHD 533 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~ 533 (711)
|||+++|+|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 99999999999997643 3599999999999999999999998 9999999999999999999999999999877543
Q ss_pred CCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHh
Q 043702 534 KSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTA 613 (711)
Q Consensus 534 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 613 (711)
. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....+ +.......
T Consensus 340 ~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~-------~~~~~-i~~~i~~~----- 404 (576)
T 2acx_A 340 Q--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK-------IKREE-VERLVKEV----- 404 (576)
T ss_dssp C--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSC-------CCHHH-HHHHHHHC-----
T ss_pred c--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccc-------hhHHH-HHHHhhcc-----
Confidence 3 233457999999999999989999999999999999999999999754221 01111 11111110
Q ss_pred hhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 043702 614 ADARLEGQFDEAEMRRVLLVGLACSHPDPLARP-----TMRGVVQ 653 (711)
Q Consensus 614 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVl~ 653 (711)
...+.......+.+++.+||+.||.+|| +++||++
T Consensus 405 -----~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 405 -----PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred -----cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 1112222335677889999999999999 7899886
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=347.62 Aligned_cols=270 Identities=25% Similarity=0.341 Sum_probs=209.3
Q ss_pred HHHHHHHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHh--cCCCCeeeeeeeeeecC
Q 043702 372 YRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGT--LRHRNLVRLQGWCHEKG 449 (711)
Q Consensus 372 ~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~~~~ 449 (711)
+..-....++|...+.||+|+||.||+|++ +++.||||++... ..+.+.+|.+++.. ++||||+++++++...+
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 333445667899999999999999999998 5899999998643 35678889999988 78999999999998775
Q ss_pred ----eEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhcc-----CCCeeeccCCCCceEEcCCCcEE
Q 043702 450 ----EILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQEC-----ENQVIHRDVKTSNIMLDEGFNAR 520 (711)
Q Consensus 450 ----~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-----~~~ivHrDlkp~NILld~~~~vk 520 (711)
..++||||+++|+|.+++.. ..+++.++++++.|++.||+|||... ..+|+||||||+|||++.++.+|
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~k 187 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 187 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEE
T ss_pred CccceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEE
Confidence 79999999999999999965 36899999999999999999999210 13999999999999999999999
Q ss_pred EeecCCceecCCCCCC---CcccccCCCcccChhhhccCC------CCccccchhHHHHHHHHHhC----------CCCC
Q 043702 521 LGDFGLARQVEHDKSP---DATVAAGTMGYLAPEYLLTGR------ATEKTDVFSYGAVVLEVASG----------RRPI 581 (711)
Q Consensus 521 L~DFGla~~~~~~~~~---~~~~~~gt~~y~APE~~~~~~------~s~ksDVwSfGvll~elltG----------~~P~ 581 (711)
|+|||+++........ ......||+.|+|||.+.... ++.++|||||||++|||++| +.||
T Consensus 188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~ 267 (342)
T 1b6c_B 188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267 (342)
T ss_dssp ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence 9999999876544321 123456999999999997763 33689999999999999999 6677
Q ss_pred ccccccccccccccchHHHHHHhhhcCchhHhhhhhccCC-CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 582 EKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQ-FDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 582 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
...... ......+.... ..... .+.+... ...+....+.+++.+||+.||.+||++.+|++.|+..
T Consensus 268 ~~~~~~------~~~~~~~~~~~-~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 268 YDLVPS------DPSVEEMRKVV-CEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp TTTSCS------SCCHHHHHHHH-TTSCC----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCcC------cccHHHHHHHH-HHHHh----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 543221 01112222111 11111 1111111 1235667889999999999999999999999999754
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=351.33 Aligned_cols=263 Identities=23% Similarity=0.322 Sum_probs=203.2
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC---CChhhhHHHHHHHHhcCCCCeeeeeeeeee--------c
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---QGKDEFLSELSIIGTLRHRNLVRLQGWCHE--------K 448 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--------~ 448 (711)
++|+..+.||+|+||.||+|++..+|+.||+|++.... .....+.+|++++++++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 57899999999999999999998899999999986532 234578899999999999999999999987 4
Q ss_pred CeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCce
Q 043702 449 GEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLAR 528 (711)
Q Consensus 449 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~ 528 (711)
+..++||||+++ +|...+......+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred ceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 568999999975 88888877777899999999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCC---CCcccccCCCcccChhhhcc-CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHh
Q 043702 529 QVEHDKS---PDATVAAGTMGYLAPEYLLT-GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSL 604 (711)
Q Consensus 529 ~~~~~~~---~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~ 604 (711)
.+..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+...
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~~ 244 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE--------QHQLALISQL 244 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHH
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHHH
Confidence 7653222 22344578999999999876 4579999999999999999999999975422 1111111111
Q ss_pred hhcC--chhHhhh-hhc--------cCCCc-HHH------HHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 605 HREG--RLLTAAD-ARL--------EGQFD-EAE------MRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 605 ~~~~--~~~~~~d-~~l--------~~~~~-~~~------~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
...- ......+ ... ..... .+. ...+.+|+.+||+.||.+|||++|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 245 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp HCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0000 0000000 000 00000 011 2347789999999999999999999984
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=351.12 Aligned_cols=251 Identities=25% Similarity=0.421 Sum_probs=207.3
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC----CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS----QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
++|...+.||+|+||.||++.+..+++.+|+|++.... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 46788899999999999999999889999999986532 23467889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
||+++++|.+++.. ...+++.+++.++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 121 e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 196 (335)
T 2owb_A 121 ELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 196 (335)
T ss_dssp CCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred ecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence 99999999998865 35799999999999999999999998 999999999999999999999999999987654332
Q ss_pred CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhh
Q 043702 536 PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 615 (711)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+...... .+.
T Consensus 197 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----------~~~~~~~~-~~~------ 257 (335)
T 2owb_A 197 -RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-----------KETYLRIK-KNE------ 257 (335)
T ss_dssp -CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-----------HHHHHHHH-HTC------
T ss_pred -cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH-----------HHHHHHHh-cCC------
Confidence 23345799999999999999999999999999999999999999965321 11111111 111
Q ss_pred hhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--HHhC
Q 043702 616 ARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ--MLVG 657 (711)
Q Consensus 616 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~--~L~~ 657 (711)
..+... ....+.+++.+||+.||.+||+++|+++ .+..
T Consensus 258 ~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~ 297 (335)
T 2owb_A 258 YSIPKH----INPVAASLIQKMLQTDPTARPTINELLNDEFFTS 297 (335)
T ss_dssp CCCCTT----SCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred CCCCcc----CCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 011111 2245678889999999999999999997 4544
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=382.19 Aligned_cols=246 Identities=26% Similarity=0.392 Sum_probs=197.3
Q ss_pred ceeecCCceEEEEEEe--CCCCeEEEEEEcccCC---CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCCC
Q 043702 386 RIIGHGAFGTVYKGIL--PQNGDIIAVKRCSHNS---QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPN 460 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~--~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 460 (711)
++||+|+||.||+|.+ ...++.||||++.... ...+++.+|+++|++++||||++++++|.. +..++|||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999965 4456889999987632 235789999999999999999999999964 568999999999
Q ss_pred CCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC--CCc
Q 043702 461 GSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS--PDA 538 (711)
Q Consensus 461 gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~--~~~ 538 (711)
|+|.+++.. ...+++..++.|+.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++.+..... ...
T Consensus 454 g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 454 GPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp EEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred CCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 999999965 45799999999999999999999998 999999999999999999999999999987754432 122
Q ss_pred ccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhh
Q 043702 539 TVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADAR 617 (711)
Q Consensus 539 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 617 (711)
....+|+.|+|||++....++.++|||||||++|||++ |+.||..... ..+ ......+.
T Consensus 530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--------~~~----~~~i~~~~-------- 589 (635)
T 4fl3_A 530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SEV----TAMLEKGE-------- 589 (635)
T ss_dssp -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHH----HHHHHTTC--------
T ss_pred cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHH----HHHHHcCC--------
Confidence 33457889999999999999999999999999999998 9999965422 111 11111111
Q ss_pred ccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 618 LEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 618 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
....+......+.+++.+||+.||++||++.+|++.|+.
T Consensus 590 -~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 590 -RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred -CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 112222334667889999999999999999999999874
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=368.03 Aligned_cols=252 Identities=24% Similarity=0.356 Sum_probs=207.3
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
++|...++||+|+||.||+|++..+|+.||+|++... ....+.+.+|++++++++||||+++++++...+.+++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 6788899999999999999999989999999998652 344567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCC---CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCC
Q 043702 456 DLMPNGSLDKALFEAR---SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEH 532 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~ 532 (711)
||+++|+|..++.... ..+++..++.++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++.+..
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 9999999999997543 4699999999999999999999998 999999999999999999999999999997754
Q ss_pred CCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhH
Q 043702 533 DKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLT 612 (711)
Q Consensus 533 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 612 (711)
... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....+....... +.
T Consensus 342 ~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~-------~~~~~~~~~i~~-~~--- 409 (543)
T 3c4z_A 342 GQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK-------VENKELKQRVLE-QA--- 409 (543)
T ss_dssp TCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC-------CCHHHHHHHHHH-CC---
T ss_pred CCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccc-------hhHHHHHHHHhh-cc---
Confidence 432 233457999999999999999999999999999999999999999754211 111111111111 00
Q ss_pred hhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCH-----HHHHH
Q 043702 613 AADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTM-----RGVVQ 653 (711)
Q Consensus 613 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~eVl~ 653 (711)
..++......+.+++.+||+.||.+||++ +++++
T Consensus 410 -------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 410 -------VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp -------CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred -------cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 11222233567788899999999999975 66764
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=343.93 Aligned_cols=257 Identities=21% Similarity=0.265 Sum_probs=202.1
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcC-CCCeeeeeeeeee--cCeEEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLR-HRNLVRLQGWCHE--KGEILLVYD 456 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~--~~~~~lV~E 456 (711)
++|+..+.||+|+||+||+|++..+++.||+|++.. ...+.+.+|++++++++ ||||+++++++.. ....++|||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e 113 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP--VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 113 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS--CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc--cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence 568899999999999999999988999999999864 34578999999999998 9999999999987 667899999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCC-cEEEeecCCceecCCCCC
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGF-NARLGDFGLARQVEHDKS 535 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~-~vkL~DFGla~~~~~~~~ 535 (711)
|+++++|.+++. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+++.......
T Consensus 114 ~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~ 186 (330)
T 3nsz_A 114 HVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 186 (330)
T ss_dssp CCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC
T ss_pred ccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc
Confidence 999999999884 388999999999999999999998 999999999999999776 899999999987654432
Q ss_pred CCcccccCCCcccChhhhcc-CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhh
Q 043702 536 PDATVAAGTMGYLAPEYLLT-GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 614 (711)
.....|++.|+|||.+.+ ..++.++|||||||++|||++|+.||...... ...+.... .......+...+
T Consensus 187 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~------~~~l~~~~-~~~~~~~~~~~~ 257 (330)
T 3nsz_A 187 --YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN------YDQLVRIA-KVLGTEDLYDYI 257 (330)
T ss_dssp --CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH------HHHHHHHH-HHHCHHHHHHHH
T ss_pred --cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch------HHHHHHHH-HhcCCchhhhHH
Confidence 234568999999999987 67899999999999999999999999543211 00111100 000000010100
Q ss_pred hh-----------------------hccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 615 DA-----------------------RLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 615 d~-----------------------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
+. .............+.+++.+||+.||.+|||++|+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00 00011111124567889999999999999999999973
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=342.57 Aligned_cols=247 Identities=24% Similarity=0.360 Sum_probs=198.9
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC---CChhhhHHHHHHHHhcCCCCeeeeeeeeee----cCeEEE
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---QGKDEFLSELSIIGTLRHRNLVRLQGWCHE----KGEILL 453 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~l 453 (711)
.|...+.||+|+||.||+|.+..++..||+|++.... ...+.+.+|+.++++++||||+++++++.. ...+++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 4777889999999999999999899999999987532 234578899999999999999999999875 356899
Q ss_pred EEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCC--eeeccCCCCceEEc-CCCcEEEeecCCceec
Q 043702 454 VYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQ--VIHRDVKTSNIMLD-EGFNARLGDFGLARQV 530 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~--ivHrDlkp~NILld-~~~~vkL~DFGla~~~ 530 (711)
||||+++|+|.+++... ..+++..++.++.|++.||.|||+. + |+||||||+|||++ +++.+||+|||++...
T Consensus 107 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 99999999999999653 5689999999999999999999997 6 99999999999997 7899999999999754
Q ss_pred CCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCch
Q 043702 531 EHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRL 610 (711)
Q Consensus 531 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 610 (711)
... ......||+.|+|||.+. +.++.++|||||||++|||++|+.||..... ........ ..+..
T Consensus 183 ~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----------~~~~~~~~-~~~~~ 247 (290)
T 1t4h_A 183 RAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN----------AAQIYRRV-TSGVK 247 (290)
T ss_dssp CTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----------HHHHHHHH-TTTCC
T ss_pred ccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc----------HHHHHHHH-hccCC
Confidence 332 233456999999999876 5689999999999999999999999965321 11111111 11111
Q ss_pred hHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 611 LTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 611 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.... +......+.+++.+||+.||.+|||+.|+++.
T Consensus 248 ~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 248 PASF--------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp CGGG--------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccc--------CCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1111 11112457788999999999999999999973
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=343.44 Aligned_cols=249 Identities=26% Similarity=0.420 Sum_probs=206.4
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC----CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS----QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLV 454 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 454 (711)
.++|...+.||+|+||.||++.+..+++.+|+|++.... ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 357889999999999999999999889999999986532 2345788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCC
Q 043702 455 YDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~ 534 (711)
|||+++++|.+++.. ...+++.++..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 94 ~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 94 LELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 999999999998864 35799999999999999999999998 99999999999999999999999999998765433
Q ss_pred CCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhh
Q 043702 535 SPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614 (711)
Q Consensus 535 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 614 (711)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .+..... ..+..
T Consensus 170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----------~~~~~~~-~~~~~---- 232 (294)
T 2rku_A 170 E-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-----------KETYLRI-KKNEY---- 232 (294)
T ss_dssp C-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-----------HHHHHHH-HTTCC----
T ss_pred c-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----------HHHHHHH-hhccC----
Confidence 2 23345699999999999998899999999999999999999999965321 1111111 11110
Q ss_pred hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 615 DARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 615 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.+ +......+.+++.+||+.||++||+++|+++.
T Consensus 233 --~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 233 --SI----PKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp --CC----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred --CC----ccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11 11223457788899999999999999999973
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=344.09 Aligned_cols=253 Identities=28% Similarity=0.433 Sum_probs=199.0
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeee-----------
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHE----------- 447 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----------- 447 (711)
.++|+..+.||+|+||.||+|+...+++.||||++.......+.+.+|++++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 467899999999999999999998889999999987655556788999999999999999999998865
Q ss_pred --cCeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecC
Q 043702 448 --KGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFG 525 (711)
Q Consensus 448 --~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFG 525 (711)
.+..++||||+++|+|.+++......+++..++.++.|+++||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred ccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeCc
Confidence 4568999999999999999987777788999999999999999999998 99999999999999999999999999
Q ss_pred CceecCCCC-------------CCCcccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCcccccccccc
Q 043702 526 LARQVEHDK-------------SPDATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKV 591 (711)
Q Consensus 526 la~~~~~~~-------------~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~ 591 (711)
+++...... ........||+.|+|||.+.+. .++.++|||||||++|||++ ||.....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~----- 233 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME----- 233 (303)
T ss_dssp CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH-----
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh-----
Confidence 998764321 1122345689999999999764 68999999999999999998 5432110
Q ss_pred ccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 592 GVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 592 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
..+..... ... ...+...+.......+.+++.+||+.||.+|||++++++.
T Consensus 234 -----~~~~~~~~-~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 234 -----RVNILKKL-RSV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp -----HHHHHHHH-HST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -----HHHHHHhc-ccc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 01111111 110 1111222333444567889999999999999999999984
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=349.61 Aligned_cols=262 Identities=21% Similarity=0.308 Sum_probs=193.7
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC---CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
.++|...++||+|+||+||+|++..+++.||||++.... ...+.+.+|++++++++||||+++++++...+..++||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 357889999999999999999999899999999987533 22456889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEE-----cCCCcEEEeecCCceec
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIML-----DEGFNARLGDFGLARQV 530 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl-----d~~~~vkL~DFGla~~~ 530 (711)
||++ |+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||+ ++++.+||+|||+++..
T Consensus 113 e~~~-~~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 113 EYAE-NDLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp ECCS-EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred ecCC-CCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 9997 5999998654 4699999999999999999999998 99999999999999 45556999999999876
Q ss_pred CCCCCCCcccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhc--
Q 043702 531 EHDKSPDATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHRE-- 607 (711)
Q Consensus 531 ~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~-- 607 (711)
..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+..........
T Consensus 188 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~~~~~~~~~~~ 259 (329)
T 3gbz_A 188 GIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI-------DQLFKIFEVLGLPDD 259 (329)
T ss_dssp C------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHHHCCCCT
T ss_pred CCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH-------HHHHHHHHHhCCCch
Confidence 53322 23345689999999999875 4899999999999999999999999654220 0111111000000
Q ss_pred CchhHh--------hhhhccCC-----CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 608 GRLLTA--------ADARLEGQ-----FDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 608 ~~~~~~--------~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
...... ..+..... ........+.+++.+||+.||.+|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 000000 00000000 00012246778999999999999999999997
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=357.54 Aligned_cols=260 Identities=13% Similarity=0.126 Sum_probs=203.5
Q ss_pred cCCcccceeecCCceEEEEEEeCC--------CCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeee-----------
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQ--------NGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVR----------- 440 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~----------- 440 (711)
++|...+.||+|+||.||+|++.. .++.||+|++... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL 117 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence 578999999999999999999976 3789999998643 46889999999999999988
Q ss_pred ----eeeeeee-cCeEEEEEEcCCCCCHHHHHhhC-CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEc
Q 043702 441 ----LQGWCHE-KGEILLVYDLMPNGSLDKALFEA-RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLD 514 (711)
Q Consensus 441 ----l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld 514 (711)
+++++.. ++..++||||+ +++|.+++... ...+++..+++++.||+.||+|||+. +|+||||||+|||++
T Consensus 118 ~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 118 AIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVD 193 (352)
T ss_dssp SCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEEE
T ss_pred CccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEc
Confidence 6777776 67899999999 99999999765 36799999999999999999999998 999999999999999
Q ss_pred CCC--cEEEeecCCceecCCCCCC------CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccc
Q 043702 515 EGF--NARLGDFGLARQVEHDKSP------DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEIT 586 (711)
Q Consensus 515 ~~~--~vkL~DFGla~~~~~~~~~------~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~ 586 (711)
.++ .+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 273 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP 273 (352)
T ss_dssp TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence 998 8999999999876533211 12334799999999999999999999999999999999999999976421
Q ss_pred cccccccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 587 GVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 587 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
. ...+.......... .....+.... .......+.+++.+||+.||.+||++++|++.|+..
T Consensus 274 ~------~~~~~~~~~~~~~~--~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 334 (352)
T 2jii_A 274 N------TEDIMKQKQKFVDK--PGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL 334 (352)
T ss_dssp C------HHHHHHHHHHHHHS--CCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred C------HHHHHHHHHhccCC--hhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence 1 01111111111110 0000000000 001135677888999999999999999999998764
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=352.78 Aligned_cols=271 Identities=24% Similarity=0.340 Sum_probs=196.6
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHH--HHhcCCCCeeeeeeeeee-----cCeE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSI--IGTLRHRNLVRLQGWCHE-----KGEI 451 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~--l~~l~H~niv~l~g~~~~-----~~~~ 451 (711)
.++|...+.||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++||||+++++++.. ...+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN--RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 35789999999999999999988 68999999986533 3445555555 445889999999986543 3367
Q ss_pred EEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhcc------CCCeeeccCCCCceEEcCCCcEEEeecC
Q 043702 452 LLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQEC------ENQVIHRDVKTSNIMLDEGFNARLGDFG 525 (711)
Q Consensus 452 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~------~~~ivHrDlkp~NILld~~~~vkL~DFG 525 (711)
++||||+++|+|.+++... ..++..+.+++.||++||+|||+.+ .++|+||||||+|||++.++.+||+|||
T Consensus 88 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG 165 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165 (336)
T ss_dssp EEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred EEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence 9999999999999999654 3589999999999999999999863 2389999999999999999999999999
Q ss_pred CceecCCCCC-------CCcccccCCCcccChhhhcc-------CCCCccccchhHHHHHHHHHhCCCCCcccccccccc
Q 043702 526 LARQVEHDKS-------PDATVAAGTMGYLAPEYLLT-------GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKV 591 (711)
Q Consensus 526 la~~~~~~~~-------~~~~~~~gt~~y~APE~~~~-------~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~ 591 (711)
+++.+..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.|+..........
T Consensus 166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~ 245 (336)
T 3g2f_A 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245 (336)
T ss_dssp TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence 9987654321 12234569999999999976 355678999999999999999988774432211000
Q ss_pred cc-------ccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 592 GV-------ASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 592 ~~-------~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
.. .....++ ................. .........+.+++.+||+.||++|||++|+++.|+..
T Consensus 246 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 246 MAFQTEVGNHPTFEDM-QVLVSREKQRPKFPEAW--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316 (336)
T ss_dssp CTTHHHHCSSCCHHHH-HHHHTTSCCCCCCCTTC--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HhhhcccCCCchHHHH-HhhhcccccCCCCCccc--ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence 00 0000000 00000000000000000 01223556789999999999999999999999998764
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=351.07 Aligned_cols=263 Identities=19% Similarity=0.286 Sum_probs=208.1
Q ss_pred ccCHHHHHHHhcCCccc-ceeecCCceEEEEEEeCCCCeEEEEEEcccCC---CChhhhHHHHHHHHhcC-CCCeeeeee
Q 043702 369 EFSYRELRSATKCFNAN-RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---QGKDEFLSELSIIGTLR-HRNLVRLQG 443 (711)
Q Consensus 369 ~~~~~el~~at~~f~~~-~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~-H~niv~l~g 443 (711)
...++......+.|... +.||+|+||.||+|....+++.||+|++.... ....++.+|+.++..++ ||||+++++
T Consensus 17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~ 96 (327)
T 3lm5_A 17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96 (327)
T ss_dssp CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 34455556667778877 88999999999999999899999999987632 33568899999999996 699999999
Q ss_pred eeeecCeEEEEEEcCCCCCHHHHHhhC-CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcC---CCcE
Q 043702 444 WCHEKGEILLVYDLMPNGSLDKALFEA-RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDE---GFNA 519 (711)
Q Consensus 444 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~---~~~v 519 (711)
++...+..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++. ++.+
T Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~ 173 (327)
T 3lm5_A 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDI 173 (327)
T ss_dssp EEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCE
T ss_pred EEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcE
Confidence 999999999999999999999988643 35699999999999999999999998 9999999999999988 7899
Q ss_pred EEeecCCceecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHH
Q 043702 520 RLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVE 599 (711)
Q Consensus 520 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~ 599 (711)
||+|||+++....... .....||+.|+|||++....++.++|||||||++|||++|+.||..... .+
T Consensus 174 kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----------~~ 240 (327)
T 3lm5_A 174 KIVDFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN-----------QE 240 (327)
T ss_dssp EECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HH
T ss_pred EEeeCccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----------hH
Confidence 9999999987654322 2345799999999999999999999999999999999999999965321 01
Q ss_pred HHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 600 WVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 600 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
........ . ..............+.+++.+||+.||.+|||++|+++.
T Consensus 241 ~~~~i~~~-~------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 241 TYLNISQV-N------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHHHHHHT-C------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred HHHHHHhc-c------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 00010000 0 000111111223557788999999999999999999974
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=360.75 Aligned_cols=198 Identities=22% Similarity=0.329 Sum_probs=176.8
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhc------CCCCeeeeeeeeeecCeEE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTL------RHRNLVRLQGWCHEKGEIL 452 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l------~H~niv~l~g~~~~~~~~~ 452 (711)
..+|+..++||+|+||.||+|.+..+++.||||++.......+++.+|+++++.+ +|+||+++++++...+..+
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 4579999999999999999999998899999999976555556788899998887 4779999999999999999
Q ss_pred EEEEcCCCCCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCc--EEEeecCCcee
Q 043702 453 LVYDLMPNGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFN--ARLGDFGLARQ 529 (711)
Q Consensus 453 lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~--vkL~DFGla~~ 529 (711)
+||||+. ++|.+++.... ..+++..+++++.||+.||+|||+. +|+||||||+||||+.++. +||+|||+++.
T Consensus 176 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~ 251 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCY 251 (429)
T ss_dssp EEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence 9999996 69999987654 4599999999999999999999998 9999999999999999887 99999999986
Q ss_pred cCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccc
Q 043702 530 VEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKE 584 (711)
Q Consensus 530 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~ 584 (711)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 252 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 252 EHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp TTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 5432 23457999999999999999999999999999999999999999754
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=351.26 Aligned_cols=252 Identities=18% Similarity=0.161 Sum_probs=203.2
Q ss_pred HHHHhcCCcccceeecCCceEEEEEE-----eCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcC---CCCeeeeeeeee
Q 043702 375 LRSATKCFNANRIIGHGAFGTVYKGI-----LPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLR---HRNLVRLQGWCH 446 (711)
Q Consensus 375 l~~at~~f~~~~~LG~G~fg~Vy~~~-----~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~ 446 (711)
+....+.|...++||+|+||+||+|. ....++.||+|++... ...++..|++++.+++ |+||+++++++.
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 33455789999999999999999994 5567889999998643 4567889999999988 999999999999
Q ss_pred ecCeEEEEEEcCCCCCHHHHHhh----CCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcC-------
Q 043702 447 EKGEILLVYDLMPNGSLDKALFE----ARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDE------- 515 (711)
Q Consensus 447 ~~~~~~lV~Ey~~~gsL~~~l~~----~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~------- 515 (711)
..+..++|||||++|+|.+++.. ....+++..++.|+.||+.||+|||+. +|+||||||+||||+.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC--
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccc
Confidence 99999999999999999999974 346799999999999999999999997 9999999999999998
Q ss_pred ----CCcEEEeecCCceecCCCC-CCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccc
Q 043702 516 ----GFNARLGDFGLARQVEHDK-SPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGK 590 (711)
Q Consensus 516 ----~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~ 590 (711)
++.+||+|||+++.+.... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.....+...
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 294 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK 294 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee
Confidence 8999999999998764322 22334567999999999999999999999999999999999999999654321000
Q ss_pred cccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCC-CCHHHHHHHHhC
Q 043702 591 VGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLAR-PTMRGVVQMLVG 657 (711)
Q Consensus 591 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R-Ps~~eVl~~L~~ 657 (711)
....+...... +.+.+++..|++.+|.+| |+++++.+.|+.
T Consensus 295 -----------------------~~~~~~~~~~~---~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~ 336 (365)
T 3e7e_A 295 -----------------------PEGLFRRLPHL---DMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK 336 (365)
T ss_dssp -----------------------ECSCCTTCSSH---HHHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred -----------------------echhccccCcH---HHHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence 00001111122 334566778999999998 577777777754
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=354.57 Aligned_cols=265 Identities=22% Similarity=0.304 Sum_probs=206.0
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcC--------CCCeeeeeeeee----
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLR--------HRNLVRLQGWCH---- 446 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~--------H~niv~l~g~~~---- 446 (711)
.++|...++||+|+||+||+|++..+++.||||++.......+.+.+|++++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 36799999999999999999999889999999999765555678899999999996 788999999987
Q ss_pred ecCeEEEEEEcCCCCCHHHHHhhC-CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCC--------
Q 043702 447 EKGEILLVYDLMPNGSLDKALFEA-RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGF-------- 517 (711)
Q Consensus 447 ~~~~~~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~-------- 517 (711)
.....++||||+ +++|.+++... ...+++..++.++.||+.||+|||+.+ +|+||||||+||||+.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~~ 192 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAA 192 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred CCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhhh
Confidence 456799999999 55666666544 467999999999999999999999842 899999999999998775
Q ss_pred -----------------------------------------cEEEeecCCceecCCCCCCCcccccCCCcccChhhhccC
Q 043702 518 -----------------------------------------NARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTG 556 (711)
Q Consensus 518 -----------------------------------------~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~ 556 (711)
.+||+|||+++..... .....||+.|+|||++.+.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~~ 268 (397)
T 1wak_A 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIGS 268 (397)
T ss_dssp HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHTS
T ss_pred hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcCC
Confidence 7999999999876543 2334689999999999999
Q ss_pred CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhc--------Cch------------------
Q 043702 557 RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHRE--------GRL------------------ 610 (711)
Q Consensus 557 ~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~--------~~~------------------ 610 (711)
.++.++|||||||++|||++|+.||.......... .............. +..
T Consensus 269 ~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (397)
T 1wak_A 269 GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTR--DEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK 346 (397)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCH--HHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCc--hHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence 99999999999999999999999997543211000 00001111110000 000
Q ss_pred ----hHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 611 ----LTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 611 ----~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.+.... ......+....+.+|+.+||+.||++|||++|+++.
T Consensus 347 ~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 347 PWGLFEVLVE--KYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCHHHHHHH--TSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred CcchhHhhhh--hcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 000000 112356677889999999999999999999999873
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=345.61 Aligned_cols=260 Identities=25% Similarity=0.371 Sum_probs=186.7
Q ss_pred HhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC--CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 378 ATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN--SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 378 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
..++|...+.||+|+||.||+|....+++.||||++... ....+++.+|++++++++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 356899999999999999999999888999999988653 334567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhh-------CCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCce
Q 043702 456 DLMPNGSLDKALFE-------ARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLAR 528 (711)
Q Consensus 456 Ey~~~gsL~~~l~~-------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~ 528 (711)
||+++++|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 99999999999864 345699999999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCC----CCcccccCCCcccChhhhcc-CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHH
Q 043702 529 QVEHDKS----PDATVAAGTMGYLAPEYLLT-GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWS 603 (711)
Q Consensus 529 ~~~~~~~----~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~ 603 (711)
....... .......||+.|+|||.+.. ..++.++|||||||++|||++|+.||...... .... ..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~--~~ 239 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM--------KVLM--LT 239 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG--------GHHH--HH
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh--------hHHH--HH
Confidence 6643321 11233569999999999876 56899999999999999999999999754221 1110 00
Q ss_pred hhhc-Cch-hHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 604 LHRE-GRL-LTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 604 ~~~~-~~~-~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.... ... ....++.....+ ...+.+++.+||+.||.+||++.++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 240 LQNDPPSLETGVQDKEMLKKY----GKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp HTSSCCCTTC-----CCCCCC----CHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hccCCCccccccccchhhhhh----hHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0000 000 001111111222 2457788999999999999999999873
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=343.04 Aligned_cols=251 Identities=25% Similarity=0.320 Sum_probs=187.4
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCC--h-hhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQG--K-DEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~--~-~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
.++|+..+.||+|+||+||+|.+..+++.||+|++...... . +.+.++...++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46789999999999999999999889999999998764322 2 23444555688889999999999999999999999
Q ss_pred EcCCCCCHHHHHhh---CCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCC
Q 043702 456 DLMPNGSLDKALFE---ARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEH 532 (711)
Q Consensus 456 Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~ 532 (711)
||++ |+|.+++.. ....+++..++.++.|++.||+|||+. .+|+||||||+|||++.++.+||+|||+++....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 9997 588887753 566799999999999999999999984 3899999999999999999999999999987654
Q ss_pred CCCCCcccccCCCcccChhhh----ccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcC
Q 043702 533 DKSPDATVAAGTMGYLAPEYL----LTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREG 608 (711)
Q Consensus 533 ~~~~~~~~~~gt~~y~APE~~----~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 608 (711)
... .....||+.|+|||.+ ....++.++|||||||++|||++|+.||..... .. ..........
T Consensus 163 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---------~~-~~~~~~~~~~ 230 (290)
T 3fme_A 163 DVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT---------PF-QQLKQVVEEP 230 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC---------HH-HHHHHHHHSC
T ss_pred ccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc---------hH-HHHHHHhccC
Confidence 332 2234699999999996 556789999999999999999999999964211 11 1111111111
Q ss_pred chhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 609 RLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 609 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
............+.+++.+||+.||.+|||+.|+++
T Consensus 231 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 231 ---------SPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ---------CCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---------CCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 001111122345778899999999999999999987
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=354.04 Aligned_cols=262 Identities=20% Similarity=0.293 Sum_probs=198.2
Q ss_pred HHHHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeec------
Q 043702 375 LRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEK------ 448 (711)
Q Consensus 375 l~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------ 448 (711)
+....++|...+.||+|+||.||+|.+..+|+.||||++.... ....+|+++++.++||||+++++++...
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP---RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT---TSCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 3456678999999999999999999999899999999986543 2345899999999999999999998443
Q ss_pred --------------------------------CeEEEEEEcCCCCCHHHHHh---hCCCCCChHHHHHHHHHHHHHHHHH
Q 043702 449 --------------------------------GEILLVYDLMPNGSLDKALF---EARSPLPWPHRSKILLGVASALAYL 493 (711)
Q Consensus 449 --------------------------------~~~~lV~Ey~~~gsL~~~l~---~~~~~l~~~~~~~i~~~ia~aL~yL 493 (711)
..+++||||++ |+|.+.+. .....+++..+..++.||++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34899999998 58887775 3456799999999999999999999
Q ss_pred HhccCCCeeeccCCCCceEEc-CCCcEEEeecCCceecCCCCCCCcccccCCCcccChhhhccC-CCCccccchhHHHHH
Q 043702 494 HQECENQVIHRDVKTSNIMLD-EGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVV 571 (711)
Q Consensus 494 H~~~~~~ivHrDlkp~NILld-~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll 571 (711)
|+. +|+||||||+|||++ .++.+||+|||+++....... .....||+.|+|||.+.+. .++.++|||||||++
T Consensus 158 H~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 158 HSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 987 999999999999998 688999999999997654332 2345689999999998775 489999999999999
Q ss_pred HHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHh--hhhh-------------ccCCCcHHHHHHHHHHHHh
Q 043702 572 LEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTA--ADAR-------------LEGQFDEAEMRRVLLVGLA 636 (711)
Q Consensus 572 ~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~--~d~~-------------l~~~~~~~~~~~l~~l~~~ 636 (711)
|||++|+.||...... ..+...+. .......... .++. ....++......+.+|+.+
T Consensus 233 ~ell~g~~pf~~~~~~-------~~~~~i~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 304 (383)
T 3eb0_A 233 GELILGKPLFSGETSI-------DQLVRIIQ-IMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQ 304 (383)
T ss_dssp HHHHHSSCSSCCSSHH-------HHHHHHHH-HHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHH
T ss_pred HHHHhCCCCCCCCChH-------HHHHHHHH-HhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHH
Confidence 9999999999754221 11111111 0000000000 0000 0000111233457889999
Q ss_pred cCCCCCCCCCCHHHHHH
Q 043702 637 CSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 637 Cl~~dP~~RPs~~eVl~ 653 (711)
||+.||.+|||+.|+++
T Consensus 305 ~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 305 ILRYEPDLRINPYEAMA 321 (383)
T ss_dssp HCCSSGGGSCCHHHHHT
T ss_pred HccCChhhCCCHHHHhc
Confidence 99999999999999985
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=347.72 Aligned_cols=258 Identities=24% Similarity=0.377 Sum_probs=207.2
Q ss_pred HHHHHHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCC---------hhhhHHHHHHHHhc-CCCCeeeee
Q 043702 373 RELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQG---------KDEFLSELSIIGTL-RHRNLVRLQ 442 (711)
Q Consensus 373 ~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---------~~~~~~Ei~~l~~l-~H~niv~l~ 442 (711)
.......++|...+.||+|+||.||+|.+..+|+.||||++...... .+.+.+|+.+++++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 33445567899999999999999999999888999999998754321 34678899999999 799999999
Q ss_pred eeeeecCeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEe
Q 043702 443 GWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLG 522 (711)
Q Consensus 443 g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~ 522 (711)
+++...+..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEE
Confidence 999999999999999999999999965 35699999999999999999999998 99999999999999999999999
Q ss_pred ecCCceecCCCCCCCcccccCCCcccChhhhccC------CCCccccchhHHHHHHHHHhCCCCCccccccccccccccc
Q 043702 523 DFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTG------RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASN 596 (711)
Q Consensus 523 DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~------~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~ 596 (711)
|||++..+.... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..
T Consensus 243 DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~--------~~ 312 (365)
T 2y7j_A 243 DFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ--------IL 312 (365)
T ss_dssp CCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HH
T ss_pred ecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH--------HH
Confidence 999998775433 23346799999999998643 578899999999999999999999965321 01
Q ss_pred hHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 597 LVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 597 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
... ....+.... ..+.. . .....+.+++.+||+.||.+||++.|+++.
T Consensus 313 ~~~----~i~~~~~~~-~~~~~-~----~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 313 MLR----MIMEGQYQF-SSPEW-D----DRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHH----HHHHTCCCC-CHHHH-S----SSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHH----HHHhCCCCC-CCccc-c----cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111 111111000 00000 0 112457789999999999999999999973
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=343.40 Aligned_cols=253 Identities=22% Similarity=0.355 Sum_probs=201.8
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC-CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEc
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN-SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
.+.|+..+.||+|+||.||+|.+..+++.||+|++... ....+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 46789999999999999999999888999999998763 34567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC
Q 043702 458 MPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD 537 (711)
Q Consensus 458 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 537 (711)
+++++|.+++......+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++....... ..
T Consensus 98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 173 (302)
T 2j7t_A 98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-QK 173 (302)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-HC
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc-cc
Confidence 999999999987677899999999999999999999998 99999999999999999999999999976432111 01
Q ss_pred cccccCCCcccChhhhc-----cCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhH
Q 043702 538 ATVAAGTMGYLAPEYLL-----TGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLT 612 (711)
Q Consensus 538 ~~~~~gt~~y~APE~~~-----~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 612 (711)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||..... .+...........
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----------~~~~~~~~~~~~~-- 240 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-----------MRVLLKIAKSDPP-- 240 (302)
T ss_dssp -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH-----------HHHHHHHHHSCCC--
T ss_pred cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH-----------HHHHHHHhccCCc--
Confidence 12346899999999984 56789999999999999999999999965321 1111111111100
Q ss_pred hhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 613 AADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 613 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
. ...+......+.+++.+||+.||.+|||+.++++.
T Consensus 241 ----~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 241 ----T--LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp ----C--CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred ----c--cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0 00111223457788999999999999999999873
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=338.37 Aligned_cols=254 Identities=19% Similarity=0.303 Sum_probs=201.7
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC-----CCChhhhHHHHHHHHhcCCCCeeeeeeeee--ecCeE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN-----SQGKDEFLSELSIIGTLRHRNLVRLQGWCH--EKGEI 451 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~--~~~~~ 451 (711)
.++|...+.||+|+||.||++.+..+++.||+|++... ....+.+.+|++++++++||||+++++++. +.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 46899999999999999999999889999999998652 344578999999999999999999999984 45678
Q ss_pred EEEEEcCCCCCHHHHHhhC-CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceec
Q 043702 452 LLVYDLMPNGSLDKALFEA-RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV 530 (711)
Q Consensus 452 ~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~ 530 (711)
++||||++++ |.+++... ...+++..+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999876 77777543 45699999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCC-CCcccccCCCcccChhhhccCC--CCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhc
Q 043702 531 EHDKS-PDATVAAGTMGYLAPEYLLTGR--ATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHRE 607 (711)
Q Consensus 531 ~~~~~-~~~~~~~gt~~y~APE~~~~~~--~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~ 607 (711)
..... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... .+.. .....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----------~~~~-~~i~~ 227 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI-----------YKLF-ENIGK 227 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH-----------HHHH-HHHHH
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH-----------HHHH-HHHhc
Confidence 53322 2223456999999999997654 37899999999999999999999975321 1111 11111
Q ss_pred CchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--HHhCC
Q 043702 608 GRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ--MLVGE 658 (711)
Q Consensus 608 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~--~L~~~ 658 (711)
+.. .+.. .....+.+++.+||+.||.+||+++|+++ .+...
T Consensus 228 ~~~------~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 228 GSY------AIPG----DCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp CCC------CCCS----SSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred CCC------CCCC----ccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 110 1111 22345778899999999999999999997 45544
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=351.17 Aligned_cols=259 Identities=22% Similarity=0.296 Sum_probs=195.9
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCC---hhhhHHHHHHHHhcCCCCeeeeeeeeeec------C
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQG---KDEFLSELSIIGTLRHRNLVRLQGWCHEK------G 449 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~ 449 (711)
.++|...+.||+|+||.||+|.+..+|+.||||++...... .+.+.+|+++++.++||||+++++++... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 35688899999999999999999889999999998653322 35688999999999999999999999765 3
Q ss_pred eEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCcee
Q 043702 450 EILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQ 529 (711)
Q Consensus 450 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~ 529 (711)
..++||||+ +++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 469999999 8899999865 4699999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCCCcccccCCCcccChhhhcc-CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHH------
Q 043702 530 VEHDKSPDATVAAGTMGYLAPEYLLT-GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVW------ 602 (711)
Q Consensus 530 ~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~------ 602 (711)
.... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ..+.....
T Consensus 178 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~l~~i~~~~g~~~ 246 (367)
T 1cm8_A 178 ADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-------DQLKEIMKVTGTPP 246 (367)
T ss_dssp CCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHHHCCCC
T ss_pred cccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHHhcCCCC
Confidence 6432 334578999999999887 67999999999999999999999999754210 00000000
Q ss_pred ----HhhhcCchhHhhhh--hc-c---CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 603 ----SLHREGRLLTAADA--RL-E---GQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 603 ----~~~~~~~~~~~~d~--~l-~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
...........+.. .. . ..........+.+|+.+||+.||.+|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 247 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 00000000000000 00 0 00111223567789999999999999999999983
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=360.98 Aligned_cols=254 Identities=12% Similarity=0.037 Sum_probs=185.0
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC----ChhhhHHHHHHHHhc--CCCCeeeee-------eee
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ----GKDEFLSELSIIGTL--RHRNLVRLQ-------GWC 445 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~Ei~~l~~l--~H~niv~l~-------g~~ 445 (711)
...|...+.||+|+||.||+|++..+++.||||++..... ..+.+.+|+++++.| +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 3458899999999999999999988999999999987442 234567785544444 699988754 444
Q ss_pred eec-----------------CeEEEEEEcCCCCCHHHHHhhCCCCCChHHH------HHHHHHHHHHHHHHHhccCCCee
Q 043702 446 HEK-----------------GEILLVYDLMPNGSLDKALFEARSPLPWPHR------SKILLGVASALAYLHQECENQVI 502 (711)
Q Consensus 446 ~~~-----------------~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~------~~i~~~ia~aL~yLH~~~~~~iv 502 (711)
... ...++|||||+ |+|.+++......+.+..+ ..++.||+.||+|||+. +|+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~iv 216 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLV 216 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCc
Confidence 332 34899999998 8999999875556677777 88889999999999998 999
Q ss_pred eccCCCCceEEcCCCcEEEeecCCceecCCCCCCCcccccCCCcccChhhhcc--CCCCccccchhHHHHHHHHHhCCCC
Q 043702 503 HRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLT--GRATEKTDVFSYGAVVLEVASGRRP 580 (711)
Q Consensus 503 HrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~s~ksDVwSfGvll~elltG~~P 580 (711)
||||||+||||+.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999876421 213457799999999987 6799999999999999999999999
Q ss_pred CccccccccccccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 581 IEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 581 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
|.......... .........................+.+++.+||+.||++|||+.|+++
T Consensus 293 f~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 293 FGLVTPGIKGS-------------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TTBCCTTCTTC-------------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCcCcccccc-------------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 97653221100 0000000000000000001122356778899999999999999999975
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=363.52 Aligned_cols=193 Identities=25% Similarity=0.421 Sum_probs=155.7
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC---ChhhhHHHHHHHHhcCCCCeeeeeeeeeec-----CeE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ---GKDEFLSELSIIGTLRHRNLVRLQGWCHEK-----GEI 451 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~ 451 (711)
++|+..++||+|+||+||+|++..+++.||||++..... ..+.+.+|+++|++++||||+++++++... +.+
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 578999999999999999999998999999999875332 245788999999999999999999999543 579
Q ss_pred EEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecC
Q 043702 452 LLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVE 531 (711)
Q Consensus 452 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~ 531 (711)
++||||+ +++|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++...
T Consensus 133 ~lv~e~~-~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp EEEECCC-SEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred EEEEecc-ccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 9999998 5799998854 45799999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCC--------------------------CCcccccCCCcccChhhh-ccCCCCccccchhHHHHHHHHHhC
Q 043702 532 HDKS--------------------------PDATVAAGTMGYLAPEYL-LTGRATEKTDVFSYGAVVLEVASG 577 (711)
Q Consensus 532 ~~~~--------------------------~~~~~~~gt~~y~APE~~-~~~~~s~ksDVwSfGvll~elltG 577 (711)
.... ...+..+||+.|+|||++ ....++.++|||||||+||||++|
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 3221 123445789999999986 456799999999999999999994
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=357.78 Aligned_cols=254 Identities=21% Similarity=0.322 Sum_probs=194.5
Q ss_pred HHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC---------CChhhhHHHHHHHHhcCCCCeeeeeeeeee
Q 043702 377 SATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---------QGKDEFLSELSIIGTLRHRNLVRLQGWCHE 447 (711)
Q Consensus 377 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 447 (711)
...++|...+.||+|+||+||+|.+..+++.||||++.... .....+.+|+++|++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 34578999999999999999999999999999999986421 22346889999999999999999999975
Q ss_pred cCeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCC---CcEEEeec
Q 043702 448 KGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEG---FNARLGDF 524 (711)
Q Consensus 448 ~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~---~~vkL~DF 524 (711)
.+..++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.+ ..+||+||
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DF 286 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDF 286 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred cCceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeec
Confidence 4568999999999999998854 45799999999999999999999998 99999999999999654 45999999
Q ss_pred CCceecCCCCCCCcccccCCCcccChhhhcc---CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHH
Q 043702 525 GLARQVEHDKSPDATVAAGTMGYLAPEYLLT---GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWV 601 (711)
Q Consensus 525 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~ 601 (711)
|+++...... .....+||+.|+|||++.. ..++.++|||||||++|||++|+.||...... ..+.+..
T Consensus 287 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-------~~~~~~i 357 (419)
T 3i6u_A 287 GHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ-------VSLKDQI 357 (419)
T ss_dssp STTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS-------CCHHHHH
T ss_pred ccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch-------HHHHHHH
Confidence 9998765432 2334679999999999853 56788999999999999999999999753221 1111111
Q ss_pred HHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 602 WSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 602 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
..+..... +.... .....+.+++.+||+.||.+||++.|+++.
T Consensus 358 ----~~~~~~~~--~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 358 ----TSGKYNFI--PEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp ----HTTCCCCC--HHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ----hcCCCCCC--chhhc----ccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 11111000 00001 123467789999999999999999999974
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=358.03 Aligned_cols=260 Identities=20% Similarity=0.260 Sum_probs=207.5
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCC-CCeeeeeeeeeecCeEEEEEEc
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRH-RNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~Ey 457 (711)
.++|.+.++||+|+||.||+|++..+++.||||++.... ..+++.+|+++++.|+| +++..+..++...+..++||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~ 84 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC-SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc-ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence 467999999999999999999998889999999876543 34568999999999996 5566666667778889999999
Q ss_pred CCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEE---cCCCcEEEeecCCceecCCCC
Q 043702 458 MPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIML---DEGFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 458 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl---d~~~~vkL~DFGla~~~~~~~ 534 (711)
+ +++|.+++......+++..++.|+.||+.||+|||+. +|+||||||+|||| +.++.+||+|||+++.+....
T Consensus 85 ~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (483)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred C-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence 9 9999999987777899999999999999999999998 99999999999999 688999999999999876543
Q ss_pred CC------CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcC
Q 043702 535 SP------DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREG 608 (711)
Q Consensus 535 ~~------~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 608 (711)
.. ......||+.|+|||++.+..++.++|||||||+||||++|+.||...... ...+..... ...
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~--------~~~~~~~~i-~~~ 231 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG--------TKKQKYEKI-SEK 231 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS--------SHHHHHHHH-HHH
T ss_pred cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccch--------hHHHHHHHH-hhc
Confidence 22 122567999999999999999999999999999999999999999764221 111111110 000
Q ss_pred chhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 609 RLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 609 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
......+ .+...+ ..++.+++..||+.||++||++.+|+++|+.
T Consensus 232 ~~~~~~~-~l~~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~ 275 (483)
T 3sv0_A 232 KVATSIE-ALCRGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRD 275 (483)
T ss_dssp HHHSCHH-HHHTTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred cccccHH-HHhcCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 1111111 011112 3467889999999999999999999998864
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=350.55 Aligned_cols=269 Identities=21% Similarity=0.286 Sum_probs=201.3
Q ss_pred CHHHHHHHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCC------------hhhhHHHHHHHHhcCCCCe
Q 043702 371 SYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQG------------KDEFLSELSIIGTLRHRNL 438 (711)
Q Consensus 371 ~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~------------~~~~~~Ei~~l~~l~H~ni 438 (711)
...++....++|...+.||+|+||.||+|.+.. ++.||||++...... .+.+.+|++++++++||||
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 357888899999999999999999999999864 899999998652211 2678899999999999999
Q ss_pred eeeeeeeee-----cCeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEE
Q 043702 439 VRLQGWCHE-----KGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIML 513 (711)
Q Consensus 439 v~l~g~~~~-----~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl 513 (711)
+++++++.. ....++||||++ |+|.+++......+++..+..++.||+.||.|||+. +|+||||||+|||+
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILL 167 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEE
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEE
Confidence 999999854 346899999997 699999887777899999999999999999999998 99999999999999
Q ss_pred cCCCcEEEeecCCceecCCCCCCCcccccCCCcccChhhhcc-CCCCccccchhHHHHHHHHHhCCCCCccccccccccc
Q 043702 514 DEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLT-GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVG 592 (711)
Q Consensus 514 d~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~ 592 (711)
+.++.+||+|||+++...... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----- 240 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY----- 240 (362)
T ss_dssp CTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----
T ss_pred cCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH-----
Confidence 999999999999998554332 2334568999999999887 67899999999999999999999999753210
Q ss_pred cccchHHHHHHhhhcCchh-----------HhhhhhccC-------CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 593 VASNLVEWVWSLHREGRLL-----------TAADARLEG-------QFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 593 ~~~~l~~~~~~~~~~~~~~-----------~~~d~~l~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.....+.......... ......... .........+.+++.+||+.||.+|||+.|+++.
T Consensus 241 ---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 241 ---NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp ---HHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---HHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 1111111111110000 000000000 0001123457789999999999999999999974
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=335.46 Aligned_cols=247 Identities=23% Similarity=0.377 Sum_probs=196.9
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
++|...+.||+|+||.||+|.+..+++.||+|++... ....+.+.+|+++++.++||||+++++++...+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 5789999999999999999999888999999998642 234567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
||+++++|.+++... ..+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 91 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 166 (276)
T 2h6d_A 91 EYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166 (276)
T ss_dssp ECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred eccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCcc
Confidence 999999999999653 4689999999999999999999998 999999999999999999999999999987654322
Q ss_pred CCcccccCCCcccChhhhccCCC-CccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhh
Q 043702 536 PDATVAAGTMGYLAPEYLLTGRA-TEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 614 (711)
.....|++.|+|||.+.+..+ +.++||||||+++|||++|+.||..... .+. ......+..
T Consensus 167 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----------~~~-~~~~~~~~~---- 228 (276)
T 2h6d_A 167 --LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV-----------PTL-FKKIRGGVF---- 228 (276)
T ss_dssp ------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHH-HHHHHHCCC----
T ss_pred --eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH-----------HHH-HHHhhcCcc----
Confidence 233468999999999987765 6899999999999999999999965321 111 111111110
Q ss_pred hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 615 DARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 615 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
..+......+.+++.+||+.||.+||+++|+++.
T Consensus 229 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 229 ------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0111123457788999999999999999999984
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=341.98 Aligned_cols=256 Identities=25% Similarity=0.376 Sum_probs=206.5
Q ss_pred HhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC-CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 378 ATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 378 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
..++|...+.||+|+||.||+++...+|+.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3467899999999999999999998889999999987643 234578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEE---cCCCcEEEeecCCceecCCC
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIML---DEGFNARLGDFGLARQVEHD 533 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl---d~~~~vkL~DFGla~~~~~~ 533 (711)
|+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||+++.....
T Consensus 87 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 87 LVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162 (304)
T ss_dssp CCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred cCCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence 99999999998653 4689999999999999999999998 99999999999999 78899999999999764322
Q ss_pred CCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHh
Q 043702 534 KSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTA 613 (711)
Q Consensus 534 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 613 (711)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ..+. .....+...
T Consensus 163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~----~~i~~~~~~-- 225 (304)
T 2jam_A 163 ---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE--------SKLF----EKIKEGYYE-- 225 (304)
T ss_dssp ---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHH----HHHHHCCCC--
T ss_pred ---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHH----HHHHcCCCC--
Confidence 22345699999999999999999999999999999999999999965321 1111 111111100
Q ss_pred hhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--HHhCC
Q 043702 614 ADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ--MLVGE 658 (711)
Q Consensus 614 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~--~L~~~ 658 (711)
............+.+++.+||+.||.+||++.|+++ .+.+.
T Consensus 226 ----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 226 ----FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp ----CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred ----CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 001111122356778999999999999999999997 55543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=362.25 Aligned_cols=240 Identities=15% Similarity=0.129 Sum_probs=188.8
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHH---HHHHhcCCCCeeeee-------ee
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSEL---SIIGTLRHRNLVRLQ-------GW 444 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei---~~l~~l~H~niv~l~-------g~ 444 (711)
.++|...+.||+|+||.||+|++..+|+.||||++... ....+.+.+|+ +++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788899999999999999999888999999998742 23456788999 555556799999998 55
Q ss_pred eeecC-----------------eEEEEEEcCCCCCHHHHHhhCC------CCCChHHHHHHHHHHHHHHHHHHhccCCCe
Q 043702 445 CHEKG-----------------EILLVYDLMPNGSLDKALFEAR------SPLPWPHRSKILLGVASALAYLHQECENQV 501 (711)
Q Consensus 445 ~~~~~-----------------~~~lV~Ey~~~gsL~~~l~~~~------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~i 501 (711)
+...+ ..++||||+ +|+|.+++.... ..+++..+++|+.||+.||+|||+. +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 55443 279999999 689999997532 1244688899999999999999998 99
Q ss_pred eeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCcccccCCCcccChhhhccC-----------CCCccccchhHHHH
Q 043702 502 IHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTG-----------RATEKTDVFSYGAV 570 (711)
Q Consensus 502 vHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----------~~s~ksDVwSfGvl 570 (711)
+||||||+||||+.++.+||+|||+++.... .....+| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999986432 2344568 999999999887 89999999999999
Q ss_pred HHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHH
Q 043702 571 VLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRG 650 (711)
Q Consensus 571 l~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 650 (711)
+|||++|+.||........ ...+... ...+ ...+.+++.+||+.||.+||++.|
T Consensus 303 l~elltg~~Pf~~~~~~~~---------------------~~~~~~~-~~~~----~~~~~~li~~~L~~dp~~Rpt~~e 356 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGG---------------------SEWIFRS-CKNI----PQPVRALLEGFLRYPKEDRLLPLQ 356 (377)
T ss_dssp HHHHHHSSCCC------CC---------------------SGGGGSS-CCCC----CHHHHHHHHHHTCSSGGGCCCHHH
T ss_pred HHHHHHCCCCCcccccccc---------------------hhhhhhh-ccCC----CHHHHHHHHHHcCCCchhCCCHHH
Confidence 9999999999965422100 0000000 0122 245778889999999999999999
Q ss_pred HHH
Q 043702 651 VVQ 653 (711)
Q Consensus 651 Vl~ 653 (711)
+++
T Consensus 357 ~l~ 359 (377)
T 3byv_A 357 AME 359 (377)
T ss_dssp HHT
T ss_pred Hhh
Confidence 986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=363.28 Aligned_cols=251 Identities=23% Similarity=0.308 Sum_probs=202.3
Q ss_pred HhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC--------------CChhhhHHHHHHHHhcCCCCeeeeee
Q 043702 378 ATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS--------------QGKDEFLSELSIIGTLRHRNLVRLQG 443 (711)
Q Consensus 378 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~Ei~~l~~l~H~niv~l~g 443 (711)
..+.|...++||+|+||+||+|++..+++.||+|++.... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3467899999999999999999999899999999987532 23467889999999999999999999
Q ss_pred eeeecCeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCC---cEE
Q 043702 444 WCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGF---NAR 520 (711)
Q Consensus 444 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~---~vk 520 (711)
++.+.+..++|||||++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+|
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEE
Confidence 999999999999999999999988653 5699999999999999999999998 999999999999998775 699
Q ss_pred EeecCCceecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHH
Q 043702 521 LGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEW 600 (711)
Q Consensus 521 L~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~ 600 (711)
|+|||+++...... ......||+.|+|||++. +.++.++||||+||++|||++|+.||..... .+.
T Consensus 190 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----------~~~ 255 (504)
T 3q5i_A 190 IVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND-----------QDI 255 (504)
T ss_dssp ECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHH
T ss_pred EEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH-----------HHH
Confidence 99999998775433 234457999999999986 5689999999999999999999999975321 111
Q ss_pred HHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 601 VWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 601 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
... ...+....... ... .....+.+++.+||+.||.+|||++|+++
T Consensus 256 ~~~-i~~~~~~~~~~--~~~----~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 256 IKK-VEKGKYYFDFN--DWK----NISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHH-HHHCCCCCCHH--HHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHH-HHcCCCCCCcc--ccC----CCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 111 11111100000 001 11245778999999999999999999997
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=355.00 Aligned_cols=200 Identities=25% Similarity=0.404 Sum_probs=170.6
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC---ChhhhHHHHHHHHhcCCCCeeeeeeeeeec-----Ce
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ---GKDEFLSELSIIGTLRHRNLVRLQGWCHEK-----GE 450 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~ 450 (711)
.++|...+.||+|+||.||+|++..+++.||||++..... ..+.+.+|+++|++++||||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 4579999999999999999999999999999999876332 245788999999999999999999999766 57
Q ss_pred EEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceec
Q 043702 451 ILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV 530 (711)
Q Consensus 451 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~ 530 (711)
+++||||+. |+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++..
T Consensus 105 ~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEecCC-cCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 999999986 599999854 45799999999999999999999998 9999999999999999999999999999976
Q ss_pred CCCCCC---------------------CcccccCCCcccChhhh-ccCCCCccccchhHHHHHHHHHhCCCCCcc
Q 043702 531 EHDKSP---------------------DATVAAGTMGYLAPEYL-LTGRATEKTDVFSYGAVVLEVASGRRPIEK 583 (711)
Q Consensus 531 ~~~~~~---------------------~~~~~~gt~~y~APE~~-~~~~~s~ksDVwSfGvll~elltG~~P~~~ 583 (711)
...... ..+..+||+.|+|||++ ....++.++|||||||++|||++|..||..
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 254 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN 254 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCS
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccc
Confidence 543211 23556799999999986 456699999999999999999997776654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=346.68 Aligned_cols=262 Identities=24% Similarity=0.375 Sum_probs=199.7
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCC---hhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQG---KDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
++|+..+.||+|+||.||+|++..+++.||+|++...... .+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 4688899999999999999999988999999998664332 3457899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCC
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP 536 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~ 536 (711)
|+++++|..++. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 105 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 179 (331)
T 4aaa_A 105 FVDHTILDDLEL-FPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE- 179 (331)
T ss_dssp CCSEEHHHHHHH-STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred cCCcchHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc-
Confidence 999998888764 345699999999999999999999998 999999999999999999999999999987654322
Q ss_pred CcccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHH----------HHhh
Q 043702 537 DATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWV----------WSLH 605 (711)
Q Consensus 537 ~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~----------~~~~ 605 (711)
......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...... ..+.... +...
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~ 252 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI-------DQLYHIMMCLGNLIPRHQELF 252 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHHHCSCCHHHHHHH
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH-------HHHHHHHHHhCCCChhhhhHh
Confidence 22345689999999999875 6899999999999999999999999754221 0111110 0000
Q ss_pred hcCch-hHhhhhhccCCCc-----HHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 606 REGRL-LTAADARLEGQFD-----EAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 606 ~~~~~-~~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
..... .....+.+..... ......+.+++.+||+.||.+|||+.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000 0000000000000 122456888999999999999999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=345.94 Aligned_cols=269 Identities=22% Similarity=0.311 Sum_probs=196.6
Q ss_pred HHHHHHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCe--
Q 043702 373 RELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGE-- 450 (711)
Q Consensus 373 ~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-- 450 (711)
.+.....++|...+.||+|+||.||+|++..+++.||||++.........+.+|++.++.++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 345667789999999999999999999998889999999987766666778889999999999999999999976443
Q ss_pred -----EEEEEEcCCCCCHHHHHh---hCCCCCChHHHHHHHHHHHHHHHHHH--hccCCCeeeccCCCCceEEcC-CCcE
Q 043702 451 -----ILLVYDLMPNGSLDKALF---EARSPLPWPHRSKILLGVASALAYLH--QECENQVIHRDVKTSNIMLDE-GFNA 519 (711)
Q Consensus 451 -----~~lV~Ey~~~gsL~~~l~---~~~~~l~~~~~~~i~~~ia~aL~yLH--~~~~~~ivHrDlkp~NILld~-~~~v 519 (711)
.++||||+++ +|...+. .....+++..+..++.|++.||.||| +. +|+||||||+|||++. ++.+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcE
Confidence 8999999976 5555443 34567899999999999999999999 65 9999999999999996 8999
Q ss_pred EEeecCCceecCCCCCCCcccccCCCcccChhhhccCC-CCccccchhHHHHHHHHHhCCCCCccccccccccccccchH
Q 043702 520 RLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGR-ATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLV 598 (711)
Q Consensus 520 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~ 598 (711)
||+|||+++....... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||...... ..+.
T Consensus 172 kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-------~~~~ 242 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA-------GQLH 242 (360)
T ss_dssp EECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHH
T ss_pred EEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH-------HHHH
Confidence 9999999987654332 23456899999999987654 899999999999999999999999754221 1111
Q ss_pred HHHHHhhhc-CchhHhhhhh----------------ccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 599 EWVWSLHRE-GRLLTAADAR----------------LEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 599 ~~~~~~~~~-~~~~~~~d~~----------------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
......... .......++. ............+.+++.+||+.||.+|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 111100000 0000000000 0011111235678899999999999999999999974
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=344.36 Aligned_cols=256 Identities=26% Similarity=0.398 Sum_probs=198.2
Q ss_pred cCCcccceeecCCceEEEEEEeCC-CC--eEEEEEEcccC----CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQ-NG--DIIAVKRCSHN----SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEIL 452 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~--~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 452 (711)
++|+..+.||+|+||.||+|++.. ++ ..||+|++... ....+.+.+|++++++++||||+++++++.... .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 578899999999999999998643 23 36899988753 223467889999999999999999999998765 89
Q ss_pred EEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCC
Q 043702 453 LVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEH 532 (711)
Q Consensus 453 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~ 532 (711)
+||||+++++|.+++......+++..+.+++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 99999999999999987667799999999999999999999998 999999999999999999999999999987754
Q ss_pred CCCC--CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCc
Q 043702 533 DKSP--DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGR 609 (711)
Q Consensus 533 ~~~~--~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 609 (711)
.... ......+|+.|+|||.+....++.++||||||+++|||++ |+.||..... .+........+.
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----------~~~~~~~~~~~~ 242 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-----------SQILHKIDKEGE 242 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----------HHHHHHHHTSCC
T ss_pred cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH-----------HHHHHHHHccCC
Confidence 3321 1223457889999999998889999999999999999999 9999965321 111111111111
Q ss_pred hhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC
Q 043702 610 LLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEA 659 (711)
Q Consensus 610 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~ 659 (711)
...........+.+++.+||+.||.+||++.++++.|+...
T Consensus 243 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 243 ---------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ---------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 00111223456788999999999999999999999998653
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=348.89 Aligned_cols=206 Identities=21% Similarity=0.299 Sum_probs=179.0
Q ss_pred HHHHHHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcC-CC-----Ceeeeeeeee
Q 043702 373 RELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLR-HR-----NLVRLQGWCH 446 (711)
Q Consensus 373 ~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~-H~-----niv~l~g~~~ 446 (711)
+......++|...+.||+|+||+||+|.+..+++.||||++.......+++..|+++++.++ |+ +++++++++.
T Consensus 47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 34445568999999999999999999999889999999999765544567888999999886 55 4999999999
Q ss_pred ecCeEEEEEEcCCCCCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEc--CCCcEEEee
Q 043702 447 EKGEILLVYDLMPNGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLD--EGFNARLGD 523 (711)
Q Consensus 447 ~~~~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld--~~~~vkL~D 523 (711)
..+..++||||++ |+|.+++.... ..+++..+..++.|++.||.|||+. +.+|+||||||+||||+ .++.+||+|
T Consensus 127 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 127 FRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp ETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred cCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 9999999999996 59999997654 5699999999999999999999953 34899999999999994 578899999
Q ss_pred cCCceecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccc
Q 043702 524 FGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKE 584 (711)
Q Consensus 524 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~ 584 (711)
||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 205 FG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 205 FGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999876432 23457999999999999999999999999999999999999999754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=348.79 Aligned_cols=267 Identities=22% Similarity=0.222 Sum_probs=194.1
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC---ChhhhHHHHHHHHhcCCCCeeeeeeeeeecC------
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ---GKDEFLSELSIIGTLRHRNLVRLQGWCHEKG------ 449 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 449 (711)
.++|...+.||+|+||.||+|.+..+++.||||++..... ..+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 3679999999999999999999988999999999876332 2356889999999999999999999997654
Q ss_pred eEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCcee
Q 043702 450 EILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQ 529 (711)
Q Consensus 450 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~ 529 (711)
..++||||+++ +|.+++. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 104 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred ceEEEEEcCCC-CHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 78999999974 7888884 3589999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccc----cccchHHH-----
Q 043702 530 VEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVG----VASNLVEW----- 600 (711)
Q Consensus 530 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~----~~~~l~~~----- 600 (711)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........... ......++
T Consensus 177 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 177 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred ccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 64332 23345799999999999999999999999999999999999999975422000000 00000000
Q ss_pred --HHHhhhcC------chhHhhhhhcc---CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 601 --VWSLHREG------RLLTAADARLE---GQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 601 --~~~~~~~~------~~~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
........ .+......... ..........+.+|+.+||+.||.+|||++|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00000000 00000000000 00112235678899999999999999999999973
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=362.76 Aligned_cols=250 Identities=22% Similarity=0.331 Sum_probs=199.7
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC---CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN---SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
.+.|...+.||+|+||+||+|++..++..||+|++... ......+.+|+++++.++||||++++++|...+..++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 34688999999999999999999989999999998753 334577899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCC---CcEEEeecCCceecCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEG---FNARLGDFGLARQVEH 532 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~---~~vkL~DFGla~~~~~ 532 (711)
|||++|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||+++....
T Consensus 116 e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 116 ECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 999999999988653 5699999999999999999999998 99999999999999764 4599999999987754
Q ss_pred CCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhH
Q 043702 533 DKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLT 612 (711)
Q Consensus 533 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 612 (711)
.. .....+||+.|+|||++. +.++.++|||||||++|||++|+.||..... .+..... ..+....
T Consensus 192 ~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----------~~~~~~i-~~~~~~~ 256 (494)
T 3lij_A 192 QK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD-----------QEILRKV-EKGKYTF 256 (494)
T ss_dssp TB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHHHHH-HHTCCCC
T ss_pred Cc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-----------HHHHHHH-HhCCCCC
Confidence 33 233457999999999886 5689999999999999999999999975321 1111111 1111100
Q ss_pred hhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 613 AADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 613 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
...........+.+++.+||+.||.+|||+.|+++
T Consensus 257 ------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 257 ------DSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp ------CSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ------CchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 00000112345778899999999999999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=340.76 Aligned_cols=260 Identities=22% Similarity=0.303 Sum_probs=205.0
Q ss_pred hcCCcccceeecCCceEEEEEEe-CCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCC------CeeeeeeeeeecCeE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGIL-PQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHR------NLVRLQGWCHEKGEI 451 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~-~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~------niv~l~g~~~~~~~~ 451 (711)
.++|+..+.||+|+||.||+|.+ ..+++.||+|++.......+.+.+|+++++.++|+ +++++++++...+..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 35799999999999999999998 55789999999976555567788999999998765 499999999999999
Q ss_pred EEEEEcCCCCCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcC---------------
Q 043702 452 LLVYDLMPNGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDE--------------- 515 (711)
Q Consensus 452 ~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~--------------- 515 (711)
++||||+ +++|.+++.... ..+++..+..++.||++||+|||+. +|+||||||+|||++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred EEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcccccc
Confidence 9999999 889999997654 4689999999999999999999998 9999999999999987
Q ss_pred ----CCcEEEeecCCceecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCcccccccccc
Q 043702 516 ----GFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKV 591 (711)
Q Consensus 516 ----~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~ 591 (711)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---- 240 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK---- 240 (339)
T ss_dssp EEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH----
T ss_pred ccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH----
Confidence 678999999999875432 23356899999999999999999999999999999999999999654221
Q ss_pred ccccchHHHHHHhhh-----------cCch--------------hHhhh---hhc--cCCCcHHHHHHHHHHHHhcCCCC
Q 043702 592 GVASNLVEWVWSLHR-----------EGRL--------------LTAAD---ARL--EGQFDEAEMRRVLLVGLACSHPD 641 (711)
Q Consensus 592 ~~~~~l~~~~~~~~~-----------~~~~--------------~~~~d---~~l--~~~~~~~~~~~l~~l~~~Cl~~d 641 (711)
.....+..... .... ..... ..+ ...........+.+++.+||+.|
T Consensus 241 ----~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 316 (339)
T 1z57_A 241 ----EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYD 316 (339)
T ss_dssp ----HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred ----HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcC
Confidence 00010000000 0000 00000 000 01112345677889999999999
Q ss_pred CCCCCCHHHHHHH
Q 043702 642 PLARPTMRGVVQM 654 (711)
Q Consensus 642 P~~RPs~~eVl~~ 654 (711)
|.+|||+.|+++.
T Consensus 317 P~~Rpt~~ell~h 329 (339)
T 1z57_A 317 PAKRITLREALKH 329 (339)
T ss_dssp TTTSCCHHHHTTS
T ss_pred cccccCHHHHhcC
Confidence 9999999999863
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=361.82 Aligned_cols=252 Identities=22% Similarity=0.318 Sum_probs=203.9
Q ss_pred HhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEccc---CCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEE
Q 043702 378 ATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSH---NSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLV 454 (711)
Q Consensus 378 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 454 (711)
..++|...++||+|+||+||+|++..+++.||||++.. .......+.+|++++++++||||+++++++...+..++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 34579999999999999999999988999999999864 344567899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEc---CCCcEEEeecCCceecC
Q 043702 455 YDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLD---EGFNARLGDFGLARQVE 531 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld---~~~~vkL~DFGla~~~~ 531 (711)
||||++|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++ .++.+||+|||+++...
T Consensus 100 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp ECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 9999999999988653 5699999999999999999999998 999999999999995 55679999999998765
Q ss_pred CCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchh
Q 043702 532 HDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLL 611 (711)
Q Consensus 532 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 611 (711)
... .....+||+.|+|||++.+ .++.++|||||||++|||++|+.||..... .+..... ..+...
T Consensus 176 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----------~~~~~~i-~~~~~~ 240 (486)
T 3mwu_A 176 QNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-----------YDILKRV-ETGKYA 240 (486)
T ss_dssp CC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHHHHH-HHTCCC
T ss_pred CCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----------HHHHHHH-HhCCCC
Confidence 432 2334579999999999865 589999999999999999999999965321 1111111 111110
Q ss_pred HhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 612 TAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 612 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.. ..........+.+++.+||+.||.+|||+.|+++.
T Consensus 241 ~~------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 241 FD------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp SC------SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CC------CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 00001123457789999999999999999999984
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=352.15 Aligned_cols=268 Identities=24% Similarity=0.324 Sum_probs=204.1
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEc
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
++|...+.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|++++++++||||+++++++..++..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 57899999999999999999999889999999987643 2246789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC
Q 043702 458 MPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD 537 (711)
Q Consensus 458 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 537 (711)
+++++|.+++... ..+++..+.+++.|++.||.|||+. ++|+||||||+|||++.++.+||+|||+++......
T Consensus 113 ~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 186 (360)
T 3eqc_A 113 MDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 186 (360)
T ss_dssp CTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC---
T ss_pred CCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCccccccc---
Confidence 9999999999653 4689999999999999999999984 279999999999999999999999999997653321
Q ss_pred cccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCcccccccccccc------------------ccchHH
Q 043702 538 ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGV------------------ASNLVE 599 (711)
Q Consensus 538 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~------------------~~~l~~ 599 (711)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||............ ...+..
T Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (360)
T 3eqc_A 187 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK 266 (360)
T ss_dssp ----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------------
T ss_pred ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccc
Confidence 22356999999999999999999999999999999999999999653221000000 000000
Q ss_pred HHHHhhhcCchhHhhhhhccC---C-CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 600 WVWSLHREGRLLTAADARLEG---Q-FDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 600 ~~~~~~~~~~~~~~~d~~l~~---~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
+...........+..+..... . ........+.+++.+||+.||.+|||++|+++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 267 FGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp -------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 000000000111111111100 0 01112346788999999999999999999987
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=339.38 Aligned_cols=252 Identities=22% Similarity=0.323 Sum_probs=198.4
Q ss_pred HhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC---------CChhhhHHHHHHHHhcCCCCeeeeeeeeeec
Q 043702 378 ATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---------QGKDEFLSELSIIGTLRHRNLVRLQGWCHEK 448 (711)
Q Consensus 378 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 448 (711)
..++|...+.||+|+||.||+|.+..+++.||||++.... .....+.+|++++++++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3467999999999999999999999899999999986532 2234688999999999999999999998765
Q ss_pred CeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCc---EEEeecC
Q 043702 449 GEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFN---ARLGDFG 525 (711)
Q Consensus 449 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~---vkL~DFG 525 (711)
+ .++||||+++++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++. +||+|||
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp S-EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred c-eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 4 8999999999999998854 45799999999999999999999998 9999999999999987654 9999999
Q ss_pred CceecCCCCCCCcccccCCCcccChhhhc---cCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHH
Q 043702 526 LARQVEHDKSPDATVAAGTMGYLAPEYLL---TGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVW 602 (711)
Q Consensus 526 la~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~ 602 (711)
+++...... ......||+.|+|||++. ...++.++|||||||++|||++|+.||...... ..+...+
T Consensus 163 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~- 232 (322)
T 2ycf_A 163 HSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ-------VSLKDQI- 232 (322)
T ss_dssp TCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS-------SCHHHHH-
T ss_pred cceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH-------HHHHHHH-
Confidence 998764321 223456999999999974 456899999999999999999999999653221 1111111
Q ss_pred HhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 603 SLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 603 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
..+.... .+.... .....+.+++.+||+.||.+||++.++++
T Consensus 233 ---~~~~~~~--~~~~~~----~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 233 ---TSGKYNF--IPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp ---HHTCCCC--CHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---HhCcccc--Cchhhh----hcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 1111100 000001 12356778999999999999999999985
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=363.10 Aligned_cols=250 Identities=26% Similarity=0.388 Sum_probs=205.4
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLV 454 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 454 (711)
.++|...++||+|+||.||+|++..+++.||||++... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 45789999999999999999999989999999998653 34467799999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEE---cCCCcEEEeecCCceecC
Q 043702 455 YDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIML---DEGFNARLGDFGLARQVE 531 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl---d~~~~vkL~DFGla~~~~ 531 (711)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||+++...
T Consensus 105 ~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp ECCCCSCBHHHHHHT-CSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 999999999998864 45699999999999999999999998 99999999999999 567899999999998765
Q ss_pred CCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchh
Q 043702 532 HDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLL 611 (711)
Q Consensus 532 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 611 (711)
... ......||+.|+|||++.+ .++.++|||||||++|||++|+.||..... ..+ ... ...+...
T Consensus 181 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~---~~~-i~~~~~~ 245 (484)
T 3nyv_A 181 ASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE--------YDI---LKK-VEKGKYT 245 (484)
T ss_dssp CCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHH---HHH-HHHCCCC
T ss_pred ccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH--------HHH---HHH-HHcCCCC
Confidence 433 3344579999999999865 689999999999999999999999975321 111 111 1111110
Q ss_pred HhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 612 TAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 612 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
. ...........+.+++.+||+.||.+|||+.|+++
T Consensus 246 ~------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 246 F------ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp C------CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 0 00000122345778999999999999999999996
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=353.13 Aligned_cols=259 Identities=25% Similarity=0.368 Sum_probs=196.2
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeec------CeEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEK------GEILL 453 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~~~l 453 (711)
..|...+.||+|+||.||+|++..+++.||||++.... +...+|+++|++++||||++++++|... ..+++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT---TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc---hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 35888999999999999999998889999999986533 3345799999999999999999998542 23679
Q ss_pred EEEcCCCCCHHHHHh---hCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCC-CcEEEeecCCcee
Q 043702 454 VYDLMPNGSLDKALF---EARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEG-FNARLGDFGLARQ 529 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~---~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~-~~vkL~DFGla~~ 529 (711)
||||+++ +|.+.+. .....+++..++.++.||++||+|||+. +|+||||||+||||+.+ +.+||+|||+++.
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 9999976 6666554 3456799999999999999999999997 99999999999999965 5689999999997
Q ss_pred cCCCCCCCcccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcC
Q 043702 530 VEHDKSPDATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREG 608 (711)
Q Consensus 530 ~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 608 (711)
+..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ...+.+.+..+-...
T Consensus 207 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~-------~~~l~~i~~~lg~p~ 277 (420)
T 1j1b_A 207 LVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-------VDQLVEIIKVLGTPT 277 (420)
T ss_dssp CCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHHHCSCC
T ss_pred cccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHHHhCCCC
Confidence 654332 2345789999999999765 789999999999999999999999975421 011222211110000
Q ss_pred c-hhHhhhh--------hccC-----CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 609 R-LLTAADA--------RLEG-----QFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 609 ~-~~~~~d~--------~l~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
. ......+ .+.. .+.......+.+|+.+||+.||.+||++.|+++.
T Consensus 278 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 278 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 0 0000000 0000 0111223568889999999999999999999863
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=336.12 Aligned_cols=252 Identities=23% Similarity=0.330 Sum_probs=204.8
Q ss_pred HhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC----------ChhhhHHHHHHHHhcC-CCCeeeeeeeee
Q 043702 378 ATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ----------GKDEFLSELSIIGTLR-HRNLVRLQGWCH 446 (711)
Q Consensus 378 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----------~~~~~~~Ei~~l~~l~-H~niv~l~g~~~ 446 (711)
..++|...+.||+|+||.||+|.+..+++.||||++..... ..+.+.+|++++++++ ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 34689999999999999999999998999999999875431 1346789999999996 999999999999
Q ss_pred ecCeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCC
Q 043702 447 EKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGL 526 (711)
Q Consensus 447 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGl 526 (711)
..+..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~ 170 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGF 170 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cCCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccc
Confidence 99999999999999999999965 35699999999999999999999998 999999999999999999999999999
Q ss_pred ceecCCCCCCCcccccCCCcccChhhhc------cCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHH
Q 043702 527 ARQVEHDKSPDATVAAGTMGYLAPEYLL------TGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEW 600 (711)
Q Consensus 527 a~~~~~~~~~~~~~~~gt~~y~APE~~~------~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~ 600 (711)
++...... ......|++.|+|||++. ...++.++|||||||++|||++|+.||..... .+.
T Consensus 171 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----------~~~ 237 (298)
T 1phk_A 171 SCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-----------MLM 237 (298)
T ss_dssp CEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHH
T ss_pred hhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH-----------HHH
Confidence 98765433 233456899999999985 45678999999999999999999999964321 111
Q ss_pred HHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 601 VWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 601 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
.... ..+... ............+.+++.+||+.||.+||++.|+++
T Consensus 238 ~~~~-~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 238 LRMI-MSGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHH-HHTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHH-hcCCcc------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1111 111100 000001122356778999999999999999999987
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=375.40 Aligned_cols=255 Identities=24% Similarity=0.401 Sum_probs=204.5
Q ss_pred HhcCCcccceeecCCceEEEEEEeCC---CCeEEEEEEcccCCC--ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEE
Q 043702 378 ATKCFNANRIIGHGAFGTVYKGILPQ---NGDIIAVKRCSHNSQ--GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEIL 452 (711)
Q Consensus 378 at~~f~~~~~LG~G~fg~Vy~~~~~~---~~~~vavK~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 452 (711)
..++|...+.||+|+||.||+|.+.. .+..||+|++..... ..+.+.+|+.++++++||||+++++++. ++..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 34678899999999999999999854 346799999875332 2367899999999999999999999985 45689
Q ss_pred EEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCC
Q 043702 453 LVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEH 532 (711)
Q Consensus 453 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~ 532 (711)
+||||+++|+|.+++......+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 467 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp EEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred EEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence 99999999999999987777899999999999999999999998 999999999999999999999999999987755
Q ss_pred CCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchh
Q 043702 533 DKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLL 611 (711)
Q Consensus 533 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 611 (711)
..........+|+.|+|||.+....++.++|||||||++|||++ |+.||..... ..... .. ..+.
T Consensus 544 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~--------~~~~~---~i-~~~~-- 609 (656)
T 2j0j_A 544 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--------NDVIG---RI-ENGE-- 609 (656)
T ss_dssp ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHH---HH-HHTC--
T ss_pred CcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH--------HHHHH---HH-HcCC--
Confidence 44333444567889999999999999999999999999999997 9999965321 11111 11 1111
Q ss_pred HhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 612 TAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 612 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
....+......+.+++.+||+.||.+||++.++++.|+.
T Consensus 610 -------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~ 648 (656)
T 2j0j_A 610 -------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 648 (656)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 011122234567789999999999999999999999875
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=342.90 Aligned_cols=262 Identities=23% Similarity=0.286 Sum_probs=202.0
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC--ChhhhHHHHHHHHhcCCCCeeeeeeeeeec-----CeE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ--GKDEFLSELSIIGTLRHRNLVRLQGWCHEK-----GEI 451 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~ 451 (711)
.++|...+.||+|+||.||+|.+..+++.||||++..... ..+.+.+|++++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 4579999999999999999999988999999999875332 236788999999999999999999999754 468
Q ss_pred EEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecC
Q 043702 452 LLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVE 531 (711)
Q Consensus 452 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~ 531 (711)
++||||+. |+|.+++.. ..+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 106 ~iv~e~~~-~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp EEEEECCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEcccC-cCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 99999997 599999865 4599999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCC--CcccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcC
Q 043702 532 HDKSP--DATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREG 608 (711)
Q Consensus 532 ~~~~~--~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 608 (711)
..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .....+.......
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~~~~i~~~~~~~ 251 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL--------DQLNHILGILGSP 251 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGG--------GHHHHHHHHHCSC
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChH--------HHHHHHHHHhCCC
Confidence 43221 12345799999999987654 5899999999999999999999999654321 1111111100000
Q ss_pred ch-----------hHhhhhhc-cCCCc-----HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 609 RL-----------LTAADARL-EGQFD-----EAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 609 ~~-----------~~~~d~~l-~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.. ........ ..... ......+.+++.+||+.||.+|||+.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 00000000 00000 1123457789999999999999999999984
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=344.84 Aligned_cols=255 Identities=22% Similarity=0.354 Sum_probs=200.2
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC---CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN---SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
.++|+..+.||+|+||.||+|.+.. .+|+|++... ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 4578889999999999999999843 4899988753 234567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCC-
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK- 534 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~- 534 (711)
||+++++|.+++......+++..++.++.||+.||+|||+. +|+||||||+|||++ ++.+||+|||+++......
T Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~ 184 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA 184 (319)
T ss_dssp BCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred ecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence 99999999999987667899999999999999999999998 999999999999998 6799999999987653211
Q ss_pred ---CCCcccccCCCcccChhhhcc---------CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHH
Q 043702 535 ---SPDATVAAGTMGYLAPEYLLT---------GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVW 602 (711)
Q Consensus 535 ---~~~~~~~~gt~~y~APE~~~~---------~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~ 602 (711)
........|++.|+|||.+.. ..++.++|||||||++|||++|+.||..... ....+
T Consensus 185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----------~~~~~ 253 (319)
T 2y4i_B 185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA-----------EAIIW 253 (319)
T ss_dssp ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH-----------HHHHH
T ss_pred cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----------HHHHH
Confidence 122333468999999999874 4578899999999999999999999965321 11111
Q ss_pred HhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC
Q 043702 603 SLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEAE 660 (711)
Q Consensus 603 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 660 (711)
... .+.. +... .......+.+++.+||+.||.+||++.+++++|+....
T Consensus 254 ~~~-~~~~-----~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 254 QMG-TGMK-----PNLS---QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp HHH-TTCC-----CCCC---CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred Hhc-cCCC-----CCCC---cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 111 1110 1110 00122357788999999999999999999999987643
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=343.58 Aligned_cols=263 Identities=21% Similarity=0.301 Sum_probs=200.5
Q ss_pred HhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC--ChhhhHHHHHHHHhcCCCCeeeeeeeeeec-----Ce
Q 043702 378 ATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ--GKDEFLSELSIIGTLRHRNLVRLQGWCHEK-----GE 450 (711)
Q Consensus 378 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~ 450 (711)
..++|...+.||+|+||.||+|.+..+|+.||||++..... ....+.+|++++++++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 34689999999999999999999988899999999865332 245678999999999999999999998764 67
Q ss_pred EEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceec
Q 043702 451 ILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV 530 (711)
Q Consensus 451 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~ 530 (711)
.++||||+. |+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 899999997 699999865 4699999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCC---------CcccccCCCcccChhhhcc-CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHH
Q 043702 531 EHDKSP---------DATVAAGTMGYLAPEYLLT-GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEW 600 (711)
Q Consensus 531 ~~~~~~---------~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~ 600 (711)
...... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||...... .....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~ 234 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR--------HQLLL 234 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHH
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcH--------HHHHH
Confidence 533211 1223468999999998765 67899999999999999999999999754210 00000
Q ss_pred HHHhhhc------------CchhHhhhhhc-cCC-----CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 601 VWSLHRE------------GRLLTAADARL-EGQ-----FDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 601 ~~~~~~~------------~~~~~~~d~~l-~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
....... ....+...... ... ........+.+++.+||+.||.+|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 235 IFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000 00000000000 000 001123467789999999999999999999983
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=373.46 Aligned_cols=249 Identities=21% Similarity=0.314 Sum_probs=207.5
Q ss_pred HhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEccc----CCCChhhhHHHHHHHHhc-CCCCeeeeeeeeeecCeEE
Q 043702 378 ATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSH----NSQGKDEFLSELSIIGTL-RHRNLVRLQGWCHEKGEIL 452 (711)
Q Consensus 378 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~----~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 452 (711)
..++|+..++||+|+||.||+|++..+++.||||++.. .....+.+..|..++..+ +||||+++++++.+.+.++
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 34679999999999999999999999999999999875 334566788999999988 5999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCC
Q 043702 453 LVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEH 532 (711)
Q Consensus 453 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~ 532 (711)
+||||+++|+|..++... ..+++..++.++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++....
T Consensus 419 lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred EEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 999999999999999754 4699999999999999999999998 999999999999999999999999999986443
Q ss_pred CCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhH
Q 043702 533 DKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLT 612 (711)
Q Consensus 533 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 612 (711)
.. ......+||+.|+|||++.+..++.++|||||||+||||++|+.||..... .+...... .+.
T Consensus 495 ~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~-----------~~~~~~i~-~~~--- 558 (674)
T 3pfq_A 495 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----------DELFQSIM-EHN--- 558 (674)
T ss_dssp TT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHHHHHH-SSC---
T ss_pred CC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH-----------HHHHHHHH-hCC---
Confidence 32 234456899999999999999999999999999999999999999975421 11111111 111
Q ss_pred hhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCH-----HHHHH
Q 043702 613 AADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTM-----RGVVQ 653 (711)
Q Consensus 613 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~eVl~ 653 (711)
..++.....++.+|+.+||+.||.+||++ +||++
T Consensus 559 -------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 559 -------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp -------CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred -------CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 11222334567788999999999999998 77765
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=337.58 Aligned_cols=263 Identities=23% Similarity=0.308 Sum_probs=202.3
Q ss_pred HHhcCCcccceeecCCceEEEEEEeC-CCCeEEEEEEcccC---CCChhhhHHHHHHHHhc---CCCCeeeeeeeee---
Q 043702 377 SATKCFNANRIIGHGAFGTVYKGILP-QNGDIIAVKRCSHN---SQGKDEFLSELSIIGTL---RHRNLVRLQGWCH--- 446 (711)
Q Consensus 377 ~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~--- 446 (711)
.+.++|...+.||+|+||.||+|.+. .+++.||+|++... ......+.+|+.+++.+ +||||++++++|.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 45678999999999999999999984 67899999988652 22345677888888777 8999999999987
Q ss_pred --ecCeEEEEEEcCCCCCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEee
Q 043702 447 --EKGEILLVYDLMPNGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGD 523 (711)
Q Consensus 447 --~~~~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~D 523 (711)
.....++||||++ |+|.+++.... ..+++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEec
Confidence 4567899999997 69999997654 4599999999999999999999998 999999999999999999999999
Q ss_pred cCCceecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHH
Q 043702 524 FGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWS 603 (711)
Q Consensus 524 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~ 603 (711)
||+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ......+..
T Consensus 164 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~i~~ 233 (326)
T 1blx_A 164 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD--------VDQLGKILD 233 (326)
T ss_dssp CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHH
T ss_pred CcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHHH
Confidence 99998654322 22345689999999999999999999999999999999999999975422 011111111
Q ss_pred hhhcCchhHh----------hh---hhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 604 LHREGRLLTA----------AD---ARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 604 ~~~~~~~~~~----------~d---~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
.......... .. ......+.......+.+++.+||+.||.+||++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 234 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp HHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000000 00 00000111122356778999999999999999999996
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=349.30 Aligned_cols=258 Identities=22% Similarity=0.296 Sum_probs=184.2
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC---ChhhhHHHHHHHHhcCCCCeeeeeeeeeec------C
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ---GKDEFLSELSIIGTLRHRNLVRLQGWCHEK------G 449 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~ 449 (711)
.++|...+.||+|+||.||+|.+..+|+.||||++..... ..+.+.+|+++++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 3678999999999999999999988999999999876432 245788999999999999999999998653 5
Q ss_pred eEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCcee
Q 043702 450 EILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQ 529 (711)
Q Consensus 450 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~ 529 (711)
..++|+||+ +++|.+++.. ..+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH 181 (367)
T ss_dssp CCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC------
T ss_pred eEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence 689999999 7899998854 5799999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCCCcccccCCCcccChhhhcc-CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhc-
Q 043702 530 VEHDKSPDATVAAGTMGYLAPEYLLT-GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHRE- 607 (711)
Q Consensus 530 ~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~- 607 (711)
.... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+......
T Consensus 182 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~l~~i~~~~g~p 249 (367)
T 2fst_X 182 TADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH--------IDQLKLILRLVGTP 249 (367)
T ss_dssp -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHHHCSC
T ss_pred cccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHHHhCCC
Confidence 5432 334579999999999987 6789999999999999999999999965421 0111111111000
Q ss_pred ----------CchhHhhhhhc-cCCCcH-----HHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 608 ----------GRLLTAADARL-EGQFDE-----AEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 608 ----------~~~~~~~d~~l-~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
........... ...... .....+.+|+.+||+.||.+|||+.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 00000000000 000000 112457789999999999999999999974
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=337.03 Aligned_cols=266 Identities=21% Similarity=0.291 Sum_probs=195.0
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC-CChhhhHHHHHHHHhcCCCCeeeeeeeee-----------
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCH----------- 446 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~----------- 446 (711)
.++|...+.||+|+||.||+|.+..+++.||+|++.... ...+++.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 357889999999999999999998889999999987543 33567889999999999999999999873
Q ss_pred ---ecCeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEc-CCCcEEEe
Q 043702 447 ---EKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLD-EGFNARLG 522 (711)
Q Consensus 447 ---~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld-~~~~vkL~ 522 (711)
+.+..++||||++ |+|.+++. ...+++..++.++.|+++||+|||+. +|+||||||+|||++ +++.+||+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE--QGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccccCceeEEeeccC-CCHHHHhh--cCCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEc
Confidence 4467899999997 69999985 35699999999999999999999998 999999999999997 56799999
Q ss_pred ecCCceecCCCCC--CCcccccCCCcccChhhhcc-CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHH
Q 043702 523 DFGLARQVEHDKS--PDATVAAGTMGYLAPEYLLT-GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVE 599 (711)
Q Consensus 523 DFGla~~~~~~~~--~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~ 599 (711)
|||+++....... .......+|..|+|||.+.. ..++.++|||||||++|||++|+.||...... ..+..
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-------~~~~~ 236 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL-------EQMQL 236 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHH
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH-------HHHHH
Confidence 9999987643221 12233467999999998876 67899999999999999999999999754220 00000
Q ss_pred HHHHhhh---------cCchhHhhhhhcc-CC-----CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--HHhC
Q 043702 600 WVWSLHR---------EGRLLTAADARLE-GQ-----FDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ--MLVG 657 (711)
Q Consensus 600 ~~~~~~~---------~~~~~~~~d~~l~-~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~--~L~~ 657 (711)
....... ...+......... .. ........+.+++.+||+.||.+||+++|+++ .+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 311 (320)
T 2i6l_A 237 ILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSI 311 (320)
T ss_dssp HHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHT
T ss_pred HHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccc
Confidence 0000000 0000000000000 00 00112356788999999999999999999987 4543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=341.23 Aligned_cols=264 Identities=19% Similarity=0.285 Sum_probs=204.3
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcC-----------CCCeeeeeeeeeec
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLR-----------HRNLVRLQGWCHEK 448 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~-----------H~niv~l~g~~~~~ 448 (711)
++|...+.||+|+||.||+|++..+++.||||++.......+.+.+|++++++++ ||||+++++++...
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~ 98 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 98 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence 5789999999999999999999889999999999765555677889999999887 89999999999865
Q ss_pred C----eEEEEEEcCCCCCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEc------CCC
Q 043702 449 G----EILLVYDLMPNGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLD------EGF 517 (711)
Q Consensus 449 ~----~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld------~~~ 517 (711)
+ ..++||||+ +++|.+++.... ..+++..+..++.||+.||+|||+. .+|+||||||+|||++ ..+
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~--~~ivH~Dikp~NIll~~~~~~~~~~ 175 (373)
T 1q8y_A 99 GPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLI 175 (373)
T ss_dssp ETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEE
T ss_pred CCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChHHeEEeccCCCcCcc
Confidence 4 789999999 889999997643 4599999999999999999999984 2899999999999994 445
Q ss_pred cEEEeecCCceecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccch
Q 043702 518 NARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNL 597 (711)
Q Consensus 518 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l 597 (711)
.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ....+
T Consensus 176 ~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~-~~~~~ 250 (373)
T 1q8y_A 176 QIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK-DDDHI 250 (373)
T ss_dssp EEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C-HHHHH
T ss_pred eEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC-hHHHH
Confidence 7999999999876543 223468999999999999999999999999999999999999997543210000 00011
Q ss_pred HHHHHHhhh--------cCc----------------------hhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCC
Q 043702 598 VEWVWSLHR--------EGR----------------------LLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPT 647 (711)
Q Consensus 598 ~~~~~~~~~--------~~~----------------------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 647 (711)
.... .... .++ +...... ...+.......+.+++.+||+.||.+|||
T Consensus 251 ~~~~-~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 251 AQII-ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE--KYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHH-HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHH--TTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHH-HhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhh--cccCCcchHHHHHHHHHHHhccCccccCC
Confidence 1100 0000 000 0000111 11345667788999999999999999999
Q ss_pred HHHHHHH
Q 043702 648 MRGVVQM 654 (711)
Q Consensus 648 ~~eVl~~ 654 (711)
++|+++.
T Consensus 328 ~~ell~h 334 (373)
T 1q8y_A 328 AGGLVNH 334 (373)
T ss_dssp HHHHHTC
T ss_pred HHHHhhC
Confidence 9999983
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=343.30 Aligned_cols=258 Identities=21% Similarity=0.285 Sum_probs=196.8
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCC---hhhhHHHHHHHHhcCCCCeeeeeeeeeecCeE----
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQG---KDEFLSELSIIGTLRHRNLVRLQGWCHEKGEI---- 451 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~---- 451 (711)
.++|...+.||+|+||.||+|.+..+|+.||||++...... .+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 45788999999999999999999989999999998764332 35788999999999999999999999876654
Q ss_pred --EEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCcee
Q 043702 452 --LLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQ 529 (711)
Q Consensus 452 --~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~ 529 (711)
++||||+. ++|.+++ ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 121 ~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIM---GMEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp CCEEEEECCC-EEHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred eEEEEEcccc-ccHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 99999997 6888877 34599999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCCCCcccccCCCcccChhhhcc-CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHh----
Q 043702 530 VEHDKSPDATVAAGTMGYLAPEYLLT-GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSL---- 604 (711)
Q Consensus 530 ~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~---- 604 (711)
.... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+.......
T Consensus 194 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~~~~i~~~~~~~~ 262 (371)
T 4exu_A 194 ADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-------DQLTQILKVTGVPG 262 (371)
T ss_dssp ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHHHCCCC
T ss_pred cccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHHHHhCCCc
Confidence 5432 234568999999999987 67899999999999999999999999754210 0010000000
Q ss_pred ------hhcCchhHhhhhhc---cCC---CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 605 ------HREGRLLTAADARL---EGQ---FDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 605 ------~~~~~~~~~~d~~l---~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.............. ... ........+.+++.+||+.||.+|||+.|+++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00000000000000 000 001123567889999999999999999999974
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=338.88 Aligned_cols=259 Identities=20% Similarity=0.310 Sum_probs=202.7
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCC-eEEEEEEcccCCCChhhhHHHHHHHHhcCCCC------eeeeeeeeeecCeE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNG-DIIAVKRCSHNSQGKDEFLSELSIIGTLRHRN------LVRLQGWCHEKGEI 451 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~n------iv~l~g~~~~~~~~ 451 (711)
.++|...+.||+|+||+||+|....++ +.||+|++.......+.+.+|++++++++|++ ++.+++++...+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 467999999999999999999997666 78999999765555677889999999998766 89999999999999
Q ss_pred EEEEEcCCCCCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEE-----------------
Q 043702 452 LLVYDLMPNGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIML----------------- 513 (711)
Q Consensus 452 ~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl----------------- 513 (711)
++||||+ +++|.+++.... ..+++.+++.++.||+.||+|||+. +|+||||||+|||+
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred EEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccccc
Confidence 9999999 667777776544 5799999999999999999999997 99999999999999
Q ss_pred --cCCCcEEEeecCCceecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCcccccccccc
Q 043702 514 --DEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKV 591 (711)
Q Consensus 514 --d~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~ 591 (711)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---- 245 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR---- 245 (355)
T ss_dssp EEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----
T ss_pred cccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH----
Confidence 67889999999999875432 23357999999999999999999999999999999999999999754221
Q ss_pred ccccchHHHHHHhhh-----------cCch--------------hHhhhhh---c--cCCCcHHHHHHHHHHHHhcCCCC
Q 043702 592 GVASNLVEWVWSLHR-----------EGRL--------------LTAADAR---L--EGQFDEAEMRRVLLVGLACSHPD 641 (711)
Q Consensus 592 ~~~~~l~~~~~~~~~-----------~~~~--------------~~~~d~~---l--~~~~~~~~~~~l~~l~~~Cl~~d 641 (711)
.....+..... .... ....... + ...........+.+++.+||+.|
T Consensus 246 ----~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 321 (355)
T 2eu9_A 246 ----EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFD 321 (355)
T ss_dssp ----HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred ----HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCC
Confidence 11111111000 0000 0000000 0 00112234567889999999999
Q ss_pred CCCCCCHHHHHH
Q 043702 642 PLARPTMRGVVQ 653 (711)
Q Consensus 642 P~~RPs~~eVl~ 653 (711)
|.+|||+.|+++
T Consensus 322 P~~Rpt~~e~l~ 333 (355)
T 2eu9_A 322 PAQRITLAEALL 333 (355)
T ss_dssp TTTSCCHHHHTT
T ss_pred hhhCcCHHHHhc
Confidence 999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=329.95 Aligned_cols=252 Identities=22% Similarity=0.316 Sum_probs=203.5
Q ss_pred HHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC---CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEE
Q 043702 377 SATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN---SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILL 453 (711)
Q Consensus 377 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 453 (711)
...++|...+.||+|+||.||+|+...+++.||+|++... ....+.+.+|++++++++||||+++++++...+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 4456899999999999999999999888999999998652 3456788999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCC---CcEEEeecCCceec
Q 043702 454 VYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEG---FNARLGDFGLARQV 530 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~---~~vkL~DFGla~~~ 530 (711)
||||+++++|.+++... ..+++..++.++.||+.||.|||+. +|+||||||+||+++.+ +.+||+|||+++..
T Consensus 99 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 99 VGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp EECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 99999999999988653 4699999999999999999999998 99999999999999754 46999999999876
Q ss_pred CCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCch
Q 043702 531 EHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRL 610 (711)
Q Consensus 531 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 610 (711)
..... .....|++.|+|||.+.+ .++.++||||||+++|||++|+.||..... .+.... ...+..
T Consensus 175 ~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----------~~~~~~-~~~~~~ 239 (287)
T 2wei_A 175 QQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-----------YDILKR-VETGKY 239 (287)
T ss_dssp CCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHHHH-HHHCCC
T ss_pred cCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH-----------HHHHHH-HHcCCC
Confidence 54332 223458999999998865 589999999999999999999999965321 111111 111111
Q ss_pred hHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 611 LTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 611 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
.... .... .....+.+++.+||+.||.+|||+.|+++
T Consensus 240 ~~~~--~~~~----~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 240 AFDL--PQWR----TISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CCCS--GGGT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCc--hhhh----hcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0000 0001 12345778899999999999999999997
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=348.27 Aligned_cols=258 Identities=22% Similarity=0.331 Sum_probs=193.4
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCe------EEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGE------ILL 453 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~------~~l 453 (711)
.+|...++||+|+||.||+|++..+++ +|+|++..... ...+|+++++.++||||+++++++...+. +++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~---~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR---FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc---hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 468889999999999999999976554 88888764332 23479999999999999999999965443 889
Q ss_pred EEEcCCCCCHHHHH--hhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEc-CCCcEEEeecCCceec
Q 043702 454 VYDLMPNGSLDKAL--FEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLD-EGFNARLGDFGLARQV 530 (711)
Q Consensus 454 V~Ey~~~gsL~~~l--~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld-~~~~vkL~DFGla~~~ 530 (711)
||||++++.+.... ......+++..+..++.||++||+|||+. +|+||||||+||||+ .++.+||+|||+++..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 99999875444333 23456799999999999999999999998 999999999999999 7999999999999877
Q ss_pred CCCCCCCcccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCc
Q 043702 531 EHDKSPDATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGR 609 (711)
Q Consensus 531 ~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 609 (711)
..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+......+ ....
T Consensus 193 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-------~~l~~i~~~~-g~p~ 262 (394)
T 4e7w_A 193 IAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI-------DQLVEIIKVL-GTPS 262 (394)
T ss_dssp CTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHHH-CCCC
T ss_pred cCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHHHh-CCCC
Confidence 54432 2345689999999998765 5899999999999999999999999754221 1111111100 0000
Q ss_pred h--hHhhhhhc-------------cCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 610 L--LTAADARL-------------EGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 610 ~--~~~~d~~l-------------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
. ....++.. ...+.......+.+|+.+||+.||.+|||+.|+++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 263 REQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0 00000000 000111233568889999999999999999999974
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=340.79 Aligned_cols=261 Identities=20% Similarity=0.349 Sum_probs=199.2
Q ss_pred CccCHHHHHHHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC---ChhhhHHHHHHHHhcC--CCCeeeee
Q 043702 368 KEFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ---GKDEFLSELSIIGTLR--HRNLVRLQ 442 (711)
Q Consensus 368 ~~~~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~Ei~~l~~l~--H~niv~l~ 442 (711)
+.+.++.+....++|...+.||+|+||.||++... +++.||+|++..... ..+.+.+|++++.+++ |+||++++
T Consensus 16 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~ 94 (313)
T 3cek_A 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94 (313)
T ss_dssp ----CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEE
T ss_pred CCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEE
Confidence 34444555556678999999999999999999985 488999999875432 3467889999999998 59999999
Q ss_pred eeeeecCeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEe
Q 043702 443 GWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLG 522 (711)
Q Consensus 443 g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~ 522 (711)
+++...+..++||| +.+++|.+++... ..+++..++.++.|+++||.|||+. +|+||||||+|||+++ +.+||+
T Consensus 95 ~~~~~~~~~~lv~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~ 168 (313)
T 3cek_A 95 DYEITDQYIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLI 168 (313)
T ss_dssp EEEECSSEEEEEEC-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEEC
T ss_pred EEeecCCEEEEEEe-cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEe
Confidence 99999999999999 5688999999754 5789999999999999999999998 9999999999999975 799999
Q ss_pred ecCCceecCCCCCC-CcccccCCCcccChhhhcc-----------CCCCccccchhHHHHHHHHHhCCCCCccccccccc
Q 043702 523 DFGLARQVEHDKSP-DATVAAGTMGYLAPEYLLT-----------GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGK 590 (711)
Q Consensus 523 DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~-----------~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~ 590 (711)
|||+++........ ......||+.|+|||.+.. ..++.++|||||||++|||++|+.||.....
T Consensus 169 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---- 244 (313)
T 3cek_A 169 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN---- 244 (313)
T ss_dssp CCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS----
T ss_pred eccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH----
Confidence 99999876543321 2234569999999999875 4688899999999999999999999964321
Q ss_pred cccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 591 VGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 591 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
. .... ....++.....+.......+.+++.+||+.||.+||++.|+++.
T Consensus 245 -----~-~~~~---------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 245 -----Q-ISKL---------HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp -----H-HHHH---------HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -----H-HHHH---------HHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 0 1111 11111111111222223467788899999999999999999973
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=349.41 Aligned_cols=200 Identities=24% Similarity=0.367 Sum_probs=156.4
Q ss_pred cCCcc-cceeecCCceEEEEEEeC--CCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeee--cCeEEEE
Q 043702 380 KCFNA-NRIIGHGAFGTVYKGILP--QNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHE--KGEILLV 454 (711)
Q Consensus 380 ~~f~~-~~~LG~G~fg~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV 454 (711)
+.|.. .++||+|+||+||+|++. .+++.||||++.... ....+.+|+++|++++||||+++++++.. ....++|
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 34555 458999999999999975 457899999987543 34578899999999999999999999954 6789999
Q ss_pred EEcCCCCCHHHHHhhC--------CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEE----cCCCcEEEe
Q 043702 455 YDLMPNGSLDKALFEA--------RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIML----DEGFNARLG 522 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~~--------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl----d~~~~vkL~ 522 (711)
|||++ |+|.+++... ...+++..++.|+.||+.||+|||+. +|+||||||+|||| +.++.+||+
T Consensus 99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 99996 5888877521 22499999999999999999999998 99999999999999 778899999
Q ss_pred ecCCceecCCCCC--CCcccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccc
Q 043702 523 DFGLARQVEHDKS--PDATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKE 584 (711)
Q Consensus 523 DFGla~~~~~~~~--~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~ 584 (711)
|||+++....... ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 9999987654322 223446799999999999874 5899999999999999999999999654
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=345.00 Aligned_cols=257 Identities=21% Similarity=0.310 Sum_probs=202.8
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC---CC-h--------------hhhHHHHHHHHhcCCCCeee
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---QG-K--------------DEFLSELSIIGTLRHRNLVR 440 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~-~--------------~~~~~Ei~~l~~l~H~niv~ 440 (711)
.++|...+.||+|+||.||+|.. +++.||+|++.... .. . +.+.+|++++++++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 46799999999999999999999 79999999986521 11 1 78999999999999999999
Q ss_pred eeeeeeecCeEEEEEEcCCCCCHHHH------HhhC-CCCCChHHHHHHHHHHHHHHHHHHh-ccCCCeeeccCCCCceE
Q 043702 441 LQGWCHEKGEILLVYDLMPNGSLDKA------LFEA-RSPLPWPHRSKILLGVASALAYLHQ-ECENQVIHRDVKTSNIM 512 (711)
Q Consensus 441 l~g~~~~~~~~~lV~Ey~~~gsL~~~------l~~~-~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivHrDlkp~NIL 512 (711)
+++++.+.+..++||||+++|+|.++ +... ...+++..+..++.|++.||.|||+ . +|+||||||+|||
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil 184 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNIL 184 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEE
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEE
Confidence 99999999999999999999999998 5432 4679999999999999999999998 6 9999999999999
Q ss_pred EcCCCcEEEeecCCceecCCCCCCCcccccCCCcccChhhhccC-CCCc-cccchhHHHHHHHHHhCCCCCccccccccc
Q 043702 513 LDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTG-RATE-KTDVFSYGAVVLEVASGRRPIEKEITGVGK 590 (711)
Q Consensus 513 ld~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~-ksDVwSfGvll~elltG~~P~~~~~~~~~~ 590 (711)
++.++.+||+|||+++..... ......|++.|+|||.+.+. .++. ++|||||||++|||++|+.||......
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--- 258 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--- 258 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS---
T ss_pred EcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH---
Confidence 999999999999999876443 23345699999999999877 5665 999999999999999999999754220
Q ss_pred cccccchHHHHHHhhhcCchhHhhh---------hhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 591 VGVASNLVEWVWSLHREGRLLTAAD---------ARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 591 ~~~~~~l~~~~~~~~~~~~~~~~~d---------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.+.. .....+......+ ..............+.+++.+||+.||.+||++.|+++.
T Consensus 259 -------~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 259 -------VELF-NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp -------HHHH-HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred -------HHHH-HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111 1111111100000 000000012223567889999999999999999999973
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=335.96 Aligned_cols=244 Identities=23% Similarity=0.371 Sum_probs=194.9
Q ss_pred HHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC-------CChhhhHHHHHHHHhc----CCCCeeeeeeee
Q 043702 377 SATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS-------QGKDEFLSELSIIGTL----RHRNLVRLQGWC 445 (711)
Q Consensus 377 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~~~~Ei~~l~~l----~H~niv~l~g~~ 445 (711)
...++|...+.||+|+||.||+|++..+++.||||++.... .....+.+|+.++.++ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 34567999999999999999999998889999999987533 2334677899999999 899999999999
Q ss_pred eecCeEEEEEEc-CCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEc-CCCcEEEee
Q 043702 446 HEKGEILLVYDL-MPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLD-EGFNARLGD 523 (711)
Q Consensus 446 ~~~~~~~lV~Ey-~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld-~~~~vkL~D 523 (711)
...+..++|+|| +++++|.+++.. ...+++..++.++.||++||+|||+. +|+||||||+||+++ +++.+||+|
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~d 183 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLID 183 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEECC
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEEEE
Confidence 999999999999 789999999975 34699999999999999999999998 999999999999999 889999999
Q ss_pred cCCceecCCCCCCCcccccCCCcccChhhhccCCCC-ccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHH
Q 043702 524 FGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRAT-EKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVW 602 (711)
Q Consensus 524 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s-~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~ 602 (711)
||+++...... .....|++.|+|||++.+..+. .++|||||||++|||++|+.||..... ..
T Consensus 184 fg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------------~~- 246 (312)
T 2iwi_A 184 FGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-------------IL- 246 (312)
T ss_dssp CSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------------HH-
T ss_pred cchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-------------Hh-
Confidence 99998765432 2345699999999999877664 589999999999999999999964311 00
Q ss_pred HhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 043702 603 SLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655 (711)
Q Consensus 603 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L 655 (711)
. .. ..+.......+.+++.+||+.||++||+++|+++.-
T Consensus 247 ---~---------~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~ 285 (312)
T 2iwi_A 247 ---E---------AE--LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDP 285 (312)
T ss_dssp ---H---------TC--CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHST
T ss_pred ---h---------hc--cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 0 00 011112234577889999999999999999999843
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=339.68 Aligned_cols=245 Identities=22% Similarity=0.347 Sum_probs=202.7
Q ss_pred HHHHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC-------CChhhhHHHHHHHHhcC--CCCeeeeeeee
Q 043702 375 LRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS-------QGKDEFLSELSIIGTLR--HRNLVRLQGWC 445 (711)
Q Consensus 375 l~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~~~~Ei~~l~~l~--H~niv~l~g~~ 445 (711)
.....++|...+.||+|+||.||+|.+..+++.||||++.... ...+.+.+|+.++++++ |+||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 3345568999999999999999999998899999999987632 12356889999999997 59999999999
Q ss_pred eecCeEEEEEEcCCC-CCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEc-CCCcEEEee
Q 043702 446 HEKGEILLVYDLMPN-GSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLD-EGFNARLGD 523 (711)
Q Consensus 446 ~~~~~~~lV~Ey~~~-gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld-~~~~vkL~D 523 (711)
...+..++|+||+.+ ++|.+++.. ...+++..++.++.||++||+|||+. +|+||||||+|||++ +++.+||+|
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECC
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEee
Confidence 999999999999976 899999965 45699999999999999999999998 999999999999999 788999999
Q ss_pred cCCceecCCCCCCCcccccCCCcccChhhhccCCC-CccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHH
Q 043702 524 FGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRA-TEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVW 602 (711)
Q Consensus 524 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~ 602 (711)
||+++...... .....||+.|+|||++....+ +.++|||||||++|||++|+.||.....
T Consensus 194 fg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---------------- 254 (320)
T 3a99_A 194 FGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---------------- 254 (320)
T ss_dssp CTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------------
T ss_pred Ccccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh----------------
Confidence 99998765432 233569999999999987765 6889999999999999999999964311
Q ss_pred HhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 603 SLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 603 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.... .. .....+ ...+.+++.+||+.||.+||+++|+++.
T Consensus 255 -~~~~-~~------~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 255 -IIRG-QV------FFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp -HHHC-CC------CCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -hhcc-cc------cccccC----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 00 011122 2457788999999999999999999984
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=338.83 Aligned_cols=258 Identities=19% Similarity=0.247 Sum_probs=177.4
Q ss_pred hcCCccc-ceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHH-HHHHhcCCCCeeeeeeeeee----cCeEE
Q 043702 379 TKCFNAN-RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSEL-SIIGTLRHRNLVRLQGWCHE----KGEIL 452 (711)
Q Consensus 379 t~~f~~~-~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei-~~l~~l~H~niv~l~g~~~~----~~~~~ 452 (711)
.++|... ++||+|+||.||+|.+..+++.||||++.... ...+|+ ..++.++||||+++++++.. +...+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 4578874 46999999999999999889999999986432 233333 44667789999999999876 45689
Q ss_pred EEEEcCCCCCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcC---CCcEEEeecCCce
Q 043702 453 LVYDLMPNGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDE---GFNARLGDFGLAR 528 (711)
Q Consensus 453 lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~---~~~vkL~DFGla~ 528 (711)
+||||+++|+|.+++.... ..+++.+++.++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++
T Consensus 103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 9999999999999997654 4699999999999999999999998 9999999999999976 4559999999998
Q ss_pred ecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcC
Q 043702 529 QVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREG 608 (711)
Q Consensus 529 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 608 (711)
...... .....||+.|+|||++....++.++|||||||++|||++|+.||....... ...........+
T Consensus 180 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~~~~~~~~~~~~ 248 (336)
T 3fhr_A 180 ETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQA--------ISPGMKRRIRLG 248 (336)
T ss_dssp EC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------------
T ss_pred eccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchh--------hhhhHHHhhhcc
Confidence 764322 234568999999999988889999999999999999999999996543210 000000000000
Q ss_pred chhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--HHhCCCC
Q 043702 609 RLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ--MLVGEAE 660 (711)
Q Consensus 609 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~--~L~~~~~ 660 (711)
.. .............+.+++.+||+.||.+|||+.|+++ .++....
T Consensus 249 ~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 296 (336)
T 3fhr_A 249 QY------GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMV 296 (336)
T ss_dssp --------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGG
T ss_pred cc------ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccccc
Confidence 00 0000011122345778899999999999999999998 5554433
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=338.93 Aligned_cols=253 Identities=27% Similarity=0.392 Sum_probs=179.2
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC--ChhhhHHHHH-HHHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ--GKDEFLSELS-IIGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
++|...+.||+|+||.||+|....+++.||||++..... ...++..|+. +++.++||||+++++++...+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 578889999999999999999988899999999876432 2345666666 6777899999999999999999999999
Q ss_pred cCCCCCHHHHHhh----CCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCC
Q 043702 457 LMPNGSLDKALFE----ARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEH 532 (711)
Q Consensus 457 y~~~gsL~~~l~~----~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~ 532 (711)
|+++ +|.+++.. ....+++..+.+++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence 9975 88877752 356799999999999999999999984 3899999999999999999999999999987654
Q ss_pred CCCCCcccccCCCcccChhhh----ccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcC
Q 043702 533 DKSPDATVAAGTMGYLAPEYL----LTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREG 608 (711)
Q Consensus 533 ~~~~~~~~~~gt~~y~APE~~----~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 608 (711)
... .....||+.|+|||.+ .+..++.++|||||||++|||++|+.||...... .+...... .+
T Consensus 179 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----------~~~~~~~~-~~ 245 (327)
T 3aln_A 179 SIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV----------FDQLTQVV-KG 245 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------------CCCC-CS
T ss_pred ccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH----------HHHHHHHh-cC
Confidence 322 2234699999999998 4567899999999999999999999999653210 00000000 00
Q ss_pred chhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 609 RLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 609 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
. .+.+...........+.+++.+||+.||.+||++.++++
T Consensus 246 ~-----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 246 D-----PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp C-----CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C-----CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 0 011111111122346778899999999999999999976
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=336.30 Aligned_cols=257 Identities=21% Similarity=0.287 Sum_probs=196.3
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCC---hhhhHHHHHHHHhcCCCCeeeeeeeeeecCe-----
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQG---KDEFLSELSIIGTLRHRNLVRLQGWCHEKGE----- 450 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~----- 450 (711)
.++|...+.||+|+||.||+|.+..+|+.||||++...... .+.+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 35788999999999999999999889999999998764332 3578899999999999999999999987653
Q ss_pred -EEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCcee
Q 043702 451 -ILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQ 529 (711)
Q Consensus 451 -~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~ 529 (711)
.++||||++ ++|.+++. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 103 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred eEEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccC
Confidence 599999997 68887763 3599999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCCCCcccccCCCcccChhhhcc-CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhh--
Q 043702 530 VEHDKSPDATVAAGTMGYLAPEYLLT-GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHR-- 606 (711)
Q Consensus 530 ~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~-- 606 (711)
.... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...... ...........
T Consensus 176 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--------~~~~~i~~~~~~~ 243 (353)
T 3coi_A 176 ADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL--------DQLTQILKVTGVP 243 (353)
T ss_dssp ------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH--------HHHHHHHHHHCBC
T ss_pred CCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHHHhCCC
Confidence 5432 234568999999999887 67899999999999999999999999754210 00000000000
Q ss_pred ---------cCchhHhhhh---hcc---CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 607 ---------EGRLLTAADA---RLE---GQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 607 ---------~~~~~~~~d~---~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.......... ... ..........+.+++.+||+.||.+|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 244 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp CHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000000000 000 01111234567889999999999999999999974
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=331.92 Aligned_cols=251 Identities=25% Similarity=0.368 Sum_probs=181.7
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCCh---hhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGK---DEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
++|+..+.||+|+||.||+|.+..+++.||||++....... +.+.++..+++.++||||+++++++...+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 56888999999999999999998889999999987643322 234445567888899999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCC
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP 536 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~ 536 (711)
|+ ++.+..+.......+++..+..++.|+++||.|||+. .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 105 ~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 180 (318)
T 2dyl_A 105 LM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA- 180 (318)
T ss_dssp CC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHH--HCCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred cc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhh--CCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc-
Confidence 99 5566666655567899999999999999999999983 2899999999999999999999999999986654322
Q ss_pred CcccccCCCcccChhhhc-----cCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchh
Q 043702 537 DATVAAGTMGYLAPEYLL-----TGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLL 611 (711)
Q Consensus 537 ~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 611 (711)
.....||+.|+|||.+. ...++.++|||||||++|||++|+.||..... ..+..........
T Consensus 181 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----------~~~~~~~~~~~~~-- 247 (318)
T 2dyl_A 181 -KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT----------DFEVLTKVLQEEP-- 247 (318)
T ss_dssp -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS----------HHHHHHHHHHSCC--
T ss_pred -ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc----------cHHHHHHHhccCC--
Confidence 23346999999999994 45688999999999999999999999965321 1111111111110
Q ss_pred HhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 612 TAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 612 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
+.+.. .......+.+++.+||+.||.+||+++++++
T Consensus 248 ----~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 248 ----PLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp ----CCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ----CCCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 00100 0112345778889999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=344.11 Aligned_cols=249 Identities=24% Similarity=0.305 Sum_probs=188.7
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhc-CCCCeeeeeeeeeecCeEEEEEEc
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTL-RHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
..+|...++||+|+||+||.... .+++.||||++... ....+.+|+++|+++ +||||+++++++.+.+..++||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~-~~~~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGM-FDNRDVAVKRILPE--CFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEE-SSSSEEEEEEECTT--TEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEE-eCCeEEEEEEECHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 34688889999999999654333 36899999998643 234577999999999 799999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcC-----CCcEEEeecCCceecCC
Q 043702 458 MPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDE-----GFNARLGDFGLARQVEH 532 (711)
Q Consensus 458 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~-----~~~vkL~DFGla~~~~~ 532 (711)
|+ |+|.+++......+.+..+..++.||+.||+|||+. +|+||||||+||||+. ...+||+|||+++....
T Consensus 100 ~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 100 CA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp CS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred CC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 96 699999987776777778889999999999999998 9999999999999943 34688999999987654
Q ss_pred CCC--CCcccccCCCcccChhhhc---cCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhh
Q 043702 533 DKS--PDATVAAGTMGYLAPEYLL---TGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHR 606 (711)
Q Consensus 533 ~~~--~~~~~~~gt~~y~APE~~~---~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~ 606 (711)
... .......||+.|+|||++. ...++.++|||||||++|||++ |+.||..... ........
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~------------~~~~~~~~ 243 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ------------RQANILLG 243 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT------------HHHHHHTT
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH------------HHHHHHhc
Confidence 322 2234467999999999997 4567889999999999999999 9999854311 00111111
Q ss_pred cCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 607 EGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 607 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
.... .. . .........+.+++.+||+.||.+||++.||++
T Consensus 244 ~~~~-~~----~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 244 ACSL-DC----L--HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CCCC-TT----S--CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCCc-cc----c--CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1000 00 0 011123345678999999999999999999985
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=339.82 Aligned_cols=249 Identities=25% Similarity=0.334 Sum_probs=186.0
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhc-CCCCeeeeeeeeeecCeEEEEEEcCC
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTL-RHRNLVRLQGWCHEKGEILLVYDLMP 459 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~ 459 (711)
.|...++||+|+||+||.+.. .+|+.||||++... ..+.+.+|+++++++ +||||+++++++..++..++|||||.
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEE-SSSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEE-ECCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 345568899999999987544 46899999998653 245678999999986 79999999999999999999999995
Q ss_pred CCCHHHHHhhCCCC------CChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCC-------------CcEE
Q 043702 460 NGSLDKALFEARSP------LPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEG-------------FNAR 520 (711)
Q Consensus 460 ~gsL~~~l~~~~~~------l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~-------------~~vk 520 (711)
|+|.+++...... .++..+++++.||+.||+|||+. +|+||||||+|||++.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 6999999754321 23445688999999999999998 99999999999999754 4899
Q ss_pred EeecCCceecCCCCCC---CcccccCCCcccChhhhcc-------CCCCccccchhHHHHHHHHHh-CCCCCcccccccc
Q 043702 521 LGDFGLARQVEHDKSP---DATVAAGTMGYLAPEYLLT-------GRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVG 589 (711)
Q Consensus 521 L~DFGla~~~~~~~~~---~~~~~~gt~~y~APE~~~~-------~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~ 589 (711)
|+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.....
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~--- 245 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS--- 245 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT---
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh---
Confidence 9999999987654322 1234579999999999975 568999999999999999999 9999964321
Q ss_pred ccccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 590 KVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 590 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
............ +.............+.+++.+||+.||.+||++.+|++
T Consensus 246 ------~~~~i~~~~~~~--------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 246 ------RESNIIRGIFSL--------DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ------HHHHHHHTCCCC--------CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------hHHHHhcCCCCc--------ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 001111100000 00111123445677889999999999999999999986
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=357.66 Aligned_cols=257 Identities=25% Similarity=0.356 Sum_probs=198.5
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeee------cCeE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHE------KGEI 451 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~------~~~~ 451 (711)
++|...+.||+|+||.||+|.+..+|+.||||++.... ...+.+.+|++++++++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 67999999999999999999998889999999987532 234678899999999999999999999765 6678
Q ss_pred EEEEEcCCCCCHHHHHhhCC--CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCc---EEEeecCC
Q 043702 452 LLVYDLMPNGSLDKALFEAR--SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFN---ARLGDFGL 526 (711)
Q Consensus 452 ~lV~Ey~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~---vkL~DFGl 526 (711)
++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999999997643 3699999999999999999999997 9999999999999987665 99999999
Q ss_pred ceecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhh
Q 043702 527 ARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHR 606 (711)
Q Consensus 527 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~ 606 (711)
++....... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ...|......
T Consensus 171 a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~----------~~~~~~~i~~ 238 (676)
T 3qa8_A 171 AKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ----------PVQWHGKVRE 238 (676)
T ss_dssp CCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH----------HHHSSTTCC-
T ss_pred ccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc----------hhhhhhhhhc
Confidence 987654432 2345799999999999999999999999999999999999999965311 1111111000
Q ss_pred cCchhHhhh------------hhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHH
Q 043702 607 EGRLLTAAD------------ARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGV 651 (711)
Q Consensus 607 ~~~~~~~~d------------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eV 651 (711)
......... ..............+.+++.+||+.||.+|||+.|+
T Consensus 239 ~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 239 KSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp -----CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred ccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 000000000 000112333456778899999999999999999763
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=318.19 Aligned_cols=229 Identities=14% Similarity=0.099 Sum_probs=182.0
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCC----hhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQG----KDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
++|...+.||+|+||.||+|++..+++.||||++...... .+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 4688889999999999999999888999999999864432 267899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
||+++++|.+++.. + ....+..+|+.|++.||+|||+. +|+||||||+|||++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~---------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA---------- 174 (286)
T ss_dssp ECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred EecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc----------
Confidence 99999999999943 2 35567889999999999999998 99999999999999999999998443
Q ss_pred CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhh
Q 043702 536 PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 615 (711)
|++| ++.++|||||||++|||++|+.||............... . .+.....
T Consensus 175 -----------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~--------~-~~~~~~~-- 225 (286)
T 3uqc_A 175 -----------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERD--------T-AGQPIEP-- 225 (286)
T ss_dssp -----------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBC--------T-TSCBCCH--
T ss_pred -----------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHH--------h-ccCCCCh--
Confidence 4443 688999999999999999999999764321100000000 0 0000000
Q ss_pred hhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 616 ARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 616 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
..+... ....+.+++.+||+.||.+| |+.|+++.|+..
T Consensus 226 ~~~~~~----~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~ 263 (286)
T 3uqc_A 226 ADIDRD----IPFQISAVAARSVQGDGGIR-SASTLLNLMQQA 263 (286)
T ss_dssp HHHCTT----SCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred hhcccC----CCHHHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence 001111 23457788999999999999 999999999764
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=355.21 Aligned_cols=237 Identities=23% Similarity=0.329 Sum_probs=191.3
Q ss_pred hcCCcccceeecCCceEEEEEEeCC-CCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCe-----
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQ-NGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGE----- 450 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~-~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~----- 450 (711)
.++|...+.||+|+||.||+|.+.. +++.||||++.... ...+.+.+|++++++++||||++++++|...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 3689999999999999999999865 68999999986533 223568899999999999999999999987665
Q ss_pred EEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceec
Q 043702 451 ILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV 530 (711)
Q Consensus 451 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~ 530 (711)
.++||||+++++|.+++.. .+++.+++.|+.||+.||.|||+. +|+||||||+|||++.+ .+||+|||+++..
T Consensus 159 ~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp EEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred eEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhc
Confidence 7999999999999987743 799999999999999999999998 99999999999999986 9999999999876
Q ss_pred CCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCch
Q 043702 531 EHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRL 610 (711)
Q Consensus 531 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 610 (711)
... ....||++|+|||++.++. +.++|||||||++|||++|..|+...... . +. .
T Consensus 232 ~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~----~----~~--------~--- 286 (681)
T 2pzi_A 232 NSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD----G----LP--------E--- 286 (681)
T ss_dssp TCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS----S----CC--------T---
T ss_pred ccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc----c----cc--------c---
Confidence 543 3456999999999987764 89999999999999999999887643210 0 00 0
Q ss_pred hHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCC-HHHHHHHHh
Q 043702 611 LTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPT-MRGVVQMLV 656 (711)
Q Consensus 611 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~eVl~~L~ 656 (711)
..........+.+++.+||+.||.+||+ ++++.+.|.
T Consensus 287 ---------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 287 ---------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp ---------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred ---------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 0000112245778899999999999995 555555554
|
| >1qmo_E Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=274.25 Aligned_cols=115 Identities=30% Similarity=0.557 Sum_probs=106.4
Q ss_pred cceEEEEeecccCCCCCCCCCCeeeEecCCCcccccccCCccccccCCCCeEEEEEEEcccccEEEEEEEecCCCCCcce
Q 043702 142 LGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLTRAFNISVSYSNLKPKVPI 221 (711)
Q Consensus 142 ~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~S~~~~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~ 221 (711)
||+|||||||++|.+++||++||||||+||+.|.++.+ +++.+|+.++|||+||+.+++|+|++++.+.+ .|+
T Consensus 1 n~~vAVEFDT~~N~e~~Dp~~nHVGIdvNsi~S~~s~~-----~~l~sG~~~~v~I~Yd~~~~~L~V~l~~~~~~--~p~ 73 (133)
T 1qmo_E 1 SNVVAVEFDTYLNPDYGDPNYIHIGIDVNSIRSKVTAK-----WDWQNGKIATAHISYNSVSKRLSVTSYYAGSK--PAT 73 (133)
T ss_dssp CCCEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEE-----CCCCTTSCEEEEEEEETTTTEEEEEEECSSSC--CEE
T ss_pred CCEEEEEEeCCcCccccCCCCCeeEEecccccccceee-----eEEcCCCEEEEEEEEeCCCcEEEEEEccCCCc--cce
Confidence 57999999999999988999999999999999987655 46889999999999999999999999986543 789
Q ss_pred eeEecCcccccccceeEEEeeeccCceeeEEEEeeccccccC
Q 043702 222 LSFTLDLDQYVNDFMYVGFSGSTQGSTEIHSIEWWSFSSSFE 263 (711)
Q Consensus 222 ls~~vdL~~~l~~~~~vGFsastg~~~~~~~i~sW~f~s~~~ 263 (711)
|+..|||+++|||+||||||||||...|.|+|++|+|++++.
T Consensus 74 ls~~vdLs~~l~e~v~VGFSAsTG~~~~~h~IlsWsF~s~l~ 115 (133)
T 1qmo_E 74 LSYDIELHTVLPEWVRVGLSASTGQDKERNTVHSWSFTSSLW 115 (133)
T ss_dssp EEEECCGGGTSCSEEEEEEEEECSSSCCEEEEEEEEEEEEEE
T ss_pred EEEeechHHhccccEEEEEEeccCCCcceeEEEEEEEEeeCC
Confidence 999999999999999999999999999999999999999873
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=338.01 Aligned_cols=241 Identities=15% Similarity=0.094 Sum_probs=182.3
Q ss_pred HhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHHHHHHHhcCC-CCeeeee---------e
Q 043702 378 ATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSELSIIGTLRH-RNLVRLQ---------G 443 (711)
Q Consensus 378 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H-~niv~l~---------g 443 (711)
.+..|...++||+|+||.||+|.+..+|+.||||++... ....+.+.+|+.+++.++| +|..... .
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 345677889999999999999999889999999998742 2335789999999999987 3221111 1
Q ss_pred e------------eee-----cCeEEEEEEcCCCCCHHHHHh------hCCCCCChHHHHHHHHHHHHHHHHHHhccCCC
Q 043702 444 W------------CHE-----KGEILLVYDLMPNGSLDKALF------EARSPLPWPHRSKILLGVASALAYLHQECENQ 500 (711)
Q Consensus 444 ~------------~~~-----~~~~~lV~Ey~~~gsL~~~l~------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ 500 (711)
. +.. ....+++|+++ +++|.+++. .....+++..++.++.||++||+|||+. +
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---G 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence 1 111 12457777765 689999884 2244588999999999999999999998 9
Q ss_pred eeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCcccccCCCcccChhhh----------ccCCCCccccchhHHHH
Q 043702 501 VIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYL----------LTGRATEKTDVFSYGAV 570 (711)
Q Consensus 501 ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~----------~~~~~s~ksDVwSfGvl 570 (711)
|+||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ ....++.++|||||||+
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 999999999999999999999999999875433 334568 999999999 45568889999999999
Q ss_pred HHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHH
Q 043702 571 VLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRG 650 (711)
Q Consensus 571 l~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 650 (711)
+|||++|+.||....... .. ...... ...+ ...+.+|+.+||+.||.+||++.+
T Consensus 307 l~elltg~~Pf~~~~~~~--------~~------------~~~~~~--~~~~----~~~~~~li~~~l~~dP~~Rpt~~~ 360 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALG--------GS------------EWIFRS--CKNI----PQPVRALLEGFLRYPKEDRLLPLQ 360 (413)
T ss_dssp HHHHHHSSCCCCTTGGGS--------CS------------GGGGSS--CCCC----CHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHCCCCCCCcchhh--------hH------------HHHHhh--cccC----CHHHHHHHHHHccCChhhCcCHHH
Confidence 999999999997543210 00 000000 0112 245778889999999999999877
Q ss_pred HHH
Q 043702 651 VVQ 653 (711)
Q Consensus 651 Vl~ 653 (711)
+++
T Consensus 361 ~l~ 363 (413)
T 3dzo_A 361 AME 363 (413)
T ss_dssp HTT
T ss_pred HHh
Confidence 653
|
| >2dur_A VIP36;, vesicular integral-membrane protein VIP36; beta sandwich, carbohydrate binding protein, cargo receptor, transport; HET: MAN; 1.65A {Canis lupus familiaris} PDB: 2dup_A 2duq_A* 2duo_A* 2e6v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=304.07 Aligned_cols=193 Identities=16% Similarity=0.170 Sum_probs=150.6
Q ss_pred CCCeEEeCceEeeCCcEEeCCCCCCCCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecCCC-CCCCCceEEEEcCC
Q 043702 43 LASLKLLGDAHMNNGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLNP-SSIGAGLAFVITPD 121 (711)
Q Consensus 43 ~~~~~~~g~a~~~~g~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~-~~~g~GlaF~l~~~ 121 (711)
.++++++|+|.+.+|.|+||++.+ ++.||+||+.|+++ +||+|+|+|+|.+++. ..+||||||+|+|.
T Consensus 24 i~~~~l~G~a~i~~g~l~LT~~~~---~~~G~~w~~~pi~~--------~sF~t~F~F~I~~~~~~~~~gdGlAF~l~~~ 92 (253)
T 2dur_A 24 MPLWDFQGSTILTSQYVRLTPDER---SKEGSIWNHQPCFL--------KDWEMHVHFKVHGTGKKNLHGDGIALWYTRD 92 (253)
T ss_dssp CCSEEEEETCEECSSCEEEECSSS---SEEEEEEESSCBCC--------SSEEEEEEEEEECCCCTTCCCCEEEEEEESC
T ss_pred cCCEEEccceEEECCEEEECCCCC---CCEEEEEeCCCCcc--------CcEEEEEEEEEecCCCCCcCCCcEEEEEECC
Confidence 369999999999999999999877 78999999999997 6899999999998765 56899999999997
Q ss_pred CCCCCCCCCcccccccCCCCcceEEEEeecccCCCCCCCCCCeeeEecCCCcccccccCC-----------ccccccC-C
Q 043702 122 GEQVGSAGGSLGLLDEKGAGLGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLD-----------TINVDLK-S 189 (711)
Q Consensus 122 ~~~~~~~g~~lgl~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~S~~~~~~~-----------~~~~~~~-~ 189 (711)
... .|++||+.+. ++.|||||||+.|.++.|+.+.||++++| ..+..+. ....++. .
T Consensus 93 ~~~---~G~~lG~~~~----~~gvAVefDT~~n~~~~~~~~~~I~~~~n----~gs~~~d~~~dg~~~~~~~c~~~~~n~ 161 (253)
T 2dur_A 93 RLV---PGPVFGSKDN----FHGLAIFLDTYPNDETTERVFPYISVMVN----NGSLSYDHSKDGRWTELAGCTADFRNR 161 (253)
T ss_dssp CSC---EETBTEECSS----CEEEEEEEECSCCCTTCCSCSSEEEEEEE----ESCCCCCGGGTTGGGCCEEEECCCBTC
T ss_pred CCC---CCcccCcCCC----CCEEEEEEECCCCCCCCCCCCcEEEEEec----CCceeeeccCCCcccccccccHhhccC
Confidence 653 5789997442 57899999999997654433444555544 3222221 1122443 4
Q ss_pred CCeEEEEEEEcccccEEEEEEEecCCCCCcceeeEecCcccccccceeEEEeeeccCceeeEEEEeecccccc
Q 043702 190 GDLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGSTEIHSIEWWSFSSSF 262 (711)
Q Consensus 190 g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastg~~~~~~~i~sW~f~s~~ 262 (711)
|..++|||+||+. .|+|++++.+..+..+++ .++ ..+||++|||||||+||...+.|+|++|+|.+-.
T Consensus 162 g~~~~v~I~Y~~~--~L~V~l~~~~~~~~~~~~--~~~-~v~Lp~~~yvGfSAaTG~~~~~h~Ilswsf~sl~ 229 (253)
T 2dur_A 162 DHDTFLAVRYSRG--RLTVMTDLEDKNEWKNCI--DIT-GVRLPTGYYFGASAGTGDLSDNHDIISMKLFQLM 229 (253)
T ss_dssp SSCEEEEEEEETT--EEEEEEECSSSSCCEEEE--EEC-CEECCSSBEEEEEEEESSSCCEEEEEEEEEEECC
T ss_pred CCCeEEEEEEECC--EEEEEEeCCCCCCceEEE--EeC-CcccCCCcEEEEEeccCCCcceEEEEEEEEEecc
Confidence 8899999999975 899999986544444444 445 4469999999999999999999999999997754
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=313.81 Aligned_cols=239 Identities=18% Similarity=0.284 Sum_probs=183.4
Q ss_pred cCCccc-ceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHH-HhcCCCCeeeeeeeeee----cCeEEE
Q 043702 380 KCFNAN-RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSII-GTLRHRNLVRLQGWCHE----KGEILL 453 (711)
Q Consensus 380 ~~f~~~-~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l-~~l~H~niv~l~g~~~~----~~~~~l 453 (711)
++|... +.||+|+||.||+|....+++.||+|++.. ...+.+|++++ +.++||||+++++++.. .+..++
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 92 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 92 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEE
Confidence 456666 789999999999999988999999999863 35678899988 55689999999999987 677999
Q ss_pred EEEcCCCCCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcC---CCcEEEeecCCcee
Q 043702 454 VYDLMPNGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDE---GFNARLGDFGLARQ 529 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~---~~~vkL~DFGla~~ 529 (711)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++.
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 169 (299)
T 3m2w_A 93 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 169 (299)
T ss_dssp EECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence 999999999999998654 4699999999999999999999998 9999999999999998 78899999999975
Q ss_pred cCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCc
Q 043702 530 VEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGR 609 (711)
Q Consensus 530 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 609 (711)
... ..++.++|||||||++|||++|+.||.............. ....+.
T Consensus 170 ~~~-----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~--------~~~~~~ 218 (299)
T 3m2w_A 170 TTG-----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT--------RIRMGQ 218 (299)
T ss_dssp CTT-----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC--------SSCTTC
T ss_pred ccc-----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH--------HHhhcc
Confidence 431 3367789999999999999999999965422100000000 000000
Q ss_pred hhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--HHhCCCCCC
Q 043702 610 LLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ--MLVGEAEVP 662 (711)
Q Consensus 610 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~--~L~~~~~~p 662 (711)
.. ...+ .. ......+.+++.+||+.||.+|||+.|+++ .+......+
T Consensus 219 ~~-~~~~-~~----~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~ 267 (299)
T 3m2w_A 219 YE-FPNP-EW----SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 267 (299)
T ss_dssp CS-SCHH-HH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSC
T ss_pred cc-CCch-hc----ccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCC
Confidence 00 0000 00 112346778899999999999999999997 455443333
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=320.32 Aligned_cols=239 Identities=15% Similarity=0.193 Sum_probs=183.0
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC---------ChhhhHHHHHHHHhcC---------CCCeee
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ---------GKDEFLSELSIIGTLR---------HRNLVR 440 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~Ei~~l~~l~---------H~niv~ 440 (711)
.++|...+.||+|+||+||+|++ +|+.||||++..... ..+.+.+|++++++++ ||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 35688899999999999999998 689999999876421 2367899999999986 666666
Q ss_pred eeeee-----------------ee-------------cCeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHH
Q 043702 441 LQGWC-----------------HE-------------KGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASAL 490 (711)
Q Consensus 441 l~g~~-----------------~~-------------~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL 490 (711)
+.+.+ .. .+.+++||||+++|++.+.+.+ ..+++..++.++.||+.||
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence 66653 32 6789999999999977666633 5689999999999999999
Q ss_pred HHHH-hccCCCeeeccCCCCceEEcCCC--------------------cEEEeecCCceecCCCCCCCcccccCCCcccC
Q 043702 491 AYLH-QECENQVIHRDVKTSNIMLDEGF--------------------NARLGDFGLARQVEHDKSPDATVAAGTMGYLA 549 (711)
Q Consensus 491 ~yLH-~~~~~~ivHrDlkp~NILld~~~--------------------~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~A 549 (711)
+||| +. +|+||||||+||||+.++ .+||+|||+++..... ..+||+.|+|
T Consensus 175 ~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~a 245 (336)
T 2vuw_A 175 AVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMD 245 (336)
T ss_dssp HHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTC
T ss_pred HHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccC
Confidence 9999 77 999999999999999887 8999999999976532 3479999999
Q ss_pred hhhhccCCCCccccchhHHHH-HHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHh--hhhhccCCCcHHH
Q 043702 550 PEYLLTGRATEKTDVFSYGAV-VLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTA--ADARLEGQFDEAE 626 (711)
Q Consensus 550 PE~~~~~~~s~ksDVwSfGvl-l~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~--~d~~l~~~~~~~~ 626 (711)
||++.+.. +.++||||+|++ .+++++|..||... .|...... .+... .............
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~--------------~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 308 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV--------------LWLHYLTD--KMLKQMTFKTKCNTPAMKQI 308 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH--------------HHHHHHHH--HHHHTCCCSSCCCSHHHHHH
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcch--------------hhhhHHHH--hhhhhhccCcccchhhhhhc
Confidence 99998665 889999998777 77888999998532 11110000 00000 0000011112345
Q ss_pred HHHHHHHHHhcCCCCCCCCCCHHHHH
Q 043702 627 MRRVLLVGLACSHPDPLARPTMRGVV 652 (711)
Q Consensus 627 ~~~l~~l~~~Cl~~dP~~RPs~~eVl 652 (711)
..++.+|+.+||+.| |++|++
T Consensus 309 s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 309 KRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHHHGGGSS-----SHHHHH
T ss_pred CHHHHHHHHHHhccC-----CHHHHH
Confidence 677889999999966 999998
|
| >1gv9_A P58/ergic-53; lectin, carbohydrate binding; 1.46A {Rattus norvegicus} SCOP: b.29.1.13 PDB: 1r1z_A 3a4u_A 3lcp_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=295.93 Aligned_cols=194 Identities=14% Similarity=0.148 Sum_probs=151.4
Q ss_pred CCeEEeCceEeeCCcEEeCCCCCCCCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecCCCCCCCCceEEEEcCCCC
Q 043702 44 ASLKLLGDAHMNNGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLNPSSIGAGLAFVITPDGE 123 (711)
Q Consensus 44 ~~~~~~g~a~~~~g~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~GlaF~l~~~~~ 123 (711)
+++.++|||.+.++.|+||++.+ ++.||+||+.|+++ ++|+|+|+|+|.+++ ..+||||||+|+|...
T Consensus 49 ~~w~~~G~a~i~~~~IrLT~~~~---~~~G~~w~~~p~~~--------~sF~t~F~F~I~~~~-~~~gdGlAF~l~~~~~ 116 (260)
T 1gv9_A 49 PFWAHAGNAIPSADQIRIAPSLK---SQRGSVWTKTKAAF--------ENWEVEVTFRVTGRG-RIGADGLAIWYTENQG 116 (260)
T ss_dssp TTEEEEETCEECSSCEEEECSST---TCEEEEEESSCBCC--------SSEEEEEEEEEECSS-SCCCCEEEEEEESSCC
T ss_pred CCeEEcccEEeeCCEEEeCCCCC---CCEEEEEECCCccc--------cCEEEEEEEEEecCC-CCCCCeEEEEEecCCC
Confidence 68999999999999999999877 78999999999964 799999999999764 3679999999999754
Q ss_pred CCCCCCCcccccccCCCCcceEEEEeecccCCCCC-CC------CCCeeeEecCC-CcccccccCCccccccC-CCCeEE
Q 043702 124 QVGSAGGSLGLLDEKGAGLGFVAVEFDTLMDVEFS-DI------NGNHVGLDLNS-MVSTEVDNLDTINVDLK-SGDLVN 194 (711)
Q Consensus 124 ~~~~~g~~lgl~~~~~~~~~~vaVEFDt~~n~~~~-d~------~~~Hvgid~ns-~~S~~~~~~~~~~~~~~-~g~~~~ 194 (711)
. .|+++|+.+. ++.||||||||.|.++. +| +++|||||+|+ +.|..... ..+++. +|..++
T Consensus 117 ~---~g~~~G~~~~----~~gvaVefDT~~N~~~~~~p~I~~~indg~~~~d~~~d~~s~~~~~---c~~~~~n~g~~~~ 186 (260)
T 1gv9_A 117 L---DGPVFGSADM----WNGVGIFFDSFDNDGKKNNPAIVVVGNNGQINYDHQNDGATQALAS---CQRDFRNKPYPVR 186 (260)
T ss_dssp C---EEEETTECSC----CEEEEEEEECCCC-----CCEEEEEEEESCCCCCHHHHHHHHCSEE---ECCCCBSCSSCEE
T ss_pred C---CCCccCCCCC----CCEEEEEEECCCCCCCCCCCceEEEeCCCceEeecCCCcccceeec---cChhhccCCCcEE
Confidence 3 5788888432 56799999999996531 23 45677777765 44432211 123443 589999
Q ss_pred EEEEEcccccEEEEEEEecC-CCCCcceeeEecCcccccccceeEEEeeeccCceeeEEEEeecccccc
Q 043702 195 SWIEYDGLTRAFNISVSYSN-LKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGSTEIHSIEWWSFSSSF 262 (711)
Q Consensus 195 ~~I~Y~~~~~~l~V~~~~~~-~~~~~~~ls~~vdL~~~l~~~~~vGFsastg~~~~~~~i~sW~f~s~~ 262 (711)
|||+|++. .|+|.+++.. .......++..+| +.+||+++||||||+||...|.|+|++|+|.+-.
T Consensus 187 ~~I~Y~~~--~L~V~l~~~~~~~~~~~~~~~~vd-~~~LP~~~~vGfSAaTG~~~e~hdIlsw~~~~l~ 252 (260)
T 1gv9_A 187 AKITYYQK--TLTVMINNGFTPDKNDYEFCAKVE-NMVIPTQGHFGISAATGGLADDHDVLSFLTFQLT 252 (260)
T ss_dssp EEEEEETT--EEEEEEECSSCCCTTCCEEEEEET-TCCCCSSBEEEEEEECCSSCCEEEEEEEEEEEEE
T ss_pred EEEEEECC--EEEEEEeeccCCCCCcceEEEEEc-ccccCCCcEEEEEEeCCCCcceEEEEEEEEEEee
Confidence 99999986 8999998742 1112346788899 6789999999999999999999999999997644
|
| >1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... | Back alignment and structure |
|---|
Probab=99.98 E-value=9.4e-33 Score=276.85 Aligned_cols=116 Identities=30% Similarity=0.505 Sum_probs=107.5
Q ss_pred cceEEEEeecccCCCCCCCCCCeeeEecCCCcccccccCCccccccCCCCeEEEEEEEcccccEEEEEEEecCCCCCcce
Q 043702 142 LGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLTRAFNISVSYSNLKPKVPI 221 (711)
Q Consensus 142 ~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~S~~~~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~ 221 (711)
||+|||||||++|.+|+||++|||||||||+.|.++.+ +++.+|+.++|||+||+.+++|+|++++.+. ..|+
T Consensus 2 n~~vAVEFDT~~n~~~~Dp~~nHVGIdvNs~~S~~~~~-----~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~ 74 (237)
T 1nls_A 2 DTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAK-----WNMQNGKVGTAHIIYNSVDKRLSAVVSYPNA--DSAT 74 (237)
T ss_dssp CCEEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEE-----CCCCTTCEEEEEEEEETTTTEEEEEEECTTS--CCEE
T ss_pred CCEEEEEEeCCCCcccCCCCCCeeeEecCCcccccccc-----ccccCCCEEEEEEEEeCCCCEEEEEEecCCC--Ccce
Confidence 68999999999999999999999999999999987665 4688999999999999999999999998654 5789
Q ss_pred eeEecCcccccccceeEEEeeeccCceeeEEEEeeccccccCc
Q 043702 222 LSFTLDLDQYVNDFMYVGFSGSTQGSTEIHSIEWWSFSSSFES 264 (711)
Q Consensus 222 ls~~vdL~~~l~~~~~vGFsastg~~~~~~~i~sW~f~s~~~~ 264 (711)
|++.|||+++|+|+|||||||+||...|.|+|++|+|++.+..
T Consensus 75 ls~~vdLs~~l~e~~~VGFSAsTG~~~~~h~IlsWsF~s~~~a 117 (237)
T 1nls_A 75 VSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSKLKS 117 (237)
T ss_dssp EEEECCGGGTSCSEEEEEEEEECSSSCCCCEEEEEEEEEEEEE
T ss_pred EEEeeChHHhCccccEEEEEeccCCcceeeeeEEEEEEecccc
Confidence 9999999999999999999999999999999999999998753
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-29 Score=290.90 Aligned_cols=185 Identities=19% Similarity=0.086 Sum_probs=132.2
Q ss_pred eecCCceEEEEEEeCCCCeEEEEEEcccCC-----------CChhhhHHHHHHHHhc-CCCCeeeeeeeeeecCeEEEEE
Q 043702 388 IGHGAFGTVYKGILPQNGDIIAVKRCSHNS-----------QGKDEFLSELSIIGTL-RHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 388 LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----------~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 455 (711)
.+.|+.|.+..++....|+.+++|.+.... ...++|.+|+++|+++ .|+||+++++++.+++.+||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 566677766665555568889999986531 1235799999999999 5999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
||++|++|.++|.. .++++.. +|+.||++||+|||+. +||||||||+||||++++++||+|||+|+.......
T Consensus 322 Eyv~G~~L~d~i~~-~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~ 394 (569)
T 4azs_A 322 EKLPGRLLSDMLAA-GEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS 394 (569)
T ss_dssp ECCCSEEHHHHHHT-TCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC---C
T ss_pred ecCCCCcHHHHHHh-CCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCCCc
Confidence 99999999999965 4456543 5899999999999998 999999999999999999999999999997755433
Q ss_pred CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCC
Q 043702 536 PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPI 581 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~ 581 (711)
.....+||++|||||++.+ .+..++|+||+|+++++|.++..++
T Consensus 395 -~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 395 -WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp -CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred -cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 3445689999999998865 5677899999999998887765554
|
| >1qmo_A Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=99.94 E-value=5.3e-27 Score=207.64 Aligned_cols=106 Identities=30% Similarity=0.487 Sum_probs=93.7
Q ss_pred cceeeecCCCC--CCCeEEeCceEeeCCcEEeCCCCCC---CCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecCC
Q 043702 32 TATEFDFGTLT--LASLKLLGDAHMNNGSVRLTRDVTV---PYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLN 106 (711)
Q Consensus 32 ~~~~f~~~~f~--~~~~~~~g~a~~~~g~~~Lt~~~~~---~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~ 106 (711)
.+++|+|++|. ..||+|+|||.+.+|.|+||++..+ ...++|||+|++||+|||+ +|+++||+|+|+|.|.+.+
T Consensus 2 ~~~~F~f~~F~~~~~nl~l~G~A~v~~g~l~LT~~~~~g~~~~~s~Gra~Y~~Pv~l~d~-tg~vaSFsT~F~F~I~~~~ 80 (113)
T 1qmo_A 2 QSLSFSFTKFDPNQEDLIFQGHATSTNNVLQVTKLDSAGNPVSSSAGRVLYSAPLRLWED-SAVLTSFDTIINFEISTPY 80 (113)
T ss_dssp EEEEEEESSCCSSCTTEEEEETCEEETTEEECSCBCTTSCBCSSCEEEEEESSCEECCCT-TEEEEEEEEEEEEEEECSS
T ss_pred cceEEEcCCCCCCCCCeEEecceEcCCCceEeCCCCCCCcccCCcEEEEEeCCCEEeeCC-CCCEEeeEEEEEEEEecCC
Confidence 35789999998 6799999999998899999997542 2267999999999999999 9999999999999999877
Q ss_pred CCCCCCceEEEEcCCCCCCCCCCCcccccccC
Q 043702 107 PSSIGAGLAFVITPDGEQVGSAGGSLGLLDEK 138 (711)
Q Consensus 107 ~~~~g~GlaF~l~~~~~~~~~~g~~lgl~~~~ 138 (711)
...+||||||||+|....+++.||||||+|.+
T Consensus 81 ~~~~gdGlAF~lap~~~~p~s~g~~LGL~n~~ 112 (113)
T 1qmo_A 81 TSRIADGLAFFIAPPDSVISYHGGFLGLFPNA 112 (113)
T ss_dssp SSCCCCEEEEEEECTTCCCCCCGGGTTTCSSC
T ss_pred CCCCCCeEEEEecCCCCCCCCCccccccccCC
Confidence 77889999999999876556889999999864
|
| >2a6y_A EMP47P (FORM1); beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.42A {Saccharomyces cerevisiae} SCOP: b.29.1.13 | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=229.35 Aligned_cols=187 Identities=11% Similarity=0.117 Sum_probs=144.0
Q ss_pred CCCeEEeCceEeeCCcEEeCCCCCCCCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecCCCCCCCCceEEEEcCCC
Q 043702 43 LASLKLLGDAHMNNGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLNPSSIGAGLAFVITPDG 122 (711)
Q Consensus 43 ~~~~~~~g~a~~~~g~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~GlaF~l~~~~ 122 (711)
.+++.++|+|.+.++.|+||++ . ++.|++|.+.|+++ .++|+++|+|+|.++. ..+||||||++++..
T Consensus 30 i~~w~~~G~a~v~~~~IrLTp~-~---~s~G~iW~~~p~~~-------~~~f~~~f~FrI~g~~-~~~gdGlAfwlt~~~ 97 (256)
T 2a6y_A 30 PNNWQTGEQASLEEGRIVLTSN-Q---NSKGSLWLKQGFDL-------KDSFTMEWTFRSVGYS-GQTDGGISFWFVQDS 97 (256)
T ss_dssp CTTEEEEETCEEETBEEECCCS-T---TCEEEEEESSCEEE-------SSCEEEEEEEEEESCC-SCCSCEEEEEEEECS
T ss_pred cCCeEEccceEEeCCEEEECCC-C---CceEEEeeCCCCcc-------cCCEEEEEEEEEecCC-CCCCCeEEEEEeCCC
Confidence 4799999999999999999998 4 56899888888874 3689999999999764 337999999999965
Q ss_pred CCCCCCCCcccccccCCCCcceEEEEeecccCCCCCCCC------CCeeeEecCCCcccccccCCcccccc-CCCCeEEE
Q 043702 123 EQVGSAGGSLGLLDEKGAGLGFVAVEFDTLMDVEFSDIN------GNHVGLDLNSMVSTEVDNLDTINVDL-KSGDLVNS 195 (711)
Q Consensus 123 ~~~~~~g~~lgl~~~~~~~~~~vaVEFDt~~n~~~~d~~------~~Hvgid~ns~~S~~~~~~~~~~~~~-~~g~~~~~ 195 (711)
..+ ..|+.+|..+. ..-+|||||||.|. .|. +.|+++|.+++.+...... ..++ .+|...++
T Consensus 98 ~~~-~~g~~~G~~~~----f~GlaV~fDT~~n~---~p~i~~~~Ndg~~~~d~~~~~~~~~~~c---~~~~rn~~~~~~v 166 (256)
T 2a6y_A 98 NIP-RDKQLYNGPVN----YDGLQLLVDNNGPL---GPTLRGQLNDGQKPVDKTKIYDQSFASC---LMGYQDSSVPSTI 166 (256)
T ss_dssp SSC-CCCTBTTBCTT----CEEEEEEEESCSTT---CSEEEEEEEESSSCCCGGGHHHHCSEEE---ECCCTTCSSCEEE
T ss_pred Ccc-cCCcccCcCCC----CCEEEEEEECCCCC---CceEEEEECCCceecccCCCcccceecc---eeecccCCCcEEE
Confidence 432 56788888753 34589999999873 343 5678888776333322111 1233 37899999
Q ss_pred EEEEc-ccccEEEEEEEecCCCCCcceeeEecCcccc-cccce-eEEEeeecc---CceeeEEEEeecccccc
Q 043702 196 WIEYD-GLTRAFNISVSYSNLKPKVPILSFTLDLDQY-VNDFM-YVGFSGSTQ---GSTEIHSIEWWSFSSSF 262 (711)
Q Consensus 196 ~I~Y~-~~~~~l~V~~~~~~~~~~~~~ls~~vdL~~~-l~~~~-~vGFsastg---~~~~~~~i~sW~f~s~~ 262 (711)
||+|+ +..+.|+|.+++ . ..+++..+ ||+++ ||||||+|| ...+.|+|++|+|.+..
T Consensus 167 ~I~Y~~~~~~~L~V~i~~------~----~c~~~~~v~LP~~~~~~GfSAaTG~~~~~~d~hdIls~~~~~~~ 229 (256)
T 2a6y_A 167 RVTYDLEDDNLLKVQVDN------K----VCFQTRKVRFPSGSYRIGVTAQNGAVNNNAESFEIFKMQFFNGV 229 (256)
T ss_dssp EEEEEGGGTSEEEEEETT------E----EEEEESCEECCSEEEEEEEEEECCSGGGCCCEEEEEEEEEEESC
T ss_pred EEEEecCCCcEEEEEEcC------E----EEEEECcEEeCCCCeEEEEEEeCCCCCCCcceEEEEEEEEEecc
Confidence 99999 878899999964 1 23344455 89997 699999999 88999999999999855
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=9.8e-27 Score=264.98 Aligned_cols=184 Identities=15% Similarity=0.145 Sum_probs=146.9
Q ss_pred cccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCC---------hhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEE
Q 043702 383 NANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQG---------KDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILL 453 (711)
Q Consensus 383 ~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---------~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 453 (711)
...++||+|+||.||+|.. .+..+++|+....... .+.+.+|++++++++||||+++..++...+..++
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 4567899999999999965 5778899876542211 2347899999999999999977777778888899
Q ss_pred EEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCC
Q 043702 454 VYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHD 533 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~ 533 (711)
||||+++++|.+++.. +.+++.|+++||+|||+. +|+||||||+|||+++ ++||+|||+++.....
T Consensus 417 VmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 417 MMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred EEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 9999999999999854 568999999999999998 9999999999999999 9999999999987543
Q ss_pred CCCC------cccccCCCcccChhhhcc--CCCCccccchhHHHHHHHHHhCCCCCc
Q 043702 534 KSPD------ATVAAGTMGYLAPEYLLT--GRATEKTDVFSYGAVVLEVASGRRPIE 582 (711)
Q Consensus 534 ~~~~------~~~~~gt~~y~APE~~~~--~~~s~ksDVwSfGvll~elltG~~P~~ 582 (711)
.... ....+||+.|||||++.. ..|+...|+|+..+-.++-+.++.+|.
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 2111 134679999999999986 567888999999999999888887763
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=5.9e-23 Score=214.63 Aligned_cols=152 Identities=13% Similarity=0.103 Sum_probs=123.8
Q ss_pred HHHHHHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC-------------------ChhhhHHHHHHHHhc
Q 043702 373 RELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ-------------------GKDEFLSELSIIGTL 433 (711)
Q Consensus 373 ~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-------------------~~~~~~~Ei~~l~~l 433 (711)
..+......|...+.||+|+||.||+|.+ .+|+.||+|++..... ....+.+|+++++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 34444556677889999999999999999 7799999999864221 234688999999999
Q ss_pred CCCCeeeeeeeeeecCeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEE
Q 043702 434 RHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIML 513 (711)
Q Consensus 434 ~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl 513 (711)
+ | +++.+++.. +..++||||+++|+|.+ +. ......++.|++.||.|||+. +|+||||||+|||+
T Consensus 162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~-------~~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl 226 (282)
T 1zar_A 162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR-------VENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLV 226 (282)
T ss_dssp T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC-------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEE
T ss_pred c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cc-------hhhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEE
Confidence 9 5 777776544 45699999999999988 41 234567999999999999997 99999999999999
Q ss_pred cCCCcEEEeecCCceecCCCCCCCcccccCCCcccChhhhcc
Q 043702 514 DEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLT 555 (711)
Q Consensus 514 d~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~ 555 (711)
+ ++.+||+|||+++. +..|+|||++..
T Consensus 227 ~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~r 253 (282)
T 1zar_A 227 S-EEGIWIIDFPQSVE--------------VGEEGWREILER 253 (282)
T ss_dssp E-TTEEEECCCTTCEE--------------TTSTTHHHHHHH
T ss_pred E-CCcEEEEECCCCeE--------------CCCCCHHHHHHH
Confidence 9 99999999999974 345789998753
|
| >1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... | Back alignment and structure |
|---|
Probab=99.87 E-value=3.5e-22 Score=200.16 Aligned_cols=106 Identities=32% Similarity=0.484 Sum_probs=91.1
Q ss_pred ccceeeecCCCC--CCCeEEeCceEee-CCcEEeCCCCCC---CCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEec
Q 043702 31 STATEFDFGTLT--LASLKLLGDAHMN-NGSVRLTRDVTV---PYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITN 104 (711)
Q Consensus 31 ~~~~~f~~~~f~--~~~~~~~g~a~~~-~g~~~Lt~~~~~---~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~ 104 (711)
...++|+|++|. ..||+|+|||.+. +|.|+||++..+ ...++|||+|++||+|||+ +++++||+|+|+|.|.+
T Consensus 123 s~~~~F~~~~F~~~~~nl~l~G~A~v~~~g~l~LT~~~~n~~~~~~~~Gra~Y~~Pv~lwd~-~~~vaSFsT~F~F~I~~ 201 (237)
T 1nls_A 123 TNALHFMFNQFSKDQKDLILQGDATTGTDGNLELTRVSSNGSPQGSSVGRALFYAPVHIWES-SAVVASFEATFTFLIKS 201 (237)
T ss_dssp EEEEEEEESCCCTTCTTEEEEETCEEEETTEEESSCBCTTSCBCSSCEEEEEESSCEECCCT-TEEEEEEEEEEEEECCC
T ss_pred cccchhhhccccccCCCeEEccceEecCCCceEecCCccCCccccCceEEEEeCCCEEeecC-CCCEeeeEEEEEEEEec
Confidence 355799999997 4599999999996 899999997632 2367999999999999997 88999999999999997
Q ss_pred CCCCCCCCceEEEEcCCCC--CCCCCCCcccccccC
Q 043702 105 LNPSSIGAGLAFVITPDGE--QVGSAGGSLGLLDEK 138 (711)
Q Consensus 105 ~~~~~~g~GlaF~l~~~~~--~~~~~g~~lgl~~~~ 138 (711)
.+ ..+||||||||+|... +.++.||||||+|.+
T Consensus 202 ~~-~~~g~GlAF~lap~~~~~p~~~~g~~LGL~n~~ 236 (237)
T 1nls_A 202 PD-SHPADGIAFFISNIDSSIPSGSTGRLLGLFPDA 236 (237)
T ss_dssp SS-SSCCCEEEEEEECTTCCCCTTCCGGGTTTCSSC
T ss_pred CC-CCCCccEEEEECCCCCCCCCCCCcCeeccccCC
Confidence 63 4589999999999763 457899999999975
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=5.4e-19 Score=182.11 Aligned_cols=137 Identities=17% Similarity=0.131 Sum_probs=107.9
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeE--EEEEEcccCCCC-------------------------hhhhHHHHHHHHhc
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDI--IAVKRCSHNSQG-------------------------KDEFLSELSIIGTL 433 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~--vavK~~~~~~~~-------------------------~~~~~~Ei~~l~~l 433 (711)
-|...+.||+|+||.||+|.+..+|+. ||||++...... ...+.+|+.+|.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 366788999999999999998667888 999986542111 12578899999999
Q ss_pred CCCCe--eeeeeeeeecCeEEEEEEcCCC-C----CHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHH-hccCCCeeecc
Q 043702 434 RHRNL--VRLQGWCHEKGEILLVYDLMPN-G----SLDKALFEARSPLPWPHRSKILLGVASALAYLH-QECENQVIHRD 505 (711)
Q Consensus 434 ~H~ni--v~l~g~~~~~~~~~lV~Ey~~~-g----sL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH-~~~~~~ivHrD 505 (711)
+|+++ ..++++ +..+|||||+.+ | +|.++... .++.....++.|++.+|.||| +. +|+|||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~---givHrD 196 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEA---ELVHAD 196 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTS---CEECSS
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHC---CEEeCC
Confidence 98764 333332 356899999942 4 67776532 235678899999999999999 76 999999
Q ss_pred CCCCceEEcCCCcEEEeecCCceec
Q 043702 506 VKTSNIMLDEGFNARLGDFGLARQV 530 (711)
Q Consensus 506 lkp~NILld~~~~vkL~DFGla~~~ 530 (711)
|||+|||+++ .++|+|||+|...
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEET
T ss_pred CCHHHEEEcC--cEEEEECcccccC
Confidence 9999999998 9999999999865
|
| >2a6z_A EMP47P (FORM2); beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.00A {Saccharomyces cerevisiae} SCOP: b.29.1.13 PDB: 2a70_A 2a71_A | Back alignment and structure |
|---|
Probab=99.77 E-value=1.1e-17 Score=167.04 Aligned_cols=185 Identities=12% Similarity=0.134 Sum_probs=129.4
Q ss_pred CCCeEEeCceEeeCCcEEeCCCCCCCCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecCCCCCCCCceEEEEcCCC
Q 043702 43 LASLKLLGDAHMNNGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLNPSSIGAGLAFVITPDG 122 (711)
Q Consensus 43 ~~~~~~~g~a~~~~g~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~GlaF~l~~~~ 122 (711)
.+++.+.|+|.+.++.|+||++ . ++.|.+|.+.|+++. .+|+++|+|+|..+. ..+||||||++++..
T Consensus 23 ~~~W~~~G~a~i~~~~IrLTp~-~---~~~G~iWs~~p~~~~-------~~weie~~Fri~g~~-~~~gdGlA~W~t~~~ 90 (222)
T 2a6z_A 23 PNNWQTGEQASLEEGRIVLTSN-Q---NSKGSLWLKQGFDLK-------DSFTMEWTFRSVGYS-GQTDGGISFWFVQDS 90 (222)
T ss_dssp CTTEEEEETCEEETTEEESCCS-T---TCEEEEEESSCEECC-------SCEEEEEEEEEESCC-SCCSCEEEEEEEECS
T ss_pred cCCcEEcccEEEcCCEEEECCC-C---CCeEEEEeCCCCCCC-------CCEEEEEEEEEeCCC-CCCCCEEEEEEECCC
Confidence 4689999999999999999998 4 558999999999864 369999999999764 347999999999865
Q ss_pred CCCCCCCCcccccccCCCCcceEEEEeecccCCCCCCCCCCeeeEecCCC-cccccc-----cCCccccccC-CCCeEEE
Q 043702 123 EQVGSAGGSLGLLDEKGAGLGFVAVEFDTLMDVEFSDINGNHVGLDLNSM-VSTEVD-----NLDTINVDLK-SGDLVNS 195 (711)
Q Consensus 123 ~~~~~~g~~lgl~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~-~S~~~~-----~~~~~~~~~~-~g~~~~~ 195 (711)
.. ...|..+|.-+. ..=+||+|||+.|. ..+|.+.+|.- .+.... ..+.-...++ .+...++
T Consensus 91 ~~-~~~g~~~G~~~~----f~GL~I~~Dt~~n~------~p~i~~~~ndG~~~yd~~~~~~~~~~~C~~~~rn~~~~~~~ 159 (222)
T 2a6z_A 91 NI-PRDKQLYNGPVN----YDGLQLLVDNNGPL------GPTLRGQLNDGQKPVDKTKIYDQSFASCLMGYQDSSVPSTI 159 (222)
T ss_dssp SS-CCCCTBTTBCTT----CEEEEEEEESCSTT------SSEEEEEEEESSSCCCGGGHHHHCSEEEECCCTTEEEEEEE
T ss_pred cc-cCCCcccCCCCC----CCEEEEEEECCCCC------CceEEEEECCCCeeeccCCCccccccccceeccCCCCcEEE
Confidence 42 134444554332 12279999999872 34566555432 121111 1111122333 4678999
Q ss_pred EEEEc-ccccEEEEEEEecCCCCCcceee-EecCcccccccc-eeEEEeeecc---CceeeEEEEeecccc
Q 043702 196 WIEYD-GLTRAFNISVSYSNLKPKVPILS-FTLDLDQYVNDF-MYVGFSGSTQ---GSTEIHSIEWWSFSS 260 (711)
Q Consensus 196 ~I~Y~-~~~~~l~V~~~~~~~~~~~~~ls-~~vdL~~~l~~~-~~vGFsastg---~~~~~~~i~sW~f~s 260 (711)
+|.|+ ...+.|+|.++. ..|+. ..|+ ||+. .|+||||+|| +..+.|+|++|++..
T Consensus 160 rI~Y~~~~~~~l~v~id~------~~C~~~~~v~----LP~~~~y~G~SA~TG~l~~~~d~hdil~~~~~~ 220 (222)
T 2a6z_A 160 RVTYDLEDDNLLKVQVDN------KVCFQTRKVR----FPSGSYRIGVTAQNGAVNNNAESFEIFKMQFFN 220 (222)
T ss_dssp EEEEEGGGTSEEEEEETT------EEEEEESCCC----CCSSEEEEEEEEECCSGGGCCCEEEEEEEEEEE
T ss_pred EEEEEcCCCcEEEEEEcC------eEEEEeCCee----cCCCCcEEEEEEcCCCCCCCCccEEEEEEEEEc
Confidence 99998 667789998853 22332 2344 4555 4799999999 888999999998753
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.60 E-value=7.6e-16 Score=165.89 Aligned_cols=139 Identities=13% Similarity=0.178 Sum_probs=99.3
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC---------------Chhhh--------HHHHHHHHhcCCC
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ---------------GKDEF--------LSELSIIGTLRHR 436 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---------------~~~~~--------~~Ei~~l~~l~H~ 436 (711)
.-|.+.+.||+|++|.||+|... +|+.||||+++.... ..... .+|...|.++.+.
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 44899999999999999999985 689999998753210 01111 2355556655443
Q ss_pred CeeeeeeeeeecCeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCC
Q 043702 437 NLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEG 516 (711)
Q Consensus 437 niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~ 516 (711)
++....-+... ..+|||||++++.|..+. .......++.|++.+|.|||+. +||||||||.||||+++
T Consensus 174 gv~vp~p~~~~--~~~LVME~i~G~~L~~l~-------~~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 174 GFPVPEPIAQS--RHTIVMSLVDALPMRQVS-------SVPDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREE 241 (397)
T ss_dssp TCSCCCEEEEE--TTEEEEECCSCEEGGGCC-------CCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEE
T ss_pred CCCCCeeeecc--CceEEEEecCCccHhhhc-------ccHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCC
Confidence 33221111112 237999999998886543 1234567889999999999987 99999999999999877
Q ss_pred C----------cEEEeecCCceecC
Q 043702 517 F----------NARLGDFGLARQVE 531 (711)
Q Consensus 517 ~----------~vkL~DFGla~~~~ 531 (711)
+ .+.|+||+-+....
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CCcccccccccceEEEEeCCcccCC
Confidence 6 38999999876543
|
| >2a6v_A EMP46P; beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.52A {Saccharomyces cerevisiae} SCOP: b.29.1.13 PDB: 2a6w_A 2a6x_A | Back alignment and structure |
|---|
Probab=99.54 E-value=3e-13 Score=134.32 Aligned_cols=184 Identities=13% Similarity=0.135 Sum_probs=124.1
Q ss_pred CCeEEeCceEeeCCcEEeCCCCCCCCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecCCCCCCCCceEEEEcCCCC
Q 043702 44 ASLKLLGDAHMNNGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLNPSSIGAGLAFVITPDGE 123 (711)
Q Consensus 44 ~~~~~~g~a~~~~g~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~GlaF~l~~~~~ 123 (711)
+++.+.|+|.+.++.|+||++ + ++.|.+|-+.|+.+- .+|+.+|+|+|.++... +||||||.++....
T Consensus 27 ~~W~~~G~t~v~~~~IrLTp~-~---s~~G~lWs~~p~~~~-------~~weiev~Fri~G~~~~-~gdGlA~Wyt~~~~ 94 (226)
T 2a6v_A 27 SQWTLGDKVKLEEGRFVLTPG-K---NTKGSLWLKPEYSIK-------DAMTIEWTFRSFGFRGS-TKGGLAFWLKQGNE 94 (226)
T ss_dssp TTEEEEETCEEETTEEESCCS-T---TCEEEEEESSCBCCS-------SCEEEEEEEEEESCCSC-CSCEEEEEEECSCC
T ss_pred CCcEEcCCeEEeCCEEEECCC-C---CceEEEeeCCCCCCC-------CCeEEEEEEEEecCCCC-CCCEEEEEEECCCC
Confidence 689999999999999999999 7 899999999999861 35999999999976533 79999999997554
Q ss_pred CCCCCCCcccccccCCCCcceEEEEeecccCCCCCCCCCCeeeEecC-CCcccccc---cCCcccccc-CCCCeEEEEEE
Q 043702 124 QVGSAGGSLGLLDEKGAGLGFVAVEFDTLMDVEFSDINGNHVGLDLN-SMVSTEVD---NLDTINVDL-KSGDLVNSWIE 198 (711)
Q Consensus 124 ~~~~~g~~lgl~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~n-s~~S~~~~---~~~~~~~~~-~~g~~~~~~I~ 198 (711)
. ..|...| ...+...=+||.|||+.|. ...|-+-+| +..+.... ..+.-...+ ..+...+++|.
T Consensus 95 ~--~~g~vfG---g~~d~f~GlgI~~Dt~~n~------~p~i~~~~NDGt~~yd~~~~~~~g~C~~~~rn~~~~t~~ri~ 163 (226)
T 2a6v_A 95 G--DSTELFG---GSSKKFNGLMILLRLDDKL------GESVTAYLNDGTKDLDIESSPYFASCLFQYQDSMVPSTLRLT 163 (226)
T ss_dssp C--CCCTBTT---TBCSSCEEEEEEEEEETTT------EEEEEEEEEESSSCCCTTTSCCSEEEECCCSSCSSCEEEEEE
T ss_pred C--CCccccc---ccCCCccEEEEEEECCCCC------CceEEEEECCCCcccCCCCCcccceEeEeccCCCCCEEEEEE
Confidence 2 2233222 1111112279999999762 122333332 22222211 111112233 34678999999
Q ss_pred Ec-ccccEEEEEEEecCCCCCcceee-EecCcccccccce--eEEEeeeccCceeeEEEEeecccc
Q 043702 199 YD-GLTRAFNISVSYSNLKPKVPILS-FTLDLDQYVNDFM--YVGFSGSTQGSTEIHSIEWWSFSS 260 (711)
Q Consensus 199 Y~-~~~~~l~V~~~~~~~~~~~~~ls-~~vdL~~~l~~~~--~vGFsastg~~~~~~~i~sW~f~s 260 (711)
|. ...+.|+|.++. ..|+. ..|+ ||..- |+||||+||+..+.|+|++-.+..
T Consensus 164 Y~~~~~~~l~v~id~------~~Cf~~~~v~----LP~g~~~yfGiSAaTg~~~D~hdils~~~~~ 219 (226)
T 2a6v_A 164 YNPLDNHLLKLQMDN------RVCFQTRKVK----FMGSSPFRIGTSAINDASKESFEILKMKLYD 219 (226)
T ss_dssp EEGGGTSEEEEEETT------EEEEEESCCC----GGGTSCBEEEEEEECCTTCCEEEEEEEEEES
T ss_pred EEccCCCEEEEEEcC------CeeEEECCee----cCCCCccEEEEEEcCCCCcccEEEEEEEEEe
Confidence 97 456789998852 23433 2233 44434 999999999999999999977644
|
| >2ltn_B PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1hkd_B 1rin_B* 1ofs_B* 1bqp_B* 1loe_B 1loa_B* 1loc_B* 1lod_B* 1lob_B 1lof_B* 1log_B* 1lof_D* 1les_B* 2b7y_B* 1lgc_B* 1lgb_B* 1len_B 1lem_B 2lal_B | Back alignment and structure |
|---|
Probab=99.49 E-value=9.4e-15 Score=109.24 Aligned_cols=45 Identities=29% Similarity=0.472 Sum_probs=42.4
Q ss_pred cceeeEecCcccccccceeEEEeeeccCceeeEEEEeeccccccC
Q 043702 219 VPILSFTLDLDQYVNDFMYVGFSGSTQGSTEIHSIEWWSFSSSFE 263 (711)
Q Consensus 219 ~~~ls~~vdL~~~l~~~~~vGFsastg~~~~~~~i~sW~f~s~~~ 263 (711)
.|+|+..|||+++|+|+|||||||+||...|.|+|++|+|++...
T Consensus 3 ~p~ls~~vdLs~~l~e~v~VGFSAsTG~~~~~h~IlsWsF~s~~~ 47 (52)
T 2ltn_B 3 SYTLSDVVSLKDVVPEWVRIGFSATTGAEYAAHEVLSWSFHSELS 47 (52)
T ss_dssp EEEEEEECCHHHHSCSEEEEEEEEECCSSCCEEEEEEEEEEEEEC
T ss_pred eeeEEEEEcHHHhcCceEEEEEEeccCCcceeEEEEEeEEEeecc
Confidence 478999999999999999999999999999999999999998763
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=1.4e-11 Score=126.27 Aligned_cols=147 Identities=15% Similarity=0.090 Sum_probs=117.5
Q ss_pred HHHHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC-CChhhhHHHHHHHHhcC-CCCeeeeeeeeeecCeEE
Q 043702 375 LRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLR-HRNLVRLQGWCHEKGEIL 452 (711)
Q Consensus 375 l~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~ 452 (711)
+......|.....++.|+.+.||+... .+..+++|+..... .....+.+|+++++.+. +..+.++++++...+..+
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~ 86 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence 445556788888899999999999976 36789999986521 33457899999999996 677888999999888999
Q ss_pred EEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhcc-----------------------------------
Q 043702 453 LVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQEC----------------------------------- 497 (711)
Q Consensus 453 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~----------------------------------- 497 (711)
+||||++|.+|.+.+. +......++.+++++|..||+..
T Consensus 87 lv~e~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEECCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEEEecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 9999999999987631 22345688999999999999810
Q ss_pred ---------------------CCCeeeccCCCCceEEcCCCcEEEeecCCcee
Q 043702 498 ---------------------ENQVIHRDVKTSNIMLDEGFNARLGDFGLARQ 529 (711)
Q Consensus 498 ---------------------~~~ivHrDlkp~NILld~~~~vkL~DFGla~~ 529 (711)
...++|+|+++.|||++++..+.|+||+.+..
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 14599999999999998766667999988753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.14 E-value=8.3e-11 Score=119.79 Aligned_cols=139 Identities=18% Similarity=0.104 Sum_probs=102.6
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCC--eeeeeeeeeecCeEEEEEE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRN--LVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~~~~~~~~~lV~E 456 (711)
...+....+.+.|..+.||+... .+|..+++|+.... ....+.+|+++++.+++.+ +.+++++...++..++|||
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred cCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 34455444334566699999976 35678999987543 3456889999999997545 4558888887788999999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhcc---------------------------------------
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQEC--------------------------------------- 497 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~--------------------------------------- 497 (711)
|+++.+|. .. . .....++.++++.|..||+..
T Consensus 96 ~i~G~~l~--~~-~------~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 96 EVPGQDLL--SS-H------LAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp CCSSEETT--TS-C------CCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred ecCCcccC--cC-c------CCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 99998874 21 1 123467788888888888742
Q ss_pred ----------------CCCeeeccCCCCceEEcCCCcEEEeecCCcee
Q 043702 498 ----------------ENQVIHRDVKTSNIMLDEGFNARLGDFGLARQ 529 (711)
Q Consensus 498 ----------------~~~ivHrDlkp~NILld~~~~vkL~DFGla~~ 529 (711)
...++|+|++|.|||++++..++|+|||.+..
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11399999999999998876677999998864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.02 E-value=8.7e-10 Score=118.48 Aligned_cols=140 Identities=14% Similarity=0.250 Sum_probs=107.3
Q ss_pred cceeecCCceEEEEEEeCCCCeEEEEEEcc--cCC--CChhhhHHHHHHHHhcC--CCCeeeeeeeeeec---CeEEEEE
Q 043702 385 NRIIGHGAFGTVYKGILPQNGDIIAVKRCS--HNS--QGKDEFLSELSIIGTLR--HRNLVRLQGWCHEK---GEILLVY 455 (711)
Q Consensus 385 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~--~~~--~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~---~~~~lV~ 455 (711)
.+.|+.|.++.||+.... +..+++|+.. ... .....+.+|+.+++.|+ +..+.+++.++.+. +..++||
T Consensus 43 ~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred EEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 467899999999998874 4678888876 322 23457889999999998 45678889988776 4589999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhcc--------------------------------------
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQEC-------------------------------------- 497 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-------------------------------------- 497 (711)
||+++..+.+. ....++..++..++.++++.|..||+..
T Consensus 121 e~v~G~~l~~~---~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 121 EFVSGRVLWDQ---SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp ECCCCBCCCCT---TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred EecCCeecCCC---ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 99999877431 1234778889999999999999999731
Q ss_pred -----------------CCCeeeccCCCCceEEcCCCc--EEEeecCCcee
Q 043702 498 -----------------ENQVIHRDVKTSNIMLDEGFN--ARLGDFGLARQ 529 (711)
Q Consensus 498 -----------------~~~ivHrDlkp~NILld~~~~--vkL~DFGla~~ 529 (711)
...++|+|+++.|||++.++. +.|.||+.+..
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999987753 68999999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.84 E-value=1.2e-09 Score=114.57 Aligned_cols=184 Identities=17% Similarity=0.174 Sum_probs=123.1
Q ss_pred cceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcC-CCC--eeeeeeeeeecC---eEEEEEEcC
Q 043702 385 NRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLR-HRN--LVRLQGWCHEKG---EILLVYDLM 458 (711)
Q Consensus 385 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~-H~n--iv~l~g~~~~~~---~~~lV~Ey~ 458 (711)
.+.++.|....||+.. ..+++|+.... .....+.+|.++|+.+. +.. +.+++..+...+ ..++|||++
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3568999999999853 45788875432 23467889999999884 332 334444443332 348899999
Q ss_pred CCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhcc-----------------------------------------
Q 043702 459 PNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQEC----------------------------------------- 497 (711)
Q Consensus 459 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~----------------------------------------- 497 (711)
+|..|..... ..++..++..++.++++.|..||+..
T Consensus 99 ~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 99 KGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp CCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred CCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 9988875432 24677888889999999999998610
Q ss_pred --------------CCCeeeccCCCCceEEcC--CCcEEEeecCCceecCCCCCCCcccccCCCcc---cChhhhcc---
Q 043702 498 --------------ENQVIHRDVKTSNIMLDE--GFNARLGDFGLARQVEHDKSPDATVAAGTMGY---LAPEYLLT--- 555 (711)
Q Consensus 498 --------------~~~ivHrDlkp~NILld~--~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y---~APE~~~~--- 555 (711)
...++|+|+++.||++++ +..+.|+||+.+..-.... .......+ ..|+....
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-----Dl~~~~~~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-----DFISLMEDDEEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-----HHHTTCCTTTSCCHHHHHHHHH
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-----HHHHHHhhccccCHHHHHHHHH
Confidence 135899999999999998 5567899999987542210 00011111 22332210
Q ss_pred --CCC---------CccccchhHHHHHHHHHhCCCCCc
Q 043702 556 --GRA---------TEKTDVFSYGAVVLEVASGRRPIE 582 (711)
Q Consensus 556 --~~~---------s~ksDVwSfGvll~elltG~~P~~ 582 (711)
+.. ....+.|+++.++|++.+|..+|.
T Consensus 251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 111 123589999999999999988764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=1.8e-06 Score=88.23 Aligned_cols=136 Identities=20% Similarity=0.177 Sum_probs=101.4
Q ss_pred eeecCCce-EEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcC-CCCeeeeeeeeeecCeEEEEEEcCCCCCHH
Q 043702 387 IIGHGAFG-TVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLR-HRNLVRLQGWCHEKGEILLVYDLMPNGSLD 464 (711)
Q Consensus 387 ~LG~G~fg-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 464 (711)
.+..|..+ .||+.....++..+++|+-... ...++.+|...|+.|. +-.+.++++++.+.+..++|||++++.++.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 35556555 6999887666778899986532 3457889999999886 434677889999999999999999998887
Q ss_pred HHHhhCCCCCChHHHHHHHHHHHHHHHHHHhcc-----------------------------------------------
Q 043702 465 KALFEARSPLPWPHRSKILLGVASALAYLHQEC----------------------------------------------- 497 (711)
Q Consensus 465 ~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~----------------------------------------------- 497 (711)
+.... .......++.++++.|.-||...
T Consensus 109 ~~~~~-----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 183 (272)
T 4gkh_A 109 QVLEE-----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEM 183 (272)
T ss_dssp HHHHH-----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHH
T ss_pred ccccC-----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHH
Confidence 76532 12345566777777777777520
Q ss_pred --------CCCeeeccCCCCceEEcCCCcEEEeecCCcee
Q 043702 498 --------ENQVIHRDVKTSNIMLDEGFNARLGDFGLARQ 529 (711)
Q Consensus 498 --------~~~ivHrDlkp~NILld~~~~vkL~DFGla~~ 529 (711)
...++|+|+.+.|||+++++.+-|.||+.+..
T Consensus 184 ~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 184 HKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 11379999999999999877677999998853
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=2.7e-06 Score=89.07 Aligned_cols=136 Identities=18% Similarity=0.179 Sum_probs=95.1
Q ss_pred cceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCC---Ceeeeeeeee-ecCeEEEEEEcCCC
Q 043702 385 NRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHR---NLVRLQGWCH-EKGEILLVYDLMPN 460 (711)
Q Consensus 385 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~---niv~l~g~~~-~~~~~~lV~Ey~~~ 460 (711)
.+.++.|....||+. +..+++|+.. .......+.+|.++|+.|.+. .+.+.+.++. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~-~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK-SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES-SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC-CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456888999999987 3557788742 222345788999999999853 2455666664 34567899999999
Q ss_pred CCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhc--------------------------------------------
Q 043702 461 GSLDKALFEARSPLPWPHRSKILLGVASALAYLHQE-------------------------------------------- 496 (711)
Q Consensus 461 gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-------------------------------------------- 496 (711)
..|..... ..++..++..++.++++.|..||+.
T Consensus 98 ~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 174 (306)
T 3tdw_A 98 QILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL 174 (306)
T ss_dssp EECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred eECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence 88876322 1234555666666666666666642
Q ss_pred -------------cCCCeeeccCCCCceEEcC---CCc-EEEeecCCcee
Q 043702 497 -------------CENQVIHRDVKTSNIMLDE---GFN-ARLGDFGLARQ 529 (711)
Q Consensus 497 -------------~~~~ivHrDlkp~NILld~---~~~-vkL~DFGla~~ 529 (711)
....++|+|+++.|||++. ++. +.|+||+.+..
T Consensus 175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1235799999999999987 455 48999998865
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.16 E-value=3.6e-06 Score=89.92 Aligned_cols=80 Identities=6% Similarity=-0.015 Sum_probs=56.2
Q ss_pred ccee-ecCCceEEEEEEeC---C---CCeEEEEEEcccCC---C-ChhhhHHHHHHHHhcC-C--CCeeeeeeeeeec--
Q 043702 385 NRII-GHGAFGTVYKGILP---Q---NGDIIAVKRCSHNS---Q-GKDEFLSELSIIGTLR-H--RNLVRLQGWCHEK-- 448 (711)
Q Consensus 385 ~~~L-G~G~fg~Vy~~~~~---~---~~~~vavK~~~~~~---~-~~~~~~~Ei~~l~~l~-H--~niv~l~g~~~~~-- 448 (711)
.+.| +.|....+|+.... + ++..+++|+..... . ....+.+|+.+++.|. + -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 78889999998763 0 15678888865432 1 2356889999999886 3 3466788877655
Q ss_pred -CeEEEEEEcCCCCCHH
Q 043702 449 -GEILLVYDLMPNGSLD 464 (711)
Q Consensus 449 -~~~~lV~Ey~~~gsL~ 464 (711)
+..++||||+++..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3568999999886653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.98 E-value=4.7e-05 Score=80.20 Aligned_cols=139 Identities=17% Similarity=0.204 Sum_probs=81.6
Q ss_pred ceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCC--CCeeeeee------eeeecCeEEEEEEc
Q 043702 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRH--RNLVRLQG------WCHEKGEILLVYDL 457 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g------~~~~~~~~~lV~Ey 457 (711)
+.|+.|..+.||+.... +..+++|+... ...++..|..++..|.. -.+.+++. +....+..+++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~--~~~~vlk~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTD--SGAVCLKRIHR---PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEET--TEEEEEEEECS---CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeC--CCCEEEEecCC---CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 34666778999998873 34588998865 23445556666666541 12333332 12346678999999
Q ss_pred CCCCCHH-----------H---HHhh--CC---C--------CCChHHHH------------------------------
Q 043702 458 MPNGSLD-----------K---ALFE--AR---S--------PLPWPHRS------------------------------ 480 (711)
Q Consensus 458 ~~~gsL~-----------~---~l~~--~~---~--------~l~~~~~~------------------------------ 480 (711)
++|..+. . .++. .. . .-.|....
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 1 1121 10 0 01232110
Q ss_pred -HHHHHHHHHHHHHHh----------ccCCCeeeccCCCCceEEcCCCcEEEeecCCcee
Q 043702 481 -KILLGVASALAYLHQ----------ECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQ 529 (711)
Q Consensus 481 -~i~~~ia~aL~yLH~----------~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~ 529 (711)
.+...+..++.+|+. .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 011123445667763 1246899999999999998888999999998753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.97 E-value=2.9e-05 Score=84.20 Aligned_cols=75 Identities=16% Similarity=0.104 Sum_probs=49.6
Q ss_pred cceeecCCceEEEEEEeCCCCeEEEEEEcccCC--------CChhhhHHHHHHHHhcCC--CCee-eeeeeeeecCeEEE
Q 043702 385 NRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS--------QGKDEFLSELSIIGTLRH--RNLV-RLQGWCHEKGEILL 453 (711)
Q Consensus 385 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~Ei~~l~~l~H--~niv-~l~g~~~~~~~~~l 453 (711)
.+.||.|..+.||++....+++.+++|...... ...+.+..|.++++.+.. +..+ +++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457999999999999775557789999754321 123456789999988752 3333 45543 3445689
Q ss_pred EEEcCCCC
Q 043702 454 VYDLMPNG 461 (711)
Q Consensus 454 V~Ey~~~g 461 (711)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00023 Score=74.61 Aligned_cols=137 Identities=12% Similarity=0.138 Sum_probs=91.7
Q ss_pred ccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcC---CCCeeeeeeeeeecCeEEEEEEcCCC
Q 043702 384 ANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLR---HRNLVRLQGWCHEKGEILLVYDLMPN 460 (711)
Q Consensus 384 ~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV~Ey~~~ 460 (711)
..+.|+.|....+|+... ++..+++|+.... ....+..|.+.|+.|. ...+.+++.++...+..++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 346789999999999876 4667888986543 3566889999999885 25677888888878889999999998
Q ss_pred CCHH--------H---HHhhCCC--C-------------------CChHHHH---HHHH----------------HHHHH
Q 043702 461 GSLD--------K---ALFEARS--P-------------------LPWPHRS---KILL----------------GVASA 489 (711)
Q Consensus 461 gsL~--------~---~l~~~~~--~-------------------l~~~~~~---~i~~----------------~ia~a 489 (711)
..+. + .|+.... . -+|.... ++.. .+++.
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 7641 1 1232211 1 1343221 1111 11111
Q ss_pred H-HHHHh-ccCCCeeeccCCCCceEEcCCCcEEEeecC
Q 043702 490 L-AYLHQ-ECENQVIHRDVKTSNIMLDEGFNARLGDFG 525 (711)
Q Consensus 490 L-~yLH~-~~~~~ivHrDlkp~NILld~~~~vkL~DFG 525 (711)
+ ..|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1 23321 1246899999999999999887 8899973
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00042 Score=75.64 Aligned_cols=77 Identities=16% Similarity=0.136 Sum_probs=47.6
Q ss_pred CCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCcccccC--CCcccChhhhccC---CCCccccchhHHHHHH
Q 043702 498 ENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAG--TMGYLAPEYLLTG---RATEKTDVFSYGAVVL 572 (711)
Q Consensus 498 ~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~g--t~~y~APE~~~~~---~~s~ksDVwSfGvll~ 572 (711)
...++|+|+++.|||++.++ ++|.||+.+..-.... +...... ...|++|+..... ......++......+|
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~--Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF--DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH--HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH--HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 45899999999999998876 9999999987532110 0000000 1245666554311 1112345567788888
Q ss_pred HHHhC
Q 043702 573 EVASG 577 (711)
Q Consensus 573 elltG 577 (711)
+.+.+
T Consensus 308 ~~y~~ 312 (420)
T 2pyw_A 308 NLFNK 312 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 87765
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.34 E-value=0.0016 Score=67.94 Aligned_cols=158 Identities=16% Similarity=0.147 Sum_probs=90.4
Q ss_pred ccCHHHHHHHhcCCcc-----cceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCC--eeee
Q 043702 369 EFSYRELRSATKCFNA-----NRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRN--LVRL 441 (711)
Q Consensus 369 ~~~~~el~~at~~f~~-----~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l 441 (711)
.++.+++......|.. .+.|+.|....+|+.... +| .+++|+.... ...+++..|+.++..|.... +.++
T Consensus 6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 3455666666555654 234667888999998874 33 5788987652 23456777888888775222 2233
Q ss_pred eee------eeecCeEEEEEEcCCCCCHH-----------H---HHhhCC----CC----C---ChHHHHH---------
Q 043702 442 QGW------CHEKGEILLVYDLMPNGSLD-----------K---ALFEAR----SP----L---PWPHRSK--------- 481 (711)
Q Consensus 442 ~g~------~~~~~~~~lV~Ey~~~gsL~-----------~---~l~~~~----~~----l---~~~~~~~--------- 481 (711)
+.. ....+..++++||++|..+. + .++... .. . .|.....
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 321 12345679999999886431 0 112110 00 1 1322111
Q ss_pred ---HHHHHHHHHHHHHhcc----CCCeeeccCCCCceEEcCCCcEEEeecCCcee
Q 043702 482 ---ILLGVASALAYLHQEC----ENQVIHRDVKTSNIMLDEGFNARLGDFGLARQ 529 (711)
Q Consensus 482 ---i~~~ia~aL~yLH~~~----~~~ivHrDlkp~NILld~~~~vkL~DFGla~~ 529 (711)
+...+.+.+++++... ...++|+|+.+.|||++++..+.|+||+.+..
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 0112444566665432 34799999999999999876568999988753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.33 E-value=0.0015 Score=67.25 Aligned_cols=78 Identities=18% Similarity=0.177 Sum_probs=55.0
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC-CChhhhHHHHHHHHhcCCC---CeeeeeeeeeecCeEEEEEE
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHR---NLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~---niv~l~g~~~~~~~~~lV~E 456 (711)
.....+.+|.|..+.||+.... +|+.+.+|+..... .....|..|...|+.|.-. .+.+++++. . -++|||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~~lv~e 90 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--RTLAME 90 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--TEEEEE
T ss_pred CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc--C--ceEEEE
Confidence 3455677999999999999985 58889999866533 2334678899999988522 234444432 2 378999
Q ss_pred cCCCCCH
Q 043702 457 LMPNGSL 463 (711)
Q Consensus 457 y~~~gsL 463 (711)
|++.+..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987653
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.28 E-value=0.0025 Score=66.66 Aligned_cols=156 Identities=14% Similarity=0.125 Sum_probs=90.1
Q ss_pred cCHHHHHHHhcCCcc-----cceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCC--eeeee
Q 043702 370 FSYRELRSATKCFNA-----NRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRN--LVRLQ 442 (711)
Q Consensus 370 ~~~~el~~at~~f~~-----~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~ 442 (711)
.+.+++..+.+.|.. ...|+ |....||+.... +|+.+++|+..........+..|..++..|.... +.+++
T Consensus 11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~ 88 (328)
T 1zyl_A 11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDE-DRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPV 88 (328)
T ss_dssp CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCT-TCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCC
T ss_pred CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcC-CCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeeccee
Confidence 444455544443322 24566 888899987663 4667899998654445667888998888876222 33444
Q ss_pred ee-----eeecCeEEEEEEcCCCCCHH-----H------H---Hhh--C------CCCCChHHH----HHH---------
Q 043702 443 GW-----CHEKGEILLVYDLMPNGSLD-----K------A---LFE--A------RSPLPWPHR----SKI--------- 482 (711)
Q Consensus 443 g~-----~~~~~~~~lV~Ey~~~gsL~-----~------~---l~~--~------~~~l~~~~~----~~i--------- 482 (711)
.. ....+..+++|||+++..+. . . ++. . ....++... ..+
T Consensus 89 ~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 168 (328)
T 1zyl_A 89 AFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPS 168 (328)
T ss_dssp CBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCT
T ss_pred ecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCH
Confidence 32 22355678999999875431 1 1 111 0 011222111 011
Q ss_pred ------HHHHHHHHHHHHhc----cCCCeeeccCCCCceEEcCCCcEEEeecCCcee
Q 043702 483 ------LLGVASALAYLHQE----CENQVIHRDVKTSNIMLDEGFNARLGDFGLARQ 529 (711)
Q Consensus 483 ------~~~ia~aL~yLH~~----~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~ 529 (711)
...+.+.++.+... ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 169 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 169 GLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp TTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 11111223333322 235689999999999999 4 899999988764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.24 E-value=0.001 Score=69.00 Aligned_cols=136 Identities=10% Similarity=0.054 Sum_probs=76.2
Q ss_pred cceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCe-eeeeeeeeecCeEEEEEEcC-CCCC
Q 043702 385 NRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNL-VRLQGWCHEKGEILLVYDLM-PNGS 462 (711)
Q Consensus 385 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~-~~gs 462 (711)
.+.|+.|....+|+. ..+++|+.........+..+|..+++.+....+ .++++++. +.-++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeecCCCcc
Confidence 577999999999998 347888776532222334678888888763333 35555433 2347899999 5544
Q ss_pred HHHH------------------HhhCCCCCC-----hHHHHHHHH--------------HHHHHHHHHH----h-ccCCC
Q 043702 463 LDKA------------------LFEARSPLP-----WPHRSKILL--------------GVASALAYLH----Q-ECENQ 500 (711)
Q Consensus 463 L~~~------------------l~~~~~~l~-----~~~~~~i~~--------------~ia~aL~yLH----~-~~~~~ 500 (711)
|... ++.....+. +....++.. .+.+.+..|. . .....
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 4210 111111111 111111110 0111111111 1 12345
Q ss_pred eeeccCCCCceEEcCCCcEEEeecCCcee
Q 043702 501 VIHRDVKTSNIMLDEGFNARLGDFGLARQ 529 (711)
Q Consensus 501 ivHrDlkp~NILld~~~~vkL~DFGla~~ 529 (711)
++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 899999999999 5667889999998864
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0022 Score=67.32 Aligned_cols=139 Identities=15% Similarity=0.130 Sum_probs=73.7
Q ss_pred ceeecCCceE-EEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCC--CeeeeeeeeeecCeEEEEEEcCCCCC
Q 043702 386 RIIGHGAFGT-VYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHR--NLVRLQGWCHEKGEILLVYDLMPNGS 462 (711)
Q Consensus 386 ~~LG~G~fg~-Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~--niv~l~g~~~~~~~~~lV~Ey~~~gs 462 (711)
+.|+.|.... +|+.... ++..+++|...... ..++..|+.+++.+... .+.+++.++.+.+ +++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~-~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSP-TGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECT-TCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcC-CCCeEEEEECCCCC--CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 3465555444 6676542 25667777654322 14566788888877522 3455666644444 68999997766
Q ss_pred HHHHHhhC---------------------C-CCCC---hHHHH-------H-H------------HHHHHHHHHHHHh--
Q 043702 463 LDKALFEA---------------------R-SPLP---WPHRS-------K-I------------LLGVASALAYLHQ-- 495 (711)
Q Consensus 463 L~~~l~~~---------------------~-~~l~---~~~~~-------~-i------------~~~ia~aL~yLH~-- 495 (711)
+.+++... . ..++ ..... . + ...+...+..|..
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 65443210 0 0111 11000 0 0 0011122222211
Q ss_pred -ccCCCeeeccCCCCceEEcCC----CcEEEeecCCcee
Q 043702 496 -ECENQVIHRDVKTSNIMLDEG----FNARLGDFGLARQ 529 (711)
Q Consensus 496 -~~~~~ivHrDlkp~NILld~~----~~vkL~DFGla~~ 529 (711)
.....++|||+.+.|||++.+ ..+.|.||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 124579999999999999875 6799999998875
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0018 Score=69.58 Aligned_cols=140 Identities=16% Similarity=0.181 Sum_probs=84.1
Q ss_pred ceeecCCceEEEEEEeCC-------CCeEEEEEEcccCCCChhhhHHHHHHHHhcC-CCCeeeeeeeeeecCeEEEEEEc
Q 043702 386 RIIGHGAFGTVYKGILPQ-------NGDIIAVKRCSHNSQGKDEFLSELSIIGTLR-HRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
+.|..|-...+|+..... ++..+++|+............+|.++++.|. +.-..++++.+.+ .+||||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~ 131 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY 131 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence 456668888899988742 3468899986443344567779999998886 3323556666543 299999
Q ss_pred CCCCCHHH--------------H---HhhCC----CCC--ChHHHHHHHHHHHH-------------------HHHHHHh
Q 043702 458 MPNGSLDK--------------A---LFEAR----SPL--PWPHRSKILLGVAS-------------------ALAYLHQ 495 (711)
Q Consensus 458 ~~~gsL~~--------------~---l~~~~----~~l--~~~~~~~i~~~ia~-------------------aL~yLH~ 495 (711)
+++..|.. . |+... ... -|.+..++..++.. .+..|..
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 98755421 1 12111 112 24455555544322 2333332
Q ss_pred c-----cCCCeeeccCCCCceEEcCC----CcEEEeecCCcee
Q 043702 496 E-----CENQVIHRDVKTSNIMLDEG----FNARLGDFGLARQ 529 (711)
Q Consensus 496 ~-----~~~~ivHrDlkp~NILld~~----~~vkL~DFGla~~ 529 (711)
. ....++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 1 13469999999999999876 7899999988853
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0033 Score=68.80 Aligned_cols=73 Identities=15% Similarity=0.198 Sum_probs=50.1
Q ss_pred cceeecCCceEEEEEEeCC-------CCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCe-eeeeeeeeecCeEEEEEE
Q 043702 385 NRIIGHGAFGTVYKGILPQ-------NGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNL-VRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 385 ~~~LG~G~fg~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E 456 (711)
.+.|+.|-...+|+..... .+..+++|+.... ...+.+..|..+++.|...++ .++++.+.+ .+|+|
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 3568888889999998753 2567889887432 222567789999998864334 556665542 38999
Q ss_pred cCCCCC
Q 043702 457 LMPNGS 462 (711)
Q Consensus 457 y~~~gs 462 (711)
|+++.+
T Consensus 153 ~l~G~~ 158 (429)
T 1nw1_A 153 YIPSRP 158 (429)
T ss_dssp CCCEEE
T ss_pred EeCCcc
Confidence 998633
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0092 Score=65.76 Aligned_cols=75 Identities=13% Similarity=0.046 Sum_probs=49.0
Q ss_pred cceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCe-eeeeeeeeecCeEEEEEEcCCCCCH
Q 043702 385 NRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNL-VRLQGWCHEKGEILLVYDLMPNGSL 463 (711)
Q Consensus 385 ~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~~gsL 463 (711)
.+.|+.|-...+|+....+.+..+++|+........-+-.+|..++..|...++ .++++.+. + .+||||+++..|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 356888888999999885435788898875432222223589999999985555 45666663 2 259999987443
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.69 E-value=0.0036 Score=66.84 Aligned_cols=73 Identities=11% Similarity=0.100 Sum_probs=44.0
Q ss_pred ceeecCCceEEEEEEeCC--------CCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCe-eeeeeeeeecCeEEEEEE
Q 043702 386 RIIGHGAFGTVYKGILPQ--------NGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNL-VRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E 456 (711)
+.|+.|..-.+|+....+ .+..+++|+.........+...|.++++.|...++ .++++.. .+ ++|||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v~e 114 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRIEE 114 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--CC--cEEEE
Confidence 457778888999988743 12678888865432222234678888888863343 3555443 22 68999
Q ss_pred cCCCCC
Q 043702 457 LMPNGS 462 (711)
Q Consensus 457 y~~~gs 462 (711)
|+++..
T Consensus 115 ~i~G~~ 120 (369)
T 3c5i_A 115 WLYGDP 120 (369)
T ss_dssp CCCSEE
T ss_pred EecCCc
Confidence 998754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.27 E-value=0.026 Score=59.50 Aligned_cols=32 Identities=13% Similarity=0.223 Sum_probs=28.4
Q ss_pred CCCeeeccCCCCceEEcCCCcEEEeecCCcee
Q 043702 498 ENQVIHRDVKTSNIMLDEGFNARLGDFGLARQ 529 (711)
Q Consensus 498 ~~~ivHrDlkp~NILld~~~~vkL~DFGla~~ 529 (711)
...++|+|+.+.||++++++.+.|.||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 35799999999999999888899999988764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.21 E-value=0.05 Score=53.14 Aligned_cols=104 Identities=14% Similarity=0.049 Sum_probs=70.0
Q ss_pred CCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCccc
Q 043702 461 GSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATV 540 (711)
Q Consensus 461 gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 540 (711)
-+|.+.|...+.++++++.+.++.|.+.+|.-+-....+ ..+=+.|..|+|..+|+|...+ ..+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc------------
Confidence 479999998899999999999999999998776221011 1233457999999999988764 1110
Q ss_pred ccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCC
Q 043702 541 AAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPI 581 (711)
Q Consensus 541 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~ 581 (711)
.....+.+||... ...+.+.=|||+|++||.-+--..|-
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e 136 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE 136 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc
Confidence 0122456787653 34578889999999999988755553
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.26 E-value=0.063 Score=58.36 Aligned_cols=140 Identities=12% Similarity=0.097 Sum_probs=84.7
Q ss_pred cceeecCCceEEEEEEeCCC-------CeEEEEEEcccCCCChhhhHHHHHHHHhcCCCC-eeeeeeeeeecCeEEEEEE
Q 043702 385 NRIIGHGAFGTVYKGILPQN-------GDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRN-LVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 385 ~~~LG~G~fg~Vy~~~~~~~-------~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~~~~lV~E 456 (711)
.+.|..|-...+|+...... +..+++|+........-+..+|..+++.+...+ ..++++.+ .+ ++|||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~e 150 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIEE 150 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEEE
Confidence 34577788899999987521 577888886543333334468999998886323 34455433 22 78999
Q ss_pred cCCCCCHH--------------HHH---hh--C----------CCCCChHHHHHHHHHH-------------------HH
Q 043702 457 LMPNGSLD--------------KAL---FE--A----------RSPLPWPHRSKILLGV-------------------AS 488 (711)
Q Consensus 457 y~~~gsL~--------------~~l---~~--~----------~~~l~~~~~~~i~~~i-------------------a~ 488 (711)
|+++..|. +.| +. . ..+..|.+..++..++ ..
T Consensus 151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 230 (424)
T 3mes_A 151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE 230 (424)
T ss_dssp CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence 99986531 011 10 0 1111244444443222 22
Q ss_pred HHHHHHhc---------------------cCCCeeeccCCCCceEEcCCCcEEEeecCCcee
Q 043702 489 ALAYLHQE---------------------CENQVIHRDVKTSNIMLDEGFNARLGDFGLARQ 529 (711)
Q Consensus 489 aL~yLH~~---------------------~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~ 529 (711)
.+..|.+. ....++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 23333321 1246899999999999 8888999999998864
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.94 E-value=0.21 Score=35.42 Aligned_cols=27 Identities=15% Similarity=0.256 Sum_probs=10.7
Q ss_pred eehhHHHHHHHHHHHHHHhhhheeccc
Q 043702 325 VAGVVTASAFFAIFAGVLIWFFSKRYK 351 (711)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~r~~ 351 (711)
|++-+++++++++++++++|++.||++
T Consensus 13 IA~gVVgGv~~~~ii~~~~~~~~RRr~ 39 (44)
T 2ks1_B 13 IATGMVGALLLLLVVALGIGLFMRRRH 39 (44)
T ss_dssp STHHHHHHHHHHHHHHHHHHHHHHTTT
T ss_pred EEeehhHHHHHHHHHHHHHHHHhhhhH
Confidence 444344433333333344444444443
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=88.25 E-value=0.24 Score=34.93 Aligned_cols=9 Identities=11% Similarity=0.139 Sum_probs=4.1
Q ss_pred eehhHHHHH
Q 043702 325 VAGVVTASA 333 (711)
Q Consensus 325 ~~~~~~~~~ 333 (711)
+++.+++.+
T Consensus 14 Ia~~vVGvl 22 (44)
T 2jwa_A 14 IISAVVGIL 22 (44)
T ss_dssp HHHHHHHHH
T ss_pred hHHHHHHHH
Confidence 444444433
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=87.39 E-value=1 Score=43.81 Aligned_cols=120 Identities=9% Similarity=0.097 Sum_probs=82.1
Q ss_pred CCCCeeeeeeeeeecCeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEE
Q 043702 434 RHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIML 513 (711)
Q Consensus 434 ~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl 513 (711)
.||+++.. .+-..++.+.+.|+.-+.+.=+..+ ..++...+++++.+|+....+++.. +|--|.|+|+++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i----k~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL~f 112 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI----KSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDELFF 112 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG----GGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGEEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH----HhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceEEE
Confidence 48888866 4556667777777765432212223 3467889999999999888766643 788899999999
Q ss_pred cCCCcEEEeecCCceecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccc
Q 043702 514 DEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEIT 586 (711)
Q Consensus 514 d~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~ 586 (711)
+.++.+++.-.|+-..+... =+.+|-+ .-.+=|++..+++++..|+.--.
T Consensus 113 ~~~~~p~i~~RGik~~l~P~-------------~~~ee~f----------L~qyKAliiall~~K~~Fe~l~~ 162 (215)
T 4ann_A 113 TRDGLPIAKTRGLQNVVDPL-------------PVSEAEF----------LTRYKALVICAFNEKQSFDALVE 162 (215)
T ss_dssp CTTSCEEESCCEETTTBSCC-------------CCCHHHH----------HHHHHHHHHHHHCTTCCHHHHHH
T ss_pred cCCCCEEEEEccCccCCCCC-------------CCCHHHH----------HHHHHHHHHHHHcCCCCHHHHHc
Confidence 99999999887764322111 0122222 33567889999999999976433
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=86.98 E-value=0.34 Score=34.26 Aligned_cols=27 Identities=19% Similarity=0.375 Sum_probs=10.4
Q ss_pred eehhHHHHHHHHHHHHHHhhhheeccc
Q 043702 325 VAGVVTASAFFAIFAGVLIWFFSKRYK 351 (711)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~r~~ 351 (711)
|++-+++++++++++++++|++.||++
T Consensus 12 IA~gVVgGv~~v~ii~~~~~~~~RRRr 38 (44)
T 2l2t_A 12 IAAGVIGGLFILVIVGLTFAVYVRRKS 38 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEeehHHHHHHHHHHHHHHHHhhhhh
Confidence 443334333333333344444444433
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=85.98 E-value=3.5 Score=44.03 Aligned_cols=30 Identities=30% Similarity=0.366 Sum_probs=25.2
Q ss_pred CeeeccCCCCceEE------cCCCcEEEeecCCcee
Q 043702 500 QVIHRDVKTSNIML------DEGFNARLGDFGLARQ 529 (711)
Q Consensus 500 ~ivHrDlkp~NILl------d~~~~vkL~DFGla~~ 529 (711)
.++|+|+.+.|||+ +++..++++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4567799999988854
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=81.87 E-value=0.78 Score=31.42 Aligned_cols=28 Identities=21% Similarity=0.242 Sum_probs=14.7
Q ss_pred cceeehhHHHHHHHHHHHHHHhhhheec
Q 043702 322 AGAVAGVVTASAFFAIFAGVLIWFFSKR 349 (711)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r 349 (711)
.++++|++++.++.+.+++.++|++.||
T Consensus 10 ~GaIAGiVvG~v~gv~li~~l~~~~~rr 37 (38)
T 2k1k_A 10 GGEIVAVIFGLLLGAALLLGILVFRSRR 37 (38)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred CCceeeeehHHHHHHHHHHHHHHHHeec
Confidence 3567777777665444444444444333
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=81.37 E-value=0.17 Score=55.64 Aligned_cols=60 Identities=3% Similarity=0.054 Sum_probs=17.5
Q ss_pred ccceeecCCceEEEEEEeCCCCeEEEE------EEccc---CCCChhhhHHHHHHHHhcCCCCeeeeeeeee
Q 043702 384 ANRIIGHGAFGTVYKGILPQNGDIIAV------KRCSH---NSQGKDEFLSELSIIGTLRHRNLVRLQGWCH 446 (711)
Q Consensus 384 ~~~~LG~G~fg~Vy~~~~~~~~~~vav------K~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~ 446 (711)
..+.|| ||.||+|.+.....+||+ |.... ..+....+.+|..+++.++|||+++.+++..
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 345566 999999999655567888 76554 2233456888999999999999999988754
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=81.34 E-value=2.9 Score=40.63 Aligned_cols=117 Identities=13% Similarity=0.082 Sum_probs=80.1
Q ss_pred CCCCeeeeeeeeeecCeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHH-HHHhccCCCeeeccCCCCceE
Q 043702 434 RHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALA-YLHQECENQVIHRDVKTSNIM 512 (711)
Q Consensus 434 ~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~-yLH~~~~~~ivHrDlkp~NIL 512 (711)
.||.+ -..+-.+++.+.+.|+.-+++.=...+ ..++...+++++.+|+.... +++. -+|--|.|+|++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i----~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL~ 116 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI----RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENLM 116 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH----HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH----HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceEE
Confidence 47777 444446677888888876554333444 34678899999999888776 5654 477889999999
Q ss_pred EcCCCcEEEeecCCceecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccc
Q 043702 513 LDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKE 584 (711)
Q Consensus 513 ld~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~ 584 (711)
+|.++.+++.-.|+-..+.. .=+.+|-+ .-.+=|++..++.++..|+.-
T Consensus 117 f~~~~~p~i~hRGi~~~lpP-------------~e~~ee~f----------l~qyKali~all~~K~~Fe~l 165 (219)
T 4ano_A 117 FNRALEPFFLHVGVKESLPP-------------DEWDDERL----------LREVKATVLALTEGEYRFDEY 165 (219)
T ss_dssp ECTTCCEEESCCEETTTBSS-------------CSCCHHHH----------HHHHHHHHHHHTTCSSCHHHH
T ss_pred EeCCCcEEEEEcCCcccCCC-------------CCCCHHHH----------HHHHHHHHHHHHcCCCCHHHH
Confidence 99999999988776432211 11222322 235668888899998888643
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 711 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-65 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-64 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-64 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-64 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 8e-64 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-63 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-62 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-61 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-60 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-60 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-59 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-59 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-58 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-57 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-57 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-56 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-56 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-56 | |
| d1hqla_ | 236 | b.29.1.1 (A:) Legume lectin {Griffonia simplicifol | 6e-56 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-55 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-55 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-55 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-54 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-54 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-54 | |
| d1avba_ | 226 | b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar | 6e-54 | |
| d1g8wa_ | 233 | b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar | 8e-54 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-54 | |
| d1g7ya_ | 253 | b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos | 1e-53 | |
| d1leda_ | 243 | b.29.1.1 (A:) Legume lectin {West-central african | 3e-53 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-53 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-53 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-53 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-52 | |
| d1gzca_ | 239 | b.29.1.1 (A:) Legume lectin {Cockspur coral tree ( | 3e-52 | |
| d1v6ia_ | 232 | b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypog | 3e-52 | |
| g1qmo.1 | 230 | b.29.1.1 (A:,E:) Legume lectin {Field bean (Dolich | 6e-52 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-51 | |
| d1fx5a_ | 240 | b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus | 3e-51 | |
| d1g9fa_ | 251 | b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) | 4e-51 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-51 | |
| d1qnwa_ | 237 | b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus | 6e-51 | |
| d2d3sa1 | 237 | b.29.1.1 (A:1-237) Legume lectin {Winged bean (Pso | 1e-49 | |
| d1f9ka_ | 234 | b.29.1.1 (A:) Legume lectin {Winged bean (Psophoca | 2e-49 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-49 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-49 | |
| d1fnya_ | 237 | b.29.1.1 (A:) Legume lectin {Black locust (Robinia | 2e-48 | |
| g2ltn.1 | 229 | b.29.1.1 (A:,B:) Legume lectin {Garden pea (Pisum | 1e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-47 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-47 | |
| d1ukga_ | 241 | b.29.1.1 (A:) Legume lectin {Bloodwood tree (Ptero | 6e-47 | |
| d1n47a_ | 233 | b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia vi | 6e-47 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-46 | |
| d1ioaa_ | 228 | b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar | 2e-46 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-45 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-44 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-44 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-44 | |
| d1dbna_ | 239 | b.29.1.1 (A:) Legume lectin {Maackia amurensis, le | 5e-44 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-44 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-43 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-43 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-42 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-42 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-41 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-41 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-40 | |
| d1dhkb_ | 204 | b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also ar | 2e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-38 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-35 | |
| d1nlsa_ | 237 | b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia | 1e-34 | |
| d1nlsa_ | 237 | b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia | 1e-17 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-29 | |
| d1gv9a_ | 228 | b.29.1.13 (A:) Carbohydrate-recognition domain of | 1e-23 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-22 | |
| d2a6va1 | 218 | b.29.1.13 (A:9-226) Emp46p N-terminal domain {Bake | 3e-09 | |
| d2a6za1 | 221 | b.29.1.13 (A:7-227) Emp47p N-terminal domain {Bake | 9e-09 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (550), Expect = 1e-65
Identities = 60/274 (21%), Positives = 110/274 (40%), Gaps = 24/274 (8%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWC 445
+ IG G+FGTVYKG + + + + Q F +E+ ++ RH N++ G+
Sbjct: 14 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 446 HEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRD 505
++ +V SL L + I A + YLH + +IHRD
Sbjct: 74 TA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRD 129
Query: 506 VKTSNIMLDEGFNARLGDFGLARQVEHDKSPD-ATVAAGTMGYLAPEYLLT---GRATEK 561
+K++NI L E ++GDFGLA +G++ ++APE + + +
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 562 TDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQ 621
+DV+++G V+ E+ +G+ P N + + + G L
Sbjct: 190 SDVYAFGIVLYELMTGQLPYSNI-----------NNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 622 FDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655
M+R++ C RP ++ +
Sbjct: 239 PK--AMKRLM---AECLKKKRDERPLFPQILASI 267
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 3e-64
Identities = 67/271 (24%), Positives = 116/271 (42%), Gaps = 26/271 (9%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWC 445
+G G FG V+ G +AVK S D FL+E +++ L+H+ LVRL
Sbjct: 19 ERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 446 HEKGEILLVYDLMPNGSLDKALFEARS-PLPWPHRSKILLGVASALAYLHQECENQVIHR 504
+ I ++ + M NGSL L L + +A +A++ E IHR
Sbjct: 78 TQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHR 133
Query: 505 DVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDV 564
D++ +NI++ + + ++ DFGLAR +E ++ A + + APE + G T K+DV
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 565 FSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDE 624
+S+G ++ E+ + R E + +L R R++ +
Sbjct: 194 WSFGILLTEIVTHGRIPYPG----------MTNPEVIQNLERGYRMV----------RPD 233
Query: 625 AEMRRVLLVGLACSHPDPLARPTMRGVVQML 655
+ + C P RPT + +L
Sbjct: 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 3e-64
Identities = 70/274 (25%), Positives = 116/274 (42%), Gaps = 24/274 (8%)
Query: 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRL 441
+ IG G FG V+ G N D +A+K + +++F+ E ++ L H LV+L
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQL 65
Query: 442 QGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQV 501
G C E+ I LV++ M +G L L R + L V +AYL + C V
Sbjct: 66 YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 122
Query: 502 IHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEK 561
IHRD+ N ++ E ++ DFG+ R V D+ +T + + +PE R + K
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 182
Query: 562 TDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQ 621
+DV+S+G ++ EV S + + + S +VE + + R
Sbjct: 183 SDVWSFGVLMWEVFSEGKIPYENRS-------NSEVVEDISTGFRL-------------Y 222
Query: 622 FDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655
V + C P RP +++ L
Sbjct: 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 256
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 8e-64
Identities = 59/275 (21%), Positives = 111/275 (40%), Gaps = 24/275 (8%)
Query: 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRL 441
+ +G G FG V G +A+K S +DEF+ E ++ L H LV+L
Sbjct: 6 LTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 442 QGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQV 501
G C ++ I ++ + M NG L L E R ++ V A+ YL Q
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQF 121
Query: 502 IHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEK 561
+HRD+ N ++++ ++ DFGL+R V D+ + + + + PE L+ + + K
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 181
Query: 562 TDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQ 621
+D++++G ++ E+ S + + L
Sbjct: 182 SDIWAFGVLMWEIYSLGKMP--------------------YERFTNSETAEHIAQGLRLY 221
Query: 622 FDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLV 656
+V + +C H RPT + ++ ++
Sbjct: 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 212 bits (540), Expect = 8e-64
Identities = 76/317 (23%), Positives = 132/317 (41%), Gaps = 43/317 (13%)
Query: 370 FSYRELRSATK---------CFNANRIIGHGAFGTVYKGILPQNGD---IIAVKRC--SH 415
F++ + A + C ++IG G FG V G L G +A+K +
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 416 NSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLP 475
+ + +FLSE SI+G H N++ L+G + ++++ + M NGSLD L +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 476 WPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535
+L G+A+ + YL +HRD+ NI+++ ++ DFGL+R +E D S
Sbjct: 127 VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 536 PDATVAA----GTMGYLAPEYLLTGRATEKTDVFSYGAVVLE-VASGRRPIEKEITGVGK 590
+A + + APE + + T +DV+SYG V+ E ++ G RP
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM------ 237
Query: 591 VGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRG 650
+ + ++ ++ RL + + L C D RP
Sbjct: 238 -----TNQDVINAIEQDYRL----------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQ 282
Query: 651 VVQMLVGEAEVPIVPRA 667
+V L P +A
Sbjct: 283 IVNTLDKMIRNPNSLKA 299
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 210 bits (535), Expect = 3e-63
Identities = 64/290 (22%), Positives = 120/290 (41%), Gaps = 24/290 (8%)
Query: 367 PKEFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSE 426
P +Y + +G G +G VY+G+ + +AVK ++ +EFL E
Sbjct: 4 PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKE 63
Query: 427 LSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEA-RSPLPWPHRSKILLG 485
+++ ++H NLV+L G C + ++ + M G+L L E R + +
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 123
Query: 486 VASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTM 545
++SA+ YL + IHRD+ N ++ E ++ DFGL+R + D A +
Sbjct: 124 ISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 180
Query: 546 GYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLH 605
+ APE L + + K+DV+++G ++ E+A+ I
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID------------------- 221
Query: 606 REGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655
++ + + E +V + AC +P RP+ + Q
Sbjct: 222 -LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (534), Expect = 1e-62
Identities = 66/292 (22%), Positives = 123/292 (42%), Gaps = 30/292 (10%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVK--RCSHNSQGKDEFLSELSIIGTLRHRNLVRLQG 443
+G G G V+K +G ++A K +++ + EL ++ +V G
Sbjct: 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 444 WCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIH 503
+ GEI + + M GSLD+ L + +P K+ + V L YL + +++++H
Sbjct: 72 AFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMH 128
Query: 504 RDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTD 563
RDVK SNI+++ +L DFG++ Q+ + GT Y++PE L + ++D
Sbjct: 129 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPERLQGTHYSVQSD 185
Query: 564 VFSYGAVVLEVASGRRPI----EKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLE 619
++S G ++E+A GR PI KE+ + V + E GR L++
Sbjct: 186 IWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSR 245
Query: 620 GQFDEAEMRRVLLVGLA------------------CSHPDPLARPTMRGVVQ 653
E+ ++ C +P R ++ ++
Sbjct: 246 PPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 4e-61
Identities = 65/289 (22%), Positives = 111/289 (38%), Gaps = 24/289 (8%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWC 445
IG G FG V++G G+ +AVK S + +E+ LRH N++
Sbjct: 9 ESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 446 HEKG----EILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQEC---- 497
++ ++ LV D +GSL L R + K+ L AS LA+LH E
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 498 -ENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK---SPDATVAAGTMGYLAPEYL 553
+ + HRD+K+ NI++ + + D GLA + + GT Y+APE L
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 554 LT------GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHRE 607
+ ++ D+++ G V E+A + R+
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH-EDYQLPYYDLVPSDPSVEEMRK 243
Query: 608 GRLLTAADARLEGQFDEAEMRRVLL-VGLACSHPDPLARPTMRGVVQML 655
+ ++ E RV+ + C + + AR T + + L
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 6e-60
Identities = 69/290 (23%), Positives = 122/290 (42%), Gaps = 31/290 (10%)
Query: 381 CFNANRIIGHGAFGTVYKGILPQNGD----IIAVKRC--SHNSQGKDEFLSELSIIGTLR 434
C ++IG G FG VYKG+L + +A+K + + + +FL E I+G
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 435 HRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLH 494
H N++RL+G + ++++ + M NG+LDK L E +L G+A+ + YL
Sbjct: 68 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA 127
Query: 495 QECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAA--GTMGYLAPEY 552
+HRD+ NI+++ ++ DFGL+R +E D T + + + APE
Sbjct: 128 ---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184
Query: 553 LLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLT 612
+ + T +DV+S+G V+ EV + W L ++
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGER-------------------PYWELSNH-EVMK 224
Query: 613 AADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEAEVP 662
A + + + + C + RP +V +L P
Sbjct: 225 AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 7e-60
Identities = 66/277 (23%), Positives = 111/277 (40%), Gaps = 26/277 (9%)
Query: 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLV 439
+ +G G FG V+ G +A+K + + FL E ++ LRH LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 440 RLQGWCHEKGEILLVYDLMPNGSLDKALF-EARSPLPWPHRSKILLGVASALAYLHQECE 498
+L + I +V + M GSL L E L P + +AS +AY+ +
Sbjct: 76 QLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER--- 131
Query: 499 NQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRA 558
+HRD++ +NI++ E ++ DFGLAR +E ++ A + + APE L GR
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 191
Query: 559 TEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARL 618
T K+DV+S+G ++ E+ + R + +L +
Sbjct: 192 TIKSDVWSFGILLTELTTKGRVPYPGMV--------------------NREVLDQVERGY 231
Query: 619 EGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655
+ + C +P RPT + L
Sbjct: 232 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 3e-59
Identities = 76/299 (25%), Positives = 127/299 (42%), Gaps = 32/299 (10%)
Query: 366 MPKEFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQN---GDIIAVKRCSHNSQGKD- 421
+ + + + ++ + N +IG G FG VY G L N AVK + + +
Sbjct: 13 LVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV 72
Query: 422 -EFLSELSIIGTLRHRNLVRLQGWCHE-KGEILLVYDLMPNGSLDKALFEARSPLPWPHR 479
+FL+E I+ H N++ L G C +G L+V M +G L +
Sbjct: 73 SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL 132
Query: 480 SKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV---EHDKSP 536
L VA + + +HRD+ N MLDE F ++ DFGLAR + E D
Sbjct: 133 IGFGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH 189
Query: 537 DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASN 596
+ T A + ++A E L T + T K+DV+S+G ++ E+ + P ++ N
Sbjct: 190 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV----------N 239
Query: 597 LVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655
+ L + RL L+ ++ + V+ L C HP RP+ +V +
Sbjct: 240 TFDITVYLLQGRRL-------LQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRI 288
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 5e-59
Identities = 78/272 (28%), Positives = 117/272 (43%), Gaps = 32/272 (11%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWC 445
+ IG G FG V G G+ +AVK N FL+E S++ LRH NLV+L G
Sbjct: 13 QTIGKGEFGDVMLGDY--RGNKVAVKCI-KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 446 HE-KGEILLVYDLMPNGSLDKALFE-ARSPLPWPHRSKILLGVASALAYLHQECENQVIH 503
E KG + +V + M GSL L RS L K L V A+ YL N +H
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVH 126
Query: 504 RDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTD 563
RD+ N+++ E A++ DFGL ++ S + + APE L + + K+D
Sbjct: 127 RDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALREKKFSTKSD 182
Query: 564 VFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFD 623
V+S+G ++ E+ S R I ++ V +G + A D
Sbjct: 183 VWSFGILLWEIYSFGRVPYPRIP-----------LKDVVPRVEKGYKMDAPDGCPP---- 227
Query: 624 EAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655
+ V+ C H D RP+ + + L
Sbjct: 228 --AVYEVM---KNCWHLDAAMRPSFLQLREQL 254
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 4e-58
Identities = 64/290 (22%), Positives = 122/290 (42%), Gaps = 31/290 (10%)
Query: 373 RELRSATKCFN-ANRIIGHGAFGTVYKGILPQNGD--IIAVKRCSHNSQGKD--EFLSEL 427
++L A+ +G G FG+V +G+ +A+K ++ D E + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 428 SIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVA 487
I+ L + +VRL G C + ++LV ++ G L K L R +P + +++L V+
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119
Query: 488 SALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDA--TVAAGTM 545
+ YL + +HRD+ N++L A++ DFGL++ + D S + +
Sbjct: 120 MGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176
Query: 546 GYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLH 605
+ APE + + + ++DV+SYG + E S + K++ G V +
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-----------PEVMAFI 225
Query: 606 REGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655
+G+ + E+ ++ C RP V Q +
Sbjct: 226 EQGKRMECPPECPP------ELYALM---SDCWIYKWEDRPDFLTVEQRM 266
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 195 bits (497), Expect = 2e-57
Identities = 73/282 (25%), Positives = 122/282 (43%), Gaps = 36/282 (12%)
Query: 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDE----FLSELSIIGTLR 434
K F+ R IGHG+FG VY +N +++A+K+ S++ + +E + E+ + LR
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 435 HRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLH 494
H N ++ +G + LV + + D + PL + + G LAYLH
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLH 132
Query: 495 QECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLL 554
+ +IHRDVK NI+L E +LGDFG A + S GT ++APE +L
Sbjct: 133 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF-----VGTPYWMAPEVIL 184
Query: 555 T---GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLL 611
G+ K DV+S G +E+A + P+ N + ++ + +
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLF-----------NMNAMSALYHIAQNESP- 232
Query: 612 TAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653
L+ R + +C P RPT +++
Sbjct: 233 -----ALQSGHWSEYFRNFV---DSCLQKIPQDRPTSEVLLK 266
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 2e-57
Identities = 67/278 (24%), Positives = 126/278 (45%), Gaps = 32/278 (11%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDE---FLSELSIIGTLRHRNLVRLQ 442
IG G++G K +G I+ K + S + E +SE++++ L+H N+VR
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 443 GWCHEK--GEILLVYDLMPNGSLDKALFEA---RSPLPWPHRSKILLGVASALAYLHQ-- 495
++ + +V + G L + + R L +++ + AL H+
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129
Query: 496 ECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLT 555
+ + V+HRD+K +N+ LD N +LGDFGLAR + HD S A GT Y++PE +
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF-AKAFVGTPYYMSPEQMNR 188
Query: 556 GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615
EK+D++S G ++ E+ + P A + E + REG+
Sbjct: 189 MSYNEKSDIWSLGCLLYELCALMPPFT-----------AFSQKE-LAGKIREGKFR---- 232
Query: 616 ARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653
R+ ++ + E+ ++ + RP++ +++
Sbjct: 233 -RIPYRYSD-ELNEII---TRMLNLKDYHRPSVEEILE 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 2e-56
Identities = 65/272 (23%), Positives = 114/272 (41%), Gaps = 33/272 (12%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCS----HNSQGKDEFLSELSIIGTLRHRNLVRL 441
R +G G FG VY Q+ I+A+K + + + E+ I LRH N++RL
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 442 QGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQV 501
G+ H+ + L+ + P G++ + L + + + +A+AL+Y H +V
Sbjct: 72 YGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRV 127
Query: 502 IHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEK 561
IHRD+K N++L ++ DFG + + GT+ YL PE + EK
Sbjct: 128 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT---LCGTLDYLPPEMIEGRMHDEK 184
Query: 562 TDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQ 621
D++S G + E G+ P E A+ E + ++ +
Sbjct: 185 VDLWSLGVLCYEFLVGKPPFE-----------ANTYQETY-------KRISRVEFTFPDF 226
Query: 622 FDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653
E R ++ +P RP +R V++
Sbjct: 227 VTE-GARDLI---SRLLKHNPSQRPMLREVLE 254
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 2e-56
Identities = 57/237 (24%), Positives = 107/237 (45%), Gaps = 29/237 (12%)
Query: 350 YKHVKKSESFTSDIIRMPKEFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIA 409
Y+HV + + P++F + + +G GAFG VYK + + A
Sbjct: 1 YEHVTRDLN--------PEDF-WEIIG----------ELGDGAFGKVYKAQNKETSVLAA 41
Query: 410 VKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALF 468
K S + ++++ E+ I+ + H N+V+L + + + ++ + G++D +
Sbjct: 42 AKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML 101
Query: 469 EARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLAR 528
E PL + AL YLH +N++IHRD+K NI+ + +L DFG++
Sbjct: 102 ELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSA 158
Query: 529 QVEHDKSPDATVAAGTMGYLAPEYLLTGRA-----TEKTDVFSYGAVVLEVASGRRP 580
+ + GT ++APE ++ + K DV+S G ++E+A P
Sbjct: 159 KNTRTIQRRDSF-IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 214
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 191 bits (487), Expect = 2e-56
Identities = 68/305 (22%), Positives = 119/305 (39%), Gaps = 54/305 (17%)
Query: 382 FNANRIIGHGAFGTVYKGILP-----QNGDIIAVKRCSHNS--QGKDEFLSELSIIGTLR 434
R IG GAFG V++ P + ++AVK + + +F E +++
Sbjct: 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD 74
Query: 435 HRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARS---------------------- 472
+ N+V+L G C + L+++ M G L++ L
Sbjct: 75 NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 134
Query: 473 -PLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV- 530
PL + I VA+ +AYL E + +HRD+ T N ++ E ++ DFGL+R +
Sbjct: 135 PPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 531 EHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGK 590
D A + ++ PE + R T ++DV++YG V+ E+ S +
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA---- 247
Query: 591 VGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRG 650
E V R+G +L E + + C P RP+
Sbjct: 248 -------HEEVIYYVRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCS 291
Query: 651 VVQML 655
+ ++L
Sbjct: 292 IHRIL 296
|
| >d1hqla_ b.29.1.1 (A:) Legume lectin {Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]} Length = 236 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]
Score = 188 bits (479), Expect = 6e-56
Identities = 72/233 (30%), Positives = 113/233 (48%), Gaps = 13/233 (5%)
Query: 37 DFGTLTLASLKLLGDAHMNNGSVRLTRDVTVP---YDGAGKALYSKPVRFRLPGTHTPAS 93
+F + S+ GDA+ G+++L + AG+ALYS PV+ T + AS
Sbjct: 8 NFWSDVEDSIIFQGDANTTAGTLQLCKTNQYGTPLQWSAGRALYSDPVQLWDNKTESVAS 67
Query: 94 FSTFFSFSITNLNPSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAGLG----FVAVEF 149
F T F+F + + + GLAF + P V AG LGL ++ A VAVEF
Sbjct: 68 FYTEFTFFL-KITGNGPADGLAFFLAPPDSDVKDAGEYLGLFNKSTATQPSKNQVVAVEF 126
Query: 150 DTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLTRAFNIS 209
DT + F + + H+G+++NS+VS + + D+ SG + + I YDG +
Sbjct: 127 DTWTNPNFPEPSYRHIGINVNSIVSVATKRWE--DSDIFSGKIATARISYDGSAEILTVV 184
Query: 210 VSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGST-EIHSIEWWSFSSS 261
+SY ILS ++D+ Q + + + VG S ST + I W FSS+
Sbjct: 185 LSYP--DGSDYILSHSVDMRQNLPESVRVGISASTGNNQFLTVYILSWRFSSN 235
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 2e-55
Identities = 65/278 (23%), Positives = 123/278 (44%), Gaps = 32/278 (11%)
Query: 385 NRIIGHGAFGTVYKGILPQN--GDIIAVKRC---SHNSQGKDEFLSELSIIGTLRHRNLV 439
++ +G G FGTV KG +AVK +++ KDE L+E +++ L + +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 440 RLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECEN 499
R+ G C E +LV ++ G L+K L + R + + +++ V+ + YL + +
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEE---S 126
Query: 500 QVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD--ATVAAGTMGYLAPEYLLTGR 557
+HRD+ N++L A++ DFGL++ + D++ T + + APE + +
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 558 ATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADAR 617
+ K+DV+S+G ++ E S + + + G V ++ +G +
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----------SEVTAMLEKGERMGCPAGC 235
Query: 618 LEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655
EM ++ C D RP V L
Sbjct: 236 PR------EMYDLM---NLCWTYDVENRPGFAAVELRL 264
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (482), Expect = 2e-55
Identities = 68/296 (22%), Positives = 110/296 (37%), Gaps = 48/296 (16%)
Query: 386 RIIGHGAFGTVYKGILP-----QNGDIIAVKRC--SHNSQGKDEFLSELSIIGTL-RHRN 437
+ +G GAFG V + +AVK S + ++ +SEL ++ L H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 438 LVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARS-----------------PLPWPHRS 480
+V L G C G L++ + G L L R L
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 481 KILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD-AT 539
VA +A+L IHRD+ NI+L G ++ DFGLAR +++D +
Sbjct: 149 SFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 540 VAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVE 599
A + ++APE + T ++DV+SYG + E+ S
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS------------------- 246
Query: 600 WVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655
+ + + E + + C DPL RPT + +VQ++
Sbjct: 247 PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 7e-55
Identities = 66/302 (21%), Positives = 110/302 (36%), Gaps = 55/302 (18%)
Query: 386 RIIGHGAFGTVYKGILPQNGDI-----IAVKRCSH--NSQGKDEFLSELSIIGTL-RHRN 437
+++G GAFG V +AVK +S ++ +SEL ++ L H N
Sbjct: 43 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 102
Query: 438 LVRLQGWCHEKGEILLVYDLMPNGSLDKALFEAR----------------------SPLP 475
+V L G C G I L+++ G L L R + L
Sbjct: 103 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 162
Query: 476 WPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV-EHDK 534
+ VA + +L +HRD+ N+++ G ++ DFGLAR +
Sbjct: 163 FEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 219
Query: 535 SPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGV 593
A + ++APE L G T K+DV+SYG ++ E+ S G P
Sbjct: 220 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI--------- 270
Query: 594 ASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653
+ + L + G + + ++ +C D RP+ +
Sbjct: 271 --PVDANFYKLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
Query: 654 ML 655
L
Sbjct: 320 FL 321
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 5e-54
Identities = 61/277 (22%), Positives = 108/277 (38%), Gaps = 33/277 (11%)
Query: 385 NRIIGHGAFGTVYKGILPQNGDIIAVKRCSH---NSQGKDEFLSELSIIGTLRHRNLVRL 441
+ IG G+F TVYKG+ + +A + F E ++ L+H N+VR
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 442 QGWCHE----KGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQEC 497
K I+LV +LM +G+L L + + L +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRT 132
Query: 498 ENQVIHRDVKTSNIML-DEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTG 556
+IHRD+K NI + + ++GD GLA + GT ++APE
Sbjct: 133 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA---KAVIGTPEFMAPEM-YEE 187
Query: 557 RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADA 616
+ E DV+++G +LE+A+ P + A+ + V S + A
Sbjct: 188 KYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQIYRRVTSGVKPASFDKVAI- 239
Query: 617 RLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653
E++ ++ C + R +++ ++
Sbjct: 240 --------PEVKEII---EGCIRQNKDERYSIKDLLN 265
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 5e-54
Identities = 66/284 (23%), Positives = 114/284 (40%), Gaps = 33/284 (11%)
Query: 386 RIIGHGAFGTVYKGILP---QNGDIIAVKRCS----HNSQGKDEFLSELSIIGTLRHRNL 438
+G G+FG V +G +AVK + D+F+ E++ + +L HRNL
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 439 VRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECE 498
+RL G + +V +L P GSL L + + S+ + VA + YL
Sbjct: 74 IRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---S 129
Query: 499 NQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD--ATVAAGTMGYLAPEYLLTG 556
+ IHRD+ N++L ++GDFGL R + + + APE L T
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 557 RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADA 616
+ +D + +G + E+ + + + N + + + +EG L
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEPWIGL----------NGSQILHKIDKEGERL----- 234
Query: 617 RLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEAE 660
E + + V + C P RPT + L+ EA+
Sbjct: 235 ----PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL-EAQ 273
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 5e-54
Identities = 60/300 (20%), Positives = 125/300 (41%), Gaps = 41/300 (13%)
Query: 363 IIRMPKEFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVK------RCSHN 416
++R+ KE +++++ ++G GAFGTVYKG+ G+ + + R + +
Sbjct: 2 LLRILKETEFKKIK----------VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS 51
Query: 417 SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPW 476
+ E L E ++ ++ + ++ RL G C + L+ LMP G L + E + +
Sbjct: 52 PKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGS 110
Query: 477 PHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV-EHDKS 535
+ + +A + YL +++HRD+ N+++ + ++ DFGLA+ + +K
Sbjct: 111 QYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 167
Query: 536 PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVAS 595
A + ++A E +L T ++DV+SYG V E+ +
Sbjct: 168 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP-------------- 213
Query: 596 NLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655
+ + + + V ++ + C D +RP R ++
Sbjct: 214 ------YDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267
|
| >d1avba_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 226 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 182 bits (464), Expect = 6e-54
Identities = 67/236 (28%), Positives = 105/236 (44%), Gaps = 15/236 (6%)
Query: 31 STATEFDFGTLTLASLKLLGDAH-MNNGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTH 89
S F+ T +L L GDA + G + LT D G+A YS P++
Sbjct: 1 SNDASFNVETFNKTNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQINDRTID 60
Query: 90 TPASFSTFFSFSITNLNPSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAGLGFVAVEF 149
ASFST F+F I N + GLAF + P G + G LGL + +
Sbjct: 61 NLASFSTNFTFRINAKNIENSAYGLAFALVPVGSRPKLKGRYLGLFN-------TTNYDR 113
Query: 150 DTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLTRAFNIS 209
D D N + +D+NS+ ++ N +G+ I YD +S
Sbjct: 114 DAHTVAVVFDTVSNRIEIDVNSIRP---IATESCNFGHNNGEKAEVRITYDSPKNDLRVS 170
Query: 210 VSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGST---QGSTEIHSIEWWSFSSSF 262
+ Y + + +S T+ L++ V D++ VGFS ++ + +TE H++ WSFSS+F
Sbjct: 171 LLYPS-SEEKCHVSATVPLEKEVEDWVSVGFSATSGSKKETTETHNVLSWSFSSNF 225
|
| >d1g8wa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 233 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 182 bits (464), Expect = 8e-54
Identities = 79/239 (33%), Positives = 117/239 (48%), Gaps = 14/239 (5%)
Query: 31 STATEFDFGTLTLASLKLLGDAH-MNNGSVRLTRD---VTVPYDGAGKALYSKPVRFRLP 86
S F+F +L L DA ++G +RLT G+A YS P++
Sbjct: 1 SNDIYFNFQRFNETNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIWDN 60
Query: 87 GTHTPASFSTFFSFSITNLNPSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAGLGFVA 146
T T ASF+T F+F+I N + GLAF + P G Q GG LGL D + VA
Sbjct: 61 TTGTVASFATSFTFNIQVPNNAGPADGLAFALVPVGSQPKDKGGFLGLFDGSNSNFHTVA 120
Query: 147 VEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLTRAF 206
VEFDTL + ++ D H+G+D+NS+ S T D +G+ I YD T
Sbjct: 121 VEFDTLYNKDW-DPTERHIGIDVNSIRSI-----KTTRWDFVNGENAEVLITYDSSTNLL 174
Query: 207 NISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGST---QGSTEIHSIEWWSFSSSF 262
S+ Y + + I+S T+DL + +++ VGFS +T +G+ E + + WSF+S
Sbjct: 175 VASLVYPS-QKTSFIVSDTVDLKSVLPEWVSVGFSATTGINKGNVETNDVLSWSFASKL 232
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 9e-54
Identities = 66/294 (22%), Positives = 110/294 (37%), Gaps = 45/294 (15%)
Query: 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVK----RCSHNSQGKDEFLSELSIIGTL-RHR 436
+IG G FG V K + ++G + + + +F EL ++ L H
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 437 NLVRLQGWCHEKGEILLVYDLMPNGSLDKALF---------------EARSPLPWPHRSK 481
N++ L G C +G + L + P+G+L L S L
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 482 ILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVA 541
VA + YL + Q IHRD+ NI++ E + A++ DFGL+R E T+
Sbjct: 132 FAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KTMG 186
Query: 542 AGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWV 601
+ ++A E L T +DV+SYG ++ E+ S E
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC----------GMTCAELY 236
Query: 602 WSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655
L + RL + + E+ ++ C P RP+ ++ L
Sbjct: 237 EKLPQGYRLEKPLNC-------DDEVYDLM---RQCWREKPYERPSFAQILVSL 280
|
| >d1g7ya_ b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]} Length = 253 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]
Score = 183 bits (464), Expect = 1e-53
Identities = 73/260 (28%), Positives = 119/260 (45%), Gaps = 20/260 (7%)
Query: 31 STATEFDFGTLTLASLKLLGDAHMNNGSVRLTRDV---TVPYDGAGKALYSKPVRFRLPG 87
+ F F +S L GDA +++ +RLT+ G+A YS P++
Sbjct: 1 ADIQSFSFKNFNSSSFILQGDATVSSSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIYDKS 60
Query: 88 THTPASFSTFFSFSITNLNPSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAG--LGFV 145
T AS++T F+ +I N SS G+AF + P G + S G LG+ D V
Sbjct: 61 TGAVASWATSFTANIFAPNKSSSADGIAFALVPVGSEPKSNSGFLGVFDSDVYDNSAQTV 120
Query: 146 AVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLTRA 205
AVEFDT + ++ D H+G+D+NS+ S T + L +G I Y+ T
Sbjct: 121 AVEFDTFSNTDW-DPTSRHIGIDVNSIKSIR-----TASWGLANGQNAEILITYNAATSL 174
Query: 206 FNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGST---QGSTEIHSIEWWSFSSSF 262
S+ + + + I+S +D+ + +++ +GFS +T +G TE H + WSF+S
Sbjct: 175 LVASLVHPS-RRTSYIVSERVDITNELPEYVSIGFSATTGLSEGYTETHDVLSWSFASKL 233
Query: 263 ESNSGTGSGSAPPPPTASLM 282
+ P AS +
Sbjct: 234 P-----DDSTTEPLDIASYL 248
|
| >d1leda_ b.29.1.1 (A:) Legume lectin {West-central african legume (Griffonia simplicifolia) [TaxId: 3850]} Length = 243 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: West-central african legume (Griffonia simplicifolia) [TaxId: 3850]
Score = 181 bits (461), Expect = 3e-53
Identities = 70/230 (30%), Positives = 108/230 (46%), Gaps = 14/230 (6%)
Query: 44 ASLKLLGDAHMNNGSVRLTRDVTVP---YDGAGKALYSKPVRFRLPGTHTPASFSTFFSF 100
+ LGDA G+++LT+ AG+A YS+PV T ASF T F+F
Sbjct: 20 TEITFLGDATRIPGALQLTKTDANGNPVRSSAGQASYSEPVFLW-DSTGKAASFYTSFTF 78
Query: 101 SITNLNPSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAGLG----FVAVEFDTLMDVE 156
+ N + GLAF + P V GG LGL + A VAVEFDT ++ +
Sbjct: 79 LLKN-YGAPTADGLAFFLAPVDSSVKDYGGFLGLFRHETAADPSKNQVVAVEFDTWINKD 137
Query: 157 FSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLTRAFNISVSYSNLK 216
++D H+G+D+NS+VS + N D + + I YD ++ + +SY
Sbjct: 138 WNDPPYPHIGIDVNSIVSVATTRWE--NDDAYGSSIATAHITYDARSKILTVLLSYE--H 193
Query: 217 PKVPILSFTLDLDQYVNDFMYVGFSGSTQGSTEIHSIEWWSFSSSFESNS 266
+ ILS +DL + + + +GFS G E+ I W F S+ + +
Sbjct: 194 GRDYILSHVVDLAKVLPQKVRIGFSAGV-GYDEVTYILSWHFFSTLDGTN 242
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 184 bits (469), Expect = 4e-53
Identities = 63/271 (23%), Positives = 107/271 (39%), Gaps = 26/271 (9%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGW 444
+G GAFG V++ G+ A K K+ E+ + LRH LV L
Sbjct: 32 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 91
Query: 445 CHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHR 504
+ E++++Y+ M G L + + + + + + + V L ++H EN +H
Sbjct: 92 FEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHL 148
Query: 505 DVKTSNIMLDEGFNAR--LGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKT 562
D+K NIM + L DFGL ++ +S T GT + APE T
Sbjct: 149 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGKPVGYYT 206
Query: 563 DVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQF 622
D++S G + + SG P G N+ W++ + D + F
Sbjct: 207 DMWSVGVLSYILLSGLSPFG----GENDDETLRNVKSCDWNMDDSAFSGISEDGK---DF 259
Query: 623 DEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653
+R++L DP R T+ ++
Sbjct: 260 ----IRKLL-------LADPNTRMTIHQALE 279
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 5e-53
Identities = 60/272 (22%), Positives = 106/272 (38%), Gaps = 27/272 (9%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCS--HNSQGKDEFLSELSIIGTLRHRNLVRLQG 443
+ +G GA+G V + + +AVK + E+ I L H N+V+ G
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 444 WCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIH 503
E L + G L + +P P + + + + YLH + H
Sbjct: 71 HRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH---GIGITH 126
Query: 504 RDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD-ATVAAGTMGYLAPEYLLTGR-ATEK 561
RD+K N++LDE N ++ DFGLA ++ GT+ Y+APE L E
Sbjct: 127 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 186
Query: 562 TDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQ 621
DV+S G V+ + +G P ++ + +S +E + ++
Sbjct: 187 VDVWSCGIVLTAMLAGELPWDQP-----------SDSCQEYSDWKEKKTYLNPWKKI--- 232
Query: 622 FDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653
++ +L +P AR T+ + +
Sbjct: 233 --DSAPLALL---HKILVENPSARITIPDIKK 259
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 6e-53
Identities = 62/276 (22%), Positives = 113/276 (40%), Gaps = 31/276 (11%)
Query: 386 RIIGHGAFGTVYKGILPQNGD---IIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVR 440
R IG G FG V++GI + +A+K C + + +++FL E + H ++V+
Sbjct: 13 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 441 LQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQ 500
L G E + ++ +L G L L + L +++ALAYL +
Sbjct: 73 LIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKR 128
Query: 501 VIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATE 560
+HRD+ N+++ +LGDFGL+R +E A+ + ++APE + R T
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 188
Query: 561 KTDVFSYGAVVLEV-ASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLE 619
+DV+ +G + E+ G +P + + + + RL +
Sbjct: 189 ASDVWMFGVCMWEILMHGVKPFQ-----------GVKNNDVIGRIENGERL------PMP 231
Query: 620 GQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655
+ ++ C DP RP + L
Sbjct: 232 PNCPP-TLYSLM---TKCWAYDPSRRPRFTELKAQL 263
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 3e-52
Identities = 71/296 (23%), Positives = 127/296 (42%), Gaps = 40/296 (13%)
Query: 382 FNANRIIGHGAFGTVYKGILP-----QNGDIIAVKRCSHNS--QGKDEFLSELSIIGTLR 434
+R +G G+FG VY+G+ + +A+K + + + + EFL+E S++
Sbjct: 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81
Query: 435 HRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEAR---------SPLPWPHRSKILLG 485
++VRL G + L++ +LM G L L R +P ++
Sbjct: 82 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141
Query: 486 VASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV-EHDKSPDATVAAGT 544
+A +AYL N+ +HRD+ N M+ E F ++GDFG+ R + E D
Sbjct: 142 IADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 545 MGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSL 604
+ +++PE L G T +DV+S+G V+ E+A+ + ++ E V
Sbjct: 199 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-----------NEQVLRF 247
Query: 605 HREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEAE 660
EG LL D + + ++ C +P RP+ ++ + E E
Sbjct: 248 VMEGGLLDKPDNCPD------MLFELM---RMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1gzca_ b.29.1.1 (A:) Legume lectin {Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]} Length = 239 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]
Score = 178 bits (453), Expect = 3e-52
Identities = 68/236 (28%), Positives = 111/236 (47%), Gaps = 17/236 (7%)
Query: 36 FDFGTLTLASLKLLGDAH-MNNGSVRLTRDV---TVPYDGAGKALYSKPVRFRLPGTHTP 91
F +L L G A +G ++LT+ +D G+ LY+KPV T T
Sbjct: 8 FSEFEPGNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMWDSTTGTV 67
Query: 92 ASFSTFFSFSITNLNPSSIGA-GLAFVITPDGEQVGSAGGSLGLLDEKGAG--LGFVAVE 148
ASF T FSFSI + A GL F + P + G LG+ + +AVE
Sbjct: 68 ASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKPAQGYGYLGVFNNSKQDNSYQTLAVE 127
Query: 149 FDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLTRAFNI 208
FDT + + H+G+D+NS+ S + T L +G + N I+YD ++ ++
Sbjct: 128 FDTFSN-PWDPPQVPHIGIDVNSIRSIK-----TQPFQLDNGQVANVVIKYDAPSKILHV 181
Query: 209 SVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGST---QGSTEIHSIEWWSFSSS 261
+ Y + + ++ +D+ Q + D++ VG SG+T + + E H + WSF +S
Sbjct: 182 VLVYPS-SGAIYTIAEIVDVKQVLPDWVDVGLSGATGAQRDAAETHDVYSWSFQAS 236
|
| >d1v6ia_ b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3818]} Length = 232 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Peanut (Arachis hypogaea) [TaxId: 3818]
Score = 178 bits (452), Expect = 3e-52
Identities = 71/240 (29%), Positives = 119/240 (49%), Gaps = 15/240 (6%)
Query: 31 STATEFDFGTLTLA--SLKLLGDAH-MNNGSVRLTRDVTVPYDGAGKALYSKPVRFRLPG 87
+ F+F + + ++ GD ++NG+++LT V + G+ LY+ PVR
Sbjct: 1 AETVSFNFNSFSEGNPAINFQGDVTVLSNGNIQLTNLNKV--NSVGRVLYAMPVRIWSSA 58
Query: 88 THTPASFSTFFSFSITNLNPSSIGAGLAFVITPDGEQV--GSAGGSLGLLDEKGAGLGFV 145
T ASF T FSF + ++ G+ F I P+ Q+ GS GG + + FV
Sbjct: 59 TGNVASFLTSFSFEMKDIKDYDPADGIIFFIAPEDTQIPAGSIGGGTLGVSDTKGAGHFV 118
Query: 146 AVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLTRA 205
VEFDT + E++D +HVG+D+NS+ S + + SG +V + YD T+
Sbjct: 119 GVEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVPW-----NSVSGAVVKVTVIYDSSTK- 172
Query: 206 FNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGST-QGSTEIHSIEWWSFSSSFES 264
+SV+ +N + ++ +DL + + + GFS S G +IH I WSF+S+ +
Sbjct: 173 -TLSVAVTNDNGDITTIAQVVDLKAKLPERVKFGFSASGSLGGRQIHLIRSWSFTSTLIT 231
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 2e-51
Identities = 64/269 (23%), Positives = 116/269 (43%), Gaps = 26/269 (9%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCS-HNSQGKDEFLSELSIIGTLRHRNLVRLQGW 444
IG GA GTVY + G +A+++ + K+ ++E+ ++ ++ N+V
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 445 CHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHR 504
E+ +V + + GSL + + + + + AL +LH NQVIHR
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHS---NQVIHR 140
Query: 505 DVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDV 564
D+K+ NI+L + +L DFG Q+ ++S +T+ GT ++APE + K D+
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRKAYGPKVDI 199
Query: 565 FSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDE 624
+S G + +E+ G P E N + ++ + G +L
Sbjct: 200 WSLGIMAIEMIEGEPPYLNE-----------NPLRALYLIATNGTPELQNPEKL-----S 243
Query: 625 AEMRRVLLVGLACSHPDPLARPTMRGVVQ 653
A R L C D R + + ++Q
Sbjct: 244 AIFRDFL---NRCLDMDVEKRGSAKELLQ 269
|
| >d1fx5a_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-I [TaxId: 3902]} Length = 240 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Furze (Ulex europaeus), UEA-I [TaxId: 3902]
Score = 176 bits (446), Expect = 3e-51
Identities = 70/243 (28%), Positives = 110/243 (45%), Gaps = 13/243 (5%)
Query: 31 STATEFDFGTLTL--ASLKLLGDAH-MNNGSVRLTRDVT-VPYDGAGKALYSKPVRFRLP 86
S F F + L G+A + G ++L + +P + G A Y P+
Sbjct: 1 SDDLSFKFKNFSQNGKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIWNC 60
Query: 87 GTHTPASFSTFFSF-SITNLNPSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAG--LG 143
T ASF T FSF T+ NP + GL F + P + AGG GL ++
Sbjct: 61 NTGELASFITSFSFFMETSANPKAATDGLTFFLAPPDSPLRRAGGYFGLFNDTKCDSSYQ 120
Query: 144 FVAVEFDT-LMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGL 202
VAVEFDT V F D H+G+D+N + S N + N ++ N I Y+
Sbjct: 121 TVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSI---NAERWNKRYGLNNVANVEIIYEAS 177
Query: 203 TRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGST-QGSTEIHSIEWWSFSSS 261
++ S++Y + ++ +DL + + +++ VGFSGST G H + W F+S+
Sbjct: 178 SKTLTASLTYPS-DQTSISVTSIVDLKEILPEWVSVGFSGSTYIGRQATHEVLNWYFTST 236
Query: 262 FES 264
F +
Sbjct: 237 FIN 239
|
| >d1g9fa_ b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) [TaxId: 3847]} Length = 251 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Soybean (Glycine max) [TaxId: 3847]
Score = 176 bits (447), Expect = 4e-51
Identities = 69/253 (27%), Positives = 113/253 (44%), Gaps = 16/253 (6%)
Query: 31 STATEFDFGTLTL--ASLKLLGDAHMN-NGSVRLTRDV---TVPYDGAGKALYSKPVRFR 84
+ F + ++ L GDA + +G ++L + T G+ALYS P+
Sbjct: 1 AETVSFSWNKFVPKQPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIW 60
Query: 85 LPGTHTPASFSTFFSFSITNLNPSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAGLGF 144
T + ASF+ F+F+ + + GLAF + P + + G LGL +E +G
Sbjct: 61 DKETGSVASFAASFNFTFYAPDTKRLADGLAFFLAPIDTKPQTHAGYLGLFNENESGDQV 120
Query: 145 VAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLTR 204
VAVEFDT + D H+G+++NS+ S T + DL + + I YD T
Sbjct: 121 VAVEFDTFRNSW--DPPNPHIGINVNSIRSI-----KTTSWDLANNKVAKVLITYDASTS 173
Query: 205 AFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGST--EIHSIEWWSFSSSF 262
S+ Y + + ILS +DL + +++ +GFS +T E H + WSF+S+
Sbjct: 174 LLVASLVYPS-QRTSNILSDVVDLKTSLPEWVRIGFSAATGLDIPGESHDVLSWSFASNL 232
Query: 263 ESNSGTGSGSAPP 275
S
Sbjct: 233 PHASSNIDPLDLT 245
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 179 bits (454), Expect = 6e-51
Identities = 56/271 (20%), Positives = 107/271 (39%), Gaps = 26/271 (9%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCS-HNSQGKDEFLSELSIIGTLRHRNLVRLQGW 444
+G GAFG V++ + G + K + K +E+SI+ L H L+ L
Sbjct: 35 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 94
Query: 445 CHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHR 504
+K E++L+ + + G L + + + L ++H E+ ++H
Sbjct: 95 FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHL 151
Query: 505 DVKTSNIMLDEGFNAR--LGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKT 562
D+K NIM + + + DFGLA ++ D+ T T + APE + T
Sbjct: 152 DIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVDREPVGFYT 209
Query: 563 DVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQF 622
D+++ G + + SG P G + N+ W + + +A+ F
Sbjct: 210 DMWAIGVLGYVLLSGLSPFA----GEDDLETLQNVKRCDWEFDEDAFSSVSPEAK---DF 262
Query: 623 DEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653
++ +L +P R T+ ++
Sbjct: 263 ----IKNLL-------QKEPRKRLTVHDALE 282
|
| >d1qnwa_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-II [TaxId: 3902]} Length = 237 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Furze (Ulex europaeus), UEA-II [TaxId: 3902]
Score = 175 bits (444), Expect = 6e-51
Identities = 67/237 (28%), Positives = 115/237 (48%), Gaps = 16/237 (6%)
Query: 36 FDFGTLTLASLKLLGDAH-MNNGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTHTPASF 94
FD ++ GDA G +++T+ G+ALY+ P++ T ASF
Sbjct: 8 FDKFVPNQKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIWDSITGKVASF 67
Query: 95 STFFSFSITNLNPSSIGAGLAFVITPDGEQV--GSAGGSLGLLDEKGAGL--GFVAVEFD 150
+T FSF + + S GLAF + P Q+ GS+ G GL + +AVEFD
Sbjct: 68 ATSFSFVVKA-DKSDGVDGLAFFLAPANSQIPSGSSAGMFGLFSSSDSKSSNQIIAVEFD 126
Query: 151 TLMDVEF--SDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLTRAFNI 208
T + D + H+G+D+NS+ S + T+ D ++G++ + I Y T++ +
Sbjct: 127 TYFGKAYNPWDPDFKHIGIDVNSIKSIK-----TVKWDWRNGEVADVVITYRAPTKSLTV 181
Query: 209 SVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGST--EIHSIEWWSFSSSFE 263
+SY + I++ ++DL + +++ VGFSG + E H + W F+S+ E
Sbjct: 182 CLSYPS-DGTSNIITASVDLKAILPEWVSVGFSGGVGNAAEFETHDVLSWYFTSNLE 237
|
| >d2d3sa1 b.29.1.1 (A:1-237) Legume lectin {Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]} Length = 237 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]
Score = 171 bits (435), Expect = 1e-49
Identities = 79/237 (33%), Positives = 118/237 (49%), Gaps = 20/237 (8%)
Query: 36 FDFGTLTLASLKLLGDAHMN-NGSVRLTRDVTVP--YDGAGKALYSKPVRFRLPGTHTPA 92
F+ LKL DA ++ N + LT+ V ++ G+ALY+KPV+ T A
Sbjct: 7 FNQFHQNEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDSTTGNVA 66
Query: 93 SFSTFFSFSITNLNPSSIGA-GLAFVITPDGEQVGSAGGSLGLLDEKGAGLGFVAVEFDT 151
SF T FSFSI P A GL F I P Q G GG G+ + FVAVEFDT
Sbjct: 67 SFETRFSFSIRQPFPRPHPADGLVFFIAPPNTQTGEGGGYFGIYNPLSPY-PFVAVEFDT 125
Query: 152 LMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLTRAFNISVS 211
+ D H+G+D+NS++ST+ L +G + N I+YD T+ ++ +
Sbjct: 126 FRNTW--DPQIPHIGIDVNSVISTKTVPF-----TLDNGGIANVVIKYDASTKILHVVLV 178
Query: 212 YSNLKPKVPILSFTLDLDQYVNDFMYVGFSGST-------QGSTEIHSIEWWSFSSS 261
+ + + ++ +DL Q + + + VGFS +T + +TE H I WSFS+S
Sbjct: 179 FPS-LGTIYTIADIVDLKQVLPESVNVGFSAATGDPSGKQRNATETHDILSWSFSAS 234
|
| >d1f9ka_ b.29.1.1 (A:) Legume lectin {Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]} Length = 234 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]
Score = 171 bits (433), Expect = 2e-49
Identities = 74/236 (31%), Positives = 114/236 (48%), Gaps = 19/236 (8%)
Query: 36 FDFGTLTLASLKLLGDAH-MNNGSVRLTRDV---TVPYDGAGKALYSKPVRFRLPGTHTP 91
FD L L A +NG + LT+ + G+ALY++P++ T
Sbjct: 7 FDHFEENSKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWDSTTGNV 66
Query: 92 ASFSTFFSFSITNLNPSSIGA-GLAFVITPDGEQVGSAGGSLGLLDEKGAGLGFVAVEFD 150
ASF T FSF+IT A GL F + P G GG+LG+ AVEFD
Sbjct: 67 ASFETRFSFNITQPYAYPEPADGLTFFMVPPNSPQGEDGGNLGVFKPPEGD-NAFAVEFD 125
Query: 151 TLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLTRAFNISV 210
T + D H+G+D+NS+VS++ + L++G + N I+YD T+ N+ +
Sbjct: 126 TFQNTW--DPQVPHIGIDVNSIVSSKTLHF-----QLENGGVANVVIKYDSPTKILNVVL 178
Query: 211 SYSNLKPKVPILSFTLDLDQYV--NDFMYVGFSGST---QGSTEIHSIEWWSFSSS 261
++ + V LS +DL Q ++++ VG S +T + + E H I WSF+SS
Sbjct: 179 AFHS-VGTVYTLSNIVDLKQEFPNSEWVNVGLSATTGYQKNAVETHEIISWSFTSS 233
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 2e-49
Identities = 49/200 (24%), Positives = 84/200 (42%), Gaps = 9/200 (4%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCS----HNSQGKDEFLSELSIIGTLRHRNLVRL 441
+I+G G+F TV A+K E ++ L H V+L
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 442 QGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQV 501
+ ++ NG L K + + + SAL YLH +
Sbjct: 74 YFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH---GKGI 129
Query: 502 IHRDVKTSNIMLDEGFNARLGDFGLARQVEHD-KSPDATVAAGTMGYLAPEYLLTGRATE 560
IHRD+K NI+L+E + ++ DFG A+ + + K A GT Y++PE L A +
Sbjct: 130 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK 189
Query: 561 KTDVFSYGAVVLEVASGRRP 580
+D+++ G ++ ++ +G P
Sbjct: 190 SSDLWALGCIIYQLVAGLPP 209
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 3e-49
Identities = 65/296 (21%), Positives = 118/296 (39%), Gaps = 49/296 (16%)
Query: 386 RIIGHGAFGTVYKGIL-------PQNGDIIAVK--RCSHNSQGKDEFLSELSIIGTL-RH 435
+ +G GAFG V P +AVK + + + +SE+ ++ + +H
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 436 RNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSP---------------LPWPHRS 480
+N++ L G C + G + ++ + G+L + L R P L
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138
Query: 481 KILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDAT- 539
VA + YL + IHRD+ N+++ E ++ DFGLAR + H T
Sbjct: 139 SCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 540 VAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVE 599
+ ++APE L T ++DV+S+G ++ E+ + + VE
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-----------VE 244
Query: 600 WVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655
++ L +EG + + ++ C H P RPT + +V+ L
Sbjct: 245 ELFKLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1fnya_ b.29.1.1 (A:) Legume lectin {Black locust (Robinia pseudoacacia) [TaxId: 35938]} Length = 237 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Black locust (Robinia pseudoacacia) [TaxId: 35938]
Score = 168 bits (425), Expect = 2e-48
Identities = 68/241 (28%), Positives = 114/241 (47%), Gaps = 17/241 (7%)
Query: 31 STATEFDFGTLTL--ASLKLLGDAH-MNNGSVRLTRDVTVP--YDGAGKALYSKPVRFRL 85
+ + F F L GDA + G ++LT V G+ALY+ P +
Sbjct: 1 TGSLSFSFPKFAPNQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWD 60
Query: 86 PGTHTPASFSTFFSFSITNLNPSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKG--AGLG 143
T ASF T F+F I NP++ GLAF + P Q GG LG+ +
Sbjct: 61 STTGNVASFVTSFTFIIQAPNPATTADGLAFFLAPVDTQPLDLGGMLGIFKDGYFNKSNQ 120
Query: 144 FVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLT 203
VAVEFDT + ++ D G H+G+++NS+ S T+ + +G++ N +I Y+ T
Sbjct: 121 IVAVEFDTFSNGDW-DPKGRHLGINVNSIESI-----KTVPWNWTNGEVANVFISYEAST 174
Query: 204 RAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGST---QGSTEIHSIEWWSFSS 260
++ S+ Y + I+ +D+ + +++ GFS +T +G + + + WSF S
Sbjct: 175 KSLTASLVYPS-LETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGYVQTNDVLSWSFES 233
Query: 261 S 261
+
Sbjct: 234 N 234
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 1e-47
Identities = 42/197 (21%), Positives = 83/197 (42%), Gaps = 7/197 (3%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWC 445
+G G FG V++ + + K + E+SI+ RHRN++ L
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 446 HEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRD 505
E++++++ + + + + + L + V AL +LH + + H D
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFD 127
Query: 506 VKTSNIMLDEGFNAR--LGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTD 563
++ NI+ ++ + +FG ARQ++ + + Y APE + TD
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--FRLLFTAPEYYAPEVHQHDVVSTATD 185
Query: 564 VFSYGAVVLEVASGRRP 580
++S G +V + SG P
Sbjct: 186 MWSLGTLVYVLLSGINP 202
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 2e-47
Identities = 70/295 (23%), Positives = 115/295 (38%), Gaps = 47/295 (15%)
Query: 386 RIIGHGAFGTVYKGILP-----QNGDIIAVKRCSHNS--QGKDEFLSELSIIG-TLRHRN 437
+ +G GAFG V + +AVK + +SEL I+ H N
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 438 LVRLQGWCHEKGE-ILLVYDLMPNGSLDKALFE---------------ARSPLPWPHRSK 481
+V L G C + G ++++ + G+L L + L H
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 482 ILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP-DATV 540
VA + +L + IHRD+ NI+L E ++ DFGLAR + D
Sbjct: 139 YSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195
Query: 541 AAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEW 600
A + ++APE + T ++DV+S+G ++ E+ S + + E
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV----------KIDEE 245
Query: 601 VWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655
+EG + A D + EM + + L C H +P RPT +V+ L
Sbjct: 246 FCRRLKEGTRMRAPD------YTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 291
|
| >d1ukga_ b.29.1.1 (A:) Legume lectin {Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]} Length = 241 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]
Score = 164 bits (416), Expect = 6e-47
Identities = 58/233 (24%), Positives = 106/233 (45%), Gaps = 17/233 (7%)
Query: 44 ASLKLLGDAHMNNGSVRLTRDVTVP---YDGAGKALYSKPVRFRLPGTHTPASFSTFFSF 100
+L GDA + N +V+LT+ + G+ L+S V + A+F + FSF
Sbjct: 16 KNLIFQGDAQIKNNAVQLTKTDSNGNPVASTVGRILFSAQVHLWEKSSSRVANFQSQFSF 75
Query: 101 SITNLNPSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAGLG-----FVAVEFDTLMDV 155
S+ + + F+ PD +GG L L G +AVEFDT
Sbjct: 76 SLKSPLSNGADGIAFFIAPPDTTIPSGSGGGLLGLFAPGTAQNTSANQVIAVEFDTFYAQ 135
Query: 156 EFSDI--NGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLTRAFNISVSYS 213
+ + N H+G+D+NS+ S + D + G +N + ++ TR ++ +YS
Sbjct: 136 DSNTWDPNYPHIGIDVNSIRSVKTVKWD-----RRDGQSLNVLVTFNPSTRNLDVVATYS 190
Query: 214 NLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGSTEIHSIEWWSFSSSFESNS 266
+S+ +D+ + +++ VGFS ++ + H++E WSF+S+ +
Sbjct: 191 --DGTRYEVSYEVDVRSVLPEWVRVGFSAASGEQYQTHTLESWSFTSTLLYTA 241
|
| >d1n47a_ b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]} Length = 233 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]
Score = 164 bits (415), Expect = 6e-47
Identities = 68/240 (28%), Positives = 105/240 (43%), Gaps = 16/240 (6%)
Query: 31 STATEFDFGTLTL--ASLKLLGDAH-MNNGSVRLTRDVT--VPYDGAGKALYSKPVRFRL 85
+ +T F F +L L DA + G++ LT D G+ALY+ P+
Sbjct: 1 TESTSFSFTNFNPNQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIH- 59
Query: 86 PGTHTPASFSTFFSFSITNLNPSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAGLGFV 145
T ASF+T FSF + +++ GLAF + P Q + GG LGL ++ +
Sbjct: 60 -DNTTLASFTTSFSFVMAAPAAAAVADGLAFFLAPPDTQPQARGGFLGLFADRAHDASYQ 118
Query: 146 AVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLTRA 205
V + D N H+G+D N + S + T D+ G+ N I Y T+A
Sbjct: 119 TVAVEFDTYSNAWDPNYTHIGIDTNGIESKK-----TTPFDMVYGEKANIVITYQASTKA 173
Query: 206 FNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGST---QGSTEIHSIEWWSFSSSF 262
S+ + +S +DL + +++ VGFS +T G E H I WSF+ S
Sbjct: 174 LAASLVFPV-SQTSYAVSARVDLRDILPEYVRVGFSATTGLNAGVVETHDIVSWSFAVSL 232
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 167 bits (423), Expect = 2e-46
Identities = 61/211 (28%), Positives = 92/211 (43%), Gaps = 15/211 (7%)
Query: 382 FNANRIIGHGAFGTVYKGILPQNGDIIAVKRCS----HNSQGKDEFLSE---LSIIGTLR 434
F+ +RIIG G FG VY G + A+K QG+ L+E LS++ T
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 435 HRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLH 494
+V + H ++ + DLM G L L + + L ++H
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMH 124
Query: 495 QECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLL 554
V++RD+K +NI+LDE + R+ D GLA K + GT GY+APE L
Sbjct: 125 N---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HASVGTHGYMAPEVLQ 178
Query: 555 TGRA-TEKTDVFSYGAVVLEVASGRRPIEKE 584
G A D FS G ++ ++ G P +
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 209
|
| >d1ioaa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]} Length = 228 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]
Score = 162 bits (410), Expect = 2e-46
Identities = 59/241 (24%), Positives = 101/241 (41%), Gaps = 21/241 (8%)
Query: 31 STATEFDF-GTLTLASLKLLGDAH-MNNGSVRLTRDVT---VPYDGAGKALYSKPVRFRL 85
+T T F+F T L L G+A + G ++LT + D G+A YS P++ +
Sbjct: 1 ATETSFNFPNFHTDDKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIK- 59
Query: 86 PGTHTPASFSTFFSFSITNLNPSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAGLGFV 145
++ ASF+T F+F I N S GLAF + P LG+ +
Sbjct: 60 -DSNNVASFNTNFTFIIRAKNQSISAYGLAFALVPVNSPPQKKQEFLGIFNTNNPEPNAR 118
Query: 146 AVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLTRA 205
V D + N + +N + +G+ + I YD
Sbjct: 119 TVAVVFNTFKNRIDFDKNFIKPYVNE----------NCDFHKYNGEKTDVQITYDSSNND 168
Query: 206 FNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGST---QGSTEIHSIEWWSFSSSF 262
+ + ++ +S T+ L++ V++++ VGFS ++ + +TE H + WSFSS F
Sbjct: 169 LRVFLHFTV-SQVKCSVSATVHLEKEVDEWVSVGFSPTSGLTEDTTETHDVLSWSFSSKF 227
Query: 263 E 263
Sbjct: 228 R 228
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (407), Expect = 7e-45
Identities = 51/218 (23%), Positives = 97/218 (44%), Gaps = 11/218 (5%)
Query: 372 YRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDE--FLSELSI 429
+++ ++ ++G GAF V + ++A+K + + E +E+++
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 430 IGTLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASA 489
+ ++H N+V L G + L+ L+ G L + E + S+++ V A
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDA 119
Query: 490 LAYLHQECENQVIHRDVKTSNIML---DEGFNARLGDFGLARQVEHDKSPDATVAAGTMG 546
+ YL + ++HRD+K N++ DE + DFGL++ D + A GT G
Sbjct: 120 VKYL---HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTPG 174
Query: 547 YLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKE 584
Y+APE L ++ D +S G + + G P E
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE 212
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 159 bits (402), Expect = 1e-44
Identities = 54/212 (25%), Positives = 90/212 (42%), Gaps = 23/212 (10%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQG----------KDEFLSELSIIGTLR- 434
I+G G V + I AVK G ++ L E+ I+ +
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 435 HRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLH 494
H N+++L+ LV+DLM G L L + L KI+ + + LH
Sbjct: 69 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRALLEVICALH 127
Query: 495 QECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLL 554
+ ++HRD+K NI+LD+ N +L DFG + Q++ + GT YLAPE +
Sbjct: 128 ---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPSYLAPEIIE 182
Query: 555 TGRA------TEKTDVFSYGAVVLEVASGRRP 580
++ D++S G ++ + +G P
Sbjct: 183 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 3e-44
Identities = 42/200 (21%), Positives = 83/200 (41%), Gaps = 10/200 (5%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDE----FLSELSIIG-TLRHRNLVR 440
+++G G+FG V+ + A+K + D+ + E ++ H L
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 441 LQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQ 500
+ K + V + + G L + + + L +L
Sbjct: 68 MFCTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFL---HSKG 123
Query: 501 VIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATE 560
+++RD+K NI+LD+ + ++ DFG+ ++ + T GT Y+APE LL +
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF-CGTPDYIAPEILLGQKYNH 182
Query: 561 KTDVFSYGAVVLEVASGRRP 580
D +S+G ++ E+ G+ P
Sbjct: 183 SVDWWSFGVLLYEMLIGQSP 202
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 157 bits (399), Expect = 3e-44
Identities = 58/282 (20%), Positives = 101/282 (35%), Gaps = 33/282 (11%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDE----FLSELSIIGTLRHRNLVRL 441
I+G G V+ + +AVK + F E L H +V +
Sbjct: 13 EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 72
Query: 442 QGWCHEKGE----ILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQEC 497
+ +V + + +L + P+ +++ AL +
Sbjct: 73 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFS---H 128
Query: 498 ENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD--ATVAAGTMGYLAPEYLLT 555
+N +IHRDVK +NIM+ ++ DFG+AR + + GT YL+PE
Sbjct: 129 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 188
Query: 556 GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615
++DV+S G V+ EV +G P + + V + RE + +A
Sbjct: 189 DSVDARSDVYSLGCVLYEVLTGEPPFTGD-----------SPVSVAYQHVREDPIPPSAR 237
Query: 616 ARLEGQFDEAEMRRVLLVGLACSHPDPLARP-TMRGVVQMLV 656
++ V+ L +P R T + LV
Sbjct: 238 HE---GLSA-DLDAVV---LKALAKNPENRYQTAAEMRADLV 272
|
| >d1dbna_ b.29.1.1 (A:) Legume lectin {Maackia amurensis, leukoagglutinin [TaxId: 37501]} Length = 239 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Maackia amurensis, leukoagglutinin [TaxId: 37501]
Score = 156 bits (395), Expect = 5e-44
Identities = 69/237 (29%), Positives = 110/237 (46%), Gaps = 17/237 (7%)
Query: 36 FDFGTLTLASLKLLGDAH-MNNGSVRLTRDV--TVPYDGAGKALYSKPVRFRLPGTHTPA 92
+ A L G+A + G ++LT+ G+ALY+ PVR T + A
Sbjct: 8 INNFVPNEADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIWGNTTGSVA 67
Query: 93 SFSTFFSFSITNLNPSSIGAGLAFVITPDGEQVG--SAGGSLGLLDEKGAGL--GFVAVE 148
SFST F+F + NP GLAF + P Q+ S LGL + + VAVE
Sbjct: 68 SFSTSFTFVVKAPNPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSNSDSSNQIVAVE 127
Query: 149 FDTLMDVEFS--DINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLTRAF 206
FDT + D N H+G+D+N + S + T+ D +G + + I Y +
Sbjct: 128 FDTYFAHSYDPWDPNYRHIGIDVNGIESIK-----TVQWDWINGGVAFATITYLAPNKTL 182
Query: 207 NISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGST--EIHSIEWWSFSSS 261
S+ Y + ++ ++DL + + +++ VGFS +T T E H + WSF+S+
Sbjct: 183 IASLVYPS-NQTTFSVAASVDLKEILPEWVRVGFSAATGYPTEVETHDVLSWSFTST 238
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 6e-44
Identities = 57/330 (17%), Positives = 120/330 (36%), Gaps = 39/330 (11%)
Query: 385 NRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGW 444
++++G G G V + + + A+K + + E + ++VR+
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRA---SQCPHIVRIVDV 73
Query: 445 CH----EKGEILLVYDLMPNGSLDKALFEARS-PLPWPHRSKILLGVASALAYLHQECEN 499
+ +L+V + + G L + + S+I+ + A+ YLH
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SI 130
Query: 500 QVIHRDVKTSNIMLDEGFN---ARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTG 556
+ HRDVK N++ +L DFG A++ S T Y+APE L
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC--YTPYYVAPEVLGPE 188
Query: 557 RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADA 616
+ + D++S G ++ + G P +++ + + R+
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFY-----------SNHGLAISPGMKTRIRMGQYEFP 237
Query: 617 RLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM--LVGEAEVPIVPRAKPSMTFS 674
E E++ ++ +P R T+ + ++ +VP P
Sbjct: 238 NPEWSEVSEEVKMLI---RNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP-------LH 287
Query: 675 TSHLLLSLQDSVSDCNGMITLSSSSSENDF 704
TS +L ++ D +T + ++ D+
Sbjct: 288 TSRVLKEDKERWEDVKEEMTSALATMRVDY 317
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (395), Expect = 2e-43
Identities = 51/281 (18%), Positives = 97/281 (34%), Gaps = 31/281 (11%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWC 445
R IG G+FG +Y G G+ +A+K ++ + E I ++ + WC
Sbjct: 13 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 446 HEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRD 505
+G+ ++ + SL+ + + S + Y+H IHRD
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRD 128
Query: 506 VKTSNIM---LDEGFNARLGDFGLARQVEHDKS------PDATVAAGTMGYLAPEYLLTG 556
VK N + +G + DFGLA++ ++ + GT Y + L
Sbjct: 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI 188
Query: 557 RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADA 616
+ + D+ S G V++ G P + + + E ++ T +
Sbjct: 189 EQSRRDDLESLGYVLMYFNLGSLPWQGLK---------AATKRQKYERISEKKMSTPIEV 239
Query: 617 RLEGQFDEAE--MRRVLLVGLACSHPDPLARPTMRGVVQML 655
+G E + C +P + Q+
Sbjct: 240 LCKGYPSEFATYLNF-------CRSLRFDDKPDYSYLRQLF 273
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 4e-43
Identities = 64/224 (28%), Positives = 108/224 (48%), Gaps = 28/224 (12%)
Query: 367 PKEFSYRELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSE 426
P+E SY + + +IG+G+FG VY+ L +G+++A+K+ + K E
Sbjct: 17 PQEVSYTDTK----------VIGNGSFGVVYQAKLCDSGELVAIKKVLQD---KRFKNRE 63
Query: 427 LSIIGTLRHRNLVRLQGWCHEKGE------ILLVYDLMPNGSLDKALF--EARSPLPWPH 478
L I+ L H N+VRL+ + + GE + LV D +P A A+ LP +
Sbjct: 64 LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY 123
Query: 479 RSKILLGVASALAYLHQECENQVIHRDVKTSNIMLD-EGFNARLGDFGLARQVEHDKSPD 537
+ + +LAY+H + HRD+K N++LD + +L DFG A+Q+ +
Sbjct: 124 VKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 180
Query: 538 ATVAAGTMGYLAPEYLLTGRA-TEKTDVFSYGAVVLEVASGRRP 580
+ + + Y APE + T DV+S G V+ E+ G+
Sbjct: 181 SYI--CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 154 bits (390), Expect = 2e-42
Identities = 53/199 (26%), Positives = 88/199 (44%), Gaps = 12/199 (6%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS----QGKDEFLSELSIIGTLRHRNLVRL 441
R +G G+FG V+ NG A+K + + E ++ + H ++R+
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 442 QGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQV 501
G + +I ++ D + G L L P P V AL YLH +
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFS-LLRKSQRFPNPVAKFYAAEVCLALEYLH---SKDI 125
Query: 502 IHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEK 561
I+RD+K NI+LD+ + ++ DFG A+ V GT Y+APE + T +
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPEVVSTKPYNKS 181
Query: 562 TDVFSYGAVVLEVASGRRP 580
D +S+G ++ E+ +G P
Sbjct: 182 IDWWSFGILIYEMLAGYTP 200
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 2e-42
Identities = 67/283 (23%), Positives = 112/283 (39%), Gaps = 20/283 (7%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDE------FLSELSIIGTLRHRNLV 439
+G G F TVYK I+A+K+ + + + L E+ ++ L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 440 RLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECEN 499
L K I LV+D M + + L H +L L YLH ++
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVI-IKDNSLVLTPSHIKAYMLMTLQGLEYLH---QH 119
Query: 500 QVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRA- 558
++HRD+K +N++LDE +L DFGLA+ T T Y APE L R
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY-THQVVTRWYRAPELLFGARMY 178
Query: 559 TEKTDVFSYGAVVLEVASGRRPIEKE-----ITGVGKVGVASNLVEW--VWSLHREGRLL 611
D+++ G ++ E+ + + +T + + +W + SL
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 612 TAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654
+ L F A + L+ +P AR T ++M
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLI-QGLFLFNPCARITATQALKM 280
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 4e-42
Identities = 52/279 (18%), Positives = 96/279 (34%), Gaps = 15/279 (5%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRC---SHNSQGKDEFLSELSIIGTLRHRNLVRLQ 442
IG G +G VYK G+++A+K+ + + E+S++ L H N+V+L
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 443 GWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVI 502
H + ++ LV++ + A + +P P L + LA+ ++V+
Sbjct: 68 DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC---HSHRVL 124
Query: 503 HRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKT 562
HRD+K N++++ +L DFGLAR L +
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 184
Query: 563 DVFSYGAVVLEVASGRRP--------IEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614
D++S G + E+ + R I + A
Sbjct: 185 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 244
Query: 615 DARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653
+ L+ H DP R + + +
Sbjct: 245 RQDFSKVVPPLDEDGRSLL-SQMLHYDPNKRISAKAALA 282
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 4e-41
Identities = 44/210 (20%), Positives = 77/210 (36%), Gaps = 17/210 (8%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDE-------FLSELSIIGTLR--HR 436
++G G FG+VY GI + +A+K + E+ ++ +
Sbjct: 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 437 NLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQE 496
++RL W +L+ + R L V A+ +
Sbjct: 70 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC--- 126
Query: 497 CENQVIHRDVKTSNIMLD-EGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLT 555
V+HRD+K NI++D +L DFG ++ T GT Y PE++
Sbjct: 127 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRY 183
Query: 556 GRA-TEKTDVFSYGAVVLEVASGRRPIEKE 584
R V+S G ++ ++ G P E +
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 7e-41
Identities = 62/285 (21%), Positives = 109/285 (38%), Gaps = 22/285 (7%)
Query: 386 RIIGHGAFGTVYKGI-LPQNGDIIAVKRCSHNSQGKDEFLS------ELSIIGTLRHRNL 438
IG GA+G V+K L G +A+KR + + LS L + T H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 439 VRLQGWCH-----EKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYL 493
VRL C + ++ LV++ + +P ++ + L +L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 494 HQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYL 553
H ++V+HRD+K NI++ +L DFGLAR + + V T+ Y APE L
Sbjct: 133 H---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV--VTLWYRAPEVL 187
Query: 554 LTGRATEKTDVFSYGAVVLEVASGRRP-----IEKEITGVGKVGVASNLVEWVWSLHREG 608
L D++S G + E+ + ++ + V +W +
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 247
Query: 609 RLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653
+ + A+ +F + L C +P R + +
Sbjct: 248 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 1e-40
Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 10/202 (4%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCS--HNSQGKDEFLSELSIIGTLRHRNLVRLQG 443
IG GA+G V N +A+K+ S + L E+ I+ RH N++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 444 WCHEKGEILLVYDLMPNGSLDKALFE--ARSPLPWPHRSKILLGVASALAYLHQECENQV 501
+ + + L++ L H L + L Y+H V
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANV 130
Query: 502 IHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDA--TVAAGTMGYLAPEYLLTGRA- 558
+HRD+K SN++L+ + ++ DFGLAR + D T T Y APE +L +
Sbjct: 131 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 190
Query: 559 TEKTDVFSYGAVVLEVASGRRP 580
T+ D++S G ++ E+ S R
Sbjct: 191 TKSIDIWSVGCILAEMLSNRPI 212
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 1e-40
Identities = 64/279 (22%), Positives = 113/279 (40%), Gaps = 35/279 (12%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRC-------SHNSQGKDEFLSELSIIGTLRHRNL 438
+G G F V K G A K S +++ E+SI+ ++H N+
Sbjct: 16 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 439 VRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECE 498
+ L K +++L+ +L+ G L L E + L ++ L + + ++
Sbjct: 76 ITLHEVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNG---VYYLHS 131
Query: 499 NQVIHRDVKTSNIMLDE----GFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLL 554
Q+ H D+K NIML + ++ DFGLA +++ GT ++APE +
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--GTPEFVAPEIVN 189
Query: 555 TGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614
+ D++S G + + SG P G K +N+ + E T+A
Sbjct: 190 YEPLGLEADMWSIGVITYILLSGASPFL----GDTKQETLANVSAVNYEFEDEYFSNTSA 245
Query: 615 DARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653
A+ F +RR+L DP R T++ +Q
Sbjct: 246 LAK---DF----IRRLL-------VKDPKKRMTIQDSLQ 270
|
| >d1dhkb_ b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 204 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 145 bits (366), Expect = 2e-40
Identities = 67/236 (28%), Positives = 105/236 (44%), Gaps = 36/236 (15%)
Query: 31 STATEFDFGTLTLASLKLLGDAHMN-NGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTH 89
+T T F +L L GDA ++ NG+++L+ + YD +A YS P++ R T
Sbjct: 1 ATETSFIIDAFNKTNLILQGDATVSSNGNLQLSYN---SYDSMSRAFYSAPIQIRDSTTG 57
Query: 90 TPASFSTFFSFSITNLNPSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAGLGFVAVEF 149
ASF T F+ +I ++ GL FV+ P + V VEF
Sbjct: 58 NVASFDTNFTMNIRTHRQANSAVGLDFVLVPVQPESKG---------------DTVTVEF 102
Query: 150 DTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLTRAFNIS 209
DT + D+N N + +V G I Y+ T+ F++S
Sbjct: 103 DTFLSRISIDVNNNDI-------------KSVPWDVHDYDGQNAEVRITYNSSTKVFSVS 149
Query: 210 VSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGST---QGSTEIHSIEWWSFSSSF 262
+S + K +S T++L++ V D++ VGFS ++ Q S E H + WSFSS F
Sbjct: 150 LSNPS-TGKSNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHDVLSWSFSSKF 204
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 143 bits (361), Expect = 6e-39
Identities = 58/278 (20%), Positives = 110/278 (39%), Gaps = 15/278 (5%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRC---SHNSQGKDEFLSELSIIGTLRHRNLVRLQ 442
IG G +G VYK G+ A+K+ + + E+SI+ L+H N+V+L
Sbjct: 8 EKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 443 GWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVI 502
H K ++LV++ + + L K L L LL + + +AY H + +V+
Sbjct: 67 DVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVL 122
Query: 503 HRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKT 562
HRD+K N++++ ++ DFGLAR + + + +
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTI 182
Query: 563 DVFSYGAVVLEVASGRRP-----IEKEITGVGKVGVASNLVEW--VWSLHREGRLLTAAD 615
D++S G + E+ +G ++ + ++ N W V L + T +
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242
Query: 616 ARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653
F + + + DP R T + ++
Sbjct: 243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 3e-38
Identities = 48/199 (24%), Positives = 75/199 (37%), Gaps = 9/199 (4%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDE----FLSELSIIGTLRHRNLVRL 441
+++G G FG V G A+K + ++E ++ RH L L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 442 QGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQV 501
+ + V + G L L + SAL V
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSAL---EYLHSRDV 126
Query: 502 IHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEK 561
++RD+K N+MLD+ + ++ DFGL ++ D + GT YLAPE L
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEVLEDNDYGRA 185
Query: 562 TDVFSYGAVVLEVASGRRP 580
D + G V+ E+ GR P
Sbjct: 186 VDWWGLGVVMYEMMCGRLP 204
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 143 bits (360), Expect = 4e-38
Identities = 47/199 (23%), Positives = 88/199 (44%), Gaps = 12/199 (6%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDE----FLSELSIIGTLRHRNLVRL 441
+ +G G+FG V ++G+ A+K K + L+E I+ + LV+L
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 442 QGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQV 501
+ + + +V + + G + L PH + YLH +
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLH---SLDL 162
Query: 502 IHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEK 561
I+RD+K N+++D+ ++ DFG A++V+ GT LAPE +L+ +
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT----WTLCGTPEALAPEIILSKGYNKA 218
Query: 562 TDVFSYGAVVLEVASGRRP 580
D ++ G ++ E+A+G P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 140 bits (353), Expect = 9e-38
Identities = 44/282 (15%), Positives = 88/282 (31%), Gaps = 31/282 (10%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRN-LVRLQGW 444
R IG G+FG +++G N +A+K S + E L + + +
Sbjct: 11 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-APQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 445 CHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHR 504
E +LV DL+ D L + + + + +H+ +++R
Sbjct: 70 GQEGLHNVLVIDLLGPSLED-LLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYR 125
Query: 505 DVKTSNIMLDEGF-----NARLGDFGLARQV------EHDKSPDATVAAGTMGYLAPEYL 553
D+K N ++ + DFG+ + +H + +GT Y++
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185
Query: 554 LTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTA 613
L + + D+ + G V + G P + R G +
Sbjct: 186 LGREQSRRDDLEALGHVFMYFLRGSLPWQ-----------GLKAATNKQKYERIGEKKQS 234
Query: 614 ADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQML 655
R E + + + A P + +
Sbjct: 235 TPLRELCAGFPEEFYKYM---HYARNLAFDATPDYDYLQGLF 273
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 4e-37
Identities = 51/210 (24%), Positives = 88/210 (41%), Gaps = 19/210 (9%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKD---EFLSELSIIGTLRHRNLVRLQ 442
IG G FG V+K + G +A+K+ ++ + L E+ I+ L+H N+V L
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 443 GWCHE--------KGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLH 494
C KG I LV+D + +++ + + L Y+
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYI- 133
Query: 495 QECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVA---AGTMGYLAPE 551
N+++HRD+K +N+++ +L DFGLAR K+ T+ Y PE
Sbjct: 134 --HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191
Query: 552 YLLTGRA-TEKTDVFSYGAVVLEVASGRRP 580
LL R D++ G ++ E+ +
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPI 221
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 5e-36
Identities = 53/280 (18%), Positives = 97/280 (34%), Gaps = 17/280 (6%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRC---SHNSQGKDEFLSELSIIGTLRHRNLVRLQ 442
IG G +GTV+K + +I+A+KR + L E+ ++ L+H+N+VRL
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 443 GWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVI 502
H ++ LV++ L L + L + H V+
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYF-DSCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVL 123
Query: 503 HRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKT 562
HRD+K N++++ +L +FGLAR + +
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 183
Query: 563 DVFSYGAVVLEVASGRRPIE---------KEITGVGKVGVASNLVEWVWSLHREGRLLTA 613
D++S G + E+A+ RP+ K I + + +
Sbjct: 184 DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYP 243
Query: 614 ADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653
A L + L+ +P+ R + +Q
Sbjct: 244 ATTSLVNVVPKLNATGRDLL-QNLLKCNPVQRISAEEALQ 282
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 2e-35
Identities = 50/205 (24%), Positives = 87/205 (42%), Gaps = 20/205 (9%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKD---EFLSELSIIGTLRHRNLVRLQ 442
+ +G GA+G V + + G +A+K+ Q + EL ++ +RH N++ L
Sbjct: 24 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 83
Query: 443 GWCHEKG------EILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQE 496
+ LV M L ++ + L Y+H
Sbjct: 84 DVFTPDETLDDFTDFYLVMPFMGTDLGK---LMKHEKLGEDRIQFLVYQMLKGLRYIH-- 138
Query: 497 CENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLL-T 555
+IHRD+K N+ ++E ++ DFGLARQ + + T T Y APE +L
Sbjct: 139 -AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS----EMTGYVVTRWYRAPEVILNW 193
Query: 556 GRATEKTDVFSYGAVVLEVASGRRP 580
R T+ D++S G ++ E+ +G+
Sbjct: 194 MRYTQTVDIWSVGCIMAEMITGKTL 218
|
| >d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} Length = 237 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Concanavalin A species: Jack bean (Canavalia ensiformis) [TaxId: 3823]
Score = 129 bits (326), Expect = 1e-34
Identities = 37/130 (28%), Positives = 68/130 (52%), Gaps = 7/130 (5%)
Query: 144 FVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLT 203
VAVE DT + + D + H+G+D+ S+ S + T ++++G + + I Y+ +
Sbjct: 4 IVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKK-----TAKWNMQNGKVGTAHIIYNSVD 58
Query: 204 RAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGSTEIHSIEWWSFSSSFE 263
+ + VSY +S+ +DLD + +++ VG S ST E ++I WSF+S +
Sbjct: 59 KRLSAVVSYP--NADSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSKLK 116
Query: 264 SNSGTGSGSA 273
SNS + +
Sbjct: 117 SNSTHETNAL 126
|
| >d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} Length = 237 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Concanavalin A species: Jack bean (Canavalia ensiformis) [TaxId: 3823]
Score = 80.7 bits (199), Expect = 1e-17
Identities = 33/124 (26%), Positives = 51/124 (41%), Gaps = 8/124 (6%)
Query: 21 FVINNAVITISTATEFDFGTLTLASLKLLGDAHMN-NGSVRLTRD---VTVPYDGAGKAL 76
N+ T + F+ + L L GDA +G++ LTR + G+AL
Sbjct: 115 LKSNSTHETNALHFMFNQFSKDQKDLILQGDATTGTDGNLELTRVSSNGSPQGSSVGRAL 174
Query: 77 YSKPVRFRLPGTHTPASFSTFFSFSITNLNPSSIGAGLAFVITPDGEQV--GSAGGSLGL 134
+ PV + ASF F+F I + + G+AF I+ + GS G LGL
Sbjct: 175 FYAPVHIW-ESSAVVASFEATFTFLIKSPDSHP-ADGIAFFISNIDSSIPSGSTGRLLGL 232
Query: 135 LDEK 138
+
Sbjct: 233 FPDA 236
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 8e-34
Identities = 55/229 (24%), Positives = 102/229 (44%), Gaps = 25/229 (10%)
Query: 373 RELRSATKCFNANRI----------IGHGAFGTVYKG---ILPQNGDIIAVK-----RCS 414
ELR+A +A ++ +G GA+G V+ G + A+K
Sbjct: 7 HELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIV 66
Query: 415 HNSQGKDEFLSELSIIGTLRHR-NLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSP 473
++ + +E ++ +R LV L + ++ L+ D + G L L + R
Sbjct: 67 QKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ-RER 125
Query: 474 LPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHD 533
+ + AL +LH + +I+RD+K NI+LD + L DFGL+++ D
Sbjct: 126 FTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 182
Query: 534 KSPDATVAAGTMGYLAPEYLLTGRA--TEKTDVFSYGAVVLEVASGRRP 580
++ A GT+ Y+AP+ + G + + D +S G ++ E+ +G P
Sbjct: 183 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 128 bits (321), Expect = 4e-33
Identities = 46/201 (22%), Positives = 81/201 (40%), Gaps = 16/201 (7%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLR-HRNLVRLQGW 444
R +G G + V++ I N + + VK K + E+ I+ LR N++ L
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADI 98
Query: 445 CHEKGE--ILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVI 502
+ LV++ + N + L + + AL Y H ++
Sbjct: 99 VKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHS---MGIM 151
Query: 503 HRDVKTSNIMLD-EGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRA-TE 560
HRDVK N+M+D E RL D+GLA + + V + + PE L+ +
Sbjct: 152 HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV--ASRYFKGPELLVDYQMYDY 209
Query: 561 KTDVFSYGAVVLEVASGRRPI 581
D++S G ++ + + P
Sbjct: 210 SLDMWSLGCMLASMIFRKEPF 230
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 2e-32
Identities = 52/204 (25%), Positives = 83/204 (40%), Gaps = 18/204 (8%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCS---HNSQGKDEFLSELSIIGTLRHRNLVRLQ 442
+ IG GA G V +A+K+ S N EL ++ + H+N++ L
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 443 GWCH------EKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQE 496
E ++ LV +LM + L S +L + + +LH
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQV----IQMELDHERMSYLLYQMLCGIKHLHSA 138
Query: 497 CENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTG 556
+IHRD+K SNI++ ++ DFGLAR S T T Y APE +L
Sbjct: 139 G---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGM 193
Query: 557 RATEKTDVFSYGAVVLEVASGRRP 580
E D++S G ++ E+ +
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 2e-30
Identities = 47/201 (23%), Positives = 81/201 (40%), Gaps = 12/201 (5%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDE---FLSELSIIGTLRHRNLVRLQ 442
+G GA+G+V + G +AVK+ S Q EL ++ ++H N++ L
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 443 GWCHEKG---EILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECEN 499
E VY + D L H ++ + L Y+H
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 140
Query: 500 QVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRAT 559
+IHRD+K SN+ ++E ++ DFGLAR + + + A L
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYN 197
Query: 560 EKTDVFSYGAVVLEVASGRRP 580
+ D++S G ++ E+ +GR
Sbjct: 198 QTVDIWSVGCIMAELLTGRTL 218
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 118 bits (297), Expect = 1e-29
Identities = 37/216 (17%), Positives = 78/216 (36%), Gaps = 19/216 (8%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWC 445
R +G G F TV+ N +A+K + + E+ ++ + + +
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 446 HE---------------KGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASAL 490
+++V++++ L +P + +I + L
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 491 AYLHQECENQVIHRDVKTSNIMLD-EGFNARLGDFGLARQVEHDKS-PDATVAAGTMGYL 548
Y+H+ C +IH D+K N++++ L +A T + T Y
Sbjct: 139 DYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 549 APEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKE 584
+PE LL D++S ++ E+ +G E +
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 232
|
| >d1gv9a_ b.29.1.13 (A:) Carbohydrate-recognition domain of P58/ERGIC-53 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 228 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Carbohydrate-recognition domain of P58/ERGIC-53 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 97.5 bits (242), Expect = 1e-23
Identities = 28/219 (12%), Positives = 58/219 (26%), Gaps = 27/219 (12%)
Query: 48 LLGDAHMNNGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLNP 107
G+A + +R+ + G F ++ +F +T
Sbjct: 28 HAGNAIPSADQIRIAPSLK---SQRGSVWTKTKAAFE--------NWEVEVTFRVTGRGR 76
Query: 108 SSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAGLGFVAVEFDTLMDVEFSDINGNHVGL 167
GLA T + G GS + + V + FD+ + N + +
Sbjct: 77 IG-ADGLAIWYTENQGLDGPVFGSADMWN-------GVGIFFDSFDNDG--KKNNPAIVV 126
Query: 168 DLNSMVSTEVDNLDTINVDLKS------GDLVNSWIEYDGLTRAFNISVSYSNLKPKVPI 221
N+ D L S + + + ++ K
Sbjct: 127 VGNNGQINYDHQNDGATQALASCQRDFRNKPYPVRAKITYYQKTLTVMINNGFTPDKNDY 186
Query: 222 LSFTLDLDQYVNDFMYVGFSGSTQGSTEIHSIEWWSFSS 260
+ + + G S +T G + H + +
Sbjct: 187 EFCAKVENMVIPTQGHFGISAATGGLADDHDVLSFLTFQ 225
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 93.3 bits (231), Expect = 2e-22
Identities = 26/164 (15%), Positives = 51/164 (31%), Gaps = 22/164 (13%)
Query: 386 RIIGHGAFGTVYKGILPQNGDIIAVKR-----------CSHNSQGKDEFLSELSIIGTLR 434
+++G G V+ VK G F
Sbjct: 6 KLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 435 HRNLVRLQGWCHEKGEILLVYDLMPNGSL-DKALFEARSPLPWPHRSKILLGVASALAYL 493
R L +LQG K VY N L + + + + ++L + +A
Sbjct: 65 FRALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKF 119
Query: 494 HQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD 537
+ ++H D+ N+++ E + DF + +V + +
Sbjct: 120 YH---RGIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWRE 159
|
| >d2a6va1 b.29.1.13 (A:9-226) Emp46p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 218 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Emp46p N-terminal domain species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 55.8 bits (134), Expect = 3e-09
Identities = 30/234 (12%), Positives = 51/234 (21%), Gaps = 38/234 (16%)
Query: 35 EFDFGTLTLASLKLLGDAHMNNGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTHTPASF 94
E L+ L + G LT G +
Sbjct: 13 EVTDQQKELSQWTLGDKVKLEEGRFVLTPGKN----TKGSLWLKPEY-------SIKDAM 61
Query: 95 STFFSFSITNLNPSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAGLGFVAVEFDTLMD 154
+ ++F S+ GLAF + E + G + +
Sbjct: 62 TIEWTFRSFGFRGST-KGGLAFWLKQGNEGDSTELFGGSSKKFNG-----LMILLRL--- 112
Query: 155 VEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLTRAFNISVSYSN 214
D G V LN + S + +Y + ++Y+
Sbjct: 113 ---DDKLGESVTAYLN--------DGTKDLDIESSPYFASCLFQYQDSMVPSTLRLTYNP 161
Query: 215 LKPKVPILSFTLDLDQYVND-------FMYVGFSGSTQGSTEIHSIEWWSFSSS 261
L + L + +G S S E I
Sbjct: 162 LDNHLLKLQMDNRVCFQTRKVKFMGSSPFRIGTSAINDASKESFEILKMKLYDG 215
|
| >d2a6za1 b.29.1.13 (A:7-227) Emp47p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 221 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Emp47p N-terminal domain species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 54.2 bits (130), Expect = 9e-09
Identities = 28/220 (12%), Positives = 60/220 (27%), Gaps = 36/220 (16%)
Query: 47 KLLGDAHMNNGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLN 106
+ A + G + LT + + G + + SF+ ++F +
Sbjct: 26 QTGEQASLEEGRIVLTSN----QNSKGSLWLKQGFDLK-------DSFTMEWTFRSVGYS 74
Query: 107 PSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAGLGFVAVEFDTLMDVEFSDINGNHVG 166
+ G++F D G ++ G + + D + G +
Sbjct: 75 GQT-DGGISFWFVQDSNIPRDKQLYNGPVNYDG-----LQLLVDN------NGPLGPTLR 122
Query: 167 LDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLTRAFNISVSYSNLKPKVPILS--- 223
LN VD + S + Y + I V+Y + +
Sbjct: 123 GQLNDG-QKPVDKTKIYDQSFASCL-----MGYQDSSVPSTIRVTYDLEDDNLLKVQVDN 176
Query: 224 ---FTLDLDQYVNDFMYVGFSGSTQGSTEIH-SIEWWSFS 259
F ++ + +G + S E +
Sbjct: 177 KVCFQTRKVRFPSGSYRIGVTAQNGAVNNNAESFEIFKMQ 216
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 711 | |||
| d1hqla_ | 236 | Legume lectin {Griffonia simplicifolia, lectin I-b | 100.0 | |
| d1leda_ | 243 | Legume lectin {West-central african legume (Griffo | 100.0 | |
| d1fx5a_ | 240 | Legume lectin {Furze (Ulex europaeus), UEA-I [TaxI | 100.0 | |
| d1gzca_ | 239 | Legume lectin {Cockspur coral tree (Erythrina cris | 100.0 | |
| d1qnwa_ | 237 | Legume lectin {Furze (Ulex europaeus), UEA-II [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1g8wa_ | 233 | Phytohemagglutinin-L, PHA-L, also arcelin {Kidney | 100.0 | |
| d2d3sa1 | 237 | Legume lectin {Winged bean (Psophocarpus tetragono | 100.0 | |
| d1g9fa_ | 251 | Legume lectin {Soybean (Glycine max) [TaxId: 3847] | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1g7ya_ | 253 | Legume lectin {Horse gram (Dolichos biflorus), dif | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1f9ka_ | 234 | Legume lectin {Winged bean (Psophocarpus tetragono | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| g1qmo.1 | 230 | Legume lectin {Field bean (Dolichos lablab), Fril | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1v6ia_ | 232 | Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3 | 100.0 | |
| d1dbna_ | 239 | Legume lectin {Maackia amurensis, leukoagglutinin | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1fnya_ | 237 | Legume lectin {Black locust (Robinia pseudoacacia) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1n47a_ | 233 | Legume lectin {Hairy vetch (Vicia villosa), isolec | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| g2ltn.1 | 229 | Legume lectin {Garden pea (Pisum sativum) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1ukga_ | 241 | Legume lectin {Bloodwood tree (Pterocarpus angolen | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1avba_ | 226 | Phytohemagglutinin-L, PHA-L, also arcelin {Kidney | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ioaa_ | 228 | Phytohemagglutinin-L, PHA-L, also arcelin {Kidney | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1dhkb_ | 204 | Phytohemagglutinin-L, PHA-L, also arcelin {Kidney | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1nlsa_ | 237 | Concanavalin A {Jack bean (Canavalia ensiformis) [ | 99.96 | |
| d1gv9a_ | 228 | Carbohydrate-recognition domain of P58/ERGIC-53 {R | 99.94 | |
| d1nlsa_ | 237 | Concanavalin A {Jack bean (Canavalia ensiformis) [ | 99.87 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d2a6va1 | 218 | Emp46p N-terminal domain {Baker's yeast (Saccharom | 99.84 | |
| d2a6za1 | 221 | Emp47p N-terminal domain {Baker's yeast (Saccharom | 99.83 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.52 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.82 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.51 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.1 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.38 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.1 |
| >d1hqla_ b.29.1.1 (A:) Legume lectin {Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]
Probab=100.00 E-value=8.8e-56 Score=445.13 Aligned_cols=225 Identities=32% Similarity=0.483 Sum_probs=200.8
Q ss_pred ceeeecCCCCC---CCeEEeCceEeeCCcEEeCCCCCC---CCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecCC
Q 043702 33 ATEFDFGTLTL---ASLKLLGDAHMNNGSVRLTRDVTV---PYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLN 106 (711)
Q Consensus 33 ~~~f~~~~f~~---~~~~~~g~a~~~~g~~~Lt~~~~~---~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~ 106 (711)
+++|+|++|.. .+|+|+|||.+.+|.|+||++... ...++|||+|++||+||+..+++++||+|+|+|.|...
T Consensus 1 ~~sF~f~~F~~~~~~~l~l~G~A~~~~~~l~LT~~~~~~~~~~~s~Gra~y~~Pv~l~~~~t~~~asFsT~F~F~i~~~- 79 (236)
T d1hqla_ 1 SVSFTFPNFWSDVEDSIIFQGDANTTAGTLQLCKTNQYGTPLQWSAGRALYSDPVQLWDNKTESVASFYTEFTFFLKIT- 79 (236)
T ss_dssp CCEEEESCSCSCGGGTEEEEETCEEETTEEECSCBCTTSCBCSSCEEEEEESSCEECCCSTTCCCCEEEEEEEEEEEEC-
T ss_pred CEEEEeCCCCCCCcCCEEEeccEEecCCEEEEecCCCCCcccccceEEEEECCCEEeecCCCCceeEEEEEEEEEEeCC-
Confidence 47899999963 679999999999999999986542 24679999999999999999999999999999999875
Q ss_pred CCCCCCceEEEEcCCCCCCCCCCCcccccccCCCC----cceEEEEeecccCCCCCCCCCCeeeEecCCCcccccccCCc
Q 043702 107 PSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAG----LGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDT 182 (711)
Q Consensus 107 ~~~~g~GlaF~l~~~~~~~~~~g~~lgl~~~~~~~----~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~S~~~~~~~~ 182 (711)
...+||||||+|+|....++..|++||+++..+++ +++|||||||++|.+++||++||||||+|++.|..+.++.
T Consensus 80 ~~~~gDGlAFvl~p~~~~~~~~G~~lGl~~~~~~~~~~~~~~vAVEFDT~~n~~~~D~~~nHIgIdvns~~s~~~~~~~- 158 (236)
T d1hqla_ 80 GNGPADGLAFFLAPPDSDVKDAGEYLGLFNKSTATQPSKNQVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVATKRWE- 158 (236)
T ss_dssp SSCCCCEEEEEEECTTCCCCCCGGGTTTSCTTTTTCGGGCCCEEEEEECSCCSSSCCCSSCEEEEEESSSSCSEEEECC-
T ss_pred CCCCCceEEEEEeCCCCCCCCCccccccccccccCCcccCceEEEEeeCccCCCCCCCCCCEEEEEcCCcccccccccc-
Confidence 45789999999999888788899999999876543 7899999999999999999999999999999998776553
Q ss_pred cccccCCCCeEEEEEEEcccccEEEEEEEecCCCCCcceeeEecCcccccccceeEEEeeeccCc-eeeEEEEeeccccc
Q 043702 183 INVDLKSGDLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGS-TEIHSIEWWSFSSS 261 (711)
Q Consensus 183 ~~~~~~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastg~~-~~~~~i~sW~f~s~ 261 (711)
..++.+|+.++|||+||+.+++|+|+|++.+ +..|+|++.|||+++|+++||||||||||.. .+.|+|++|+|+++
T Consensus 159 -~~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~ls~~vdL~~~l~~~v~vGFSasTG~~~~~~h~I~sWsF~s~ 235 (236)
T d1hqla_ 159 -DSDIFSGKIATARISYDGSAEILTVVLSYPD--GSDYILSHSVDMRQNLPESVRVGISASTGNNQFLTVYILSWRFSSN 235 (236)
T ss_dssp -HHHHTSCSCEEEEEEEETTTTEEEEEEEETT--TEEEEEEEECCGGGTSCSEEEEEEEEECCSCCCEEEEEEEEEEEEE
T ss_pred -cccccCCCEEEEEEEEeCCCcEEEEEEecCC--CCCeeEEEEeCHHHhCCCcEEEEEEeECCCCCceEEEEEEeEeEec
Confidence 4678999999999999999999999999854 5678999999999999999999999999974 68899999999986
Q ss_pred c
Q 043702 262 F 262 (711)
Q Consensus 262 ~ 262 (711)
+
T Consensus 236 l 236 (236)
T d1hqla_ 236 L 236 (236)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >d1leda_ b.29.1.1 (A:) Legume lectin {West-central african legume (Griffonia simplicifolia) [TaxId: 3850]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: West-central african legume (Griffonia simplicifolia) [TaxId: 3850]
Probab=100.00 E-value=7.7e-55 Score=439.72 Aligned_cols=225 Identities=31% Similarity=0.484 Sum_probs=199.9
Q ss_pred cceeeecCCCC------CCCeEEeCceEeeCCcEEeCCCCCC---CCCceEEEEeCCceeccCCCCCCceeeEEEEEEEE
Q 043702 32 TATEFDFGTLT------LASLKLLGDAHMNNGSVRLTRDVTV---PYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSI 102 (711)
Q Consensus 32 ~~~~f~~~~f~------~~~~~~~g~a~~~~g~~~Lt~~~~~---~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i 102 (711)
.+++|+|++|. ..||+|+|||.+.+|.|+||++... ...++|||+|++||+||++ +++++||+|+|+|.|
T Consensus 2 ~s~sF~f~~F~~~~~~~~~~l~l~G~A~~~~g~l~LT~~~~~~~~~~~s~Gra~y~~Pv~l~~~-t~~~asFsT~F~f~i 80 (243)
T d1leda_ 2 NTVNFTYPDFWSYSLKNGTEITFLGDATRIPGALQLTKTDANGNPVRSSAGQASYSEPVFLWDS-TGKAASFYTSFTFLL 80 (243)
T ss_dssp CCCEEEESCBCCTTSCTTTSEEEEETCEEETBEEECSCBCTTSCBCSSEEEEEEESSCEECBCT-TSCBCEEEEEEEEEE
T ss_pred CceEEEcCCCCCCCCCCCCcEEEeeeeEEcCCEEEeccCCCCCCccccceEEEEeCCCeEecCC-CCcEeeEEEEEEEEc
Confidence 46899999995 3689999999999999999986532 2368999999999999995 799999999999998
Q ss_pred ecCCCCCCCCceEEEEcCCCCCCCCCCCcccccccCCCC----cceEEEEeecccCCCCCCCCCCeeeEecCCCcccccc
Q 043702 103 TNLNPSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAG----LGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVD 178 (711)
Q Consensus 103 ~~~~~~~~g~GlaF~l~~~~~~~~~~g~~lgl~~~~~~~----~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~S~~~~ 178 (711)
.... ..+||||||+|+|...+++..|++||+++..+.+ +++|||||||++|.+++||++||||||+|++.|..+.
T Consensus 81 ~~~~-~~~gdGlAF~l~p~~~~~~~~g~~lGl~~~~~~~~~~~~~~vAVEFDT~~n~~~~d~~~nHVgIdvns~~s~~~~ 159 (243)
T d1leda_ 81 KNYG-APTADGLAFFLAPVDSSVKDYGGFLGLFRHETAADPSKNQVVAVEFDTWINKDWNDPPYPHIGIDVNSIVSVATT 159 (243)
T ss_dssp EESS-SSCBCEEEEEEEETTCCCCCCGGGTTTCCTTTTTCGGGCCCEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEE
T ss_pred CCCC-CCCCCceEEEEcCCCCCCCCCccccccccccccCCCccCcEEEEEEeCccccccCCCCCCceEEEecCccccccc
Confidence 7654 5689999999999887778899999999876653 7899999999999999999999999999999998776
Q ss_pred cCCccccccCCCCeEEEEEEEcccccEEEEEEEecCCCCCcceeeEecCcccccccceeEEEeeeccCceeeEEEEeecc
Q 043702 179 NLDTINVDLKSGDLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGSTEIHSIEWWSF 258 (711)
Q Consensus 179 ~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastg~~~~~~~i~sW~f 258 (711)
++. ..++.+|+.++|||+||+.+++|+|+|++.. +..|+|++.|||+++|+++||||||||||. .|.|+|++|+|
T Consensus 160 ~~~--~~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~--~~~p~ls~~idL~~~l~~~vyvGFSAsTG~-~~~h~I~sWsF 234 (243)
T d1leda_ 160 RWE--NDDAYGSSIATAHITYDARSKILTVLLSYEH--GRDYILSHVVDLAKVLPQKVRIGFSAGVGY-DEVTYILSWHF 234 (243)
T ss_dssp ECC--HHHHTSCCEEEEEEEEETTTTEEEEEEEETT--SCEEEEEEECCHHHHSCSEEEEEEEEEECB-SEEEEEEEEEE
T ss_pred ccc--cCCcccCceeEEEEEEECCCCEEEEEEeeCC--CCCceEEEecCHHHhcCCcEEEEEEcccCC-cceeeEEEEEE
Confidence 654 3578899999999999999999999999753 567899999999999999999999999995 69999999999
Q ss_pred ccccC
Q 043702 259 SSSFE 263 (711)
Q Consensus 259 ~s~~~ 263 (711)
+++++
T Consensus 235 ~s~l~ 239 (243)
T d1leda_ 235 FSTLD 239 (243)
T ss_dssp EEECT
T ss_pred EeeCC
Confidence 99885
|
| >d1fx5a_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-I [TaxId: 3902]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Furze (Ulex europaeus), UEA-I [TaxId: 3902]
Probab=100.00 E-value=5.5e-53 Score=427.16 Aligned_cols=228 Identities=29% Similarity=0.459 Sum_probs=199.8
Q ss_pred cceeeecCCCCC--CCeEEeCceEee-CCcEEeCCCCCC-CCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecC-C
Q 043702 32 TATEFDFGTLTL--ASLKLLGDAHMN-NGSVRLTRDVTV-PYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNL-N 106 (711)
Q Consensus 32 ~~~~f~~~~f~~--~~~~~~g~a~~~-~g~~~Lt~~~~~-~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~-~ 106 (711)
.+++|+|++|.. .||+|+|||.+. +|.|+||++... ...++|||+|++||+|||+++++++||+|+|+|.|... +
T Consensus 2 ~~~sF~f~~F~~~~~~l~l~G~A~~~~~g~l~LT~~~~~~~~~~~G~a~y~~Pv~l~~~~t~~~~sF~t~F~f~i~~~~~ 81 (240)
T d1fx5a_ 2 DDLSFKFKNFSQNGKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIWNCNTGELASFITSFSFFMETSAN 81 (240)
T ss_dssp CEEEEEESSCCTTCSSEEEEETCEECTTSCEESCCCSSSSCSEEEEEEEESSCEECEETTTTEECEEEEEEEEEEEESSC
T ss_pred CceEEECCCCCCCCCCEEEeeeeEecCCCEEEccCCCCCCccceeEEEecCCCceeecCCCCceeeeEEEEEEEEeCCCC
Confidence 468999999973 689999999875 789999986542 33578999999999999999999999999999999654 4
Q ss_pred CCCCCCceEEEEcCCCCCCCCCCCcccccccCCCC--cceEEEEeecccCC-CCCCCCCCeeeEecCCCcccccccCCcc
Q 043702 107 PSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAG--LGFVAVEFDTLMDV-EFSDINGNHVGLDLNSMVSTEVDNLDTI 183 (711)
Q Consensus 107 ~~~~g~GlaF~l~~~~~~~~~~g~~lgl~~~~~~~--~~~vaVEFDt~~n~-~~~d~~~~Hvgid~ns~~S~~~~~~~~~ 183 (711)
+..+||||||+|+|...+.+..|++||+++..+.+ +++|||||||++|+ +++||++||||||+|++.|..+..+
T Consensus 82 ~~~ggdG~AFvl~p~~~~~~~~g~~lGl~~~~~~~~~~~~vAVEFDT~~n~~~~~D~~~nHIgid~ns~~s~~~~~~--- 158 (240)
T d1fx5a_ 82 PKAATDGLTFFLAPPDSPLRRAGGYFGLFNDTKCDSSYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAERW--- 158 (240)
T ss_dssp GGGCCCEEEEEEECTTCCCCBCGGGTTTBSSSCCCGGGCCEEEEEECCCTTTSTTSCSSCEEEEEESSSSCSEEEEC---
T ss_pred CCCCCCcEEEEECCCCCCCCCCCccccccccCCCCccCceEEEEeeccccccccCCCCCCceEEccCCccccccccc---
Confidence 45689999999999887778899999999876544 78999999999985 6789999999999999998765544
Q ss_pred ccccCCCCeEEEEEEEcccccEEEEEEEecCCCCCcceeeEecCcccccccceeEEEeeeccC-ceeeEEEEeecccccc
Q 043702 184 NVDLKSGDLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQG-STEIHSIEWWSFSSSF 262 (711)
Q Consensus 184 ~~~~~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastg~-~~~~~~i~sW~f~s~~ 262 (711)
...+.+|+.++|||+||+.+++|+|+|++.. ++..|+++..|||+++|+++||||||||||. ..|.|+|++|+|++++
T Consensus 159 ~~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~ls~~vdLs~~l~~~v~vGFSasTG~~~~~~H~I~sWsFsst~ 237 (240)
T d1fx5a_ 159 NKRYGLNNVANVEIIYEASSKTLTASLTYPS-DQTSISVTSIVDLKEILPEWVSVGFSGSTYIGRQATHEVLNWYFTSTF 237 (240)
T ss_dssp CCCCSGGGCEEEEEEEETTTTEEEEEEEETT-TTEEEEEEEECCGGGTSCSEEEEEEEEEEETTSCEEEEEEEEEEEEES
T ss_pred ccccCCCCeEEEEEEEcCCCCEEEEEEecCC-CceeeEEeEEEchHHhCCCcEEEEEEeECCCCCCceEEEEEEEeEEec
Confidence 3567889999999999999999999999765 5678899999999999999999999999995 6799999999999987
Q ss_pred C
Q 043702 263 E 263 (711)
Q Consensus 263 ~ 263 (711)
.
T Consensus 238 ~ 238 (240)
T d1fx5a_ 238 I 238 (240)
T ss_dssp S
T ss_pred c
Confidence 4
|
| >d1gzca_ b.29.1.1 (A:) Legume lectin {Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]
Probab=100.00 E-value=3.9e-52 Score=420.63 Aligned_cols=224 Identities=30% Similarity=0.508 Sum_probs=198.0
Q ss_pred cceeeecCCCC--CCCeEEeCceEee-CCcEEeCCCCCC---CCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecC
Q 043702 32 TATEFDFGTLT--LASLKLLGDAHMN-NGSVRLTRDVTV---PYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNL 105 (711)
Q Consensus 32 ~~~~f~~~~f~--~~~~~~~g~a~~~-~g~~~Lt~~~~~---~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~ 105 (711)
.+++|+|++|. .+|++|+|||.+. +|.|+||++.+. ..+++|||+|++||+||++.+++++||+|+|+|.|...
T Consensus 2 ~~~sF~f~~F~~~~~nl~l~G~A~i~~~g~l~LT~~~~~~~~~~~~~Gr~~y~~Pv~l~~~~~~~~~sFst~F~f~i~~~ 81 (239)
T d1gzca_ 2 ETISFSFSEFEPGNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMWDSTTGTVASFETRFSFSIEQP 81 (239)
T ss_dssp EEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCBCTTSCBCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCC
T ss_pred eeEEEEeCCCCCCCCCeEEeeeeEECCCCeEEccCCCCCCcccccceEEEEeCCCeEecCCCCCceeeEEEEEEEEEecC
Confidence 46899999997 4689999999986 789999997553 23678999999999999999999999999999999754
Q ss_pred -CCCCCCCceEEEEcCCCCCCCCCCCcccccccCCCC--cceEEEEeecccCCCCCCCCCCeeeEecCCCcccccccCCc
Q 043702 106 -NPSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAG--LGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDT 182 (711)
Q Consensus 106 -~~~~~g~GlaF~l~~~~~~~~~~g~~lgl~~~~~~~--~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~S~~~~~~~~ 182 (711)
....+||||||+|+|.+..++..||+||+++..+.+ ++.|||||||++| +++||+++|||||+|++.|..+.
T Consensus 82 ~~~~~g~dG~aF~l~p~~~~~~~~~g~lg~~~~~~~~~~~~~vaVEFDT~~n-~~~d~~~~HvgI~vn~~~s~~t~---- 156 (239)
T d1gzca_ 82 YTRPLPADGLVFFMGPTKSKPAQGYGYLGVFNNSKQDNSYQTLAVEFDTFSN-PWDPPQVPHIGIDVNSIRSIKTQ---- 156 (239)
T ss_dssp CSSSCCCEEEEEEEECSSCCCCCCGGGTTTCSSSSCCGGGCCEEEEEECSCC-TTSCSSSSEEEEEESSSSCSEEE----
T ss_pred CCCCCCCCeEEEEECCCCCCCCCCcccccccccCCCCCccceEEEEEEcccc-CCCCCCCCEEEEEECCccccccC----
Confidence 345689999999999888778889999998765444 7889999999999 57899999999999999987654
Q ss_pred cccccCCCCeEEEEEEEcccccEEEEEEEecCCCCCcceeeEecCcccccccceeEEEeeeccC---ceeeEEEEeeccc
Q 043702 183 INVDLKSGDLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQG---STEIHSIEWWSFS 259 (711)
Q Consensus 183 ~~~~~~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastg~---~~~~~~i~sW~f~ 259 (711)
+.++.+|+.++|||+||+.+++|+|++++.+ +|..|.|++.|||+++|+++|||||||+||. ..|.|+|++|+|+
T Consensus 157 -~~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~~~~H~V~sWsF~ 234 (239)
T d1gzca_ 157 -PFQLDNGQVANVVIKYDAPSKILHVVLVYPS-SGAIYTIAEIVDVKQVLPDWVDVGLSGATGAQRDAAETHDVYSWSFQ 234 (239)
T ss_dssp -ECCCCTTCEEEEEEEEETTTTEEEEEEECTT-TCCEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCCCCCEEEEEEEE
T ss_pred -CccccCCCEEEEEEEEeCCCcEEEEEEecCC-CCcceeeeeEechHHhcCCcEEEEEEEEcCCCCCCceeeEEEEEEeE
Confidence 4578999999999999999999999998755 5778999999999999999999999999994 5799999999999
Q ss_pred ccc
Q 043702 260 SSF 262 (711)
Q Consensus 260 s~~ 262 (711)
+++
T Consensus 235 s~l 237 (239)
T d1gzca_ 235 ASL 237 (239)
T ss_dssp EEE
T ss_pred eeC
Confidence 986
|
| >d1qnwa_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-II [TaxId: 3902]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Furze (Ulex europaeus), UEA-II [TaxId: 3902]
Probab=100.00 E-value=6.3e-52 Score=418.93 Aligned_cols=225 Identities=29% Similarity=0.517 Sum_probs=195.2
Q ss_pred cceeeecCCCC--CCCeEEeCceEee-CCcEEeCCCCCCCCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecCCCC
Q 043702 32 TATEFDFGTLT--LASLKLLGDAHMN-NGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLNPS 108 (711)
Q Consensus 32 ~~~~f~~~~f~--~~~~~~~g~a~~~-~g~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~ 108 (711)
.+++|+|++|. ..|++|+|||.+. +|.|+||++......++|||+|++||+||++.+++++||+|+|+|.|.+++ .
T Consensus 2 ~~lsF~f~~F~~~~~~l~l~GdA~i~~~g~l~LT~~~~~~~~~~G~a~y~~Pi~l~~~~~~~~~sF~t~F~f~i~~~~-~ 80 (237)
T d1qnwa_ 2 DDLSFNFDKFVPNQKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIWDSITGKVASFATSFSFVVKADK-S 80 (237)
T ss_dssp CSEEEEESSCCTTCTTEEEEETCEECTTSCEESSCCC--CCCEEEEEEESSCEECBCTTTCCBCEEEEEEEEECCBSS-S
T ss_pred CcEEEEcCCCCCCCCCEEEeeceEEcCCCeEEeccCCCCccccEEEEEECCCEEecCCCCcceeeEEEEEEEEEecCC-C
Confidence 46899999995 4689999999986 789999997654447899999999999999999999999999999998764 5
Q ss_pred CCCCceEEEEcCCCCC--CCCCCCcccccccCCCC--cceEEEEeecccCCCCC--CCCCCeeeEecCCCcccccccCCc
Q 043702 109 SIGAGLAFVITPDGEQ--VGSAGGSLGLLDEKGAG--LGFVAVEFDTLMDVEFS--DINGNHVGLDLNSMVSTEVDNLDT 182 (711)
Q Consensus 109 ~~g~GlaF~l~~~~~~--~~~~g~~lgl~~~~~~~--~~~vaVEFDt~~n~~~~--d~~~~Hvgid~ns~~S~~~~~~~~ 182 (711)
.+||||||+|+|.... .++.|+++|+.+..+.. +++|||||||++|.+++ ||+++|||||+|++.|....
T Consensus 81 ~ggdG~aF~l~p~~~~~~~~~~~~~~g~~~~~~~~~~~~~vAVEFDT~~n~~~~~~d~~~nHvgid~ns~~s~~~~---- 156 (237)
T d1qnwa_ 81 DGVDGLAFFLAPANSQIPSGSSAGMFGLFSSSDSKSSNQIIAVEFDTYFGKAYNPWDPDFKHIGIDVNSIKSIKTV---- 156 (237)
T ss_dssp CCCCEEEEEEEETTCCCCTTCCGGGTTTCSSSSCCTTSCCEEEEEECCCCTTTCTTSCSSCEEEEEESSSSCSEEE----
T ss_pred CCcceeEEEEeCCCCCCCCCCccccccccCCCCCCCcccEEEEEeeceecCCcCCCCCCCCeEEEECCCCCccccc----
Confidence 6899999999998753 36788899998865433 88999999999998754 69999999999999886543
Q ss_pred cccccCCCCeEEEEEEEcccccEEEEEEEecCCCCCcceeeEecCcccccccceeEEEeeeccCc--eeeEEEEeecccc
Q 043702 183 INVDLKSGDLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGS--TEIHSIEWWSFSS 260 (711)
Q Consensus 183 ~~~~~~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastg~~--~~~~~i~sW~f~s 260 (711)
.+++.+|+.++|||+||+.+++|+|++++.. +|..|+|++.|||+++|+++||||||||||.. .|.|+|++|+|++
T Consensus 157 -~~~~~~G~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~p~ls~~vDLs~~l~~~vyvGFSasTG~~~~~q~h~I~sWsF~s 234 (237)
T d1qnwa_ 157 -KWDWRNGEVADVVITYRAPTKSLTVCLSYPS-DGTSNIITASVDLKAILPEWVSVGFSGGVGNAAEFETHDVLSWYFTS 234 (237)
T ss_dssp -ECCCCTTCCEEEEEEEEGGGTEEEEEEECTT-TCCEEEEEEECCHHHHSCSEEEEEEEEEESCGGGCBCCEEEEEEEEE
T ss_pred -ccccCCCcEEEEEEEEcCCCcEEEEEEecCC-CCccceEEEEEChHHhCCCcEEEEEEeECCCCCCccEeEEEEeEeEE
Confidence 4578899999999999999999999998754 67789999999999999999999999999975 4899999999998
Q ss_pred ccC
Q 043702 261 SFE 263 (711)
Q Consensus 261 ~~~ 263 (711)
+++
T Consensus 235 ~l~ 237 (237)
T d1qnwa_ 235 NLE 237 (237)
T ss_dssp EC-
T ss_pred ecC
Confidence 763
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-52 Score=429.74 Aligned_cols=254 Identities=28% Similarity=0.410 Sum_probs=202.3
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCC
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMP 459 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 459 (711)
++|+..+.||+|+||+||+|++. +++.||||++.......++|.+|++++++++||||++++|+|..++..++|||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 46888999999999999999986 57889999998877778899999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCcc
Q 043702 460 NGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDAT 539 (711)
Q Consensus 460 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 539 (711)
+|+|.+++......++|..+++++.|||+||+|||+. +|+||||||+||||++++.+||+|||+++...........
T Consensus 84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 160 (263)
T d1sm2a_ 84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160 (263)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence 9999999988778899999999999999999999997 9999999999999999999999999999887655444444
Q ss_pred cccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCC-CCccccccccccccccchHHHHHHhhhcCchhHhhhhhc
Q 043702 540 VAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRR-PIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARL 618 (711)
Q Consensus 540 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~-P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 618 (711)
...||+.|+|||++.+..++.++|||||||++|||+|+.. |+.... ..+..... ..+ .
T Consensus 161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~-----------~~~~~~~i-~~~---------~ 219 (263)
T d1sm2a_ 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-----------NSEVVEDI-STG---------F 219 (263)
T ss_dssp ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC-----------HHHHHHHH-HHT---------C
T ss_pred ceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC-----------HHHHHHHH-Hhc---------C
Confidence 5679999999999999999999999999999999999544 443221 11111111 111 1
Q ss_pred cCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 619 EGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
....+.....++.+++.+||+.||++||||+||++.|+..
T Consensus 220 ~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 220 RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 1111222335678899999999999999999999999753
|
| >d1g8wa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=1.8e-51 Score=414.44 Aligned_cols=224 Identities=34% Similarity=0.524 Sum_probs=201.3
Q ss_pred cceeeecCCCCCCCeEEeCceEee-CCcEEeCCCCCC---CCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecCCC
Q 043702 32 TATEFDFGTLTLASLKLLGDAHMN-NGSVRLTRDVTV---PYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLNP 107 (711)
Q Consensus 32 ~~~~f~~~~f~~~~~~~~g~a~~~-~g~~~Lt~~~~~---~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~ 107 (711)
.+++|+|++|..+|++|+|||.+. +|.|+||++... ...++|||+|++||+||++.++.++||+|+|+|+|.+.+.
T Consensus 2 ~~~sF~f~~F~~~nl~l~GdA~i~~~g~l~LT~~~~~~~~~~~~~G~~~y~~Pi~l~~~~~~~~~sF~t~f~f~i~~~~~ 81 (233)
T d1g8wa_ 2 NDIYFNFQRFNETNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIWDNTTGTVASFATSFTFNIQVPNN 81 (233)
T ss_dssp EEEEEEESSCCGGGEEEEETCEECTTSCEECSCCCSTTCCCTTCEEEEEESSCEECBCTTTCCBEEEEEEEEEECCCCSS
T ss_pred CceEEECCCCCcCcEEEeccEEECCCCEEEecCCCCCCCcccceeEEEEcCCCeEeecCCCCceeeEEEEEEEEEecCCC
Confidence 568999999999999999999986 789999986442 2368999999999999999999999999999999998777
Q ss_pred CCCCCceEEEEcCCCCCCCCCCCcccccccCCCCcceEEEEeecccCCCCCCCCCCeeeEecCCCcccccccCCcccccc
Q 043702 108 SSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAGLGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDL 187 (711)
Q Consensus 108 ~~~g~GlaF~l~~~~~~~~~~g~~lgl~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~S~~~~~~~~~~~~~ 187 (711)
..+||||||+|+|.+..++..|++||+++..+..++.||||||||+|.++ ||+++||||++|++.|..+. ..++
T Consensus 82 ~~~gDGlAF~l~~~~~~~g~~g~~lG~~~g~~~~~~~vaVEFDT~~N~~~-d~~~~Hvgi~~n~~~s~~~~-----~~~~ 155 (233)
T d1g8wa_ 82 AGPADGLAFALVPVGSQPKDKGGFLGLFDGSNSNFHTVAVEFDTLYNKDW-DPTERHIGIDVNSIRSIKTT-----RWDF 155 (233)
T ss_dssp CBCCEEEEEEEEETTCCCCCCGGGTTTCCSSCCCCCCEEEEEECSCCTTT-CCSSCEEEEEESSSSCSEEE-----ECCC
T ss_pred CCCCCeEEEEEecCCCCCCcccccCCccccCCCcccEEEEEeecccCCCC-CCCCCeEEEECCCcceeeec-----cccc
Confidence 77899999999998887888999999998776668899999999999876 99999999999999886543 4578
Q ss_pred CCCCeEEEEEEEcccccEEEEEEEecCCCCCcceeeEecCcccccccceeEEEeeecc---CceeeEEEEeecccccc
Q 043702 188 KSGDLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQ---GSTEIHSIEWWSFSSSF 262 (711)
Q Consensus 188 ~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastg---~~~~~~~i~sW~f~s~~ 262 (711)
.+|+.+.|||+||+.+++|.|++.+.. ++..++++..|||+.+||++|||||||+|| +..|.|+|++|+|++++
T Consensus 156 ~~g~~~~~~I~yd~~~~~l~v~l~~~~-~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~~~~~~~h~I~sWsFss~l 232 (233)
T d1g8wa_ 156 VNGENAEVLITYDSSTNLLVASLVYPS-QKTSFIVSDTVDLKSVLPEWVSVGFSATTGINKGNVETNDVLSWSFASKL 232 (233)
T ss_dssp CTTCCEEEEEEEETTTTEEEEEEEETT-TTEEEEEEEECCHHHHSCSEEEEEEEEEECSSTTBCCCCEEEEEEEEEEE
T ss_pred cCCcEEEEEEEEeCCCcEEEEEEEeCC-CCCcEEEEEEechhHcCCCcEEEEEEEEcCCCCCCceeeEEEEEEEEEEc
Confidence 899999999999999999999998865 567789999999999999999999999999 45688999999999875
|
| >d2d3sa1 b.29.1.1 (A:1-237) Legume lectin {Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]
Probab=100.00 E-value=2e-51 Score=414.53 Aligned_cols=221 Identities=35% Similarity=0.560 Sum_probs=194.3
Q ss_pred ceeeecCCCC--CCCeEEeCceEee-CCcEEeCCCCCC--CCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecC-C
Q 043702 33 ATEFDFGTLT--LASLKLLGDAHMN-NGSVRLTRDVTV--PYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNL-N 106 (711)
Q Consensus 33 ~~~f~~~~f~--~~~~~~~g~a~~~-~g~~~Lt~~~~~--~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~-~ 106 (711)
+++|+|++|. .++++|+|||.+. +|.|+||++... ..+++|||+|++||+|||+.+++++||+|+|+|.|... +
T Consensus 2 t~sF~f~~F~~~~~~l~l~G~A~i~~~g~l~LT~~~~~~~~~~~~G~a~y~~pi~l~~~~~~~~~sF~t~F~f~i~~~~~ 81 (237)
T d2d3sa1 2 TISFNFNQFHQNEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDSTTGNVASFETRFSFSIRQPFP 81 (237)
T ss_dssp EEEEEESSCCSSCTTEEEEETCEECTTSCEECSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCSCC
T ss_pred eEEEEeCCCCCCCCCEEEeeeeEeCCCCeEEcCCCCCCCcccccEEEEEeCCCEEeecCCCCceeeEEEEEEEEeecCCC
Confidence 5899999995 4689999999986 689999985431 23789999999999999999999999999999999754 3
Q ss_pred CCCCCCceEEEEcCCCCCCCCCCCcccccccCCCCcceEEEEeecccCCCCCCCCCCeeeEecCCCcccccccCCccccc
Q 043702 107 PSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAGLGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVD 186 (711)
Q Consensus 107 ~~~~g~GlaF~l~~~~~~~~~~g~~lgl~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~S~~~~~~~~~~~~ 186 (711)
...+||||||+|+|.+..++..|++||+++..+ .+++|||||||++|. +||+++|||||+|++.|.+. ..++
T Consensus 82 ~~~g~dGlaFvl~p~~~~~~~~gg~lG~~~~~~-~~~~vaVEFDT~~n~--~d~~~nHvgI~vns~~s~~~-----~~~~ 153 (237)
T d2d3sa1 82 RPHPADGLVFFIAPPNTQTGEGGGYFGIYNPLS-PYPFVAVEFDTFRNT--WDPQIPHIGIDVNSVISTKT-----VPFT 153 (237)
T ss_dssp SSCCCEEEEEEEECSSCCCCBCGGGTTTBCTTS-CCCCEEEEEECSCCT--TCCSSSEEEEEESSSSCSEE-----EECC
T ss_pred CCCCCCeEEEEeCCCCccCCccccccccccCCC-cCceEEEEEEeecCC--CCCCCCcEEEEcCCCccccc-----ccee
Confidence 356789999999998877788999999988643 378899999999985 49999999999999998654 3457
Q ss_pred cCCCCeEEEEEEEcccccEEEEEEEecCCCCCcceeeEecCcccccccceeEEEeeeccC-------ceeeEEEEeeccc
Q 043702 187 LKSGDLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQG-------STEIHSIEWWSFS 259 (711)
Q Consensus 187 ~~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastg~-------~~~~~~i~sW~f~ 259 (711)
+.+|+.++|||+||+.+++|+|+|++.+ ++..|+++..|||+.+|+++||||||||||. +.|.|+|++|+|+
T Consensus 154 l~~G~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~ls~~vdL~~~l~~~vyvGFSasTG~~~~~~~~~~e~h~I~sWsFs 232 (237)
T d2d3sa1 154 LDNGGIANVVIKYDASTKILHVVLVFPS-LGTIYTIADIVDLKQVLPESVNVGFSAATGDPSGKQRNATETHDILSWSFS 232 (237)
T ss_dssp CCTTCEEEEEEEEETTTTEEEEEEEETT-TTEEEEEEEECCHHHHSCSEEEEEEEEEECCGGGCCTTCCCCCEEEEEEEE
T ss_pred ecCCCEEEEEEEEECCCCEEEEEEEcCC-CCcccceeeEechHHhCCCcEEEEEEeECCCCccCccccceeeEEEEeEeE
Confidence 8999999999999999999999999865 4677899999999999999999999999994 5799999999999
Q ss_pred ccc
Q 043702 260 SSF 262 (711)
Q Consensus 260 s~~ 262 (711)
+++
T Consensus 233 s~l 235 (237)
T d2d3sa1 233 ASL 235 (237)
T ss_dssp EEC
T ss_pred eeC
Confidence 976
|
| >d1g9fa_ b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Soybean (Glycine max) [TaxId: 3847]
Probab=100.00 E-value=2.3e-51 Score=418.05 Aligned_cols=224 Identities=29% Similarity=0.481 Sum_probs=194.4
Q ss_pred ccceeeecCCCC--CCCeEEeCceEee-CCcEEeCCCCCC---CCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEec
Q 043702 31 STATEFDFGTLT--LASLKLLGDAHMN-NGSVRLTRDVTV---PYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITN 104 (711)
Q Consensus 31 ~~~~~f~~~~f~--~~~~~~~g~a~~~-~g~~~Lt~~~~~---~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~ 104 (711)
+.+++|+|++|. .++++|+|||.+. +|.|+||++... ...++|||+|++||+||++.++++++|+|+|+|.|..
T Consensus 1 a~~~sF~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~~~~~~~~~sf~t~f~F~i~~ 80 (251)
T d1g9fa_ 1 AETVSFSWNKFVPKQPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIWDKETGSVASFAASFNFTFYA 80 (251)
T ss_dssp CEEEEEEESSCCC-CTTEEEEETCBCCTTC-CBCSCBC---CBCTTCEEEEEESSCEECBCC-CCCBCEEEEEEEEEEEC
T ss_pred CceEEEEeCCCCCCCCCEEEeeeEEECCCCEEEecCCcCCCcccCceEEEEEeCCCEEccCCCCccceeeEEEEEEEEec
Confidence 357899999997 4589999999986 789999986542 2368999999999999999999999999999999998
Q ss_pred CCCCCCCCceEEEEcCCCCCCCCCCCcccccccCCCCcceEEEEeecccCCCCCCCCCCeeeEecCCCcccccccCCccc
Q 043702 105 LNPSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAGLGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTIN 184 (711)
Q Consensus 105 ~~~~~~g~GlaF~l~~~~~~~~~~g~~lgl~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~S~~~~~~~~~~ 184 (711)
.+...+||||||+|+|.+..++..||+||+++.....+++||||||||+|. +||+++|||||+|++.|..+. .
T Consensus 81 ~~~~~~gDGlAFvl~p~~~~~~~~~g~lG~~~~~~~~~~~vaVEFDT~~n~--~D~~~~Hvgi~~n~~~s~~~~-----~ 153 (251)
T d1g9fa_ 81 PDTKRLADGLAFFLAPIDTKPQTHAGYLGLFNENESGDQVVAVEFDTFRNS--WDPPNPHIGINVNSIRSIKTT-----S 153 (251)
T ss_dssp SCC--CCEEEEEEEEETTCCCCCCGGGTTTCCTTSCCCSCEEEEEECC-CT--TSCSSSEEEEEESSSSCSEEE-----E
T ss_pred CCCCCCCCceEEEEecCCCCCCCccCccCcccccCCCcceEEEEEecccCC--CCCCCCcEeEEecCccccccc-----c
Confidence 877889999999999988877888999999988777788999999999985 599999999999999886543 4
Q ss_pred cccCCCCeEEEEEEEcccccEEEEEEEecCCCCCcceeeEecCcccccccceeEEEeeeccCce--eeEEEEeecccccc
Q 043702 185 VDLKSGDLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGST--EIHSIEWWSFSSSF 262 (711)
Q Consensus 185 ~~~~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastg~~~--~~~~i~sW~f~s~~ 262 (711)
+++.+|+.++|||+||+.+++|+|++.+.. ++..|+++..|||+.+|+++||||||||||... |.|+|++|+|+++.
T Consensus 154 ~~l~~g~~~~v~I~Yd~~~~~L~v~l~~~~-~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~~~~~~h~I~sWsF~s~~ 232 (251)
T d1g9fa_ 154 WDLANNKVAKVLITYDASTSLLVASLVYPS-QRTSNILSDVVDLKTSLPEWVRIGFSAATGLDIPGESHDVLSWSFASNL 232 (251)
T ss_dssp CCCCTTCCEEEEEEEETTTTEEEEEEEEGG-GTEEEEEEEECCC-CCSCSEEEEEEEEEECSSSCCCEEEEEEEEEEEEE
T ss_pred eEecCCCEEEEEEEEECCccEEEEEEecCC-CCcceeEEEEecchhhCCCcEEEEEEeecCCCCCCceeEEEEeEeECCC
Confidence 578999999999999999999999998754 567889999999999999999999999999755 89999999999876
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.4e-52 Score=436.41 Aligned_cols=258 Identities=25% Similarity=0.394 Sum_probs=218.3
Q ss_pred HhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEc
Q 043702 378 ATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 378 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
..++|+..+.||+|+||+||+|++..+++.||||++.......++|.+|+++|++++|||||+++|+|.+++..++||||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 34678889999999999999999988899999999988777788999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhC-CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCC
Q 043702 458 MPNGSLDKALFEA-RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP 536 (711)
Q Consensus 458 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~ 536 (711)
|++|+|.+++... ...+++..++.|+.|||+||+|||+. +|+||||||+||||++++.+||+|||+++........
T Consensus 95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~ 171 (287)
T d1opja_ 95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 171 (287)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE
T ss_pred ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCce
Confidence 9999999999764 45799999999999999999999997 9999999999999999999999999999977655444
Q ss_pred CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhh
Q 043702 537 DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADA 616 (711)
Q Consensus 537 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 616 (711)
......|++.|+|||++.++.++.++|||||||++|||++|..|+..... ..+ +.... ..
T Consensus 172 ~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~----------~~~-~~~~i---------~~ 231 (287)
T d1opja_ 172 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID----------LSQ-VYELL---------EK 231 (287)
T ss_dssp EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC----------HHH-HHHHH---------HT
T ss_pred eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch----------HHH-HHHHH---------hc
Confidence 44445689999999999999999999999999999999998777643211 111 11111 11
Q ss_pred hccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 617 RLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 617 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
......+.....++.+|+.+||+.||++||||+||++.|+..
T Consensus 232 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 232 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 122222333445688899999999999999999999999754
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.3e-52 Score=435.76 Aligned_cols=265 Identities=28% Similarity=0.478 Sum_probs=203.6
Q ss_pred cCHHHHHHHh---------cCCcccceeecCCceEEEEEEeCCCCe---EEEEEEcccCC--CChhhhHHHHHHHHhcCC
Q 043702 370 FSYRELRSAT---------KCFNANRIIGHGAFGTVYKGILPQNGD---IIAVKRCSHNS--QGKDEFLSELSIIGTLRH 435 (711)
Q Consensus 370 ~~~~el~~at---------~~f~~~~~LG~G~fg~Vy~~~~~~~~~---~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H 435 (711)
++|+++..++ ++|+..++||+|+||+||+|+++.+++ .||||++.... ...++|.+|+++|++++|
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H 86 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence 4455555554 345667899999999999999875553 68999886533 334679999999999999
Q ss_pred CCeeeeeeeeeecCeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcC
Q 043702 436 RNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDE 515 (711)
Q Consensus 436 ~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~ 515 (711)
||||+++|+|.+.+.+++|||||++|+|.+++......++|.++++++.|||+||+|||+. +|+||||||+||||+.
T Consensus 87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~ 163 (299)
T d1jpaa_ 87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNS 163 (299)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECT
T ss_pred CCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECC
Confidence 9999999999999999999999999999999988777899999999999999999999997 9999999999999999
Q ss_pred CCcEEEeecCCceecCCCCCCC----cccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccc
Q 043702 516 GFNARLGDFGLARQVEHDKSPD----ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGK 590 (711)
Q Consensus 516 ~~~vkL~DFGla~~~~~~~~~~----~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~ 590 (711)
++.+||+|||+++.+....... .....||+.|||||.+.++.++.++|||||||+||||+| |+.||.....
T Consensus 164 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~---- 239 (299)
T d1jpaa_ 164 NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN---- 239 (299)
T ss_dssp TCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----
T ss_pred CCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH----
Confidence 9999999999999775443221 222458999999999999999999999999999999998 8999965321
Q ss_pred cccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 591 VGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 591 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
..+.. .. .. ......+.+....+.+|+.+||+.||.+||||+||++.|+..
T Consensus 240 ----~~~~~---~i-~~---------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 240 ----QDVIN---AI-EQ---------DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp ----HHHHH---HH-HT---------TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ----HHHHH---HH-Hc---------CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11111 11 11 111112233445678899999999999999999999998753
|
| >d1g7ya_ b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]
Probab=100.00 E-value=7.8e-51 Score=415.45 Aligned_cols=224 Identities=31% Similarity=0.479 Sum_probs=201.0
Q ss_pred cceeeecCCCCCCCeEEeCceEeeCCcEEeCCCCCC---CCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecCCCC
Q 043702 32 TATEFDFGTLTLASLKLLGDAHMNNGSVRLTRDVTV---PYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLNPS 108 (711)
Q Consensus 32 ~~~~f~~~~f~~~~~~~~g~a~~~~g~~~Lt~~~~~---~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~ 108 (711)
...+|+|++|..++|+++|||.+.++.|+||++... ...++|||+|++||+||++.+++++||+|+|+|+|.+....
T Consensus 2 ~~~sF~f~~F~~~~l~l~GdA~~~~~~l~LT~~~~~~~~~~~~~G~a~y~~pv~l~~~~~~~~~sF~t~F~F~i~~~~~~ 81 (253)
T d1g7ya_ 2 DIQSFSFKNFNSSSFILQGDATVSSSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIYDKSTGAVASWATSFTANIFAPNKS 81 (253)
T ss_dssp EEEEEEESSCCSSCEEEEETCEEETTEEECSCBCTTSCBCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCSSGG
T ss_pred cccEEecCCCCcccEEEEeeeEEcCCEEEeCCCCCCCCcccceeEEEEeCCCeEeecCCCCceeeEEEEEEEEEecCCCC
Confidence 357899999999999999999999999999986542 23578999999999999999999999999999999887777
Q ss_pred CCCCceEEEEcCCCCCCCCCCCcccccccCCCC--cceEEEEeecccCCCCCCCCCCeeeEecCCCcccccccCCccccc
Q 043702 109 SIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAG--LGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVD 186 (711)
Q Consensus 109 ~~g~GlaF~l~~~~~~~~~~g~~lgl~~~~~~~--~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~S~~~~~~~~~~~~ 186 (711)
.+||||||+|+|.+..++..||++|+++..+.+ ++.|||||||++|.++ ||+++|||||+|++.|..+. ...
T Consensus 82 ~ggDGlAF~l~~~~~~~~~~~g~lgl~~~~~~~~~~~~vaVEFDT~~n~~~-d~~~~Hvgi~~ns~~s~~~~-----~~~ 155 (253)
T d1g7ya_ 82 SSADGIAFALVPVGSEPKSNSGFLGVFDSDVYDNSAQTVAVEFDTFSNTDW-DPTSRHIGIDVNSIKSIRTA-----SWG 155 (253)
T ss_dssp GCCCEEEEEEEETTCCCCCCGGGTTTCSCSSCCGGGCCEEEEEECSCCTTT-CCSSCEEEEEESSSSCSEEE-----ECC
T ss_pred CCCCceEEEEeCCCCCCCCCcccccccccCCCCCcCceEEEEEeceecCCC-CCCCCcEEEeeCCccccccc-----CCC
Confidence 789999999999888788889999999865443 7899999999999875 99999999999999887643 457
Q ss_pred cCCCCeEEEEEEEcccccEEEEEEEecCCCCCcceeeEecCcccccccceeEEEeeecc---CceeeEEEEeecccccc
Q 043702 187 LKSGDLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQ---GSTEIHSIEWWSFSSSF 262 (711)
Q Consensus 187 ~~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastg---~~~~~~~i~sW~f~s~~ 262 (711)
+.+|+.++|||+||+.+++|+|++++.. +|..|+++..|||+.+||++|||||||+|| ...|.|+|++|+|++++
T Consensus 156 ~~~g~~~~v~I~Yd~~~~~L~v~l~~~~-~~~~~~ls~~vdL~~~l~~~~yvGFSAsTG~~~~~~~~H~IlsWsF~s~l 233 (253)
T d1g7ya_ 156 LANGQNAEILITYNAATSLLVASLVHPS-RRTSYIVSERVDITNELPEYVSIGFSATTGLSEGYTETHDVLSWSFASKL 233 (253)
T ss_dssp CCTTSEEEEEEEEETTTTEEEEEEEETT-TTEEEEEEEECCHHHHSCSEEEEEEEEECCSSSSCCCCCEEEEEEEEEEE
T ss_pred ccCCCEEEEEEEEeCCcEEEEEEEecCC-CCCceEEEEEechhhcCCCcEEEEEEeEcCCCCCcccccEEEEEEeEEeC
Confidence 8999999999999999999999998754 677889999999999999999999999999 56799999999999876
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-51 Score=419.09 Aligned_cols=253 Identities=25% Similarity=0.408 Sum_probs=218.3
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCC
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMP 459 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 459 (711)
++|+..++||+|+||+||+|+++ +++.||||+++......++|++|++++++++||||++++|+|.+++.+++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 57889999999999999999995 67899999998877778899999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCcc
Q 043702 460 NGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDAT 539 (711)
Q Consensus 460 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 539 (711)
+|+|..++......+++..+.+++.|+|+||+|||+. +|+||||||+|||+++++.+||+|||+++.+.........
T Consensus 83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (258)
T d1k2pa_ 83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 159 (258)
T ss_dssp TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence 9999999988778899999999999999999999997 9999999999999999999999999999887665555555
Q ss_pred cccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhc
Q 043702 540 VAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARL 618 (711)
Q Consensus 540 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 618 (711)
...||+.|+|||++..+.++.++|||||||++|||+| |+.||..... .+..... ..+.
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~-----------~~~~~~i-~~~~--------- 218 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-----------SETAEHI-AQGL--------- 218 (258)
T ss_dssp CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH-----------HHHHHHH-HTTC---------
T ss_pred ccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH-----------HHHHHHH-HhCC---------
Confidence 5679999999999999999999999999999999998 8999975421 1111111 1111
Q ss_pred cCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 619 EGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
....+......+.+++.+||+.||++|||++++++.|.+
T Consensus 219 ~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 219 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 111122233567889999999999999999999999864
|
| >d1f9ka_ b.29.1.1 (A:) Legume lectin {Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]
Probab=100.00 E-value=2.6e-50 Score=405.92 Aligned_cols=221 Identities=33% Similarity=0.531 Sum_probs=192.9
Q ss_pred ceeeecCCCC--CCCeEEeCceEee-CCcEEeCCCCCC---CCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecCC
Q 043702 33 ATEFDFGTLT--LASLKLLGDAHMN-NGSVRLTRDVTV---PYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLN 106 (711)
Q Consensus 33 ~~~f~~~~f~--~~~~~~~g~a~~~-~g~~~Lt~~~~~---~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~ 106 (711)
+++|+|++|. .++++|+|||.+. +|.|+||++..+ ...++|||+|++||+||++.+++++||+|+|+|.|.+..
T Consensus 2 ~~SF~f~~F~~~~~~l~l~G~A~~~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~~~~~~~~~sFsT~F~f~i~~~~ 81 (234)
T d1f9ka_ 2 TQSFNFDHFEENSKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWDSTTGNVASFETRFSFNITQPY 81 (234)
T ss_dssp EEEEEESSCCSSCTTEEEEETCEECTTSCEECSCSEETTEECCSCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECCC
T ss_pred ceEEEeCCCCCCCCCEEEeeeEEEcCCCEEEeecCCCCCCcccceeEEEEeCCCEEeeCCCCCcCcceEEEEEEEEECCC
Confidence 5789999996 5789999999986 789999997542 236789999999999999999999999999999998643
Q ss_pred -CCCCCCceEEEEcCCCCCCCCCCCcccccccCCCCcceEEEEeecccCCCCCCCCCCeeeEecCCCcccccccCCcccc
Q 043702 107 -PSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAGLGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINV 185 (711)
Q Consensus 107 -~~~~g~GlaF~l~~~~~~~~~~g~~lgl~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~S~~~~~~~~~~~ 185 (711)
...+||||||+|+|.+.+.+..|+++|+++..+ .++.|||||||++|. +||++||||||+|++.|.+.. .+
T Consensus 82 ~~~~g~dG~aF~i~p~~~~~~~~g~~~g~~~~~~-~~~~vaVEFDT~~n~--~Dp~~nHvgi~~ns~~s~~~~-----~~ 153 (234)
T d1f9ka_ 82 AYPEPADGLTFFMVPPNSPQGEDGGNLGVFKPPE-GDNAFAVEFDTFQNT--WDPQVPHIGIDVNSIVSSKTL-----HF 153 (234)
T ss_dssp SSSCCCEEEEEEEECTTCCCCCSGGGTTTCCSSC-CSCCEEEEEECSCCT--TCCSSSEEEEEESSSSCSEEE-----EC
T ss_pred CCCCccceEEEEECCCCCCcccccccccccCCCC-ccceEEEEEeccccC--CCCCCCcEeEecCCccccccc-----cc
Confidence 345789999999998887788999999987643 367899999999995 599999999999999886543 46
Q ss_pred ccCCCCeEEEEEEEcccccEEEEEEEecCCCCCcceeeEecCcccccc--cceeEEEeeeccC---ceeeEEEEeecccc
Q 043702 186 DLKSGDLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVN--DFMYVGFSGSTQG---STEIHSIEWWSFSS 260 (711)
Q Consensus 186 ~~~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~ls~~vdL~~~l~--~~~~vGFsastg~---~~~~~~i~sW~f~s 260 (711)
++.+|+.++|||+||+.+++|+|++++.. ++..|.|++.|||+++|+ |+||||||||||. ..|.|+|++|+|++
T Consensus 154 ~l~~G~~~~v~I~Yd~~~~~l~V~l~~~~-~~~~~~ls~~idL~~~l~~~~~v~vGFSasTG~~~~~~~~h~I~sWsF~s 232 (234)
T d1f9ka_ 154 QLENGGVANVVIKYDSPTKILNVVLAFHS-VGTVYTLSNIVDLKQEFPNSEWVNVGLSATTGYQKNAVETHEIISWSFTS 232 (234)
T ss_dssp CCCTTCCEEEEEEEETTTTEEEEEEEETT-TTEEEEEEEECCHHHHSTTCSEEEEEEEEEECSSTTCCCEEEEEEEEEEE
T ss_pred cccCCCEEEEEEEEcCCCcEEEEEEEeCC-CCccceEEEEEcHHHhcCCCCEEEEEEEeecCCCCCceeeeEEEEEEeEE
Confidence 89999999999999999999999999865 456789999999999997 5799999999994 57899999999998
Q ss_pred cc
Q 043702 261 SF 262 (711)
Q Consensus 261 ~~ 262 (711)
++
T Consensus 233 ~l 234 (234)
T d1f9ka_ 233 SL 234 (234)
T ss_dssp EC
T ss_pred eC
Confidence 64
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-51 Score=423.87 Aligned_cols=253 Identities=26% Similarity=0.383 Sum_probs=208.7
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCC
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMP 459 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 459 (711)
++|+..+.||+|+||+||+|+++ ++..||||++.......++|.+|++++++++|||||+++|+|.+ +.+++|||||+
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~ 90 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence 46888999999999999999985 57889999998877778899999999999999999999998865 56799999999
Q ss_pred CCCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCc
Q 043702 460 NGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDA 538 (711)
Q Consensus 460 ~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 538 (711)
+|+|.+++.... ..++|.++++|+.||++||+|||+. +|+||||||+||||++++.+||+|||+|+.+........
T Consensus 91 ~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~ 167 (272)
T d1qpca_ 91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167 (272)
T ss_dssp TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCccccc
Confidence 999999875433 3699999999999999999999997 999999999999999999999999999998765544444
Q ss_pred ccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhc
Q 043702 539 TVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARL 618 (711)
Q Consensus 539 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 618 (711)
....||+.|||||++.++.++.++|||||||++|||+||..|+..... ..+.. .....+ .
T Consensus 168 ~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~----------~~~~~-~~i~~~---------~ 227 (272)
T d1qpca_ 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT----------NPEVI-QNLERG---------Y 227 (272)
T ss_dssp TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC----------HHHHH-HHHHTT---------C
T ss_pred cccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC----------HHHHH-HHHHhc---------C
Confidence 556799999999999999999999999999999999997666533211 11111 111111 1
Q ss_pred cCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 619 EGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
....+......+.+|+.+||+.||++||||+||++.|+.
T Consensus 228 ~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 111122233567889999999999999999999998863
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-51 Score=421.85 Aligned_cols=256 Identities=24% Similarity=0.370 Sum_probs=202.5
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC---CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN---SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
++|...+.||+|+||+||+|++. ..||||++... ....+.|.+|+++|++++|||||+++|++.+ +.+++|||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred ccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 57888999999999999999873 35999998753 3445688999999999999999999999865 56899999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC-
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS- 535 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~- 535 (711)
||++|+|.+++...+..+++..+++|+.|||+||+|||+. +|+||||||+||||+.++.+||+|||+|+.......
T Consensus 84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 9999999999988778899999999999999999999997 999999999999999999999999999987654332
Q ss_pred CCcccccCCCcccChhhhcc---CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhH
Q 043702 536 PDATVAAGTMGYLAPEYLLT---GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLT 612 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~---~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 612 (711)
.......||+.|||||++.. +.++.++|||||||+||||+||+.||..... ...+......+...
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~-----------~~~~~~~~~~~~~~- 228 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-----------RDQIIFMVGRGYLS- 228 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----------HHHHHHHHHHTSCC-
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh-----------HHHHHHHHhcCCCC-
Confidence 23345679999999999964 3589999999999999999999999975321 01111111111110
Q ss_pred hhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 613 AADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 613 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
+.+ ..........+.+|+.+||+.||.+|||++||++.|+..
T Consensus 229 ---p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l 270 (276)
T d1uwha_ 229 ---PDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270 (276)
T ss_dssp ---CCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---Ccc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 000 111223345678899999999999999999999998754
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-51 Score=420.47 Aligned_cols=251 Identities=24% Similarity=0.341 Sum_probs=204.2
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEc
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
++|+..+.||+|+||+||+|+++.+|+.||||++.... ...+.+.+|+++|++++||||+++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57899999999999999999999899999999987532 3346789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC-C
Q 043702 458 MPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS-P 536 (711)
Q Consensus 458 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~-~ 536 (711)
|++|+|.+++.. ...+++.+++.++.||++||+|||+. +|+||||||+|||+++++++||+|||+|+.+..... .
T Consensus 85 ~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 85 CSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp CTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred cCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 999999999853 45799999999999999999999998 999999999999999999999999999998754332 2
Q ss_pred CcccccCCCcccChhhhccCCC-CccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhh
Q 043702 537 DATVAAGTMGYLAPEYLLTGRA-TEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615 (711)
Q Consensus 537 ~~~~~~gt~~y~APE~~~~~~~-s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 615 (711)
.....+||+.|||||++.+..+ +.++|||||||++|||++|+.||...... ...+ ..........
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~---------~~~~-~~~~~~~~~~---- 226 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS---------CQEY-SDWKEKKTYL---- 226 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT---------SHHH-HHHHTTCTTS----
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChH---------HHHH-HHHhcCCCCC----
Confidence 3445689999999999988775 67899999999999999999999654221 0111 1111111100
Q ss_pred hhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 616 ARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 616 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
.........+.+|+.+||+.||++|||++|+++
T Consensus 227 -----~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 227 -----NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp -----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 001112245668889999999999999999976
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=422.57 Aligned_cols=256 Identities=26% Similarity=0.440 Sum_probs=203.3
Q ss_pred cCCcccceeecCCceEEEEEEeCCCC----eEEEEEEcccCCC--ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNG----DIIAVKRCSHNSQ--GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILL 453 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~----~~vavK~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 453 (711)
+.|+..++||+|+||+||+|.++.++ ..||||++..... ...+|.+|++++++++|||||+++|+|.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 46888999999999999999986544 4799999875332 34578999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCC
Q 043702 454 VYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHD 533 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~ 533 (711)
|||||.+|+|.+++......++|.++++++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++.+...
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 9999999999999988888899999999999999999999997 9999999999999999999999999999977543
Q ss_pred CC--CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchh
Q 043702 534 KS--PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLL 611 (711)
Q Consensus 534 ~~--~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 611 (711)
.. .......||+.|||||++.++.++.++|||||||++|||++|..|+..... ..+. .
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~----------~~~~----------~ 223 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS----------NHEV----------M 223 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----------HHHH----------H
T ss_pred CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC----------HHHH----------H
Confidence 32 223345689999999999999999999999999999999997666543211 1111 1
Q ss_pred HhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 612 TAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 612 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
..+........+.+....+.+|+.+||+.||++||||.||+++|+..
T Consensus 224 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 224 KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp HHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence 11112222223333456688899999999999999999999999764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-50 Score=413.67 Aligned_cols=245 Identities=27% Similarity=0.420 Sum_probs=207.3
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEccc----CCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSH----NSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
++|+..+.||+|+||+||+|+++.+++.||+|++.. .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 468899999999999999999999999999999864 3344667899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
|||++|+|.+++.. ...+++.++..++.||++||+|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 86 Ey~~~g~L~~~l~~-~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~- 160 (263)
T d2j4za1 86 EYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 160 (263)
T ss_dssp ECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-
T ss_pred eecCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCCc-
Confidence 99999999999965 35699999999999999999999998 99999999999999999999999999998664332
Q ss_pred CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhh
Q 043702 536 PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 615 (711)
.....||+.|||||++.+..++.++|||||||+||||++|+.||..... .+.. .....+.
T Consensus 161 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----------~~~~-~~i~~~~------ 220 (263)
T d2j4za1 161 --RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-----------QETY-KRISRVE------ 220 (263)
T ss_dssp --CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----------HHHH-HHHHTTC------
T ss_pred --ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH-----------HHHH-HHHHcCC------
Confidence 3446799999999999999999999999999999999999999965321 1111 1111111
Q ss_pred hhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 616 ARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 616 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
..++......+.+++.+||+.||.+|||++|+++
T Consensus 221 ----~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 221 ----FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1112222345778889999999999999999987
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-49 Score=414.13 Aligned_cols=249 Identities=25% Similarity=0.357 Sum_probs=209.4
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC-CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcC
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN-SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
++|+..+.||+|+||+||+|++..+|+.||||++... ....+.+.+|++++++++||||+++++++.+++.+++|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4699999999999999999999989999999998763 345677999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCc
Q 043702 459 PNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDA 538 (711)
Q Consensus 459 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 538 (711)
++|+|.+++.+ ..+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+..... ..
T Consensus 100 ~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~ 173 (293)
T d1yhwa1 100 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR 173 (293)
T ss_dssp TTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CB
T ss_pred CCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc-cc
Confidence 99999998865 4699999999999999999999998 999999999999999999999999999998754432 33
Q ss_pred ccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhc
Q 043702 539 TVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARL 618 (711)
Q Consensus 539 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 618 (711)
...+||+.|||||++.+..++.++|||||||++|||++|+.||..... .+........+..
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-----------~~~~~~~~~~~~~-------- 234 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-----------LRALYLIATNGTP-------- 234 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----------HHHHHHHHHHCSC--------
T ss_pred cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH-----------HHHHHHHHhCCCC--------
Confidence 456799999999999999999999999999999999999999965321 1111111111110
Q ss_pred cCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 619 EGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
....+......+.+++.+||+.||.+|||+.|+++
T Consensus 235 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01111222356778999999999999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-50 Score=419.34 Aligned_cols=253 Identities=24% Similarity=0.411 Sum_probs=206.8
Q ss_pred cCCcccc-eeecCCceEEEEEEeCC--CCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEE
Q 043702 380 KCFNANR-IIGHGAFGTVYKGILPQ--NGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLV 454 (711)
Q Consensus 380 ~~f~~~~-~LG~G~fg~Vy~~~~~~--~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 454 (711)
++|...+ +||+|+||+||+|.++. ++..||||++.... ...++|.+|+++|++++|||||+++|+|.. +.+++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 3566666 49999999999998753 35589999987643 234679999999999999999999999965 568999
Q ss_pred EEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCC
Q 043702 455 YDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~ 534 (711)
||||++|+|.+++...+..+++.++++++.|||+||+|||+. +|+||||||+||||+.++.+||+|||+++.+....
T Consensus 87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 999999999999987778899999999999999999999997 99999999999999999999999999999876543
Q ss_pred C--CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchh
Q 043702 535 S--PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLL 611 (711)
Q Consensus 535 ~--~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 611 (711)
. .......||+.|||||++..+.++.++|||||||++|||+| |+.||..... ..+. ..+..+..
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~--------~~~~----~~i~~~~~- 230 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------PEVM----AFIEQGKR- 230 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--------HHHH----HHHHTTCC-
T ss_pred cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH--------HHHH----HHHHcCCC-
Confidence 2 22234568999999999999999999999999999999998 9999975321 1111 11222211
Q ss_pred HhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 612 TAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 612 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
...+.....++.+|+.+||+.||++|||+.+|++.|+.
T Consensus 231 --------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 231 --------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp --------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred --------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11222334567889999999999999999999998863
|
| >d1v6ia_ b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3818]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Peanut (Arachis hypogaea) [TaxId: 3818]
Probab=100.00 E-value=2.6e-49 Score=399.19 Aligned_cols=224 Identities=29% Similarity=0.489 Sum_probs=190.7
Q ss_pred ccceeeecCCCCCC--CeEEeCceEee-CCcEEeCCCCCCCCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecCCC
Q 043702 31 STATEFDFGTLTLA--SLKLLGDAHMN-NGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLNP 107 (711)
Q Consensus 31 ~~~~~f~~~~f~~~--~~~~~g~a~~~-~g~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~ 107 (711)
+.+++|+|++|... +++|+|||.+. +|.|+||++.. .+++|||+|++||+||++.++++++|+|+|+|.|.+.+.
T Consensus 1 a~~~sF~~~~F~~~~~~l~l~GdA~i~~~g~l~LT~~~~--~~~~G~a~y~~Pi~l~~~~~~~~~sf~t~f~f~i~~~~~ 78 (232)
T d1v6ia_ 1 AETVSFNFNSFSEGNPAINFQGDVTVLSNGNIQLTNLNK--VNSVGRVLYAMPVRIWSSATGNVASFLTSFSFEMKDIKD 78 (232)
T ss_dssp CEEEEEEESSCCTTCTTEEEEESCEECTTSCEECSCTTS--TTCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECCSS
T ss_pred CccEEEECCCCCCCCCCEEEeeeeEEcCCCEEEeCCCCC--CCceEEEEcCCCEEccCCCCCccceeEEEEEEEeccCCC
Confidence 35789999999864 59999999886 78999998643 268999999999999999999999999999999998877
Q ss_pred CCCCCceEEEEcCCCCCCCCCCCccccc--ccCCCCcceEEEEeecccCCCCCCCCCCeeeEecCCCcccccccCCcccc
Q 043702 108 SSIGAGLAFVITPDGEQVGSAGGSLGLL--DEKGAGLGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINV 185 (711)
Q Consensus 108 ~~~g~GlaF~l~~~~~~~~~~g~~lgl~--~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~S~~~~~~~~~~~ 185 (711)
..+||||||+|+|.....+..|+.+|+. +..+..++.|||||||++|.+++||+++|||||+|++.|.... ..
T Consensus 79 ~~~gDG~AF~l~~~~~~~~~~~~~g~~~~~~~~~~~~~~~aVEfDT~~n~~~~d~~~~Higid~n~~~s~~~~-----~~ 153 (232)
T d1v6ia_ 79 YDPADGIIFFIAPEDTQIPAGSIGGGTLGVSDTKGAGHFVGVEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTV-----PW 153 (232)
T ss_dssp SBCCCEEEEEEEETTCCCCTTCCCGGGTTTSCTTSEEEEEEEEEECSCCGGGTCCSSCEEEEEEEESSCSEEE-----EC
T ss_pred CCCCCeEEEEEECCCCCCCCCccCCcccccccCCCCCceEEEEEEeEecCCCCCCCCccEeEeeCCccccccc-----cc
Confidence 7899999999999876543333222222 2223337899999999999988999999999999999876532 45
Q ss_pred ccCCCCeEEEEEEEcccccEEEEEEEecCCCCCcceeeEecCcccccccceeEEEeeeccCc-eeeEEEEeeccccccC
Q 043702 186 DLKSGDLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGS-TEIHSIEWWSFSSSFE 263 (711)
Q Consensus 186 ~~~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastg~~-~~~~~i~sW~f~s~~~ 263 (711)
++.+|+.++|||+||+.+++|+|++++.. +..|.++..|||+.+||++|||||||+||.. .|.|+|++|+|++++.
T Consensus 154 ~~~~g~~~~v~I~Yd~~~~~L~V~~~~~~--~~~~~l~~~vdL~~~l~~~vyvGFSAsTG~~~~~~H~I~sWsFss~l~ 230 (232)
T d1v6ia_ 154 NSVSGAVVKVTVIYDSSTKTLSVAVTNDN--GDITTIAQVVDLKAKLPERVKFGFSASGSLGGRQIHLIRSWSFTSTLI 230 (232)
T ss_dssp CCCTTCEEEEEEEEETTTTEEEEEEECTT--SCEEEEEEECCHHHHSCSEEEEEEEEECCSSBCCEEEEEEEEEEEEEC
T ss_pred ccCCCCEEEEEEEEeCCceEEEEEEecCC--CCcceEEEEEchhhccCCcEEEEEEEECCCCCCcccEEEEeEeEEeee
Confidence 78899999999999999999999998654 4578899999999999999999999999975 5999999999999885
|
| >d1dbna_ b.29.1.1 (A:) Legume lectin {Maackia amurensis, leukoagglutinin [TaxId: 37501]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Maackia amurensis, leukoagglutinin [TaxId: 37501]
Probab=100.00 E-value=1.8e-49 Score=402.81 Aligned_cols=226 Identities=31% Similarity=0.471 Sum_probs=196.0
Q ss_pred ccceeeecCCCC--CCCeEEeCceEee-CCcEEeCCCCCC--CCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecC
Q 043702 31 STATEFDFGTLT--LASLKLLGDAHMN-NGSVRLTRDVTV--PYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNL 105 (711)
Q Consensus 31 ~~~~~f~~~~f~--~~~~~~~g~a~~~-~g~~~Lt~~~~~--~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~ 105 (711)
+.+++|+|++|. .+||+|+|||.+. +|.|+||++... ...++|||+|++||+||++.+++++||+|+|+|.|.+.
T Consensus 1 ~~~~sF~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~G~a~y~~pi~l~~~~~~~~~sFst~F~F~i~~~ 80 (239)
T d1dbna_ 1 SDELSFTINNFVPNEADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIWGNTTGSVASFSTSFTFVVKAP 80 (239)
T ss_dssp CCEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCS
T ss_pred CCceEEEeCCCCCCCCCEEEeeeeEECCCCEEEccCCCCCCcccceeEEEeecCCEEccCCCCccceEEEEEEEEEEECC
Confidence 356899999996 4689999999987 689999986432 23679999999999999999999999999999999987
Q ss_pred CCCCCCCceEEEEcCCCCC--CCCCCCcccccccCCCC--cceEEEEeecccCCCC--CCCCCCeeeEecCCCccccccc
Q 043702 106 NPSSIGAGLAFVITPDGEQ--VGSAGGSLGLLDEKGAG--LGFVAVEFDTLMDVEF--SDINGNHVGLDLNSMVSTEVDN 179 (711)
Q Consensus 106 ~~~~~g~GlaF~l~~~~~~--~~~~g~~lgl~~~~~~~--~~~vaVEFDt~~n~~~--~d~~~~Hvgid~ns~~S~~~~~ 179 (711)
....+||||||+|+|.... ++..|++||+++..+.. ++.|||||||++|.++ +||+++|||||+|++.|....
T Consensus 81 ~~~~~gdG~AF~l~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~aVEfDT~~n~~~~~~d~~~~hvgid~n~~~s~~~~- 159 (239)
T d1dbna_ 81 NPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSNSDSSNQIVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIESIKTV- 159 (239)
T ss_dssp STTSCCEEEEEEEECTTCCCCSSSCGGGTTSCSSSCCCTTSCCEEEEEECCCCTTTCTTSCSSCEEEEEESSSSCSEEE-
T ss_pred CCCCCCCCEEEEEeCCCccCCcccCccccccccccCCCcccCeeeeEEeeeecCCCCCCCCCCceeeEEcCCccccccc-
Confidence 7778999999999997753 46788999999865433 7899999999999775 388999999999999886543
Q ss_pred CCccccccCCCCeEEEEEEEcccccEEEEEEEecCCCCCcceeeEecCcccccccceeEEEeeeccCc--eeeEEEEeec
Q 043702 180 LDTINVDLKSGDLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGS--TEIHSIEWWS 257 (711)
Q Consensus 180 ~~~~~~~~~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastg~~--~~~~~i~sW~ 257 (711)
...+.+|+.+.|||+|++.++.|.|.+.+.. ++..|.++..|||+++|+++||||||||||.. .|.|+|++|+
T Consensus 160 ----~~~~~~g~~~~~~i~y~~~~~~l~v~l~~~~-~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~~~H~I~sWs 234 (239)
T d1dbna_ 160 ----QWDWINGGVAFATITYLAPNKTLIASLVYPS-NQTTFSVAASVDLKEILPEWVRVGFSAATGYPTEVETHDVLSWS 234 (239)
T ss_dssp ----ECCCCTTCCEEEEEEEEGGGTEEEEEEEETT-TTEEEEEEEECCHHHHSCSEEEEEEEEEECSGGGCCCCEEEEEE
T ss_pred ----cceEeCCceeEEEEEEcCCCCEEEEEEEecC-CCccEEEEEecchHHhcCCcEEEEEEEeCCCCCCcceeEEEEEE
Confidence 3456789999999999999999999998855 56678999999999999999999999999964 5889999999
Q ss_pred ccccc
Q 043702 258 FSSSF 262 (711)
Q Consensus 258 f~s~~ 262 (711)
|++++
T Consensus 235 Fss~l 239 (239)
T d1dbna_ 235 FTSTL 239 (239)
T ss_dssp EEEEC
T ss_pred eEEeC
Confidence 99864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-50 Score=417.79 Aligned_cols=252 Identities=26% Similarity=0.374 Sum_probs=194.9
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC---ChhhhHHHHHHHHhcCCCCeeeeeeeeee--cCeEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ---GKDEFLSELSIIGTLRHRNLVRLQGWCHE--KGEILLV 454 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV 454 (711)
++|+..+.||+|+||+||+|+++.+|+.||||++..... ..+.+.+|++++++++||||+++++++.+ .+.+++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 579999999999999999999999999999999876433 23568899999999999999999999865 4568999
Q ss_pred EEcCCCCCHHHHHhh---CCCCCChHHHHHHHHHHHHHHHHHHhcc--CCCeeeccCCCCceEEcCCCcEEEeecCCcee
Q 043702 455 YDLMPNGSLDKALFE---ARSPLPWPHRSKILLGVASALAYLHQEC--ENQVIHRDVKTSNIMLDEGFNARLGDFGLARQ 529 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~--~~~ivHrDlkp~NILld~~~~vkL~DFGla~~ 529 (711)
||||++|+|.+++.+ ....+++..++.++.||+.||+|||+.. .++|+||||||+||||+.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 999999999999864 3467999999999999999999999862 23599999999999999999999999999998
Q ss_pred cCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCc
Q 043702 530 VEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGR 609 (711)
Q Consensus 530 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 609 (711)
+..... .....+||+.|||||++.+..++.++|||||||++|||++|+.||..... .+. ......+.
T Consensus 164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~-----------~~~-~~~i~~~~ 230 (269)
T d2java1 164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-----------KEL-AGKIREGK 230 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----------HHH-HHHHHHTC
T ss_pred cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH-----------HHH-HHHHHcCC
Confidence 754432 23446799999999999999999999999999999999999999965321 111 11111111
Q ss_pred hhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 610 LLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 610 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
.. .+ +.....++.+|+.+||+.||.+|||+.|+++
T Consensus 231 ~~-----~~----~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 231 FR-----RI----PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp CC-----CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CC-----CC----CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11 11 1222345778899999999999999999986
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-50 Score=416.65 Aligned_cols=251 Identities=22% Similarity=0.338 Sum_probs=207.3
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEccc-CCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcC
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSH-NSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
+.|+..+.||+|+||+||+|++..+++.||||++.. .....+.+.+|+++|++++|||||++++++.+++.+++|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 358889999999999999999999999999999876 3445678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCc
Q 043702 459 PNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDA 538 (711)
Q Consensus 459 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 538 (711)
++|+|.+++.+....+++.++..++.||+.||+|||+. +|+||||||+|||++.++++||+|||+|+...... ...
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~~ 167 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRR 167 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HHH
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc-ccc
Confidence 99999999877777899999999999999999999998 99999999999999999999999999998653221 112
Q ss_pred ccccCCCcccChhhhc-----cCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHh
Q 043702 539 TVAAGTMGYLAPEYLL-----TGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTA 613 (711)
Q Consensus 539 ~~~~gt~~y~APE~~~-----~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 613 (711)
...+||+.|||||++. ...++.++|||||||++|||++|+.||..... ... ....... ..
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~--------~~~---~~~i~~~-~~--- 232 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP--------MRV---LLKIAKS-EP--- 232 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG--------GGH---HHHHHHS-CC---
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH--------HHH---HHHHHcC-CC---
Confidence 3457999999999984 45688999999999999999999999975422 111 1111111 10
Q ss_pred hhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 614 ADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 614 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
+.+ ..+......+.+|+.+||+.||.+|||++|+++
T Consensus 233 --~~~--~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 233 --PTL--AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp --CCC--SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CCC--CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 111223356778899999999999999999987
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=413.49 Aligned_cols=254 Identities=26% Similarity=0.388 Sum_probs=203.8
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCC
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMP 459 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 459 (711)
++|++.+.||+|+||+||+|+++. +..||||++.......+.|.+|+.++++++|||||+++|+|.+ +..++|||||+
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 468999999999999999999964 5679999998877778899999999999999999999999965 56899999999
Q ss_pred CCCHHHHHhhC-CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCCc
Q 043702 460 NGSLDKALFEA-RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPDA 538 (711)
Q Consensus 460 ~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 538 (711)
+|+|..++... ...++|.++++|+.|||.||+|||+. +|+||||||+|||||+++.+||+|||+++..........
T Consensus 95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 171 (285)
T d1fmka3 95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 171 (285)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCceee
Confidence 99999988653 35699999999999999999999997 999999999999999999999999999998765554455
Q ss_pred ccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhhc
Q 043702 539 TVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARL 618 (711)
Q Consensus 539 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 618 (711)
....||+.|+|||++..+.++.++|||||||++|||++|..|+..... ..+..... ..+ .
T Consensus 172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~----------~~~~~~~i-~~~---------~ 231 (285)
T d1fmka3 172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV----------NREVLDQV-ERG---------Y 231 (285)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC----------HHHHHHHH-HTT---------C
T ss_pred ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC----------HHHHHHHH-Hhc---------C
Confidence 556799999999999999999999999999999999997777643211 11111111 111 1
Q ss_pred cCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 619 EGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 619 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
....+....+++.+++.+||+.||++||+|++|+++|+..
T Consensus 232 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~ 271 (285)
T d1fmka3 232 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271 (285)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhh
Confidence 1122233345678899999999999999999999999864
|
| >d1fnya_ b.29.1.1 (A:) Legume lectin {Black locust (Robinia pseudoacacia) [TaxId: 35938]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Black locust (Robinia pseudoacacia) [TaxId: 35938]
Probab=100.00 E-value=4.6e-49 Score=399.39 Aligned_cols=224 Identities=30% Similarity=0.490 Sum_probs=196.9
Q ss_pred cceeeecCCCC--CCCeEEeCceEee-CCcEEeCCCCCC--CCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecCC
Q 043702 32 TATEFDFGTLT--LASLKLLGDAHMN-NGSVRLTRDVTV--PYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLN 106 (711)
Q Consensus 32 ~~~~f~~~~f~--~~~~~~~g~a~~~-~g~~~Lt~~~~~--~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~ 106 (711)
.+++|+|++|. .++++|+|||.+. +|.|+||++... ...++|||+|++||+||++.+++++||+|+|+|.|.+..
T Consensus 2 ~~~sF~f~~F~~~~~~l~l~G~A~v~~~g~i~LT~~~~~~~~~~~~G~~~y~~Pi~l~~~~~~~~~sF~t~F~F~i~~~~ 81 (237)
T d1fnya_ 2 GSLSFSFPKFAPNQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWDSTTGNVASFVTSFTFIIQAPN 81 (237)
T ss_dssp EEEEEEESSCCTTCTTEEEEETCEECTTSCEECSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCSS
T ss_pred ceEEEEeCCCCCCCCCeEEcccEEEcCCCEEECCCCCCCCcccccEEEEEeCCCeEcccCCCCcceeeEEEEEEEEecCC
Confidence 36899999996 3699999999986 789999986431 236899999999999999999999999999999999887
Q ss_pred CCCCCCceEEEEcCCCCCCCCCCCcccccccCCC--CcceEEEEeecccCCCCCCCCCCeeeEecCCCcccccccCCccc
Q 043702 107 PSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGA--GLGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTIN 184 (711)
Q Consensus 107 ~~~~g~GlaF~l~~~~~~~~~~g~~lgl~~~~~~--~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~S~~~~~~~~~~ 184 (711)
...+||||||+|+|.+..++..||+||+++..+. .++.+||||||+.|.++ ||+++|||||+|++.|..+. .
T Consensus 82 ~~~~gDG~AF~l~~~~~~~~~~gg~lg~~~~~~~~~~~~~~aVefDT~~n~~~-d~~~~Higi~~n~~~s~~~~-----~ 155 (237)
T d1fnya_ 82 PATTADGLAFFLAPVDTQPLDLGGMLGIFKDGYFNKSNQIVAVEFDTFSNGDW-DPKGRHLGINVNSIESIKTV-----P 155 (237)
T ss_dssp TTSCCEEEEEEEEETTCCCCCCGGGTTTCC---CCTTSCCEEEEEECSCCTTT-CCSSSEEEEEESSSSCSEEE-----E
T ss_pred CCCCCCeeEEEEcCCCCCcccccCcccccCCCCccCccceEEEEeccccccCC-CCCCceEEEecCCCcccccc-----c
Confidence 7889999999999988877888999999875432 27899999999999876 99999999999999886543 3
Q ss_pred cccCCCCeEEEEEEEcccccEEEEEEEecCCCCCcceeeEecCcccccccceeEEEeeecc---CceeeEEEEeeccccc
Q 043702 185 VDLKSGDLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQ---GSTEIHSIEWWSFSSS 261 (711)
Q Consensus 185 ~~~~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastg---~~~~~~~i~sW~f~s~ 261 (711)
.++.+|+.++|||+||+.+++|.|++.+.+ ++..++++..|||+.+||++|||||||+|| ...|.|+|++|+|+++
T Consensus 156 ~~~~~g~~~~v~I~Y~~~~~~l~v~l~~~~-~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~s~~~e~H~I~sWsF~s~ 234 (237)
T d1fnya_ 156 WNWTNGEVANVFISYEASTKSLTASLVYPS-LETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGYVQTNDVLSWSFESN 234 (237)
T ss_dssp CCCCTTCCEEEEEEEEGGGTEEEEEEEETT-TTEEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCCCCCEEEEEEEEEE
T ss_pred ccccCCcEEEEEEEEeCCccEEEEEEEeCC-CCcceeEEEEechhhcCCCcEEEEEEEECCCCCCcccccEEEEeEeEEe
Confidence 567899999999999999999999998865 456789999999999999999999999999 5678999999999997
Q ss_pred c
Q 043702 262 F 262 (711)
Q Consensus 262 ~ 262 (711)
+
T Consensus 235 l 235 (237)
T d1fnya_ 235 L 235 (237)
T ss_dssp E
T ss_pred C
Confidence 6
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=422.08 Aligned_cols=254 Identities=27% Similarity=0.428 Sum_probs=207.0
Q ss_pred cCCcccceeecCCceEEEEEEeCCCC-----eEEEEEEccc--CCCChhhhHHHHHHHHhc-CCCCeeeeeeeeeecCeE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNG-----DIIAVKRCSH--NSQGKDEFLSELSIIGTL-RHRNLVRLQGWCHEKGEI 451 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~-----~~vavK~~~~--~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 451 (711)
++|++.++||+|+||+||+|++...+ ..||+|++.. .......+.+|+.+|.++ +|||||+++++|.+.+.+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 57889999999999999999986443 3699998865 334456899999999998 799999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhhCC----------------------CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCC
Q 043702 452 LLVYDLMPNGSLDKALFEAR----------------------SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTS 509 (711)
Q Consensus 452 ~lV~Ey~~~gsL~~~l~~~~----------------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~ 509 (711)
++|||||++|+|.++|+..+ ..+++..++.++.||++||+|||+. +|+||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchh
Confidence 99999999999999997643 2489999999999999999999997 9999999999
Q ss_pred ceEEcCCCcEEEeecCCceecCCCCCC-CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCcccccc
Q 043702 510 NIMLDEGFNARLGDFGLARQVEHDKSP-DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITG 587 (711)
Q Consensus 510 NILld~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~ 587 (711)
|||++.++.+||+|||+|+........ ......||+.|||||++.++.++.++|||||||+||||+| |+.||......
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999999876554432 2234568999999999999999999999999999999998 89999653221
Q ss_pred ccccccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 043702 588 VGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLV 656 (711)
Q Consensus 588 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 656 (711)
..+ ......+ .....+......+.+|+.+||+.||++|||++||+++|.
T Consensus 274 -------~~~----~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 -------ANF----YKLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp -------HHH----HHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -------HHH----HHHHhcC---------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 111 1111111 111222233456888999999999999999999999985
|
| >d1n47a_ b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]
Probab=100.00 E-value=1.1e-48 Score=394.73 Aligned_cols=221 Identities=33% Similarity=0.514 Sum_probs=194.1
Q ss_pred cceeeecCCCC--CCCeEEeCceEee-CCcEEeCCCCCC--CCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecCC
Q 043702 32 TATEFDFGTLT--LASLKLLGDAHMN-NGSVRLTRDVTV--PYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLN 106 (711)
Q Consensus 32 ~~~~f~~~~f~--~~~~~~~g~a~~~-~g~~~Lt~~~~~--~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~ 106 (711)
.+++|+|++|. .++++|+|||.+. +|.|+||++... ..+++|||+|++||+||+.. .+++|+|+|+|.|....
T Consensus 2 ~~~sF~f~~F~~~~~~l~l~G~A~i~~~g~i~LT~~~~~~~~~~~~G~~~y~~Pv~l~~~~--~~~sF~t~f~f~i~~~~ 79 (233)
T d1n47a_ 2 ESTSFSFTNFNPNQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIHDNT--TLASFTTSFSFVMAAPA 79 (233)
T ss_dssp EEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCBSSSSBCTTCEEEEEESSCEECBCSS--CBCEEEEEEEEECCCSS
T ss_pred CceEEEeCCCCCCCCCeEEecceEECCCCEEEecCCCCCCcCCCceEEEEeCCCEEccCCC--eeeeEEEEEEEEEeCCC
Confidence 46899999995 4799999999986 789999987542 23689999999999999863 67999999999998877
Q ss_pred CCCCCCceEEEEcCCCCCCCCCCCcccccccCCCC--cceEEEEeecccCCCCCCCCCCeeeEecCCCcccccccCCccc
Q 043702 107 PSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAG--LGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTIN 184 (711)
Q Consensus 107 ~~~~g~GlaF~l~~~~~~~~~~g~~lgl~~~~~~~--~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~S~~~~~~~~~~ 184 (711)
...+||||||+|+|....++..||+||+++..+.+ ++.|||||||++|. +||+++|||||+|++.|.... .
T Consensus 80 ~~~~gDGlAF~l~~~~~~~~~~gg~lGl~~~~~~~~~~~~~aVefDT~~n~--~d~~~~higi~~n~~~s~~~~-----~ 152 (233)
T d1n47a_ 80 AAAVADGLAFFLAPPDTQPQARGGFLGLFADRAHDASYQTVAVEFDTYSNA--WDPNYTHIGIDTNGIESKKTT-----P 152 (233)
T ss_dssp TTSCCEEEEEEEECTTCCCCCCGGGTTTCSSSSCCGGGCCEEEEEECSCCT--TSCSSCEEEEEESSSSCSEEE-----E
T ss_pred CCCCCCceEEEECCCCCCCCCCCCccccccccCCCCcCceEEEEEEeeecC--CCCCCCceeEccCCccccccc-----c
Confidence 77899999999999888778889999999765433 78899999999986 599999999999999886543 4
Q ss_pred cccCCCCeEEEEEEEcccccEEEEEEEecCCCCCcceeeEecCcccccccceeEEEeeecc---CceeeEEEEeeccccc
Q 043702 185 VDLKSGDLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQ---GSTEIHSIEWWSFSSS 261 (711)
Q Consensus 185 ~~~~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastg---~~~~~~~i~sW~f~s~ 261 (711)
+.+.+|+.++|||+||+.+++|.|++.+.. ++..|.++..|||+++||++|||||||+|| ...|.|+|++|+|+++
T Consensus 153 ~~l~~g~~~~v~I~Y~~~~~~l~v~l~~~~-~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~~~~H~I~sWsFss~ 231 (233)
T d1n47a_ 153 FDMVYGEKANIVITYQASTKALAASLVFPV-SQTSYAVSARVDLRDILPEYVRVGFSATTGLNAGVVETHDIVSWSFAVS 231 (233)
T ss_dssp CCCCTTSCEEEEEEEETTTTEEEEEEEETT-TTEEEEEEEECCGGGTSCSEEEEEEEEEECSSTTCCCCCEEEEEEEEEE
T ss_pred ceecCCCEEEEEEEEcCCCeEEEEEEEeCC-CCccEEEEEEechHHhcCCcEEEEEEEecCCCCCcccccEEEEEEeEEE
Confidence 578899999999999999999999998765 567889999999999999999999999999 4679999999999987
Q ss_pred c
Q 043702 262 F 262 (711)
Q Consensus 262 ~ 262 (711)
+
T Consensus 232 l 232 (233)
T d1n47a_ 232 L 232 (233)
T ss_dssp E
T ss_pred c
Confidence 5
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=411.86 Aligned_cols=245 Identities=26% Similarity=0.391 Sum_probs=197.6
Q ss_pred ceeecCCceEEEEEEeCC--CCeEEEEEEcccCC---CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcCCC
Q 043702 386 RIIGHGAFGTVYKGILPQ--NGDIIAVKRCSHNS---QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLMPN 460 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~~--~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 460 (711)
++||+|+||+||+|.+.. .++.||||++.... ...++|.+|+++|++++|||||+++|+|.. +..++|||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998743 45789999986532 224679999999999999999999999965 567899999999
Q ss_pred CCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCC--Cc
Q 043702 461 GSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP--DA 538 (711)
Q Consensus 461 gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~--~~ 538 (711)
|+|.+++.. ...+++.++++|+.|||.||+|||+. +|+||||||+||||+.++.+||+|||+++.+...... ..
T Consensus 92 g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 92 GPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp EEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 999999865 45699999999999999999999997 9999999999999999999999999999987544332 22
Q ss_pred ccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhhhhh
Q 043702 539 TVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADAR 617 (711)
Q Consensus 539 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 617 (711)
....||+.|||||.+..+.++.++|||||||++|||++ |+.||..... ..+. .....+.
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~--------~~~~----~~i~~~~-------- 227 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SEVT----AMLEKGE-------- 227 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHH----HHHHTTC--------
T ss_pred cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH--------HHHH----HHHHcCC--------
Confidence 33569999999999999999999999999999999998 8999975321 1111 1112221
Q ss_pred ccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 043702 618 LEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLV 656 (711)
Q Consensus 618 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 656 (711)
....+.....++.+|+.+||+.||++|||+++|++.|+
T Consensus 228 -~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~ 265 (277)
T d1xbba_ 228 -RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265 (277)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred -CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence 11122233456778999999999999999999998885
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-49 Score=406.56 Aligned_cols=246 Identities=24% Similarity=0.374 Sum_probs=196.9
Q ss_pred cccceeecCCceEEEEEEeCCCCeEEEEEEcccCC---CChhhhHHHHHHHHhcCCCCeeeeeeeeee----cCeEEEEE
Q 043702 383 NANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---QGKDEFLSELSIIGTLRHRNLVRLQGWCHE----KGEILLVY 455 (711)
Q Consensus 383 ~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 455 (711)
+..++||+|+||+||+|++..+++.||+|++.... ...+.+.+|+++|++++|||||++++++.. +..+++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 56678999999999999999899999999987533 234578899999999999999999999865 34689999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEc-CCCcEEEeecCCceecCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLD-EGFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld-~~~~vkL~DFGla~~~~~~~ 534 (711)
|||++|+|.+++.+ ...+++..++.++.||++||+|||+. +.+|+||||||+||||+ +++.+||+|||+++.....
T Consensus 92 E~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~- 168 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 168 (270)
T ss_dssp ECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred eCCCCCcHHHHHhc-cccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-
Confidence 99999999999965 35799999999999999999999987 22399999999999996 5789999999999864332
Q ss_pred CCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhh
Q 043702 535 SPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614 (711)
Q Consensus 535 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 614 (711)
.....+||+.|||||++.+ .++.++|||||||++|||++|+.||..... ..+ +......+.....
T Consensus 169 --~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~----------~~~-~~~~i~~~~~~~~- 233 (270)
T d1t4ha_ 169 --FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN----------AAQ-IYRRVTSGVKPAS- 233 (270)
T ss_dssp --SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----------HHH-HHHHHTTTCCCGG-
T ss_pred --ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc----------HHH-HHHHHHcCCCCcc-
Confidence 2345689999999998865 699999999999999999999999964321 111 1111111111111
Q ss_pred hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 615 DARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 615 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
+ +.....++.+|+.+||+.||++|||++|+++
T Consensus 234 ---~----~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 234 ---F----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ---G----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---c----CccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1 1112234678899999999999999999986
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-49 Score=416.51 Aligned_cols=200 Identities=29% Similarity=0.444 Sum_probs=179.4
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
.++|+..++||+|+||+||+|++..+|+.||+|++.... ...+.+.+|+.+|++++|||||+++++|.+++++++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 467999999999999999999999899999999987532 335678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCC
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP 536 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~ 536 (711)
||++|+|.+++.+. ..+++..+..++.|++.||.|||+. ++|+||||||+||||++++.+||+|||+|+.+....
T Consensus 85 y~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-- 159 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 159 (322)
T ss_dssp CCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT--
T ss_pred cCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc--
Confidence 99999999999753 4699999999999999999999974 289999999999999999999999999998764332
Q ss_pred CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccc
Q 043702 537 DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKE 584 (711)
Q Consensus 537 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~ 584 (711)
....+||+.|||||++.+..|+.++||||+||++|||++|+.||...
T Consensus 160 -~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 160 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp -C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred -cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 23458999999999999999999999999999999999999999654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-49 Score=411.64 Aligned_cols=248 Identities=21% Similarity=0.287 Sum_probs=204.7
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEccc----CCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSH----NSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
++|+..+.||+|+||+||+|++..+|+.||||++.. .....+.+.+|+++|++++||||+++++++.+++.+++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 468999999999999999999998999999999864 2344567999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
|||++|+|.+++.. .+.+++..++.++.|++.||+|||+. +|+||||||+||||++++.+||+|||+|+.+.....
T Consensus 88 Ey~~gg~L~~~~~~-~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp CCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EccCCCCHHHhhhc-cCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 99999999998864 45799999999999999999999998 999999999999999999999999999998764332
Q ss_pred -CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhh
Q 043702 536 -PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614 (711)
Q Consensus 536 -~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 614 (711)
......+||+.|||||++.+..++.++|||||||++|||++|+.||..... .+ +......+..
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----------~~-~~~~i~~~~~---- 227 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-----------YL-IFQKIIKLEY---- 227 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HH-HHHHHHTTCC----
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH-----------HH-HHHHHHcCCC----
Confidence 233456799999999999999999999999999999999999999975321 11 1111111111
Q ss_pred hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 615 DARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 615 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
.++.....++.+|+.+||+.||.+|||++|+++
T Consensus 228 ------~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 ------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp ------CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred ------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 112222345778999999999999999998743
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-48 Score=411.46 Aligned_cols=253 Identities=25% Similarity=0.430 Sum_probs=204.4
Q ss_pred CCcccceeecCCceEEEEEEeCCCCe----EEEEEEccc--CCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEE
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGD----IIAVKRCSH--NSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLV 454 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~----~vavK~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 454 (711)
+|+..++||+|+||+||+|.+..+|+ .||+|++.. ..+..++|.+|++++++++|||||+++|+|.++ ..+++
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v 88 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI 88 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEE
Confidence 58899999999999999999876665 589998865 334567899999999999999999999999865 57888
Q ss_pred EEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCC
Q 043702 455 YDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~ 534 (711)
+||+.+|+|.+++......+++..+++++.|||.||+|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 89 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred EEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 999999999999988888999999999999999999999997 99999999999999999999999999999876544
Q ss_pred CC-CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhH
Q 043702 535 SP-DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLT 612 (711)
Q Consensus 535 ~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 612 (711)
.. ......||+.|||||++.++.++.++|||||||+||||+| |+.||..... ..+.. ....+
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~--------~~~~~----~i~~~---- 229 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--------SEISS----ILEKG---- 229 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG--------GGHHH----HHHHT----
T ss_pred ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH--------HHHHH----HHHcC----
Confidence 32 2334568999999999999999999999999999999998 7888865321 11111 11111
Q ss_pred hhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 613 AADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 613 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
.....+......+.+|+.+||+.||.+|||++||++.|+..
T Consensus 230 -----~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 230 -----ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp -----CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 11122223345678899999999999999999999987653
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=405.03 Aligned_cols=253 Identities=24% Similarity=0.400 Sum_probs=197.6
Q ss_pred cCCcccceeecCCceEEEEEEeCCC---CeEEEEEEcccCCC--ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQN---GDIIAVKRCSHNSQ--GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLV 454 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~---~~~vavK~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 454 (711)
++|+..+.||+|+||.||+|++..+ +..||||++..... ..+.|.+|++++++++||||++++|+|. ++.+++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 5788899999999999999998643 35789999865332 3467999999999999999999999996 4678999
Q ss_pred EEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCC
Q 043702 455 YDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~ 534 (711)
|||+++|+|.+++......+++..++.++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 999999999999888888899999999999999999999998 99999999999999999999999999999876555
Q ss_pred CCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHh
Q 043702 535 SPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTA 613 (711)
Q Consensus 535 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 613 (711)
........||+.|+|||++..+.++.++|||||||++|||++ |++||..... ..+...+ ..+..
T Consensus 163 ~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~--------~~~~~~i----~~~~~--- 227 (273)
T d1mp8a_ 163 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--------NDVIGRI----ENGER--- 227 (273)
T ss_dssp --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG--------GGHHHHH----HTTCC---
T ss_pred ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH--------HHHHHHH----HcCCC---
Confidence 445556678999999999999999999999999999999998 8999875432 1121111 11111
Q ss_pred hhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 614 ADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 614 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
...+......+.+|+.+||+.||.+|||++||++.|+.
T Consensus 228 ------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 228 ------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11222334567889999999999999999999998864
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=9.9e-48 Score=411.99 Aligned_cols=253 Identities=22% Similarity=0.310 Sum_probs=210.0
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC-CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEc
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
.++|++.+.||+|+||+||+|++..+|+.||||++.... ...+.+.+|+++|++++|||||++++++.+++.+++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999999899999999987643 3356788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEc--CCCcEEEeecCCceecCCCCC
Q 043702 458 MPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLD--EGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 458 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld--~~~~vkL~DFGla~~~~~~~~ 535 (711)
|++|+|.+++......+++..+..|+.||+.||+|||+. +|+||||||+||||+ .++.+||+|||+++.+....
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~- 180 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ- 180 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS-
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccccc-
Confidence 999999999977777899999999999999999999998 999999999999995 46789999999999875443
Q ss_pred CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhh
Q 043702 536 PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 615 (711)
......||+.|||||++.+..++.++|||||||++|||++|+.||..... .+....... +..
T Consensus 181 -~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----------~~~~~~i~~-~~~----- 242 (350)
T d1koaa2 181 -SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-----------DETLRNVKS-CDW----- 242 (350)
T ss_dssp -CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHHHHHHH-TCC-----
T ss_pred -ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH-----------HHHHHHHHh-CCC-----
Confidence 23456799999999999999999999999999999999999999965321 111111111 110
Q ss_pred hhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 616 ARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 616 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.............+.+|+.+||+.||.+|||++|+++.
T Consensus 243 -~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 243 -NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp -CSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred -CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000011123457788999999999999999999984
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-48 Score=411.21 Aligned_cols=262 Identities=26% Similarity=0.413 Sum_probs=211.8
Q ss_pred HHHHHHhcCCcccceeecCCceEEEEEEeCC-----CCeEEEEEEcccCCC--ChhhhHHHHHHHHhcCCCCeeeeeeee
Q 043702 373 RELRSATKCFNANRIIGHGAFGTVYKGILPQ-----NGDIIAVKRCSHNSQ--GKDEFLSELSIIGTLRHRNLVRLQGWC 445 (711)
Q Consensus 373 ~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~ 445 (711)
.+++...++|+..+.||+|+||+||+|+++. +++.||||++..... ..++|.+|+++|++++||||++++++|
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 3444456789999999999999999999753 457899999875332 246799999999999999999999999
Q ss_pred eecCeEEEEEEcCCCCCHHHHHhhCC-----------------------CCCChHHHHHHHHHHHHHHHHHHhccCCCee
Q 043702 446 HEKGEILLVYDLMPNGSLDKALFEAR-----------------------SPLPWPHRSKILLGVASALAYLHQECENQVI 502 (711)
Q Consensus 446 ~~~~~~~lV~Ey~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iv 502 (711)
...+..++||||+++|+|.++++... ..+++.++++|+.|++.||+|||+. +|+
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeE
Confidence 99999999999999999999996432 2489999999999999999999997 999
Q ss_pred eccCCCCceEEcCCCcEEEeecCCceecCCCCC-CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCC-CC
Q 043702 503 HRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS-PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGR-RP 580 (711)
Q Consensus 503 HrDlkp~NILld~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~-~P 580 (711)
||||||+|||||.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|. +|
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 999999999999999999999999987644332 2334467899999999999999999999999999999999986 56
Q ss_pred CccccccccccccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 581 IEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 581 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
|..... .+.... ...+... ..+.....++.+|+.+||+.||++||||.||+++|+..
T Consensus 243 ~~~~~~-----------~e~~~~-v~~~~~~---------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 243 YYGMAH-----------EEVIYY-VRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TTTSCH-----------HHHHHH-HHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCCH-----------HHHHHH-HHcCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 654321 111111 1222211 12223345688899999999999999999999999865
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-48 Score=409.69 Aligned_cols=249 Identities=28% Similarity=0.427 Sum_probs=204.0
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCC----hhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQG----KDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
+.|+..+.||+|+||+||+|++..+++.||||++...... .+.+.+|+++|++++|||||++++++.+++.+++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 3588999999999999999999989999999998764322 346889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
|||++|+|..++.. +..+++.+++.++.||+.||.|||+. +|+||||||+||||++++.+||+|||+++.....
T Consensus 95 E~~~~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-- 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (309)
T ss_dssp ECCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred EecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC--
Confidence 99999999876644 46799999999999999999999998 9999999999999999999999999999865432
Q ss_pred CCcccccCCCcccChhhhcc---CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhH
Q 043702 536 PDATVAAGTMGYLAPEYLLT---GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLT 612 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~---~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 612 (711)
....||+.|||||++.+ +.|+.++|||||||++|||++|+.||..... .+........ .
T Consensus 169 ---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~-----------~~~~~~i~~~-~--- 230 (309)
T d1u5ra_ 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----------MSALYHIAQN-E--- 230 (309)
T ss_dssp ---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----------HHHHHHHHHS-C---
T ss_pred ---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH-----------HHHHHHHHhC-C---
Confidence 33579999999999864 4689999999999999999999999964321 1111111111 1
Q ss_pred hhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--HHhC
Q 043702 613 AADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ--MLVG 657 (711)
Q Consensus 613 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~--~L~~ 657 (711)
.+.+. +......+.+++.+||+.||.+|||++|+++ ++..
T Consensus 231 --~~~~~---~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 231 --SPALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp --CCCCS---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred --CCCCC---CCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 11111 1112345778899999999999999999987 4543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-48 Score=412.46 Aligned_cols=252 Identities=22% Similarity=0.374 Sum_probs=192.5
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
.+.|+..+.||+|+||+||+|+++.+++.||||++.... .....+.+|+++|++++||||+++++++.+++.+++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 456999999999999999999999899999999987532 334568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEc---CCCcEEEeecCCceecCCC
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLD---EGFNARLGDFGLARQVEHD 533 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld---~~~~vkL~DFGla~~~~~~ 533 (711)
||++|+|.++|.. ...+++.++..++.||+.||+|||+. +|+||||||+|||+. +++.+||+|||+++.....
T Consensus 88 ~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 88 LVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp CCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred ccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 9999999999964 56799999999999999999999998 999999999999994 5789999999999876543
Q ss_pred CCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHh
Q 043702 534 KSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTA 613 (711)
Q Consensus 534 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 613 (711)
.. ....+||+.|||||++.+..++.++|||||||++|||++|+.||..... ..+.. ... .+..
T Consensus 164 ~~--~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------~~~~~---~i~-~~~~--- 226 (307)
T d1a06a_ 164 SV--LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND--------AKLFE---QIL-KAEY--- 226 (307)
T ss_dssp -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHH---HHH-TTCC---
T ss_pred Ce--eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH--------HHHHH---HHh-ccCC---
Confidence 32 3346799999999999999999999999999999999999999965321 11111 111 1110
Q ss_pred hhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 614 ADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 614 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.............+.+++.+||+.||.+|||++|+++.
T Consensus 227 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 227 ---EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp ---CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ---CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 01111111223467789999999999999999999984
|
| >d1ukga_ b.29.1.1 (A:) Legume lectin {Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]
Probab=100.00 E-value=5.9e-47 Score=384.79 Aligned_cols=224 Identities=30% Similarity=0.499 Sum_probs=193.9
Q ss_pred cceeeecCCCC--CCCeEEeCceEeeCCcEEeCCCCCC---CCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecCC
Q 043702 32 TATEFDFGTLT--LASLKLLGDAHMNNGSVRLTRDVTV---PYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLN 106 (711)
Q Consensus 32 ~~~~f~~~~f~--~~~~~~~g~a~~~~g~~~Lt~~~~~---~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~ 106 (711)
.+++|+|++|. .++|+|+|||.+.++.|+||++... ...++|||+|++||+||+..++++++|+|+|+|+|....
T Consensus 2 ~~~sF~f~~F~~~~~~l~l~G~A~i~~~~i~LT~~~~~~~~~~~~~G~~~y~~Pi~l~~~~~~~~~sF~t~F~f~i~~~~ 81 (241)
T d1ukga_ 2 DSLSFGFPTFPSDQKNLIFQGDAQIKNNAVQLTKTDSNGNPVASTVGRILFSAQVHLWEKSSSRVANFQSQFSFSLKSPL 81 (241)
T ss_dssp CEEEEEESSCCSCCSSEEEEETCEEETTEEECSCBCTTSCBCSSEEEEEEESSCEECEETTTTEEEEEEEEEEEEEECSS
T ss_pred ccEEEEeCCCCCCCCCEEEeeeEEEeCCEEEeCCCCCCCCccccceEEEEeCCCeecccCCCCceeeeEEEEEEEEecCC
Confidence 46899999995 4689999999999999999986543 247899999999999999999999999999999998654
Q ss_pred CCCCCCceEEEEcCCCCC--CCCCCCcccccccCCCC----cceEEEEeecccCCCC--CCCCCCeeeEecCCCcccccc
Q 043702 107 PSSIGAGLAFVITPDGEQ--VGSAGGSLGLLDEKGAG----LGFVAVEFDTLMDVEF--SDINGNHVGLDLNSMVSTEVD 178 (711)
Q Consensus 107 ~~~~g~GlaF~l~~~~~~--~~~~g~~lgl~~~~~~~----~~~vaVEFDt~~n~~~--~d~~~~Hvgid~ns~~S~~~~ 178 (711)
...|||+|||+++.... .+..|+++|+++....+ ++.|||||||++|.+. +||+++|||||+|++.|.+.
T Consensus 82 -~~~~~g~~f~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~n~~vaVEfDt~~n~~~~~~~~~~~Higid~n~~~s~~~- 159 (241)
T d1ukga_ 82 -SNGADGIAFFIAPPDTTIPSGSGGGLLGLFAPGTAQNTSANQVIAVEFDTFYAQDSNTWDPNYPHIGIDVNSIRSVKT- 159 (241)
T ss_dssp -SSCCCEEEEEEECTTCCCCTTCCGGGTTTSCGGGTTCGGGCCCEEEEEECCCCTTTCTTSCSSCEEEEEESSSSCSEE-
T ss_pred -CCCCCceEEEEeCCCCCcccccCcccccccccccccCCccCcccceeccCEecCccCCCCCCCccEeeecCCcccccc-
Confidence 46799999999986643 35677888887654322 7899999999998764 35899999999999998653
Q ss_pred cCCccccccCCCCeEEEEEEEcccccEEEEEEEecCCCCCcceeeEecCcccccccceeEEEeeeccCceeeEEEEeecc
Q 043702 179 NLDTINVDLKSGDLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGSTEIHSIEWWSF 258 (711)
Q Consensus 179 ~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastg~~~~~~~i~sW~f 258 (711)
...++.+|..++|||+||+.+++|+|++++.. +..|.+++.|||+++|+++||||||||||...|.|+|++|+|
T Consensus 160 ----~~~~~~~g~~~~v~I~Yd~~~~~L~v~~~~~~--~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~~~~H~IlsWsF 233 (241)
T d1ukga_ 160 ----VKWDRRDGQSLNVLVTFNPSTRNLDVVATYSD--GTRYEVSYEVDVRSVLPEWVRVGFSAASGEQYQTHTLESWSF 233 (241)
T ss_dssp ----EECCCCTTCCEEEEEEEETTTTEEEEEEEETT--CCEEEEEEECCGGGTSCSEEEEEEEEEESSSCCEEEEEEEEE
T ss_pred ----cccccCCCcEEEEEEEEeCCCcEEEEEEccCC--CCceEEEEEEehHHhCCCcEEEEEEEecCCCCceeEEEEeEE
Confidence 34578899999999999999999999998753 567889999999999999999999999999999999999999
Q ss_pred ccccC
Q 043702 259 SSSFE 263 (711)
Q Consensus 259 ~s~~~ 263 (711)
++++.
T Consensus 234 ss~l~ 238 (241)
T d1ukga_ 234 TSTLL 238 (241)
T ss_dssp EEEEE
T ss_pred EEEee
Confidence 99875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-48 Score=397.90 Aligned_cols=247 Identities=31% Similarity=0.441 Sum_probs=197.2
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeee-cCeEEEEEEcC
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHE-KGEILLVYDLM 458 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV~Ey~ 458 (711)
++|+..+.||+|+||.||+|.+ .|..||||+++.. ...+++.+|++++++++||||++++|+|.+ .+.+++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 4678889999999999999999 4789999999653 446789999999999999999999999865 45689999999
Q ss_pred CCCCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC
Q 043702 459 PNGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD 537 (711)
Q Consensus 459 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 537 (711)
++|+|.++|.... ..++|..+++|+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---- 156 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 156 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC----
Confidence 9999999997543 3599999999999999999999997 9999999999999999999999999999875432
Q ss_pred cccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCchhHhhhh
Q 043702 538 ATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADA 616 (711)
Q Consensus 538 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 616 (711)
.....+|+.|+|||++.++.++.++|||||||++|||+| |+.||..... ..+..++ ..+
T Consensus 157 ~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~--------~~~~~~i----~~~-------- 216 (262)
T d1byga_ 157 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KDVVPRV----EKG-------- 216 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--------GGHHHHH----TTT--------
T ss_pred CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH--------HHHHHHH----HcC--------
Confidence 223458999999999999999999999999999999998 6777754321 1222222 111
Q ss_pred hccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 617 RLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 617 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
....++.....++.+|+.+||+.||.+||||.+|+++|+.
T Consensus 217 -~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~ 256 (262)
T d1byga_ 217 -YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256 (262)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 1222233334567789999999999999999999999975
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=394.84 Aligned_cols=250 Identities=22% Similarity=0.291 Sum_probs=206.3
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC-------CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS-------QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEI 451 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 451 (711)
.+.|+..+.||+|+||+||+|+++.+|+.||||++.... ...+.+.+|+++|++++|||||++++++.+++.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 357999999999999999999999899999999986421 1246789999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCC----cEEEeecCCc
Q 043702 452 LLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGF----NARLGDFGLA 527 (711)
Q Consensus 452 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~----~vkL~DFGla 527 (711)
++|||||++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||++
T Consensus 89 ~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhh
Confidence 9999999999999999653 4799999999999999999999998 999999999999998776 4999999999
Q ss_pred eecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhc
Q 043702 528 RQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHRE 607 (711)
Q Consensus 528 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~ 607 (711)
+....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+........
T Consensus 165 ~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----------~~~~~~i~~~ 231 (293)
T d1jksa_ 165 HKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-----------QETLANVSAV 231 (293)
T ss_dssp EECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHHHHHHTT
T ss_pred hhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH-----------HHHHHHHHhc
Confidence 88754432 3345799999999999999999999999999999999999999975321 1111111111
Q ss_pred -CchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 608 -GRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 608 -~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
........ ......+.+++.+||+.||.+|||++|+++
T Consensus 232 ~~~~~~~~~--------~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 232 NYEFEDEYF--------SNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CCCCCHHHH--------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCCCchhc--------CCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00011110 112345778999999999999999999987
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=9.7e-48 Score=412.38 Aligned_cols=255 Identities=21% Similarity=0.303 Sum_probs=211.6
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC-CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcC
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS-QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
+.|++.+.||+|+||+||+|++..+|+.||||++.... .+.+.+.+|+++|++++|||||++++++.+++.+++|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999999999999999899999999987643 33457889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEc--CCCcEEEeecCCceecCCCCCC
Q 043702 459 PNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLD--EGFNARLGDFGLARQVEHDKSP 536 (711)
Q Consensus 459 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld--~~~~vkL~DFGla~~~~~~~~~ 536 (711)
++|+|.+++......+++.+++.|+.||+.||+|||+. +|+||||||+||||+ .++.+||+|||+|+.+....
T Consensus 109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~-- 183 (352)
T d1koba_ 109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-- 183 (352)
T ss_dssp CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS--
T ss_pred CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCC--
Confidence 99999998877677899999999999999999999997 999999999999997 67899999999999876543
Q ss_pred CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhhh
Q 043702 537 DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAADA 616 (711)
Q Consensus 537 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 616 (711)
......||+.|||||++.+..++.++|||||||++|||++|+.||..... .+..... ..+..
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----------~~~~~~i-~~~~~------ 245 (352)
T d1koba_ 184 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-----------LETLQNV-KRCDW------ 245 (352)
T ss_dssp CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-----------HHHHHHH-HHCCC------
T ss_pred ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-----------HHHHHHH-HhCCC------
Confidence 23456799999999999999999999999999999999999999965321 1111111 11110
Q ss_pred hccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH--HhC
Q 043702 617 RLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM--LVG 657 (711)
Q Consensus 617 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~--L~~ 657 (711)
.............+.+|+.+||+.||.+|||++|+++. +++
T Consensus 246 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~ 288 (352)
T d1koba_ 246 EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 288 (352)
T ss_dssp CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 01111111223457789999999999999999999984 544
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-47 Score=400.75 Aligned_cols=251 Identities=29% Similarity=0.439 Sum_probs=203.3
Q ss_pred cceeecCCceEEEEEEeCCCC---eEEEEEEcccCC--CChhhhHHHHHHHHhcCCCCeeeeeeeeee-cCeEEEEEEcC
Q 043702 385 NRIIGHGAFGTVYKGILPQNG---DIIAVKRCSHNS--QGKDEFLSELSIIGTLRHRNLVRLQGWCHE-KGEILLVYDLM 458 (711)
Q Consensus 385 ~~~LG~G~fg~Vy~~~~~~~~---~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV~Ey~ 458 (711)
.++||+|+||+||+|++..++ ..||||++.... ...++|.+|+++|++++||||++++|+|.+ ++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 578999999999999986543 368999987532 334679999999999999999999999876 46899999999
Q ss_pred CCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCC--
Q 043702 459 PNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP-- 536 (711)
Q Consensus 459 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~-- 536 (711)
++|+|.+++......+++..+++++.|+|+||.|||+. +|+||||||+||||++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 99999999988778899999999999999999999998 9999999999999999999999999999987544322
Q ss_pred -CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhh
Q 043702 537 -DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615 (711)
Q Consensus 537 -~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 615 (711)
......||+.|+|||.+..+.++.++|||||||++|||++|+.||...... ..+..++ ..+...
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-------~~~~~~i----~~g~~~---- 253 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-------FDITVYL----LQGRRL---- 253 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------------CHHHH----HTTCCC----
T ss_pred eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH-------HHHHHHH----HcCCCC----
Confidence 223356899999999999999999999999999999999988887643211 1122221 111110
Q ss_pred hhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 616 ARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 616 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
..+......+.+|+.+||+.||++||+|+||++.|+..
T Consensus 254 -----~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 254 -----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11112234677899999999999999999999999765
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=401.81 Aligned_cols=247 Identities=23% Similarity=0.299 Sum_probs=208.0
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEccc----CCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSH----NSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
++|+..+.||+|+||+||+|+.+.+|+.||||++.. .....+.+.+|+.+|++++||||+++++++.+++.+++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 579999999999999999999999999999999874 3345677899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
|||++|+|.+++.. ...+++...+.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+|+......
T Consensus 85 ey~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~- 159 (337)
T d1o6la_ 85 EYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG- 159 (337)
T ss_dssp ECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-
T ss_pred eccCCCchhhhhhc-ccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCC-
Confidence 99999999999865 45689999999999999999999998 99999999999999999999999999998764433
Q ss_pred CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhh
Q 043702 536 PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 615 (711)
......+||+.|||||++.+..|+.++||||+||++|||++|++||..... .+. ......+.+
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~-----------~~~-~~~i~~~~~----- 222 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----------ERL-FELILMEEI----- 222 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHH-HHHHHHCCC-----
T ss_pred cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH-----------HHH-HHHHhcCCC-----
Confidence 234456899999999999999999999999999999999999999975421 111 111111111
Q ss_pred hhccCCCcHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH
Q 043702 616 ARLEGQFDEAEMRRVLLVGLACSHPDPLARPT-----MRGVVQ 653 (711)
Q Consensus 616 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~eVl~ 653 (711)
.++.....++.+|+.+||+.||.+||+ ++|+++
T Consensus 223 -----~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 -----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -----CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 111222345678899999999999995 888876
|
| >d1avba_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=1.4e-47 Score=385.59 Aligned_cols=220 Identities=30% Similarity=0.453 Sum_probs=198.0
Q ss_pred cceeeecCCCCCCCeEEeCceEee-CCcEEeCCCCCCCCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecCCCCCC
Q 043702 32 TATEFDFGTLTLASLKLLGDAHMN-NGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLNPSSI 110 (711)
Q Consensus 32 ~~~~f~~~~f~~~~~~~~g~a~~~-~g~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~ 110 (711)
.+++|+|++|..+|++|+|||.+. +|.|+||++..+...++|||+|++||+|||+.++.++||+|+|+|+|.+.+...+
T Consensus 2 ~~~sf~f~~F~~~nl~l~GdA~v~~~g~i~LT~~~~~~~~~~G~~~y~~Pv~l~~~~~~~~~sF~t~f~f~i~~~~~~~~ 81 (226)
T d1avba_ 2 NDASFNVETFNKTNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQINDRTIDNLASFSTNFTFRINAKNIENS 81 (226)
T ss_dssp EEEEEEESSCCGGGEEEEETCEECTTSCEECSCSSSCCTTCEEEEEESSCEECEEGGGTEEEEEEEEEEEEEEESSTTSC
T ss_pred CceEEECCCCCccceeEecceEECCCCeEEccCCCCCCccceEEEEeCCCeEcccCCCCcccceEEEEEEEEecCCCCCC
Confidence 468999999999999999999987 6899999865545578999999999999999999999999999999999877889
Q ss_pred CCceEEEEcCCCCCCCCCCCcccccccCCCCcceEEEEeecccCCCCCCCCCCeeeEecCCCcccccccCCccccccCCC
Q 043702 111 GAGLAFVITPDGEQVGSAGGSLGLLDEKGAGLGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSG 190 (711)
Q Consensus 111 g~GlaF~l~~~~~~~~~~g~~lgl~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~S~~~~~~~~~~~~~~~g 190 (711)
||||||+|+|.....+..||++|+++. ++|||||+.|...+|+.+||||||+|+..|....+. ...+.+|
T Consensus 82 gDG~aF~i~~~~~~~g~~gg~~gl~~~-------~~v~fdt~~~~~~~d~~~nhi~i~~n~~~s~~~~~~---~~~~~~g 151 (226)
T d1avba_ 82 AYGLAFALVPVGSRPKLKGRYLGLFNT-------TNYDRDAHTVAVVFDTVSNRIEIDVNSIRPIATESC---NFGHNNG 151 (226)
T ss_dssp CEEEEEEEEETTCCCCCCGGGTTTCSC-------SSCCGGGCCEEEEEETTTTEEEEEESSSSCSEEEEC---CSGGGTT
T ss_pred CceEEEEEccCCCCCCCccccCCcccc-------ccccccceeccccccCCCCEEEEeCCCCcccccccc---ccccCCC
Confidence 999999999988877888999999875 479999999876669999999999999988766544 3578899
Q ss_pred CeEEEEEEEcccccEEEEEEEecCCCCCcceeeEecCcccccccceeEEEeeeccC---ceeeEEEEeecccccc
Q 043702 191 DLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQG---STEIHSIEWWSFSSSF 262 (711)
Q Consensus 191 ~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastg~---~~~~~~i~sW~f~s~~ 262 (711)
+.++|||+||+.+++|+|++++.. ++..+.++..|||+.+||++|||||||+||. ..|.|+|+||+|++++
T Consensus 152 ~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~~~~~vdL~~~l~~~~y~GFSAaTG~~s~~~~~H~IlsWsF~s~~ 225 (226)
T d1avba_ 152 EKAEVRITYDSPKNDLRVSLLYPS-SEEKCHVSATVPLEKEVEDWVSVGFSATSGSKKETTETHNVLSWSFSSNF 225 (226)
T ss_dssp CEEEEEEEEEGGGTEEEEEEEETT-TTEEEEEEEECCHHHHSCSEEEEEEEEEECSSGGGCEEEEEEEEEEEEEE
T ss_pred eEEEEEEEEcCCCcEEEEEEEeCC-CCccEEEEEEecHHHccCCcEEEEEEEEcCCCCCCeeeeEEEEEEeEEec
Confidence 999999999999999999999865 5677889999999999999999999999995 5789999999999875
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=402.31 Aligned_cols=253 Identities=27% Similarity=0.394 Sum_probs=203.2
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCe--EEEEEEccc--CCCChhhhHHHHHHHHhc-CCCCeeeeeeeeeecCeEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGD--IIAVKRCSH--NSQGKDEFLSELSIIGTL-RHRNLVRLQGWCHEKGEILLV 454 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~--~vavK~~~~--~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 454 (711)
++|++.++||+|+||+||+|+++.++. .||||++.. .....++|.+|+++|+++ +|||||+++|+|.+++.+++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 568888999999999999999987776 477888754 334567899999999999 699999999999999999999
Q ss_pred EEcCCCCCHHHHHhhC---------------CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcE
Q 043702 455 YDLMPNGSLDKALFEA---------------RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNA 519 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~v 519 (711)
|||+++|+|.++|+.. ...+++.++.+++.|||+||.|||+. +|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 9999999999999753 35799999999999999999999998 99999999999999999999
Q ss_pred EEeecCCceecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCC-CCccccccccccccccchH
Q 043702 520 RLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRR-PIEKEITGVGKVGVASNLV 598 (711)
Q Consensus 520 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~-P~~~~~~~~~~~~~~~~l~ 598 (711)
||+|||+++....... .....||..|+|||.+..+.++.++|||||||++|||++|.. ||.... ..
T Consensus 167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~-----------~~ 233 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-----------CA 233 (309)
T ss_dssp EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-----------HH
T ss_pred EEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC-----------HH
Confidence 9999999986543322 234468999999999999999999999999999999999765 564321 11
Q ss_pred HHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 599 EWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 599 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
+.... ...+ .....+.....++.+|+.+||+.||++||||+||++.|+..
T Consensus 234 ~~~~~-i~~~---------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 234 ELYEK-LPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp HHHHH-GGGT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHH-HHhc---------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11111 1111 11122223345678899999999999999999999988664
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.4e-46 Score=397.74 Aligned_cols=244 Identities=25% Similarity=0.329 Sum_probs=206.0
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEccc----CCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSH----NSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
++|++.+.||+|+||+||+|+++.+|+.||||++.. .....+.+.+|+.++++++||||+++++++.+++.+++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 468999999999999999999998999999999864 3345678999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
|||++|+|..++.. ...+++.....++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp CCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred eecCCccccccccc-cccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence 99999999998864 45688999999999999999999998 9999999999999999999999999999986543
Q ss_pred CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhh
Q 043702 536 PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 615 (711)
....+||+.|||||++.+..++.++|||||||+||||++|+.||..... .+...... .+..
T Consensus 158 --~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-----------~~~~~~i~-~~~~----- 218 (316)
T d1fota_ 158 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-----------MKTYEKIL-NAEL----- 218 (316)
T ss_dssp --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----------HHHHHHHH-HCCC-----
T ss_pred --cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH-----------HHHHHHHH-cCCC-----
Confidence 2346799999999999999999999999999999999999999975321 11111111 1110
Q ss_pred hhccCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 043702 616 ARLEGQFDEAEMRRVLLVGLACSHPDPLARP-----TMRGVVQ 653 (711)
Q Consensus 616 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVl~ 653 (711)
.++......+.+++.+||+.||.+|| |++++++
T Consensus 219 -----~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 219 -----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -----CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 11122234577888999999999996 8999986
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-47 Score=397.26 Aligned_cols=268 Identities=24% Similarity=0.289 Sum_probs=202.1
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHH--HHHHHHhcCCCCeeeeeeeeeecC----eEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLS--ELSIIGTLRHRNLVRLQGWCHEKG----EILL 453 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~--Ei~~l~~l~H~niv~l~g~~~~~~----~~~l 453 (711)
+.|...+.||+|+||.||+|++ +|+.||||++.... .+++.. |+..+.+++||||++++|+|.+.+ .+++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~--~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc--hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 4577889999999999999998 68999999987543 334444 455556789999999999998754 6899
Q ss_pred EEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhcc-----CCCeeeccCCCCceEEcCCCcEEEeecCCce
Q 043702 454 VYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQEC-----ENQVIHRDVKTSNIMLDEGFNARLGDFGLAR 528 (711)
Q Consensus 454 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-----~~~ivHrDlkp~NILld~~~~vkL~DFGla~ 528 (711)
|||||++|+|.++|++. .++|..+++++.|+|.||+|||+.+ .++|+||||||+||||++++.+||+|||+++
T Consensus 79 v~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 99999999999999753 6999999999999999999999742 4699999999999999999999999999999
Q ss_pred ecCCCCC---CCcccccCCCcccChhhhccCC------CCccccchhHHHHHHHHHhCCCCCcccccccccccc---ccc
Q 043702 529 QVEHDKS---PDATVAAGTMGYLAPEYLLTGR------ATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGV---ASN 596 (711)
Q Consensus 529 ~~~~~~~---~~~~~~~gt~~y~APE~~~~~~------~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~---~~~ 596 (711)
....... .......||++|||||++.... ++.++|||||||+||||+||..|+............ ...
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 8754432 1234467999999999987643 577899999999999999999888553322111100 011
Q ss_pred hHHHHHHhhhcCchhHhhhhhccCC-CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 597 LVEWVWSLHREGRLLTAADARLEGQ-FDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 597 l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
..+........+.. ++.+... ...+....+.+|+.+||+.||++|||+.||++.|+.
T Consensus 237 ~~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~ 294 (303)
T d1vjya_ 237 SVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp CHHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred hHHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 11222222221111 1111111 133456778899999999999999999999999864
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=397.20 Aligned_cols=254 Identities=26% Similarity=0.385 Sum_probs=198.4
Q ss_pred cCCcccceeecCCceEEEEEEeCCC---CeEEEEEEcccC----CCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQN---GDIIAVKRCSHN----SQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEIL 452 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~---~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 452 (711)
++|+..+.||+|+||.||+|++... ...||||++... ....++|.+|+++|++++||||++++|+|.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 4688899999999999999986432 247899988753 2234679999999999999999999999975 4678
Q ss_pred EEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCC
Q 043702 453 LVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEH 532 (711)
Q Consensus 453 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~ 532 (711)
+|||||++|+|.+++......+++..+++++.|||+||.|||+. +|+||||||+||||+.++.+||+|||+++.+..
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 99999999999999887777899999999999999999999997 999999999999999999999999999998755
Q ss_pred CCCC--CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccccccchHHHHHHhhhcCc
Q 043702 533 DKSP--DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVGVASNLVEWVWSLHREGR 609 (711)
Q Consensus 533 ~~~~--~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 609 (711)
.... ......|+..|+|||++.+..++.++|||||||++|||+| |+.||..... .+......+.+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~-----------~~~~~~i~~~~~ 232 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-----------SQILHKIDKEGE 232 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----------HHHHHHHHTSCC
T ss_pred CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH-----------HHHHHHHHhCCC
Confidence 4332 2233468889999999999999999999999999999998 8999965321 111222222221
Q ss_pred hhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 610 LLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 610 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
. ..........+.+|+.+||+.||++|||+.||++.|+.
T Consensus 233 ~---------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 233 R---------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C---------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 1 11112223567789999999999999999999999874
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-46 Score=395.62 Aligned_cols=251 Identities=19% Similarity=0.237 Sum_probs=209.9
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEcC
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
.++|++.+.||+|+||+||+|.+..+++.||||++.....+...+.+|+++|++++||||+++++++.+++.+|+|||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 45789999999999999999999999999999999876655667889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcC--CCcEEEeecCCceecCCCCCC
Q 043702 459 PNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDE--GFNARLGDFGLARQVEHDKSP 536 (711)
Q Consensus 459 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~--~~~vkL~DFGla~~~~~~~~~ 536 (711)
++|+|.+++......+++.++..++.||++||+|||+. +|+||||||+|||++. ...+||+|||+++......
T Consensus 84 ~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~-- 158 (321)
T d1tkia_ 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-- 158 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCC--
Confidence 99999999977666899999999999999999999998 9999999999999985 4589999999998765432
Q ss_pred CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcC-chhHhhh
Q 043702 537 DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREG-RLLTAAD 615 (711)
Q Consensus 537 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~d 615 (711)
......||+.|+|||.+.+..++.++||||+||++|||++|+.||..... .+......... .......
T Consensus 159 ~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~-----------~~~~~~i~~~~~~~~~~~~ 227 (321)
T d1tkia_ 159 NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-----------QQIIENIMNAEYTFDEEAF 227 (321)
T ss_dssp EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-----------HHHHHHHHHTCCCCCHHHH
T ss_pred cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH-----------HHHHHHHHhCCCCCChhhc
Confidence 23445799999999999999999999999999999999999999975421 11111111110 0011000
Q ss_pred hhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 616 ARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 616 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
.. ...++.+++.+||+.||.+|||++|+++
T Consensus 228 ----~~----~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 228 ----KE----ISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ----TT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----cC----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 1245778999999999999999999998
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-47 Score=397.04 Aligned_cols=256 Identities=27% Similarity=0.378 Sum_probs=196.7
Q ss_pred hcCCcccceeecCCceEEEEEEeCC-----CCeEEEEEEcccCC--CChhhhHHHHHHHHhc-CCCCeeeeeeeeeec-C
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQ-----NGDIIAVKRCSHNS--QGKDEFLSELSIIGTL-RHRNLVRLQGWCHEK-G 449 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~-~ 449 (711)
.++|+..++||+|+||.||+|++.. +++.||||++.... ...+.+.+|..++.++ +|+||+.+++++.+. +
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 3578999999999999999999743 34689999987533 3345788888888887 589999999998765 4
Q ss_pred eEEEEEEcCCCCCHHHHHhhCC---------------CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEc
Q 043702 450 EILLVYDLMPNGSLDKALFEAR---------------SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLD 514 (711)
Q Consensus 450 ~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld 514 (711)
.+++|||||++|+|.++|+..+ ..+++.+++.++.||++||+|||+. +|+||||||+||||+
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeEC
Confidence 6899999999999999997532 3589999999999999999999998 999999999999999
Q ss_pred CCCcEEEeecCCceecCCCCC-CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCC-CCCccccccccccc
Q 043702 515 EGFNARLGDFGLARQVEHDKS-PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGR-RPIEKEITGVGKVG 592 (711)
Q Consensus 515 ~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~-~P~~~~~~~~~~~~ 592 (711)
+++.+||+|||+|+....... .......||+.|||||++.++.++.++|||||||++|||++|. .||.....
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~------ 242 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI------ 242 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC------
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH------
Confidence 999999999999987654433 2334567999999999999999999999999999999999975 56654321
Q ss_pred cccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 593 VASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 593 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
.+........+.. ...+.....++.+++.+||+.||++|||++||+++|+.
T Consensus 243 -----~~~~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ 293 (299)
T d1ywna1 243 -----DEEFCRRLKEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293 (299)
T ss_dssp -----SHHHHHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -----HHHHHHHHhcCCC---------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1111122222211 11222234567889999999999999999999999874
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-47 Score=398.16 Aligned_cols=255 Identities=25% Similarity=0.417 Sum_probs=204.7
Q ss_pred cCCcccceeecCCceEEEEEEeCCCC-------eEEEEEEcccCCC--ChhhhHHHHHHHHhc-CCCCeeeeeeeeeecC
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNG-------DIIAVKRCSHNSQ--GKDEFLSELSIIGTL-RHRNLVRLQGWCHEKG 449 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~-------~~vavK~~~~~~~--~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 449 (711)
++|+..+.||+|+||.||+|+....+ ..||||+++.... ...++.+|...+.++ +|||||+++++|.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 46888899999999999999875443 4799999976443 346788999999888 7999999999999999
Q ss_pred eEEEEEEcCCCCCHHHHHhhCC---------------CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEc
Q 043702 450 EILLVYDLMPNGSLDKALFEAR---------------SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLD 514 (711)
Q Consensus 450 ~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld 514 (711)
..++|||||++|+|.++|.... ..+++.++++++.||+.||+|||+. +|+||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeec
Confidence 9999999999999999997543 3589999999999999999999998 999999999999999
Q ss_pred CCCcEEEeecCCceecCCCCCC-CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHh-CCCCCccccccccccc
Q 043702 515 EGFNARLGDFGLARQVEHDKSP-DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVAS-GRRPIEKEITGVGKVG 592 (711)
Q Consensus 515 ~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ellt-G~~P~~~~~~~~~~~~ 592 (711)
.++.+||+|||+++........ ......||+.|+|||.+.++.++.++|||||||++|||++ |++||.....
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~------ 243 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------ 243 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH------
Confidence 9999999999999987654432 3345679999999999999999999999999999999998 6888764321
Q ss_pred cccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Q 043702 593 VASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGE 658 (711)
Q Consensus 593 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 658 (711)
..++..+..+. ....+.....++.+|+.+||+.||.+|||+.||++.|+..
T Consensus 244 ------~~~~~~i~~~~---------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 244 ------EELFKLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp ------HHHHHHHHTTC---------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------HHHHHHHHcCC---------CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 11222222221 1112222345688899999999999999999999999753
|
| >d1ioaa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]
Probab=100.00 E-value=1.1e-46 Score=379.44 Aligned_cols=217 Identities=29% Similarity=0.444 Sum_probs=187.6
Q ss_pred cceeeecCCCCCC-CeEEeCceEee-CCcEEeCCCCCC---CCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecCC
Q 043702 32 TATEFDFGTLTLA-SLKLLGDAHMN-NGSVRLTRDVTV---PYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLN 106 (711)
Q Consensus 32 ~~~~f~~~~f~~~-~~~~~g~a~~~-~g~~~Lt~~~~~---~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~ 106 (711)
+.++|+|++|... +|+|+|||.+. +|.|+||++.+. ...++|||+|++||+||+ +++++||+|+|+|.|.+.+
T Consensus 2 ~~~sF~f~~F~~~~~l~l~GdA~i~~~g~l~LT~~~~~~~~~~~s~G~a~y~~Pv~l~~--~~~~~sFst~F~f~i~~~~ 79 (228)
T d1ioaa_ 2 TETSFNFPNFHTDDKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIKD--SNNVASFNTNFTFIIRAKN 79 (228)
T ss_dssp CCCEEEESSCCTTSSEEEEETCEECTTSCEETTCBCTTSSBCSSCBEEEEESSCEECBC--SSCBEEEEEEEEEECCBSC
T ss_pred ccceEEcCCCCCCCcEEEeeeeEEcCCCEEEecCCCCCCccccceeEEEEECCceEecC--CCceeeEEEEEEEEEecCC
Confidence 4578999999754 59999999986 789999986543 236789999999999998 4789999999999999887
Q ss_pred CCCCCCceEEEEcCCCCCCCCCCCcccccccCCCC--cceEEEEeecccCCCCCCCCCCeeeEecCCCcccccccCCccc
Q 043702 107 PSSIGAGLAFVITPDGEQVGSAGGSLGLLDEKGAG--LGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTIN 184 (711)
Q Consensus 107 ~~~~g~GlaF~l~~~~~~~~~~g~~lgl~~~~~~~--~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~S~~~~~~~~~~ 184 (711)
...+||||||+|+|.+.+++..|++||+++..... ++.|||||||+.|. .|++.+||++++++.. .
T Consensus 80 ~~~~gDGlAF~l~~~~~~~~~~g~~lgl~~~~~~~~~~~~vave~dt~~n~--~~~~~~~~~~~~~~~~----------~ 147 (228)
T d1ioaa_ 80 QSISAYGLAFALVPVNSPPQKKQEFLGIFNTNNPEPNARTVAVVFNTFKNR--IDFDKNFIKPYVNENC----------D 147 (228)
T ss_dssp TTSCCEEEEEEEEETTCCCCCCGGGTTTCCCSSCCGGGCCEEEEEETTTTE--EEEEESSSSCSEEEEC----------C
T ss_pred CCCCCCEEEEEEeCCCCCCCCCccccccccccCCCCcceeEEEEecCcccc--ccCCCCccceeccccc----------c
Confidence 77899999999999888888899999998865433 78899999999874 4788888888876532 3
Q ss_pred cccCCCCeEEEEEEEcccccEEEEEEEecCCCCCcceeeEecCcccccccceeEEEeeecc---CceeeEEEEeeccccc
Q 043702 185 VDLKSGDLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQ---GSTEIHSIEWWSFSSS 261 (711)
Q Consensus 185 ~~~~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastg---~~~~~~~i~sW~f~s~ 261 (711)
.++.+|+.++|||+||+.+++|+|++++.. ++..|.++..|||+++|+++|||||||||| +..|.|+|++|+|+|+
T Consensus 148 ~~~~~g~~~~v~I~Yd~~~~~l~V~l~~~~-~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~~~~h~I~sWsFss~ 226 (228)
T d1ioaa_ 148 FHKYNGEKTDVQITYDSSNNDLRVFLHFTV-SQVKCSVSATVHLEKEVDEWVSVGFSPTSGLTEDTTETHDVLSWSFSSK 226 (228)
T ss_dssp HHHHCSSCEEEEEEEETTTTEEEEEEEETT-TCCEEEEEEECCGGGTSCSEEEEEEEEEECSSTTTCBCCEEEEEEEEEE
T ss_pred cccccCcEEEEEEEEcCCCCEEEEEEEeCC-CCceeeEEEEEchHHcCCCcEEEEEEeecCCCCCCceEEEEEEEEeEEe
Confidence 467789999999999999999999999864 667889999999999999999999999999 5679999999999987
Q ss_pred cC
Q 043702 262 FE 263 (711)
Q Consensus 262 ~~ 263 (711)
++
T Consensus 227 ~~ 228 (228)
T d1ioaa_ 227 FR 228 (228)
T ss_dssp EC
T ss_pred cC
Confidence 63
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=398.26 Aligned_cols=256 Identities=27% Similarity=0.388 Sum_probs=208.8
Q ss_pred hcCCcccceeecCCceEEEEEEeC-----CCCeEEEEEEcccCCC--ChhhhHHHHHHHHhc-CCCCeeeeeeeeeecCe
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILP-----QNGDIIAVKRCSHNSQ--GKDEFLSELSIIGTL-RHRNLVRLQGWCHEKGE 450 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~~--~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 450 (711)
.++|+..++||+|+||.||+|++. ..++.||||+++.... ...++.+|+.+++++ +|||||+++|+|.+++.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 357888999999999999999863 3567899999976432 345789999999999 69999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhhCC-----------------CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEE
Q 043702 451 ILLVYDLMPNGSLDKALFEAR-----------------SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIML 513 (711)
Q Consensus 451 ~~lV~Ey~~~gsL~~~l~~~~-----------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl 513 (711)
.++|||||++|+|.++++... ..+++..+.+++.||++||+|||+. +++||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccccc
Confidence 999999999999999997543 2589999999999999999999998 99999999999999
Q ss_pred cCCCcEEEeecCCceecCCCCCC-CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhC-CCCCcccccccccc
Q 043702 514 DEGFNARLGDFGLARQVEHDKSP-DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASG-RRPIEKEITGVGKV 591 (711)
Q Consensus 514 d~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG-~~P~~~~~~~~~~~ 591 (711)
+.++.+||+|||+++........ ......||+.|+|||++.++.++.++|||||||++|||+|+ .+|+.....
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~----- 253 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV----- 253 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS-----
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH-----
Confidence 99999999999999987654332 23346799999999999999999999999999999999995 544433211
Q ss_pred ccccchHHHHHHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 592 GVASNLVEWVWSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 592 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
.+-++.. +........+......+.+|+.+||+.||.+||||.||+++|++
T Consensus 254 ------~~~~~~~---------i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 254 ------DSKFYKM---------IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp ------SHHHHHH---------HHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ------HHHHHHH---------HhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 0111111 11222222223334668889999999999999999999999975
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5e-46 Score=386.57 Aligned_cols=257 Identities=23% Similarity=0.298 Sum_probs=201.8
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC----ChhhhHHHHHHHHhcCCCCeeeeeeeeeecC----e
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ----GKDEFLSELSIIGTLRHRNLVRLQGWCHEKG----E 450 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~ 450 (711)
.++|++.+.||+|+||+||+|++..+|+.||||++..... ..+.+.+|++++++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 3579999999999999999999988999999999876332 2346889999999999999999999997654 3
Q ss_pred EEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceec
Q 043702 451 ILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV 530 (711)
Q Consensus 451 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~ 530 (711)
+++|||||++|+|.+++.. .+.+++.+++.++.||+.||+|||+. +|+||||||+||||+.++..+|+|||+++..
T Consensus 86 ~~lvmE~~~g~~L~~~~~~-~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred EEEEEECCCCCEehhhhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhh
Confidence 8999999999999998865 35799999999999999999999997 9999999999999999999999999999866
Q ss_pred CCCCC--CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcC
Q 043702 531 EHDKS--PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREG 608 (711)
Q Consensus 531 ~~~~~--~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 608 (711)
..... ......+||+.|||||++.+..++.++|||||||++|||++|+.||..... .+........+
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----------~~~~~~~~~~~ 230 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP-----------VSVAYQHVRED 230 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----------HHHHHHHHHCC
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH-----------HHHHHHHHhcC
Confidence 43332 233456799999999999999999999999999999999999999975321 12222222222
Q ss_pred chhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHhC
Q 043702 609 RLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARP-TMRGVVQMLVG 657 (711)
Q Consensus 609 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~eVl~~L~~ 657 (711)
.... ..........+.+++.+||+.||.+|| |++++++.|..
T Consensus 231 ~~~~-------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 231 PIPP-------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp CCCG-------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCCC-------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 1110 011112235677888999999999999 89999888754
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-45 Score=395.25 Aligned_cols=244 Identities=21% Similarity=0.313 Sum_probs=206.1
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEccc----CCCChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSH----NSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVY 455 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 455 (711)
++|+..+.||+|+||+||+|+++.+|+.||||++.. .....+.+.+|+++|+.++||||+++++++...+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 478999999999999999999998999999999864 2344567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCC
Q 043702 456 DLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 456 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~ 535 (711)
||+.+|+|..++... ..+++.+++.++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp ECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred ccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence 999999999998654 4699999999999999999999998 9999999999999999999999999999987532
Q ss_pred CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhhh
Q 043702 536 PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAAD 615 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 615 (711)
.....||+.|||||++.+..++.++|||||||++|||++|+.||..... ....... ..+..
T Consensus 195 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-----------~~~~~~i-~~~~~----- 255 (350)
T d1rdqe_ 195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-----------IQIYEKI-VSGKV----- 255 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHHHHH-HHCCC-----
T ss_pred --cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH-----------HHHHHHH-hcCCC-----
Confidence 2346799999999999999999999999999999999999999965321 1111111 11111
Q ss_pred hhccCCCcHHHHHHHHHHHHhcCCCCCCCC-----CCHHHHHH
Q 043702 616 ARLEGQFDEAEMRRVLLVGLACSHPDPLAR-----PTMRGVVQ 653 (711)
Q Consensus 616 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R-----Ps~~eVl~ 653 (711)
..+.....++.+++.+||+.||.+| ||++++++
T Consensus 256 -----~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 -----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -----CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 1111223457788999999999999 48999986
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6e-46 Score=385.52 Aligned_cols=251 Identities=24% Similarity=0.348 Sum_probs=205.9
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCC----------hhhhHHHHHHHHhcC-CCCeeeeeeeeeec
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQG----------KDEFLSELSIIGTLR-HRNLVRLQGWCHEK 448 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~----------~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~ 448 (711)
++|+..+.||+|+||+||+|++..+|+.||||++...... .+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5789999999999999999999889999999998764321 235789999999998 99999999999999
Q ss_pred CeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCce
Q 043702 449 GEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLAR 528 (711)
Q Consensus 449 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~ 528 (711)
+.+++|||||++|+|.++|.. ...+++.+++.++.||++||+|||+. +|+||||||+||||+.++.+||+|||+++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred cceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchhee
Confidence 999999999999999999975 45799999999999999999999997 99999999999999999999999999999
Q ss_pred ecCCCCCCCcccccCCCcccChhhhcc------CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHH
Q 043702 529 QVEHDKSPDATVAAGTMGYLAPEYLLT------GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVW 602 (711)
Q Consensus 529 ~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~ 602 (711)
.+..... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||..... ....
T Consensus 159 ~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~------------~~~~ 224 (277)
T d1phka_ 159 QLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------------MLML 224 (277)
T ss_dssp ECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHH
T ss_pred EccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH------------HHHH
Confidence 8765432 344679999999999863 3468899999999999999999999975421 1111
Q ss_pred HhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 603 SLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 603 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
..+..+... ...........++.+++.+||+.||++|||++||++.
T Consensus 225 ~~i~~~~~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 225 RMIMSGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHHHHTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHhCCCC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 111111111 0011111223467788999999999999999999763
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=397.33 Aligned_cols=256 Identities=25% Similarity=0.424 Sum_probs=208.0
Q ss_pred cCCcccceeecCCceEEEEEEeCC-----CCeEEEEEEcccCCC--ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQ-----NGDIIAVKRCSHNSQ--GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEIL 452 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 452 (711)
++|...+.||+|+||+||+|.+.. .++.||||++..... +...|.+|++++++++||||++++|+|..++..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 577888999999999999998742 357899999976332 2346899999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhhC---------CCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEee
Q 043702 453 LVYDLMPNGSLDKALFEA---------RSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGD 523 (711)
Q Consensus 453 lV~Ey~~~gsL~~~l~~~---------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~D 523 (711)
+|||||++|+|.+++... ...+++..+.+++.|+|+||.|||+. +|+||||||+||||++++++||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEee
Confidence 999999999999998642 23578999999999999999999997 999999999999999999999999
Q ss_pred cCCceecCCCCCC-CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCC-CCCccccccccccccccchHHHH
Q 043702 524 FGLARQVEHDKSP-DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGR-RPIEKEITGVGKVGVASNLVEWV 601 (711)
Q Consensus 524 FGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~-~P~~~~~~~~~~~~~~~~l~~~~ 601 (711)
||+++.+...... ......||+.|+|||.+.++.++.++|||||||++|||+||+ .||... ...++.
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~-----------~~~~~~ 245 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-----------SNEQVL 245 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-----------CHHHHH
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC-----------CHHHHH
Confidence 9999876543332 233446899999999999999999999999999999999985 666432 112222
Q ss_pred HHhhhcCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC
Q 043702 602 WSLHREGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVGEA 659 (711)
Q Consensus 602 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~ 659 (711)
... ..+... ..+......+.+++.+||+.||.+||||++|+++|+...
T Consensus 246 ~~i-~~~~~~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 246 RFV-MEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp HHH-HTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HHH-HhCCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 211 122111 111222356888999999999999999999999998753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7.6e-46 Score=399.56 Aligned_cols=248 Identities=26% Similarity=0.356 Sum_probs=200.0
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC----CCChhhhHHH---HHHHHhcCCCCeeeeeeeeeecCeEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN----SQGKDEFLSE---LSIIGTLRHRNLVRLQGWCHEKGEIL 452 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~E---i~~l~~l~H~niv~l~g~~~~~~~~~ 452 (711)
++|++.++||+|+||.||+|++..+|+.||||++... ......+.+| +++++.++|||||++++++.+.+.++
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 5799999999999999999999999999999998642 2233344444 66777778999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCC
Q 043702 453 LVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEH 532 (711)
Q Consensus 453 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~ 532 (711)
+|||||++|+|.++|.. ...+++..++.++.||+.||+|||+. +|+||||||+||||++++.+||+|||+|+.+..
T Consensus 84 ivmE~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEECCCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEecCCCcHHHHHHh-cccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 99999999999999965 35689999999999999999999998 999999999999999999999999999997754
Q ss_pred CCCCCcccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchh
Q 043702 533 DKSPDATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLL 611 (711)
Q Consensus 533 ~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 611 (711)
.. ....+||+.|||||++..+ .++.++|||||||+||||++|+.||...... .... +.......
T Consensus 160 ~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--------~~~~-~~~~~~~~--- 224 (364)
T d1omwa3 160 KK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--------DKHE-IDRMTLTM--- 224 (364)
T ss_dssp SC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS--------CHHH-HHHHSSSC---
T ss_pred Cc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH--------HHHH-HHHhcccC---
Confidence 43 3345799999999999754 6899999999999999999999999754221 1111 11110000
Q ss_pred HhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH
Q 043702 612 TAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPT-----MRGVVQ 653 (711)
Q Consensus 612 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~eVl~ 653 (711)
...++.....++.+|+.+||+.||.+||| ++|+++
T Consensus 225 -------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 225 -------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp -------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred -------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 01111122345778899999999999999 688875
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-46 Score=390.30 Aligned_cols=261 Identities=23% Similarity=0.260 Sum_probs=198.4
Q ss_pred ccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC------ChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEEc
Q 043702 384 ANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ------GKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 384 ~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 457 (711)
..++||+|+||+||+|+++.+|+.||||++..... ..+.+.+|+++|++++|||||++++++..++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 35789999999999999998999999999865321 135688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCCC
Q 043702 458 MPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSPD 537 (711)
Q Consensus 458 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 537 (711)
+.++++..++ .....+++.++..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 82 ~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~- 156 (299)
T d1ua2a_ 82 METDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA- 156 (299)
T ss_dssp CSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC-
T ss_pred hcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCccc-
Confidence 9887666544 5566799999999999999999999998 9999999999999999999999999999876554332
Q ss_pred cccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHh---
Q 043702 538 ATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTA--- 613 (711)
Q Consensus 538 ~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~--- 613 (711)
....+||+.|+|||++..+ .++.++|||||||++|||++|+.||...... ....-+.+..........
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~--------~~l~~i~~~~~~~~~~~~~~~ 228 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL--------DQLTRIFETLGTPTEEQWPDM 228 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHHHCCCCTTTSSST
T ss_pred ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH--------HHHHHHHHhcCCCChhhccch
Confidence 2345799999999998755 5799999999999999999999999654220 111111111000000000
Q ss_pred ------hhhhccCCCc-----HHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--HHhC
Q 043702 614 ------ADARLEGQFD-----EAEMRRVLLVGLACSHPDPLARPTMRGVVQ--MLVG 657 (711)
Q Consensus 614 ------~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~--~L~~ 657 (711)
.......... ......+.+|+.+||+.||++|||++|+++ .++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 229 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285 (299)
T ss_dssp TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred hccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence 0000000000 011346788999999999999999999998 4543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=394.03 Aligned_cols=262 Identities=19% Similarity=0.267 Sum_probs=204.8
Q ss_pred hcCCcccc-eeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhc-CCCCeeeeeeeeee----cCeEE
Q 043702 379 TKCFNANR-IIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTL-RHRNLVRLQGWCHE----KGEIL 452 (711)
Q Consensus 379 t~~f~~~~-~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~----~~~~~ 452 (711)
.++|.+.+ +||+|+||+||+|++..+++.||||++.. ...+.+|++++.++ +||||+++++++.+ +..+|
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 35787764 69999999999999988999999999863 45678899987654 79999999999865 46789
Q ss_pred EEEEcCCCCCHHHHHhhCC-CCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcC---CCcEEEeecCCce
Q 043702 453 LVYDLMPNGSLDKALFEAR-SPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDE---GFNARLGDFGLAR 528 (711)
Q Consensus 453 lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~---~~~vkL~DFGla~ 528 (711)
+|||||++|+|.++|.... ..+++.+++.|+.||+.||+|||+. +|+||||||+|||+++ ++.+||+|||+++
T Consensus 86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceee
Confidence 9999999999999997643 4699999999999999999999998 9999999999999975 5579999999999
Q ss_pred ecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcC
Q 043702 529 QVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREG 608 (711)
Q Consensus 529 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 608 (711)
....... ....+||+.|||||++.+..|+.++|||||||+||||++|+.||...... ............+
T Consensus 163 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~--------~~~~~~~~~i~~~ 232 (335)
T d2ozaa1 163 ETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--------AISPGMKTRIRMG 232 (335)
T ss_dssp ECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------------CCCSC
T ss_pred eccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHH--------HHHHHHHHHHhcC
Confidence 8765433 34467999999999999999999999999999999999999999754221 1111111111111
Q ss_pred chhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--HHhCCCCCCC
Q 043702 609 RLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ--MLVGEAEVPI 663 (711)
Q Consensus 609 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~--~L~~~~~~p~ 663 (711)
... +..........++.+|+.+||+.||.+|||+.|+++ ++......+.
T Consensus 233 ~~~------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~ 283 (335)
T d2ozaa1 233 QYE------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 283 (335)
T ss_dssp SSS------CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSSCC
T ss_pred CCC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCCCC
Confidence 100 000011123456788999999999999999999998 3554444443
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=385.61 Aligned_cols=264 Identities=23% Similarity=0.350 Sum_probs=201.6
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC---CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
++|+..++||+|+||+||+|++..+|+.||||++.... ...+.+.+|+++|++++||||+++++++.+++.+++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 57999999999999999999999899999999986532 345688999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCC
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP 536 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~ 536 (711)
|+.++.+..........+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+.......
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~- 157 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 157 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB-
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCcc-
Confidence 9976544444444566799999999999999999999998 999999999999999999999999999987654332
Q ss_pred CcccccCCCcccChhhhccCC-CCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCc-----h
Q 043702 537 DATVAAGTMGYLAPEYLLTGR-ATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGR-----L 610 (711)
Q Consensus 537 ~~~~~~gt~~y~APE~~~~~~-~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~-----~ 610 (711)
......||+.|+|||.+.... ++.++|||||||++|||++|+.||...... ..+............ .
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~ 230 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-------DQLFRIFRTLGTPDEVVWPGV 230 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHHHCCCCTTTSTTG
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH-------HHHHHHHHhcCCCchhhcccc
Confidence 233457999999999887765 588999999999999999999999653210 000000000000000 0
Q ss_pred hHhhh--hh---c-cCCC---cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 611 LTAAD--AR---L-EGQF---DEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 611 ~~~~d--~~---l-~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
....+ .. . ...+ .......+.+++.+||+.||++|||++|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00000 00 0 0000 00112467788999999999999999999984
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-46 Score=392.80 Aligned_cols=247 Identities=19% Similarity=0.326 Sum_probs=205.1
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEccc----CCCChhhhHHHHHHHH-hcCCCCeeeeeeeeeecCeEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSH----NSQGKDEFLSELSIIG-TLRHRNLVRLQGWCHEKGEILLV 454 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~----~~~~~~~~~~Ei~~l~-~l~H~niv~l~g~~~~~~~~~lV 454 (711)
++|++.+.||+|+||+||+|+++.+++.||||++.. .....+.+..|..++. .++||||+++++++.+++.+++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 578999999999999999999999999999999864 2344566778887765 68999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCC
Q 043702 455 YDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDK 534 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~ 534 (711)
||||++|+|.+++.. ...+++.+++.++.||+.||+|||+. +|+||||||+|||+++++++||+|||+++......
T Consensus 82 mEy~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EeecCCCcHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccccc
Confidence 999999999999965 45689999999999999999999998 99999999999999999999999999998765433
Q ss_pred CCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCchhHhh
Q 043702 535 SPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGRLLTAA 614 (711)
Q Consensus 535 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 614 (711)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..++.....+.
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~------------~~~~~~i~~~~----- 219 (320)
T d1xjda_ 158 -AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE------------EELFHSIRMDN----- 219 (320)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHHCC-----
T ss_pred -ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH------------HHHHHHHHcCC-----
Confidence 233446799999999999999999999999999999999999999975321 11111111111
Q ss_pred hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHH-HHHH
Q 043702 615 DARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMR-GVVQ 653 (711)
Q Consensus 615 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-eVl~ 653 (711)
+. ++.....++.+|+.+||+.||.+||++. |+++
T Consensus 220 -~~----~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 220 -PF----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -CC----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -CC----CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11 1112234577899999999999999996 6764
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-45 Score=379.87 Aligned_cols=240 Identities=23% Similarity=0.360 Sum_probs=198.7
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC-------CChhhhHHHHHHHHhcC--CCCeeeeeeeeeecCe
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS-------QGKDEFLSELSIIGTLR--HRNLVRLQGWCHEKGE 450 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~ 450 (711)
++|++.++||+|+||+||+|++..+|+.||||++.... .....+.+|+.+|++++ ||||+++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999999999899999999986522 12345789999999997 8999999999999999
Q ss_pred EEEEEEcCCC-CCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcC-CCcEEEeecCCce
Q 043702 451 ILLVYDLMPN-GSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDE-GFNARLGDFGLAR 528 (711)
Q Consensus 451 ~~lV~Ey~~~-gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~-~~~vkL~DFGla~ 528 (711)
.++||||+.+ +++.+++.. ...+++.+++.++.||++||+|||+. +|+||||||+|||++. ++.+||+|||+++
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccce
Confidence 9999999976 678777754 45799999999999999999999997 9999999999999985 4799999999998
Q ss_pred ecCCCCCCCcccccCCCcccChhhhccCCC-CccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhc
Q 043702 529 QVEHDKSPDATVAAGTMGYLAPEYLLTGRA-TEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHRE 607 (711)
Q Consensus 529 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~ 607 (711)
...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... ..+
T Consensus 160 ~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----------------i~~- 218 (273)
T d1xwsa_ 160 LLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----------------IIR- 218 (273)
T ss_dssp ECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----------------HHH-
T ss_pred eccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-----------------Hhh-
Confidence 764432 344679999999999987765 6778999999999999999999965311 000
Q ss_pred CchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 608 GRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 608 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
+. ..+...+ ..++.+++.+||+.||++|||++|+++.
T Consensus 219 ~~------~~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 219 GQ------VFFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp CC------CCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cc------cCCCCCC----CHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 00 0111222 2457788999999999999999999873
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-44 Score=377.96 Aligned_cols=264 Identities=23% Similarity=0.304 Sum_probs=200.6
Q ss_pred hcCCcccceeecCCceEEEEEEeCCC-CeEEEEEEcccC---CCChhhhHHHHHHHHhc---CCCCeeeeeeeeee----
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQN-GDIIAVKRCSHN---SQGKDEFLSELSIIGTL---RHRNLVRLQGWCHE---- 447 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~-~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~---- 447 (711)
.++|+..++||+|+||+||+|++..+ ++.||||++... ......+.+|+++|+.| +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999998644 678999998652 23345677888887776 79999999999853
Q ss_pred -cCeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCC
Q 043702 448 -KGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGL 526 (711)
Q Consensus 448 -~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGl 526 (711)
...++++|||+.++.+..........+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhh
Confidence 3468999999998887766666677899999999999999999999998 999999999999999999999999999
Q ss_pred ceecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhh
Q 043702 527 ARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHR 606 (711)
Q Consensus 527 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~ 606 (711)
++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..+.........
T Consensus 163 ~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~-------~~~~~i~~~~~~ 233 (305)
T d1blxa_ 163 ARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-------DQLGKILDVIGL 233 (305)
T ss_dssp CCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHHHCC
T ss_pred hhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH-------HHHHHHHHhhCC
Confidence 98654332 234567999999999999999999999999999999999999999754221 001110000000
Q ss_pred cC--------chhHhhh----hhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 607 EG--------RLLTAAD----ARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 607 ~~--------~~~~~~d----~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.. ....... ......+.......+.+|+.+||+.||++|||++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 0000000 000001111223456788999999999999999999873
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.9e-43 Score=368.59 Aligned_cols=260 Identities=22% Similarity=0.317 Sum_probs=197.8
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC---CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
++|+..++||+|+||+||+|+++ +|+.||||++.... ...+.+.+|+.+|++++||||+++++++...+..++++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 57899999999999999999996 68999999986632 335689999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCC
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP 536 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~ 536 (711)
|+.++.+..+. .....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 81 ~~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~- 155 (286)
T d1ob3a_ 81 HLDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR- 155 (286)
T ss_dssp CCSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred eehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc-
Confidence 99776665554 5567899999999999999999999997 999999999999999999999999999987654332
Q ss_pred CcccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCc------
Q 043702 537 DATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGR------ 609 (711)
Q Consensus 537 ~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~------ 609 (711)
......|++.|+|||.+... .++.++|||||||++|||++|+.||...... ..+... ........
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~-------~~~~~i-~~~~~~~~~~~~~~ 227 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA-------DQLMRI-FRILGTPNSKNWPN 227 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHH-HHHHCCCCTTTSTT
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH-------HHHHHH-HHhhCCCChhhccc
Confidence 23344689999999998765 5689999999999999999999999653210 001000 00000000
Q ss_pred hhHh---------hhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 610 LLTA---------ADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 610 ~~~~---------~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
.... ..+.............+.+++.+||+.||++|||++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 0000000011112346778999999999999999999985
|
| >d1dhkb_ b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=2.7e-43 Score=348.29 Aligned_cols=198 Identities=32% Similarity=0.482 Sum_probs=165.5
Q ss_pred cceeeecCCCCCCCeEEeCceEee-CCcEEeCCCCCCCCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecCCCCCC
Q 043702 32 TATEFDFGTLTLASLKLLGDAHMN-NGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLNPSSI 110 (711)
Q Consensus 32 ~~~~f~~~~f~~~~~~~~g~a~~~-~g~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~ 110 (711)
..++|+|++|..+||+|+|||.+. +|.|+||++.. +++|||+|++||+||+..+++++||+|+|+|+|.+.+...+
T Consensus 2 ~~~sF~~~~F~~~~l~l~GdA~v~~~g~i~LT~~~~---~~~G~~~y~~Pi~l~~~~~~~~~sF~t~F~f~i~~~~~~~~ 78 (204)
T d1dhkb_ 2 TETSFIIDAFNKTNLILQGDATVSSNGNLQLSYNSY---DSMSRAFYSAPIQIRDSTTGNVASFDTNFTMNIRTHRQANS 78 (204)
T ss_dssp CCCEEEESSCCGGGEEEESSEEECTTSCEEESSSCS---SEEEEEEESSCEESEETTTTEECEEEEEEEEEEECCC---C
T ss_pred ccceEECCCCCccCeeEecceEEcCCCeEEeCCCCC---CCEEEEEeCCCEeccCCCCcccccEEEEEEEEEecCCCCCC
Confidence 467899999999999999999986 78999999877 89999999999999999999999999999999998877778
Q ss_pred CCceEEEEcCCCCCCCCCCCcccccccCCCCcceEEEEeecccCCCCCCCCCCeeeEecCCCcccccccCCccccccCCC
Q 043702 111 GAGLAFVITPDGEQVGSAGGSLGLLDEKGAGLGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSG 190 (711)
Q Consensus 111 g~GlaF~l~~~~~~~~~~g~~lgl~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~S~~~~~~~~~~~~~~~g 190 (711)
||||||+|+|..... .++.|||||||+.| |+++|+|+...... .....+.+|
T Consensus 79 gdGlaf~~~~~~~~~---------------~~~~~~vefDt~~n---------~~~~d~~~~~~~~~----~~~~~~~~g 130 (204)
T d1dhkb_ 79 AVGLDFVLVPVQPES---------------KGDTVTVEFDTFLS---------RISIDVNNNDIKSV----PWDVHDYDG 130 (204)
T ss_dssp CSEEEEEEEEC---------------------CCEEEEEETTTT---------EEEEEETTEEEEEE----ECCGGGTTT
T ss_pred CceEEEEecCCCCCC---------------CCcEeeEeeEcccc---------cccCcccccccccc----ccccEecCC
Confidence 999999999854311 13579999999975 56666665432211 124578899
Q ss_pred CeEEEEEEEcccccEEEEEEEecCCCCCcceeeEecCcccccccceeEEEeeeccCc---eeeEEEEeeccccc
Q 043702 191 DLVNSWIEYDGLTRAFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGS---TEIHSIEWWSFSSS 261 (711)
Q Consensus 191 ~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastg~~---~~~~~i~sW~f~s~ 261 (711)
+.++|||+||+..++|+|++++.+ ++..+.|+..|||+++||++||||||||||.. .|.|+|++|+|+|+
T Consensus 131 ~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~l~~~vdL~~~l~~~~yvGFSAaTG~~~~~~e~H~IlsWsFss~ 203 (204)
T d1dhkb_ 131 QNAEVRITYNSSTKVFSVSLSNPS-TGKSNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHDVLSWSFSSK 203 (204)
T ss_dssp SCEEEEEEEETTTTEEEEEEECTT-TCCEEEEEEECCCCSGGGSEEEEEEEEEECSGGGSCCEEEEEEEEEEEE
T ss_pred CEEEEEEEEcCCCEEEEEEEecCC-CCCceeEEEEecchhccCCcEEEEEEeecCCCCCCceeeEEEEEEEEec
Confidence 999999999999999999999866 45678899999999999999999999999964 68899999999985
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-43 Score=375.21 Aligned_cols=258 Identities=26% Similarity=0.346 Sum_probs=194.8
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeeeeeeeec------CeEEEE
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQGWCHEK------GEILLV 454 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~~~lV 454 (711)
.|+..++||+|+||+||+|++..+|+.||||++..... ...+|+++|++++||||+++++++... ..+++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 97 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence 57788999999999999999999999999999875432 345899999999999999999998643 357999
Q ss_pred EEcCCCCCHHHHHh--hCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCC-cEEEeecCCceecC
Q 043702 455 YDLMPNGSLDKALF--EARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGF-NARLGDFGLARQVE 531 (711)
Q Consensus 455 ~Ey~~~gsL~~~l~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~-~vkL~DFGla~~~~ 531 (711)
||||+++.+..+.. .....+++.+++.++.||+.||+|||+. +|+||||||+||||+.++ .+||+|||+++.+.
T Consensus 98 ~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 98 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 99998764444332 3456799999999999999999999987 999999999999999775 89999999999875
Q ss_pred CCCCCCcccccCCCcccChhhhcc-CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHH--------
Q 043702 532 HDKSPDATVAAGTMGYLAPEYLLT-GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVW-------- 602 (711)
Q Consensus 532 ~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~-------- 602 (711)
..... ....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...... ..+.....
T Consensus 175 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~-------~~l~~i~~~~g~~~~~ 245 (350)
T d1q5ka_ 175 RGEPN--VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-------DQLVEIIKVLGTPTRE 245 (350)
T ss_dssp TTSCC--CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-------HHHHHHHHHHCCCCHH
T ss_pred CCccc--ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH-------HHHHHHHHHhCCChHH
Confidence 54332 33579999999998875 46899999999999999999999999654221 11111110
Q ss_pred ---Hhhh---cCchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 603 ---SLHR---EGRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 603 ---~~~~---~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
.... ......................++.+|+.+||+.||++|||++|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 00000000000000011122345778899999999999999999996
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.9e-43 Score=366.30 Aligned_cols=259 Identities=19% Similarity=0.220 Sum_probs=200.8
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCeeeee-eeeeecCeEEEEEEcC
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNLVRLQ-GWCHEKGEILLVYDLM 458 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~-g~~~~~~~~~lV~Ey~ 458 (711)
++|++.+.||+|+||+||+|++..+|+.||||++.... ..+++..|+++++.++|+|++..+ ++..+.+..++||||+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 46999999999999999999998899999999877543 345688999999999977765554 4556778889999999
Q ss_pred CCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEc---CCCcEEEeecCCceecCCCCC
Q 043702 459 PNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLD---EGFNARLGDFGLARQVEHDKS 535 (711)
Q Consensus 459 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld---~~~~vkL~DFGla~~~~~~~~ 535 (711)
+++|...+......+++..+..++.|++.||+|||+. +|+||||||+|||++ .+..+||+|||+|+.+.....
T Consensus 86 -~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 86 -GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred -CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 5678777777778899999999999999999999998 999999999999985 456799999999998764432
Q ss_pred C------CcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCc
Q 043702 536 P------DATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGR 609 (711)
Q Consensus 536 ~------~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 609 (711)
. ......||+.|||||.+.+..++.++|||||||++|||++|+.||....... .......+... .
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~----~~~~~~~~~~~-----~ 232 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT----KRQKYERISEK-----K 232 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-----------HHHHHHH-----H
T ss_pred ccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHH----HHHHHHHhhcc-----c
Confidence 1 2334579999999999999999999999999999999999999997543210 00011111000 0
Q ss_pred hhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 610 LLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 610 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
. ....+.+...+ ..++.+++..||+.+|++||++.++.+.|+.
T Consensus 233 ~-~~~~~~~~~~~----p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 233 M-STPIEVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp H-HSCHHHHTTTS----CHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred C-CCChhHhccCC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 0 00001111122 2457788899999999999999988887753
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-42 Score=366.13 Aligned_cols=263 Identities=22% Similarity=0.291 Sum_probs=196.6
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccC---CCChhhhHHHHHHHHhcCCCCeeeeeeeeee--------c
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHN---SQGKDEFLSELSIIGTLRHRNLVRLQGWCHE--------K 448 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--------~ 448 (711)
++|+..++||+|+||+||+|++..+|+.||||++... ....+.+.+|+++|++++|||++++++++.. +
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 6799999999999999999999889999999998653 2345678899999999999999999998855 3
Q ss_pred CeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCce
Q 043702 449 GEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLAR 528 (711)
Q Consensus 449 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~ 528 (711)
+.+++||||++++.+..+ ......++...+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 90 ~~~~iv~e~~~~~~~~~~-~~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLL-SNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp -CEEEEEECCCEEHHHHH-TCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ceEEEEEeccCCCccchh-hhcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecceee
Confidence 468999999987766544 34556799999999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCC---CCcccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHh
Q 043702 529 QVEHDKS---PDATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSL 604 (711)
Q Consensus 529 ~~~~~~~---~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~ 604 (711)
....... ......+||+.|+|||++... .++.++|||||||++|||++|+.||...... ....-....
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~--------~~~~~i~~~ 237 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ--------HQLALISQL 237 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHH
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH--------HHHHHHHHh
Confidence 7654332 122335799999999998765 6899999999999999999999999653220 000000000
Q ss_pred hhc-----------CchhHhhhhhccCCCcH-------HHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 605 HRE-----------GRLLTAADARLEGQFDE-------AEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 605 ~~~-----------~~~~~~~d~~l~~~~~~-------~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
... ................. .....+.+|+.+||+.||++|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 000 00000000000000000 112356678999999999999999999985
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.6e-42 Score=362.88 Aligned_cols=259 Identities=17% Similarity=0.191 Sum_probs=207.6
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCC-CCeeeeeeeeeecCeEEEEEEcC
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRH-RNLVRLQGWCHEKGEILLVYDLM 458 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~Ey~ 458 (711)
++|++.++||+|+||+||+|++..+|+.||||++... ...+.+.+|+++++.|+| +|++.+++++..+...++||||+
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC-TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccc-cCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 5799999999999999999999989999999987653 334578899999999985 89999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcC-----CCcEEEeecCCceecCCC
Q 043702 459 PNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDE-----GFNARLGDFGLARQVEHD 533 (711)
Q Consensus 459 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~-----~~~vkL~DFGla~~~~~~ 533 (711)
+++|.+++......+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+|+.....
T Consensus 84 -~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~ 159 (293)
T d1csna_ 84 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 159 (293)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred -CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence 6899999988778899999999999999999999998 9999999999999974 568999999999987543
Q ss_pred CC------CCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhc
Q 043702 534 KS------PDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHRE 607 (711)
Q Consensus 534 ~~------~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~ 607 (711)
.. ......+||+.|||||.+.+..++.++|||||||++|||++|+.||...... ...+..... ..
T Consensus 160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~--------~~~~~~~~i-~~ 230 (293)
T d1csna_ 160 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA--------TNKQKYERI-GE 230 (293)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC--------CHHHHHHHH-HH
T ss_pred ccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccch--------hHHHHHHHH-Hh
Confidence 22 1233457999999999999999999999999999999999999999754221 111111111 00
Q ss_pred CchhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Q 043702 608 GRLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQMLVG 657 (711)
Q Consensus 608 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 657 (711)
.+.... -+.+...++ .++.+++..|++.+|++||+++.+.+.|+.
T Consensus 231 ~~~~~~-~~~l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 231 KKQSTP-LRELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp HHHHSC-HHHHTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred ccCCCC-hHHhcCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 000000 011112222 457778889999999999999988877754
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=372.41 Aligned_cols=269 Identities=22% Similarity=0.244 Sum_probs=198.6
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCC--ChhhhHHHHHHHHhcCCCCeeeeeeeeeecC----eEE
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQ--GKDEFLSELSIIGTLRHRNLVRLQGWCHEKG----EIL 452 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~ 452 (711)
+.+|+..++||+|+||+||+|++..+|+.||||++..... ..+.+++|+++|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 4568999999999999999999988999999999875332 2457889999999999999999999997643 234
Q ss_pred EEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCC
Q 043702 453 LVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEH 532 (711)
Q Consensus 453 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~ 532 (711)
+++||+.+|+|.+++.. ..+++..++.++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++....
T Consensus 87 ~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 44566779999999965 3699999999999999999999998 999999999999999999999999999987644
Q ss_pred CCC--CCcccccCCCcccChhhhcc-CCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcCc
Q 043702 533 DKS--PDATVAAGTMGYLAPEYLLT-GRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREGR 609 (711)
Q Consensus 533 ~~~--~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 609 (711)
... ......+||+.|+|||++.. ..++.++||||+||++|||++|+.||...... ..............
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~--------~~~~~~~~~~~~~~ 233 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL--------DQLNHILGILGSPS 233 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHHHCSCC
T ss_pred CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHH--------HHHHHHhhhccCCC
Confidence 322 22344679999999999854 46789999999999999999999999654221 00000000000000
Q ss_pred -----------hhHhhhhh-ccCCCcH-----HHHHHHHHHHHhcCCCCCCCCCCHHHHHHH--HhCCCC
Q 043702 610 -----------LLTAADAR-LEGQFDE-----AEMRRVLLVGLACSHPDPLARPTMRGVVQM--LVGEAE 660 (711)
Q Consensus 610 -----------~~~~~d~~-l~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~--L~~~~~ 660 (711)
........ .....+. ....++.+++.+||+.||.+|||+.|+++. |+....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~ 303 (345)
T d1pmea_ 234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303 (345)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence 00000000 0000000 112357789999999999999999999984 544433
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-42 Score=371.55 Aligned_cols=262 Identities=23% Similarity=0.285 Sum_probs=195.9
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCC---hhhhHHHHHHHHhcCCCCeeeeeeeeeecC------
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQG---KDEFLSELSIIGTLRHRNLVRLQGWCHEKG------ 449 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 449 (711)
.++|+..++||+|+||+||+|++..+|+.||||++...... .+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 35799999999999999999999989999999999763322 356889999999999999999999997654
Q ss_pred eEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCcee
Q 043702 450 EILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQ 529 (711)
Q Consensus 450 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~ 529 (711)
.+++||||+ +.+|..++.. ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceec
Confidence 579999999 5678887754 4699999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCCCcccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHH-------
Q 043702 530 VEHDKSPDATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWV------- 601 (711)
Q Consensus 530 ~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~------- 601 (711)
.... .+...||+.|+|||.+.+. .++.++||||+||++|||++|+.||...... ..+....
T Consensus 171 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~-------~~~~~~~~~~~~~~ 239 (346)
T d1cm8a_ 171 ADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-------DQLKEIMKVTGTPP 239 (346)
T ss_dssp CCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHHHCCCC
T ss_pred cCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH-------HHHHHHHhccCCCc
Confidence 6543 2345799999999998764 5689999999999999999999999654210 0000000
Q ss_pred ---HHhhhcCchhHhhhhhc---c----CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH--HhCC
Q 043702 602 ---WSLHREGRLLTAADARL---E----GQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM--LVGE 658 (711)
Q Consensus 602 ---~~~~~~~~~~~~~d~~l---~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~--L~~~ 658 (711)
+..... .........+ . ..........+.+|+.+||+.||.+|||++|+++. ++..
T Consensus 240 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 240 AEFVQRLQS-DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHHTCSC-HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHHhhhcc-hhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 000000 0000000000 0 00011122456788999999999999999999984 5544
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=368.16 Aligned_cols=252 Identities=22% Similarity=0.290 Sum_probs=202.8
Q ss_pred cCCcccceeecCCceEEEEEEe---CCCCeEEEEEEcccC-----CCChhhhHHHHHHHHhcCC-CCeeeeeeeeeecCe
Q 043702 380 KCFNANRIIGHGAFGTVYKGIL---PQNGDIIAVKRCSHN-----SQGKDEFLSELSIIGTLRH-RNLVRLQGWCHEKGE 450 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~---~~~~~~vavK~~~~~-----~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~ 450 (711)
++|+..+.||+|+||+||+|+. +.+|+.||||++... ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5699999999999999999987 346899999988642 2345678899999999976 899999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceec
Q 043702 451 ILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV 530 (711)
Q Consensus 451 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~ 530 (711)
.+++|||+.+|+|.+++... ..++......++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++.+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eeeeeecccccHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 99999999999999998654 4577889999999999999999998 9999999999999999999999999999877
Q ss_pred CCCCCCCcccccCCCcccChhhhccC--CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcC
Q 043702 531 EHDKSPDATVAAGTMGYLAPEYLLTG--RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREG 608 (711)
Q Consensus 531 ~~~~~~~~~~~~gt~~y~APE~~~~~--~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 608 (711)
............|++.|+|||.+... .++.++|||||||+||||++|+.||...... ....-+.....
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~--------~~~~~i~~~~~-- 249 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK--------NSQAEISRRIL-- 249 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC--------CCHHHHHHHHH--
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHHhcc--
Confidence 65444444556799999999999765 4688999999999999999999999764321 11111111000
Q ss_pred chhHhhhhhccCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 043702 609 RLLTAADARLEGQFDEAEMRRVLLVGLACSHPDPLARP-----TMRGVVQ 653 (711)
Q Consensus 609 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVl~ 653 (711)
.. ...++.....++.+++.+||+.||.+|| +++|+++
T Consensus 250 ------~~--~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 250 ------KS--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ------HC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ------cC--CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 00 1111223345677889999999999999 4889986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-42 Score=358.48 Aligned_cols=263 Identities=21% Similarity=0.298 Sum_probs=204.3
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCC---CChhhhHHHHHHHHhcCCCCeeeeeeeeeecCeEEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNS---QGKDEFLSELSIIGTLRHRNLVRLQGWCHEKGEILLVYD 456 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 456 (711)
++|+..++||+|+||+||+|++..+++.||||+++... ...+.+.+|+.+|+.++||||+++++++......++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57899999999999999999999999999999986533 234678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceecCCCCCC
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQVEHDKSP 536 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~ 536 (711)
++.+++|..++. ....+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||.++.......
T Consensus 82 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~- 156 (292)
T d1unla_ 82 FCDQDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR- 156 (292)
T ss_dssp CCSEEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-
T ss_pred eccccccccccc-cccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCc-
Confidence 999988887764 556789999999999999999999997 999999999999999999999999999998765433
Q ss_pred CcccccCCCcccChhhhccCC-CCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhc---Cc---
Q 043702 537 DATVAAGTMGYLAPEYLLTGR-ATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHRE---GR--- 609 (711)
Q Consensus 537 ~~~~~~gt~~y~APE~~~~~~-~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~---~~--- 609 (711)
......+++.|+|||.+.... ++.++|||||||++|||++|+.||...... .....-+...... ..
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~ 229 (292)
T d1unla_ 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-------DDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH-------HHHHHHHHHHHCCCCTTTCTT
T ss_pred cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCH-------HHHHHHHHhhcCCCChhhhhh
Confidence 223345788999999987665 689999999999999999999997432110 0111101000000 00
Q ss_pred hhHhhhh---------hccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 610 LLTAADA---------RLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 610 ~~~~~d~---------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
.....+. .-...........+.+|+.+||+.||.+|||++|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000 00001111223457788899999999999999999873
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.2e-41 Score=360.00 Aligned_cols=260 Identities=19% Similarity=0.257 Sum_probs=198.4
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcC-CCCeeeeeeeeee--cCeEEEEEE
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLR-HRNLVRLQGWCHE--KGEILLVYD 456 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~--~~~~~lV~E 456 (711)
++|++.++||+|+||+||+|++..+|+.||||++... ..+++.+|+++|++++ ||||+++++++.. ...+++|||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 4799999999999999999999989999999998643 3567899999999996 9999999999874 356999999
Q ss_pred cCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCC-cEEEeecCCceecCCCCC
Q 043702 457 LMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGF-NARLGDFGLARQVEHDKS 535 (711)
Q Consensus 457 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~-~vkL~DFGla~~~~~~~~ 535 (711)
||++++|..+. +.+++.+++.++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+++.......
T Consensus 113 ~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~ 185 (328)
T d3bqca1 113 HVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 185 (328)
T ss_dssp CCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC
T ss_pred ecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCCCc
Confidence 99999987653 4699999999999999999999998 999999999999998655 699999999998765432
Q ss_pred CCcccccCCCcccChhhhccCC-CCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHH-----HHHhhhcCc
Q 043702 536 PDATVAAGTMGYLAPEYLLTGR-ATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEW-----VWSLHREGR 609 (711)
Q Consensus 536 ~~~~~~~gt~~y~APE~~~~~~-~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~-----~~~~~~~~~ 609 (711)
....+||+.|+|||.+.+.. ++.++||||+||+++||++|+.||......... ...+... .........
T Consensus 186 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~---~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 186 --YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ---LVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp --CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH---HHHHHHHHCHHHHHHHHHHTT
T ss_pred --ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHH---HHHHHHHHCCchhhhhhhhcc
Confidence 34457999999999987654 799999999999999999999999654221000 0000000 000000000
Q ss_pred h------hHhh--------hhhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 043702 610 L------LTAA--------DARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQ 653 (711)
Q Consensus 610 ~------~~~~--------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 653 (711)
. .... ..............++.+|+.+||+.||.+|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0000 000000011112345778999999999999999999987
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-41 Score=362.56 Aligned_cols=266 Identities=22% Similarity=0.227 Sum_probs=191.5
Q ss_pred cCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCC---hhhhHHHHHHHHhcCCCCeeeeeeeeee------cCe
Q 043702 380 KCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQG---KDEFLSELSIIGTLRHRNLVRLQGWCHE------KGE 450 (711)
Q Consensus 380 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~------~~~ 450 (711)
++|+..++||+|+||+||+|++..+|+.||||++...... ...+.+|+.++++++||||+++++++.. .+.
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 6799999999999999999999989999999999764332 3468899999999999999999999864 368
Q ss_pred EEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceec
Q 043702 451 ILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV 530 (711)
Q Consensus 451 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~ 530 (711)
+|+|||||.++ +.+.+ ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+|++|||+++..
T Consensus 97 ~~iv~Ey~~~~-l~~~~---~~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVI---QMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEEEECCSEE-HHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred eEEEEeccchH-HHHhh---hcCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhcc
Confidence 89999999665 44444 24689999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccc-----------cccchHH
Q 043702 531 EHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVG-----------VASNLVE 599 (711)
Q Consensus 531 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~-----------~~~~l~~ 599 (711)
.... .....+||+.|+|||++.+..++.++||||+||+++||++|+.||........... .......
T Consensus 170 ~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (355)
T d2b1pa1 170 GTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_dssp -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred cccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence 5433 33445799999999999999999999999999999999999999965321100000 0000000
Q ss_pred HHHHhhhcC------chhHhhhhhcc---CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 043702 600 WVWSLHREG------RLLTAADARLE---GQFDEAEMRRVLLVGLACSHPDPLARPTMRGVVQM 654 (711)
Q Consensus 600 ~~~~~~~~~------~~~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 654 (711)
......... ........... ..........+.+|+.+||+.||++|||++|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000000 00001101111 11122345678899999999999999999999974
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-41 Score=360.77 Aligned_cols=262 Identities=21% Similarity=0.266 Sum_probs=196.0
Q ss_pred hcCCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCC---hhhhHHHHHHHHhcCCCCeeeeeeeeeec-----Ce
Q 043702 379 TKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQG---KDEFLSELSIIGTLRHRNLVRLQGWCHEK-----GE 450 (711)
Q Consensus 379 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~ 450 (711)
.++|+..++||+|+||+||+|++..+|+.||||++...... .+.+.+|+++|++++|||++++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 45799999999999999999999889999999999764433 34688999999999999999999998633 34
Q ss_pred EEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEeecCCceec
Q 043702 451 ILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQV 530 (711)
Q Consensus 451 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~ 530 (711)
.++++||+.+|+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+|++|||++...
T Consensus 97 ~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred eEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhccc
Confidence 4667778889999999853 5699999999999999999999998 9999999999999999999999999999765
Q ss_pred CCCCCCCcccccCCCcccChhhhccC-CCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHHHHHHhhhcC-
Q 043702 531 EHDKSPDATVAAGTMGYLAPEYLLTG-RATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVEWVWSLHREG- 608 (711)
Q Consensus 531 ~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~~~~~~~~~~- 608 (711)
.. ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...... .....+.......
T Consensus 172 ~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~--------~~~~~i~~~~~~~~ 239 (348)
T d2gfsa1 172 DD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI--------DQLKLILRLVGTPG 239 (348)
T ss_dssp TG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHHHCCCC
T ss_pred Cc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH--------HHHHHHHHhcCCCC
Confidence 32 23345689999999987765 4688999999999999999999999653211 0000000000000
Q ss_pred ---------chhHhhhhhcc--CCCc-----HHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--HHhC
Q 043702 609 ---------RLLTAADARLE--GQFD-----EAEMRRVLLVGLACSHPDPLARPTMRGVVQ--MLVG 657 (711)
Q Consensus 609 ---------~~~~~~d~~l~--~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~--~L~~ 657 (711)
.........+. .... ......+.+|+.+||+.||.+|||++|+++ .++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~ 306 (348)
T d2gfsa1 240 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306 (348)
T ss_dssp HHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred hHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCC
Confidence 00000000000 0000 011245678999999999999999999998 4544
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3e-37 Score=332.05 Aligned_cols=267 Identities=19% Similarity=0.218 Sum_probs=195.3
Q ss_pred CCcccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcC-----------CCCeeeeeeeeeec-
Q 043702 381 CFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLR-----------HRNLVRLQGWCHEK- 448 (711)
Q Consensus 381 ~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~-----------H~niv~l~g~~~~~- 448 (711)
+|++.++||+|+||+||+|++..+|+.||||++.......+.+.+|+++++.++ |+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~ 93 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence 489999999999999999999989999999999765544567889999998886 47899999988653
Q ss_pred -CeEEEEEEcCCCCCHHHH--HhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCc------E
Q 043702 449 -GEILLVYDLMPNGSLDKA--LFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFN------A 519 (711)
Q Consensus 449 -~~~~lV~Ey~~~gsL~~~--l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~------v 519 (711)
...+++++++..+..... .......+++..+..++.||+.||+|||+. .+|+||||||+||||+.++. +
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCccccccee
Confidence 456777777655543332 233446789999999999999999999983 38999999999999986553 9
Q ss_pred EEeecCCceecCCCCCCCcccccCCCcccChhhhccCCCCccccchhHHHHHHHHHhCCCCCccccccccccccccchHH
Q 043702 520 RLGDFGLARQVEHDKSPDATVAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVASGRRPIEKEITGVGKVGVASNLVE 599 (711)
Q Consensus 520 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~elltG~~P~~~~~~~~~~~~~~~~l~~ 599 (711)
|++|||.+....... ...+||+.|+|||++....++.++||||+||+++||++|+.||........ ......+..
T Consensus 172 kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~-~~~~~~~~~ 246 (362)
T d1q8ya_ 172 KIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY-TKDDDHIAQ 246 (362)
T ss_dssp EECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----------CHHHHHHH
T ss_pred eEeeccccccccccc----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccc-cchhHHHHH
Confidence 999999998654322 345699999999999999999999999999999999999999975432110 000011111
Q ss_pred HHHHhh-------hcCch-hHhhh-------------------hhccCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHH
Q 043702 600 WVWSLH-------REGRL-LTAAD-------------------ARLEGQFDEAEMRRVLLVGLACSHPDPLARPTMRGVV 652 (711)
Q Consensus 600 ~~~~~~-------~~~~~-~~~~d-------------------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl 652 (711)
.++.+- ..+.. ....+ ..............+.+|+.+||+.||.+|||++|++
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 111100 00000 00000 0011234456778899999999999999999999999
Q ss_pred HH
Q 043702 653 QM 654 (711)
Q Consensus 653 ~~ 654 (711)
+.
T Consensus 327 ~H 328 (362)
T d1q8ya_ 327 NH 328 (362)
T ss_dssp TC
T ss_pred cC
Confidence 84
|
| >d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Concanavalin A species: Jack bean (Canavalia ensiformis) [TaxId: 3823]
Probab=99.96 E-value=1.5e-30 Score=258.17 Aligned_cols=116 Identities=30% Similarity=0.509 Sum_probs=106.7
Q ss_pred cceEEEEeecccCCCCCCCCCCeeeEecCCCcccccccCCccccccCCCCeEEEEEEEcccccEEEEEEEecCCCCCcce
Q 043702 142 LGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEVDNLDTINVDLKSGDLVNSWIEYDGLTRAFNISVSYSNLKPKVPI 221 (711)
Q Consensus 142 ~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~S~~~~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~ 221 (711)
|++||||||||+|.+++||++||||||+|++.|.++. .+++.+|+.++|||+||+.+++|+|++++.. +..|+
T Consensus 2 n~ivAVEFDT~~N~~~~Dp~~nHIgIdvns~~S~~~~-----~~~l~~G~~~~v~I~Yd~~~~~L~V~~~~~~--~~~~~ 74 (237)
T d1nlsa_ 2 DTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTA-----KWNMQNGKVGTAHIIYNSVDKRLSAVVSYPN--ADSAT 74 (237)
T ss_dssp CCEEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEE-----ECCCCTTCEEEEEEEEETTTTEEEEEEECTT--SCCEE
T ss_pred CCEEEEEEECCcCCCCCCCCCCEEEEEeCCCCcccee-----cccccCCCEEEEEEEEecCCcEEEEEEecCC--CCCeE
Confidence 6899999999999888899999999999999986543 4689999999999999999999999998653 56789
Q ss_pred eeEecCcccccccceeEEEeeeccCceeeEEEEeeccccccCc
Q 043702 222 LSFTLDLDQYVNDFMYVGFSGSTQGSTEIHSIEWWSFSSSFES 264 (711)
Q Consensus 222 ls~~vdL~~~l~~~~~vGFsastg~~~~~~~i~sW~f~s~~~~ 264 (711)
+++.|||+++|+++||||||||||...|.|+|++|+|++++..
T Consensus 75 ls~~vdL~~~l~~~vyvGFSAsTG~~~~~h~I~sWsFsS~~~~ 117 (237)
T d1nlsa_ 75 VSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSKLKS 117 (237)
T ss_dssp EEEECCGGGTSCSEEEEEEEEECSSSCCCCEEEEEEEEEEEEE
T ss_pred EEEEEChHHhCCCcEEEEEEeecCCCccceEEEEEEEEeeccc
Confidence 9999999999999999999999999999999999999998854
|
| >d1gv9a_ b.29.1.13 (A:) Carbohydrate-recognition domain of P58/ERGIC-53 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Carbohydrate-recognition domain of P58/ERGIC-53 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.94 E-value=2.7e-27 Score=237.33 Aligned_cols=192 Identities=16% Similarity=0.153 Sum_probs=134.3
Q ss_pred CCeEEeCceEeeCCcEEeCCCCCCCCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecCCCCCCCCceEEEEcCCCC
Q 043702 44 ASLKLLGDAHMNNGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLNPSSIGAGLAFVITPDGE 123 (711)
Q Consensus 44 ~~~~~~g~a~~~~g~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~GlaF~l~~~~~ 123 (711)
+++.++|+|.+.++.|+||++.. +++|+++|+.|+++ .+|+++|+|.|.... ..+||||||+|++...
T Consensus 24 ~~w~~~G~a~i~~~~i~LT~~~~---~~~G~v~~~~p~~~--------~~F~~~f~f~~~~~~-~~ggdG~aF~i~~~~~ 91 (228)
T d1gv9a_ 24 PFWAHAGNAIPSADQIRIAPSLK---SQRGSVWTKTKAAF--------ENWEVEVTFRVTGRG-RIGADGLAIWYTENQG 91 (228)
T ss_dssp TTEEEEETCEECSSCEEEECSST---TCEEEEEESSCBCC--------SSEEEEEEEEEECSS-SCCCCEEEEEEESSCC
T ss_pred cceEEeeeEEEECCEEEECCCCC---CCEEEEEeCCCccc--------cCcEEEEEEeccCCC-CCCCCEEEEEEecCCC
Confidence 46899999999999999999887 89999999999997 369999999998643 4689999999998654
Q ss_pred CCCCCCCcccccccCCCCcceEEEEeecccCCCCCCCCCCeeeEecCCCcc-cccc------cCCcccccc-CCCCeEEE
Q 043702 124 QVGSAGGSLGLLDEKGAGLGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVS-TEVD------NLDTINVDL-KSGDLVNS 195 (711)
Q Consensus 124 ~~~~~g~~lgl~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~S-~~~~------~~~~~~~~~-~~g~~~~~ 195 (711)
. .|+.+|..+. .+-+||||||+.|. ++++.+|+.+++|.... .... ......... ..+..+++
T Consensus 92 ~---~g~~~G~~~~----~~glaVefDt~~n~--~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 162 (228)
T d1gv9a_ 92 L---DGPVFGSADM----WNGVGIFFDSFDND--GKKNNPAIVVVGNNGQINYDHQNDGATQALASCQRDFRNKPYPVRA 162 (228)
T ss_dssp C---EEEETTECSC----CEEEEEEEECCCC-------CCEEEEEEEESCCCCCHHHHHHHHCSEEECCCCBSCSSCEEE
T ss_pred C---CCCccCcCCC----CceEEEEEEccccc--CCCCCCcEEEEecCCcceeeecCCCccccccceeeeecCCceEEEE
Confidence 3 3455554322 34589999999985 47788888887764331 1110 011111111 22344555
Q ss_pred EEEEcccccEEEEEEEecCCCCCc-ceeeEecCcccccccceeEEEeeeccCceeeEEEEeeccc
Q 043702 196 WIEYDGLTRAFNISVSYSNLKPKV-PILSFTLDLDQYVNDFMYVGFSGSTQGSTEIHSIEWWSFS 259 (711)
Q Consensus 196 ~I~Y~~~~~~l~V~~~~~~~~~~~-~~ls~~vdL~~~l~~~~~vGFsastg~~~~~~~i~sW~f~ 259 (711)
|++| ..+.|+|.++........ +.....++ ...+++++||||||+||...+.|+|++|.+.
T Consensus 163 ~~~~--~~~~l~v~i~~~~~~~~~~~~~~~~~~-~~~l~~~~y~GFTAsTG~~~~~H~I~s~~~~ 224 (228)
T d1gv9a_ 163 KITY--YQKTLTVMINNGFTPDKNDYEFCAKVE-NMVIPTQGHFGISAATGGLADDHDVLSFLTF 224 (228)
T ss_dssp EEEE--ETTEEEEEEECSSCCCTTCCEEEEEET-TCCCCSSBEEEEEEECCSSCCEEEEEEEEEE
T ss_pred EEEe--cCCEEEEEEeccccCCCcceeEEEEec-ccccCCCEEEEEEEeCCCCcCeEEEEEEEEE
Confidence 5555 568899999865432222 33333333 5578999999999999999999999999874
|
| >d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Concanavalin A species: Jack bean (Canavalia ensiformis) [TaxId: 3823]
Probab=99.87 E-value=7.3e-23 Score=202.53 Aligned_cols=108 Identities=31% Similarity=0.468 Sum_probs=92.9
Q ss_pred CccceeeecCCCC--CCCeEEeCceEee-CCcEEeCCCCCC---CCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEe
Q 043702 30 ISTATEFDFGTLT--LASLKLLGDAHMN-NGSVRLTRDVTV---PYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSIT 103 (711)
Q Consensus 30 ~~~~~~f~~~~f~--~~~~~~~g~a~~~-~g~~~Lt~~~~~---~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~ 103 (711)
.+.+++|+|++|. ..||+|+|||.+. +|.|+||+.+.+ ...++|||+|++||||||+ +++++||+|+|+|.|.
T Consensus 122 esn~~~F~f~~F~~~~~nl~l~G~A~i~~~G~l~LT~~~~~~~~~~~s~Gra~y~~Pv~l~d~-t~~~~SFsT~F~F~I~ 200 (237)
T d1nlsa_ 122 ETNALHFMFNQFSKDQKDLILQGDATTGTDGNLELTRVSSNGSPQGSSVGRALFYAPVHIWES-SAVVASFEATFTFLIK 200 (237)
T ss_dssp CEEEEEEEESCCCTTCTTEEEEETCEEEETTEEESSCBCTTSCBCSSCEEEEEESSCEECCCT-TEEEEEEEEEEEEECC
T ss_pred ccccceEEeeecCCCCCCEEEeeeeEecCCCcEEecCCCCCCcccCcceEEEEeCCCEEEECC-CCcEeeEEEEEEEEEe
Confidence 3567999999996 5699999999986 899999986532 3477999999999999996 8899999999999998
Q ss_pred cCCCCCCCCceEEEEcCCCC--CCCCCCCcccccccCC
Q 043702 104 NLNPSSIGAGLAFVITPDGE--QVGSAGGSLGLLDEKG 139 (711)
Q Consensus 104 ~~~~~~~g~GlaF~l~~~~~--~~~~~g~~lgl~~~~~ 139 (711)
+.+ ..+||||||||+|... ++++.||||||||.+|
T Consensus 201 ~~~-~~~gdG~aF~iap~~~~~p~~~~g~~LGL~n~~n 237 (237)
T d1nlsa_ 201 SPD-SHPADGIAFFISNIDSSIPSGSTGRLLGLFPDAN 237 (237)
T ss_dssp CSS-SSCCCEEEEEEECTTCCCCTTCCGGGTTTCSSCC
T ss_pred cCC-CCCCCCEEEEEeCCCCCCCCCCCCCeeeeccCCC
Confidence 765 4679999999999764 4588999999999764
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=1.6e-22 Score=196.46 Aligned_cols=162 Identities=14% Similarity=0.185 Sum_probs=121.2
Q ss_pred cccceeecCCceEEEEEEeCCCCeEEEEEEcccCCCC-------------------hhhhHHHHHHHHhcCCCCeeeeee
Q 043702 383 NANRIIGHGAFGTVYKGILPQNGDIIAVKRCSHNSQG-------------------KDEFLSELSIIGTLRHRNLVRLQG 443 (711)
Q Consensus 383 ~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~-------------------~~~~~~Ei~~l~~l~H~niv~l~g 443 (711)
...++||+|+||+||+|++. +|+.||||+++..... .....+|...+.++.|.+++..++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred hhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 45789999999999999985 6899999986531110 123456888999999999988876
Q ss_pred eeeecCeEEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCceEEcCCCcEEEee
Q 043702 444 WCHEKGEILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQECENQVIHRDVKTSNIMLDEGFNARLGD 523 (711)
Q Consensus 444 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~D 523 (711)
+.. .+++|||+++..+. .++.....+++.|++++|+|||+. +|+||||||+|||++++ .++|+|
T Consensus 82 ~~~----~~lvme~~~~~~~~--------~l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 82 WEG----NAVLMELIDAKELY--------RVRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp EET----TEEEEECCCCEEGG--------GCCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECC
T ss_pred ecC----CEEEEEeecccccc--------chhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEE
Confidence 532 27999999886543 255667788999999999999997 99999999999999965 599999
Q ss_pred cCCceecCCCCCCCcccccCCCcccCh------hhhccCCCCccccchhHHHHH
Q 043702 524 FGLARQVEHDKSPDATVAAGTMGYLAP------EYLLTGRATEKTDVFSYGAVV 571 (711)
Q Consensus 524 FGla~~~~~~~~~~~~~~~gt~~y~AP------E~~~~~~~s~ksDVwSfGvll 571 (711)
||+|....+.... .|... |. ..+.|..++|+||..--+
T Consensus 146 FG~a~~~~~~~~~---------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 146 FPQSVEVGEEGWR---------EILERDVRNIITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CTTCEETTSTTHH---------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred CCCcccCCCCCcH---------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence 9999876433211 11111 22 245678899999976444
|
| >d2a6va1 b.29.1.13 (A:9-226) Emp46p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Emp46p N-terminal domain species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.84 E-value=3.2e-20 Score=183.27 Aligned_cols=187 Identities=15% Similarity=0.168 Sum_probs=132.7
Q ss_pred CCCeEEeCceEeeCCcEEeCCCCCCCCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecCCCCCCCCceEEEEcCCC
Q 043702 43 LASLKLLGDAHMNNGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLNPSSIGAGLAFVITPDG 122 (711)
Q Consensus 43 ~~~~~~~g~a~~~~g~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~GlaF~l~~~~ 122 (711)
.+++.+.|+|.+.++.|+||++ . ++.|++|++.|+++++ +|+++|+|+|.... ..+||||||++++..
T Consensus 21 ~~~W~~~G~~~~~~~~i~LTp~-~---~~~G~~w~~~~i~~~~-------~f~i~~~F~i~g~~-~~~~dG~afw~~~~~ 88 (218)
T d2a6va1 21 LSQWTLGDKVKLEEGRFVLTPG-K---NTKGSLWLKPEYSIKD-------AMTIEWTFRSFGFR-GSTKGGLAFWLKQGN 88 (218)
T ss_dssp TTTEEEEETCEEETTEEESCCS-T---TCEEEEEESSCBCCSS-------CEEEEEEEEEESCC-SCCSCEEEEEEECSC
T ss_pred cCccEECCCEEEECCEEEECCC-C---CCeeEEEeCCcccccc-------cceEEEEEEEeCCC-CCCCCcEEEEEEcCC
Confidence 4789999999999999999987 4 5689999999999975 49999999998653 567999999999855
Q ss_pred CCCC--CCCCcccccccCCCCcceEEEEeecccCCCCCCCCCCeeeEecCCCcc-cccc---cCCccccc-cCCCCeEEE
Q 043702 123 EQVG--SAGGSLGLLDEKGAGLGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVS-TEVD---NLDTINVD-LKSGDLVNS 195 (711)
Q Consensus 123 ~~~~--~~g~~lgl~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~S-~~~~---~~~~~~~~-~~~g~~~~~ 195 (711)
...+ ..+|..+.++. +|||||||.|. .+||.+.+|.-.. .... ..+..... ..++...++
T Consensus 89 ~~~~~~~~~G~~~~f~G-------laV~fDt~~n~------~~~i~~~~ndGs~~~~~~~d~~~g~c~~~~~~~~~~~~~ 155 (218)
T d2a6va1 89 EGDSTELFGGSSKKFNG-------LMILLRLDDKL------GESVTAYLNDGTKDLDIESSPYFASCLFQYQDSMVPSTL 155 (218)
T ss_dssp CCCCCTBTTTBCSSCEE-------EEEEEEEETTT------EEEEEEEEEESSSCCCTTTSCCSEEEECCCSSCSSCEEE
T ss_pred cccCCCcccccCCCcce-------EEEEEECCCCC------CCeEEEEeCCCCccccccCCcccceEEecccCCCCcEEE
Confidence 4322 22344444332 79999999873 2578776653221 1111 11111222 345778999
Q ss_pred EEEEccccc-EEEEEEEecCCCCCccee-eEecCcccccccceeEEEeeeccCceeeEEEEeecccccc
Q 043702 196 WIEYDGLTR-AFNISVSYSNLKPKVPIL-SFTLDLDQYVNDFMYVGFSGSTQGSTEIHSIEWWSFSSSF 262 (711)
Q Consensus 196 ~I~Y~~~~~-~l~V~~~~~~~~~~~~~l-s~~vdL~~~l~~~~~vGFsastg~~~~~~~i~sW~f~s~~ 262 (711)
+|.|+..+. .++|.+.. ..|+ ...|+| ..++++|+||||+||...+.|+|++|++.+.+
T Consensus 156 ~i~Y~~~~~~~l~v~id~------~~c~~t~~i~l--p~~~~~yfG~SA~Tg~~~d~~dIls~~~~~~~ 216 (218)
T d2a6va1 156 RLTYNPLDNHLLKLQMDN------RVCFQTRKVKF--MGSSPFRIGTSAINDASKESFEILKMKLYDGV 216 (218)
T ss_dssp EEEEEGGGTSEEEEEETT------EEEEEESCCCG--GGTSCBEEEEEEECCTTCCEEEEEEEEEESSC
T ss_pred EEEEECcccceEEEEeCC------cEEEEECCeec--CCCCcEEEEEEECCCCCcCcEEEEEEEEEecc
Confidence 999987654 57777641 2233 223444 34577999999999999999999999997654
|
| >d2a6za1 b.29.1.13 (A:7-227) Emp47p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Emp47p N-terminal domain species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.83 E-value=4.2e-20 Score=183.12 Aligned_cols=184 Identities=10% Similarity=0.062 Sum_probs=123.6
Q ss_pred CCeEEeCceEeeCCcEEeCCCCCCCCCceEEEEeCCceeccCCCCCCceeeEEEEEEEEecCCCCCCCCceEEEEcCCCC
Q 043702 44 ASLKLLGDAHMNNGSVRLTRDVTVPYDGAGKALYSKPVRFRLPGTHTPASFSTFFSFSITNLNPSSIGAGLAFVITPDGE 123 (711)
Q Consensus 44 ~~~~~~g~a~~~~g~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~GlaF~l~~~~~ 123 (711)
+++.+.|+|.+.++.|+||++ . ++.|.+|++.|+++++ .|+++|.|+|.... ..+||||||++++...
T Consensus 23 ~~W~~~g~a~~~~~~i~LTp~-~---~~~G~~w~~~~i~~~~-------~f~~~~~F~i~g~~-~~ggdG~af~~~~~~~ 90 (221)
T d2a6za1 23 NNWQTGEQASLEEGRIVLTSN-Q---NSKGSLWLKQGFDLKD-------SFTMEWTFRSVGYS-GQTDGGISFWFVQDSN 90 (221)
T ss_dssp TTEEEEETCEEETTEEESCCS-T---TCEEEEEESSCEECCS-------CEEEEEEEEEESCC-SCCSCEEEEEEEECSS
T ss_pred CccEEcceeEEECCEEEECCC-C---CCceEEEECCccccCC-------CeEEEEEEEEeCCC-CCCCCcEEEEEEcCCC
Confidence 589999999999999999986 4 5789999999999975 49999999998653 4679999999997543
Q ss_pred CCCCCCCcccccccCCCCcceEEEEeecccCCCCCCCCCCeeeEecCCCccccc----ccCCcccccc-CCCCeEEEEEE
Q 043702 124 QVGSAGGSLGLLDEKGAGLGFVAVEFDTLMDVEFSDINGNHVGLDLNSMVSTEV----DNLDTINVDL-KSGDLVNSWIE 198 (711)
Q Consensus 124 ~~~~~g~~lgl~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~S~~~----~~~~~~~~~~-~~g~~~~~~I~ 198 (711)
. +..|+++|..+. ..-+||||||+.|. ....|+.++.++..-... .........+ .++...+++|.
T Consensus 91 ~-~~~g~~~G~~~~----~~GlaV~fDt~~n~----~~~~~~~~ndgt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~I~ 161 (221)
T d2a6za1 91 I-PRDKQLYNGPVN----YDGLQLLVDNNGPL----GPTLRGQLNDGQKPVDKTKIYDQSFASCLMGYQDSSVPSTIRVT 161 (221)
T ss_dssp S-CCCCTBTTBCTT----CEEEEEEEESCSTT----SSEEEEEEEESSSCCCGGGHHHHCSEEEECCCTTEEEEEEEEEE
T ss_pred c-cccccccccCCC----CceEEEEEECCCCC----CCceEEEecCCCccccccCCcccccceeeecccCCCCCEEEEEE
Confidence 2 334455554222 23489999999873 222333443333221111 1111112333 35677899999
Q ss_pred Eccccc-EEEEEEEecCCCCCcceeeEecCcccccccceeEEEeeeccCceeeEEEEee
Q 043702 199 YDGLTR-AFNISVSYSNLKPKVPILSFTLDLDQYVNDFMYVGFSGSTQGSTEIHSIEWW 256 (711)
Q Consensus 199 Y~~~~~-~l~V~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastg~~~~~~~i~sW 256 (711)
|+..++ .|.|.++. ..++. ++--.+-++++|+||||+||...+.|+++.+
T Consensus 162 y~~~~~~~l~v~id~------~~c~~--~~~v~lp~~~~~fG~SA~TG~~~~~hd~~~i 212 (221)
T d2a6za1 162 YDLEDDNLLKVQVDN------KVCFQ--TRKVRFPSGSYRIGVTAQNGAVNNNAESFEI 212 (221)
T ss_dssp EEGGGTSEEEEEETT------EEEEE--ESCCCCCSSEEEEEEEEECCSGGGCCCEEEE
T ss_pred EecCccceEEEEecC------cEeEE--ECCeecCCCCEEEEEEEccCCccCCCceEEE
Confidence 987654 57787742 12221 2221223567899999999998888887665
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.52 E-value=4.9e-07 Score=89.64 Aligned_cols=149 Identities=15% Similarity=0.104 Sum_probs=104.2
Q ss_pred HHHHHHhcCCcccceeecCCceEEEEEEeCCCCeEEEEEEccc-CCCChhhhHHHHHHHHhcC-CCCeeeeeeeeeecCe
Q 043702 373 RELRSATKCFNANRIIGHGAFGTVYKGILPQNGDIIAVKRCSH-NSQGKDEFLSELSIIGTLR-HRNLVRLQGWCHEKGE 450 (711)
Q Consensus 373 ~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~-~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~ 450 (711)
.|++..-+.|...+..+-+..+.||+... ++..+.+|+... .......+.+|...+..+. +--+.+++.++..++.
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~ 84 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence 35666667777666554455579998764 566678888765 3334556788999988876 4445677888888889
Q ss_pred EEEEEEcCCCCCHHHHHhhCCCCCChHHHHHHHHHHHHHHHHHHhcc---------------------------------
Q 043702 451 ILLVYDLMPNGSLDKALFEARSPLPWPHRSKILLGVASALAYLHQEC--------------------------------- 497 (711)
Q Consensus 451 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~--------------------------------- 497 (711)
.++|||++++..+.+.... .....+++.++++.|..||+..
T Consensus 85 ~~lv~~~l~G~~~~~~~~~------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEEECCSSEEHHHHTTT------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred eEEEEEecccccccccccc------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 9999999999887654421 1223445555666666666410
Q ss_pred -----------------------CCCeeeccCCCCceEEcCCCcEEEeecCCcee
Q 043702 498 -----------------------ENQVIHRDVKTSNIMLDEGFNARLGDFGLARQ 529 (711)
Q Consensus 498 -----------------------~~~ivHrDlkp~NILld~~~~vkL~DFGla~~ 529 (711)
...++|+|+.|.|||++++..+-|.||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12379999999999999876667999998863
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.82 E-value=1.8e-05 Score=77.40 Aligned_cols=139 Identities=21% Similarity=0.194 Sum_probs=83.9
Q ss_pred eecCCc-eEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCC--CCeeeeeeeeeecCeEEEEEEcCCCCCHH
Q 043702 388 IGHGAF-GTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRH--RNLVRLQGWCHEKGEILLVYDLMPNGSLD 464 (711)
Q Consensus 388 LG~G~f-g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 464 (711)
+..|.. +.||+.... ++..+++|..... ....+..|...++.+.. -.+.+++.++.+++..++|||++++.++.
T Consensus 18 ~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~--~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQ-GRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEECT-TSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCcccCCeEEEEEeC-CCCEEEEEeCCcc--CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 444543 689998774 4667888876543 23467889988888763 33566788888888899999999876542
Q ss_pred H--------------HHhh-C-----CCCCCh--HHHHHHH--------------------HHHHHHHHHHHhcc----C
Q 043702 465 K--------------ALFE-A-----RSPLPW--PHRSKIL--------------------LGVASALAYLHQEC----E 498 (711)
Q Consensus 465 ~--------------~l~~-~-----~~~l~~--~~~~~i~--------------------~~ia~aL~yLH~~~----~ 498 (711)
+ .|.+ + ...+.+ .....-. ......+..+.... .
T Consensus 95 ~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 174 (255)
T d1nd4a_ 95 SSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGED 174 (255)
T ss_dssp TSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCC
T ss_pred cccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccCC
Confidence 2 1100 0 000100 0000000 00112223333221 1
Q ss_pred CCeeeccCCCCceEEcCCCcEEEeecCCcee
Q 043702 499 NQVIHRDVKTSNIMLDEGFNARLGDFGLARQ 529 (711)
Q Consensus 499 ~~ivHrDlkp~NILld~~~~vkL~DFGla~~ 529 (711)
..++|+|+.|.|||++++..+-|+||+.+..
T Consensus 175 ~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 175 LVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp EEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 2489999999999999876678999988753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.51 E-value=0.00021 Score=74.82 Aligned_cols=75 Identities=15% Similarity=0.098 Sum_probs=48.3
Q ss_pred ceeecCCceEEEEEEeCCCCeEEEEEEccc-----C---CCChhhhHHHHHHHHhcC-C--CCeeeeeeeeeecCeEEEE
Q 043702 386 RIIGHGAFGTVYKGILPQNGDIIAVKRCSH-----N---SQGKDEFLSELSIIGTLR-H--RNLVRLQGWCHEKGEILLV 454 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~~~~~~vavK~~~~-----~---~~~~~~~~~Ei~~l~~l~-H--~niv~l~g~~~~~~~~~lV 454 (711)
+.||.|..-.||+.....+++.++||.-.. . ....+....|.+.|+.+. + ..+.+++.+ +....++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 458999999999998877788899996432 1 122344567888888764 2 334455554 34456889
Q ss_pred EEcCCCCC
Q 043702 455 YDLMPNGS 462 (711)
Q Consensus 455 ~Ey~~~gs 462 (711)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.10 E-value=0.0014 Score=66.43 Aligned_cols=134 Identities=18% Similarity=0.203 Sum_probs=81.0
Q ss_pred ceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCe-----eeee--eeeeecCeEEEEEEcCCCCCH--
Q 043702 393 FGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNL-----VRLQ--GWCHEKGEILLVYDLMPNGSL-- 463 (711)
Q Consensus 393 fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~ni-----v~l~--g~~~~~~~~~lV~Ey~~~gsL-- 463 (711)
--.||+.... +|+.+++|+........+++..|+..+..|....+ +..- .....++..+.++++++|..+
T Consensus 35 EN~vy~v~~~-dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDE-DRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCT-TCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcC-CCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 3589999884 68889999987766677889999999888863222 1111 123445678899999976432
Q ss_pred ---HH------HH---hh--------CCCCCCh-------------------HHHHHHHHHHHHHHHHHHhc----cCCC
Q 043702 464 ---DK------AL---FE--------ARSPLPW-------------------PHRSKILLGVASALAYLHQE----CENQ 500 (711)
Q Consensus 464 ---~~------~l---~~--------~~~~l~~-------------------~~~~~i~~~ia~aL~yLH~~----~~~~ 500 (711)
.. .+ +. .+..+++ ..+..+...+.+.++.+... ...+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 11 11 10 0111221 11112222223333333322 2457
Q ss_pred eeeccCCCCceEEcCCCcEEEeecCCcee
Q 043702 501 VIHRDVKTSNIMLDEGFNARLGDFGLARQ 529 (711)
Q Consensus 501 ivHrDlkp~NILld~~~~vkL~DFGla~~ 529 (711)
+||+|+.+.|||++++ ..+.||+-++.
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 9999999999999754 45899998864
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.38 E-value=0.013 Score=58.26 Aligned_cols=157 Identities=15% Similarity=0.089 Sum_probs=86.4
Q ss_pred cCHHHHHHHhcCCccccee-----ecCCceEEEEEEeCCCCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCC-----ee
Q 043702 370 FSYRELRSATKCFNANRII-----GHGAFGTVYKGILPQNGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRN-----LV 439 (711)
Q Consensus 370 ~~~~el~~at~~f~~~~~L-----G~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~n-----iv 439 (711)
.+.+|++...++|...+.. ..|---+.|+.+.. +| .+++|+.... ...+++..|++++..|...+ .+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~-~~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEEC-CC-cEEEEEcCCC-CCHHHHHHHHHHHHhhhhccccccccc
Confidence 4667888888888775543 35555778998874 34 5889987643 23456667888888775322 22
Q ss_pred eee-e--eeeecCeEEEEEEcCCCCCHH-----------HH---Hhh--C--CC-----CCCh-----------------
Q 043702 440 RLQ-G--WCHEKGEILLVYDLMPNGSLD-----------KA---LFE--A--RS-----PLPW----------------- 476 (711)
Q Consensus 440 ~l~-g--~~~~~~~~~lV~Ey~~~gsL~-----------~~---l~~--~--~~-----~l~~----------------- 476 (711)
... | +....+....++.++.+.... .. ++. . .. ...+
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 211 1 122345567777777654321 00 110 0 00 0000
Q ss_pred HHHHHHHHHHHHHHHHHHh-ccCCCeeeccCCCCceEEcCCCcEEEeecCCcee
Q 043702 477 PHRSKILLGVASALAYLHQ-ECENQVIHRDVKTSNIMLDEGFNARLGDFGLARQ 529 (711)
Q Consensus 477 ~~~~~i~~~ia~aL~yLH~-~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~ 529 (711)
......+..+...+.-.+. ....++||+|+.+.||+++.+...-|.||+.+..
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 0111122222222222221 1245899999999999999887778999998853
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.10 E-value=0.013 Score=60.64 Aligned_cols=73 Identities=16% Similarity=0.235 Sum_probs=49.9
Q ss_pred ceeecCCceEEEEEEeCC-------CCeEEEEEEcccCCCChhhhHHHHHHHHhcCCCCe-eeeeeeeeecCeEEEEEEc
Q 043702 386 RIIGHGAFGTVYKGILPQ-------NGDIIAVKRCSHNSQGKDEFLSELSIIGTLRHRNL-VRLQGWCHEKGEILLVYDL 457 (711)
Q Consensus 386 ~~LG~G~fg~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey 457 (711)
+.|+.|-.=.+|+..... ..+.|.+++... .....+..+|..+++.+.-.++ .++++++.+ .+|+||
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef 122 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 122 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence 468888889999988743 235577766553 3334456789999998873344 467777643 688999
Q ss_pred CCCCCH
Q 043702 458 MPNGSL 463 (711)
Q Consensus 458 ~~~gsL 463 (711)
+++..|
T Consensus 123 i~g~~l 128 (395)
T d1nw1a_ 123 IPSRPL 128 (395)
T ss_dssp CCEEEC
T ss_pred eccccC
Confidence 987443
|